PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Buurke, TJW; Lamoth, CJC; van der Woude, LHV; den Otter, AR				Buurke, Tom J. W.; Lamoth, Claud J. C.; van der Woude, Lucas H. V.; den Otter, A. Rob			Synergistic Structure in the Speed Dependent Modulation of Muscle Activity in Human Walking	PLOS ONE			English	Article							HUMAN LOCOMOTION; EMG PROFILES; ACTIVATION PATTERNS; SENSORY FEEDBACK; MOTOR MODULES; GAIT; PROGRESSION; COORDINATION; ADJUSTMENTS; STRATEGIES	Recently, a modular organisation has been proposed to simplify control of the large number of muscles involved in human walking. Although previous research indicates that a single set of modular activation patterns can account for muscle activity at different speeds, these studies only provide indirect evidence for the idea that speed regulation in human walking is under modular control. Here, a more direct approach was taken to assess the synergistic structure that underlies speed regulation, by isolating speed effects through the construction of gain functions that represent the linear relation between speed and amplitude for each point in the time-normalized gait cycle. The activity of 13 muscles in 13 participants was measured at 4 speeds (0.69, 1.00, 1.31, and 1.61 ms(-1)) during treadmill walking. Gain functions were constructed for each of the muscles, and gain functions and the activity patterns at 1.00 ms(-1) were both subjected to dimensionality reduction, to obtain modular gain functions and modular basis functions, respectively. The results showed that 4 components captured most of the variance in the gain functions (74.0% +/- 1.3%), suggesting that the neuromuscular regulation of speed is under modular control. Correlations between modular gain functions and modular basis functions (range 0.58-0.89) and the associated synergistic muscle weightings (range 0.6-0.95) were generally high, suggesting substantial overlap in the synergistic control of the basic phasing of muscle activity and its modulation through speed. Finally, the combined set of modular functions and associated weightings were well capable of predicting muscle activity patterns obtained at a speed (1.31 ms(-1)) that was not involved in the initial dimensionality reduction, confirming the robustness of the presently used approach. Taken together, these findings provide direct evidence of synergistic structure in speed regulation, and may inspire further work on flexibility in the modular control of gait.	[Buurke, Tom J. W.; Lamoth, Claud J. C.; van der Woude, Lucas H. V.; den Otter, A. Rob] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	den Otter, AR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	a.r.den.otter@umcg.nl	van der Woude, Lucas H/E-7986-2018; Buurke, Tom J. W./T-9190-2019; Lamoth, Claudine JC/N-4325-2013	van der Woude, Lucas H/0000-0002-8472-334X; Buurke, Tom J. W./0000-0002-6441-7855; Lamoth, Claudine JC/0000-0002-6495-2823				Bernstein N, 1967, COORDINATION REGULAT; Bizzi E, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00051; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Cavagna GA, 2002, J EXP BIOL, V205, P3413; Cheung VCK, 2005, J NEUROSCI, V25, P6419, DOI 10.1523/JNEUROSCI.4904-04.2005; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; DAVIS BL, 1993, J ELECTROMYOGR KINES, V3, P51, DOI 10.1016/1050-6411(93)90023-P; den Otter AR, 2004, GAIT POSTURE, V19, P270, DOI 10.1016/S0966-6362(03)00071-7; Duysens J, 2000, PHYSIOL REV, V80, P83, DOI 10.1152/physrev.2000.80.1.83; Gizzi L, 2011, J NEUROPHYSIOL, V106, P202, DOI 10.1152/jn.00727.2010; Gonzalez-Vargas J, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00114; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Hof AL, 2005, GAIT POSTURE, V21, P171, DOI 10.1016/j.gaitpost.2004.01.015; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Honeine JL, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.229; Honeine JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052943; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Lacquaniti F, 2012, J PHYSIOL-LONDON, V590, P2189, DOI 10.1113/jphysiol.2011.215137; Latash ML, 2012, EXP BRAIN RES, V217, P1, DOI 10.1007/s00221-012-3000-4; MacLellan MJ, 2014, J NEUROPHYSIOL, V111, P1541, DOI 10.1152/jn.00437.2013; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Martino G, 2015, J NEUROPHYSIOL, V114, P2867, DOI 10.1152/jn.00029.2015; MURRAY M P, 1984, Journal of Orthopaedic Research, V2, P272, DOI 10.1002/jor.1100020309; Nene A, 1999, GAIT POSTURE, V9, P1, DOI 10.1016/S0966-6362(98)00042-3; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Neptune RR, 2009, J BIOMECH, V42, P1282, DOI 10.1016/j.jbiomech.2009.03.009; Neptune RR, 2004, GAIT POSTURE, V19, P194, DOI 10.1016/S0966-6362(03)00062-6; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; NILSSON J, 1985, ACTA PHYSIOL SCAND, V123, P457, DOI 10.1111/j.1748-1716.1985.tb07612.x; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Perotto A, 2011, ANATOMICAL GUIDE ELE; Perry J., 1992, GAIT ANAL NORMAL PAT; Ranganathan R, 2012, J NEUROPHYSIOL, V108, P1537, DOI 10.1152/jn.01112.2011; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Safavynia Seyed A, 2011, Top Spinal Cord Inj Rehabil, V17, P16; Sartori M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00079; Shiavi R, 1987, J Rehabil Res Dev, V24, P13; Sinkjaer T, 2000, J PHYSIOL-LONDON, V523, P817, DOI 10.1111/j.1469-7793.2000.00817.x; Tang PF, 1998, EXP BRAIN RES, V119, P141, DOI 10.1007/s002210050327; Turvey MT, 2007, HUM MOVEMENT SCI, V26, P657, DOI 10.1016/j.humov.2007.04.002; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053; YANG JF, 1985, ELECTROEN CLIN NEURO, V60, P485, DOI 10.1016/0013-4694(85)91108-3; Zelik KE, 2014, J NEUROPHYSIOL, V111, P1686, DOI 10.1152/jn.00776.2013	45	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152784	10.1371/journal.pone.0152784	http://dx.doi.org/10.1371/journal.pone.0152784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035131	Green Published, gold			2022-12-26	WOS:000373201200039
J	Joly, S; Rhea, L; Volk, P; Moreland, JG; Dunnwald, M				Joly, Sophie; Rhea, Lindsey; Volk, Paige; Moreland, Jessica G.; Dunnwald, Martine			Interferon Regulatory Factor 6 Has a Protective Role in the Host Response to Endotoxic Shock	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; KERATINOCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; ADAPTIVE IMMUNITY; WOUDE-SYNDROME; IRF6; EXPRESSION; MIGRATION; VAN; PHAGOCYTOSIS	Interferon Regulatory Factor (IRF) 6, a member of the IRF family, is essential for epidermal and orofacial embryonic development. Irf6 is strongly expressed in keratinocytes, in which it regulates epidermal proliferation, differentiation, and migration. A recent role for Irf6 in Tolllike receptor 2-dependent chemokine gene expression was also reported in an epithelial cell line. However, a function for Irf6 in innate immune cells was not previously reported. In the present study, we investigated the expression and function of Irf6 in bone marrow-derived neutrophils and macrophages. We show here, using a conditional knockout of Irf6 in lysosymeM expressing cells, that Irf6 is required for resistance to LPS-induced endotoxic shock. In addition, Irf6-deficient bone marrow-derived neutrophils exhibited increased chemotactic index and velocity compared with wild-type cells in vitro. TLR4-specific KC and IL6 secretions were upregulated in Irf6-deficient bone marrow-derived macrophages in vitro. These cells also exhibited an increased level of phosphorylated IkBa. Collectively, our findings suggest a role for Irf6 in the resistance to endotoxic shock due to NFk-B-mediated alteration of cytokine production.	[Joly, Sophie] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Rhea, Lindsey; Volk, Paige; Moreland, Jessica G.; Dunnwald, Martine] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Rhea, Lindsey] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA	University of Iowa; University of Iowa; United States Department of the Interior; United States Geological Survey	Dunnwald, M (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	martine-dunnwald@uiowa.edu			National Institutes of Health [AR0615086, AR067731]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067731, R03AR061586, R01AR067739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funds from the National Institutes of Health (AR0615086 and AR067731 to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bailey CM, 2009, DEV GROWTH DIFFER, V51, P473, DOI 10.1111/j.1440-169X.2009.01110.x; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Biggs LC, 2014, J CELL SCI, V127, P2840, DOI 10.1242/jcs.139246; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Biswas PS, 2010, IMMUNOL REV, V233, P79, DOI 10.1111/j.0105-2896.2009.00864.x; Descargues P, 2008, EMBO J, V27, P2639, DOI 10.1038/emboj.2008.196; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jones JLP, 2010, J CRANIOFAC SURG, V21, P1350, DOI 10.1097/SCS.0b013e3181ec6aad; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Kwa MQ, 2014, J BIOL CHEM, V289, P31077, DOI 10.1074/jbc.M114.589382; Kwa MQ, 2014, J BIOL CHEM, V289, P19758, DOI 10.1074/jbc.M114.584540; Leslie EJ, 2015, AM J MED GENET A, V167, P545, DOI 10.1002/ajmg.a.36896; Li P, 2011, BLOOD, V117, P2847, DOI 10.1182/blood-2010-07-294272; Lin Y, 2015, CELLULAR MOL NEUROBI; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Slattery ML, 2011, CARCINOGENESIS; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/shk.0b013e318157ee55, 10.1097/SHK.0b013e318157ee55]; Volk APD, 2008, J BIOL CHEM, V283, P34315, DOI 10.1074/jbc.M803141200; Young RE, 2004, J IMMUNOL, V172, P4493, DOI 10.4049/jimmunol.172.7.4493; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152385	10.1371/journal.pone.0152385	http://dx.doi.org/10.1371/journal.pone.0152385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035130	gold, Green Published			2022-12-26	WOS:000373201200015
J	Kosinova, L; Cahova, M; Fabryova, E; Tycova, I; Koblas, T; Leontovyc, I; Saudek, F; Kriz, J				Kosinova, Lucie; Cahova, Monika; Fabryova, Eva; Tycova, Irena; Koblas, Tomas; Leontovyc, Ivan; Saudek, Frantisek; Kriz, Jan			Unstable Expression of Commonly Used Reference Genes in Rat Pancreatic Islets Early after Isolation Affects Results of Gene Expression Studies	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME; HOUSEKEEPING GENES; RIBOSOMAL-RNA; RT-PCR; NORMALIZATION; VALIDATION; STRESS; TRANSPLANTATION; INAPPROPRIATE	The use of RT-qPCR provides a powerful tool for gene expression studies; however, the proper interpretation of the obtained data is crucially dependent on accurate normalization based on stable reference genes. Recently, strong evidence has been shown indicating that the expression of many commonly used reference genes may vary significantly due to diverse experimental conditions. The isolation of pancreatic islets is a complicated procedure which creates severe mechanical and metabolic stress leading possibly to cellular damage and alteration of gene expression. Despite of this, freshly isolated islets frequently serve as a control in various gene expression and intervention studies. The aim of our study was to determine expression of 16 candidate reference genes and one gene of interest (F3) in isolated rat pancreatic islets during short-term cultivation in order to find a suitable endogenous control for gene expression studies. We compared the expression stability of the most commonly used reference genes and evaluated the reliability of relative and absolute quantification using RT-qPCR during 0-120 hrs after isolation. In freshly isolated islets, the expression of all tested genes was markedly depressed and it increased several times throughout the first 48 hrs of cultivation. We observed significant variability among samples at 0 and 24 hrs but substantial stabilization from 48 hrs onwards. During the first 48 hrs, relative quantification failed to reflect the real changes in respective mRNA concentrations while in the interval 48-120 hrs, the relative expression generally paralleled the results determined by absolute quantification. Thus, our data call into question the suitability of relative quantification for gene expression analysis in pancreatic islets during the first 48 hrs of cultivation, as the results may be significantly affected by unstable expression of reference genes. However, this method could provide reliable information from 48 hrs onwards.	[Kosinova, Lucie; Fabryova, Eva; Koblas, Tomas; Leontovyc, Ivan; Saudek, Frantisek] Inst Clin & Expt Med, Ctr Med Expt, Lab Pancreat Islets, Prague, Czech Republic; [Kosinova, Lucie] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Cahova, Monika] Inst Clin & Expt Med, Ctr Med Expt, Dept Metab & Diabet, Prague, Czech Republic; [Tycova, Irena] Inst Clin & Expt Med, Transplant Lab, Ctr Med Expt, Prague, Czech Republic; [Saudek, Frantisek; Kriz, Jan] Inst Clin & Expt Med, Ctr Diabet, Dept Diabet, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM)	Kosinova, L (corresponding author), Inst Clin & Expt Med, Ctr Med Expt, Lab Pancreat Islets, Prague, Czech Republic.; Kosinova, L (corresponding author), Charles Univ Prague, Fac Med 1, Prague, Czech Republic.; Kriz, J (corresponding author), Inst Clin & Expt Med, Ctr Diabet, Dept Diabet, Prague, Czech Republic.	kosl@ikem.cz; jkri@ikem.cz	Kosinová, Lucie/AAW-8533-2021; Cahova, Monika/Z-1568-2018; Kriz, Jan/G-1067-2019; Saudek, František/E-1975-2018	Cahova, Monika/0000-0003-2640-5084; Kriz, Jan/0000-0001-7695-3885; Saudek, František/0000-0002-0448-4351; Kosinova, Lucie/0000-0001-5837-5508	Czech Science Foundation (CSF) [14-03305S]; Grant Agency of the Charles University in Prague [GA UK 108214]; Ministry of Health (MHCZ-IGA) [NT13099-4]; Ministry of Health (MH CR-DRO Institute for Clinical and Experimental Medicine - IKEM) [IN 00023001]	Czech Science Foundation (CSF); Grant Agency of the Charles University in Prague; Ministry of Health (MHCZ-IGA); Ministry of Health (MH CR-DRO Institute for Clinical and Experimental Medicine - IKEM)	J.K. was supported by the Czech Science Foundation (CSF #14-03305S), http://gacr.cz/; L.K. was supported by the Grant Agency of the Charles University in Prague (GA UK 108214), http://www.cuni.cz/UK-33.html; F.S. was supported by the Ministry of Health (MHCZ-IGA #NT13099-4), http://www.mzcr.cz/; M.C. was supported by Ministry of Health (MH CR-DRO Institute for Clinical and Experimental Medicine - IKEM, IN 00023001), http://www.mzcr.cz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Gorzelniak K, 2001, HORM METAB RES, V33, P625, DOI 10.1055/s-2001-17911; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ihm SH, 2009, TRANSPL INT, V22, P207, DOI 10.1111/j.1432-2277.2008.00769.x; Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357; Karge W H 3rd, 1998, Methods Mol Biol, V110, P43; Kriz J, 2008, TRANSPL P, V40, P444, DOI 10.1016/j.transproceed.2008.02.018; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Marzorati S, 2006, AM J TRANSPLANT, V6, P2791, DOI 10.1111/j.1600-6143.2006.01512.x; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Pileggi A, 2001, CLIN CHIM ACTA, V310, P3, DOI 10.1016/S0009-8981(01)00503-4; Planas R, 2010, CLIN EXP IMMUNOL, V159, P23, DOI 10.1111/j.1365-2249.2009.04053.x; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Rodriguez-Mulero S, 2005, TRANSPLANTATION, V80, P650, DOI 10.1097/01.tp.0000173790.12227.7b; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tang C, 2012, DIABETOLOGIA, V55, P1366, DOI 10.1007/s00125-012-2474-8; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Turabelidze A, 2010, WOUND REPAIR REGEN, V18, P460, DOI 10.1111/j.1524-475X.2010.00611.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasir B, 1998, DIABETES, V47, P1894, DOI 10.2337/diabetes.47.12.1894; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Zhan C, 2014, ACTA BIOCH BIOPH SIN, V46, P330, DOI 10.1093/abbs/gmt153	31	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152664	10.1371/journal.pone.0152664	http://dx.doi.org/10.1371/journal.pone.0152664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035827	gold, Green Submitted, Green Published			2022-12-26	WOS:000373201200029
J	Zhao, X; Liu, CM; Xu, MJ; Li, XL; Bi, KS; Jia, Y				Zhao, Xu; Liu, Chunmei; Xu, Mengjie; Li, Xiaolong; Bi, Kaishun; Jia, Ying			Total Lignans of Schisandra chinensis Ameliorates A beta(1-42)-Induced Neurodegeneration with Cognitive Impairment in Mice and Primary Mouse Neuronal Cells	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE BRAIN; BETA-PROTEIN; ANTIOXIDANT THERAPY; LIPID-PEROXIDATION; OXIDATIVE STRESS; RATS; NEUROPATHOLOGY; HYPOTHESIS; MICROGLIA	Lignan compounds extracted from Schisandra chinensis (Turcz.) Baill. have been reported to possess various biological activities, and have potential in the treatment of Alzheimer's disease. This study was designed to investigate the effects of total lignans of Schisandra chinensis (TLS) on cognitive function and neurodegeneration in the model of AD induced by A beta(1-42) in vivo and in vitro. It was found that intragastric infusion with TLS (50 and 200 mg/kg) to A beta(1-42)-induced mice significantly increased the number of avoidances in the shuttle-box test and swimming time in the target quadrant in the Morris water maze test. TLS at dose of 200 mg/kg significantly restored the activities of total antioxidant capacity (T-AOC), as well as the level of malondialdehyde (MDA) both in the hippocampus and cerebral cortex in mice. Results of histopathological examination indicated that TLS noticeably ameliorated the neurodegeneration in the hippocampus in mice. On the other hand, TLS (100 mu M) could protect the A beta(1-42)-induced primary mouse neuronal cells by blocking the decrease of mitochondrial membrane potential (MMP), change the expressions of Bcl-2 (important regulator in the mitochondria apoptosis pathway). Moreover, TLS also decreased the activity of beta-secretase 1 (BACE1), crucial protease contributes to the hydrolysis of amyloid precursor protein (APP), and inhibited the expression of JKN/p38, which involved in the MAPKs signaling pathways in both mice and primary mouse neuronal cells. In summary, TLS might protect against cognitive deficits and neurodegeneration by releasing the damage of oxidative stress, inhibiting the expression of BACE1 and the MAPKs inflammatory signaling pathways.	[Zhao, Xu; Liu, Chunmei; Xu, Mengjie; Li, Xiaolong; Jia, Ying] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Wenhua Rd 103, Shenyang 110016, Peoples R China; [Bi, Kaishun] Shenyang Pharmaceut Univ, Sch Pharm, Wenhua Rd 103, Shenyang 110016, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Jia, Y (corresponding author), Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Wenhua Rd 103, Shenyang 110016, Peoples R China.	jiayingsyphu@126.com	Li, xiaolong/GRS-9148-2022					Ahmad M, 2005, J NEUROCHEM, V93, P94, DOI 10.1111/j.1471-4159.2005.03000.x; Ahmed T, 2010, NEUROSCIENCE, V169, P1296, DOI 10.1016/j.neuroscience.2010.05.078; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Chauhan Ved, 2006, Pathophysiology, V13, P195, DOI 10.1016/j.pathophys.2006.05.004; Cho Jae-Young, 2005, Prog Neuropsychopharmacol Biol Psychiatry, V29, P901, DOI 10.1016/j.pnpbp.2005.04.022; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; dos Santos VV, 2013, BEHAV BRAIN RES, V244, P107, DOI 10.1016/j.bbr.2013.01.039; Ellis JM, 2005, J AM OSTEOPATH ASSOC, V105, P145; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hu D, 2014, PHYTOCHEMISTRY, V104, P72, DOI 10.1016/j.phytochem.2014.04.014; Jeong EJ, 2013, J ETHNOPHARMACOL, V146, P347, DOI 10.1016/j.jep.2013.01.003; Jin SL, 2012, FOOD CHEM TOXICOL, V50, P3814, DOI 10.1016/j.fct.2012.07.046; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lee JK, 2013, IMMUNOLOGY, V140, P288, DOI 10.1111/imm.12133; Lee TH, 2012, FOOD CHEM TOXICOL, V50, P4239, DOI 10.1016/j.fct.2012.08.047; Li JE, 2013, INT IMMUNOPHARMACOL, V17, P267, DOI 10.1016/j.intimp.2013.05.033; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUGGE A, 1991, AM J PHYSIOL, V260, pC219, DOI 10.1152/ajpcell.1991.260.2.C219; Nagakannan P, 2012, J ETHNOPHARMACOL, V140, P247, DOI 10.1016/j.jep.2012.01.012; Ohno M, 2014, NEUROBIOL AGING, V35, P213, DOI 10.1016/j.neurobiolaging.2013.07.014; Park EJ, 2012, BIOCHEM PHARMACOL, V83, P378, DOI 10.1016/j.bcp.2011.11.002; Park SY, 2013, INT IMMUNOPHARMACOL, V17, P415, DOI 10.1016/j.intimp.2013.06.032; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; PRICE DL, 1994, ANNU REV MED, V45, P435; Ramin M, 2011, BEHAV BRAIN RES, V217, P424, DOI 10.1016/j.bbr.2010.11.017; Salminen A, 2013, PROG NEUROBIOL, V106, P33, DOI 10.1016/j.pneurobio.2013.06.002; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Shah RS, 2008, BIOMED PHARMACOTHER, V62, P199, DOI 10.1016/j.biopha.2008.02.005; SLATER TF, 1984, METHOD ENZYMOL, V105, P283; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang CM, 2013, PHARMACOL BIOCHEM BE, V106, P57, DOI 10.1016/j.pbb.2013.03.010	42	24	25	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152772	10.1371/journal.pone.0152772	http://dx.doi.org/10.1371/journal.pone.0152772			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035824	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200037
J	Jamal, WY; Albert, MJ; Rotimi, VO				Jamal, Wafaa Y.; Albert, M. John; Rotimi, Vincent O.			High Prevalence of New Delhi Metallo-beta-Lactamase-1 (NDM-1) Producers among Carbapenem-Resistant Enterobacteriaceae in Kuwait	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; NDM-1-PRODUCING KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; GLOBAL SPREAD; EMERGENCE; SPECTRUM; OXA-48; ASSOCIATION; INFECTIONS	The aim of the study was to determine the prevalence of New Delhi metallo-beta lactamase-1 (NDM-1) producing Enterobacteriaceae in Kuwait over a one year period. Consecutive Enterobacteriaceae isolates with reduced susceptibility to carbapenems were collected from four government hospitals in Kuwait from January-December 2014. Their susceptibility to 18 antibiotics was performed by determining the minimum inhibitory concentration. Isolates resistant to carbapenems were tested by PCR for resistant genes. Finger printing of the positive isolates was done by DiversiLab (R). Clinical data of patients harboring NDM-1 positive isolates were analyzed. A total of 764 clinically significant Enterobacteriaceae isolates were studied. Of these, 61 (8%) were carbapenem-resistant. Twenty one out of these 61 (34.4%) were NDM-1-producers. All patients positive for NDM-1-carrying bacteria were hospitalized. About half were females (11/21 [52.3%]), average age was 53.3 years and the majority were Kuwaitis (14/21 [66.6%]). Six patients (28.5%) gave a history of travel or healthcare contact in an endemic area. Mortality rate was relatively high (28.6%). The predominant organism was Klebsiella pneumoniae (14 [66.6%]) followed by E. coli (4 [19%]). All NDM-1-positive isolates were resistant to meropenem, ertapenem, cefotaxime, cefoxitin and ampicillin, while 95.2% were resistant to imipenem, cefepime, and piperacillin-tazobactam. They were multidrug resistant including resistance to tigecycline, but 90% remained susceptible to colistin. About two-thirds of isolates (61.9%) co-produced-extended spectrum beta-lactamases. During the study period, an outbreak of NDM-1 positive K. pneumoniae occurred in one hospital involving 3 patients confirmed by DiversiLab (R) analysis. In conclusion, NDM-1-producing Enterobacteriaceae is a growing healthcare problem with increasing prevalence in Kuwait, especially in hospitalized patients, leaving few therapeutic options. A high prevalence of NDM-1 necessitates the implementation of strict infection control to prevent the spread of these organisms.	[Jamal, Wafaa Y.] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait; Mubarak Al Kabir Hosp, Microbiol Unit, Jabriya, Kuwait	Kuwait University; Mubarak Al-Kabeer Hospital	Jamal, WY (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	wjamal@hsc.edu.kw			Kuwait University Research grant [MI06/10]	Kuwait University Research grant	This work was supported by the Kuwait University Research grant number MI06/10. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Sweih N, 2005, MED PRIN PRACT, V14, P401, DOI 10.1159/000088113; Baroud M, 2013, INT J ANTIMICROB AG, V41, P75, DOI 10.1016/j.ijantimicag.2012.08.010; Bathoorn E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.42.20610; Ben Nasr A, 2013, ANTIMICROB AGENTS CH, V57, P4089, DOI 10.1128/AAC.00536-13; CDC, 2013, ANTIBIOTIC RESISTANC; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Dortet L, 2015, ANTIMICROB AGENTS CH, V59, P7420, DOI 10.1128/AAC.01636-15; Fluit AC, 2010, J CLIN MICROBIOL, V48, P3979, DOI 10.1128/JCM.01191-10; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Gharout-Sait A, 2014, J MED MICROBIOL, V63, P1316, DOI 10.1099/jmm.0.073767-0; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Hidalgo L, 2013, J ANTIMICROB CHEMOTH, V68, P1543, DOI 10.1093/jac/dkt078; Jain A, 2014, J ANTIMICROB CHEMOTH, V69, P1777, DOI 10.1093/jac/dku084; Jamal W, 2012, INT J ANTIMICROB AG, V39, P183, DOI 10.1016/j.ijantimicag.2011.10.002; Jamal W, 2013, J MED MICROBIOL, V62, P1239, DOI 10.1099/jmm.0.059915-0; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lachish T, 2012, INT J ANTIMICROB AG, V40, P566, DOI 10.1016/j.ijantimicag.2012.07.011; Lukinmaa-Aberg S, 2013, FOODBORNE PATHOG DIS, V10, P632, DOI 10.1089/fpd.2012.1411; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Nordmann P, 2012, CLIN INFECT DIS, V54, P150, DOI 10.1093/cid/cir720; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V67, P2860, DOI 10.1093/jac/dks299; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Poirel L, 2014, ANTIMICROB AGENTS CH, V58, P2929, DOI 10.1128/AAC.02047-13; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P2781, DOI 10.1093/jac/dkr384; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Rotimi VO, 2008, J MED MICROBIOL, V57, P881, DOI 10.1099/jmm.0.47509-0; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Struelens M.J., 2010, EUROSURVEILLANCE, V15, P15; US Centers for Disease Control and Prevention (CDC), 2015, FAC GUID CONTR CARB; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zowawi HM, 2014, ANTIMICROB AGENTS CH, V58, P3085, DOI [10.1128/AAC.02050-13, 10.1128/AAC.]	35	57	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152638	10.1371/journal.pone.0152638	http://dx.doi.org/10.1371/journal.pone.0152638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031521	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800106
J	Klooster, J; Kamermans, M				Klooster, Jan; Kamermans, Maarten			An Ultrastructural and Immunohistochemical Analysis of the Outer Plexiform Layer of the Retina of the European Silver Eel (Anguilla anguilla L)	PLOS ONE			English	Article							CELL INPUT MECHANISMS; HORIZONTAL CELLS; BIPOLAR CELLS; RECEPTOR SUBUNITS; VISUAL PIGMENTS; AMPA RECEPTORS; CYPRINID FISH; GIANT DANIO; GLUTAMATE; EXPRESSION	Here we studied the ultrastructural organization of the outer retina of the European silver eel, a highly valued commercial fish species. The retina of the European eel has an organization very similar to most vertebrates. It contains both rod and cone photoreceptors. Rods are abundantly present and immunoreactive for rhodopsin. Cones are sparsely present and only show immunoreactivity for M-opsin and not for L-, S- or UV-cone opsins. As in all other vertebrate retinas, Muller cells span the width of the retina. OFF-bipolar cells express the ionotropic glutamate receptor GluR4 and ON-bipolar cells, as identified by their PKCa immunoreactivity, express the metabotropic receptor mGluR6. Both the ON- and the OFF-bipolar cell dendrites innervate the cone pedicle and rod spherule. Horizontal cells are surrounded by punctate Cx53.8 immunoreactivity indicating that the horizontal cells are strongly electrically coupled by gap-junctions. Connexin-hemichannels were found at the tips of the horizontal cell dendrites invaginating the photoreceptor synapse. Such hemichannels are implicated in the feedback pathway from horizontal cells to cones. Finally, horizontal cells are surrounded by tyrosine hydroxylase immunoreactivity, illustrating a strong dopaminergic input from interplexiform cells.	[Klooster, Jan; Kamermans, Maarten] Netherlands Inst Neurosci, Retinal Signal Proc Lab, Amsterdam, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam	Kamermans, M (corresponding author), Netherlands Inst Neurosci, Retinal Signal Proc Lab, Amsterdam, Netherlands.; Kamermans, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.kamermans@nin.knaw.nl						Aoyama Jun, 2009, Aqua-Bioscience Monographs, V2, P1; BALDRIDGE WH, 1987, J COMP NEUROL, V265, P428, DOI 10.1002/cne.902650310; Bowmaker JK, 2008, VISUAL NEUROSCI, V25, P249, DOI 10.1017/S0952523808080152; BRAEKEVELT CR, 1988, ANAT ANZEIGER, V167, P1; Cheng CL, 2007, VISUAL NEUROSCI, V24, P269, DOI 10.1017/S0952523807070137; Cheng CL, 2007, J EXP BIOL, V210, P4123, DOI 10.1242/jeb.009217; Connaughton VP, 2000, J PHYSIOL-LONDON, V524, P135, DOI 10.1111/j.1469-7793.2000.t01-1-00135.x; Cottrill PB, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-71; Damjanovic I, 2005, ANN NY ACAD SCI, V1048, P69, DOI 10.1196/annals.1342.007; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DJAMGOZ MBA, 1988, PROC R SOC SER B-BIO, V235, P281, DOI 10.1098/rspb.1988.0076; DOWNING JEG, 1989, J COMP NEUROL, V289, P537, DOI 10.1002/cne.902890402; Endeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068540; GORDON J, 1978, J GEN PHYSIOL, V71, P123, DOI 10.1085/jgp.71.2.123; Grant GB, 1996, J NEUROPHYSIOL, V76, P3842, DOI 10.1152/jn.1996.76.6.3842; Haverkamp S, 2001, J NEUROSCI, V21, P2488, DOI 10.1523/JNEUROSCI.21-07-02488.2001; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; Huang H, 2004, BRAIN RES, V1002, P86, DOI 10.1016/j.brainres.2003.12.019; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035256; Janssen-Bienhoid U, 2009, J COMP NEUROL, V513, P363, DOI 10.1002/cne.21965; Janssen-Bienhold U, 2001, Prog Brain Res, V131, P93; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; KAMERMANS M, 1995, PROG RETIN EYE RES, V14, P313, DOI 10.1016/1350-9462(94)00003-2; Klaassen LJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001107; Klooster J, 2001, J COMP NEUROL, V441, P155, DOI 10.1002/cne.1404; Klooster J, 2011, INVEST OPHTH VIS SCI, V52, P8356, DOI 10.1167/iovs.11-7575; Klooster J, 2009, J CHEM NEUROANAT, V37, P254, DOI 10.1016/j.jchemneu.2009.02.004; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Li YN, 2009, J COMP NEUROL, V516, P442, DOI 10.1002/cne.22135; LYTHGOE JN, 1984, VISION RES, V24, P1539, DOI 10.1016/S0042-6989(84)80003-6; Morigiwa K, 1999, J COMP NEUROL, V405, P173, DOI 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L; PANKHURST NW, 1982, J FISH BIOL, V21, P127, DOI 10.1111/j.1095-8649.1982.tb03994.x; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Rousseau K, 2009, METAMORPHOSIS FISH; Rousseau K, 2012, SPAWNING MIGRATION E, P39; Schultz K, 1997, J NEUROCYTOL, V26, P651, DOI 10.1023/A:1018597811439; Schultz K, 2001, J COMP NEUROL, V435, P433, DOI 10.1002/cne.1042; Shields CR, 2007, J COMP NEUROL, V501, P765, DOI 10.1002/cne.21282; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; STELL WK, 1967, AM J ANAT, V121, P401, DOI 10.1002/aja.1001210213; SUZUKI S, 1990, VISUAL NEUROSCI, V5, P223, DOI 10.1017/S0952523800000298; Tesch F-W, 1977, EEL BIOL MANAGEMENT, P68; van Ginneken VJT, 2005, REV FISH BIOL FISHER, V15, P367, DOI 10.1007/s11160-006-0005-8; VANDENPOL AN, 1986, J COMP NEUROL, V252, P507, DOI 10.1002/cne.902520407; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Vroman R, 2015, J PHYSIOL-LONDON, V593, P2927, DOI 10.1113/JP270158; Vroman R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00612; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong KY, 2005, J NEUROPHYSIOL, V93, P84, DOI 10.1152/jn.00259.2004; Wong KY, 2005, J NEUROPHYSIOL, V93, P94, DOI 10.1152/jn.00270.2004; WOOD P, 1992, J FISH BIOL, V41, P601, DOI 10.1111/j.1095-8649.1992.tb02686.x; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yazulla S, 1999, J NEUROCYTOL, V28, P63, DOI 10.1023/A:1007015801586	53	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152967	10.1371/journal.pone.0152967	http://dx.doi.org/10.1371/journal.pone.0152967			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032102	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800161
J	Ramadona, AL; Lazuardi, L; Hii, YL; Holmner, A; Kusnanto, H; Rocklov, J				Ramadona, Aditya Lia; Lazuardi, Lutfan; Hii, Yien Ling; Holmner, Asa; Kusnanto, Hari; Rocklov, Joacim			Prediction of Dengue Outbreaks Based on Disease Surveillance and Meteorological Data	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; TRANSMISSION; CLIMATE; BURDEN	Research is needed to create early warnings of dengue outbreaks to inform stakeholders and control the disease. This analysis composes of a comparative set of prediction models including only meteorological variables; only lag variables of disease surveillance; as well as combinations of meteorological and lag disease surveillance variables. Generalized linear regression models were used to fit relationships between the predictor variables and the dengue surveillance data as outcome variable on the basis of data from 2001 to 2010. Data from 2011 to 2013 were used for external validation purposed of prediction accuracy of the model. Model fit were evaluated based on prediction performance in terms of detecting epidemics, and for number of predicted cases according to RMSE and SRMSE, as well as AIC. An optimal combination of meteorology and autoregressive lag terms of dengue counts in the past were identified best in predicting dengue incidence and the occurrence of dengue epidemics. Past data on disease surveillance, as predictor alone, visually gave reasonably accurate results for outbreak periods, but not for non-outbreaks periods. A combination of surveillance and meteorological data including lag patterns up to a few years in the past showed most predictive of dengue incidence and occurrence in Yogyakarta, Indonesia. The external validation showed poorer results than the internal validation, but still showed skill in detecting outbreaks up to two months ahead. Prior studies support the fact that past meteorology and surveillance data can be predictive of dengue. However, to a less extent has prior research shown how the longer-term past disease incidence data, up to years, can play a role in predicting outbreaks in the coming years, possibly indicating cross-immunity status of the population.	[Ramadona, Aditya Lia; Hii, Yien Ling; Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Umea, Sweden; [Ramadona, Aditya Lia; Kusnanto, Hari] Univ Gadjah Mada, Ctr Environm Studies, Yogyakarta, Indonesia; [Lazuardi, Lutfan; Kusnanto, Hari] Univ Gadjah Mada, Fac Med, Dept Publ Hlth, Yogyakarta, Indonesia; [Holmner, Asa] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Gadjah Mada University; Gadjah Mada University; Umea University	Ramadona, AL (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Umea, Sweden.; Ramadona, AL (corresponding author), Univ Gadjah Mada, Ctr Environm Studies, Yogyakarta, Indonesia.	alramadona@ugm.ac.id	Lazuardi, Lutfan/K-6812-2019; Ramadona, Aditya L/M-2677-2013; Ramadona, Aditya Lia/N-1518-2019	Lazuardi, Lutfan/0000-0001-5146-8162; Ramadona, Aditya L/0000-0003-0968-988X; Ramadona, Aditya Lia/0000-0003-0968-988X; Rocklov, Joacim/0000-0003-4030-0449	Swedish Research Councils Swedish Research Links Program [348-2013-6692]; Umea Centre for Global Health Research from The Swedish Council for Working Life and Social Research [20061512]	Swedish Research Councils Swedish Research Links Program; Umea Centre for Global Health Research from The Swedish Council for Working Life and Social Research	The authors acknowledge the financial support from the Swedish Research Councils Swedish Research Links Program (grant no. 348-2013-6692), and the Umea Centre for Global Health Research with support from The Swedish Council for Working Life and Social Research (grant no. 20061512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN SR, 1978, T I BRIT GEOGR, V3, P476, DOI 10.2307/622125; Anastuti RA, 2013, THESIS U GADJAH MADA; Arcari P, 2007, SINGAPORE J TROP GEO, V28, P251, DOI 10.1111/j.1467-9493.2007.00300.x; Azad S, 2014, J VECTOR DIS, V51, P165; Badan Lingkungan Hidup, 2012, STAT LINGK HID DAER; Banu S, 2014, ENVIRON INT, V63, P137, DOI 10.1016/j.envint.2013.11.002; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Dieng Hamady, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P228, DOI 10.1016/S2221-1691(12)60047-1; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Handoko D, 2011, MODUL PENGENDALIAN D; Hii YL, 2009, GLOBAL HEALTH ACTION, V2, P124, DOI 10.3402/gha.v2i0.2036; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001848; Indriani C, 2011, BER KEDOKT MASY, V27, P41; IRI, 2014, EM EL NIN COND NOT G; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Juffrie M, 2009, BERKALA ILMU KEDOKTE, V41, P134; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; OhAinle M, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P229, DOI 10.1079/9781845939649.0229; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Perkins TA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P99, DOI 10.1079/9781845939649.0099; Promprou S, 2005, DENGUE B, V29; R Core Team, 2013, R LANG ENV STAT COMP; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Rodriguez-Roche R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/690835; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Stahl HC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1048; Suhail Jeelani, 2013, International Journal of Current Microbiology and Applied Sciences, V2, P313; Widiarti, 2011, BUL PENELIT KESEHAT, V39, P176; Wiwanitkit V., 2014, Asian Pacific Journal of Tropical Disease, V4, P67; Wongkoon S, 2013, TROP BIOMED, V30, P631; Wongkoon S, 2013, INDIAN J MED RES, V138, P347; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World health organization, 2013, WORLD HLTH STAT 2013; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT	39	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152688	10.1371/journal.pone.0152688	http://dx.doi.org/10.1371/journal.pone.0152688			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031524	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800116
J	Choi, JI; Wang, CJ; Thomas, MJ; Pitt, GS				Choi, Jong-Il; Wang, Chaojian; Thomas, Matthew J.; Pitt, Geoffrey S.			alpha 1-Syntrophin Variant Identified in Drug-Induced Long QT Syndrome Increases Late Sodium Current	PLOS ONE			English	Article							FACTOR HOMOLOGOUS FACTORS; SARCOLEMMAL CALCIUM-PUMP; NITRIC-OXIDE SYNTHASE; CARDIAC-ARRHYTHMIA; HEART-FAILURE; CHANNEL; MUTATION; COMPLEX; REPOLARIZATION; PROTEIN	Drug-induced long-QT syndrome (diLQTS) is often due to drug block of I-Kr, especially in genetically susceptible patients with subclinical mutations in the I-Kr-encoding KCHN2. Few variants in the cardiac Na(V)1.5 Na+ channel complex have been associated with diLQTS. We tested whether a novel SNTA1 (alpha 1-syntrophin) variant (p.E409Q) found in a patient with diLQTS increases late sodium current (INa-L), thereby providing a disease mechanism. Electrophysiological studies were performed in HEK293T cells co-expressing human Na(V)1.5/nNOS/PMCA4b with either wild type (WT) or SNTA1 variants (A390V-previously reported in congenital LQTS; and E409Q); and in adult rat ventricular cardiomyocytes infected with SNTA1 expressing adenoviruses (WT or one of the two SNTA1 variants). In HEK293T cells and in cardiomyocytes, there was no significant difference in the peak I-Na densities among the SNTA1 WT and variants. However, both variants increased INa-L (% of peak current) in HEK293T cells (0.58 +/- 0.10 in WT vs. 0.90 +/- 0.11 in A390V, p = 0.048; vs. 0.88 +/- 0.07 in E409Q, p = 0.023). In cardiomyocytes, INa-L was significantly increased by E409Q, but not by A390V compared to WT (0.49 +/- 0.14 in WT vs. 0.94 +/- 0.23 in A390V, p = 0.099; vs. 1.12 +/- 0.24 in E409Q, p = 0.019). We demonstrated that a novel SNTA1 variant is likely causative for diLQTS by augmenting INa-L. These data suggest that variants within the Na(V)1.5-interacting alpha 1-syntrophin are a potential mechanism for diLQTS, thereby expanding the concept that variants within congenital LQTS loci can cause diLQTS.	[Choi, Jong-Il; Wang, Chaojian; Pitt, Geoffrey S.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA; [Choi, Jong-Il; Wang, Chaojian; Pitt, Geoffrey S.] Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC USA; [Choi, Jong-Il] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 136705, South Korea; [Choi, Jong-Il] Korea Univ, Med Ctr, Seoul, South Korea; [Thomas, Matthew J.] Univ Virginia Hlth Syst, Dept Pediat, Div Genet, Charlottesville, VA USA	Duke University; Duke University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Virginia	Choi, JI; Pitt, GS (corresponding author), Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA.; Choi, JI; Pitt, GS (corresponding author), Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC USA.; Choi, JI (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 136705, South Korea.; Choi, JI (corresponding author), Korea Univ, Med Ctr, Seoul, South Korea.	jongilchoi@korea.ac.kr; geoffrey.pitt@duke.edu	Pitt, Geoffrey/L-4927-2019	Choi, Jong-Il/0000-0001-6617-508X	National Institutes of Health [R01 HL112918]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2015R1D1A1A02061859]; Korea University Grant; Kim Sang-Hee Fellowship Fund Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122967, R01HL112918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Korea University Grant; Kim Sang-Hee Fellowship Fund Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health R01 HL112918 (GSP), the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education 2015R1D1A1A02061859 (J-IC), and the Korea University Grant and the Kim Sang-Hee Fellowship Fund Inc. (J-IC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahern GP, 2000, J BIOL CHEM, V275, P28810, DOI 10.1074/jbc.M003090200; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ballou LM, 2015, CIRC RES, V116, P127, DOI 10.1161/CIRCRESAHA.116.303975; Belardinelli L, 2015, HEART RHYTHM, V12, P440, DOI 10.1016/j.hrthm.2014.11.009; Bhat HF, 2013, CELL MOL LIFE SCI, V70, P2533, DOI 10.1007/s00018-012-1233-9; Cheng JD, 2009, CIRC-ARRHYTHMIA ELEC, V2, P667, DOI 10.1161/CIRCEP.109.891440; Cronk LB, 2007, HEART RHYTHM, V4, P161, DOI 10.1016/j.hrthm.2006.11.030; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Gee SH, 1998, J NEUROSCI, V18, P128; Hennessey JA, 2013, CIRC RES, V113, P381, DOI 10.1161/CIRCRESAHA.113.301215; Hund TJ, 2014, CIRCULATION, V130, P132, DOI 10.1161/CIRCULATIONAHA.114.010867; Itoh H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P511, DOI 10.1161/CIRCEP.109.862649; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lu Z, 2012, SCI TRANSL MED, V4, P131, DOI DOI 10.1126/SCITRANSLMED.3003623; Lu ZJ, 2013, DIABETES, V62, P4257, DOI 10.2337/db13-0420; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Oceandy D, 2007, CIRCULATION, V115, P483, DOI 10.1161/CIRCULATIONAHA.106.643791; Roden DM, 2008, CIRCULATION, V118, P981, DOI 10.1161/CIRCULATIONAHA.108.798918; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shryock JC, 2013, CARDIOVASC RES, V99, P600, DOI 10.1093/cvr/cvt145; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Sun AY, 2011, CIRC-CARDIOVASC GENE, V4, P163, DOI 10.1161/CIRCGENETICS.110.958652; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Vicente J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001615; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang C, 2011, CIRC RES, V109, P775, DOI 10.1161/CIRCRESAHA.111.247957; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Wu GR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P193, DOI 10.1161/CIRCEP.108.769224; Wu L, 2011, CIRCULATION, V123, P1713, DOI 10.1161/CIRCULATIONAHA.110.000661; Yang T, 2014, CIRCULATION, V130, P224, DOI 10.1161/CIRCULATIONAHA.113.007765; Zhao CM, 1999, J BIOL CHEM, V274, P19649, DOI 10.1074/jbc.274.28.19649; ZIPES DP, 1987, AM J CARDIOL, V59, pE26, DOI 10.1016/0002-9149(87)90198-6	42	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152355	10.1371/journal.pone.0152355	http://dx.doi.org/10.1371/journal.pone.0152355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028743	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500039
J	Lubell, Y; Althaus, T; Blacksell, SD; Paris, DH; Mayxay, M; Pan-Ngum, W; White, LJ; Day, NPJ; Newton, PN				Lubell, Yoel; Althaus, Thomas; Blacksell, Stuart D.; Paris, Daniel H.; Mayxay, Mayfong; Pan-Ngum, Wirichada; White, Lisa J.; Day, Nicholas P. J.; Newton, Paul N.			Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ANTIBIOTIC USE; RAPID TEST; PROCALCITONIN; ANTIGEN; AMPLIFICATION; SUPERBUGS; COUNTRIES; ACCURACY; ASSAYS	Background Malaria accounts for a small fraction of febrile cases in increasingly large areas of the malaria endemic world. Point-of-care tests to improve the management of non-malarial fevers appropriate for primary care are few, consisting of either diagnostic tests for specific pathogens or testing for biomarkers of hosct response that indicate whether antibiotics might be required. The impact and cost-effectiveness of these approaches are relatively unexplored and methods to do so are not well-developed. Methods We model the ability of dengue and scrub typhus rapid tests to inform antibiotic treatment, as compared with testing for elevated C-Reactive Protein (CRP), a biomarker of host-inflammation. Using data on causes of fever in rural Laos, we estimate the proportion of outpatients that would be correctly classified as requiring an antibiotic and the likely cost-effectiveness of the approaches. Results Use of either pathogen-specific test slightly increased the proportion of patients correctly classified as requiring antibiotics. CRP testing was consistently superior to the pathogen-specific tests, despite heterogeneity in causes of fever. All testing strategies are likely to result in higher average costs, but only the scrub typhus and CRP tests are likely to be cost-effective when considering direct health benefits, with median cost per disability adjusted life year averted of approximately $48 USD and $94 USD, respectively. Conclusions Testing for viral infections is unlikely to be cost-effective when considering only direct health benefits to patients. Testing for prevalent bacterial pathogens can be cost-effective, having the benefit of informing not only whether treatment is required, but also as to the most appropriate antibiotic; this advantage, however, varies widely in response to heterogeneity in causes of fever. Testing for biomarkers of host inflammation is likely to be consistently cost-effective despite high heterogeneity, and can also offer substantial reductions in overuse of antimicrobials in viral infections.	[Lubell, Yoel; Althaus, Thomas; Blacksell, Stuart D.; Paris, Daniel H.; Pan-Ngum, Wirichada; White, Lisa J.; Day, Nicholas P. J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand; [Lubell, Yoel; Blacksell, Stuart D.; Paris, Daniel H.; Mayxay, Mayfong; White, Lisa J.; Day, Nicholas P. J.; Newton, Paul N.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Mayxay, Mayfong; Newton, Paul N.] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Lubell, Y (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand.; Lubell, Y (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England.	yoel@tropmedres.ac	Paris, Daniel/GLN-7566-2022; Paris, Daniel/AFV-4762-2022; Althaus, Thomas/J-3759-2019; Blacksell, Stuart/D-5530-2018; White, Lisa/AAC-9396-2020	Althaus, Thomas/0000-0002-6997-3877; Blacksell, Stuart/0000-0001-6576-726X; White, Lisa/0000-0002-6523-185X; Newton, Paul/0000-0002-4608-6431; pan-ngum, wirichada/0000-0002-9839-5359; Lubell, Yoel/0000-0002-0237-1070	WHO's Regional Office for the Western Pacific; Australian Agency for International Development; Ministry of Foreign Affairs of Japan; US Agency for International Development; Foundation for Innovative New Diagnostics through a grant from the UK Department for International Development; Influenza Division, National Center for Immunization and Respiratory Diseases; US Centers for Disease Control and Prevention; Wellcome Trust of Great Britain; Grand Challenges Canada [S5 0443-01]; Wellcome Trust of Great Britain [077166/Z/05/Z]	WHO's Regional Office for the Western Pacific; Australian Agency for International Development; Ministry of Foreign Affairs of Japan; US Agency for International Development(United States Agency for International Development (USAID)); Foundation for Innovative New Diagnostics through a grant from the UK Department for International Development; Influenza Division, National Center for Immunization and Respiratory Diseases; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust of Great Britain(Wellcome Trust); Grand Challenges Canada(CGIAR); Wellcome Trust of Great Britain(Wellcome Trust)	The fever study where the aetiology data originated was funded by the WHO's Regional Office for the Western Pacific; with grants from the Australian Agency for International Development, the Ministry of Foreign Affairs of Japan, and the US Agency for International Development; by the Foundation for Innovative New Diagnostics through a grant from the UK Department for International Development, the Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention; and by the Wellcome Trust of Great Britain. Yoel Lubell received a Stars in Global Health award from Grand Challenges Canada (Round 5, grant number S5 0443-01). The Mahidol-Oxford Tropical Medicine Research Unit and the Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU) are supported by the Wellcome Trust of Great Britain (grant number 077166/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010130.pub2; Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; Bank TW, LAO PDR WORLD DEV IN; Binnicker MJ, 2015, J CLIN MICROBIOLOGY; Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P391, DOI 10.1128/CVI.05478-11; Blacksell SD, 2010, CLIN VACCINE IMMUNOL, V17, P263, DOI 10.1128/CVI.00448-08; Brouwer N, 2014, CLIN CHIMICA ACTA; Castonguay-Vanier J, 2013, J CLIN MICROBIOL, V51, P142, DOI 10.1128/JCM.02360-12; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; Coast J, 2002, HEALTH ECON, V11, P637, DOI 10.1002/hec.693; Coast J, 1996, HEALTH ECON, V5, P217, DOI 10.1002/(SICI)1099-1050(199605)5:3<217::AID-HEC200>3.0.CO;2-S; Cooke J, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2015-000086; Crump JA, 2014, T ROY SOC TROP MED H, V108, P61, DOI 10.1093/trstmh/trt120; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Kardas P, 2005, INT J ANTIMICROB AG, V26, P106, DOI 10.1016/j.ijantimicag.2005.04.017; Keddy KH, 2011, B WORLD HEALTH ORGAN, V89, P640, DOI 10.2471/BLT.11.087627; Kingston HWF, 2015, CLIN VACCINE IMMUNOL, V22, P1130, DOI 10.1128/CVI.00390-15; Lee J, 2015, DIAGN MICR INFEC DIS, V82, P128, DOI 10.1016/j.diagmicrobio.2015.03.009; Lim C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114930; Lubell Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1272-6; Lubell Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017439; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Murray C.J.L., 2012, DISABILITY ADJUSTED; Nguyen DTK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066030; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Phommasone K, BMC INFECT IN PRESS; Phommasone K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1360-2; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Senn N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090990; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Suputtamongkol Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000610; Van den Bruel A, 2011, BMJ, V342; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; White LJ, 2012, DEFINING DIS HETEROG	37	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152420	10.1371/journal.pone.0152420	http://dx.doi.org/10.1371/journal.pone.0152420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27027303	Green Published, gold, Green Submitted			2022-12-26	WOS:000373116500043
J	Moreira, X; Sampedro, L; Zas, R; Pearse, IS				Moreira, Xoaquin; Sampedro, Luis; Zas, Rafael; Pearse, Ian S.			Defensive Traits in Young Pine Trees Cluster into Two Divergent Syndromes Related to Early Growth Rate	PLOS ONE			English	Article							PLANT DEFENSE; ANTIHERBIVORE DEFENSES; RESOURCE AVAILABILITY; INDUCED RESISTANCE; TRADE-OFFS; CHEMICAL DEFENSES; SCOTS PINE; EVOLUTION; PATTERNS; HERBIVORES	The combination of defensive traits leads to the evolution of 'plant defense syndromes' which should provide better protection against herbivores than individual traits on their own. Defense syndromes can be generally driven by plant phylogeny and/or biotic and abiotic factors. However, we lack a solid understanding of (i) the relative importance of shared evolution vs. convergence due to similar ecological conditions and (ii) the role of induced defense strategies in shaping defense syndromes. We investigate the relative roles of evolutionary and ecological factors shaping the deployment of pine defense syndromes including multiple constitutive and induced chemical defense traits. We performed a greenhouse experiment with seedlings of eighteen species of Pinaceae family, and measured plant growth rate, constitutive chemical defenses and their inducibility. Plant growth rate, but not phylogenetic relatedness, determined the deployment of two divergent syndromes. Slow-growing pine species living in harsh environments where tissue replacement is costly allocated more to constitutive defenses (energetically more costly to produce than induced). In contrast, fast-growing species living in resource-rich habitats had greater inducibility of their defenses, consistent with the theory of constitutive-induced defense trade-offs. This study contributes to a better understanding of evolutionary and ecological factors driving the deployment of defense syndromes.	[Moreira, Xoaquin; Sampedro, Luis; Zas, Rafael] Mision Biol Galicia MBG CSIC, Apdo 28, Pontevedra 36080, Galicia, Spain; [Pearse, Ian S.] Illinois Nat Hist Survey, 1816 South Oak St, Champaign, IL 61820 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG); Illinois Natural History Survey	Moreira, X (corresponding author), Mision Biol Galicia MBG CSIC, Apdo 28, Pontevedra 36080, Galicia, Spain.	xmoreira1@gmail.com	Sampedro, Luis/B-7187-2011; Zas, Rafael/I-5729-2014; Moreira, Xoaquín/J-9427-2018	Sampedro, Luis/0000-0002-3921-2575; Zas, Rafael/0000-0001-6563-2461; Moreira, Xoaquín/0000-0003-0166-838X	Spanish National Research Grant [AGL2010-18724]	Spanish National Research Grant(Spanish Government)	Funding for this work came from the Spanish National Research Grant (AGL2010-18724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P1804, DOI 10.1890/0012-9658(2000)081[1804:BACOIP]2.0.CO;2; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Agrawal AA, 2009, P NATL ACAD SCI USA, V106, P18067, DOI 10.1073/pnas.0904862106; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Cacho NI, 2015, NEW PHYTOL, V208, P915, DOI 10.1111/nph.13561; Carrillo-Gavilan A, 2015, J BIOGEOGR, V42, P684, DOI 10.1111/jbi.12444; Carrillo-Gavilan A, 2012, FUNCT ECOL, V26, P283, DOI 10.1111/j.1365-2435.2011.01931.x; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Endara MJ, 2015, J ECOL, V103, P1107, DOI 10.1111/1365-2745.12431; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Gomez S, 2010, PLANT BIOLOGY, V12, P512, DOI 10.1111/j.1438-8677.2009.00234.x; Grivet D, 2013, MOL PHYLOGENET EVOL, V68, P555, DOI 10.1016/j.ympev.2013.03.032; Haak DC, 2014, ECOLOGY, V95, P1633, DOI 10.1890/13-1145.1; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Johnson MTJ, 2014, NEW PHYTOL, V203, P267, DOI 10.1111/nph.12763; Karban R, 1997, ECOLOGY, V78, P1351; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kempel A, 2011, P NATL ACAD SCI USA, V108, P5685, DOI 10.1073/pnas.1016508108; KINLOCH BB, 1986, NEW PHYTOL, V104, P703, DOI 10.1111/j.1469-8137.1986.tb00671.x; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; Kursar TA, 2009, P NATL ACAD SCI USA, V106, P18073, DOI 10.1073/pnas.0904786106; Littell R. C., 2006, SAS SYSTEM MIXED MOD; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Moreira X, 2014, ECOL LETT, V17, P537, DOI 10.1111/ele.12253; Moreira X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034006; Moreira X, 2012, TREES-STRUCT FUNCT, V26, P677, DOI 10.1007/s00468-011-0602-6; Mumm R, 2006, TRENDS PLANT SCI, V11, P351, DOI 10.1016/j.tplants.2006.05.007; da Silva DM, 2011, PLANT ECOL, V212, P181, DOI 10.1007/s11258-010-9813-y; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Orians CM, 2010, ANNU REV ENTOMOL, V55, P439, DOI 10.1146/annurev-ento-112408-085333; Pearse IS, 2012, EVOLUTION, V66, P2272, DOI 10.1111/j.1558-5646.2012.01591.x; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Rasmann S, 2011, ECOL LETT, V14, P476, DOI 10.1111/j.1461-0248.2011.01609.x; Richardson D. M., 1998, ECOLOGY BIOGEOGRAPHY; Rudgers JA, 2004, AM J BOT, V91, P871, DOI 10.3732/ajb.91.6.871; Sampedro L, 2011, J ECOL, V99, P818, DOI 10.1111/j.1365-2745.2011.01814.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; STEWARD JL, 1988, OIKOS, V53, P79, DOI 10.2307/3565666; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thaler JS, 1997, AM NAT, V149, P1139, DOI 10.1086/286042; Thoss V, 2007, J CHEM ECOL, V33, P477, DOI 10.1007/s10886-006-9244-3; Travers-Martin N, 2008, FUNCT ECOL, V22, P1033, DOI 10.1111/j.1365-2435.2008.01487.x; Volf M, 2015, J ANIM ECOL, V84, P1123, DOI 10.1111/1365-2656.12349; Walters D. R., 2010, PLANT DEFENSE WARDIN; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Zangerl AR, 1996, AM NAT, V147, P599, DOI 10.1086/285868	54	17	17	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152537	10.1371/journal.pone.0152537	http://dx.doi.org/10.1371/journal.pone.0152537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028433	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500052
J	Nghiem, LTP; Papworth, SK; Lim, FKS; Carrasco, LR				Nghiem, Le T. P.; Papworth, Sarah K.; Lim, Felix K. S.; Carrasco, Luis R.			Analysis of the Capacity of Google Trends to Measure Interest in Conservation Topics and the Role of Online News	PLOS ONE			English	Article							SCIENCE COMMUNICATION; PUBLIC-INTEREST; MEDIA; OPINION; SUPPORT	With the continuous growth of internet usage, Google Trends has emerged as a source of information to investigate how social trends evolve over time. Knowing how the level of interest in conservation topics-approximated using Google search volume-varies over time can help support targeted conservation science communication. However, the evolution of search volume over time and the mechanisms that drive peaks in searches are poorly understood. We conducted time series analyses on Google search data from 2004 to 2013 to investigate: (i) whether interests in selected conservation topics have declined and (ii) the effect of news reporting and academic publishing on search volume. Although trends were sensitive to the term used as benchmark, we did not find that public interest towards conservation topics such as climate change, ecosystem services, deforestation, orangutan, invasive species and habitat loss was declining. We found, however, a robust downward trend for endangered species and an upward trend for ecosystem services. The quantity of news articles was related to patterns in Google search volume, whereas the number of research articles was not a good predictor but lagged behind Google search volume, indicating the role of news in the transfer of conservation science to the public.	[Nghiem, Le T. P.; Lim, Felix K. S.; Carrasco, Luis R.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Papworth, Sarah K.] Univ London, Royal Holloway, Egham Hill, Egham TW20 0EX, Surrey, England	National University of Singapore; University of London; Royal Holloway University London	Nghiem, LTP; Carrasco, LR (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	nghphuongle@nus.edu.sg; dbsctlr@nus.edu.sg	Carrasco, Luis R/H-8017-2012	Carrasco, Luis R/0000-0002-2894-1473; Papworth, Sarah/0000-0002-8746-1912; Lim, Felix/0000-0003-1227-460X	Tier 2 grant from the Ministry of Education of Singapore [R154000574112]	Tier 2 grant from the Ministry of Education of Singapore(Ministry of Education, Singapore)	L.T.P.N., F.K.S.L., and L.R.C. acknowledge funding from the Tier 2 grant R154000574112 from the Ministry of Education of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg WRL, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/5/054005; Bhatia S, 2013, CONSERV BIOL, V27, P588, DOI 10.1111/cobi.12037; Bickford D, 2012, BIOL CONSERV, V151, P74, DOI 10.1016/j.biocon.2011.12.016; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Bubela T, 2009, NAT BIOTECHNOL, V27, P514, DOI 10.1038/nbt0609-514; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Chan K.-S, 2015, PACKAGE TSA TIME SER; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Clements CF, 2013, BIODIVERS CONSERV, V22, P2695, DOI 10.1007/s10531-013-0535-z; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; DOWNS A, 1972, PUBLIC INTEREST, P38; DUNLAP RE, 1991, SOC NATUR RESOUR, V4, P285, DOI 10.1080/08941929109380761; Ficetola GF, 2013, BIODIVERS CONSERV, V22, P2983, DOI 10.1007/s10531-013-0552-y; Funk SM, 2014, BIODIVERS CONSERV, V23, P3101, DOI 10.1007/s10531-014-0767-6; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gittelman S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3970; Gollust SE, 2012, SOC SCI MED, V74, P1544, DOI 10.1016/j.socscimed.2012.01.021; Gomez-Baggethun E, 2010, ECOL ECON, V69, P1209, DOI 10.1016/j.ecolecon.2009.11.007; Hipel KW, 1994, TIME SERIES MODELLIN; Hyndman RobJ., 2018, FORECASTING PRINCIPL; INGLEHART R, 1995, PS, V28, P57, DOI 10.2307/420583; Jacobson SK, 2012, CONSERV BIOL, V26, P171, DOI 10.1111/j.1523-1739.2011.01750.x; Malcevschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042128; Mccallum ML, 2013, BIODIVERS CONSERV, V22, P1355, DOI 10.1007/s10531-013-0476-6; McLeod A.I., 2011, R PACKAGE KENDALL KE; Messmer TA, 2001, WILDLIFE SOC B, V29, P1253; Miller S, 2001, PUBLIC UNDERST SCI, V10, P115, DOI 10.1088/0963-6625/10/1/308; Muter BA, 2013, CONSERV BIOL, V27, P187, DOI 10.1111/j.1523-1739.2012.01952.x; Nau R, 2015, SUMMARY RULES IDENTI; NetMarketshare.com, 2014, DESKT SEARCH ENG MAR; Onoz B., 2003, Turkish Journal of Engineering and Environmental Sciences, V27, P247; Papworth SK, 2015, CONSERV BIOL, V29, P825, DOI 10.1111/cobi.12455; Phillis CC, 2013, CONSERV LETT, V6, P98, DOI 10.1111/j.1755-263X.2012.00294.x; Probst WN, 2012, ICES J MAR SCI, V69, P670, DOI 10.1093/icesjms/fss015; Proulx R, 2014, CONSERV BIOL, V28, P44, DOI 10.1111/cobi.12131; Shanley P, 2009, BIOTROPICA, V41, P535, DOI 10.1111/j.1744-7429.2009.00561.x; Shumway RH, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7865-3; Soroka SN, 2003, HARV INT J PRESS-POL, V8, P27, DOI 10.1177/1081180X02238783; Sullivan D, 2013, GOOGLE STILL WORLDS; Uscinski JE, 2009, SOC SCI QUART, V90, P796, DOI 10.1111/j.1540-6237.2009.00663.x; van der Ploeg J, 2011, CONSERV LETT, V4, P313, DOI 10.1111/j.1755-263X.2011.00181.x; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7; Zmihorski M, 2013, OIKOS, V122, P183, DOI 10.1111/j.1600-0706.2012.20486.x	45	86	87	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152802	10.1371/journal.pone.0152802	http://dx.doi.org/10.1371/journal.pone.0152802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27028399	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500068
J	Paraje, G				Paraje, Guillermo			The Effect of Price and Socio-Economic Level on the Consumption of Sugar-Sweetened Beverages (SSB): The Case of Ecuador	PLOS ONE			English	Article							TAXES; ELASTICITIES; SUBSIDIES; QUALITY; HEALTH; FOOD	The objective of this article is to estimate the own-price, cross-price and income elasticities of demand for SSB in Ecuador, as an indispensable step for predicting a reduction in the consumption of said beverages caused by the potential implementation of taxes in Ecuador. In addition, the own-price, cross-price and income elasticities of sugar-free substitutes like mineral water and diet soft drinks and juices are also estimated. The data from the 20112012 ENIGHUR, which contains detailed information on household consumption and socioeconomic variables, was used. The estimates are done using Deaton's Almost Ideal Demand System (AIDS) which accounts for differences in the quality of goods purchased. This demand system is estimated for different socio-economic groups, according to total household expenditure. The results reveal own-price elasticities for SSB between -1.17 and -1.33 depending on the socio-economic group, in line with the existing evidence for developed countries. Own-price elasticity for non-SSB is between -1 and -1.24. Income elasticities reveal that both SSB and non-SSB are normal goods with elasticities decreasing for higher socio-economic groups. These results show that the consumption of SSB is sensitive to price changes, meaning that the implementation of taxes on said beverages could be effective in reducing their consumption. The fact that non-SSB are also sensitive to price changes would indicate that subsidies could be implemented for the production of some of them.	[Paraje, Guillermo] Univ Adolfo Ibanez, Sch Business, Santiago, Chile	Universidad Adolfo Ibanez	Paraje, G (corresponding author), Univ Adolfo Ibanez, Sch Business, Santiago, Chile.	guillermo.paraje@uai.cl		Paraje, Guillermo/0000-0002-7863-907X	Pan-American Health Organization; UNICEF	Pan-American Health Organization; UNICEF	This study was funded by the Pan-American Health Organization and UNICEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Chaloupka FJ, 2000, TOBACCO CONTROL IN D; Claro RM, 2012, AM J PUBLIC HEALTH, V102, P178, DOI 10.2105/AJPH.2011.300313; DEATON A, 1988, AM ECON REV, V78, P418; DEATON A, 1987, J ECONOMETRICS, V36, P7, DOI 10.1016/0304-4076(87)90041-8; DEATON A, 1990, J ECONOMETRICS, V44, P281, DOI 10.1016/0304-4076(90)90060-7; Deaton A, 1997, THE ANALYSIS OF HOUS; Delipalla S, 2001, INT J IND ORGAN, V19, P885, DOI 10.1016/S0167-7187(99)00057-0; Department of Justice, 2010, HORIZONTAL MERGER GU; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Euromonitor International, 2015, CARBONATES IN ECUADO; Euromonitor International, 2015, SOFT DRINKS STAT 201; Freire WB., 2014, ENSA NUT ECU 2012; Grogger J., 2015, NATIONAL BUREAU OF E, DOI [10.3386/w21197, DOI 10.3386/W21197]; Guindon GE, 2011, NATIONAL BUREAU OF E, DOI [10.3386/w17580, DOI 10.3386/W17580]; Instituto Nacional de Estadistica y Censos, 2012, ENCUESTA NACL INGRES; Instituto Nacional de Estadisticas y Censos del Ecuador, 2014, REPORTE DE POBREZA P; McKelvey C, 2011, J DEV ECON, V95, P157, DOI 10.1016/j.jdeveco.2010.05.004; Mozaffarian D, 2014, JAMA-J AM MED ASSOC, V312, P889, DOI 10.1001/jama.2014.8232; Organizacion Panamericana de la Salud (PAHO), 2011, AGUA Y SANEAMIENTO E; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Rtveladze K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068785; Singh GM, 2015, CIRCULATION; The World Health Organization The World Bank, 2013, JOINT WHO WORLD BANK; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782	27	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152260	10.1371/journal.pone.0152260	http://dx.doi.org/10.1371/journal.pone.0152260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27028608	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500038
J	Ren, S; Wang, J; Chen, TL; Li, HY; Wan, YS; Peng, NF; Gui, XE; Zhu, Y				Ren, Sheng; Wang, Jun; Chen, Tie-Long; Li, Hao-Yu; Wan, Yu-Shun; Peng, Nan-Fang; Gui, Xi-En; Zhu, Ying			Hepatitis B Virus Stimulated Fibronectin Facilitates Viral Maintenance and Replication through Two Distinct Mechanisms	PLOS ONE			English	Article							CELL-SURFACE; EXPRESSION; HEPATOCYTES; SEQUENCE; PROTEIN; ENTRY; GENE; EPIDEMIOLOGY; ACTIVATION; INDUCTION	Fibronectin (FN) is a high molecular weight extracellular matrix protein that functions in cell adhesion, growth, migration, and embryonic development. However, little is known about the role of FN during viral infection. In the present study, we found significantly higher levels of FN in sera, and liver tissues from hepatitis B virus (HBV) patients relative to healthy individuals. HBV expression enhanced FN mRNA and protein levels in the hepatic cell lines Huh7 and HepG2. HBV infection of susceptible HepG2-sodium taurocholate co-transporting polypeptide cells also increased FN expression. We also found that transcriptional factor specificity protein 1 was involved in the induction of FN by HBV. Knockdown of FN expression significantly inhibited HBV DNA replication and protein synthesis through activating endogenous IFN-alpha production. In addition, FN interacted with the transforming growth factor beta-activated protein kinase 1 (TAK1) and TAK1-binding protein complex and attenuated interferon signaling by inhibiting TAK1 phosphorylation. Furthermore, the nuclear translocation of NF-kappa B/p65 was found to be inhibited by FN. We also observed that FN promoted HBV enhancers to support HBV expression. These results suggest novel functions of endogenous FN involved in immune evasion and maintenance of HBV replication.	[Ren, Sheng; Li, Hao-Yu; Wan, Yu-Shun; Peng, Nan-Fang; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Wang, Jun] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, Tie-Long; Gui, Xi-En] Wuhan Univ, Dept Infect Dis, Zhongnan Hosp, Wuhan 430072, Peoples R China	Wuhan University; Huazhong University of Science & Technology; Wuhan University	Zhu, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	yingzhu@whu.edu.cn	Wan, Yushun/AFS-1315-2022; Wan, Yushun/AFT-0087-2022	Wan, Yushun/0000-0003-0496-6315; 	Major State Basic Research Development Program of China [2013CB911102]; National Natural Science Foundation of China [81461130019, 81271821, 31570870]; National Mega Project on Major Infectious Diseases Prevention [2012ZX10004503-004]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Diseases Prevention	This work was supported by research grants from the Major State Basic Research Development Program of China (2013CB911102), National Natural Science Foundation of China (81461130019, 81271821 and 31570870), National Mega Project on Major Infectious Diseases Prevention (2012ZX10004503-004). The funding agencies had no role in study design, data collection, or analysis, decision to publish, or preparation of the manuscript.	Bearzotti M, 1999, J VIROL, V73, P7703, DOI 10.1128/JVI.73.9.7703-7709.1999; Beer C, 2007, J VIROL, V81, P8247, DOI 10.1128/JVI.00312-07; Breous E, 2009, HEPATOLOGY, V50, P612, DOI 10.1002/hep.23043; BUDKOWSKA A, 1995, J VIROL, V69, P840, DOI 10.1128/JVI.69.2.840-848.1995; Chang ML, 2014, J HEPATOL, V61, P1407, DOI 10.1016/j.jhep.2014.08.033; Chung HY, 2014, J VIROL, V88, P11022, DOI 10.1128/JVI.01582-14; Cobbs SL, 2007, BIOCHEM BIOPH RES CO, V362, P288, DOI 10.1016/j.bbrc.2007.07.186; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fu J, 2011, HEPATOLOGY, V53, P181, DOI 10.1002/hep.24015; Fukai K, 1997, VIROLOGY, V236, P279, DOI 10.1006/viro.1997.8750; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; HAUGEN PK, 1992, J NEUROSCI, V12, P2597; He WH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004840; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Jackson NE, 2008, J BIOL CHEM, V283, P34178, DOI 10.1074/jbc.M807553200; Kaminska R, 1999, J INVEST DERMATOL, V113, P567, DOI 10.1046/j.1523-1747.1999.00738.x; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kay A, 2014, J VIRAL HEPATITIS, V21, P921, DOI 10.1111/jvh.12267; Kim YJ, 2011, LIVER INT, V31, P819, DOI 10.1111/j.1478-3231.2011.02516.x; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; Lau DTY, 2003, J VIRAL HEPATITIS, V10, P331, DOI 10.1046/j.1365-2893.2003.00418.x; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Leung HSY, 2012, J VIROL, V86, P10704, DOI 10.1128/JVI.01166-12; Li H, 2014, CELL MOL IMMUNOL, V11, P175, DOI 10.1038/cmi.2013.66; Li YK, 2013, J BIOL CHEM, V288, P20927, DOI 10.1074/jbc.M112.440115; Liaw YF, 2011, LIVER INT, V31, P117, DOI 10.1111/j.1478-3231.2010.02388.x; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Luangsay S, 2015, J HEPATOL, V63, P1314, DOI 10.1016/j.jhep.2015.07.014; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; MOSESSON MW, 1980, BLOOD, V56, P145; Norton PA, 2004, J VIRAL HEPATITIS, V11, P332, DOI 10.1111/j.1365-2893.2004.00555.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Reese V, 2011, INT J BIOCHEM CELL B, V43, P230, DOI 10.1016/j.biocel.2009.11.016; Samal J, 2012, CLIN MICROBIOL REV, V25, P142, DOI 10.1128/CMR.00018-11; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Seo Y, 2014, WORLD J GASTROENTERO, V20, P13284, DOI 10.3748/wjg.v20.i37.13284; Shang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10066; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tseng L, 2003, DNA CELL BIOL, V22, P633, DOI 10.1089/104454903770238102; van der Straaten HM, 2004, J INVEST DERMATOL, V123, P1057, DOI 10.1111/j.0022-202X.2004.23474.x; VARTIO T, 1987, J CELL SCI, V88, P419; Villiers MB, 2015, J CLIN MICROBIOL, V53, P1164, DOI 10.1128/JCM.03002-14; Wang F, 2012, MOL MED REP, V6, P1145, DOI 10.3892/mmr.2012.1029; Wang Xue-Qing, 2008, BMC Biochemistry, V9, P30, DOI 10.1186/1471-2091-9-30; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yang J, 2006, BIOCHEM BIOPH RES CO, V344, P757, DOI 10.1016/j.bbrc.2006.03.204; Yang J, 2010, ARCH VIROL, V155, P881, DOI 10.1007/s00705-010-0657-5; Yu SY, 2010, J GEN VIROL, V91, P2080, DOI 10.1099/vir.0.020552-0; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405; Zhao FP, 2014, J BIOL CHEM, V289, P35029, DOI 10.1074/jbc.M114.589978	57	7	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152721	10.1371/journal.pone.0152721	http://dx.doi.org/10.1371/journal.pone.0152721			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023403	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900091
J	Zhou, WJ; Kavelaars, A; Heijnen, CJ				Zhou, Wenjun; Kavelaars, Annemieke; Heijnen, Cobi J.			Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice	PLOS ONE			English	Article							CANCER SURVIVORS; CHEMOTHERAPY; MECHANISMS; RATS; NEUROTOXICITY; HIPPOCAMPUS; OXALIPLATIN; PREVALENCE; PROTECTS	Rationale Chemotherapy-induced cognitive impairment, also known as ` chemobrain', is now widely recognized as a frequent adverse side effect of cancer treatment that often persists into survivorship. There are no drugs available to prevent or treat chemotherapy-induced cognitive deficits. The aim of this study was to establish a mouse model of cisplatin-induced cognitive deficits and to determine the potential preventive effects of the anti-diabetic drug metformin. Results Treatment of C57/BL6J mice with cisplatin (cumulative dose 34.5mg/kg) impaired performance in the novel object and place recognition task as well as in the social discrimination task indicating cognitive deficits. Co-administration of metformin prevented these cisplatininduced cognitive impairments. At the structural level, we demonstrate that cisplatin reduces coherency of white matter fibers in the cingulate cortex. Moreover, the number of dendritic spines and neuronal arborizations as quantified on Golgi-stained brains was reduced after cisplatin treatment. Co-administration of metformin prevented all of these structural abnormalities in cisplatin-treated mice. In contrast to what has been reported in other models of chemobrain, we do not have evidence for persistent microglial or astrocyte activation in the brains of cisplatin-treated mice. Finally, we show that co-administration of metformin also protects against cisplatin-induced peripheral neuropathy. Conclusion In summary, we show here for the first time that treatment of mice with cisplatin induces cognitive deficits that are associated with structural abnormalities in the brain. Moreover, we present the first evidence that the widely used and safe anti-diabetic drug metformin protects against these deleterious effects of cancer treatment. In view of the ongoing clinical trials to examine the potential efficacy of metformin as add-on therapy in patients treated for cancer, these findings should allow rapid clinical translation.	[Zhou, Wenjun; Kavelaars, Annemieke; Heijnen, Cobi J.] UT MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX USA; [Zhou, Wenjun] Baylor Coll Med, Dept Med, Div Endocrinol, Diabet Res Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Heijnen, CJ (corresponding author), UT MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX USA.	CJHeijnen@mdanderson.org	Zhou, Wenjun/H-2824-2016	Zhou, Wenjun/0000-0003-4042-4329; Zhou, wenjun/0000-0002-8268-0251	STAR grant of the University of Texas System NIH [RO1 NS073939, RO1 NS074999, R21CA183736, RO1 CA193522]; Acetylon Pharmaceuticals; NIH [RO1 NS073939, RO1 NS074999, R21 CA183736]; NATIONAL CANCER INSTITUTE [R01CA193522, R21CA183736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073939, R01NS074999] Funding Source: NIH RePORTER	STAR grant of the University of Texas System NIH; Acetylon Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Annemieke Kavelaars is supported by a STAR grant of the University of Texas System (http://influuent.utsystem.edu/award_stars.php) NIH RO1 NS073939 & RO1 NS074999 (https://projectreporter.nih.gov/reporter_searchresults.cfm) R21CA183736 (https://projectreporter.nih.gov/project_info_description.cfm?aid=8920522& RO1 CA193522 (https://projectreporter.nih.gov/project_info_description.cfm?aid=8863142&icde=27469224&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC) Acetylon Pharmaceuticals (not related to the studies in this manuscript) GAP Project M.D. Anderson Cancer Center (internal seed grand) Cobi J. Heijnen is supported by NIH R21 CA183736 (https://projectreporter.nih.gov/project_info_description.cfm?aid=8920522&icde=27469204) RO1 NS074999 & RO1 NS073939 (https://projectreporter.nih.gov/reporter_searchresults.cfm) Acetylon Pharmaceuticals (not related to the studies in this manuscript). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles TA, 2008, BREAST CANCER RES TR, V110, P143, DOI 10.1007/s10549-007-9686-5; Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bost F, 2012, CURR OPIN ONCOL, V24, P103, DOI 10.1097/CCO.0b013e32834d8155; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Briones TL, 2014, BRAIN BEHAV IMMUN, V35, P23, DOI 10.1016/j.bbi.2013.07.175; Chung MM, 2015, BBA-MOL BASIS DIS, V1852, P720, DOI 10.1016/j.bbadis.2015.01.006; de Moor JS, 2013, CANCER EPIDEM BIOMAR, V22, P561, DOI 10.1158/1055-9965.EPI-12-1356; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Engelmann M, 2011, NAT PROTOC, V6, P1152, DOI 10.1038/nprot.2011.353; Ferguson RJ, 2007, J CLIN ONCOL, V25, P3866, DOI 10.1200/JCO.2007.10.8639; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Fung C, 2011, NAT REV UROL, V8, P213, DOI 10.1038/nrurol.2011.26; Gan HK, 2011, INT J RADIAT ONCOL, V81, P126, DOI 10.1016/j.ijrobp.2010.05.004; Giridharan VV, 2012, FREE RADICAL RES, V46, P50, DOI 10.3109/10715762.2011.638291; Guterstam A, 2015, CURRENT BIOL, V25, P1416; Hinduja S, 2015, NEUROTOX RES, V27, P199, DOI 10.1007/s12640-014-9503-y; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Janelsins MC, 2014, INT REV PSYCHIATR, V26, P102, DOI 10.3109/09540261.2013.864260; Jiang T, 2014, BRIT J PHARMACOL, V171, P3146, DOI 10.1111/bph.12655; Kesler SR, 2013, P NATL ACAD SCI USA, V110, P11600, DOI 10.1073/pnas.1214551110; Labuzek K, 2010, PHARMACOL REP, V62, P956; Le Merrer J, 2013, NEUROPSYCHOPHARMACOL, V38, P1050, DOI 10.1038/npp.2013.1; Lee KFH, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/704103; Lepage C, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-444; Li J, 2010, STROKE, V41, P2645, DOI 10.1161/STROKEAHA.110.589697; Liu Y, 2014, J INEQUAL APPL, DOI 10.1186/1029-242X-2014-194; Mannelli LD, 2014, EXP NEUROL, V261, P22, DOI 10.1016/j.expneurol.2014.06.016; Mao-Ying QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100701; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-14; Melemedjian OK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-70; Miller AMP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00586; Moore HCF, 2014, ONCOLOGY-NY, V28, P797; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; O'Farrell E, 2013, CURR ONCOL REP, V15, P260, DOI 10.1007/s11912-013-0307-7; Park HJ, 2013, ANESTH ANALG, V116, P224, DOI 10.1213/ANE.0b013e31826e1007; Riedmaier AE, 2013, TRENDS PHARMACOL SCI, V34, P126, DOI 10.1016/j.tips.2012.11.005; Robinson CR, 2014, NEUROSCIENCE, V274, P308, DOI 10.1016/j.neuroscience.2014.05.051; Schagen SB, 2008, ACTA ONCOL, V47, P63, DOI 10.1080/02841860701518058; Selamat MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108002; Simo M, 2015, J THORAC ONCOL, V10, P38, DOI 10.1097/JTO.0000000000000345; Simo M, 2013, NEUROSCI BIOBEHAV R, V37, P1311, DOI 10.1016/j.neubiorev.2013.04.015; Skoogh J, 2012, ACTA ONCOL, V51, P185, DOI 10.3109/0284186X.2011.602113; Song TY, 2010, FOOD CHEM TOXICOL, V48, P3492, DOI 10.1016/j.fct.2010.09.030; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; Vardy J, 2007, CRIT REV ONCOL HEMAT, V63, P183, DOI 10.1016/j.critrevonc.2007.06.001; Vichaya EG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00131; Wang HJ, 2013, J CLIN INVEST, V123, P5023, DOI 10.1172/JCI66241; Wefel JS, 2012, CURR NEUROL NEUROSCI, V12, P267, DOI 10.1007/s11910-012-0264-9; Whitney Kriscinda A, 2008, J Support Oncol, V6, P313; Wile DJ, 2010, DIABETES CARE, V33, P156, DOI 10.2337/dc09-0606; Winocur G, 2015, BEHAV BRAIN RES, V281, P239, DOI 10.1016/j.bbr.2014.12.028; Winocur G, 2012, CLIN CANCER RES, V18, P3112, DOI 10.1158/1078-0432.CCR-12-0060; Wu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10147; Yang JCH, 2013, J CLIN ONCOL, V31, P3342, DOI 10.1200/JCO.2012.46.1764; Yoon SH, 2007, BIOL PHARM BULL, V30, P2196, DOI 10.1248/bpb.30.2196; Yoon SY, 2013, J PAIN, V14, P205, DOI 10.1016/j.jpain.2012.11.002; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	60	90	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151890	10.1371/journal.pone.0151890	http://dx.doi.org/10.1371/journal.pone.0151890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018597	Green Submitted, Green Published, gold			2022-12-26	WOS:000372807800023
J	Haenzi, B; Gers-Barlag, K; Akhoundzadeh, H; Hutson, TH; Menezes, SC; Bunge, MB; Moon, LDF				Haenzi, Barbara; Gers-Barlag, Katharina; Akhoundzadeh, Halima; Hutson, Thomas H.; Menezes, Sean C.; Bunge, Mary Bartlett; Moon, Lawrence D. F.			Overexpression of the Fibroblast Growth Factor Receptor 1 (FGFR1) in a Model of Spinal Cord Injury in Rats	PLOS ONE			English	Article							ADENOASSOCIATED VIRAL VECTOR; CORTICOSPINAL TRACT AXONS; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; N-CAM; EXPRESSION; ACTIVATION; CELLS; SEQUENCE; NEURONS	Spinal cord injury (SCI) is a severe condition that affects many people and results in high health care costs. Therefore, it is essential to find new targets for treatment. The fibroblast growth factor receptor 1 (FGFR1) signalling pathway has a history of being explored for SCI treatment. Several groups have examined the effect of high availability of different FGFR1 ligands at the injury site and reported corticospinal tract (CST) regeneration as well as improved motor functions. In this study, we investigated overexpression of the FGFR1 in rat corticospinal neurons in vivo after injury (unilateral pyramidotomy) and in cerebellar granule neurons (CGNs) in vitro. We show that overexpression of FGFR1 using AAV1 intracortical injections did not increase sprouting of the treated corticospinal tract and did not improve dexterity or walking in a rat model of SCI. Furthermore, we show that overexpression of FGFR1 in vitro resulted in decreased neurite outgrowth compared to control. Thus, our results suggest that the FGFR1 is not a suitable therapeutic target after SCI.	[Haenzi, Barbara; Gers-Barlag, Katharina; Akhoundzadeh, Halima; Hutson, Thomas H.; Menezes, Sean C.; Moon, Lawrence D. F.] Kings Coll London, Wolfson Ctr Age Related Dis, Neurorestorat Grp, London SE1 1UL, England; [Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Cell Biol, Miami, FL 33136 USA; [Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol, Miami, FL 33136 USA	University of London; King's College London; University of Miami; University of Miami; University of Miami	Haenzi, B (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Neurorestorat Grp, London SE1 1UL, England.	bh432@cam.ac.uk	Moon, Lawrence/C-4906-2008	Moon, Lawrence/0000-0001-9622-0312; Gers-Barlag, Katharina/0000-0003-2836-2831	Swiss National Science Foundation (SNSF); Henry Smith Charity; Wings for Life Spinal Cord Research Foundation; Miami Project to Cure Paralysis; National Institute of Neurological Disorders and Stroke [09923]; Christopher and Dana Reeve Foundation International Research Consortium	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Henry Smith Charity; Wings for Life Spinal Cord Research Foundation; Miami Project to Cure Paralysis; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Christopher and Dana Reeve Foundation International Research Consortium	This submission was supported by funding from the Swiss National Science Foundation (SNSF), the Henry Smith Charity, the Wings for Life Spinal Cord Research Foundation, the Miami Project to Cure Paralysis, the National Institute of Neurological Disorders and Stroke (09923) and the Christopher and Dana Reeve Foundation International Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Buchser WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038101; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Duricki DA, 2016, BRAIN, V139, P259, DOI 10.1093/brain/awv341; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; Gartner A, 2006, METHOD ENZYMOL, V406, P374, DOI 10.1016/S0076-6879(06)06027-7; Guest JD, 1997, J NEUROSCI RES, V50, P888, DOI 10.1002/(SICI)1097-4547(19971201)50:5<888::AID-JNR24>3.0.CO;2-W; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; He JCJ, 2006, CAN J PHYSIOL PHARM, V84, P687, DOI 10.1139/Y06-025; Hutson TH, 2016, GENE THER, V23, P231, DOI 10.1038/gt.2015.103; Hutson TH, 2012, GENE THER, V19, P49, DOI 10.1038/gt.2011.71; Hutson TH, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00055; Hutson TH, 2014, METHODS MOL BIOL, V1162, P189, DOI 10.1007/978-1-4939-0777-9_16; Jacobi A, 2015, EMBO J, V34, P1231, DOI 10.15252/embj.201490578; Kasai M, 2014, J NEUROTRAUM, V31, P1584, DOI 10.1089/neu.2009.1108; Kathe C, 2014, JOVE-J VIS EXP, DOI 10.3791/51843; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; Kolkova K, 2000, J NEUROSCI, V20, P2238; KOSHINAGA M, 1993, EXP NEUROL, V120, P32, DOI 10.1006/exnr.1993.1038; Leclere PG, 2005, J NEUROSCI METH, V142, P137, DOI 10.1016/j.jneumeth.2004.08.012; Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; LOGAN A, 1992, J NEUROSCI, V12, P3828; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1994, J NEUROCHEM, V62, P1231; WILLIAMS EJ, 1994, J CELL BIOL, V124, P1029, DOI 10.1083/jcb.124.6.1029	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0150541	10.1371/journal.pone.0150541	http://dx.doi.org/10.1371/journal.pone.0150541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015635	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708900021
J	Panti-May, JA; Carvalho-Pereira, TSA; Serrano, S; Pedra, GG; Taylor, J; Penile, AC; Minter, A; Airam, V; Carvalho, M; Junior, NN; Rodrigues, G; Reis, MG; Ko, AI; Childs, JE; Begon, M; Costa, F				Panti-May, Jesus A.; Carvalho-Pereira, Ticiana S. A.; Serrano, Soledad; Pedra, Gabriel G.; Taylor, Josh; Penile, Arsinoe C.; Minter, Amanda; Airam, Vladimir; Carvalho, Mayara; Junior, Nivison N.; Rodrigues, Gorete; Reis, Mitermayer G.; Ko, Albert I.; Childs, James E.; Begon, Mike; Costa, Federico			A Two-Year Ecological Study of Norway Rats (Rattus norvegicus) in a Brazilian Urban Slum	PLOS ONE			English	Article							BARTONELLA SPP.; INFESTATION; POPULATION; LEPTOSPIROSIS; TRANSMISSION; ENVIRONMENT; BALTIMORE; RISK	The Norway or brown rat (Rattus norvegicus) is among the most ubiquitous of rodents. However, the lack of studies describing Norway rat populations from tropical areas have limited our understanding regarding their demography and seasonal dynamics. In this study, we describe seasonal pattern in the abundance, reproductive parameters, and morphometrics of Norway rat populations in Salvador, Brazil. Rodents were trapped over four seasonal trapping periods (2013-2014) from three valleys. A total of 802 Norway rats were trapped over the course of the study over 7653 trap-nights. Norway rat abundance was high, but there was no significant differences between seasons. The reproductive parameters (e. g. frequency of pregnant and lactating females) did not show statistical differences between seasons. Female rats collected in the rainy season were heavier and older than females from the dry season. Salvador rats had a high incidence of pregnancy and birth rate (estimated birth rate of 79 young per year) compared to previous studies. The information generated is critical for the understanding of the ecology of Norway rat, the main reservoir of Leptospira in Salvador. However, future studies examining the effect of rodent control programs aimed at reducing populations, and determining rates of recovery, will further clarify our understanding of population dynamics.	[Panti-May, Jesus A.; Carvalho-Pereira, Ticiana S. A.; Serrano, Soledad; Pedra, Gabriel G.; Taylor, Josh; Penile, Arsinoe C.; Airam, Vladimir; Carvalho, Mayara; Junior, Nivison N.; Reis, Mitermayer G.; Ko, Albert I.; Costa, Federico] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [Taylor, Josh; Minter, Amanda; Begon, Mike; Costa, Federico] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Rodrigues, Gorete] Minist Saude, Ctr Controle Zoonoses, Secretaria Municipal Saude, Salvador, BA, Brazil; [Reis, Mitermayer G.; Ko, Albert I.; Childs, James E.; Costa, Federico] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; University of Liverpool; Yale University; Universidade Federal da Bahia	Costa, F (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.; Costa, F (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.; Costa, F (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.; Costa, F (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.	fcosta2001@gmail.com	Ko, Albert/P-2343-2015; Costa, Federico/G-1838-2015; Panti-May, Jesús Alonso/U-2798-2019; Reis, Mitermayer/AAO-9742-2020	Ko, Albert/0000-0001-9023-2339; Costa, Federico/0000-0001-6951-2336; Panti-May, Jesús Alonso/0000-0003-1669-5727; Reis, Mitermayer/0000-0002-3051-9060; , Amanda/0000-0003-1171-5688; Begon, Mike/0000-0003-1715-5327; Carvalho Pereira, Ticiana/0000-0003-2370-2198	Oswaldo Cruz Foundation; Secretariat of Health Surveillance, Brazilian Ministry of Health; National Institutes of Health [F31 AI114245, R01 AI052473, U01 AI088752, R01 TW009504, R25 TW009338]; Wellcome Trust [102330/Z/13/Z]; FOGARTY INTERNATIONAL CENTER [R01TW009504, R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI114245, U01AI088752, R01AI121207, R01AI052473] Funding Source: NIH RePORTER	Oswaldo Cruz Foundation; Secretariat of Health Surveillance, Brazilian Ministry of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Oswaldo Cruz Foundation and Secretariat of Health Surveillance, Brazilian Ministry of Health, the National Institutes of Health (grants F31 AI114245, R01 AI052473, U01 AI088752, R01 TW009504 and R25 TW009338) and by the Wellcome Trust (102330/Z/13/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; [Anonymous], 1907, J HYG-CAMBRIDGE, V7, P724; Berdoy Manuel, 2007, P380; Bergallo HG, 1999, J MAMMAL, V80, P472, DOI 10.2307/1383294; BISHOP JA, 1976, J ANIM ECOL, V45, P623, DOI 10.2307/3572; BLANCHARD DC, 1984, BEHAV PROCESS, V9, P31, DOI 10.1016/0376-6357(84)90006-8; Burthe SJ, 2010, OECOLOGIA, V162, P653, DOI 10.1007/s00442-009-1495-6; Buxton PA, 1936, J ANIM ECOL, V5, P53, DOI 10.2307/1091; CALHOUN JB, 1952, J MAMMAL, V33, P139, DOI 10.2307/1375923; CALHOUN JB, 1962, ECOLOGY SOCIOLOGY NO; Cavia R, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P147; Channon D, 2006, EPIDEMIOL INFECT, V134, P41, DOI 10.1017/S0950268805004607; Childs JE, 1998, AM J EPIDEMIOL, V148, P78, DOI 10.1093/oxfordjournals.aje.a009563; Costa F, 2016, J HERED, P1; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819; Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338; Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378; DAVIS DE, 1951, ECOLOGY, V32, P469, DOI 10.2307/1931724; DAVIS DE, 1949, J MAMMAL, V30, P125, DOI 10.2307/1375259; DAVIS DE, 1951, ECOLOGY, V32, P462, DOI 10.2307/1931722; DAVIS DE, 1948, ECOLOGY, V29, P437, DOI 10.2307/1932636; DAVIS DE, 1948, PHYSIOL ZOOL, V21, P272, DOI 10.1086/physzool.21.3.30152004; DAVIS DE, 1951, PHYSIOL ZOOL, V24, P9, DOI 10.1086/physzool.24.1.30152099; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; EMLEN JT, 1948, PHYSIOL ZOOL, V21, P59, DOI 10.1086/physzool.21.1.30151981; FARHANGAZAD A, 1977, J PARASITOL, V63, P117, DOI 10.2307/3280114; Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927; Glass G.E., 1989, Occasional Papers of the Museum of Natural History University of Kansas, VNo. 130, P1; GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350; Villafane IEG, 2013, MAMMALIA, V77, P187, DOI 10.1515/mammalia-2012-0075; Herbreteau V., 2011, PROTOCOLS FIELD LAB; Himsworth CG, 2015, VECTOR-BORNE ZOONOT, V15, P21, DOI 10.1089/vbz.2014.1657; Himsworth CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091654; Langton SD, 2001, J APPL ECOL, V38, P699, DOI 10.1046/j.1365-2664.2001.00631.x; Lantz DE, 1917, FARMERS B USDA; Leary S, 2013, AVMA GUIDELINES EUTH; Masi E, 2010, J PEST SCI, V83, P228, DOI 10.1007/s10340-010-0290-9; McDonald J.H., 2014, HDB BIOL STAT; McGuire B, 2006, AM MIDL NAT, V155, P221, DOI 10.1674/0003-0031(2006)155[0221:GEOARP]2.0.CO;2; Miller N, 1911, AM NAT, V45, P623, DOI 10.1086/279243; Mills J. N., 1995, METHODS TRAPPING SAM; ORGAIN H, 1953, ECOLOGY, V34, P467, DOI 10.2307/1929719; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; PERRY JS, 1945, P ZOOL SOC LOND, V115, P19; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Porter FH, 2015, J MAMMAL, V96, P317, DOI 10.1093/jmammal/gyv033; Sarkar U, 2002, AM J TROP MED HYG, V66, P605; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Vadell MV, 2014, WILDLIFE RES, V41, P172, DOI 10.1071/WR14005; World Health Organization, 1992, WHO M ROD EC POP DYN; Zar J. H., 1996, BIOSTATISTICAL ANAL	52	39	42	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152511	10.1371/journal.pone.0152511	http://dx.doi.org/10.1371/journal.pone.0152511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015422	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708900071
J	Zhang, QH; Gao, M; Luo, GF; Han, XF; Bao, WJ; Cheng, YY; Tian, W; Yan, MC; Yang, GL; An, J				Zhang, Qinghao; Gao, Mei; Luo, Guifen; Han, Xiaofeng; Bao, Wenjing; Cheng, Yanyan; Tian, Wang; Yan, Maocai; Yang, Guanlin; An, Jing			Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the beta-Catenin/Tcf4 Interaction	PLOS ONE			English	Article							CATENIN SIGNALING PATHWAY; BETA-CATENIN; STEM-CELLS; DOWN-REGULATION; WNT PATHWAY; TUMOR; RESISTANCE; TRANSCRIPTION; RADIOTHERAPY; ACTIVATION	Radiation therapy is an important treatment choice for unresectable advanced human lung cancers, and a critical adjuvant treatment for surgery. However, radiation as a lung cancer treatment remains far from satisfactory due to problems associated with radiation resistance in cancer cells and severe cytotoxicity to non-cancer cells, which arise at doses typically administered to patients. We have recently identified a promising novel inhibitor of beta-catenin/Tcf4 interaction, named BC-23 (C21H14ClN3O4S), which acts as a potent cell death enhancer when used in combination with radiation. Sequential exposure of human p53-null non-small cell lung cancer (NSCLC) H1299 cells to low doses of x-ray radiation, followed 1 hour later by administration of minimally cytotoxic concentrations of BC-23, resulted in a highly synergistic induction of clonogenic cell death (combination index < 1.0). Co-treatment with BC-23 at low concentrations effectively inhibits Wnt/beta-catenin signaling and down-regulates c-Myc and cyclin D1 expression. S phase arrest and ROS generation are also involved in the enhancement of radiation effectiveness mediated by BC-23. BC-23 therefore represents a promising new class of radiation enhancer.	[Zhang, Qinghao; Gao, Mei; Luo, Guifen; Han, Xiaofeng; Bao, Wenjing; Cheng, Yanyan; Tian, Wang; An, Jing] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Zhang, Qinghao; Gao, Mei; Luo, Guifen; Han, Xiaofeng; Bao, Wenjing; Cheng, Yanyan; Tian, Wang; An, Jing] SUNY Upstate Med Univ, SUNY Upstate Canc Res Inst, Syracuse, NY 13210 USA; [Bao, Wenjing; Cheng, Yanyan; Yang, Guanlin] Liaoning Univ Chinese Tradit Med, Dept Med, 33 Beiling St, Shenyang, Peoples R China; [Yan, Maocai] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA; [An, Jing] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	An, J (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.; An, J (corresponding author), SUNY Upstate Med Univ, SUNY Upstate Canc Res Inst, Syracuse, NY 13210 USA.; An, J (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jan@ticsd.edu	Yan, Maocai/Q-1435-2015	Yan, Maocai/0000-0002-1117-9398	Connolly Endowment/Hendricks Fund; LUNGevity Foundation	Connolly Endowment/Hendricks Fund; LUNGevity Foundation	This work was supported in part by grants from the Connolly Endowment/Hendricks Fund and the LUNGevity Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2004, J BIOL CHEM, V279, P19133, DOI 10.1074/jbc.M400295200; An J, 2007, ONCOGENE, V26, P652, DOI 10.1038/sj.onc.1209830; Baas P, 2011, CURR OPIN ONCOL, V23, P140, DOI 10.1097/CCO.0b013e328341eed6; Bogart JA, 2010, SEMIN THORAC CARDIOV, V22, P44, DOI 10.1053/j.semtcvs.2010.04.006; Bridges KA, 2011, CLIN CANCER RES, V17, P5638, DOI 10.1158/1078-0432.CCR-11-0650; Brunori M, 2001, J VIROL, V75, P2857, DOI 10.1128/JVI.75.6.2857-2865.2001; Chang JY, 2010, SEMIN RADIAT ONCOL, V20, P171, DOI 10.1016/j.semradonc.2010.01.005; Chen MS, 2007, J CELL SCI, V120, P468, DOI 10.1242/jcs.03348; Chen SS, 2011, INT J RADIAT ONCOL, V81, P1524, DOI 10.1016/j.ijrobp.2011.05.031; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; Ding YJ, 2014, J CELL SCI, V127, P4833, DOI 10.1242/jcs.146977; Dose M, 2014, P NATL ACAD SCI USA, V111, P391, DOI 10.1073/pnas.1315752111; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Campelo MRG, 2011, CLIN TRANSL ONCOL, V13, P77, DOI 10.1007/s12094-011-0622-0; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Janikova M, 2010, BIOMED PAP, V154, P321, DOI 10.5507/bp.2010.048; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Kazi A, 2009, CELL CYCLE, V8, P1940, DOI 10.4161/cc.8.12.8798; Kendziorra E, 2011, CARCINOGENESIS, V32, P1824, DOI 10.1093/carcin/bgr222; Lee SB, 2013, BIOCHEM BIOPH RES CO, V431, P746, DOI 10.1016/j.bbrc.2013.01.038; Li XX, 2013, J APPL MATH, DOI 10.1155/2013/245963; Luoto KR, 2010, CANCER RES, V70, P8748, DOI 10.1158/0008-5472.CAN-10-0944; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Nguyen Giang Huong, 2011, Cancers (Basel), V3, P1232, DOI 10.3390/cancers3011232; Shin SY, 2004, CANCER LETT, V212, P225, DOI 10.1016/j.canlet.2004.03.003; Stewart DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt356; Sullivan JP, 2010, CANCER METAST REV, V29, P61, DOI 10.1007/s10555-010-9216-5; Sun YG, 2011, J THORAC ONCOL, V6, P8, DOI 10.1097/JTO.0b013e3181fa646a; Takita H, 2009, LUNG CANCER, V63, P387, DOI 10.1016/j.lungcan.2008.06.010; Tian W, 2012, J BIOMOL SCREEN, V17, P530, DOI 10.1177/1087057111429745; Tian W, 2012, BIOCHEMISTRY-US, V51, P724, DOI 10.1021/bi201428h; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Wang L, 2013, WORLD J GASTROENTERO, V19, P6876, DOI 10.3748/wjg.v19.i40.6876; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yagui-Beltran A, 2009, ANN THORAC CARDIOVAS, V15, P213; Yue W, 2008, CARCINOGENESIS, V29, P84, DOI 10.1093/carcin/bgm267	38	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152407	10.1371/journal.pone.0152407	http://dx.doi.org/10.1371/journal.pone.0152407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27014877	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708900062
J	Griveau, A; Devailly, G; Eberst, L; Navaratnam, N; Le Calve, B; Ferrand, M; Faull, P; Augert, A; Dante, R; Vanacker, JM; Vindrieux, D; Bernard, D				Griveau, A.; Devailly, G.; Eberst, L.; Navaratnam, N.; Le Calve, B.; Ferrand, M.; Faull, P.; Augert, A.; Dante, R.; Vanacker, J. M.; Vindrieux, D.; Bernard, D.			The PLA2R1-JAK2 pathway upregulates ERR alpha and its mitochondrial program to exert tumor-suppressive action	ONCOGENE			English	Article							ESTROGEN-RELATED RECEPTOR; BREAST-CANCER; CELLS; PGC-1-ALPHA; METABOLISM; PGC-1-BETA; MIGRATION; STRESS; GROWTH; VEGF	Little is known about the biological role of the phospholipase A2 receptor (PLA2R1) transmembrane protein. In recent years, PLA2R1 has been shown to have an important role in regulating tumor-suppressive responses via JAK2 activation, but the underlying mechanisms are largely undeciphered. In this study, we observed that PLA2R1 increases the mitochondrial content, judged by increased levels of numerous mitochondrial proteins, of the mitochondrial structural component cardiolipin, of the mitochondrial DNA content, and of the mitochondrial DNA replication and transcription factor TFAM. This effect of PLA2R1 relies on a transcriptional program controlled by the estrogen-related receptor alpha1 (ERR alpha) mitochondrial master regulator. Expression of ERR alpha and of its nucleus-encoded mitochondrial targets is upregulated upon PLA2R1 ectopic expression, and this effect is mediated by JAK2. Conversely, downregulation of PLA2R1 decreases the level of ERR alpha and of its nucleus-encoded mitochondrial targets. Finally, blocking the ERR alpha-controlled mitochondrial program largely inhibits the PLA2R1-induced tumor-suppressive response. Together, our data document ERR alpha and its mitochondrial program as downstream effectors of the PLA2R1-JAK2 pathway leading to oncosuppression.	[Griveau, A.; Devailly, G.; Eberst, L.; Le Calve, B.; Ferrand, M.; Augert, A.; Dante, R.; Vindrieux, D.; Bernard, D.] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France; [Griveau, A.; Devailly, G.; Eberst, L.; Le Calve, B.; Ferrand, M.; Augert, A.; Dante, R.; Vindrieux, D.; Bernard, D.] CNRS, UMR 5286, Lyon, France; [Griveau, A.; Devailly, G.; Eberst, L.; Le Calve, B.; Ferrand, M.; Augert, A.; Dante, R.; Vindrieux, D.; Bernard, D.] Ctr Leon Berard, Lyon, France; [Griveau, A.; Devailly, G.; Eberst, L.; Le Calve, B.; Ferrand, M.; Augert, A.; Dante, R.; Vindrieux, D.; Bernard, D.] Univ Lyon, Lyon, France; [Navaratnam, N.] Imperial Coll, Fac Med, MRC Clin Sci Ctr, Cellular Stress Grp, Hammersmith Campus, London, England; [Faull, P.] Imperial Coll London, MRC Clin Sci Ctr, Biol Mass Spectrometry & Prote Lab, London, England; [Vanacker, J. M.] Univ Lyon 1, CNRS, UMR5242, Inst Genom Fonctionnelle Lyon,Ecole Normale Super, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; Imperial College London; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON)	Bernard, D (corresponding author), Ctr Rech Cancerol Lyon, CNRS, INSERM, U1052, F-69373 Lyon 08, France.	david.bernard@lyon.unicancer.fr	Devailly, Guillaume/S-3998-2019; Bernard, David/D-6265-2018	Devailly, Guillaume/0000-0001-8878-9357; Bernard, David/0000-0002-1557-2074; Vindrieux, David/0000-0002-4713-5768; Faull, Peter/0000-0001-8491-8086; GRIVEAU, Audrey/0000-0002-5928-6328	Association for International Cancer Research [AICR-11-0722]; ANR [ANR-14-CE12-0003]; Groupe Pasteur Mutualite; Ligue contre le cancer, comite du Puy de Dome et de la Drome	Association for International Cancer Research; ANR(French National Research Agency (ANR)); Groupe Pasteur Mutualite; Ligue contre le cancer, comite du Puy de Dome et de la Drome	We thank the laboratory members for helpful discussions. This work was carried out with the support of the Association for International Cancer Research (AICR-11-0722) and the ANR (ANR-14-CE12-0003) for DB, the Groupe Pasteur Mutualite for LE and the Ligue contre le cancer, comite du Puy de Dome et de la Drome for JMV.	Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Augert A, 2013, FREE RADICAL BIO MED, V65, P969, DOI 10.1016/j.freeradbiomed.2013.08.177; Augert A, 2009, EMBO REP, V10, P271, DOI 10.1038/embor.2008.255; Bernard D, 2014, BBA-REV CANCER, V1846, P40, DOI 10.1016/j.bbcan.2014.03.003; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Deblois G, 2010, CANCER RES, V70, P10277, DOI 10.1158/0008-5472.CAN-10-2840; Devailly G, 2015, NUCLEIC ACIDS RES, V43, P5838, DOI 10.1093/nar/gkv508; Ferbeyre G, 2011, BBA-REV CANCER, V1815, P104, DOI 10.1016/j.bbcan.2010.10.004; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Gallet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054837; Hong EJ, 2013, P NATL ACAD SCI USA, V110, P17975, DOI 10.1073/pnas.1315319110; Li Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003230; Manna S, 2015, CLIN CANC RES; Menschikowski M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-576; Miwa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4837; Sailland J, 2014, P NATL ACAD SCI USA, V111, P15108, DOI 10.1073/pnas.1402094111; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Vindrieux D, 2014, ONCOTARGET, V5, P1004, DOI 10.18632/oncotarget.1681; Vindrieux D, 2013, CANCER RES, V73, P6334, DOI 10.1158/0008-5472.CAN-13-0318; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Zou C, 2014, J PATHOL, V233, P61, DOI 10.1002/path.4329	29	14	15	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 22	2016	35	38					5033	5042		10.1038/onc.2016.43	http://dx.doi.org/10.1038/onc.2016.43			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW9GT	27041564				2022-12-26	WOS:000383965300007
J	Vashchenko, G; Das, S; Moon, KM; Rogalski, JC; Taves, MD; Soma, KK; Van Petegem, F; Foster, LJ; Hammond, GL				Vashchenko, Ganna; Das, Samir; Moon, Kyung-Mee; Rogalski, Jason C.; Taves, Matthew D.; Soma, Kiran K.; Van Petegem, Filip; Foster, Leonard J.; Hammond, Geoffrey L.			Identification of Avian Corticosteroid-binding Globulin (SerpinA6) Reveals the Molecular Basis of Evolutionary Adaptations in SerpinA6 Structure and Function as a Steroid-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen; glucocorticoid; N-linked glycosylation; progesterone; protein crystallization; stress; birds; serine proteinase inhibitor	APOLIPOPROTEIN-A-I; HORMONE-BINDING; CORTISOL; BIOSYNTHESIS; PLASMA; GENE; TETRAHYDROCORTISOL; TESTOSTERONE; RESPONSES; PITUITARY	Corticosteroid-binding globulin (CBG) was isolated from chicken serum and identified by mass spectrometry and genomic analysis. This revealed that the organization and synteny of avian and mammalian SerpinA6 genes are conserved. Recombinant zebra finch CBG steroid-binding properties reflect those of the natural protein in plasma and confirm its identity. Zebra finch and rat CBG crystal structures in complex with cortisol resemble each other, but their primary structures share only approximate to 40% identity, and their steroid-binding site topographies differ in several unexpected ways. Remarkably, a tryptophan that anchors ligands in mammalian CBG steroid-binding sites is replaced by an asparagine. Phylogenetic comparisons show that reptilian CBG orthologs share this unexpected property. Glycosylation of this asparagine in zebra finch CBG does not influence its steroid-binding affinity, but we present evidence that it may participate in protein folding and steroid-binding site formation. Substitutions of amino acids within zebra finch CBG that are conserved only in birds reveal how they contribute to their distinct steroid-binding properties, including their high (nanomolar) affinities for glucocorticoids, progesterone, and androgens. As in mammals, a protease secreted by Pseudomonas aeruginosa cleaves CBG in zebra finch plasma within its reactive center loop and disrupts steroid binding, suggesting an evolutionarily conserved property of CBGs. Measurements of CBG mRNA in zebra finch tissues indicate that liver is the main site of plasma CBG production, and anti-zebra finch CBG antibodies cross-react with CBGs in other birds, extending opportunities to study how CBG regulates the actions of glucocorticoids and sex steroids in these species.	[Vashchenko, Ganna; Hammond, Geoffrey L.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Das, Samir; Moon, Kyung-Mee; Rogalski, Jason C.; Van Petegem, Filip; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Taves, Matthew D.; Soma, Kiran K.] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Hammond, GL (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada.	geoffrey.hammond@ubc.ca	Taves, Matthew Donald/AAW-3148-2020; Van Petegem, Filip/M-6061-2016; Soma, Kiran K/B-9772-2012	Taves, Matthew Donald/0000-0002-4841-059X; Van Petegem, Filip/0000-0003-2728-8537; Soma, Kiran K/0000-0003-2169-8092; Hammond, Geoffrey/0000-0002-4639-7336	Canadian Institutes of Health [MOP111102, MOP77688, MOP119404]; Natural Sciences and Engineering Research Council [RGPIN-2014-04884]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Grants MOP111102 (to G. L. H.), MOP77688 (to L. J. F.), and MOP119404 (to F. V. P.) and Natural Sciences and Engineering Research Council Grant RGPIN-2014-04884 (to K. K. S). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AVVAKUMOV GV, 1993, J BIOL CHEM, V268, P862; Baker ME, 2013, J STEROID BIOCHEM, V137, P57, DOI 10.1016/j.jsbmb.2013.07.009; BERDUSCO ETM, 1993, ENDOCRINOLOGY, V132, P2001, DOI 10.1210/en.132.5.2001; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Charlier TD, 2009, HORM BEHAV, V56, P339, DOI 10.1016/j.yhbeh.2009.06.012; Colombo L, 2006, J ENDOCRINOL INVEST, V29, P373, DOI 10.1007/BF03344112; Deviche P, 2001, GEN COMP ENDOCR, V122, P67, DOI 10.1006/gcen.2001.7613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Fredslund J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-315; Gardill BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052759; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Goodson JL, 2005, HORM BEHAV, V48, P461, DOI 10.1016/j.yhbeh.2005.04.005; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; HAMMOND GL, 1986, J STEROID BIOCHEM, V24, P815, DOI 10.1016/0022-4731(86)90442-5; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HAMMOND GL, 1990, ENDOCR REV, V11, P65, DOI 10.1210/edrv-11-1-65; Harms MJ, 2014, NATURE, V512, P203, DOI 10.1038/nature13410; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Hill LA, 2012, J CLIN ENDOCR METAB, V97, P4260, DOI 10.1210/jc.2012-2467; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; Huntington JA, 2003, STRUCTURE, V11, P205, DOI 10.1016/S0969-2126(02)00944-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; KONISHI M, 1989, SCIENCE, V246, P465, DOI 10.1126/science.2683069; Lewis JG, 2014, MOL CELL ENDOCRINOL, V384, P96, DOI 10.1016/j.mce.2014.01.005; Li DM, 2012, HORM BEHAV, V61, P582, DOI 10.1016/j.yhbeh.2012.02.007; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lin HY, 2010, MOL CELL ENDOCRINOL, V316, P3, DOI 10.1016/j.mce.2009.06.015; Lin HY, 2009, J BIOL CHEM, V284, P884, DOI 10.1074/jbc.M807376200; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Lynn SE, 2010, HORM BEHAV, V58, P214, DOI 10.1016/j.yhbeh.2010.03.015; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malisch JL, 2010, MOL CELL ENDOCRINOL, V316, P42, DOI 10.1016/j.mce.2009.09.019; Malisch JL, 2010, GEN COMP ENDOCR, V165, P345, DOI 10.1016/j.ygcen.2009.08.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ousova O, 2004, MOL ENDOCRINOL, V18, P1687, DOI 10.1210/me.2004-0005; Panin LE, 2007, B EXP BIOL MED+, V144, P291, DOI 10.1007/s10517-007-0313-6; Panin LE, 2003, J STEROID BIOCHEM, V87, P309, DOI 10.1016/j.jsbmb.2003.09.004; Parker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011096; ROBINSON PA, 1985, J ENDOCRINOL, V104, P259, DOI 10.1677/joe.0.1040259; Romero LM, 2006, GEN COMP ENDOCR, V149, P66, DOI 10.1016/j.ygcen.2006.05.011; Romero LM, 2006, GEN COMP ENDOCR, V149, P58, DOI 10.1016/j.ygcen.2006.05.004; Schmidt KL, 2010, BRAIN BEHAV IMMUN, V24, P908, DOI 10.1016/j.bbi.2010.02.008; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P910, DOI 10.1210/en.132.2.910; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P903, DOI 10.1210/en.132.2.903; SERALINI GE, 1990, MOL ENDOCRINOL, V4, P1166, DOI 10.1210/mend-4-8-1166; SERALINI GE, 1990, HUM GENET, V86, P73; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Simard M, 2015, J CLIN ENDOCR METAB, V100, pE129, DOI 10.1210/jc.2014-3130; Simard M, 2014, ENDOCRINOLOGY, V155, P2900, DOI 10.1210/en.2014-1055; Smith C L, 1988, Steroids, V52, P331, DOI 10.1016/0039-128X(88)90132-8; UNDERHILL DA, 1995, GENE, V162, P205, DOI 10.1016/0378-1119(95)00337-6; UNDERHILL DA, 1989, MOL ENDOCRINOL, V3, P1448, DOI 10.1210/mend-3-9-1448; Verhoog N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110702; Walker SE, 2002, AVIAN DIS, V46, P1045, DOI 10.1637/0005-2086(2002)046[1045:COPAIA]2.0.CO;2; Westphal U, 1986, Monogr Endocrinol, V27, P1; WINGFIELD JC, 1984, GEN COMP ENDOCR, V53, P281, DOI 10.1016/0016-6480(84)90254-5; Wingfield JC, 2005, HORM BEHAV, V48, P395, DOI 10.1016/j.yhbeh.2005.06.003; Zhang GJ, 2014, SCIENCE, V346, P1308, DOI 10.1126/science.346.6215.1308; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zinzow-Kramer WM, 2014, HORM BEHAV, V66, P267, DOI 10.1016/j.yhbeh.2014.04.011	66	10	10	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11300	11312		10.1074/jbc.M116.714378	http://dx.doi.org/10.1074/jbc.M116.714378			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27026706	Green Published, hybrid			2022-12-26	WOS:000377042100029
J	Moreno-Marin, F; Vergara, JJ; Perez-Llorens, JL; Pedersen, MF; Brun, FG				Moreno-Marin, Francisco; Vergara, Juan J.; Lucas Perez-Llorens, J.; Pedersen, Morten F.; Brun, Fernando G.			Interaction between Ammonium Toxicity and Green Tide Development Over Seagrass Meadows: A Laboratory Study	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; NITROGEN UPTAKE; MACROALGAL BLOOMS; NUTRIENT CONTROL; COASTAL WATERS; ULVA-RIGIDA; GROWTH; NOLTII; CANOPIES; ECOSYSTEM	Eutrophication affects seagrasses negatively by increasing light attenuation through stimulation of biomass of fast-growing, bloom-forming algae and because high concentrations of ammonium in the water can be toxic to higher plants. We hypothesized nevertheless, that moderate amounts of nitrophilic macroalgae that coexists with seagrasses under eutrophic conditions, can alleviate the harmful effects of eutrophication on seagrasses by reducing ammonium concentrations in the seawater to non-toxic levels because such algae have a very large capacity to take up inorganic nutrients. We studied therefore how combinations of different ammonium concentrations (0, 25 and 50 mu M) and different standing stocks of macroalgae (i.e. 0, 1 and 6 layers of Ulva sp.) affected survival, growth and net production of the seagrass Zostera noltei. In the absence of Ulva sp., increasing ammonium concentrations had a negative influence on the performance of Z. noltei. The presence of Ulva sp. without ammonium supply had a similar, but slightly smaller, negative effect on seagrass fitness due to light attenuation. When ammonium enrichment was combined with presence of Ulva sp., Ulva sp. ameliorated some of negative effects caused by high ammonium availability although Ulva sp. lowered the availability of light. Benthic microalgae, which increased in biomass during the experiment, seemed to play a similar role as Ulva sp.-they contributed to remove ammonium from the water, and thus, aided to keep the ammonium concentrations experienced by Z. noltei at relatively non-toxic levels. Our findings show that moderate amounts of drift macroalgae, eventually combined with increasing stocks of benthic microalgae, may aid seagrasses to alleviate toxic effects of ammonium under eutrophic conditions, which highlights the importance of high functional diversity for ecosystem resistance to anthropogenic disturbance.	[Moreno-Marin, Francisco; Vergara, Juan J.; Lucas Perez-Llorens, J.; Brun, Fernando G.] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus Excelencia Int Mar CEIMAR, Puerto Real 11510, Cadiz, Spain; [Moreno-Marin, Francisco; Pedersen, Morten F.] Roskilde Univ, Dept Nat Sci & Environm, POB 2660, DK-4000 Roskilde, Denmark	Universidad de Cadiz; Roskilde University	Moreno-Marin, F (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus Excelencia Int Mar CEIMAR, Puerto Real 11510, Cadiz, Spain.; Moreno-Marin, F (corresponding author), Roskilde Univ, Dept Nat Sci & Environm, POB 2660, DK-4000 Roskilde, Denmark.	francisco.moreno@uca.es	Perez-Llorens, Jose Lucas/B-9361-2009; Perez-Llorens, Jose Lucas/GQR-0711-2022; Brun, Fernando G. G/L-1346-2014; Vergara, Juan J/H-9808-2012; Perez-Llorens, Jose Lucas/AAD-7078-2020	Perez-Llorens, Jose Lucas/0000-0003-2813-1443; Perez-Llorens, Jose Lucas/0000-0003-2813-1443; Brun, Fernando G. G/0000-0002-6313-9531; Vergara, Juan J/0000-0003-4479-4693; Perez-Llorens, Jose Lucas/0000-0003-2813-1443	Spanish Ministry of Science and Innovation [CTM2011-24482]; Junta de Andalucia Excellence Project PRODESCA [P12-RNM-03020]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia Excellence Project PRODESCA(Junta de Andalucia)	This work was supported by the Spanish Project Sea-Live (CTM2011-24482) from the Spanish Ministry of Science and Innovation and by the Junta de Andalucia Excellence Project PRODESCA (P12-RNM-03020). Francisco Moreno holds a contract financed by the Spanish Project Sea-Live (CTM2011-24482) from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borum J, 2005, J ECOL, V93, P148, DOI 10.1111/j.1365-2745.2004.00943.x; Borum J, 1996, OIKOS, V76, P406, DOI 10.2307/3546213; BOWER CE, 1980, CAN J FISH AQUAT SCI, V37, P794, DOI 10.1139/f80-106; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Brun FG, 2008, MAR ECOL PROG SER, V365, P67, DOI 10.3354/meps07512; Brun FG, 2003, MAR ECOL PROG SER, V265, P85, DOI 10.3354/meps265085; Brun FG, 2003, FUNCT PLANT BIOL, V30, P551, DOI 10.1071/FP03010; Brun FG, 2002, MAR ECOL PROG SER, V225, P177, DOI 10.3354/meps225177; Conley DJ, 2007, ECOL APPL, V17, pS165, DOI 10.1890/05-0766.1; Costanza R, 1997, FRONTIERS ECOLOGICAL; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; DEBUSK TA, 1986, BOT MAR, V29, P381, DOI 10.1515/botm.1986.29.5.381; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; Gerendas J, 1997, Z PFLANZ BODENKUNDE, V160, P239, DOI 10.1002/jpln.19971600218; GOYAL SS, 1982, J AM SOC HORTIC SCI, V107, P125; Greve TM, 2003, LIMNOL OCEANOGR, V48, P210, DOI 10.4319/lo.2003.48.1.0210; Hauxwell J, 2001, ECOLOGY, V82, P1007, DOI 10.2307/2679899; Holmer M, 2001, AQUAT BOT, V70, P29, DOI 10.1016/S0304-3770(00)00142-X; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; IIZUMI H, 1982, AQUAT BOT, V12, P245, DOI 10.1016/0304-3770(82)90020-1; Marschener H, 1995, MINERAL NUTR HIGHER; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; McGlathery KJ, 2001, J PHYCOL, V37, P453, DOI 10.1046/j.1529-8817.2001.037004453.x; McGlathery KJ, 1996, J PHYCOL, V32, P393, DOI 10.1111/j.0022-3646.1996.00393.x; Meyers L. S., 2006, APPL MULTIVARIATE RE; Pedersen MF, 1996, MAR ECOL PROG SER, V142, P261, DOI 10.3354/meps142261; Pedersen MF, 1997, AQUAT BOT, V56, P105, DOI 10.1016/S0304-3770(96)01100-X; Pedersen MF, 1997, MAR ECOL PROG SER, V161, P155, DOI 10.3354/meps161155; Peralta G, 2002, J EXP MAR BIOL ECOL, V269, P9, DOI 10.1016/S0022-0981(01)00393-8; Perez M, 2007, J EXP MAR BIOL ECOL, V344, P149, DOI 10.1016/j.jembe.2006.12.020; Rasmussen JR, 2013, ESTUAR COAST SHELF S, V119, P167, DOI 10.1016/j.ecss.2013.01.006; Ritchie RJ, 2008, PHOTOSYNTHETICA, V46, P115, DOI 10.1007/s11099-008-0019-7; SANDJENSEN K, 1991, AQUAT BOT, V41, P137, DOI 10.1016/0304-3770(91)90042-4; Santandreu M, 2012, THESIS U CADIZ; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; SHORT FT, 1984, BOT MAR, V27, P547, DOI 10.1515/botm.1984.27.12.547; Small C, 2003, J COASTAL RES, V19, P584; Stapel J, 1996, MAR ECOL PROG SER, V134, P195, DOI 10.3354/meps134195; THURSBY GB, 1982, MAR BIOL, V72, P109, DOI 10.1007/BF00396910; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P133, DOI 10.1016/S0022-0981(00)00195-7; ULLRICH WR, 1984, PHYSIOL PLANTARUM, V61, P369, DOI 10.1111/j.1399-3054.1984.tb06342.x; Underwood AJ, 1997, THEIR LOGICAL DESIGN; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; van der Heide T, 2008, OECOLOGIA, V158, P411, DOI 10.1007/s00442-008-1155-2; Van Engeland T, 2013, MAR ECOL PROG SER, V478, P87, DOI 10.3354/meps10183; Van Engeland T, 2011, MAR ECOL PROG SER, V427, P71, DOI 10.3354/meps09054; vanKatwijk MM, 1997, MAR ECOL PROG SER, V157, P159, DOI 10.3354/meps157159; Vergara JJ, 1998, MAR ECOL PROG SER, V165, P283, DOI 10.3354/meps165283; Vergara JJ, 2012, ESTUAR COAST SHELF S, V112, P255, DOI 10.1016/j.ecss.2012.07.031; Villazan B, 2016, MAR ECOL PROG SER, V545, P109, DOI 10.3354/meps11631; Villazan B, 2013, MAR ECOL PROG SER, V493, P141, DOI 10.3354/meps10517; Villazan B, 2013, MAR ECOL PROG SER, V488, P133, DOI 10.3354/meps10395; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zhang M, 2011, CHEMOSPHERE, V82, P329, DOI 10.1016/j.chemosphere.2010.10.038	57	24	25	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152971	10.1371/journal.pone.0152971	http://dx.doi.org/10.1371/journal.pone.0152971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035662	Green Published, gold			2022-12-26	WOS:000373201200051
J	Fu, XY; Yu, SF; Yang, BY; Lao, SH; Li, BQ; Wu, CY				Fu, Xiaoying; Yu, Sifei; Yang, Binyan; Lao, Suihua; Li, Baiqing; Wu, Changyou			Memory-Like Antigen-Specific Human NK Cells from TB Pleural Fluids Produced IL-22 in Response to IL-15 or Mycobacterium tuberculosis Antigens	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BACILLE CALMETTE-GUERIN; INNATE LYMPHOID-CELLS; ADAPTIVE IMMUNITY; EFFECTOR FUNCTION; TRAINED IMMUNITY; IFN-GAMMA; CD4(+); INFLAMMATION; INFECTION	Our previous result indicated that memory-like human natural killer (NK) cells from TB pleural fluid cells (PFCs) produced large amounts of IFN-gamma in response to Bacille Calmette Guerin (BCG). Furthermore, recent studies have shown that human lymphoid tissues harbored a unique NK cell subset that specialized in production of interleukin (IL)-22, a proinflammatory cytokine that mediates host defense against pathogens. Yet little information was available with regard to the properties of IL-22 production by memory-like human NK cells. In the present study, we found that cytokines IL-15 induced and IL-12 enhanced the levels of IL-22 by NK cells from TB PFCs. In addition, IL-22 but not IL-17 was produced by NK cells from PFCs in response to BCG and M. tb-related Ags. More importantly, the subset of specific IL-22-producing NK cells were distinct from IFN-gamma-producing NK cells in PFCs. CD45RO(+) or CD45RO(-) NK cells were sorted, co-cultured with autologous monocytes and stimulated with BCG for the production of IL-22. The result demonstrated that CD45RO(+) but not CD45RO(-) NK cells produced significantly higher level of IL-22. Anti-IL-12R beta 1 mAbs (2B10) partially inhibit the expression of IL-22 by NK cells under the culture with BCG. Consistently, BCG specific IL-22-producing NK cells from PFCs expressed CD45RO(high)NKG2D(high)granzyme B-high. In conclusion, our data demonstrated that memory-like antigen-specific CD45RO(+) NK cells might participate in the recall immune response for M. tb infection via producing IL-22, which display a critical role to fight against M. tb.	[Fu, Xiaoying; Yu, Sifei; Yang, Binyan; Wu, Changyou] Sun Yat Sen Univ, Key Lab Trop Dis Control Res, Zhongshan Sch Med, Inst Immunol,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Lao, Suihua] Chest Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China; [Li, Baiqing] Bengbu Med Coll, Dept Immunol, Immunol Res Ctr, Bengbu, Peoples R China	Sun Yat Sen University; Bengbu Medical College	Wu, CY (corresponding author), Sun Yat Sen Univ, Key Lab Trop Dis Control Res, Zhongshan Sch Med, Inst Immunol,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	changyou_wu@yahoo.com			National Basic Research Program of China [2013CB531500]; Guangdong Provinicial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology [2013A061401007]	National Basic Research Program of China(National Basic Research Program of China); Guangdong Provinicial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology	This study was funded by grants from the National Basic Research Program of China (no. 2013CB531500) and Guangdong Provinicial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology (no. 2013A061401007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2005, J INFECT DIS, V192, P399, DOI 10.1086/431680; Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Cummings KJ, 2007, TUBERCULOSIS CONTROL, P683; Dhiman R, 2012, J IMMUNOL, V189, P897, DOI 10.4049/jimmunol.1102833; Dhiman R, 2009, J IMMUNOL, V183, P6639, DOI 10.4049/jimmunol.0902587; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Esin S, 2004, IMMUNOLOGY, V112, P143, DOI 10.1111/j.1365-2567.2004.01858.x; Feng L, 2011, EUR J IMMUNOL, V41, P3261, DOI 10.1002/eji.201141625; Fu XY, 2013, CLIN IMMUNOL, V148, P113, DOI 10.1016/j.clim.2013.04.003; Fu XY, 2011, IMMUNOLOGY, V134, P41, DOI 10.1111/j.1365-2567.2011.03464.x; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kleinnijenhuis J, 2014, CLIN IMMUNOL, V155, P213, DOI 10.1016/j.clim.2014.10.005; Le Bert N, 2014, IMMUNOL CELL BIOL, V92, P230, DOI 10.1038/icb.2013.111; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082196; Li L, 2012, TUBERCULOSIS, V92, P63, DOI 10.1016/j.tube.2011.11.004; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023700; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020165; Li L, 2011, IMMUNOBIOLOGY, V216, P477, DOI 10.1016/j.imbio.2010.09.003; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Liu Y, 2011, IMMUNOLOGY, V132, P540, DOI 10.1111/j.1365-2567.2010.03399.x; Liu Y, 2009, EUR J IMMUNOL, V39, P1472, DOI 10.1002/eji.200838811; Luetke-Eversloh M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004441; Mackay CR, 2001, SCIENCE, V291, P2323, DOI 10.1126/science.1059984; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Qiao D, 2011, INFECT IMMUN, V79, P3358, DOI 10.1128/IAI.00014-11; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Schierloh P, 2007, INFECT IMMUN, V75, P5325, DOI 10.1128/IAI.00381-07; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Smith-Garvin JE, 2013, NATURE, V497, P194, DOI 10.1038/497194b; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Yeste A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4753; Yonkers NL, 2009, CLIN IMMUNOL, V131, P288, DOI 10.1016/j.clim.2008.12.012; Zeng GC, 2011, J IMMUNOL, V187, P190, DOI 10.4049/jimmunol.1004129; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	47	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151721	10.1371/journal.pone.0151721	http://dx.doi.org/10.1371/journal.pone.0151721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031950	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800020
J	Rolle, K; Piwecka, M; Belter, A; Wawrzyniak, D; Jeleniewicz, J; Barciszewska, MZ; Barciszewski, J				Rolle, Katarzyna; Piwecka, Monika; Belter, Agnieszka; Wawrzyniak, Dariusz; Jeleniewicz, Jaroslaw; Barciszewska, Miroslawa Z.; Barciszewski, Jan			The Sequence and Structure Determine the Function of Mature Human miRNAs	PLOS ONE			English	Article							MESSENGER-RNA DECAY; BINDING PROTEIN; MICRORNA; TRANSLATION; SPECIFICITY; BIOGENESIS; MECHANISMS; REPEATS; PATHWAY; GENOME	Micro RNAs (miRNAs) (19-25 nucleotides in length) belong to the group of non-coding RNAs are the most abundant group of posttranscriptional regulators in multicellular organisms. They affect a gene expression by binding of fully or partially complementary sequences to the 3'-UTR of target mRNA. Furthermore, miRNAs present a mechanism by which genes with diverse functions on multiple pathways can be simultaneously regulated at the post-transcriptional level. However, little is known about the specific pathways through which miRNAs with specific sequence or structural motifs regulate the cellular processes. In this paper we showed the broad and deep characteristics of mature miRNAs according to their sequence and structural motifs. We investigated a distinct group of miRNAs characterized by the presence of specific sequence motifs, such as UGUGU, GUrepeats and purine/pyrimidine contents. Using computational function and pathway analysis of their targeted genes, we were able to observe the relevance of sequence and the type of targeted mRNAs. As the consequence of the sequence analysis we finally provide the comprehensive description of pathways, biological processes and proteins associated with the distinct group of characterized miRNAs. Here, we found that the specific group of miRNAs with UGUGU can activate the targets associated to the interferon induction pathway or pathways prominently observed during carcinogenesis. GU-rich miRNAs are prone to regulate mostly processes in neurogenesis, whereas purine/pyrimidine rich miRNAs could be involved rather in transport and/or degradation of RNAs. Additionally, we have also analyzed the simple sequence repeats (SSRs). Their variation within mature miRNAs might be critical for normal miRNA regular activity. Expansion or contraction of SSRs in mature miRNA might directly affect its mRNA interaction or even change the function of that distinct miRNA. Our results prove that due to the specific sequence features, these molecules can also be involved in well-defined cellular processes depending on their sequence contents. The pathway mapping and theoretical gene target identification allowed us to create a biological framework to show the relevance of the specific miRNAs in regulation the distinct type of targets.	[Rolle, Katarzyna; Piwecka, Monika; Belter, Agnieszka; Wawrzyniak, Dariusz; Jeleniewicz, Jaroslaw; Barciszewska, Miroslawa Z.; Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland	Polish Academy of Sciences	Rolle, K; Barciszewski, J (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	Katarzyna.Rolle@ibch.poznan.pl; Jan.Barciszewski@ibch.poznan.pl	Belter, Agnieszka/W-6074-2018; Barciszewski, Jan/N-9283-2019	Belter, Agnieszka/0000-0001-7082-4986; Barciszewski, Jan/0000-0001-7766-5594; Piwecka, Monika/0000-0003-4104-6577; Wawrzyniak, Dariusz/0000-0002-6128-5383; Rolle, Katarzyna/0000-0002-4175-2490	European Regional Development Fund within the Innovative Economy Programme [POIG.01.03.01-30-050/09]; National Science Centre [5955/B/P01/2010/38]; Ministry of Science and Higher Education of the Republic of Poland by KNOW program	European Regional Development Fund within the Innovative Economy Programme; National Science Centre(National Science Centre, Poland); Ministry of Science and Higher Education of the Republic of Poland by KNOW program	This work was supported by the European Regional Development Fund within the Innovative Economy Programme, action 1.3.1. (POIG.01.03.01-30-050/09), http://www.poig.2007-2013.gov.pl/Strony/default.aspx, the National Science Centre, grant 5955/B/P01/2010/38, https://www.ncn.gov.pl/?language=en, and the Ministry of Science and Higher Education of the Republic of Poland by KNOW program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2005, J HERED, V96, P644, DOI 10.1093/jhered/esi097; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Belter A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113848; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen M, 2010, MOL BIOL EVOL, V27, P2227, DOI 10.1093/molbev/msq100; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; Das A.K., 2011, INT J AGR SCI, V3, P62; Dereeper A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-465; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fang ZD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054215; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flannery ML, 2006, THEOR APPL GENET, V113, P1221, DOI 10.1007/s00122-006-0377-0; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; Fu Y, 2012, CHEMBIOCHEM, V13, P112, DOI 10.1002/cbic.201100487; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Halees AS, 2011, RNA BIOL, V8, P681, DOI 10.4161/rna.8.4.16283; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ito K, 2011, J AM CHEM SOC, V133, P19153, DOI 10.1021/ja206353c; Janas MM, 2012, EMBO J, V31, P2446, DOI 10.1038/emboj.2012.119; JUCKER FM, 1995, RNA, V1, P219; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kiliszek A, 2012, NUCLEIC ACIDS RES, V40, P8155, DOI 10.1093/nar/gks557; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maiti M, 2010, BIOCHEM BIOPH RES CO, V392, P572, DOI 10.1016/j.bbrc.2010.01.072; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Mishra AK, 2009, BIOINFORMATION, V4, P151, DOI 10.6026/97320630004151; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rother M, 2011, NUCLEIC ACIDS RES, V39, P4007, DOI 10.1093/nar/gkq1320; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Stewart CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021552; Subramanian S, 2003, BIOINFORMATICS, V19, P549, DOI 10.1093/bioinformatics/btg029; Taulli R, 2013, NAT STRUCT MOL BIOL, V20, P541, DOI 10.1038/nsmb.2580; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang B, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/951570; Yang H, 2012, INT J ONCOL, V41, P2213, DOI 10.3892/ijo.2012.1658; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024	70	32	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151246	10.1371/journal.pone.0151246	http://dx.doi.org/10.1371/journal.pone.0151246			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031951	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800010
J	Romeiras, MM; Vieira, A; Silva, DN; Moura, M; Santos-Guerra, A; Batista, D; Duarte, MC; Paulo, OS				Romeiras, Maria M.; Vieira, Ana; Silva, Diogo N.; Moura, Monica; Santos-Guerra, Arnoldo; Batista, Dora; Duarte, Maria Cristina; Paulo, Octavio S.			Evolutionary and Biogeographic Insights on the Macaronesian Beta-Patellifolia Species (Amaranthaceae) from a Time-Scaled Molecular Phylogeny	PLOS ONE			English	Article							CERCOSPORA-BETICOLA; GENETIC-STRUCTURE; WILD RELATIVES; POLYMYXA-BETAE; VULGARIS; HYBRIDIZATION; RESISTANCE; PROCUMBENS; ADDITIONS; NETWORKS	The Western Mediterranean Region and Macaronesian Islands are one of the top biodiversity hotspots of Europe, containing a significant native genetic diversity of global value among the Crop Wild Relatives (CWR). Sugar beet is the primary crop of the genus Beta (subfamily Betoideae, Amaranthaceae) and despite the great economic importance of this genus, and of the close relative Patellifolia species, a reconstruction of their evolutionary history is still lacking. We analyzed nrDNA (ITS) and cpDNA gene (matK, trnH-psbA, trnL intron, rbcL) sequences to: (i) investigate the phylogenetic relationships within the Betoideae subfamily, and (ii) elucidate the historical biogeography of wild beet species in the Western Mediterranean Region, including the Macaronesian Islands. The results support the Betoideae as a monophyletic group (excluding the Acroglochin genus) and provide a detailed inference of relationships within this subfamily, revealing: (i) a deep genetic differentiation between Beta and Patellifolia species, which may have occurred in Late Oligocene; and (ii) the occurrence of a West-East genetic divergence within Beta, indicating that the Mediterranean species probably differentiated by the end of the Miocene. This was interpreted as a signature of species radiation induced by dramatic habitat changes during the Messinian Salinity Crisis (MSC, 5.96-5.33 Mya). Moreover, colonization events during the Pleistocene also played a role in shaping the current diversity patterns among and within the Macaronesian Islands. The origin and number of these events could not be revealed due to insufficient phylogenetic resolution, suggesting that the diversification was quite recent in these archipelagos, and unravelling potential complex biogeographic patterns with hybridization and gene flow playing an important role. Finally, three evolutionary lineages were identified corresponding to major gene pools of sugar beet wild relatives, which provide useful information for establishing in situ and ex situ conservation priorities in the hotspot area of the Macaronesian Islands.	[Romeiras, Maria M.] Univ Lisbon, Fac Ciencias, Biosyst & Integrat Sci Inst BioISI, Lisbon, Portugal; [Romeiras, Maria M.; Vieira, Ana; Silva, Diogo N.; Batista, Dora; Duarte, Maria Cristina; Paulo, Octavio S.] Univ Lisbon, Fac Ciencias, CE3C, Lisbon, Portugal; [Vieira, Ana; Silva, Diogo N.; Batista, Dora] Univ Lisbon, Inst Super Agron, Ctr Invest Ferrugens Cafeeiro, Oeiras, Portugal; [Moura, Monica] Univ Porto, Associate Lab CIBIO InBIO, Res Network Biodivers & Evolutionary Biol, Vairao, Portugal; [Moura, Monica] Univ Acores, Dept Biol, Ponta Delgada, Portugal; [Santos-Guerra, Arnoldo] Jardin Aclimatac La Orotava ICIA, Unidad Bot, Tenerife, Spain	BIOISI; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade do Porto; Universidade dos Acores	Romeiras, MM (corresponding author), Univ Lisbon, Fac Ciencias, Biosyst & Integrat Sci Inst BioISI, Lisbon, Portugal.; Romeiras, MM (corresponding author), Univ Lisbon, Fac Ciencias, CE3C, Lisbon, Portugal.	mromeiras@yahoo.co.uk	Duarte, Maria Cristina/L-7571-2013; Paulo, Octávio/D-9921-2011; Duarte, Maria Cristina/AAA-9211-2021; Romeiras, Maria M./J-4552-2013; Batista, Dora/N-7385-2013	Duarte, Maria Cristina/0000-0002-3823-4369; Paulo, Octávio/0000-0001-5408-5212; Duarte, Maria Cristina/0000-0002-3823-4369; Romeiras, Maria M./0000-0002-9373-6302; Batista, Dora/0000-0003-4031-8999; Vieira, Ana/0000-0003-4384-6746; Moura, Monica/0000-0001-5555-2388; Silva, Diogo/0000-0002-6827-2673	Portuguese Foundation for Science and Technology (FCT); European Social Fund through project [PTDC/BIA-BIC/4113/2012]; FCT [SFRH/BGCT/113708/2015, SFRH/BD/89397/2012, SFRH/BD/86736/2012, SFRH/BPD/104629/2014]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund through project; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Some of the authors were supported by FCT grants: MMR: SFRH/BGCT/113708/2015: AV: SFRH/BD/89397/2012; DS: SFRH/BD/86736/2012; DB: SFRH/BPD/104629/2014. This research was supported by the Portuguese Foundation for Science and Technology (FCT) and the European Social Fund through project PTDC/BIA-BIC/4113/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksidze G, 2009, REPORT WORKING GROUP, P38; Barber JC, 2007, TAXON, V56, P74, DOI 10.2307/25065737; Bateman RM, 2013, PEERJ, V1, DOI 10.7717/peerj.218; Bilz M., 2011, EUROPEAN RED LIST VA, DOI DOI 10.1007/s11258-005-2182-2; Boratynski A, 2014, BOT J LINN SOC, V174, P637, DOI 10.1111/boj.12147; Bramwell D., 2011, BIOL ISLAND FLORAS; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Casimiro-Soriguer R, 2010, MOL PHYLOGENET EVOL, V56, P441, DOI 10.1016/j.ympev.2010.02.025; Castro S, 2013, PLANT SCI, V207, P72, DOI 10.1016/j.plantsci.2013.02.012; Castroviejo S., 1990, FLORA IBERICA, VII, P476; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Davis PH, 1988, FLORA OF TURKEY AND, V10; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Food and Agriculture Organization of the United Nations, 2010, 2 REP STAT WORLDS PL; Ford-Lloyd BV, 2011, BIOSCIENCE, V61, P559, DOI 10.1525/bio.2011.61.7.10; Ford-Lloyd BV, 2005, GENETICS BREEDING SU, P25; Frese L., 2003, Schriften zu Genetischen Ressourcen, P170; Frese L, 2009, REPORT WORKING GROUP, P45; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Heleno R, 2015, GLOBAL ECOL BIOGEOGR, V24, P518, DOI 10.1111/geb.12273; Hohmann S, 2006, TAXON, V55, P67, DOI 10.2307/25065529; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jung B, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.1, 10.1038/NPLANTS.2014.1]; Kadereit Gudrun, 2006, Willdenowia, V36, P9, DOI 10.3372/wi.36.36101; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kell S., 2007, BOCCONEA, V21, P413; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kuhn U, 1993, FAMILIES GENERA VASC, P253, DOI DOI 10.1007/978-3-662-02899-5_26; Leys M, 2014, ECOL EVOL, V4, P1828, DOI 10.1002/ece3.1061; Maxted N., 2008, P3, DOI 10.1079/9781845930998.0003; Maxted N., 2009, FAO COMM GENET RESOU, P1; McGrath JM, 2011, WILD CROP RELATIVES, P1, DOI 10.1007/978-3-642-21102-7_1; Mesbah M, 1997, EUPHYTICA, V97, P117, DOI 10.1023/A:1003088922086; Miller MA, 2014, CIPRES PORTALS; Monteiro F., 2013, American Journal of Plant Sciences, V4, P21; Muller K, 2005, ANN MO BOT GARD, V92, P66; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; PAUL H, 1992, PLANT BREEDING, V109, P265, DOI 10.1111/j.1439-0523.1992.tb00184.x; Pinheiro-de-Carvalho M, 2013, IUCN RED LIST THREAT; REAMONRAMOS SM, 1992, THEOR APPL GENET, V84, P411, DOI 10.1007/BF00229501; Rodriguez-Sanchez F, 2009, J BIOGEOGR, V36, P1270, DOI 10.1111/j.1365-2699.2009.02091.x; Romeiras MM, 2016, BOT J LINN SOC, V180, P413, DOI 10.1111/boj.12370; Romeiras MM, 2011, TAXON, V60, P1375, DOI 10.1002/tax.605013; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos-Guerra A, 2013, IUCN RED LIST THREAT; SCOTT AJ, 1977, TAXON, V26, P284, DOI 10.2307/1220567; Silva DN, 2014, ELCONCATENERO, DOI [10.5281/zenodo.10588, DOI 10.5281/ZENODO.10588]; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stuessy TF, 2014, BOT J LINN SOC, V174, P276, DOI 10.1111/boj.12088; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Villain S, 2007, THESIS; Villain S, 2009, REPORT WORKING GROUP, P31; Vincent H, 2013, BIOL CONSERV, V167, P265, DOI 10.1016/j.biocon.2013.08.011; Volkens G., 1892, NATURL PFLANZ, V1a, P36; Weiland J, 2004, MOL PLANT PATHOL, V5, P157, DOI 10.1111/J.1364-3703.2004.00218.X; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	64	27	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152456	10.1371/journal.pone.0152456	http://dx.doi.org/10.1371/journal.pone.0152456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031338	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800075
J	Thomas, S; Straathof, K; Himoudi, N; Anderson, J; Pule, M				Thomas, Simon; Straathof, Karin; Himoudi, Nourredine; Anderson, John; Pule, Martin			An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers	PLOS ONE			English	Article							CHIMERIC ANTIGEN RECEPTORS; MODIFIED T-CELLS; ANTITUMOR-ACTIVITY; SPACER DOMAIN; DESIGN; PERSISTENCE; EXPRESSION; TARGET; IMMUNOTHERAPY; EXPANSION	Neuroblastoma is the commonest extra cranial solid cancer of childhood. Despite escalation of treatment regimens, a significant minority of patients die of their disease. Disialogan-glioside (GD2) is consistently expressed at high-levels in neuroblastoma tumors, which have been targeted with some success using therapeutic monoclonal antibodies. GD2 is also expressed in a range of other cancer but with the exception of some peripheral nerves is largely absent from non-transformed tissues. Chimeric Antigen Receptors (CARs) are artificial type I proteins which graft the specificity of a monoclonal antibody onto a T-cell. Clinical data with early CAR designs directed against GD2 have shown some promise in Neuroblastoma. Here, we describe a GD2-targeting CAR retroviral cassette, which has been optimized for CAR T-cell persistence, efficacy and safety.	[Thomas, Simon; Pule, Martin] UCL, Inst Canc, London, England; [Straathof, Karin; Himoudi, Nourredine; Anderson, John] UCL, Inst Child Hlth, London, England	University of London; University College London; University of London; University College London	Pule, M (corresponding author), UCL, Inst Canc, London, England.; Anderson, J (corresponding author), UCL, Inst Child Hlth, London, England.	j.anderson@ucl.ac.uk; m.pule@ucl.ac.uk		Anderson, William/0000-0001-7509-3203; Straathof, Karin/0000-0001-9673-8568; Pule, Martin/0000-0002-8347-9867	Neuroblastoma UK; UK NIHR Biomedical Research Centre; Wellcome Trust; Great Ormond Street Hospital, Biomedical Research Centre; Great Ormond Street Hospital Children's Charity; Cancer Research UK [14779] Funding Source: researchfish; National Institute for Health Research [CL-2009-18-011] Funding Source: researchfish; Wellcome Trust [102803/Z/13/Z] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1243, W1006] Funding Source: researchfish	Neuroblastoma UK; UK NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital, Biomedical Research Centre; Great Ormond Street Hospital Children's Charity; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital Childrens Charity	The study was funded by neuroblastoma Society now re-labelled "Neuroblastoma UK". This small charity provided a grant of  pound 133,000 in 2005 for a project entitled "Genetic Engineering of T-cells for Adoptive Immunotherapy of Neuroblastoma". Martin Pule is supported by the UK NIHR Biomedical Research Centre and the Wellcome Trust. John Anderson is supported by the Great Ormond Street Hospital, Biomedical Research Centre and the Great Ormond Street Hospital Children's Charity. Karin Straathof is supported by the Great Ormond Street Hospital, Biomedical Research Centre and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasbak H, 2015, GENE THER, V22, P391, DOI 10.1038/gt.2015.4; Bollard CM, 2014, J CLIN ONCOL, V32, P798, DOI 10.1200/JCO.2013.51.5304; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Finney HM, 1998, J IMMUNOL, V161, P2791; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guest RD, 2005, J IMMUNOTHER, V28, P203, DOI 10.1097/01.cji.0000161397.96582.59; Hombach A, 2010, GENE THER, V17, P1206, DOI 10.1038/gt.2010.91; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Jensen MC, 2014, IMMUNOL REV, V257, P127, DOI 10.1111/imr.12139; Jonnalagadda M, 2015, MOL THER, V23, P757, DOI 10.1038/mt.2014.208; Kurre P, 2003, BLOOD, V102, P3117, DOI 10.1182/blood-2003-03-0962; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; London WB, 2011, J CLIN ONCOL, V29, P3286, DOI 10.1200/JCO.2010.34.3392; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; MacArthur CC, 2012, STEM CELLS DEV, V21, P191, DOI 10.1089/scd.2011.0163; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Moreno R, 2011, TISSUE ENG PART C-ME, V17, P275, DOI [10.1089/ten.tec.2010.0383, 10.1089/ten.TEC.2010.0383]; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Nakamura K, 2001, CANCER IMMUNOL IMMUN, V50, P275, DOI 10.1007/PL00006689; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Suzuki M, 2015, EXPERT OPIN THER TAR, V19, P349, DOI 10.1517/14728222.2014.986459; Turatti F, 2005, J GENE MED, V7, P158, DOI 10.1002/jgm.647; Westwood JA, 2005, P NATL ACAD SCI USA, V102, P19051, DOI 10.1073/pnas.0504312102; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	38	36	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152196	10.1371/journal.pone.0152196	http://dx.doi.org/10.1371/journal.pone.0152196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030986	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800042
J	Sagredo, S; de la Cruz, F; Moncalian, G				Sagredo, Sandra; de la Cruz, Fernando; Moncalian, Gabriel			Design of Novel Relaxase Substrates Based on Rolling Circle Replicases for Bioconjugation to DNA Nanostructures	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; CLEAVING-JOINING REACTION; ALPHA PLASMID RP4; BACTERIAL CONJUGATION; SITE; CLEAVAGE; BINDING; PROTEIN; MECHANISM; DOMAIN	During bacterial conjugation and rolling circle replication, HUH endonucleases, respectively known as relaxases and replicases, form a covalent bond with ssDNA when they cleave their target sequence (nic site). Both protein families show structural similarity but limited amino acid identity. Moreover, the organization of the inverted repeat (IR) and the loop that shape the nic site differs in both proteins. Arguably, replicases cleave their target site more efficiently, while relaxases exert more biochemical control over the process. Here we show that engineering a relaxase target by mimicking the replicase target, results in enhanced formation of protein-DNA covalent complexes. Three widely different relaxases, which belong to MOBF, MOBQ and MOBP families, can properly cleave DNA sequences with permuted target sequences. Collaterally, the secondary structure that the permuted targets acquired within a supercoiled plasmid DNA resulted in poor conjugation frequencies underlying the importance of relaxase accessory proteins in conjugative DNA processing. Our results reveal that relaxase and replicase targets can be interchangeable in vitro. The new Rep substrates provide new bioconjugation tools for the design of sophisticated DNA-protein nanostructures.	[de la Cruz, Fernando; Moncalian, Gabriel] Univ Cantabria, Consejo Super Invest Cient SODERCAN, Dept Biol Mol, C Albert Einstein 22, Santander 39011, Spain; Univ Cantabria, Consejo Super Invest Cient SODERCAN, Inst Biomed & Biotecnol Cantabria, C Albert Einstein 22, Santander 39011, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	de la Cruz, F; Moncalian, G (corresponding author), Univ Cantabria, Consejo Super Invest Cient SODERCAN, Dept Biol Mol, C Albert Einstein 22, Santander 39011, Spain.	delacruz@unican.es; moncalig@unican.es	de la Cruz, Fernando/L-2812-2014; Moncalian, Gabriel/K-3493-2014	de la Cruz, Fernando/0000-0003-4758-6857; Moncalian, Gabriel/0000-0002-3007-6490; Sagredo, Sandra/0000-0003-0271-4106	Spanish Ministry of Economy and Competitiveness [BFU2014-55534-C2-1-P, BFU2014-55534-C2-2-P]; European Union Seventh Framework Programme [612146/FP7-ICT-2013, 282004/FP7-HEALTH.2011.2.3.1-2]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union Seventh Framework Programme(European Commission)	This work was financed by grants BFU2014-55534-C2-1-P from the Spanish Ministry of Economy and Competitiveness and 612146/FP7-ICT-2013 and 282004/FP7-HEALTH.2011.2.3.1-2 from the European Union Seventh Framework Programme to FC and grant BFU2014-55534-C2-2-P from the Spanish Ministry of Economy and Competitiveness to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez L, 2011, APPL ENVIRON MICROB, V77, P201, DOI 10.1128/AEM.01371-10; Boer R, 2006, J MOL BIOL, V358, P857, DOI 10.1016/j.jmb.2006.02.018; BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990; Campos-Olivas R, 2002, P NATL ACAD SCI USA, V99, P10310, DOI 10.1073/pnas.152342699; Chandler M, 2013, NAT REV MICROBIOL, V11, P525, DOI 10.1038/nrmicro3067; Carballeira JD, 2014, NUCLEIC ACIDS RES, V42, P10632, DOI 10.1093/nar/gku741; Edwards JS, 2013, P NATL ACAD SCI USA, V110, P2804, DOI 10.1073/pnas.1219701110; Gonzalez-Perez B, 2007, EMBO J, V26, P3847, DOI 10.1038/sj.emboj.7601806; Gonzalez-Prieto C, 2013, TRENDS BIOTECHNOL, V31, P41, DOI 10.1016/j.tibtech.2013.02.002; Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; Khan SA, 2005, PLASMID, V53, P126, DOI 10.1016/j.plasmid.2004.12.008; Khan SA, 1997, MICROBIOL MOL BIOL R, V61, P442, DOI 10.1128/.61.4.442-455.1997; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; LLOSA M, 1991, MOL GEN GENET, V226, P473, DOI 10.1007/BF00260661; Lucas M, 2010, J BIOL CHEM, V285, P8918, DOI 10.1074/jbc.M109.057539; Lujan SA, 2007, P NATL ACAD SCI USA, V104, P12282, DOI 10.1073/pnas.0702760104; Moncalian G, 2004, BBA-PROTEINS PROTEOM, V1701, P15, DOI 10.1016/j.bbapap.2004.05.009; Moncalian G, 1999, MOL MICROBIOL, V31, P1643, DOI 10.1046/j.1365-2958.1999.01288.x; Monzingo AF, 2007, J MOL BIOL, V366, P165, DOI 10.1016/j.jmb.2006.11.031; PANSEGRAU W, 1994, J BIOL CHEM, V269, P2782; Pansegrau W, 1996, J BIOL CHEM, V271, P13068, DOI 10.1074/jbc.271.22.13068; PANSEGRAU W, 1993, P NATL ACAD SCI USA, V90, P2925, DOI 10.1073/pnas.90.7.2925; Boer DR, 2009, EMBO J, V28, P1666, DOI 10.1038/emboj.2009.125; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sagredo S, 2016, ANGEW CHEM INT EDIT, V55, P4348, DOI 10.1002/anie.201510313; SCHERZINGER E, 1992, NUCLEIC ACIDS RES, V20, P41, DOI 10.1093/nar/20.1.41; Simmel FC, 2012, CURR OPIN BIOTECH, V23, P516, DOI 10.1016/j.copbio.2011.12.024; Varsaki A, 2009, J BACTERIOL, V191, P1446, DOI 10.1128/JB.01342-08; Vega-Rocha S, 2007, J MOL BIOL, V367, P473, DOI 10.1016/j.jmb.2007.01.002; Yang YR, 2015, BIOCONJUGATE CHEM, V26, P1381, DOI 10.1021/acs.bioconjchem.5b00194; Yoshida H, 2008, J MOL BIOL, V384, P690, DOI 10.1016/j.jmb.2008.09.067; Zhao AC, 1997, MOL MICROBIOL, V24, P535, DOI 10.1046/j.1365-2958.1997.3641730.x	33	4	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152666	10.1371/journal.pone.0152666	http://dx.doi.org/10.1371/journal.pone.0152666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027740	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500062
J	Filannino, P; Cavoski, I; Thlien, N; Vincentini, O; De Angelis, M; Silano, M; Gobbetti, M; Di Cagno, R				Filannino, Pasquale; Cavoski, Ivana; Thlien, Nadia; Vincentini, Olimpia; De Angelis, Maria; Silano, Marco; Gobbetti, Marco; Di Cagno, Raffaella			Lactic Acid Fermentation of Cactus Cladodes (Opuntia ficus-indica L.) Generates Flavonoid Derivatives with Antioxidant and AntiInflammatory Properties	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SOURDOUGH FERMENTATION; BACTERIA; HEALTH; WHEAT; POLYPHENOLS; PRODUCTS; EXTRACTS; FRUITS; MILK	Cactus pear (Opuntia ficus-indica L.) is widely distributed in the arid and semi-arid regions throughout the world. In the last decades, the interest towards vegetative crop increased, and cladodes are exploited for nutraceutical and health-promoting properties. This study aimed at investigating the capacity of selected lactic acid bacteria to increase the antioxidant and anti-inflammatory properties of cactus cladodes pulp, with the perspective of producing a functional ingredient, dietary supplement or pharmaceutical preparation. Preliminarily, the antioxidant activity was determined through in vitro assays. Further, it was confirmed through ex vivo analysis on intestinal Caco-2/TC7 cells, and the profile of flavonoids was characterized. Cactus cladode pulp was fermented with lactic acid bacteria, which were previously selected from plant materials. Chemically acidified suspension, without bacterial inoculum and incubated under the same conditions, was used as the control. Lactobacillus plantarum CIL6, POM1 and 1MR20, Lactobacillus brevis POM2 and POM4, Lactobacillus rossiae 2LC8 and Pediococcus pentosaceus CILSWE5 were the best growing strains. Fermentation of cladode pulp with L. brevis POM2 and POM4 allowed the highest concentration of.-amino butyric acid. Lactic acid fermentation had preservative effects (P<0.05) on the levels of vitamin C and carotenoids. Two flavonoid derivatives (kaemferol and isorhamnetin) were identified in the ethyl acetate extracts, which were considered to be the major compounds responsible for the increased radical scavenging activity. After inducing oxidative stress by IL-1 beta, the increased antioxidant activity (P<0.05) of fermented cladode pulp was confirmed using Caco-2/TC7 cells. Fermented cladode pulp had also immune-modulatory effects towards Caco-2 cells. Compared to the control, fermented cladode pulp exhibited a significantly (P<0.05) higher inhibition of IL-8, TNF alpha and prostaglandins PGE2 synthesis. The highest functional effect was found using ethyl acetate extracts. In conclusion, fermentation, especially with L. plantarum strains and L. brevis POM4, enhanced the antioxidant and immune-modulation features of cladode pulp.	[Filannino, Pasquale; De Angelis, Maria; Gobbetti, Marco; Di Cagno, Raffaella] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Cavoski, Ivana; Thlien, Nadia] Mediterranean Agron Inst Bari, CIHEAM MAIB, Bari, Italy; [Vincentini, Olimpia; Silano, Marco] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Unit Human Nutr & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy	Universita degli Studi di Bari Aldo Moro; CIHEAM; CIHEAM BARI; Istituto Superiore di Sanita (ISS)	Di Cagno, R (corresponding author), Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy.	raffaella.dicagno@uniba.it	Cavoski, Ivana/P-6589-2014; Filannino, Pasquale/I-8065-2019; Silano, Marco/AAC-9792-2022; De Angelis, Maria/AAA-9909-2019; vincentini, olimpia/N-3332-2019	Filannino, Pasquale/0000-0002-1235-5138; vincentini, olimpia/0000-0002-4137-4135; Cavoski, Ivana/0000-0002-7114-076X				Akanni GB, 2015, J SCI FOOD AGR, V95, P1094, DOI 10.1002/jsfa.6985; [Anonymous], 2003, FOODSTUFFS DETERMINA; Antunes-Ricardo M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/847320; Atanassova M, 2003, INT J FOOD MICROBIOL, V87, P63, DOI 10.1016/S0168-1605(03)00054-0; BORENFREUND E, 1988, TOXICOL IN VITRO, V2, P1, DOI 10.1016/0887-2333(88)90030-6; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; CHANTRET I, 1994, J CELL SCI, V107, P213; Chirumbolo Salvatore, 2010, Inflammation & Allergy Drug Targets, V9, P263; CHURCH FC, 1983, J DAIRY SCI, V66, P1219, DOI 10.3168/jds.S0022-0302(83)81926-2; Coda R, 2012, APPL ENVIRON MICROB, V78, P1087, DOI 10.1128/AEM.06837-11; Cayupan YSC, 2011, FOOD CHEM, V126, P514, DOI 10.1016/j.foodchem.2010.11.033; Di Cagno R, 2009, INT J FOOD MICROBIOL, V128, P473, DOI 10.1016/j.ijfoodmicro.2008.10.017; Di Cagno R, 2008, INT J FOOD MICROBIOL, V127, P220, DOI 10.1016/j.ijfoodmicro.2008.07.010; Di Cagno R, 2013, FOOD MICROBIOL, V33, P1, DOI 10.1016/j.fm.2012.09.003; Di Cagno R, 2011, FOOD MICROBIOL, V28, P1062, DOI 10.1016/j.fm.2011.02.011; Di Cagno R, 2011, FOOD MICROBIOL, V28, P900, DOI 10.1016/j.fm.2010.12.008; Di Cagno R, 2010, FOOD MICROBIOL, V27, P381, DOI 10.1016/j.fm.2009.11.012; Di Cagno R, 2009, INT J FOOD MICROBIOL, V130, P108, DOI 10.1016/j.ijfoodmicro.2009.01.019; El-Mostafa K, 2014, MOLECULES, V19, P14879, DOI 10.3390/molecules190914879; El-Razek F. H. A., 2011, Australian Journal of Basic and Applied Sciences, V5, P356; Esteban-Torres M, 2013, APPL ENVIRON MICROB, V79, P5130, DOI 10.1128/AEM.01523-13; Feugang JM, 2006, FRONT BIOSCI-LANDMRK, V11, P2574, DOI 10.2741/1992; Filannino P, 2014, APPL ENVIRON MICROB, V80, P2206, DOI 10.1128/AEM.03885-13; Filannino P, 2015, FOOD MICROBIOL, V46, P272, DOI 10.1016/j.fm.2014.08.018; Gabriel A., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P171; Gobbetti M, 2010, CRIT REV FOOD SCI, V50, P716, DOI 10.1080/10408398.2010.499770; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guevara JC, 2003, POSTHARVEST BIOL TEC, V29, P167, DOI 10.1016/S0925-5214(03)00021-8; Inoue K, 2003, EUR J CLIN NUTR, V57, P490, DOI 10.1038/sj.ejcn.1601555; Kim J, 2015, J SCI FOOD AGR, V95, P2601, DOI 10.1002/jsfa.6968; Kubola J, 2011, FOOD CHEM, V127, P1138, DOI 10.1016/j.foodchem.2011.01.115; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Matias A, 2014, FOOD FUNCT, V5, P3269, DOI [10.1039/C4FO00071D, 10.1039/c4fo00071d]; McDermott MF, 2001, CELL MOL BIOL, V47, P619; MOHAMEDYASSEEN Y, 1995, PLANT CELL TISS ORG, V42, P117, DOI 10.1007/BF00037690; MohamedYasseen Y, 1996, J ARID ENVIRON, V32, P347, DOI 10.1006/jare.1996.0028; Moreno-Alvarez MJ, 2009, J PROF ASSOC CACTUS, V11, P78; O'Leary KA, 2004, MUTAT RES-FUND MOL M, V551, P245, DOI 10.1016/j.mrfmmm.2004.01.015; Oh SH, 2003, FOOD SCI BIOTECHNOL, V12, P248; Patel S, 2014, MEDITERR J NUTR META, V7, P11, DOI 10.3233/MNM-140003; Rizzello CG, 2012, FOOD RES INT, V46, P304, DOI 10.1016/j.foodres.2011.12.024; Rizzello CG, 2010, FOOD CHEM, V119, P1079, DOI 10.1016/j.foodchem.2009.08.016; Romier-Crouzet B, 2009, FOOD CHEM TOXICOL, V47, P1221, DOI 10.1016/j.fct.2009.02.015; SELMAN JD, 1994, FOOD CHEM, V49, P137, DOI 10.1016/0308-8146(94)90150-3; Siragusa S, 2007, APPL ENVIRON MICROB, V73, P7283, DOI 10.1128/AEM.01064-07; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Stintzing FC, 2005, MOL NUTR FOOD RES, V49, P175, DOI 10.1002/mnfr.200400071; STRIETER RM, 1993, CRIT CARE MED, V21, pS447, DOI 10.1097/00003246-199310001-00006; Trombetta D, 2006, PHYTOMEDICINE, V13, P352, DOI 10.1016/j.phymed.2005.06.006; Vitali B, 2012, FOOD MICROBIOL, V31, P116, DOI 10.1016/j.fm.2011.12.027; Wang YC, 2006, FOOD MICROBIOL, V23, P128, DOI 10.1016/j.fm.2005.01.020; Winata A, 1996, J FOOD PROCESS PRES, V20, P417, DOI 10.1111/j.1745-4549.1996.tb00757.x; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696; Yeddes N, 2013, ANTIOXIDANTS-BASEL, V2, P37, DOI 10.3390/antiox2020037; Yu LL, 2003, J AGR FOOD CHEM, V51, P1566, DOI 10.1021/jf020950z; Zeppa G, 2001, J AGR FOOD CHEM, V49, P2722, DOI 10.1021/jf0009403; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	58	45	47	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152575	10.1371/journal.pone.0152575	http://dx.doi.org/10.1371/journal.pone.0152575			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023062	Green Submitted, gold, Green Published			2022-12-26	WOS:000373113900079
J	Zhu, ZQ; Tang, JS; Wang, JQ; Duan, G; Zhou, L; Zhou, XQ				Zhu, Ziqiang; Tang, Jinshan; Wang, Jianqiang; Duan, Gang; Zhou, Lei; Zhou, Xiaoqing			MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells	PLOS ONE			English	Article							RESISTANCE; CHEMOTHERAPY; METHYLATION	Chemotherapeutic insensitivity remains a major obstacle to treating osteosarcoma effectively. Recently, increasing evidence has suggested that microRNAs (miRNAs) are involved in drug resistance. However, the effect of miR-138 on cisplatin chemoresistance in osteosarcoma has not been reported. We used real-time PCR to detect the expression of mature miR-138 in osteosarcoma tissues and cell lines. Cell proliferation, invasion, and migration assays were used to observe changes to the osteosarcoma malignant phenotype. MiR-138 was downregulated in osteosarcoma tissues and cell lines, and miR-138 overexpression negatively regulated osteosarcoma cell proliferation, migration, and invasion. We also verified that EZH2 is a direct target of miR-138. Furthermore, enhancing EZH2 expression reduced the inhibitory effects of miR-138 on osteosarcoma. Proliferation, apoptosis assays and caspase-3 activity assay confirmed that elevated miR-138 expression enhanced osteosarcoma cell chemosensitivity to cisplatin by targeting EZH2. In conclusion, the present study demonstrates that miR-138 acts as a tumor suppressor by enhancing osteosarcoma cell chemosensitivity and supports its potential application for treating osteosarcoma in the future.	[Zhu, Ziqiang; Wang, Jianqiang; Duan, Gang; Zhou, Lei] Xuzhou Med Coll, Dept Orthopaed, Affiliated Hosp 2, Xuzhou, Jiangsu, Peoples R China; [Tang, Jinshan; Zhou, Xiaoqing] Xuzhou Med Coll, Dept Orthoped, Affiliated Huaian Hosp, Huaian, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Zhou, XQ (corresponding author), Xuzhou Med Coll, Dept Orthoped, Affiliated Huaian Hosp, Huaian, Jiangsu, Peoples R China.	xqzhou_xz@163.com	Wang, Jian-qiang/B-5012-2019					Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chou AJ, 2006, EXPERT REV ANTICANC, V6, P1075, DOI 10.1586/14737140.6.7.1075; Ding ML, 2015, ONCOL LETT, V9, P2261, DOI 10.3892/ol.2015.3036; Grilli A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0106-0; Jiang LD, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-383; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li Z, 2015, GASTRIC CANCER, V18, P43, DOI 10.1007/s10120-014-0340-8; Ma F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126499; Martinez-Velez N, 2014, J BONE MINER RES, V29, P2287, DOI 10.1002/jbmr.2253; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Shi ZM, 2013, RNA, V19, P552, DOI 10.1261/rna.035972.112; Tsang DPF, 2011, J GASTROEN HEPATOL, V26, P19, DOI 10.1111/j.1440-1746.2010.06447.x; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Volkel P, 2015, AM J TRANSL RES, V7, P175; Wang HF, 2014, GENET MOL RES, V13, P9939, DOI 10.4238/2014.November.27.23; Wu ZM, 2015, LIFE SCI, V137, P14, DOI 10.1016/j.lfs.2015.06.020; Xu J, 2015, BIOCHEM BIOPH RES CO, V463, P1159, DOI 10.1016/j.bbrc.2015.06.076; Xu M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0972-x; Xu XL, 2014, CARCINOGENESIS, V35, P2457, DOI 10.1093/carcin/bgu159; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Ye XW, 2015, CLIN RESPIR J, V9, P27, DOI 10.1111/crj.12100; Zhang JX, 2015, CANCER LETT, V356, P929, DOI 10.1016/j.canlet.2014.11.003; Zhou Wen, 2015, Asian Pac J Cancer Prev, V16, P2425; Zhou Y, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-12; Zhu Shao-Wen, 2015, Asian Pac J Cancer Prev, V16, P4509; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087780	31	64	70	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0150026	10.1371/journal.pone.0150026	http://dx.doi.org/10.1371/journal.pone.0150026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019355	Green Published, gold, Green Submitted			2022-12-26	WOS:000372807800004
J	Coffey, EBJ; Colagrosso, EMG; Lehmann, A; Schonwiesner, M; Zatorre, RJ				Coffey, Emily B. J.; Colagrosso, Emilia M. G.; Lehmann, Alexandre; Schoenwiesner, Marc; Zatorre, Robert J.			Individual Differences in the Frequency-Following Response: Relation to Pitch Perception	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; HESCHLS GYRUS; BIOLOGICAL MARKER; SPEECH; MUSICIANS; REPRESENTATION; ENHANCEMENT; PLASTICITY; RELEVANT; CHILDREN	The scalp-recorded frequency-following response (FFR) is a measure of the auditory nervous system's representation of periodic sound, and may serve as a marker of training-related enhancements, behavioural deficits, and clinical conditions. However, FFRs of healthy normal subjects show considerable variability that remains unexplained. We investigated whether the FFR representation of the frequency content of a complex tone is related to the perception of the pitch of the fundamental frequency. The strength of the fundamental frequency in the FFR of 39 people with normal hearing was assessed when they listened to complex tones that either included or lacked energy at the fundamental frequency. We found that the strength of the fundamental representation of the missing fundamental tone complex correlated significantly with people's general tendency to perceive the pitch of the tone as either matching the frequency of the spectral components that were present, or that of the missing fundamental. Although at a group level the fundamental representation in the FFR did not appear to be affected by the presence or absence of energy at the same frequency in the stimulus, the two conditions were statistically distinguishable for some subjects individually, indicating that the neural representation is not linearly dependent on the stimulus content. In a second experiment using a within-subjects paradigm, we showed that subjects can learn to reversibly select between either fundamental or spectral perception, and that this is accompanied both by changes to the fundamental representation in the FFR and to cortical-based gamma activity. These results suggest that both fundamental and spectral representations coexist, and are available for later auditory processing stages, the requirements of which may also influence their relative strength and thus modulate FFR variability. The data also highlight voluntary mode perception as a new paradigm with which to study top-down vs bottom-up mechanisms that support the emerging view of the FFR as the outcome of integrated processing in the entire auditory system.	[Coffey, Emily B. J.; Colagrosso, Emilia M. G.; Schoenwiesner, Marc; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Coffey, Emily B. J.; Lehmann, Alexandre; Schoenwiesner, Marc; Zatorre, Robert J.] Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Coffey, Emily B. J.; Lehmann, Alexandre; Schoenwiesner, Marc; Zatorre, Robert J.] CRBLM, Montreal, PQ, Canada; [Lehmann, Alexandre; Schoenwiesner, Marc] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada; [Lehmann, Alexandre] McGill Univ, Dept Otolaryngol Head & Neck Surg, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; McGill University	Coffey, EBJ (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.; Coffey, EBJ (corresponding author), Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada.; Coffey, EBJ (corresponding author), CRBLM, Montreal, PQ, Canada.	emily@flighteducation.net		Schonwiesner, Marc/0000-0002-2023-1207; Coffey, Emily/0000-0001-8249-7396	Canadian Institutes of Health Research; Canada Foundation for Innovation; Vanier Canada Graduate Scholarship; NSERC-CREATE award; Fonds de Recherche Quebec Nature Technologie/Societe Culture; Quebec Research Scholar career award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Vanier Canada Graduate Scholarship; NSERC-CREATE award; Fonds de Recherche Quebec Nature Technologie/Societe Culture; Quebec Research Scholar career award	Research was supported by operating grants to RJZ from the Canadian Institutes of Health Research and from the Canada Foundation for Innovation, by a Vanier Canada Graduate Scholarship to EBJC, and by an NSERC-CREATE award to EMGC. The center is supported by funding from the Fonds de Recherche Quebec Nature Technologie/Societe Culture. MS was supported by a Quebec Research Scholar career award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevic A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00210; Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; Basar E, 2013, INT J PSYCHOPHYSIOL, V90, P99, DOI 10.1016/j.ijpsycho.2013.07.005; BasarEroglu C, 1996, INT J PSYCHOPHYSIOL, V24, P113, DOI 10.1016/S0167-8760(96)00055-4; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bidebnan GM, 2010, BRAIN RES, V1355, P112, DOI 10.1016/j.brainres.2010.07.100; Bidelman GM, 2015, HEARING RES, V323, P68, DOI 10.1016/j.heares.2015.01.011; Bidelman GM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00264; Bidelman GM, 2011, EUR J NEUROSCI, V33, P530, DOI 10.1111/j.1460-9568.2010.07527.x; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Bregman A.S., 1994, AUDITORY SCENE ANAL; Cha K, 2016, CEREB CORTEX, V26, P211, DOI 10.1093/cercor/bhu193; Chandrasekaran B, 2012, J NEUROPHYSIOL, V107, P1325, DOI 10.1152/jn.00923.2011; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Coffey EBJ, 2011, NEUROSCIENCE MUSIC; Coffey EBJ, 2016, NAT COMMUN IN PRESS; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deutsch W.S.R., 1978, MITTEILUNGEN KOMMISS, P41; Di Nocera F, 2000, BEHAV RES METH INS C, V32, P111, DOI 10.3758/BF03200793; GALBRAITH GC, 1994, ELECTROEN CLIN NEURO, V92, P321, DOI 10.1016/0168-5597(94)90100-7; Galbraith GC, 2000, NEUROSCI LETT, V292, P123, DOI 10.1016/S0304-3940(00)01436-1; Gelfand S.A., 2009, HEARING INTRO PSYCHO, V5th ed., P146; Gockel HE, 2011, JARO-J ASSOC RES OTO, V12, P767, DOI 10.1007/s10162-011-0284-1; GREENBERG S, 1987, HEARING RES, V25, P91, DOI 10.1016/0378-5955(87)90083-9; Hairston WD, 2013, PLOS ONE, V8; He C, 2009, J NEUROSCI, V29, P7718, DOI 10.1523/JNEUROSCI.0157-09.2009; Herholz SC, 2015, CEREB CORTEX, DOI DOI 10.1093/CERCOR/BHV138; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Hornickel J, 2012, HEARING RES, V284, P52, DOI 10.1016/j.heares.2011.12.005; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Kraus N, 2005, TRENDS NEUROSCI, V28, P176, DOI 10.1016/j.tins.2005.02.003; Kraus N, 2015, TRENDS COGN SCI, V19, P642, DOI 10.1016/j.tics.2015.08.017; Kraus N, 2014, SPRINGER HANDB AUDIT, V50, P299, DOI 10.1007/978-1-4614-9102-6_17; Krishnan A, 2012, NEUROPSYCHOLOGIA, V50, P2849, DOI 10.1016/j.neuropsychologia.2012.08.013; Krishnan A, 2012, NEUROREPORT, V23, P498, DOI 10.1097/WNR.0b013e328353764d; Krishnan A, 2009, J COGNITIVE NEUROSCI, V21, P1092, DOI 10.1162/jocn.2009.21077; Ladd DR, 2013, J EXP PSYCHOL HUMAN, V39, P1386, DOI 10.1037/a0031261; Lee KM, 2009, J NEUROSCI, V29, P5832, DOI 10.1523/JNEUROSCI.6133-08.2009; Lehmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085442; Licklider J. C. R., 1956, INFORMATION THEORY, P253; Mathys C, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00193; Matsushita R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00174; Middlebrooks JC, 2013, J NEUROSCI, V33, P10986, DOI 10.1523/JNEUROSCI.1065-13.2013; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Parbery-Clark A, 2012, NEUROSCIENCE, V219, P111, DOI 10.1016/j.neuroscience.2012.05.042; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; Plack CJ, 2014, HEARING RES, V307, P53, DOI 10.1016/j.heares.2013.07.020; Postma-Nilsenova M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00826; Ruggles D, 2012, CURR BIOL, V22, P1417, DOI 10.1016/j.cub.2012.05.025; Russo NM, 2008, CLIN NEUROPHYSIOL, V119, P1720, DOI 10.1016/j.clinph.2008.01.108; Russo N, 2009, DEVELOPMENTAL SCI, V12, P557, DOI 10.1111/j.1467-7687.2008.00790.x; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Schneider P, 2005, ANN NY ACAD SCI, V1060, P387, DOI 10.1196/annals.1360.033; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schneider P, 2009, CONTEMP MUSIC REV, V28, P315, DOI 10.1080/07494460903404402; Schouten JF, 1940, P K NED AKAD WETENSC, V43, P356; Schulte Michael, 2002, Neural Plasticity, V9, P161, DOI 10.1155/NP.2002.161; Seebeck A., 1841, ANN PHYS CHEM, V53, P417, DOI [10.1002/andp.18411290702, DOI 10.1002/ANDP.18411290702]; Seither-Preisler A, 2009, BRAIN RES J, V2, P125; Seither-Preisler A, 2007, J EXP PSYCHOL HUMAN, V33, P743, DOI 10.1037/0096-1523.33.3.743; Skoe E, 2013, NEUROSCIENCE, V243, P104, DOI 10.1016/j.neuroscience.2013.03.009; Skoe E, 2015, CEREB CORTEX, V25, P1415, DOI 10.1093/cercor/bht311; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; SMITH JC, 1978, SCIENCE, V201, P639, DOI 10.1126/science.675250; Song JH, 2011, CLIN NEUROPHYSIOL, V122, P346, DOI 10.1016/j.clinph.2010.07.009; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; White-Schwoch T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002196; White-Schwoch T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00899; Wile D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000369; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; Zhu L, 2013, J ACOUST SOC AM, V134, P384, DOI 10.1121/1.4807498	76	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152374	10.1371/journal.pone.0152374	http://dx.doi.org/10.1371/journal.pone.0152374			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3TE	27015271	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708900058
J	Hwang, DE; Ryou, JH; Oh, JR; Han, JW; Park, TK; Kim, HS				Hwang, Da-Eun; Ryou, Jeong-Hyun; Oh, Jong Rok; Han, Jung Woo; Park, Tae Kwann; Kim, Hak-Sung			Anti-Human VEGF Repebody Effectively Suppresses Choroidal Neovascularization and Vascular Leakage	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; PROTEIN BINDER; BASIC SCIENCE; ANGIOGENESIS; RANIBIZUMAB; BEVACIZUMAB; MECHANISMS; ANTIBODIES; PROGRESS	Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness among people over the age of 60. Vascular endothelial growth factor (VEGF) plays a major role in pathological angiogenesis in AMD. Herein, we present the development of an antihuman VEGF repebody, which is a small-sized protein binder consisting of leucine-rich repeat (LRR) modules. The anti-VEGF repebody selected through a phage-display was shown to have a high affinity and specificity for human VEGF. We demonstrate that this repebody effectively inhibits in vitro angiogenic cellular processes, such as proliferation and migration, by blocking the VEGF-mediated signaling pathway. The repebody was also shown to have a strong suppression effect on choroidal neovascularization (CNV) and vascular leakage in vivo. Our results indicate that the anti-VEGF repebody has a therapeutic potential for treating neovascular AMD as well as other VEGF-involved diseases including diabetic retinopathy and metastatic cancers.	[Hwang, Da-Eun; Ryou, Jeong-Hyun; Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 305701, South Korea; [Ryou, Jeong-Hyun] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 305701, South Korea; [Oh, Jong Rok; Han, Jung Woo; Park, Tae Kwann] Soonchunhyang Univ, Coll Med, Bucheon Hosp, Dept Ophthalmol, Bucheon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Soonchunhyang University	Kim, HS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 305701, South Korea.	hskim76@kaist.ac.kr	Kim, Hak-Sung/C-1929-2011		Mid career Researcher Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014R1A2A1A01004198]; Global Research Laboratory of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2015K1A1A2033346]; Brain Korea 21 - Ministry of Education	Mid career Researcher Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; Global Research Laboratory of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; Brain Korea 21 - Ministry of Education(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was supported by the Mid career Researcher Program (NRF-2014R1A2A1A01004198) and Global Research Laboratory (NRF-2015K1A1A2033346) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, and Brain Korea 21 funded by the Ministry of Education.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Haller CA, 2008, CLIN PHARMACOL THER, V84, P624, DOI 10.1038/clpt.2008.158; Heu W, 2014, ANAL CHEM, V86, P6019, DOI 10.1021/ac501158t; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Jo DH, 2014, BIOMATERIALS, V35, P3052, DOI 10.1016/j.biomaterials.2013.12.031; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Lee JJ, 2015, ANGEW CHEM INT EDIT, V54, P11020, DOI 10.1002/anie.201505964; Lee JJ, 2014, MOL THER, V22, P1254, DOI 10.1038/mt.2014.59; Lee SC, 2012, P NATL ACAD SCI USA, V109, P3299, DOI 10.1073/pnas.1113193109; Lien S., 2008, V181, P131; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Meyer T, 2016, FUNCTIONAL CHARACTER, P79, DOI [10.1007/s10456-015-9490-5, DOI 10.1007/S10456-015-9490-5]; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Ratner M, 2008, NAT BIOTECHNOL, V26, P867, DOI 10.1038/nbt0808-867; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Stahl A, 2013, ANGIOGENESIS, V16, P101, DOI 10.1007/s10456-012-9302-0; Syed BA, 2012, NAT REV DRUG DISCOV, V11, P827, DOI 10.1038/nrd3790; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070544; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Zhang Y, 2010, ONCOGENE, V29, P5404, DOI 10.1038/onc.2010.270	33	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152522	10.1371/journal.pone.0152522	http://dx.doi.org/10.1371/journal.pone.0152522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015541	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900072
J	Melgaard, L; Gorst-Rasmussen, A; Rasmussen, LH; Lip, GYH; Larsen, TB				Melgaard, Line; Gorst-Rasmussen, Anders; Rasmussen, Lars Hvilsted; Lip, Gregory Y. H.; Larsen, Torben Bjerregaard			Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; VENTRICULAR DYSFUNCTION; ANTITHROMBOTIC THERAPY; PREDICTING STROKE; RANDOMIZED-TRIAL; COMPETING RISKS; ESC GUIDELINES; SINUS RHYTHM; FOLLOW-UP; THROMBOEMBOLISM	Background Stroke and mortality risk among heart failure patients previously diagnosed with different manifestations of vascular disease is poorly described. We conducted an observational study to evaluate the stroke and mortality risk among heart failure patients without diagnosed atrial fibrillation and with peripheral artery disease (PAD) or prior myocardial infarction (MI). Methods Population-based cohort study of patients diagnosed with incident heart failure during 2000- 2012 and without atrial fibrillation, identified by record linkage between nationwide registries in Denmark. Hazard rate ratios of ischemic stroke and all-cause death after 1 year of follow- up were used to compare patients with either: a PAD diagnosis; a prior MI diagnosis; or no vascular disease. Results 39,357 heart failure patients were included. When compared to heart failure patients with no vascular disease, PAD was associated with a higher 1-year rate of ischemic stroke (adjusted hazard rate ratio [HR]: 1.34, 95% confidence interval [CI]: 1.08-1.65) and allcause death (adjusted HR: 1.47, 95% CI: 1.35-1.59), whereas prior MI was not (adjusted HR: 1.00, 95% CI: 0.86-1.15 and 0.94, 95% CI: 0.89-1.00, for ischemic stroke and allcause death, respectively). When comparing patients with PAD to patients with prior MI, PAD was associated with a higher rate of both outcomes. Conclusions Among incident heart failure patients without diagnosed atrial fibrillation, a previous diagnosis of PAD was associated with a significantly higher rate of the ischemic stroke and allcause death compared to patients with no vascular disease or prior MI. Prevention strategies may be particularly relevant among HF patients with PAD.	[Melgaard, Line; Gorst-Rasmussen, Anders; Rasmussen, Lars Hvilsted; Lip, Gregory Y. H.; Larsen, Torben Bjerregaard] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Gorst-Rasmussen, Anders] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Larsen, Torben Bjerregaard] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital; University of Birmingham; Aalborg University; Aalborg University Hospital	Larsen, TB (corresponding author), Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark.; Larsen, TB (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.	tobl@m.dk	Larsen, Torben Bjerregaard/I-5081-2012	Larsen, Torben Bjerregaard/0000-0002-8485-8674				Alberts MJ, 2009, EUR HEART J, V30, P2318, DOI 10.1093/eurheartj/ehp355; Ambrogi F, 2008, STAT MED, V27, P6407, DOI 10.1002/sim.3455; Anandasundaram B, 2013, J THROMB HAEMOST, V11, P975, DOI 10.1111/jth.12177; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Badheka AO, 2011, AM J CARDIOL, V108, P1283, DOI 10.1016/j.amjcard.2011.06.045; BURN J, 1994, STROKE, V25, P333, DOI 10.1161/01.STR.25.2.333; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Cleland JGF, 2004, AM HEART J, V148, P157, DOI 10.1016/j.ahj.2004.03.010; Cokkinos DV, 2006, EUR J HEART FAIL, V8, P428, DOI 10.1016/j.ejheart.2006.02.012; Gronewold J, 2014, ATHEROSCLEROSIS, V233, P545, DOI 10.1016/j.atherosclerosis.2014.01.044; Hebert Kathy, 2010, Congest Heart Fail, V16, P118, DOI 10.1111/j.1751-7133.2010.00140.x; Hermann DM, 2013, STROKE, V44, P1008, DOI 10.1161/STROKEAHA.111.678078; Homma S, 2012, NEW ENGL J MED, V366, P1859, DOI 10.1056/NEJMoa1202299; Hwang SJ, 2014, J AM COLL CARDIOL, V63, P2817, DOI 10.1016/j.jacc.2014.03.034; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Lip G, 2012, BMJ OPEN, V2, P1; Lip GYH, 2012, THROMB HAEMOSTASIS, V108, P1009, DOI 10.1160/TH12-08-0578; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mard Shan, 2010, Clin Epidemiol, V2, P235, DOI 10.2147/CLEP.S12457; Marin F, 2013, EUR J HEART FAIL, V15, P3, DOI 10.1093/eurjhf/hfs198; Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753; McDermott MM, 2002, J GEN INTERN MED, V17, P895, DOI 10.1046/j.1525-1497.2002.20307.x; Melgaard L, 2015, JAMA-J AM MED ASSOC, V314, P1030, DOI 10.1001/jama.2015.10725; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nakamura Y, 2015, CIRC J, V79, P785, DOI 10.1253/circj.CJ-14-1280; Nielsen PB, 2015, THROMB HAEMOSTASIS, V113, P1170, DOI 10.1160/TH15-03-0210; Olesen JB, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.11.024; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pullicino PM, 2013, J STROKE CEREBROVASC, V22, P620, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.012; Rasmussen LH, 2011, J THROMB HAEMOST, V9, P1301, DOI 10.1111/j.1538-7836.2011.04308.x; Sandhu RK, 2015, STROKE, V46, P667, DOI 10.1161/STROKEAHA.114.007140; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Zeymer U, 2009, CLIN RES CARDIOL, V98, P249, DOI 10.1007/s00392-009-0754-1; Zoller B, 2012, EUR J CANCER, V48, P1875, DOI 10.1016/j.ejca.2012.01.005	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152269	10.1371/journal.pone.0152269	http://dx.doi.org/10.1371/journal.pone.0152269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015524	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900048
J	Li, Q; Huang, Y; Liu, XC; Gan, JH; Chen, H; Yang, CG				Li, Qi; Huang, Yue; Liu, Xichun; Gan, Jianhua; Chen, Hao; Yang, Cai-Guang			Rhein Inhibits AlkB Repair Enzymes and Sensitizes Cells to Methylated DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; cancer therapy; chemical biology; DNA repair; DNA-protein interaction; enzyme inhibitor; enzyme structure	ESCHERICHIA-COLI; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; PROSTATE-CANCER; STRANDED-DNA; IN-VIVO; PROTEIN; RNA	The AlkB repair enzymes, including Escherichia coli AlkB and two human homologues, ALKBH2 and ALKBH3, are iron(II)- and 2-oxoglutarate-dependent dioxygenases that efficiently repair N-1-methyladenine and N-3-methylcytosine methylated DNA damages. The development of small molecule inhibitors of these enzymes has seen less success. Here we have characterized a previously discovered natural product rhein and tested its ability to inhibit AlkB repair enzymes in vitro and to sensitize cells to methyl methane sulfonate that mainly produces N-1-methyladenine and N-3-methylcytosine lesions. Our investigation of the mechanism of rhein inhibition reveals that rhein binds to AlkB repair enzymes in vitro and promotes thermal stability in vivo. In addition, we have determined a new structural complex of rhein bound to AlkB, which shows that rhein binds to a different part of the active site in AlkB than it binds to in fat mass and obesity-associated protein (FTO). With the support of these observations, we put forth the hypothesis that AlkB repair enzymes would be effective pharmacological targets for cancer treatment.	[Li, Qi; Huang, Yue; Yang, Cai-Guang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Biol Chem Lab, Shanghai 201203, Peoples R China; [Liu, Xichun; Chen, Hao] Nanjing Univ, Inst Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China; [Liu, Xichun; Chen, Hao] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China; [Gan, Jianhua] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Nanjing University; Nanjing University; Fudan University	Yang, CG (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Biol Chem Lab, Shanghai 201203, Peoples R China.	yangcg@simm.ac.cn			National Natural Science Foundation of China [21372237, 91313303]; National Basic Research Program [2015CB910603]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant [2014ZX09507009-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant	This work was supported by National Natural Science Foundation of China Grants 21372237 and 91313303, National Basic Research Program Grant 2015CB910603, and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant 2014ZX09507009-01. The authors declare that they have no conflicts of interest with the contents of this article.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bleijlevens B, 2008, EMBO REP, V9, P872, DOI 10.1038/embor.2008.120; Bunnage ME, 2013, NAT CHEM BIOL, V9, P195, DOI 10.1038/nchembio.1197; Cetica V, 2009, J NEURO-ONCOL, V94, P195, DOI 10.1007/s11060-009-9837-0; Chen BE, 2014, SCI CHINA CHEM, V57, P307, DOI 10.1007/s11426-013-5029-z; Chen BE, 2012, J AM CHEM SOC, V134, P17963, DOI 10.1021/ja3064149; Chen BE, 2010, MOL BIOSYST, V6, P2143, DOI 10.1039/c005148a; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; DAY RS, 1987, J CELL SCI, P333; Dietlein F, 2014, TRENDS GENET, V30, P326, DOI 10.1016/j.tig.2014.06.003; Dinglay S, 2000, GENE DEV, V14, P2097; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Hopkinson RJ, 2013, CHEM SCI, V4, P3110, DOI [10.1039/c3sc51122g, 10.1039/C3SC51122G]; Huang Y, 2015, NUCLEIC ACIDS RES, V43, P373, DOI 10.1093/nar/gku1276; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Johannessen TCA, 2013, NEURO-ONCOLOGY, V15, P269, DOI 10.1093/neuonc/nos301; Konishi N, 2005, CLIN CANCER RES, V11, P5090, DOI 10.1158/1078-0432.CCR-05-0195; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; Li DY, 2013, CHEM RES TOXICOL, V26, P1182, DOI 10.1021/tx400096m; Li PS, 2013, CELL REP, V4, P817, DOI 10.1016/j.celrep.2013.07.027; Liefke R, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0180-0; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Mielecki D, 2016, DNA REPAIR, V39, P34, DOI 10.1016/j.dnarep.2015.12.010; Mishina Y, 2006, CHEM REV, V106, P215, DOI 10.1021/cr0404702; Mitra S, 2007, DNA REPAIR, V6, P1064, DOI 10.1016/j.dnarep.2007.03.007; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakao S, 2014, BIOORG MED CHEM LETT, V24, P1071, DOI 10.1016/j.bmcl.2014.01.008; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shah D, 2003, BIOCHEMISTRY-US, V42, P12610, DOI 10.1021/bi035315g; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Sikora A, 2010, MUTAGENESIS, V25, P139, DOI 10.1093/mutage/gep052; Srinivasan A, 2012, FUTURE MED CHEM, V4, P1093, DOI [10.4155/FMC.12.58, 10.4155/fmc.12.58]; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Vagbo CB, 2013, DNA REPAIR, V12, P188, DOI 10.1016/j.dnarep.2012.11.010; van den Born E, 2009, NUCLEIC ACIDS RES, V37, P7124, DOI 10.1093/nar/gkp774; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Verdemato PE, 2000, NUCLEIC ACIDS RES, V28, P3710, DOI 10.1093/nar/28.19.3710; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Wang P, 2015, CELL REP, V13, P2353, DOI 10.1016/j.celrep.2015.11.029; Wang TL, 2015, J AM CHEM SOC, V137, P13736, DOI 10.1021/jacs.5b06690; Welford RWD, 2003, J BIOL CHEM, V278, P10157, DOI 10.1074/jbc.M211058200; Woon ECY, 2012, J MED CHEM, V55, P2173, DOI 10.1021/jm201417e; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yi CQ, 2012, NAT STRUCT MOL BIOL, V19, P671, DOI 10.1038/nsmb.2320; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; ZHANG Y, 1993, BIOCHEMISTRY-US, V32, P7954, DOI 10.1021/bi00082a017; Zhao Y, 2015, EMBO J, V34, P1687, DOI 10.15252/embj.201490497; Zhou YX, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/578107; Zhu CX, 2014, ANGEW CHEM INT EDIT, V53, P3659, DOI 10.1002/anie.201310050	62	52	55	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11083	11093		10.1074/jbc.M115.711895	http://dx.doi.org/10.1074/jbc.M115.711895			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27015802	Green Published, hybrid			2022-12-26	WOS:000377042100012
J	Rhoden, JJ; Dyas, GL; Wroblewski, VJ				Rhoden, John J.; Dyas, Gregory L.; Wroblewski, Victor J.			A Modeling and Experimental Investigation of the Effects of Antigen Density, Binding Affinity, and Antigen Expression Ratio on Bispecific Antibody Binding to Cell Surface Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; antibody engineering; cooperativity; kinetics; mathematical modeling; multifunctional protein; avidity; bispecific antibody	FRAGMENTS; DOMAINS; DESIGN; CANCER; SPECIFICITY; SCATTERING; RECEPTOR; THERAPY; DISPLAY; GROWTH	Despite the increasing number of multivalent antibodies, bispecific antibodies, fusion proteins, and targeted nanoparticles that have been generated and studied, the mechanism of multivalent binding to cell surface targets is not well understood. Here, we describe a conceptual and mathematical model of multivalent antibody binding to cell surface antigens. Our model predicts that properties beyond 1:1 antibody:antigen affinity to target antigens have a strong influence on multivalent binding. Predicted crucial properties include the structure and flexibility of the antibody construct, the target antigen(s) and binding epitope(s), and the density of antigens on the cell surface. For bispecific antibodies, the ratio of the expression levels of the two target antigens is predicted to be critical to target binding, particularly for the lower expressed of the antigens. Using bispecific antibodies of different valencies to cell surface antigens including MET and EGF receptor, we have experimentally validated our modeling approach and its predictions and observed several nonintuitive effects of avidity related to antigen density, target ratio, and antibody affinity. In some biological circumstances, the effect we have predicted and measured varied from the monovalent binding interaction by several orders of magnitude. Moreover, our mathematical framework affords us a mechanistic interpretation of our observations and suggests strategies to achieve the desired antibody-antigen binding goals. These mechanistic insights have implications in antibody engineering and structure/activity relationship determination in a variety of biological contexts.	[Rhoden, John J.; Dyas, Gregory L.; Wroblewski, Victor J.] Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA	Eli Lilly	Rhoden, JJ (corresponding author), Eli Lilly & Co, Lilly Res Labs, Lilly Corp Ctr, S Delaware St, Indianapolis, IN 46285 USA.	rhoden_john_j@lilly.com						Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109; Castoldi R, 2012, PROTEIN ENG DES SEL, V25, P551, DOI 10.1093/protein/gzs048; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Chen C, 2014, MOL CANCER THER, V13, P90, DOI 10.1158/1535-7163.MCT-13-0558; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; Diaz-Rohrer B, 2014, BBA-BIOMEMBRANES, V1838, P3003, DOI 10.1016/j.bbamem.2014.07.029; Garber K, 2014, NAT REV DRUG DISCOV, V13, P799, DOI 10.1038/nrd4478; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Harms BD, 2014, METHODS, V65, P95, DOI 10.1016/j.ymeth.2013.07.017; Nguyen HH, 2015, SENSORS-BASEL, V15, P10481, DOI 10.3390/s150510481; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Kang JC, 2014, MABS-AUSTIN, V6, P340, DOI 10.4161/mabs.27658; KAUFMAN EN, 1992, CANCER RES, V52, P4157; Kearns JD, 2015, MOL CANCER THER, V14, P1625, DOI 10.1158/1535-7163.MCT-14-0772; Kontermann RE, 2012, ARCH BIOCHEM BIOPHYS, V526, P194, DOI 10.1016/j.abb.2012.03.001; Kontermann RE, 2011, BISPECIFIC ANTIBODIES, P1, DOI 10.1007/978-3-642-20910-9_1; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; Mazor Y, 2015, MABS-AUSTIN, V7, P377, DOI 10.1080/19420862.2015.1007816; MURPHY RM, 1988, BIOPHYS J, V54, P45, DOI 10.1016/S0006-3495(88)82929-1; Nelson AL, 2010, MABS-AUSTIN, V2, P77, DOI 10.4161/mabs.2.1.10786; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nielsen UB, 2000, CANCER RES, V60, P6434; Olafsen T, 2010, SEMIN NUCL MED, V40, P167, DOI 10.1053/j.semnuclmed.2009.12.005; Omidfar K, 2015, EXPERT OPIN DRUG DIS, V10, P651, DOI 10.1517/17460441.2015.1037738; Reichert JM, 2015, MABS-AUSTIN, V7, P1, DOI 10.4161/19420862.2015.988944; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shen Y, 2015, MABS-AUSTIN, V7, P931, DOI 10.1080/19420862.2015.1055442; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P1779, DOI 10.1021/bi00121a028; Spangler JB, 2012, J MOL BIOL, V422, P532, DOI 10.1016/j.jmb.2012.06.014; Zhang K, 2015, MABS-AUSTIN, V7, P42, DOI 10.4161/19420862.2014.985933; Zhou Y, 2012, MOL CANCER THER, V11, P1467, DOI 10.1158/1535-7163.MCT-11-1038	37	30	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11337	11347		10.1074/jbc.M116.714287	http://dx.doi.org/10.1074/jbc.M116.714287			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022022	hybrid, Green Published			2022-12-26	WOS:000377042100032
J	Nawata, A; Noguchi, H; Mazaki, Y; Kurahashi, T; Izumi, H; Wang, KY; Guo, X; Uramoto, H; Kohno, K; Taniguchi, H; Tanaka, Y; Fujii, J; Sasaguri, Y; Tanimoto, A; Nakayama, T; Yamada, S				Nawata, Aya; Noguchi, Hirotsugu; Mazaki, Yuichi; Kurahashi, Toshihiro; Izumi, Hiroto; Wang, Ke-Yong; Guo, Xin; Uramoto, Hidetaka; Kohno, Kimitoshi; Taniguchi, Hatsumi; Tanaka, Yoshiya; Fujii, Junichi; Sasaguri, Yasuyuki; Tanimoto, Akihide; Nakayama, Toshiyuki; Yamada, Sohsuke			Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							METABOLIC SYNDROME; SIGNALING PATHWAY; GENE-EXPRESSION; LXR-ALPHA; STEATOHEPATITIS; MICE; CHOLESTEROL; APOPTOSIS; RECEPTOR; MECHANISMS	Background Accumulating evidence has shown that methionine- and choline-deficient high fat (MCD+HF) diet induces the development of nonalcoholic fatty liver disease (NAFLD), in which elevated reactive oxygen species play a crucial role. We have reported that peroxiredoxin 4 (PRDX4), a unique secretory member of the PRDX antioxidant family, protects against NAFLD progression. However, the detailed mechanism and potential effects on the intestinal function still remain unclear. Methods & Results Two weeks after feeding mice a MCD+HF diet, the livers of human PRDX4 transgenic (Tg) mice exhibited significant suppression in the development of NAFLD compared with wildtype (WT) mice. The serum thiobarbituric acid reactive substances levels were significantly lower in Tg mice. In contrast, the Tg small intestine with PRDX4 overexpression showed more suppressed shortening of total length and villi height, and more accumulation of lipid in the jejunum, along with lower levels of dihydroethidium binding. The enterocytes exhibited fewer apoptotic but more proliferating cells, and inflammation was reduced in the mucosa. Furthermore, the small intestine of Tg mice had significantly higher expression of cholesterol absorption-regulatory factors, including liver X receptor-alpha, but lower expression of microsomal triglyceride-transfer protein. Conclusion Our present data provide the first evidence of the beneficial effects of PRDX4 on intestinal function in the reduction of the severity of NAFLD, by ameliorating oxidative stress-induced local and systemic injury. We can suggest that both liver and intestine are spared, to some degree, by the antioxidant properties of PRDX4.	[Nawata, Aya; Noguchi, Hirotsugu; Wang, Ke-Yong; Guo, Xin; Sasaguri, Yasuyuki; Nakayama, Toshiyuki; Yamada, Sohsuke] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan; [Nawata, Aya; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan; [Mazaki, Yuichi] Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Sapporo, Hokkaido 0608638, Japan; [Kurahashi, Toshihiro; Fujii, Junichi] Yamagata Univ, Grad Sch Med Sci, Dept Biomol Funct, Yamagata 9909585, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Sch Med, Dept Occupat Pneumol, Kitakyushu, Fukuoka 8078555, Japan; [Wang, Ke-Yong] Univ Occupat & Environm Hlth, Sch Med, Shared Use Res Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Guo, Xin] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Kitakyushu, Fukuoka 8078555, Japan; [Uramoto, Hidetaka] Med Univ, Hebei Canc Inst, Hosp Hebei 4, Pathol Lab, Jiankang Rd 12, Shijiazhuang 050011, Hebei, Peoples R China; [Uramoto, Hidetaka] Saitama Canc Ctr, Dept Thorac Surg, 818 Komuro, Ina, Saitama 3620806, Japan; [Kohno, Kimitoshi] Univ Occupat & Environm Hlth, Sch Med, President Lab, Kitakyushu, Fukuoka 8078555, Japan; [Kohno, Kimitoshi] Asahi Matsumoto Hosp, Kitakyushu, Fukuoka 8000242, Japan; [Taniguchi, Hatsumi] Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka 8078555, Japan; [Sasaguri, Yasuyuki] Fukuoka Wajiro Hosp, Pathol Lab, Fukuoka 8110213, Japan; [Tanimoto, Akihide; Yamada, Sohsuke] Kagoshima Univ, Dept Pathol, Field Oncol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; [Yamada, Sohsuke] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria; [Yamada, Sohsuke] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Hokkaido University; Yamagata University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Kagoshima University; Medical University of Graz; University of Graz	Yamada, S (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan.; Yamada, S (corresponding author), Kagoshima Univ, Dept Pathol, Field Oncol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan.; Yamada, S (corresponding author), Med Univ Graz, Inst Pathol, A-8010 Graz, Austria.; Yamada, S (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	sohsuke@m.kufm.kagoshima-u.ac.jp	Nawata, Aya/AHA-1272-2022	Mazaki, Yuichi/0000-0003-4192-0834; wang, ke-yong/0000-0001-8295-1229	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [24790394]; Fukuoka Foundation for Sound Health Cancer Research Fund, Fukuoka, Japan	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fukuoka Foundation for Sound Health Cancer Research Fund, Fukuoka, Japan	This work was supported in part by Grants-in-Aid for Scientific Research (24790394) from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan (to S.Y.) and by the Fukuoka Foundation for Sound Health Cancer Research Fund, Fukuoka, Japan (to S.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MY, 2012, EUR J INTERN MED, V23, P649, DOI 10.1016/j.ejim.2012.05.001; Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Ahn SB, 2014, DIGEST DIS SCI, V59, P2975, DOI 10.1007/s10620-014-3289-x; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Cruz-Garcia L, 2014, J LIPID RES, V55, P1944, DOI 10.1194/jlr.M052845; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fujii J, 2015, FREE RADICAL BIO MED, V83, P373, DOI 10.1016/j.freeradbiomed.2015.01.025; Giguere P, 2007, FEBS LETT, V581, P3863, DOI 10.1016/j.febslet.2007.07.011; Guo X, 2012, ANTIOXID REDOX SIGN, V17, P1362, DOI 10.1089/ars.2012.4549; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Ito R, 2012, MOL MED REP, V6, P379, DOI 10.3892/mmr.2012.935; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; Kurahashi T, 2012, FEBS LETT, V586, P4289, DOI 10.1016/j.febslet.2012.09.047; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Meier JL, 1996, INTERVIROLOGY, V39, P331, DOI 10.1159/000150504; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Morotomi N, 2011, BIOL PHARM BULL, V34, P1011, DOI 10.1248/bpb.34.1011; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; Neuschwander-Tetri BA, 2005, AM J MED SCI, V330, P326, DOI 10.1097/00000441-200512000-00011; Noguchi H, 2014, AM J PATHOL, V184, P644, DOI 10.1016/j.ajpath.2013.11.030; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Syn WK, 2009, CLIN LIVER DIS, V13, P565, DOI 10.1016/j.cld.2009.07.003; Tasaki T, 2013, AM J PATHOL, V182, P597, DOI 10.1016/j.ajpath.2012.10.008; Usui S, 2002, J LIPID RES, V43, P805; Vallejo SJH, 2009, AM J PHYSIOL-GASTR L, V296, pG782, DOI 10.1152/ajpgi.90324.2008; Wang KY, 2010, AM J PATHOL, V177, P713, DOI 10.2353/ajpath.2010.091198; Wang N, 2013, EXP THER MED, V6, P635, DOI 10.3892/etm.2013.1214; Yamada S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113509; Yamada Sohsuke, 2012, Journal of UOEH, V34, P27; Zhang Y, 2012, J CLIN INVEST, V122, P1688, DOI 10.1172/JCI59817	44	24	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152549	10.1371/journal.pone.0152549	http://dx.doi.org/10.1371/journal.pone.0152549			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035833	gold, Green Published			2022-12-26	WOS:000373201200021
J	Kim, DK; Koo, KC; Raheem, AA; Kim, KH; Chung, BH; Choi, YD; Rha, KH				Kim, Dae Keun; Koo, Kyo Chul; Raheem, Ali Abdel; Kim, Ki Hong; Chung, Byung Ha; Choi, Young Deuk; Rha, Koon Ho			Single Positive Lymph Node Prostate Cancer Can Be Treated Surgically without Recurrence	PLOS ONE			English	Article							ASSISTED RADICAL PROSTATECTOMY; MEN; DISSECTION; OUTCOMES	Purpose/Objectives To investigate pN1 prostate cancer (PCa) patients treated surgically without immediate adjuvant treatment. Materials and Methods We analyzed the database of 2316 patients at our institution who underwent robot-assisted radical prostatectomy (RARP)/radical prostatectomy (RP) between July 2005 and November 2012. 87 patients with pN1 PCa and received no neoadjuvant and immediate adjuvant therapy were included in the study. Included pN1 PCa patients were followed up for median of 60 months. Biochemical recurrence (BCR)-free survival, metastasis-free survival (MFS), cancer specific survival (CSS), and overall survival (OS) rates were determined by using Kaplan-Meier analysis. Cox regression analysis was performed to investigate the impact of prostate-specific antigen (PSA) level, Gleason score, extraprostatic extension, seminal vesicle invasion, perineural invasion, lymphovascular invasion, positive surgical margin, tumor volume, early post-operative PSA(6 weeks), PSA nadir, lymph node yield, and number of pathologically positive lymph nodes on survival. Results The 5-year OS rate of patients was 86.1%, while the CSS rate was 89.6%. The metastasis-free and BCR-free survival rates were 71% and 19.1%, respectively, and each was significantly correlated with the number of positive lymph nodes on log rank tests (p = 0.004 and p = 0.039, respectively). The presence of 2 or more pathologically positive LNs (HR: 2.20; 95% CI 1.30-3.72; p = 0.003) and a Gleason score >= 8 (HR: 2.40; 95% CI: 1.32-4.38; p = 0.04) were significant negative predictors of BCR free survival on multivariable regression analysis. Furthermore, the presence of 2 or more positive lymph nodes (HR: 1.06; 95% CI 1.01-1.11; p = 0.029) were significant negative predictors of metastasis-free survival on multivariable regression analysis. Additionally, in the patients who had no BCR without adjuvant treatment 9 patients out of 10 (90%) had single positive LN and 5 patients out of 10 (50%) had Gleason score 7. Therefore, single positive LN, and Gleason scores <= 7 have significantly low risk of disease progression. Conclusions pN1 PCa patients have heterogenous clinical courses. Patients with single positive LN, and Gleason scores <= 7 have low risk of recurrence. Close observation with delayed adjuvant hormone therapy can be considered in these patients.	[Kim, Dae Keun] CHA Univ, CHA Seoul Stn, CHA Med Sch, Dept Urol,Med Ctr, Seoul, South Korea; [Kim, Dae Keun] Hanyang Univ, Grad Sch, Sch Med, Dept Urol, Seoul 133791, South Korea; [Koo, Kyo Chul; Raheem, Ali Abdel; Chung, Byung Ha; Choi, Young Deuk; Rha, Koon Ho] Yonsei Univ, Coll Med, Dept Urol, Urol Sci Inst, Seoul, South Korea; [Raheem, Ali Abdel] Tanta Univ, Dept Urol, Tanta, Egypt; [Kim, Ki Hong] Soonchunhyang Univ, Cheonan Hosp, Dept Urol, Cheonan, Chungcheongnam, South Korea	Pochon Cha University; Hanyang University; Yonsei University; Yonsei University Health System; Egyptian Knowledge Bank (EKB); Tanta University; Soonchunhyang University	Rha, KH (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Urol Sci Inst, Seoul, South Korea.	khrha@yuhs.ac	김, 대근/X-8040-2019	김, 대근/0000-0003-3237-6304; Choi, Young Deuk/0000-0002-8545-5797; Koo, Kyo Chul/0000-0001-7303-6256; Rha, Koon Ho/0000-0001-8588-7584; Chung, Byung Ha/0000-0001-9817-3660				Abdollah F, 2012, BJU INT, V109, P1177, DOI 10.1111/j.1464-410X.2011.10518.x; Boorjian SA, 2007, J UROLOGY, V178, P864, DOI 10.1016/j.juro.2007.05.048; Feifer AH, 2011, CANCER-AM CANCER SOC, V117, P3933, DOI 10.1002/cncr.25981; Gerber GS, 1997, EUR UROL, V32, P385, DOI 10.1159/000480794; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Kim KH, 2014, BJU INT, V113, P598, DOI 10.1111/bju.12280; Kim KH, 2013, BJU INT, V112, P216, DOI 10.1111/j.1464-410X.2012.11765.x; Koo KC, 2014, PROSTATE INT, V2, P127, DOI 10.12954/PI.14050; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Mohler JL, 2014, J NATL COMPR CANC NE, V12, P686, DOI 10.6004/jnccn.2014.0072; Moschini M, 2015, EUR UROL; Nini A., 2015, EUR UROL; Palapattu GS, 2004, J UROLOGY, V172, P1860, DOI 10.1097/01.ju.0000139886.25848.4a; Pierorazio PM, 2013, PROSTATE, V73, P1673, DOI 10.1002/pros.22702; Seiler R, 2014, J UROLOGY, V191, P1280, DOI 10.1016/j.juro.2013.11.029; Spiess PE, 2007, BJU INT, V99, P321, DOI 10.1111/j.1464-410X.2006.06648.x; Touijer KA, 2014, EUR UROL, V65, P20, DOI 10.1016/j.eururo.2013.03.053; Zwergel U, 2004, J UROLOGY, V171, P1128, DOI 10.1097/01.ju.0000113202.37783.1f	18	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152391	10.1371/journal.pone.0152391	http://dx.doi.org/10.1371/journal.pone.0152391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031340	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800065
J	Kim, JH; Furrow, E; Ritt, MG; Utz, PJ; Robinson, WH; Yu, LP; Eckert, A; Stuebner, K; O'Brien, TD; Steinman, L; Modiano, JF				Kim, Jong-Hyuk; Furrow, Eva; Ritt, Michelle G.; Utz, Paul J.; Robinson, William H.; Yu, Liping; Eckert, Andrea; Stuebner, Kathleen; O'Brien, Timothy D.; Steinman, Lawrence; Modiano, Jaime F.			Anti-Insulin Immune Responses Are Detectable in Dogs with Spontaneous Diabetes	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; SUSCEPTIBILITY GENES; MELLITUS; INSULIN; AUTOANTIBODIES; POLYMORPHISMS; ANTIBODIES; HUMANS	Diabetes mellitus occurs spontaneously in dogs. Although canine diabetes shares many features with human type-1 diabetes, there are differences that have cast doubt on the immunologic origin of the canine disease. In this study, we examined whether peripheral immune responses directed against islet antigens were present in dogs with diabetes. Routine diagnostics were used to confirm diabetic status, and serum samples from dogs with (N = 15) and without (N = 15) diabetes were analyzed for the presence of antibodies against islet antigens (insulin, glutamic acid decarboxylase, insulinoma-associated protein tyrosine phosphatase, and islet beta-cell zinc cation efflux transporter) using standard radioassays. Interferon-gamma production from peripheral blood T cells stimulated by porcine insulin and by human insulin was tested using Elispot assays. Anti-insulin antibodies were detectable in a subset of diabetic dogs receiving insulin therapy. Pre-activated T cells and incipient insulin-reactive T cells in response to porcine or human insulin were identified in non-diabetic dogs and in dogs with diabetes. The data show that humoral and cellular anti-insulin immune responses are detectable in dogs with diabetes. This in turn provides support for the potential to ethically use dogs with diabetes to study the therapeutic potential of antigen-specific tolerance.	[Kim, Jong-Hyuk; Furrow, Eva; Ritt, Michelle G.; Modiano, Jaime F.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Kim, Jong-Hyuk; Stuebner, Kathleen; O'Brien, Timothy D.; Modiano, Jaime F.] Univ Minnesota, Anim Canc Care & Res Program, St Paul, MN 55108 USA; [Kim, Jong-Hyuk; O'Brien, Timothy D.; Modiano, Jaime F.] Univ Minnesota, Masonic Canc Ctr, St Paul, MN 55108 USA; [Utz, Paul J.; Robinson, William H.] Stanford Univ, Dept Med, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Utz, Paul J.; Robinson, William H.; Steinman, Lawrence] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Yu, Liping] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Eckert, Andrea; Stuebner, Kathleen] Univ Minnesota, Coll Vet Med, Clin Invest Ctr, St Paul, MN 55108 USA; [O'Brien, Timothy D.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [O'Brien, Timothy D.; Modiano, Jaime F.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA; [Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Steinman, Lawrence] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Modiano, Jaime F.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Modiano, JF (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.; Modiano, JF (corresponding author), Univ Minnesota, Anim Canc Care & Res Program, St Paul, MN 55108 USA.; Modiano, JF (corresponding author), Univ Minnesota, Masonic Canc Ctr, St Paul, MN 55108 USA.; Modiano, JF (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA.; Modiano, JF (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN USA.	modiano@umn.edu	MODIANO, JAIME/K-3583-2019; Furrow, Eva/W-9963-2018; KIM, JONG HYUK/AAC-7433-2020	MODIANO, JAIME/0000-0001-6398-7648; KIM, JONG HYUK/0000-0002-1645-0036; O'Brien, Timothy/0000-0001-9742-0930; Steinman, Lawrence/0000-0002-2437-2250; Robinson, William/0000-0003-4385-704X; Furrow, Eva/0000-0002-7339-2354	Morris Animal Foundation grant [D12CA-031]; NIH ORIP K01 Mentored Research Scientist Development Award [1K01OD019912-01]; Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; Animal Cancer Care and Research Program of the University of Minnesota; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019912] Funding Source: NIH RePORTER	Morris Animal Foundation grant; NIH ORIP K01 Mentored Research Scientist Development Award; Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; Animal Cancer Care and Research Program of the University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded in part by a Morris Animal Foundation grant (#D12CA-031) to EF. Partial funding for EF was provided by an NIH ORIP K01 Mentored Research Scientist Development Award (1K01OD019912-01). JFM was supported in part by the Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota. Donations to the Animal Cancer Care and Research Program of the University of Minnesota also helped support this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105473; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Arif S, 2011, DIABETES, V60, P2112, DOI 10.2337/db10-1643; Catchpole B, 2005, DIABETOLOGIA, V48, P1948, DOI 10.1007/s00125-005-1921-1; Catchpole B, 2013, VET J, V195, P139, DOI 10.1016/j.tvjl.2012.11.013; Cook Audrey K, 2012, J Diabetes Sci Technol, V6, P491; Davison LJ, 2008, J VET INTERN MED, V22, P1317, DOI 10.1111/j.1939-1676.2008.0194.x; Davison LJ, 2008, VET IMMUNOL IMMUNOP, V126, P83, DOI 10.1016/j.vetimm.2008.06.016; Davison LJ, 2003, VET IMMUNOL IMMUNOP, V91, P53, DOI 10.1016/S0165-2427(02)00267-2; Davison LJ, 2011, RES VET SCI, V91, P58, DOI 10.1016/j.rvsc.2010.08.007; Eisenbarth GS, 2008, ARQ BRAS ENDOCRINOL, V52, P146, DOI 10.1590/S0004-27302008000200002; Eisenbarth GS, 2007, J CLIN ENDOCR METAB, V92, P2403, DOI 10.1210/jc.2007-0339; Haley PJ, 1997, IMMUNOPHARM IMMUNOT, V19, P459, DOI 10.3109/08923979709007668; Hess RS, 2000, J AM VET MED ASSOC, V216, P1414, DOI 10.2460/javma.2000.216.1414; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Kumar P, 2014, VET WORLD, V7, P952, DOI 10.14202/vetworld.2014.952-959; KWOK SCM, 1983, J BIOL CHEM, V258, P2357; Nelson RW, 2014, J ENDOCRINOL, V222, pT1, DOI 10.1530/JOE-14-0202; Orban T, 2009, DIABETES CARE, V32, P2269, DOI 10.2337/dc09-0934; Phillips Jenny M, 2009, Rev Diabet Stud, V6, P97, DOI 10.1900/RDS.2009.6.97; Roep BO, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006103; Shields EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129809; Short AD, 2010, TISSUE ANTIGENS, V75, P242, DOI 10.1111/j.1399-0039.2009.01434.x; Short AD, 2007, J HERED, V98, P518, DOI 10.1093/jhered/esm048; Short AD, 2009, VET IMMUNOL IMMUNOP, V128, P137, DOI 10.1016/j.vetimm.2008.10.301; SMITH LF, 1966, AM J MED, V40, P662, DOI 10.1016/0002-9343(66)90145-8; VARDI P, 1987, DIABETES, V36, P1286, DOI 10.2337/diabetes.36.11.1286; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	30	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152397	10.1371/journal.pone.0152397	http://dx.doi.org/10.1371/journal.pone.0152397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031512	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800066
J	Milutinovic, S; Heynen-Genel, S; Chao, E; Dewing, A; Solano, R; Milan, L; Barron, N; He, M; Diaz, PW; Matsuzawa, S; Reed, JC; Hassig, CA				Milutinovic, Snezana; Heynen-Genel, Susanne; Chao, Elizabeth; Dewing, Antimone; Solano, Ricardo; Milan, Loribelle; Barron, Nikki; He, Min; Diaz, Paul W.; Matsuzawa, Shuichi; Reed, John C.; Hassig, Christian A.			Cardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML)	PLOS ONE			English	Article							ARSENIC TRIOXIDE; CARDIOTONIC STEROIDS; APOPTOSIS; INHIBITION; ATPASE; MULTIPLE; CELL	Cardiac glycosides (CGs), inhibitors of Na+/K+-ATPase (NKA), used clinically to treat heart failure, have garnered recent attention as potential anti-cancer and anti-viral agents. A high-throughput phenotypic screen designed to identify modulators of promyelocytic leukemia protein (PML) nuclear body (NB) formation revealed the CG gitoxigenin as a potent activator of PML. We demonstrate that multiple structurally distinct CGs activate the formation of PML NBs and induce PML protein SUMOylation in an NKA-dependent fashion. CG effects on PML occur at the post-transcriptional level, mechanistically distinct from previously described PML activators and are mediated through signaling events downstream of NKA. Curiously, genomic deletion of PML in human cancer cells failed to abrogate the cytotoxic effects of CGs and other apoptotic stimuli such as ceramide and arsenic trioxide that were previously shown to function through PML in mice. These findings suggest that alternative pathways can compensate for PML loss to mediate apoptosis in response to CGs and other apoptotic stimuli.	[Milutinovic, Snezana; Heynen-Genel, Susanne; Chao, Elizabeth; Dewing, Antimone; Solano, Ricardo; Milan, Loribelle; Matsuzawa, Shuichi; Reed, John C.; Hassig, Christian A.] Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Barron, Nikki] Bemer USA LLC, Carlsbad, CA USA; [He, Min] NCI, Bethesda, MD 20892 USA; [Diaz, Paul W.] P William Diaz Pharmaceut Consulting, Riverside, CA USA; [Reed, John C.] Roche, Grenzacherstr 124, CH-4070 Basel, Switzerland	Sanford Burnham Prebys Medical Discovery Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Roche Holding	Hassig, CA (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chassig@sbpdiscovery.org			National Cancer Institute NExT Program, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	National Cancer Institute NExT Program, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute NExT Program, National Institutes of Health, under contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.; We are grateful to members of the Reed laboratory and the Conrad Prebys Center for Chemical Genomics for assistance with assay optimization and screening. This project was supported in part by federal funds from the National Cancer Institute NExT Program, National Institutes of Health, under contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Akimova Olga A, 2005, Pathophysiology, V12, P125, DOI 10.1016/j.pathophys.2005.03.003; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Cheng Xiwen, 2012, Front Oncol, V2, P210, DOI 10.3389/fonc.2012.00210; de The H, 2012, J CELL BIOL, V198, P11, DOI 10.1083/jcb.201112044; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dodson AW, 2007, VIROLOGY, V366, P340, DOI 10.1016/j.virol.2007.05.001; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Fasci D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3929; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Hands KJ, 2014, J CELL SCI, V127, P365, DOI 10.1242/jcs.132290; Hartley C, 2006, ARCH VIROL, V151, P2495, DOI 10.1007/s00705-006-0824-x; HOLLMAN A, 1985, BRIT HEART J, V54, P258; Joe YS, 2006, J BIOL CHEM, V281, P28764, DOI 10.1074/jbc.M604392200; Kapoor A, 2012, ANTIMICROB AGENTS CH, V56, P4891, DOI 10.1128/AAC.00898-12; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Komura N, 2007, EXP CELL RES, V313, P2753, DOI 10.1016/j.yexcr.2007.03.032; Li L, 2006, CANCER LETT, V236, P259, DOI 10.1016/j.canlet.2005.05.034; Lim JH, 2011, J BIOL CHEM, V286, P44403, DOI 10.1074/jbc.M111.289512; Mathews V, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.056; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Rabellino A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00060; SCHONFELD W, 1986, BIOCHEM PHARMACOL, V35, P3221, DOI 10.1016/0006-2952(86)90416-8; Stadler M, 1995, ONCOGENE, V11, P2565; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; TOBIN T, 1975, EUR J PHARMACOL, V32, P133, DOI 10.1016/0014-2999(75)90276-9; Wang ZG, 1998, BLOOD, V92, P1497, DOI 10.1182/blood.V92.5.1497.417k41_1497_1504; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Xu ZX, 2004, J BIOL CHEM, V279, P1838, DOI 10.1074/jbc.M310987200; Yip KW, 2011, J BIOMOL SCREEN, V16, P251, DOI 10.1177/1087057110394181; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152692	10.1371/journal.pone.0152692	http://dx.doi.org/10.1371/journal.pone.0152692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031987	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800120
J	Pickens, CA; Matsuo, KH; Fenton, JI				Pickens, C. Austin; Matsuo, Karen H.; Fenton, Jenifer I.			Relationship between Body Mass Index, C-Peptide, and Delta-5-Desaturase Enzyme Activity Estimates in Adult Males	PLOS ONE			English	Article							INSULIN-RESISTANCE; FATTY-ACIDS; LINOLEIC-ACID; SERUM-LIPIDS; OBESITY; DELTA-6; ASSOCIATION; ADIPONECTIN; DESATURASE; ADIPOKINES	Obesity, in particular abdominal obesity, alters the composition of plasma and tissue fatty acids (FAs), which contributes to inflammation and insulin resistance. FA metabolism is modulated by desaturases and may affect adipokine and insulin secretion. Therefore, we examined relationships between adipokines, a marker of insulin production, and plasma FA desaturase enzyme activity estimates (EAEs) in obesity. Plasma phospholipid (PPL) FAs were isolated from 126 males (ages 48 to 65 years), derivatized, and analyzed using gas chromatography. Delta-6 desaturase (D6D) and delta-5 desaturase (D5D) EAEs were calculated as the ratio of PPL 20:3/18:2 and 20:4/20:3, respectively. In body mass index (BMI) and waist circumference (WC) adjusted polytomous logistic regression analyses, PPL FAs and FA desaturase EAEs were associated with C-peptide and adiponectin. Individuals with elevated D6D EAEs were less likely (OR 0.33) to have serum adiponectin concentrations > 5.37 mu g/mL, compared with adiponectin concentrations <= 3.62 mu g/mL. Individuals with increased D5D EAEs were less likely (OR 0.8) to have C-peptide concentrations >= 3.32 ng/mL, and > 1.80 and <= 3.29 ng/mL, compared with those with C-peptide <= 1.76 ng/mL. The proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) was positively associated with C-peptide, but TNF-a was not associated with the D5D EAE. C-peptide and adiponectin concentrations are associated with specific PPL FAs and FA desaturase EAEs. The relationship between C-peptide concentrations and D5D EAEs remained significant after adjusting for BMI, WC, and TNF-alpha. Thus, future research should investigate whether D5D inhibition may occur through a C-peptide mediated pathway.	[Pickens, C. Austin; Matsuo, Karen H.; Fenton, Jenifer I.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA	Michigan State University	Fenton, JI (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	imigjeni@msu.edu		Pickens, Austin/0000-0003-1632-5777	National Institutes of Health [R03CA142000]; NATIONAL CANCER INSTITUTE [R03CA142000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was made possible by National Institutes of Health award number R03CA142000. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the United States Government.	AGREN JJ, 1992, J LIPID RES, V33, P1871; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Burdge GC, 2000, BRIT J NUTR, V84, P781; Comstock SS, 2014, CANCER EPIDEM BIOMAR, V23, P1843, DOI 10.1158/1055-9965.EPI-14-0249-T; Comstock SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085939; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gurzell EA, 2014, PROSTAG LEUKOTR ESS, V91, P87, DOI 10.1016/j.plefa.2014.04.001; HORWITZ DL, 1975, J CLIN INVEST, V55, P1278, DOI 10.1172/JCI108047; Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5; Kitamura T, 2002, BIOCHEM J, V366, P737, DOI 10.1042/BJ20020344; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Matthan NR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000764; Min Y, 2011, EUR J CLIN NUTR, V65, P690, DOI 10.1038/ejcn.2011.19; Pham MN, 2013, DIABETES-METAB RES, V29, P166, DOI 10.1002/dmrr.2378; Montanaro MA, 2003, LIPIDS, V38, P827, DOI 10.1007/s11745-003-1132-7; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Obukowicz MG, 1998, J PHARMACOL EXP THER, V287, P157; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Perreault M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088539; Phillips CM, 2012, J NUTR, V142, P824, DOI 10.3945/jn.111.153460; Pickens CA, 2015, PROSTAG LEUKOTR ESS, V95, P31, DOI 10.1016/j.plefa.2014.12.001; POISSON JP, 1985, ENZYME, V34, P1; ROSE HG, 1965, J LIPID RES, V6, P428; Saadatian-Elahi M, 2009, AM J CLIN NUTR, V89, P331, DOI 10.3945/ajcn.2008.26834; Staiger H, 2004, DIABETES, V53, P2195, DOI 10.2337/diabetes.53.9.2195; Thiebaut ACM, 2009, NUTR CANCER, V61, P500, DOI 10.1080/01635580802710717; Tunstall RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66, DOI 10.1152/ajpendo.00475.2001; Wang J, 2008, OBESITY, V16, P172, DOI 10.1038/oby.2007.42; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930	37	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0149305	10.1371/journal.pone.0149305	http://dx.doi.org/10.1371/journal.pone.0149305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023786	gold, Green Published			2022-12-26	WOS:000373113900004
J	Starkie, DO; Compson, JE; Rapecki, S; Lightwood, DJ				Starkie, Dale O.; Compson, Joanne E.; Rapecki, Stephen; Lightwood, Daniel J.			Generation of Recombinant Monoclonal Antibodies from Immunised Mice and Rabbits via Flow Cytometry and Sorting of Antigen-Specific IgG(+) Memory B Cells	PLOS ONE			English	Article							SECRETING CELLS; RAPID GENERATION; SINGLE CELLS; PLASMA-CELLS; EXPRESSION; DISCOVERY; TECHNOLOGIES; HYBRIDOMAS; SELECTION; CLONING	Single B cell screening strategies, which avoid both hybridoma fusion and combinatorial display, have emerged as important technologies for efficiently sampling the natural antibody repertoire of immunized animals and humans. Having access to a range of methods to interrogate different B cell subsets provides an attractive option to ensure large and diverse panels of high quality antibody are produced. The generation of multiple antibodies and having the ability to find rare B cell clones producing IgG with unique and desirable characteristics facilitates the identification of fit-for-purpose molecules that can be developed into therapeutic agents or research reagents. Here, we describe a multi-parameter flow cytometry single-cell sorting technique for the generation of antigen-specific recombinant monoclonal antibodies from single IgG(+) memory B cells. Both mouse splenocytes and rabbit PBMC from immunised animals were used as a source of B cells. Reagents staining both B cells and other unwanted cell types enabled efficient identification of class-switched IgG(+) memory B cells. Concurrent staining with antigen labelled separately with two spectrally-distinct fluorophores enabled antigen-specific B cells to be identified, i.e. those which bind to both antigen conjugates (double-positive). These cells were then typically sorted at one cell per well using FACS directly into a 96-well plate containing reverse transcriptase reaction mix. Following production of cDNA, PCR was performed to amplify cognate heavy and light chain variable region genes and generate transcriptionally-active PCR (TAP) fragments. These linear expression cassettes were then used directly in a mammalian cell transfection to generate recombinant antibody for further testing. We were able to successfully generate antigen-specific recombinant antibodies from both the rabbit and mouse IgG(+) memory B cell subset within one week. This included the generation of an anti-TNFR2 blocking antibody from mice with an affinity of 90 pM.	[Starkie, Dale O.; Compson, Joanne E.; Rapecki, Stephen; Lightwood, Daniel J.] UCB Pharma, 216 Bath Rd, Slough SL1 3WE, Berks, England	UCB Pharma SA	Lightwood, DJ (corresponding author), UCB Pharma, 216 Bath Rd, Slough SL1 3WE, Berks, England.	Daniel.lightwood@ucb.com			UCB Pharma	UCB Pharma(UCB Pharma SA)	The work detailed here was privately funded by UCB Pharma. All authors are UCB Pharma employees. UCB Pharma provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Bell J, 2003, J EXP MED, V197, P1233, DOI 10.1084/jem.20020270; Bowers PM, 2014, METHODS, V65, P44, DOI 10.1016/j.ymeth.2013.06.010; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Carroll S, 2005, J IMMUNOL METHODS, V296, P171, DOI 10.1016/j.jim.2004.11.007; Clargo AM, 2014, MABS-AUSTIN, V6, P143, DOI 10.4161/mabs.27044; Di NR, 2010, J IMMUNOL, V185, P5377, DOI [10.4049/jimmunol.1001587, DOI 10.4049/JIMMUNOL.1001587]; Dohmen SE, 2005, J IMMUNOL METHODS, V298, P9, DOI 10.1016/j.jim.2004.12.013; Doucett VP, 2005, J IMMUNOL METHODS, V303, P40, DOI 10.1016/j.jim.2005.05.014; Ellis M, 2010, Patent application number, Patent No. [WO2010/097437, 2010097437]; Fong RH, 2014, J VIROL, V88, P14364, DOI 10.1128/JVI.01943-14; Franz B, 2011, BLOOD, V118, P348, DOI 10.1182/blood-2011-03-341917; GREENSTEIN JL, 1980, J IMMUNOL, V124, P1472; He XS, 2011, J IMMUNOL METHODS, V365, P67, DOI 10.1016/j.jim.2010.12.008; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hutchings CJ, 2014, MABS-AUSTIN, V6, P246, DOI 10.4161/mabs.27226; Jin A, 2011, NAT PROTOC, V6, P668, DOI 10.1038/nprot.2011.322; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Kohler G, 1992, Biotechnology, V24, P524; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Lightwood D, 2013, J MOL BIOL, V425, P577, DOI 10.1016/j.jmb.2012.11.036; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; Ogunniyi AO, 2009, NAT PROTOC, V4, P767, DOI 10.1038/nprot.2009.40; Ozawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052383; Park S, 2011, J BIOTECHNOL, V156, P197, DOI 10.1016/j.jbiotec.2011.08.031; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; RAYBOULD TJG, 1988, SCIENCE, V240, P1788, DOI 10.1126/science.3289119; Reichert JM, THERAPEUTIC MONOCLON; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Stephens PE, 2010, Patent application, Patent No. [WO2010/097435, 2010097435]; Taddeo A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0551-3; Tickle S, 2015, J BIOMOL SCREEN, V20, P492, DOI 10.1177/1087057114564760; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2011, NEW BIOTECHNOL, V28, P453, DOI 10.1016/j.nbt.2011.03.014; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Townsend SE, 2001, J IMMUNOL METHODS, V249, P137, DOI 10.1016/S0022-1759(00)00352-5; Weitkamp JH, 2003, J IMMUNOL METHODS, V275, P223, DOI 10.1016/S0022-1759(03)00013-9; Yoshimoto N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01191; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008	42	32	36	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152282	10.1371/journal.pone.0152282	http://dx.doi.org/10.1371/journal.pone.0152282			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022949	gold, Green Submitted, Green Published			2022-12-26	WOS:000373113900038
J	Bermudez, EB; Klerman, EB; Czeisler, CA; Cohen, DA; Wyatt, JK; Phillips, AJK				Bermudez, Eduardo B.; Klerman, Elizabeth B.; Czeisler, Charles A.; Cohen, Daniel A.; Wyatt, James K.; Phillips, Andrew J. K.			Prediction of Vigilant Attention and Cognitive Performance Using Self-Reported Alertness, Circadian Phase, Hours since Awakening, and Accumulated Sleep Loss	PLOS ONE			English	Article							SUBJECTIVE ALERTNESS; MONITOR PERFORMANCE; MATHEMATICAL-MODEL; RESTRICTION; DEPRIVATION; FATIGUE; IMPAIRMENT; DURATION; DEGRADATION; TEMPERATURE	Sleep restriction causes impaired cognitive performance that can result in adverse consequences in many occupational settings. Individuals may rely on self-perceived alertness to decide if they are able to adequately perform a task. It is therefore important to determine the relationship between an individual's self-assessed alertness and their objective performance, and how this relationship depends on circadian phase, hours since awakening, and cumulative lost hours of sleep. Healthy young adults (aged 18-34) completed an inpatient schedule that included forced desynchrony of sleep/wake and circadian rhythms with twelve 42.85-hour " days" and either a 1:2 (n = 8) or 1:3.3 (n = 9) ratio of sleep-opportunity: enforced-wakefulness. We investigated whether subjective alertness (visual analog scale), circadian phase (melatonin), hours since awakening, and cumulative sleep loss could predict objective performance on the Psychomotor Vigilance Task (PVT), an Addition/Calculation Test (ADD) and the Digit Symbol Substitution Test (DSST). Mathematical models that allowed nonlinear interactions between explanatory variables were evaluated using the Akaike Information Criterion (AIC). Subjective alertness was the single best predictor of PVT, ADD, and DSST performance. Subjective alertness alone, however, was not an accurate predictor of PVT performance. The best AIC scores for PVT and DSST were achieved when all explanatory variables were included in the model. The best AIC score for ADD was achieved with circadian phase and subjective alertness variables. We conclude that subjective alertness alone is a weak predictor of objective vigilant or cognitive performance. Predictions can, however, be improved by knowing an individual's circadian phase, current wake duration, and cumulative sleep loss.	[Bermudez, Eduardo B.] Morehouse Sch Med, Atlanta, GA 30310 USA; [Klerman, Elizabeth B.; Czeisler, Charles A.; Phillips, Andrew J. K.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Klerman, Elizabeth B.; Czeisler, Charles A.; Phillips, Andrew J. K.] Harvard Univ, Sch Med, Boston, MA USA; [Cohen, Daniel A.] Sentara Healthcare, Norfolk, VA USA; [Wyatt, James K.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Morehouse School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Sentara Healthcare; Rush University	Phillips, AJK (corresponding author), Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA.; Phillips, AJK (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	ajphillips@partners.org	Wyatt, James K/F-1785-2011	Czeisler, Charles Andrew/0000-0002-7408-1849; Phillips, Andrew/0000-0003-1156-7056	National Space Biomedical Research Institute (NSBRI) [HFP02802]; NSBRI through NASA [NCC 9-58]; National Institutes of Health (NIH) [K24-HL105664, K99-HL119618, R00-HL119618, NCC-9-58-24, P01-AG009975, RC2-HL101340, R01-HL114088, T32-HLO7901]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL119618, K24HL105664, K99HL119618, R01HL114088, RC2HL101340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER	National Space Biomedical Research Institute (NSBRI); NSBRI through NASA; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work supported was by the National Space Biomedical Research Institute (NSBRI, www.nsbri.org) HFP02802 (AJKP, EBB, EBK) and a NSBRI grant to Morehouse Medical School (EBB) through NASA Cooperative Agreement NCC 9-58; the National Institutes of Health (NIH, www.nih.gov) awards K24-HL105664 (EBK), K99-HL119618 (AJKP), R00-HL119618 (AJKP), NCC-9-58-24, P01-AG009975, RC2-HL101340, R01-HL114088, and T32-HLO7901 (EBB), plus grants supporting the original experimental work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 1998, Sleep Med Rev, V2, P117, DOI 10.1016/S1087-0792(98)90004-1; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benitez PL, 2009, METHOD ENZYMOL, V454, P405, DOI 10.1016/S0076-6879(08)03816-0; BROWN ID, 1994, HUM FACTORS, V36, P298, DOI 10.1177/001872089403600210; Caldwell JA, 1997, AVIAT SPACE ENVIR MD, V68, P932; Cohen DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000458; Costa G, 1996, APPL ERGON, V27, P9, DOI 10.1016/0003-6870(95)00047-X; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Czeisler CA, 2010, PRINCIPLES PRACTICES, P375; Dalziel JR, 1998, MANAGING FATIGUE IN TRANSPORTATION, P287, DOI 10.1016/B978-008043357-8/50016-9; Dawson D, 2011, ACCIDENT ANAL PREV, V43, P549, DOI 10.1016/j.aap.2009.12.030; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dorrian J, 2000, J SLEEP RES, V9, P137, DOI 10.1046/j.1365-2869.2000.00195.x; Dorrian J, 2003, SLEEP, V26, P871, DOI 10.1093/sleep/26.7.871; Dorrian J., 2005, THESIS, P39; Gander P, 2008, CHRONOBIOL INT, V25, P1077, DOI 10.1080/07420520802551428; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Jewett ME, 1999, J BIOL RHYTHM, V14, P588, DOI 10.1177/074873099129000920; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Komada Y, 2013, IATSS RES, V37, P1, DOI 10.1016/j.iatssr.2013.06.001; Leproult R, 2003, AM J PHYSIOL-REG I, V284, pR280, DOI 10.1152/ajpregu.00197.2002; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; McCauley P, 2009, J THEOR BIOL, V256, P227, DOI 10.1016/j.jtbi.2008.09.012; Neylan TC, 2010, CHRONOBIOL INT, V27, P1493, DOI 10.3109/07420528.2010.504992; Otmani S, 2005, PHYSIOL BEHAV, V84, P715, DOI 10.1016/j.physbeh.2005.02.021; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Pomplun M, 2012, J VISION, V12, DOI 10.1167/12.7.14; Rajdev P, 2013, J THEOR BIOL, V331, P66, DOI 10.1016/j.jtbi.2013.04.013; Short M, 2010, SLEEP, V33, P123, DOI 10.1093/sleep/33.1.123; Silva EJ, 2010, SLEEP, V33, P481, DOI 10.1093/sleep/33.4.481; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Van Dongen HPA, 2007, SLEEP, V30, P1129, DOI 10.1093/sleep/30.9.1129; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2005, CLIN SPORT MED, V24, P237, DOI 10.1016/j.csm.2004.12.007; Van Dongen HPA, 2004, SLEEP, V27, P423; Wheaton A. G., 2011, Morbidity and Mortality Weekly Report, V60, P239; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Wyatt JK, 2004, SLEEP, V27, P374, DOI 10.1093/sleep/27.3.374; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Zhou X, 2012, J SLEEP RES, V21, P40, DOI 10.1111/j.1365-2869.2011.00924.x	45	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151770	10.1371/journal.pone.0151770	http://dx.doi.org/10.1371/journal.pone.0151770			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH5EH	27019198	gold, Green Published, Green Submitted			2022-12-26	WOS:000372807800019
J	Boyce, RM; Reyes, R; Matte, M; Ntaro, M; Mulogo, E; Lin, FC; Siedner, MJ				Boyce, Ross M.; Reyes, Raquel; Matte, Michael; Ntaro, Moses; Mulogo, Edgar; Lin, Feng-Chang; Siedner, Mark J.			Practical Implications of the Non-Linear Relationship between the Test Positivity Rate and Malaria Incidence	PLOS ONE			English	Article								Background The test positivity rate (TPR), defined as the number of laboratory-confirmed malaria tests per 100 suspected cases examined, is widely used by malaria surveillance programs as one of several key indicators of temporal trends in malaria incidence. However, there have been few studies using empiric data to examine the quantitative nature of this relationship. Methods To characterize the relationship between the test positivity rate and the incidence of malaria, we fit regression models using the confirmed malaria case rate as the outcome of interest and TPR as the predictor of interest. We varied the relationship between the two by alternating linear and polynomial terms for TPR, and compared the goodness of fit of each model. Results A total of 7,668 encounters for malaria diagnostic testing were recorded over the study period within a catchment area of 25,617 persons. The semi-annual TPR ranged from 4.5% to 59% and the case rates ranged from 0.5 to 560 per 1,000 persons. The best fitting model was an exponential growth model (R-2 = 0.80, AIC = 637). At low transmission levels (TPR<10%), the correlation between TPR and CMCR was poor, with large reductions in the TPR, for example from 10% to 1%, was associated with a minimal change in the CMCR (3.9 to 1.7 cases per 1,000 persons). At higher transmission levels, the exponential relationship made relatively small changes in TPR suggestive of sizeable change in estimated malaria incidence, suggesting that TPR remains a valuable surveillance indicator in such settings. Conclusions The TPR and the confirmed malaria case rate have a non-linear relationship, which is likely to have important implications for malaria surveillance programs, especially at the extremes of transmission.	[Boyce, Ross M.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; [Reyes, Raquel] Univ N Carolina, Div Gen Med, Chapel Hill, NC USA; [Matte, Michael; Ntaro, Moses; Mulogo, Edgar] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Lin, Feng-Chang] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Siedner, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Siedner, Mark J.] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Mbarara University of Science & Technology; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Boyce, RM (corresponding author), Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA.	ross.boyce@unchealth.unc.edu	Lin, Feng-Chang/ABE-9659-2020; Boyce, Ross/U-2207-2019	Boyce, Ross/0000-0002-9489-6324	Harvard Global Health Institute; Thrasher Research Fund; National Institutes of Health [K23MH099916]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH099916] Funding Source: NIH RePORTER	Harvard Global Health Institute; Thrasher Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	RMB receives support from the Harvard Global Health Institute (http://globalhealth.harvard.edu/) and Thrasher Research Fund (https://www.thrasherresearch.org/default.aspx). MJS receives support from the National Institutes of Health (K23MH099916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2010, MAL PROGR REV MAN RE; [Anonymous], DISEASE SURVEILLANCE; [Anonymous], 2000, FRAM MON PROGR EV OU; Bi Y, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-117; Boyce RM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0725-0; Breman JG, 2007, AM J TROP MED HYG, V77, P36; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Francis D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-229; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Jensen TP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-213; Joshi P. L., 1997, Journal of Communicable Diseases, V29, P41; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Partnership RBM, 2008, GLOB MAL ACT PLAN MA; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2012, DIS SURV MAL CONTR O; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004	20	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152410	10.1371/journal.pone.0152410	http://dx.doi.org/10.1371/journal.pone.0152410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018990	gold, Green Submitted, Green Published			2022-12-26	WOS:000372807800052
J	Lee, WW; Ehm, G; Yang, HJ; Song, IH; Lim, YH; Kim, MR; Kim, YE; Hwang, JH; Park, HR; Lee, JM; Kim, JW; Kim, HJ; Kim, C; Kim, HC; Park, E; Kim, IY; Kim, DG; Jeon, B; Paek, SH				Lee, Woong-Woo; Ehm, Gwanhee; Yang, Hui-Jun; Song, In Ho; Lim, Yong Hoon; Kim, Mi-Ryoung; Kim, Young Eun; Hwang, Jae Ha; Park, Hye Ran; Lee, Jae Min; Kim, Jin Wook; Kim, Han-Joon; Kim, Cheolyoung; Kim, Hee Chan; Park, Eunkyoung; Kim, In Young; Kim, Dong Gyu; Jeon, Beomseok; Paek, Sun Ha			Bilateral Deep Brain Stimulation of the Subthalamic Nucleus under Sedation with Propofol and Fentanyl	PLOS ONE			English	Article							PARKINSON-DISEASE; GENERAL-ANESTHESIA; SURGERY; SHIFT; ACCURACY; FUSION	Awakening during deep brain stimulation (DBS) surgery may be stressful to patients. The aim of the current study was to evaluate the effect on MER signals and their applicability to subthalmic nucleus (STN) DBS surgery for patients with Parkinson's disease (PD) under sedation with propofol and fentanyl. Sixteen consecutive patients with PD underwent STN-DBS surgery with propofol and fentanyl. Their MER signals were achieved during the surgery. To identify the microelectrodes positions, the preoperative MRI and postoperative CT were used. Clinical profiles were also collected at the baseline and at 6 months after surgery. All the signals were slightly attenuated and contained only bursting patterns, compared with our previous report. All electrodes were mostly located in the middle one third part of the STN on both sides of the brain in the fused images. Six months later, the patients were improved significantly in the medication-off state and they met with less dyskinesia and less off-duration. Our study revealed that the sedation with propofol and fentanyl was applicable to STN-DBS surgery. There were no significant problems in precise positioning of bilateral electrodes. The surgery also improved significantly clinical outcomes in 6-month follow-up.	[Lee, Woong-Woo] Eulji Gen Hosp, Dept Neurol, Seoul, South Korea; [Ehm, Gwanhee] Myongji Hosp, Dept Neurol, Gyeonggi, South Korea; [Yang, Hui-Jun] Ulsan Univ Hosp, Dept Neurol, Ulsan, South Korea; [Song, In Ho] Osong Med Innovat Fdn, Med Device Dev Ctr, Chungcheong, South Korea; [Lim, Yong Hoon; Kim, Mi-Ryoung; Park, Hye Ran; Lee, Jae Min; Kim, Jin Wook; Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea; [Kim, Young Eun] Hallym Univ, Sacred Heart Hosp, Dept Neurol, Gyeonggi, South Korea; [Hwang, Jae Ha] Daejeon Woori Hosp, Dept Neurosurg, Gyeonggi, South Korea; [Kim, Han-Joon; Jeon, Beomseok] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Kim, Cheolyoung] CyberMed Inc, Med Imaging Lab, Seoul, South Korea; [Kim, Hee Chan] Seoul Natl Univ, Coll Med, Dept Med Engn, Seoul, South Korea; [Park, Eunkyoung; Kim, In Young] Han Yang Univ, Dept Biomed Engn, Seoul, South Korea; [Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Jeon, Beomseok] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea	Eulji University; Myongji Hospital; University of Ulsan; Ulsan University Hospital; Osong Medical Innovation Foundation; Seoul National University (SNU); Seoul National University Hospital; Hallym University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hanyang University; Seoul National University (SNU); Seoul National University (SNU)	Paek, SH (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea.; Paek, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea.	paeksh@snu.ac.kr		Park, Eunkyoung/0000-0001-7700-0250; Kim, Han-Joon/0000-0001-8219-9663	Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea [311011-05-3-SB020]; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI09C13540100, HI10C14110400, HI11C21100200, HI12C02050101]; Technology Innovation Program - Ministry of Trade, industry & Energy (MI, Korea) [10050154]; Bio & Medical Technology Development Program of the NRF - the Korean government, MSIP [2015M3C7A1028926]; CyberMed Inc.	Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Technology Innovation Program - Ministry of Trade, industry & Energy (MI, Korea); Bio & Medical Technology Development Program of the NRF - the Korean government, MSIP; CyberMed Inc.	This work was partly supported by a grant from the Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea (No. 311011-05-3-SB020), a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (No. HI09C13540100, HI10C14110400, HI11C21100200 and HI12C02050101), and a grant from the Technology Innovation Program (10050154, Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) funded By the Ministry of Trade, industry & Energy (MI, Korea), and a grant from the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3C7A1028926). CyberMed Inc. provided support in the form of salaries for an author [CK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Benazzouz A, 2002, MOVEMENT DISORD, V17, pS145, DOI 10.1002/mds.10156; Burchiel KJ, 2013, J NEUROSURG, V119, P301, DOI 10.3171/2013.4.JNS122324; Chakrabarti R, 2014, N AM J MED SCI, V6, P359, DOI 10.4103/1947-2714.139281; Halpern CH, 2008, STEREOT FUNCT NEUROS, V86, P37, DOI 10.1159/000108587; Harries AM, 2012, J NEUROSURG, V116, P107, DOI 10.3171/2011.7.JNS11319; Hertel Frank, 2006, Neurosurgery, V59, pE1138; Houeto JL, 2003, ARCH NEUROL-CHICAGO, V60, P690, DOI 10.1001/archneur.60.5.690; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Khan MF, 2008, STEREOT FUNCT NEUROS, V86, P44, DOI 10.1159/000108588; Kim W, 2014, J KOREAN MED SCI, V29, P1278, DOI 10.3346/jkms.2014.29.9.1278; Kocabicak E, 2013, J NEUROL SURG PART A, V74, P332, DOI 10.1055/s-0033-1342939; Lefaucheur JP, 2008, EUR NEUROL, V60, P186, DOI 10.1159/000148246; Lin SH, 2008, J NEUROSURG, V109, P238, DOI 10.3171/JNS/2008/109/8/0238; MacIver MB, 2011, ANESTHESIOLOGY, V115, P254, DOI 10.1097/ALN.0b013e3182217126; Magnin M, 2000, NEUROSCIENCE, V96, P549, DOI 10.1016/S0306-4522(99)00583-7; Maltete D, 2004, ARCH NEUROL-CHICAGO, V61, P390, DOI 10.1001/archneur.61.3.390; Martinez-Santiesteban FM, 2007, PHYS MED BIOL, V52, P2073, DOI 10.1088/0031-9155/52/8/003; Mirzadeh Z, 2014, MOVEMENT DISORD, V29, P1788, DOI 10.1002/mds.26056; Miyagi Y, 2007, J NEUROSURG, V107, P989, DOI 10.3171/JNS-07/11/0989; Moll Christian K E, 2013, Acta Neurochir Suppl, V117, P19, DOI 10.1007/978-3-7091-1482-7_4; Murata J, 2001, No To Shinkei, V53, P457; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Paek SH, 2008, NEUROSURGERY, V63, P925, DOI 10.1227/01.NEU.0000334045.43940.FB; Paek SH, 2011, WORLD NEUROSURG, V75, P517, DOI 10.1016/j.wneu.2010.12.003; Ponce FA, 2014, WORLD NEUROSURG, V81, P6, DOI 10.1016/j.wneu.2013.11.018; Raz A, 2010, ANESTH ANALG, V111, P1285, DOI 10.1213/ANE.0b013e3181f565f2; Rodriguez-Oroz MC, 2001, BRAIN, V124, P1777, DOI 10.1093/brain/124.9.1777; Santos P, 2004, Rev Esp Anestesiol Reanim, V51, P523; Schaltenbrand G., 1998, ATLAS STEREOTAXY HUM; Schrock LE, 2009, J NEUROPHYSIOL, V102, P3740, DOI 10.1152/jn.00544.2009; Sonkajarvi E, 2008, ACTA ANAESTH SCAND, V52, P274, DOI 10.1111/j.1399-6576.2007.01501.x; Starr PA, 2010, J NEUROSURG, V112, P479, DOI 10.3171/2009.6.JNS081161; Steigerwald F, 2008, J NEUROPHYSIOL, V100, P2515, DOI 10.1152/jn.90574.2008; Tao H, 2014, MED SCI MONITOR, V20, P1902, DOI [10.12659/MSM.892271, 10.12659/MSM.892485]; Velly LJ, 2007, ANESTHESIOLOGY, V107, P202, DOI 10.1097/01.anes.0000270734.99298.b4; Welter ML, 2014, NEUROLOGY, V82, P1352, DOI 10.1212/WNL.0000000000000315; Yamada K, 2007, PARKINSONISM RELAT D, V13, P101, DOI 10.1016/j.parkreldis.2006.07.008	40	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152619	10.1371/journal.pone.0152619	http://dx.doi.org/10.1371/journal.pone.0152619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018855	Green Published, Green Submitted, gold			2022-12-26	WOS:000372807800064
J	Kim, JW; Brawley, SH; Prochnik, S; Chovatia, M; Grimwood, J; Jenkins, J; LaButti, K; Mavromatis, K; Nolan, M; Zane, M; Schmutz, J; Stiller, JW; Grossman, AR				Kim, Jay W.; Brawley, Susan H.; Prochnik, Simon; Chovatia, Mansi; Grimwood, Jane; Jenkins, Jerry; LaButti, Kurt; Mavromatis, Konstantinos; Nolan, Matt; Zane, Matthew; Schmutz, Jeremy; Stiller, John W.; Grossman, Arthur R.			Genome Analysis of Planctomycetes Inhabiting Blades of the Red Alga Porphyra umbilicalis	PLOS ONE			English	Article							ZOBELLIA-GALACTANIVORANS; MARINE MACROALGAE; ESCHERICHIA-COLI; CELL-WALLS; SP-NOV; BACTERIA; SULFATASES; EVOLUTION; SELENIUM; STRESS	Porphyra is a macrophytic red alga of the Bangiales that is important ecologically and economically. We describe the genomes of three bacteria in the phylum Planctomycetes (designated P1, P2 and P3) that were isolated from blades of Porphyra umbilicalis (P. um. 1). These three Operational Taxonomic Units (OTUs) belong to distinct genera; P2 belongs to the genus Rhodopirellula, while P1 and P3 represent undescribed genera within the Planctomycetes. Comparative analyses of the P1, P2 and P3 genomes show large expansions of distinct gene families, which can be widespread throughout the Planctomycetes (e.g., protein kinases, sensors/response regulators) and may relate to specific habitat (e.g., sulfatase gene expansions in marine Planctomycetes) or phylogenetic position. Notably, there are major differences among the Planctomycetes in the numbers and sub-functional diversity of enzymes (e.g., sulfatases, glycoside hydrolases, polysaccharide lyases) that allow these bacteria to access a range of sulfated polysaccharides in macroalgal cell walls. These differences suggest that the microbes have varied capacities for feeding on fixed carbon in the cell walls of P. um. 1 and other macrophytic algae, although the activities among the various bacteria might be functionally complementary in situ. Additionally, phylogenetic analyses indicate augmentation of gene functions through expansions arising from gene duplications and horizontal gene transfers; examples include genes involved in cell wall degradation (e.g., kappa-carrageenase, alginate lyase, fucosidase) and stress responses (e.g., efflux pump, amino acid transporter). Finally P1 and P2 contain various genes encoding selenoproteins, many of which are enzymes that ameliorate the impact of environmental stresses that occur in the intertidal habitat.	[Kim, Jay W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Brawley, Susan H.] Univ Maine, Sch Marine Sci, Orono, ME USA; [Prochnik, Simon; Chovatia, Mansi; Grimwood, Jane; Jenkins, Jerry; LaButti, Kurt; Mavromatis, Konstantinos; Nolan, Matt; Zane, Matthew; Schmutz, Jeremy] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Grimwood, Jane; Jenkins, Jerry; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Stiller, John W.] E Carolina Univ, Dept Biol, Greenville, NC USA; [Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; University of Maine System; University of Maine Orono; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; HudsonAlpha Institute for Biotechnology; University of North Carolina; East Carolina University; Carnegie Institution for Science	Kim, JW (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	jay.wj.kim@gmail.com	Grimwood, Jane/ABD-5737-2021; Jenkins, Jerry/ABE-6479-2020; Schmutz, Jeremy/N-3173-2013	Jenkins, Jerry/0000-0002-7943-3997; Schmutz, Jeremy/0000-0001-8062-9172; Chovatia, Mansi/0000-0001-8175-782X; Mavrommatis, Konstantinos/0000-0003-4549-385X	NSF Porphyra Research Collaboration Network grant [NSF IOS 074097]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Direct For Biological Sciences [0741907] Funding Source: National Science Foundation	NSF Porphyra Research Collaboration Network grant; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study design, data collection and analysis for this work was supported by an NSF Porphyra Research Collaboration Network grant (NSF IOS 074097 to S. H. Brawley, E. Gantt, A. R. Grossman, J. Stiller). The work conducted by the Joint Genome Institute (Dept. of Energy), consisting of sequencing and assembly, was through a Community Science Program award from the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231 (to SHB, EG, ARG, JS).	Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Arbogast S, 2010, ANTIOXID REDOX SIGN, V12, P893, DOI 10.1089/ars.2009.2890; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Barbeyron T, 2001, INT J SYST EVOL MICR, V51, P985, DOI 10.1099/00207713-51-3-985; Barbeyron T, 2000, J BIOL CHEM, V275, P35499, DOI 10.1074/jbc.M003404200; Bengtsson MM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-261; Blouin NA, 2012, MAR BIOL, V159, P2723, DOI 10.1007/s00227-012-2029-z; Blouin NA, 2010, PORPHYRA UMILICALIS; Bondoso J, 2014, FEMS MICROBIOL ECOL, V88, P445, DOI 10.1111/1574-6941.12258; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Correc G, 2011, CARBOHYD POLYM, V83, P277, DOI 10.1016/j.carbpol.2010.07.060; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Fernandes N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050854; FRIES L, 1975, BOT MAR, V18, P251, DOI 10.1515/botm.1975.18.4.251; Ghosh D, 2007, CELL MOL LIFE SCI, V64, P2013, DOI 10.1007/s00018-007-7175-y; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Gobler CJ, 2013, ISME J, V7, P1333, DOI 10.1038/ismej.2013.25; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Gromer S, 2003, P NATL ACAD SCI USA, V100, P12618, DOI 10.1073/pnas.2134510100; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Hehemann JH, 2012, J BIOL CHEM, V287, P13985, DOI 10.1074/jbc.M112.345645; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hofstetter V, 2007, MOL PHYLOGENET EVOL, V44, P412, DOI 10.1016/j.ympev.2006.10.016; Hou SB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-26; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Jenkins C, 2002, GENOME BIOL, V3; Jogler C, 2012, J BACTERIOL, V194, P6419, DOI 10.1128/JB.01325-12; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kazamia E, 2012, ENVIRON MICROBIOL, V14, P1466, DOI 10.1111/j.1462-2920.2012.02733.x; KLOAREG B, 1988, OCEANOGR MAR BIOL, V26, P259; Kraan S, 2012, CARBOHYDRATES - COMPREHENSIVE STUDIES ON GLYCOBIOLOGY AND GLYCOTECHNOLOGY, P489, DOI 10.5772/51572; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lage OM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00267; Levican G, 2009, ADV MATER RES-SWITZ, V71-73, P187, DOI 10.4028/www.scientific.net/AMR.71-73.187; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; Lu PL, 2013, CELL RES, V23, P635, DOI 10.1038/cr.2013.13; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Matsuo Y, 2005, SCIENCE, V307, P1598, DOI 10.1126/science.1105486; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Miranda LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058269; MUKAI LS, 1981, J PHYCOL, V17, P192, DOI 10.1111/j.0022-3646.1981.00192.x; Nedashkovskaya OI, 2004, INT J SYST EVOL MICR, V54, P1643, DOI 10.1099/ijs.0.63091-0; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Preston GM, 1998, CURR OPIN MICROBIOL, V1, P589, DOI 10.1016/S1369-5274(98)80094-5; Provasoli L, 1974, ALGAL PHYSL BIOCH, P741; Puerto-Galan L, 2012, FEMS MICROBIOL LETT, V337, P10, DOI 10.1111/j.1574-6968.2012.02664.x; Pushker R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r27; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Romero H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r66; Rosner JL, 2013, J BACTERIOL, V195, P1042, DOI 10.1128/JB.01996-12; Santarella-Mellwig R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001565; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; SIEBURTH JM, 1988, J PHYCOL, V24, P416, DOI 10.1111/j.1529-8817.1988.tb00192.x; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Spoerner M, 2012, J PHYCOL, V48, P1433, DOI 10.1111/j.1529-8817.2012.01231.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217; Tait K, 2005, ENVIRON MICROBIOL, V7, P229, DOI 10.1111/j.1462-2920.2004.00706.x; Toesch M, 2014, APPL MICROBIOL BIOT, V98, P1485, DOI 10.1007/s00253-013-5438-0; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Vorholt JA, 1997, MOL MICROBIOL, V23, P1033, DOI 10.1046/j.1365-2958.1997.2931653.x; Vorholt JA, 2005, J BACTERIOL, V187, P6069, DOI 10.1128/jb.187.17.6069-6074.2005; Waring J, 2010, J PHYCOL, V46, P1206, DOI 10.1111/j.1529-8817.2010.00919.x; Wegner CE, 2013, MAR GENOM, V9, P51, DOI 10.1016/j.margen.2012.12.001; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhang QB, 2005, CARBOHYD RES, V340, P2447, DOI 10.1016/j.carres.2005.08.009; Zhang Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r37	75	20	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151883	10.1371/journal.pone.0151883	http://dx.doi.org/10.1371/journal.pone.0151883			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015628	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708900033
J	Alesi, GN; Jin, L; Li, D; Magliocca, K; Kang, Y; Chen, ZG; Shin, DM; Khuri, FR; Kang, S				Alesi, G. N.; Jin, L.; Li, D.; Magliocca, K. R.; Kang, Y.; Chen, Z. G.; Shin, D. M.; Khuri, F. R.; Kang, S.			RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis	ONCOGENE			English	Article							CANCER METASTASIS; MAP KINASE; TYROSINE PHOSPHORYLATION; PROTEOMIC ANALYSIS; POTENTIAL TARGET; CELL-MIGRATION; PROTEIN; IDENTIFICATION; PATHWAY; EXPRESSION	Metastasis is responsible for 490% of cancer-related deaths. Complex signaling in cancer cells orchestrates the progression from a primary to a metastatic cancer. However, the mechanisms of these cellular changes remain elusive. We previously demonstrated that p90 ribosomal S6 kinase 2 (RSK2) promotes tumor metastasis. Here we investigated the role of RSK2 in the regulation of microtubule dynamics and its potential implication in cancer cell invasion and tumor metastasis. Stable knockdown of RSK2 disrupted microtubule stability and decreased phosphorylation of stathmin, a microtubule-destabilizing protein, at serine 16 in metastatic human cancer cells. We found that RSK2 directly binds and phosphorylates stathmin at the leading edge of cancer cells. Phosphorylation of stathmin by RSK2 reduced stathmin-mediated microtubule depolymerization. Moreover, overexpression of phospho-mimetic mutant stathmin S16D significantly rescued the decreased invasive and metastatic potential mediated by RSK2 knockdown in vitro and in vivo. Furthermore, stathmin phosphorylation positively correlated with RSK2 expression and metastatic cancer progression in primary patient tumor samples. Our finding demonstrates that RSK2 directly phosphorylates stathmin and regulates microtubule polymerization to provide a pro-invasive and pro-metastatic advantage to cancer cells. Therefore, the RSK2-stathmin pathway represents a promising therapeutic target and a prognostic marker for metastatic human cancers.	[Alesi, G. N.; Jin, L.; Li, D.; Chen, Z. G.; Shin, D. M.; Khuri, F. R.; Kang, S.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE,Suite C3006, Atlanta, GA 30322 USA; [Magliocca, K. R.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Kang, Y.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Emory University; Emory University; Princeton University	Kang, S (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE,Suite C3006, Atlanta, GA 30322 USA.	smkang@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Kang, Yibin/0000-0002-1626-6730	NIH [R01 CA175316, F31 CA183365]; ACS grant [RSG-11-081-01]; NATIONAL CANCER INSTITUTE [R01CA175316, F31CA183365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Dr Anthea Hammond for editorial assistance. We thank the shared resources facilities of the Winship Cancer Institute and the Integrated Cellular Imaging Core of Emory University. We also acknowledge and thank Dr Shi-Yong Sun for his insightful scientific input in the development of this work. This work was supported in part by NIH grants R01 CA175316 (to SK), F31 CA183365 (to GNA) and ACS grant RSG-11-081-01 (to SK). GNA is an NIH predoctoral fellow. FRK and SK are Georgia Cancer Coalition Scholars. SK is a Robbins Scholar and an American Cancer Society Basic Research Scholar.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Cheng AL, 2008, CLIN CANCER RES, V14, P435, DOI 10.1158/1078-0432.CCR-07-1215; Clarkl DE, 2001, EMBO J, V20, P3484, DOI 10.1093/emboj/20.13.3484; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Holmfeldt P, 2006, MOL BIOL CELL, V17, P2921, DOI 10.1091/mbc.e06-02-0165; Hsieh SY, 2010, MOL CARCINOGEN, V49, P476, DOI 10.1002/mc.20627; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; Jin LT, 2013, MOL CELL BIOL, V33, P2574, DOI 10.1128/MCB.01677-12; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kinoshita I, 2003, ONCOGENE, V22, P2710, DOI 10.1038/sj.onc.1206371; Li D, 2013, J BIOL CHEM, V288, P32528, DOI 10.1074/jbc.M113.500561; Li N, 2011, P NATL ACAD SCI USA, V108, P12851, DOI 10.1073/pnas.1017372108; Li Y, 2010, ENDOCRINOLOGY, V151, P5146, DOI 10.1210/en.2009-1506; MARKLUND U, 1994, EUR J BIOCHEM, V225, P53, DOI 10.1111/j.1432-1033.1994.00053.x; Misek DE, 2002, CANCER CELL, V2, P217, DOI 10.1016/S1535-6108(02)00124-1; Mistry SJ, 1998, BIOCHEM J, V334, P23, DOI 10.1042/bj3340023; Mizumura K, 2006, J CELL PHYSIOL, V206, P363, DOI 10.1002/jcp.20465; Morrison KC, 2012, ANAL BIOCHEM, V420, P26, DOI 10.1016/j.ab.2011.08.020; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Polzin RG, 2004, GENE, V341, P209, DOI 10.1016/j.gene.2004.06.052; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; San-Marina S, 2012, BBA-GENE REGUL MECH, V1819, P1164, DOI 10.1016/j.bbagrm.2012.09.004; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Tan HT, 2012, J PROTEOME RES, V11, P1433, DOI 10.1021/pr2010956; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537	46	17	19	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 13	2016	35	41					5412	5421		10.1038/onc.2016.79	http://dx.doi.org/10.1038/onc.2016.79			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA5QU	27041561	Green Accepted			2022-12-26	WOS:000386677800007
J	Koher, A; Lentz, HHK; Hovel, P; Sokolov, IM				Koher, Andreas; Lentz, Hartmut H. K.; Hoevel, Philipp; Sokolov, Igor M.			Infections on Temporal Networks-A Matrix-Based Approach	PLOS ONE			English	Article							DISEASE; PERCOLATION; EVOLUTION; COMPLEX; SPREAD; MODEL	We extend the concept of accessibility in temporal networks to model infections with a finite infectious period such as the susceptible-infected-recovered (SIR) model. This approach is entirely based on elementary matrix operations and unifies the disease and network dynamics within one algebraic framework. We demonstrate the potential of this formalism for three examples of networks with high temporal resolution: networks of social contacts, sexual contacts, and livestock-trade. Our investigations provide a new methodological framework that can be used, for instance, to estimate the epidemic threshold, a quantity that determines disease parameters, for which a large-scale outbreak can be expected.	[Koher, Andreas; Hoevel, Philipp] Tech Univ Berlin, Inst Theoret Phys, Hardenbergstr 36, D-10623 Berlin, Germany; [Lentz, Hartmut H. K.] Friedrich Loeffler Inst, Inst Epidemiol, Sudufer 10, D-17493 Greifswald, Germany; [Hoevel, Philipp] Humboldt Univ, Bernstein Ctr Computat Neurosci Berlin, Philippstr 13, D-10115 Berlin, Germany; [Sokolov, Igor M.] Humboldt Univ, Inst Phys, Newtonstr 15, D-12489 Berlin, Germany	Technical University of Berlin; Friedrich Loeffler Institute; Humboldt University of Berlin; Humboldt University of Berlin	Koher, A (corresponding author), Tech Univ Berlin, Inst Theoret Phys, Hardenbergstr 36, D-10623 Berlin, Germany.	andreas.koher@tu-berlin.de	Sokolov, Igor M/D-1668-2009	Sokolov, Igor M/0000-0002-4688-9162; Hoevel, Philipp/0000-0002-1370-4272; Lentz, Hartmut/0000-0002-1713-9506; Koher, Andreas/0000-0001-7049-9538	Deutsche Forschungsgemeinschaft of the Collaborative Research Center [(SFB) 910]; Federal Ministry of Education and Research (BMBF), Germany [01GQ1001B]; Deutsche Forschungsgemeinschaft of the International Research Training Group (IRTG) [1740]	Deutsche Forschungsgemeinschaft of the Collaborative Research Center(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft of the International Research Training Group (IRTG)(German Research Foundation (DFG))	AK and PH acknowledge funding by the Deutsche Forschungsgemeinschaft in the framework of the Collaborative Research Center (SFB) 910. PH was partially supported by the Federal Ministry of Education and Research (BMBF), Germany (grant no. 01GQ1001B). IMS acknowledges support by the Deutsche Forschungsgemeinschaft in the framework of the International Research Training Group (IRTG) 1740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; BARTLETT MS, 1949, J R STAT SOC B, V11, P211; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Casteigts A, 2012, INT J PARALLEL EMERG, V27, P387, DOI [10.1080/17445760.2012.668546, 10.1007/978-3-642-22450-8_27]; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Danon Leon, 2011, Interdiscip Perspect Infect Dis, V2011, P284909, DOI 10.1155/2011/284909; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Gleeson JP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026106; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Grindrod P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046120; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; KIRKPATRICK S, 1973, REV MOD PHYS, V45, P574, DOI 10.1103/RevModPhys.45.574; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Konschake M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055223; Lentz HHK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.118701; LUCE RD, 1952, P AM MATH SOC, V3, P382, DOI 10.2307/2031888; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Sander LM, 2003, PHYSICA A, V325, P1, DOI 10.1016/S0378-4371(03)00176-6; Sander LM, 2002, MATH BIOSCI, V180, P293, DOI 10.1016/S0025-5564(02)00117-7; STAUFFER D, 1994, INTRO PERCOLATION TH; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Valdano E, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021005; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Van Mieghem P, 2014, ARXIV14021731; Wang Y, 2003, SYM REL DIST SYST, P25	41	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0151209	10.1371/journal.pone.0151209	http://dx.doi.org/10.1371/journal.pone.0151209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035128	gold, Green Published, Green Submitted			2022-12-26	WOS:000373201200007
J	Tran, A; Fortier, C; Giovannini-Chami, L; Demonchy, D; Caci, H; Desmontils, J; Montaudie-Dumas, I; Bensaid, R; Haas, H; Berard, E				Tran, Antoine; Fortier, Clara; Giovannini-Chami, Lisa; Demonchy, Diane; Caci, Herve; Desmontils, Jonathan; Montaudie-Dumas, Isabelle; Bensaid, Ronny; Haas, Herve; Berard, Etienne			Evaluation of the Bladder Stimulation Technique to Collect Midstream Urine in Infants in a Pediatric Emergency Department	PLOS ONE			English	Article							TRACT-INFECTION; YOUNG-CHILDREN; CLEAN-CATCH; PAIN SCALE; DIAGNOSIS; BAG; PREVALENCE; URINALYSIS; EVENDOL	Objective Midstream clean-catch urine is an accepted method to diagnose urinary tract infection but is impracticable in infants before potty training. We tested the bladder stimulation technique to obtain a clean-catch urine sample in infants. Materials and methods We included 142 infants under walking age who required a urine sample in a cross-sectional study carried out during a 3-months period, from September to November 2014, in the emergency department of the University Children's Hospital of Nice (France). A technique based on bladder stimulation and lumbar stimulation maneuvers, with at least two attempts, was tested by four trained physicians. The success rate and time to obtain urine sample within 3 minutes were evaluated. Discomfort (EVENDOL score >= 4/15) was measured. We estimated the risk factors in the failure of the technique. Chi-square test or Fisher's exact test were used to compare frequencies. T-test and Wilcoxon test were used to compare quantitative data according to the normality of the distribution. Risk factors for failure of the technique were evaluated using a multivariate logistic regression model. Results We obtained midstream clean-catch urine in 55.6% of infants with a median time of 52.0 s (10.0; 110.0). The success rate decreased with age from 88.9% (newborn) to 28.6% (>1 y) (p = 0.0001) and with weight, from 85.7% (<4kg) to 28.6% (>10kg) (p = 0.0004). The success rate was 60.8% for infants without discomfort (p<0.0001). Heavy weight and discomfort were associated with failure, with adjusted ORs of 1.47 [1.04-2.31] and 6.65 [2.85-15.54], respectively. Conclusion Bladder stimulation seems to be efficient in obtaining midstream urine with a moderate success rate in our study sample. This could be an alternative technique for infants before potty training but further randomized multicenter studies are needed to validate this procedure.	[Tran, Antoine; Fortier, Clara; Giovannini-Chami, Lisa; Demonchy, Diane; Caci, Herve; Desmontils, Jonathan; Montaudie-Dumas, Isabelle; Bensaid, Ronny; Haas, Herve] CHU Lenval, Hop Pediat Nice, Nice, France; [Berard, Etienne] CHU Nice, Serv Nephrol Pediat, Archet 2, F-06202 Nice, France	CHU Nice; CHU Nice	Tran, A (corresponding author), CHU Lenval, Hop Pediat Nice, Nice, France.	tran.a@pediatrie-chulenval-nice.fr						Al-Orifi F, 2000, J PEDIATR-US, V137, P221, DOI 10.1067/mpd.2000.107466; Altuntas N, 2015, EUR J PEDIATR, V174, P577, DOI 10.1007/s00431-014-2434-z; Bachur R, 2001, ARCH PEDIAT ADOL MED, V155, P60, DOI 10.1001/archpedi.155.1.60; Bagga Arvind, 2001, Indian Journal of Pediatrics, V68, pS40; Chang SL, 2006, PEDIATR CLIN N AM, V53, P379, DOI 10.1016/j.pcl.2006.02.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coulthard MG, 2014, ARCH DIS CHILD, V99, P342, DOI 10.1136/archdischild-2013-304428; Dai B, 2010, ARCH DIS CHILD, V95, P499, DOI 10.1136/adc.2009.173112; Etoubleau C, 2009, J PEDIATR-US, V154, P803, DOI 10.1016/j.jpeds.2009.01.008; Finnell SME, 2011, PEDIATRICS, V128, P749, DOI 10.1542/peds.2011-1332; Fournier-Charriere E, 2013, ANN FR ANESTH, V32, P447, DOI 10.1016/j.annfar.2013.05.001; Fournier-Charriere E, 2012, PAIN, V153, P1573, DOI 10.1016/j.pain.2012.02.024; HARDY JD, 1976, BRIT J UROL, V48, P279, DOI 10.1111/j.1464-410X.1976.tb03021.x; Hari Pankaj, 2003, Indian Journal of Pediatrics, V70, P235, DOI 10.1007/BF02725591; Hay AD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6316; Fernandez MLH, 2013, ARCH DIS CHILD, V98, P27, DOI 10.1136/archdischild-2012-301872; HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8; Jansson UB, 2000, J UROLOGY, V164, P2050, DOI 10.1016/S0022-5347(05)66963-7; Karacan C, 2010, MED PRIN PRACT, V19, P188, DOI 10.1159/000273068; Lau AY, 2007, ACTA PAEDIATR, V96, P432, DOI 10.1111/j.1651-2227.2006.00146.x; McGillivray D, 2005, J PEDIATR-US, V147, P451, DOI 10.1016/j.jpeds.2005.05.007; Montini G, 2011, NEW ENGL J MED, V365, P239, DOI 10.1056/NEJMra1007755; NCC for W and CH, 2007, UR TRACT INF CHILR; Oswald J, 2002, J UROLOGY, V168, P2586, DOI 10.1016/S0022-5347(05)64222-X; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Saadeh SA, 2011, PEDIATR NEPHROL, V26, P1967, DOI 10.1007/s00467-011-1801-5; Schlager T A, 2001, Paediatr Drugs, V3, P219, DOI 10.2165/00128072-200103030-00004; Shaw KN, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e16; Shim YH, 2009, PEDIATR NEPHROL, V24, P309, DOI 10.1007/s00467-008-1001-0; Sillen U, 2001, J UROLOGY, V166, P2376, DOI 10.1016/S0022-5347(05)65594-2; Tullus K, 2015, PEDIATR NEPHROL, V30, P1375, DOI 10.1007/s00467-015-3130-6; Tullus K, 2012, PEDIATR NEPHROL, V27, P509, DOI 10.1007/s00467-011-2077-5; Tullus K, 2011, PEDIATR NEPHROL, V26, P1923, DOI 10.1007/s00467-011-1966-y; Woock JP, 2011, AM J PHYSIOL-REG I, V300, pR398, DOI 10.1152/ajpregu.00154.2010	34	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152598	10.1371/journal.pone.0152598	http://dx.doi.org/10.1371/journal.pone.0152598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031953	Green Submitted, gold, Green Published			2022-12-26	WOS:000373121800100
J	Ward-Fear, G; Greenlees, MJ; Shine, R				Ward-Fear, Georgia; Greenlees, Matthew J.; Shine, Richard			Toads on Lava: Spatial Ecology and Habitat Use of Invasive Cane Toads (Rhinella marina) in Hawai'i	PLOS ONE			English	Article							BUFO-MARINUS; DISPERSAL BEHAVIOR; EVOLUTION; MOVEMENT; IMPACT; ISLAND; FRONT; SEX	Most ecological research on cane toads (Rhinella marina) has focused on invasive populations in Australia, ignoring other areas where toads have been introduced. We radio-tracked and spool-tracked 40 toads, from four populations on the island of Hawai'i. Toads moved extensively at night (mean 116 m, from spool-tracking) but returned to the same or a nearby retreat-site each day (from radio-tracking, mean distance between successive retreat sites 11 m; 0 m for 70% of records). Males followed straighter paths during nocturnal movements than did females. Because moist sites are scarce on the highly porous lava substrate, Hawai'ian toads depend on anthropogenic disturbance for shelter (e.g. beneath buildings), foraging (e.g. suburban lawns, golf courses) and breeding (artificial ponds). Foraging sites are further concentrated by a scarcity of flying insects (negating artificial lights as prey-attractors). Habitat use of toads shifted with time (at night, toads selected areas with less bare ground, canopy, understory and leaf-litter), and differed between sexes (females foraged in areas of bare ground with dense understory vegetation). Cane toads in Hawai'i thrive in scattered moist patches within a severely arid matrix, despite a scarcity of flying insects, testifying to the species' ability to exploit anthropogenic disturbance.	[Ward-Fear, Georgia; Greenlees, Matthew J.; Shine, Richard] Univ Sydney, Sch Life & Environm Sci, Heydon Laurence Bldg A08, Sydney, NSW 2006, Australia	University of Sydney	Shine, R (corresponding author), Univ Sydney, Sch Life & Environm Sci, Heydon Laurence Bldg A08, Sydney, NSW 2006, Australia.	rick.shine@sydney.edu.au		Ward-Fear, Georgia/0000-0002-4808-1933	Australian Research Council [fl120100074]	Australian Research Council(Australian Research Council)	The study was funded by the Australian Research Council under Richard Shine's grant number: fl120100074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2009, WILDLIFE RES, V36, P23, DOI 10.1071/WR08021; BAYLISS P, 1995, THESIS U QUEENSLAND; Boland CRJ, 2004, BIOL CONSERV, V120, P53, DOI 10.1016/j.biocon.2004.01.025; Bowcock H, 2008, ANIM BEHAV, V75, P1571, DOI 10.1016/j.anbehav.2007.10.011; BOYCE MS, 1987, ECOLOGY, V68, P142, DOI 10.2307/1938814; Brasier CM, 2000, INTERCONTINENTAL SPR, P61, DOI DOI 10.1007/978-1-4615-4507-1_4; BRATTSTROM BAYARD H., 1962, HERPETOLOGICA, V18, P176; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; Brown GP, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1385; Brown GP, 2011, FUNCT ECOL, V25, P1339, DOI 10.1111/j.1365-2435.2011.01888.x; Cabrera-Guzman E, 2012, BIOL CONSERV, V153, P1, DOI 10.1016/j.biocon.2012.04.012; CARPENTER CC, 1987, J HERPETOL, V21, P158, DOI 10.2307/1564475; Dorrance WH, 2000, SUGAR ISLANDS 165 YE; Feit B, 2015, ECOSYSTEMS, V18, P826, DOI 10.1007/s10021-015-9865-x; Florance D, 2011, P ROY SOC B-BIOL SCI, V278, P2900, DOI 10.1098/rspb.2011.0032; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Gonzalez-Bernal E, 2015, AUSTRAL ECOL, V40, P953, DOI 10.1111/aec.12279; Gonzalez-Bernal E, 2011, BEHAV ECOL SOCIOBIOL, V65, P1367, DOI 10.1007/s00265-011-1147-9; JUVIK JO, 1994, J APPL METEOROL, V33, P1304, DOI 10.1175/1520-0450(1994)033&lt;1304:ACTTTM&gt;2.0.CO;2; Kraus F, 2008, ALIEN REPTILES AMPHI, V4; LEVER C., 2001, CANE TOAD HIST ECOLO; Lindstrom T, 2013, P NATL ACAD SCI USA, V110, P13452, DOI 10.1073/pnas.1303157110; McCoy KA, 2008, ENVIRON HEALTH PERSP, V116, P1526, DOI 10.1289/ehp.11536; McKeown S., 1996, FIELD GUIDE REPTILES; Mooney HA, 2012, ECOLOGY BIOL INVASIO, V58; Narayan E, 2008, HERPETOL J, V18, P63; NOAA, 1981, NAT OC ATM ADM 1981; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Pramuk JB, 2008, GLOBAL ECOL BIOGEOGR, V17, P72, DOI 10.1111/j.1466-8238.2007.00348.x; Sanderson M., 1993, PREVAILING TRADE WIN; Schwarzkopf L, 1996, FUNCT ECOL, V10, P193, DOI 10.2307/2389843; Schwarzkopf L, 2002, OIKOS, V96, P492, DOI 10.1034/j.1600-0706.2002.960311.x; Seebacher F, 1999, J HERPETOL, V33, P208, DOI 10.2307/1565716; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Shine R, 2012, ADV STUD BEHAV, V44, P1, DOI 10.1016/B978-0-12-394288-3.00001-0; Shine R, 2012, EVOL APPL, V5, P107, DOI 10.1111/j.1752-4571.2011.00201.x; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Slade RW, 1998, P ROY SOC B-BIOL SCI, V265, P769, DOI 10.1098/rspb.1998.0359; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Tingley R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025979; Turvey N, 2013, ANIM PUB, P1; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; ZUG G.R., 1979, SMITHSON CONTRIB ZOO, V284, P1	45	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151700	10.1371/journal.pone.0151700	http://dx.doi.org/10.1371/journal.pone.0151700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027738	gold, Green Published			2022-12-26	WOS:000373116500030
J	Belichenko, PV; Madani, R; Rey-Bellet, L; Pihlgren, M; Becker, A; Plassard, A; Vuillermot, S; Giriens, V; Nosheny, RL; Kleschevnikov, AM; Valletta, JS; Bengtsson, SKS; Linke, GR; Maloney, MT; Hickman, DT; Reis, P; Granet, A; Mlaki, D; Lopez-Deber, MP; Do, L; Singhal, N; Masliah, E; Pearn, ML; Pfeifer, A; Muhs, A; Mobley, WC				Belichenko, Pavel V.; Madani, Rime; Rey-Bellet, Lorianne; Pihlgren, Maria; Becker, Ann; Plassard, Adeline; Vuillermot, Stephanie; Giriens, Valerie; Nosheny, Rachel L.; Kleschevnikov, Alexander M.; Valletta, Janice S.; Bengtsson, Sara K. S.; Linke, Gordon R.; Maloney, Michael T.; Hickman, David T.; Reis, Pedro; Granet, Anne; Mlaki, Dorin; Lopez-Deber, Maria Pilar; Do, Long; Singhal, Nishant; Masliah, Eliezer; Pearn, Matthew L.; Pfeifer, Andrea; Muhs, Andreas; Mobley, William C.			An Anti-beta-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DEMENTIA; TRANSPORT; RECEPTOR; PEPTIDE; MICE; ABNORMALITIES; IMMUNIZATION; PATHOGENESIS; IMMUNOLOGY	In Down syndrome (DS) or trisomy of chromosome 21, the beta-amyloid (A beta) peptide product of the amyloid precursor protein (APP) is present in excess. Evidence points to increased APP gene dose and A beta as playing a critical role in cognitive difficulties experienced by people with DS. Particularly, A beta is linked to the late-life emergence of dementia as associated with neuropathological markers of Alzheimer's disease (AD). At present, no treatment targets A beta-related pathogenesis in people with DS. Herein we used a vaccine containing the A beta 1-15 peptide embedded into liposomes together with the adjuvant monophosphoryl lipid A (MPLA). Ts65Dn mice, a model of DS, were immunized with the anti-A beta vaccine at 5 months of age and were examined for cognitive measures at 8 months of age. The status of basal forebrain cholinergic neurons and brain levels of APP and its proteolytic products were measured. Immunization of Ts65Dn mice resulted in robust anti-A beta IgG titers, demonstrating the ability of the vaccine to break self-tolerance. The vaccine-induced antibodies reacted with A beta without detectable binding to either APP or its C-terminal fragments. Vaccination of Ts65Dn mice resulted in a modest, but non-significant reduction in brain A beta levels relative to vehicle-treated Ts65Dn mice, resulting in similar levels of A beta as diploid (2N) mice. Importantly, vaccinated Ts65Dn mice showed resolution of memory deficits in the novel object recognition and contextual fear conditioning tests, as well as reduction of cholinergic neuron atrophy. No treatment adverse effects were observed; vaccine did not result in inflammation, cellular infiltration, or hemorrhage. These data are the first to show that an anti-A beta immunotherapeutic approach may act to target A beta-related pathology in a mouse model of DS.	[Belichenko, Pavel V.; Becker, Ann; Nosheny, Rachel L.; Kleschevnikov, Alexander M.; Valletta, Janice S.; Bengtsson, Sara K. S.; Linke, Gordon R.; Do, Long; Singhal, Nishant; Masliah, Eliezer; Pearn, Matthew L.; Mobley, William C.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Madani, Rime; Rey-Bellet, Lorianne; Pihlgren, Maria; Plassard, Adeline; Vuillermot, Stephanie; Giriens, Valerie; Hickman, David T.; Reis, Pedro; Granet, Anne; Mlaki, Dorin; Lopez-Deber, Maria Pilar; Pfeifer, Andrea; Muhs, Andreas] AC Immune SA, Lausanne, Switzerland; [Maloney, Michael T.] Stanford Med Sch, Dept Neurol & Neurol Sci, Stanford, CA USA	University of California System; University of California San Diego; Stanford University	Muhs, A (corresponding author), AC Immune SA, Lausanne, Switzerland.	andreas.muhs@acimmune.com		Do, Long/0000-0003-0911-1463; Singhal, Nishant/0000-0002-7988-5125	AC Immune SA; NIH [NS055371, NS24054]; Larry L. Hillblom Foundation; Lumind Foundation; Research Down Syndrome; Thrasher Research Fund; Adler Foundation; Alzheimer Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024054, R01NS066072, R01NS055371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	AC Immune SA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; Lumind Foundation; Research Down Syndrome; Thrasher Research Fund; Adler Foundation; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was sponsored by AC Immune SA. The sponsors were involved in the study design, data collection, analysis, decision to publish and preparation of the manuscript. The authors, R.M., L. RB., A.PI., S.V., M.P., V.G., D.T.H., P.R., A.G., D.M., M.P.L.D., A.P. and A.M. are or were supported in the form of salaries by the sponsors. The authors P.V.B. and W.C.M. have not received personal income from the sponsors related to this study and are or were partially supported by the grants from NIH (grants #NS055371 and #NS24054), Larry L. Hillblom Foundation, Lumind Foundation (formerly Down Syndrome Research and Treatment Foundation), Research Down Syndrome, Thrasher Research Fund, Adler Foundation, and Alzheimer Association.	Akwa Y, 1998, J IMMUNOL, V161, P5016; Antonarakis SE, 2003, COLD SPRING HARB SYM, V68, P425, DOI 10.1101/sqb.2003.68.425; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Belichenko PV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134861; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Coppus A, 2006, J INTELL DISABIL RES, V50, P768, DOI 10.1111/j.1365-2788.2006.00842.x; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Emy PY, 1997, AM J ROENTGENOL, V168, P1011, DOI 10.2214/ajr.168.4.9124106; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; Faizi M, 2011, NEUROBIOL DIS, V43, P397, DOI 10.1016/j.nbd.2011.04.011; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Gardiner KJ, 2014, DRUG DES DEV THER, V9, P103, DOI 10.2147/DDDT.S51476; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hartley D, 2014, ALZHEIMERS DEMENT; Head Elizabeth, 2012, Curr Gerontol Geriatr Res, V2012, P412536, DOI 10.1155/2012/412536; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hunter CL, 2004, NEUROBIOL AGING, V25, P873, DOI 10.1016/j.neurobiolaging.2003.10.010; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; Monsonego A, 2001, P NATL ACAD SCI USA, V98, P10273, DOI 10.1073/pnas.191118298; Muhs A, 2007, P NATL ACAD SCI USA, V104, P9810, DOI 10.1073/pnas.0703137104; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pihlgren M, 2013, BLOOD, V121, P85, DOI 10.1182/blood-2012-02-413831; Prasher VP, 2004, INT J GERIATR PSYCH, V19, P509, DOI 10.1002/gps.1077; PRASHER VP, 1993, BRIT J PSYCHIAT, V162, P711, DOI 10.1192/bjp.162.5.711a; Rafii MS, 2010, REV RECENT CLIN TRIA, V5, P57, DOI 10.2174/157488710790820490; Ryman DC, 2014, NEUROLOGY, V83, P253, DOI 10.1212/WNL.0000000000000596; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Schupf N, 2002, BRIT J PSYCHIAT, V180, P405, DOI 10.1192/bjp.180.5.405; Seabrook TJ, 2007, NEUROBIOL AGING, V28, P813, DOI 10.1016/j.neurobiolaging.2006.04.007; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; Sherman SL, 2007, MENT RETARD DEV D R, V13, P221, DOI 10.1002/mrdd.20157; Sigurdsson EM, 2002, NEUROBIOL AGING, V23, P1001, DOI 10.1016/S0197-4580(02)00124-0; Sleegers K, 2010, TRENDS GENET, V26, P84, DOI 10.1016/j.tig.2009.12.004; Stanton L.R., 2004, ADV PSYCHIAT TREATME, V10, P50, DOI [DOI 10.1192/APT.10.1.50, 10.1192/apt.10.1.50]; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Trotta MBF, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-4; UGAZIO AG, 1990, AM J MED GENET, P204; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Weissmiller AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118379; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Zhang K, 2013, J NEUROSCI, V33, P7451, DOI 10.1523/JNEUROSCI.4322-12.2013; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163	59	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152471	10.1371/journal.pone.0152471	http://dx.doi.org/10.1371/journal.pone.0152471			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023444	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900062
J	Chen, YY; Zhao, Q; Liu, BY; Wang, LZ; Sun, YN; Li, HX; Wang, XJ; Syed, SF; Zhang, GP; Zhou, EM				Chen, Yiyang; Zhao, Qin; Liu, Baoyuan; Wang, Lizhen; Sun, Yani; Li, Huixia; Wang, Xinjie; Syed, Shahid Faraz; Zhang, Gaiping; Zhou, En-Min			A Novel Blocking ELISA for Detection of Antibodies against Hepatitis E Virus in Domestic Pigs	PLOS ONE			English	Article							SEROLOGICAL PREVALENCE; MONOCLONAL-ANTIBODIES; RT-QPCR; CHINA; INFECTION; SWINE; HEV; GENOTYPE; ANIMALS; TRANSMISSION	Hepatitis E virus (HEV) infects both humans and animals, with an overall human mortality rate generally less than 1%, but as high as 20% among pregnant women. HEV strains fall into 4 major genotypes. Zoonotic genotypes 3 and 4 associate with sporadic human and animal HEV cases in many industrialized countries. To date, collective evidence implicates pigs as the main HEV reservoir, justifying the importance of monitoring HEV infection rates in pig herds to prevent human illness. Due to the lack of a robust in vitro cell culture system for viral propagation, no "gold standard" assay has yet been developed to detect HEV infection in domestic pigs. 1E4, a monoclonal antibody (mAb) specific for the C-terminal 268 amino acids of HEV genotype 4 ORF2 capsid protein (sORF2-C), was generated and conjugated to horseradish peroxidase (HRP) for use in a blocking ELISA (bELISA). Optimal sORF2-C coating antigen concentration (8 mu g/ml), HRP-1E4 dilution (1:1000), and test pig serum dilution (1:20) were determined using a checkerboard titration test. A cut-off value of 16.9% was chosen to differentiate between positive vs. negative sera after mean percent inhibition (PI) testing of 230 negative pig sera. Compared with the indirect ELISA (iELISA), western blot, and a commercial ELISA kit for detecting anti-HEV antibodies in human sera, the bELISA showed no statistical differences and statistically high coincidence of 93.23%, 92%, and 95% with the other tests, respectively. A blocking ELISA (bELISA) for detecting anti-HEV antibodies in pig serum samples was developed with high sensitivity and high specificity comparable to that of the indirect ELISA. The bELISA results exhibited high agreement with iELISA, western blot, and a commercial ELISA kit designed to detect human anti-HEV antibodies. Therefore, bELISA should serve as an ideal method for large-scale serological investigation of anti-HEV antibodies in domestic pigs.	[Chen, Yiyang; Zhao, Qin; Liu, Baoyuan; Wang, Lizhen; Sun, Yani; Li, Huixia; Wang, Xinjie; Syed, Shahid Faraz; Zhou, En-Min] Northwest A&F Univ, Coll Vet Med, Dept Vet Prevent Med, Yangling, Shaanxi, Peoples R China; [Chen, Yiyang; Zhao, Qin; Liu, Baoyuan; Wang, Lizhen; Sun, Yani; Li, Huixia; Wang, Xinjie; Syed, Shahid Faraz; Zhou, En-Min] Minist Agr, Sci Observing & Expt Stn Vet Pharmacol & Vet Biot, Yangling, Shaanxi, Peoples R China; [Zhang, Gaiping] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Henan Agricultural University	Zhou, EM (corresponding author), Northwest A&F Univ, Coll Vet Med, Dept Vet Prevent Med, Yangling, Shaanxi, Peoples R China.; Zhou, EM (corresponding author), Minist Agr, Sci Observing & Expt Stn Vet Pharmacol & Vet Biot, Yangling, Shaanxi, Peoples R China.	zhouem@nwsuaf.edu.cn		Chen, Yiyang/0000-0003-0152-8563; Liu, Baoyuan/0000-0002-4001-1383	National Natural Science Foundation of China [31372464, 31402233]; Open Fund of Key Laboratory of Veterinary Etiologic Biology [SKLVEB2013KFKT008]; Specialized Fund for the Basic Research Operating Expenses Program of Central Colleges [Z109021307]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of Key Laboratory of Veterinary Etiologic Biology; Specialized Fund for the Basic Research Operating Expenses Program of Central Colleges	This study was supported by grants from the National Natural Science Foundation of China (No. 31372464) to EMZ and (No. 31402233) to QZ, the Open Fund of Key Laboratory of Veterinary Etiologic Biology (SKLVEB2013KFKT008) and the Specialized Fund for the Basic Research Operating Expenses Program of Central Colleges (Z109021307) to QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2011, VIRUS RES, V161, P47, DOI 10.1016/j.virusres.2011.02.011; Arends JE, 2014, J CLIN VIROL, V59, P81, DOI 10.1016/j.jcv.2013.11.013; Avellon A, 2015, J MED VIROL, V87, P1934, DOI 10.1002/jmv.24251; Bouwknegt M, 2008, VET RES, V39, DOI 10.1051/vetres:2008017; Costanzo N, 2015, J FOOD PROTECT, V78, P2099, DOI 10.4315/0362-028X.JFP-15-159; Di Bartolo I, 2015, INT J FOOD MICROBIOL, V193, P29, DOI 10.1016/j.ijfoodmicro.2014.10.005; Dong SW, 2011, J VIROL METHODS, V171, P374, DOI 10.1016/j.jviromet.2010.11.025; Drexler JF, 2012, J VIROL, V86, P9134, DOI 10.1128/JVI.00800-12; Fan J, 2009, J GEN VIROL, V90, P1353, DOI 10.1099/vir.0.009431-0; Galiana C, 2008, AM J TROP MED HYG, V78, P1012, DOI 10.4269/ajtmh.2008.78.1012; Gao SY, 2011, ARCH VIROL, V156, P1621, DOI 10.1007/s00705-011-1007-y; Geng YS, 2010, VECTOR-BORNE ZOONOT, V10, P765, DOI 10.1089/vbz.2009.0168; Giron-Callejas A, 2015, J VIROL METHODS, V214, P25, DOI 10.1016/j.jviromet.2014.11.025; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Johne R, 2010, EMERG INFECT DIS, V16, P1452, DOI 10.3201/eid1609.100444; Kamar N, 2015, CLIN RES HEPATOL GAS, V39, P20, DOI 10.1016/j.clinre.2014.07.005; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Li WG, 2011, ARCH VIROL, V156, P1989, DOI 10.1007/s00705-011-1089-6; Li XJ, 2008, J MED VIROL, V80, P1391, DOI 10.1002/jmv.21246; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Nakamura M, 2006, HEPATOL RES, V34, P137, DOI 10.1016/j.hepres.2005.10.010; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Pezzoni G, 2014, J VIROL METHODS, V207, P95, DOI 10.1016/j.jviromet.2014.06.025; Ponterio E, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-133; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Raj VS, 2012, EMERG INFECT DIS, V18, P1369, DOI 10.3201/eid1808.111659; Ren Hong, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P419; Serracca L, 2015, FOOD ENVIRON VIROL, V7, P206, DOI 10.1007/s12560-015-9201-9; Smith DB, 2015, J GEN VIROL, V96, P1191, DOI 10.1099/vir.0.000115; Thiry D, 2014, VET MICROBIOL, V172, P407, DOI 10.1016/j.vetmic.2014.06.004; Wang XJ, 2014, VET MICROBIOL, V172, P415, DOI 10.1016/j.vetmic.2014.06.006; Wang YC, 2002, J MED VIROL, V67, P516, DOI 10.1002/jmv.10131; Wilhelm B, 2014, INT J FOOD MICROBIOL, V185, P33, DOI 10.1016/j.ijfoodmicro.2014.05.006; Woo PCY, 2014, EMERG INFECT DIS, V20, P1044, DOI 10.3201/eid2006.140140; Xia JK, 2015, ARCH VIROL, V160, P2791, DOI 10.1007/s00705-015-2574-0; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536; Zhao Q, 2013, VET MICROBIOL, V167, P242, DOI 10.1016/j.vetmic.2013.08.006; Zhao Q, 2010, EMERG INFECT DIS, V16, P1469, DOI 10.3201/eid1609.100626; Zhou EM, 1999, RES VET SCI, V66, P247, DOI 10.1053/rvsc.1998.0282; Zwettler D, 2012, BERL MUNCH TIERARZTL, V125, P281, DOI 10.2376/0005-9366-125-281	42	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152639	10.1371/journal.pone.0152639	http://dx.doi.org/10.1371/journal.pone.0152639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023902	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900085
J	Furfaro, AL; Piras, S; Domenicotti, C; Fenoglio, D; De Luigi, A; Salmona, M; Moretta, L; Marinari, UM; Pronzato, MA; Traverso, N; Nitti, M				Furfaro, A. L.; Piras, S.; Domenicotti, C.; Fenoglio, D.; De Luigi, A.; Salmona, M.; Moretta, L.; Marinari, U. M.; Pronzato, M. A.; Traverso, N.; Nitti, M.			Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; HEME OXYGENASE-1; PROTEASOME INHIBITION; SIGNALING PATHWAY; RETINOIC ACID; UP-REGULATION; TUMOR-GROWTH; GLUTATHIONE; CANCER	The activation of Nrf2 has been demonstrated to play a crucial role in cancer cell resistance to different anticancer therapies. The inhibition of proteasome activity has been proposed as a chemosensitizing therapy but the activation of Nrf2 could reduce its efficacy. Using the highly chemoresistant neuroblastoma cells HTLA-230, here we show that the strong reduction in proteasome activity, obtained by using low concentration of bortezomib (BTZ, 2.5 nM), fails in reducing cell viability. BTZ treatment favours the binding of Nrf2 to the ARE sequences in the promoter regions of target genes such as heme oxygenase 1 (HO-1), the modulatory subunit of gamma-glutamylcysteine ligase (GCLM) and the transporter for cysteine (x-CT), enabling their transcription. GSH level is also increased after BTZ treatment. The upregulation of Nrf2 target genes is responsible for cell resistance since HO-1 silencing and GSH depletion synergistically decrease BTZ-treated cell viability. Moreover, cell exposure to all-trans-Retinoic acid (ATRA, 3 mu M) reduces the binding of Nrf2 to the ARE sequences, decreases HO-1 induction and lowers GSH level increasing the efficacy of bortezomib. These data suggest the role of Nrf2, HO-1 and GSH as molecular targets to improve the efficacy of low doses of bortezomib in the treatment of malignant neuroblastoma.	[Furfaro, A. L.] Giannina Gaslini Inst, Via Gerolamo Gaslini 5, I-16147 Genoa, Italy; [Piras, S.; Domenicotti, C.; Marinari, U. M.; Pronzato, M. A.; Traverso, N.; Nitti, M.] Univ Genoa, Dept Expt Med, Via LB Alberti 2, I-16132 Genoa, Italy; [Fenoglio, D.] Univ Genoa, Dept Internal Med, Ctr Excellence Biomed Res, Via LB Alberti 2, I-16132 Genoa, Italy; [De Luigi, A.; Salmona, M.] IRCCS Ist Ric Farmacol Mario Negri, Via Giuseppe La Masa 19, I-20156 Milan, Italy; [Moretta, L.] Bambino Gesu Pediat Hosp, IRCCS, Piazza S Onofrio 4, I-00165 Rome, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Bambino Gesu	Nitti, M (corresponding author), Univ Genoa, Dept Expt Med, Via LB Alberti 2, I-16132 Genoa, Italy.	Mariapaola.Nitti@unige.it	salmona, mario/ABI-4066-2020; Moretta, Lorenzo/AAA-7239-2020; Nitti, Mariapaola/ABB-1067-2020; De Luigi, Ada/ABF-7913-2020; salmona, mario/AAA-7116-2020; Fenoglio, Daniela/I-7220-2018	Moretta, Lorenzo/0000-0003-4658-1747; De Luigi, Ada/0000-0001-7907-7139; salmona, mario/0000-0002-9098-9873; Fenoglio, Daniela/0000-0001-9532-6473	Ministero dell'Istruzione, dell'Universita e della Ricerca - Progetto di Ricerca di Interesse Nazionale [20125S38FA]	Ministero dell'Istruzione, dell'Universita e della Ricerca - Progetto di Ricerca di Interesse Nazionale	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca - Progetto di Ricerca di Interesse Nazionale 20125S38FA (MN).	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Aghajanian C, 2002, CLIN CANCER RES, V8, P2505; Airoldi I, 2008, CANCER IMMUNOL IMMUN, V57, P541, DOI 10.1007/s00262-007-0392-2; Alam J, 2004, ANTIOXID REDOX SIGN, V6, P924, DOI 10.1089/1523086041798114; Alkhateeb AA, 2013, BBA-REV CANCER, V1836, P245, DOI 10.1016/j.bbcan.2013.07.002; Amato RJ, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi002; Armstrong Michael B, 2008, J Exp Ther Oncol, V7, P135; Asensi M, 1999, METHOD ENZYMOL, V299, P267; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Cullen SJ, 2009, MOL IMMUNOL, V47, P600, DOI 10.1016/j.molimm.2009.09.008; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dreger H, 2009, CARDIOVASC RES, V83, P354, DOI 10.1093/cvr/cvp107; Edelman Martin J, 2005, Clin Lung Cancer, V7 Suppl 2, pS64, DOI 10.3816/CLC.2005.s.011; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; Fraser JA, 2003, J BIOL CHEM, V278, P46369, DOI 10.1074/jbc.M308035200; Furfaro AL, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1958174; Furfaro AL, 2014, BBA-MOL BASIS DIS, V1842, P613, DOI 10.1016/j.bbadis.2013.12.008; Furfaro AL, 2012, INT J MOL MED, V29, P899, DOI 10.3892/ijmm.2012.915; Furfaro AL, 2012, FREE RADICAL BIO MED, V52, P488, DOI 10.1016/j.freeradbiomed.2011.11.007; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; HUANG CS, 1993, J BIOL CHEM, V268, P19675; Itahana Y, 2014, ONCOGENE; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Jagannath S, 2004, BRIT J HAEMATOL, V127, P165, DOI 10.1111/j.1365-2141.2004.05188.x; Joazeiro CAP, 2006, CANCER RES, V66, P7840, DOI 10.1158/0008-5472.CAN-06-2033; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Jung T, 2014, REDOX BIOL, V2, P388, DOI 10.1016/j.redox.2013.12.029; Kim DS, 2009, IMMUNOPHARM IMMUNOT, V31, P64, DOI 10.1080/08923970802354762; Kim SS, 2013, ANTICANCER RES, V33, P4913; Kim SS, 2013, BIOCHEM BIOPH RES CO, V440, P658, DOI 10.1016/j.bbrc.2013.09.120; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kwak MK, 2007, LIFE SCI, V80, P2411, DOI 10.1016/j.lfs.2007.04.014; Lara PN, 2004, SEMIN ONCOL, V31, P40, DOI 10.1053/j.seminoncol.2003.12.013; Lee S, 2012, TOXICOL APPL PHARM, V264, P431, DOI 10.1016/j.taap.2012.08.021; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mauro L, 2007, CANCER RES, V67, P3412, DOI 10.1158/0008-5472.CAN-06-2890; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Miyazaki I, 2016, J NEUROCHEM, V136, P194, DOI 10.1111/jnc.13405; Na HK, 2014, FREE RADICAL BIO MED, V67, P353, DOI 10.1016/j.freeradbiomed.2013.10.819; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nuhn P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-37; Numazawa Satoshi, 2004, J Toxicol Sci, V29, P81, DOI 10.2131/jts.29.81; Pagnan G, 2009, CLIN CANCER RES, V15, P1199, DOI 10.1158/1078-0432.CCR-08-2477; Patriarca S, 2005, BBA-MOL BASIS DIS, V1741, P48, DOI 10.1016/j.bbadis.2005.04.003; Piccirillo S, 2009, J BIOL CHEM, V284, P27721, DOI 10.1074/jbc.M109.014837; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Raffaghello L, 2005, ONCOGENE, V24, P4634, DOI 10.1038/sj.onc.1208594; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Singh Simendra, 2012, J Exp Ther Oncol, V9, P303; Spataro V, 1998, BRIT J CANCER, V77, P448, DOI 10.1038/bjc.1998.71; Tan KP, 2007, MOL PHARMACOL, V72, P1380, DOI 10.1124/mol.107.039370; Thompson SA, 1999, TOXICOL LETT, V110, P1, DOI 10.1016/S0378-4274(99)00133-2; Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913; Urru SAM, 2010, J MED CHEM, V53, P7452, DOI 10.1021/jm100362x; Valenzuela M, 2014, BRIT J CANCER, V111, P874, DOI 10.1038/bjc.2014.380; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wang HY, 2013, CANCER RES, V73, P3097, DOI 10.1158/0008-5472.CAN-12-3386; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Wright JJ, 2010, CLIN CANCER RES, V16, P4094, DOI 10.1158/1078-0432.CCR-09-2882; Xue M, 2014, ANTIOXID REDOX SIGNA; Yamamoto N, 2007, J BIOL CHEM, V282, P4364, DOI 10.1074/jbc.M603712200; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zuccari G, 2015, J CONTROL RELEASE, V211, P44, DOI 10.1016/j.jconrel.2015.05.286	68	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152465	10.1371/journal.pone.0152465	http://dx.doi.org/10.1371/journal.pone.0152465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023064	Green Submitted, Green Published, gold			2022-12-26	WOS:000373113900059
J	Kundu, S; Kers, JG; Janssens, ACJW				Kundu, Suman; Kers, Jannigje G.; Janssens, A. Cecile J. W.			Constructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk	PLOS ONE			English	Article							PREDICTIVE ABILITY; COMPLEX DISEASES; BREAST; SUSCEPTIBILITY; PROSTATE; GENES	Background Modeling studies using hypothetical polygenic risk data can be an efficient tool for investigating the effectiveness of downstream applications such as targeting interventions to risk groups to justify whether empirical investigation is warranted. We investigated the assumptions underlying a method that simulates risk data for specific values of the area under the receiver operating characteristic curve (AUC). Methods The simulation method constructs risk data for a hypothetical population based on the population disease risk, and the odds ratios and frequencies of genetic variants. By systematically varying the parameters, we investigated under what conditions AUC values represent unique ROC curves with unique risk distributions for patients and nonpatients, and to what extend risk data can be simulated for precise values of the AUC. Results Using larger number of genetic variants each with a modest effect, we observed that the distributions of estimated risks of patients and nonpatients were similar for various combinations of the odds ratios and frequencies of the risk alleles. Simulated ROC curves overlapped empirical curves with the same AUC. Conclusions Polygenic risk data can be effectively and efficiently created using a simulation method. This allows to further investigate the potential applications of stratifying interventions on the basis of polygenic risk.	[Kundu, Suman; Janssens, A. Cecile J. W.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Kundu, Suman] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Kers, Jannigje G.; Janssens, A. Cecile J. W.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, EMGO Inst Hlth & Care Res,Sect Community Genet, Amsterdam, Netherlands	Emory University; Rollins School Public Health; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Janssens, ACJW (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.; Janssens, ACJW (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, EMGO Inst Hlth & Care Res,Sect Community Genet, Amsterdam, Netherlands.	cecile.janssens@emory.edu	Kundu, Suman/I-2603-2019	Kundu, Suman/0000-0002-6305-2559	Netherlands Organization for Scientific Research (NWO); European Research Council (GENOMICMEDICINE)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council (GENOMICMEDICINE)	This work was supported by a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a consolidator grant from the European Research Council (GENOMICMEDICINE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton H, 2013, NAT GENET, V45, P349, DOI 10.1038/ng.2582; Chowdhury S, 2013, GENET MED, V15, P423, DOI 10.1038/gim.2012.167; Chung CM, 2014, CLIN INTERV AGING, V9, P1495, DOI 10.2147/CIA.S68544; den Engelsen C, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-25; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Garcia-Closas M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju305; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kalf RRJ, 2014, GENET MED, V16, P85, DOI 10.1038/gim.2013.80; Kundu S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00179; Kundu S, 2012, EUR J HUM GENET, V20, P1270, DOI 10.1038/ejhg.2012.89; Lu Q, 2008, AM J HUM GENET, V82, P641, DOI 10.1016/j.ajhg.2007.12.025; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Moonesinghe R, 2010, EUR J HUM GENET, V18, P485, DOI 10.1038/ejhg.2009.209; Pashayan N, 2011, BRIT J CANCER, V104, P1656, DOI 10.1038/bjc.2011.118; Pashayan N, 2015, GENETICS MED; Pashayan N, 2013, PERSONALIZED MED, V10; Pepe M. S., 2003, STAT EVALUATION MED; Pepe MS, 2010, CANCER EPIDEM BIOMAR, V19, P655, DOI 10.1158/1055-9965.EPI-09-0510; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; So HC, 2011, AM J HUM GENET, V88, P548, DOI 10.1016/j.ajhg.2011.04.001; Taniguchi L, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-187; Zadeh-Vakili A, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-18	23	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152359	10.1371/journal.pone.0152359	http://dx.doi.org/10.1371/journal.pone.0152359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023073	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900049
J	Natarajan, C; Yao, SY; Sriram, S				Natarajan, Chandramohan; Yao, Song-Yi; Sriram, Subramaniam			TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TOLL-LIKE RECEPTORS; ACTIVATED PROTEIN-KINASE; MULTIPLE-SCLEROSIS; PRELIMINARY TRIAL; IN-VITRO; DEMYELINATION; INJURY; RESPONSES	Background Impaired remyelination of demyelinated axons is a major cause of neurological disability. In inflammatory demyelinating disease of the central nervous system (CNS), although remyelination does happen, it is often incomplete, resulting in poor clinical recovery. Poly-IC a known TLR3 agonist and IL-33, a cytokine which is induced by poly-IC are known to influence recovery and promote repair in experimental models of CNS demyelination. Methodology and Principal Findings We examined the effect of addition of poly-IC and IL-33 on the differentiation and maturation of oligodendrocyte precursor cells (OPC) cultured in vitro. Both Poly-IC and IL-33 induced transcription of myelin genes and the differentiation of OPC to mature myelin forming cells. Poly-IC induced IL-33 in OPC and addition of IL-33 to in vitro cultures, amplified further, IL-33 expression suggesting an autocrine regulation of IL-33. Poly-IC and IL-33 also induced phosphorylation of p38MAPK, a signaling molecule involved in myelination. Following the induction of gliotoxic injury with lysolecithin to the corpus callosum (CC), treatment of animals with poly-IC resulted in greater recruitment of OPC and increased staining for myelin in areas of demyelination. Also, poly-IC treated animals showed greater expression of IL-33 and higher expression of M2 phenotype macrophages in the CC. Conclusion/Significance Our studies suggest that poly-IC and IL-33 play a role in myelin repair by enhancing expression of myelin genes and are therefore attractive therapeutic agents for use as remyelinating agents in human demyelinating disease.	[Natarajan, Chandramohan; Yao, Song-Yi; Sriram, Subramaniam] Vanderbilt Univ, Dept Neurol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University	Sriram, S (corresponding author), Vanderbilt Univ, Dept Neurol, 221 Kirkland Hall, Nashville, TN 37235 USA.	subramaniam.sriram@vanderbilt.edu						Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; BEVER CT, 1986, NEUROLOGY, V36, P494, DOI 10.1212/WNL.36.4.494; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Bsibsi M, 2012, J NEUROSCI RES, V90, P388, DOI 10.1002/jnr.22767; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; Colello R J, 2001, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0312s03; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Fragoso G, 2007, GLIA, V55, P1531, DOI 10.1002/glia.20567; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Hudson CA, 2008, J LEUKOCYTE BIOL, V84, P631, DOI 10.1189/jlb.1207830; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Khorooshi R, 2015, ACTA NEUROPATHOL, V130, P107, DOI 10.1007/s00401-015-1418-z; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kuhlmann T, 2006, AM J PATHOL, V169, P584, DOI 10.2353/ajpath.2006.051086; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Marriott MP, 2008, GLIA, V56, P686, DOI 10.1002/glia.20646; Martins KA, 2015, EXPERT REV VACCINES, V14, P447, DOI 10.1586/14760584.2015.966085; MCFARLIN DE, 1985, J BIOL RESP MODIF, V4, P544; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Miron VE, 2014, J NEUROCHEM, V130, P165, DOI 10.1111/jnc.12705; Mitchell WM, 2014, AM J PATHOL, V184, P1062, DOI 10.1016/j.ajpath.2013.12.006; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Natarajan C, 2013, J NEUROIMMUNOL, V265, P51, DOI 10.1016/j.jneuroim.2013.09.009; Nicodemus CF, 2010, IMMUNOTHERAPY-UK, V2, P137, DOI 10.2217/IMT.10.8; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Pellagrino LJ, 1979, STEROTAXIC ATLAS RAT; SALAZAR AM, 1981, ARCH NEUROL-CHICAGO, V38, P382, DOI 10.1001/archneur.1981.00510060084018; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Slaets H, 2010, TRENDS MOL MED, V16, P493, DOI 10.1016/j.molmed.2010.08.007; Suh HS, 2009, CURR TOP MICROBIOL, V336, P63, DOI 10.1007/978-3-642-00549-7_4; Touil T, 2006, J IMMUNOL, V177, P7505, DOI 10.4049/jimmunol.177.11.7505; Tretiakova A, 1999, J CELL PHYSIOL, V181, P160, DOI 10.1002/(SICI)1097-4652(199910)181:1<160::AID-JCP17>3.0.CO;2-H; Wang PF, 2014, J IMMUNOL, V192, P4783, DOI 10.4049/jimmunol.1303108; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Zhang F, 2014, ANN CLIN TR IN PRESS; Zhang JY, 2011, FEBS LETT, V585, P3813, DOI 10.1016/j.febslet.2011.08.017	48	29	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152163	10.1371/journal.pone.0152163	http://dx.doi.org/10.1371/journal.pone.0152163			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022724	gold, Green Submitted, Green Published			2022-12-26	WOS:000373113900026
J	Sato, D; Tsuchikawa, T; Mitsuhashi, T; Hatanaka, Y; Marukawa, K; Morooka, A; Nakamura, T; Shichinohe, T; Matsuno, Y; Hirano, S				Sato, Daisuke; Tsuchikawa, Takahiro; Mitsuhashi, Tomoko; Hatanaka, Yutaka; Marukawa, Katsuji; Morooka, Asami; Nakamura, Toru; Shichinohe, Toshiaki; Matsuno, Yoshihiro; Hirano, Satoshi			Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; PODOPLANIN EXPRESSION; NEOADJUVANT THERAPY; PROTEIN PALLADIN; CARCINOMA; ACTIN; CELLS; CHEMORADIOTHERAPY; CHEMORADIATION; HETEROGENEITY	It has been clear that cancer-associated fibroblasts (CAFs) in the tumor microenvironment play an important role in pancreatic ductal adenocarcinoma (PDAC) progression. However, how CAFs relate to the patients' prognosis and the effects of chemoradiation therapy (CRT) has not been fully investigated. Tissue microarrays (TMAs) representing 167 resected PDACs without preoperative treatment were used for immunohistochemical studies (IHC) of palladin, alpha-smooth muscle actin (SMA), and podoplanin. Correlations between the expression levels of these markers and clinicopathological findings were analyzed statistically. Whole sections of surgical specimens from PDACs with and without preoperative CRT, designated as the chemotherapy-first group (CF, n = 19) and the surgery-first group (SF, n = 21), respectively, were also analyzed by IHC. In TMAs, the disease-specific survival rate (DSS) at 5 years for all 167 cases was 23.1%. Seventy cases (41.9%) were positive for palladin and had significantly lower DSS (p = 0.0430). alpha-SMA and podoplanin were positive in 167 cases (100%) and 131 cases (78.4%), respectively, and they were not significantly associated with DSS. On multivariable analysis, palladin expression was an independent poor prognostic factor (p = 0.0243, risk ratio 1.60). In the whole section study, palladin positivity was significantly lower (p = 0.0037) in the CF group (5/19) with a significantly better DSS (p = 0.0144) than in the SF group (16/22), suggesting that stromal palladin expression is a surrogate indicator of the treatment effect after chemoradiation therapy.	[Sato, Daisuke; Tsuchikawa, Takahiro; Nakamura, Toru; Shichinohe, Toshiaki; Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan; [Sato, Daisuke; Mitsuhashi, Tomoko; Hatanaka, Yutaka; Marukawa, Katsuji; Morooka, Asami; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Surg Pathol, Sapporo, Hokkaido 060, Japan; [Hatanaka, Yutaka; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Res Div Compan Diagnost, Sapporo, Hokkaido 060, Japan; [Sato, Daisuke] Tonan Hosp, Dept Surg, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Tsuchikawa, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan.	tsuchi-t@med.hokudai.ac.jp	Tsuchikawa, Takahiro/A-7739-2012; Mitsuhashi, Tomoko/A-6996-2012					Ansari D, 2012, WORLD J GASTROENTERO, V18, P1417, DOI 10.3748/wjg.v18.i13.1417; Berdiel-Acer M, 2014, MOL ONCOL, V8, P1290, DOI 10.1016/j.molonc.2014.04.006; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Cannon AR, 2015, CYTOSKELETON, V72, P402, DOI 10.1002/cm.21239; Chatterjee D, 2012, CANCER-AM CANCER SOC, V118, P3182, DOI 10.1002/cncr.26651; Cheng JD, 2002, CANCER RES, V62, P4767; Choi SY, 2013, J KOREAN MED SCI, V28, P1293, DOI 10.3346/jkms.2013.28.9.1293; College of American Pathologists, PROTOCOL FOR THE EXA; Egawa S, 2008, SUIZO, V23, P105, DOI DOI 10.2958/SUIZO.23.105; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; Goicoechea SM, 2014, ONCOGENE, V33, P1265, DOI 10.1038/onc.2013.68; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Greer SE, 2008, J AM COLL SURGEONS, V206, P451, DOI 10.1016/j.jamcollsurg.2007.10.002; Gupta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021494; Hartman DJ, 2012, ARCH PATHOL LAB MED, V136, P100, DOI 10.5858/arpa.2011-0144-RA; Hawinkels LJAC, 2014, ONCOGENE, V33, P97, DOI 10.1038/onc.2012.536; Heinemann V, 2014, CANCER TREAT REV, V40, P118, DOI 10.1016/j.ctrv.2013.04.004; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kitano H, 2010, ARCH PATHOL LAB MED, V134, P1520, DOI 10.1043/2009-0114-OA.1; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Mhawech-Fauceglia P, 2014, CANCER MICROENVIRON, V7, P33, DOI 10.1007/s12307-013-0140-4; Motoi F, 2013, ANN SURG ONCOL, V20, P3794, DOI 10.1245/s10434-013-3129-9; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Ostman A, 2014, SEMIN CANCER BIOL, V25, P1, DOI 10.1016/j.semcancer.2014.02.004; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; Satoi S, 2013, J HEPATO-BIL-PAN SCI, V20, P590, DOI 10.1007/s00534-013-0616-0; Shindo K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-168; Sobin LH, 2009, TNM CLASSIFICATION O; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Takeda Y, 2014, JPN J CLIN ONCOL, V44, P1172, DOI 10.1093/jjco/hyu143; von Nandelstadh P, 2014, MOL BIOL CELL, V25, P2556, DOI 10.1091/mbc.E13-11-0667; White RR, 2005, ANN SURG ONCOL, V12, P214, DOI 10.1245/ASO.2005.03.105; Zhao Q, 2012, ANN DIAGN PATHOL, V16, P29, DOI 10.1016/j.anndiagpath.2011.08.005	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152523	10.1371/journal.pone.0152523	http://dx.doi.org/10.1371/journal.pone.0152523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023252	Green Submitted, Green Published, gold			2022-12-26	WOS:000373113900070
J	Taneike, M; Nishida, K; Omiya, S; Zarrinpashneh, E; Misaka, T; Kitazume-Taneike, R; Austin, R; Takaoka, M; Yamaguchi, O; Gambello, MJ; Shah, AM; Otsu, K				Taneike, Manabu; Nishida, Kazuhiko; Omiya, Shigemiki; Zarrinpashneh, Elham; Misaka, Tomofumi; Kitazume-Taneike, Rika; Austin, Ruth; Takaoka, Minoru; Yamaguchi, Osamu; Gambello, Michael J.; Shah, Ajay M.; Otsu, Kinya			mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy	PLOS ONE			English	Article							CELL-GROWTH; MAMMALIAN TARGET; RHEB GTPASE; ATP RELEASE; TSC2; GENE; PROLIFERATION; RAPAMYCIN; MODEL; MICE	Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth, proliferation and metabolism. mTORC1 regulates protein synthesis positively and autophagy negatively. Autophagy is a major system to manage bulk degradation and recycling of cytoplasmic components and organelles. Tuberous sclerosis complex (TSC) 1 and 2 form a heterodimeric complex and inactivate Ras homolog enriched in brain, resulting in inhibition of mTORC1. Here, we investigated the effects of hyperactivation of mTORC1 on cardiac function and structure using cardiac-specific TSC2-deficient (TSC2(-/-)) mice. TSC2(-/-) mice were born normally at the expected Mendelian ratio. However, the median life span of TSC2(-/-) mice was approximately 10 months and significantly shorter than that of control mice. TSC2(-/-) mice showed cardiac dysfunction and cardiomyocyte hypertrophy without considerable fibrosis, cell infiltration or apoptotic cardiomyocyte death. Ultrastructural analysis of TSC2(-/-) hearts revealed misalignment, aggregation and a decrease in the size and an increase in the number of mitochondria, but the mitochondrial function was maintained. Autophagic flux was inhibited, while the phosphorylation level of S6 or eukaryotic initiation factor 4E -binding protein 1, downstream of mTORC1, was increased. The upregulation of autophagic flux by trehalose treatment attenuated the cardiac phenotypes such as cardiac dysfunction and structural abnormalities of mitochondria in TSC2(-/-) hearts. The results suggest that autophagy via the TSC2-mTORC1 signaling pathway plays an important role in maintenance of cardiac function and mitochondrial quantity and size in the heart and could be a therapeutic target to maintain mitochondrial homeostasis in failing hearts.	[Taneike, Manabu; Nishida, Kazuhiko; Omiya, Shigemiki; Zarrinpashneh, Elham; Misaka, Tomofumi; Kitazume-Taneike, Rika; Austin, Ruth; Takaoka, Minoru; Shah, Ajay M.; Otsu, Kinya] Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr Excellence, London WC2R 2LS, England; [Yamaguchi, Osamu] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Gambello, Michael J.] Emory Univ, Div Med Genet, Sch Med, Atlanta, GA 30322 USA	University of London; King's College London; Osaka University; Emory University	Otsu, K (corresponding author), Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr Excellence, London WC2R 2LS, England.	kinya.otsu@kcl.ac.uk		Yamaguchi, Osamu/0000-0002-7461-369X; Takaoka, Minoru/0000-0002-8515-8282; Shah, Ajay/0000-0002-6547-0631	Medical Research Council [MR/K019031/1]; British Heart Foundation [CH/11/3/29051, RG/11/12/29052]; MRC [MR/K019031/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council (MR/K019031/1), http://www.mrc.ac.uk/, KO; British Heart Foundation (CH/11/3/29051, RG/11/12/29052), https://www.bhf.org.uk/, KO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422; Di Nardo A, 2014, HUM MOL GENET, V23, P3865, DOI 10.1093/hmg/ddu101; Dutta AK, 2004, J PHYSIOL-LONDON, V559, P799, DOI 10.1113/jphysiol.2004.069245; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; FROLDI G, 1990, CIRC RES, V67, P960, DOI 10.1161/01.RES.67.4.960; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ishihara R, 1997, GENE, V202, P69, DOI 10.1016/S0378-1119(97)00455-1; Joubert F, 2008, J PHYSIOL-LONDON, V586, P5181, DOI 10.1113/jphysiol.2008.157677; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kobayashi T, 1999, CANCER RES, V59, P1206; Koyanagi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023238; Kunugi S, 2011, BIOCHEM BIOPH RES CO, V416, P409, DOI 10.1016/j.bbrc.2011.11.068; Lacher MD, 2010, ONCOGENE, V29, P6543, DOI 10.1038/onc.2010.393; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Meikle L, 2005, HUM MOL GENET, V14, P429, DOI 10.1093/hmg/ddi039; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Sato A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2295; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tamai T, 2013, J BIOL CHEM, V288, P10176, DOI 10.1074/jbc.M112.423640; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054221, 10.1371/journal.pone.0071727]	55	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152628	10.1371/journal.pone.0152628	http://dx.doi.org/10.1371/journal.pone.0152628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023784	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900084
J	Utheim, TP; Islam, R; Fostad, IG; Eidet, JR; Sehic, A; Olstad, OK; Dartt, DA; Messelt, EB; Griffith, M; Pasovic, L				Utheim, Tor Paaske; Islam, Rakibul; Fostad, Ida G.; Eidet, Jon R.; Sehic, Amer; Olstad, Ole K.; Dartt, Darlene A.; Messelt, Edward B.; Griffith, May; Pasovic, Lara			Storage Temperature Alters the Expression of Differentiation-Related Genes in Cultured Oral Keratinocytes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MUCOSAL EPITHELIAL-CELLS; PROLINE-RICH PROTEINS; TUMOR-SUPPRESSOR; SONIC HEDGEHOG; EPIDERMAL DIFFERENTIATION; STEM-CELLS; ENVIRONMENTAL HUMIDITY; ATOPIC-DERMATITIS; BREAST-CANCER	Purpose Storage of cultured human oral keratinocytes (HOK) allows for transportation of cultured transplants to eye clinics worldwide. In a previous study, one-week storage of cultured HOK was found to be superior with regard to viability and morphology at 12 degrees C compared to 4 degrees C and 37 degrees C. To understand more of how storage temperature affects cell phenotype, gene expression of HOK before and after storage at 4 degrees C, 12 degrees C, and 37 degrees C was assessed. Materials and Methods Cultured HOK were stored in HEPES-and sodium bicarbonate-buffered Minimum Essential Medium at 4 degrees C, 12 degrees C, and 37 degrees C for one week. Total RNA was isolated and the gene expression profile was determined using DNA microarrays and analyzed with Partek Genomics Suite software and Ingenuity Pathway Analysis. Differentially expressed genes (fold change > 1.5 and P < 0.05) were identified by one-way ANOVA. Key genes were validated using qPCR. Results Gene expression of cultures stored at 4 degrees C and 12 degrees C clustered close to the unstored control cultures. Cultures stored at 37 degrees C displayed substantial change in gene expression compared to the other groups. In comparison with 12 degrees C, 2,981 genes were differentially expressed at 37 degrees C. In contrast, only 67 genes were differentially expressed between the unstored control and the cells stored at 12 degrees C. The 12 degrees C and 37 degrees C culture groups differed most significantly with regard to the expression of differentiation markers. The Hedgehog signaling pathway was significantly downregulated at 37 degrees C compared to 12 degrees C. Conclusion HOK cultures stored at 37 degrees C showed considerably larger changes in gene expression compared to unstored cells than cultured HOK stored at 4 degrees C and 12 degrees C. The changes observed at 37 degrees C consisted of differentiation of the cells towards a squamous epithelium-specific phenotype. Storing cultured ocular surface transplants at 37 degrees C is therefore not recommended. This is particularly interesting as 37 degrees C is the standard incubation temperature used for cell culture.	[Utheim, Tor Paaske; Islam, Rakibul; Eidet, Jon R.; Olstad, Ole K.; Pasovic, Lara] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Utheim, Tor Paaske; Islam, Rakibul; Fostad, Ida G.; Sehic, Amer; Messelt, Edward B.] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Utheim, Tor Paaske] Vestre Viken HF Trust, Dept Ophthalmol, Drammen, Norway; [Utheim, Tor Paaske] Buskerud & Vestfold Univ Coll, Fac Hlth Sci, Natl Ctr Opt Vis & Eye Care, Kongsberg, Norway; [Eidet, Jon R.] Oslo Univ Hosp, Dept Ophthalmol, Oslo, Norway; [Dartt, Darlene A.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA USA; [Griffith, May] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Pasovic, Lara] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University College of Southeast Norway; University of Oslo; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Linkoping University; University of Oslo	Pasovic, L (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.; Pasovic, L (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	lara.pasovic@medisin.uio.no		Islam, Rakibul/0000-0002-7174-9225; Pasovic, Lara/0000-0002-3871-9841; Griffith, May/0000-0003-1222-6720	Department of Oral Biology, Faculty of Dentistry, University of Oslo; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; NATIONAL EYE INSTITUTE [R01EY019470] Funding Source: NIH RePORTER	Department of Oral Biology, Faculty of Dentistry, University of Oslo; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was received from Department of Oral Biology, Faculty of Dentistry, University of Oslo and Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.	Ahmad S, 2010, J CELL PHYSIOL, V225, P15, DOI 10.1002/jcp.22251; BACKENDORF C, 1992, NAT GENET, V2, P91, DOI 10.1038/ng1092-91; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Calenic B, 2010, ROM J MORPHOL EMBRYO, V51, P641; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; Cui T, 2011, BRIT J CANCER, V104, P1013, DOI 10.1038/bjc.2011.28; Cui TT, 2012, CARCINOGENESIS, V33, P2326, DOI 10.1093/carcin/bgs273; Daniels JT, 2006, REGEN MED, V1, P715, DOI 10.2217/17460751.1.5.715; Feijoo CG, 2009, DEV DYNAM, V238, P2034, DOI 10.1002/dvdy.22006; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Gibbs S, 2000, ARCH ORAL BIOL, V45, P149, DOI 10.1016/S0003-9969(99)00116-8; Glavic A, 2009, MECH DEVELOP, V126, P184, DOI 10.1016/j.mod.2008.11.005; Hill SM, 2015, ENDOCR-RELAT CANCER, V22, pR183, DOI 10.1530/ERC-15-0030; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; Huber M, 2005, J INVEST DERMATOL, V124, P998, DOI 10.1111/j.0022-202X.2005.23675.x; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Islam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128306; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Janjetovic Z, 2014, J PINEAL RES, V57, P90, DOI 10.1111/jpi.12146; Jones MP, 2000, CANCER LETT, V151, P133, DOI 10.1016/S0304-3835(99)00394-8; Karbownik M, 2001, INT J BIOCHEM CELL B, V33, P735, DOI 10.1016/S1357-2725(01)00059-0; Kawasaki S, 2003, EXP EYE RES, V77, P17, DOI 10.1016/S0014-4835(03)00087-3; Komine M, 2000, J BIOL CHEM, V275, P32077, DOI 10.1074/jbc.M001253200; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Kumar C A, 2000, Med Sci Monit, V6, P471; Lieden A, 2009, ALLERGY, V64, P304, DOI 10.1111/j.1398-9995.2008.01856.x; Lin FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121677; Little TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001003; Martin M, 2000, FASEB J, V14, P1677; Nakamura E, 2008, CANCER SCI, V99, P1390, DOI 10.1111/j.1349-7006.2008.00838.x; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Niethammer D, 1999, RHEUMATOLOGY, V38, P747, DOI 10.1093/rheumatology/38.8.747; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Oomizu S, 2000, GENE, V256, P19, DOI 10.1016/S0378-1119(00)00357-7; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pasovic L, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/263756; Pasovic L, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/216359; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Ram PT, 2002, CANCER LETT, V179, P141, DOI 10.1016/S0304-3835(01)00873-4; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Seki Y, 2014, BIOCHEM BIOPH RES CO, V443, P1141, DOI 10.1016/j.bbrc.2013.12.106; Shinohara M, 1998, J PATHOL, V184, P369, DOI 10.1002/(SICI)1096-9896(199804)184:4<369::AID-PATH1236>3.0.CO;2-L; Slominski A, 2005, ENDOCRINE, V27, P137, DOI 10.1385/ENDO:27:2:137; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Sugiyama H, 2014, MOL THER, V22, P1544, DOI 10.1038/mt.2014.69; Takei K, 2013, EXP DERMATOL, V22, P662, DOI 10.1111/exd.12224; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Thyssen JP, 2014, J ALLERGY CLIN IMMUN, V134, P792, DOI 10.1016/j.jaci.2014.06.014; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Tsuchida S, 2004, J INVEST DERMATOL, V122, P1225, DOI 10.1111/j.0022-202X.2004.22511.x; Utheim TP, 2009, INVEST OPHTH VIS SCI, V50, P5165, DOI 10.1167/iovs.08-2884; Utheim TP, 2015, STEM CELLS, V33, P1685, DOI 10.1002/stem.1999; Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wang K, 2013, ONCOL REP, V29, P1175, DOI 10.3892/or.2012.2213; Wang LH, 2007, VIRCHOWS ARCH, V451, P959, DOI 10.1007/s00428-007-0485-5; WEBER E, 1994, J CELL BIOL, V125, P583, DOI 10.1083/jcb.125.3.583; Yagui-Beltran A, 2001, EUR J BIOCHEM, V268, P5343, DOI 10.1046/j.0014-2956.2001.02468.x; Yamamoto Y, 2003, BIOCHEM BIOPH RES CO, V308, P270, DOI 10.1016/S0006-291X(03)01358-5; Zhu G, 2014, EXP DERMATOL, V23, P15, DOI 10.1111/exd.12275	73	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152526	10.1371/journal.pone.0152526	http://dx.doi.org/10.1371/journal.pone.0152526			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023475	gold, Green Published			2022-12-26	WOS:000373113900072
J	Oh, SA; Yea, JW; Kang, MK; Park, JW; Kim, SK				Oh, Se An; Yea, Ji Woon; Kang, Min Kyu; Park, Jae Won; Kim, Sung Kyu			Analysis of the Setup Uncertainty and Margin of the Daily ExacTrac 6D Image Guide System for Patients with Brain Tumors	PLOS ONE			English	Article							ACCURACY; INCLUSION	This study evaluated the setup uncertainties for brain sites when using BrainLAB's ExacTrac X-ray 6D system for daily pretreatment to determine the optimal planning target volume (PTV) margin. Between August 2012 and April 2015, 28 patients with brain tumors were treated by daily image-guided radiotherapy using the BrainLAB ExacTrac 6D image guidance system of the Novalis-Tx linear accelerator. DUONTM (Orfit Industries, Wijnegem, Belgium) masks were used to fix the head. The radiotherapy was fractionated into 27-33 treatments. In total, 844 image verifications were performed for 28 patients and used for the analysis. The setup corrections along with the systematic and random errors were analyzed for six degrees of freedom in the translational (lateral, longitudinal, and vertical) and rotational (pitch, roll, and yaw) dimensions. Optimal PTV margins were calculated based on van Herk et al.'s [margin recipe = 2.5 Sigma + 0.7 sigma-3 mm] and Stroom et al.'s [margin recipe = 2 Sigma + 0.7 sigma] formulas. The systematic errors (Sigma) were 0.72, 1.57, and 0.97mmin the lateral, longitudinal, and vertical translational dimensions, respectively, and 0.72 degrees, 0.87 degrees, and 0.83 degrees in the pitch, roll, and yaw rotational dimensions, respectively. The random errors (sigma) were 0.31, 0.46, and 0.54mm in the lateral, longitudinal, and vertical rotational dimensions, respectively, and 0.28 degrees, 0.24 degrees, and 0.31 in the pitch, roll, and yaw rotational dimensions, respectively. According to van Herk et al.' s and Stroom et al.' s recipes, the recommended lateral PTV margins were 0.97 and 1.66mm, respectively; the longitudinalmargins were 1.26 and 3.47mm, respectively; and the vertical margins were 0.21 and 2.31mm, respectively. Therefore, daily setup verifications using the BrainLAB ExacTrac 6D image guide system are very useful for evaluating the setup uncertainties and determining the setup margin.	[Oh, Se An; Yea, Ji Woon; Park, Jae Won; Kim, Sung Kyu] Yeungnam Univ, Dept Radiat Oncol, Med Ctr, Daegu, South Korea; [Yea, Ji Woon; Kim, Sung Kyu] Yeungnam Univ, Dept Radiat Oncol, Coll Med, Daegu, South Korea; [Kang, Min Kyu] Kyungpook Natl Univ, Sch Med, Dept Radiat Oncol, Daegu, South Korea	Yeungnam University; Yeungnam University; Kyungpook National University	Kim, SK (corresponding author), Yeungnam Univ, Dept Radiat Oncol, Med Ctr, Daegu, South Korea.; Kim, SK (corresponding author), Yeungnam Univ, Dept Radiat Oncol, Coll Med, Daegu, South Korea.	skkim3@ynu.ac.kr	KANG, MIN KYU/ACI-8824-2022	KANG, MIN KYU/0000-0002-7962-7054; Oh, SeAn/0000-0002-8835-2814	Yeungnam University [214A480005]	Yeungnam University	This work was supported by the 2014 Yeungnam University Research Grant(214A480005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran C, 2011, INT J RADIAT ONCOL, V79, P1266, DOI 10.1016/j.ijrobp.2009.12.057; Das S., 2010, J APPL CLIN MED PHYS, V12; Dzyubak O, 2014, MED PHYS, V41, DOI 10.1118/1.4896101; Gevaert T, 2012, INT J RADIAT ONCOL, V82, P1627, DOI 10.1016/j.ijrobp.2011.01.052; Gilbeau L, 2001, RADIOTHER ONCOL, V58, P155, DOI 10.1016/S0167-8140(00)00280-2; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Hong LX, 2009, INT J RADIAT ONCOL, V73, P556, DOI 10.1016/j.ijrobp.2008.09.055; Infusino E, 2015, J APPL CLIN MED PHYS, V16, P99, DOI 10.1120/jacmp.v16i2.5102; Kataria T, 2011, J CANCER RES THER, V7, P40, DOI 10.4103/0973-1482.80457; Linthout N, 2007, RADIOTHER ONCOL, V83, P168, DOI 10.1016/j.radonc.2007.04.015; Miyabe Y, 2011, MED PHYS, V38, P2535, DOI 10.1118/1.3578607; Oh YK, 2014, J APPL CLIN MED PHYS, V15, P85, DOI 10.1120/jacmp.v15i2.4418; OHSEAN, 2013, [PROGRESS in MEDICAL PHYSICS, 의학물리], V24, P145, DOI 10.14316/pmp.2013.24.3.145; Remeijer P, 2000, INT J RADIAT ONCOL, V46, P1281, DOI 10.1016/S0360-3016(99)00468-X; Shi C., 2012, J APPL CLIN MED PHYS, V13; Shiraishi K., 2014, VALIDATION PLANNING, V2014; Stanley DN, 2014, J APPL CLIN MED PHYS, V15, P81, DOI 10.1120/jacmp.v15i6.4877; Stroom JC, 1999, INT J RADIAT ONCOL, V43, P905, DOI 10.1016/S0360-3016(98)00468-4; van Herk M, 2000, INT J RADIAT ONCOL, V47, P1121, DOI 10.1016/S0360-3016(00)00518-6; van Herk M, 2004, SEMIN RADIAT ONCOL, V14, P52, DOI 10.1053/j.semradonc.2003.10.003; van Herk M, 2002, INT J RADIAT ONCOL, V52, P1407, DOI 10.1016/S0360-3016(01)02805-X; Yin F.-F., 2009, ROLE IN ROOM KV XRAY, V104; Zaghloul MS, 2010, CLIN ONCOL-UK, V22, P850, DOI 10.1016/j.clon.2010.08.006; Zhou JN, 2010, MED DOSIM, V35, P31, DOI 10.1016/j.meddos.2009.01.005	24	14	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151709	10.1371/journal.pone.0151709	http://dx.doi.org/10.1371/journal.pone.0151709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019082	Green Published, Green Submitted, gold			2022-12-26	WOS:000372807800018
J	Olivares, CN; Alaniz, LD; Menger, MD; Baranao, RI; Laschke, MW; Meresman, GF				Olivares, Carla N.; Alaniz, Laura D.; Menger, Michael D.; Baranao, Rosa I.; Laschke, Matthias W.; Meresman, Gabriela F.			Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions	PLOS ONE			English	Article							CELLS IN-VITRO; DOWN-REGULATION; HOST TISSUE; 4-METHYLUMBELLIFERONE; GROWTH; VIVO; CD44; ACTIVATION; REGRESSION; THERAPY	Background The development and long-term survival of endometriotic lesions is crucially dependent on an adequate vascularization. Hyaluronic acid (HA) through its receptor CD44 has been described to be involved in the process of angiogenesis. Objective To study the effect of HA synthesis inhibition using non-toxic doses of 4-methylumbellifer-one (4-MU) on endometriosis-related angiogenesis. Materials and Methods The cytotoxicity of different in vitro doses of 4-MU on endothelial cells was firstly tested by means of a lactate dehydrogenase assay. The anti-angiogenic action of non-cytotoxic doses of 4-MU was then assessed by a rat aortic ring assay. In addition, endometriotic lesions were induced in dorsal skinfold chambers of female BALB/c mice, which were daily treated with an intraperitoneal injection of 0.9% NaCl (vehicle group; n = 6), 20mg/kg 4-MU (n = 8) or 80mg/kg 4-MU (n = 7) throughout an observation period of 14 days. The effect of 4-MU on their vascularization, survival and growth were studied by intravital fluorescence microscopy, histology and immunohistochemistry. Main Results Non-cytotoxic doses of 4-MU effectively inhibited vascular sprout formation in the rat aortic ring assay. Endometriotic lesions in dorsal skinfold chambers of 4-MU-treated mice dose-dependently exhibited a significantly smaller vascularized area and lower functional micro-vessel density when compared to vehicle-treated controls. Histological analyses revealed a downregulation of HA expression in 4-MU-treated lesions. This was associated with a reduced density of CD31-positive microvessels within the lesions. In contrast, numbers of PCNA-positive proliferating and cleaved caspase-3-positive apoptotic cells did not differ between 4-MU-treated and control lesions. Conclusions The present study demonstrates for the first time that targeting the synthesis of HA suppresses angiogenesis in developing endometriotic lesions. Further studies have to clarify now whether in the future this anti-angiogenic effect can be used beneficially for the treatment of endometriosis.	[Olivares, Carla N.; Baranao, Rosa I.; Meresman, Gabriela F.] Inst Biol & Med Expt IBYME CONICET, Buenos Aires, DF, Argentina; [Alaniz, Laura D.] Univ Nacl Noroeste Prov Buenos Aires CONICET UNNO, CIT NOBA, Buenos Aires, DF, Argentina; [Menger, Michael D.; Laschke, Matthias W.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Universidad Nacional del Noroeste de la Provincia de Buenos Aires; Saarland University	Olivares, CN (corresponding author), Inst Biol & Med Expt IBYME CONICET, Buenos Aires, DF, Argentina.	carla.olivares@ibyme.conicet.gov.ar	Alaniz, Laura/AAM-2676-2020; , Ph.D/K-4540-2019	Alaniz, Laura/0000-0002-6070-6078; Meresman, Gabriela Fabiana/0000-0002-5058-8450	Agencia Nacional de Promocion Cientifica y Tecnologica [1055]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This study was funded by a grant from the Agencia Nacional de Promocion Cientifica y Tecnologica (Prestamo BID PICT 2011 No 1055). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamia Sophia, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P3, DOI 10.2174/1568006053005056; Afify Alaa M, 2005, Ann Diagn Pathol, V9, P312, DOI 10.1016/j.anndiagpath.2005.07.004; Angioni S, 2014, GYNECOL ENDOCRINOL, V30, P769, DOI 10.3109/09513590.2014.950646; Arai E, 2011, BRIT J CANCER, V105, P1839, DOI 10.1038/bjc.2011.459; Bello L, 2001, CANCER RES, V61, P7501; Benitez A, 2013, J UROLOGY, V190, P285, DOI 10.1016/j.juro.2012.12.011; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S; Dechaud H, 2001, FERTIL STERIL, V76, P1012, DOI 10.1016/S0015-0282(01)02839-4; Ehrmantraut S, 2010, EUR CELLS MATER, V19, P107, DOI 10.22203/eCM.v019a11; Feng DL, 2014, DIS MODEL MECH, V7, P225, DOI 10.1242/dmm.013664; Feng DL, 2012, ANGIOGENESIS, V15, P243, DOI 10.1007/s10456-012-9256-2; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; FONTAINE L, 1968, Therapie (London/Paris), V23, P51; Garcia-Vilas JA, 2013, J AGR FOOD CHEM, V61, P4063, DOI 10.1021/jf303062h; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Griffith JS, 2010, FERTIL STERIL, V93, P1745, DOI 10.1016/j.fertnstert.2008.12.012; Gu Y, 2013, ANTI-CANCER DRUG, V24, P781, DOI 10.1097/CAD.0b013e328362fb84; Hasegawa A, 2008, FERTIL STERIL, V89, P1267, DOI 10.1016/j.fertnstert.2007.05.051; Hasegawa A, 2010, FERTIL STERIL, V93, P2757, DOI 10.1016/j.fertnstert.2010.02.053; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Laschke MW, 2006, BRIT J PHARMACOL, V149, P137, DOI 10.1038/sj.bjp.0706857; Laschke MW, 2012, HUM REPROD UPDATE, V18, P682, DOI 10.1093/humupd/dms026; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Laschke MW, 2008, HUM REPROD, V23, P2308, DOI 10.1093/humrep/den245; Laschke MW, 2007, FERTIL STERIL, V87, P163, DOI 10.1016/j.fertnstert.2006.05.068; Laschke MW, 2007, HUM REPROD UPDATE, V13, P331, DOI 10.1093/humupd/dmm006; Laschke MW, 2005, FERTIL STERIL, V84, P1199, DOI 10.1016/j.fertnstert.2005.05.010; Lokeshwar VB, 2010, CANCER RES, V70, P2613, DOI 10.1158/0008-5472.CAN-09-3185; Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.03-1376fje; Nenicu A, 2014, HUM REPROD, V29, P1011, DOI 10.1093/humrep/deu035; Nykopp TK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-512; Olivares C, 2008, HUM REPROD, V23, P2701, DOI 10.1093/humrep/den315; Olivares C, 2011, FERTIL STERIL, V96, P428, DOI 10.1016/j.fertnstert.2011.05.063; Piccioni F, 2012, GLYCOBIOLOGY, V22, P400, DOI 10.1093/glycob/cwr158; Platteeuw L, 2014, CURR OPIN OBSTET GYN, V26, P243, DOI 10.1097/GCO.0000000000000084; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Saegusa M, 1998, J PATHOL, V184, P297, DOI 10.1002/(SICI)1096-9896(199803)184:3<297::AID-PATH995>3.0.CO;2-7; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Soares SR, 2012, FERTIL STERIL, V98, P529, DOI 10.1016/j.fertnstert.2012.07.1120; Svensson A, 2007, ANTICANCER RES, V27, P3883; TAKEDA S, 1981, J PHARMACOBIO-DYNAM, V4, P724, DOI 10.1248/bpb1978.4.724; Twarock S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-30; Uchakina ON, 2013, LEUKEMIA RES, V37, P1294, DOI 10.1016/j.leukres.2013.07.009; Urakawa H, 2012, INT J CANCER, V130, P454, DOI 10.1002/ijc.26014; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; WEST DC, 1989, CIBA F SYMP, V143, P187; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861; Zhao YW, 2011, CANCER SCI, V102, P1469, DOI 10.1111/j.1349-7006.2011.01979.x	51	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152302	10.1371/journal.pone.0152302	http://dx.doi.org/10.1371/journal.pone.0152302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018976	Green Submitted, Green Published, gold			2022-12-26	WOS:000372807800043
J	Wu, H; Feng, Y; Jiang, L; Pan, Q; Liu, YL; Liu, C; He, CF; Chen, HS; Liu, XM; Hu, C; Hu, YQ; Mei, LY				Wu, Hong; Feng, Yong; Jiang, Lu; Pan, Qian; Liu, Yalan; Liu, Chang; He, Chufeng; Chen, Hongsheng; Liu, Xueming; Hu, Chang; Hu, Yiqiao; Mei, Lingyun			Application of a New Genetic Deafness Microarray for Detecting Mutations in the Deaf in China	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; PAX3; PREVALENCE; CHILDREN; DEFECTS	Objective The aim of this study was to evaluate the GoldenGate microarray as a diagnostic tool and to elucidate the contribution of the genes on this array to the development of both nonsyndromic and syndromic sensorineural hearing loss in China. Methods We developed a microarray to detect 240 mutations underlying syndromic and nonsyndromic sensorineural hearing loss. The microarray was then used for analysis of 382 patients with nonsyndromic sensorineural hearing loss (including 15 patients with enlarged vestibular aqueduct syndrome), 21 patients with Waardenburg syndrome, and 60 unrelated controls. Subsequently, we analyzed the sensitivity, specificity, and reproducibility of this new approach after Sanger sequencing-based verification, and also determined the contribution of the genes on this array to the development of distinct hearing disorders. Results The sensitivity and specificity of the microarray chip were 98.73% and 98.34%, respectively. Genetic defects were identified in 61.26% of the patients with nonsyndromic sensorineural hearing loss, and 9 causative genes were identified. The molecular etiology was confirmed in 19.05% and 46.67% of the patients with Waardenburg syndrome and enlarged vestibular aqueduct syndrome, respectively. Conclusion Our new mutation-based microarray comprises an accurate and comprehensive genetic tool for the detection of sensorineural hearing loss. This microarray-based detection method could serve as a first-pass screening (before next-generation-sequencing screening) for deafness-causing mutations in China.	[Wu, Hong; Feng, Yong; Jiang, Lu; Liu, Chang; He, Chufeng; Chen, Hongsheng; Liu, Xueming; Mei, Lingyun] Cent South Univ, Xiangya Hosp, ENT Dept, Changsha, Hunan, Peoples R China; [Pan, Qian; Hu, Yiqiao] Cent South Univ, Natl Lab Med Genet China, Sch Life Sci, Changsha, Hunan, Peoples R China; [Liu, Yalan] Cent South Univ, Prov Key Lab Otolaryngol Crit Dis, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Hu, Chang] Changsha First Hosp, ENT Dept, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Mei, LY (corresponding author), Cent South Univ, Xiangya Hosp, ENT Dept, Changsha, Hunan, Peoples R China.	entmly@163.com		Chen, Hongsheng/0000-0002-1373-6434	Major State Basic Research Development Program of China (973 Program) [2014CB943003, 2014CB541700]; National Natural Science Foundation of China [81470705, 81170923]; National Health Industry Scientific Research Program [201302001]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health Industry Scientific Research Program	This work was funded by the following: Major State Basic Research Development Program of China (973 Program, 2014CB943003), Major State Basic Research Development Program of China (973 Program, 2014CB541700), National Natural Science Foundation of China (81470705), National Natural Science Foundation of China (81170923), and National Health Industry Scientific Research Program (201302001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2007, GENET TEST, V11, P333, DOI 10.1089/gte.2007.0002; BALDWIN CT, 1994, HUM MUTAT, V3, P205, DOI 10.1002/humu.1380030306; Bayazit YA, 2006, ORL-J OTO-RHIN-LARYN, V68, P57, DOI 10.1159/000091090; Bitner-Glindzicz M, 2002, BRIT MED BULL, V63, P73, DOI 10.1093/bmb/63.1.73; Chen HS, 2010, BIOCHEM BIOPH RES CO, V397, P70, DOI 10.1016/j.bbrc.2010.05.066; Svidnicki MCCM, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0232-8; De Leenheer EMR, 2002, ADV OTO-RHINO-LARYNG, V61, P41; Dourmishev AL, 1999, INT J DERMATOL, V38, P656, DOI 10.1046/j.1365-4362.1999.00750.x; FARRER LA, 1992, AM J HUM GENET, V50, P902; Gardner P, 2006, PEDIATRICS, V118, P985, DOI 10.1542/peds.2005-2519; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Li Haibo, 2012, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V26, P589; LIU XZ, 1995, AM J MED GENET, V55, P95, DOI 10.1002/ajmg.1320550123; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Mizutari K, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0276-z; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Nayak CS, 2003, ANN OTO RHINOL LARYN, V112, P817, DOI 10.1177/000348940311200913; Pandya A, 1996, HUM MOL GENET, V5, P497, DOI 10.1093/hmg/5.4.497; Piatto Vania B, 2005, Braz J Otorhinolaryngol, V71, P216; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Qu CY, 2012, INT J PEDIATR OTORHI, V76, P235, DOI 10.1016/j.ijporl.2011.11.009; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Rehm HL, 2005, SEMIN PERINATOL, V29, P173, DOI 10.1053/j.semperi.2004.12.002; Rodriguez-Paris J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011804; Sagong B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057237; Shearer AE, 2011, HEARING RES, V282, P1, DOI 10.1016/j.heares.2011.10.001; Shen ZS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-4; Smith RJ., 1993, GENEREVIEWS; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; Wang JA, 2010, MOL VIS, V16, P1146; Wang QJ, 2011, INT J PEDIATR OTORHI, V75, P535, DOI 10.1016/j.ijporl.2011.01.016; Wu CC, 2007, EAR HEARING, V28, P332, DOI 10.1097/AUD.0b013e318047941e; Yang Xiao-lin, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P530, DOI 10.3760/cma.j.issn.1003-9406.2010.05.012; Yoshinaga-Itano C, 1999, OTOLARYNG CLIN N AM, V32, P1089, DOI 10.1016/S0030-6665(05)70196-1; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	40	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151909	10.1371/journal.pone.0151909	http://dx.doi.org/10.1371/journal.pone.0151909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018795	Green Submitted, Green Published, gold			2022-12-26	WOS:000372807800024
J	Serban, AI; Stanca, L; Geicu, OL; Munteanu, MC; Dinischiotu, A				Serban, Andreea Iren; Stanca, Loredana; Geicu, Ovidiu Lonut; Munteanu, Maria Cristina; Dinischiotu, Anca			RAGE and TGF-beta 1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast Cells	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; GROWTH-FACTOR-BETA; CONVERTING-ENZYME TACE; TNF-ALPHA; COLLAGEN PRODUCTION; LUNG FIBROBLASTS; KAPPA-B; RECEPTOR; ACTIVATION; EXPRESSION	AGEs accumulation in the skin affects extracellularmatrix (ECM) turnover and triggers diabetes associated skin conditions and accelerated skin aging. The receptor of AGEs (RAGE) has an essential contribution to cellular dysfunction driven by chronic inflammatory responses while TGF-beta 1 is critical in both dermal homeostasis and inflammation. We investigated the contribution of RAGE and TGF-beta 1 to the modulation of inflammatory response and ECM turnover in AGEs milieu, using a normal fibroblast cell line. RAGE, TGF-beta 1, collagen I and III gene and protein expression were upregulated after exposure to AGEs-BSA, and MMP-2 was activated. AGEs-RAGE was pivotal in NF-kappa B dependent collagen I expression and joined with TGF-beta 1 to stimulate collagen III expression, probably via ERK1/2 signaling. AGEs-RAGE axis induced upregulation of TGF-beta 1, TNF-alpha and IL-8 cytokines. TNF-alpha and IL-8 were subjected to TGF-beta 1 negative regulation. RAGE's proinflammatory signaling also antagonized AGEs-TGF-beta 1 induced fibroblast contraction, suggesting the existence of an inhibitory cross-talk mechanism between TGF-beta 1 and RAGE signaling. RAGE and TGF-beta 1 stimulated anti-inflammatory cytokines IL-2 and IL-4 expression. GM-CSF and IL-6 expression appeared to be dependent only on TGF-beta 1 signaling. Our data also indicated that IFN-gamma upregulated in AGEs-BSA milieu in a RAGE and TGF-beta 1 independent mechanism. Our findings raise the possibility that RAGE and TGF-beta 1 are both involved in fibrosis development in a complex cross-talk mechanism, while also acting on their own individual targets. This study contributes to the understanding of impaired wound healing associated with diabetes complications.	[Serban, Andreea Iren; Stanca, Loredana; Geicu, Ovidiu Lonut] Univ Agron Sci & Vet Med, Dept Preclin Sci, 105 Splaiul Independentei, Bucharest 050097, Romania; [Geicu, Ovidiu Lonut; Dinischiotu, Anca] Univ Bucharest, Dept Biochem & Mol Biol, 91-95 Splaiul Independentei, Bucharest 050095, Romania; [Munteanu, Maria Cristina] Oklahoma State Univ, Dept Physiol Sci, 264 McElroy Hall, Stillwater, OK 74078 USA	University of Agronomic Science & Veterinary Medicine - Bucharest; University of Bucharest; Oklahoma State University System; Oklahoma State University - Stillwater	Serban, AI (corresponding author), Univ Agron Sci & Vet Med, Dept Preclin Sci, 105 Splaiul Independentei, Bucharest 050097, Romania.	irensro@yahoo.com	Stanca, Loredana/AAS-9248-2021; Stanca, Loredana/AAO-9297-2021; Serban, Andreea Iren/B-8485-2012	Serban, Andreea Iren/0000-0003-1862-3524	Romanian Executive Unit for Financing Education Higher Research Development and Innovation (UEFISCDI) [TE_2012-3-0034]	Romanian Executive Unit for Financing Education Higher Research Development and Innovation (UEFISCDI)	This work was supported by the Romanian Executive Unit for Financing Education Higher Research Development and Innovation (UEFISCDI), research project TE_2012-3-0034, 15/26.04.2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Aoudjehane L, 2008, LAB INVEST, V88, P973, DOI 10.1038/labinvest.2008.61; Balaji S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124302; Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Bermudez DM, 2011, AM J PATHOL, V178, P2215, DOI 10.1016/j.ajpath.2011.01.015; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BOOKCHIN RM, 1968, BIOCHEM BIOPH RES CO, V32, P86, DOI 10.1016/0006-291X(68)90430-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Candido R, 2003, CIRC RES, V92, P785, DOI 10.1161/01.RES.0000065620.39919.20; Chen QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108528; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chuah YK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/403460; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Denard B, 2011, CELL HOST MICROBE, V10, P65, DOI 10.1016/j.chom.2011.06.006; Duivenvoorden WCM, 1999, CLIN EXP METASTAS, V17, P27; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fowlkes V, 2013, LIFE SCI, V92, P669, DOI 10.1016/j.lfs.2013.01.003; Frykberg R G, 1998, J Foot Ankle Surg, V37, P440; Fukami K, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-86; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; George SJ, 2005, J VASC RES, V42, P247, DOI 10.1159/000085657; Giacomoni PU, 2001, BIOGERONTOLOGY, V2, P219, DOI 10.1023/A:1013222629919; Gkogkolou P, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.22028; Goel SA, 2013, CELL SIGNAL, V25, P955, DOI 10.1016/j.cellsig.2012.12.021; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; HEIN R, 1992, BRIT J DERMATOL, V126, P496, DOI 10.1111/j.1365-2133.1992.tb15122.x; Hobizal KB, 2012, DIABET FOOT ANKLE, V3, DOI 10.3402/dfa.v3i0.18409; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Howard EW, 1996, EXP CELL RES, V228, P132, DOI 10.1006/excr.1996.0308; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jiang K, 2013, J CLIN EXPT OPHTHA S, VS2, P007; JORDANA M, 1994, EUR RESPIR J, V7, P2212, DOI 10.1183/09031936.94.07122212; KAHAN A, 1989, AM J MED, V87, P273; Kanellakis P, 2012, CARDIOVASC RES, V95, P77, DOI 10.1093/cvr/cvs142; Karagiannis ED, 2004, J BIOL CHEM, V279, P39105, DOI 10.1074/jbc.M403627200; Karsdal MA, 2002, J BIOL CHEM, V277, P44061, DOI 10.1074/jbc.M207205200; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; LANNG S, 1994, ACTA PAEDIATR, V83, P72, DOI 10.1111/j.1651-2227.1994.tb12956.x; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Leivonen SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057474; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Liao HJ, 2009, BIOMATERIALS, V30, P1689, DOI 10.1016/j.biomaterials.2008.11.038; Ling EM, 2002, CLIN EXP ALLERGY, V32, P175, DOI 10.1046/j.1365-2222.2002.01287.x; Lohwasser C, 2006, J INVEST DERMATOL, V126, P291, DOI 10.1038/sj.jid.5700070; LONNEMANN G, 1995, KIDNEY INT, V47, P845, DOI 10.1038/ki.1995.127; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; Meng J, 1998, ATHEROSCLEROSIS, V136, P355, DOI 10.1016/S0021-9150(97)00238-4; Mohan MJ, 2002, BIOCHEMISTRY-US, V41, P9462, DOI 10.1021/bi0260132; Nagase H, 2011, BIOL EXTRACELL MATR, P95, DOI 10.1007/978-3-642-16861-1_5; Nah SS, 2007, FEBS LETT, V581, P1928, DOI 10.1016/j.febslet.2007.03.090; Ngo P, 2006, METH MOL B, V341, P103; Okano Y, 2002, J DERMATOL SCI, V29, P171, DOI 10.1016/S0923-1811(02)00021-X; OPPENHEIM JJ, 1994, FASEB J, V8, P158, DOI 10.1096/fasebj.8.2.8119486; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Peng YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18822; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin HW, 1998, J IMMUNOL, V161, P6664; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; Ramasamy R, 2008, ANN NY ACAD SCI, V1126, P7, DOI 10.1196/annals.1433.056; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Roomi MW, 2009, ONCOL REP, V21, P821, DOI 10.3892/or_00000290; SAEZROYUELA F, 1991, HEPATOLOGY, V13, P327, DOI 10.1002/hep.1840130220; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; SAPPINO AP, 1990, LAB INVEST, V63, P144; Sell DR, 2005, J BIOL CHEM, V280, P12310, DOI 10.1074/jbc.M500733200; SELL DR, 1992, DIABETES, V41, P1286, DOI 10.2337/diabetes.41.10.1286; Serban AI, 2015, INT J MOL SCI, V16, P20100, DOI 10.3390/ijms160920100; Serban AI, 2015, J DIABETES, V7, P114, DOI 10.1111/1753-0407.12154; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Smith WB, 1996, J IMMUNOL, V157, P360; STALLMACH A, 1992, GASTROENTEROLOGY, V102, P1920, DOI 10.1016/0016-5085(92)90314-O; Sullivan DE, 2009, J CELL MOL MED, V13, P1866, DOI 10.1111/j.1582-4934.2009.00647.x; Tsoutsou PG, 2006, RESP MED, V100, P938, DOI 10.1016/j.rmed.2005.06.016; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; VLASSARA H, 1994, LAB INVEST, V70, P138; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Xu X, 2013, CLIN EXP IMMUNOL, V173, P523, DOI 10.1111/cei.12139; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yang JL, 2011, DIABETES-METAB RES, V27, P311, DOI 10.1002/dmrr.1175; Zhao J, 2014, WORLD J DIABETES, V5, P860, DOI 10.4239/wjd.v5.i6.860; Zhou Y, 2004, AM J PATHOL, V165, P659, DOI 10.1016/S0002-9440(10)63330-5	93	49	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152376	10.1371/journal.pone.0152376	http://dx.doi.org/10.1371/journal.pone.0152376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015414	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708900059
J	Zhang, CX; Zhang, HM; Shi, JN; Wang, D; Zhang, XW; Yang, J; Zhai, QZ; Ma, AX				Zhang, Chunxiang; Zhang, Hongmei; Shi, Jinning; Wang, Dong; Zhang, Xiuwei; Yang, Jian; Zhai, Qizhi; Ma, Aixia			Trial-Based Cost-Utility Analysis of Icotinib versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in China	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; RECEPTOR GENE-MUTATIONS; CHEMOTHERAPY; MULTICENTER	Background Our objective is to compare the cost-utility of icotinib and gefitinib for the second-line treatment of advanced non-small cell lung cancer (NSCLC) from the perspective of the Chinese healthcare system. Methods Model technology was applied to assess the data of randomized clinical trials and the direct medical costs from the perspective of the Chinese healthcare system. Five-year quality-adjusted life years (QALYs) and incremental cost-utility ratios (ICURs) were calculated. One-way and probabilistic sensitivity analyses (PSA) were performed. Results Our model suggested that the median progression-free survival (PFS) was 4.2 months in the icotinib group and 3.5 months in the gefitinib group while they were 4.6 months and 3.4 months, respectively, in the trials. The 5-year QALYs was 0.279 in the icotinib group and 0.269 in the gefitinib group, and the according medical costs were $10662.82 and $13127.57. The ICUR/QALY of icotinib versus gefitinib presented negative in this study. The most sensitive parameter to the ICUR was utility of PFS, ranging from $-1,259,991.25 to $-182,296.61; accordingly the icotinib treatment consistently represented a dominant cost-utility strategy. Conclusions The icotinib strategy, as a second-line therapy for advanced NSCLC patients in China, is the preferred strategy relative to gefitinib because of the dominant cost-utility. In addition, icotinib shows a good curative effect and safety, resulting in a strong demand for the Chinese market.	[Zhang, Chunxiang; Ma, Aixia] China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China; [Zhang, Chunxiang] Nanjing Jiangning Hosp, Dept Pharm, Nanjing, Jiangsu, Peoples R China; [Zhang, Hongmei; Shi, Jinning; Wang, Dong] Nanjing Jiangning Hosp, Dept Blood Transfus, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiuwei; Yang, Jian; Zhai, Qizhi] Nanjing Jiangning Hosp, Dept Resp, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Zhang, CX; Ma, AX (corresponding author), China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China.; Zhang, CX (corresponding author), Nanjing Jiangning Hosp, Dept Pharm, Nanjing, Jiangsu, Peoples R China.	lucky7cx@126.com; aixiama73@126.com						[Anonymous], 2015, 2015 NCCN CLIN PRACT; Hirsch FR, 2009, LANCET ONCOL, V10, P432, DOI 10.1016/S1470-2045(09)70110-X; Hu XS, 2014, LUNG CANCER, V86, P207, DOI 10.1016/j.lungcan.2014.08.014; Krishnan VG, 2014, CANCER RES, V74, P6071, DOI 10.1158/0008-5472.CAN-13-3195; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Nafees B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-84; Ohsaki Y, 2000, ONCOL REP, V7, P603; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Shi YK, 2013, LANCET ONCOL, V14, P953, DOI 10.1016/S1470-2045(13)70355-3; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Tan F, 2009, CHIN J NEW DRUGS, V18, P1, DOI DOI 10.3321/J.ISSN:1003-3734.2009.18.002; Tan FL, 2012, LUNG CANCER, V76, P177, DOI 10.1016/j.lungcan.2011.10.023; Tseng HH, 2013, CHIN J CANCER, V32, P59, DOI 10.5732/cjc.013.10011; Wang HP, 2011, CHINESE MED J-PEKING, V124, P1933, DOI 10.3760/cma.j.issn.0366-6999.2011.13.003; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055917; WHO, 2015, TABL THRESH VAL INT, V2015; Wu B, 2011, CLIN THER, V33, P1446, DOI 10.1016/j.clinthera.2011.09.016; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Zeng X, 2014, PLOS ONE, V9; Zhao QO, 2011, LUNG CANCER, V73, P195, DOI 10.1016/j.lungcan.2010.11.007; Zhu J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-39	25	14	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151846	10.1371/journal.pone.0151846	http://dx.doi.org/10.1371/journal.pone.0151846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015267	gold, Green Submitted, Green Published			2022-12-26	WOS:000372708900030
J	Wang, H; Sun, RQ; Camera, D; Zeng, XY; Jo, E; Chan, SMH; Herbert, TP; Molero, JC; Ye, JM				Wang, Hao; Sun, Ruo-Qiong; Camera, Daria; Zeng, Xiao-Yi; Jo, Eunjung; Chan, Stanley M. H.; Herbert, Terence P.; Molero, Juan C.; Ye, Ji-Ming			Endoplasmic reticulum stress up-regulates Nedd4-2 to induce autophagy	FASEB JOURNAL			English	Article						Nedd4l; autophagosome; UPR; ubiquitin ligase	UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; INSULIN SIGNALING TRANSDUCTION; UBIQUITIN-PROTEASOME SYSTEM; CELL-SURVIVAL; MICE; POLYUBIQUITINATION; APOPTOSIS; PROMOTES; DISEASE	The accumulation of unfolded proteins within the endoplasmic reticulum (ER) causes ER stress and activation of unfolded protein response (UPR). This response can trigger ER-associated degradation and autophagy, which clear unfolded proteins and restore protein homeostasis. Recently, it has become clear that ubiquitination plays an important role in the regulation of autophagy. In the present study, we investigated how the E3 ubiquitin ligase neural precursor cell-expressed, developmentally down-regulated protein 4-2 (Nedd4-2) interacts with ER stress and autophagy. In mice, we found that an increase in the expression of Nedd4-2, which was concomitant with the activation of the UPR and autophagy, was caused by a prolonged high-fructose and high-fat diet that induces ER stress in the liver. Pharmacologic induction of ER stress also led to an increase in Nedd4-2 expression in cultured cells, which was coincident with UPR and autophagy activation. The inhibition of inositol-requiring enzyme 1 significantly suppressed Nedd4-2 expression. Moreover, increased Nedd4-2 expression in vivo was closely associated with the activation of inositol-requiring enzyme1 and increased expression of the spliced form of X-box binding protein 1. Furthermore, knockdown of Nedd4-2 in cultured cells suppressed both basal autophagy and ER stress-induced autophagy, whereas overexpression of Nedd4-2-induced autophagy. Taken together, our findings provide evidence that Nedd4-2 is up-regulated in response to ER stress by the spliced form of X-box binding protein 1 and that this is important in the induction of an appropriate autophagic response.	[Wang, Hao; Sun, Ruo-Qiong; Camera, Daria; Zeng, Xiao-Yi; Jo, Eunjung; Chan, Stanley M. H.; Herbert, Terence P.; Molero, Juan C.; Ye, Ji-Ming] RMIT Univ, Sch Hlth & Biomed Sci, Lipid Biol & Metab Dis Lab, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Molero, JC; Ye, JM (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, POB 71, Melbourne, Vic 3083, Australia.	juan.molero@rmit.edu.au; jiming.ye@rmit.edu.au		Herbert, Terence/0000-0001-5402-0814; Wang, Hao/0000-0002-0901-5183; Chan, Stanley/0000-0002-4103-9441	Australian National Health and Medical Research Council Program Grant [535921]; Diabetes Australia Research Program; Royal Melbourne Institute of Technology (RMIT) scholarships	Australian National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Program; Royal Melbourne Institute of Technology (RMIT) scholarships	The authors thank Songpei Li and Dr. Xiu Zhou for assistance with the animal study, and Dr. Ray Helliwell for critical review of the manuscript. This study was supported by the Australian National Health and Medical Research Council Program Grant 535921 (to J.-M.Y.), by the Diabetes Australia Research Program (to J.-M.Y.), and by Royal Melbourne Institute of Technology (RMIT) scholarships (to H.W. and R.-Q.S.). J.C.M. was a RMIT Vice Chancellor Senior Research Fellow (2011-2015). The authors declare no conflicts of interest.	Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Chen ZL, 2014, J GENET GENOMICS, V41, P357, DOI 10.1016/j.jgg.2014.05.005; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Darom A, 2010, MOL BIOL CELL, V21, P1788, DOI 10.1091/mbc.E09-09-0774; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Fu JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078522; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kuang ES, 2013, TRENDS BIOCHEM SCI, V38, P453, DOI 10.1016/j.tibs.2013.06.008; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Madaro L, 2013, FASEB J, V27, P1990, DOI 10.1096/fj.12-215475; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Nijholt DAT, 2011, CELL DEATH DIFFER, V18, P1071, DOI 10.1038/cdd.2010.176; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ossareh-Nazari B, 2014, J CELL BIOL, V204, P909, DOI 10.1083/jcb.201308139; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Qiagen, EPITECT CHIP QPCR PR; Ren LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030816; Scortegagna M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004348; Sun RQ, 2015, BBA-MOL BASIS DIS, V1852, P156, DOI 10.1016/j.bbadis.2014.11.017; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tong JB, 2012, J NEUROCHEM, V123, P406, DOI 10.1111/jnc.12014; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wang H, 2015, ENDOCRINOLOGY, V156, P169, DOI 10.1210/en.2014-1454; Xu CF, 2014, AUTOPHAGY, V10, P2239, DOI 10.4161/15548627.2014.981792; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	39	26	27	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2549	2556		10.1096/fj.201500119	http://dx.doi.org/10.1096/fj.201500119			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27022162				2022-12-26	WOS:000379249500010
J	Chahi, AK; Martin, CE; Jones, N				Chahi, Ava Keyvani; Martin, Claire E.; Jones, Nina			Nephrin Suppresses Hippo Signaling through the Adaptor Proteins Nck and WTIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; PODOCYTE PHENOTYPE; CELL; YAP; REORGANIZATION; RECRUITMENT; PATHWAY; COMPLEX; YAP/TAZ; GROWTH	Podocytes are key components of the kidney blood filtration barrier, and their ability to withstand hemodynamic strain is proposed to be closely tied to their unique and flexible cytoarchitecture. However, the mechanisms that control such mechanotransduction are poorly understood. We have previously established that tyrosine phosphorylation of the transmembrane protein nephrin promotes recruitment of the Nck1/2 cytoskeletal adaptor proteins and downstream actin remodeling. We now reveal that Nck integrates nephrin with the Hippo kinase cascade through association with the adaptor protein WTIP. Using mutational analysis, we show that Nck sequesters WTIP and its binding partner Lats1 to phosphorylated nephrin, resulting in decreased phospho-activation of Lats1. We further demonstrate that, coincident with nephrin dephosphorylation in a transient model of podocyte injury in mice, Lats1 is rapidly activated, and this precedes significant down-regulation of the transcription regulator Yap. Moreover, we show reduced levels of Yap protein in mice with chronic disruption of nephrin phospho-signaling. Together, these findings support the existence of a dynamic molecular link between nephrin signaling and the canonical Hippo pathway in podocytes, which may facilitate the conversion of mechanical cues to biochemical signals promoting podocyte viability.	[Chahi, Ava Keyvani; Martin, Claire E.; Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E,Rm 3461,Summerlee Sci Complex, Guelph, ON N1G 2W1, Canada	University of Guelph	Jones, N (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E,Rm 3461,Summerlee Sci Complex, Guelph, ON N1G 2W1, Canada.	jonesmcb@uoguelph.ca			Kidney Foundation of Canada; Ontario Graduate Scholarships; NSERC Alexander Graham Bell Canada Graduate Doctoral Scholarship; KRESCENT program	Kidney Foundation of Canada; Ontario Graduate Scholarships(Ontario Graduate Scholarship); NSERC Alexander Graham Bell Canada Graduate Doctoral Scholarship; KRESCENT program(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Kidney Foundation of Canada (to N. J.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Ontario Graduate Scholarships.r Supported by an NSERC Alexander Graham Bell Canada Graduate Doctoral Scholarship.r Holder of a Tier II Canada Research Chair in Eukaryotic Cellular Signaling and recipient of a New Investigator Award from the KRESCENT program.	Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Campbell KN, 2013, J BIOL CHEM, V288, P17057, DOI 10.1074/jbc.C113.457390; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Endlich N, 2012, SEMIN NEPHROL, V32, P327, DOI 10.1016/j.semnephrol.2012.06.004; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Hoppe John M, 2014, Methods Mol Biol, V1169, P159, DOI 10.1007/978-1-4939-0882-0_15; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kann M, 2015, J AM SOC NEPHROL, V26, P2097, DOI 10.1681/ASN.2014090940; Kim JH, 2012, AM J PHYSIOL-RENAL, V302, pF103, DOI 10.1152/ajprenal.00419.2011; Kim JH, 2010, J BIOL CHEM, V285, P9995, DOI 10.1074/jbc.M109.061671; Kriz W, 2015, J AM SOC NEPHROL, V26, P258, DOI 10.1681/ASN.2014030278; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li HP, 2006, BIOCHEM BIOPH RES CO, V349, P310, DOI 10.1016/j.bbrc.2006.08.053; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; New LA, 2016, J AM SOC NEPHROL, V27, P2422, DOI 10.1681/ASN.2015091048; New LA, 2014, CURR OPIN NEPHROL HY, V23, P420, DOI 10.1097/01.mnh.0000447018.28852.b6; New LA, 2013, J BIOL CHEM, V288, P1500, DOI 10.1074/jbc.M112.439463; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Schwartzman M, 2016, J AM SOC NEPHROL, V27, P216, DOI 10.1681/ASN.2014090916; Simons M, 2008, KIDNEY INT, V73, P671, DOI 10.1038/sj.ki.5002798; Srichai MB, 2004, J BIOL CHEM, V279, P14398, DOI 10.1074/jbc.M314155200; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476	31	15	15	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12799	12808		10.1074/jbc.M116.724245	http://dx.doi.org/10.1074/jbc.M116.724245			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27033705	Green Published, hybrid			2022-12-26	WOS:000378119900031
J	Ozawa, A; Sato, Y; Imabayashi, T; Uemura, T; Takagi, J; Sekiguchi, K				Ozawa, Akio; Sato, Yuya; Imabayashi, Tsukasa; Uemura, Toshihiko; Takagi, Junichi; Sekiguchi, Kiyotoshi			Molecular Basis of the Ligand Binding Specificity of alpha v beta 8 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE; STRUCTURAL BASIS; CELL-ADHESION; MICE LACKING; MOUSE; ALPHA(V)BETA(3); FIBRONECTIN; RECOGNITION; ACTIVATION; SUBUNIT	alpha v beta 8 is an integrin that recognizes an Arg-Gly-Asp (RGD) motif and interacts with fibronectin, vitronectin, and latent TGF-beta 1. We comprehensively determined the binding activity of the alpha v beta 8 integrin toward 25 secreted proteins having an RGD motif. The alpha v beta 8 integrin strongly bound to latent TGF-beta 1 but showed marginal activity for other RGD-containing proteins, including fibronectin and vitronectin. Site-directed mutagenesis of latent TGF-beta 1 demonstrated that the high affinity binding of alpha v beta 8 integrin to latent TGF-beta 1 was defined by Leu-218 immediately following the RGD motif within the latency-associated peptide of TGF-beta 1. Consistent with the critical role of Leu-218 in latent TGF-beta 1 recognition by alpha v beta 8 integrin, a 9-mer synthetic peptide containing an RGDL sequence strongly inhibited interactions of latent TGF-beta 1 with alpha v beta 8 integrin, whereas a 9-mer peptide with an RGDA sequence was similar to 60-fold less inhibitory. Because alpha v beta 3 integrin did not exhibit strong binding to latent TGF-beta 1 or distinguish between RGDL- and RGDA-containing peptides, we explored the mechanism by which the integrin beta 8 subunit defines the high affinity binding of latent TGF-beta 1 by alpha v beta 8 integrin. Production of a series of swap mutants of integrin beta 8 and beta 3 subunits indicated that the high affinity binding of alpha v beta 8 integrin with latent TGF-beta 1 was ensured by interactions between the Leu-218 residue and the beta 8 I-like domain, with the former serving as an auxiliary recognition residue defining the restricted ligand specificity of alpha v beta 8 integrin toward latent TGF-beta 1. In support of this conclusion, high affinity binding toward the alpha v beta 8 integrin was conferred on fibronectin by substitution of its RGDS motif with an RGDL sequence.	[Ozawa, Akio; Sato, Yuya; Imabayashi, Tsukasa; Uemura, Toshihiko; Takagi, Junichi; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	AOTA S, 1994, J BIOL CHEM, V269, P24756; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arnold TD, 2014, DEVELOPMENT, V141, P4489, DOI 10.1242/dev.107193; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cambier S, 2000, CANCER RES, V60, P7084; Chen CM, 2013, BIOINFORMATICS, V29, P2808, DOI 10.1093/bioinformatics/btt484; Cheng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081609; DAMSKY C, 1993, FASEB J, V7, P1320, DOI 10.1096/fasebj.7.14.8224605; DELANNET M, 1994, DEVELOPMENT, V120, P2687; DiCara D, 2007, J BIOL CHEM, V282, P9657, DOI 10.1074/jbc.M610461200; Dong XC, 2014, NAT STRUCT MOL BIOL, V21, P1091, DOI 10.1038/nsmb.2905; Dong XC, 2012, BIOCHEMISTRY-US, V51, P8814, DOI 10.1021/bi300734n; DRAKE CJ, 1995, J CELL SCI, V108, P2655; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Jovanovic J, 2008, BIOCHEM SOC T, V36, P257, DOI 10.1042/BST0360257; Kiyozumi D, 2005, EXP CELL RES, V306, P9, DOI 10.1016/j.yexcr.2005.01.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; MOYLE M, 1991, J BIOL CHEM, V266, P19650; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; Nishimura SL, 1998, BRAIN RES, V791, P271, DOI 10.1016/S0006-8993(98)00118-8; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sato Y, 2009, J BIOL CHEM, V284, P14524, DOI 10.1074/jbc.M900200200; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P3967; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; VENSTROM K, 1995, MOL BIOL CELL, V6, P419, DOI 10.1091/mbc.6.4.419; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhu JW, 2002, DEVELOPMENT, V129, P2891	54	31	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11551	11565		10.1074/jbc.M116.719138	http://dx.doi.org/10.1074/jbc.M116.719138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27033701	Green Published, hybrid			2022-12-26	WOS:000377264800008
J	Li, JJ; Chen, K; Li, SN; Liu, T; Wang, F; Xia, YJ; Lu, J; Zhou, YQ; Guo, CY				Li, Jingjing; Chen, Kan; Li, Sainan; Liu, Tong; Wang, Fan; Xia, Yujing; Lu, Jie; Zhou, Yingqun; Guo, Chuanyong			Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; A-INDUCED HEPATITIS; KAPPA-B ACTIVATION; CONCANAVALIN-A; TNF-ALPHA; AUTOIMMUNE HEPATITIS; CYTOKINE EXPRESSION; MICE; AUTOPHAGY; PATHWAY	This study aimed to explore the effects of fucoidan from Fucus vesiculosus on concanavalin A (ConA)-induced acute liver injury in mice. Pretreatment with fucoidan protected liver function indicated by ALT, AST and histopathological changes by suppressing inflammatory cytokines, such as tumor necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma). In addition, intrinsic and extrinsic apoptosis mediated by Bax, Bid, Bcl-2, Bcl-xL and Caspase 3, 8, and 9 were inhibited by fucoidan and the action was associated with the TRADD/TRAF2 and JAK2/STAT1 signal pathways. Our results demonstrated that fucoidan from Fucus vesiculosus alleviated ConA-induced acute liver injury via the inhibition of intrinsic and extrinsic apoptosis mediated by the TRADD/TRAF2 and JAK2/STAT1 pathways which were activated by TNF-alpha and IFN-gamma. These findings could provide a potential powerful therapy for T cell-related hepatitis.	[Li, Jingjing; Chen, Kan; Li, Sainan; Liu, Tong; Wang, Fan; Xia, Yujing; Lu, Jie; Zhou, Yingqun; Guo, Chuanyong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200072, Peoples R China	Tongji University	Zhou, YQ; Guo, CY (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200072, Peoples R China.	yqzh02@163.com; guochuanyong@hotmail.com		Li, Sainan/0000-0002-1880-6294; Guo, Chuanyong/0000-0002-6527-4673	Natural Science Foundation of China [81270515, 81500466]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (grant No. 81270515; 81500466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2012, MAR DRUGS, V10, P2337, DOI 10.3390/md10102337; Baker SJ, 1996, ONCOGENE, V12, P1; Bird GM, 1931, BIOCHEM J, V25, P403, DOI 10.1042/bj0250403; Chen K, 2014, PPAR RES, V2014, DOI 10.1155/2014/215631; Cheng P, 2014, DRUG DES DEV THER, V8, P1277, DOI 10.2147/DDDT.S66573; Cui YQ, 2012, CNS NEUROSCI THER, V18, P827, DOI 10.1111/j.1755-5949.2012.00372.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Do H, 2010, J NUTR BIOCHEM, V21, P671, DOI 10.1016/j.jnutbio.2009.03.013; Erusalimsky JD, 2007, ARTERIOSCL THROM VAS, V27, P2524, DOI 10.1161/ATVBAHA.107.151167; Gambin Anna, 2013, JAKSTAT, V2, pe24672, DOI 10.4161/jkst.24672; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131; Garcia FAO, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-283; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Granert C, 1999, INFECT IMMUN, V67, P2071, DOI 10.1128/IAI.67.5.2071-2074.1999; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Kang GH, 2012, J NEUROL SCI, V318, P25, DOI 10.1016/j.jns.2012.04.013; Kawano N, 2007, J NUTR SCI VITAMINOL, V53, P315, DOI 10.3177/jnsv.53.315; Ksontini R, 1998, J IMMUNOL, V160, P4082; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kunstle G, 1999, HEPATOLOGY, V30, P1241, DOI 10.1002/hep.510300517; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Kylin H., 1913, Z PHYSL CHEM, V83, P3, DOI DOI 10.1515/bchm2.1913.83.3.171; Lee DH, 2015, EUR J PHARMACOL, V749, P39, DOI 10.1016/j.ejphar.2014.11.048; Li CM, 2011, FOOD CHEM TOXICOL, V49, P2090, DOI 10.1016/j.fct.2011.05.022; Li JJ, 2015, MAR DRUGS, V13, P3368, DOI 10.3390/md13063368; Li JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120440; LOHSE AW, 1990, HEPATOLOGY, V11, P24, DOI 10.1002/hep.1840110106; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; NISHINO T, 1994, CARBOHYD RES, V255, P213, DOI 10.1016/S0008-6215(00)90980-7; Park A, 1996, J BIOL CHEM, V271, P9858, DOI 10.1074/jbc.271.16.9858; Park B, 2011, BIOCHEM PHARMACOL, V82, P1134, DOI 10.1016/j.bcp.2011.07.062; Park Mi Sun, 2014, Genes Cancer, V5, P470; PERCIVAL EGV, 1950, J CHEM SOC, P717, DOI 10.1039/jr9500000717; Thinh PD, 2013, MAR DRUGS, V11, P1456, DOI 10.3390/md11051456; Raghavendran HRB, 2011, INT IMMUNOPHARMACOL, V11, P157, DOI 10.1016/j.intimp.2010.11.002; Saito A, 2006, HEPATOL RES, V35, P190, DOI 10.1016/j.hepres.2006.03.012; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Senthilkumar K, 2013, INT J BIOL MACROMOL, V60, P366, DOI 10.1016/j.ijbiomac.2013.06.030; Shen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087977; Shen M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/461536; Soares PAG, 2011, J CHROMATOGR B, V879, P457, DOI 10.1016/j.jchromb.2010.12.030; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Tao YY, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-449; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; Ward J, 2015, EUR J TRAUMA EMERG S, V41, P229, DOI 10.1007/s00068-015-0521-0; Xue ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043483	51	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152570	10.1371/journal.pone.0152570	http://dx.doi.org/10.1371/journal.pone.0152570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035150	Green Submitted, Green Published, gold			2022-12-26	WOS:000373201200023
J	Ji, H; Zhu, YT; Zhang, YY; Li, ZH; Ge, J; Zhuo, YH				Ji, Hong; Zhu, Yingting; Zhang, Yingying; Li, Zuohong; Ge, Jian; Zhuo, Yehong			Dry Eye Disease in Patients with Functioning Filtering Blebs after Trabeculectomy	PLOS ONE			English	Article							OCULAR SURFACE DISEASE; MITOMYCIN-C; TEAR-FILM; WORKSHOP 2007; GLAUCOMA; PREVALENCE; TESTS; CLASSIFICATION; CORNEAL; SUBCOMMITTEE	Purpose The aim of this study was to analyze dry eye disease (DED) in patients with functioning filtering blebs and to explore the relationship between the morphology of filtering blebs and ocular surface instability. Methods This was a cross-sectional, case-comparison study. Seventy glaucomatous patients (70 eyes) with functioning blebs who had undergone trabeculectomy more than 6 months prior (study group) and 35 control subjects (35 eyes) (control group) were included. All subjects completed an ocular symptom questionnaire that referred to the Shihpai Eye Study. Evaluation of meibomian gland obstruction, a tear film break-up time test (TFBUT), fluorescein corneal staining and a Schirmer's tear test were then performed. Filtering bleb morphology was analyzed using Wuerzburg bleb classification scoring criteria in the study group. The presence of DED was defined as the concomitant presence of TFBUT <10 seconds and the presence of superficial punctate keratitis. Results The patients with functioning blebs presented higher corneal staining scores (P = 0.012) and lower TFBUT values (P = 0.043) than the control group. DED was present in 28/70 patients in the study group and 6/35 patients in the control group (P = 0.018). More patients in the study group complained of dryness (P = 0.001), a gritty or sandy sensation (P < 0.001) and redness (P = 0.048). In the study group, the patients with DED were significantly different from the patients without DED in both TFBUT (P < 0.001) and corneal staining (P < 0.001). More patients in the DED group were likely to report dryness (P = 0.013) and watery or teary eyes (P = 0.012). The differences in meibomian gland obstruction scores between the study and the control group, the DED and the non-DED group were not significant (P = 0.105 and P = 0.077, respectively). The values for microcysts and bleb heights were significantly higher in the DED group (P = 0.040 and P = 0.011, respectively). A Spearman's rank correlation showed that microcysts were positively correlated with corneal staining (r = 0.270, P = 0.024). Bleb height was negatively correlated with TFBUT (r = -0.299, P = 0.012) and positively correlated with corneal staining (r = 0.275, P = 0.021). The relationships between DED and microcysts and between DED and bleb height were significant (r = 0.247, P = 0.039 and r = 0.307, P = 0.010, respectively). Conclusion DED is relatively common in patients with functioning filtering blebs following trabeculectomy. In DED patients, dryness and watery are common symptoms. Microcysts and bleb height are related to ocular surface instability and DED.	[Ji, Hong; Zhu, Yingting; Zhang, Yingying; Li, Zuohong; Ge, Jian; Zhuo, Yehong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhuo, YH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuoyh@mail.sysu.edu.cn			Guangdong Province National Natural Science Foundation [2014A030308016]	Guangdong Province National Natural Science Foundation	This work was supported by Guangdong Province National Natural Science Foundation (2014A030308016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albietz JM, 2004, J REFRACT SURG, V20, P62; Amar N, 2008, OPHTHALMOLOGY, V115, P1154, DOI 10.1016/j.ophtha.2007.10.024; Argueso P, 2001, EXP EYE RES, V73, P281, DOI 10.1006/exer.2001.1045; Baudouin C, 2014, BRIT J OPHTHALMOL, V98, P1168, DOI 10.1136/bjophthalmol-2013-304619; Baudouin C, 2012, DEV OPHTHALMOL, V50, P64, DOI 10.1159/000334791; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2007, OCUL SURF, V5, P108; Budenz DL, 2001, AM J OPHTHALMOL, V131, P626, DOI 10.1016/S0002-9394(00)00901-6; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Ghosh S, 2012, CLIN EXP OPHTHALMOL, V40, P675, DOI 10.1111/j.1442-9071.2012.02781.x; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Hardten DR, 2008, CORNEA, V27, P855, DOI 10.1097/ICO.0b013e31816f6854; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Johnston PR, 2013, CLIN OPHTHALMOL, V7, P253, DOI 10.2147/OPTH.S39104; Khanal S, 2008, OPHTHAL PHYSL OPT, V28, P127, DOI 10.1111/j.1475-1313.2008.00539.x; Klink T, 2008, OPHTHALMOLOGICA, V222, P408, DOI 10.1159/000161555; Korb DR, 2000, CORNEA, V19, P483, DOI 10.1097/00003226-200007000-00016; Lemp MA, 2007, OCUL SURF, V5, P75; Li J, 2001, Zhonghua Yan Ke Za Zhi, V37, P43; Liang SYW, 2009, CLIN EXP OPHTHALMOL, V37, P316, DOI 10.1111/j.1442-9071.2009.02023.x; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; MATHERS WD, 1991, CORNEA, V10, P277, DOI 10.1097/00003226-199107000-00001; Mohammadi SF, 2014, J CATARACT REFR SURG, V40, P937, DOI 10.1016/j.jcrs.2013.10.043; Nemeth J, 2012, BRIT J OPHTHALMOL, V96, P1380, DOI 10.1136/bjophthalmol-2012-301580; Mendes CRN, 2012, CURR EYE RES, V37, P309, DOI 10.3109/02713683.2011.635400; Nichols KK, 2000, CORNEA, V19, P477, DOI 10.1097/00003226-200007000-00015; Pflugfelder SC, 1998, CORNEA, V17, P38, DOI 10.1097/00003226-199801000-00007; Picht G, 1998, Curr Opin Ophthalmol, V9, P2, DOI 10.1097/00055735-199804000-00002; Picht G, 1998, OPHTHALMOLOGE, V95, P380, DOI 10.1007/s003470050285; Rossi GCM, 2013, EUR J OPHTHALMOL, V23, P296, DOI 10.5301/ejo.5000220; Sacu S, 2003, J GLAUCOMA, V12, P430, DOI 10.1097/00061198-200310000-00006; SHIELDS MB, 1993, AM J OPHTHALMOL, V116, P673, DOI 10.1016/S0002-9394(14)73465-8; Shigeeda T, 2006, J GLAUCOMA, V15, P195, DOI 10.1097/01.ijg.0000212202.57029.45; Stedman T.L., 2000, STEDMANS MED DICT, V27th ed.; Sullivan BD, 2012, CORNEA, V31, P1000, DOI 10.1097/ICO.0b013e318242fd60; XIN C, 2010, OPHTHALMOL CHINA, V19, P19	36	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152696	10.1371/journal.pone.0152696	http://dx.doi.org/10.1371/journal.pone.0152696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032098	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800121
J	Pessoa, R; Loureiro, P; Lopes, ME; Carneiro-Proietti, ABF; Sabino, EC; Busch, MP; Sanabani, SS				Pessoa, Rodrigo; Loureiro, Paula; Lopes, Maria Esther; Carneiro-Proietti, Anna B. F.; Sabino, Ester C.; Busch, Michael P.; Sanabani, Sabri S.			Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DUAL INFECTION; DRUG-RESISTANCE; SAO-PAULO; SUBTYPE-C; RECOMBINANTS; TRANSMISSION; PREVALENCE; FREQUENCY; JANEIRO	Background Here, we aimed to gain a comprehensive picture of the HIV-1 diversity in the northeast and southeast part of Brazil. To this end, a high-throughput sequencing-by-synthesis protocol and instrument were used to characterize the near full length (NFLG) and partial HIV-1 proviral genome in 259 HIV-1 infected blood donors at four major blood centers in Brazil: Pro-Sangue foundation (Sao Paulo state (SP), n 51), Hemominas foundation (Minas Gerais state (MG), n 41), Hemope foundation (Recife state (PE), n 96) and Hemorio blood bank (Rio de Janeiro (RJ), n 70). Materials and Methods A total of 259 blood samples were obtained from 195 donors with long-standing infections and 64 donors with a lack of stage information. DNA was extracted from the peripheral blood mononuclear cells (PBMCs) to amplify the HIV-1 NFLGs from five overlapping fragments. The amplicons were molecularly bar-coded, pooled, and sequenced by Illumina paired-end protocol. Results Of the 259 samples studied, 208 (80%) NFLGs and 49 (18.8%) partial fragments were de novo assembled into contiguous sequences and successfully subtyped. Of these 257 samples, 183 (71.2%) were pure subtypes consisting of clade B (n = 167, 65%), C (n = 10, 3.9%), F1 (n = 4, 1.5%), and D (n = 2, 0.7%). Recombinant viruses were detected in 74 (28.8%) samples and consist of unique BF1 (n = 41, 15.9%), BC (n = 7, 2.7%), BCF1 (n = 4, 1.5%), CF1 and CDK (n = 1, 0.4%, each), CRF70_BF1 (n = 4, 1.5%), CRF71_BF1 (n = 12, 4.7%), and CRF72_BF1 (n = 4, 1.5%). Evidence of dual infection was detected in four patients coinfected with the same subtype (n = 3) and distinct subtype (n = 1). Conclusion Based on this work, subtype B appears to be the prevalent subtype followed by a high proportion of intersubtype recombinants that appeared to be arising continually in this country. Our study represents the largest analysis of the viral NFLG ever undertaken worldwide and provides insights into the understanding the genesis of the HIV-1 epidemic in this particular area of South America and informs vaccine design and clinical trials.	[Pessoa, Rodrigo; Sanabani, Sabri S.] Univ Sao Paulo, Sch Med, Clin Lab, Dept Pathol,LIM 03,HC, Sao Paulo, Brazil; [Loureiro, Paula] Pernambuco State Ctr Hematol & Hemotherapy HEMOPE, Recife, PE, Brazil; [Lopes, Maria Esther] Hemorio, Rio De Janeiro, Brazil; [Carneiro-Proietti, Anna B. F.] Minas Gerais State Ctr Hematol & Hemotherapy HEMO, Belo Horizonte, MG, Brazil; [Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Dept Infect Dis, Sao Paulo, Brazil; [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Vitalant; Vitalant Research Institute	Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Clin Lab, Dept Pathol,LIM 03,HC, Sao Paulo, Brazil.	sabyem_63@yahoo.com	Sabino, Ester C/F-7750-2010; Loureiro, Paula/A-2965-2013; Pessôa, Rodrigo/B-7206-2018; Sanabani, Sabri Saeed/F-5600-2012	Sabino, Ester C/0000-0003-2623-5126; Loureiro, Paula/0000-0003-1849-0047; Sanabani, Sabri Saeed/0000-0002-8876-8262	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/11090-5, 2011/12297-2, 2014/24596-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants 2011/11090-5, 2011/12297-2, and 2014/24596-2 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; Essex M, 1999, ADV VIRUS RES, V53, P71, DOI 10.1016/S0065-3527(08)60343-7; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hemelaar J, 2013, J INFECTION, V66, P391, DOI 10.1016/j.jinf.2012.10.026; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Janini LM, 1998, J INFECT DIS, V177, P227, DOI 10.1086/517360; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Kuiken C, 2000, AM J EPIDEMIOL, V152, P814, DOI 10.1093/aje/152.9.814; Lau KA, 2013, INFECT DIS REP, V5, P15, DOI 10.4081/idr.2013.s1.e4; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Pessoa R, 2015, TRANSFUSION, V55, P980, DOI 10.1111/trf.12936; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112674; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093374; Piantadosi A, 2007, PLOS PATHOG, V3, P1745, DOI 10.1371/journal.ppat.0030177; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; de Oliveira ACS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-223; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanuri A, 1999, J ACQ IMMUN DEF SYND, V20, P60, DOI 10.1097/00042560-199901010-00009; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; de Castro CAV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-224; Zeng PB, 2012, TRANSFUSION, V52, P1041, DOI 10.1111/j.1537-2995.2011.03415.x; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	38	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152499	10.1371/journal.pone.0152499	http://dx.doi.org/10.1371/journal.pone.0152499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031505	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800086
J	Costa, FRC; Mota, CM; Santiago, FM; Silva, MV; Ferreira, MD; Fonseca, DM; Silva, JS; Mineo, JR; Mineo, TWP				Costa, Frederico R. C.; Mota, Caroline M.; Santiago, Fernanda M.; Silva, Murilo V.; Ferreira, Marcela D.; Fonseca, Denise M.; Silva, Joao S.; Mineo, Jose R.; Mineo, Tiago W. P.			GITR Activation Positively Regulates Immune Responses against Toxoplasma gondii	PLOS ONE			English	Article							INDUCED TNF RECEPTOR; T-CELLS; CD25(+); INFECTION; STIMULATION; MACROPHAGES	Toxoplasma gondii is a widespread parasite responsible for causing clinical diseases especially in pregnant and immunosuppressed individuals. Glucocorticoid-induced TNF receptor (GITR), which is also known as TNFRS18 and belongs to the TNF receptor superfamily, is found to be expressed in various cell types of the immune system and provides an important costimulatory signal for T cells and myeloid cells. However, the precise role of this receptor in the context of T. gondii infection remains elusive. Therefore, the current study investigated the role of GITR activation in the immunoregulation mechanisms induced during the experimental infection of mice with T. gondii. Our data show that T. gondii infection slightly upregulates GITR expression in Treg cells and B cells, but the most robust increment in expression was observed in macrophages and dendritic cells. Interestingly, mice infected and treated with an agonistic antibody anti-GITR (DTA-1) presented a robust increase in pro-inflammatory cytokine production at preferential sites of parasite replication, which was associated with the decrease in latent brain parasitism of mice under treatment with DTA-1. Several in vivo and in vitro analysis were performed to identify the cellular mechanisms involved in GITR activation upon infection, however no clear alterations were detected in the phenotype/function of macrophages, Tregs and B cells under treatment with DTA-1. Therefore, GITR appears as a potential target for intervention during infection by the parasite Toxoplasma gondii, even though further studies are still necessary to better characterize the immune response triggered by GITR activation during T. gondii infection.	[Costa, Frederico R. C.; Mota, Caroline M.; Santiago, Fernanda M.; Silva, Murilo V.; Ferreira, Marcela D.; Mineo, Jose R.; Mineo, Tiago W. P.] Univ Fed Uberlandia, Inst Ciencias Biomed, Lab Imunoparasitol Dr Mario Endsfeldz Camargo, Av Amazonas S-N,Bloco 4C,Sala 4C01, BR-38405320 Uberlandia, MG, Brazil; [Costa, Frederico R. C.; Ferreira, Marcela D.; Fonseca, Denise M.; Silva, Joao S.] Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil	Universidade Federal de Uberlandia	Mineo, TWP (corresponding author), Univ Fed Uberlandia, Inst Ciencias Biomed, Lab Imunoparasitol Dr Mario Endsfeldz Camargo, Av Amazonas S-N,Bloco 4C,Sala 4C01, BR-38405320 Uberlandia, MG, Brazil.	tiago.mineo@ufu.br	Mineo, Jose R/B-4151-2009; Mineo, Tiago W. P./B-4153-2009; Silva, Joao/A-4484-2008; Mota, Caroline/AAT-6995-2021; Fonseca, Denise/E-7419-2012	Mineo, Jose R/0000-0002-9010-7228; Mineo, Tiago W. P./0000-0002-2339-2743; Silva, Joao/0000-0002-3410-3927; Fonseca, Denise/0000-0001-8310-0186; Santiago, Fernanda Maria/0000-0002-6204-0863; Silva, Murilo/0000-0002-3397-0113	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [309011/2013-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [AUX-PE-Parasitologia-1348/2011]; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [RED-00013-14, CVZ-PPM-00784-15, APQ01313-14]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the following Brazilian research funding agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 309011/2013-2), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, AUX-PE-Parasitologia-1348/2011) and Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG, RED-00013-14, CVZ-PPM-00784-15, APQ01313-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae E, 2007, CLIN EXP IMMUNOL, V148, P410, DOI 10.1111/j.1365-2249.2007.03363.x; Cote AL, 2011, J IMMUNOL, V186, P275, DOI 10.4049/jimmunol.1001308; DUBEY JP, 1972, J PROTOZOOL, V19, P155, DOI 10.1111/j.1550-7408.1972.tb03431.x; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Kim WJ, 2006, IMMUNOLOGY, V119, P421, DOI 10.1111/j.1365-2567.2006.02453.x; Mariano FS, 2008, MICROBES INFECT, V10, P825, DOI 10.1016/j.micinf.2008.04.009; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Silva DAO, 2007, VET PARASITOL, V143, P234, DOI 10.1016/j.vetpar.2006.08.028; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Teodorovic LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031632; Uraushihara K, 2003, J IMMUNOL, V171, P708, DOI 10.4049/jimmunol.171.2.708; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004	20	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152622	10.1371/journal.pone.0152622	http://dx.doi.org/10.1371/journal.pone.0152622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027302	gold, Green Published, Green Submitted			2022-12-26	WOS:000373116500059
J	Worthy, TH; Mitri, M; Handley, WD; Lee, MSY; Anderson, A; Sand, C				Worthy, Trevor H.; Mitri, Miyess; Handley, Warren D.; Lee, Michael S. Y.; Anderson, Atholl; Sand, Christophe			Osteology Supports a Stem-Galliform Affinity for the Giant Extinct Flightless Bird Sylviornis neocaledoniae (Sylviornithidae, Galloanseres)	PLOS ONE			English	Article							HEUWELTJIE EARTH MOUNDS; PHYLOGENETIC ANALYSIS; EARLY EOCENE; AVES; ANSERIFORMES; MEGAPODIIDAE; PRESBYORNIS; REVEALS; ORIGINS; KIWI	The giant flightless bird Sylviornis neocaledoniae (Aves: Sylviornithidae) existed on La Grande Terre and Ile des Pins, New Caledonia, until the late Holocene when it went extinct shortly after human arrival on these islands. The species was generally considered to be a megapode (Megapodiidae) until the family Sylviornithidae was erected for it in 2005 to reflect multiple cranial autapomorphies. However, despite thousands of bones having been reported for this unique and enigmatic taxon, the postcranial anatomy has remained largely unknown. We rectify this deficiency and describe the postcranial skeleton of S. neocaledoniae based on similar to 600 fossils and use data from this and its cranial anatomy to make a comprehensive assessment of its phylogenetic affinities. Sylviornis neocaledoniae is found to be a stem galliform, distant from megapodiids, and the sister taxon to the extinct flightless Megavitiornis altirostris from Fiji, which we transfer to the family Sylviornithidae. These two species form the sister group to extant crown-group galliforms. Several other fossil galloanseres also included in the phylogenetic analysis reveal novel hypotheses of their relationships as follows: Dromornis planei (Dromornithidae) is recovered as a stem galliform rather than a stem anseriform; Presbyornis pervetus (Presbyornithidae) is the sister group to Anseranatidae, not to Anatidae; Vegavis iaai is a crown anseriform but remains unresolved relative to Presbyornis pervetus, Anseranatidae and Anatidae. Sylviornis neocaledoniae was reconstructed herein to be 0.8 m tall in a resting stance and weigh 27-34 kg. The postcranial anatomy of S. neocaledoniae shows no indication of the specialised adaptation to digging seen in megapodiids, with for example, its ungual morphology differing little from that of chicken Gallus gallus. These observations and its phylogenetic placement as stem galliforms makes it improbable that this species employed ectothermic incubation or was a mound-builder. Sylviornis neocaledoniae can therefore be excluded as the constructor of tumuli in New Caledonia.	[Worthy, Trevor H.; Mitri, Miyess; Handley, Warren D.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Lee, Michael S. Y.] S Australian Museum, Earth Sci Sect, Adelaide, SA 5000, Australia; [Lee, Michael S. Y.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Anderson, Atholl] Australian Natl Univ, Archaeol & Nat Hist, Coll Asia & Pacific, Canberra, ACT, Australia; [Sand, Christophe] Inst Archeol Nouvelle Caledonie & Pacific, BP 11423, Noumea 98802, New Caledonia	Flinders University South Australia; University of Adelaide; Australian National University	Worthy, TH (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	trevor.worthy@flinders.edu.au	Worthy, Trevor/B-3781-2012	Worthy, Trevor/0000-0001-7047-4680; Handley, Warren/0000-0001-8109-7673	Australian Research Council DECRA project [DE130101133]; National Geographic Society; Service des Musees et du Patrimoine (Departement Archeologie); Australian National University (ANU, Canberra)	Australian Research Council DECRA project(Australian Research Council); National Geographic Society(National Geographic Society); Service des Musees et du Patrimoine (Departement Archeologie); Australian National University (ANU, Canberra)	This research was funded by the Australian Research Council DECRA project DE130101133 to THW. The National Geographic Society, the Service des Musees et du Patrimoine (Departement Archeologie) and the Australian National University (ANU, Canberra) provided financial and material assistance for the expedition that collected the material. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2010, J PAC ARCHAEOL, V1, P89; [Anonymous], 1819, SYNOPSIS CONTENTS BR; Balouet J. C., 1989, SMITHSONIAN CONTRIBU, V469; Balouet Jean Christophe, 1991, P1383; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; BEALE G, 1991, J ROY SOC NEW ZEAL, V21, P219; Bertelli S, 2014, ZOOL J LINN SOC-LOND, V172, P145, DOI 10.1111/zoj12156; Bochenski Z.M., 2009, KEY IDENTIFICATION D; Bourdon E., 2011, LIVING DINOSAURS, P209; Bourdon E, 2009, BIOL LETTERS, V5, P639, DOI 10.1098/rsbl.2009.0310; Bourdon E, 2009, ZOOL J LINN SOC-LOND, V156, P641, DOI 10.1111/j.1096-3642.2008.00509.x; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Campbell Kenneth E. Jr, 1992, Natural History Museum of Los Angeles County Science Series, V36, P395; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Cope E. D., 1876, Proceedings of the Academy Philadelphia, P10; Cramer MD, 2014, PALAEOGEOGR PALAEOCL, V409, P72, DOI 10.1016/j.palaeo.2014.04.026; Cramer MD, 2012, PALAEOGEOGR PALAEOCL, V350, P189, DOI 10.1016/j.palaeo.2012.06.030; Crowe TM, 2006, CLADISTICS, V22, P495, DOI 10.1111/j.1096-0031.2006.00120.x; DELHOYO J, 1994, HDB BIRDS WORLD, V2, P638; Dickinson E. C., 2013, HOWARD MOORE COMPLET; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Dyke Gareth J., 2001, American Museum Novitates, V3354, P1, DOI 10.1206/0003-0082(2001)354<0001:TFWAAF>2.0.CO;2; Dyke GJ, 2003, ZOOL J LINN SOC-LOND, V137, P227, DOI 10.1046/j.1096-3642.2003.00048.x; Elzanowski A, 2010, J MORPHOL, V271, P305, DOI 10.1002/jmor.10799; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Ericson PGP, 1997, ZOOL J LINN SOC-LOND, V121, P429; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Field DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082000; Gangl D, 2004, ANAT HISTOL EMBRYOL, V33, P100, DOI 10.1111/j.1439-0264.2003.00522.x; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; Green R.C., 1988, ARCHAEOLOGY NZ, V31, P153; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOLMAN J. A., 1964, QUART J FLORIDA ACAD SCI, V27, P230; Houde PW, 1988, PUBL NUTTALL ORNITHO, V22, P1; Hume J., 2008, LOST LAND DODO; Ilin A, 2010, J MACH LEARN RES, V11, P1957; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; JONES D, 1992, TRENDS ECOL EVOL, V7, P88, DOI 10.1016/0169-5347(92)90247-9; Jones D. N., 1995, BIRD FAMILIES WORLD; Kirch PV, 1997, ASIAN PERSPECT, V36, P232; Kitchener Andrew C., 1993, Archives of Natural History, V20, P279, DOI 10.3366/anh.1993.20.2.279; Ksepka DT, 2009, CLADISTICS, V25, P173, DOI 10.1111/j.1096-0031.2009.00250.x; Kurochkin EN, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)386<0001:ANPBAA>2.0.CO;2; Kurochkin EN, 2010, GEOL J, V45, P375, DOI 10.1002/gj.1177; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Liu G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109701; Livezey BC, 1996, ANN CARNEGIE MUS, V65, P27; Livezey BC, 1996, SYST BIOL, V45, P415, DOI 10.2307/2413524; Livezey BC, 1998, PHILOS T R SOC B, V353, P2077, DOI 10.1098/rstb.1998.0353; Livezey BC, 1997, ZOOL J LINN SOC-LOND, V121, P361, DOI 10.1111/j.1096-3642.1997.tb01285.x; LIVEZEY BC, 1986, AUK, V103, P737, DOI 10.1093/auk/103.4.737; Livezey BC, 1998, ZOOL J LINN SOC-LOND, V124, P397, DOI 10.1111/j.1096-3642.1998.tb00584.x; LIVEZEY BC, 1993, J ZOOL, V230, P247, DOI 10.1111/j.1469-7998.1993.tb02686.x; Livezey Bradley C., 2006, Bulletin of Carnegie Museum of Natural History, V37, P1; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Matthew WD, 1917, B AM MUS NAT HIST, V37, P307; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr G, 2008, NEUES JAHRB GEOL P-A, V248, P365, DOI 10.1127/0077-7749/2008/0248-0365; Mayr G, 2016, ACTA ZOOL-STOCKHOLM, V97, P196, DOI 10.1111/azo.12117; Mayr G, 2014, PALAEONTOLOGY, V57, P231, DOI 10.1111/pala.12103; Mayr G, 2011, B GEOL SOC DENMARK, V59, P23; Mayr G, 2011, ZOOL SCR, V40, P448, DOI 10.1111/j.1463-6409.2011.00484.x; McAuliffe JR, 2014, EARTH SURF PROC LAND, V39, P1900, DOI 10.1002/esp.3583; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; Mourer-Chauvire Cecile, 2005, Monografies de la Societat d'Historia Natural de les Balears, V12, P205; MOURERCHAUVIRE C, 1985, RECHERCHE, V16, P1094; Murray Paul, 2004, SHADOW DRACULA LIFE; Murray Peter F., 1998, Records of the South Australian Museum (Adelaide), V31, P51; Noriega Jorge I., 1995, Ameghiniana, V32, P57; Olson S.L., 1980, Smithsonian Contributions to Zoology, P1; Olson SL, 1999, SM C PALEOB, P231; Olson SL, 1991, ORNITHOL MONOGR, V45, P1, DOI DOI 10.2307/40166794; Owen R, 1846, T ZOOL SOC LONDON, V3, P307; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Parker W. K., 1866, Philosophical Transactions, P113; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Polly PD, 2015, PALAEONTOL ELECTRON, V18; POPLIN F, 1985, GEOBIOS-LYON, V18, P73, DOI 10.1016/S0016-6995(85)80182-0; POPLIN F, 1983, CR ACAD SCI II, V297, P301; Poplin F., 1980, CR ACAD SCI D NAT, P691; QUAMMEN D, 1996, SONG DODO ISLAND BIO; Rich P. V., 1979, BUREAU NATL RESOURCE, V184; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Stegmann BC., 1978, RELATIONSHIPS SUPERO; Stein RW, 2015, MOL PHYLOGENET EVOL, V92, P155, DOI 10.1016/j.ympev.2015.06.005; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; van Tets G.F., 1974, Transactions Roy Soc South Australia, V98, P213; WETMORE ALEXANDER, 1926, ANN CARNEGIE MUS, V16, P391; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; Worthy T. H., 2002, LOST WORLD MOA PREHI; Worthy TH, 2001, J ROY SOC NEW ZEAL, V31, P763, DOI 10.1080/03014223.2001.9517673; Worthy TH, 2000, J ROY SOC NEW ZEAL, V30, P337, DOI 10.1080/03014223.2000.9517627; Worthy TH, 2008, PALAEONTOLOGY, V51, P677, DOI 10.1111/j.1475-4983.2008.00778.x; Worthy TH, 2015, PAC SCI, V69, P205, DOI 10.2984/69.2.6; Worthy TH, 2009, ZOOL J LINN SOC-LOND, V156, P411, DOI 10.1111/j.1096-3642.2008.00483.x; Zinoviev Andrei V., 2013, P253; Zinoviev AV., 2010, COMP ANATOMY STRUCTU; [No title captured]	104	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150871	10.1371/journal.pone.0150871	http://dx.doi.org/10.1371/journal.pone.0150871			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027304	gold, Green Published			2022-12-26	WOS:000373116500011
J	Biggs, D; Amar, F; Valdebenito, A; Gelcich, S				Biggs, Duan; Amar, Francisca; Valdebenito, Abel; Gelcich, Stefan			Potential Synergies between Nature-Based Tourism and Sustainable Use of Marine Resources: Insights from Dive Tourism in Territorial User Rights for Fisheries in Chile	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; BIODIVERSITY CONSERVATION; PROTECTED AREAS; REEF TOURISM; CORAL-REEFS; RESILIENCE; COMANAGEMENT; PERCEPTIONS; MANAGEMENT; FEES	Novel solutions to conserve biodiversity whilst allowing for resource harvesting are urgently needed. In marine systems, Territorial User Rights for Fisheries (TURFs) are promoted to enable sustainable use of resources. We investigate the potential for synergies between nature-based tourism and TURFs on Chile's central coast. Of 135 recreational divers surveyed, 77% indicated that the fish species they preferred sighting were declining and 80% indicated that they would dive more often in TURFs, which have higher abundance of favoured species. Regression analysis shows that respondents that perceive that TURFs fulfil a conservation function are more willing to pay to dive in a TURF. However, respondents who understand the bureaucratic functioning of a TURF are less willing to pay, and there is diversity in how divers feel payments should be made. A participatory approach is required to navigate these complexities to achieve synergies between nature-based tourism and resource harvesting in TURFs.	[Biggs, Duan] Univ Queensland, ARC Ctr Excellence Environm Decis, Ctr Biodivers Conservat Sci, Brisbane, Qld 4072, Australia; [Biggs, Duan] Univ Stellenbosch, Dept Conservat Ecol & Entomol, Private Bag X1, ZA-7602 Matieland, South Africa; [Amar, Francisca; Valdebenito, Abel; Gelcich, Stefan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Appl Ecol & Sustainabil CAPES, Dept Ecol, Alameda 340, Santiago, Chile; [Amar, Francisca; Valdebenito, Abel; Gelcich, Stefan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Conservac Marina, Dept Ecol, Alameda 340, Santiago, Chile; [Gelcich, Stefan] Inst Mediterraneo Estudios Avanzados, CSIC, Lab Int Cambio Global, Esporles, Mallorca, Spain; [Gelcich, Stefan] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of Queensland; Stellenbosch University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); University of California System; University of California Santa Barbara	Biggs, D (corresponding author), Univ Queensland, ARC Ctr Excellence Environm Decis, Ctr Biodivers Conservat Sci, Brisbane, Qld 4072, Australia.; Biggs, D (corresponding author), Univ Stellenbosch, Dept Conservat Ecol & Entomol, Private Bag X1, ZA-7602 Matieland, South Africa.; Gelcich, S (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Appl Ecol & Sustainabil CAPES, Dept Ecol, Alameda 340, Santiago, Chile.; Gelcich, S (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Conservac Marina, Dept Ecol, Alameda 340, Santiago, Chile.; Gelcich, S (corresponding author), Inst Mediterraneo Estudios Avanzados, CSIC, Lab Int Cambio Global, Esporles, Mallorca, Spain.; Gelcich, S (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	d.biggs@uq.edu.au; sgelcich@bio.puc.cl	Biggs, Duan/F-9445-2011	Biggs, Duan/0000-0003-3177-4677	FONDECYT Iniciativa Cientifica Milenio of the Ministerio de Economia, Fomento y Turismo [11070034, RC130024, NC 120086]; financiamiento Basal [FB0002]	FONDECYT Iniciativa Cientifica Milenio of the Ministerio de Economia, Fomento y Turismo; financiamiento Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	FONDECYT (project 11070034) Iniciativa Cientifica Milenio of the Ministerio de Economia, Fomento y Turismo grants RC130024 and NC 120086 and financiamiento Basal FB0002.	Arin T, 2002, OCEAN COAST MANAGE, V45, P171, DOI 10.1016/S0964-5691(02)00049-2; Bakopoulou S, 2010, DESALINATION, V250, P329, DOI 10.1016/j.desal.2009.09.051; Baral N, 2008, ECOL ECON, V66, P218, DOI 10.1016/j.ecolecon.2008.02.004; Biggs D, 2012, ENVIRON CONSERV, V39, P370, DOI 10.1017/S0376892912000239; Biggs D., 2011, Conservation and Society, V9, P80, DOI 10.4103/0972-4923.79198; Biggs D, 2015, OCEAN COAST MANAGE, V105, P65, DOI 10.1016/j.ocecoaman.2014.12.019; Biggs D, 2014, KOEDOE, V56, DOI 10.4102/koedoe.v56i2.1164; Biggs D, 2012, J SUSTAIN TOUR, V20, P645, DOI 10.1080/09669582.2011.630080; Biggs D, 2011, ECOL SOC, V16; Boon P. I., 2002, Journal of Ecotourism, V1, P93, DOI 10.1080/14724040208668117; Carlsen J., 2001, Journal of Sustainable Tourism, V9, P281, DOI 10.1080/09669580108667403; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Catlin J, 2010, TOURISM MANAGE, V31, P386, DOI 10.1016/j.tourman.2009.04.004; Chapin FS, 2010, TRENDS ECOL EVOL, V25, P241, DOI 10.1016/j.tree.2009.10.008; Child B, 1996, BIODIVERS CONSERV, V5, P369, DOI 10.1007/BF00051780; Child G, 1996, BIODIVERS CONSERV, V5, P355, DOI 10.1007/BF00051779; CONAF, 2015, TAR INGR AR SILV PRO; Davis K, 2015, CONSERV BIOL, V29, P226, DOI 10.1111/cobi.12358; Depondt F, 2006, OCEAN COAST MANAGE, V49, P188, DOI 10.1016/j.ocecoaman.2006.02.003; Dharmaratne GS, 2000, ANN TOURISM RES, V27, P590, DOI 10.1016/S0160-7383(99)00109-7; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fjeldstad OH, 2004, J MOD AFR STUD, V42, P539, DOI 10.1017/S0022278X04000394; Gelcich S, B MATINE SC IN PRESS; Gelcich S, 2008, ENVIRON CONSERV, V35, P36, DOI 10.1017/S0376892908004475; Gelcich S, 2008, ECOL APPL, V18, P273, DOI 10.1890/06-1896.1; Gelcich S, 2006, ECOSYSTEMS, V9, P951, DOI 10.1007/s10021-005-0007-8; Gelcich S, 2015, MARIT STUD, V14, DOI 10.1186/s40152-015-0022-0; Gelcich S, 2015, CONSERV BIOL, V29, P1076, DOI 10.1111/cobi.12477; Gelcich S, 2013, AMBIO, V42, P975, DOI 10.1007/s13280-013-0453-z; Gelcich S, 2012, CONSERV BIOL, V26, P1005, DOI 10.1111/j.1523-1739.2012.01928.x; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Gelcich S, 2009, OCEAN COAST MANAGE, V52, P424, DOI 10.1016/j.ocecoaman.2009.07.005; Godoy N, 2010, ECOL APPL, V20, P1504, DOI 10.1890/09-1806.1; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Ledolter J, 2013, DATA MINING AND BUSINESS ANALYTICS WITH R, P132; Leujak W, 2007, ENVIRON MANAGE, V39, P472, DOI 10.1007/s00267-006-0040-1; Likert R., 1976, ATTITUDE THEORY MEAS, P90; Lindberg K., 1991, POLICIES MAXIMIZING; Lopez-Mosquera N, 2013, J ENVIRON PSYCHOL, V34, P27, DOI 10.1016/j.jenvp.2012.11.004; Lopez-Mosquera N, 2011, LAND USE POLICY, V28, P151, DOI 10.1016/j.landusepol.2010.05.008; Meltzoff SK, 2002, COAST MANAGE, V30, P85, DOI 10.1080/08920750252692634; Navarrete SA, 2010, REV CHIL HIST NAT, V83, P143; Ovando DA, 2013, MAR POLICY, V37, P132, DOI 10.1016/j.marpol.2012.03.012; Peters H, 2009, OCEAN COAST MANAGE, V52, P219, DOI 10.1016/j.ocecoaman.2008.12.001; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Reynisdottir M, 2008, TOURISM MANAGE, V29, P1076, DOI 10.1016/j.tourman.2008.02.016; Sandbrook CG, 2010, CONSERV LETT, V3, P21, DOI 10.1111/j.1755-263X.2009.00085.x; Thur SM, 2010, MAR POLICY, V34, P63, DOI 10.1016/j.marpol.2009.04.008; Togridou A, 2006, ECOL ECON, V60, P308, DOI 10.1016/j.ecolecon.2005.12.006; Uyarra M, 2009, ENVIRON MANAGE, V43, P1, DOI 10.1007/s00267-008-9198-z; Uyarra MC, 2005, ENVIRON CONSERV, V32, P11, DOI 10.1017/S0376892904001808	53	21	21	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0148862	10.1371/journal.pone.0148862	http://dx.doi.org/10.1371/journal.pone.0148862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9KB	27023451	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900002
J	Heffernan, C; Azbel-Jackson, L; Brownlie, J; Gunn, G				Heffernan, Claire; Azbel-Jackson, Lena; Brownlie, Joe; Gunn, George			Farmer Attitudes and Livestock Disease: Exploring Citizenship Behaviour and Peer Monitoring across Two BVD Control Schemes in the UK	PLOS ONE			English	Article							WORK GROUPS; PERFORMANCE; COHESION; COHESIVENESS; METAANALYSIS; SCOTLAND	The eradication of BVD in the UK is technically possible but appears to be socially untenable. The following study explored farmer attitudes to BVD control schemes in relation to advice networks and information sharing, shared aims and goals, motivation and benefits of membership, notions of BVD as a priority disease and attitudes toward regulation. Two concepts from the organisational management literature framed the study: citizenship behaviour where actions of individuals support the collective good (but are not explicitly recognised as such) and peer to peer monitoring (where individuals evaluate other's behaviour). Farmers from two BVD control schemes in the UK participated in the study: Orkney Livestock Association BVD Eradication Scheme and Norfolk and Suffolk Cattle Breeders Association BVD Eradication Scheme. In total 162 farmers participated in the research (109 in-scheme and 53 out of scheme). The findings revealed that group helping and information sharing among scheme members was low with a positive BVD status subject to social censure. Peer monitoring in the form of gossip with regard to the animal health status of other farms was high. Interestingly, farmers across both schemes supported greater regulation with regard to animal health, largely due to the mistrust of fellow farmers following voluntary disease control measures. While group cohesiveness varied across the two schemes, without continued financial inducements, longer-term sustainability is questionable.	[Heffernan, Claire] Univ Bristol, Sch Vet Sci, Bristol, Avon, England; [Azbel-Jackson, Lena] Univ Reading, Livestock Dev Grp, Reading, Berks, England; [Brownlie, Joe] Royal Vet Coll, Hatfield, Herts, England; [Gunn, George] Scotlands Rural Coll, Aberdeen, Scotland	University of Bristol; University of Reading; University of London; University of London Royal Veterinary College; Scotland's Rural College	Heffernan, C (corresponding author), Univ Bristol, Sch Vet Sci, Bristol, Avon, England.	ch15664@bristol.ac.uk			DEFRA [SE4003]	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA))	This study was funded by DEFRA study: SE4003.	Ackfeldt AL, 2005, J BUS RES, V58, P151, DOI 10.1016/S0148-2963(03)00110-3; Beal DJ, 2003, J APPL PSYCHOL, V88, P989, DOI 10.1037/0021-9010.88.6.989; Bennett R, 2003, J AGR ECON, V54, P55, DOI 10.1111/j.1477-9552.2003.tb00048.x; Borgatti S. P., 1999, UCINET 6 0 VERSION 1; Brulisauer F, 2010, VET J, V186, P226, DOI 10.1016/j.tvjl.2009.08.011; CAMPION MA, 1993, PERS PSYCHOL, V46, P823, DOI 10.1111/j.1744-6570.1993.tb01571.x; Chiaburu DS, 2008, J APPL PSYCHOL, V93, P1082, DOI 10.1037/0021-9010.93.5.1082; Choi JN, 2009, J MANAGE STUD, V46, P1396, DOI 10.1111/j.1467-6486.2009.00851.x; Craig T.Y., 1999, GROUP DYN-THEOR RES, V3, P243, DOI [DOI 10.1037/1089-2699.3.4.243, 10.1037/1089-2699.3.4.243]; Eisenhardt K, ACAD MANAGE REV, V14, P57; EVANS CR, 1991, SMALL GR RES, V22, P175, DOI 10.1177/1046496491222002; Falk A, 2003, 3834 CEPR; Friedkin NE, 2004, ANNU REV SOCIOL, V30, P409, DOI 10.1146/annurev.soc.30.012703.110625; Heffernan C, 2008, PREV VET MED, V87, P358, DOI 10.1016/j.prevetmed.2008.05.007; Hogg M. A., 1993, EUROPEAN REV SOCIAL, V4, P85, DOI [10.1080/14792779343000031, DOI 10.1080/14792779343000031]; Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4; KANDEL E, 1992, J POLIT ECON, V100, P801, DOI 10.1086/261840; Kidwell RE, 1997, J MANAGE, V23, P775, DOI 10.1016/S0149-2063(97)90029-5; LePine JA, 2002, J APPL PSYCHOL, V87, P52, DOI 10.1037//0021-9010.87.1.52; Loughry ML, 2008, ORGAN SCI, V19, P876, DOI 10.1287/orsc.1080.0356; Mahmood, 2012, INT J COOPERATIVE ST, V1, P15; MOORMAN RH, 1995, J ORGAN BEHAV, V16, P127, DOI 10.1002/job.4030160204; Mullen B, 1995, RELATION GROUP COHES; Organ D. W., 1988, ORGANISATIONAL CITIZ; Podsakoff PM, 2000, J MANAGE, V26, P513, DOI 10.1177/014920630002600306; Shaw M.E., 1981, GROUP DYNAMICS PSYCH; SMITH CA, 1983, J APPL PSYCHOL, V68, P653, DOI 10.1037/0021-9010.68.4.653; STIGLITZ JE, 1990, WORLD BANK ECON REV, V4, P351, DOI 10.1093/wber/4.3.351; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Weldegebriel HT, 2009, PREV VET MED, V88, P49, DOI 10.1016/j.prevetmed.2008.07.001; ZACCARO SJ, 1988, J APPL SOC PSYCHOL, V18, P837, DOI 10.1111/j.1559-1816.1988.tb01178.x	31	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152295	10.1371/journal.pone.0152295	http://dx.doi.org/10.1371/journal.pone.0152295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9KB	27023269	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000373113900041
J	Song, QS; Zhang, GQ; Jiang, HB; Ren, YW; Lu, XW				Song, Qisheng; Zhang, Guoqing; Jiang, Hongbo; Ren, Yanwei; Lu, Xiwei			Imaging Features of Pulmonary CT in Type 2 Diabetic Patients with Multidrug-Resistant Tuberculosis	PLOS ONE			English	Article							DRUG-SENSITIVE TUBERCULOSIS; MELLITUS; ADULTS	Background Until now, radiographic manifestations of multidrug-resistant pulmonary tuberculosis (MDR-TB) in patients with diabetes mellitus (DM) have not been reported. We conducted a study to investigate the imaging features of pulmonary computed tomography (CT) for type 2 diabetic (T2DM) patients with MDR-TB. Methods The clinical data and pulmonary CT findings of 39 type 2 diabetic patients with MDR-TB, 46 type 2 diabetic patients with drug-susceptible tuberculosis (DS-TB), and 72 pure drug-susceptible TB cases (without T2DM and MDR) treated at Dalian Tuberculosis Hospital from 2012 to 2015 were collected, and the clinical features and imaging differences of the three groups were compared. Results The clinical characteristics of the three groups of patients were not significantly different except with respect to age and previous treatment history. However, on imaging, the patients with MDR-TB showed consolidation in and above the pulmonary segments was significantly more extensive than that seen in the DS-TB group with or without T2DM. Conclusion Consolidation in or above multiple pulmonary segments with multiple mouth-eaten cavities and bronchial damage on pulmonary CT images in type 2 diabetic patients with tuberculosis suggests the possibility of multi-drug resistance.	[Song, Qisheng; Jiang, Hongbo; Ren, Yanwei; Lu, Xiwei] Dalian TB Hosp, Dept Internal Med, Liaoning, Peoples R China; [Zhang, Guoqing] Dalian TB Hosp, Dept Radiol, Liaoning, Peoples R China		Song, QS; Lu, XW (corresponding author), Dalian TB Hosp, Dept Internal Med, Liaoning, Peoples R China.	sqsconquer@126.com; tb_luxiwei@126.com	zhang, guoqing/GXG-4800-2022					Al-Tawfiq JA, 2009, INT J TUBERC LUNG D, V13, P367; Baghaei P., 2010, TANAFFOS - Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, V9, P13; Basaraba Randall J., 2008, TUBERCULOSIS EDINB, V88, P69; Bashar M, 2001, CHEST, V120, P1514, DOI 10.1378/chest.120.5.1514; Cha J, 2009, KOREAN J RADIOL, V10, P207, DOI 10.3348/kjr.2009.10.3.207; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Chung MJ, 2006, EUR RADIOL, V16, P1934, DOI 10.1007/s00330-006-0174-9; Fisher-Hoch SP, 2008, SCAND J INFECT DIS, V40, P888, DOI 10.1080/00365540802342372; Fishman JE, 1998, J THORAC IMAG, V13, P65, DOI 10.1097/00005382-199801000-00015; Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Kim HC, 2004, J COMPUT ASSIST TOMO, V28, P366, DOI 10.1097/00004728-200405000-00011; Kocfa CD, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0119332; Perez-Navarro LM, 2011, GAC MED MEX, V147, P219; Ocal S, 2009, J DIABETES, V1, P107, DOI 10.1111/j.1753-0407.2009.00013.x; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Perez-Guzman C, 2001, INT J TUBERC LUNG D, V5, P455; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Ruslami R, 2010, ANTIMICROB AGENTS CH, V54, P1068, DOI 10.1128/AAC.00447-09; Tatar D, 2009, JPN J INFECT DIS, V62, P423; UMUT S, 1994, CHEST, V106, P326; WHO, 2014, GLOB TUB REP 2014; Yeom JA, 2009, J COMPUT ASSIST TOMO, V33, P956, DOI 10.1097/RCT.0b013e31819877ab; Zhang Q, 2009, JPN J INFECT DIS, V62, P390	26	11	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152507	10.1371/journal.pone.0152507	http://dx.doi.org/10.1371/journal.pone.0152507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022735	gold, Green Submitted, Green Published			2022-12-26	WOS:000373113900066
J	Abd Rahman, M; Ramli, F; Karimian, H; Dehghan, F; Nordin, N; Ali, HM; Mohan, S; Hashim, NM				Abd Rahman, Mashitoh; Ramli, Faiqah; Karimian, Hamed; Dehghan, Firouzeh; Nordin, Noraziah; Ali, Hapipah Mohd; Mohan, Syam; Hashim, Najihah Mohd			Artonin E Induces Apoptosis via Mitochondrial Dysregulation in SKOV-3 Ovarian Cancer Cells	PLOS ONE			English	Article							DRUG-RESISTANCE; CYCLE; CASPASES; PATHWAYS; DEATH; PROLIFERATION; CARCINOMA; MIGRATION; SURVIVIN; INVASION	Artonin E is a prenylated flavonoid isolated from the stem bark of Artocarpus elasticus Reinw.(Moraceae). This study aimed to investigate the apoptotic mechanisms induced by artonin E in a metastatic human ovarian cancer cell line SKOV-3 in vitro. MTT assay, clonogenic assay, acridine orange and propidium iodide double staining, cell cycle and annexin V analyses were performed to explore the mode of artonin E-induced cell death at different time points. DNA laddering, activation of caspases-3, -8, and -9, multi-parametric cytotoxicity- 3analysis by high-content screening, measurement of reactive oxygen species generation, and Western blot were employed to study the pathways involved in the apoptosis. MTT results showed that artonin E inhibited the growth of SKOV-3 cells, with IC50 values of 6.5 +/- 0.5 mu g/mL after 72 h treatment, and showed less toxicity toward a normal human ovarian cell lineT1074, with IC50 value of 32.5 +/- 0.5 mu g/mL. Results showed that artonin E induced apoptosis and cell cycle arrest at the S phase. This compound also promoted the activation of caspases-3, -8, and -9. Further investigation into the depletion of mitochondrial membrane potential and release of cytochrome c revealed that artonin E treatment induced apoptosis via regulation of the expression of pro-survival and pro-apoptotic Bcl-2 family members. The expression levels of survivin and HSP70 proteins were also down regulated in SKOV-3 cells treated with artonin E. We propose that artonin E induced an antiproliferative effect that led to S phase cell cycle arrest and apoptosis through dysregulation of mitochondrial pathways, particularly the pro-and anti-apoptosis signaling pathways.	[Abd Rahman, Mashitoh; Ramli, Faiqah; Karimian, Hamed; Nordin, Noraziah; Hashim, Najihah Mohd] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Dehghan, Firouzeh] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Mohan, Syam] Jazan Univ, Med Res Ctr, Jazan, Saudi Arabia; [Ali, Hapipah Mohd; Hashim, Najihah Mohd] Univ Malaya, Dept Chem, Fac Sci, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 59100, Malaysia; [Ramli, Faiqah] Univ Technol Malaysia, Fac Chem Engn, Inst Bioprod Dev, Johor Baharu, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Jazan University; Universiti Malaya; Universiti Teknologi Malaysia	Abd Rahman, M; Hashim, NM (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.; Hashim, NM (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 59100, Malaysia.	mashitohabdrahman@gmail.com; najihahmh@um.edu.my	Hashim, Najihah Mohd/J-5508-2015; Abd Rahman, Mashitoh/GLQ-7432-2022; Mohan, Syam/A-1231-2011	Hashim, Najihah Mohd/0000-0003-1133-7998; 	University of Malaya under UMRG project [RG077-12BIO]; Institute of Research Management and Monitoring Research Grant [PG162-2014B]; Ministry of Higher Education Malaysia under High Impact Research Grant [UM-MOHE UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya under UMRG project; Institute of Research Management and Monitoring Research Grant; Ministry of Higher Education Malaysia under High Impact Research Grant	The authors wish to thank University of Malaya for providing the research grants under UMRG project (RG077-12BIO), Institute of Research Management and Monitoring Research Grant (PG162-2014B), and Ministry of Higher Education Malaysia under High Impact Research Grant (UM-MOHE UM.C/625/1/HIR/MOHE/SC/09) for their financial support to carry out this research.	Achmad SA, 2004, J CHEM SOC PAKISTAN, V26, P316; Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Arung ET, 2005, J WOOD SCI, V51, P520, DOI 10.1007/s10086-004-0690-7; Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; Blagosklonny MV, 2005, TRENDS PHARMACOL SCI, V26, P77, DOI 10.1016/j.tips.2004.12.002; Brodska B, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/253529; Brown DP, 2008, CANC CHEMOTHER PHARM; Chan KT, 2010, CANCER LETT, V294, P118, DOI 10.1016/j.canlet.2010.01.029; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Eswani N, 2010, JOURNAL OF AGRICULTU, V2, pP189; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Goto S, 1999, FREE RADICAL RES, V31, P549, DOI 10.1080/10715769900301121; HANO Y, 1990, HETEROCYCLES, V31, P877; Hensley P, 2013, BIOL CHEM, V394, P831, DOI 10.1515/hsz-2013-0128; Hu L, 2010, BRIT J CANCER, V102, P1276, DOI 10.1038/sj.bjc.6605626; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Jagtap UB, 2010, J ETHNOPHARMACOL, V129, P142, DOI 10.1016/j.jep.2010.03.031; Jamia Azdina Jamal, 2011, Pharmacognosy Journal, V3, P15, DOI 10.5530/pj.2011.24.4; Jayasinghe ULB, 2008, FITOTERAPIA, V79, P37, DOI 10.1016/j.fitote.2007.07.014; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim M, 2012, MOL CANCER RES, V10, P1419, DOI 10.1158/1541-7786.MCR-12-0361; Kim M, 2012, MOL CANCER RES, V10, P11, DOI 10.1158/1541-7786.MCR-11-0256; Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x; Kumada Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010305; Landriscina M, 2010, GYNECOL ONCOL, V117, P177, DOI 10.1016/j.ygyno.2009.10.078; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Lim GCC, 2008, CANC INCIDENCE PENIN; Lotulung Puspa D N, 2008, Pak J Biol Sci, V11, P2517, DOI 10.3923/pjbs.2008.2517.2520; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Markman M, 2008, TRENDS PHARMACOL SCI, V29, P515, DOI 10.1016/j.tips.2008.07.007; Martin KR, 2006, EXP BIOL MED, V231, P117; McEligot AJ, 2005, ANNU REV NUTR, V25, P261, DOI 10.1146/annurev.nutr.25.050304.092633; Munshi A, 2005, METH MOLEC MED, V110, P21; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Nordin N, 2015, DRUG DES DEV THER, V9, P1437, DOI 10.2147/DDDT.S77727; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Plaibua K, 2013, ANTICANCER RES, V33, P3079; Ramli F, 2013, PHYTOCHEM LETT, V6, P582, DOI 10.1016/j.phytol.2013.07.009; REDDY GR, 1991, BIOCHEM PHARMACOL, V41, P115, DOI 10.1016/0006-2952(91)90018-Z; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soekamto NH, 2003, PHYTOCHEMISTRY, V64, P831, DOI 10.1016/j.phytochem.2003.08.009; Sorriento D, 2014, SCI WORLD J, DOI 10.1155/2014/604685; Suhartati T, 2001, FITOTERAPIA, V72, P912, DOI 10.1016/S0367-326X(01)00343-4; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang YH, 2004, J NAT PROD, V67, P757, DOI 10.1021/np030467y; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Wongpankam E, 2012, ANTICANCER RES, V32, P5343; Xue H, 2013, ANTI-CANCER DRUG, V24, P937, DOI 10.1097/CAD.0b013e328364efe0; Zhivotovsky B, 2014, ANTIOXIDANTS REDOX S	57	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151466	10.1371/journal.pone.0151466	http://dx.doi.org/10.1371/journal.pone.0151466			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019365	Green Submitted, gold, Green Published			2022-12-26	WOS:000372807800013
J	Liu, XJ; Du, FF; Li, NW; Chang, YJ; Yao, DR				Liu, Xiaojing; Du, Fengfeng; Li, Naiwei; Chang, Yajun; Yao, Dongrui			Gene Expression Profile in the Long-Living Lotus: Insights into the Heat Stress Response Mechanism	PLOS ONE			English	Article							SHOCK PROTEINS; SACRED LOTUS; ARABIDOPSIS; THERMOTOLERANCE; IDENTIFICATION; CHAPERONES; EVOLUTION; DROUGHT; GENOME; FRUITS	Lotus (Nelumbo Adans) is an aquatic perennial plant that flourished during the middle Albian stage. In this study, we characterized the digital gene expression signatures for China Antique lotus under conditions of heat shock stress. Using RNA-seq technology, we sequenced four libraries, specifically, two biological replicates for control plant samples and two for heat stress samples. As a result, 6,528,866 to 8,771,183 clean reads were mapped to the reference genome, accounting for 92-96% total clean reads. A total of 396 significantly altered genes were detected across the genome, among which 315 were upregulated and 81 were downregulated by heat shock stress. Gene ontology (GO) enrichment of differentially expressed genes revealed protein folding, cell morphogenesis and cellular component morphogenesis as the top three functional terms under heat shock stress. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis led to the identification of protein processing in endoplasmic reticulum, plant-pathogen interactions, spliceosome, endocytosis, and protein export as significantly enriched pathways. Among the upregulated genes, small heat shock proteins (sHsps) and genes related to cell morphogenesis were particularly abundant under heat stress. Data from the current study provide valuable clues that may help elucidate the molecular events underlying heat stress response in China Antique lotus.	[Liu, Xiaojing; Yao, Dongrui] Inst Bot, Nanjing 210014, Jiangsu, Peoples R China; Chinese Acad Sci, Nanjing 210014, Jiangsu, Peoples R China	Chinese Academy of Sciences	Liu, XJ; Yao, DR (corresponding author), Inst Bot, Nanjing 210014, Jiangsu, Peoples R China.	liuxiaojingcau@126.com; shuishengzu@126.com			National Natural Science Foundation of China [31400604]; Natural Science Foundation of Jiangsu Province [BK20151370]; Public science and technology research funds projects of ocean [201505023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Public science and technology research funds projects of ocean	The National Natural Science Foundation of China, Grant No. 31400604, http://www.nsfc.gov.cn/; the Natural Science Foundation of Jiangsu Province, Grant No. BK20151370, http://www.jstd.gov.cn/; Public science and technology research funds projects of ocean, Grant No. 201505023, http://www.soa.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S., 2010, HTSEQ ANAL HIGH THRO; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; Dafny-Yelin M, 2008, PLANT MOL BIOL, V67, P363, DOI 10.1007/s11103-008-9326-4; Ding YF, 2008, SCI CHINA SER C, V51, P842, DOI 10.1007/s11427-008-0107-8; Doukhanina EV, 2006, J BIOL CHEM, V281, P18793, DOI 10.1074/jbc.M511794200; Fernandes J, 2008, PLANT BIOTECHNOL J, V6, P782, DOI 10.1111/j.1467-7652.2008.00360.x; Guo SJ, 2007, J PLANT PHYSIOL, V164, P126, DOI 10.1016/j.jplph.2006.01.004; Huang GH, 1987, CHINA LOTUS, P9; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Li JK, 2010, AUST J BOT, V58, P463, DOI 10.1071/BT10002; Li YF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-153; Lin BL, 2001, CELL STRESS CHAPERON, V6, P201, DOI 10.1379/1466-1268(2001)006<0201:GAOTHS>2.0.CO;2; Mangelsen E, 2011, MOL PLANT, V4, P97, DOI 10.1093/mp/ssq058; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Miller JS, 2002, AM J BOT, V89, P1907, DOI 10.3732/ajb.89.2.236; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Sanmiya K, 2004, FEBS LETT, V557, P265, DOI 10.1016/S0014-5793(03)01494-7; Shen-Miller J, 2002, SEED SCI RES, V12, P131, DOI 10.1079/SSR2002112; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Wu ZH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0289-0; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; ZHANG X, 2012, PLOS COMPUT BIOL, V8, P49652, DOI DOI 10.1371/JOURNAL.PONE.0049652	37	4	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152540	10.1371/journal.pone.0152540	http://dx.doi.org/10.1371/journal.pone.0152540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018792	Green Submitted, Green Published, gold			2022-12-26	WOS:000372807800056
J	Nicoli, ER; Al Eisa, N; Cluzeau, CVM; Wassif, CA; Gray, J; Burkert, KR; Smith, DA; Morris, L; Cologna, SM; Peer, CJ; Sissung, TM; Uscatu, CD; Figg, WD; Pavan, WJ; Vite, CH; Porter, FD; Platt, FM				Nicoli, Elena-Raluca; Al Eisa, Nada; Cluzeau, Celine V. M.; Wassif, Christopher A.; Gray, James; Burkert, Kathryn R.; Smith, David A.; Morris, Lauren; Cologna, Stephanie M.; Peer, Cody J.; Sissung, Tristan M.; Uscatu, Constantin-Daniel; Figg, William D.; Pavan, William J.; Vite, Charles H.; Porter, Forbes D.; Platt, Frances M.			Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease	PLOS ONE			English	Article							MOUSE MODEL; URSODEOXYCHOLIC ACID; CHOLESTEROL; EXPRESSION; THERAPY; MIGLUSTAT; CURCUMIN; BRAIN; RAT; MIDAZOLAM	Niemann-Pick type C (NPC) disease is a neurodegenerative lysosomal storage disease caused by mutations in either the NPC1 or NPC2 gene. NPC is characterised by storage of multiple lipids in the late endosomal/lysosomal compartment, resulting in cellular and organ system dysfunction. The underlying molecular mechanisms that lead to the range of clinical presentations in NPC are not fully understood. While evaluating potential small molecule therapies in Npc1(-/-) mice, we observed a consistent pattern of toxicity associated with drugs metabolised by the cytochrome P450 system, suggesting a potential drug metabolism defect in NPC1 disease. Investigation of the P450 system in the context of NPC1 dysfunction revealed significant changes in the gene expression of many P450 associated genes across the full lifespan of Npc1(-/-) mice, decreased activity of cytochrome P450 reductase, and a global decrease of multiple cytochrome P450 catalysed dealkylation reactions. In vivo drug metabolism studies using a prototypic P450 metabolised drug, midazolam, confirmed dysfunction in drug clearance in the Npc1(-/-) mouse. Expression of the Phase II enzyme uridinediphosphate- glucuronosyltransferase (UGT) was also significantly reduced in Npc1(-/-) mice. Interestingly, reduced activity within the P450 system was also observed in heterozygous Npc1(+/-) mice. The reduced activity of P450 enzymes may be the result of bile acid deficiency/imbalance in Npc1(-/-) mice, as bile acid treatment significantly rescued P450 enzyme activity in Npc1(-/-) mice and has the potential to be an adjunctive therapy for NPC disease patients. The dysfunction in the cytochrome P450 system were recapitulated in the NPC1 feline model. Additionally, we present the first evidence that there are alterations in the P450 system in NPC1 patients.	[Nicoli, Elena-Raluca; Al Eisa, Nada; Wassif, Christopher A.; Gray, James; Smith, David A.; Morris, Lauren; Uscatu, Constantin-Daniel; Platt, Frances M.] Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England; [Cluzeau, Celine V. M.; Wassif, Christopher A.; Burkert, Kathryn R.; Cologna, Stephanie M.; Porter, Forbes D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Dysmorphol, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Peer, Cody J.; Sissung, Tristan M.; Figg, William D.] NCI, Clin Pharmacol Program, Med Oncol Branch, US Dept HHS, Bethesda, MD 20892 USA; [Uscatu, Constantin-Daniel] Univ Med & Pharm Craiova, Dept Cellular & Mol Biol, Craiova, Romania; [Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Vite, Charles H.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Medicine & Pharmacy of Craiova; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania	Platt, FM (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.; Porter, FD (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Dysmorphol, NIH, Dept Hlth & Human Serv, Bethesda, MD USA.	fdporter@mail.nih.gov; Frances.platt@pharm.ox.ac.uk	Figg, William D/M-2411-2016; Nicoli, Elena-Raluca/F-3968-2011	Nicoli, Elena-Raluca/0000-0002-5545-630X; Figg, William/0000-0003-2428-5613; Pavan, William/0000-0001-8281-5120; Platt, Frances/0000-0001-7614-0403	Niemann-Pick Research Foundation (NPRF) UK; Action Medical Research; King Saud bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City; National Guard Health Affairs; Saudi Ministry of Higher Education; NPRF; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; Ara Parseghian Medical Research Foundation; Dana's Angels Research Trust; NIH [R01 NS073661, RR02512]; European Social Fund, Human Resources Development Operational Programme [POSDRU/159/1.5/136893]; NPRF (Niemann-Pick Research Foundation); NPUK (Niemann-Pick, UK); SOAR-NPC (support of accelerated research for Niemann-Pick Type C); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008824, ZIAHD000139] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICSC006537] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073661] Funding Source: NIH RePORTER; Action Medical Research [2157, 1766] Funding Source: researchfish	Niemann-Pick Research Foundation (NPRF) UK; Action Medical Research; King Saud bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City; National Guard Health Affairs; Saudi Ministry of Higher Education; NPRF; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ara Parseghian Medical Research Foundation; Dana's Angels Research Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Social Fund, Human Resources Development Operational Programme; NPRF (Niemann-Pick Research Foundation); NPUK (Niemann-Pick, UK); SOAR-NPC (support of accelerated research for Niemann-Pick Type C); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Action Medical Research	The Npc1 mouse studies were funded by an infrastructure grant to FMP from the Niemann-Pick Research Foundation (NPRF) UK. ERN was supported by Action Medical Research. NA was supported by King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs and the Saudi Ministry of Higher Education. DS and LM were supported by NPRF. CAW, CVMC, KB, SMC and FDP were funded by the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. CJP, TMS and WDF were all funded by the intramural research program of the National Cancer Institute. CHV was supported by the Ara Parseghian Medical Research Foundation, Dana's Angels Research Trust, and NIH (R01 NS073661 and RR02512). CDU was supported by European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/136893. FMP was supported by NPRF (Niemann-Pick Research Foundation) and NPUK (Niemann-Pick, UK), SOAR-NPC (support of accelerated research for Niemann-Pick Type C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Alvelius G, 2001, J LIPID RES, V42, P1571; Amigo L, 2002, HEPATOLOGY, V36, P819, DOI 10.1053/jhep.2002.35617; [Anonymous], 2008, DRUG METAB PHARMACOK, V23, P14, DOI 10.2133/dmpk.23.14; Appiah-Opong R, 2007, TOXICOLOGY, V235, P83, DOI 10.1016/j.tox.2007.03.007; Borbon IA, 2012, PHARMACOL BIOCHEM BE, V101, P125, DOI 10.1016/j.pbb.2011.12.009; BRITTO MR, 1992, DRUG METAB DISPOS, V20, P446; BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8; Carey EJ, 2015, LANCET, V386, P1565, DOI 10.1016/S0140-6736(15)00154-3; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; CONNER MW, 1984, FUND APPL TOXICOL, V4, pS341, DOI 10.1016/0272-0590(84)90262-8; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1053/j.gastro.2004.11.009; Diczfalusy U, 2013, BIOCHIMIE, V95, P455, DOI 10.1016/j.biochi.2012.06.016; Elbaz A, 2004, ANN NEUROL, V55, P430, DOI 10.1002/ana.20051; Elliot-Smith E, 2008, MOL GENET METAB, V94, P204, DOI 10.1016/j.ymgme.2008.02.005; Eloranta JJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P397, DOI 10.1016/j.abb.2004.09.019; Gandhi AS, 2012, BRIT J PHARMACOL, V166, P2176, DOI 10.1111/j.1476-5381.2012.01933.x; Hafner M, 2011, CURR DRUG METAB, V12, P173, DOI 10.2174/138920011795016890; Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200; HEIZMANN P, 1983, BRIT J CLIN PHARMACO, V16, pS43, DOI 10.1111/j.1365-2125.1983.tb02270.x; Hsu AW, 2009, MOVEMENT DISORD, V24, P1984, DOI 10.1002/mds.22744; JALBERT G, 1992, CANCER LETT, V66, P21, DOI 10.1016/0304-3835(92)90275-Z; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; KEIM KL, 1987, DRUG DEVELOP RES, V11, P107, DOI 10.1002/ddr.430110205; KELLY DA, 1993, J PEDIATR-US, V123, P242, DOI 10.1016/S0022-3476(05)81695-6; Kennedy BE, 2014, J BIOL CHEM, V289, P16278, DOI 10.1074/jbc.M114.559914; KRONBACH T, 1989, MOL PHARMACOL, V36, P89; Lachmann RH, 2004, NEUROBIOL DIS, V16, P654, DOI 10.1016/j.nbd.2004.05.002; Lachmann Robin H, 2003, Curr Opin Investig Drugs, V4, P472; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lindor KD, 2000, LANCET, V355, P657, DOI 10.1016/S0140-6736(05)72401-6; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Maekawa M, 2015, ANN CLIN BIOCHEM, V52, P576, DOI 10.1177/0004563214568871; Maekawa M, 2013, STEROIDS, V78, P967, DOI 10.1016/j.steroids.2013.05.017; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Mendez-Sanchez Nahum, 2004, Ann Hepatol, V3, P108; Miksys S, 2000, BIOCHEM PHARMACOL, V59, P1501, DOI 10.1016/S0006-2952(00)00281-1; Mortiboys Heather, 2015, Neurology, V85, P846, DOI 10.1212/WNL.0000000000001905; Mortiboys H, 2013, BRAIN, V136, P3038, DOI 10.1093/brain/awt224; NAMKUNG MJ, 1988, MOL PHARMACOL, V34, P628; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; NERURKAR PV, 1993, BIOCHEM PHARMACOL, V46, P933, DOI 10.1016/0006-2952(93)90504-P; Ottinger EA, 2014, CURR TOP MED CHEM, V14, P330, DOI 10.2174/1568026613666131127160118; PARKE DV, 1981, ANNU REV NUTR, V1, P207, DOI 10.1146/annurev.nu.01.070181.001231; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-12; Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012; Patterson MC, 2010, J CHILD NEUROL, V25, P300, DOI 10.1177/0883073809344222; Perkins S, 2002, CANCER EPIDEM BIOMAR, V11, P535; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Roe AL, 1999, INT J OBESITY, V23, P48, DOI 10.1038/sj.ijo.0800756; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Seo KA, 2010, DRUG METAB DISPOS, V38, P2007, DOI 10.1124/dmd.110.035295; Sequeira JSS, 1998, J INHERIT METAB DIS, V21, P149, DOI 10.1023/A:1005395709826; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Spencer TA, 2001, J MED CHEM, V44, P886, DOI 10.1021/jm0004749; Van Herwaarden AE, 2005, DRUG METAB DISPOS, V33, P892, DOI 10.1124/dmd.105.004721; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vanier MT, 1999, NEUROCHEM RES, V24, P481, DOI 10.1023/A:1022575511354; Wassif CA, 2016, GENET MED, V18, P41, DOI 10.1038/gim.2015.25; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wraith JE, 2010, MOL GENET METAB, V99, P351, DOI 10.1016/j.ymgme.2009.12.006; Xie CL, 2000, J NEUROPATH EXP NEUR, V59, P1106, DOI 10.1093/jnen/59.12.1106; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7	73	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152007	10.1371/journal.pone.0152007	http://dx.doi.org/10.1371/journal.pone.0152007			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019000	Green Published, gold			2022-12-26	WOS:000372807800026
J	Jenkins, BJ; Daly, TM; Morrisey, JM; Mather, MW; Vaidya, AB; Bergman, LW				Jenkins, Bethany J.; Daly, Thomas M.; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.; Bergman, Lawrence W.			Characterization of a Plasmodium falciparum Orthologue of the Yeast Ubiquinone-Binding Protein, Coq10p	PLOS ONE			English	Article							COENZYME-Q; ELECTRON-TRANSPORT; BIOSYNTHESIS; POLYPEPTIDE; GROWTH	m Coenzyme Q (CoQ, ubiquinone) is a central electron carrier in mitochondrial respiration. CoQ is synthesized through multiple steps involving a number of different enzymes. The prevailing view that the CoQ used in respiration exists as a free pool that diffuses throughout the mitochondrial inner membrane bilayer has recently been challenged. In the yeast Saccharomyces cerevisiae, deletion of the gene encoding Coq10p results in respiration deficiency without inhibiting the synthesis of CoQ, suggesting that the Coq10 protein is critical for the delivery of CoQ to the site(s) of respiration. The precise mechanism by which this is achieved remains unknown at present. We have identified a Plasmodium orthologue of Coq10 (PfCoq10), which is predominantly expressed in trophozoite-stage parasites, and localizes to the parasite mitochondrion. Expression of PfCoq10 in the S. cerevisiae coq10 deletion strain restored the capability of the yeast to grow on respiratory substrates, suggesting a remarkable functional conservation of this protein over a vast evolutionary distance, and despite a relatively low level of amino acid sequence identity. As the antimalarial drug atovaquone acts as a competitive inhibitor of CoQ, we assessed whether over-expression of PfCoq10 altered the atovaquone sensitivity in parasites and in yeast mitochondria, but found no alteration of its activity.	[Jenkins, Bethany J.; Daly, Thomas M.; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.; Bergman, Lawrence W.] Drexel Univ, Coll Med, Ctr Mol Parasitol, Philadelphia, PA 19104 USA	Drexel University	Bergman, LW (corresponding author), Drexel Univ, Coll Med, Ctr Mol Parasitol, Philadelphia, PA 19104 USA.	lbergman@drexelmed.edu		Mather, Michael/0000-0002-1062-0137	National Institute of Allergy and Infectious Diseases [R01 AI098413, R01 AI068137]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068137, R01AI028398, R01AI098413] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	R01 AI098413 (ABV) National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov). R01 AI068137 (LWB) National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CM, 2013, BBA-MOL CELL BIOL L, V1831, P776, DOI 10.1016/j.bbalip.2012.12.007; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; Birth D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5029; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; de Macedo CS, 2002, FEMS MICROBIOL LETT, V207, P13, DOI 10.1111/j.1574-6968.2002.tb11021.x; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; He CWH, 2014, BBA-MOL CELL BIOL L, V1841, P630, DOI 10.1016/j.bbalip.2013.12.017; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jain S, 2013, CELL MICROBIOL, V15, P1660, DOI 10.1111/cmi.12142; Jordao FM, 2011, MEM I OSWALDO CRUZ, V106, P134, DOI 10.1590/S0074-02762011000900018; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawamukai M, 2016, BIOSCI BIOTECH BIOCH, V80, P23, DOI 10.1080/09168451.2015.1065172; MacRae JI, 2012, CURR PHARM DESIGN, V18, P3490; Mather MW, 2007, CURR DRUG TARGETS, V8, P49, DOI 10.2174/138945007779315632; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Murai M, 2014, BIOCHEMISTRY-US, V53, P3995, DOI 10.1021/bi500347s; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Renvoise M, 2014, J PROTEOMICS, V106, P140, DOI 10.1016/j.jprot.2014.04.022; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111; Shen Y, 2005, PROTEINS, V58, P747, DOI 10.1002/prot.20365; Siregar JE, 2015, PARASITOL INT, V64, P295, DOI 10.1016/j.parint.2014.09.011; Tonhosolo R, 2005, BIOCHEM J, V392, P117, DOI 10.1042/BJ20050441; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Vaidya AB, 2005, CURR TOP MICROBIOL, V295, P233; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x	32	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152197	10.1371/journal.pone.0152197	http://dx.doi.org/10.1371/journal.pone.0152197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015086	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900046
J	Ohtsuki, T; Nakamura, R; Kubo, S; Otabe, A; Oobayashi, Y; Suzuki, S; Yoshida, M; Yoshida, M; Tatebe, C; Sato, K; Akiyama, H				Ohtsuki, Takashi; Nakamura, Ryoichiro; Kubo, Satoru; Otabe, Akira; Oobayashi, Yoko; Suzuki, Shoko; Yoshida, Mika; Yoshida, Mitsuya; Tatebe, Chiye; Sato, Kyoko; Akiyama, Hiroshi			Development of an HPLC Method with an ODS Column to Determine Low Levels of Aspartame Diastereomers in Aspartame	PLOS ONE			English	Article							STEREOCHEMICAL RESOLUTION; LIQUID-CHROMATOGRAPHY; STATIONARY-PHASE; DEGRADATION; PRODUCTS; TASTE	alpha-L-Aspartyl-D-phenylalanine methyl ester (L, D-APM) and alpha-D-aspartyl-L-phenylalanine methyl ester (D, L-APM) are diastereomers of aspartame (N-L-alpha-Aspartyl-L-phenylalanine1- methyl ester, L, L-APM). The Joint FAO/WHO Expert Committee on Food Additives has set 0.04 wt% as the maximum permitted level of the sum of L, D-APM and D, L-APM in commercially available L, L-APM. In this study, we developed and validated a simple high-performance liquid chromatography (HPLC) method using an ODS column to determine L, DAPM and D, L-APM in L, L-APM. The limits of detection and quantification, respectively, of L, D-APM and D, L-APM were found to be 0.0012 wt% and 0.004 wt%. This method gave excellent accuracy, repeatability, and reproducibility in a recovery test performed on five different days. Moreover, the method was successfully applied to the determination of these diastereomers in commercial L, L-APM samples. Thus, the developed method is a simple, useful, and practical tool for determining L, D-APM and D, L-APM levels in L, L-APM.	[Ohtsuki, Takashi; Tatebe, Chiye; Sato, Kyoko; Akiyama, Hiroshi] Natl Inst Hlth Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan; [Nakamura, Ryoichiro; Kubo, Satoru; Otabe, Akira; Oobayashi, Yoko] Ajinomoto Co Inc, Chuo Ku, 1-15-1 Kyobashi, Tokyo, Japan; [Suzuki, Shoko; Yoshida, Mika; Yoshida, Mitsuya] Japan Food Res Labs, 6-11-10 Nagayama, Tama, Tokyo, Japan	National Institute of Health Sciences - Japan; Ajinomoto Co Inc	Sato, K (corresponding author), Natl Inst Hlth Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	ksato@rchs.go.ip			Ajinomoto Co., Inc.; Ajinomoto Co., Ltd.	Ajinomoto Co., Inc.; Ajinomoto Co., Ltd.	This study received financial support from Ajinomoto Co., Inc. In addition, Ajinomoto Co., Ltd. provided support in the form of salaries for authors RN, SK, AO, and YO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the' author contributions' section.	GAINES SM, 1987, J CHROMATOGR, V389, P219, DOI 10.1016/S0021-9673(01)94425-5; Hagiwara T, 1999, J FOOD HYG SOC JPN, V40, P62, DOI 10.3358/shokueishi.40.62; JADAUD P, 1990, CHIRALITY, V2, P32, DOI 10.1002/chir.530020105; Maeda M, 2009, JPN J FOOD CHEM SAFE, V16, P72; Marinovich M, 2013, FOOD CHEM TOXICOL, V60, P109, DOI 10.1016/j.fct.2013.07.040; MAZUR RH, 1969, J AM CHEM SOC, V91, P2684, DOI 10.1021/ja01038a046; Ministry of Health Labour and Welfare, 2011, JAP PHARM; MOTELLIER S, 1990, J CHROMATOGR, V516, P365, DOI 10.1016/S0021-9673(01)89277-3; Pattanaargson S, 2001, J FOOD SCI, V66, P808, DOI 10.1111/j.1365-2621.2001.tb15177.x; Rencuzogullari E, 2004, DRUG CHEM TOXICOL, V27, P257, DOI 10.1081/DCT-120037506; Sabah S, 1998, J PHARMACEUT BIOMED, V16, P1089, DOI 10.1016/S0731-7085(97)00054-X; Saleh A. A. S., 2015, Journal of Basic and Applied Zoology, V72, P73, DOI 10.1016/j.jobaz.2015.05.001; Shimadu T, 2014, TECH J FOOD CHEM CHE, V30, P24; SUAMI T, 1993, FOOD CHEM, V46, P235, DOI 10.1016/0308-8146(93)90112-S; Yannacopoulos, 2012, MATH ANAL DETERMINIS, Vvol 42	15	0	0	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152174	10.1371/journal.pone.0152174	http://dx.doi.org/10.1371/journal.pone.0152174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015640	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900044
J	Zevel, D; Millay, DP; Seo, J; Graff, JM				Zevel, Daniel; Millay, Douglas P.; Seo, Jin; Graff, Jonathan M.			Exercise-Induced Skeletal Muscle Adaptations Alter the Activity of Adipose Progenitor Cells	PLOS ONE			English	Article							INDUCED OBESE MICE; HIGH-FAT-DIET; WEIGHT-LOSS; FIBER-TYPE; WHITE FAT; TISSUE; ADIPOGENESIS; METABOLISM; HUMANS; RATS	Exercise decreases adiposity and improves metabolic health; however, the physiological and molecular underpinnings of these phenomena remain unknown. Here, we investigate the effect of endurance training on adipose progenitor lineage commitment. Using mice with genetically labeled adipose progenitors, we show that these cells react to exercise by decreasing their proliferation and differentiation potential. Analyses of mouse models that mimic the skeletal muscle adaptation to exercise indicate that muscle, in a non-autonomous manner, regulates adipose progenitor homeostasis, highlighting a role for muscle-derived secreted factors. These findings support a humoral link between skeletal muscle and adipose progenitors and indicate that manipulation of adipose stem cell function may help address obesity and diabetes.	[Zevel, Daniel; Seo, Jin; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Millay, Douglas P.; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Millay, Douglas P.; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Med, Div Endocrinol, Dallas, TX 75390 USA; [Zevel, Daniel] Icahn Sch Med, Dept Pediat, New York, NY USA; [Millay, Douglas P.] Univ Cincinnati, Dept Pediat, Div Mol Cardiovasc Biol, Cincinnati, OH USA; [Seo, Jin] Rogers State Univ, Dept Biol, Claremore, OK USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Cincinnati	Graff, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.; Graff, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Graff, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.; Graff, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Div Endocrinol, Dallas, TX 75390 USA.	jon.graff@utsouthwestern.edu		Zeve, Daniel/0000-0002-4117-1282	Postdoctoral fellowship grant from South Central Affiliate of the American Heart Association; National Institute of Health and the National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK066556, R01 DK064261, R01 DK088220]; National Institute of Health Ruth L. Kirschstein National Research Service Award [F32AR05948403]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064261, R01DK088220, R01DK066556] Funding Source: NIH RePORTER	Postdoctoral fellowship grant from South Central Affiliate of the American Heart Association; National Institute of Health and the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Health Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DZ: Predoctoral fellowship grant from the South Central Affiliate of the American Heart Association. DPM: National Institute of Health Ruth L. Kirschstein National Research Service Award (F32AR05948403). JS: Postdoctoral fellowship grant from the South Central Affiliate of the American Heart Association. JMG: National Institute of Health and the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK066556, R01 DK064261 and R01 DK088220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER P, 1995, INT J OBESITY, V19, pS18; Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; BUNT JC, 1986, SPORTS MED, V3, P331, DOI 10.2165/00007256-198603050-00003; Carpenter KC, 2012, COMPARATIVE MED, V62, P21; Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015; HENRIKSSON J, 1992, DIABETES CARE, V15, P1701, DOI 10.2337/diacare.15.11.1701; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim SM, 2014, CELL METAB, V20, P1049, DOI 10.1016/j.cmet.2014.10.010; King NA, 2012, BRIT J SPORT MED, V46, P315, DOI 10.1136/bjsm.2010.082495; KRIKETOS AD, 1995, AM J PHYSIOL-REG I, V269, pR1154, DOI 10.1152/ajpregu.1995.269.5.R1154; Lapid K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6196; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Parrott CR, 2011, J DIABETES MELL, V1, P71, DOI DOI 10.4236/JDM.2011.14011; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; POEHLMAN ET, 1991, SPORTS MED, V11, P78, DOI 10.2165/00007256-199111020-00002; Poirier Paul, 2001, Cardiology Clinics, V19, P459, DOI 10.1016/S0733-8651(05)70229-0; Popovic V, 2005, HORM METAB RES, V37, P533, DOI 10.1055/s-2005-870418; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sakurai T, 2010, ACTA PHYSIOL, V200, P325, DOI [10.1111/j.1748-1716.2010.02159.x, 10.1111/j.1748-1708.2010.02159.x]; Sennott Jacqueline, 2008, Pathophysiology, V15, P173, DOI 10.1016/j.pathophys.2008.06.001; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Sertie RAL, 2013, J APPL PHYSIOL, V115, P394, DOI 10.1152/japplphysiol.01272.2012; Soderlund A, 2009, PERSPECT PUBLIC HEAL, V129, P132, DOI 10.1177/1757913908094805; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Stanford KI, 2015, DIABETES, V64, P2361, DOI 10.2337/db15-0227; Stanford KI, 2015, DIABETES, V64, P2002, DOI 10.2337/db14-0704; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Tchoukalova YD, 2012, DIABETES, V61, P137, DOI 10.2337/db10-1768; Terjung R, 1979, Exerc Sport Sci Rev, V7, P153; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Zeve D, 2012, CELL METAB, V15, P492, DOI 10.1016/j.cmet.2012.03.010; Zeve D, 2009, CELL STEM CELL, V5, P472, DOI 10.1016/j.stem.2009.10.014	51	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152129	10.1371/journal.pone.0152129	http://dx.doi.org/10.1371/journal.pone.0152129			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015423	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708900042
J	Shrestha, E; Hussein, MA; Savas, JN; Ouimet, M; Barrett, TJ; Leone, S; Yates, JR; Moore, KJ; Fisher, EA; Garabedian, MJ				Shrestha, Elina; Hussein, Maryem A.; Savas, Jeffery N.; Ouimet, Mireille; Barrett, Tessa J.; Leone, Sarah; Yates, John R., III; Moore, Kathryn J.; Fisher, Edward A.; Garabedian, Michael J.			Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; atherosclerosis; cholesterol regulation; gene expression; nuclear receptor; transcription corepressor; ABCA1; ADP-ribosylation; LXR; PARP-1	SIGNALING PATHWAY; GENE-EXPRESSION; LXR; PARP-1; INHIBITION; PROTEIN; MICE; ATHEROSCLEROSIS; METABOLISM; ALPHA	Liver X receptors (LXR) are oxysterol-activated nuclear receptors that play a central role in reverse cholesterol transport through up-regulation of ATP-binding cassette transporters (ABCA1 and ABCG1) that mediate cellular cholesterol efflux. Mouse models of atherosclerosis exhibit reduced atherosclerosis and enhanced regression of established plaques upon LXR activation. However, the coregulatory factors that affect LXR-dependent gene activation in macrophages remain to be elucidated. To identify novel regulators of LXR that modulate its activity, we used affinity purification and mass spectrometry to analyze nuclear LXR complexes and identified poly(ADP-ribose) polymerase-1 (PARP-1) as an LXR-associated factor. In fact, PARP-1 interacted with both LXR and LXR. Both depletion of PARP-1 and inhibition of PARP-1 activity augmented LXR ligand-induced ABCA1 expression in the RAW 264.7 macrophage line and primary bone marrow-derived macrophages but did not affect LXR-dependent expression of other target genes, ABCG1 and SREBP-1c. Chromatin immunoprecipitation experiments confirmed PARP-1 recruitment at the LXR response element in the promoter of the ABCA1 gene. Further, we demonstrated that LXR is poly(ADP-ribosyl)ated by PARP-1, a potential mechanism by which PARP-1 influences LXR function. Importantly, the PARP inhibitor 3-aminobenzamide enhanced macrophage ABCA1-mediated cholesterol efflux to the lipid-poor apolipoprotein AI. These findings shed light on the important role of PARP-1 on LXR-regulated lipid homeostasis. Understanding the interplay between PARP-1 and LXR may provide insights into developing novel therapeutics for treating atherosclerosis.	[Shrestha, Elina; Hussein, Maryem A.; Leone, Sarah; Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA; [Savas, Jeffery N.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Ouimet, Mireille; Barrett, Tessa J.; Moore, Kathryn J.; Fisher, Edward A.] NYU, Sch Med, Dept Med, Div Cardiol,Marc & Ruti Bell Program Vasc Biol, New York, NY 10016 USA; [Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	New York University; Northwestern University; Feinberg School of Medicine; New York University; Scripps Research Institute	Garabedian, MJ (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.	michael.garabedian@nyumc.org	Fisher, Edward/ABE-7469-2020; Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Barrett, Tessa/0000-0003-0751-1578; Fisher, Edward/0000-0001-9802-143X	National Institutes of Health from the National Center for the Advancement of Translational Science [T32GM007238, UL1TR000038]; Vilcek Foundation; American Heart Association [15POST25090199];  [P41GM103533];  [R01MH067880];  [F32AG039127];  [R00DC013805];  [T32AI07180];  [T32GM007308];  [R01HL117226];  [R01HL117334]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117334, R01HL117226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, T32GM007308, T32GM007238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC013805] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for the Advancement of Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilcek Foundation; American Heart Association(American Heart Association); ; ; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported in part by National Institutes of Health Grants T32GM007238 and UL1TR000038 from the National Center for the Advancement of Translational Science (to E. S.) and Grants P41GM103533 and R01MH067880 (to J. R. Y.), F32AG039127 and R00DC013805 (to J. N. S.), T32AI07180 and T32GM007308 (to M. A. H.), R01HL117226 (to M. J. G. and E. A. F.), and R01HL117334 (to K. J. M.); by a fellowship from the Vilcek Foundation (to E. S.); and by American Heart Association Fellowship 15POST25090199 (to M. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aiello RJ, 2003, ARTERIOSCL THROM VAS, V23, P972, DOI 10.1161/01.ATV.0000054661.21499.FB; Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Costet P, 2000, J BIOL CHEM, V275, P28240; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Hans CP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007430; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kong RR, 2011, J BIOL CHEM, V286, P7139, DOI 10.1074/jbc.M110.173393; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Mita P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063879; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Muthurajan UM, 2014, P NATL ACAD SCI USA, V111, P12752, DOI 10.1073/pnas.1405005111; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Peng XN, 2012, ACTA BIOCH BIOPH SIN, V44, P911, DOI 10.1093/abbs/gms080; Petrilli V, 2004, J CLIN INVEST, V114, P1072, DOI 10.1172/JCI200421854; Radovits T, 2007, EUR J PHARMACOL, V564, P158, DOI 10.1016/j.ejphar.2007.02.060; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Savas JN, 2008, P NATL ACAD SCI USA, V105, P10820, DOI 10.1073/pnas.0800658105; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Torra IP, 2008, MOL CELL BIOL, V28, P2626, DOI 10.1128/MCB.01575-07; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; Vainio S, 2003, ANN MED, V35, P146, DOI 10.1080/07853890310008198; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang C, 2013, MOL CELL BIOL, V33, P4492, DOI 10.1128/MCB.00160-13; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wei SJ, 2013, BBA-MOL CELL RES, V1833, P479, DOI 10.1016/j.bbamcr.2012.11.007; Xu SW, 2014, MED RES REV, V34, P644, DOI 10.1002/med.21300; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang FX, 2013, J BIOL CHEM, V288, P11348, DOI 10.1074/jbc.M112.429134	63	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11172	11184		10.1074/jbc.M116.726729	http://dx.doi.org/10.1074/jbc.M116.726729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27026705	Green Published, hybrid			2022-12-26	WOS:000377042100020
J	Bahijri, SM; Jambi, HA; Al Raddadi, RM; Ferns, G; Tuomilehto, J				Bahijri, Suhad M.; Jambi, Hanan A.; Al Raddadi, Rajaa M.; Ferns, Gordon; Tuomilehto, Jaakko			The Prevalence of Diabetes and Prediabetes in the Adult Population of Jeddah, Saudi Arabia- A Community-Based Survey	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; UNITED-STATES; METABOLIC SYNDROME; RISK-FACTORS; LIFE-STYLE; OBESITY; PREVENTION	Background Type 2 (T2DM) is believed to be common in Saudi Arabia, but data are limited. In this population survey, we determined the prevalence of T2DM and prediabetes. Materials and Methods A representative sample among residents aged >= 18 years of the city of Jeddah was obtained comprising both Saudi and non-Saudi families (N = 1420). Data on dietary, clinical and sociodemographic characteristics were collected and anthropometric measurements taken. Fasting plasma glucose and glycated hemoglobin (HbA1c) were used to diagnose diabetes and prediabetes employing American Diabetes Association criteria. Multiple logistic regression analysis was used to identify factors associated with T2DM. Results Age and sex standardized prevalence of prediabetes was 9.0% (95% CI 7.5-10.5); 9.4% (7.1-11.8) in men and 8.6% (6.6-10.6) in women. For DM it was 12.1% (10.7-13.5); 12.9% (10.7-13.5) in men and 11.4% (9.5-13.3) in women. The prevalence based on World Population as standard was 18.3% for DM and 11.9% for prediabetes. The prevalence of DM and prediabetes increased with age. Of people aged >= 50 years 46% of men and 44% of women had DM. Prediabetes and DM were associated with various measures of adiposity. DM was also associated with and family history of dyslipidemia in women, cardiovascular disease in men, and with hypertension, dyslipidemia and family history of diabetes in both sexes. Discussion Age was the strongest predictor of DM and prediabetes followed by obesity. Of people aged 50 years or over almost half had DM and another 10-15% had prediabetes leaving only a small proportion of people in this age group with normoglycemia. Since we did not use an oral glucose tolerance test the true prevalence of DM and prediabetes is thus likely to be even higher than reported here. These results demonstrate the urgent need to develop primary prevention strategies for type 2 diabetes in Saudi Arabia.	[Bahijri, Suhad M.] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21413, Saudi Arabia; [Bahijri, Suhad M.; Jambi, Hanan A.; Al Raddadi, Rajaa M.; Ferns, Gordon; Tuomilehto, Jaakko] King Abdulaziz Univ, King Fahd Med Res Ctr, Saudi Diabet Study Res Group, Jeddah 21413, Saudi Arabia; [Jambi, Hanan A.] King Abdulaziz Univ, Dept Food & Nutr, Home Econ, Jeddah 21413, Saudi Arabia; [Al Raddadi, Rajaa M.] Minist Hlth, Publ Hlth Directorate, Jeddah, Saudi Arabia; [Ferns, Gordon] Brighton & Sussex Med Sch, Div Med Educ, Mayfield House, Brighton, E Sussex, England; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman, Kuwait	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; Ministry of Health - Saudi Arabia; University of Brighton; University of Sussex; Danube University Krems	Bahijri, SM (corresponding author), King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21413, Saudi Arabia.; Bahijri, SM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Saudi Diabet Study Res Group, Jeddah 21413, Saudi Arabia.	sbahijri@gmail.com	Al-Raddadi, Rajaa/F-8337-2010; Bahijri, Suhad M/AAF-4141-2020; Ghayour-Mobarhan, Majid/AAY-5963-2020	Al-Raddadi, Rajaa/0000-0002-8921-9628; Bahijri, Suhad M/0000-0001-6674-5409; 	King Abdulaziz University Deanship of Scientific Research [01-33-RG]	King Abdulaziz University Deanship of Scientific Research	This study was funded by King Abdulaziz University Deanship of Scientific Research, grant number (01-33-RG), http://dsr.kau.edu.sa/Default.aspx?Site_ID=305&lng=AR.	Al-Kaabba A., 2012, OJEMD, V2, P89, DOI [10.4236/ojemd.2012.24014, DOI 10.4236/OJEMD.2012.24014]; Al-Nozha MM, 2007, SAUDI MED J, V28, P77; Al-Nozha MM, 2005, SAUDI MED J, V26, P824; Al-Nozha MM, 2004, DIABETES MELLITUS SA; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alqurashi KA, 2011, ANN SAUDI MED, V31, P19, DOI 10.4103/0256-4947.75773; [Anonymous], 2003, WORLD POPULATION PRO; [Anonymous], 2000, WHO NCD RISK FACTORS; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Bahijri SM, 2013, THER ADV ENDOCRINOL, V4, P51, DOI 10.1177/2042018813483165; Balkau B, 2006, EUR J CLIN NUTR, V60, P295, DOI 10.1038/sj.ejcn.1602308; Borch-Johnsen K, 2003, DIABETIC MED, V20, P175, DOI 10.1046/j.1464-5491.2003.00842.x; Bray GA, 2008, AM J CLIN NUTR, V87, P1212, DOI 10.1093/ajcn/87.5.1212; Cheng C, 2006, METABOLISM, V55, P434, DOI 10.1016/j.metabol.2005.10.003; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cox BD, 1996, BRIT MED J, V313, P1487, DOI 10.1136/bmj.313.7070.1487; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Elhadd TA, 2007, ANN SAUDI MED, V27, P241; Grais R.F., 2007, EMERG THEMES EPIDEMI, V4, P1; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; IDF, 2014, INT DIAB FED 2013; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karter AJ, 2005, DIABETES OBES METAB, V7, P230, DOI 10.1111/j.1463-1326.2004.00441.x; Kim KS, 2008, DIABETIC MED, V25, P997, DOI 10.1111/j.1464-5491.2008.02489.x; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; MACMAHON S, 1987, EUR HEART J, V8, P57, DOI 10.1093/eurheartj/8.suppl_B.57; MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Okosun IS, 2001, OBES RES, V9, P1, DOI 10.1038/oby.2001.1; Patel P., 2010, DIABETES, V100, P13; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Ramachandran A, 2002, J Indian Med Assoc, V100, P425; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Satman I, 2013, EUR J EPIDEMIOL, V28, P169, DOI 10.1007/s10654-013-9771-5; Schwarz PEH, 2008, EXP CLIN ENDOCR DIAB, V116, P167, DOI 10.1055/s-2007-992115; Scott CL, 2003, AM J CARDIOL, V92, p35I, DOI 10.1016/S0002-9149(03)00507-1; Thabit H, 2013, DIABETES VASC DIS RE, V10, P337, DOI 10.1177/1479164113479808; Uusitupa MI, 2011, DIABETES CARE, V34, P418, DOI 10.2337/dc10-1013; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhao XL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-821; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743; Zimmet PZ, 2005, MED J AUSTRALIA, V183, P175, DOI 10.5694/j.1326-5377.2005.tb06987.x	50	62	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152559	10.1371/journal.pone.0152559	http://dx.doi.org/10.1371/journal.pone.0152559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035920	Green Published, gold, Green Accepted			2022-12-26	WOS:000373201200022
J	Choo, SW; Dutta, A; Wong, GJ; Wee, WY; Ang, MY; Siow, CC				Choo, Siew Woh; Dutta, Avirup; Wong, Guat Jah; Wee, Wei Yee; Ang, Mia Yang; Siow, Cheuk Chuen			Comparative Genomic Analysis Reveals a Possible Novel Non-Tuberculous Mycobacterium Species with High Pathogenic Potential	PLOS ONE			English	Article							VIRULENCE FACTOR; NITRATE REDUCTASE; ELEMENT PSAM2; PPE PROTEINS; TUBERCULOSIS; BIOSYNTHESIS; GROWTH; IDENTIFICATION; DISRUPTION; GENES	Mycobacteria have been reported to cause a wide range of human diseases. We present the first whole-genome study of a Non-Tuberculous Mycobacterium, Mycobacterium sp. UM_CSW (referred to hereafter as UM_CSW), isolated from a patient diagnosed with bronchiectasis. Our data suggest that this clinical isolate is likely a novel mycobacterial species, supported by clear evidence from molecular phylogenetic, comparative genomic, ANI and AAI analyses. UM_CSW is closely related to the Mycobacterium avium complex. While it has characteristic features of an environmental bacterium, it also shows a high pathogenic potential with the presence of a wide variety of putative genes related to bacterial virulence and shares very similar pathogenomic profiles with the known pathogenic mycobacterial species. Thus, we conclude that this possible novel Mycobacterium species should be tightly monitored for its possible causative role in human infections.	[Choo, Siew Woh; Wee, Wei Yee] Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur 50603, Malaysia; [Choo, Siew Woh; Dutta, Avirup; Wong, Guat Jah; Wee, Wei Yee; Ang, Mia Yang; Siow, Cheuk Chuen] Univ Malaya, Genome Informat Res Lab, High Impact Res HIR Bldg, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Choo, SW (corresponding author), Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur 50603, Malaysia.; Choo, SW (corresponding author), Univ Malaya, Genome Informat Res Lab, High Impact Res HIR Bldg, Kuala Lumpur 50603, Malaysia.	lchoo@um.edu.my		Dutta, Avirup/0000-0002-3595-6198	University of Malaya (UM) High Impact Research grant [UM-MOHE UM.C/HIR/MOHE/08]; University of Malaya Research Grant (UMRG) [RG541-13HTM]; UM High Impact Research grant from Ministry of Higher Education Malaysia [UM-MOHE UM.C/HIR/MOHE/08]; UMRG grant from the University of Malaya [RG541-13HTM]	University of Malaya (UM) High Impact Research grant; University of Malaya Research Grant (UMRG); UM High Impact Research grant from Ministry of Higher Education Malaysia; UMRG grant from the University of Malaya	This work was supported by University of Malaya (UM) High Impact Research grant (grant number: UM-MOHE UM.C/HIR/MOHE/08), and University of Malaya Research Grant (UMRG) grant (Project code: RG541-13HTM).; We would like to thank all members from the Genome Research Informatics Group for their IT or bioinformatics assistance and supports. Special thanks to Professor Dr. Ngeow Yun Fong from University of Malaya for her generosity in providing DNA material, valuable inputs and proofreading this manuscript. This research was funded by the UM High Impact Research grant (grant number: UM-MOHE UM.C/HIR/MOHE/08) from the Ministry of Higher Education Malaysia and the UMRG grant (Project code: RG541-13HTM) from the University of Malaya	Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Basu P., 2010, MICROBE MAG, V5, P53, DOI DOI 10.1128/MICR0BE.5.53.1; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Cayrou C, 2010, MICROBIOL-SGM, V156, P687, DOI 10.1099/mic.0.033522-0; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Cook JL, 2010, BRIT MED BULL, V96, P45, DOI 10.1093/bmb/ldq035; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; Falkinham JO, 2013, SEMIN RESP CRIT CARE, V34, P95, DOI 10.1055/s-0033-1333568; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Fischer LJ, 1996, INFECT IMMUN, V64, P269, DOI 10.1128/IAI.64.1.269-276.1996; Garcia-Pelayo MC, 2004, TUBERCULOSIS, V84, P159, DOI 10.1016/j.tube.2003.12.002; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gaur RL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004376; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Giffin MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045459; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; HAGEGE J, 1993, J BACTERIOL, V175, P5529; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Hutter B, 1999, FEMS MICROBIOL LETT, V178, P63, DOI 10.1016/S0378-1097(99)00348-1; KING CH, 1993, INFECT IMMUN, V61, P2708, DOI 10.1128/IAI.61.6.2708-2712.1993; Klink M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073333; Knoll BM, 2012, TRANSPL INFECT DIS, V14, P452, DOI 10.1111/j.1399-3062.2012.00753.x; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Li W, 2013, CELL PHYSIOL BIOCHEM, V31, P1, DOI 10.1159/000343343; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Park SJ, 2003, J BACTERIOL, V185, P5391, DOI 10.1128/JB.185.18.5391-5397.2003; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Puri RV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070514; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rindi L, 2002, MICROBIOL-SGM, V148, P3873, DOI 10.1099/00221287-148-12-3873; Roberts GD, 1991, MANUAL CLIN MICROBIO, P304; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sezonov G, 2000, J BACTERIOL, V182, P1243, DOI 10.1128/JB.182.5.1243-1250.2000; Sherman DR, 1999, BIOFACTORS, V10, P211, DOI 10.1002/biof.5520100219; Shi L, 2008, TUBERCULOSIS, V88, P1, DOI 10.1016/j.tube.2007.08.007; Shukla S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004471; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; UDOU T, 1994, CAN J MICROBIOL, V40, P318, DOI 10.1139/m94-052; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	67	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0150413	10.1371/journal.pone.0150413	http://dx.doi.org/10.1371/journal.pone.0150413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035710	Green Published, gold, Green Submitted			2022-12-26	WOS:000373201200004
J	Bolanca, I; Obhodas, J; Ljiljak, D; Matjacic, L; Kuna, K				Bolanca, Ivan; Obhodas, Jasmina; Ljiljak, Dejan; Matjacic, Lidija; Kuna, Krunoslav			Synergetic Effects of K, Ca, Cu and Zn in Human Semen in Relation to Parameters Indicative of Spontaneous Hyperactivation of Spermatozoa	PLOS ONE			English	Article							SPERM HYPERACTIVATION; CATSPER CHANNELS; MAMMALIAN SPERM; CALCIUM; ZINC; MAGNESIUM; PH	We have observed that sperm quality parameters indicative of spermatozoa hyperactivation such are lower "linearity" and "straightness", and as showed by this research "elongation", were more pronounced in patients with normal spermiogram compared to the group of men with reduced sperm motility who were undergoing routine in vitro fertilisation. The research encompassed 97 men diagnosed with normozoospermia (n = 20), asthenozoospermia (n = 54) and oligoasthenozoospermia (n = 23). The findings indicate that sperm quality of patients with normal spermiogram diagnosed according to WHO criteria, may be compromised by showing premature spontaneous hyperactivation which can decrease the chances of natural conception. We assessed synergistic effects of multiple chemical elements in ejaculated semen to find if premature spontaneous hyperactivation of spermatozoa can be a sign of imbalanced semen composition especially of elements K, Ca, Cu and Zn. Human semen samples showing low or high baseline status of chemical elements concentrations were found in samples from all three diagnostic groups. However, correlation of K/Ca and Cu/Zn ratios, taking into account samples from all three groups of men, were negative at statistical significance level p = 0.01. We tested if the negative correlation between K/Ca and Cu/Zn ratio works for greater number of semen samples. We found the negative correlation to be valid for 175 semen samples at statistical significance of p = 0.00002. The ratio of K/Ca and Cu/Zn, i.e. increased concentrations of K and Zn in comparison to concentrations of Ca and Cu, were associated with a decrease of "straightness" in the group of men with normal spermiogram and pronounced spontaneous hyperactivation of spermatozoa, implying that these elements act in synergy and that the balance of elements and not their absolute concentrations plays the major role in premature spermatozoa hyperactivation in ejaculated semen.	[Bolanca, Ivan; Ljiljak, Dejan; Kuna, Krunoslav] Univ Hosp Ctr Sestre Milosrdnice, Dept Obstet & Gynecol, Vinogradska C 29, Zagreb 10000, Croatia; [Obhodas, Jasmina; Matjacic, Lidija] Rudjer Boskovic Inst, Bijenicka C 54, Zagreb 10000, Croatia	Rudjer Boskovic Institute	Obhodas, J (corresponding author), Rudjer Boskovic Inst, Bijenicka C 54, Zagreb 10000, Croatia.	jobhodas@irb.hr		Matjacic, Lidija/0000-0003-4765-2877	Croatian Ministry of Science, Education and Sports project (MZOS) [098-0362975-2881]	Croatian Ministry of Science, Education and Sports project (MZOS)	This work was supported by the Croatian Ministry of Science, Education and Sports project (MZOS) grant No.098-0362975-2881 (http://zprojekti.mzos.hr/page.aspx?pid=96&lid=1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2015, ASIAN J ANDROL, V17, P633, DOI 10.4103/1008-682X.153850; BABCOCK DF, 1987, J BIOL CHEM, V262, P15041; Beltran C, 2014, DEV BIOL, V394, P15, DOI 10.1016/j.ydbio.2014.07.017; Bjorndahl L, 2010, MOL HUM REPROD, V16, P23, DOI 10.1093/molehr/gap099; Chavez JC, 2014, J BIOL CHEM, V289, P32266, DOI 10.1074/jbc.M114.607556; Coomes RK, 1968, SELECTIVE UPTAKE 90Y, P146; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; DELAMIRANDE E, 1993, FERTIL STERIL, V59, P1291; DELAMIRANDE E, 1995, HUM REPROD, V10, P15, DOI 10.1093/humrep/10.suppl_1.15; Gavella M, 1998, DIABETOLOGIA CROATIC, P27; Horovitz CT, 2000, BIOCH ELEMENTS B, V13, P324; HUACUJA L, 1973, LIFE SCI, V13, P1383, DOI 10.1016/0024-3205(73)90159-8; Juyena NS, 2012, J ANDROL, V33, P536, DOI 10.2164/jandrol.110.012583; KAVANAGH JP, 1985, J REPROD FERTIL, V75, P35; Kirichok Y, 2011, MOL HUM REPROD, V17, P478, DOI 10.1093/molehr/gar044; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2010, J PHYSIOL-LONDON, V588, P4667, DOI 10.1113/jphysiol.2010.194142; Marquez B, 2007, BIOL REPROD, V76, P660, DOI 10.1095/biolreprod.106.055038; Marzec-Wroblewska U, 2011, BIOL TRACE ELEM RES, V143, P167, DOI 10.1007/s12011-010-8868-x; Mortimer ST, 2015, ASIAN J ANDROL, V17, P545, DOI 10.4103/1008-682X.154312; Mortimer ST, 2000, J ANDROL, V21, P515; ORGEBINCRIST MC, 1971, ANN BIOL ANIM BIOCH, V11, P547, DOI 10.1051/rnd:19710403; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Perez-Cerezales S, 2015, ASIAN J ANDROL, V17, P628, DOI 10.4103/1008-682X.154308; QUINN PJ, 1968, J REPROD FERTIL, V17, P35, DOI 10.1530/jrf.0.0170035; Sasaki H, 2005, PHOTODERMATOL PHOTO, V21, P9, DOI 10.1111/j.1600-0781.2005.00117.x; Singh H. P., 1998, Indian Journal of Physiology and Pharmacology, V42, P311; Snell RS, 2000, STRUCTURES ANTERIOR, P153; Sorensen MB, 1999, MOL HUM REPROD, V5, P331, DOI 10.1093/molehr/5.4.331; SUAREZ SS, 1987, J EXP ZOOL, V244, P331, DOI 10.1002/jez.1402440218; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; World Health Organization, 2010, LAB MAN EX PROC HUM; Wroblewski N, 2003, FERTIL STERIL, V79, P1584, DOI 10.1016/S0015-0282(03)00255-3	33	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152445	10.1371/journal.pone.0152445	http://dx.doi.org/10.1371/journal.pone.0152445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031102	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800073
J	Goncalves, F; de Moraes, MS; Ferreira, LB; Carreira, ACO; Kossugue, PM; Boaro, LCC; Bentini, R; Garcia, CRD; Sogayar, MC; Arana-Chavez, VE; Catalani, LH				Goncalves, Flavia; de Moraes, Miriam Santos; Ferreira, Lorraine Braga; Oliveira Carreira, Ana Claudia; Kossugue, Patricia Mayumi; Cidreira Boaro, Leticia Cristina; Bentini, Ricardo; da Silva Garcia, Celia Regina; Sogayar, Mari Cleide; Arana-Chavez, Victor Elias; Catalani, Luiz Henrique			Combination of Bioactive Polymeric Membranes and Stem Cells for Periodontal Regeneration: In Vitro and In Vivo Analyses	PLOS ONE			English	Article							GUIDED TISSUE REGENERATION; BONE MORPHOGENETIC PROTEIN-7; OSTEOBLASTIC DIFFERENTIATION; MECHANICAL-PROPERTIES; BARRIER MEMBRANES; GENE-EXPRESSION; GROWTH-FACTOR; SCAFFOLDS; DEFECTS; INFILTRATION	Regeneration of periodontal tissues requires a concerted effort to obtain consistent and predictable results in vivo. The aim of the present study was to test a new family of bioactive polymeric membranes in combination with stem cell therapy for periodontal regeneration. In particular, the novel polyester poly(isosorbide succinate-co-L-lactide) (PisPLLA) was compared with poly(L-lactide) (PLLA). Both polymers were combined with collagen (COL), hydroxyapatite (HA) and the growth factor bone morphogenetic protein-7 (BMP7), and their osteoinductive capacity was evaluated via in vitro and in vivo experiments. Membranes composed of PLLA/COL/HA or PisPLLA/COL/HA were able to promote periodontal regeneration and new bone formation in fenestration defects in rat jaws. According to quantitative real-time polymerase chain reaction (qRT-PCR) and Alizarin Red assays, better osteoconductive capacity and increased extracellular mineralization were observed for PLLA/COL/HA, whereas better osteoinductive properties were associated with PisPLLA/COL/HA. We concluded that membranes composed of either PisPLLA/COL/HA or PLLA/COL/HA present promising results in vitro as well as in vivo and that these materials could be potentially applied in periodontal regeneration.	[Goncalves, Flavia; Bentini, Ricardo; Catalani, Luiz Henrique] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, BR-05508000 Sao Paulo, SP, Brazil; [de Moraes, Miriam Santos; da Silva Garcia, Celia Regina] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, BR-05508090 Sao Paulo, SP, Brazil; [Ferreira, Lorraine Braga; Cidreira Boaro, Leticia Cristina; Arana-Chavez, Victor Elias] Univ Sao Paulo, Fac Odontol, Dept Biomat & Biol Oral, BR-05508000 Sao Paulo, SP, Brazil; [Oliveira Carreira, Ana Claudia; Kossugue, Patricia Mayumi; Sogayar, Mari Cleide] Univ Sao Paulo, Fac Med, NUCEL NETCEM Nucleo Terapia Celular & Mol, BR-05360130 Sao Paulo, SP, Brazil; [Sogayar, Mari Cleide] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Catalani, LH (corresponding author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, BR-05508000 Sao Paulo, SP, Brazil.	catalani@usp.br	Carreira, Ana Claudia Oliveira/B-7655-2012; Sogayar, Mari C/B-3980-2017; Gonçalves, Flavia/T-7159-2019; Boaro, Leticia CC/C-3167-2015; Goncalves, Flavia/ABJ-9410-2022; Catalani, Luiz Henrique/E-2841-2010; Goncalves, Flavia/L-6881-2015; Garcia, Celia R. S./A-4093-2011; Carreira, Ana Claudia Oliveira/AAR-4474-2021	Carreira, Ana Claudia Oliveira/0000-0002-9142-1155; Sogayar, Mari C/0000-0003-4805-4609; Gonçalves, Flavia/0000-0002-7202-7849; Boaro, Leticia CC/0000-0002-6687-585X; Catalani, Luiz Henrique/0000-0003-3689-1792; Goncalves, Flavia/0000-0002-7202-7849; Garcia, Celia R. S./0000-0003-2825-1701; Carreira, Ana Claudia Oliveira/0000-0002-9142-1155	CNPq; FAPESP [2010/17698-2, 2011/21442-6, 2011/51295-5]; BNDES; FAPESP; FINEP; MCTI; MS-DECIT	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); BNDES; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); MCTI; MS-DECIT	The authors FG, RB and LHC would like to thank CNPq and FAPESP (2010/17698-2 and 2011/21442-6) for funding. Additionally, MM and CRSG acknowledge funding from CNPq and FAPESP (2011/51295-5), and ACOC, PMK and MCS acknowledge funding from BNDES, CNPq, FAPESP, FINEP, MCTI and MS-DECIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichelmann-Reidy ME, 2008, J PERIODONTOL, V79, P387, DOI 10.1902/jop.2008.060521 ; Alfotawei R, 2014, J CRANIO MAXILL SURG, V42, P863, DOI 10.1016/j.jcms.2013.12.006; Alpar B, 2000, Clin Oral Investig, V4, P219, DOI 10.1007/s007840000079; Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032; Behfarnia Parichehr, 2012, Dent Res J (Isfahan), V9, P574; Benayahu D, 1997, BIOCHEM BIOPH RES CO, V231, P442, DOI 10.1006/bbrc.1997.6116; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Bottino MC, 2012, DENT MATER, V28, P703, DOI 10.1016/j.dental.2012.04.022; Burrows MC, 2012, MACROMOL BIOSCI, V12, P1660, DOI 10.1002/mabi.201200154; Bustos-Valenzuela JC, 2010, MOL BIOTECHNOL, V46, P118, DOI 10.1007/s12033-010-9287-0; Campos DM, 2014, BIORESEARCH OPEN ACC, V3, P117, DOI 10.1089/biores.2014.0015; Casarano R, 2009, POLYMER, V50, P6218, DOI 10.1016/j.polymer.2009.10.048; Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]; Cirelli JA, 1997, BIOMATERIALS, V18, P1227, DOI 10.1016/S0142-9612(97)00053-7; Costa PF, 2014, J CLIN PERIODONTOL, V41, P283, DOI 10.1111/jcpe.12214; Darby I, 2011, AUST DENT J, V56, P107, DOI 10.1111/j.1834-7819.2010.01301.x; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; Goncalves F, 2015, MATERIALS, V8, P408, DOI 10.3390/ma8020408; Hong JK, 2011, TISSUE ENG PART B-RE, V17, P125, DOI [10.1089/ten.teb.2010.0552, 10.1089/ten.TEB.2010.0552]; Huang KK, 2005, J PERIODONTAL RES, V40, P1, DOI 10.1111/j.1600-0765.2004.00752.x; Hunter KT, 2013, J BIOMED MATER RES A, V101, P1016, DOI 10.1002/jbm.a.34396; Imbronito AV, 2002, BIOMATERIALS, V23, P4079, DOI 10.1016/S0142-9612(02)00145-X; Kim JH, 2014, J DENT RES; King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801; Lee CH, 2014, TISSUE ENG PT A, V20, P1342, DOI [10.1089/ten.tea.2013.0386, 10.1089/ten.TEA.2013.0386]; Leong MF, 2009, J BIOMED MATER RES A, V91A, P231, DOI 10.1002/jbm.a.32208; Li JH, 2011, CHINESE MED J-PEKING, V124, P4022, DOI 10.3760/cma.j.issn.0366-6999.2011.23.033; Liu TM, 2013, TISSUE ENG PART B-RE, V19, P254, DOI [10.1089/ten.TEB.2012.0527, 10.1089/ten.teb.2012.0527]; Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mitchell A, 2014, J BIOMED MATER RES A, V102, P655, DOI 10.1002/jbm.a.34728; Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824; Nanci A, 2006, PERIODONTOL 2000, V40, P11, DOI 10.1111/j.1600-0757.2005.00141.x; Needleman IG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001724.pub2; Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402; Ngiam M, 2009, TISSUE ENG PT A, V15, P535, DOI 10.1089/ten.tea.2008.0011; Ni PY, 2011, INT J NANOMED, V6, P3065, DOI 10.2147/IJN.S25297; Nygaard-Ostby P, 2010, J CLIN PERIODONTOL, V37, P366, DOI 10.1111/j.1600-051X.2010.01532.x; Piattelli A, 1996, BIOMATERIALS, V17, P791, DOI 10.1016/0142-9612(96)81416-5; Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007; Rakhmatia YD, 2013, J PROSTHODONT RES, V57, P3, DOI 10.1016/j.jpor.2012.12.001; Reis ECC, 2011, BIOMATERIALS, V32, P9244, DOI 10.1016/j.biomaterials.2011.08.040; Requicha JF, 2014, TISSUE ENG PT A, V20, P2483, DOI [10.1089/ten.tea.2013.0360, 10.1089/ten.TEA.2013.0360]; Sanz M, 2000, PERIODONTOL 2000, V22, P169, DOI 10.1034/j.1600-0757.2000.2220111.x; Schofer MD, 2009, THESCIENTIFICWORLDJO, V9, P118, DOI 10.1100/tsw.2009.13; Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Simion M, 1994, Int J Periodontics Restorative Dent, V14, P166; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Torricelli P, 2014, MAT SCI ENG C-MATER, V36, P130, DOI 10.1016/j.msec.2013.11.050; Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x; VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2; Yang C, 2013, J PERIODONTAL IMPLAN, V43, P315, DOI 10.5051/jpis.2013.43.6.315; Zeng J, 2004, MACROMOL BIOSCI, V4, P1118, DOI 10.1002/mabi.200400092; Zohar R, 1997, J CELL PHYSIOL, V170, P88	55	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152412	10.1371/journal.pone.0152412	http://dx.doi.org/10.1371/journal.pone.0152412			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031990	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800070
J	Mahoney, S; Najera, M; Bai, Q; Burton, EA; Veser, G				Mahoney, Sharlee; Najera, Michelle; Bai, Qing; Burton, Edward A.; Veser, Goetz			The Developmental Toxicity of Complex Silica-Embedded Nickel Nanoparticles Is Determined by Their Physicochemical Properties	PLOS ONE			English	Article							DANIO-RERIO; SILVER NANOPARTICLES; LARVAL BEHAVIOR; IN-VITRO; ZEBRAFISH; EXPOSURE; CHLORPYRIFOS; CYTOTOXICITY; SIZE; COPPER	Complex engineered nanomaterials (CENs) are a rapidly developing class of structurally and compositionally complex materials that are expected to dominate the next generation of functional nanomaterials. The development of methods enabling rapid assessment of the toxicity risk associated with this type of nanomaterial is therefore critically important. We evaluated the toxicity of three differently structured nickel-silica nanomaterials as prototypical CENs: simple, surface-deposited Ni-SiO2 and hollow and non-hollow core-shell Ni@SiO2 materials (i.e., similar to 1-2 nm Ni nanoparticles embedded into porous silica shells with and without a central cavity, respectively). Zebrafish embryos were exposed to these CENs, and morphological (survival and malformations) and physiological (larval motility) endpoints were coupled with thorough characterization of physiochemical characteristics (including agglomeration, settling and nickel ion dissolution) to determine how toxicity differed between these CENs and equivalent quantities of Ni2+ salt (based on total Ni). Exposure to Ni2+ ions strongly compromised zebrafish larva viability, and surviving larvae showed severe malformations. In contrast, exposure to the equivalent amount of Ni CEN did not result in these abnormalities. Interestingly, exposure to Ni-SiO2 and hollow Ni@SiO2 provoked abnormalities of zebrafish larval motor function, indicating developmental toxicity, while non-hollow Ni@SiO2 showed no toxicity. Correlating these observations with physicochemical characterization of the CENs suggests that the toxicity of the Ni-SiO2 and hollow Ni@SiO2 material may result partly from an increased effective exposure at the bottom of the well due to rapid settling. Overall, our data suggest that embedding nickel NPs in a porous silica matrix may be a straightforward way to mitigate their toxicity without compromising their functional properties. At the same time, our results also indicate that it is critical to consider modification of the effective exposure when comparing different nanomaterial configurations, because effective exposure might influence NP toxicity more than specific "nano-chemistry" effects.	[Mahoney, Sharlee; Najera, Michelle; Veser, Goetz] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Najera, Michelle; Veser, Goetz] Univ Pittsburgh, Mascaro Ctr Sustainable Innovat, Pittsburgh, PA USA; [Bai, Qing; Burton, Edward A.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Burton, Edward A.] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Veser, G (corresponding author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.; Veser, G (corresponding author), Univ Pittsburgh, Mascaro Ctr Sustainable Innovat, Pittsburgh, PA USA.	gveser@pitt.edu	Burton, Edward/AAO-9677-2021; Burton, Edward/ABB-1324-2021; Veser, Goetz/I-5727-2013	Burton, Edward/0000-0002-8072-4636; Veser, Goetz/0000-0002-2084-4636	National Science Foundation-Chemical, Bioengineering, Environmental and Transport systems award [1236258]; U.S. Department of Education Graduate Assistance in Areas of National Need fellowship [P200A060149]; National Science Foundation Integrative Graduate Education and Research Traineeship Program [DGE0504645]; Directorate For Engineering [1236258] Funding Source: National Science Foundation	National Science Foundation-Chemical, Bioengineering, Environmental and Transport systems award; U.S. Department of Education Graduate Assistance in Areas of National Need fellowship(US Department of Education); National Science Foundation Integrative Graduate Education and Research Traineeship Program(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by National Science Foundation-Chemical, Bioengineering, Environmental and Transport systems award #1236258 (EB, GV; http://www.nsf.gov/div/index.jsp?div=cbet), U.S. Department of Education Graduate Assistance in Areas of National Need fellowship (P200A060149) (GV; http://www2.ed.gov/programs/gaann/index.html), and National Science Foundation Integrative Graduate Education and Research Traineeship Program DGE0504645 (GV; https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=12759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada K, 2010, FOLIA HISTOCHEM CYTO, V48, P524, DOI 10.2478/v10042-010-0045-8; ALEXANDER GB, 1954, J PHYS CHEM-US, V58, P453, DOI 10.1021/j150516a002; Alsop D, 2014, COMP BIOCHEM PHYS C, V165, P67, DOI 10.1016/j.cbpc.2014.05.001; [Anonymous], 2000, D85900 ASTM; Association NPER, 2013, NAT TOX PROGR PROP L; Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242; Auffan M, 2009, ENVIRON POLLUT, V157, P1127, DOI 10.1016/j.envpol.2008.10.002; Baganz D, 1998, WATER RES, V32, P948, DOI 10.1016/S0043-1354(97)00207-8; Bai W, 2010, J NANOPART RES, V12, P1645, DOI 10.1007/s11051-009-9740-9; Bar-Ilan O, 2012, NANOTOXICOLOGY, V6, P670, DOI 10.3109/17435390.2011.604438; Bhavsar S, 2014, CATAL TODAY, V228, P96, DOI 10.1016/j.cattod.2013.12.025; Borgmann U, 2001, ENVIRON POLLUT, V111, P189, DOI 10.1016/S0269-7491(00)00076-2; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Boudjahem AG, 2004, J CATAL, V221, P325, DOI 10.1016/j.jcat.2003.08.002; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Cao A, 2010, PHYS CHEM CHEM PHYS, V12, P13499, DOI 10.1039/c0cp00729c; Cario CL, 2011, J PHYSIOL-LONDON, V589, P3703, DOI 10.1113/jphysiol.2011.207308; Couto GG, 2007, J COLLOID INTERF SCI, V311, P461, DOI 10.1016/j.jcis.2007.03.045; Das KK, 2008, INDIAN J MED RES, V128, P412; DAVE G, 1991, ARCH ENVIRON CON TOX, V21, P126, DOI 10.1007/BF01055567; Deng XY, 2004, MATER LETT, V58, P276, DOI 10.1016/S0167-577X(03)00469-5; Duan JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074606; Duan JC, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1700-8; Duan JC, 2013, BIOMATERIALS, V34, P5853, DOI 10.1016/j.biomaterials.2013.04.032; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Farrell TC, 2011, NEUROBIOL DIS, V44, P9, DOI 10.1016/j.nbd.2011.05.016; George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Group TW, IMPORTANCE NICKEL CO; He MD, 2011, TOXICOL APPL PHARM, V253, P38, DOI 10.1016/j.taap.2011.03.008; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Ispas C, 2009, ENVIRON SCI TECHNOL, V43, P6349, DOI 10.1021/es9010543; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Jin P, 2004, J PHYS CHEM B, V108, P6311, DOI 10.1021/jp049754g; Johnson A, 2007, AQUAT TOXICOL, V84, P431, DOI 10.1016/j.aquatox.2007.07.003; Kienle C, 2009, ECOTOX ENVIRON SAFE, V72, P1740, DOI 10.1016/j.ecoenv.2009.04.014; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirchhoff M, 2005, NANOTECHNOLOGY, V16, pS401, DOI 10.1088/0957-4484/16/7/014; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Leite ER, 2002, J NANOSCI NANOTECHNO, V2, P89, DOI 10.1166/jnn.2002.070; Levin ED, 2004, NEUROTOXICOL TERATOL, V26, P719, DOI 10.1016/j.ntt.2004.06.013; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Limbach LK, 2007, ENVIRON SCI TECHNOL, V41, P4158, DOI 10.1021/es062629t; Lin SJ, 2013, SMALL, V9, P1608, DOI 10.1002/smll.201202115; Lin SJ, 2011, ACS NANO, V5, P7284, DOI 10.1021/nn202116p; Metin O, 2010, J AM CHEM SOC, V132, P1468, DOI 10.1021/ja909243z; Napierska D, 2012, CHEM RES TOXICOL, V25, P828, DOI 10.1021/tx200361v; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h; Nusslein-Volhard C, 2002, ZEBRAFISH; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Orger MB, 2009, ESSENTIAL ZEBRAFISH, P113; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001; Park J, 2005, MONODISPERSE NANOPAR; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; Powers CM, 2011, NEUROTOXICOL TERATOL, V33, P708, DOI 10.1016/j.ntt.2011.02.002; Powers CM, 2010, NEUROTOXICOL TERATOL, V32, P391, DOI 10.1016/j.ntt.2010.01.009; Prakasham RS, 2010, APPL BIOCHEM BIOTECH, V160, P1888, DOI 10.1007/s12010-009-8726-5; Roco MC, 2011, SCI POL REP, V1, P1, DOI 10.1007/978-94-007-1168-6_1; Rostrup-Nielsen JR, 2002, ADV CATAL, V47, P65, DOI 10.1016/S0360-0564(02)47006-X; Scheil V, 2009, ARCH ENVIRON CON TOX, V56, P238, DOI 10.1007/s00244-008-9192-8; Scheil V, 2010, ENVIRON TOXICOL, V25, P83, DOI 10.1002/tox.20477; Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004; Semisch A, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-10; Shang Y, 2009, SCI CHINA SER B, V52, P1033, DOI 10.1007/s11426-009-0141-9; Slotkin TA, 2008, TOXICOL APPL PHARM, V233, P211, DOI 10.1016/j.taap.2008.08.020; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Teeguarden JG, 2007, TOXICOL SCI, V95, P300, DOI 10.1093/toxsci/kfl165; Thomas JK, 2014, AQUAT TOXICOL, V152, P20, DOI 10.1016/j.aquatox.2014.03.022; Uzio D, 2010, CATAL REV, V52, P106, DOI 10.1080/01614940903510496; Warheit DB, 2008, TOXICOL SCI, V101, P183, DOI 10.1093/toxsci/kfm279; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Xu SC, 2011, J PINEAL RES, V51, P426, DOI 10.1111/j.1600-079X.2011.00906.x; Yang SP, 2013, ENVIRON SCI TECHNOL, V47, P4718, DOI 10.1021/es3047334; Zhao JS, 2009, J ENVIRON PATHOL TOX, V28, P177, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i3.10; Zhou YZ, 2014, NAT PROTOC, V9, P1533, DOI 10.1038/nprot.2014.094; Zhu XS, 2008, J ENVIRON SCI HEAL A, V43, P278, DOI 10.1080/10934520701792779; Zhu XF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/47/475303; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	84	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152010	10.1371/journal.pone.0152010	http://dx.doi.org/10.1371/journal.pone.0152010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031643	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000373121800027
J	McInroy, GR; Beraldi, D; Raiber, EA; Modrzynska, K; van Delft, P; Billker, O; Balasubramanian, S				McInroy, Gordon R.; Beraldi, Dario; Raiber, Eun-Ang; Modrzynska, Katarzyna; van Delft, Pieter; Billker, Oliver; Balasubramanian, Shankar			Enhanced Methylation Analysis by Recovery of Unsequenceable Fragments	PLOS ONE			English	Article							DNA-METHYLATION; PLASMODIUM-FALCIPARUM; SEQUENCING DATA; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; AMPLIFICATION; RESIDUES; DISPLAY; CANCER	Bisulfite sequencing is a valuable tool for mapping the position of 5-methylcytosine in the genome at single base resolution. However, the associated chemical treatment causes strand scission, which depletes the number of sequenceable DNA fragments in a library and thus necessitates PCR amplification. The AT-rich nature of the library generated from bisulfite treatment adversely affects this amplification, resulting in the introduction of major biases that can confound methylation analysis. Here, we report a method that enables more accurate methylation analysis, by rebuilding bisulfite-damaged components of a DNA library. This recovery after bisulfite treatment (ReBuilT) approach enables PCR-free bisulfite sequencing from low nanogram quantities of genomic DNA. We apply the ReBuilT method for the first whole methylome analysis of the highly AT-rich genome of Plasmodium berghei. Side-by-side comparison to a commercial protocol involving amplification demonstrates a substantial improvement in uniformity of coverage and reduction of sequence context bias. Our method will be widely applicable for quantitative methylation analysis, even for technically challenging genomes, and where limited sample DNA is available.	[McInroy, Gordon R.; Raiber, Eun-Ang; van Delft, Pieter; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, Cambs, England; [Beraldi, Dario; Balasubramanian, Shankar] Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, Cambs, England; [Modrzynska, Katarzyna; Billker, Oliver] Wellcome Trust Sanger Inst, Cambridge, Cambs, England; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge, Cambs, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; Wellcome Trust Sanger Institute; University of Cambridge	Balasubramanian, S (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, Cambs, England.; Balasubramanian, S (corresponding author), Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, Cambs, England.; Balasubramanian, S (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge, Cambs, England.	sb10031@cam.ac.uk	Balasubramanian, Shankar/C-1671-2009	Beraldi, Dario/0000-0003-1504-5212; Balasubramanian, Shankar/0000-0002-0281-5815; Billker, Oliver/0000-0003-1716-168X	Trinity College Cambridge; Wellcome Trust [099232/Z/12/Z]; Cancer Research UK; Cancer Research UK [19836] Funding Source: researchfish	Trinity College Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	GRM is supported by funding from Trinity College Cambridge and Herchel Smith. DB is supported by funding from the Wellcome Trust and Herchel Smith. EAR is a Herchel Smith Fellow. PVD is a Marie Curie Fellow of the European Union (FP7-PEOPLE-2013-IEF/624885). The Balasubramanian lab is supported by a Senior Investigator Award from the Wellcome Trust (099232/Z/12/Z to SB) and by core funding from Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GRM is supported by funding from Trinity College Cambridge and Herchel Smith. DB is supported by funding from the Wellcome Trust and Herchel Smith. EAR is a Herchel Smith Fellow. PVD is a Marie Curie Fellow of the European Union (FP7-PEOPLE-2013-IEF/624885). The Balasubramanian lab is supported by a Senior Investigator Award from the Wellcome Trust (099232/Z/12/Z to S.B.) and by core funding from Cancer Research UK.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Doolan D. L., METHODS MOL MED, V72, P25; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gelfman S, 2013, GENOME RES, V23, P789, DOI 10.1101/gr.143503.112; Gupta AP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003170; Hoeijmakers WAM, 2011, NAT PROTOC, V6, P1026, DOI 10.1038/nprot.2011.345; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ji LX, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00341; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Malmquist NA, 2012, P NATL ACAD SCI USA, V109, P16708, DOI 10.1073/pnas.1205414109; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Merrick CJ, 2010, EUKARYOT CELL, V9, P1150, DOI 10.1128/EC.00093-10; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Pedersen B. S., 2014, ARXIV14011129V2; Ponts N, 2013, CELL HOST MICROBE, V14, P696, DOI 10.1016/j.chom.2013.11.007; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; SANO H, 1982, P NATL ACAD SCI-BIOL, V79, P3584, DOI 10.1073/pnas.79.11.3584; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanaka K, 2007, BIOORG MED CHEM LETT, V17, P1912, DOI 10.1016/j.bmcl.2007.01.040; Taramasco O, 2013, RHMM HIDDEN MARKOV M; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Wang Q, 2013, NAT PROTOC, V8, P2022, DOI 10.1038/nprot.2013.118; WANG RYH, 1980, NUCLEIC ACIDS RES, V8, P4777, DOI 10.1093/nar/8.20.4777; Yu M, 2012, NAT PROTOC, V7, P2159, DOI 10.1038/nprot.2012.137; Zhang DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-59	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152322	10.1371/journal.pone.0152322	http://dx.doi.org/10.1371/journal.pone.0152322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031619	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000373121800057
J	Mynarova, A; Foitova, I; Kvac, M; Kvetonova, D; Rost, M; Morrogh-Bernard, H; Nurcahyo, W; Nguyen, C; Supriyadi, S; Sak, B				Mynarova, Anna; Foitova, Ivona; Kvac, Martin; Kvetonova, Dana; Rost, Michael; Morrogh-Bernard, Helen; Nurcahyo, Wisnu; Nguyen, Cathleen; Supriyadi, Supriyadi; Sak, Bohumil			Prevalence of Cryptosporidium spp., Enterocytozoon bieneusi, Encephalitozoon spp. and Giardia intestinalis in Wild, Semi-Wild and Captive Orangutans (Pongo abelii and Pongo pygmaeus) on Sumatra and Borneo, Indonesia	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; GORILLA-GORILLA-BERINGEI; NONHUMAN-PRIMATES; INFECTED PATIENTS; GASTROINTESTINAL PARASITES; MOLECULAR CHARACTERIZATION; ZOONOTIC TRANSMISSION; RISK-FACTORS; DUODENALIS; IDENTIFICATION	Background Orangutans are critically endangered primarily due to loss and fragmentation of their natural habitat. This could bring them into closer contact with humans and increase the risk of zoonotic pathogen transmission. Aims To describe the prevalence and diversity of Cryptosporidium spp., microsporidia and Giardia intestinalis in orangutans at seven sites on Sumatra and Kalimantan, and to evaluate the impact of orangutans' habituation and location on the occurrence of these zoonotic protists. Result The overall prevalence of parasites in 298 examined animals was 11.1%. The most prevalent microsporidia was Encephalitozoon cuniculi genotype II, found in 21 animals (7.0%). Enterocytozoon bieneusi genotype D (n = 5) and novel genotype Pongo 2 were detected only in six individuals (2.0%). To the best of our knowledge, this is the first report of theseparasites in orangutans. Eight animals were positive for Cryptosporidium spp. (2.7%), including C. parvum (n = 2) and C. muris (n = 6). Giardia intestinalis assemblage B, subtype MB6, was identified in a single individual. While no significant differences between the different human contact level groups (p = 0.479-0.670) or between the different islands (p = 0.992) were reported in case of E. bieneusi or E. cuniculi, Cryptosporidium spp. was significantly less frequently detected in wild individuals (p < 2x10(-16)) and was significantly more prevalent in orangutans on Kalimantan than on Sumatra (p < 2x10(-16)). Conclusion Our results revealed that wild orangutans are significantly less frequently infected by Cryptosporidium spp. than captive and semi-wild animals. In addition, this parasite was more frequently detected at localities on Kalimantan. In contrast, we did not detect any significant difference in the prevalence of microsporidia between the studied groups of animals. The sources and transmission modes of infections were not determined, as this would require repeated sampling of individuals, examination of water sources, and sampling of humans and animals sharing the habitat with orangutans.	[Mynarova, Anna] Univ South Bohemia Ceske Budejovice, Fac Sci, Ceske Budejovice, Czech Republic; [Mynarova, Anna; Kvac, Martin; Kvetonova, Dana; Sak, Bohumil] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic; [Foitova, Ivona] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Kvac, Martin] Univ South Bohemia Ceske Budejovice, Fac Agr, Ceske Budejovice, Czech Republic; [Rost, Michael] Univ South Bohemia Ceske Budejovice, Fac Econ, Ceske Budejovice, Czech Republic; [Morrogh-Bernard, Helen] Outrop, Sabangau, Indonesia; [Nurcahyo, Wisnu] Gadjah Mada Univ, Fac Vet Med, Dept Parasitol, Yogyakarta, Indonesia; [Foitova, Ivona; Nguyen, Cathleen] UMI Saving Pongidae Fdn, Brno, Czech Republic; [Supriyadi, Supriyadi] Univ West Nusa Tenggara UNTB, Mataram, Indonesia	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Masaryk University Brno; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; Gadjah Mada University	Sak, B (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.; Foitova, I (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.; Foitova, I (corresponding author), UMI Saving Pongidae Fdn, Brno, Czech Republic.	foitova@sci.muni.cz; casio@paru.cas.cz	Kvac, Martin/G-7299-2014; Kvac, Martin/AAT-9533-2020; Supriadi, Supriadi/AAQ-5713-2020; Sak, Bohumil/G-9262-2014; Nurcahyo, Wisnu/R-6603-2019; Rost, Michael/Y-6857-2018	Kvac, Martin/0000-0003-0013-6090; Supriadi, Supriadi/0000-0002-0760-7871; Rost, Michael/0000-0002-4081-6392	Foundation "UMI - Saving of Pongidae" Parasites and Natural Antiparasitics in Orangutan; Grant Agency of the Czech Republic [P505/11/1163]	Foundation "UMI - Saving of Pongidae" Parasites and Natural Antiparasitics in Orangutan; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The study was financially supported by the Foundation "UMI - Saving of Pongidae" Parasites and Natural Antiparasitics in Orangutan, and by Grant Agency of the Czech Republic P505/11/1163.	AHMAD SR, 1995, WATER RES, V29, P1599, DOI 10.1016/0043-1354(94)00266-A; Al-Mekhlafi MSH, 2005, T ROY SOC TROP MED H, V99, P686, DOI 10.1016/j.trstmh.2005.02.006; Ananta SM, 2014, ASIAN PAC J TROP MED, V7, P197, DOI 10.1016/S1995-7645(14)60020-1; Anuar TS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071870, 10.1371/]; Asma L, 2011, TROP BIOMED, V28, P400; Boubli Jean Philippe, 2004, Ecotropica (Bonn), V10, P149; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Butel C, 2015, INT J PRIMATOL, V36, P227, DOI 10.1007/s10764-015-9820-x; Choy SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06909; da Silva AJ, 2003, VET PARASITOL, V111, P297, DOI 10.1016/S0304-4017(02)00384-9; Descovich KA, 2011, INT J PRIMATOL, V32, P616, DOI 10.1007/s10764-011-9491-1; DIDIER ES, 1995, PARASITOLOGY, V111, P411, DOI 10.1017/S0031182000065914; Du SZ, 2015, KOREAN J PARASITOL, V53, P395, DOI 10.3347/kjp.2015.53.4.395; Farizawati S, 2005, Trop Biomed, V22, P89; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Foitova Ivona, 2009, P157; Galdikas BM, 2013, PRIMATES, V54, P61, DOI 10.1007/s10329-012-0331-5; GALDIKAS BMF, 1988, INT J PRIMATOL, V9, P1, DOI 10.1007/BF02740195; GOMEZ MS, 1992, PARASITOL RES, V78, P619, DOI 10.1007/BF00936462; Gomez MS, 2000, PARASITOL RES, V86, P318, DOI 10.1007/s004360050049; Graczyk TK, 2002, J PARASITOL, V88, P905, DOI 10.1645/0022-3395(2002)088[0905:AGDGAA]2.0.CO;2; Graczyk TK, 2002, PARASITOL RES, V88, P926, DOI 10.1007/s00436-002-0693-5; Graczyk TK, 2001, PARASITOL RES, V87, P368, DOI 10.1007/s004360000337; Hardus ME, 2012, BIOL CONSERV, V146, P177, DOI 10.1016/j.biocon.2011.12.014; Hasajova A, 2014, EUR J CLIN MICROBIOL, V33, P1401, DOI 10.1007/s10096-014-2082-2; HEUSCHELE WP, 1986, J WILDLIFE DIS, V22, P493, DOI 10.7589/0090-3558-22.4.493; Hope K, 2004, VET PARASITOL, V122, P165, DOI 10.1016/j.vetpar.2004.03.017; Husson Simon J., 2009, P77; ISEKI M, 1989, PARASITOL RES, V75, P218, DOI 10.1007/BF00931279; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Jones-Engel L, 2008, EMERG INFECT DIS, V14, P1200, DOI 10.3201/eid1408.071430; Karim MR, 2014, INT J PARASITOL, V44, P1039, DOI 10.1016/j.ijpara.2014.07.006; Katsumata T, 1998, AM J TROP MED HYG, V59, P628, DOI 10.4269/ajtmh.1998.59.628; KatzwinkelWladarsch S, 1996, TROP MED INT HEALTH, V1, P373, DOI 10.1046/j.1365-3156.1996.d01-51.x; Keita MB, 2014, MICROB PATHOGENESIS, V77, P149, DOI 10.1016/j.micpath.2014.09.003; Koehler AV, 2014, BIOTECHNOL ADV, V32, P280, DOI 10.1016/j.biotechadv.2013.10.009; Kurniawan A, 2013, ANN EPIDEMIOL, V23, P720, DOI 10.1016/j.annepidem.2013.07.019; Kvac M., 2014, CRYPTOSPORIDIUM PARA, P237, DOI DOI 10.1007/978-3-7091-1562-6_5; Labes EM, 2010, PARASITOLOGY, V137, P123, DOI 10.1017/S0031182009991120; Lai Karen P. F., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P578; Lalle M, 2005, J PARASITOL, V91, P203, DOI 10.1645/GE-293R; Langhout MV, 2010, J ZOO WILDLIFE MED, V41, P210, DOI 10.1638/2009-0051R1.1; Le Blancq SM, 1997, MOL BIOCHEM PARASIT, V90, P463, DOI 10.1016/S0166-6851(97)00181-3; Leelayoova S, 2006, J CLIN MICROBIOL, V44, P3001, DOI 10.1128/JCM.00945-06; Legesse M, 2004, ACTA TROP, V90, P231, DOI 10.1016/j.actatropica.2003.12.003; Lim YAL, 2008, VET PARASITOL, V157, P154, DOI 10.1016/j.vetpar.2008.07.015; Lim Y. A. L., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P801; Lim YAL, 2010, ADV PARASIT, V71, P1, DOI 10.1016/S0065-308X(10)71003-4; Lono A, 2011, T ROY SOC TROP MED H, V105, P409, DOI 10.1016/j.trstmh.2011.03.006; Lono A, 2010, T ROY SOC TROP MED H, V104, P214, DOI 10.1016/j.trstmh.2009.07.006; Mahdy AKM, 2008, T ROY SOC TROP MED H, V102, P465, DOI 10.1016/j.trstmh.2008.02.004; MAJEWSKA AC, 1990, VET PARASITOL, V35, P169, DOI 10.1016/0304-4017(90)90127-W; Manduell KL, 2012, AM J PRIMATOL, V74, P1128, DOI 10.1002/ajp.22072; McEvoy JM, 2009, LETT APPL MICROBIOL, V48, P302, DOI 10.1111/j.1472-765X.2008.02516.x; Meamar AR, 2007, APPL ENVIRON MICROB, V73, P1033, DOI 10.1128/AEM.00964-06; Menon B. S., 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P319; Messenger AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089055; MILLER RA, 1990, LAB ANIM SCI, V40, P42; MIRMANTO E, 2010, BIODIVERSITAS, V11, P82, DOI DOI 10.13057/biodiv/d110206; Mul IF, 2007, INT J PRIMATOL, V28, P407, DOI 10.1007/s10764-007-9119-7; Muriuki SMK, 1997, VET PARASITOL, V72, P141, DOI 10.1016/S0304-4017(97)00021-6; Muriuki SMK, 1998, ACTA TROP, V71, P73, DOI 10.1016/S0001-706X(98)00040-0; Nater A, 2013, J HERED, V104, P2, DOI 10.1093/jhered/ess065; Nizeyi JB, 2002, PARASITOL RES, V88, P380, DOI 10.1007/s00436-001-0543-x; Nizeyi JB, 1999, J PARASITOL, V85, P1084, DOI 10.2307/3285672; Norhayati M, 2007, ANN TROP MED PARASIT, V101, P547, DOI 10.1179/136485907X193789; Pedraza-Diaz S, 2009, VET PARASITOL, V160, P204, DOI 10.1016/j.vetpar.2008.11.003; Raoult D, 2012, CLIN MICROBIOL INFEC, V18, P513, DOI 10.1111/j.1469-0691.2012.03810.x; RIJKSEN H D, 1978, Mededelingen Landbouwhogeschool Wageningen, V78, P1; RUSSELL RG, 1987, LAB ANIM SCI, V37, P309; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sak B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109751; Sak B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071840; Sak B, 2011, FOLIA PARASIT, V58, P81, DOI 10.14411/fp.2011.008; Soba B, 2006, CLIN MICROBIOL INFEC, V12, P918, DOI 10.1111/j.1469-0691.2006.01465.x; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; van Schaik CP, 2005, PRIMATES, V46, P249, DOI 10.1007/s10329-005-0134-z; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; vanSchaik CP, 1995, NEGLECTED APE, P109; Meireles MV, 2007, VET PARASITOL, V147, P166, DOI 10.1016/j.vetpar.2007.03.034; Warren KS, 1998, J MED PRIMATOL, V27, P33, DOI 10.1111/j.1600-0684.1998.tb00066.x; Warren KS, 1999, J VIROL, V73, P7860, DOI 10.1128/JVI.73.9.7860-7865.1999; Wich SA, 2012, BIOL CONSERV, V146, P163, DOI 10.1016/j.biocon.2011.12.006; Wich SA, 2008, ORYX, V42, P620; Wilson HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102174; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653	91	31	33	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152771	10.1371/journal.pone.0152771	http://dx.doi.org/10.1371/journal.pone.0152771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031241	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800134
J	Nah, G; Lee, M; Kim, DS; Rayburn, AL; Voigt, T; Lee, DK				Nah, Gyoungju; Lee, Moonsub; Kim, Do-Soon; Rayburn, A. Lane; Voigt, Thomas; Lee, D. K.			Transcriptome Analysis of Spartina pectinata in Response to Freezing Stress	PLOS ONE			English	Article							ABIOTIC STRESS; PRAIRIE CORDGRASS; ARABIDOPSIS-THALIANA; PHOSPHOLIPASE-C; COLD TOLERANCE; PLANT-RESPONSES; CIRCADIAN CLOCK; GENE-EXPRESSION; ORYZA-SATIVA; PROTEIN	Prairie cordgrass (Spartina pectinata), a perennial C-4 grass native to the North American prairie, has several distinctive characteristics that potentially make it a model crop for production in stressful environments. However, little is known about the transcriptome dynamics of prairie cordgrass despite its unique freezing stress tolerance. Therefore, the purpose of this work was to explore the transcriptome dynamics of prairie cordgrass in response to freezing stress at -5 degrees C for 5 min and 30 min. We used a RNA-sequencing method to assemble the S. pectinata leaf transcriptome and performed gene-expression profiling of the transcripts under freezing treatment. Six differentially expressed gene (DEG) groups were categorized from the profiling. In addition, two major consecutive orders of gene expression were observed in response to freezing; the first being the acute up-regulation of genes involved in plasma membrane modification, calcium-mediated signaling, proteasome-related proteins, and transcription regulators (e.g., MYB and WRKY). The follow-up and second response was of genes involved in encoding the putative anti-freezing protein and the previously known DNA and cell-damage-repair proteins. Moreover, we identified the genes involved in epigenetic regulation and circadian-clock expression. Our results indicate that freezing response in S. pectinata reflects dynamic changes in rapid-time duration, as well as in metabolic, transcriptional, post-translational, and epigenetic regulation.	[Nah, Gyoungju; Kim, Do-Soon; Lee, D. K.] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Coll Agr & Life Sci, 599 Gwanangno, Seoul 08826, South Korea; [Lee, Moonsub; Rayburn, A. Lane; Voigt, Thomas; Lee, D. K.] Univ Illinois, Dept Crop Sci, 1120 S Goodwin Ave, Urbana, IL 61801 USA	Seoul National University (SNU); University of Illinois System; University of Illinois Urbana-Champaign	Lee, DK (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Coll Agr & Life Sci, 599 Gwanangno, Seoul 08826, South Korea.; Lee, DK (corresponding author), Univ Illinois, Dept Crop Sci, 1120 S Goodwin Ave, Urbana, IL 61801 USA.	leedk@illinois.edu			Brain Pool Program through the Korean Federation of Science and Technology Societies of the Ministry of Science, ICT and Future Planning (KOFST) [151S-4-3-1269]	Brain Pool Program through the Korean Federation of Science and Technology Societies of the Ministry of Science, ICT and Future Planning (KOFST)	The work was supported by Brain Pool Program through the Korean Federation of Science and Technology Societies of the Ministry of Science, ICT and Future Planning (KOFST), http://www.kofst.or.kr/main.bit?sys_type=000, Grant receiver: DKL, Grant Number: 151S-4-3-1269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Brain Pool Program through the Korean Federation of Science and Technology Societies of the Ministry of Science, ICT and Future Planning (151S-4-3-1269).	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Alves MS, 2011, PLANT SIGNAL BEHAV, V6, P1993, DOI 10.4161/psb.6.12.18268; Anderson E, 2013, WAT FOOD EN INN SUST; Arisz SA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00001; Baldoni E, 2015, INT J MOL SCI, V16, P15811, DOI 10.3390/ijms160715811; Banerjee Aditya, 2015, ScientificWorldJournal, V2015, P807560, DOI 10.1155/2015/807560; Blum A, 1988, PLANT BREEDING STRES, P286; Boe A, 2009, GCB BIOENERGY, V1, P240, DOI 10.1111/j.1757-1707.2009.01018.x; Byun MY, 2015, PLANT SCI, V236, P61, DOI 10.1016/j.plantsci.2015.03.020; Castells E, 2010, PLANT SIGNAL BEHAV, V5, P409, DOI 10.4161/psb.5.4.11213; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Choi C, 2015, NEW PHYTOL, V208, P846, DOI 10.1111/nph.13516; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Cybulska I, 2010, ENERG FUEL, V24, P718, DOI 10.1021/ef9009179; Dametto A, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1057369; Ding ZJ, 2015, PLANT J, V84, P56, DOI 10.1111/tpj.12958; Dudal R, 1976, INVENTORY MAJOR SOIL, P3; Dutilleul C, 2015, PLANT CELL ENVIRON, V38, P2688, DOI 10.1111/pce.12578; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Friesen PC, 2015, J EXP BOT, V66, P4403, DOI 10.1093/jxb/erv085; Gao Y, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/310402; Gedye K, 2010, PLANT GENOME-US, V3, P69, DOI 10.3835/plantgenome2010.06.0012; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Gulick PJ, 2005, GENOME, V48, P913, DOI 10.1139/g05-039; Guo J, 2015, BIOENERG RES, V8, P1371, DOI 10.1007/s12155-015-9604-3; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; Hichcock A., 1971, MANUAL GRASSES US; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; Ishikawa T, 2013, METHOD ENZYMOL, V527, P239, DOI 10.1016/B978-0-12-405882-8.00013-1; Janmohammadi M, 2015, PHYTOCHEMISTRY, V117, P76, DOI 10.1016/j.phytochem.2015.06.003; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Kim JM, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.00114, 10.3389/fpsyg.2015.00248]; Kim S, 2012, BIOENERG RES, V5, P225, DOI 10.1007/s12155-011-9145-3; Kim S, 2010, CROP SCI, V50, P2277, DOI 10.2135/cropsci2010.03.0140; Kim SM, 2015, BIORESOURCE TECHNOL, V183, P70, DOI 10.1016/j.biortech.2015.02.020; Kim YJ, 2004, FEBS LETT, V556, P127, DOI 10.1016/S0014-5793(03)01388-7; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Korasick DA, 2014, P NATL ACAD SCI USA, V111, P5427, DOI 10.1073/pnas.1400074111; Kurepa J, 2009, PLANT SIGNAL BEHAV, V4, P924, DOI 10.4161/psb.4.10.9469; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Los DA, 2004, BBA-BIOMEMBRANES, V1666, P142, DOI 10.1016/j.bbamem.2004.08.002; Luo JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138974; Luo M, 2012, BBA-GENE REGUL MECH, V1819, P129, DOI 10.1016/j.bbagrm.2011.06.008; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Mobberley D.G., 1953, TAXONOMY DISTRIBUTIO; Montemayor MB, 2008, ENVIRON EXP BOT, V62, P333, DOI 10.1016/j.envexpbot.2007.10.004; Msanne J, 2011, PLANTA, V234, P97, DOI 10.1007/s00425-011-1387-y; Nagarajan S, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9_1; Nah G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134419; Nakagawa M, 2011, PLANT PHYSIOL, V155, P414, DOI 10.1104/pp.110.166082; Nakaminami K, 2014, MOL CELL PROTEOMICS, V13, P3602, DOI 10.1074/mcp.M114.039081; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Ren L, 2015, PLANT CELL REP, V34, P2161, DOI 10.1007/s00299-015-1859-9; Ruelland E, 2002, PLANT PHYSIOL, V130, P999, DOI 10.1104/pp.006080; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Sanchez-Moran E, 2007, GENE DEV, V21, P2220, DOI 10.1101/gad.439007; Seung D, 2012, PROTOPLASMA, V249, P445, DOI 10.1007/s00709-011-0304-3; Shimoni-Shor E, 2010, PLANT CELL ENVIRON, V33, P1029, DOI 10.1111/j.1365-3040.2010.02124.x; Shimosaka E, 2015, BREEDING SCI, V65, P363, DOI 10.1270/jsbbs.65.363; Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062494; Sinha S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00932; Skinner RH, 2009, J SOIL WATER CONSERV, V64, P413, DOI 10.2489/jswc.64.6.413; Stone SL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00135; Stubbendieck J., 1997, N AM RANGE PLANTS, V5th ed.; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vergnolle C, 2005, PLANT PHYSIOL, V139, P1217, DOI 10.1104/pp.105.068171; Wang HH, 2015, PLANT MOL BIOL, V89, P157, DOI 10.1007/s11103-015-0360-8; Wang JM, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-203, 10.1186/1471-2156-15-33, 10.1186/1471-2164-15-415]; Wang S, 2011, DNA REPAIR, V10, P620, DOI 10.1016/j.dnarep.2011.04.009; Wang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058952; Wang XT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00615; Wathugala DL, 2011, NEW PHYTOL, V191, P984, DOI 10.1111/j.1469-8137.2011.03759.x; Weaver JE., 1954, N AM PRAIRIE; Weis C, 2013, J EXP BOT, V64, P3855, DOI 10.1093/jxb/ert217; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Xu MY, 2011, PLANT CELL REP, V30, P1949, DOI 10.1007/s00299-011-1103-1; Yang YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131391; Zeng HQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00600; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305	90	16	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152294	10.1371/journal.pone.0152294	http://dx.doi.org/10.1371/journal.pone.0152294			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032112	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800051
J	Kodama, Y				Kodama, Yutaka			Time Gating of Chloroplast Autofluorescence Allows Clearer Fluorescence Imaging In Planta	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; AGARTRAP; LOCALIZATION	Chloroplast, an organelle facilitating photosynthesis, exhibits strong autofluorescence, which is an undesired background signal that restricts imaging experiments with exogenous fluorophore in plants. In this study, the autofluorescence was characterized in planta under confocal laser microscopy, and it was found that the time-gated imaging technique completely eliminates the autofluorescence. As a demonstration of the technique, a clearer signal of fluorescent protein-tagged phototropin, a blue-light photoreceptor localized at the chloroplast periphery, was visualized in planta.	[Kodama, Yutaka] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 3218505, Japan	Utsunomiya University	Kodama, Y (corresponding author), Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 3218505, Japan.	kodama@cc.utsunomiya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26840088]; Plant Transgenic Design Initiative of University of Tsukuba; Japan Science Society; Utsunomiya University	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Plant Transgenic Design Initiative of University of Tsukuba; Japan Science Society; Utsunomiya University(Utsunomiya University)	This work was supported by the Japan Society for the Promotion of Science (JSPS); KAKENHI No. 26840088 (https://kaken.nii.ac.jp/d/p/26840088.en.html), the Plant Transgenic Design Initiative of University of Tsukuba (http://www.gene.tsukuba.ac.jp/en/ptrad), the Sasagawa Grants for Science Fellows (SGSF) of the Japan Science Society (http://www.jss.or.jp/), and the Research Projects (CORE Adopted & UU-COE-Next) of Utsunomiya University (http://www.utsunomiya-u.ac.jp/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Ishizaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138876; Kodama Y, 2010, P NATL ACAD SCI USA, V107, P19591, DOI 10.1073/pnas.1007836107; Komatsu A, 2014, PLANT PHYSIOL, V166, P411, DOI 10.1104/pp.114.245100; Kong SG, 2013, PLANT CELL PHYSIOL, V54, P80, DOI 10.1093/pcp/pcs151; Kong SG, 2006, PLANT J, V45, P994, DOI 10.1111/j.1365-313X.2006.02667.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; MARRIOTT G, 1991, BIOPHYS J, V60, P1374, DOI 10.1016/S0006-3495(91)82175-0; Ogasawara Y, 2013, PLANT CELL ENVIRON, V36, P1520, DOI 10.1111/pce.12085; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Tsuboyama S, 2014, PLANT CELL PHYSIOL, V55, P229, DOI 10.1093/pcp/pct168; Tsuboyama-Tanaka S, 2015, PLANT BIOTECHNOL-NAR, V32, P333, DOI 10.5511/plantbiotechnology.15.0813a; Tsuboyama-Tanaka S, 2015, J PLANT RES, V128, P337, DOI 10.1007/s10265-014-0695-2; Wu CL, 2008, IN VITRO CELL DEV-PL, V44, P540, DOI 10.1007/s11627-008-9126-1; Zhang L, 2010, BIOTECHNIQUES, V48, P125, DOI 10.2144/000113345; Zhou X, 2005, NEW PHYTOL, V168, P313, DOI 10.1111/j.1469-8137.2005.01489.x	17	62	61	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152484	10.1371/journal.pone.0152484	http://dx.doi.org/10.1371/journal.pone.0152484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027881	Green Submitted, gold, Green Published			2022-12-26	WOS:000373116500047
J	Szklany, K; Ruiter, E; Mian, F; Kunze, W; Bienenstock, J; Forsythe, P; Karimi, K				Szklany, Kirsten; Ruiter, Evelyn; Mian, Firoz; Kunze, Wolfgang; Bienenstock, John; Forsythe, Paul; Karimi, Khalil			Superior Cervical Ganglia Neurons Induce Foxp3+Regulatory T Cells via Calcitonin Gene-Related Peptide	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; VASOACTIVE-INTESTINAL-PEPTIDE; COLLAGEN-INDUCED ARTHRITIS; TRANSCRIPTION FACTOR FOXP3; COLONY-STIMULATING FACTOR; TGF-BETA; IMMUNE-SYSTEM; CUTTING EDGE; SYMPATHETIC NEURONS; REGULATORY CELLS	The nervous and immune systems communicate bidirectionally, utilizing diverse molecular signals including cytokines and neurotransmitters to provide an integrated response to changes in the body's internal and external environment. Although, neuro-immune interactions are becoming better understood under inflammatory circumstances and it has been evidenced that interaction between neurons and T cells results in the conversion of encephalitogenic T cells to T regulatory cells, relatively little is known about the communication between neurons and naive T cells. Here, we demonstrate that following co-culture of naive CD4(+) T cells with superior cervical ganglion neurons, the percentage of Foxp3 expressing CD4(+) CD25(+) cells significantly increased. This was mediated in part by immune-regulatory cytokines TGF-beta and IL-10, as well as the neuropeptide calcitonin gene-related peptide while vasoactive intestinal peptide was shown to play no role in generation of T regulatory cells. Additionally, T cells co-cultured with neurons showed a decrease in the levels of proinflammatory cytokine IFN-gamma released upon in vitro stimulation. These findings suggest that the generation of Tregs may be promoted by naive CD4(+) T cell: neuron interaction through the release of neuropeptide CGRP.	[Szklany, Kirsten; Ruiter, Evelyn; Mian, Firoz; Kunze, Wolfgang; Bienenstock, John; Forsythe, Paul; Karimi, Khalil] McMaster Univ, Brain Body Inst, Hamilton, ON, Canada; [Forsythe, Paul; Karimi, Khalil] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Bienenstock, John; Karimi, Khalil] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Karimi, K (corresponding author), McMaster Univ, Brain Body Inst, Hamilton, ON, Canada.; Karimi, K (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Karimi, K (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	karimik@mcmaster.ca	Karimi, Khalil/ABA-4735-2020	Karimi, Khalil/0000-0002-7245-5851				Ader R, 2000, EUR J PHARMACOL, V405, P167, DOI 10.1016/S0014-2999(00)00550-1; ADER R, 1995, LANCET, V345, P99, DOI 10.1016/S0140-6736(95)90066-7; Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Barouch R, 2001, J LEUKOCYTE BIOL, V69, P1019; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; BLALOCK JE, 1994, IMMUNOL TODAY, V15, P504, DOI 10.1016/0167-5699(94)90205-4; BOUDARD F, 1991, J NEUROSCI RES, V29, P29, DOI 10.1002/jnr.490290104; Burghardt S, 2014, J LEUKOCYTE BIOL, V96, P571, DOI 10.1189/jlb.2AB0613-342RR; Burghardt S, 2013, J IMMUNOL, V191, P5574, DOI 10.4049/jimmunol.1300826; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CHUN LLY, 1977, J CELL BIOL, V75, P705, DOI 10.1083/jcb.75.3.705; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Delgado M, 2005, J LEUKOCYTE BIOL, V78, P1327, DOI 10.1189/jlb.0605299; Delgado M, 2001, J IMMUNOL, V166, P2907, DOI 10.4049/jimmunol.166.5.2907; Deng SH, 2010, CELL IMMUNOL, V265, P105, DOI 10.1016/j.cellimm.2010.07.010; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; FELTEN DL, 1987, IMMUNOL REV, V100, P225, DOI 10.1111/j.1600-065X.1987.tb00534.x; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Freund-Michel V, 2008, PHARMACOL THERAPEUT, V117, P52, DOI 10.1016/j.pharmthera.2007.07.003; Gonzalez-Rey E, 2006, ARTHRITIS RHEUM-US, V54, P864, DOI 10.1002/art.21652; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Hida TH, 2013, INT J MED MUSHROOMS, V15, P525, DOI 10.1615/IntJMedMushr.v15.i6.20; Holzmann B, 2013, AMINO ACIDS, V45, P1, DOI 10.1007/s00726-011-1161-2; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Kannan Y, 1996, J IMMUNOL, V157, P313; Kannan Y, 2000, NEUROIMMUNOMODULAT, V8, P132, DOI 10.1159/000054273; Kared H, 2008, BLOOD, V112, P2575, DOI 10.1182/blood-2008-02-140681; Kelso ML, 2015, J NEUROIMMUNOL, V278, P162, DOI 10.1016/j.jneuroim.2014.11.002; Kobayashi H, 2002, BLOOD, V99, P2214, DOI 10.1182/blood.V99.6.2214; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lambiase A, 1997, J ALLERGY CLIN IMMUN, V100, P408, DOI 10.1016/S0091-6749(97)70256-2; Lim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081218; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Liston A, 2013, ADV IMMUNOL, V119, P85, DOI 10.1016/B978-0-12-407707-2.00003-5; Liu J, 2000, IMMUNOLOGY, V101, P61, DOI 10.1046/j.1365-2567.2000.00082.x; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Maynard CL, 2008, IMMUNOL REV, V226, P219, DOI 10.1111/j.1600-065X.2008.00711.x; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; MCGILLIS JP, 1993, CELL IMMUNOL, V150, P391, DOI 10.1006/cimm.1993.1207; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; MILES K, 1984, INT J IMMUNOPHARMACO, V6, P171, DOI 10.1016/0192-0561(84)90014-6; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murphy K., 2008, JANEWAYS IMMUNO BIOL; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002; Rochlitzer S, 2011, CLIN EXP ALLERGY, V41, P1609, DOI 10.1111/j.1365-2222.2011.03822.x; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; SANTAMBROGIO L, 1994, J IMMUNOL, V153, P4488; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Tokoyoda K, 2004, INT IMMUNOL, V16, P643, DOI 10.1093/intimm/dxh072; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; Tung JW, 2007, CLIN LAB MED, V27, P453, DOI 10.1016/j.cll.2007.05.001; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x	69	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152443	10.1371/journal.pone.0152443	http://dx.doi.org/10.1371/journal.pone.0152443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022966	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900058
J	Mistry, N; Rangan, S; Dholakia, Y; Lobo, E; Shah, S; Patil, A				Mistry, Nerges; Rangan, Sheela; Dholakia, Yatin; Lobo, Eunice; Shah, Shimoni; Patil, Akshaya			Durations and Delays in Care Seeking, Diagnosis and Treatment Initiation in Uncomplicated Pulmonary Tuberculosis Patients in Mumbai, India	PLOS ONE			English	Article							PUBLIC-PRIVATE MIX; TAMIL-NADU; BEHAVIOR; DOTS; ETHIOPIA; QUALITY; VIETNAM; GENDER; WOMEN; URBAN	Background Timely diagnosis and treatment initiation are critical to reduce the chain of transmission of Tuberculosis (TB) in places like Mumbai, where almost 60% of the inhabitants reside in overcrowded slums. This study documents the pathway from the onset of symptoms suggestive of TB to initiation of TB treatment and examines factors responsible for delay among uncomplicated pulmonary TB patients in Mumbai. Methods A population-based retrospective survey was conducted in the slums of 15 high TB burden administrative wards to identify 153 self-reported TB patients. Subsequently in-depth interviews of 76 consenting patients that fit the inclusion criteria were undertaken using an openended interview schedule. Mean total, first care seeking, diagnosis and treatment initiation duration and delays were computed for new and retreatment patients. Patients showing defined delays were divided into outliers and non-outliers for all three delays using the median values. Results The mean duration for the total pathway was 65 days with 29% of patients being outliers. Importantly the mean duration of first care seeking was similar in new (24 days) and retreatment patients (25 days). Diagnostic duration contributed to 55% of the total pathway largely in new patients. Treatment initiation was noted to be the least among the three durations with mean duration in retreatment patients twice that of new patients. Significantly more female patients experienced diagnostic delay. Major shift of patients from the private to public sector and non-allopaths to allopaths was observed, particularly for treatment initiation. Conclusion Achieving positive behavioural changes in providers (especially non-allopaths) and patients needs to be considered in TB control strategies. Specific attention is required in counselling of TB patients so that timely care seeking is effected at the time of relapse. Prioritizing improvement of environmental health in vulnerable locations and provision of point of care diagnostics would be singularly effective in curbing pathway delays.	[Mistry, Nerges; Rangan, Sheela; Dholakia, Yatin; Lobo, Eunice; Shah, Shimoni; Patil, Akshaya] Fdn Med Res, 84A,RG Thadani Marg, Bombay, Maharashtra, India; [Rangan, Sheela] Savitribai Phule Univ, Maharashtra Assoc Anthropol Sci, Ctr Hlth Res & Dev, Pune, Maharashtra, India	Savitribai Phule Pune University	Mistry, N (corresponding author), Fdn Med Res, 84A,RG Thadani Marg, Bombay, Maharashtra, India.	fmr@fmrindia.org	Dholakia, Yatin/I-7339-2019; Lobo, Eunice/P-6512-2019	Dholakia, Yatin/0000-0001-8482-1305; Lobo, Eunice/0000-0002-0621-9295; Shah, Shimoni/0000-0003-0991-5138	Bill & Melinda Gates Foundation through Sambodhi Research & Communications Pvt. Ltd. [OPP1091874]	Bill & Melinda Gates Foundation through Sambodhi Research & Communications Pvt. Ltd.	Funding was provided by the Bill & Melinda Gates Foundation, grant number - OPP1091874 through Sambodhi Research & Communications Pvt. Ltd. to NM. The funders had no role in study design, analysis, decision to publish, or preparation of manuscript.	Alavi SM, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.19238; Almeida D, 2003, CLIN INFECT DIS, V36, pE152, DOI 10.1086/374931; Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423; [Anonymous], 2015, GLOB TUB CONTR 2015; Bajpai V, 2010, NATL MED J INDIA, V23, P231; Bates L, 2004, LANCET INFECT DIS, V4, P368, DOI 10.1016/S1473-3099(04)01047-3; Buregyeya E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-586; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Dalal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116798; Das J, 2015, LANCET INFECT DIS, V15, P1305, DOI 10.1016/S1473-3099(15)00077-8; Dhanvij P, 2009, J MGIMS, V14, P56; Farah MG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-33; Isaakidis P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110461; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Konda S, 2014, INT J MED SCI PUBLIC, V3, P140, DOI [10.5455/ijmsph.2013.011120131, DOI 10.5455/IJMSPH.2013.011120131]; Kulkarni P. Y., 2013, International Journal of Medicine and Public Health, V3, P286; Lal SS, 2011, INT J TUBERC LUNG D, V15, P97; Lawn SD, 1998, INT J TUBERC LUNG D, V2, P635; Long NH, 1999, INT J TUBERC LUNG D, V3, P388; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; Madebo T., 1999, MED GEN MED, pE6; Mistry N, 2012, OPER RES HEALTH CARE, V1, P45, DOI 10.1016/j.orhc.2012.06.001; Mohammed S, 2015, AFR HEALTH SCI, V15, P385, DOI 10.4314/ahs.v15i2.11; Odusanya OO, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-18; Paul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039040; Pradhan A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-263; Price Waterhouse Coopers, 2007, HLTH CAR IN IND; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Selvam JM, 2007, INT J TUBERC LUNG D, V11, P161; Sonkong K, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-3; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; Tamhane A, 2012, INT J PREVENTIVE MED, V3, P569; United Nations, 2005, HOUS SMAPL SURV DEV, P105; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Uplekar MW, 2003, INT J TUBERC LUNG D, V7, P1113; Wells WA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001842; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2014, STAND TB CAR IND; World Health Organization Geneva, 2014, GLOB TUB CONTR 2011; World Health Organization regional office for Eastern Mediterranean, 2006, DIAGNOSTIC AND TREAT; Yamasaki-Nakagawa M, 2001, INT J TUBERC LUNG D, V5, P24; Yen YL, 2015, HEART LUNG, V44, P353, DOI 10.1016/j.hrtlng.2015.03.004; Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112; Yimer SA, 2015, J CLIN MICROBIOL, V53, P1301, DOI 10.1128/JCM.03566-14	49	48	48	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152287	10.1371/journal.pone.0152287	http://dx.doi.org/10.1371/journal.pone.0152287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018589	Green Published, gold			2022-12-26	WOS:000372807800040
J	Prado-Lima, M; Val, AL				Prado-Lima, Marcos; Val, Adalberto Luis			Transcriptomic Characterization of Tambaqui (Colossoma macropomum, Cuvier, 1818) Exposed to Three Climate Change Scenarios	PLOS ONE			English	Article							FRESH-WATER FISHES; HEAT-STRESS; GENE-EXPRESSION; RNA-SEQ; MICROSATELLITE MARKERS; TEMPERATURE; ACCLIMATION; ADAPTATION; RESPONSES; GENOME	Climate change substantially affects biodiversity around the world, especially in the Amazon region, which is home to a significant portion of the world's biodiversity. Freshwater fishes are susceptible to increases in water temperature and variations in the concentrations of dissolved gases, especially oxygen and carbon dioxide. It is important to understand the mechanisms underlying the physiological and biochemical abilities of fishes to survive such environmental changes. In the present study, we applied RNA-Seq and de novo transcriptome sequencing to evaluate transcriptome alterations in tambaqui when exposed to five or fifteen days of the B1, A1B and A2 climate scenarios foreseen by the IPCC. The generated ESTs were assembled into 54,206 contigs. Gene ontology analysis and the STRING tool were then used to identify candidate protein domains, genes and gene families potentially responsible for the adaptation of tambaqui to climate changes. After sequencing eight RNA-Seq libraries, 32,512 genes were identified and mapped using the Danio rerio genome as a reference. In total, 236 and 209 genes were differentially expressed at five and fifteen days, respectively, including chaperones, energetic metabolism-related genes, translation initiation factors and ribosomal genes. Gene ontology enrichment analysis revealed that mitochondrion, protein binding, protein metabolic process, metabolic processes, gene expression, structural constituent of ribosome and translation were the most represented terms. In addition, 1,202 simple sequence repeats were detected, 88 of which qualified for primer design. These results show that cellular response to climate change in tambaqui is complex, involving many genes, and it may be controlled by different cues and transcription/translation regulation mechanisms. The data generated from this study provide a valuable resource for further studies on the molecular mechanisms involved in the adaptation of tambaqui and other closely related teleost species to climate change.	[Prado-Lima, Marcos; Val, Adalberto Luis] Brazilian Natl Inst Res Amazon, Lab Ecophysiol & Mol Evolut, Manaus, Amazonas, Brazil; [Prado-Lima, Marcos] Fed Univ Western Para, Inst Water Sci & Technol, Santarem, Para, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Federal do Oeste do Para	Prado-Lima, M (corresponding author), Brazilian Natl Inst Res Amazon, Lab Ecophysiol & Mol Evolut, Manaus, Amazonas, Brazil.; Prado-Lima, M (corresponding author), Fed Univ Western Para, Inst Water Sci & Technol, Santarem, Para, Brazil.	marcospradolima@yahoo.com.br	Val, Adalberto Luis/I-3377-2014; Val, Adalberto/AAE-3983-2020	Val, Adalberto/0000-0002-3823-3868	CAPES; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work forms part of INCT-ADAPTA (CNPq/FAPEAM). MPL was a recipient of a Ph.D. fellowship from CAPES, and ALV is a recipient of a research fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MV, 2007, PHILOS T R SOC B, V362, P2095, DOI 10.1098/rstb.2007.2102; Basu N, 2002, GENE, V295, P173, DOI 10.1016/S0378-1119(02)00687-X; Bilyk KT, 2014, MAR GENOM, V18, P163, DOI 10.1016/j.margen.2014.06.006; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Brazil, 2012, B ESTATISTICO PESCA; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Cheng H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2415; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Cossins AR, 2005, NAT REV GENET, V6, P324, DOI 10.1038/nrg1590; Ellers J, 2008, J EXP ZOOL PART B, V310B, P137, DOI 10.1002/jez.b.21194; Feary DA, 2010, J FISH BIOL, V77, P1931, DOI 10.1111/j.1095-8649.2010.02777.x; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Hamoy IG, 2011, CONSERV GENET RESOUR, V3, P33, DOI 10.1007/s12686-010-9275-5; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hori TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-72; Imsland AK, 1995, NETH J SEA RES, V34, P149, DOI 10.1016/0077-7579(95)90023-3; Iranawati F, 2012, INT J MOL SCI, V13, P10807, DOI 10.3390/ijms130910807; Jeffries KM, 2014, EVOL APPL, V7, P286, DOI 10.1111/eva.12119; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Ju Z, 2002, MOL GENET GENOMICS, V268, P87, DOI 10.1007/s00438-002-0727-9; Junk WJ, 2007, AQUAT ECOSYST HEALTH, V10, P153, DOI 10.1080/14634980701351023; Kinoshita M, 2000, DEV GROWTH DIFFER, V42, P469; Lima MP, 2010, CONSERV GENET RESOUR, V2, P215, DOI 10.1007/s12686-010-9240-3; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Logan CA, 2011, AM J PHYSIOL-REG I, V300, pR1373, DOI 10.1152/ajpregu.00689.2010; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Long Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037209; Lopez-Olmeda JF, 2011, J THERM BIOL, V36, P91, DOI 10.1016/j.jtherbio.2010.12.005; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Matsuo AYO, 2003, FISH ADAPTATIONS, P1; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Narum SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1246-5; Nowicki JP, 2012, J EXP MAR BIOL ECOL, V412, P46, DOI 10.1016/j.jembe.2011.10.020; OConnell M, 1997, REV FISH BIOL FISHER, V7, P331, DOI 10.1023/A:1018443912945; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Papakostas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5071; Lemgruber RDP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081083; Pletterbauer F, 2015, HYDROBIOLOGIA, V744, P235, DOI 10.1007/s10750-014-2079-y; Podrabsky JE, 2004, J EXP BIOL, V207, P2237, DOI 10.1242/jeb.01016; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Quinn NL, 2011, PHYSIOL GENOMICS, V43, P1056, DOI 10.1152/physiolgenomics.00090.2011; Quinn NL, 2011, PHYSIOL GENOMICS, V43, P685, DOI 10.1152/physiolgenomics.00008.2011; Reis R. E., 2013, International Zoo Yearbook, V47, P65, DOI 10.1111/izy.12000; Rockstrom J, 2014, EARTHS FUTURE, V2, P606, DOI 10.1002/2014EF000280; Rozen S, 2000, Methods Mol Biol, V132, P365; Santana GX, 2012, CONSERV GENET RESOUR, V4, P197, DOI 10.1007/s12686-011-9507-3; Santos MDF, 2009, MOL ECOL RESOUR, V9, P874, DOI 10.1111/j.1755-0998.2008.02331.x; Seebacher F, 2010, PHYSIOL BIOCHEM ZOOL, V83, P721, DOI 10.1086/649964; SHARMA S, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0022906; Solomon S, 2007, CLIM CHANG 2007 CONT; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sun J, 2014, GENE, V552, P59, DOI 10.1016/j.gene.2014.09.013; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Val A.L., 1995, FISHES AMAZON THEIR; Val AL, 2000, COMP BIOCHEM PHYS A, V125, P417, DOI 10.1016/S1095-6433(00)00184-7; Vergauwen L, 2010, COMP BIOCHEM PHYS A, V157, P149, DOI 10.1016/j.cbpa.2010.06.160; Vilas R, 2015, MAR GENOM, V23, P77, DOI 10.1016/j.margen.2015.04.011; Wang SJ, 2012, INT J MOL SCI, V13, P7963, DOI 10.3390/ijms13077963; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393; Windisch HS, 2014, MOL ECOL, V23, P3469, DOI 10.1111/mec.12822	64	29	29	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152366	10.1371/journal.pone.0152366	http://dx.doi.org/10.1371/journal.pone.0152366			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018790	Green Published, Green Submitted, gold			2022-12-26	WOS:000372807800050
J	Murata, K; Ishida, J; Ishimaru, T; Mizukami, H; Hamada, J; Saito, C; Fukamizu, A				Murata, Kazuya; Ishida, Junji; Ishimaru, Tomohiro; Mizukami, Hayase; Hamada, Juri; Saito, Chiaki; Fukamizu, Akiyoshi			Lactation Is a Risk Factor of Postpartum Heart Failure in Mice with Cardiomyocyte-specific Apelin Receptor (APJ) Overexpression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; cardiomyopathy; G protein-coupled receptor (GPCR); heart; heart failure; pregnancy; APJ; lactation	PERIPARTUM CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; TRANSGENIC MICE; PREGNANCY; SYSTEM; GENE; CONTRACTILITY; HOMEOSTASIS; MUTATIONS	The G protein-coupled receptor APJ and its ligand apelin are highly expressed in cardiovascular tissues and are associated with the regulation of blood pressure and cardiac function. Although accumulating evidence suggests that APJ plays a crucial role in the heart, it remains unclear whether up-regulation of APJ affects cardiac function. Here we generated cardiomyocyte-specific APJ-overexpressing (APJ-TG) mice and investigated the cardiac phenotype in APJ-TG mice. Male and non-pregnant APJ-TG mice showed cardiac hypertrophy, contractile dysfunction, and elevation of B-type natriuretic peptide gene expression in the heart but not cardiac fibrosis and symptoms of heart failure, including breathing abnormality and pleural effusion. We further examined the influence of APJ overexpression in response to physiological stress induced by pregnancy and lactation in the heart. Interestingly, repeating pregnancy and lactation (pregnancy-lactation cycle) exacerbated cardiac hypertrophy and systolic dysfunction and induced cardiac fibrosis, lung congestion, pleural effusion, and abnormal breathing in APJ-TG mice. These data indicate that female APJ-TG mice develop postpartum cardiomyopathy. We showed that lactation, but not parturition, was critical for the onset of postpartum cardiomyopathy in APJ-TG mice. Furthermore, we found that lactating APJ-TG mice showed impaired myocardial angiogenesis and imbalance of pro- and antiangiogenic gene expression in the heart. These results demonstrate that overexpression of APJ in cardiomyocytes has adverse effects on cardiac function in male and non-pregnant mice and that lactation contributes to the development of postpartum cardiomyopathy in the heart with APJ overexpression.	[Murata, Kazuya; Ishida, Junji; Hamada, Juri; Fukamizu, Akiyoshi] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, 1-1-1 Ten-noudai, Tsukuba, Ibaraki 3058577, Japan; [Ishida, Junji; Ishimaru, Tomohiro; Mizukami, Hayase; Saito, Chiaki; Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Ten-noudai, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba; University of Tsukuba	Fukamizu, A (corresponding author), Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, 1-1-1 Ten-noudai, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp	Murata, Kazuya/GLR-2334-2022	Murata, Kazuya/0000-0002-3328-069X	Japan Society for the Promotion of Science KAKENHI [23300152]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science KAKENHI Grant 23300152. The authors declare that they have no conflicts of interest with the contents of this article.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Chung E, 2014, CARDIOVASC RES, V101, P561, DOI 10.1093/cvr/cvu013; DEMAKIS JG, 1971, CIRCULATION, V44, P964, DOI 10.1161/01.CIR.44.5.964; Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073; Elkayam U, 2005, CIRCULATION, V111, P2050, DOI 10.1161/01.CIR.0000162478.36652.7E; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Hamada J, 2008, INT J MOL MED, V22, P547, DOI 10.3892/ijmm_00000054; Hamada J, 2015, AM J PHYSIOL-HEART C, V308, pH931, DOI 10.1152/ajpheart.00703.2013; HANWELL A, 1973, J PHYSIOL-LONDON, V233, P93, DOI 10.1113/jphysiol.1973.sp010299; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Hayakawa Y, 2003, CIRCULATION, V108, P3036, DOI 10.1161/01.CIR.0000101920.72665.58; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Hilfiker-Kleiner D, 2015, EUR HEART J, V36, P1090, DOI 10.1093/eurheartj/ehv009; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Japp AG, 2008, BIOCHEM PHARMACOL, V75, P1882, DOI 10.1016/j.bcp.2007.12.015; Kamiya CA, 2011, CIRC J, V75, P1975, DOI 10.1253/circj.CJ-10-1214; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Kishimoto I, 2009, CURR CARDIOL REV, V5, P45, DOI 10.2174/157340309787048068; Kleinz MJ, 2008, REGUL PEPTIDES, V146, P271, DOI 10.1016/j.regpep.2007.10.002; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Kunduzova O, 2008, FASEB J, V22, P4146, DOI 10.1096/fj.07-104018; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Li JY, 2012, AM J CARDIOVASC DIS, V2, P192; Malek MH, 2009, EXP PHYSIOL, V94, P749, DOI 10.1113/expphysiol.2008.045989; Mesa A, 1999, CIRCULATION, V99, P511, DOI 10.1161/01.CIR.99.4.511; Morales A, 2010, CIRCULATION, V121, P2176, DOI 10.1161/CIRCULATIONAHA.109.931220; Murata K, 2013, ENDOCRINOLOGY, V154, P597, DOI 10.1210/en.2012-1789; Ntusi NBA, 2009, INT J CARDIOL, V131, P168, DOI 10.1016/j.ijcard.2008.06.054; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Poole AT, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.004; Ricke-Hoch M, 2014, CARDIOVASC RES, V101, P587, DOI 10.1093/cvr/cvu010; Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004; Safirstein JG, 2012, INT J CARDIOL, V154, P27, DOI 10.1016/j.ijcard.2010.08.065; SAKANASHI TM, 1987, J NUTR, V117, P1469, DOI 10.1093/jn/117.8.1469; Schwarz EB, 2009, OBSTET GYNECOL, V113, P974, DOI 10.1097/01.AOG.0000346884.67796.ca; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; van Spaendonck-Zwarts KY, 2014, EUR HEART J, V35, P2165, DOI 10.1093/eurheartj/ehu050; van Spaendonck-Zwarts KY, 2010, CIRCULATION, V121, P2169, DOI 10.1161/CIRCULATIONAHA.109.929646; Wang X, 1998, AM J PHYSIOL-ENDOC M, V275, pE265, DOI 10.1152/ajpendo.1998.275.2.E265; Xu L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-13; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576	48	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11241	11251		10.1074/jbc.M115.699009	http://dx.doi.org/10.1074/jbc.M115.699009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033703	hybrid, Green Published			2022-12-26	WOS:000377042100025
J	Humada, AM; Hojabri, M; Bin Sulaiman, MH; Hamada, HM; Ahmed, MN				Humada, Ali M.; Hojabri, Mojgan; Bin Sulaiman, Mohd Herwan; Hamada, Hussein M.; Ahmed, Mushtaq N.			Photovoltaic Grid-Connected Modeling and Characterization Based on Experimental Results	PLOS ONE			English	Article							EQUIVALENT-CIRCUIT MODELS; ELECTRIC VEHICLES; PARAMETER-IDENTIFICATION; DIFFERENTIAL EVOLUTION; GENETIC ALGORITHM; MODULES; ULTRACAPACITOR; OPTIMIZATION; EXTRACTION; BATTERY	A grid-connected photovoltaic (PV) system operates under fluctuated weather condition has been modeled and characterized based on specific test bed. A mathematical model of a small-scale PV system has been developed mainly for residential usage, and the potential results have been simulated. The proposed PV model based on three PV parameters, which are the photocurrent, I-L, the reverse diode saturation current, I-o, the ideality factor of diode, n. Accuracy of the proposed model and its parameters evaluated based on different benchmarks. The results showed that the proposed model fitting the experimental results with high accuracy compare to the other models, as well as the I-V characteristic curve. The results of this study can be considered valuable in terms of the installation of a grid-connected PV system in fluctuated climatic conditions.	[Humada, Ali M.; Hojabri, Mojgan; Bin Sulaiman, Mohd Herwan; Ahmed, Mushtaq N.] Univ Malaysia Pahang, Fac Elect & Elect Engn, Pekan, Malaysia; [Humada, Ali M.] Minist Elect, Elect Prod Directorate Salahaldeen, Baiji 34007, Iraq; [Hamada, Hussein M.] Univ Malaysia Pahang, Fac Civil Engn & Earth Resources, Gambang 26300, Malaysia	Universiti Malaysia Pahang; Universiti Malaysia Pahang	Humada, AM (corresponding author), Univ Malaysia Pahang, Fac Elect & Elect Engn, Pekan, Malaysia.; Humada, AM (corresponding author), Minist Elect, Elect Prod Directorate Salahaldeen, Baiji 34007, Iraq.	alimhm82@yahoo.com	Ahmed, Mushtaq Najeeb/G-4196-2019; Sulaiman, Mohd Herwan/J-5606-2019; Humada, Ali M./X-8703-2019	Ahmed, Mushtaq Najeeb/0000-0002-3087-2390; Sulaiman, Mohd Herwan/0000-0003-2590-3807; 	University Malaysia Pahang [RDU1403133]	University Malaysia Pahang	The financial support was provided by the University Malaysia Pahang, grant no. RDU1403133, http://www.ump.edu.my/.	Akkaya R, 2004, APPL ENERG, V78, P419, DOI 10.1016/j.apenergy.2003.09.005; Amin N, 2009, RENEW ENERG, V34, P1939, DOI 10.1016/j.renene.2008.12.005; Cibira G, 2014, APPL SURFACE SCI; Dizqah AM, 2014, RENEW ENERG, V72, P212, DOI 10.1016/j.renene.2014.07.014; Dkhichi F, 2014, SOL ENERGY, V110, P781, DOI 10.1016/j.solener.2014.09.033; Gong WY, 2013, SOL ENERGY, V94, P209, DOI 10.1016/j.solener.2013.05.007; Hu XS, 2011, J ZHEJIANG UNIV-SC A, V12, P818, DOI 10.1631/jzus.A1100141; Hu XS, 2011, J CENT SOUTH UNIV T, V18, P1525, DOI 10.1007/s11771-011-0869-1; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2012, J POWER SOURCES, V198, P359, DOI 10.1016/j.jpowsour.2011.10.013; Humada AM, 2014, POW EL MOT CONTR C E; Humada AM, 2014, PROPOSED METHOD PHOT; Hurnada AM, 2016, RENEW SUST ENERG REV, V56, P494, DOI 10.1016/j.rser.2015.11.051; Ishaque K, 2011, SOL ENERGY, V85, P2349, DOI 10.1016/j.solener.2011.06.025; Ismail MS, 2013, ENERG CONVERS MANAGE, V73, P10, DOI 10.1016/j.enconman.2013.03.033; Khezzar R, 2014, SOL ENERGY, V110, P452, DOI 10.1016/j.solener.2014.09.039; Laudani A, 2014, APPL ENERG, V111, P894; Micheli D, 2014, ENERG CONVERS MANAGE, V80, P436, DOI 10.1016/j.enconman.2014.01.053; Rajasekar N, 2013, SOL ENERGY, V97, P255, DOI 10.1016/j.solener.2013.08.019; Wolf P, 2013, SOL ENERGY, V93, P151, DOI 10.1016/j.solener.2013.03.018; Yuan XF, 2014, SOL ENERGY, V108, P238, DOI 10.1016/j.solener.2014.07.013; Zhang L, 2014, RESIDUAL CAPACITY ES; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204	25	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152766	10.1371/journal.pone.0152766	http://dx.doi.org/10.1371/journal.pone.0152766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035575	Green Published, gold, Green Submitted			2022-12-26	WOS:000373201200034
J	Warwick-Evans, VC; Atkinson, PW; Robinson, LA; Green, JA				Warwick-Evans, Victoria C.; Atkinson, Philip W.; Robinson, Leonie A.; Green, Jonathan A.			Predictive Modelling to Identify Near-Shore, Fine-Scale Seabird Distributions during the Breeding Season	PLOS ONE			English	Article							SHAGS PHALACROCORAX-ARISTOTELIS; SPECIES DISTRIBUTION; HABITAT SELECTION; TOP PREDATOR; PREY; BEHAVIOR; PERFORMANCE; LOCATIONS; ECOLOGY; IMPACT	During the breeding season seabirds are constrained to coastal areas and are restricted in their movements, spending much of their time in near-shore waters either loafing or foraging. However, in using these areas they may be threatened by anthropogenic activities such as fishing, watersports and coastal developments including marine renewable energy installations. Although many studies describe large scale interactions between seabirds and the environment, the drivers behind near-shore, fine-scale distributions are not well understood. For example, Alderney is an important breeding ground for many species of seabird and has a diversity of human uses of the marine environment, thus providing an ideal location to investigate the near-shore fine-scale interactions between seabirds and the environment. We used vantage point observations of seabird distribution, collected during the 2013 breeding season in order to identify and quantify some of the environmental variables affecting the near-shore, fine-scale distribution of seabirds in Alderney's coastal waters. We validate the models with observation data collected in 2014 and show that water depth, distance to the intertidal zone, and distance to the nearest seabird nest are key predictors in the distribution of Alderney's seabirds. AUC values for each species suggest that these models perform well, although the model for shags performed better than those for auks and gulls. While further unexplained underlying localised variation in the environmental conditions will undoubtedly effect the fine-scale distribution of seabirds in near-shore waters we demonstrate the potential of this approach in marine planning and decision making.	[Warwick-Evans, Victoria C.; Robinson, Leonie A.; Green, Jonathan A.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Atkinson, Philip W.] British Trust Ornithol, Thetford, Norfolk, England	University of Liverpool; British Trust for Ornithology	Warwick-Evans, VC (corresponding author), Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England.	v.warwick-evans@liverpool.ac.uk	Green, Jonathan A/B-8799-2011; Atkinson, Philip/B-8975-2009	Green, Jonathan A/0000-0001-8692-0163; Atkinson, Philip/0000-0002-0838-557X	Natural Environment Research Council [NE/K500975/1]; Alderney Commission for Renewable Energy	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Alderney Commission for Renewable Energy	Funding was provided by Natural Environment Research Council PhD studentship to VWE NE/K500975/1; and Alderney Commission for Renewable Energy, http://www.acre.gov.gg/, to VWE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim P, 2009, ICES J MAR SCI, V66, P29, DOI 10.1093/icesjms/fsn175; [Anonymous], 2016, GADM DATABASE GLOBAL; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Barrett RT, 1990, ORNIS SCAND, P179; Barton K., 2014, MUMIN MULTIMODEL INF; Bates D., 2013, LME4 LINEAR MIXED EF; Becker BH, 2003, MAR ECOL PROG SER, V256, P243, DOI 10.3354/meps256243; Benjamins S, 2015, OCEANOGR MAR BIOL, V53, P1; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Burger AE, 1997, COLON WATERBIRD, V20, P55, DOI 10.2307/1521764; Camphuysen C.J., 2004, STANDARDISED SEABIRD; Carney KM, 1999, WATERBIRDS, V22, P68, DOI 10.2307/1521995; Cox SL, 2013, MAR ECOL PROG SER, V479, P203, DOI 10.3354/meps10176; Daunt F, 2006, BEHAV ECOL SOCIOBIOL, V59, P381, DOI 10.1007/s00265-005-0061-4; Davoren GK, 2003, MAR ECOL PROG SER, V256, P229, DOI 10.3354/meps256229; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Embling CB, 2013, PROG OCEANOGR, V117, P106, DOI 10.1016/j.pocean.2013.06.013; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Favero M, 2014, ANIM CONSERV, V17, P532, DOI 10.1111/acv.12180; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Furness RW, 2012, ICES J MAR SCI, V69, P1466, DOI 10.1093/icesjms/fss131; Gremillet D, 1998, IBIS, V140, P113, DOI 10.1111/j.1474-919X.1998.tb04547.x; Guinet C, 1998, P ROY SOC B-BIOL SCI, V265, P1001, DOI 10.1098/rspb.1998.0390; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harris Michael P., 2012, Ringing & Migration, V27, P43; Hawkins P., 2004, MEM NATL I POLAR RES, V58, P58; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans R. J., 2014, GEOSPHERE SPHERICAL; Hope BK, 2006, ENVIRON INT, V32, P983, DOI 10.1016/j.envint.2006.06.005; Hunt G.L. Jr, 1987, P7; HUNT GL, 1999, P 22 INT ORN C DURB, P2040; Jones AR, 2014, PROG OCEANOGR, V128, P30, DOI 10.1016/j.pocean.2014.08.002; Knights AM, 2014, ENVIRON SCI POLICY, V39, P56, DOI 10.1016/j.envsci.2014.02.010; Kubetzki U, 2003, MAR BIOL, V143, P199, DOI 10.1007/s00227-003-1036-5; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martin E, 2014, ALDERNEY REGIONAL EN; Mehlum Fridtjof, 2001, Marine Ornithology, V29, P19; Morley T, 2014, ANN RAMSAR PROJECT R; Myers L, 2005, RENEW ENERG, V30, P1713, DOI 10.1016/j.renene.2005.02.008; Neill SP, 2012, RENEW ENERG, V37, P387, DOI 10.1016/j.renene.2011.07.003; Oedekoven CS, 2001, MAR ECOL PROG SER, V212, P265, DOI 10.3354/meps212265; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rome MS, 2004, WATERBIRDS, V27, P200, DOI 10.1675/1524-4695(2004)027[0200:FEAIBH]2.0.CO;2; Scales KL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0679; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Scott BE, 2010, MAR ECOL PROG SER, V408, P207, DOI 10.3354/meps08552; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Soanes LM, 2013, MAR POLICY, V38, P507, DOI 10.1016/j.marpol.2012.08.006; Soanes LM, 2013, J APPL ECOL, V50, P671, DOI 10.1111/1365-2664.12069; Stevick PT, 2008, MAR ECOL PROG SER, V363, P15, DOI 10.3354/meps07475; STONE CJ, 1995, BIRD STUDY, V42, P50, DOI 10.1080/00063659509477148; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; Thompson DR, 1999, TROPHIC RELATIONSHIP, P898; Waggitt JJ, 2014, INT J MAR ENERGY, V8, P36, DOI 10.1016/j.ijome.2014.10.004; Waggitt JJ, 2013, USING SPATIAL OVERLA; Wanless S, 1998, ICES J MAR SCI, V55, P1141, DOI 10.1006/jmsc.1998.0372; WANLESS S, 1991, IBIS, V133, P30, DOI 10.1111/j.1474-919X.1991.tb04806.x; WANLESS S, 1993, J ZOOL, V231, P11, DOI 10.1111/j.1469-7998.1993.tb05349.x; Warwick-Evans V, 2015, MAR ECOL PROG SER, V527, P233, DOI 10.3354/meps11262; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Wilson LJ, 2009, BIOL CONSERV, V142, P1808, DOI 10.1016/j.biocon.2009.03.019; Witt MJ, 2012, PHILOS T R SOC A, V370, P502, DOI 10.1098/rsta.2011.0265	66	17	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0150592	10.1371/journal.pone.0150592	http://dx.doi.org/10.1371/journal.pone.0150592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031616	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800007
J	de Carvalho, SS; Silva, ACSE; Sabino, AD; Evangelista, FCG; Gomes, KB; Dusse, LMS; Rios, DRA				de Carvalho, Sara Santos; Simoes e Silva, Ana Cristina; Sabino, Adriano de Paula; Gontijo Evangelista, Fernanda Cristina; Gomes, Karina Braga; SantAna Dusse, Luci Maria; Alves Rios, Danyelle Romana			Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor beta 1 in Patients Undergoing Hemodialysis	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; PLASMA T-PA; RENIN-ANGIOTENSIN; GENE POLYMORPHISM; INSERTION/DELETION POLYMORPHISM; CARDIOVASCULAR MORTALITY; DELETION POLYMORPHISM; SALT SENSITIVITY; RENAL-DISEASE; SYSTEM	Background There is substantial evidence that chronic renal and cardiovascular diseases are associated with coagulation disorders, endothelial dysfunction, inflammation and fibrosis. Angiotensin-Converting Enzyme Insertion/Deletion polymorphism (ACE I/D polymorphism) has also be linked to cardiovascular diseases. Therefore, this study aimed to compare plasma levels of ultrassensible C-reactive protein (usCRP), PAI-1, D-dimer and TGF-beta 1 in patients undergoing HD with different ACE I/D polymorphisms. Methods The study was performed in 138 patients at ESRD under hemodialysis therapy for more than six months. The patients were divided into three groups according to the genotype. Genomic DNA was extracted from blood cells (leukocytes). ACE I/D polymorphism was investigated by single polymerase chain reaction (PCR). Plasma levels of D-dimer, PAI-1 and TGF-beta 1 were measured by enzyme-linked immunosorbent assay (ELISA), and the determination of plasma levels of usCRP was performed by immunonephelometry. Data were analyzed by the software SigmaStat 2.03. Results Clinical characteristics were similar in patients with these three ACE I/D polymorphisms, except for interdialytic weight gain. I allele could be associated with higher interdialytic weight gain (P = 0.017). Patients genotyped as DD and as ID had significantly higher levels of PAI-1 than those with II genotype. Other laboratory parameters did not significantly differ among the three subgroups (P = 0.033). Despite not reaching statistical significance, plasma levels of usCRP were higher in patients carrying the D allele. Conclusion ACE I/D polymorphisms could be associated with changes in the regulation of sodium, fibrinolytic system, and possibly, inflammation. Our data showed that high levels of PAI-1 are detected when D allele is present, whereas greater interdialytic gain is associated with the presence of I allele. However, further studies with different experimental designs are necessary to elucidate the mechanisms involved in these associations.	[de Carvalho, Sara Santos; Alves Rios, Danyelle Romana] Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil; [Simoes e Silva, Ana Cristina] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Interdisciplinary Lab Med Invest, Belo Horizonte, MG, Brazil; [Sabino, Adriano de Paula; Gontijo Evangelista, Fernanda Cristina; Gomes, Karina Braga; SantAna Dusse, Luci Maria] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Fac Pharm, Belo Horizonte, MG, Brazil	Universidade Federal de Sao Joao del-Rei; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Rios, DRA (corresponding author), Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.	danyelleromana@gmail.com	Simões e Silva, Ana Cristina/A-4409-2013; Rios, Danyelle Romana Alves/AAR-4367-2021; Sabino, Adriano de Paula/W-4538-2019; Sabino, Adriano de Paula/I-5120-2014; Evangelista, Fernanda/AAX-4787-2021	Simões e Silva, Ana Cristina/0000-0001-9222-3882; Rios, Danyelle Romana Alves/0000-0001-6377-241X; Sabino, Adriano de Paula/0000-0001-8562-8689; 	FAPEMIG; CNPq/Brazil	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPEMIG and CNPq/Brazil. LMSD and KBG are grateful for a CNPq Research Fellowship (PQ).	Agarwal I, 2014, AM J EPIDEMIOL, V179, P1331, DOI 10.1093/aje/kwu067; Alvarez R, 1998, CARDIOVASC RES, V40, P375, DOI 10.1016/S0008-6363(98)00179-5; Arici M, 2001, KIDNEY INT, V59, P407, DOI 10.1046/j.1523-1755.2001.059002407.x; Arikan H, 2009, RENAL FAILURE, V31, P438, DOI 10.1080/08860220902963772; Asselbergs FW, 2007, GENOMICS, V89, P362, DOI 10.1016/j.ygeno.2006.11.004; Aucella F, 2003, NEPHROL DIAL TRANSPL, V18, P1142, DOI 10.1093/ndt/gfg118; Burns KD, 2000, AM J KIDNEY DIS, V36, P449, DOI 10.1053/ajkd.2000.16192; Caprioli J, 2008, CAN J PHYSIOL PHARM, V86, P505, DOI 10.1139/Y08-045; CORVOL P, 1995, METHOD ENZYMOL, V248, P283; COSTEROUSSE O, 1993, BIOCHEM J, V290, P33, DOI 10.1042/bj2900033; Devaraj S, 2003, CIRCULATION, V107, P398, DOI 10.1161/01.CIR.0000052617.91920.FD; Dusse LM, 2011, CLIN CHIM ACTA, V412, P17, DOI 10.1016/j.cca.2010.09.030; Felmeden D C, 2000, J Renin Angiotensin Aldosterone Syst, V1, P240, DOI 10.3317/jraas.2000.036; Franco V, 2006, J AM COLL NUTR, V25, p247S, DOI 10.1080/07315724.2006.10719574; Giner V, 2000, HYPERTENSION, V35, P512, DOI 10.1161/01.HYP.35.1.512; Guney AI, 2013, GENET MOL RES, V12, P6895, DOI 10.4238/2013.December.19.8; HAMSTEN A, 1987, LANCET, V2, P3; Hiraga H, 1996, HYPERTENSION, V27, P569, DOI 10.1161/01.HYP.27.3.569; Husain Kazim, 2015, World J Biol Chem, V6, P209, DOI 10.4331/wjbc.v6.i3.209; Ishimitsu T, 2004, AM J KIDNEY DIS, V44, P466, DOI 10.1053/j.ajkd.2004.04.050; Jablonski Kristen L, 2014, F1000Prime Rep, V6, P72, DOI 10.12703/P6-72; Kim DK, 1997, ARTERIOSCL THROM VAS, V17, P3242, DOI 10.1161/01.ATV.17.11.3242; Kim S, 2000, PHARMACOL REV, V52, P11; Kirmizis D, 2006, MED SCI MONITOR, V12, pCR55; Kunz R, 1998, J AM SOC NEPHROL, V9, P1653; Lopez-Gomez JM, 2005, KIDNEY INT, V67, pS63, DOI 10.1111/j.1523-1755.2005.09314.x; Malgorzewicz S, 2013, INT J MOL MED, V31, P503, DOI 10.3892/ijmm.2013.1234; Mallamaci F, 2000, AM J HYPERTENS, V13, P433, DOI 10.1016/S0895-7061(99)00195-8; Margaglione M, 1998, ARTERIOSCL THROM VAS, V18, P562, DOI 10.1161/01.ATV.18.4.562; MARRE M, 1994, DIABETES, V43, P384, DOI 10.2337/diabetes.43.3.384; Milburn JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067799; Moore JH, 2002, CLIN GENET, V62, P53, DOI 10.1034/j.1399-0004.2002.620107.x; Munhoz Terezinha P., 2005, Rev. Bras. Hematol. Hemoter., V27, P87, DOI 10.1590/S1516-84842005000200006; Oda H, 2000, Adv Perit Dial, V16, P152; Pasceri V, 2000, CIRCULATION, V102, P2165; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Pontremoli R, 2000, KIDNEY INT, V57, P561, DOI 10.1046/j.1523-1755.2000.t01-1-00876.x; RIDKER PM, 1993, CIRCULATION, V87, P1969, DOI 10.1161/01.CIR.87.6.1969; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rosenberg MA, 2014, AM HEART J, V167, P723, DOI 10.1016/j.ahj.2014.01.010; Sabovic M, 2005, PATHOPHYSIOL HAEMO T, V34, P274, DOI 10.1159/000093107; Sakhteh M, 2014, J RENIN-ANGIO-ALDO S, P1; Samani NJ, 1996, CIRCULATION, V94, P708, DOI 10.1161/01.CIR.94.4.708; Shah PK, 2000, CIRCULATION, V101, P1758, DOI 10.1161/01.CIR.101.15.1758; Stenvinkel P, 2002, NEPHROL DIAL TRANSPL, V17, P33, DOI 10.1093/ndt/17.suppl_8.33; Suliman Mohamed E, 2008, Saudi J Kidney Dis Transpl, V19, P329; Taal MW, 2000, CURR OPIN NEPHROL HY, V9, P651, DOI 10.1097/00041552-200011000-00011; Tronvik E, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-4; UEDA S, 1995, HYPERTENSION, V25, P1266, DOI 10.1161/01.HYP.25.6.1266; VAUGHAN DE, 1995, J CLIN INVEST, V95, P995, DOI 10.1172/JCI117809; Yamagishi K, 2007, AM J HYPERTENS, V20, P751, DOI 10.1016/j.amjhyper.2007.01.018; Yamamoto K, 2005, CARDIOVASC RES, V66, P276, DOI 10.1016/j.cardiores.2004.11.013; Yaren A, 2008, EXP BIOL MED, V233, P32, DOI 10.3181/0705-RM-141; Zhang ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046495	54	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0150613	10.1371/journal.pone.0150613	http://dx.doi.org/10.1371/journal.pone.0150613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022914	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900007
J	Palisson, A; Courcoul, A; Durand, B				Palisson, Aurore; Courcoul, Aurelie; Durand, Benoit			Role of Cattle Movements in Bovine Tuberculosis Spread in France between 2005 and 2014	PLOS ONE			English	Article							RISK-BASED SURVEILLANCE; NETWORK ANALYSIS; MYCOBACTERIUM-BOVIS; DISEASE-CONTROL; TRADE PATTERNS; IRELAND; HERDS	Live animal movements are a major transmission route for the spread of infectious agents such as Mycobacterium bovis, the main agent of bovine Tuberculosis (bTB). France became officially bTB-free in 2001, but M. bovis is still circulating in the cattle population, with about a hundred of outbreaks per year, most located in a few geographic areas. The aim of this study was to analyse the role of cattle movements in bTB spread in France between 2005 and 2014, using social network analysis and logistic regression models. At a global scale, the trade network was studied to assess the association between several centrality measures and bTB infection though a case-control analysis. The bTB infection status was associated with a higher in-degree (odds-ratio [OR] = 2.4 [1.1-5.4]) and with a higher ingoing contact chain (OR = 2.2 [1.0-4.7]). At a more local scale, a second case-control analysis was conducted to estimate the relative importance of cattle movements and spatial neighbourhood. Only direct purchase from infected herds was shown to be associated with bTB infection (OR = 2.9 [1.7-5.2]), spatial proximity to infected herds being the predominant risk factor, with decreasing ORs when distance increases. Indeed, the population attributable fraction was 12% [5%-18%] for cattle movements and 73% [68%-78%] for spatial neighbourhood. Based on these results, networks of potential effective contacts between herds were built and analysed for the three major spoligotypes reported in France. In these networks, the links representing cattle movements were associated with higher edge betweenness than those representing the spatial proximity between infected herds. They were often links connecting distinct communities and sometimes distinct geographical areas. Therefore, although their role was quantitatively lower than the one of spatial neighbourhood, cattle movements appear to have been essential in the French bTB dynamics between 2005 and 2014.	[Palisson, Aurore] Univ Paris Sud, Orsay, France; [Palisson, Aurore; Courcoul, Aurelie; Durand, Benoit] Univ Paris Est, Epidemiol Unit, Hlth Anim Lab, Anses, Maisons Alfort, France	UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Durand, B (corresponding author), Univ Paris Est, Epidemiol Unit, Hlth Anim Lab, Anses, Maisons Alfort, France.	benoit.durand@anses.fr	Durand, Benoit/GSE-2511-2022	Durand, Benoit/0000-0003-0669-1394	Paris Sud University; French Ministry of Agriculture	Paris Sud University; French Ministry of Agriculture	This work was supported by the Paris Sud University and the French Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; [Anonymous], 2015, VET REC, V177, DOI 10.1136/vr.h4687; [Anonymous], [No title captured]; [Anonymous], 2006, INT J; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2011, VET MED INT, DOI DOI 10.4061/2011/874924; [Anonymous], [No title captured]; Ashford DA, 2001, REV SCI TECH OIE, V20, P325, DOI 10.20506/rst.20.1.1266; Berrian AM, 2012, VET REC, V170, P620, DOI 10.1136/vr.100674; Biek R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003008; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Brooks-Pollock E, 2014, NATURE, V511, P228, DOI 10.1038/nature13529; Carrique-Mas JJ, 2008, PREV VET MED, V84, P85, DOI 10.1016/j.prevetmed.2007.11.001; Clegg TA, 2008, PREV VET MED, V84, P94, DOI 10.1016/j.prevetmed.2007.11.004; Clegg TA, 2013, PREV VET MED, V109, P246, DOI 10.1016/j.prevetmed.2012.10.005; Dommergues L, 2012, TRANSBOUND EMERG DIS, V59, P292, DOI 10.1111/j.1865-1682.2011.01269.x; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Dutta BL, 2014, PREV VET MED, V117, P79, DOI 10.1016/j.prevetmed.2014.09.005; Fox J., 2019, R COMPANION APPL REG, V.; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Frossling J, 2012, PREV VET MED, V105, P202, DOI 10.1016/j.prevetmed.2011.12.011; Gates MC, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-225; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Griffin JM, 2005, IRISH VET J, V58, P629, DOI 10.1186/2046-0481-58-11-629; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; Humblet MF, 2010, J CLIN MICROBIOL, V48, P2802, DOI 10.1128/JCM.00293-10; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Mweu MM, 2013, PREV VET MED, V110, P379, DOI 10.1016/j.prevetmed.2013.02.015; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Noremark M, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-71; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Rautureau S, 2011, TRANSBOUND EMERG DIS, V58, P110, DOI 10.1111/j.1865-1682.2010.01187.x; Ribeiro-Lima J, 2015, PREV VET MED, V118, P328, DOI 10.1016/j.prevetmed.2014.12.007; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sinha SK, 2009, CAN J STAT, V37, P219, DOI 10.1002/cjs.10012; Skuce RA, 2005, VET REC, V157, P501, DOI 10.1136/vr.157.17.501	42	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152578	10.1371/journal.pone.0152578	http://dx.doi.org/10.1371/journal.pone.0152578			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019291	Green Published, gold, Green Submitted			2022-12-26	WOS:000372807800061
J	Moura, MR; Villalobos, F; Costa, GC; Garcia, PCA				Moura, Mario R.; Villalobos, Fabricio; Costa, Gabriel C.; Garcia, Paulo C. A.			Disentangling the Role of Climate, Topography and Vegetation in Species Richness Gradients	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; GLOBAL PATTERNS; HABITAT HETEROGENEITY; NICHE CONSERVATISM; DISPERSAL DISTANCE; SPATIAL-ANALYSIS; MOUNTAIN PASSES; ECOLOGY; ENERGY; DISTRIBUTIONS	Environmental gradients (EG) related to climate, topography and vegetation are among the most important drivers of broad scale patterns of species richness. However, these different EG do not necessarily drive species richness in similar ways, potentially presenting synergistic associations when driving species richness. Understanding the synergism among EG allows us to address key questions arising from the effects of global climate and land use changes on biodiversity. Herein, we use variation partitioning (also know as commonality analysis) to disentangle unique and shared contributions of different EG in explaining species richness of Neotropical vertebrates. We use three broad sets of predictors to represent the environmental variability in (i) climate (annual mean temperature, temperature annual range, annual precipitation and precipitation range), (ii) topography (mean elevation, range and coefficient of variation of elevation), and (iii) vegetation (land cover diversity, standard deviation and range of forest canopy height). The shared contribution between two types of EG is used to quantify synergistic processes operating among EG, offering new perspectives on the causal relationships driving species richness. To account for spatially structured processes, we use Spatial EigenVector Mapping models. We perform analyses across groups with distinct dispersal abilities (amphibians, non-volant mammals, bats and birds) and discuss the influence of vagility on the partitioning results. Our findings indicate that broad scale patterns of vertebrate richness are mainly affected by the synergism between climate and vegetation, followed by the unique contribution of climate. Climatic factors were relatively more important in explaining species richness of good dispersers. Most of the variation in vegetation that explains vertebrate richness is climatically structured, supporting the productivity hypothesis. Further, the weak synergism between topography and vegetation urges caution when using topographic complexity as a surrogate of habitat (vegetation) heterogeneity.	[Moura, Mario R.; Garcia, Paulo C. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil; [Villalobos, Fabricio] Inst Ecol AC, Red Biol Evolutiva, Xalapa, Veracruz, Mexico; [Costa, Gabriel C.] Univ Fed Rio Grande do Norte, Dept Ecol, Ctr Biociencias, BR-59072970 Natal, RN, Brazil	Universidade Federal de Minas Gerais; Instituto de Ecologia - Mexico; Universidade Federal do Rio Grande do Norte	Moura, MR (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil.	mariormoura@gmail.com	Garcia, Paulo/A-9983-2010; Villalobos, Fabricio/J-6246-2012; Moura, Mario/N-1692-2014; Costa, Gabriel C/A-4147-2008	Garcia, Paulo/0000-0002-4789-7033; Villalobos, Fabricio/0000-0002-5230-2217; Moura, Mario/0000-0002-7369-7502; Costa, Gabriel/0000-0002-6777-6706	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CNPq [141265/2013, 2233356/2014-2]; CNPq [563352/2010-8, 302776/2012-5, 201413/2014-0]; CAPES [PVE 018/2012]; Division Of Environmental Biology [1136586] Funding Source: National Science Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CNPq; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study has received grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CNPq grants 141265/2013 and 2233356/2014-2. Briefly, MRM was supported by CNPq and CAPES through a doctoral grant. FV was supported by a CNPq postdoctoral grant. GC was supported by CNPq grants 563352/2010-8, 302776/2012-5 and 201413/2014-0 and CAPES PVE 018/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon P, 2010, GLOBAL ECOL BIOGEOGR, V19, P40, DOI 10.1111/j.1466-8238.2009.00488.x; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Arita HT, 2004, GLOBAL ECOL BIOGEOGR, V13, P15, DOI 10.1111/j.1466-882X.2004.00067.x; Atauri JA, 2001, LANDSCAPE ECOL, V16, P147, DOI 10.1023/A:1011115921050; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1106, DOI 10.1111/j.1466-8238.2011.00753.x; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Bohning-Gaese K, 1998, EVOL ECOL, V12, P767, DOI 10.1023/A:1006538414645; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.2307/3071786; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Diniz JAF, 2007, P ROY SOC B-BIOL SCI, V274, P43, DOI 10.1098/rspb.2006.3712; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Flojgaard C, 2011, GLOBAL ECOL BIOGEOGR, V20, P218, DOI 10.1111/j.1466-8238.2010.00604.x; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Goetz SJ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034013; Gouveia SF, 2014, J ANIM ECOL, V83, P1523, DOI 10.1111/1365-2656.12241; GRIFFITH DA, 2003, ADV SPAT SCI, pR7, DOI 10.1007/978-3-540-24806-4; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hurlbert AH, 2005, ECOL LETT, V8, P319, DOI 10.1111/j.1461-0248.2005.00726.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KERLINGER FN, 1973, MULTIPLE REGRESSION; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kerr JT, 2001, P NATL ACAD SCI USA, V98, P11365, DOI 10.1073/pnas.201398398; Latham J., 2014, GLOBAL LAND COVER SH; Le Galliard JF, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P317; Legendre P., 2012, NUMERICAL ECOLOGY, V24; Li LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066450; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Padial AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111227; Prunier JG, 2015, MOL ECOL, V24, P263, DOI 10.1111/mec.13029; R Core Team, 2021, R LANGUAGE ENV STAT; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 2011, PHILOS T R SOC B, V366, P2438, DOI 10.1098/rstb.2011.0066; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Ruggiero A, 2004, ECOGRAPHY, V27, P401, DOI 10.1111/j.0906-7590.2004.03801.x; Ruggiero A, 2008, ECOGRAPHY, V31, P306, DOI 10.1111/j.0906-7590.2008.05333.x; Santini L, 2013, HYSTRIX, V24, P181, DOI 10.4404/hystrix-24.2-8746; Simard M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001708; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; Wiens JA, 2002, APPLYING LANDSCAPE ECOLOGY IN BIOLOGICAL CONSERVATION, P3; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	70	57	61	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152468	10.1371/journal.pone.0152468	http://dx.doi.org/10.1371/journal.pone.0152468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27014872	Green Published, gold			2022-12-26	WOS:000372708900068
J	Ozes, AR; Miller, DF; Ozes, ON; Fang, F; Liu, Y; Matei, D; Huang, T; Nephew, KP				Ozes, A. R.; Miller, D. F.; Ozes, O. N.; Fang, F.; Liu, Y.; Matei, D.; Huang, T.; Nephew, K. P.			NF-kappa B-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer	ONCOGENE			English	Article							NONCODING RNA HOTAIR; EPITHELIAL-MESENCHYMAL TRANSITION; ONCOGENE-INDUCED SENESCENCE; GENE-EXPRESSION; CISPLATIN RESISTANCE; SECRETORY PHENOTYPE; IN-VIVO; CELLS; METASTASIS; ACTIVATION	The transcription factor nuclear factor kappa B (NF-kappa B) and the long non-coding RNA (lncRNA) HOTAIR (HOX transcript antisense RNA) have diverse functional roles in cancer. In this study, we show that upregulation of HOTAIR induced platinum resistance in ovarian cancer, and increased HOTAIR levels were observed in recurrent platinum-resistant ovarian tumors vs primary ovarian tumors. To investigate the role of HOTAIR during DNA damage induced by platinum, we monitored double-strand breaks and show that HOTAIR expression results in sustained activation of DNA damage response (DDR) after platinum treatment. We demonstrate that ectopic expression of HOTAIR induces NF-kappa B activation during DDR and interleukin-6 and interleukin-6 expression, both key NF-kappa B target genes. We show that HOTAIR regulates activation of NF-kappa B by decreasing I kappa-B alpha (NF-kappa B inhibitor) and establish that by inducing prolonged NF-kappa B activation and expression of NF-kappa B target genes during DNA damage, HOTAIR has a critical role in cellular senescence and platinum sensitivity. Our findings suggest that an NF-.B- HOTAIR axis drives a positive-feedback loop cascade during DDR and contributes to cellular senescence and chemotherapy resistance in ovarian and other cancers.	[Ozes, A. R.; Nephew, K. P.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN USA; [Miller, D. F.; Fang, F.; Nephew, K. P.] Indiana Univ Sch Med, Med Sci Program, Bloomington, IN USA; [Ozes, O. N.] Akdeniz Univ, Dept Med Biol & Genet, Antalya, Turkey; [Liu, Y.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Liu, Y.] Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Liu, Y.; Matei, D.; Nephew, K. P.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Matei, D.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Matei, D.; Nephew, K. P.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Huang, T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78229 USA; [Nephew, K. P.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Akdeniz University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Texas System; University of Texas Health San Antonio; Indiana University System; Indiana University Bloomington	Nephew, KP (corresponding author), Indiana Univ Sch Med, Med Sci Program, Dept Cellular & Integrat Physiol, Jordan Hall 302,1001 East Third St, Bloomington, IN 47405 USA.	knephew@indiana.edu		Matei, Daniela/0000-0003-2169-5035	National Cancer Institute [CA13001, CA182832]; Walther Cancer Foundation (Indianapolis, IN); Doane and Eunice Dahl Wright Fellowship (Medical Sciences Program, Indiana University, Bloomington, IN); NATIONAL CANCER INSTITUTE [R01CA182832, U54CA113001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Walther Cancer Foundation (Indianapolis, IN); Doane and Eunice Dahl Wright Fellowship (Medical Sciences Program, Indiana University, Bloomington, IN); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Aaron Buechlein (Indiana University) for help with bioinformatic analysis of TCGA data, Dr Craig Pikaard (Indian University) for the pAV-spinach vector, Dr Howard Chang (Stanford University) for LZRS-HOTAIR vector, and Dr Heather O'Hagan for carefully reading this manuscript and helpful suggestions. This work was made possible by funding from the National Cancer Institute (Awards CA13001 and CA182832), Walther Cancer Foundation (Indianapolis, IN), and the Doane and Eunice Dahl Wright Fellowship (Medical Sciences Program, Indiana University, Bloomington, IN).	Almeida LO, 2014, FEBS OPEN BIO, V4, P96, DOI 10.1016/j.fob.2013.12.003; Batch C, 2004, AM J OBSTET GYNECOL, V191, P1552, DOI 10.1016/j.agoj.2004.05.025; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P664, DOI 10.1038/nsmb.2315; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heubach J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0371-8; Hu S, 2010, CANCER BIOL THER, V10, P788, DOI 10.4161/cbt.10.8.12913; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Jing L, 2014, TUMOR BIOL, V36, P3611; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Liu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077293; Malek E, 2014, ONCOTARGET, V5, P8027, DOI 10.18632/oncotarget.2469; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Miller DFB, 2013, METHODS, V63, P126, DOI 10.1016/j.ymeth.2013.03.023; Miller DF, 2015, CURR PROTOC HUM GENE; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Ozes ON, 1999, NATURE, V401, P82; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Qiu JJ, 2014, GYNECOL ONCOL, V134, P121, DOI 10.1016/j.ygyno.2014.03.556; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tian C, 2014, TUMOR BIOL, V35, P3003, DOI 10.1007/s13277-013-1387-6; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wan GH, 2013, EMBO J, V32, P2833, DOI 10.1038/emboj.2013.221; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Wang YN, 2014, CANCER RES, V74, P4922, DOI 10.1158/0008-5472.CAN-14-1022; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Wu ZH, 2014, ONCOL REP, V32, P395, DOI 10.3892/or.2014.3186; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yang G, 2011, CLIN CANCER RES, V17, P2181, DOI 10.1158/1078-0432.CCR-10-3265; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang XP, 2012, BIOPHYS J, V102, P2251, DOI 10.1016/j.bpj.2012.04.002	57	188	199	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 13	2016	35	41					5350	5361		10.1038/onc.2016.75	http://dx.doi.org/10.1038/onc.2016.75			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA5QU	27041570	Green Submitted, Green Accepted			2022-12-26	WOS:000386677800002
J	Nodomi, S; Umeda, K; Saida, S; Kinehara, T; Hamabata, T; Daifu, T; Kato, I; Hiramatsu, H; Watanabe, KI; Kuwahara, Y; Iehara, T; Adachi, S; Konishi, E; Nakahata, T; Hosoi, H; Heike, T				Nodomi, S.; Umeda, K.; Saida, S.; Kinehara, T.; Hamabata, T.; Daifu, T.; Kato, I.; Hiramatsu, H.; Watanabe, K-I; Kuwahara, Y.; Iehara, T.; Adachi, S.; Konishi, E.; Nakahata, T.; Hosoi, H.; Heike, T.			CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor	ONCOGENE			English	Article							CANCER STEM-CELLS; ATYPICAL TERATOID/RHABDOID TUMOR; CENTRAL-NERVOUS-SYSTEM; NATIONAL-WILMS-TUMOR; INITIATING CELLS; HUMAN-MELANOMA; BREAST-CANCER; LINE; IDENTIFICATION; EXPRESSION	Malignant rhabdoid tumor (MRT) is a rare, highly aggressive pediatric malignancy that primarily develops during infancy and early childhood. Despite the existing standard of intensive multimodal therapy, the prognosis of patients with MRT is dismal; therefore, a greater understanding of the biology of this disease is required to establish novel therapies. In this study, we identified a highly tumorigenic sub-population in MRT, based on the expression of CD146 (also known as melanoma cell adhesion molecule), a cell adhesion molecule expressed by neural crest cells and various derivatives. CD146(+) cells isolated from four MRT cell lines by cell sorting exhibited enhanced self-renewal and invasive potential in vitro. In a xenograft model using immunodeficient NOD/Shi-scid IL-2R gamma-null mice, purified CD146+ cells obtained from MRT cell lines or a primary tumor exhibited the exclusive ability to form tumors in vivo. Blocking of CD146-related mechanisms, either by short hairpin RNA knockdown or treatment with a polyclonal antibody against CD146, effectively suppressed tumor growth of MRT cells both in vitro and in vivo via induction of apoptosis by inactivating Akt. Furthermore, CD146 positivity in immunohistological analysis of 11 MRT patient samples was associated with poor patient outcomes. These results suggest that CD146 defines a distinct sub-population in MRT with high tumorigenic capacity and that this marker represents a promising therapeutic target.	[Nodomi, S.; Umeda, K.; Saida, S.; Kinehara, T.; Hamabata, T.; Daifu, T.; Kato, I.; Hiramatsu, H.; Watanabe, K-I; Heike, T.] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan; [Kuwahara, Y.; Iehara, T.; Hosoi, H.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Adachi, S.] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Konishi, E.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Surg Pathol, Kyoto, Japan; [Nakahata, T.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Kyoto, Japan	Kyoto University; Kyoto Prefectural University of Medicine; Kyoto University; Kyoto Prefectural University of Medicine; Kyoto University	Umeda, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Kawahara Cho, Kyoto, Kyoto 6068507, Japan.	umeume@kuhp.kyoto-u.ac.jp		Kuwahara, Yasumichi/0000-0002-0139-8503; Konishi, Eiichi/0000-0002-7122-2271	Takeda Science Foundation;  [24591407];  [25461602]	Takeda Science Foundation(Takeda Science Foundation (TSF)); ; 	We thank all staff for help with histological analysis. We also thank Dr Y Yui and Dr R Nishikomori for providing a critical reading of the manuscript. We are grateful to Dr R Yamada for helpful discussions about statistical analysis of microarray data. This study was supported by grants from the Grant-in-Aid for Scientific Research (C) (24591407 and 25461602) and the Takeda Science Foundation.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Biegel JA, 1999, CANCER RES, V59, P74; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen DH, 2013, CANCER RES, V73, P5821, DOI 10.1158/0008-5472.CAN-13-1080; Chiou SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002090; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Gadd S, 2010, LAB INVEST, V90, P724, DOI 10.1038/labinvest.2010.66; Ginn KF, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00114; Hilden JM, 2004, J CLIN ONCOL, V22, P2877, DOI 10.1200/jco.2004.07.073; Ho DMT, 2000, ACTA NEUROPATHOL, V99, P482, DOI 10.1007/s004010051149; Ito A, 2009, J IMMUNOL, V183, P4782, DOI 10.4049/jimmunol.0900699; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Jouve N, 2013, J BIOL CHEM, V288, P2571, DOI 10.1074/jbc.M112.418848; Katsumi Y, 2008, CLIN CANCER RES, V14, P1192, DOI 10.1158/1078-0432.CCR-07-1661; Kuroda H, 2005, CANCER GENET CYTOGEN, V158, P172, DOI 10.1016/j.cancergencyto.2004.08.032; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li G, 2003, ONCOGENE, V22, P6891, DOI 10.1038/sj.onc.1206819; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; McGary EC, 2003, CLIN CANCER RES, V9, P6560; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mills L, 2002, CANCER RES, V62, P5106; Misawa A, 2004, J HUM GENET, V49, P586, DOI 10.1007/s10038-004-0191-y; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Okuno K, 2010, ONCOL REP, V23, P485, DOI 10.3892/or_00000659; PARHAM DM, 1994, AM J SURG PATHOL, V18, P1010, DOI 10.1097/00000478-199410000-00005; Pujades C, 2002, INT J DEV BIOL, V46, P263; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Shiokawa M, 2010, BIOCHEM BIOPH RES CO, V399, P733, DOI 10.1016/j.bbrc.2010.07.145; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stewart JM, 2011, P NATL ACAD SCI USA, V108, P6468, DOI 10.1073/pnas.1005529108; Sugimoto T, 1999, INT J CANCER, V82, P678, DOI 10.1002/(SICI)1097-0215(19990827)82:5<678::AID-IJC10>3.0.CO;2-K; Sultan I, 2010, PEDIATR BLOOD CANCER, V54, P35, DOI 10.1002/pbc.22285; Tekautz TM, 2005, J CLIN ONCOL, V23, P1491, DOI 10.1200/JCO.2005.05.187; Tomlinson GE, 2005, J CLIN ONCOL, V23, P7641, DOI 10.1200/JCO.2004.00.8110; Tu T, 2015, CELL RES, V25, P275, DOI 10.1038/cr.2015.15; van den Heuvel-Eibrink MM, 2011, PEDIAT BLOOD CANC, V56, P733; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; WEEKS DA, 1989, AM J SURG PATHOL, V13, P439, DOI 10.1097/00000478-198906000-00001; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Yanagisawa S, 2009, CLIN CANCER RES, V15, P3014, DOI 10.1158/1078-0432.CCR-08-2237; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Zhang Y, 2008, HYBRIDOMA, V27, P345, DOI 10.1089/hyb.2008.0034; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	15	18	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5317	5327		10.1038/onc.2016.72	http://dx.doi.org/10.1038/onc.2016.72			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	27041577	hybrid, Green Published			2022-12-26	WOS:000386053000010
J	Bradford, HN; Krishnaswamy, S				Bradford, Harlan N.; Krishnaswamy, Sriram			The Fragment 1 Region of Prothrombin Facilitates the Favored Binding of Fragment 12 to Zymogen and Enforces Zymogen-like Character in the Proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; prothrombin; serine protease; thermodynamics; thrombin	ACTIVE-SITE; CRYSTAL-STRUCTURE; ENZYME COMPLEXES; FACTOR-VA; ACTIVATION; THROMBIN; MEIZOTHROMBIN; SUBSTRATE; SPECIFICITY; PRODUCTS	Thrombin is produced from the C-terminal half of prothrombin following its proteolytic activation. The N-terminal half, released as the propiece Fragment 12 (F12), is composed of an N-terminal -carboxyglutamate domain (Gla) followed by two kringles (K1 and K2). The propiece plays essential roles in regulating prothrombin activation and proteinase function. The latter results from the ability of F12 to reversibly bind to the (pro)catalytic domain through K2 with high affinity and highly favorable thermodynamic constants when it is a zymogen in comparison to proteinase. Such discrimination is lost for K2 binding after proteolytic removal of the N-terminal Gla-K1 region of F12. The Ca2+-stabilized structure of the Gla domain is not required for F12 to bind the zymogen form more favorably. Enhanced binding to zymogen versus proteinase correlates with the ability of the propiece to enforce zymogen-like character in the proteinase. This is evident in variants of meizothrombin, an intermediate of prothrombin activation that contains the propiece covalently attached. This phenomenon is also independent of the Gla domain. Thus, the presence of K1 in covalent linkage with K2 in the propiece governs the ability of K2 to bind the (pro)catalytic domain in favor of zymogen, thereby enforcing zymogen-like character in the proteinase.	[Bradford, Harlan N.; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Bradford, Harlan/0000-0001-5582-278X	National Institutes of Health [HL-074124, HL-108933];  [HL-12722]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL108933, R01HL125422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-074124 and HL-108933 (to S. K.) and by Project 1 of HL-12722. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams TE, 2016, BIOCHIMIE, V122, P235, DOI 10.1016/j.biochi.2015.09.013; ARMSTRONG SA, 1990, J BIOL CHEM, V265, P6210; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Bevington P. R., 1992, DATA REDUCTION ERROR, P161; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P1957, DOI 10.1021/bi00577a017; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bradford HN, 2013, J BIOL CHEM, V288, P27789, DOI 10.1074/jbc.M113.502005; Bradford HN, 2012, J BIOL CHEM, V287, P30414, DOI 10.1074/jbc.M112.394809; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; COTE HCF, 1994, J BIOL CHEM, V269, P11374; DOYLE MF, 1993, METHOD ENZYMOL, V222, P299; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JENNY NS, 2006, HEMOSTASIS THROMBOSI, P193; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Krishnaswamy S, 2013, J THROMB HAEMOST, V11, P265, DOI 10.1111/jth.12217; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Lechtenberg BC, 2013, BLOOD, V122, P2777, DOI 10.1182/blood-2013-06-511733; Lu GM, 2005, J BIOL CHEM, V280, P15471, DOI 10.1074/jbc.M500881200; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 2003, CHEST, V124, p4S, DOI 10.1378/chest.124.3_suppl.4S; MANN KG, 1990, BLOOD, V76, P1; Matafonov A, 2011, BLOOD, V118, P437, DOI 10.1182/blood-2010-10-312983; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; POLLOCK JS, 1988, J BIOL CHEM, V263, P14216; Pozzi N, 2016, J BIOL CHEM, V291, P6071, DOI 10.1074/jbc.M115.700401; Pozzi N, 2014, P NATL ACAD SCI USA, V111, P7630, DOI 10.1073/pnas.1403779111; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; TANS G, 1994, J BIOL CHEM, V269, P15969	40	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11114	11123		10.1074/jbc.M116.723072	http://dx.doi.org/10.1074/jbc.M116.723072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27013660	Green Published, hybrid			2022-12-26	WOS:000377042100015
J	Motta, P; Molla, G; Pollegioni, L; Nardini, M				Motta, Paolo; Molla, Gianluca; Pollegioni, Loredano; Nardini, Marco			Structure-Function Relationships in L-Amino Acid Deaminase, a Flavoprotein Belonging to a Novel Class of Biotechnologically Relevant Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOTORULA-GRACILIS; ACTIVE-SITE; CRYSTAL-STRUCTURE; WEB SERVER; OXIDASE; PROTEUS; MECHANISM; COMPLEX; PURIFICATION; CYTOCHROMES	L-Amino acid deaminase from Proteus myxofaciens (PmaLAAD) is a membrane flavoenzyme that catalyzes the deamination of neutral and aromatic L-amino acids into alpha-keto acids and ammonia. PmaLAAD does not use dioxygen to re-oxidize reduced FADH(2) and thus does not produce hydrogen peroxide; instead, it uses a cytochrome b-like protein as an electron acceptor. Although the overall fold of this enzyme resembles that of known amine or amino acid oxidases, it shows the following specific structural features: an additional novel alpha+beta subdomain placed close to the putative transmembrane alpha-helix and to the active-site entrance; an FAD isoalloxazine ring exposed to solvent; and a large and accessible active site suitable to bind large hydrophobic substrates. In addition, PmaLAAD requires substrate-induced conformational changes of part of the active site, particularly in Arg-316 and Phe-318, to achieve the correct geometry for catalysis. These studies are expected to pave the way for rationally improving the versatility of this flavoenzyme, which is critical for biocatalysis of enantiomerically pure amino acids.	[Motta, Paolo; Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy; [Molla, Gianluca; Pollegioni, Loredano] Politecn Milan, Prot Factory, I-21100 Varese, Italy; [Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, I-21100 Varese, Italy; [Nardini, Marco] Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy	University of Insubria; Polytechnic University of Milan; University of Insubria; University of Milan	Molla, G (corresponding author), Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy.; Nardini, M (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.	gianluca.molla@uninsubria.it; marco.nardini@unimi.it	Nardini, Marco/B-7842-2017	Nardini, Marco/0000-0002-3718-2165; POLLEGIONI, LOREDANO/0000-0003-1733-7243	Fondo di Ateneo per la Ricerca	Fondo di Ateneo per la Ricerca	This work was supported by a grant from Fondo di Ateneo per la Ricerca (to G. M. and L. P.). The authors declare that they have no conflicts of interest with the content of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baek JO, 2011, J BASIC MICROB, V51, P129, DOI 10.1002/jobm.201000086; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Busto E, 2014, CHEM-EUR J, V20, P11225, DOI 10.1002/chem.201403195; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; Caldinelli L, 2013, BBA-MOL BASIS DIS, V1832, P400, DOI 10.1016/j.bbadis.2012.11.019; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZW, 2006, J MOL BIOL, V360, P1000, DOI 10.1016/j.jmb.2006.05.067; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FONDA ML, 1968, J BIOL CHEM, V243, P1931; Giammanco GM, 2011, INT J SYST EVOL MICR, V61, P1638, DOI 10.1099/ijs.0.021964-0; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris CM, 1999, J BIOL CHEM, V274, P36233, DOI 10.1074/jbc.274.51.36233; Harris CM, 2001, EUR J BIOCHEM, V268, P5504, DOI 10.1046/j.1432-1033.2001.02462.x; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hou Y, 2015, APPL MICROBIOL BIOT, V99, P8391, DOI 10.1007/s00253-015-6757-0; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Molla G, 2000, J BIOL CHEM, V275, P24715, DOI 10.1074/jbc.M908193199; Molla G, 2012, METHODS MOL BIOL, V794, P273, DOI 10.1007/978-1-61779-331-8_18; Moriguchi T, 2010, J BIOCHEM, V148, P491, DOI 10.1093/jb/mvq083; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pantaleone DP, 2001, J MOL CATAL B-ENZYM, V11, P795, DOI 10.1016/S1381-1177(00)00155-7; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; POLLEGIONI L, 1993, J BIOL CHEM, V268, P13850; Pollegioni L, 2007, CURR PROTEIN PEPT SC, V8, P600, DOI 10.2174/138920307783018677; Pollegioni L, 2013, APPL MICROBIOL BIOT, V97, P9323, DOI 10.1007/s00253-013-5230-1; Pollegioni L, 2011, TRENDS BIOTECHNOL, V29, P276, DOI 10.1016/j.tibtech.2011.01.010; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Sacchi S, 2012, AMINO ACIDS, V43, P1833, DOI 10.1007/s00726-012-1345-4; Shabbiri K, 2010, BRAZ J MICROBIOL, V41, P796, DOI 10.1590/S1517-83822010005000032; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tessaro D, 2015, ACS CATAL, V5, P1604, DOI 10.1021/cs502064s; Tsuge H, 2005, J BIOL CHEM, V280, P31045, DOI 10.1074/jbc.C500234200; Turner NJ, 2004, CURR OPIN CHEM BIOL, V8, P114, DOI 10.1016/j.cbpa.2004.02.001; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; VANWIELINK JE, 1983, ARCH MICROBIOL, V136, P152, DOI 10.1007/BF00404791; VANWIELINK JE, 1983, ARCH MICROBIOL, V134, P118, DOI 10.1007/BF00407943; Volbeda A, 2013, STRUCTURE, V21, P184, DOI 10.1016/j.str.2012.11.010; Volonte F, 2008, PROTEIN EXPRES PURIF, V61, P131, DOI 10.1016/j.pep.2008.05.010	51	40	43	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10457	10475		10.1074/jbc.M115.703819	http://dx.doi.org/10.1074/jbc.M115.703819			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27022028	hybrid, Green Published			2022-12-26	WOS:000377042600003
J	Hopes, L; Grolez, G; Moreau, C; Lopes, R; Ryckewaert, G; Carriere, N; Auger, F; Laloux, C; Petrault, M; Devedjian, JC; Bordet, R; Defebvre, L; Jissendi, P; Delmaire, C; Devos, D				Hopes, Lucie; Grolez, Guillaume; Moreau, Caroline; Lopes, Renaud; Ryckewaert, Gilles; Carriere, Nicolas; Auger, Florent; Laloux, Charlotte; Petrault, Maud; Devedjian, Jean-Christophe; Bordet, Regis; Defebvre, Luc; Jissendi, Patrice; Delmaire, Christine; Devos, David			Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; BASAL GANGLIA; IRON CONTENT; BRAIN; DEMENTIA; DEGENERATION; SHAPE; AGE	Introduction Magnetic resonance imaging (MRI) can be used to identify biomarkers in Parkinson's disease (PD); R2* values reflect iron content related to high levels of oxidative stress, whereas volume and/or shape changes reflect neuronal death. We sought to assess iron overload in the nigrostriatal system and characterize its relationship with focal and overall atrophy of the striatum in the pivotal stages of PD. Methods Twenty controls and 70 PD patients at different disease stages (untreated de novo patients, treated early-stage patients and advanced-stage patients with L-dopa-related motor complications) were included in the study. We determined the R2* values in the substantia nigra, putamen and caudate nucleus, together with striatal volume and shape analysis. We also measured R2* in an acute MPTP mouse model and in a longitudinal follow-up two years later in the early-stage PD patients. Results The R2* values in the substantia nigra, putamen and caudate nucleus were significantly higher in de novo PD patients than in controls. Early-stage patients displayed significantly higher R2* values in the substantia nigra (with changes in striatal shape), relative to de novo patients. Measurements after a two-year follow-up in early-stage patients and characterization of the acute MPTP mouse model confirmed that R2* changed rapidly with disease progression. Advanced-stage patients displayed significant atrophy of striatum, relative to earlier disease stages. Conclusion Each pivotal stage in PD appears to be characterized by putative nigrostriatal MRI biomarkers: iron overload at the de novo stage, striatal shape changes at early-stage disease and generalized striatal atrophy at advanced disease.	[Hopes, Lucie; Grolez, Guillaume; Moreau, Caroline; Ryckewaert, Gilles; Carriere, Nicolas; Defebvre, Luc; Devos, David] Lille Univ Hosp, Dept Movement Disorders & Neurol, Lille, France; [Hopes, Lucie; Grolez, Guillaume; Moreau, Caroline; Lopes, Renaud; Carriere, Nicolas; Auger, Florent; Laloux, Charlotte; Petrault, Maud; Devedjian, Jean-Christophe; Bordet, Regis; Defebvre, Luc; Jissendi, Patrice; Delmaire, Christine; Devos, David] Univ Lille, INSERM, U1171, Fac Med, Lille, France; [Lopes, Renaud; Jissendi, Patrice; Delmaire, Christine] Lille Univ Hosp, Dept Neuroradiol, Lille, France; [Auger, Florent] Univ Lille, Dept Small Anim Imaging Unit, Lille, France; [Laloux, Charlotte; Petrault, Maud; Devedjian, Jean-Christophe; Bordet, Regis; Devos, David] Univ Lille, Dept Med Pharmacol, Lille, France	Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Hopes, L (corresponding author), Lille Univ Hosp, Dept Movement Disorders & Neurol, Lille, France.; Hopes, L (corresponding author), Univ Lille, INSERM, U1171, Fac Med, Lille, France.	lucie.hopes@hotmail.fr	; Devos, David/E-4059-2013	Lopes, Renaud/0000-0002-2425-2283; Devos, David/0000-0002-2417-799X; LALOUX, Charlotte/0000-0001-7039-9940	French Ministry of Health as part of the Projet Hospitalier Recherche Clinique (PHRC) programme [2008-006842-25]	French Ministry of Health as part of the Projet Hospitalier Recherche Clinique (PHRC) programme	The study was funded by the French Ministry of Health as part of the Projet Hospitalier Recherche Clinique (PHRC) programme (grant reference number: 2008-006842-25).	APA, 2000, DIAGN STAT MAN MENT; Apostolova LG, 2010, MOVEMENT DISORD, V25, P687, DOI 10.1002/mds.22799; Aquino D, 2014, NEUROL SCI, V35, P753, DOI 10.1007/s10072-013-1595-2; Bunzeck N, 2013, PARKINSONISM RELAT D, V19, P1136, DOI 10.1016/j.parkreldis.2013.08.011; Carriere N, 2014, MOVEMENT DISORD, V29, P897, DOI 10.1002/mds.25904; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; DEXTER DT, 1987, LANCET, V2, P1219; Du GW, 2011, MOVEMENT DISORD, V26, P1627, DOI 10.1002/mds.23643; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Geng DY, 2006, NEUROSURGERY, V58, P256, DOI 10.1227/01.NEU.0000194845.19462.7B; GRIFFITHS PD, 1993, DEMENTIA, V4, P61, DOI 10.1159/000107298; Haegelen C, 2012, INT J COMPUT ASSIST, V18; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Laloux C, 2012, PHARMACOL RES, V65, P514, DOI 10.1016/j.phrs.2012.02.008; Lee HM, 2014, PARKINSONISM RELAT D, V20, P622, DOI 10.1016/j.parkreldis.2014.03.009; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Minati L, 2007, AM J NEURORADIOL, V28, P309; Napolitano A, 2011, CURR MED CHEM, V18, P1832, DOI 10.2174/092986711795496863; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pitcher TL, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-17; Rossi ME, 2014, ACAD RADIOL, V21, P64, DOI 10.1016/j.acra.2013.09.018; Siemonsen S, 2008, AM J NEURORADIOL, V29, P950, DOI 10.3174/ajnr.A0951; Sterling NW, 2013, NEUROBIOL AGING, V34, P2510, DOI 10.1016/j.neurobiolaging.2013.05.017; Styner Martin, 2006, Insight J, P242; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; You LH, 2015, NEUROSCIENCE, V284, P234, DOI 10.1016/j.neuroscience.2014.09.071	30	48	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0147947	10.1371/journal.pone.0147947	http://dx.doi.org/10.1371/journal.pone.0147947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035571	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200002
J	Paulose, T; Montevil, M; Speroni, L; Cerruti, F; Sonnenschein, C; Soto, AM				Paulose, Tessie; Montevil, Mael; Speroni, Lucia; Cerruti, Florent; Sonnenschein, Carlos; Soto, Ana M.			SAMA: A Method for 3D Morphological Analysis	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; IMAGE-ANALYSIS; CULTURE MODEL; BREAST-CANCER; MAMMARY-GLAND; HORMONAL-REGULATION; SOFTWARE; MORPHOGENESIS; ORGANIZATION; MICROSCOPY	Three-dimensional (3D) culture models are critical tools for understanding tissue morphogenesis. A key requirement for their analysis is the ability to reconstruct the tissue into computational models that allow quantitative evaluation of the formed structures. Here, we present Software for Automated Morphological Analysis (SAMA), a method by which epithelial structures grown in 3D cultures can be imaged, reconstructed and analyzed with minimum human intervention. SAMA allows quantitative analysis of key features of epithelial morphogenesis such as ductal elongation, branching and lumen formation that distinguish different hormonal treatments. SAMA is a user-friendly set of customized macros operated via FIJI (http://fiji.sc/Fiji), an open-source image analysis platform in combination with a set of functions in R (http://www.r-project.org/), an open-source program for statistical analysis. SAMA enables a rapid, exhaustive and quantitative 3D analysis of the shape of a population of structures in a 3D image. SAMA is cross-platform, licensed under the GPLv3 and available at http://montevil.theobio.org/content/sama.	[Paulose, Tessie; Montevil, Mael; Speroni, Lucia; Cerruti, Florent; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA	Tufts University	Soto, AM (corresponding author), Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA.	Ana.soto@tufts.edu	Montévil, Maël/S-2378-2017	Montévil, Maël/0000-0001-7177-5995; Speroni, Lucia/0000-0003-1567-8925	National Institute of Environmental Health Sciences of the National Institutes of Health [R01ES08314]; Avon Foundation for Women [02-2009-093, 02-2011-095]; Avon Grant [02-2009-093, 02-2011-095]; NIEHS/NIH [ES08314]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008314] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Avon Foundation for Women; Avon Grant; NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Award Number R01ES08314 from the National Institute of Environmental Health Sciences of the National Institutes of Health (https://www.niehs.nih.gov/) and Award numbers #02-2009-093 and #02-2011-095 from the Avon Foundation for Women (http://www.avonfoundation.org/) to AMS. The content does not necessarily represent the official views of the funding agencies and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly appreciate the editorial assistance by Cheryl Schaeberle. This research was supported by Avon Grant #02-2009-093, and 02-2011-095. Additional support was provided by NIEHS/NIH ES08314. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Environmental Health Sciences or the National Institutes of Health.	Billeci L, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00002; Biot E, 2008, 5 IEEE INT S MIOM IM; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dhimolea E, 2010, BIOMATERIALS, V31, P3622, DOI 10.1016/j.biomaterials.2010.01.077; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Fessart D, 2013, EUR RESPIR J, V42, P1345, DOI 10.1183/09031936.00118812; Gjorevski N, 2012, BIOPHYS J, V103, P152, DOI 10.1016/j.bpj.2012.05.048; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kohl P, 2000, PHILOS T R SOC A, V358, P579, DOI 10.1098/rsta.2000.0547; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Luisier F, 2010, SIGNAL PROCESS, V90, P415, DOI 10.1016/j.sigpro.2009.07.009; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Pageau SC, 2011, BIOMATERIALS, V32, P7169, DOI 10.1016/j.biomaterials.2011.06.017; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Soto AM, 2008, BASIC CLIN PHARMACOL, V102, P125, DOI 10.1111/j.1742-7843.2007.00165.x; Soto AM, 2013, J MAMMARY GLAND BIOL, V18, P199, DOI 10.1007/s10911-013-9293-5; Speroni L, 2014, TISSUE ENG PART C-ME, V20, P42, DOI [10.1089/ten.tec.2013.0054, 10.1089/ten.TEC.2013.0054]; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006	28	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0153022	10.1371/journal.pone.0153022	http://dx.doi.org/10.1371/journal.pone.0153022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035711	gold, Green Submitted, Green Published			2022-12-26	WOS:000373201200052
J	Xu, TS; Le, TD; Liu, L; Wang, RJ; Sun, BY; Li, JY				Xu, Taosheng; Thuc Duy Le; Liu, Lin; Wang, Rujing; Sun, Bingyu; Li, Jiuyong			Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data	PLOS ONE			English	Article							CLINICALLY RELEVANT SUBTYPES; CLASS DISCOVERY; BREAST; CLASSIFICATION; CARCINOMAS; RESOURCE; MODEL	Background Identifying cancer subtypes is an important component of the personalised medicine framework. An increasing number of computational methods have been developed to identify cancer subtypes. However, existing methods rarely use information from gene regulatory networks to facilitate the subtype identification. It is widely accepted that gene regulatory networks play crucial roles in understanding the mechanisms of diseases. Different cancer subtypes are likely caused by different regulatory mechanisms. Therefore, there are great opportunities for developing methods that can utilise network information in identifying cancer subtypes. Results In this paper, we propose a method, weighted similarity network fusion (WSNF), to utilise the information in the complex miRNA-TF-mRNAregulatory network in identifying cancer subtypes. We firstly build the regulatory network where the nodes represent the features, i.e. the microRNAs (miRNAs), transcription factors (TFs) and messenger RNAs (mRNAs) and the edges indicate the interactions between the features. The interactions are retrieved from various interatomic databases. We then use the network information and the expression data of the miRNAs, TFs and mRNAs to calculate the weight of the features, representing the level of importance of the features. The feature weight is then integrated into a network fusion approach to cluster the samples (patients) and thus to identify cancer subtypes. We applied our method to the TCGA breast invasive carcinoma (BRCA) and glioblastoma multiforme (GBM) datasets. The experimental results show that WSNF performs better than the other commonly used computational methods, and the information from miRNA-TF-mRNA regulatory network contributes to the performance improvement. The WSNF method successfully identified five breast cancer subtypes and three GBM subtypes which show significantly different survival patterns. We observed that the expression patterns of the features in some miRNA-TF-mRNA sub-networks vary across different identified subtypes. In addition, pathway enrichment analyses show that the top pathways involving the most differentially expressed genes in each of the identified subtypes are different. The results would provide valuable information for understanding the mechanisms characterising different cancer subtypes and assist the design of treatment therapies. All datasets and the R scripts to reproduce the results are available online at the website:http://nugget.unisa.edu.au/Thuc/cancersubtypes/.	[Xu, Taosheng; Wang, Rujing; Sun, Bingyu] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Intelligent Machines, Hefei, Anhui, Peoples R China; [Xu, Taosheng] Univ Sci & Technol China, Dept Automat, Hefei 230026, Anhui, Peoples R China; [Thuc Duy Le; Liu, Lin; Li, Jiuyong] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of South Australia	Le, TD; Li, JY (corresponding author), Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia.	thuc.le@unisa.edu.au; jiuyong.li@unisa.edu.au	Liu, Lin/ABD-1224-2020; Le, Thuc Duy D/G-8444-2019; Li, Jiuyong/A-8134-2008; Li, Jiuyong/AAY-2706-2020	Liu, Lin/0000-0003-2843-5738; Le, Thuc Duy D/0000-0002-9732-4313; Li, Jiuyong/0000-0002-9023-1878; Li, Jiuyong/0000-0002-9023-1878; Xu, Taosheng/0000-0001-8283-7274	Australian Research Council [DP130104090]; National Natural Science Foundation of China [31371340]	Australian Research Council(Australian Research Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been partially supported by Australian Research Council (http://www.arc.gov.au/) Discovery Project DP130104090 (JL and LL), and the National Natural Science Foundation of China 31371340 (BS), http://www.nsfc.gov.cn/publish/portal1/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brin S, 2012, COMPUT NETW, V56, P3825, DOI 10.1016/j.comnet.2012.10.007; Carlson M., 2013, GENOME WIDE ANNOTATI; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dutta B, 2012, BRIT J CANCER, V106, P1107, DOI 10.1038/bjc.2011.584; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hastie T, 2012, IMPUTE IMPUTATION MI, V1; Higham DJ, 2003, I MATH ITS APPL IMA, V39, P192; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kamvar S. D., 2003, P 12 INT C WORLD WID, P261; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li J. -H., 2013, NUCLEIC ACIDS RES; Liu YY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-37; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Morrison JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-233; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Page Lawrence, 1999, TECHNICAL REPORT; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Serra A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0680-3; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang Yifan, 2011, Chin J Cancer, V30, P603, DOI 10.5732/cjc.011.10226; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851	46	40	40	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152792	10.1371/journal.pone.0152792	http://dx.doi.org/10.1371/journal.pone.0152792			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035433	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000373201200041
J	Yin, Q; Yang, CZ; Wu, JM; Lu, HY; Zheng, XH; Zhang, YY; Lv, ZZ; Zheng, XP; Li, ZJ				Yin, Qian; Yang, Chengzhi; Wu, Jimin; Lu, Haiyan; Zheng, Xiaohui; Zhang, Youyi; Lv, Zhizhen; Zheng, Xiaopu; Li, Zijian			Downregulation of beta-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; RECEPTOR MESSENGER-RNA; LEFT-VENTRICULAR HYPERTROPHY; C6 GLIOMA-CELLS; BETA(2)-ADRENERGIC RECEPTOR; HEART-FAILURE; IN-VIVO; ARRIVE GUIDELINES; AGONIST; STABILIZATION	beta-adrenergic receptors (beta-ARs) play an important role in cardiac remodeling, which is the key pathological process in various heart diseases and leads to heart failure. However, the regulation of beta-AR expression in remodeling hearts is still unclear. This study aims to clarify the possible mechanisms underlying the regulation of beta(1)- and beta(2)-AR expression in cardiac remodeling. The rat model of cardiac remodeling was established by subcutaneous injection of isoproterenol(ISO) at the dose of 0.25 mg.kg(-1).d(-1) for 7days. We found that the expression of beta(1)-and beta(2)-ARs decreased in the remodeling heart. The mechanisms may include the inhibition of DNA transcription and the increase of mRNA degradation. cAMPresponse element binding protein(CREB) is a well-known transcription factor of beta-AR. However, the expression and activation of CREB was not changed in the remodeling heart. Further, human Antigen-R (HuR), a RNA binding protein, which binds to the 3'-untranslated region of the beta-AR mRNA and promotes RNA degradation, was increased in the remodeling model. And in vitro, HuR deficiency reversed the reduction of beta-AR mRNA induced by ISO. Therefore, the present findings indicate that HuR, but not CREB, is responsible for the reduction of beta-AR expression in ISO induced cardiac remodeling.	[Yin, Qian; Zheng, Xiaopu] Xi An Jiao Tong Univ, Dept Cardiovasc Med, Affiliated Hosp 1, Xian 71006, Peoples R China; [Yin, Qian; Yang, Chengzhi; Wu, Jimin; Lu, Haiyan; Zhang, Youyi; Lv, Zhizhen; Li, Zijian] Peking Univ, Inst Vasc Med, Hosp 3,Minist Hlth, Beijing Key Lab Cardiovasc Receptors Res,Key Lab, Beijing 100191, Peoples R China; [Yin, Qian; Yang, Chengzhi; Wu, Jimin; Lu, Haiyan; Zhang, Youyi; Lv, Zhizhen; Li, Zijian] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China; [Lu, Haiyan; Zheng, Xiaohui] NW Univ Xian, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Coll Life Sci, Xian 710069, Peoples R China; [Li, Zijian] Beijing Univ Chinese Med, Key Lab Chinese Internal Med MOE & Beijing, Dongzhimen Hosp, 5 Haiyuncang Lane, Beijing 100700, Peoples R China	Xi'an Jiaotong University; Peking University; Northwest University Xi'an; Beijing University of Chinese Medicine	Zheng, XP (corresponding author), Xi An Jiao Tong Univ, Dept Cardiovasc Med, Affiliated Hosp 1, Xian 71006, Peoples R China.; Li, ZJ (corresponding author), Peking Univ, Inst Vasc Med, Hosp 3,Minist Hlth, Beijing Key Lab Cardiovasc Receptors Res,Key Lab, Beijing 100191, Peoples R China.; Li, ZJ (corresponding author), Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China.; Li, ZJ (corresponding author), Beijing Univ Chinese Med, Key Lab Chinese Internal Med MOE & Beijing, Dongzhimen Hosp, 5 Haiyuncang Lane, Beijing 100700, Peoples R China.	zhengxp001@mail.xjtu.edu.cn; lizijian@bjmu.edu.cn	Wu, Jimin/A-3814-2013	Wu, Jimin/0000-0003-0749-2012	National Basic Research Program of China [2014CBA02000]; National Natural Science Foundation of China [81270157, 81471893, 91539123, 81070078]; National key Scientific Instrument and Equipment Development Project of China [2013YQ170525]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key Scientific Instrument and Equipment Development Project of China	This work was supported by grants from the National Basic Research Program of China (No. 2014CBA02000), the National Natural Science Foundation of China (Nos. 81270157, 81471893,91539123, and 81070078), and the National key Scientific Instrument and Equipment Development Project of China (2013YQ170525).	Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Bai Y, 2006, BBA-MOL CELL RES, V1763, P1076, DOI 10.1016/j.bbamcr.2006.08.009; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Cox B., 2000, IUPHAR COMPENDIUM RE, P321; Dangel V, 1996, BIOCHEM J, V317, P925, DOI 10.1042/bj3170925; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FOWLER MB, 1986, CIRCULATION, V74, P1290, DOI 10.1161/01.CIR.74.6.1290; GOLDSPINK PH, 1994, CIRC RES, V74, P1042, DOI 10.1161/01.RES.74.6.1042; HOSODA K, 1994, J NEUROCHEM, V63, P1635; Jiang BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059621; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kirigiti P, 2001, MOL PHARMACOL, V60, P1308, DOI 10.1124/mol.60.6.1308; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li H, 2014, CLIN EXP PHARMACOL P, V41, P58, DOI 10.1111/1440-1681.12176; Li Y, 2012, CELL SIGNAL, V24, P2297, DOI 10.1016/j.cellsig.2012.07.010; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; MAK JCW, 1995, J CLIN INVEST, V96, P99, DOI 10.1172/JCI118084; Maurer F, 1999, NUCLEIC ACIDS RES, V27, P1664, DOI 10.1093/nar/27.7.1664; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Merlet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064711; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; Mitchusson KD, 1998, BIOCHEM BIOPH RES CO, V252, P357, DOI 10.1006/bbrc.1998.9598; Morioka N, 2010, J PHARMACOL SCI, V113, P234, DOI 10.1254/jphs.10031FP; Muller AL, 2012, HEART FAIL REV, V17, P395, DOI 10.1007/s10741-011-9269-8; O'Connell TD, 2014, PHARMACOL REV, V66, P308, DOI 10.1124/pr.112.007203; Ohte N, 2012, EUR J NUCL MED MOL I, V39, P1246, DOI 10.1007/s00259-012-2138-4; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pfeffer M, 1998, EUR J NEUROSCI, V10, P2896, DOI 10.1111/j.1460-9568.1998.00309.x; Renard M, 1990, B MEMOIRES ACAD ROYA, V146, P305; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Sato S, 2011, J TOXICOL SCI, V36, P479, DOI 10.2131/jts.36.479; Schlaich MP, 2003, CIRCULATION, V108, P560, DOI 10.1161/01.CIR.0000081775.72651.B6; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Simko F, 1996, CAN J CARDIOL, V12, P507; Subramaniam K, 2011, MOL CELL BIOCHEM, V352, P125, DOI 10.1007/s11010-011-0747-z; Sutton MS, 2003, CIRCULATION, V107, P2577, DOI 10.1161/01.CIR.0000070420.51787.A8; SYLVEN C, 1991, CARDIOVASC RES, V25, P737, DOI 10.1093/cvr/25.9.737; TEERLINK JR, 1994, CIRC RES, V75, P105, DOI 10.1161/01.RES.75.1.105; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Zhang JJ, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-4703; Zhou S, 2014, OXIDATIVE MED CELLUL, V2014	46	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152005	10.1371/journal.pone.0152005	http://dx.doi.org/10.1371/journal.pone.0152005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035432	Green Published, gold, Green Submitted			2022-12-26	WOS:000373201200009
J	Chandra, J; Miao, Y; Romoff, N; Frazer, IH				Chandra, Janin; Miao, Yan; Romoff, Natasha; Frazer, Ian H.			Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; HIGH-RISK; LANGERHANS CELLS; E-CADHERIN; IFN-GAMMA; T-CELLS; SUBSETS; INDUCE; RESPONSES; CANCER	Antigen presenting cells (APCs) in skin can promote either antigen-specific effector functions or antigen tolerance, and thus determine clearance or persistence of cutaneous viral infections. Human papillomavirus (HPV) infections can persist in squamous epithelium in immunocompetent individuals, and some persisting HPV infections, particularly with HPV16, promote malignant epithelial transformation. Here, we investigate whether local expression of the HPV16 protein most associated with malignant transformation, HPV16-E7, affects the phenotype and function of APC subsets in the skin. We demonstrate an expanded population of Langerhans cells in HPV16-E7 transgenic skin with distinct cell surface markers which express immune-modulatory enzymes and cytokines not expressed by cells from non transgenic skin. Furthermore, HPV16-E7 transgene expression in keratinocytes attracts new APC subsets to the epidermis. In vivo migration and transport of antigen to the draining lymph node by these APCs is markedly enhanced in HPV16-E7 expressing skin, whereas antigen-processing, as measured by proteolytic cleavage of DQ-OVA and activation of T cells in vivo by APCs, is significantly impaired. These data suggest that local expression of HPV16-E7 in keratinocytes can contribute to persisting infection with this oncogenic virus, by altering the phenotype and function of local APCs.	[Chandra, Janin; Miao, Yan; Romoff, Natasha; Frazer, Ian H.] Univ Queensland, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld 4102, Australia	University of Queensland	Frazer, IH (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld 4102, Australia.	i.frazer@uq.edu.au	Chandra, Janin/Y-2037-2019; Chandra, Janin/D-6580-2018; Frazer, Ian/A-1137-2007	Chandra, Janin/0000-0002-4456-9480; Chandra, Janin/0000-0002-4456-9480; Frazer, Ian/0000-0002-8002-4680	NIH [5U01CA141583]; ARC Discovery Scheme [DP130100996]; National Health and Medical Research Council of Australia [569938]; Queensland Government Premiers Fellowship; University of Queensland postdoctoral fellowship; NATIONAL CANCER INSTITUTE [U01CA141583] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Discovery Scheme(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government Premiers Fellowship; University of Queensland postdoctoral fellowship(University of Queensland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to IHF from from the NIH (5U01CA141583), the ARC Discovery Scheme (Grant ID# DP130100996) and the National Health and Medical Research Council of Australia (Grant ID # 569938) IHF was recipient of Queensland Government Premiers Fellowship. JC is a recipient of University of Queensland postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Azukizawa H, 2011, EUR J IMMUNOL, V41, P1420, DOI 10.1002/eji.201040930; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bergot AS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004466; Caberg JHD, 2008, CARCINOGENESIS, V29, P1441, DOI 10.1093/carcin/bgn145; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dunn LA, 1997, VIROLOGY, V235, P94, DOI 10.1006/viro.1997.8650; Frazer IH, 2011, CURR OPIN VIROL, V1, P268, DOI 10.1016/j.coviro.2011.07.007; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; Ginhoux F, 2010, IMMUNOL CELL BIOL, V88, P387, DOI 10.1038/icb.2010.38; Gosmann C, 2014, J INVEST DERMATOL, V134, P2562, DOI 10.1038/jid.2014.201; Gosmann C, 2014, J IMMUNOL, V193, P2248, DOI 10.4049/jimmunol.1400216; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Iijima N, 2013, VIROLOGY, V444, P257, DOI 10.1016/j.virol.2013.06.020; Jaafar F, 2009, AM J PATHOL, V175, P1525, DOI 10.2353/ajpath.2009.090295; Kim HS, 2016, CANCER RES TREAT, V48, P527, DOI 10.4143/crt.2015.249; Tran LS, 2014, J INVEST DERMATOL, V134, P2438, DOI 10.1038/jid.2014.186; Lee BN, 2006, CANCER-AM CANCER SOC, V107, P999, DOI 10.1002/cncr.22092; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Leong CM, 2010, BRIT J DERMATOL, V163, P1253, DOI 10.1111/j.1365-2133.2010.09968.x; Matsumoto K, 2004, JNCI-J NATL CANCER I, V96, P1611, DOI 10.1093/jnci/djh301; Mattarollo SR, 2010, J IMMUNOL, V184, P5663, DOI 10.4049/jimmunol.0903730; Mattarollo SR, 2010, J IMMUNOL, V184, P1242, DOI 10.4049/jimmunol.0902191; Matthews K, 2003, J VIROL, V77, P8378, DOI 10.1128/JVI.77.15.8378-8385.2003; Mezache L, 2015, MODERN PATHOL, V28, P1594, DOI 10.1038/modpathol.2015.108; Mittal D, 2013, J INVEST DERMATOL, V133, P2686, DOI 10.1038/jid.2013.222; Molling JW, 2007, INT J CANCER, V121, P1749, DOI 10.1002/ijc.22894; Monnier-Benoit S, 2006, GYNECOL ONCOL, V102, P22, DOI 10.1016/j.ygyno.2005.11.039; Nakayama Y, 2011, J DERMATOL SCI, V63, P173, DOI 10.1016/j.jdermsci.2011.05.006; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Sperling T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002833; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stoermer KA, 2012, J IMMUNOL, V189, P4047, DOI 10.4049/jimmunol.1201240; STRAIGHT SW, 1995, J VIROL, V69, P3185, DOI 10.1128/JVI.69.5.3185-3192.1995; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Warif NMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127155; Yang W, 2013, IMMUNOLOGY, V139, P513, DOI 10.1111/imm.12101; Zhang WB, 2009, AM J PATHOL, V175, P891, DOI 10.2353/ajpath.2009.081115; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	48	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152886	10.1371/journal.pone.0152886	http://dx.doi.org/10.1371/journal.pone.0152886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031095	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800153
J	Chu, HK; Hou, XH				Chu, Huikuan; Hou, Xiaohua			Understanding of Constipation Symptoms and the Diagnosis and Management of Constipation in Chinese Physicians	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; UNITED-STATES; TRANSIT-TIME; BIOFEEDBACK; POPULATION; EPIDEMIOLOGY; DEFINITION; MUSCLES; ASIA; AGE	Background and Aims Although a range of guidelines for the diagnosis and treatment of chronic constipation has been carried out, there was very little information about the understanding on constipation. The aim of the present study was to estimate the understanding of constipation symptoms and the diagnosis and management of constipation by clinical physicians in China. Methods Participants were physicians and researchers in the field of gastroenterology in China who were scheduled to attend the National Conference on gastrointestinal motility(Constipation). Based on the recommendation of the Rome Foundation Board, the self-reported questionnaire was constructed. Findings Although most of the opinions on symptoms of constipation were consistent, there were still some differences. Opinions on the Bristol stool form during constipation were discordant, 34% of the doctors thought that it was type 1 and type 2, while 46% of the doctors suggested that type 3 should also be considered constipation. There was no significant difference between them(P = 0.05); We investigated the interpretation on the duration of defecation prolonged, 27% of the doctors suggested it should be longer than 10 minutes, 22% of the doctors suggested it should be longer than 20 minutes, and other 22% of the doctors suggested it should be time of defecation became longer compared to previously bowel habits, there was no significant difference among them(P = 0.38). Only 36% of the doctors thought that psychotherapy was most important in the treatment of severe constipation, while 37% of the doctors thought that medication treatment was most important in the treatment of severe constipation, there was no significant difference between them(P = 0.895). Conclusion We were able to obtain valuable information about current views on symptoms of constipation and the diagnosis and treatment of constipation among Chinese doctors. Although most of the opinions were consistent there were still some differences. This study indicated that in practice in China there was a need for further study on the role of constipation symptoms and there may also be a need for better establishment of consensus guidelines for constipation.	[Chu, Huikuan; Hou, Xiaohua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Div Gastroenterol, 1277 Jiefang Rd, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Hou, XH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Div Gastroenterol, 1277 Jiefang Rd, Wuhan 430074, Peoples R China.	houxh@medmail.com.cn		Chu, Huikuan/0000-0001-5349-8429				American Gastroenterological Association, 2013, Gastroenterology, V144, P211, DOI 10.1053/j.gastro.2012.10.029; American Gastroenterology Association, 2010, CHRON CONST AGAGUIDE; [Anonymous], 2005, J FAM PRACTICE, V54, P932; [Anonymous], 2004, Chin J Dig Dis, V5, P134; [Anonymous], 2004, CHINESE J DIGESTIVE, V5, P134; BARNES PRH, 1988, INT J COLORECTAL DIS, V3, P207, DOI 10.1007/BF01660715; Bassotti G, 2004, WORLD J GASTROENTERO, V10, P713, DOI 10.3748/wjg.v10.i5.713; Bharucha AE, 2010, AM J GASTROENTEROL, V105, P786, DOI 10.1038/ajg.2010.70; Bytzer P, 2001, GUT, V49, P66, DOI 10.1136/gut.49.1.66; Chan YK, 2004, J GASTROEN HEPATOL, V19, P1270, DOI 10.1111/j.1440-1746.2004.03492.x; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; Cheng C, 2003, ALIMENT PHARM THERAP, V18, P319, DOI 10.1046/j.1365-2036.2003.01663.x; Chu HK, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/532734; Corazziari E, 2004, BEST PRACT RES CL GA, V18, P613, DOI 10.1016/j.bpg.2004.04.012; Cottone C, 2014, UNITED EUR GASTROENT, V2, P232, DOI 10.1177/2050640614527283; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Garrigues V, 2004, AM J EPIDEMIOL, V159, P520, DOI 10.1093/aje/kwh072; Ghoshal Uday C, 2008, Indian J Gastroenterol, V27, P22; Guo Xiao Feng, 2004, Chin J Dig Dis, V5, P98, DOI 10.1111/j.1443-9573.2004.00166.x; Gwee KA, 2012, NEUROGASTROENT MOTIL, V24, P114; Gwee KA, 2013, J NEUROGASTROENTEROL, V19, P149, DOI 10.5056/jnm.2013.19.2.149; Harris Lucinda A, 2005, Manag Care Interface, V18, P23; Hart SL, 2012, INT J COLORECTAL DIS, V27, P459, DOI 10.1007/s00384-011-1355-9; HEATON KW, 1993, DIGEST DIS SCI, V38, P1004, DOI 10.1007/BF01295713; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; Ke M, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01983.x; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Ko CY, 1997, ARCH SURG-CHICAGO, V132, P829; Koch A, 1997, DIS COLON RECTUM, V40, P902, DOI 10.1007/BF02051196; Lindberg G, 2011, J CLIN GASTROENTEROL, V45, P483, DOI 10.1097/MCG.0b013e31820fb914; Liu BH, 2005, INT J COLORECTAL DIS, V20, P317, DOI 10.1007/s00384-004-0637-x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Cara MAL, 2006, REV ESP ENFERM DIG, V98, P449, DOI 10.4321/s1130-01082006000600006; Murakami K, 2006, EUR J CLIN NUTR, V60, P650, DOI 10.1038/sj.ejcn.1602365; Pare P, 2001, AM J GASTROENTEROL, V96, P3130, DOI 10.1111/j.1572-0241.2001.05259.x; Park JM, 2011, J NEUROGASTROENTEROL, V17, P279, DOI 10.5056/jnm.2011.17.3.279; Patankar SK, 1997, DIS COLON RECTUM, V40, P827, DOI 10.1007/BF02055441; Prather Charlene M, 2004, Rev Gastroenterol Disord, V4 Suppl 2, pS11; Sakakibara R, 2003, J NEUROL NEUROSUR PS, V74, P268, DOI 10.1136/jnnp.74.2.268; SANDLER RS, 1990, AM J PUBLIC HEALTH, V80, P185, DOI 10.2105/AJPH.80.2.185; Shafik A, 2003, J SURG RES, V112, P162, DOI 10.1016/S0022-4804(03)00125-2; Shin YM, 2002, J PEDIATR SURG, V37, P1762, DOI 10.1053/jpsu.2002.36716; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Sun XB, 2009, J PEDIATR SURG, V44, P2384, DOI 10.1016/j.jpedsurg.2009.07.062; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059	45	3	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152801	10.1371/journal.pone.0152801	http://dx.doi.org/10.1371/journal.pone.0152801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031865	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800139
J	Lin, X; He, Y; Hou, X; Zhang, ZM; Wang, R; Wu, Q				Lin, Xiao; He, Yu; Hou, Xue; Zhang, Zhenming; Wang, Rui; Wu, Qiong			Endothelial Cells Can Regulate Smooth Muscle Cells in Contractile Phenotype through the miR-206/ARF6&NCX1/Exosome Axis	PLOS ONE			English	Article							EXOSOME BIOGENESIS; MEDIATED TRANSFER; ANGIOGENESIS; EXPRESSION; SECRETION; EXCHANGER; SYNTENIN; RELEASE; HEART; ARF6	Active interactions between endothelial cells and smooth muscle cells (SMCs) are critical to maintaining the SMC phenotype. Exosomes play an important role in intercellular communication. However, little is known about the mechanisms that regulate endothelial cells and SMCs crosstalk. We aimed to determine the mechanisms underlying the regulation of the SMC phenotype by human umbilical vein endothelial cells (HUVECs) through exosomes. We found that HUVECs overexpressing miR-206 upregulated contractile marker (alpha-SMA, Smoothelin and Calponin) mRNA expression in SMCs. We also found that the expression of miR-206 by HUVECs reduced exosome production by regulating ADP-Ribosylation Factor 6 (ARF6) and sodium/calcium exchanger 1 (NCX1). Using real-time PCR and western blot analysis, we showed that HUVEC-derived exosomes decreased the expression of contractile phenotype marker genes (alpha-SMA, Smoothelin and Calponin) in SMCs. Furthermore, a reduction of the miR-26a-containing exosomes secreted from HUVECs affects the SMC phenotype. We propose a novel mechanism in which miR-206 expression in HUVECs maintains the contractile phenotype of SMCs by suppressing exosome secretion from HUVECs, particularly miR-26a in exosomes, through targeting ARF6 and NCX1.	[Lin, Xiao; He, Yu; Zhang, Zhenming; Wang, Rui; Wu, Qiong] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Hou, Xue] Qinghai Univ, Coll Med, Dept Basic Med, Xining 810016, Peoples R China	Tsinghua University; Qinghai University	Wu, Q (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	wuqiong@mail.tsinghua.edu.cn	wu, qiong/GRY-4672-2022		National Natural Science Foundation of China [31170940, 31070095]; State Basic Science Foundation 973 [2012CB725204]; National High Technology Research and Development Program of China (863) [2012AA020503, 2011AA02A201, 2012AA02A700]; Tsinghua University Initiative Scientific Research Program [20131089199]; National Fund for Talent Training in Basic Science [J1310020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Basic Science Foundation 973(National Basic Research Program of China); National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); Tsinghua University Initiative Scientific Research Program; National Fund for Talent Training in Basic Science	This work was supported by the National Natural Science Foundation of China (Grant No. 31170940, No. 31070095); The State Basic Science Foundation 973 (Grant No. 2012CB725204); National High Technology Research and Development Program of China (863) (Grant No. 2012AA020503, No. 2011AA02A201, No. 2012AA02A700); Tsinghua University Initiative Scientific Research Program (Grant No. 20131089199) and National Fund for Talent Training in Basic Science (No. J1310020).	Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Fedele C, 2015, J BIOL CHEM, V290, P4545, DOI 10.1074/jbc.C114.617662; Friand V, 2015, BIOL CELL, V107, P331, DOI 10.1111/boc.201500010; Ghossoub R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4477; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Glebov K, 2015, GLIA, V63, P626, DOI 10.1002/glia.22772; Gui T, 2012, LAB INVEST, V92, P1250, DOI 10.1038/labinvest.2012.85; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Herrmann S, 2013, CARDIOVASC RES, V99, P780, DOI 10.1093/cvr/cvt154; Heydarkhan-Hagvall S, 2003, J CELL BIOCHEM, V89, P1250, DOI 10.1002/jcb.10583; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Li J, 2013, J BIOL CHEM, V288, P23586, DOI 10.1074/jbc.M113.489302; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Roucourt B, 2015, CELL RES, V25, P412, DOI 10.1038/cr.2015.29; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Sharma A, 2015, J VIS EXP; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; Tritsch E, 2013, CARDIOVASC RES, V98, P372, DOI 10.1093/cvr/cvt042; van Balkom BWM, 2013, BLOOD, V121, P3997, DOI 10.1182/blood-2013-02-478925; Wang XH, 2014, J MOL CELL CARDIOL, V74, P139, DOI 10.1016/j.yjmcc.2014.05.001; Wanichawan P, 2014, J BIOL CHEM, V289, P33984, DOI 10.1074/jbc.M114.602581; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yin Y, 2014, CELL RES, V24, P1164, DOI 10.1038/cr.2014.121	35	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152959	10.1371/journal.pone.0152959	http://dx.doi.org/10.1371/journal.pone.0152959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031991	gold, Green Submitted, Green Published			2022-12-26	WOS:000373121800160
J	Shi, X; Walter, NAR; Harkness, JH; Neve, KA; Williams, RW; Lu, L; Belknap, JK; Eshleman, AJ; Phillips, TJ; Janowsky, A				Shi, Xiao; Walter, Nicole A. R.; Harkness, John H.; Neve, Kim A.; Williams, Robert W.; Lu, Lu; Belknap, John K.; Eshleman, Amy J.; Phillips, Tamara J.; Janowsky, Aaron			Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; PROTEIN-COUPLED RECEPTORS; METHAMPHETAMINE INTAKE; BETA-PHENYLETHYLAMINE; CELL-TYPE; TAAR1; AMPHETAMINE; AGONISTS; MICE; METABOLITES	Methamphetamine (MA) and neurotransmitter precursors and metabolites such as tyramine, octopamine, and beta-phenethylamine stimulate the G protein-coupled trace amine-associated receptor 1 (TAAR1). TAAR1 has been implicated in human conditions including obesity, schizophrenia, depression, fibromyalgia, migraine, and addiction. Additionally TAAR1 is expressed on lymphocytes and astrocytes involved in inflammation and response to infection. In brain, TAAR1 stimulation reduces synaptic dopamine availability and alters glutamatergic function. TAAR1 is also expressed at low levels in heart, and may regulate cardiovascular tone. Taar1 knockout mice orally self-administer more MA than wild type and are insensitive to its aversive effects. DBA/2J (D2) mice express a non-synonymous single nucleotide polymorphism (SNP) in Taar1 that does not respond to MA, and D2 mice are predisposed to high MA intake, compared to C57BL/6 (B6) mice. Here we demonstrate that endogenous agonists stimulate the recombinant B6 mouse TAAR1, but do not activate the D2 mouse receptor. Progeny of the B6XD2 (BxD) family of recombinant inbred (RI) strains have been used to characterize the genetic etiology of diseases, but contrary to expectations, BXDs derived 30-40 years ago express only the functional B6 Taar1 allele whereas some more recently derived BXD RI strains express the D2 allele. Data indicate that the D2 mutation arose subsequent to derivation of the original RIs. Finally, we demonstrate that SNPs in human TAAR1 alter its function, resulting in expressed, but functional, sub-functional and non-functional receptors. Our findings are important for identifying a predisposition to human diseases, as well as for developing personalized treatment options.	[Shi, Xiao; Walter, Nicole A. R.; Harkness, John H.; Neve, Kim A.; Belknap, John K.; Eshleman, Amy J.; Phillips, Tamara J.; Janowsky, Aaron] Vet Affairs Portland Hlth Care Syst, Portland, OR USA; [Shi, Xiao; Neve, Kim A.; Belknap, John K.; Phillips, Tamara J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Methamphetamine Abuse Res Ctr, Portland, OR 97201 USA; [Shi, Xiao; Walter, Nicole A. R.; Harkness, John H.; Neve, Kim A.; Belknap, John K.; Eshleman, Amy J.; Phillips, Tamara J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Williams, Robert W.; Lu, Lu] Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Lu, Lu] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China; [Janowsky, Aaron] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University; University of Tennessee System; University of Tennessee Health Science Center; Nantong University; Oregon Health & Science University	Janowsky, A (corresponding author), Vet Affairs Portland Hlth Care Syst, Portland, OR USA.; Janowsky, A (corresponding author), Oregon Hlth & Sci Univ, Methamphetamine Abuse Res Ctr, Portland, OR 97201 USA.; Janowsky, A (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.; Janowsky, A (corresponding author), Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA.	janowsky@ohsu.edu	Harkness, John/AAE-6965-2020; Williams, Robert W./H-8789-2016	Harkness, John/0000-0002-4044-0647; Williams, Robert W./0000-0001-8924-4447; Walter, Nicole/0000-0003-0431-8078	NIH [T32 DA007262]; Methamphetamine Abuse Research Center [P50 DA018165]; Portland Alcohol Research Center [P60 AA010760]; VA Merit Review grants from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service [I01 BX002106, I01 BX002758]; VA Research Career Scientist Program; NIAAA [U01 AA016662, U01 AA013499, U01 AA014425]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, P60AA010760, U01AA014425, U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA018165, T32DA007262] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002106, I01BX002758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Methamphetamine Abuse Research Center; Portland Alcohol Research Center; VA Merit Review grants from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service; VA Research Career Scientist Program; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	The authors have no personal or professional associations that could be considered conflicts of interest. This work was supported by NIH grant T32 DA007262, the Methamphetamine Abuse Research Center (P50 DA018165) the Portland Alcohol Research Center (P60 AA010760), and by a VA Merit Review grants (I01 BX002106 and I01 BX002758) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service, and the VA Research Career Scientist Program. Production of the new BXD strains was supported in part by NIAAA U01 AA016662, U01 AA013499, and U01 AA014425. The contents of this article may not necessarily represent the views of the U.S. Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Babusyte A, 2013, J LEUKOCYTE BIOL, V93, P387, DOI 10.1189/jlb.0912433; BAUD P, 1985, J PHARMACOL EXP THER, V235, P220; Belknap JK, 2013, MAMM GENOME, V24, P446, DOI 10.1007/s00335-013-9484-9; Berry MD, 2013, SYNAPSE, V67, P656, DOI 10.1002/syn.21670; Berry MD, 2004, J NEUROCHEM, V90, P257, DOI 10.1111/j.1471-4159.2004.02501.x; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Cichero E, 2013, CHEM BIOL DRUG DES, V81, P509, DOI 10.1111/cbdd.12018; Cisneros IE, 2014, NEUROPHARMACOLOGY, V85, P499, DOI 10.1016/j.neuropharm.2014.06.011; D'Andrea G, 2013, CEPHALALGIA, V33, P932, DOI 10.1177/0333102413480755; Deb I, 2010, J NEUROCHEM, V112, P486, DOI 10.1111/j.1471-4159.2009.06472.x; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Espinoza S, 2015, NEUROPSYCHOPHARMACOL, V40, P2217, DOI 10.1038/npp.2015.65; Espinoza S, 2015, NEUROPHARMACOLOGY, V93, P308, DOI 10.1016/j.neuropharm.2015.02.010; Espinoza S, 2011, MOL PHARMACOL, V80, P416, DOI 10.1124/mol.111.073304; Federici M, 2005, MOL PHARMACOL, V67, P1283, DOI 10.1124/mol.104.007427; Fortin JP, 2010, MOL PHARMACOL, V78, P837, DOI 10.1124/mol.110.064188; Galley G, 2012, BIOORG MED CHEM LETT, V22, P5244, DOI 10.1016/j.bmcl.2012.06.060; Grandy DK, 2007, PHARMACOL THERAPEUT, V116, P355, DOI 10.1016/j.pharmthera.2007.06.007; Gulaboski R, 2007, ANAL BIOCHEM, V361, P236, DOI 10.1016/j.ab.2006.11.006; Harkness JH, 2015, NEUROPSYCHOPHARMACOL, V40, P2175, DOI 10.1038/npp.2015.61; Ishida K, 2005, BIOL PHARM BULL, V28, P1626, DOI 10.1248/bpb.28.1626; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; Liu XH, 2014, J PHARMACOL EXP THER, V350, P124, DOI 10.1124/jpet.114.213116; Lu H, 2011, INVEST OPHTH VIS SCI, V52, P4132, DOI 10.1167/iovs.10-6493; Lynch LJ, 2013, SUBST ABUS-RES TREAT, V7, P117, DOI 10.4137/SART.S12110; Panas MW, 2012, J NEUROIMMUNE PHARM, V7, P866, DOI 10.1007/s11481-011-9321-4; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Pei Y, 2014, NEUROPSYCHOPHARMACOL, V39, P2299, DOI 10.1038/npp.2014.88; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Raab S, 2016, MOL METAB, V5, P47, DOI 10.1016/j.molmet.2015.09.015; Reese EA, 2007, J PHARMACOL EXP THER, V321, P178, DOI 10.1124/jpet.106.115402; Reese EA, 2014, J MED CHEM, V57, P378, DOI 10.1021/jm401316v; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Revel FG, 2013, MOL PSYCHIATR, V18, P543, DOI 10.1038/mp.2012.57; Revel FG, 2012, BIOL PSYCHIAT, V72, P934, DOI 10.1016/j.biopsych.2012.05.014; Revel FG, 2011, P NATL ACAD SCI USA, V108, P8485, DOI 10.1073/pnas.1103029108; Rickli A, 2015, BRIT J PHARMACOL, V172, P3412, DOI 10.1111/bph.13128; Shabani S, 2011, GENES BRAIN BEHAV, V10, P625, DOI 10.1111/j.1601-183X.2011.00700.x; Shabani S, 2012, NEUROPHARMACOLOGY, V62, P2169, DOI 10.1016/j.neuropharm.2012.01.002; Shabani S, 2012, NEUROPHARMACOLOGY, V62, P1134, DOI 10.1016/j.neuropharm.2011.11.005; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Snead AN, 2008, BIOORG MED CHEM LETT, V18, P5920, DOI 10.1016/j.bmcl.2008.08.013; Sotnikova TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013452; Sotnikova TD, 2009, MOL PHARMACOL, V76, P229, DOI 10.1124/mol.109.055970; Sotnikova Tatyana D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS99, DOI 10.1016/j.parkreldis.2008.04.006; Stalder H, 2011, BIOORG MED CHEM LETT, V21, P1227, DOI 10.1016/j.bmcl.2010.12.075; Sukhanov I, 2014, INT J NEUROPSYCHOPH, V17, P1683, DOI 10.1017/S1461145714000509; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Wang DX, 2001, J BIOL CHEM, V276, P34624, DOI 10.1074/jbc.M104083200; Watts VJ, 1998, J NEUROSCI, V18, P8692; Wheeler JM, 2009, GENES BRAIN BEHAV, V8, P758, DOI 10.1111/j.1601-183X.2009.00522.x; Wolinsky TD, 2007, GENES BRAIN BEHAV, V6, P628, DOI 10.1111/j.1601-183X.2006.00292.x; Xie ZH, 2007, J PHARMACOL EXP THER, V321, P128, DOI 10.1124/jpet.106.117382; Zhao WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133132	58	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152581	10.1371/journal.pone.0152581	http://dx.doi.org/10.1371/journal.pone.0152581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031617	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800097
J	Sui, YY; Ou, Y; Yan, BX; Xu, XH; Rousseau, AN; Zhang, Y				Sui, Yuanyuan; Ou, Yang; Yan, Baixing; Xu, Xiaohong; Rousseau, Alain N.; Zhang, Yu			Assessment of Micro-Basin Tillage as a Soil and Water Conservation Practice in the Black Soil Region of Northeast China	PLOS ONE			English	Article							RESERVOIR TILLAGE; FURROW DIKING; EROSION; CROP; PHOSPHORUS; RUNOFF; IMPACT	Micro-basin tillage is a soil and water conservation practice that requires building individual earth blocks along furrows. In this study, plot experiments were conducted to assess the efficiency of micro-basin tillage on sloping croplands between 2012 and 2013 (5 degrees and 7 degrees). The conceptual, optimal, block interval model was used to design micro-basins which are meant to capture the maximum amount of water per unit area. Results indicated that when compared to the up-down slope tillage, micro-basin tillage could increase soil water content and maize yield by about 45% and 17%, and reduce runoff, sediment and nutrients loads by about 63%, 96% and 86%, respectively. Meanwhile, micro-basin tillage could reduce the peak runoff rates and delay the initial runoff-yielding time. In addition, micro-basin tillage with the optimal block interval proved to be the best one among all treatments with different intervals. Compared with treatments of other block intervals, the optimal block interval treatments increased soil moisture by around 10% and reduced runoff rate by around 15%. In general, micro-basin tillage with optimal block interval represents an effective soil and water conservation practice for sloping farmland of the black soil region.	[Sui, Yuanyuan; Ou, Yang; Yan, Baixing] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun 130102, Peoples R China; [Sui, Yuanyuan] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Xu, Xiaohong; Zhang, Yu] Soil & Water Conservat Res Inst Jilin Prov, Changchun 130033, Peoples R China; [Rousseau, Alain N.] Inst Natl Rech Sci INRS ETE, Ctr Eau Terre Environm, 490 Couronne, Quebec City, PQ, Canada	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Quebec; Institut national de la recherche scientifique (INRS)	Ou, Y (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun 130102, Peoples R China.	ouyang@iga.ac.cn	Ou, Yang/AAE-4514-2020		National Key Technology R & D Program of China [2011BAD31B01]; Natural Science Foundation of China [41201534, 41571480]; Natural Science Foundation of Jilin Province [20130522072JH, 20150224046SF]	National Key Technology R & D Program of China(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This work was supported by the National Key Technology R & D Program of China (No. 2011BAD31B01), http://www.most.gov.cn/eng/organization/mission/index.htm; Natural Science Foundation of China (No. 41201534, 41571480), http://www.nsfc.gov.cn/publish/portal1/; and Natural Science Foundation of Jilin Province (No. 20130522072JH, 20150224046SF), http://kjt.jl.gov.cn/kjt/4/tindex.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brhane G, 2006, AGRON J, V98, P124, DOI 10.2134/agronj2005-0148; Campos H, 2006, MAYDICA, V51, P369; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Duan XW, 2011, CATENA, V87, P268, DOI 10.1016/j.catena.2011.06.012; [范昊明 Fan Haoming], 2005, [自然资源学报, Journal of Natural Resources], V20, P387; GERARD CJ, 1984, AGRON J, V76, P945, DOI 10.2134/agronj1984.00021962007600060019x; Gordon RJ, 2011, AGR WATER MANAGE, V98, P1782, DOI 10.1016/j.agwat.2011.07.007; Guzha AC, 2004, SOIL TILL RES, V76, P105, DOI 10.1016/j.still.2003.09.002; Hackwell S, 1991, T ASAE US; JONES OR, 1990, SOIL TILL RES, V18, P249, DOI 10.1016/0167-1987(90)90064-K; JONES OR, 1987, SOIL SCI SOC AM J, V51, P1307, DOI 10.2136/sssaj1987.03615995005100050039x; KRISHNA JH, 1989, AGR WATER MANAGE, V16, P87, DOI 10.1016/0378-3774(89)90043-7; Liu HH, 2013, ENVIRON EARTH SCI, V68, P1723, DOI 10.1007/s12665-012-1863-0; Liu XB, 2011, SOIL TILL RES, V117, P44, DOI 10.1016/j.still.2011.08.005; Ma Y-s, 2004, J SHENYANG AGR U, pZ1; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Nuti RC, 2009, AGR WATER MANAGE, V96, P1078, DOI 10.1016/j.agwat.2009.03.006; Organization WH, 2004, GUID DRINK WAT QUAL; Patrick C, 2007, SOIL USE MANAGE, V23, P185, DOI 10.1111/j.1475-2743.2006.00069.x; Pendke M. S., 2004, Journal of Maharashtra Agricultural Universities, V29, P319; Previati M, 2010, AGR WATER MANAGE, V97, P449, DOI 10.1016/j.agwat.2009.11.004; ROCHESTER EW, 1994, T ASAE, V37, P1183, DOI 10.13031/2013.28192; Salem HM, 2014, CATENA, V113, P353, DOI 10.1016/j.catena.2013.08.018; Sanders JH., 1996, EC AGR TECHNOLOGY SE; Sharpley A, 2003, J ENVIRON QUAL, V32, P2172, DOI 10.2134/jeq2003.2172; Sun T, 2014, J HYDROL, V519, P1141, DOI 10.1016/j.jhydrol.2014.08.048; Truman CC, 2010, AGR WATER MANAGE, V97, P835, DOI 10.1016/j.agwat.2010.01.004; Truman CC, 2009, AGR WATER MANAGE, V96, P1071, DOI 10.1016/j.agwat.2008.12.002; Withers PJA, 2008, SCI TOTAL ENVIRON, V400, P379, DOI 10.1016/j.scitotenv.2008.08.002; Wiyo KA, 2000, AGR WATER MANAGE, V45, P101, DOI 10.1016/S0378-3774(99)00103-1; Xiao B, 2012, SOIL TILL RES, V122, P22, DOI 10.1016/j.still.2012.02.006; Xu XZ, 2010, ENVIRON SCI POLICY, V13, P793, DOI 10.1016/j.envsci.2010.07.004; ZHANG X, 2006, SCI GEOGRAPHICA SINI, V26, P692; Zhao J, 2015, POTENTIAL YIELD IMPR, P2	34	14	15	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152313	10.1371/journal.pone.0152313	http://dx.doi.org/10.1371/journal.pone.0152313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031339	Green Published, gold, Green Accepted			2022-12-26	WOS:000373121800055
J	Wandeler, G; Musukuma, K; Zurcher, S; Vinikoor, MJ; Llenas-Garcia, J; Aly, MM; Mulenga, L; Chi, BH; Ehmer, J; Hobbins, MA; Bolton-Moore, C; Hoffmann, CJ; Egger, M				Wandeler, Gilles; Musukuma, Kalo; Zuercher, Samuel; Vinikoor, Michael J.; Llenas-Garcia, Jara; Aly, Mussa M.; Mulenga, Lloyd; Chi, Benjamin H.; Ehmer, Jochen; Hobbins, Michael A.; Bolton-Moore, Carolyn; Hoffmann, Christopher J.; Egger, Matthias		IeDEA-Southern Africa	Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia	PLOS ONE			English	Article							1ST-LINE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; COINFECTED PATIENTS; VIRUS INFECTION; TENOFOVIR; EPIDEMIOLOGY; PREVALENCE; VALIDATION; LAMIVUDINE; MUTATIONS	Background Few data on the virological determinants of hepatitis B virus (HBV) infection are available from southern Africa. Methods We enrolled consecutive HIV-infected adult patients initiating antiretroviral therapy (ART) at two urban clinics in Zambia and four rural clinics in Northern Mozambique between May 2013 and August 2014. HBsAg screening was performed using the Determine (R) rapid test. Quantitative real-time PCR and HBV sequencing were performed in HBsAg-positive patients. Risk factors for HBV infection were evaluated using Chi-square and Mann-Whitney tests and associations between baseline characteristics and high level HBV replication explored in multivariable logistic regression. Results Seventy-eight of 1,032 participants in Mozambique (7.6%, 95% confidence interval [CI]: 6.1-9.3) and 90 of 797 in Zambia (11.3%, 95% CI: 9.3-13.4) were HBsAg-positive. HBsAg-positive individuals were less likely to be female compared to HBsAg-negative ones (52.3% vs. 66.1%, p<0.001). Among 156 (92.9%) HBsAg-positive patients with an available measurement, median HBV viral load was 13,645 IU/mL (interquartile range: 192-8,617,488 IU/mL) and 77 (49.4%) had high values (>20,000 UI/mL). HBsAg-positive individuals had higher levels of ALT and AST compared to HBsAg-negative ones (both p<0.001). In multivariable analyses, male sex (adjusted odds ratio: 2.59, 95% CI: 1.22-5.53) and CD4 cell count below 200/mu l (2.58, 1.20-5.54) were associated with high HBV DNA. HBV genotypes A1 (58.8%) and E (38.2%) were most prevalent. Four patients had probable resistance to lamivudine and/or entecavir. Conclusion One half of HBsAg-positive patients demonstrated high HBV viremia, supporting the early initiation of tenofovir-containing ART in HIV/HBV-coinfected adults.	[Wandeler, Gilles] Univ Bern, Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland; [Wandeler, Gilles; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Wandeler, Gilles] Univ Dakar, Dept Infect Dis, Dakar, Senegal; [Musukuma, Kalo; Vinikoor, Michael J.; Mulenga, Lloyd; Bolton-Moore, Carolyn] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Zuercher, Samuel] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Vinikoor, Michael J.; Bolton-Moore, Carolyn] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Llenas-Garcia, Jara] SolidarMed, Ancuabe, Mozambique; [Aly, Mussa M.] Nucleo Invest Operat Pemba, Pemba, Mozambique; [Chi, Benjamin H.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Ehmer, Jochen; Hobbins, Michael A.] SolidarMed, Luzern, Switzerland; [Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Egger, Matthias] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of Cape Town	Wandeler, G (corresponding author), Univ Bern, Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland.; Wandeler, G (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Wandeler, G (corresponding author), Univ Dakar, Dept Infect Dis, Dakar, Senegal.	gilles.wandeler@ispm.unibe.ch	Wandeler, Gilles/ABB-2961-2020; Prozesky, Hans Walter/ABE-6956-2020	Prozesky, Hans Walter/0000-0001-9715-3449; Llenas-Garcia, Jara/0000-0001-9125-7706; Hoffmann, Christopher/0000-0002-9422-0519; Egger, Matthias/0000-0001-7462-5132; Bolton Moore, Carolyn/0000-0001-9103-7746	National Institute of Allergy and Infectious Diseases [5U01-AI069924-05]; Fogarty International Center of the National Institutes of Health [1K01TW009998]; Ambizione-PROSPER fellowship from the Swiss National Science Foundation [PZ00P3_154730]; FOGARTY INTERNATIONAL CENTER [K01TW009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, P30AI050410] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Ambizione-PROSPER fellowship from the Swiss National Science Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases (Grant number 5U01-AI069924-05) and Fogarty International Center (Grant number 1K01TW009998) of the National Institutes of Health. GW was supported by an Ambizione-PROSPER fellowship from the Swiss National Science Foundation (PZ00P3_154730). Support for Zambian laboratory capacity building came from the HIV Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all study participants and staff of all participating sites. This study was supported by the National Institute of Allergy and Infectious Diseases (Grant number 5U01-AI069924-05) and Fogarty International Center (Grant number 1K01TW009998) of the National Institutes of Health. GW was supported by an Ambizione-PROSPER fellowship from the Swiss National Science Foundation (PZ00P3_154730). Support for Zambian laboratory capacity building came from the HIV Research Trust.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Amini-Bavil-Olyaee S, 2009, HEPATOLOGY, V49, P1158, DOI 10.1002/hep.22790; Aoudjane S, 2014, CLIN INFECT DIS, V59, P1618, DOI 10.1093/cid/ciu630; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Brunelle MN, 2005, HEPATOLOGY, V41, P1391, DOI 10.1002/hep.20723; Chadwick D, 2012, J ANTIMICROB CHEMOTH, V67, P2939, DOI 10.1093/jac/dks333; Childs K, 2013, AIDS, V27, P1443, DOI 10.1097/QAD.0b013e32836011c2; Cunha L, 2007, J MED VIROL, V79, P1832, DOI 10.1002/jmv.21010; Day SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059346; Delaney WE, 2006, ANTIMICROB AGENTS CH, V50, P2471, DOI 10.1128/AAC.00138-06; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Hawkins C, 2013, AIDS, V27, P919, DOI 10.1097/QAD.0b013e32835cb9c8; Hill A, 2015, J VIRUS ERAD, V1, P103; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Kapembwa KC, 2011, J GLOB INFECT DIS, V3, P269, DOI 10.4103/0974-777X.83534; Lacombe K, 2005, AIDS, V19, P907, DOI 10.1097/01.aids.0000171404.07995.5c; Makondo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046345; Mallory MA, 2011, J VIROL METHODS, V177, P31, DOI 10.1016/j.jviromet.2011.06.009; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Matthews PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134037; Schildgen O, 2006, NEW ENGL J MED, V354, P1807, DOI 10.1056/NEJMoa051214; Sheldon J, 2005, ANTIVIR THER, V10, P727; Stabinski L, 2015, JAIDS-J ACQ IMM DEF, V68, pS274, DOI 10.1097/QAI.0000000000000496; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Vinikoor MJ, 2015, J CLIN VIROL, V72, P20, DOI 10.1016/j.jcv.2015.08.019; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wandeler G, 2013, J INFECT DIS, V208, P1454, DOI 10.1093/infdis/jit351; WHO, 2015, WHO GUID PREV CAR TR	31	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152043	10.1371/journal.pone.0152043	http://dx.doi.org/10.1371/journal.pone.0152043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032097	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800031
J	Beckley, CS; Shaban, S; Palmer, GH; Hudak, AT; Noh, SM; Futse, JE				Beckley, Carl S.; Shaban, Salisu; Palmer, Guy H.; Hudak, Andrew T.; Noh, Susan M.; Futse, James E.			Disaggregating Tropical Disease Prevalence by Climatic and Vegetative Zones within Tropical West Africa	PLOS ONE			English	Article							INFECTIOUS-DISEASES; DOMESTIC RUMINANTS; BORNE DISEASES; ANIMAL HEALTH; TICKS; VECTOR; SURVEILLANCE; DATABASE; GHANA	Tropical infectious disease prevalence is dependent on many socio-cultural determinants. However, rainfall and temperature frequently underlie overall prevalence, particularly for vector-borne diseases. As a result these diseases have increased prevalence in tropical as compared to temperate regions. Specific to tropical Africa, the tendency to incorrectly infer that tropical diseases are uniformly prevalent has been partially overcome with solid epidemiologic data. This finer resolution data is important in multiple contexts, including understanding risk, predictive value in disease diagnosis, and population immunity. We hypothesized that within the context of a tropical climate, vector-borne pathogen prevalence would significantly differ according to zonal differences in rainfall, temperature, relative humidity and vegetation condition. We then determined if these environmental data were predictive of pathogen prevalence. First we determined the prevalence of three major pathogens of cattle, Anaplasma marginale, Babesia bigemina and Theileria spp, in the three vegetation zones where cattle are predominantly raised in Ghana: Guinea savannah, semi-deciduous forest, and coastal savannah. The prevalence of A. marginale was 63%, 26% for Theileria spp and 2% for B. bigemina. A. marginale and Theileria spp. were significantly more prevalent in the coastal savannah as compared to either the Guinea savanna or the semi-deciduous forest, supporting acceptance of the first hypothesis. To test the predictive power of environmental variables, the data over a three year period were considered in best subsets multiple linear regression models predicting prevalence of each pathogen. Corrected Akaike Information Criteria (AICc) were assigned to the alternative models to compare their utility. Competitive models for each response were averaged using AICc weights. Rainfall was most predictive of pathogen prevalence, and EVI also contributed to A. marginale and B. bigemina prevalence. These findings support the utility of environmental data for understanding vector-borne disease epidemiology on a regional level within a tropical environment.	[Shaban, Salisu; Futse, James E.] Univ Ghana, Dept Anim Sci, Coll Basic & Appl Sci, Legon, Ghana; [Beckley, Carl S.] CSIR, Anim Res Inst, Accra, Ghana; [Noh, Susan M.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Palmer, Guy H.; Noh, Susan M.] Washington State Univ, Dept Vet Microbiol & Pathol, Program Vector Borne Dis, Pullman, WA 99164 USA; [Palmer, Guy H.; Noh, Susan M.; Futse, James E.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Hudak, Andrew T.] US Forest Serv, Rocky Mt Res Stn, USDA, Moscow, ID USA	University of Ghana; United States Department of Agriculture (USDA); Washington State University; Washington State University; United States Department of Agriculture (USDA); United States Forest Service	Futse, JE (corresponding author), Univ Ghana, Dept Anim Sci, Coll Basic & Appl Sci, Legon, Ghana.; Futse, JE (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	jefutse@ug.edu.gh			Wellcome Trust [097171/Z/11/Z]; International Foundation for Science [B/5120-1]; National Institute of Health (NIH) [R37 AI44005]; United States Department of Agriculture -Agricultural Research Service [USDA-ARS 5348-32000-033-00D]; Wellcome trust; NIH [R37 AI44005]; USDA-ARS [5348-32000-033-00D]; Jan and Jack Creighton Endowment fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); International Foundation for Science(International Foundation for Science); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture -Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Wellcome trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Jan and Jack Creighton Endowment fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The Wellcome Trust for the fellowship in Public Health and Tropical Medicine grant, #097171/Z/11/Z, URL: www.wellcome.ac.uk/.../Publichealth-and-tropical-medicine/wtd025883.htm, to JEF; International Foundation for Science, #B/5120-1, URL: http://www.ifs.se/to JEF; National Institute of Health (NIH) Grant R37 AI44005, URL: http://nih.gov/ to GHP; and United States Department of Agriculture -Agricultural Research Service, (USDA-ARS 5348-32000-033-00D, URL: http://www.usda.gov/wps/portal/usda/usdahome?, to GHP. The Wellcome trust provided funding for the study, including money for reagents, data collection, and preparation of the manuscript. NIH and USDA-ARS provided some molecular biology reagents. Jan and Jack Creighton Endowment fund provided travel support for Professor Palmer to visit project site in Ghana.; This work was supported by the International Foundation for Science grant B/5120-1, the Wellcome Trust for the fellowship in Public Health and Tropical Medicine grant 097171/Z/11/Z, NIH Grant (R37 AI44005), USDA-ARS 5348-32000-033-00D, and the Jan and Jack Creighton Endowment fund. We wish to thank Crystal Davis and Alexis Gantz for graphics support and the Ghana Meteorological Agency for providing the rainfall, temperature, and relative humidity data for the study period.	Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; [Anonymous], 2014, R LANG ENV STAT COMP; Bell-Sakyi L, 2004, VET PARASITOL, V124, P25, DOI 10.1016/j.vetpar.2004.05.027; Bilgic HB, 2013, EXP PARASITOL, V133, P222, DOI 10.1016/j.exppara.2012.11.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chipwaza B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003750; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Estrada-Pena A, 2008, VET PARASITOL, V151, P256, DOI 10.1016/j.vetpar.2007.11.014; Feasey N, 2010, BRIT MED BULL, V93, P179, DOI 10.1093/bmb/ldp046; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hurlimann E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001404; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Kilpatrick AM, 2013, AM J EPIDEMIOL, V178, P829, DOI 10.1093/aje/kwt046; Kivaria FM, 2010, VET J, V184, P7, DOI 10.1016/j.tvjl.2009.12.003; Moffett A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000378; Nahum A, 2010, AM J TROP MED HYG, V83, P465, DOI 10.4269/ajtmh.2010.09-0611; NEEDHAM GR, 1991, ANNU REV ENTOMOL, V36, P659, DOI 10.1146/annurev.en.36.010191.003303; Nutsukpo DK, 2013, W AFRICAN AGR CLIMAT; Okantah SA., 2002, ANIMAL GENETICS TRAI; Organization WH, 2010, WORK OV GLOB IMP NEG; Randolph SE, 2000, ADV PARASIT, V47, P217, DOI 10.1016/S0065-308X(00)47010-7; Royston P, 1992, STAT COMPUT, V2, P117, DOI [DOI 10.1007/BF01891203, 10.1007/BF01891203]; Snow RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128792; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; UILENBERG G, 1995, VET PARASITOL, V57, P19, DOI 10.1016/0304-4017(94)03107-8; Van den Bossche P, 2008, REV SCI TECH OIE, V27, P551; Walker AR, 1999, B ENTOMOL RES, V89, P473, DOI 10.1017/S0007485399000619	32	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152560	10.1371/journal.pone.0152560	http://dx.doi.org/10.1371/journal.pone.0152560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022740	gold, Green Published, Green Submitted			2022-12-26	WOS:000373113900076
J	Garcia-Molina, MD; Garcia-Olmo, J; Barro, F				Garcia-Molina, Maria Dolores; Garcia-Olmo, Juan; Barro, Francisco			Effective Identification of Low-Gliadin Wheat Lines by Near Infrared Spectroscopy (NIRS): Implications for the Development and Analysis of Foodstuffs Suitable for Celiac Patients	PLOS ONE			English	Article							SEED STORAGE PROTEINS; ALPHA-GLIADIN; DISEASE; DIAGNOSIS; EPITOPES; GLUTEN; DURUM	Scope The aim of this work was to assess the ability of Near Infrared Spectroscopy (NIRS) to distinguish wheat lines with low gliadin content, obtained by RNA interference (RNAi), from non-transgenic wheat lines. The discriminant analysis was performed using both whole grain and flour. The transgenic sample set included 409 samples for whole grain sorting and 414 samples for flour experiments, while the non-transgenic set consisted of 126 and 156 samples for whole grain and flour, respectively. Methods and Results Samples were scanned using a Foss-NIR Systems 6500 System II instrument. Discrimination models were developed using the entire spectral range (400-2500 nm) and ranges of 400-780 nm, 800-1098 nm and 1100-2500 nm, followed by analysis of means of partial least square (PLS). Two external validations were made, using samples from the years 2013 and 2014 and a minimum of 99% of the flour samples and 96% of the whole grain samples were classified correctly. Conclusions The results demonstrate the ability of NIRS to successfully discriminate between wheat samples with low-gliadin content and wild types. These findings are important for the development and analysis of foodstuff for celiac disease (CD) patients to achieve better dietary composition and a reduction in disease incidence.	[Garcia-Molina, Maria Dolores; Barro, Francisco] CSIC, IAS, Dept Mejora Genet, Cordoba, Spain; [Garcia-Olmo, Juan] Univ Cordoba, Cent Serv Res Support, NIR MIR Spect Unit, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Universidad de Cordoba	Barro, F (corresponding author), CSIC, IAS, Dept Mejora Genet, Cordoba, Spain.	fbarro@ias.csic.es	Barro, Francisco/E-8572-2017; Barro, Francisco/J-3254-2014; García-Olmo, J./D-3524-2014	Barro, Francisco/0000-0002-7652-229X; García-Olmo, J./0000-0003-3408-4428; Garcia-Molina, Maria Dolores/0000-0003-3606-6178	Spanish Ministry of Economy and Competitiveness [AGL2010-19643-C02-02, AGL2013-48946-C3-1-R]; European Regional Development Fund (FEDER); Junta de Andalucia [P11-AGR-7920]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia)	The Spanish Ministry of Economy and Competitiveness (Projects AGL2010-19643-C02-02 and AGL2013-48946-C3-1-R), the European Regional Development Fund (FEDER) and Junta de Andalucia (Project P11-AGR-7920) supported this work.	Altenbach Susan B, 2011, GM Crops, V2, P66, DOI 10.4161/gmcr.2.1.15884; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Barro F., 2015, PLANT BIOTECHNOL J, P1; Becker D, 2012, J APPL BOT FOOD QUAL, V85, P23; Blakeney AB, 2005, MOL NUTR FOOD RES, V49, P546, DOI 10.1002/mnfr.200500038; Candolfi A, 1999, J PHARMACEUT BIOMED, V21, P115, DOI 10.1016/S0731-7085(99)00125-9; Cocchi M, 2005, ANAL CHIM ACTA, V544, P100, DOI 10.1016/j.aca.2005.02.075; De Girolamo A, 2009, FOOD ADDIT CONTAM A, V26, P907, DOI 10.1080/02652030902788946; De Palma G, 2009, BRIT J NUTR, V102, P1154, DOI 10.1017/S0007114509371767; Dhanoa MS., 1994, J NEAR INFRARED SPEC, V2, P43, DOI [10.1255/jnirs.30, DOI 10.1255/JNIRS.30]; Farrell RJ, 2001, AM J GASTROENTEROL, V96, P3237; Ferre S., 2004, P 18 M WORK GROUP PR, P65; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; Gil-Humanes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091931; Gil-Humanes J, 2011, J EXP BOT, V62, P4203, DOI 10.1093/jxb/err119; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Marine M, 2011, ALIMENT PHARM THER, V33, P477, DOI 10.1111/j.1365-2036.2010.04543.x; Osborne B. G., 1993, PRACTICAL NIR SPECTR; Piston F, 2011, PLOS ONE, V6, P15; Piston F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-136; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Segtnan VH, 2006, MOL NUTR FOOD RES, V50, P811, DOI 10.1002/mnfr.200500260; Shenk J.S., 1996, NEAR INFRARED SPECTR, P198; Shewry P.R., 2009, WHEAT CHEM TECHNOLOG, P223, DOI DOI 10.1094/9781891127557.008; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Silvester JA, 2007, CAN J GASTROENTEROL, V21, P557, DOI 10.1155/2007/342685; Sissons M, 2006, J NEAR INFRARED SPEC, V14, P17, DOI 10.1255/jnirs.582; Stellacci A.M., 2012, ITAL J AGRON, V7, P247, DOI [10.4081/ija.2012.e34, DOI 10.4081/IJA.2012.E34]; Trier JS, 1998, GASTROENTEROLOGY, V115, P211, DOI 10.1016/S0016-5085(98)70383-X; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Wieser H, 1998, J SCI FOOD AGR, V76, P49, DOI [10.1002/(SICI)1097-0010(199801)76:1<49::AID-JSFA950>3.0.CO;2-2, 10.1002/(SICI)1097-0010(199801)76:1&lt;49::AID-JSFA950&gt;3.0.CO;2-2]; World Health Organization, 2008, CODEX ALIMENTARIUS C	35	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152292	10.1371/journal.pone.0152292	http://dx.doi.org/10.1371/journal.pone.0152292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018786	Green Submitted, Green Published, gold			2022-12-26	WOS:000372807800041
J	Mitchell, EJ; Dewar, D; Maxwell, DJ				Mitchell, Emma J.; Dewar, Deborah; Maxwell, David J.			Is Remodelling of Corticospinal Tract Terminations Originating in the Intact Hemisphere Associated with Recovery following Transient Ischaemic Stroke in the Rat?	PLOS ONE			English	Article							MOTOR CORTEX STROKE; MARROW STROMAL CELL; SPINAL-CORD; ADULT MICE; STIMULATION; CONNECTIONS; ANATOMY; NEURONS; SYSTEM; INJURY	Following large strokes that encompass the cerebral cortex, it has been suggested that the corticospinal tract originating from the non-ischaemic hemisphere reorganises its pattern of terminal arborisation within the spinal cord to compensate for loss of function. However many strokes in humans predominantly affect subcortical structures with minimal involvement of the cerebral cortex. The aim of the present study was to determine whether remodelling of corticospinal terminals arising from the non-ischaemic hemisphere was associated with spontaneous recovery in rats with subcortical infarcts. Rats were subjected to transient middle cerebral artery occlusion or sham surgery and 28 days later, when animals exhibited functional recovery, cholera toxin b subunit was injected into the contralesional, intact forelimb motor cortex in order to anterogradely label terminals within cervical spinal cord segments. Infarcts were limited to subcortical structures and resulted in partial loss of corticospinal tract axons from the ischaemic hemisphere. Quantitative analysis revealed there was no significant difference in the numbers of terminals on the contralesional side of the spinal grey matter between ischaemic and sham rats. The results indicate that significant remodelling of the corticospinal tract from the non-ischaemic hemisphere is not associated with functional recovery in animals with subcortical infarcts.	[Mitchell, Emma J.; Dewar, Deborah; Maxwell, David J.] Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet Med & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Dewar, D (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet Med & Life Sci, Glasgow, Lanark, Scotland.	Deborah.Dewar@glasgow.ac.uk			Medical Research Council; Neurosciences Foundation, Glasgow	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neurosciences Foundation, Glasgow	EM was funded by a PhD Studentship from Medical Research Council http://www.mrc.ac.uk/. Additional support was from Neurosciences Foundation, Glasgow. http://neurosciencesfoundation. org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstermark B, 2004, J NEUROPHYSIOL, V91, P1832, DOI 10.1152/jn.00820.2003; Bachmann LC, 2014, J NEUROSCI, V34, P3378, DOI 10.1523/JNEUROSCI.4384-13.2014; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Brosamle C, 2000, J NEUROCYTOL, V29, P499, DOI 10.1023/A:1007297712821; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Corbetta M, 2015, NEURON, V85, P927, DOI 10.1016/j.neuron.2015.02.027; Daniels CML, 2009, NEUROSCI LETT, V450, P191, DOI 10.1016/j.neulet.2008.11.017; Du Beau A, 2012, NEUROSCIENCE, V227, P67, DOI 10.1016/j.neuroscience.2012.09.037; Edgley SA, 2004, J NEUROSCI, V24, P7804, DOI 10.1523/JNEUROSCI.1941-04.2004; GRIBNAU AAM, 1989, NEUROSCI LETT, V105, P47, DOI 10.1016/0304-3940(89)90009-8; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Kang DW, 2003, ARCH NEUROL-CHICAGO, V60, P1730, DOI 10.1001/archneur.60.12.1730; Kim D, 2015, J CEREBR BLOOD F MET, V35, P11, DOI 10.1038/jcbfm.2014.178; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Liu Z, 2014, PLOS ONE, V9; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Liu ZW, 2013, STROKE, V44, P1951, DOI 10.1161/STROKEAHA.113.001162; Liu ZW, 2009, STROKE, V40, P2546, DOI 10.1161/STROKEAHA.109.547265; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lotze M, 2009, EXP NEUROL, V217, P440, DOI 10.1016/j.expneurol.2009.03.012; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Puig J, 2011, AM J NEURORADIOL, V32, P857, DOI 10.3174/ajnr.A2400; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Reitmeir R, 2011, BRAIN, V134, P84, DOI 10.1093/brain/awq344; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Wessels T, 2006, AM J NEURORADIOL, V27, P35; Yang HW, 2003, EXP BRAIN RES, V149, P458, DOI 10.1007/s00221-003-1393-9; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115	39	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152176	10.1371/journal.pone.0152176	http://dx.doi.org/10.1371/journal.pone.0152176			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27014870	gold, Green Published, Green Accepted			2022-12-26	WOS:000372708900045
J	Rajendran, D; Zhang, Y; Berry, DM; McGlade, CJ				Rajendran, D.; Zhang, Y.; Berry, D. M.; McGlade, C. J.			Regulation of Numb isoform expression by activated ERK signaling	ONCOGENE			English	Article							TRACT-BINDING-PROTEIN; PROMOTES NEURONAL DIFFERENTIATION; CELL LUNG-CANCER; MAMMALIAN NUMB; BREAST-CANCER; MULTIPLE ROLES; MOUSE NUMB; NOTCH; KINASE; GROWTH	The endocytic adaptor protein Numb has a major role in development as an intrinsic regulator of cell fate determination and inhibitor of the Notch signaling pathway. In vertebrates, four protein isoforms of Numb are produced through alternative splicing (AS) of two cassette exons (exons 3 and 9). AS of coding exon 9 (E9) produces E9-included (p72/p71) and -excluded (p66/p65) protein products. Expression of Numb isoforms is developmentally regulated and E9-included products are expressed in progenitors, whereas E9-excluded isoforms are dominantly expressed in differentiated cells. Analyses of AS events in multiple cancers previously identified a switch in Numb transcript and protein expression from the E9-excluded to the E9-included isoform, suggesting that misregulation of the mechanisms that control E9 inclusion may have a role in tumorigenesis. Here we identify splicing factors ASF/SF2 and PTBP1 as regulators of E9 splicing and show that activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway promotes E9 inclusion in cancer cells. Our evidence supports a mechanism by which Numb AS is regulated in response to oncogenic signaling pathways, and contributes to activation of downstream pathways to promote tumorigenesis.	[Rajendran, D.; Zhang, Y.; Berry, D. M.; McGlade, C. J.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Cell Biol, Room 17-9706, Toronto, ON M5G 0A4, Canada; [Rajendran, D.; Zhang, Y.; Berry, D. M.; McGlade, C. J.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Arthur & Sonia Labatt Brain Tumour Res Ctr, Room 17-9706, Toronto, ON M5G 0A4, Canada; [Rajendran, D.; Zhang, Y.; McGlade, C. J.] Univ Toronto, Dept Med Biophys, Room 17-9706, Toronto, ON M5G 0A4, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	McGlade, CJ (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Cell Biol, Room 17-9706, Toronto, ON M5G 0A4, Canada.; McGlade, CJ (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Arthur & Sonia Labatt Brain Tumour Res Ctr, Room 17-9706, Toronto, ON M5G 0A4, Canada.; McGlade, CJ (corresponding author), Univ Toronto, Dept Med Biophys, Room 17-9706, Toronto, ON M5G 0A4, Canada.	jmcglade@sickkids.ca		Zhang, Yangjing/0000-0003-3762-0767	Canadian Institutes of Health Research [MOP-106507]; RESTRACOMP studentship from Garron Family Cancer Centre and Sickkids Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); RESTRACOMP studentship from Garron Family Cancer Centre and Sickkids Research Institute	We thank J Woodgett (University of Toronto) for activated MEK and MEKK, V Stambolic (University of Toronto) for Akt constructs, G Zadeh (University of Toronto) for activated RAS, M Moran (University of Toronto) for A549 cells, A Huang (University of Toronto) for YBX1 plasmid, B Blencowe (University of Toronto) for ExonTrap pet01 plasmid, SPARC BioCentre (Hospital for Sick Children, Toronto) for cDNAs and S Dho for comments on the manuscript. This work was supported by an operating grant to CJM from the Canadian Institutes of Health Research (MOP-106507). YZ is supported by a RESTRACOMP studentship from the Garron Family Cancer Centre and Sickkids Research Institute.	Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Blissenbach M, 2010, J VIROL, V84, P6598, DOI 10.1128/JVI.02264-09; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brognard J, 2001, CANCER RES, V61, P3986; Cheung HC, 2006, MODERN PATHOL, V19, P1034, DOI 10.1038/modpathol.3800635; Cheung HC, 2009, BRAIN, V132, P2277, DOI 10.1093/brain/awp153; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Das S, 2012, CELL REP, V1, P110, DOI 10.1016/j.celrep.2011.12.001; Dho SE, 2006, MOL BIOL CELL, V17, P4142, DOI 10.1091/mbc.E06-02-0097; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dooley CM, 2003, J NEUROBIOL, V54, P313, DOI 10.1002/neu.10176; French MB, 2002, J IMMUNOL, V168, P3173, DOI 10.4049/jimmunol.168.7.3173; Guo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062729; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; He X, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.47; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Izaguirre DI, 2012, MOL CARCINOGEN, V51, P895, DOI 10.1002/mc.20859; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Karaczyn A, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-31; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maraver A, 2012, CANCER CELL, V22, P222, DOI 10.1016/j.ccr.2012.06.014; McCutcheon IE, 2004, NEURO-ONCOLOGY, V6, P9, DOI 10.1215/S1152851703000279; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; Nieber F, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-36; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Paz I, 2010, NUCLEIC ACIDS RES, V38, pW281, DOI 10.1093/nar/gkq444; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Reugels AM, 2006, DEV DYNAM, V235, P934, DOI 10.1002/dvdy.20699; Revil T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-399; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Sato K, 2011, MOL BIOL CELL, V22, P3103, DOI 10.1091/mbc.E11-03-0274; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Toriya M, 2006, DEV NEUROSCI-BASEL, V28, P142, DOI 10.1159/000090760; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Yoshida T, 2003, DIFFERENTIATION, V71, P486, DOI 10.1046/j.1432-0436.2003.7108006.x; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091466; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X; Zong FY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004289	60	15	18	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5202	5213		10.1038/onc.2016.69	http://dx.doi.org/10.1038/onc.2016.69			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	27041567				2022-12-26	WOS:000384433000011
J	Polanco, JC; Scicluna, BJ; Hill, AF; Gotz, J				Polanco, Juan Carlos; Scicluna, Benjamin James; Hill, Andrew Francis; Gotz, Jurgen			Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENTS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; ABNORMAL PHOSPHORYLATION; PATHOGENIC PROTEINS; MOUSE MODEL; IN-VITRO; PROPAGATION; EXOSOMES; TAUOPATHY	The microtubule-associated protein tau has a critical role in Alzheimer disease and related tauopathies. There is accumulating evidence that tau aggregates spread and replicate in a prion-like manner, with the uptake of pathological tau seeds causing misfolding and aggregation of monomeric tau in recipient cells. Here we focused on small extracellular vesicles enriched for exosomes that were isolated from the brains of tau transgenic rTg4510 and control mice. We found that these extracellular vesicles contained tau, although the levels were significantly higher in transgenic mice that have a pronounced tau pathology. Tau in the vesicles was differentially phosphorylated, although to a lower degree than in the brain cells from which they were derived. Several phospho-epitopes (AT8, AT100, and AT180) thought to be critical for tau pathology were undetected in extracellular vesicles. Despite this, when assayed with FRET tau biosensor cells, extracellular vesicles derived from transgenic mice were capable of seeding tau aggregation in a threshold-dependent manner. We also observed that the dye used to label extracellular vesicle membranes was still present during nucleation and formation of tau inclusions, suggesting either a role for membranes in the seeding or in the process of degradation. Together, we clearly demonstrate that extracellular vesicles can transmit tau pathology. This indicates a role for extracellular vesicles in the transmission and spreading of tau pathology. The characteristics of tau in extracellular vesicles and the seeding threshold we identified may explain why tau pathology develops very slowly in neurodegenerative diseases such as Alzheimer disease.	[Polanco, Juan Carlos; Gotz, Jurgen] Univ Queensland, Clem Jones Ctr Ageing Dementia Res, Queensland Brain Inst, St. Lucia Campus, Brisbane, Qld 4072, Australia; [Scicluna, Benjamin James; Hill, Andrew Francis] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Scicluna, Benjamin James; Hill, Andrew Francis] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia	University of Queensland; University of Melbourne; La Trobe University	Gotz, J (corresponding author), Univ Queensland, Clem Jones Ctr Ageing Dementia Res, Queensland Brain Inst, St. Lucia Campus, Brisbane, Qld 4072, Australia.	j.goetz@uq.edu.au	Hill, Andrew F./GZL-4124-2022; Polanco, Juan Carlos/J-4272-2013; Hill, Andrew F./AAH-2854-2020; Götz, Jürgen/C-2448-2014; Polanco, Juan Carlos/AAE-1529-2019	Hill, Andrew F./0000-0001-5581-2354; Polanco, Juan Carlos/0000-0002-3335-6332; Götz, Jürgen/0000-0001-8501-7896; Polanco, Juan Carlos/0000-0002-3335-6332	Estate of Dr. Clem Jones; Australian Research Council [DP130101932]; National Health and Medical Research Council of Australia [APP1037746, APP1003150]	Estate of Dr. Clem Jones; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Estate of Dr. Clem Jones, Australian Research Council Grant DP130101932, and National Health and Medical Research Council of Australia Grants APP1037746 and APP1003150. The authors declare that they have no conflicts of interest with the contents of this article.	Alonso AD, 2001, J BIOL CHEM, V276, P37967; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Ambegaokar SS, 2012, AUTOPHAGY, V8, P1144, DOI 10.4161/auto.20515; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Attems J, 2012, BIOCHEM SOC T, V40, P711, DOI 10.1042/BST20120034; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Dujardin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100760; Dujardin S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-14; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Frost B, 2015, TRENDS CELL BIOL, V25, P46, DOI 10.1016/j.tcb.2014.07.005; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Henkins KM, 2012, BRAIN PATHOL, V22, P826, DOI 10.1111/j.1750-3639.2012.00598.x; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kanmert D, 2015, J NEUROSCI, V35, P10851, DOI 10.1523/JNEUROSCI.0387-15.2015; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kohler C, 2014, NEUROBIOL DIS, V71, P169, DOI 10.1016/j.nbd.2014.07.006; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Wang Z, 2012, PROTEOMICS, V12, P329, DOI 10.1002/pmic.201100477; Webber J, 2015, SEMIN CELL DEV BIOL, V40, P27, DOI 10.1016/j.semcdb.2015.01.013; Wren MC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0042-7	59	151	151	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12445	12466		10.1074/jbc.M115.709485	http://dx.doi.org/10.1074/jbc.M115.709485			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27030011	Green Published, hybrid			2022-12-26	WOS:000378119900002
J	Meng, XY; Guo, J; Fang, WW; Dou, L; Li, M; Huang, XQ; Zhou, ST; Man, Y; Tang, WQ; Yu, LQ; Li, J				Meng, Xiangyu; Guo, Jun; Fang, Weiwei; Dou, Lin; Li, Meng; Huang, Xiuqing; Zhou, Shutong; Man, Yong; Tang, Weiqing; Yu, Liqing; Li, Jian			Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase alpha 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; EMBRYONIC STEM-CELLS; INSULIN SENSITIVITY; LIPID-ACCUMULATION; NATURAL-HISTORY; CANCER CELLS; MICE; METABOLISM; EXPRESSION; DISEASE	In a microarray study, we found that hepatic miR-291b-3p was significantly increased in leptin-receptor-deficient type 2 mice (db/db), a mouse model of diabetes. The function of miR-291b-3p is unknown. The potential role of miR-291b-3p in regulating hepatic lipid metabolism was explored in this study. High-fat diet (HFD)- and chow-fed mice were injected with an adenovirus expressing a miR-2916-3p inhibitor and a miR-291b-3p mimic through the tail vein. Hepatic lipids and lipogenic gene expression were analyzed. Additionally, gain- and loss-of-function studies were performed in vitro to identify direct targets of miR-291b-3p. MiR-291b-3p expression and the protein levels of sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FAS) were increased in the steatotic liver of db/db mice and HFD-fed mice versus their respective controls. Inhibition of hepatic miR-291b-3p expression prevented increases in hepatic lipogenesis and steatosis in HFD-fed mice. The opposite was observed when miR-291b-3p was overexpressed in the livers of chow-fed C57BL/6J wild-type mice. In vitro studies revealed that silencing of miR-291b-3p in NCTC1469 hepatic cells ameliorated oleic acid/palmitic acid mixture-induced elevation of cellular triglycerides. Importantly, we identified AMP-activated protein kinase (AMPK)-alpha 1 as a direct target of miR-291b-3p. Using metformin, an activator of AMPK, we showed that AMPK activation-induced inhibition of hepatic lipid accumulation was accompanied by reduced expression of miR-2916-3p in the liver. Liver miR-291b-3p promoted hepatic lipogenesis and lipid accumulation in mice. AMPK alpha 1 is a direct target of miR-291b-3p. In conclusion, our findings indicate that miR-291b-3p promotes hepatic lipogenesis by suppressing AMPK alpha 1 expression and activity, indicating the therapeutic potential of miR-291b-3p inhibitors in fatty liver disease.	[Meng, Xiangyu; Guo, Jun; Fang, Weiwei; Dou, Lin; Li, Meng; Huang, Xiuqing; Zhou, Shutong; Man, Yong; Tang, Weiqing; Li, Jian] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China; [Meng, Xiangyu; Guo, Jun; Fang, Weiwei; Dou, Lin; Li, Meng; Huang, Xiuqing; Zhou, Shutong; Man, Yong; Tang, Weiqing; Li, Jian] Beijing Inst Geriatr, Minist Hlth, Beijing 100730, Peoples R China; [Meng, Xiangyu; Guo, Jun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Tang, Weiqing; Yu, Liqing] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	Beijing Hospital; Chinese Academy of Sciences; Institute of Biophysics, CAS; University System of Maryland; University of Maryland College Park	Li, J (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China.; Li, J (corresponding author), Beijing Inst Geriatr, Minist Hlth, Beijing 100730, Peoples R China.; Yu, LQ (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	lyu123@umd.edu; lijian@bjhmoh.cn		Meng, Xiangyu/0000-0003-3382-587X	973 program from the National Basic Research Program of China [2012CB517502, 2014CB910503]; National Natural Science Foundation of China [81270887, 81270495, 81170381]; Chinese Medical Association [13060970482]; NIDDK, National Institutes of Health [R01DK085176]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085176] Funding Source: NIH RePORTER	973 program from the National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Medical Association; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 973 program grants from the National Basic Research Program of China (2012CB517502, 2014CB910503, to J. L.), the National Natural Science Foundation of China (81270887, 81270495, 81170381, to J. L.), the Specific Fund of Clinical Medical Research of the Chinese Medical Association (13060970482, to M. S.), and the NIDDK, National Institutes of Health (R01DK085176, to L. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Ajmal Masihur Rehman, 2014, Indian Heart J, V66, P574, DOI 10.1016/j.ihj.2014.08.006; Aljada A, 2012, PHARMACOL THERAPEUT, V133, P108, DOI 10.1016/j.pharmthera.2011.09.004; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cao Y, 2015, EMBO J, V34, P609, DOI 10.15252/embj.201490441; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cho K, 2009, J MED FOOD, V12, P1293, DOI 10.1089/jmf.2009.0085; Chu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08801; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Guo J, 2014, CELL PHYSIOL BIOCHEM, V33, P810, DOI 10.1159/000358654; HA J, 1994, J BIOL CHEM, V269, P22162; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708; Kaspi H, 2013, STEM CELLS, V31, P2266, DOI 10.1002/stem.1465; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kong Yong, 2005, GeoActa, V3, P62; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Kyung-Hee, 2015, Prev Nutr Food Sci, V20, P298, DOI 10.3746/pnf.2015.20.4.298; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002; Luningschror P, 2012, STEM CELLS, V30, P655, DOI 10.1002/stem.1033; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Nangia-Makker P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084369; Ng R, 2014, HEPATOLOGY, V60, P554, DOI 10.1002/hep.27153; Ramirez CM, 2013, MOL CELL BIOL, V33, P2891, DOI 10.1128/MCB.00016-13; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rottiers V, 2011, COLD SH Q B, V76, P225, DOI 10.1101/sqb.2011.76.011049; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Tangeman Larissa, 2012, J RNAi Gene Silencing, V8, P470; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wen J, 2012, J CLIN INVEST, V122, P2773, DOI 10.1172/JCI63966; Xiao F, 2014, DIABETES, V63, P2631, DOI 10.2337/db13-1689; Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439; Zovoilis A, 2009, DIFFERENTIATION, V78, P69, DOI 10.1016/j.diff.2009.06.003	50	31	32	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10625	10634		10.1074/jbc.M116.713768	http://dx.doi.org/10.1074/jbc.M116.713768			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27013659	Green Published, hybrid			2022-12-26	WOS:000377042600016
J	Coupat-Goutaland, B; Regoudis, E; Besseyrias, M; Mularoni, A; Binet, M; Herbelin, P; Pelandakis, M				Coupat-Goutaland, Benedicte; Regoudis, Estelle; Besseyrias, Matthieu; Mularoni, Angelique; Binet, Marie; Herbelin, Pascaline; Pelandakis, Michel			Population Structure in Naegleria fowleri as Revealed by Microsatellite Markers	PLOS ONE			English	Article							FREE-LIVING AMEBA; INTERNAL TRANSCRIBED SPACERS; RIBOSOMAL-RNA GENE; TIME PCR ASSAY; WATER SAMPLES; IDENTIFICATION; DNA; EXPLORATION; ENVIRONMENT; ITALICA	Naegleria sp. is a free living amoeba belonging to the Heterolobosea class. Over 40 species of Naegleria were identified and recovered worldwide in different habitats such as swimming pools, freshwater lakes, soil or dust. Among them, N. fowleri, is a human pathogen responsible for primary amoeboic meningoencephalitis (PAM). Around 300 cases were reported in 40 years worldwide but PAM is a fatal disease of the central nervous system with only 5% survival of infected patients. Since both pathogenic and non pathogenic species were encountered in the environment, detection and dispersal mode are crucial points in the fight against this pathogenic agent. Previous studies on identification and genotyping of N. fowleri strains were focused on RAPD analysis and on ITS sequencing and identified 5 variants: euro-american, south pacific, widespread, cattenom and chooz. Microsatellites are powerful markers in population genetics with broad spectrum of applications (such as paternity test, fingerprinting, genetic mapping or genetic structure analysis). They are characterized by a high degree of length polymorphism. The aim of this study was to genotype N. fowleri strains using microsatellites markers in order to track this population and to better understand its evolution. Six microsatellite loci and 47 strains from different geographical origins were used for this analysis. The microsatellite markers revealed a level of discrimination higher than any other marker used until now, enabling the identification of seven genetic groups, included in the five main genetic groups based on the previous RAPD and ITS analyses. This analysis also allowed us to go further in identifying private alleles highlighting intra-group variability. A better identification of the N. fowleri isolates could be done with this type of analysis and could allow a better tracking of the clinical and environmental N. fowleri strains.	[Coupat-Goutaland, Benedicte; Regoudis, Estelle; Pelandakis, Michel] Univ Lyon 1, CNRS, UMR Microbiol Adaptat & Pathogenesis 5240, F-69622 Villeurbanne, France; [Besseyrias, Matthieu] Univ Lyon 1, F-69622 Villeurbanne, France; [Mularoni, Angelique] Univ Lyon 1, ISPB EA Bioact Mol & Med Chem 4446, F-69365 Lyon, France; [Binet, Marie; Herbelin, Pascaline] EDF Res & Dev, Lab Natl Hydraul & Environm, Chatou, France	Centre National de la Recherche Scientifique (CNRS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Electricite de France (EDF)	Pelandakis, M (corresponding author), Univ Lyon 1, CNRS, UMR Microbiol Adaptat & Pathogenesis 5240, F-69622 Villeurbanne, France.	michel.pelandakis@univ-lyon1.fr	COUPAT, Bénédicte/G-5488-2019	COUPAT, Bénédicte/0000-0002-0614-9848; Mularoni, Angelique/0000-0002-3289-805X	EDF	EDF(Electricite de France (EDF))	The funder EDF played a role in the strains collection, the site access and agreement and decision to publish (insofar the confidentiality of the site is respected). The funder provided support in the form of salaries for authors ER and BCG but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	ADAMS M, 1989, INT J PARASITOL, V19, P823, DOI 10.1016/0020-7519(89)90107-0; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], 1996, 5000 CNRS UMR; Behets J, 2007, WATER RES, V41, P118, DOI 10.1016/j.watres.2006.10.003; CARIOU ML, 1987, GENETICS, V115, P265; De Jonckheere JF, 1998, PROTIST, V149, P221, DOI 10.1016/S1434-4610(98)70030-6; De Jonckheere JF, 2014, EXP PARASITOL, V145, pS2, DOI 10.1016/j.exppara.2014.07.011; De Jonckheere JF, 2011, INFECT GENET EVOL, V11, P1520, DOI 10.1016/j.meegid.2011.07.023; DEJONCKHEERE JF, 1988, BIOSYSTEMS, V21, P269, DOI 10.1016/0303-2647(88)90022-6; DEJONCKHEERE JF, 1984, J PROTOZOOL, V31, P324, DOI 10.1111/j.1550-7408.1984.tb02971.x; DEJONCKHEERE JF, 1987, MOL BIOCHEM PARASIT, V24, P55, DOI 10.1016/0166-6851(87)90115-0; Fritz-Laylin LK, 2011, RES MICROBIOL, V162, P607, DOI 10.1016/j.resmic.2011.03.003; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gur-Arie R, 2000, GENOME RES, V10, P62; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Kebede N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-160; KILVINGTON S, 1995, APPL ENVIRON MICROB, V61, P3764, DOI 10.1128/AEM.61.10.3764-3767.1995; Madarova L, 2010, EXP PARASITOL, V126, P37, DOI 10.1016/j.exppara.2009.11.001; Mallon M, 2003, J MOL EVOL, V56, P407, DOI 10.1007/s00239-002-2412-3; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pelandakis M, 2002, APPL ENVIRON MICROB, V68, P2061, DOI 10.1128/AEM.68.4.2061-2065.2002; Pelandakis M, 1997, FEMS MICROBIOL LETT, V151, P31, DOI 10.1016/S0378-1097(97)00129-8; Pelandakis M, 1998, APPL ENVIRON MICROB, V64, P2977; Pelandakis M, 2000, J EUKARYOT MICROBIOL, V47, P116, DOI 10.1111/j.1550-7408.2000.tb00020.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Puzon GJ, 2009, ENVIRON SCI TECHNOL, V43, P6691, DOI 10.1021/es900432m; Qvarnstrom Y, 2006, J CLIN MICROBIOL, V44, P3589, DOI 10.1128/JCM.00875-06; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reveiller FL, 2003, J EUKARYOT MICROBIOL, V50, P109, DOI 10.1111/j.1550-7408.2003.tb00244.x; Robinson BS, 2004, PARASITOL INT, V53, P23, DOI 10.1016/j.parint.2003.10.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010; Siddiqui R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003017; Tiewcharoen S, 2007, PARASITOL RES, V101, P139, DOI 10.1007/s00436-006-0442-2; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Visvesvara GS, 2007, TROPICAL INFECT DIS, P707; Zhou L, 2003, J EUKARYOT MICROBIOL, V50, P522, DOI 10.1111/j.1550-7408.2003.tb00617.x; Zysset-Burri DC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-496	41	8	8	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152434	10.1371/journal.pone.0152434	http://dx.doi.org/10.1371/journal.pone.0152434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035434	gold, Green Published			2022-12-26	WOS:000373201200017
J	Martin, PM; Palhiere, I; Ricard, A; Tosser-Klopp, G; Rupp, R				Martin, Pauline Marie; Palhiere, Isabelle; Ricard, Anne; Tosser-Klopp, Gwenola; Rupp, Rachel			Genome Wide Association Study Identifies New Loci Associated with Undesired Coat Color Phenotypes in Saanen Goats	PLOS ONE			English	Article							AGOUTI SIGNALING PROTEIN; ASIP GENE; BLACK SHEEP; MISSENSE; BREEDS; MUTATIONS	This paper reports a quantitative genetics and genomic analysis of undesirable coat color patterns in goats. Two undesirable coat colors have routinely been recorded for the past 15 years in French Saanen goats. One fifth of Saanen females have been phenotyped "pink" (8.0%) or "pink neck" (11.5%) and consequently have not been included in the breeding program as elite animals. Heritability of the binary "pink" and "pink neck" phenotype, estimated from 103,443 females was 0.26 for "pink" and 0.21 for "pink neck". Genome wide association studies (using haplotypes or single SNPs) were implemented using a daughter design of 810 Saanen goats sired by 9 Artificial Insemination bucks genotyped with the goatSNP50 chip. A highly significant signal (-log10pvalue = 10.2) was associated with the "pink neck" phenotype on chromosome 11, suggesting the presence of a major gene. Highly significant signals for the "pink" phenotype were found on chromosomes 5 and 13 (-log10p values of 7.2 and, 7.7 respectively). The most significant SNP on chromosome 13 was in the ASIP gene region, well known for its association with coat color phenotypes. Nine significant signals were also found for both traits. The highest signal for each trait was detected by both single SNP and haplotype approaches, whereas the smaller signals were not consistently detected by the two methods. Altogether these results demonstrated a strong genetic control of the "pink" and "pink neck" phenotypes in French Saanen goats suggesting that SNP information could be used to identify and remove undesired colored animals from the breeding program.	[Martin, Pauline Marie; Palhiere, Isabelle; Ricard, Anne; Tosser-Klopp, Gwenola; Rupp, Rachel] INRA, UMR Genet Physiol & Syst Elevage 1388, F-31326 Castanet Tolosan, France; [Martin, Pauline Marie; Palhiere, Isabelle; Ricard, Anne; Tosser-Klopp, Gwenola; Rupp, Rachel] Univ Toulouse, UMR Genet Physiol & Syst Elevage 1388, INPT ENSAT, Castanet Tolosan, France; [Martin, Pauline Marie; Palhiere, Isabelle; Ricard, Anne; Tosser-Klopp, Gwenola; Rupp, Rachel] Univ Toulouse, UMR Genet Physiol & Syst Elevage 1388, INPT ENVT, Toulouse, France	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Martin, PM (corresponding author), INRA, UMR Genet Physiol & Syst Elevage 1388, F-31326 Castanet Tolosan, France.; Martin, PM (corresponding author), Univ Toulouse, UMR Genet Physiol & Syst Elevage 1388, INPT ENSAT, Castanet Tolosan, France.; Martin, PM (corresponding author), Univ Toulouse, UMR Genet Physiol & Syst Elevage 1388, INPT ENVT, Toulouse, France.	pauline.martin@toulouse.inra.fr		Rupp, Rachel/0000-0003-3375-5816; TOSSER-KLOPP, GWENOLA/0000-0003-0550-4673	French organization through "Genomcap" (INRA); French organization through "Genomcap" (APIS-GENE); French organization through "Genomcap" (UNCEIA); French organization through "Genomcap" (CAPGENES); French organization through "Genomcap" (FCEL); EC (FP7) [245140]	French organization through "Genomcap" (INRA); French organization through "Genomcap" (APIS-GENE); French organization through "Genomcap" (UNCEIA); French organization through "Genomcap" (CAPGENES); French organization through "Genomcap" (FCEL); EC (FP7)	This work was supported by grants from French organizations through "Genomcap" (a research program including INRA, APIS-GENE, UNCEIA, CAPGENES and FCEL) and EC (FP7/2007-2013), grant no 245140, "3SR", Sustainable Solutions for Small Ruminants (http://www.3srbreeding.eu/). This Publication reflects only the authors' views and the EC is not liable for any use that may be made of the information contained herein.	Abitbol M, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0112-x; ADALSTEINSSON S, 1994, J HERED, V85, P267, DOI 10.1093/oxfordjournals.jhered.a111454; Adefenwa MA, 2013, MOL BIOL REP, V40, P4447, DOI 10.1007/s11033-013-2535-1; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cuenot L., 1905, ARCH ZOOL EXP GEN, V3, P123; Davenport CB, 1905, SCIENCE, V22, P674, DOI 10.1126/science.22.569.674; Dong Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1606-1; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Fontanesi L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-639; Fontanesi L, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-47; Gershony LC, 2014, ANIM GENET, V45, P893, DOI 10.1111/age.12206; Gilmour AR, 2009, ASREML USER GUIDE RE; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; Jackson IJ, PIGMENT CELL RES, V7, P73; Lorenz AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014079; McNulty JC, 2005, J MOL BIOL, V346, P1059, DOI 10.1016/j.jmb.2004.12.030; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Peters K.J., 1982, TROP ANIM HEALTH PRO, V7, P296; Searle A.G., 1968, COMP GENETICS COAT C; Sponenberg D. P., 1996, MENDELIAN INHERITANC, P15; Tosser-Klopp G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086227; Wilson BD, 1999, MOL MED TODAY, V5, P250, DOI 10.1016/S1357-4310(99)01471-9; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	27	24	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152426	10.1371/journal.pone.0152426	http://dx.doi.org/10.1371/journal.pone.0152426			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030980	Green Published, gold			2022-12-26	WOS:000373121800072
J	Zimmermann, MT; Oberg, AL; Grill, DE; Ovsyannikova, IG; Haralambieva, IH; Kennedy, RB; Poland, GA				Zimmermann, Michael T.; Oberg, Ann L.; Grill, Diane E.; Ovsyannikova, Inna G.; Haralambieva, Iana H.; Kennedy, Richard B.; Poland, Gregory A.			System-Wide Associations between DNA-Methylation, Gene Expression, and Humoral Immune Response to Influenza Vaccination	PLOS ONE			English	Article							GENOME BROWSER; SEASONAL INFLUENZA; OLDER-ADULTS; B-CELLS; DATABASE; MEASLES; BIOLOGY; EPIGENETICS; DROSOPHILA; PROFILES	Failure to achieve a protected state after influenza vaccination is poorly understood but occurs commonly among aged populations experiencing greater immunosenescence. In order to better understand immune response in the elderly, we studied epigenetic and transcriptomic profiles and humoral immune response outcomes in 50-74 year old healthy participants. Associations between DNA methylation and gene expression reveal a systemwide regulation of immune-relevant functions, likely playing a role in regulating a participant's propensity to respond to vaccination. Our findings show that sites of methylation regulation associated with humoral response to vaccination impact known cellular differentiation signaling and antigen presentation pathways. We performed our analysis using per-site and regionally average methylation levels, in addition to continuous or dichotomized outcome measures. The genes and molecular functions implicated by each analysis were compared, highlighting different aspects of the biologic mechanisms of immune response affected by differential methylation. Both cis-acting (within the gene or promoter) and trans-acting (enhancers and transcription factor binding sites) sites show significant associations with measures of humoral immunity. Specifically, we identified a group of CpGs that, when coordinately hypo-methylated, are associated with lower humoral immune response, and methylated with higher response. Additionally, CpGs that individually predict humoral immune responses are enriched for polycomb-group and FOXP2 transcription factor binding sites. The most robust associations implicate differential methylation affecting gene expression levels of genes with known roles in immunity (e.g. HLA-B and HLA-DQB2) and immunosenescence. We believe our data and analysis strategy highlight new and interesting epigenetic trends affecting humoral response to vaccination against influenza; one of the most common and impactful viral pathogens.	[Zimmermann, Michael T.; Oberg, Ann L.; Grill, Diane E.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Zimmermann, Michael T.; Oberg, Ann L.; Grill, Diane E.; Ovsyannikova, Inna G.; Haralambieva, Iana H.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN USA.	poland.gregory@mayo.edu		Zimmermann, Michael/0000-0001-7073-0525; Kennedy, Rick/0000-0001-6164-4967	NIH [U01AI089859]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI089859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge support from NIH grant U01AI089859 for this work. This publication was supported by Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Caromile LA, 2010, J BIOL CHEM, V285, P10487, DOI 10.1074/jbc.M109.066563; Chappell C, 2006, J IMMUNOL, V176, P4562, DOI 10.4049/jimmunol.176.8.4562; CREMER NE, 1985, J CLIN MICROBIOL, V21, P869, DOI 10.1128/JCM.21.6.869-874.1985; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dedeurwaerder S, 2014, BRIEF BIOINFORM, V15, P929, DOI 10.1093/bib/bbt054; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Haralambieva IH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122282; Haralambieva IH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062149; Hoek KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118528; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jacobson RM, 2015, HUM VACC IMMUNOTHER, V11, P961, DOI 10.1080/21645515.2015.1011990; Jacoby M, 2012, EPIGENETICS-US, V7, P1421, DOI 10.4161/epi.22845; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jones MJ, 2015, AGING CELL; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kennedy RB, 2013, GENES IMMUN, V14, P277, DOI 10.1038/gene.2013.14; Kennedy RB, 2015, VACCINE, V33, P3682, DOI 10.1016/j.vaccine.2015.06.031; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Lai AY, 2013, GENOME RES, V23, P2030, DOI 10.1101/gr.155473.113; Lambert ND, 2012, EXPERT REV VACCINES, V11, P985, DOI [10.1586/erv.12.61, 10.1586/ERV.12.61]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledford H, 2008, NATURE, V455, P1023, DOI 10.1038/4551023a; Lu YT, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-12; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McCleary-Wheeler AL, 2013, CANCER LETT, V328, P212, DOI 10.1016/j.canlet.2012.10.005; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; O'Keefe DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-498; Oberg AL, 2015, VACCINE; Ovsyannikova IG, 2015, GENESET SIGNATURES A, P58; Ovsyannikova IG, 2014, VIRAL IMMUNOL, V27, P174, DOI 10.1089/vim.2013.0111; Oysyannikova IG, 2014, VACCINE, V32, P881, DOI 10.1016/j.vaccine.2013.12.009; Painter SD, 2014, VIRAL IMMUNOL, V27, P32, DOI 10.1089/vim.2013.0099; Poland GA, 2014, CURR OPIN IMMUNOL, V29, P62, DOI 10.1016/j.coi.2014.04.005; Poland GA, 2013, SEMIN IMMUNOL, V25, P89, DOI 10.1016/j.smim.2013.04.007; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Reynolds LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6366; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Salk HM, 2013, J IMMUNOL METHODS, V398, P44, DOI 10.1016/j.jim.2013.09.007; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Umlauf BJ, 2012, VIRAL IMMUNOL, V25, P29, DOI 10.1089/vim.2011.0051; Umlauf BJ, 2012, DETECTION VACCINIA V, P199, DOI 10.1007/978-1-61779-325-7_16; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang LG, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku846; Wang SX, 2006, J VIROL, V80, P11628, DOI 10.1128/JVI.01065-06; Webster DE, 2002, J VIROL, V76, P7910, DOI 10.1128/JVI.76.15.7910-7912.2002; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Youngblood B, 2013, CURR OPIN VIROL, V3, P371, DOI 10.1016/j.coviro.2013.05.017; Yusuf D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r24; Zhu SK, 2005, CIRCULATION, V112, P1353, DOI 10.1161/CIRCULATIONAHA.104.519025	88	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152034	10.1371/journal.pone.0152034	http://dx.doi.org/10.1371/journal.pone.0152034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031986	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800030
J	Vassal, F; Schneider, F; Boutet, C; Jean, B; Sontheimer, A; Lemaire, JJ				Vassal, Francois; Schneider, Fabien; Boutet, Claire; Jean, Betty; Sontheimer, Anna; Lemaire, Jean-Jacques			Combined DTI Tractography and Functional MRI Study of the Language Connectome in Healthy Volunteers: Extensive Mapping of White Matter Fascicles and Cortical Activations	PLOS ONE			English	Article							FMRI TIME-SERIES; TENSOR IMAGING TRACTOGRAPHY; HUMAN BRAIN; IN-VIVO; INTERSUBJECT VARIABILITY; LONGITUDINAL FASCICLE; PLANUM TEMPORALE; FIBER TRACKING; PATHWAYS; LATERALIZATION	Despite a better understanding of brain language organization into large-scale cortical networks, the underlying white matter (WM) connectivity is still not mastered. Here we combined diffusion tensor imaging (DTI) fiber tracking (FT) and language functional magnetic resonance imaging (fMRI) in twenty healthy subjects to gain new insights into the macroscopic structural connectivity of language. Eight putative WM fascicles for language were probed using a deterministic DTI-FT technique: the arcuate fascicle (AF), superior longitudinal fascicle (SLF), uncinate fascicle (UF), temporo-occipital fascicle, inferior fronto-occipital fascicle (IFOF), middle longitudinal fascicle (MdLF), frontal aslant fascicle and operculopre-motor fascicle. Specific measurements (i.e. volume, length, fractional anisotropy) and precise cortical terminations were derived for each WM fascicle within both hemispheres. Connections between these WM fascicles and fMRI activations were studied to determine which WM fascicles are related to language. WM fascicle volumes showed asymmetries: leftward for the AF, temporoparietal segment of SLF and UF, and rightward for the frontoparietal segment of the SLF. The lateralization of the AF, IFOF and MdLF extended to differences in patterns of anatomical connections, which may relate to specific hemispheric abilities. The leftward asymmetry of the AF was correlated to the leftward asymmetry of fMRI activations, suggesting that the lateralization of the AF is a structural substrate of hemispheric language dominance. We found consistent connections between fMRI activations and terminations of the eight WM fascicles, providing a detailed description of the language connectome. WM fascicle terminations were also observed beyond fMRI-confirmed language areas and reached numerous cortical areas involved in different functional brain networks. These findings suggest that the reported WM fascicles are not exclusively involved in language and might be related to other cognitive functions such as visual recognition, spatial attention, executive functions, memory, and processing of emotional and behavioral aspects.	[Vassal, Francois; Sontheimer, Anna; Lemaire, Jean-Jacques] Univ Auvergne, Unite Format & Rech Med, EA 7282, IGCNC, Clermont Ferrand, France; [Vassal, Francois] Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Serv Neurochirurg, St Etienne, France; [Schneider, Fabien; Boutet, Claire] Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Unite Neuroradiol, St Etienne, France; [Jean, Betty] Hop Gabriel Montpied, Unite Neuroradiol, Ctr Hosp Univ Clermont Ferrand, Clermont Ferrand, France; [Sontheimer, Anna; Lemaire, Jean-Jacques] Hop Gabriel Montpied, Ctr Hosp Univ Clermont Ferrand, Serv Neurochirurg, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); CHU de St Etienne; CHU de St Etienne; CHU Clermont Ferrand; CHU Clermont Ferrand	Vassal, F; Lemaire, JJ (corresponding author), Univ Auvergne, Unite Format & Rech Med, EA 7282, IGCNC, Clermont Ferrand, France.; Vassal, F (corresponding author), Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Serv Neurochirurg, St Etienne, France.; Lemaire, JJ (corresponding author), Hop Gabriel Montpied, Ctr Hosp Univ Clermont Ferrand, Serv Neurochirurg, Clermont Ferrand, France.	francois.vassal@chu-st-etienne.fr; jjlemaire@chu-clermontferrand.fr						Amunts K, 2006, BRAIN LANG, V96, P147, DOI 10.1016/j.bandl.2005.06.004; [Anonymous], 2011, EPILEPTOLOGIE; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Beaucousin V, 2007, CEREB CORTEX, V17, P339, DOI 10.1093/cercor/bhj151; Binder JR, 1997, CLIN NEUROSCI, V4, P87; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Corina DP, 2010, BRAIN LANG, V115, P101, DOI 10.1016/j.bandl.2010.04.001; de Champfleur NM, 2013, EUR J RADIOL, V82, P151, DOI 10.1016/j.ejrad.2012.05.034; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Desmond JE, 1995, BRAIN, V118, P1411, DOI 10.1093/brain/118.6.1411; Dick AS, 2014, NEUROSCIENTIST, V20, P453, DOI 10.1177/1073858413513502; Dorsaint-Pierre R, 2006, BRAIN, V129, P1164, DOI 10.1093/brain/awl055; Duffau H, 2008, NEUROPSYCHOLOGIA, V46, P927, DOI 10.1016/j.neuropsychologia.2007.10.025; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Griffiths JD, 2013, CEREB CORTEX, V23, P139, DOI 10.1093/cercor/bhr386; Hagmann P, 2006, HUM BRAIN MAPP, V27, P828, DOI 10.1002/hbm.20224; Hirano Asao, 1995, P49; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Lehericy S, 2000, NEUROLOGY, V54, P1625, DOI 10.1212/WNL.54.8.1625; Lemaire JJ, 2013, BRAIN TOPOGR, V26, P428, DOI 10.1007/s10548-012-0257-7; Lurito JT, 2001, NEUROIMAG CLIN N AM, V11, P355; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Makris N, 2013, BRAIN STRUCT FUNCT, V218, P951, DOI 10.1007/s00429-012-0441-2; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Ocklenburg S, 2014, NEUROSCI LETT, V580, P32, DOI 10.1016/j.neulet.2014.07.044; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Steinmetz H, 1996, NEUROSCI BIOBEHAV R, V20, P587, DOI 10.1016/0149-7634(95)00071-2; Stieglitz LH, 2012, NEUROSURGERY, V70, P56, DOI 10.1227/NEU.0b013e31822cb882; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	51	35	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152614	10.1371/journal.pone.0152614	http://dx.doi.org/10.1371/journal.pone.0152614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029050	Green Published, gold, Green Submitted			2022-12-26	WOS:000373116500058
J	Lv, HX; Cui, XG; Wahid, F; Xia, F; Zhong, C; Jia, SR				Lv, Hexin; Cui, Xianggan; Wahid, Fazli; Xia, Feng; Zhong, Cheng; Jia, Shiru			Analysis of the Physiological and Molecular Responses of Dunaliella salina to Macronutrient Deprivation	PLOS ONE			English	Article							BETA-CAROTENE; GREEN-ALGA; BIOSYNTHESIS; ACCUMULATION; STRESS; LIMITATION; PATHWAY	The halotolerant chlorophyte Dunaliella salina can accumulate up to 10% of its dry weight as a-carotene in chloroplasts when subjected to adverse conditions, including nutrient deprivation. However, the mechanisms of carotenoid biosynthesis are poorly understood. Here, the physiological and molecular responses to the deprivation of nitrogen (-N), sulfur (-S), phosphorus (-P) and different combinations of those nutrients (-N-P, -N-S, -P-S and -N-P-S) were compared to gain insights into the underlying regulatory mechanisms of carotenoid biosynthesis. The results showed that both the growth and photosynthetic rates of cells were decreased during nutrient deprivation, accompanied by lipid globule accumulation and reduced chlorophyll levels. The SOD and CAT activities of the cells were altered during nutrient deprivation, but their responses were different. The total carotenoid contents of cells subjected to multiple nutrient deprivation were higher than those of cells subjected to single nutrient deprivation and non-stressed cells. The A-carotene contents of cells subjected to -N-P, -N-S and -N-P-S were higher than those of cells subjected to single nutrient deprivation. Cells subjected to sulfur deprivation accumulated more lutein than cells subjected to nitrogen and phosphorous deprivation. In contrast, no cumulative effects of nutrient deprivation on the transcription of genes in the carotenogenic pathway were observed because MEP and carotenogenic pathway genes were up-regulated during single nutrient deprivation but were downregulated during multiple nutrient deprivation. Therefore, we proposed that the carotenoid biosynthesis pathway of D. salina is regulated at both the transcriptional and posttranscriptional levels and that a complex crosstalk occurs at the physiological and molecular levels in response to the deprivation of different nutrients.	[Lv, Hexin; Cui, Xianggan; Wahid, Fazli; Xia, Feng; Zhong, Cheng; Jia, Shiru] Tianjin Univ Sci & Technol, Minist Educ, Key Lab Ind Fermentat Microbiol, Tianjin, Peoples R China; [Lv, Hexin; Cui, Xianggan; Wahid, Fazli; Xia, Feng; Zhong, Cheng; Jia, Shiru] Tianjin Univ Sci & Technol, Tianjin Key Lab Ind Microbiol, Tianjin, Peoples R China	Tianjin University Science & Technology; Tianjin University Science & Technology	Lv, HX; Jia, SR (corresponding author), Tianjin Univ Sci & Technol, Minist Educ, Key Lab Ind Fermentat Microbiol, Tianjin, Peoples R China.; Lv, HX; Jia, SR (corresponding author), Tianjin Univ Sci & Technol, Tianjin Key Lab Ind Microbiol, Tianjin, Peoples R China.	lvhx@tust.edu.cn; jiashiru@tust.edu.cn	Wahid, Fazli/U-3561-2017; jia, shi/HHS-4172-2022	Wahid, Fazli/0000-0002-4491-8265; 	National Natural Science Foundation of China [31401029]; Foundation of Key Laboratory of Industrial Fermentation Microbiology of Ministry of Education; Tianjin Key Lab of Industrial Microbiology (Tianjin University of Science Technology)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Key Laboratory of Industrial Fermentation Microbiology of Ministry of Education; Tianjin Key Lab of Industrial Microbiology (Tianjin University of Science Technology)	This work was supported by the National Natural Science Foundation of China (No. 31401029) and the Foundation (No. 2015IM101) of Key Laboratory of Industrial Fermentation Microbiology of Ministry of Education and Tianjin Key Lab of Industrial Microbiology (Tianjin University of Science & Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BenAmotz A., 2009, ALGA DUNALIELLA BIOD; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Cao HM, 2001, J APPL PHYCOL, V13, P25, DOI 10.1023/A:1008131412909; Capa-Robles W, 2009, NAT PROD RES, V23, P1021, DOI 10.1080/14786410802689689; Chen H, 2011, CHEMOSPHERE, V84, P664, DOI 10.1016/j.chemosphere.2011.03.032; Coesel SN, 2008, MAR BIOTECHNOL, V10, P602, DOI 10.1007/s10126-008-9100-2; Tran D, 2014, WORLD J MICROB BIOT, V30, P317, DOI 10.1007/s11274-013-1413-2; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Fu WQ, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-3; Garcia-Gonzalez M, 2005, J BIOTECHNOL, V115, P81, DOI 10.1016/j.jbiotec.2004.07.010; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; JOHNSON MK, 1968, J BACTERIOL, V95, P1461, DOI 10.1128/JB.95.4.1461-1468.1968; Kichtenthaler H.K., 1983, BIOCHEM SOC T, V603, P591; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; Lamers PP, 2012, J BIOTECHNOL, V162, P21, DOI 10.1016/j.jbiotec.2012.04.018; LERS A, 1990, PLANT PHYSIOL, V93, P389, DOI 10.1104/pp.93.2.389; Nikookar K, 2005, BIOMOL ENG, V22, P141, DOI 10.1016/j.bioeng.2005.07.001; Okamoto OK, 2001, ARCH ENVIRON CON TOX, V40, P18; Paniagua-Michel J, 2009, MAR DRUGS, V7, P45, DOI 10.3390/md7010045; Prieto A, 2011, J BIOTECHNOL, V151, P180, DOI 10.1016/j.jbiotec.2010.11.011; Rabbani S, 1998, PLANT PHYSIOL, V116, P1239, DOI 10.1104/pp.116.4.1239; RABINOWITCH HD, 1987, FREE RADICAL BIO MED, V3, P125, DOI 10.1016/S0891-5849(87)80007-2; Ramos A, 2008, APPL MICROBIOL BIOT, V79, P819, DOI 10.1007/s00253-008-1492-4; Ramos AA, 2009, J PLANT PHYSIOL, V166, P968, DOI 10.1016/j.jplph.2008.11.008; Saha SK, 2013, BIOTECHNOL LETT, V35, P1067, DOI 10.1007/s10529-013-1176-8; Salguero A, 2003, BIOMOL ENG, V20, P249, DOI 10.1016/S1389-0344(03)00065-0; Sanchez-Estudillo L, 2006, BIOTECHNOL LETT, V28, P787, DOI 10.1007/s10529-006-9001-2; Sano Y, 2015, PHOTOSYNTH RES, V125, P105, DOI 10.1007/s11120-014-0073-x; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; SCHERER S, 1990, TRENDS BIOCHEM SCI, V15, P458, DOI 10.1016/0968-0004(90)90296-N; SHAISH A, 1993, PLANTA, V190, P363; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Tafreshi AH, 2009, J APPL MICROBIOL, V107, P14, DOI 10.1111/j.1365-2672.2009.04153.x; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Yang XJ, 2010, ANN BOT-LONDON, V105, P513, DOI 10.1093/aob/mcq015; Ye ZW, 2008, BIOTECHNOL ADV, V26, P352, DOI 10.1016/j.biotechadv.2008.03.004	36	25	27	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152226	10.1371/journal.pone.0152226	http://dx.doi.org/10.1371/journal.pone.0152226			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023397	Green Published, gold			2022-12-26	WOS:000373113900032
J	Woolway, RI; Jones, ID; Maberly, SC; French, JR; Livingstone, DM; Monteith, DT; Simpson, GL; Thackeray, SJ; Andersen, MR; Battarbee, RW; DeGasperi, CL; Evans, CD; de Eyto, E; Feuchtmayr, H; Hamilton, DP; Kernan, M; Krokowski, J; Rimmer, A; Rose, KC; Rusak, JA; Ryves, DB; Scott, DR; Shilland, EM; Smyth, RL; Staehr, PA; Thomas, R; Waldron, S; Weyhenmeyer, GA				Woolway, R. Iestyn; Jones, Ian D.; Maberly, Stephen C.; French, Jon R.; Livingstone, David M.; Monteith, Donald T.; Simpson, Gavin L.; Thackeray, Stephen J.; Andersen, Mikkel R.; Battarbee, Richard W.; DeGasperi, Curtis L.; Evans, Christopher D.; de Eyto, Elvira; Feuchtmayr, Heidrun; Hamilton, David P.; Kernan, Martin; Krokowski, Jan; Rimmer, Alon; Rose, Kevin C.; Rusak, James A.; Ryves, David B.; Scott, Daniel R.; Shilland, Ewan M.; Smyth, Robyn L.; Staehr, Peter A.; Thomas, Rhian; Waldron, Susan; Weyhenmeyer, Gesa A.			Diel Surface Temperature Range Scales with Lake Size	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; DEEP SUBTROPICAL RESERVOIR; THERMAL STRUCTURE; CLIMATE-CHANGE; STRATIFICATION; DEPENDENCE; QIANDAOHU; RESPONSES; DIOXIDE; FLUXES	Ecological and biogeochemical processes in lakes are strongly dependent upon water temperature. Long-term surface warming of many lakes is unequivocal, but little is known about the comparative magnitude of temperature variation at diel timescales, due to a lack of appropriately resolved data. Here we quantify the pattern and magnitude of diel temperature variability of surface waters using high-frequency data from 100 lakes. We show that the near-surface diel temperature range can be substantial in summer relative to long-term change and, for lakes smaller than 3 km(2), increases sharply and predictably with decreasing lake area. Most small lakes included in this study experience average summer diel ranges in their near-surface temperatures of between 4 and 7 degrees C. Large diel temperature fluctuations in the majority of lakes undoubtedly influence their structure, function and role in biogeochemical cycles, but the full implications remain largely unexplored.	[Woolway, R. Iestyn; Jones, Ian D.; Maberly, Stephen C.; Monteith, Donald T.; Thackeray, Stephen J.; Feuchtmayr, Heidrun] Ctr Ecol & Hydrol, Lake Ecosyst Grp, Lancaster, England; [Woolway, R. Iestyn; French, Jon R.; Battarbee, Richard W.; Kernan, Martin; Shilland, Ewan M.] UCL, Dept Geog, Environm Change Res Ctr, London, England; [Woolway, R. Iestyn] Univ Reading, Dept Meteorol, Reading, Berks, England; [Livingstone, David M.] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dept Water Resources & Drinking Water, Dubendorf, Switzerland; [Simpson, Gavin L.] Univ Regina, Inst Environm Change & Soc, Regina, SK S4S 0A2, Canada; [Simpson, Gavin L.] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Andersen, Mikkel R.] Univ Copenhagen, Freshwater Biol Sect, Copenhagen, Denmark; [DeGasperi, Curtis L.] King Cty Water & Land Resources Div, Seattle, WA USA; [Evans, Christopher D.] Ctr Ecol & Hydrol, Bangor, Gwynedd, Wales; [de Eyto, Elvira] Inst Marine, Newport, Co Mayo, Ireland; [Hamilton, David P.] Univ Waikato, Environm Res Inst, Hamilton, New Zealand; [Krokowski, Jan] ASB Eurocent, Scottish Environm Protect Agcy, Motherwell, North Lanarkshi, Scotland; [Rimmer, Alon] Israel Oceanog & Limnol Res, Kinneret Limnol Lab, Migdal, Israel; [Rose, Kevin C.] Rensselaer Polytech Inst, New York, NY USA; [Rusak, James A.] Ontario Minist Environm & Climate Change, Dorset Environm Sci Ctr, Dorset, ON, Canada; [Ryves, David B.; Scott, Daniel R.] Univ Loughborough, Ctr Hydrol & Ecosyst Sci, Dept Geog, Loughborough, Leics, England; [Smyth, Robyn L.] Bard Coll, Ctr Environm Policy, New York, NY USA; [Staehr, Peter A.] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Thomas, Rhian] Cyfoeth Naturiol Cymru Nat Resources Wales, Bangor, Gwynedd, Wales; [Waldron, Susan] Univ Glasgow, Sch Geog & Earth Sci, Glasgow, Lanark, Scotland; [Weyhenmeyer, Gesa A.] Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden	UK Centre for Ecology & Hydrology (UKCEH); University of London; University College London; University of Reading; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Regina; University of Regina; University of Copenhagen; UK Centre for Ecology & Hydrology (UKCEH); Marine Institute Ireland; University of Waikato; Israel Oceanographic & Limnological Research Institute; Rensselaer Polytechnic Institute; Loughborough University; Aarhus University; University of Glasgow; Uppsala University	Woolway, RI (corresponding author), Ctr Ecol & Hydrol, Lake Ecosyst Grp, Lancaster, England.; Woolway, RI (corresponding author), UCL, Dept Geog, Environm Change Res Ctr, London, England.; Woolway, RI (corresponding author), Univ Reading, Dept Meteorol, Reading, Berks, England.	riwoolway@gmail.com	Monteith, Donald/C-1534-2008; Evans, Christopher D/F-2087-2010; Weyhenmeyer, Gesa/Y-6135-2019; Staehr, Peter/J-3693-2013; Feuchtmayr, Heidrun/K-2530-2016; Thackeray, Stephen J/D-2415-2013; Hamilton, David P/F-5039-2012; Maberly, Stephen C/J-3361-2012; Hamilton, David/ABI-6870-2020; French, Jon/C-2455-2008; Jones, Ian/E-5507-2015; Hamilton, David/AAI-9851-2020; Shilland, Ewan/S-3823-2019; Staehr, Peter/S-6110-2018	Monteith, Donald/0000-0003-3219-1772; Evans, Christopher D/0000-0002-7052-354X; Weyhenmeyer, Gesa/0000-0002-4013-2281; Staehr, Peter/0000-0002-1580-4875; Feuchtmayr, Heidrun/0000-0002-2028-4843; Thackeray, Stephen J/0000-0003-3274-2706; Hamilton, David P/0000-0002-9341-8777; Maberly, Stephen C/0000-0003-3541-5903; Hamilton, David/0000-0002-9341-8777; French, Jon/0000-0002-0330-3555; Jones, Ian/0000-0002-6898-1429; Shilland, Ewan/0000-0001-9978-8595; Staehr, Peter/0000-0002-1580-4875; Rusak, James/0000-0002-4939-6478; Woolway, Richard Iestyn/0000-0003-0498-7968; Andersen, Mikkel/0000-0003-2104-2894; Simpson, Gavin/0000-0002-9084-8413; WALDRON, SUSAN/0000-0002-2683-0761	OTT Hydrometry Ltd; University College London; Natural Environment Research Council (NERC) Sensor Network project United Kingdom Lake Ecological Observatory Network (UKLEON) [NE/I007407/1]; Bay of Plenty Regional Council; UK Upland Waters Monitoring Network; DEFRA; Natural Resources Wales; NERC [NE/I007520/1, NE/I007407/1, NE/I007261/1, NE/H011978/1, NE/I007253/1] Funding Source: UKRI; Natural Environment Research Council [NE/I007261/1, NE/I007407/1, NE/I007520/1, NE/I007253/1] Funding Source: researchfish; Direct For Biological Sciences [1440297] Funding Source: National Science Foundation	OTT Hydrometry Ltd; University College London(General Electric); Natural Environment Research Council (NERC) Sensor Network project United Kingdom Lake Ecological Observatory Network (UKLEON)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Bay of Plenty Regional Council; UK Upland Waters Monitoring Network; DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Resources Wales; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by OTT Hydrometry Ltd and a University College London impact award awarded to RIW and is part of the Natural Environment Research Council (NERC) Sensor Network project United Kingdom Lake Ecological Observatory Network (UKLEON; NE/I007407/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by OTT Hydrometry Ltd and a University College London impact award awarded to RIW and is part of the Natural Environment Research Council (NERC) Sensor Network project United Kingdom Lake Ecological Observatory Network (UKLEON; NE/I007407/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials'. This work also benefited from participation in the Global Lake Ecological Observatory Network (GLEON) and the Networking Lake Observatories in Europe (NETLAKE). We would like to thank all of the individual data providers, especially Chris McBride (University of Waikato), the Bay of Plenty Regional Council, the UK Upland Waters Monitoring Network (and all its sponsors, especially DEFRA), Natural Resources Wales (who fund the monitoring station on Llyn Tegid), D. Pierson, C.J. McConnell, S.E. Jones, S. Meis, C.T. Solomon, B.C. Weidel, J.A. Zwart, Kathleen Weathers, and Jordan S. Read. This manuscript contains data from Scottish Environment Protection Agency and Natural Resources Wales. Any views expressed in this paper do not necessarily reflect the views of Natural Resources Wales.	Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Barton K, 2014, MUMIN MULTIMODEL INF; Butterwick C, 2005, FRESHWATER BIOL, V50, P291; CHRISTIE GC, 1988, CAN J FISH AQUAT SCI, V45, P301, DOI 10.1139/f88-036; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Downing JA, 2010, LIMNETICA, V29, P9; EDINGER JE, 1968, WATER RESOUR RES, V4, P1137, DOI 10.1029/WR004i005p01137; Fee EJ, 1996, LIMNOL OCEANOGR, V41, P912, DOI 10.4319/lo.1996.41.5.0912; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GORHAM E, 1989, J GREAT LAKES RES, V15, P233, DOI 10.1016/S0380-1330(89)71479-9; Gudasz C, 2010, NATURE, V466, P478, DOI 10.1038/nature09186; Hampton SE, 2008, GLOBAL CHANGE BIOL, V14, P1947, DOI 10.1111/j.1365-2486.2008.01616.x; Hanson PC, 2007, FRESHWATER BIOL, V52, P814, DOI 10.1111/j.1365-2427.2007.01730.x; Larsen S, 2011, GLOBAL CHANGE BIOL, V17, P1186, DOI 10.1111/j.1365-2486.2010.02257.x; Marra G, 2011, COMPUT STAT DATA AN, V55, P2372, DOI 10.1016/j.csda.2011.02.004; MAZUMDER A, 1990, SCIENCE, V247, P312, DOI 10.1126/science.247.4940.312; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Mortimer CH, 1982, MITT INT VER LIMNOL, V22, P1; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Persson I, 2008, FRESHWATER BIOL, V53, P2345, DOI 10.1111/j.1365-2427.2008.02049.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Read JS, 2013, LIMNOL OCEANOGR, V58, P921, DOI 10.4319/lo.2013.58.3.0921; Read JS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051886; REBSDORF A, 1991, FRESHWATER BIOL, V25, P419, DOI 10.1111/j.1365-2427.1991.tb01386.x; REGIER HA, 1990, T AM FISH SOC, V119, P374, DOI 10.1577/1548-8659(1990)119<0374:IOTCOA>2.3.CO;2; Staehr PA, 2012, AQUAT SCI, V74, P155, DOI 10.1007/s00027-011-0207-6; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Tanentzap AJ, 2008, LIMNOL OCEANOGR, V53, P404, DOI 10.4319/lo.2008.53.1.0404; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Verpoorter C, 2014, GEOPHYS RES LETT, V41, P6396, DOI 10.1002/2014GL060641; Wood SN, 2013, BIOMETRIKA, V100, P221, DOI 10.1093/biomet/ass048; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Woolway RI, 2015, ENVIRON MODELL SOFTW, V70, P191, DOI 10.1016/j.envsoft.2015.04.013; Woolway RI, 2015, INLAND WATERS, V5, P139, DOI 10.5268/IW-5.2.748; Xenopoulos MA, 2003, LIMNOL OCEANOGR, V48, P2321, DOI 10.4319/lo.2003.48.6.2321; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205; Zhang YL, 2015, WATER RES, V75, P249, DOI 10.1016/j.watres.2015.02.052; Zhang YL, 2014, LIMNOL OCEANOGR, V59, P1193, DOI 10.4319/lo.2014.59.4.1193	44	77	78	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152466	10.1371/journal.pone.0152466	http://dx.doi.org/10.1371/journal.pone.0152466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023200	Green Published, Green Accepted, gold			2022-12-26	WOS:000373113900060
J	Hendifar, A; Osipovl, A; Khanujal, J; Nissen, N; Naziri, J; Yang, W; Li, QL; Tuli, R				Hendifar, Andrew; Osipovl, Arsen; Khanujal, Jasleen; Nissen, Nicholas; Naziri, Jason; Yang, Wensha; Li, Quanlin; Tuli, Richard			Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma	PLOS ONE			English	Article							DIABETES-MELLITUS; SERUM-ALBUMIN; CANCER RISK; METAANALYSIS; SARCOPENIA; PREDICTOR; MORTALITY; OBESITY; COHORT; IMPACT	Obesity is a known risk factor for PDA and recent reports suggest obesity has a negative impact on clinical outcomes in patients with PDA. Pretreatment body mass index (BMI) and serum albumin (SA) have been shown to be associated with worse overall survival in patients with advanced and metastatic PDA. However, minimal data exists on the impact of BMI and SA on perioperative and long-term clinical outcomes in patients with early-stage resected PDA. Herein, we report on the impact of these variables on perioperative clinical outcomes, overall survival (OS) and disease free survival (DFS) in patients with resected PDA. With IRB approval, we evaluated 1,545 patients with PDA treated at a single institution from 2007-2013 and identified 106 patients who underwent upfront resection with curative intent. BMI and SA were calculated preoperatively and at the time of last clinical evaluation. Influence of preoperative BMI, SA, change in either variable, and influence of other clinical and pathologic variables on perioperative morbidity and mortality was assessed. The impact of these variables on DFS and OS was assessed with cox regression modeling and ANOVA. Actuarial estimates for DFS and OS were calculated using KaplanMeier methods. Median follow up time was 16 months (3-89). Mean age was 68 years. Median survival was 14 months (3-65) and median time to recurrence was 11 months (179). Length of hospital stay was associated with BMI (p =.023), change in BMI (p =.003) and SA (p =.004). Post-operative transfusion rate was associated with SA (p =.021). There was a strong correlation between BMI change and positive margin (p =.04) and lymph node status (p =.01). On multivariate analysis, change in SA (p =.03) and node positivity (p =.008) were associated with decreased DFS. Additionally, preoperative SA (p =.023), node positivity (p =.026) and poor differentiation (p =.045) were associated with worse OS on multivariate analysis. Low preoperative SA was associated with worse DFS and OS in patients with resected PDA. Lower BMI and SA were associated with longer post-operative hospital stay. Our study is one of the first to describe how pre-operative BMI and SA and post-operative changes in these variables impact clinical and perioperative outcomes. This data supports nutritional status and weight loss as predictors of outcome in resected pancreatic cancer patients and warrants further prospective investigation.	[Hendifar, Andrew; Osipovl, Arsen; Khanujal, Jasleen; Li, Quanlin] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Nissen, Nicholas] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Nissen, Nicholas; Naziri, Jason; Yang, Wensha; Tuli, Richard] Cedars Sinai Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Tuli, R (corresponding author), Cedars Sinai Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90048 USA.	Rchard.Tuli@cshs.org	Yang, Wensha/K-6785-2019	Yang, Wensha/0000-0002-7274-9454				Amini N, 2015, J GASTROINTEST SURG, V19, P1593, DOI 10.1007/s11605-015-2835-y; Ariyama J, 1998, PANCREAS, V16, P396, DOI 10.1097/00006676-199804000-00030; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Bachmann Jeannine, 2009, BMC Cancer, V9, P255, DOI 10.1186/1471-2407-9-255; Batabyal P, 2014, ANN SURG ONCOL, V21, P2453, DOI 10.1245/s10434-014-3625-6; Campbell F, 2009, HISTOPATHOLOGY, V55, P277, DOI 10.1111/j.1365-2559.2009.03376.x; Carpelan-Holmstrom M, 2005, GUT, V54, P385, DOI 10.1136/gut.2004.047191; Coughlin SS, 2000, CANCER CAUSE CONTROL, V11, P915, DOI 10.1023/A:1026580131793; Esposito I, 2008, ANN SURG ONCOL, V15, P1651, DOI 10.1245/s10434-008-9839-8; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; Hendifar AE, 2014, 2014 ASCO ANN M CHIC; Joglekar S, 2015, J SURG ONCOL, V111, P771, DOI 10.1002/jso.23862; Larsson SC, 2007, INT J CANCER, V120, P1993, DOI 10.1002/ijc.22535; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Luo J, 2008, BRIT J CANCER, V99, P527, DOI 10.1038/sj.bjc.6604487; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Pant S, 2014, CANCER-AM CANCER SOC, V120, P1780, DOI 10.1002/cncr.28648; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Schenk M, 2001, JNCI-J NATL CANCER I, V93, P640, DOI 10.1093/jnci/93.8.640; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silverman DT, 1999, BRIT J CANCER, V80, P1830, DOI 10.1038/sj.bjc.6690607; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Tan CR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00088; Verbeke CS, 2013, PATHOLOGE, V34, P241, DOI 10.1007/s00292-013-1799-5; Yuan C, 2013, J CLIN ONCOL, V31, P4229, DOI 10.1200/JCO.2013.51.7532	28	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152172	10.1371/journal.pone.0152172	http://dx.doi.org/10.1371/journal.pone.0152172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015568	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708900043
J	Griffiths, K; Dolezal, O; Cao, B; Nilsson, SK; See, HB; Pfleger, KDG; Roche, M; Gorry, PR; Pow, A; Viduka, K; Lim, K; Lu, BGC; Chang, DHC; Murray-Rust, T; Kvansakul, M; Perugini, MA; Dogovski, C; Doerflinger, M; Zhang, Y; Parisi, K; Casey, JL; Nuttall, SD; Foley, M				Griffiths, Katherine; Dolezal, Olan; Cao, Benjamin; Nilsson, Susan K.; See, Heng B.; Pfleger, Kevin D. G.; Roche, Michael; Gorry, Paul R.; Pow, Andrew; Viduka, Katerina; Lim, Kevin; Lu, Bernadine G. C.; Chang, Denison H. C.; Murray-Rust, Thomas; Kvansakul, Marc; Perugini, Matthew A.; Dogovski, Con; Doerflinger, Marcel; Zhang, Yuan; Parisi, Kathy; Casey, Joanne L.; Nuttall, Stewart D.; Foley, Michael			i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEMATOPOIETIC STEM; MONOCLONAL-ANTIBODIES; RAPID MOBILIZATION; CRYSTAL-STRUCTURE; ANTIGEN RECEPTOR; PROGENITOR CELLS; AMD3100; HIV-1; FRAGMENTS	CXCR4 is a G protein-coupled receptor with excellent potential as a therapeutic target for a range of clinical conditions, including stem cell mobilization, cancer prognosis and treatment, fibrosis therapy, and HIV infection. We report here the development of a fully human single-domain antibody-like scaffold termed an "i-body," the engineering of which produces an i-body library possessing a long complementarity determining region binding loop, and the isolation and characterization of a panel of i-bodies with activity against human CXCR4. The CXCR4-specific i-bodies show antagonistic activity in a range of in vitro and in vivo assays, including inhibition of HIV infection, cell migration, and leukocyte recruitment but, importantly, not the mobilization of hematopoietic stem cells. Epitope mapping of the three CXCR4 i-bodies AM3-114, AM4-272, and AM3-523 revealed binding deep in the binding pocket of the receptor.	[Griffiths, Katherine; Pow, Andrew; Viduka, Katerina; Lim, Kevin; Lu, Bernadine G. C.; Chang, Denison H. C.; Murray-Rust, Thomas; Doerflinger, Marcel; Parisi, Kathy; Casey, Joanne L.; Foley, Michael] AdAlta Pty Ltd, 15-2 Pk Dr, Bundoora, Vic 3083, Australia; [Dolezal, Olan; Nuttall, Stewart D.] CSIRO Mfg, Biomed Mfg, 343 Royal Parade, Parkville, Vic 3052, Australia; [Cao, Benjamin; Nilsson, Susan K.] Monash Univ, Australian Regenerat Med Inst, Wellington Rd, Clayton, Vic 3800, Australia; [Cao, Benjamin; Nilsson, Susan K.] CSIRO Mfg, Biomed Mfg, Bayview Ave, Clayton, Vic 3168, Australia; [See, Heng B.; Pfleger, Kevin D. G.] Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [See, Heng B.; Pfleger, Kevin D. G.] Univ Western Australia, Ctr Med Res, Crawley, WA 6009, Australia; [Pfleger, Kevin D. G.] Dimerix Biosci Ltd, Nedlands, WA 6009, Australia; [Roche, Michael] Univ Melbourne, Doherty Inst Infect & Immun, 792 Elizabeth St, Melbourne, Vic 3000, Australia; [Roche, Michael] Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia; [Gorry, Paul R.] RMIT Univ, Coll Sci Engn & Hlth, Sch Hlth & Biomed Sci, Melbourne, Vic 3001, Australia; [Kvansakul, Marc; Perugini, Matthew A.; Dogovski, Con; Parisi, Kathy; Foley, Michael] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Zhang, Yuan] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Pow, Andrew] Compugen Ltd, 260 East Grand Ave, San Francisco, CA 94080 USA; [Viduka, Katerina] AgriBio Ctr, Dept Econ Dev Jobs Transport & Resources, 5 Ring Rd, Bundoora, Vic 3083, Australia; [Lim, Kevin] Imunexus, 343 Royal Parade, Parkville, Vic 3052, Australia; [Lu, Bernadine G. C.] CSL Ltd, 45 Poplar Rd, Parkville, Vic 3052, Australia; [Chang, Denison H. C.] Virbac, Milperra, NSW 2214, Australia; [Dogovski, Con] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Doerflinger, Marcel; Casey, Joanne L.] Nexvet, 21-31 Wright St, Clayton, Vic 3168, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Regenerative Medicine Institute; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Harry Perkins Institute of Medical Research; University of Western Australia; University of Melbourne; Burnet Institute; Royal Melbourne Institute of Technology (RMIT); La Trobe University; St Vincent's Hospital Melbourne; University of Melbourne; CSL; University of Melbourne	Foley, M (corresponding author), La Trobe Univ, Dept Biochem, Plenty Rd, Bundoora, Vic 3086, Australia.	m.foley@latrobe.edu.au	Kvansakul, Marc/AAF-2453-2019; Dolezal, Olan/E-1691-2015; Cao, Benjamin/AAI-1626-2021; Nuttall, Stewart D/C-2016-2013; Nilsson, Susie K/C-5563-2015	Kvansakul, Marc/0000-0003-2639-2498; Cao, Benjamin/0000-0002-3024-3893; Nilsson, Susie K/0000-0002-7926-7335; Foley, Michael/0000-0003-1349-4698; DOLEZAL, OLAN/0000-0002-5823-6978; Perugini, Matthew/0000-0001-8052-5584; Roche, Michael/0000-0001-8819-0096; Pfleger, Kevin/0000-0001-8261-9189; Griffiths, Katherine/0000-0003-0580-1125; Doerflinger, Marcel/0000-0001-9159-3021	CSIRO OCE Science Leader Fellowship; State Government of Victoria; Australian Government	CSIRO OCE Science Leader Fellowship; State Government of Victoria; Australian Government(Australian GovernmentCGIAR)	This work was supported by a CSIRO OCE Science Leader Fellowship (to S. K. N.). The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. K. Lim, J. L. Casey, K. Parisi, and M. Foley are shareholders in Adalta. K. Griffiths, T. Murray-Rust, and M. Foley are currently employed by Adalta. A. Pow, K. Viduka, K. Lim, B. G. C. Lu, D. H. C. Chang, K. Parisi, and J. Casey are former employees of Adalta. All authors or institutions received payment or services from a third party to conduct the research reported here. Some authors have non-financial relationships with entities in the biomedical arena that could be perceived to influence, or that give the appearance of potentially influencing, what is written in this work. K. G. and S. D. N. have an issued patent relating to the reported work, and K. G., A. P., K. V., and M. F. have a pending patent relating to the reported work.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Avniel S, 2006, J INVEST DERMATOL, V126, P468, DOI 10.1038/sj.jid.5700069; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Cao B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11007; Carnec X, 2005, J VIROL, V79, P1930, DOI 10.1128/JVI.79.3.1930-1933.2005; Cashen AF, 2009, DRUG TODAY, V45, P497, DOI 10.1358/dot.2009.45.7.1395292; Castaldo C, 2014, J BIOMOL SCREEN, V19, P859, DOI 10.1177/1087057114526283; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Coia G, 1996, J IMMUNOL METHODS, V192, P13, DOI 10.1016/0022-1759(95)00264-2; Coley AM, 2001, PROTEIN ENG, V14, P691, DOI 10.1093/protein/14.9.691; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; Duarte Djane B, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0506s56; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Goodchild SA, 2011, MOL IMMUNOL, V48, P2027, DOI 10.1016/j.molimm.2011.06.437; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Griffiths K, 2013, ANTIBODIES, V2, P66, DOI 10.3390/antib2010066; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Herr DR, 2012, INT REV CEL MOL BIO, V297, P45, DOI 10.1016/B978-0-12-394308-8.00002-9; Heym RG, 2015, BBA-PROTEINS PROTEOM, V1854, P979, DOI 10.1016/j.bbapap.2015.04.003; Hor L, 2013, BIOCHIMIE, V95, P1949, DOI 10.1016/j.biochi.2013.06.026; Hosse RJ, 2009, ANAL BIOCHEM, V385, P346, DOI 10.1016/j.ab.2008.11.026; Hummel S, 2014, CURR OPIN HEMATOL, V21, P29, DOI 10.1097/MOH.0000000000000002; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Jakobsen MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065950; Jost C, 2014, CURR OPIN STRUC BIOL, V27, P102, DOI 10.1016/j.sbi.2014.05.011; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kuhne MR, 2013, CLIN CANCER RES, V19, P357, DOI 10.1158/1078-0432.CCR-12-2333; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034038; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Liu JL, 2014, MOL IMMUNOL, V59, P194, DOI 10.1016/j.molimm.2014.02.014; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; MINSKY A, 1986, P NATL ACAD SCI USA, V83, P4180, DOI 10.1073/pnas.83.12.4180; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nuttall Stewart D, 2012, Methods Mol Biol, V911, P27, DOI 10.1007/978-1-61779-968-6_3; Peng L, 2016, MABS-AUSTIN, V8, P163, DOI 10.1080/19420862.2015.1113359; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pfleger KDG, 2008, ENDOCRINOLOGY, V149, P3118, DOI 10.1210/en.2008-0002; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Roche M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-43; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Roumen L, 2012, Drug Discov Today Technol, V9, pe281, DOI 10.1016/j.ddtec.2012.05.002; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shu HKG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079768; Shukra AM, 2014, EUR J MICROBIOL IMMU, V4, P91, DOI 10.1556/EuJMI.4.2014.2.1; Simmons DP, 2008, PROTEINS, V71, P119, DOI 10.1002/prot.21663; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Streltsov VA, 2004, P NATL ACAD SCI USA, V101, P12444, DOI 10.1073/pnas.0403509101; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Walsh R, 2011, VIROLOGY, V411, P132, DOI 10.1016/j.virol.2010.12.034; Weidle UH, 2013, CANCER GENOM PROTEOM, V10, P155; Weitzenfeld P, 2014, CANCER LETT, V352, P36, DOI 10.1016/j.canlet.2013.10.006; Wurch T, 2012, TRENDS BIOTECHNOL, V30, P575, DOI 10.1016/j.tibtech.2012.07.006; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC	75	40	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12641	12657		10.1074/jbc.M116.721050	http://dx.doi.org/10.1074/jbc.M116.721050			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27036939	hybrid, Green Published			2022-12-26	WOS:000378119900020
J	Hashimoto, A; Sato, T; Iyama, S; Yoshida, M; Ibata, S; Tatekoshi, A; Kamihara, Y; Horiguchi, H; Murase, K; Kawano, Y; Takada, K; Miyanishi, K; Kobune, M; Ichimiya, S; Kato, J				Hashimoto, Akari; Sato, Tsutomu; Iyama, Satoshi; Yoshida, Masahiro; Ibata, Soushi; Tatekoshi, Ayumi; Kamihara, Yusuke; Horiguchi, Hiroto; Murase, Kazuyuki; Kawano, Yutaka; Takada, Kohichi; Miyanishi, Koji; Kobune, Masayoshi; Ichimiya, Shingo; Kato, Junji			Narrow-Band Ultraviolet B Phototherapy Ameliorates Acute Graft-Versus-Host Disease of the Intestine by Expansion of Regulatory T Cells	PLOS ONE			English	Article							STEROID-REFRACTORY ACUTE; PITUITARY-ADRENAL AXIS; EXTRACORPOREAL PHOTOPHERESIS; ACUTE GVHD; THERAPY; UVB; TRANSPLANTATION; PREDNISONE; ANTIGENS; SOCIETY	Narrowband ultraviolet B (NB-UVB) has been widely used in dermatological phototherapy. As for the application of NB-UVB phototherapy to graft-versus-host disease (GVHD), we previously reported that it was highly efficacious for cutaneous lesions of acute GVHD (aGVHD) and that expansion of regulatory T (Treg) cells induced by NB-UVB might be one of the mechanisms. In order to examine whether NB-UVB irradiation through expansion of Treg cells is effective for the treatment of not only cutaneous aGVHD but also aGVHD of inner organs such as the intestine or liver, we conducted experiments in which a murine lethal aGVHD model, characterized by severe involvement of the intestine, was irradiated with NB-UVB. We found that NB-UVB irradiation improved the clinical score and survival rate. The pathological score of aGVHD was improved in all affected organs: intestine, liver, and skin. In the serum of mice irradiated with NB-UVB, the levels of Treg cells-associated cytokines such as transforming growth factor beta (TGF beta) and interleukin-10 (IL-10) were elevated. The numbers of infiltrating Treg cells in inflamed tissue of the intestine and those in spleen were increased in mice treated with NB-UVB. This is the first report demonstrating that NB-UVB phototherapy has the ability to ameliorate intestinal aGVHD through the expansion of Treg cells.	[Hashimoto, Akari; Sato, Tsutomu; Iyama, Satoshi; Yoshida, Masahiro; Ibata, Soushi; Tatekoshi, Ayumi; Kamihara, Yusuke; Horiguchi, Hiroto; Murase, Kazuyuki; Kawano, Yutaka; Takada, Kohichi; Miyanishi, Koji; Kobune, Masayoshi; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan; [Ichimiya, Shingo] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Human Immunol, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University	Kato, J (corresponding author), Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan.	jkato@sapmed.ac.jp	Horiguchi, Hiroto/ADC-8272-2022; Iyama, Satoshi/AAA-6237-2019	Horiguchi, Hiroto/0000-0001-6811-3042; Goto, Akari/0000-0003-2582-851X; Miyanishi, Koji/0000-0002-6466-3458	Japan Society for the Promotion of Science [25461429]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (C: 25461429 to Tsutomu Sato, Satoshi Iyama, and Yutaka Kawano) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Dalle I, 2014, BIOL BLOOD MARROW TR, V20, P1677, DOI 10.1016/j.bbmt.2014.05.017; Akiyama T, 2012, WORLD J ORTHOP, V3, P142, DOI 10.5312/wjo.v3.i9.142; Brazzelli V, 2010, BRIT J DERMATOL, V162, P404, DOI 10.1111/j.1365-2133.2009.09503.x; Christensen ME, 2010, HAEMATOL-HEMATOL J, V95, P2102, DOI 10.3324/haematol.2010.028910; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Dawe RS, 1998, BRIT J DERMATOL, V138, P833; Dickinson AM, 2008, BEST PRACT RES CL HA, V21, P149, DOI 10.1016/j.beha.2008.03.004; Dignan FL, 2012, BRIT J HAEMATOL, V158, P30, DOI 10.1111/j.1365-2141.2012.09129.x; Feldstein JV, 2011, J AM ACAD DERMATOL, V65, P733, DOI 10.1016/j.jaad.2010.08.006; Flowers MED, 2008, BLOOD, V112, P2667, DOI 10.1182/blood-2008-03-141481; Girerd S, 2013, BONE MARROW TRANSPL, V48, P1243, DOI 10.1038/bmt.2013.16; Hannani D, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00349; HINGS IM, 1993, TRANSPLANTATION, V56, P577, DOI 10.1097/00007890-199309000-00016; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Jagasia M, 2013, BIOL BLOOD MARROW TR, V19, P1129, DOI 10.1016/j.bbmt.2013.04.018; Kambham N, 2014, ADV ANAT PATHOL, V21, P301, DOI 10.1097/PAP.0000000000000032; Kaplan DH, 2004, J IMMUNOL, V173, P5467, DOI 10.4049/jimmunol.173.9.5467; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Kunisada M, 2007, J INVEST DERMATOL, V127, P2865, DOI 10.1038/sj.jid.5701001; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; MacMillan ML, 2002, BIOL BLOOD MARROW TR, V8, P387, DOI 10.1053/bbmt.2002.v8.pm12171485; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; MARTIN PJ, 1990, BLOOD, V76, P1464, DOI 10.1182/blood.V76.8.1464.1464; Mielcarek M, 2009, BLOOD, V113, P2888, DOI 10.1182/blood-2008-07-168401; Miklos S, 2008, BIOL BLOOD MARROW TR, V14, P1004, DOI 10.1016/j.bbmt.2008.06.015; Panoskaltsis-Mortari A, 2011, AM J RESP CRIT CARE, V183, P1262, DOI 10.1164/rccm.2007-413ST; Reich A, 2013, INT J MOL SCI, V14, P8456, DOI 10.3390/ijms14048456; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2016, EXP DERMATOL, V25, P120, DOI 10.1111/exd.12890; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Thompson JS, 2010, BONE MARROW TRANSPL, V45, P712, DOI 10.1038/bmt.2009.215; Treister N, 2015, PHOTODERMATOL PHOTO, V31, P75, DOI 10.1111/phpp.12141; van Leeuwen L, 2002, BONE MARROW TRANSPL, V29, P151, DOI 10.1038/sj.bmt.1703328; Van Lint MT, 1998, BLOOD, V92, P2288; vanLeeuwen L, 1997, TRANSPLANTATION, V64, P1097, DOI 10.1097/00007890-199710270-00002; Ward DM, 2011, J CLIN APHERESIS, V26, P276, DOI 10.1002/jca.20300; Wong YS, 2015, PEDIATR DERMATOL, V32, pE221, DOI 10.1111/pde.12632	47	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152823	10.1371/journal.pone.0152823	http://dx.doi.org/10.1371/journal.pone.0152823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031239	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800144
J	Richter, MJ; Milger, K; Haase, S; Sommer, N; Tello, K; Seeger, W; Mayer, E; Wiedenroth, CB; Grimminger, F; George, W; Ghofrani, HA; Guth, S; Gall, H				Richter, Manuel Jonas; Milger, Katrin; Haase, Sarah; Sommer, Natascha; Tello, Khodr; Seeger, Werner; Mayer, Eckhard; Wiedenroth, Christoph Benjamin; Grimminger, Friedrich; George, Wolfgang; Ghofrani, Hossein Ardeschir; Guth, Stefan; Gall, Henning			The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; INSULIN-RESISTANCE; ENDARTERECTOMY; DISEASE; HEART; ASSOCIATION; PREDICTORS; ADULTS	Background Glycosylated hemoglobin A1c (HbA1c) has been proposed as an independent predictor of long-term prognosis in pulmonary arterial hypertension. However, the clinical relevance of HbA1c in patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) remains unknown. The aim of the present study was to investigate the clinical significance of HbA1c as a biomarker in CTEPH. Methods Prospectively, 102 patients underwent pulmonary endarterectomy (PEA) in our national referral center between March 2013 and March 2014, of which after exclusion 45 patients were analyzed. HbA1c- levels, hemodynamic and exercise parameters were analyzed prior and one-year post-PEA. Results 45 patients (BMI: 27.3 +/- 6.0 kg/m(2); age: 62.7 +/- 12.3 years) with a mean pulmonary arterial pressure (mPAP) of 43.6 +/- 9.4 mmHg, a pulmonary vascular resistance (PVR) of 712.1 +/- 520.4 dyn*s/cm(5), a cardiac index (CI) of 2.4 +/- 0.5 l/min/m(2) and a mean HbA1c-level of 39.8 +/- 5.6 mmol/mol were included. One-year post-PEA pulmonary hemodynamic and functional status significantly improved in our cohort. Baseline HbA1c-levels were significantly associated with CI, right atrial pressure, peak oxygen uptake and the change of 6-minute walking distance using linear regression analysis. However, using logistic regression analysis baseline HbA1c-levels were not significantly associated with residual post-PEA PH. Conclusions This is the first prospective study to describe an association of HbA1c-levels with pulmonary hemodynamics and exercise capacity in operable CTEPH patients. Our preliminary results indicate that in these patients impaired glucose metabolism as assessed by HbA1c is of clinical significance. However, HbA1c failed as a predictor of the hemodynamic outcome one-year post-PEA.	[Richter, Manuel Jonas; Grimminger, Friedrich; Ghofrani, Hossein Ardeschir] Kerckhoff Heart Rheuma & Thorac Ctr, Dept Pneumol, Bad Nauheim, Germany; [Richter, Manuel Jonas; Milger, Katrin; Haase, Sarah; Sommer, Natascha; Tello, Khodr; Seeger, Werner; Grimminger, Friedrich; Ghofrani, Hossein Ardeschir; Gall, Henning] Univ Giessen, Dept Internal Med, UGMLC, Giessen, Germany; [Milger, Katrin] Univ Munich, Comprehens Pneumol Ctr, Med Clin 5, Munich, Germany; [Mayer, Eckhard; Wiedenroth, Christoph Benjamin] Kerckhoff Heart Rheuma & Thorac Ctr, Dept Thorac Surg, Bad Nauheim, Germany; [George, Wolfgang; Guth, Stefan] THM Univ Appl Sci, TransMIT Project Div Hlth Serv Res & Consulting, Giessen, Germany	Kerckhoff Clinic; Justus Liebig University Giessen; University of Munich; Kerckhoff Clinic	Richter, MJ (corresponding author), Kerckhoff Heart Rheuma & Thorac Ctr, Dept Pneumol, Bad Nauheim, Germany.; Richter, MJ (corresponding author), Univ Giessen, Dept Internal Med, UGMLC, Giessen, Germany.	manuel.richter@innere.med.uni-giessen.de	Milger, Katrin/AFI-3881-2022; Sommer, Natascha/AAD-5406-2020; Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022	Ghofrani, Ardeschir/0000-0002-2029-4419; George, Wolfgang/0000-0001-5462-7309; Sommer, Natascha/0000-0002-8915-7762; Milger, Katrin/0000-0003-2914-8773; Grimminger, Friedrich/0000-0001-8725-6276; Seeger, Werner/0000-0003-1946-0894				Abernethy AD, 2015, PULM CIRC, V5, P117, DOI 10.1086/679705; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Belly MJ, 2012, J HEART LUNG TRANSPL, V31, P1109, DOI 10.1016/j.healun.2012.08.014; Bresser Paul, 2006, Proc Am Thorac Soc, V3, P594, DOI 10.1513/pats.200605-115LR; Corsico AG, 2008, AM J RESP CRIT CARE, V178, P419, DOI 10.1164/rccm.200801-101OC; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Delcroix M, 2013, EUR RESPIR J, V41, P224, DOI 10.1183/09031936.00047712; Freed DH, 2008, EUR J CARDIO-THORAC, V34, P525, DOI 10.1016/j.ejcts.2008.04.018; Freed DH, 2011, J THORAC CARDIOV SUR, V141, P383, DOI 10.1016/j.jtcvs.2009.12.056; Gopal DM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001597; Grignola JC, 2013, WORLD J CARDIOL, V5, P18, DOI 10.4330/wjc.v5.i3.18; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Hernandez D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-151; Ishida K, 2012, J THORAC CARDIOV SUR, V144, P321, DOI 10.1016/j.jtcvs.2011.09.004; Kim NH, 2013, J AM COLL CARDIOL, V62, pD92, DOI 10.1016/j.jacc.2013.10.024; Kunihara T, 2011, EUR J CARDIO-THORAC, V40, P154, DOI 10.1016/j.ejcts.2010.10.043; Kunihara T, 2010, ANN THORAC SURG, V90, P957, DOI 10.1016/j.athoracsur.2010.05.008; Lang IM, 2013, THROMB HAEMOSTASIS, V110, P83, DOI 10.1160/TH13-02-0097; Lankeit M, 2008, EUR RESPIR J, V31, P1024, DOI 10.1183/09031936.00100407; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Lopez-Lopez JG, 2008, AM J PHYSIOL-LUNG C, V295, pL727, DOI 10.1152/ajplung.90354.2008; Mauritz GJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-5; Mayer E, 2010, EUR RESPIR REV, V19, P64, DOI 10.1183/09059180.00007409; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Poms AD, 2013, CHEST, V144, P169, DOI 10.1378/chest.11-3241; Pugh ME, 2010, INT J CLIN PRACT, V64, P5, DOI 10.1111/j.1742-1241.2010.02523.x; Pugh ME, 2011, J HEART LUNG TRANSPL, V30, P904, DOI 10.1016/j.healun.2011.02.016; Rahnavardi M, 2011, ANN THORAC CARDIOVAS, V17, P435, DOI 10.5761/atcs.oa.10.01653; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Ross RVM, 2013, AM J PHYSIOL-HEART C, V305, pH259, DOI 10.1152/ajpheart.00128.2013; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sato Masato, 2013, Ann Vasc Dis, V6, P578, DOI 10.3400/avd.oa.13-00056; Taboada D, 2014, EUR RESPIR J, V44, P1635, DOI 10.1183/09031936.00050114; Task Force for D, 2009, EUROPEAN RESP J, V34, P1219, DOI [DOI 10.1183/09031936.00139009, 10.1183/09031936.00139009]; Thistlethwaite PA, 2002, J THORAC CARDIOV SUR, V124, P1203, DOI 10.1067/mtc.2002.127313; van der Plas MN, 2010, ANN THORAC SURG, V89, P347, DOI 10.1016/j.athoracsur.2009.08.001; von Haehling S, 2010, INT J CARDIOL, V144, P206, DOI 10.1016/j.ijcard.2009.04.019; West J, 2013, EUR RESPIR J, V41, P861, DOI 10.1183/09031936.00030312; Widya RL, 2013, DIABETES CARE, V36, P457, DOI 10.2337/dc12-0474; Zabini D, 2014, EUR RESPIR J, V44, P951, DOI 10.1183/09031936.00145013; Zamanian RT, 2009, EUR RESPIR J, V33, P318, DOI 10.1183/09031936.00000508	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152580	10.1371/journal.pone.0152580	http://dx.doi.org/10.1371/journal.pone.0152580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031508	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800096
J	Santos-Pontelli, TEG; Rimoli, BP; Favoretto, DB; Mazin, SC; Truong, DQ; Leite, JP; Pontes-Neto, OM; Babyar, SR; Reding, M; Bikson, M; Edwards, DJ				Santos-Pontelli, Taiza E. G.; Rimoli, Brunna P.; Favoretto, Diandra B.; Mazin, Suleimy C.; Truong, Dennis Q.; Leite, Joao P.; Pontes-Neto, Octavio M.; Babyar, Suzanne R.; Reding, Michael; Bikson, Marom; Edwards, Dylan J.			Polarity-Dependent Misperception of Subjective Visual Vertical during and after Transcranial Direct Current Stimulation (tDCS)	PLOS ONE			English	Article							GALVANIC-VESTIBULAR STIMULATION; NONINVASIVE BRAIN-STIMULATION; MOTOR CORTEX EXCITABILITY; RANDOMIZED-TRIALS; PERCEPTION; MODULATION; NEGLECT; STROKE; LATEROPULSION; RECOVERY	Pathologic tilt of subjective visual vertical (SVV) frequently has adverse functional consequences for patients with stroke and vestibular disorders. Repetitive transcranial magnetic stimulation (rTMS) of the supramarginal gyrus can produce a transitory tilt on SVV in healthy subjects. However, the effect of transcranial direct current stimulation (tDCS) on SVV has never been systematically studied. We investigated whether bilateral tDCS over the temporal-parietal region could result in both online and offline SVV misperception in healthy subjects. In a randomized, sham-controlled, single-blind crossover pilot study, thirteen healthy subjects performed tests of SVV before, during and after the tDCS applied over the temporal- parietal region in three conditions used on different days: right anode/left cathode; right cathode/left anode; and sham. Subjects were blind to the tDCS conditions. Montage-specific current flow patterns were investigated using computational models. SVV was significantly displaced towards the anode during both active stimulation conditions when compared to sham condition. Immediately after both active conditions, there were rebound effects. Longer lasting after-effects towards the anode occurred only in the right cathode/left anode condition. Current flow models predicted the stimulation of temporal-parietal regions under the electrodes and deep clusters in the posterior limb of the internal capsule. The present findings indicate that tDCS over the temporal-parietal region can significantly alter human SVV perception. This tDCS approach may be a potential clinical tool for the treatment of SVV misperception in neurological patients.	[Santos-Pontelli, Taiza E. G.; Rimoli, Brunna P.; Favoretto, Diandra B.; Mazin, Suleimy C.; Leite, Joao P.; Pontes-Neto, Octavio M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, BR-14049 Ribeirao Preto, SP, Brazil; [Truong, Dennis Q.; Bikson, Marom] CUNY City Coll, Neural Engn Lab, Dept Biomed Engn, New York, NY 10031 USA; [Babyar, Suzanne R.; Reding, Michael; Edwards, Dylan J.] Cornell Univ, Coll Med, Burke Med Res Inst, Noninvas Brain Stimulat & Human Motor Control Lab, White Plains, NY 10605 USA; [Babyar, Suzanne R.; Reding, Michael; Edwards, Dylan J.] Cornell Univ, Dept Neurol, Weill Med Coll, New York, NY 10021 USA	Universidade de Sao Paulo; City University of New York (CUNY) System; City College of New York (CUNY); Cornell University; Cornell University	Santos-Pontelli, TEG (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, BR-14049 Ribeirao Preto, SP, Brazil.	taiza@fmrp.usp.br	Edwards, Taiza GS/F-9214-2012; Leite, Joao/B-9070-2012; Pontes-Neto, Octavio Marques/G-4294-2012	Edwards, Taiza GS/0000-0003-3033-2981; Leite, Joao/0000-0003-0558-3519; Pontes-Neto, Octavio Marques/0000-0003-0317-843X; Babyar, Suzanne/0000-0002-3367-3717; Edwards, Dylan/0000-0001-7346-3100; Favoretto, Diandra/0000-0001-6853-1914	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil; NICHD of the National Institutes of Health - USA [R01HD069776]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069776] Funding Source: NIH RePORTER	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NICHD of the National Institutes of Health - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil. DJE was supported by NICHD of the National Institutes of Health - USA, under award number R01HD069776.; This work was supported by funds from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil. DJE was supported by NICHD of the National Institutes of Health-USA, under award number R01HD069776. The authors declare no competing financial interests.	Ahmad H, 2014, J VESTIBUL RES-EQUIL, V24, P453, DOI 10.3233/VES-140530; Arshad Q, 2014, BRAIN STIMUL, V7, P85, DOI 10.1016/j.brs.2013.07.002; Baier B, 2012, NEUROLOGY, V78, P728, DOI 10.1212/WNL.0b013e318248e544; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Batuecas-Caletrio A, 2013, ACTA OTO-LARYNGOL, V133, P475, DOI 10.3109/00016489.2012.757798; Bjasch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049311; Bonan IV, 2007, J NEUROL NEUROSUR PS, V78, P49, DOI 10.1136/jnnp.2006.087791; Brandt T, 2000, NEUROREHAB NEURAL RE, V14, P1, DOI 10.1177/154596830001400101; Bronstein AM, 1999, ANN NY ACAD SCI, V871, P324, DOI 10.1111/j.1749-6632.1999.tb09195.x; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Cauquil AS, 2003, EXP BRAIN RES, V148, P414, DOI 10.1007/s00221-002-1326-z; Cocks K, 2013, J CLIN EPIDEMIOL, V66, P197, DOI 10.1016/j.jclinepi.2012.09.002; Cohen J.E., 1988, STAT POWER ANAL BEHA; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; DIETERICH M, 1993, NEUROLOGY, V43, P1732, DOI 10.1212/WNL.43.9.1732; Donaldson PH, 2015, NEUROSCI BIOBEHAV R, V55, P547, DOI 10.1016/j.neubiorev.2015.05.017; Fertonani A, 2011, J NEUROSCI, V31, P15416, DOI 10.1523/JNEUROSCI.2002-11.2011; Giglia G, 2011, BRAIN STIMUL, V4, P294, DOI 10.1016/j.brs.2011.01.003; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jones B., 2003, DESIGN ANAL CROSS OV, V2nd edn; Karnath HO, 2006, BRAIN, V129, P293, DOI 10.1093/brain/awh698; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Kerkhoff G, 1998, EXP BRAIN RES, V122, P108, DOI 10.1007/s002210050497; Kheradmand A, 2015, CEREB CORTEX, V25, P765, DOI 10.1093/cercor/bht267; Kyriakareli A, 2013, NEUROREPORT, V24, P808, DOI 10.1097/WNR.0b013e3283646e65; Laakso I, 2015, BRAIN STIMUL, V8, P906, DOI 10.1016/j.brs.2015.05.002; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lang N, 2007, INVEST OPHTH VIS SCI, V48, P5782, DOI 10.1167/iovs.07-0706; Lopez C, 2011, NEUROSCIENCE, V181, P134, DOI 10.1016/j.neuroscience.2011.02.009; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Mars F, 2001, NEUROREPORT, V12, P2991, DOI 10.1097/00001756-200109170-00047; Martin DM, 2014, EXP BRAIN RES, V232, P3345, DOI 10.1007/s00221-014-4022-x; Min KK, 2007, OTOL NEUROTOL, V28, P520, DOI 10.1097/01.mao.0000271674.41307.f2; Nasseri P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00054; Oppenlander K, 2015, NEUROPSYCHOLOGIA, V74, P178, DOI 10.1016/j.neuropsychologia.2015.03.004; Oppenlander K, 2015, NEUROPSYCHOLOGIA, V74, P170, DOI 10.1016/j.neuropsychologia.2014.10.039; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Pergolizzi D, 2015, NEUROPSYCHOLOGIA, V66, P88, DOI 10.1016/j.neuropsychologia.2014.11.012; Rohrmeier C, 2013, OTOL NEUROTOL, V34, P297, DOI 10.1097/MAO.0b013e31827d0901; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rousseaux M, 2013, NEUROLOGY, V81, P1291, DOI 10.1212/WNL.0b013e3182a823a7; Saj A, 2006, NEUROPSYCHOLOGIA, V44, P1509, DOI 10.1016/j.neuropsychologia.2005.11.018; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Shin YI, 2015, NEUROPSYCHOLOGIA, V69, P154, DOI 10.1016/j.neuropsychologia.2015.02.002; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stinear CM, 2015, BRAIN STIMUL, V8, P1183, DOI 10.1016/j.brs.2015.06.015; Sunwoo H, 2013, NEUROSCI LETT, V554, P94, DOI 10.1016/j.neulet.2013.08.064; Tazoe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114244; Truong DQ, 2013, NEUROIMAGE-CLIN, V2, P759, DOI 10.1016/j.nicl.2013.05.011; Turkeltaub PE, 2012, BRAIN STIMUL, V5, P201, DOI 10.1016/j.brs.2011.04.002; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Volkening K, 2014, NEUROSCI LETT, V581, P75, DOI 10.1016/j.neulet.2014.08.028; Wagner TA, 2004, IEEE T BIO-MED ENG, V51, P1586, DOI 10.1109/TBME.2004.827925; Yelnik AP, 2002, STROKE, V33, P2247, DOI 10.1161/01.STR.0000027212.26686.48; Zwergal A, 2009, NEUROLOGY, V72, P1689, DOI 10.1212/WNL.0b013e3181a55ecf	60	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152331	10.1371/journal.pone.0152331	http://dx.doi.org/10.1371/journal.pone.0152331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031726	Green Published, gold			2022-12-26	WOS:000373121800058
J	Sink, R; Kotnik, M; Zega, A; Barreteau, H; Gobec, S; Blanot, D; Dessen, A; Contreras-Martel, C				Sink, Roman; Kotnik, Miha; Zega, Anamarija; Barreteau, Helene; Gobec, Stanislav; Blanot, Didier; Dessen, Andrea; Contreras-Martel, Carlos			Crystallographic Study of Peptidoglycan Biosynthesis Enzyme MurD: Domain Movement Revisited	PLOS ONE			English	Article							GLUTAMIC-ACID-DERIVATIVES; ESCHERICHIA-COLI; ALANINE LIGASE; ADDING ENZYME; CONFORMATIONAL-CHANGE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; KINETIC MECHANISM; CYTOPLASMIC STEPS; D-GLU	The biosynthetic pathway of peptidoglycan, an essential component of bacterial cell wall, is a well-recognized target for antibiotic development. Peptidoglycan precursors are synthesized in the bacterial cytosol by various enzymes including the ATP-hydrolyzing Mur ligases, which catalyze the stepwise addition of amino acids to a UDP-MurNAc precursor to yield UDP-MurNAc-pentapeptide. MurD catalyzes the addition of D-glutamic acid to UDP-MurNAc-L-Ala in the presence of ATP; structural and biochemical studies have suggested the binding of the substrates with an ordered kinetic mechanism in which ligand binding inevitably closes the active site. In this work, we challenge this assumption by reporting the crystal structures of intermediate forms of MurD either in the absence of ligands or in the presence of small molecules. A detailed analysis provides insight into the events that lead to the closure of MurD and reveals that minor structural modifications contribute to major overall conformation alterations. These novel insights will be instrumental in the development of new potential antibiotics designed to target the peptidoglycan biosynthetic pathway.	[Sink, Roman; Zega, Anamarija; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Askerceva 7, Ljubljana, Slovenia; [Kotnik, Miha] Lek Pharmaceut Dd, Verovskova 57, Ljubljana, Slovenia; [Barreteau, Helene; Blanot, Didier] Univ Paris 11, Inst Biol Integrat Cellule I2BC, Lab Enveloppes Bacteriennes & Antibiot, CEA,CNRS, Gif Sur Yvette, France; [Dessen, Andrea; Contreras-Martel, Carlos] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Dessen, Andrea; Contreras-Martel, Carlos] CNRS, IBS, Grenoble, France; [Dessen, Andrea; Contreras-Martel, Carlos] CEA, IBS, Grenoble, France; [Dessen, Andrea] Brazilian Natl Lab Biosci LNBio, CNPEM, Sao Paulo, Brazil	University of Ljubljana; Novartis; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Contreras-Martel, C (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France.; Contreras-Martel, C (corresponding author), CNRS, IBS, Grenoble, France.; Contreras-Martel, C (corresponding author), CEA, IBS, Grenoble, France.	carlos.contreras-martel@ibs.fr	Contreras-Martel, Carlos/AAA-1212-2021	Dessen, Andrea/0000-0001-6487-4020; Gobec, Stanislav/0000-0002-9678-3083	European Union FP6 Integrated Project EURINTAFAR [LSHM-CT-2004-512138]; Slovenian Research Agency [L1-6745]; Proteus program [31185YL]; Institut Francais Charles Nodier; FRISBI [ANR-10-INSB-05-02]; GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	European Union FP6 Integrated Project EURINTAFAR; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Proteus program; Institut Francais Charles Nodier; FRISBI; GRAL within the Grenoble Partnership for Structural Biology (PSB)	This work was financially supported by the European Union FP6 Integrated Project EURINTAFAR (project no. LSHM-CT-2004-512138; http://www.eur-intafar.ulg.ac.be/usefulllinks/index.html); the Slovenian Research Agency (grant no. L1-6745; https://www.arrs.gov.si/en/novo.asp); the Proteus program (project 31185YL; http://www.campusfrance.org/fr/proteus) and the Institut Francais Charles Nodier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB)[Lek Pharmaceuticals d.d. http://www.lek.si]. The funder provided support in the form of salaries for MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 1996, BIOCHEMISTRY-US, V35, P16264, DOI 10.1021/bi961872+; [Anonymous], PYMOL MOL GRAPH SYST; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Barreteau H, 2012, BIOCHEM PHARMACOL, V84, P625, DOI 10.1016/j.bcp.2012.06.006; Bertrand JA, 1999, J MOL BIOL, V289, P579, DOI 10.1006/jmbi.1999.2800; Bertrand JA, 2000, J MOL BIOL, V301, P1257, DOI 10.1006/jmbi.2000.3994; Bertrand JA, 1997, EMBO J, V16, P3416, DOI 10.1093/emboj/16.12.3416; Best RB, 2006, P NATL ACAD SCI USA, V103, P10901, DOI 10.1073/pnas.0511156103; Bouhss A, 1997, BIOCHEMISTRY-US, V36, P11556, DOI 10.1021/bi970797f; Bouhss A, 2002, METHOD ENZYMOL, V354, P189; Bratkovic T, 2008, J BASIC MICROB, V48, P202, DOI 10.1002/jobm.200700133; Burra PV, 2009, P NATL ACAD SCI USA, V106, P10505, DOI 10.1073/pnas.0812152106; Buszek KR, 2007, ORG LETT, V9, P4135, DOI 10.1021/ol701595n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chopra I, 2013, J ANTIMICROB CHEMOTH, V68, P496, DOI 10.1093/jac/dks436; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Contreras-Martel C, 2009, J MOL BIOL, V387, P899, DOI 10.1016/j.jmb.2009.02.024; Dementin S, 2001, EUR J BIOCHEM, V268, P5800, DOI 10.1046/j.0014-2956.2001.02524.x; Emanuele JJ, 1997, BIOCHEMISTRY-US, V36, P7264, DOI 10.1021/bi970266r; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eveland SS, 1997, BIOCHEMISTRY-US, V36, P6223, DOI 10.1021/bi9701078; Favini-Stabile S, 2013, ENVIRON MICROBIOL, V15, P3218, DOI 10.1111/1462-2920.12171; Frlan R, 2008, MOLECULES, V13, P11, DOI 10.3390/molecules13010011; Frlan R, 2011, ACTA CHIM SLOV, V58, P295; Frlan R, 2009, ACTA CHIM SLOV, V56, P580; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hrast M, 2014, BIOORG CHEM, V55, P2, DOI 10.1016/j.bioorg.2014.03.008; Hubbard R.E., 2010, ELS; Humljan J, 2008, J MED CHEM, V51, P7486, DOI 10.1021/jm800762u; HURWITZ C, 1967, J BIOL CHEM, V242, P3719; IMHOFF JF, 1989, J GEN MICROBIOL, V135, P237; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kotnik M, 2007, J MOL BIOL, V370, P107, DOI 10.1016/j.jmb.2007.04.048; Kouidmi I, 2014, MOL MICROBIOL, V94, P242, DOI 10.1111/mmi.12758; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liger D, 1996, MICROB DRUG RESIST, V2, P25, DOI 10.1089/mdr.1996.2.25; Longenecker KL, 2005, PROTEIN SCI, V14, P3039, DOI 10.1110/ps.051604805; Macheboeuf P, 2007, NAT CHEM BIOL, V3, P565, DOI 10.1038/nchembio.2007.21; Mol CD, 2003, J BACTERIOL, V185, P4152, DOI 10.1128/JB.185.14.4152-4162.2003; Munshi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060143; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perdih A, 2007, PROTEINS, V68, P243, DOI 10.1002/prot.21374; Perdih A, 2012, COMPUT THEOR CHEM, V979, P73, DOI 10.1016/j.comptc.2011.10.018; Perdih A, 2009, BIOORG MED CHEM LETT, V19, P2668, DOI 10.1016/j.bmcl.2009.03.141; Shanmugam A, 2012, MED CHEM RES, V21, P4341, DOI 10.1007/s00044-011-9958-9; Sheng Y, 2000, J MOL BIOL, V302, P427, DOI 10.1006/jmbi.2000.3987; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Simcic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052817; Simcic M, 2009, J MED CHEM, V52, P2899, DOI 10.1021/jm900117n; Sink R, 2008, CHEMMEDCHEM, V3, P1362, DOI 10.1002/cmdc.200800087; Sink Roman, 2013, Biomol Concepts, V4, P539, DOI 10.1515/bmc-2013-0024; Smith CA, 2006, J MOL BIOL, V362, P640, DOI 10.1016/j.jmb.2006.07.066; Sosic I, 2011, EUR J MED CHEM, V46, P2880, DOI 10.1016/j.ejmech.2011.04.011; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tomasic T, 2012, ACS MED CHEM LETT, V3, P626, DOI 10.1021/ml300047h; Tomasic T, 2012, J MOL MODEL, V18, P1063, DOI 10.1007/s00894-011-1139-8; Tomasic T, 2011, EUR J MED CHEM, V46, P3964, DOI 10.1016/j.ejmech.2011.05.070; Tomasic T, 2011, J MED CHEM, V54, P4600, DOI 10.1021/jm2002525; Tomasic T, 2010, CHEMMEDCHEM, V5, P286, DOI 10.1002/cmdc.200900449; Tomasic T, 2009, BIOORG MED CHEM LETT, V19, P153, DOI 10.1016/j.bmcl.2008.10.129; Turk S, 2009, BIOORGAN MED CHEM, V17, P1884, DOI 10.1016/j.bmc.2009.01.052; Vaganay S, 1996, MICROB DRUG RESIST, V2, P51, DOI 10.1089/mdr.1996.2.51; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; Zidar N, 2011, EUR J MED CHEM, V46, P5512, DOI 10.1016/j.ejmech.2011.09.017; Zidar N, 2010, J MED CHEM, V53, P6584, DOI 10.1021/jm100285g	75	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152075	10.1371/journal.pone.0152075	http://dx.doi.org/10.1371/journal.pone.0152075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031227	Green Submitted, gold, Green Published			2022-12-26	WOS:000373121800034
J	Hua, W; Zhang, XQ; Zhu, JH; Shang, Y; Wang, JM; Jia, QJ; Zhang, QS; Yang, JM; Li, CD				Hua, Wei; Zhang, Xiao-Qi; Zhu, Jinghuan; Shang, Yi; Wang, Junmei; Jia, Qiaojun; Zhang, Qisen; Yang, Jianming; Li, Chengdao			Identification and Fine Mapping of a White Husk Gene in Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CHLOROPLAST DEVELOPMENT; CONSENSUS MAP; DART MARKERS; ORYZA-SATIVA; RICE; SSR; SEQUENCE; ENCODES; LEMMA	Barley is the only crop in the Poaceae family with adhering husks at maturity. The color of husk at barely development stage could influence the agronomic traits and malting qualities of grains. A barley mutant with a white husk was discovered from the malting barley cultivar Supi 3 and designated wh (white husk). Morphological changes and the genetics of white husk barley were investigated. Husks of the mutant were white at the heading and flowering stages but yellowed at maturity. The diastatic power and a-amino nitrogen contents also significantly increased in wh mutant. Transmission electron microscopy examination showed abnormal chloroplast development in the mutant. Genetic analysis of F-2 and BC1F1 populations developed from a cross of wh and Yangnongpi 5 (green husk) showed that the white husk was controlled by a single recessive gene (wh). The wh gene was initially mapped between 49.64 and 51.77 cM on chromosome 3H, which is syntenic with rice chromosome 1 where a white husk gene wlp1 has been isolated. The barley orthologous gene of wlp1 was sequenced from both parents and a 688 bp deletion identified in the wh mutant. We further fine-mapped the wh gene between SSR markers Bmac0067 and Bmag0508a with distances of 0.36 cM and 0.27 cM in an F-2 population with 1115 individuals of white husk. However, the wlp1 orthologous gene was mapped outside the interval. New candidate genes were identified based on the barley genome sequence.	[Hua, Wei; Zhu, Jinghuan; Shang, Yi; Wang, Junmei; Jia, Qiaojun; Yang, Jianming] Zhejiang Acad Agr Sci, Hangzhou 310021, Zhejiang, Peoples R China; [Zhang, Xiao-Qi; Li, Chengdao] Murdoch Univ, Western Barley Genet Alliance, Murdoch, WA 6150, Australia; [Zhang, Qisen] Australian Export Grain Innovat Ctr, S Perth, WA 6151, Australia	Zhejiang Academy of Agricultural Sciences; Murdoch University	Yang, JM; Li, CD (corresponding author), Zhejiang Acad Agr Sci, Hangzhou 310021, Zhejiang, Peoples R China.; Li, CD (corresponding author), Murdoch Univ, Western Barley Genet Alliance, Murdoch, WA 6150, Australia.	yangjm@mail.zaas.ac.cn; c.li@murdoch.edu.au			National Natural Science Foundation of China [31571659, 31101149]; Natural Science Foundation of Zhejiang Province [Y3110574]; Public Benefit Technology Applied Research Project of Zhejiang Province [2012C22029]; China Agriculture Research System [CARS-05]; Key Research Foundation of Science and Technology Department of Zhejiang Province of China [2012C12902-2]; Agro-scientific Research in the Public Interest [201303016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Public Benefit Technology Applied Research Project of Zhejiang Province; China Agriculture Research System; Key Research Foundation of Science and Technology Department of Zhejiang Province of China; Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China (Grant No. 31571659 and 31101149), Natural Science Foundation of Zhejiang Province (Grant No. Y3110574), Public Benefit Technology Applied Research Project of Zhejiang Province (Project No. 2012C22029), China Agriculture Research System (CARS-05), the Key Research Foundation of Science and Technology Department of Zhejiang Province of China (2012C12902-2) and Agro-scientific Research in the Public Interest (201303016).	Abebe T, 2004, CROP SCI, V44, P942, DOI 10.2135/cropsci2004.0942; AHN S, 1993, MOL GEN GENET, V241, P483, DOI 10.1007/BF00279889; Ariyadasa R, 2014, PLANT PHYSIOL, V164, P412, DOI 10.1104/pp.113.228213; AWAN MA, 1980, CROP SCI, V20, P663, DOI 10.2135/cropsci1980.0011183X002000050030x; BENNETZEN JL, 1993, TRENDS GENET, V9, P259, DOI 10.1016/0168-9525(93)90001-X; Costa JM, 2001, THEOR APPL GENET, V103, P415, DOI 10.1007/s001220100622; Duffus C. M., 1993, P31; Dunford RP, 2002, GENETICS, V161, P825; Estevez JM, 2000, PLANT PHYSIOL, V124, P95, DOI 10.1104/pp.124.1.95; Franckowiak J, 1997, REVISED LINKAGE MAPS; Franckowiak JD, 2005, BARLEY GENET NEWSLET, V35, P155; Frey-Wyssling A, 1959, PHOTOSYNTHESIS EAR B; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gerdes L, 2006, J BIOL CHEM, V281, P16632, DOI 10.1074/jbc.M513623200; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; Guevara-Garcia A, 2005, PLANT CELL, V17, P628, DOI 10.1105/tpc.104.028860; Hearnden PR, 2007, THEOR APPL GENET, V115, P383, DOI 10.1007/s00122-007-0572-7; Jia QJ, 2011, THEOR APPL GENET, V122, P1451, DOI 10.1007/s00122-011-1544-5; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li CD, 2004, FUNCT INTEGR GENOMIC, V4, P84, DOI 10.1007/s10142-004-0104-3; Li HC, 2003, CHINESE SCI BULL, V48, P457, DOI 10.1360/03tb9096; Li JZ, 2003, THEOR APPL GENET, V107, P1021, DOI 10.1007/s00122-003-1345-6; Ma XD, 2013, PLANT MOL BIOL REP, V31, P98, DOI 10.1007/s11105-012-0480-0; Mandel MA, 1996, PLANT J, V9, P649, DOI 10.1046/j.1365-313X.1996.9050649.x; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Ooijen JW, 2001, JOINMAP 3 0 SOFTWARE; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Qin D, 2015, BMC GENOMICS, V16, P1; Ramsay L, 2000, GENETICS, V156, P1997; SANCHEZ AC, 1994, J HERED, V85, P297, DOI 10.1093/oxfordjournals.jhered.a111461; Sanchez AC, 2000, PLANT BREEDING, V119, P84, DOI 10.1046/j.1439-0523.2000.00424.x; Song J, 2014, PLANT MOL BIOL, V84, P301, DOI 10.1007/s11103-013-0134-0; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Su N, 2012, PLANT PHYSIOL, V159, P227, DOI 10.1104/pp.112.195081; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Takahashi R, 1959, LINKAGE STUDY ALBINO, V11, P132; Tsuchiya T., 1980, Barley Genetics Newsletter, V10, P99; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Wang JM, 2015, THEOR APPL GENET, V128, P943, DOI 10.1007/s00122-015-2481-5; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Yi J, 2011, CHINESE J RICE SCI, V25, P461; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang J, 2006, DESCRIPTORS DATA STA; ZIEGLERJONS A, 1989, PLANTA, V178, P164, DOI 10.1007/BF00392530	46	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152128	10.1371/journal.pone.0152128	http://dx.doi.org/10.1371/journal.pone.0152128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028408	Green Published, gold			2022-12-26	WOS:000373116500036
J	Senevirathne, G; Thomas, A; Kerney, R; Hanken, J; Biju, SD; Meegaskumbura, M				Senevirathne, Gayani; Thomas, Ashish; Kerney, Ryan; Hanken, James; Biju, S. D.; Meegaskumbura, Madhava			From Clinging to Digging: The Postembryonic Skeletal Ontogeny of the Indian Purple Frog, Nasikabatrachus sahyadrensis (Anura: Nasikabatrachidae)	PLOS ONE			English	Article							AMPHIBIA; PHYLOGENY; EVOLUTION; CHONDROCRANIUM; METAMORPHOSIS; MORPHOLOGY; FAMILY	The Indian Purple frog, Nasikabatrachus sahyadrensis, occupies a basal phylogenetic position among neobatrachian anurans and has a very unusual life history. Tadpoles have a large ventral oral sucker, which they use to cling to rocks in torrents, whereas metamorphs possess adaptations for life underground. The developmental changes that underlie these shifts in habits and habitats, and especially the internal remodeling of the cranial and post-cranial skeleton, are unknown. Using a nearly complete metamorphic series from free-living larva to metamorph, we describe the postembryonic skeletal ontogeny of this ancient and unique monotypic lineage. The torrent-dwelling larva possesses a dorsoventrally flattened body and a head with tiny dorsal eyes, robust lower and upper jaw cartilages, well-developed trabecular horns, and a definable gap between the trabecular horns and the tip of the snout. Unlike tadpoles of many other frogs, those of Nasikabatrachus retain larval mouth-parts into late metamorphic stages. This unusual feature enables the larvae to maintain their clinging habit until near the end of metamorphosis. The subsequent ontogenetic shift from clinging to digging is correlated with rapid morphological changes and behavioral modifications. Metamorphs are equipped with a shortened tibiafibula and ossified prehallical elements, which likely facilitate initial digging using the hind limbs. Subsequently, the frogs may shift to headfirst burrowing by using the wedge-shaped skull, anteriorly positioned pectoral girdle, well-developed humeral crests and spatula-shaped forelimbs. The transition from an aquatic life in torrents to a terrestrial life underground entails dramatic changes in skeletal morphology and function that represent an extreme in metamorphic remodeling. Our analysis enhances the scope for detailed comparative studies across anurans, a group renowned for the diversity of its life history strategies.	[Senevirathne, Gayani; Meegaskumbura, Madhava] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka; [Thomas, Ashish; Biju, S. D.] Univ Delhi, Dept Environm Studies, Systemat Lab, Delhi 110007, India; [Kerney, Ryan] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA; [Hanken, James] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hanken, James] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Peradeniya; University of Delhi; Gettysburg College; Harvard University; Harvard University	Meegaskumbura, M (corresponding author), Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka.; Biju, SD (corresponding author), Univ Delhi, Dept Environm Studies, Systemat Lab, Delhi 110007, India.	sdbiju@es.du.ac.in; madhava88m@gmail.com	Senevirathne, Gayani/ABD-5713-2021; Meegaskumbura, Madhava/F-8782-2013; Hanken, James/S-9286-2019	Meegaskumbura, Madhava/0000-0002-4599-6724; Hanken, James/0000-0003-2782-9671; Kerney, Ryan/0000-0002-4740-7735; Senevirathne, Gayani/0000-0001-6704-9691; THOMAS, ASHISH/0000-0002-0189-7580	People Trust for Endangered Species (PTES), London; Evolutionarily Distinct and Globally Endangered species (EDGE), London; Government of India [DU/DST '2015/868']; University of Delhi RD [2007/130, 2007/858, 2008/302]; National Research Council [NRC-11-124]	People Trust for Endangered Species (PTES), London; Evolutionarily Distinct and Globally Endangered species (EDGE), London; Government of India; University of Delhi RD; National Research Council	This research was supported by grants to SDB from People Trust for Endangered Species (PTES), London, Evolutionarily Distinct and Globally Endangered species (EDGE), London, and DU/DST '2015/868,' Government of India; and University of Delhi R&D 2007/130, 2007/858, 2008/302. MM is supported by the National Research Council (NRC-11-124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo R, 2009, J MORPHOL, V270, P1431, DOI 10.1002/jmor.10768; ALTIG R, 1970, Herpetologica, V26, P180; Altig R, 1999, TADPOLES, P24; ALTIG R, 1972, Journal of Herpetology, V6, P21, DOI 10.2307/1563089; Annandale N., 1918, Records of the Indian Museum, V15; Annandale N, 1917, P ASIATIC SOC BENGAL, V13, P185; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Bossuyt Franky, 2009, P357; Cannatella D, 1999, TADPOLES, P52; Dempster WT, 1930, J MORPHOL, V50, P71, DOI 10.1002/jmor.1050500104; Duellman W. E., 1986, BIOL AMPHIBIANS; Dutta SK, 2004, CURR SCI INDIA, V86, P211; EMERSON SB, 1976, J MORPHOL, V149, P437, DOI 10.1002/jmor.1051490402; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gaige H. T., 1920, OCCAS PAP MUS ZOOL U, V84, P1; Gosner K. L., 1960, Herpetologica, V16, P183; Haas A, 2003, CLADISTICS, V19, P23, DOI 10.1111/j.1096-0031.2003.tb00405.x; HAAS A, 1995, J MORPHOL, V224, P241, DOI 10.1002/jmor.1052240302; Haas A, 1998, J MORPHOL, V238, P109, DOI 10.1002/(SICI)1097-4687(199811)238:2<109::AID-JMOR1>3.0.CO;2-#; HANKEN J, 1988, J MORPHOL, V195, P247, DOI 10.1002/jmor.1051950303; Hedges SB, 2003, NATURE, V425, P669, DOI 10.1038/425669a; LUTZ BERTHA, 1946, BOL MUS NACION RIO DE JANEIRO ZOOL, V70, P1; Maglia AM, 2007, J MORPHOL, V268, P194, DOI 10.1002/jmor.10508; Meegaskumbura M, 2015, ZOOTAXA, V3911, P245, DOI 10.11646/zootaxa.3911.2.6; METTER DE, 1967, COPEIA, P634, DOI 10.2307/1442243; NODZENSKI E, 1990, COPEIA, P1047, DOI 10.2307/1446488; Nussbaum RA, 2007, ZOOL STUD, V46, P322; Pugener LA, 2009, J MORPHOL, V270, P52, DOI 10.1002/jmor.10665; Pugener LA, 2003, ZOOL J LINN SOC-LOND, V139, P129, DOI 10.1046/j.1096-3642.2003.00075.x; Pugener LA, 1997, J MORPHOL, V233, P267, DOI 10.1002/(SICI)1097-4687(199709)233:3<267::AID-JMOR6>3.0.CO;2-0; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Raj P, 2012, ZOOTAXA, P65; Ramaswami LS, 1944, J MORPHOL, V74, P347, DOI 10.1002/jmor.1050740303; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Scott E, 2005, CLADISTICS, V21, P507, DOI 10.1111/j.1096-0031.2005.00079.x; SOKOL OM, 1981, J MORPHOL, V169, P161, DOI 10.1002/jmor.1051690204; SZARSKI H, 1957, AM NAT, V91, P283, DOI 10.1086/281990; TAYLOR W R, 1985, Cybium, V9, P107; Thomas A, 2015, SALAMANDRA, V51, P252; Thomas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084809; Trueb L., 1973, P65; TRUEB L, 1983, J ZOOL, V199, P189; Wake Marvalee H., 1993, P197; WASSERSUG RJ, 1982, EVOL BIOL, V15, P223; WASSERSUG RJ, 1979, BIOL J LINN SOC, V12, P225, DOI 10.1111/j.1095-8312.1979.tb00056.x; WASSERSUG RJ, 1977, ECOLOGY, V58, P830, DOI 10.2307/1936218; Zachariah A, 2012, ZOOTAXA, P53; ZUG GR, 1972, COPEIA, P613, DOI 10.2307/1442720	48	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151114	10.1371/journal.pone.0151114	http://dx.doi.org/10.1371/journal.pone.0151114			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028113	Green Published, gold			2022-12-26	WOS:000373116500017
J	Terada, M; Seki, M; Takahashi, R; Yamada, S; Higashibata, A; Majima, HJ; Sudoh, M; Mukai, C; Ishioka, N				Terada, Masahiro; Seki, Masaya; Takahashi, Rika; Yamada, Shin; Higashibata, Akira; Majima, Hideyuki J.; Sudoh, Masamichi; Mukai, Chiaki; Ishioka, Noriaki			Effects of a Closed Space Environment on Gene Expression in Hair Follicles of Astronauts in the International Space Station	PLOS ONE			English	Article							STEM; SPACEFLIGHT; MERCURY; INCREASES; INDUCE; TISSUE; PHASE; PART; RNA	Adaptation to the space environment can sometimes pose physiological problems to International Space Station (ISS) astronauts after their return to earth. Therefore, it is important to develop healthcare technologies for astronauts. In this study, we examined the feasibility of using hair follicles, a readily obtained sample, to assess gene expression changes in response to spaceflight adaptation. In order to investigate the gene expression changes in human hair follicles during spaceflight, hair follicles of 10 astronauts were analyzed by microarray and real time qPCR analyses. We found that spaceflight alters human hair follicle gene expression. The degree of changes in gene expression was found to vary among individuals. In some astronauts, genes related to hair growth such as FGF18, ANGPTL7 and COMP were upregulated during flight, suggesting that spaceflight inhibits cell proliferation in hair follicles.	[Terada, Masahiro; Sudoh, Masamichi] Jikei Univ, Sch Med, Div Aerosp Med, Minato Ku, Tokyo, Japan; [Terada, Masahiro; Yamada, Shin; Higashibata, Akira; Sudoh, Masamichi; Mukai, Chiaki; Ishioka, Noriaki] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki, Japan; [Terada, Masahiro] NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA; [Seki, Masaya; Takahashi, Rika] Adv Engn Serv Co Ltd, Tsukuba, Ibaraki, Japan; [Higashibata, Akira; Majima, Hideyuki J.; Ishioka, Noriaki] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Kagoshima 890, Japan; [Ishioka, Noriaki] Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 229, Japan; [Ishioka, Noriaki] SOKENDAI, Sch Phys Sci, Dept Space & Astronaut Sci, Sagamihara, Kanagawa, Japan	Jikei University; Japan Aerospace Exploration Agency (JAXA); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Advanced Engineering Services Co., Ltd. (A.E.S.); Kagoshima University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Terada, M (corresponding author), Jikei Univ, Sch Med, Div Aerosp Med, Minato Ku, Tokyo, Japan.; Terada, M (corresponding author), Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki, Japan.; Terada, M (corresponding author), NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA.	terada.masahiro@jikei.ac.jp	Majima, Hideyuki J./K-3778-2019		Japan Aerospace Exploration Agency (JAXA); Advanced Engineering Services Co., Ltd.	Japan Aerospace Exploration Agency (JAXA); Advanced Engineering Services Co., Ltd.	The experimental cost for this study was funded by Japan Aerospace Exploration Agency (JAXA). Advanced Engineering Services Co., Ltd. provided support in the form of salaries for authors MS (2nd author) and RT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn SY, 2012, ANN DERMATOL, V24, P26, DOI 10.5021/ad.2012.24.1.26; Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; BATZEVICH VA, 1995, SCI TOTAL ENVIRON, V164, P89, DOI 10.1016/0048-9697(95)91020-4; CHASE ES, 1981, AM J CLIN NUTR, V34, P2280, DOI 10.1093/ajcn/34.10.2280; Chuong C-M, 1998, MOL BASIC EPITHELIAL; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; de Schellenberger AA, 2011, EXP DERMATOL, V20, P361, DOI 10.1111/j.1600-0625.2010.01217.x; Dev H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-121; Donati G, 2014, P NATL ACAD SCI USA, V111, pE1501, DOI 10.1073/pnas.1312880111; GREENLEAF JE, 1989, J APPL PHYSIOL, V67, P2191, DOI 10.1152/jappl.1989.67.6.2191; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Harada M, 1999, SCI TOTAL ENVIRON, V227, P249, DOI 10.1016/S0048-9697(99)00031-5; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Jelliffe DB, 1966, MONOGR SER WHO, V53, P3; Kim SJ, 2006, ANN CLIN LAB SCI, V36, P115; Kimura-Ueki M, 2012, J INVEST DERMATOL, V132, P1338, DOI 10.1038/jid.2011.490; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Lei X, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-014-0147-z; Leishman E, 2013, DEVELOPMENT, V140, P3809, DOI 10.1242/dev.097477; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Mao XW, 2014, FREE RADICAL RES, V48, P890, DOI 10.3109/10715762.2014.920086; Mash DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001187; Mirkina I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084417; Neutelings T, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.2; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Rodushkin I, 2000, SCI TOTAL ENVIRON, V250, P83, DOI 10.1016/S0048-9697(00)00369-7; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sato T, 2006, J VET MED SCI, V68, P503, DOI 10.1292/jvms.68.503; Schatten H, 2001, ACTA ASTRONAUT, V49, P399, DOI 10.1016/S0094-5765(01)00116-3; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SEKIGUCHI C, 1994, ACTA PHYSIOL SCAND, V150, P89; SPERLING LC, 1991, J AM ACAD DERMATOL, V25, P1, DOI 10.1016/0190-9622(91)70167-Z; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; SUZUKI T, 1993, ARCH ENVIRON HEALTH, V48, P221, DOI 10.1080/00039896.1993.9940363; Terada M, 2012, ACTA ASTRONAUT, V73, P23, DOI 10.1016/j.actaastro.2011.12.016; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; WIBOWO AAE, 1986, ENVIRON RES, V40, P346, DOI 10.1016/S0013-9351(86)80109-8; Wu GJ, 2008, MOL CANCER RES, V6, P1666, DOI 10.1158/1541-7786.MCR-07-2200; Xiao YR, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0102-4; Xu XW, 2003, AM J PATHOL, V163, P969, DOI 10.1016/S0002-9440(10)63456-6; Yamamoto N, 2015, CHRONOBIOL INT, V32, P327, DOI 10.3109/07420528.2014.979940; Yasuda H., 2005, BIOMED RES TRACE ELE, V16, P39; Yasutake A, 2003, TOHOKU J EXP MED, V199, P161, DOI 10.1620/tjem.199.161; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Zhang WF, 2015, J VIROL, V89, P2553, DOI 10.1128/JVI.02269-14	51	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150801	10.1371/journal.pone.0150801	http://dx.doi.org/10.1371/journal.pone.0150801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029003	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500009
J	Sharma, BB; Kalia, P; Yadava, DK; Singh, D; Sharma, TR				Sharma, Brij Bihari; Kalia, Pritam; Yadava, Devendra Kumar; Singh, Dinesh; Sharma, Tilak Raj			Genetics and Molecular Mapping of Black Rot Resistance Locus Xca1bc on Chromosome B-7 in Ethiopian Mustard (Brassica carinata A. Braun)	PLOS ONE			English	Article							CAMPESTRIS PV. CAMPESTRIS; QUANTITATIVE TRAIT LOCI; LINKAGE MAP; MARKERS; INHERITANCE; CRUCIFERS; JUNCEA; TRANSFERABILITY; POLYMORPHISMS; OLERACEA	Black rot caused by Xanthomonas campestris pv. campestris (Pam.) Dowson is the most destructive disease of cauliflower causing huge loss to the farmers throughout the world. Since there are limited sources of resistance to black rot in B. oleracea (C genome Brassica), exploration of A and B genomes of Brassica was planned as these were thought to be potential reservoirs of black rot resistance gene(s). In our search for new gene(s) for black rot resistance, F-2 mapping population was developed in Brassica carinata (BBCC) by crossing NPC-17, a susceptible genotype with NPC-9, a resistant genotype. Out of 364 Intron length polymorphic markers and microsatellite primers used in this study, 41 distinguished the parental lines. However, resistant and susceptible bulks could be distinguished by three markers At1g70610, SSR Na14-G02 and At1g71865 which were used for genotyping of F2 mapping population. These markers were placed along the resistance gene, according to order, covering a distance of 36.30 cM. Intron length polymorphic markers At1g70610 and At1g71865 were found to be linked to black rot resistance locus (Xca1bc) at 6.2 and 12.8 cM distance, respectively. This is the first report of identification of markers linked to Xca1bc locus in Brassica carinata on B-7 linkage group. Intron length polymorphic markers provided a novel and attractive option for marker assisted selection due to high cross transferability and cost effectiveness for marker assisted alien gene introgression into cauliflower.	[Sharma, Brij Bihari; Kalia, Pritam] ICAR Indian Agr Res Inst, Div Vegetable Sci, New Delhi, India; [Yadava, Devendra Kumar] ICAR Indian Agr Res Inst, Div Seed Sci & Technol, New Delhi, India; [Singh, Dinesh] ICAR Indian Agr Res Inst, Div Plant Pathol, New Delhi, India; [Sharma, Tilak Raj] ICAR Natl Res Ctr Plant Biotechnol, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Kalia, P (corresponding author), ICAR Indian Agr Res Inst, Div Vegetable Sci, New Delhi, India.	pritam.kalia@gmail.com	Yadava, Devendra K/ABG-6470-2021; Kalia, Pritam/ABE-4790-2021		Department of Science and Technology, Ministry of Science and Technology, Govt. of India New Delhi [IF10432]	Department of Science and Technology, Ministry of Science and Technology, Govt. of India New Delhi(Department of Science & Technology (India))	Brij Bihari Sharma is grateful to the Department of Science and Technology, Ministry of Science and Technology, Govt. of India New Delhi, for providing INSPIRE Fellowship, Grant Number IF10432, http://inspire-dst.gov.in/Final_Offer.pdf.	Artemyeva AM, 2013, ACTA HORTIC, V1005, P105; Becker A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015993; Bisht DS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0225-5; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CAMARGO LEA, 1995, PHYTOPATHOLOGY, V85, P1296, DOI 10.1094/Phyto-85-1296; COOK AA, 1952, PHYTOPATHOLOGY, V42, P162; Enjalbert JN, 2013, IND CROP PROD, V47, P176, DOI 10.1016/j.indcrop.2013.02.037; GUO H, 1991, HORTSCIENCE, V26, P1545, DOI 10.21273/HORTSCI.26.12.1545; Guo SM, 2012, THEOR APPL GENET, V125, P1113, DOI 10.1007/s00122-012-1898-3; Gupta SK, 2012, MOL BREEDING, V30, P1363, DOI 10.1007/s11032-012-9722-y; Gupta S, 2011, GENOME, V54, P586, DOI [10.1139/G11-020, 10.1139/g11-020]; Hayward A. C., 1993, Xanthomonas., P1; Ignatov A. N., 2000, Genetika, V36, P357; KAPOOR KS, 1985, PHYTOPATHOL Z, V112, P191; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pan X, 2012, CAN J PLANT SCI, V92, P961, DOI [10.4141/CJPS2011-169, 10.4141/cjps2011-169]; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Panse VG, 1967, STAT METHODS AGR WOR; Ramchiary N, 2007, THEOR APPL GENET, V115, P807, DOI 10.1007/s00122-007-0610-5; Rimmer SR, 2006, CAN J PLANT PATHOL, V28, pS288, DOI 10.1080/07060660609507386; Saha P, 2016, EUPHYTICA, V207, P35, DOI 10.1007/s10681-015-1524-y; Saha P, 2014, PLANT BREEDING, V133, P268, DOI 10.1111/pbr.12152; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Singh D, 2016, PLANT PATHOL, V65, P1411, DOI 10.1111/ppa.12508; Singh D, 2011, CURR MICROBIOL, V63, P551, DOI 10.1007/s00284-011-0024-0; Soengas P, 2007, THEOR APPL GENET, V114, P637, DOI 10.1007/s00122-006-0464-2; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Taylor JD, 2002, PHYTOPATHOLOGY, V92, P105, DOI 10.1094/PHYTO.2002.92.1.105; Tonguc M, 2003, EUPHYTICA, V134, P269, DOI 10.1023/B:EUPH.0000004947.37512.92; Tonu N. N., 2013, American Journal of Plant Sciences, V4, P11; Vicente JG, 2002, PHYTOPATHOLOGY, V92, P1134, DOI 10.1094/PHYTO.2002.92.10.1134; Vicente JG, 2013, MOL PLANT PATHOL, V14, P2, DOI 10.1111/j.1364-3703.2012.00833.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang XS, 2005, DNA RES, V12, P417, DOI 10.1093/dnares/dsi019; Wang YY, 2010, THEOR APPL GENET, V121, P1199, DOI 10.1007/s00122-010-1381-y; Warwick SI, 2011, PLANT GENET GENOMICS, V9, P33, DOI 10.1007/978-1-4419-7118-0_2; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Westman AL, 1999, EUPHYTICA, V106, P253, DOI 10.1023/A:1003544025146; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Williams P. H., 1980, Plant Disease, V64, P736, DOI 10.1094/PD-64-736; WILLIAMS PH, 1972, PHYTOPATHOLOGY, V62, P247, DOI 10.1094/Phyto-62-247; Yadava DK, 2009, J PLANT BIOCHEM BIOT, V18, P29, DOI 10.1007/BF03263292; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151; Zou J, 2014, THEOR APPL GENET, V127, P1593, DOI 10.1007/s00122-014-2321-z	47	29	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152290	10.1371/journal.pone.0152290	http://dx.doi.org/10.1371/journal.pone.0152290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023128	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900040
J	Henning, J; Pfeiffer, DU; Stevenson, M; Yulianto, D; Priyono, W; Meers, J				Henning, Joerg; Pfeiffer, Dirk U.; Stevenson, Mark; Yulianto, Didik; Priyono, Walujo; Meers, Joanne			Who Is Spreading Avian Influenza in the Moving Duck Flock Farming Network of Indonesia?	PLOS ONE			English	Article							DOMESTIC DUCKS; VIRUSES; PERSISTENCE; MANAGEMENT; DYNAMICS	Duck populations are considered to be a reservoir of Highly pathogenic avian influenza (HPAI) virus H5N1 in some agricultural production systems, as they are able to shed the virus for several days without clinical signs. Countries endemically affected with HPAI in Asia are characterised by production systems where ducks are fed on post-harvest spilled rice. During this scavenging process it is common for ducks to come into contact with other duck flocks or wild birds, thereby providing opportunities for virus spread. Effective risk management for HPAI has been significantly compromised by a limited understanding of management of moving duck flocks in these countries, despite of a small number of recent investigations. Here, for the first time, we described the management of moving duck flocks and the structure of the moving duck flock network in quantitative terms so that factors influencing the risk of HPAIV transmission can be identified. By following moving duck flock farmers over a period of 6 months in Java, Indonesia, we were able to describe the movement of flocks and to characterise the network of various types of actors associated with the production system. We used these data to estimate the basic reproductive number for HPAI virus spread. Our results suggest that focussing HPAI prevention measures on duck flocks alone will not be sufficient. Instead, the role of transporters of moving duck flocks, hatcheries and rice paddy owners, in the spread of the HPAI virus needs to be recognised.	[Henning, Joerg; Meers, Joanne] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Pfeiffer, Dirk U.] Univ London, Royal Vet Coll, London, England; [Stevenson, Mark] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3052, Australia; [Yulianto, Didik; Priyono, Walujo] Dis Invest Ctr, Wates, Indonesia	University of Queensland; University of London; University of London Royal Veterinary College; University of Melbourne	Henning, J (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	j.henning@uq.edu.au	Pfeiffer, Dirk U/C-5002-2009; Henning, Joerg/G-8662-2017	Pfeiffer, Dirk U/0000-0001-7000-0530; Henning, Joerg/0000-0002-0282-1318; Stevenson, Mark/0000-0003-1890-9784	Australian Centre for Agriculture Research [AH/2004/040]	Australian Centre for Agriculture Research	Funding for this project was provided by the Australian Centre for Agriculture Research (project no. AH/2004/040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Catley A, 2000, REV SCI TECH OIE, V19, P702, DOI 10.20506/rst.19.3.1239; CIVAS, 2006, REV FREE RANG DUCK F; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; FAO, 2003, TECHNICAL REPORT; FAO, 2013, FAO EM CTR TRANSB AN; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Fournie G, 2013, P NATL ACAD SCI USA, V110, P9177, DOI 10.1073/pnas.1220815110; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Guan Y, 2012, NATURE, V483, P535, DOI 10.1038/483535a; Hannemann RA, 2005, INTRO SOCIAL NETWORK; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henning J, 2012, WORLD POULTRY SCI J, V68, P513, DOI 10.1017/S004393391200061X; Henning J, 2009, P INT SOC VET EP EC, P30; Horm VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034160; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Idris S, 2010, RURAL DEV RES CONSOR, V33; Knoke D., 2008, BASIC METHODS ANAL N, P46; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; OIE, 2014, MAN DIAGN TESTS VACC; Saenz RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045059; Songserm T., 2006, OIE/FAO international scientific conference on avian influenza, Paris, France, 7-8 April, 2005, P254; Songserm T, 2006, EMERG INFECT DIS, V12, P575, DOI 10.3201/eid1204.051614; Ssematimba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040929; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Thomas JC, 2001, EPIDEMIOLOGIC METHOD; Trinidad L, 2007, AL037R; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WHO, 2015, CUM NUMB CONF HUM CA; Wibawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083417; Wu P, 2014, EMERG INFECT DIS, V20, P1891, DOI 10.3201/eid2011.140556	35	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152123	10.1371/journal.pone.0152123	http://dx.doi.org/10.1371/journal.pone.0152123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019344	Green Accepted, Green Published, gold			2022-12-26	WOS:000372807800029
J	Qiao, Q; Grandy, S; Hiller, J; Kostev, K				Qiao, Qing; Grandy, Susan; Hiller, Josh; Kostev, Karel			Clinical and Patient-Related Variables Associated with Initiating GLP-1 Receptor Agonist Therapy in Type 2 Diabetes Patients in Primary Care in Germany	PLOS ONE			English	Article							MANAGEMENT; INSULIN; EFFICACY; DATABASE	Aims To investigate real-world clinical and patient-related variables associated with initiating GLP-1 receptor agonist (GLP-1RA) treatment relative to initiation of other glucose-lowering therapies in type 2 diabetes (T2D) patients of primary care in Germany. Methods Data for 938 T2D patients who started therapy with a GLP-1RA within 823 practices of primary care throughout Germany were retrospectively analyzed (Disease Analyser: 01/2011-03/2014). 5,197 T2D patients who initiated other non-GLP-1RA antidiabetic therapies were selected as controls. Multivariate logistic regression analyses were applied to identify factors associated with GLP-1RA initiation in primary care. Results Mean age (SD) of GLP-1RA users was 57.8 (11.8) years (males: 55.5%) and the average BMI was 36.1 (6.7) kg/m2. 22.8% were in diabetologist care and 12.0% had private health insurance. In multivariate regression, choice of GLP-1RA therapy instead of a different glucose-lowering drug class was associated with obesity (odds ratio: 1.68; 95% CI: 1.34-2.10), private health insurance (2.42; 1.89-3.09), younger age (0.94; 0.93-0.95 per year), male sex (0.85; 0.73-0.99), diabetologist care (2.11; 1.73-2.57), and geographic practice location (East vs. West-Germany; 1.25; 1.05-1.49). Among co-medication, angiotensin II antagonists (increased) and non-steroidal antirheumatic agents (decreased) were related to GLP-1RA prescriptions (both p<0.001). Conclusions Consistent with German guidelines, GLP-1RA is mainly prescribed preferentially in T2D patients who are obese. GLP-1RA drugs were more frequently used than other options in privately health insured patients and in patients seeing a diabetologist.	[Qiao, Qing] AstraZeneca, Global Med Dev, Molndal, Sweden; [Grandy, Susan] AstraZeneca, Global Med Dev, Gaithersburg, MD USA; [Hiller, Josh] IMS Hlth, Real World Evidence Solut, London, England; [Kostev, Karel] IMS Hlth, Epidemiol, Frankfurt, Germany	AstraZeneca; AstraZeneca	Kostev, K (corresponding author), IMS Hlth, Epidemiol, Frankfurt, Germany.	kkostev@de.imshealth.com	Kostev, Karel/S-4755-2019	Kostev, Karel/0000-0002-2124-7227	Astrazeneca; IMS Health	Astrazeneca(AstraZeneca); IMS Health	Astrazeneca provided support in the form of salaries for authors [QQ, SG]. IMS Health provided support in the form of salaries for authors [KK, JH]. IMS Health as well as Astrazeneca played roles in study design, manuscript preparation, and the decision to publish this study. The funders had no role in data collection and analysis.	[Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Becher H, 2009, INT J CLIN PHARM TH, V47, P617; Bundesarztekammer (BAK) Kassenarztliche Bundesvereinigung (KBV) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), 2013, NAT VERS THER TYP 2; Busse R, 2004, HEALTH AFFAIR, V23, P56, DOI 10.1377/hlthaff.23.3.56; Busse R, 2014, HEALT SYST TRANSIT, V16, P1; Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0; Fabunmi R, 2009, CURR MED RES OPIN, V25, P777, DOI [10.1185/03007990802715199, 10.1185/03007990802715199 ]; Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231; Hall GC, 2013, DIABETIC MED, V30, P681, DOI 10.1111/dme.12137; Hirsch IB, 2011, ENDOCR PRACT, V17, P707, DOI 10.4158/EP11014.OR; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Matthaei Stephan, 2012, Diabetes Ther, V3, P6, DOI 10.1007/s13300-012-0006-7; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rathmann W, 2015, PRIM CARE DIABETES; Swart E, 2015, GESUNDHEITSWESEN, V77, P120, DOI [10.1055/s-0034-1396815, 10.1055/s-0035-1562981]; Tamayo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099773; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771	17	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152281	10.1371/journal.pone.0152281	http://dx.doi.org/10.1371/journal.pone.0152281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019360	Green Published, Green Submitted, gold			2022-12-26	WOS:000372807800038
J	Wu, TF; Xie, C; Han, J; Ye, YJ; Singh, S; Zhou, JC; Li, YJ; Ding, HH; Li, QZ; Zhou, X; Putterman, C; Saxena, R; Mohan, C				Wu, Tianfu; Xie, Chun; Han, Jie; Ye, Yujin; Singh, Sandeep; Zhou, Jinchun; Li, Yajuan; Ding, Huihua; Li, Quan-zhen; Zhou, Xin; Putterman, Chaim; Saxena, Ramesh; Mohan, Chandra			Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; TERM-FOLLOW-UP; RENAL INVOLVEMENT; IMMUNOSUPPRESSIVE THERAPY; PROGNOSTIC-FACTORS; MESSENGER-RNAS; UNITED-STATES; FACTOR SYSTEM; ERYTHEMATOSUS; KIDNEY	Kidney biopsy remains the mainstay of Lupus Nephritis (LN) diagnosis and prognostication. The objective of this study is to identify non-invasive biomarkers that closely parallel renal pathology in LN. Previous reports have demonstrated that serum Insulin-like growth factor binding protein 4 (IGFBP-4) was increased in diabetic nephropathy in both animal models and patients. We proceeded to assess if IGFBP4 could be associated with LN. We performed ELISA using the serum of 86 patients with LN. Normal healthy adults (N = 23) and patients with other glomerular diseases (N = 20) served as controls. Compared to the healthy controls or other glomerular disease controls, serum IGFBP-4 levels were significantly higher in the patients with LN. Serum IGFBP-4 did not correlate well with systemic lupus erythematosus disease activity index (SLEDAI), renal SLEDAI or proteinuria, but it did correlate with estimated glomerular filtration rate (R = 0.609, P < 0.0001). Interestingly, in 18 patients with proliferative LN whose blood samples were obtained at the time of renal biopsy, serum IGFBP-4 levels correlated strongly with the chronicity index of renal pathology (R = 0.713, P < 0.001). IGFBP-4 emerges a potential marker of lupus nephritis, reflective of renal pathology chronicity changes.	[Wu, Tianfu; Ding, Huihua; Mohan, Chandra] Univ Houston, Dept Biomed Engn, Houston, TX USA; [Xie, Chun; Han, Jie; Ye, Yujin; Saxena, Ramesh] Univ Texas SW Med Ctr Dallas, Div Rheumatol, Dallas, TX 75390 USA; [Xie, Chun; Singh, Sandeep] Univ Texas SW Med Ctr Dallas, Div Nephrol, Dallas, TX 75390 USA; [Zhou, Jinchun; Li, Yajuan; Li, Quan-zhen] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Zhou, Xin] Baylor Univ, Med Ctr Dallas, Dallas, TX USA; [Putterman, Chaim] Albert Einstein Coll Med, Div Rheumatol, Bronx, NY 10467 USA	University of Houston System; University of Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center; Yeshiva University; Albert Einstein College of Medicine	Mohan, C (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX USA.	cmohan@central.uh.edu	Putterman, Chaim/AFR-0429-2022; Ding, Huihua/H-7768-2019; Wu, Tianfu/G-6672-2019; Mohan, Chandra/GPX-8233-2022	Ding, Huihua/0000-0002-7530-8953; Wu, Tianfu/0000-0003-4406-1449	NIH [R01 DK 081872]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081872] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant R01 DK 081872.	APPEL GB, 1978, MEDICINE, V57, P371, DOI 10.1097/00005792-197809000-00001; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; AUSTIN HA, 1983, AM J MED, V75, P382, DOI 10.1016/0002-9343(83)90338-8; Avihingsanon Y, 2006, KIDNEY INT, V69, P747, DOI 10.1038/sj.ki.5000132; Bajaj S, 2000, J RHEUMATOL, V27, P2822; Christopher-Stine L, 2007, J RHEUMATOL, V34, P332; Contreras G, 2005, LUPUS, V14, P890, DOI 10.1191/0961203305lu2238oa; Cross J, 2005, BEST PRACT RES CL RH, V19, P785, DOI 10.1016/j.berh.2005.05.005; do Nascimento AP, 2006, ARTHRITIS RHEUM-US, V54, P1568, DOI 10.1002/art.21875; El Hachmi M, 2003, LUPUS, V12, P692, DOI 10.1191/0961203303lu444oa; Faurschou M, 2006, J RHEUMATOL, V33, P1563; Fiehn C, 2003, ANN RHEUM DIS, V62, P435, DOI 10.1136/ard.62.5.435; Gladman DD, 2000, J RHEUMATOL, V27, P373; GOLBUS J, 1994, RHEUM DIS CLIN N AM, V20, P213; Houssiau FA, 2004, ARTHRITIS RHEUM-US, V50, P3934, DOI 10.1002/art.20666; Houssiau FA, 2004, J AM SOC NEPHROL, V15, P2694, DOI 10.1097/01.ASN.0000140218.77174.0A; Huong DLT, 1999, MEDICINE, V78, P148; Illei GG, 2002, ARTHRITIS RHEUM, V46, P995, DOI 10.1002/art.10142; Jehle PM, 2000, KIDNEY INT, V57, P423, DOI 10.1046/j.1523-1755.2000.00862.x; Korbet SM, 2000, AM J KIDNEY DIS, V35, P904, DOI 10.1016/S0272-6386(00)70262-9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LindenberghKortleve DJ, 1997, MOL CELL ENDOCRINOL, V132, P81, DOI 10.1016/S0303-7207(97)00123-8; Manoharan A, 2010, RHEUM DIS CLIN N AM, V36, P131, DOI 10.1016/j.rdc.2009.12.009; Marks SD, 2008, NEPHROL DIAL TRANSPL, V23, P3521, DOI 10.1093/ndt/gfn270; MATSELL DG, 1994, KIDNEY INT, V46, P1031, DOI 10.1038/ki.1994.364; Mazerbourg S, 2004, GROWTH HORM IGF RES, V14, P71, DOI 10.1016/j.ghir.2003.10.002; Moroni G, 1999, AM J KIDNEY DIS, V34, P530, DOI 10.1016/S0272-6386(99)70082-X; Moroni G, 1996, KIDNEY INT, V50, P2047, DOI 10.1038/ki.1996.528; Moroni G, 2007, NEPHROL DIAL TRANSPL, V22, P2531, DOI 10.1093/ndt/gfm245; Mosca M, 1997, LUPUS, V6, P371, DOI 10.1177/096120339700600405; Nakayamada S, 2007, ARTHRITIS RHEUM, V56, P1559, DOI 10.1002/art.22581; Oates JC, 2005, KIDNEY INT, V68, P2588, DOI 10.1111/j.1523-1755.2005.00730.x; Oates JC, 2008, ARTHRITIS RHEUM, V58, P263, DOI 10.1002/art.23153; PRICE GJ, 1995, KIDNEY INT, V48, P402, DOI 10.1038/ki.1995.308; Reich HN, 2011, J MOL DIAGN, V13, P143, DOI 10.1016/j.jmoldx.2010.10.005; Reyes-Thomas J, 2011, CLIN REV ALLERG IMMU, V40, P138, DOI 10.1007/s12016-010-8197-z; Rovin BH, 2009, CLIN J AM SOC NEPHRO, V4, P1858, DOI 10.2215/CJN.03530509; Singh S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3912; Snyder JJ, 2009, AM J KIDNEY DIS, V53, P218, DOI 10.1053/j.ajkd.2008.07.034; Ulinski T, 2000, PEDIATR NEPHROL, V14, P589, DOI 10.1007/s004670000361; van Doorn J, 2001, CLIN ENDOCRINOL, V54, P655, DOI 10.1046/j.1365-2265.2001.01248.x; Wakasugi D, 2012, J RHEUMATOL, V39, P79, DOI 10.3899/jrheum.110532; Ward MM, 2009, J RHEUMATOL, V36, P63, DOI 10.3899/jrheum.080625; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wu TF, 2007, ARTHRITIS RHEUM-US, V56, P949, DOI 10.1002/art.22556; Wu TF, 2013, MOL CELL PROTEOMICS, V12, P1170, DOI 10.1074/mcp.M112.021667; Wu TF, 2010, J IMMUNOL, V184, P2183, DOI 10.4049/jimmunol.0900292; Zhou R, 2003, J ENDOCRINOL, V178, P177, DOI 10.1677/joe.0.1780177	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151491	10.1371/journal.pone.0151491	http://dx.doi.org/10.1371/journal.pone.0151491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019456	Green Published, gold			2022-12-26	WOS:000372807800014
J	Zheng, XJ; Li, YQ; Zhao, JL; Wang, DY; Xia, HB; Mao, QW				Zheng, Xiaojing; Li, Yanqing; Zhao, Junli; Wang, Dongyang; Xia, Haibin; Mao, Qinwen			Production and Characterization of Monoclonal Antibodies against Human Nuclear Protein FAM76B	PLOS ONE			English	Article							REGIONS	Human FAM76B (hFAM76B) is a 39 kDa protein that contains homopolymeric histidine tracts, a targeting signal for nuclear speckles. FAM76B is highly conserved among different species, suggesting that it may play an important physiological role in normal cellular functions. However, a lack of appropriate tools has hampered study of this potentially important protein. To facilitate research into the biological function(s) of FAM76B, murine monoclonal antibodies (MAbs) against hFAM76B were generated by using purified, prokaryotically expressed hFAM76B protein. Six strains of MAbs specific for hFAM76B were obtained and characterized. The specificity of MAbs was validated by using FAM76B(-/-) HEK 293 cell line. Double immunofluorescence followed by laser confocal microscopy confirmed the nuclear speckle localization of hFAM76B, and the specific domains recognized by different MAbs were further elucidated by Western blot. Due to the high conservation of protein sequences between mouse and human FAM76B, MAbs against hFAM76B were shown to react with mouse FAM76B (mFAM76B) specifically. Lastly, FAM76B was found to be expressed in the normal tissues of most human organs, though to different extents. The MAbs produced in this study should provide a useful tool for investigating the biological function(s) of FAM76B.	[Zheng, Xiaojing; Li, Yanqing; Zhao, Junli; Wang, Dongyang; Xia, Haibin] Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Regions Sustainable Dev, Xian 710062, Shaanxi, Peoples R China; [Mao, Qinwen] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Shaanxi Normal University; Northwestern University; Feinberg School of Medicine	Xia, HB (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Regions Sustainable Dev, Xian 710062, Shaanxi, Peoples R China.	hbxia2001@163.com		Mao, Qinwen/0000-0001-7876-2046	Fundamental Research Funds for the Central Universities of Shaanxi Normal University [2010ZYGX015]; Fundamental Research Funds for the Central Universities [GK201301010]; National Natural Science Foundation of China [81272543, 81471772, 81301957]; Key Program of the Natural Science Foundation of Shaanxi Province, China [2014JZ005]; Natural Science Foundation of Shaanxi Province, China [2014JM4113]	Fundamental Research Funds for the Central Universities of Shaanxi Normal University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of the Natural Science Foundation of Shaanxi Province, China; Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by the Fundamental Research Funds for the Central Universities of Shaanxi Normal University (2010ZYGX015), the Fundamental Research Funds for the Central Universities (GK201301010), research grants to HX and XZ from the National Natural Science Foundation of China (No. 81272543, No. 81471772, and 81301957), a grant to HX from the Key Program of the Natural Science Foundation of Shaanxi Province, China (No. 2014JZ005) and a grant to XZ from the Natural Science Foundation of Shaanxi Province, China (No. 2014JM4113).	Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Herrmann CH, 2001, J CELL SCI, V114, P1491; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397	6	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152237	10.1371/journal.pone.0152237	http://dx.doi.org/10.1371/journal.pone.0152237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018871	gold, Green Published, Green Submitted			2022-12-26	WOS:000372807800034
J	Bustamante, E; Burquez, A; Scheinvar, E; Eguiarte, LE				Bustamante, Enriquena; Burquez, Alberto; Scheinvar, Enrique; Enrique Eguiarte, Luis			Population Genetic Structure of a Widespread Bat-Pollinated Columnar Cactus	PLOS ONE			English	Article							STENOCEREUS-PRUINOSUS CACTACEAE; TEHUACAN VALLEY; LEPTONYCTERIS-CURASOAE; FLOWERING PHENOLOGY; FORAGING BEHAVIOR; F-STATISTICS; DIVERSITY; EVOLUTION; FLOW; DOMESTICATION	Bats are the main pollinators and seed dispersers of Stenocereus thurberi, a xenogamous columnar cactus of northwestern Mexico and a good model to illustrate spatial dynamics of gene flow in long-lived species. Previous studies in this cactus showed differences among populations in the type and abundance of pollinators, and in the timing of flowering and fruiting. In this study we analyzed genetic variability and population differentiation among populations. We used three primers of ISSR to analyze within and among populations genetic variation from eight widely separated populations of S. thurberi in Sonora, Mexico. Sixty-six out of 99 of the ISSR bands (P = 66.7%) were polymorphic. Total heterozygosity for all populations sampled revealed high genetic diversity (H-sp = 0.207, H-BT = 0.224). The AMOVA showed that most of the genetic variation was within populations (80.5%). At the species level, estimates of population differentiation, theta = 0.175 and theta(B) = 0.194, indicated moderate gene flow among populations. The absence of a significant correlation between genetic and geographic distances indicated little isolation by geographic distance. The large genetic variation and diversity found in S. thurberi is consistent with its open reproductive system and the high mobility of bats, a major pollinator. However, small changes in number or kind of pollinators and seed dispersal agents, in the directionality of migratory routes, and/or in the timing of flowering and fruiting among populations, can critically affect gene flow dynamics.	[Bustamante, Enriquena; Burquez, Alberto] Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Inst Ecol, Hermosillo, Sonora, Mexico; [Scheinvar, Enrique; Enrique Eguiarte, Luis] Univ Nacl Autonoma Mexico, Dept Ecol Evolutiva, Inst Ecol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Bustamante, E; Burquez, A (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Inst Ecol, Hermosillo, Sonora, Mexico.	ebustamante@ecologia.unam.mx; montijo@unam.mx	Burquez, Alberto/J-7599-2017	Burquez, Alberto/0000-0002-7738-700X	Programa de Apoyos para la Superacion del Personal Academic, Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico; Secretaria del Medio Ambiente y Recursos Naturales-Consejo Nacional de Ciencia y Tecnologia [C01-0580]; Programa de Apoyos a la Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IN213814]	Programa de Apoyos para la Superacion del Personal Academic, Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico; Secretaria del Medio Ambiente y Recursos Naturales-Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyos a la Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico	AB acknowledges financial support for a sabbatical leave at the University of Arizona from Programa de Apoyos para la Superacion del Personal Academic, Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico. This work was supported by Secretaria del Medio Ambiente y Recursos Naturales-Consejo Nacional de Ciencia y Tecnologia (grant number C01-0580 to AB), and by the Programa de Apoyos a la Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [grant number IN213814 to AB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARITA HT, 1993, J MAMMAL, V74, P693, DOI 10.2307/1382291; Axelrod DI, 1979, OCCAS PAPERS CALIFOR, V132, P1; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Brown ADH, 1992, CONSERVATION BIODIVE, P219; Burquez A, 2006, DRY BORDERS GREAT NA; Burquez Alberto, 1999, P36; Bustamante E, 2008, ANN BOT-LONDON, V102, P1019, DOI 10.1093/aob/mcn194; Bustamante E, 2010, AM J BOT, V97, P2020, DOI 10.3732/ajb.1000071; Casas Alejandro, 1999, Journal of Ethnobiology, V19, P71; Clark-Tapia R, 2003, HEREDITY, V90, P443, DOI 10.1038/sj.hdy.6800252; COCKRUM E L, 1991, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V62, P181; CROW JF, 1984, P NATL ACAD SCI-BIOL, V81, P6073, DOI 10.1073/pnas.81.19.6073; Cruse-Sanders JM, 2013, ECOL EVOL, V3, P1340, DOI 10.1002/ece3.524; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Ellstrand Norman C., 1992, New Forests, V6, P241, DOI 10.1007/BF00120647; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falcon L.I., 2007, ECOLOG A MOL, P499; Falush D, 2003, GENETICS, V164, P1567; Figueredo CJ, 2010, J ARID ENVIRON, V74, P1392, DOI 10.1016/j.jaridenv.2010.05.020; Fleming TH, 1998, OECOLOGIA, V114, P368, DOI 10.1007/s004420050459; Fleming TH, 2001, ECOL MONOGR, V71, P511, DOI 10.1890/0012-9615(2001)071[0511:SDCCAT]2.0.CO;2; Goettsch B, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.142, 10.1038/NPLANTS.2015.142]; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; HAMRICK JL, 1982, AM J BOT, V69, P1685, DOI 10.2307/2442923; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hamrick JL, 2002, COLUMNAR CACTI THEIR, P122; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Holsinger K. E., 2003, HICKORY PACKAGE ANAL; Holsinger KE, 1999, HEREDITAS, V130, P245, DOI 10.1111/j.1601-5223.1999.00245.x; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Horner MA, 1998, J ZOOL, V244, P575, DOI 10.1111/j.1469-7998.1998.tb00062.x; LASKA M, 1990, Z SAUGETIERKD, V55, P49; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Martins K, 2011, GENET MOL RES, V10, P665, DOI 10.4238/vol10-2gmr1046; Miller MP, 1997, TOOLS POPULATION GEN; Moraes EM, 2005, GENETICA, V125, P311, DOI 10.1007/s10709-005-0716-0; MORRISON DW, 1980, OECOLOGIA, V45, P270, DOI 10.1007/BF00346469; NABHAN GP, 2002, NEW ISLAND BIOGEOGRA, P407; Nason JD, 2002, EVOLUTION, V56, P2214, DOI 10.1111/j.0014-3820.2002.tb00146.x; Nassar JM, 2003, AM J BOT, V90, P1628, DOI 10.3732/ajb.90.11.1628; Nassar JM, 2002, J HERED, V93, P193, DOI 10.1093/jhered/93.3.193; Nassar JM, 2001, HEREDITY, V87, P69, DOI 10.1046/j.1365-2540.2001.00910.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Oddou-Muratorio S, 2001, EVOLUTION, V55, P1123, DOI 10.1111/j.0014-3820.2001.tb00632.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Otero-Arnaiz A, 2005, MOL ECOL, V14, P1603, DOI 10.1111/j.1365-294X.2005.02494.x; Parra F, 2008, J ARID ENVIRON, V72, P1997, DOI 10.1016/j.jaridenv.2008.06.007; Parra F, 2010, ANN BOT-LONDON, V106, P483, DOI 10.1093/aob/mcq143; Perez-Villafana M. G., 2009, Open Biology Journal, V2, P101; PINKAVA DJ, 1982, B TORREY BOT CLUB, V109, P121, DOI 10.2307/2996251; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez J., 2011, POPULATION GENETIC S; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rodney JD, 2014, GSTUDIO ANAL FUNCTIO; Rojas-Martinez A, 1999, J BIOGEOGR, V26, P1065, DOI 10.1046/j.1365-2699.1999.00354.x; Rousset F, 1997, GENETICS, V145, P1219; Ruan-Tejeda I, 2014, BIOCHEM SYST ECOL, V55, P125, DOI 10.1016/j.bse.2014.03.005; Sahley CT, 1996, AM J BOT, V83, P1329, DOI 10.2307/2446118; SCHMITT J, 1983, EVOLUTION, V37, P1247, DOI 10.1111/j.1558-5646.1983.tb00241.x; SCHMITT J, 1980, EVOLUTION, V34, P934, DOI 10.1111/j.1558-5646.1980.tb04031.x; Shreve F., 1951, VEGETATION SONORAN D, V1, P591; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Sosa VJ, 1997, SEED DISPERSAL RECRU; Tinoco A, 2005, GENET RESOUR CROP EV, V52, P525, DOI 10.1007/s10722-003-6012-x; Turner R.M., 1995, SONORAN DESERT PLANT; Van Devender T.R., 1990, PACKRAT MIDDENS LAST; Waser NM, 1988, FUNCT ECOL, V2, P41, DOI 10.2307/2389458; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkinson GS, 1996, MOL ECOL, V5, P329; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yetman D., 2002, MAYO ETHNOBOTANY LAN, DOI 10.1525/california/9780520227217.001.0001; Yetman D., 2007, GREAT CACTI BIOGEOGR; Yetman DA, 1996, DESERT PLANTS, V2, P23; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	85	16	16	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152329	10.1371/journal.pone.0152329	http://dx.doi.org/10.1371/journal.pone.0152329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015281	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708900052
J	Frolova, SR; Gaiko, O; Tsvelaya, VA; Pimenov, OY; Agladze, KI				Frolova, Sheyda R.; Gaiko, Olga; Tsvelaya, Valeriya A.; Pimenov, Oleg Y.; Agladze, Konstantin I.			Photocontrol of Voltage-Gated Ion Channel Activity by Azobenzene Trimethylammonium Bromide in Neonatal Rat Cardiomyocytes	PLOS ONE			English	Article							VENTRICULAR MYOCYTES; OPTICAL SWITCHES; SODIUM-CHANNELS; NA+ CHANNELS; LIGHT; PROTEIN; INACTIVATION; EXCITABILITY; SURFACTANTS; MECHANISMS	The ability of azobenzene trimethylammonium bromide (azoTAB) to sensitize cardiac tissue excitability to light was recently reported. The dark, thermally relaxed trans-isomer of azoTAB suppressed spontaneous activity and excitation propagation speed, whereas the cisisomer had no detectable effect on the electrical properties of cardiomyocyte monolayers. As the membrane potential of cardiac cells is mainly controlled by activity of voltage-gated ion channels, this study examined whether the sensitization effect of azoTAB was exerted primarily via the modulation of voltage-gated ion channel activity. The effects of trans-and cis-isomers of azoTAB on voltage-dependent sodium (INav), calcium (ICav), and potassium (IKv) currents in isolated neonatal rat cardiomyocytes were investigated using the whole-cell patch-clamp technique. The experiments showed that azoTAB modulated ion currents, causing suppression of sodium (Na+) and calcium (Ca2+) currents and potentiation of net potassium (K+) currents. This finding confirms that azoTAB-effect on cardiac tissue excitability do indeed result from modulation of voltage-gated ion channels responsible for action potential.	[Frolova, Sheyda R.; Gaiko, Olga; Tsvelaya, Valeriya A.; Agladze, Konstantin I.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Pimenov, Oleg Y.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Russia	Moscow Institute of Physics & Technology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Agladze, KI (corresponding author), Moscow Inst Phys & Technol, Dolgoprudnyi, Russia.	agladze@yahoo.com	Agladze, Konstantin/X-5496-2019; Agladze, Konstantin/J-6142-2012; Tsvelaya, Valeriya/AAZ-8876-2020; Frolova, Sheida/AAO-3744-2020	Agladze, Konstantin/0000-0002-9258-436X; Agladze, Konstantin/0000-0002-9258-436X; Frolova, Sheida/0000-0001-5325-8118; Pimenov, Oleg Yu/0000-0001-5456-3376	Russian Government [5-top-100]	Russian Government	The work was supported by the Russian Government program 5-top-100.	Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Banghart MR, 2006, BIOCHEMISTRY-US, V45, P15129, DOI 10.1021/bi0618058; Banghart MR, 2009, ANGEW CHEM INT EDIT, V48, P9097, DOI 10.1002/anie.200904504; Beharry AA, 2011, J AM CHEM SOC, V133, P19684, DOI 10.1021/ja209239m; Beharry AA, 2011, CHEM SOC REV, V40, P4422, DOI 10.1039/c1cs15023e; Diguet A, 2012, J AM CHEM SOC, V134, P4898, DOI 10.1021/ja211664f; Erofeev IS, 2011, JETP LETT+, V94, P477, DOI 10.1134/S0021364011180056; Estacion M, 2013, J NEUROPHYSIOL, V109, P306, DOI 10.1152/jn.00438.2012; Fleidervish IA, 1996, J NEUROPHYSIOL, V76, P2125, DOI 10.1152/jn.1996.76.3.2125; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Fujiyoshi Y, 2008, CURR OPIN STRUC BIOL, V18, P587, DOI 10.1016/j.sbi.2008.07.005; GENNIS RB, 1977, ANNU REV BIOPHYS BIO, V6, P195, DOI 10.1146/annurev.bb.06.060177.001211; Gorostiza P, 2008, PHYSIOLOGY, V23, P238, DOI 10.1152/physiol.00018.2008; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Gorostiza P, 2007, MOL BIOSYST, V3, P686, DOI 10.1039/b710287a; Hamill AC, 2005, BIOCHEMISTRY-US, V44, P15139, DOI 10.1021/bi051646c; Hamill AC, 2007, BIOCHEMISTRY-US, V46, P7694, DOI 10.1021/bi700233k; Hoppmann C, 2011, ANGEW CHEM INT EDIT, V50, P7699, DOI 10.1002/anie.201101398; Khan A, 2006, CHEM-EUR J, V12, P4764, DOI 10.1002/chem.200501564; Kimbrough JT, 2000, J PHYSIOL-LONDON, V529, P93, DOI 10.1111/j.1469-7793.2000.00093.x; Le Ny ALM, 2006, J AM CHEM SOC, V128, P6400, DOI 10.1021/ja0576738; Lee CT, 2005, BIOCHEMISTRY-US, V44, P524, DOI 10.1021/bi048556c; Lippiat Jonathan D., 2008, V491, P141, DOI 10.1007/978-1-59745-526-8_11; Magome N, 2011, TISSUE ENG PT A, V17, P2703, DOI 10.1089/ten.tea.2010.0745; Magome N, 2010, PHYSICA D, V239, P1560, DOI 10.1016/j.physd.2010.04.002; Maltsev AV, 2013, BIOCHEM MOSC SUPPL S, V7, P100, DOI 10.1134/S1990747813020050; Mourot A, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00005; Mourot A, 2012, NAT METHODS, V9, P396, DOI [10.1038/NMETH.1897, 10.1038/nmeth.1897]; Mourot A, 2011, ACS CHEM NEUROSCI, V2, P536, DOI 10.1021/cn200037p; OLEARY ME, 1994, J GEN PHYSIOL, V104, P507, DOI 10.1085/jgp.104.3.507; Pelzmann B, 1998, CARDIOVASC RES, V38, P424, DOI 10.1016/S0008-6363(98)00002-9; Rau H., 1990, PHOTOCHEMISTRY PHOTO, V2, P119; ROJAS E, 1976, J PHYSIOL-LONDON, V262, P501, DOI 10.1113/jphysiol.1976.sp011608; Scholz A, 2002, BRIT J ANAESTH, V89, P52, DOI 10.1093/bja/aef163; Shaw RM, 1997, CIRC RES, V81, P727; Sung DJ, 2012, BIOL PHARM BULL, V35, P1469, DOI 10.1248/bpb.b12-00002; WANG GK, 1991, J GEN PHYSIOL, V98, P1005, DOI 10.1085/jgp.98.5.1005; Wang SC, 2006, J PHYS CHEM B, V110, P16117, DOI 10.1021/jp060981n; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	39	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152018	10.1371/journal.pone.0152018	http://dx.doi.org/10.1371/journal.pone.0152018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015602	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708900038
J	Peronnet, E; Nguyen, K; Cerrato, E; Guhadasan, R; Venet, F; Textoris, J; Pachot, A; Monneret, G; Carrol, ED				Peronnet, Estelle; Nguyen, Kha; Cerrato, Elisabeth; Guhadasan, Rathi; Venet, Fabienne; Textoris, Julien; Pachot, Alexandre; Monneret, Guillaume; Carrol, Enitan Delphine			Evaluation of mRNA Biomarkers to Identify Risk of Hospital Acquired Infections in Children Admitted to Paediatric Intensive Care Unit	PLOS ONE			English	Article							TUMOR NECROSIS FACTOR; HLA-DR EXPRESSION; SEPTIC SHOCK; INCREASED MORTALITY; GENE-EXPRESSION; SEPSIS; INTERLEUKIN-10; LYMPHOPENIA; APOPTOSIS; INFLAMMATION	Objectives Hospital-acquired infections (HAI) are associated with significant mortality and morbidity and prolongation of hospital stay, adding strain on limited hospital resources. Despite stringent infection control practices some children remain at high risk of developing HAI. The development of biomarkers which could identify these patients would be useful. In this study our objective was to evaluate mRNA candidate biomarkers for HAI prediction in a pediatric intensive care unit. Design Serial blood samples were collected from patients admitted to pediatric intensive care unit between March and June 2012. Candidate gene expression (IL1B, TNF, IL10, CD3D, BCL2, BID) was quantified using RT-qPCR. Comparisons of relative gene expression between those that did not develop HAI versus those that did were performed using Mann Whitney U-test. Patients Exclusion criteria were: age < 28 days or >= 16 years, expected length of stay < 24 hours, expected survival < 28 days, end-stage renal disease and end-stage liver disease. Finally, 45 children were included in this study. Main Results The overall HAI rate was 30% of which 62% were respiratory infections. Children who developed HAI had a three-fold increase in hospital stay compared to those who did not (27 days versus 9 days, p< 0.001). An increased expression of cytokine genes (IL1B and IL10) was observed in patients who developed HAI, as well as a pro-apoptosis pattern (higher expression of BID and lower expression of BCL2). CD3D, a key TCR co-factor was also significantly down-modulated in patients who developed HAI. Conclusions To our knowledge, this is the first study of mRNA biomarkers of HAI in the paediatric population. Increased mRNA expressions of anti-inflammatory cytokine and modulation of apoptotic genes suggest the development of immunosuppression in critically ill children. Immune monitoring using a panel of genes may offer a novel stratification tool to identify HAI risk.	[Peronnet, Estelle; Cerrato, Elisabeth; Venet, Fabienne; Textoris, Julien; Pachot, Alexandre; Monneret, Guillaume] Univ Lyon 1, Joint Res Unit Hospices Civils Lyon BioMerieux, Hop Edouard Herriot,Hosp Civils Lyon BioMerieux, Pathophysiol Injury Induced Immunosuppress PI3 La, F-69365 Lyon, France; [Nguyen, Kha] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Guhadasan, Rathi; Carrol, Enitan Delphine] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Venet, Fabienne; Monneret, Guillaume] Hosp Civils Lyon, Hop Edouard Herriot, Immunol Lab, Lyon, France; [Textoris, Julien] Hosp Civils Lyon, Hop Edouard Herriot, Anesthesiol & Intens Care Dept, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Liverpool; University of Liverpool; CHU Lyon; CHU Lyon	Peronnet, E (corresponding author), Univ Lyon 1, Joint Res Unit Hospices Civils Lyon BioMerieux, Hop Edouard Herriot,Hosp Civils Lyon BioMerieux, Pathophysiol Injury Induced Immunosuppress PI3 La, F-69365 Lyon, France.	estelle.peronnet@biomerieux.com	Textoris, Julien/H-3317-2019	Textoris, Julien/0000-0002-3821-9337; Carrol, Enitan/0000-0001-8357-7726; Venet, Fabienne/0000-0003-0462-4235	Liverpool National Institute of Health Research- Biomedical Research Centre; Alder Hey Charity; National Institute of Health Research; bioMerieux; Advanced Diagnostics for New Therapeutic Approaches, a program dedicated to personalized medicine; French public agency, OSEO	Liverpool National Institute of Health Research- Biomedical Research Centre; Alder Hey Charity; National Institute of Health Research(National Institute for Health Research (NIHR)); bioMerieux; Advanced Diagnostics for New Therapeutic Approaches, a program dedicated to personalized medicine; French public agency, OSEO	RG was funded by the Liverpool National Institute of Health Research- Biomedical Research Centre and Alder Hey Charity. KN was an NIHR Academic Clinical Fellow funded by the National Institute of Health Research. bioMerieux provided support to this study in form of salaries for EP, EC, AP, JT. The specific roles of these authors are articulated in the 'author contributions' section. bioMerieux received funding from Advanced Diagnostics for New Therapeutic Approaches, a program dedicated to personalized medicine, coordinated by Merieux Alliance and supported by the French public agency, OSEO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2006, CRIT CARE MED, V34, P2658, DOI 10.1097/01.CCM.0000240243.28129.36; Almansa R, 2015, J INFECTION, V70, P445, DOI 10.1016/j.jinf.2014.12.010; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2014, CDC NHSN SURVEILLANC; Bell MJ, 1997, ACT NEUR S, V70, P96; Carrol ED, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-20; Dauwalder O, 2012, FEMS IMMUNOL MED MIC, V66, P116, DOI 10.1111/j.1574-695X.2012.00990.x; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Felmet KA, 2005, J IMMUNOL, V174, P3765, DOI 10.4049/jimmunol.174.6.3765; Fontaine M, 2011, CRIT CARE MED, V39, P2684, DOI 10.1097/CCM.0b013e3182282a40; GIRARDIN E, 1988, NEW ENGL J MED, V319, P397, DOI 10.1056/NEJM198808183190703; Gouel-Cheron A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033095; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hall MW, 2011, INTENS CARE MED, V37, P525, DOI 10.1007/s00134-010-2088-x; Heffernan DS, 2012, CRIT CARE, V16, DOI 10.1186/cc11157; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hinrichs C, 2010, CLIN CHEM, V56, P613, DOI 10.1373/clinchem.2009.133876; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Kumpf O, 2010, J INNATE IMMUN, V2, P381, DOI 10.1159/000314269; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Monneret G, 2004, IMMUNOL LETT, V95, P193, DOI 10.1016/j.imlet.2004.07.009; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Muszynski JA, 2014, CRIT CARE, V18, DOI 10.1186/cc13980; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Sherry RM, 1996, J TRAUMA, V40, P613, DOI 10.1097/00005373-199604000-00016; Sikora JP, 2009, MED SCI MONITOR, V15, pCR26; Tissieres P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032863; Turrel-Davin F, 2010, CRIT CARE, V14, DOI 10.1186/cc9181; Umberger R, 2015, DIMENS CRIT CARE NUR, V34, P100, DOI 10.1097/DCC.0000000000000098; Venet F, 2013, CURR OPIN IMMUNOL, V25, P477, DOI 10.1016/j.coi.2013.05.006; Vogel TR, 2010, ANN SURG, V252, P1065, DOI 10.1097/SLA.0b013e3181dcf36e; WAAGE A, 1986, SCAND J IMMUNOL, V24, P739, DOI 10.1111/j.1365-3083.1986.tb02194.x; Weber SU, 2008, CRIT CARE, V12, DOI 10.1186/cc7088; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152388	10.1371/journal.pone.0152388	http://dx.doi.org/10.1371/journal.pone.0152388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015534	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708900060
J	Seijger, CGW; Drost, G; Posma, JM; van Engelen, BGM; Heijdra, YF				Seijger, Charlotte G. W.; Drost, Gea; Posma, Joram M.; van Engelen, Baziel G. M.; Heijdra, Yvonne F.			Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BODY-COMPOSITION; CTG REPEAT; STANDARDIZATION; ADULTS; IMPAIRMENT; MORTALITY; FATIGUE	Background In this large observational study population of 105 myotonic dystrophy type 1 (DM1) patients, we investigate whether bodyweight is a contributor of total lung capacity (TLC) independent of the impaired inspiratory muscle strength. Methods Body composition was assessed using the combination of body mass index (BMI) and fat-free mass index. Pulmonary function tests and respiratory muscle strength measurements were performed on the same day. Patients were stratified into normal (BMI < 25 kg/m(2)) and overweight (BMI >= 25 kg/m(2)) groups. Multiple linear regression was used to find significant contributors for TLC. Results Overweight was present in 59% of patients, and body composition was abnormal in almost all patients. In overweight patients, TLC was significantly (p = 2.40x10(-3)) decreased, compared with normal-weight patients, while inspiratory muscle strength was similar in both groups. The decrease in TLC in overweight patients was mainly due to a decrease in expiratory reserve volume (ERV) further illustrated by a highly significant (p = 1.33x10(-10)) correlation between BMI and ERV. Multiple linear regression showed that TLC can be predicted using only BMI and the forced inspiratory volume in 1 second, as these were the only significant contributors. Conclusions This study shows that, in DM1 patients, overweight further reduces lung volumes, as does impaired inspiratory muscle strength. Additionally, body composition is abnormal in almost all DM1 patients.	[Seijger, Charlotte G. W.; Heijdra, Yvonne F.] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6525 ED Nijmegen, Netherlands; [Drost, Gea] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Dept Neurosurg, Groningen, Netherlands; [Posma, Joram M.] Univ London Imperial Coll Sci Technol & Med, Div Computat & Syst Med, Dept Surg & Canc, Fac Med, South Kensington Campus, London, England; [Posma, Joram M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Fac Med, Sch Publ Hlth, St Marys Campus, London, England; [van Engelen, Baziel G. M.] Radboud Univ Nijmegen, Med Ctr, Inst Neurol, Neuromuscular Ctr Nijmegen, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Groningen; Imperial College London; Imperial College London; Radboud University Nijmegen	Seijger, CGW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6525 ED Nijmegen, Netherlands.	Charlotte.Seijger@radboudumc.nl	van Engelen, Baziel/H-8027-2014; Heijdra, Yvonne/N-3585-2014	van Engelen, Baziel/0000-0001-9867-9047; Drost, Gea/0000-0002-3546-4548; Posma, Joram/0000-0002-4971-9003				Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Baarends EM, 1997, EUR RESPIR J, V10, P2807, DOI 10.1183/09031936.97.10122807; Begin P, 1997, AM J RESP CRIT CARE, V156, P133, DOI 10.1164/ajrccm.156.1.9509041; BELLEMARE F, 1982, J APPL PHYSIOL, V53, P1190, DOI 10.1152/jappl.1982.53.5.1190; BOGAARD JM, 1992, LUNG, V170, P143, DOI 10.1007/BF00174317; BROOK, 1992, CELL, V69, P385; Cup EH, 2007, ARCH PHYS MED REHAB, V88, P1452, DOI 10.1016/j.apmr.2007.07.024; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; Gagnon C, 2013, CAN J NEUROL SCI, V40, P42, DOI 10.1017/S0317167100012932; Groh WJ, 2011, MUSCLE NERVE, V43, P648, DOI 10.1002/mus.21934; Harper PS, 2001, MYOTONIC DYSTROPHY; Kalkman JS, 2005, J NEUROL NEUROSUR PS, V76, P1406, DOI 10.1136/jnnp.2004.050005; Kiyan E, 2010, SLEEP BREATH, V14, P19, DOI 10.1007/s11325-009-0270-6; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Littleton SW, 2012, RESPIROLOGY, V17, P43, DOI 10.1111/j.1440-1843.2011.02096.x; Loring SH, 2009, J APPL PHYSIOL, V107, P309, DOI 10.1152/japplphysiol.00008.2009; LUKASKI HC, 1985, AM J CLIN NUTR, V41, P810, DOI 10.1093/ajcn/41.4.810; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Motlagh B, 2005, MUSCLE NERVE, V31, P713, DOI 10.1002/mus.20317; Pruna L, 2011, MUSCLE NERVE, V44, P503, DOI 10.1002/mus.22099; REFSUM HE, 1990, INT J OBESITY, V14, P175; SCHMIDTNOWARA WW, 1984, CHEST, V85, P792, DOI 10.1378/chest.85.6.792; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Terzi N, 2008, EUR RESPIR J, V31, P93, DOI 10.1183/09031936.00094707; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005	30	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152344	10.1371/journal.pone.0152344	http://dx.doi.org/10.1371/journal.pone.0152344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015655	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708900055
J	Zhang, W; Hong, S; Maniar, KP; Cheng, S; Jie, C; Rademaker, AW; Krensky, AM; Clayberger, C				Zhang, W.; Hong, S.; Maniar, K. P.; Cheng, S.; Jie, C.; Rademaker, A. W.; Krensky, A. M.; Clayberger, C.			KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8	ONCOGENE			English	Article							KRUPPEL-LIKE FACTORS; TUMOR-SUPPRESSOR; CLINICAL-IMPLICATIONS; CHEMOKINE RANTES; CERVICAL-CANCER; INTERLEUKIN-8; EXPRESSION; ANGIOGENESIS; GROWTH; TRANSFORMATION	High-risk strains of human papillomavirus (HPV) are the causative agents of cervical and anogenital cancers and are associated with 5% of all human cancers. Although prophylactic vaccines targeting a subset of HPV types are available, they are ineffective in HPV-infected individuals. Elucidation of the mechanisms controlling HPV replication may allow development of novel anti-HPV therapeutics. Infectious HPV virions are produced during terminal differentiation of host cells. The process of viral maturation requires synergistic interactions between viral and cellular proteins that leads to amplification of the viral genome and expression of late viral genes. Here we show that the transcription factor Kruppel-like factor 13 (KLF13) has a critical role in the HPV life cycle. KLF13 is overexpressed in HPV-positive keratinocytes and cervical cancer cell lines. Expression of KLF13 in normal cervical epithelium is low but increases significantly in cervical intraepithelial neoplasia and invasive squamous cervical cancer. After HPV infection, the E7 protein suppresses ubiquitin ligase FBW7 expression leading to an increase in KLF13 expression. Reduction of KLF13 with short hairpin RNA in differentiating HPV-positive cells resulted in diminished levels of viral gene expression and genome amplification. Knockdown of KLF13 also reduced the level of the transcription factor signal transducer and activator of transcription 5, which led to the downregulation of the ataxia-telangiectasia mutated DNA damage pathway and the chemokine interleukin-8 (IL-8). In addition, neutralization of IL-8 diminished viral genome amplification in differentiating HPV-positive cells. Thus, KLF13 is critical for the activation of the HPV productive life cycle and is likely involved in initiation and progression of cervical cancer.	[Zhang, W.; Hong, S.; Cheng, S.; Krensky, A. M.; Clayberger, C.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, 300 East Super St, Chicago, IL 60611 USA; [Maniar, K. P.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Jie, C.] Des Moines Univ, Dept Res Biostat, Des Moines, IA USA; [Rademaker, A. W.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Rademaker, A. W.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Krensky, A. M.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine	Clayberger, C (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, 300 East Super St, Chicago, IL 60611 USA.	Clayberger@northwestern.edu	zhang, wei/A-7015-2011		H Foundation Cancer Research Fund; Robert H Lurie Comprehensive Cancer Center	H Foundation Cancer Research Fund; Robert H Lurie Comprehensive Cancer Center	This work was supported in part by the H Foundation Cancer Research Fund and Robert H Lurie Comprehensive Cancer Center (to W Zhang). We thank Dr Laimonis A Laimins for helpful discussions.	Ahn YT, 2007, MOL CELL BIOL, V27, P253, DOI 10.1128/MCB.01071-06; Ai WD, 2000, J VIROL, V74, P5198, DOI 10.1128/JVI.74.11.5198-5205.2000; Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; ANTTILA HSI, 1992, CLIN EXP IMMUNOL, V89, P509; Apt D, 1996, VIROLOGY, V224, P281, DOI 10.1006/viro.1996.0530; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Britschgi A, 2012, CANCER CELL, V22, P419; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Chen JJW, 2003, CLIN CANCER RES, V9, P729; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; Desaintes C, 1996, SEMIN CANCER BIOL, V7, P339, DOI 10.1006/scbi.1996.0043; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fehrmann Frauke, 2005, Methods Mol Biol, V292, P317; Forte E, 2015, J VIROL, V89, P2333, DOI 10.1128/JVI.03317-14; Fujimoto J, 2000, CANCER RES, V60, P2632; Grone A, 2002, VET IMMUNOL IMMUNOP, V88, P1, DOI 10.1016/S0165-2427(02)00136-8; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Harry BL, 2012, EXPERT OPIN INV DRUG, V21, P637, DOI 10.1517/13543784.2012.677432; Henson B J, 2010, Cytogenet Genome Res, V128, P192, DOI 10.1159/000308303; Hong SY, 2013, FUTURE MICROBIOL, V8, P1547, DOI 10.2217/fmb.13.127; Hong S, 2013, J NANOMATER, V2013, DOI [10.1155/2013/246328, 10.1155/2013/790323]; Kajitani N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00152; Kim DS, 2012, BLOOD, V120, P1658, DOI 10.1182/blood-2012-03-415968; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Limame R, 2014, ONCOTARGET, V5, P29, DOI 10.18632/oncotarget.1456; Marrero-Rodriguez D, 2014, TUMOR BIOL, V35, P11399, DOI 10.1007/s13277-014-2380-4; Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003321; Simard JC, 2014, FEBS LETT, V588, P2141, DOI 10.1016/j.febslet.2014.04.027; Steenbergen RDM, 2014, NAT REV CANCER, V14, P395, DOI 10.1038/nrc3728; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Walker J, 2011, VIROLOGY, V410, P283, DOI 10.1016/j.virol.2010.11.010; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wu SH, 2013, MOL CELL BIOCHEM, V375, P69, DOI 10.1007/s11010-012-1529-y; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12; Zhao X, 2010, ARTHRITIS RHEUM-US, V62, P3425, DOI 10.1002/art.27632	48	17	20	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 20	2016	35	42					5565	5575		10.1038/onc.2016.97	http://dx.doi.org/10.1038/onc.2016.97			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XO	27041562				2022-12-26	WOS:000386998200010
J	Muramatsu, T; Kozaki, KI; Imoto, S; Yamaguchi, R; Tsuda, H; Kawano, T; Fujiwara, N; Morishita, M; Miyano, S; Inazawa, J				Muramatsu, T.; Kozaki, K-I; Imoto, S.; Yamaguchi, R.; Tsuda, H.; Kawano, T.; Fujiwara, N.; Morishita, M.; Miyano, S.; Inazawa, J.			The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma	ONCOGENE			English	Article							TRANSLATION INITIATION-FACTOR; FACTOR 5A EIF5A; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; PROTEOMIC ANALYSIS; COLORECTAL-CANCER; PANCREATIC-CANCER; TUMOR-METASTASIS; LIVER-CANCER; IN-VIVO	Metastasis is a critical factor contributing to poor prognosis in cancer, but the underlying mechanisms of metastasis are still poorly understood. We established a highly metastatic cell subline (HOC313-LM) derived from an oral squamous cell carcinoma cell line (HOC313) for uncovering the mechanisms of metastasis, and identified deoxyhypusine synthase (DHPS) as a metastasis-associated gene within the specific amplification at 19p13.2-p13.13 in HOC313-LM. DHPS-mediated hypusine-modification of eukaryotic translation factor 5A facilitated the translation of RhoA, resulting in the activation of the RhoA signaling pathway and leading to not only increased cell motility, invasion and metastasis of cancer cells in vitro, but also increased tumor growth in vivo. Moreover, the use of N1-Guanyl-1,7-diaminoheptane, a DHPS inhibitor, resulted in a significant decrease in tumor formation in vivo. In patients with esophageal squamous cell carcinoma (ESCC), overexpression of DHPS in ESCC tumors was significantly associated with worse recurrence-free survival, and correlated with distant metastasis. The elucidation of these molecular mechanisms within the hypusine cascade suggests opportunities for novel therapeutic targets in SCC.	[Muramatsu, T.; Kozaki, K-I; Fujiwara, N.; Morishita, M.; Inazawa, J.] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Muramatsu, T.; Inazawa, J.] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE, Program Frontier Res Mol Destruct & Reconstitut T, Tokyo, Japan; [Muramatsu, T.] Japan Soc Promot Sci, Tokyo, Japan; [Kozaki, K-I; Inazawa, J.] Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan; [Kozaki, K-I] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama, Japan; [Imoto, S.; Yamaguchi, R.; Miyano, S.] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Dept DNA Informat Anal, Tokyo, Japan; [Tsuda, H.] Natl Def Med Coll, Dept Basic Pathol, Saitama, Japan; [Kawano, T.; Fujiwara, N.] Tokyo Med & Dent Univ, Grad Sch, Dept Surg, Tokyo, Japan; [Inazawa, J.] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Society for the Promotion of Science; Tokyo Medical & Dental University (TMDU); Okayama University; University of Tokyo; National Defense Medical College - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	johinaz.cgen@mri.tmd.ac.jp		Imoto, Seiya/0000-0002-2989-308X; Miyano, Satoru/0000-0002-1753-6616	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22134002, 15H05908, 22240090, 25250019, 15K18401, 26890012]; Tailor-Made Medical Treatment; BioBank Japan Project (BBJ); Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development [15Ack0106017h0002]; AMED; Global Center of Excellence (GCOE) Program for International Research Center for Molecular Science in Tooth and Bone Diseases; Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tailor-Made Medical Treatment; BioBank Japan Project (BBJ); Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED)); AMED; Global Center of Excellence (GCOE) Program for International Research Center for Molecular Science in Tooth and Bone Diseases; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in Aid for Scientific Research (KAKENHI) for Innovative Areas (22134002, 15H05908) (Integrative Systems Understanding of Cancer for Advanced Diagnosis, Therapy and Prevention), Scientific Research (A) (22240090, 25250019), Challenging Exploratory Research (B) (15K18401), Research Activity Start-up (26890012), JSPS Fellows from Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Tailor-Made Medical Treatment with the BioBank Japan Project (BBJ) and the Practical Research for Innovative Cancer Control (15Ack0106017h0002) from Japan Agency for Medical Research and development, AMED and Global Center of Excellence (GCOE) Program for International Research Center for Molecular Science in Tooth and Bone Diseases, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Caraglia M, 2013, AMINO ACIDS, V44, P103, DOI 10.1007/s00726-011-1182-x; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Cipollini G, 1997, INT J CANCER, V73, P297, DOI 10.1002/(SICI)1097-0215(19971009)73:2<297::AID-IJC22>3.0.CO;2-B; Dong ZZ, 2005, MOL CELL PROTEOMICS, V4, P993, DOI 10.1074/mcp.M500044-MCP200; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; Fujimura K, 2015, J BIOL CHEM, V290, P29907, DOI 10.1074/jbc.M115.687418; Fujimura K, 2014, CANCER RES, V74, P6671, DOI 10.1158/0008-5472.CAN-14-1031; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Guan XY, 2004, CANCER RES, V64, P4197, DOI 10.1158/0008-5472.CAN-03-3747; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; He XY, 2012, CARCINOGENESIS, V33, P555, DOI 10.1093/carcin/bgs002; Huang YF, 2007, P NATL ACAD SCI USA, V104, P4194, DOI 10.1073/pnas.0611609104; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jasiulionis MG, 2007, CELL BIOCHEM FUNCT, V25, P109, DOI 10.1002/cbf.1351; Kaiser A, 2012, AMINO ACIDS, V42, P679, DOI 10.1007/s00726-011-1042-8; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Lee NP, 2010, INT J CANCER, V127, P968, DOI 10.1002/ijc.25100; Li YJ, 2012, PROCEEDINGS OF INTERNATIONAL SYMPOSIUM ON EMERGENCY MANAGEMENT 2011, P5; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lou B, 2013, EXP CELL RES, V319, P2708, DOI 10.1016/j.yexcr.2013.08.010; Lu ZJ, 2014, CELL PHYSIOL BIOCHEM, V33, P859, DOI 10.1159/000358658; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Memin E, 2014, CANCER RES, V74, P552, DOI 10.1158/0008-5472.CAN-13-0474; Minden MD, 2014, AM J HEMATOL, V89, P363, DOI 10.1002/ajh.23640; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Neeb A, 2012, ONCOGENE, V31, P3796, DOI 10.1038/onc.2011.535; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ono H, 2012, ONCOGENE, V31, P4923, DOI 10.1038/onc.2011.646; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Preukschas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043468; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Semenza GL, 2003, NAT REV CANCER, V4, P191; Shih IM, 2011, MODERN PATHOL, V24, P638, DOI 10.1038/modpathol.2010.230; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Straume O, 2012, P NATL ACAD SCI USA, V109, P8699, DOI 10.1073/pnas.1017909109; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Taylor CA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-35; Tunca B, 2013, J CANCER RES CLIN, V139, P691, DOI 10.1007/s00432-013-1372-x; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang FW, 2013, INT J BIOL SCI, V9, P1013, DOI 10.7150/ijbs.7191; Wei JH, 2014, BRIT J CANCER, V110, P1767, DOI 10.1038/bjc.2014.52; Yap KL, 2012, CANCER RES, V72, P4085, DOI 10.1158/0008-5472.CAN-12-0302; Yasumoto E, 2004, ANTICANCER RES, V24, P755; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255; Zhu W, 2014, GASTROENTEROLOGY, V146	56	24	26	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5304	5316		10.1038/onc.2016.71	http://dx.doi.org/10.1038/onc.2016.71			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	27041563				2022-12-26	WOS:000386053000009
J	Yu, S; Li, SJ; Henke, A; Muse, ED; Cheng, B; Welzel, G; Chatterjee, AK; Wang, DL; Roland, J; Glass, CK; Tremblay, M				Yu, Shan; Li, Sijia; Henke, Adam; Muse, Evan D.; Cheng, Bo; Welzel, Gustav; Chatterjee, Arnab K.; Wang, Danling; Roland, Jason; Glass, Christopher K.; Tremblay, Matthew			Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases	FASEB JOURNAL			English	Article						LXR; traumatic brain injury; ulcerative colitis; drug discovery	ELEMENT-BINDING PROTEIN-1C; LIPID-METABOLISM; LXR AGONIST; GENE; MICE; OXYSTEROLS; PATHWAYS; TRANSREPRESSION; INTEGRATION; LIPOGENESIS	Liver X receptor (LXR), a nuclear hormone receptor, is an essential regulator of immune responses. Activation of LXR-mediated transcription by synthetic agonists, such as T0901317 and GW3965, attenuates progression of inflammatory disease in animal models. However, the adverse effects of these conventional LXR agonists in elevating liver lipids have impeded exploitation of this intriguing mechanism for chronic therapy. Here, we explore the ability of a series of sterol-based LXR agonists to alleviate inflammatory conditions in mice without hepatotoxicity. We show that oral treatment with sterol-based LXR agonists in mice significantly reduces dextran sulfate sodium colitis-induced body weight loss, which is accompanied by reduced expression of inflammatory markers in the large intestine. The anti-inflammatory property of these agonists is recapitulated in vitro in mouse lamina propria mononuclear cells, human colonic epithelial cells, and human peripheral blood mononuclear cells. In addition, treatment with LXR agonists dramatically suppresses inflammatory cytokine expression in a model of traumatic brain injury. Importantly, in both disease models, the sterol-based agonists do not affect the liver, and the conventional agonist T0901317 results in significant liver lipid accumulation and injury. Overall, these results provide evidence for the development of sterol-based LXR agonists as novel therapeutics for chronic inflammatory diseases.	[Yu, Shan; Li, Sijia; Henke, Adam; Cheng, Bo; Welzel, Gustav; Chatterjee, Arnab K.; Wang, Danling; Roland, Jason; Tremblay, Matthew] Calif Inst Biomed Res, 11119 N Torrey Pines Rd,Suite 100, La Jolla, CA 92037 USA; [Muse, Evan D.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Muse, Evan D.] Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Tremblay, M (corresponding author), Calif Inst Biomed Res, 11119 N Torrey Pines Rd,Suite 100, La Jolla, CA 92037 USA.; Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, GPL Rm 217,9500 Gilman Dr,Mail Code 0651, La Jolla, CA 92093 USA.	cglass@ucsd.edu; mtremblay@calibr.org	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	Crohn's and Colitis Foundation of America Research Fellowship Award [368561]; U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award [UL1-TR001114]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America Research Fellowship Award; U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Crohn's and Colitis Foundation of America Research Fellowship Award (368561; to S.Y.), and by a U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award (UL1-TR001114; to Scripps Translational Science Institute).	Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Cheng O, 2010, NEUROSCIENCE, V166, P1101, DOI 10.1016/j.neuroscience.2010.01.024; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Danese S, 2015, NAT REV GASTRO HEPAT, V12, P537, DOI 10.1038/nrgastro.2015.135; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hu BH, 2010, J MED CHEM, V53, P3296, DOI 10.1021/jm100034x; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jakobsson T, 2014, MUCOSAL IMMUNOL, V7, P1416, DOI 10.1038/mi.2014.31; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Katz A, 2009, J CLIN PHARMACOL, V49, P643, DOI 10.1177/0091270009335768; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lim RKV, 2015, BIOCONJUGATE CHEM, V26, P2216, DOI 10.1021/acs.bioconjchem.5b00203; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Quinet EM, 2009, J LIPID RES, V50, P2358, DOI 10.1194/jlr.M900037-JLR200; Quinet EM, 2004, J LIPID RES, V45, P1929, DOI 10.1194/jlr.M400257-JLR200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Shih DM, 2013, FASEB J, V27, P3805, DOI 10.1096/fj.12-223008; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Temml V, 2014, J CHEM INF MODEL, V54, P367, DOI 10.1021/ci400682b; Tice CM, 2014, J MED CHEM, V57, P7182, DOI 10.1021/jm500442z; Traversari C, 2014, EUR J IMMUNOL, V44, P1896, DOI 10.1002/eji.201344292; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	33	17	17	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2570	2579		10.1096/fj.201600244R	http://dx.doi.org/10.1096/fj.201600244R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27025962	Green Published			2022-12-26	WOS:000379249500012
J	Patel, SJ; Lewis, BE; Long, JE; Nambi, S; Sassetti, CM; Stemmler, TL; Arguello, JM				Patel, Sarju J.; Lewis, Brianne E.; Long, Jarukit E.; Nambi, Subhalaxmi; Sassetti, Christopher M.; Stemmler, Timothy L.; Argueello, Jose M.			Fine-tuning of Substrate Affinity Leads to Alternative Roles of Mycobacterium tuberculosis Fe2+-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BINDING DOMAIN; HYDROGEN-PEROXIDE DISRUPTS; CHLOROPLAST-ENVELOPE; FERROUS IRON; TRANSPORT; PROTEIN; ZINC; ATPASE; SYSTEM; IDENTIFICATION	Little is known about iron efflux transporters within bacterial systems. Recently, the participation of Bacillus subtilis PfeT, a P-1B4-ATPase, in cytoplasmic Fe2+ efflux has been proposed. We report here the distinct roles of mycobacterial P-1B4-ATPases in the homeostasis of Co2+ and Fe2+. Mutation of Mycobacterium smegmatis ctpJ affects the homeostasis of both ions. Alternatively, an M. tuberculosis ctpJ mutant is more sensitive to Co2+ than Fe2+, whereas mutation of the homologous M. tuberculosis ctpD leads to Fe2+ sensitivity but no alterations in Co2+ homeostasis. In vitro, the three enzymes are activated by both Fe2+ and Co2+ and bind 1 eq of either ion at their transport site. However, equilibrium binding affinities and activity kinetics show that M. tuberculosis CtpD has higher affinity for Fe2+ and twice the Fe2+-stimulated activity than the CtpJs. These parameters are paralleled by a lower activation and affinity for Co2+. Analysis of Fe2+ and Co2+ binding to CtpD by x-ray absorption spectroscopy shows that both ions are five-to six-coordinate, constrained within oxygen/nitrogen environments with similar geometries. Mutagenesis studies suggest the involvement of invariant Ser, His, and Glu residues in metal coordination. Interestingly, replacement of the conserved Cys at the metal binding pocket leads to a large reduction in Fe2+ but not Co2+ binding affinity. We propose that CtpJ ATPases participate in the control of steady state Fe2+ levels. CtpD, required for M. tuberculosis virulence, is a high affinity Fe2+ transporter involved in the rapid response to iron dyshomeostasis generated upon redox stress.	[Patel, Sarju J.; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA; [Lewis, Brianne E.; Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Long, Jarukit E.; Nambi, Subhalaxmi; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Sassetti, Christopher M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Worcester Polytechnic Institute; Wayne State University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Lewis, Brianne/AAU-5344-2021; Arguello, Jose/D-1997-2012	Lewis, Brianne/0000-0003-1584-6407; Nambi, Subhalaxmi/0000-0001-7104-659X; Arguello, Jose/0000-0003-3940-6297	Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064282, R21AI082484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114949] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Andrew Baez (Worcester Polytechnic Institute) for assistance with early experiments. X-ray absorption spectroscopic studies were performed at the Stanford Synchrotron Radiation Lightsource (SSRL). SSRL is a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Arguello JM, 2012, J BIOL CHEM, V287, P13510, DOI 10.1074/jbc.R111.319343; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Bennett BD, 2015, APPL ENVIRON MICROB, V81, P7938, DOI 10.1128/AEM.02835-15; Boutigny S, 2014, J EXP BOT, V65, P1529, DOI 10.1093/jxb/eru020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chou CJ, 2004, J BIOL CHEM, V279, P53554, DOI 10.1074/jbc.M407385200; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Eren E, 2007, BIOCHEMISTRY-US, V46, P7754, DOI 10.1021/bi7001345; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Frawley ER, 2014, MOL MICROBIOL, V93, P609, DOI 10.1111/mmi.12709; Gaballa A, 2002, MOL MICROBIOL, V45, P997, DOI 10.1046/j.1365-2958.2002.03068.x; George G.N., 1995, EXAFSPAK SUITE COMPU; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Guan GH, 2015, MOL MICROBIOL, V98, P787, DOI 10.1111/mmi.13158; Guo JQ, 1997, BIOCHEMISTRY-US, V36, P730, DOI 10.1021/bi9617769; HEYSE S, 1994, J GEN PHYSIOL, V104, P197, DOI 10.1085/jgp.104.2.197; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lucarelli D, 2008, INT J MOL SCI, V9, P1548, DOI 10.3390/ijms9081548; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; McLaughlin HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030928; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P11334, DOI 10.1074/jbc.M112.448175; Pandey R, 2014, MOL MICROBIOL, V91, P98, DOI 10.1111/mmi.12441; Raimunda D, 2014, MOL MICROBIOL, V91, P185, DOI 10.1111/mmi.12454; Raimunda D, 2012, MOL MICROBIOL, V84, P1139, DOI 10.1111/j.1365-2958.2012.08082.x; Raimunda D, 2012, BBA-BIOMEMBRANES, V1818, P1374, DOI 10.1016/j.bbamem.2012.02.020; Rhine MA, 2014, J AM CHEM SOC, V136, P12560, DOI 10.1021/ja5064444; Rodriguez GM, 2006, TRENDS MICROBIOL, V14, P320, DOI 10.1016/j.tim.2006.05.006; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Rosadini CV, 2011, INFECT IMMUN, V79, P3366, DOI 10.1128/IAI.05135-11; Rosenzweig AC, 2012, CURR TOP MEMBR, V69, P113, DOI 10.1016/B978-0-12-394390-3.00005-7; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Scherer J, 2009, MOL MICROBIOL, V73, P601, DOI 10.1111/j.1365-2958.2009.06792.x; Segel I. H., 1993, ENZYME KINETICS, P534; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Smith AT, 2015, NAT CHEM BIOL, V11, P678, DOI [10.1038/NCHEMBIO.1863, 10.1038/nchembio.1863]; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; YEOWELL HN, 1982, ANTIMICROB AGENTS CH, V22, P961, DOI 10.1128/AAC.22.6.961; Zielazinski EL, 2012, BIOCHEMISTRY-US, V51, P7891, DOI 10.1021/bi3006708	50	22	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11529	11539		10.1074/jbc.M116.718239	http://dx.doi.org/10.1074/jbc.M116.718239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27022029	Green Published, hybrid			2022-12-26	WOS:000377264800006
J	McCallum, M; Tammam, S; Little, DJ; Robinson, H; Koo, J; Shah, M; Calmettes, C; Moraes, TF; Burrows, LL; Howell, PL				McCallum, Matthew; Tammam, Stephanie; Little, Dustin J.; Robinson, Howard; Koo, Jason; Shah, Megha; Calmettes, Charles; Moraes, Trevor F.; Burrows, Lori L.; Howell, P. Lynne			PilN Binding Modulates the Structure and Binding Partners of the Pseudomonas aeruginosa Type IVa Pilus Protein PilM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ligand-binding protein; protein chimera; Pseudomonas aeruginosa (P; aeruginosa); type IV pili; x-ray crystallography; PilM; PilN	INNER MEMBRANE PLATFORM; II SECRETION SYSTEM; CYTOPLASMIC DOMAIN; TWITCHING MOTILITY; BIOFILM FORMATION; BIOGENESIS; COMPLEX; ACTIN; RETRACTION; INTERACTS	Pseudomonas aeruginosa is an opportunistic bacterial pathogen that expresses type IVa pili. The pilus assembly system, which promotes surface-associated twitching motility and virulence, is composed of inner and outer membrane subcomplexes, connected by an alignment subcomplex composed of PilMNOP. PilM binds to the N terminus of PilN, and we hypothesize that this interaction causes functionally significant structural changes in PilM. To characterize this interaction, we determined the crystal structures of PilM and a PilM chimera where PilM was fused to the first 12 residues of PilN (PilMPilN(1-12)). Structural analysis, multiangle light scattering coupled with size exclusion chromatography, and bacterial two-hybrid data revealed that PilM forms dimers mediated by the binding of a novel conserved motif in the N terminus of PilM, and binding PilN abrogates this binding interface, resulting in PilM monomerization. Structural comparison of PilM with PilMPilN(1-12) revealed that upon PilN binding, there is a large domain closure in PilM that alters its ATP binding site. Using biolayer interferometry, we found that the association rate of PilN with PilM is higher in the presence of ATP compared with ADP. Bacterial two-hybrid data suggested the connectivity of the cytoplasmic and inner membrane components of the type IVa pilus machinery in P. aeruginosa, with PilM binding to PilB, PilT, and PilC in addition to PilN. Pull-down experiments demonstrated direct interactions of PilM with PilB and PilT. We propose a working model in which dynamic binding of PilN facilitates functionally relevant structural changes in PilM.	[McCallum, Matthew; Little, Dustin J.; Shah, Megha; Calmettes, Charles; Moraes, Trevor F.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [McCallum, Matthew; Tammam, Stephanie; Little, Dustin J.; Koo, Jason; Howell, P. Lynne] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Mol Struct & Funct, 686 Bay St, Toronto, ON M5G 0A4, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA; [Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); United States Department of Energy (DOE); Brookhaven National Laboratory; McMaster University; McMaster University	Howell, PL (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Mol Struct & Funct, 686 Bay St, Toronto, ON M5G 0A4, Canada.; Burrows, LL (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.; Burrows, LL (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.	burrowl@mcmaster.ca; howell@sickkids.ca		calmettes, charles/0000-0002-2542-4382	Department of Energy; National Institutes of Health National Center for Research Resources; Canadian Foundation for Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Patrick Yip for technical assistance and Liliana Sampaleanu, Ryan Buensuceso, Tiffany Leighton, Hanjeong Harvey, and Daniel Yong for generation of initial PilM vectors and several BACTH constructs and for helpful discussions. Beamline X29 at the National Synchrotron Light Source, Brookhaven National Laboratory, is supported by the Department of Energy and by a grant from the National Institutes of Health National Center for Research Resources. Funds for the x-ray facilities at the Hospital for Sick Children were provided, in part, by the Canadian Foundation for Innovation.	Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anyan ME, 2014, P NATL ACAD SCI USA, V111, P18013, DOI 10.1073/pnas.1414661111; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Bahar O, 2009, MOL PLANT MICROBE IN, V22, P909, DOI 10.1094/MPMI-22-8-0909; Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bischof LF, 2016, J BIOL CHEM, V291, P6946, DOI 10.1074/jbc.M115.701284; Brown P, 2016, BIOINFORMATICS, V32, P370, DOI 10.1093/bioinformatics/btv580; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Busiek KK, 2012, J BACTERIOL, V194, P1989, DOI 10.1128/JB.06683-11; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Conrad JC, 2011, BIOPHYS J, V100, P1608, DOI 10.1016/j.bpj.2011.02.020; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Day ES, 2012, BIOCHEMISTRY-US, V51, P9124, DOI 10.1021/bi301039t; Dominguez R., 2000, M CURIE BIOSCIENCE D; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng JA, 2011, ANAL BIOCHEM, V409, P144, DOI 10.1016/j.ab.2010.10.025; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Holmes Ken C., 1993, Trends in Cell Biology, V3, P53, DOI 10.1016/0962-8924(93)90161-S; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2000, INT J MED MICROBIOL, V290, P441; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krupka M, 2014, MBIO, V5, DOI 10.1128/mBio.02221-14; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Leighton TL, 2015, ENVIRON MICROBIOL, V17, P4148, DOI 10.1111/1462-2920.12849; Leighton TL, 2015, J BACTERIOL, V197, P2229, DOI 10.1128/JB.00220-15; Lu C, 2014, J STRUCT BIOL, V187, P223, DOI 10.1016/j.jsb.2014.07.006; Luo Y, 2015, MBIO, V6, DOI 10.1128/mBio.02456-14; MARTIN PR, 1995, MOL MICROBIOL, V16, P497, DOI 10.1111/j.1365-2958.1995.tb02414.x; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2015, MOL MICROBIOL, V95, P971, DOI 10.1111/mmi.12907; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Roine E, 1996, J BACTERIOL, V178, P410, DOI 10.1128/jb.178.2.410-417.1996; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Sandkvist M, 2000, INT J MED MICROBIOL, V290, P345, DOI 10.1016/S1438-4221(00)80038-7; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Szwedziak P, 2013, CURR OPIN MICROBIOL, V16, P745, DOI 10.1016/j.mib.2013.09.003; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tammam S, 2014, ADV M C M, P85, DOI 10.1079/9781780642550.0085; Tammam S, 2013, J BACTERIOL, V195, P2126, DOI 10.1128/JB.00032-13; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor D, 2014, BIOINFORMATICS, V30, P3189, DOI 10.1093/bioinformatics/btu506; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006; Tsang MJ, 2015, CURR OPIN MICROBIOL, V24, P60, DOI 10.1016/j.mib.2015.01.002; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; WHITCHURCH CB, 1991, GENE, V101, P33, DOI 10.1016/0378-1119(91)90221-V; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Yamagata A, 2012, J MOL BIOL, V419, P110, DOI 10.1016/j.jmb.2012.02.041; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	69	24	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11003	11015		10.1074/jbc.M116.718353	http://dx.doi.org/10.1074/jbc.M116.718353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022027	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000377042100005
J	Keavy, D; Bristow, LJ; Sivarao, DV; Batchelder, M; King, D; Thangathirupathy, S; Macor, JE; Weed, MR				Keavy, Deborah; Bristow, Linda J.; Sivarao, Digavalli V.; Batchelder, Margaret; King, Dalton; Thangathirupathy, Srinivasan; Macor, John E.; Weed, Michael R.			The qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug Development	PLOS ONE			English	Article							D-ASPARTATE ANTAGONIST; MAJOR DEPRESSION; RANDOMIZED-TRIAL; CHANNEL BLOCKER; KETAMINE; SCHIZOPHRENIA; HUMANS	The antidepressant activity of the N-methyl-D-aspartate (NMDA) receptor channel blocker, ketamine, has led to the investigation of negative allosteric modulators (NAMs) selective for the NR2B receptor subtype. The clinical development of NR2B NAMs would benefit from a translational pharmacodynamic biomarker that demonstrates brain penetration and functional inhibition of NR2B receptors in preclinical species and humans. Quantitative electro-encephalography (qEEG) is a translational measure that can be used to demonstrate pharmacodynamic effects across species. NMDA receptor channel blockers, such as ketamine and phencyclidine, increase the EEG gamma power band, which has been used as a pharmacodynamic biomarker in the development of NMDA receptor antagonists. However, detailed qEEG studies with ketamine or NR2B NAMs are lacking in nonhuman primates. The aim of the present study was to determine the effects on the qEEG power spectra of the NR2B NAMs traxoprodil (CP-101,606) and BMT-108908 in nonhuman primates, and to compare them to the NMDA receptor channel blockers, ketamine and lanicemine. Cynomolgus monkeys were surgically implanted with EEG radio-telemetry transmitters, and qEEG was measured after vehicle or drug administration. The relative power for a number of frequency bands was determined. Ketamine and lanicemine increased relative gamma power, whereas the NR2B NAMs traxoprodil and BMT-108908 had no effect. Robust decreases in beta power were elicited by ketamine, traxoprodil and BMT-108908; and these agents also produced decreases in alpha power and increases in delta power at the doses tested. These results suggest that measurement of power spectra in the beta and delta bands may represent a translational pharmacodynamic biomarker to demonstrate functional effects of NR2B NAMs. The results of these studies may help guide the selection of qEEG measures that can be incorporated into early clinical evaluation of NR2B NAMs in healthy humans.	[Keavy, Deborah; Bristow, Linda J.; Sivarao, Digavalli V.; Weed, Michael R.] Bristol Myers Squibb Co, Genetically Defined Dis & Genom, 5 Res Pkwy, Wallingford, CT 06492 USA; [Batchelder, Margaret] Bristol Myers Squibb Co, Dept Vet Sci, 5 Res Pkwy, Wallingford, CT 06492 USA; [King, Dalton; Thangathirupathy, Srinivasan; Macor, John E.] Bristol Myers Squibb Co, Discovery Chem, 5 Res Pkwy, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Weed, MR (corresponding author), Bristol Myers Squibb Co, Genetically Defined Dis & Genom, 5 Res Pkwy, Wallingford, CT 06492 USA.	michael.weed@bms.com			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This work was funded in full by Bristol-Myers Squibb, and all authors were BMS employees during their contribution to this project. No other individuals employed or contracted by Bristol-Myers Squibb (other than the named authors) played any role in: study design, data collection and analysis, or preparation of the manuscript. Others were involved in the decision to publish, for instance, in vetting the manuscript material for disclosure of proprietary information pertaining to BMS assets other than BMT-108908. BMS is not developing BMT-108908 for clinical use. There are no additional conflicts of interest to report for the authors, other than employment at BMS.	Association WAP, 2000, AM PSYCH ASS DIAGN S; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Celesia G G, 1974, Electroencephalogr Clin Neurophysiol, V37, P354; Chilukuri Harihar, 2014, Indian J Psychol Med, V36, P71, DOI 10.4103/0253-7176.127258; CLEMENTS JA, 1982, J PHARM SCI, V71, P539, DOI 10.1002/jps.2600710516; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Gil-Da-Costa R, 2013, P NATL ACAD SCI USA, V110, P15425, DOI 10.1073/pnas.1312264110; GINSKI MJ, 1994, PSYCHOPHARMACOLOGY, V114, P573, DOI 10.1007/BF02244987; Goonawardena AV, 2015, NEUROPSYCHOPHARMACOL; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Hong LE, 2010, NEUROPSYCHOPHARMACOL, V35, P632, DOI 10.1038/npp.2009.168; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Kocsis B, 2012, BIOL PSYCHIAT, V71, P987, DOI 10.1016/j.biopsych.2011.10.002; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Nagy D, 2015, NEUROPSYCHOPHARMACOL; Preskorn SH, 2008, J CLIN PSYCHOPHARM, V28, P631, DOI 10.1097/JCP.0b013e31818a6cea; Sanacora G, 2014, MOL PSYCHIATR, V19, P978, DOI 10.1038/mp.2013.130; Sanacora G, 2015, NEUROPSYCHOPHARMACOL, V40, P259, DOI 10.1038/npp.2014.261; SCHUTTLER J, 1987, J PHARMACOKINET BIOP, V15, P241, DOI 10.1007/BF01066320; Sivarao DV, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00096; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Thompson L, 2016, MEDI217 ACS; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Weed MR, 2016, NEUROPSYCHOPHARMACOL, V41, P568, DOI 10.1038/npp.2015.184; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zarate CA, 2013, BIOL PSYCHIAT, V74, P257, DOI 10.1016/j.biopsych.2012.10.019	27	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152729	10.1371/journal.pone.0152729	http://dx.doi.org/10.1371/journal.pone.0152729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035340	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200032
J	Munukka, E; Wiklund, P; Partanen, T; Valimaki, S; Laakkonen, EK; Lehti, M; Fischer-Posovzsky, P; Wabitsch, M; Cheng, SL; Huovinen, P; Pekkala, S				Munukka, Eveliina; Wiklund, Petri; Partanen, Tiina; Valimaki, Sakari; Laakkonen, Eija K.; Lehti, Maarit; Fischer-Posovzsky, Pamela; Wabitsch, Martin; Cheng, Sulin; Huovinen, Pentti; Pekkala, Satu			Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ADIPOSE-TISSUE INFLAMMATION; INSULIN-RESISTANCE; LIVER-DISEASE; NLRP3 INFLAMMASOME; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; OBESITY; CELLS; ATHEROSCLEROSIS	While the role of both elevated levels of circulating bacterial cell wall components and adipose tissue in hepatic fat accumulation has been recognized, it has not been considered that the bacterial components-recognizing adipose tissue receptors contribute to the hepatic fat content. In this study we found that the expression of adipose tissue bacterial flagellin (FLG)-recognizing Toll-like receptor (TLR) 5 associated with liver fat content (r = 0.699, p = 0.003) and insulin sensitivity (r = -0.529, p = 0.016) in humans (n = 23). No such associations were found for lipopolysaccharides (LPS)-recognizing TLR4. To study the underlyingmolecular mechanisms of these associations, human HepG2 hepatoma cells were exposed in vitro to the conditioned culture media derived from FLG or LPS-challenged human adipocytes. The adipocyte-mediated effects were also compared to the effects of direct HepG2 exposure to FLG and LPS. We found that the media derived from FLG-treated adipocytes stimulated fat accumulation in HepG2 cells, whereas either media derived from LPS-treated adipocytes or direct FLG or LPS exposure did not. This is likely due to that FLG-treatment of adipocytes increased lipolysis and secretion of glycerol, which is known to serve a substrate for triglyceride synthesis in hepatocytes. Similarly, only FLG-media significantly decreased insulin signaling-related Akt phosphorylation, IRS1 expression and mitochondrial respiratory chain ATP5A. In conclusion, our results suggest that the FLG-induced TLR5 activation in adipocytes increases glycerol secretion fromadipocytes and decreases insulin signaling and mitochondrial functions, and increases fat accumulation in hepatocytes. These mechanisms could, at least partly, explain the adipose tissue TLR5 expression associated with liver fat content in humans.	[Munukka, Eveliina; Wiklund, Petri; Partanen, Tiina; Valimaki, Sakari; Laakkonen, Eija K.; Cheng, Sulin; Pekkala, Satu] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Munukka, Eveliina; Huovinen, Pentti; Pekkala, Satu] Univ Turku, Dept Clin Microbiol & Immunol, Turku, Finland; [Lehti, Maarit] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Fischer-Posovzsky, Pamela; Wabitsch, Martin] Univ Med Ctr Ulm, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Cheng, Sulin] Shanghai Jiao Tong Univ, Dept Phys Educ, Shanghai 200030, Peoples R China	University of Jyvaskyla; University of Turku; Ulm University; Shanghai Jiao Tong University	Pekkala, S (corresponding author), Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland.; Pekkala, S (corresponding author), Univ Turku, Dept Clin Microbiol & Immunol, Turku, Finland.	satu.p.pekkala@jyu.fi	Huovinen, Pentti/C-9121-2019; Munukka, Eveliina/GQP-6540-2022; Laakkonen, Eija/G-3345-2017; Lehti, Maarit/ABB-1812-2021; Lehti, Maarit/T-3824-2019	Huovinen, Pentti/0000-0003-0003-1539; Laakkonen, Eija/0000-0001-6655-9489; Valimaki, Sakari/0000-0002-4777-8157; Lehti, Maarit/0000-0002-9063-6541; Pekkala, Satu/0000-0003-3107-0813	Academy of Finland [ID 267719]; Finnish Diabetes Research Foundation; Finnish Culture Foundation (Central and Southwest Finland funds); Academy of Finland SKIDI-KID Project [ID 135038]	Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Culture Foundation (Central and Southwest Finland funds); Academy of Finland SKIDI-KID Project	This study was financially supported by The Academy of Finland postdoctoral research fellow for Dr. Satu Pekkala (Grant ID 267719), by The Finnish Diabetes Research Foundation and by the Finnish Culture Foundation (Central and Southwest Finland funds). The study of the human project was supported by Academy of Finland SKIDI-KID Project (PI: Sulin Cheng, Grant ID 135038).	Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Besse-Patin Aurele, 2014, Int J Cell Biol, V2014, P519153, DOI 10.1155/2014/519153; Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Dasu MR, 2012, CLIN SCI, V122, P203, DOI 10.1042/CS20110357; Esser N, 2013, DIABETOLOGIA, V56, P2487, DOI 10.1007/s00125-013-3023-9; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Franchini M, 2010, HORM METAB RES, V42, P703, DOI 10.1055/s-0030-1261872; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Gaggini M, 2013, NUTRIENTS, V5, P1544, DOI 10.3390/nu5051544; Henao-Mejia J, 2013, J AUTOIMMUN, V46, P66, DOI 10.1016/j.jaut.2013.07.001; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kanuri G, 2014, LIVER INT; Ke BB, 2012, J HEPATOL, V56, P359, DOI 10.1016/j.jhep.2011.05.023; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Miura K, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/362847; Munukka E, 2014, J HEPATOL, V61, P132, DOI 10.1016/j.jhep.2014.02.020; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Pekkala S, 2015, OBESITY, V23, P581, DOI 10.1002/oby.20993; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Peyrin-Biroulet L, 2007, GUT, V56, P577, DOI 10.1136/gut.2005.082925; Pinzone Marilia Rita, 2012, Int J Microbiol, V2012, P694629, DOI 10.1155/2012/694629; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Svineng G, 2008, CONNECT TISSUE RES, V49, P197, DOI 10.1080/03008200802143166; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Watanabe Y, 2013, NUTRIENTS, V5, P3757, DOI 10.3390/nu5093757; Wobser H, 2009, CELL RES, V19, P996, DOI 10.1038/cr.2009.73; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	38	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152786	10.1371/journal.pone.0152786	http://dx.doi.org/10.1371/journal.pone.0152786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035341	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200040
J	Anandan, A; Anumalla, M; Pradhan, SK; Ali, J				Anandan, Annamalai; Anumalla, Mahender; Pradhan, Sharat Kumar; Ali, Jauhar			Population Structure, Diversity and Trait Association Analysis in Rice (Oryza sativa L.) Germplasm for Early Seedling Vigor (ESV) Using Trait Linked SSR Markers	PLOS ONE			English	Article							GENETIC DIVERSITY; COMPLEX TRAITS; IDENTIFICATION; LOCI; GERMINATION; DISSECTION; VARIETIES; GENOTYPES; SOFTWARE; EASTERN	Early seedling vigor (ESV) is the essential trait for direct seeded rice to dominate and smother the weed growth. In this regard, 629 rice genotypes were studied for their morphological and physiological responses in the field under direct seeded aerobic situation on 14th, 28th and 56th days after sowing (DAS). It was determined that the early observations taken on 14th and 28th DAS were reliable estimators to study ESV as compared to56th DAS. Further, 96 were selected from 629 genotypes by principal component (PCA) and discriminate function analyses. The selected genotypes were subjected to decipher the pattern of genetic diversity in terms of both phenotypic and genotypic by using ESV QTL linked simple sequence repeat (SSR) markers. To assess the genetic structure, model and distance based approaches were used. Genotyping of 96 rice lines using 39 polymorphic SSRs produced a total of 128 alleles with the phenotypic information content (PIC) value of 0.24. The model based population structure approach grouped the accession into two distinct populations, whereas unrooted tree grouped the genotypes into three clusters. Both model based and structure based approach had clearly distinguished the early vigor genotypes from non-early vigor genotypes. Association analysis revealed that 16 and 10 SSRs showed significant association with ESV traits by general linear model (GLM) and mixed linear model (MLM) approaches respectively. Marker alleles on chromosome 2 were associated with shoot dry weight on 28 DAS, vigor index on 14 and 28 DAS. Improvement in the rate of seedling growth will be useful for identifying rice genotypes acquiescent to direct seeded conditions through marker- assisted selection.	[Anandan, Annamalai; Anumalla, Mahender; Pradhan, Sharat Kumar] Natl Rice Res Inst, Div Crop Improvement, Cuttack, Odisha, India; [Ali, Jauhar] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines	Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; CGIAR; International Rice Research Institute (IRRI)	Ali, J (corresponding author), Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines.	j.ali@irri.org	Anumalla, Mahender/AAU-9955-2021; Ali, Jauhar Ali or A. Jauhar/E-4432-2012	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607				Abe A, 2012, THEOR APPL GENET, V125, P647, DOI 10.1007/s00122-012-1857-z; Ali ML, 2011, CROP SCI, V51, P2021, DOI 10.2135/cropsci2010.11.0641; Anandan A, 2015, FIELD CROP RES, V172, P153, DOI 10.1016/j.fcr.2014.11.007; Anandan A, 2012, FUNCT PLANT BIOL, V39, P137, DOI 10.1071/FP11184; Behera L., 2012, Australian Journal of Crop Science, V6, P1369; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cairns JE, 2009, FIELD CROP RES, V113, P207, DOI 10.1016/j.fcr.2009.05.007; Cheng XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080002; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Cui KH, 2002, THEOR APPL GENET, V105, P745, DOI 10.1007/s00122-002-0908-2; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Diwan J, 2013, RES JOUR BIOL, V1, P24; Ekta Joshi, 2013, Plant Knowledge Journal, V2, P119; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Han Longzhi, 2007, Journal of Genetics and Genomics, V34, P239, DOI 10.1016/S1673-8527(07)60025-3; Huang Zheng, 2004, Acta Genetica Sinica, V31, P596; Jiang L, 2006, FIELD CROP RES, V98, P68, DOI 10.1016/j.fcr.2005.12.015; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Kannan B, SCI WORLD J, V2014; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lu XL, 2007, PLANT SCI, V172, P212, DOI 10.1016/j.plantsci.2006.08.012; MAGUIRE JAMES D., 1962, CROP SCI, V2, P176, DOI 10.2135/cropsci1962.0011183X000200020033x; Mahender A, 2015, PLANTA, V241, P1027, DOI 10.1007/s00425-015-2273-9; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nachimuthu VV, 2015, RICE, V8, DOI 10.1186/s12284-015-0062-5; Namuco OS, 2009, FIELD CROP RES, V113, P197, DOI 10.1016/j.fcr.2009.05.008; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; PATEL M Z, 1989, Indian Journal of Genetics and Plant Breeding, V49, P113; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; Salgotra RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131858; Shah SM, 2013, PAK J BOT, V45, P423; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; Sow M, 2014, GENET RESOUR CROP EV, V61, P199, DOI 10.1007/s10722-013-0026-9; Wang ZF, 2010, J ZHEJIANG UNIV-SC B, V11, P958, DOI 10.1631/jzus.B1000238; Xie LX, 2014, J INTEGR PLANT BIOL, V56, P749, DOI 10.1111/jipb.12190; Yang W, 2010, ACTA AGRON SIN, V36, P754, DOI DOI 10.3724/SP.J.1006.2010.00754; Yeh FC, 1999, POPGEVE VERSION 1 31; Zhang DL, 2007, CHINESE SCI BULL, V52, P343, DOI 10.1007/s11434-007-0063-x; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhang ZH, 2005, ANN BOT-LONDON, V95, P423, DOI 10.1093/aob/mci039; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou L, 2007, FIELD CROP RES, V100, P294, DOI 10.1016/j.fcr.2006.08.003	48	52	54	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152406	10.1371/journal.pone.0152406	http://dx.doi.org/10.1371/journal.pone.0152406			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031620	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800067
J	Faulks, L; Ostman, O				Faulks, Leanne; Ostman, Oerjan			Genetic Diversity and Hybridisation between Native and Introduced Salmonidae Fishes in a Swedish Alpine Lake	PLOS ONE			English	Article							CHAR SALVELINUS-ALPINUS; ARCTIC CHARR; FRESH-WATER; POPULATION-STRUCTURE; BROWN TROUT; BROOK CHARR; MICROSATELLITE VARIATION; NATURAL HYBRIDIZATION; MITOCHONDRIAL GENOME; S-FONTINALIS	Understanding the processes underlying diversification can aid in formulating appropriate conservation management plans that help maintain the evolutionary potential of taxa, particularly under human-induced activities and climate change. Here we assessed the microsatellite genetic diversity and structure of three salmonid species, two native (Arctic charr, Salvelinus alpinus and brown trout, Salmo trutta) and one introduced (brook charr, Salvelinus fontinalis), from an alpine lake in sub-arctic Sweden, Lake Ann. The genetic diversity of the three species was similar and sufficiently high from a conservation genetics perspective: corrected total heterozygosity, H'(T) = 0.54, 0.66, 0.60 and allelic richness, A(R) = 4.93, 5.53 and 5.26 for Arctic charr, brown trout and brook charr, respectively. There were indications of elevated inbreeding coefficients in brown trout (G(IS) = 0.144) and brook charr (G(IS) = 0.129) although sibling relationships were likely a confounding factor, as a high proportion of siblings were observed in all species within and among sampling locations. Overall genetic structure differed between species, Fst = 0.01, 0.02 and 0.04 in Arctic charr, brown trout and brook charr respectively, and there was differentiation at only a few specific locations. There was clear evidence of hybridisation between the native Arctic charr and the introduced brook charr, with 6% of individuals being hybrids, all of which were sampled in tributary streams. The ecological and evolutionary consequences of the observed hybridisation are priorities for further research and the conservation of the evolutionary potential of native salmonid species.	[Faulks, Leanne; Ostman, Oerjan] Uppsala Univ, Dept Ecol & Genet Anim Ecol, Norbyvagen 18D, S-75236 Uppsala, Sweden; [Faulks, Leanne] Univ Tsukuba, Sugadaira Montane Res Ctr, Sugadaira Kogen 1278-294, Ueda, Nagano 3862204, Japan; [Ostman, Oerjan] Inst Coastal Res, Dept Aquat Resources, Skolvagen 6, S-74242 Oregrund, Sweden	Uppsala University; University of Tsukuba	Faulks, L (corresponding author), Uppsala Univ, Dept Ecol & Genet Anim Ecol, Norbyvagen 18D, S-75236 Uppsala, Sweden.; Faulks, L (corresponding author), Univ Tsukuba, Sugadaira Montane Res Ctr, Sugadaira Kogen 1278-294, Ueda, Nagano 3862204, Japan.	leanne.k.faulks@gmail.com	Östman, Örjan/ABF-8714-2020; Faulks, Leanne/AAE-8802-2019	Östman, Örjan/0000-0002-1930-0148; 	Olsson Borghs Stiftelse; Carl Tryggers Stiftelese; Vetenskapsradet; Lake Ann advisory board	Olsson Borghs Stiftelse; Carl Tryggers Stiftelese; Vetenskapsradet(Swedish Research Council); Lake Ann advisory board	LKF received funding from OlssonBorghs Stiftelse (www.stiftelsemedel.se/olsson-borghsstiftelse) and Carl Tryggers Stiftelese (www.carltryggersstiftelse.se) and OO received funding from Vetenskapsradet (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted with the support and animal ethics permit of the local agency responsible for managing the lake, Jamtlands Lansstyrelse, Ostersund. Lake Ann advisory board also supported the study. Assistance in the lab from G. Engstrom. Assistance with sample collection from S. Hellestam, L. Bergwall, P.A. Jamting and members of the Lake Ann Protection Group.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Adams BK, 2003, J FISH BIOL, V62, P517, DOI 10.1046/j.1095-8649.2003.00032.x; Adams SB, 2001, ECOSYSTEMS, V4, P296, DOI 10.1007/s10021-001-0012-5; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Amundsen PA, 2008, ENVIRON BIOL FISH, V83, P45, DOI 10.1007/s10641-007-9262-1; Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Anderson EC, 2002, GENETICS, V160, P1217; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Belmar-Lucero S, 2012, ECOL EVOL, V2, P562, DOI 10.1002/ece3.196; Bergwall L, 2010, FISK UNDERSOKNINGAR; Bernardi G, 2013, MOL ECOL, V22, P5487, DOI 10.1111/mec.12494; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; Bhat S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091208; Blanchfield PJ, 1997, CAN J FISH AQUAT SCI, V54, P747, DOI 10.1139/cjfas-54-4-747; Briers RA, 2013, ECOL FRESHW FISH, V22, P137, DOI 10.1111/eff.12011; Brinkmann H, 2004, J MOL EVOL, V59, P834, DOI 10.1007/s00239-004-0122-8; Brunner PC, 1998, MOL ECOL, V7, P209, DOI 10.1046/j.1365-294x.1998.00341.x; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Campos JL, 2006, CONSERV GENET, V7, P515, DOI 10.1007/s10592-005-9063-z; Castric V, 2001, EVOLUTION, V55, P1016, DOI 10.1554/0014-3820(2001)055[1016:LSAHGD]2.0.CO;2; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; CHEVASSUS B, 1979, AQUACULTURE, V17, P113, DOI 10.1016/0044-8486(79)90047-4; Costanza R, 1998, ECOL ECON, V25, P67, DOI 10.1016/S0921-8009(98)00019-6; Coyne J.A., 2004, SPECIATION; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; DEMARAIS BD, 1992, P NATL ACAD SCI USA, V89, P2747, DOI 10.1073/pnas.89.7.2747; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Dierking J, 2014, EVOL APPL, V7, P1068, DOI 10.1111/eva.12166; DOWLING TE, 1992, CONSERV BIOL, V6, P355, DOI 10.1046/j.1523-1739.1992.06030355.x; Drinan TJ, 2012, ECOL FRESHW FISH, V21, P420, DOI 10.1111/j.1600-0633.2012.00561.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Fitzpatrick BM, 2015, CURR ZOOL, V61, P206, DOI 10.1093/czoolo/61.1.206; Fitzpatrick BM, 2010, P NATL ACAD SCI USA, V107, P3606, DOI 10.1073/pnas.0911802107; Ford JS, 2008, PLOS BIOL, V6, P411, DOI 10.1371/journal.pbio.0060033; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Fraser DJ, 2004, MOL ECOL, V13, P67, DOI 10.1046/j.1365-294X.2003.02038.x; Gagnaire PA, 2013, EVOLUTION, V67, P2483, DOI 10.1111/evo.12075; GIBSON RJ, 1993, REV FISH BIOL FISHER, V3, P39, DOI 10.1007/BF00043297; Glemet H, 1998, MOL ECOL, V7, P1655, DOI 10.1046/j.1365-294x.1998.00494.x; Gomez-Uchida D, 2013, ECOL EVOL, V3, P569, DOI 10.1002/ece3.485; Gomez-Uchida D, 2009, MOL ECOL, V18, P4854, DOI 10.1111/j.1365-294X.2009.04409.x; Goudet J, 1995, FSTAT VERSION 2 9 3; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; HAMMAR J, 1991, CAN J FISH AQUAT SCI, V48, P1437, DOI 10.1139/f91-171; HAMMAR J, 1989, AMBIO, V18, P6; Hansen MM, 1997, MOL ECOL, V6, P469, DOI 10.1046/j.1365-294X.1997.t01-1-00202.x; HARPER JL, 1994, PHILOS T R SOC B, V345, P5, DOI 10.1098/rstb.1994.0081; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Hendry AP, 2010, EVOLUTION, V64, P1517, DOI 10.1111/j.1558-5646.2010.00947.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hoagstrom CW, 2015, GLOBAL CHANGE BIOL, V21, P4, DOI 10.1111/gcb.12578; HOLCIK J, 1991, CAN J FISH AQUAT SCI, V48, P13, DOI 10.1139/f91-300; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kitano S, 2014, ICHTHYOL RES, V61, P1, DOI 10.1007/s10228-013-0362-y; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Koehn JD, 2011, MAR FRESHWATER RES, V62, P1148, DOI 10.1071/MF11139; Mace GM, 2008, MOL ECOL, V17, P9, DOI 10.1111/j.1365-294X.2007.03455.x; McLellan R, 2014, LIVING PLANET REPORT; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Meli A, 2013, J FISH BIOL, V82, P1514, DOI 10.1111/jfb.12082; Miller H, 2015, ECOL FRESHW FISH, V24, P32, DOI 10.1111/eff.12122; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Naiman RJ, 2002, ENVIRON MANAGE, V30, P455, DOI 10.1007/s00267-002-2734-3; Ostergren J, 2012, ECOL FRESHW FISH, V21, P119, DOI 10.1111/j.1600-0633.2011.00529.x; Paxton RJ, 1996, MOL ECOL, V5, P511, DOI 10.1111/j.1365-294X.1996.tb00343.x; Pilgrim BL, 2012, ECOL EVOL, V2, P885, DOI 10.1002/ece3.200; Poissant J, 2005, MOL ECOL, V14, P1321, DOI 10.1111/j.1365-294X.2005.02500.x; Primmer CR, 1999, HEREDITAS, V130, P277, DOI 10.1111/j.1601-5223.1999.00277.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Scribner KT, 2000, REV FISH BIOL FISHER, V10, P293, DOI 10.1023/A:1016642723238; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; SNORRASON SS, 1994, BIOL J LINN SOC, V52, P1; Soule M. E., 1980, CONSERVATION BIOL EV; Stelkens RB, 2012, MOL ECOL, V21, P2896, DOI 10.1111/j.1365-294X.2012.05581.x; Swatdipong A, 2010, J FISH BIOL, V77, P2048, DOI 10.1111/j.1095-8649.2010.02784.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Westgaard JI, 2004, J FISH BIOL, V65, P1185, DOI 10.1111/j.0022-1112.2004.00524.x; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Wilson AJ, 2004, MOL ECOL, V13, P1129, DOI 10.1111/j.1365-294X.2004.02149.x; Wilson CC, 1998, MOL ECOL, V7, P127, DOI 10.1046/j.1365-294x.1998.00302.x	89	8	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152732	10.1371/journal.pone.0152732	http://dx.doi.org/10.1371/journal.pone.0152732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032100	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800131
J	Murray, ET; Jones, R; Thomas, C; Ghosh, AK; Sattar, N; Deanfield, J; Hardy, R; Kuh, D; Hughes, AD; Whincup, P				Murray, Emily T.; Jones, Rebecca; Thomas, Claudia; Ghosh, Arjun K.; Sattar, Naveed; Deanfield, John; Hardy, Rebecca; Kuh, Diana; Hughes, Alun D.; Whincup, Peter			Life Course Socioeconomic Position: Associations with Cardiac Structure and Function at Age 60-64 Years in the 1946 British Birth Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; VENTRICULAR DIASTOLIC DYSFUNCTION; OLDER MEN; EJECTION FRACTION; OF-CARDIOLOGY; FAILURE; RISK; ECHOCARDIOGRAPHY; HEALTH; POPULATION	Although it is recognized that risks of cardiovascular diseases associated with heart failure develop over the life course, no studies have reported whether life course socioeconomic inequalities exist for heart failure risk. The Medical Research Council's National Survey of Health and Development was used to investigate associations between occupational socioeconomic position during childhood, early adulthood and middle age and measures of cardiac structure [left ventricular (LV) mass index and relative wall thickness (RWT)] and function [systolic: ejection fraction (EF) and midwall fractional shortening (mFS); diastolic: left atrial (LA) volume, E/A ratio and E/e' ratio)]. Different life course models were compared with a saturated model to ascertain the nature of the relationship between socioeconomic position across the life course and each cardiac marker. Findings showed that models where socioeconomic position accumulated over multiple time points in life provided the best fit for 3 of the 7 cardiac markers: childhood and early adulthood periods for the E/A ratio and E/e' ratio, and all three life periods for LV mass index. These associations were attenuated by adjustment for adiposity, but were little affected by adjustment for other established or novel cardio-metabolic risk factors. There was no evidence of a relationship between socioeconomic position at any time point and RWT, EF, mFS or LA volume index. In conclusion, socioeconomic position across multiple points of the lifecourse, particularly earlier in life, is an important determinant of some measures of LV structure and function. BMI may be an important mediator of these associations.	[Murray, Emily T.; Jones, Rebecca; Thomas, Claudia; Whincup, Peter] St Georges Univ London, Populat Hlth Res Ctr, Div Populat Hlth Sci & Educ, London, England; [Ghosh, Arjun K.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Acad Hlth Sci Ctr, London, England; [Sattar, Naveed] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Deanfield, John] UCL, Vasc Physiol Unit, Inst Cardiovasc Sci, London, England; [Ghosh, Arjun K.; Hardy, Rebecca; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Hughes, Alun D.] UCL, Inst Cardiovasc Sci, London, England; [Murray, Emily T.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Jones, Rebecca] UCL, Div Psychiat, Fac Brain Sci, London, England	St Georges University London; Imperial College London; University of Glasgow; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Murray, ET (corresponding author), St Georges Univ London, Populat Hlth Res Ctr, Div Populat Hlth Sci & Educ, London, England.; Murray, ET (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	emily.murray@ucl.ac.uk	Ghosh, Arjun/ABC-9543-2020; Hughes, Alun David/N-3781-2013; Kuh, Diana/L-6019-2014; Hardy, Rebecca/AFR-1989-2022; Slimings, Claudia/AAE-6550-2019	Ghosh, Arjun/0000-0003-4992-2412; Hughes, Alun David/0000-0001-5432-5271; Kuh, Diana/0000-0001-7386-2857; Slimings, Claudia/0000-0001-7988-1186; Deanfield, John/0000-0001-8806-6052; Hardy, Rebecca/0000-0001-9949-0799; Murray, Emily/0000-0001-6297-6920; Whincup, Peter/0000-0002-5589-4107	Medical Research Council United Kingdom;  [MC_UU_12019/1];  [MC_UU_12019/2];  [U1200632239];  [G1001143]; MRC [MC_UU_12019/1, MC_UU_12019/2, G1001143] Funding Source: UKRI; Medical Research Council [MC_UU_12019/2, G1001143, MR/K006584/1, MC_UU_12019/1] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Medical Research Council United Kingdom funded this project [http://www.mrc.ac.uk/]. PW received specific funding for this project through G1001143. The National Survey of Health and Development, as well as RH and DK are supported by core funding and grant funding (U1200632239), as well as funding for the age 60-64 data collection (MC_UU_12019/1, MC_UU_12019/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; Bradley BJ, 2013, J ADOLESCENT HEALTH, V52, P523, DOI 10.1016/j.jadohealth.2013.01.008; Christensen S, 2011, EUR HEART J, V32, P450, DOI 10.1093/eurheartj/ehq435; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Espelt A, 2011, CURR DIABETES REV, V7, P148, DOI 10.2174/157339911795843131; Falkstedt D, 2011, EUR J PUBLIC HEALTH, V21, P713, DOI 10.1093/eurpub/ckq158; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Gaasch WH, 2004, ANNU REV MED, V55, P373, DOI 10.1146/annurev.med.55.091902.104417; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Glezeva N, 2013, HEART FAIL REV; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; Heidenreich PA, 2012, CIRC-CARDIOVASC QUAL, V5, P37, DOI 10.1161/CIRCOUTCOMES.110.959122; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Kannel W B, 2000, Heart Fail Rev, V5, P167; Kristenson M, 2004, SOC SCI MED, V58, P1511, DOI 10.1016/S0277-9536(03)00353-8; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Lang RM, 2012, J AM SOC ECHOCARDIOG, V25, P3, DOI 10.1016/j.echo.2011.11.010; Lawlor D. A., 2014, LIFE COURSE APPROACH, P146; Lawlor DA, 2004, AM J PUBLIC HEALTH, V94, P1386, DOI 10.2105/AJPH.94.8.1386; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Mogelvang R, 2009, CIRCULATION, V119, P2679, DOI 10.1161/CIRCULATIONAHA.108.793471; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Ramsay SE, 2007, INT J EPIDEMIOL, V36, P560, DOI 10.1093/ije/dym060; Ramsay SE, 2014, EUR HEART J, V35, P442, DOI 10.1093/eurheartj/eht449; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rodevand O, 1999, INT J CARDIAC IMAG, V15, P397, DOI 10.1023/A:1006276513186; Rodriguez CJ, 2004, HYPERTENSION, V43, P775, DOI 10.1161/01.HYP.0000118055.90533.88; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Vardeny O, 2013, JACC-HEART FAIL, V1, P531, DOI 10.1016/j.jchf.2013.07.006; Wahad S. R. A., 2012, INT PROCEEDING EC DE, P421; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P1870, DOI 10.1016/j.jacc.2011.06.057	37	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152691	10.1371/journal.pone.0152691	http://dx.doi.org/10.1371/journal.pone.0152691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031846	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000373121800119
J	Garcia, CP; Richardson, GAV; Dimopoulos, NA; Espinosa, DDF; Miriuka, SG; Sevlever, GE; Romorini, L; Scassa, ME				Paola Garcia, Carolina; Videla Richardson, Guillermo Agustin; Alexis Dimopoulos, Nicolas; Fernandez Espinosa, Damian Dario; Gabriel Miriuka, Santiago; Emilio Sevlever, Gustavo; Romorini, Leonardo; Elida Scassa, Maria			Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; DNA-BINDING DOMAIN; P53-DEPENDENT APOPTOSIS; RAPID APOPTOSIS; NERVOUS-SYSTEM; P53; DEATH; MITOCHONDRIA; INHIBITOR; BAX	Human embryonic stem cells (hESCs) are hypersensitive to genotoxic stress and display lower survival ability relative to their differentiated progeny. Herein, we attempted to investigate the source of this difference by comparing the DNA damage responses triggered by the topoisomerase I inhibitor camptothecin, in hESCs, human induced pluripotent stem cells (hiPSCs) and hESCs-derived neuroprogenitors (NP). We observed that upon camptothecin exposure pluripotent stem cells underwent apoptosis more swiftly and at a higher rate than differentiated cells. However, the cellular response encompassing ataxia-telangiectasia mutated kinase activation and p53 phosphorylation both on serine 15 as well as on serine 46 resulted very similar among the aforementioned cell types. Importantly, we observed that hESCs and hiPSCs express lower levels of the anti-apoptotic protein Bcl-2 than NP. To assess whether Bcl-2 abundance could account for this differential response we treated cells with ABT-263, WEHI-539 and ABT-199, small molecules that preferentially target the BH3-binding pocket of Bcl-xL and/or Bcl-2 and reduce their ability to sequester pro-apoptotic factors. We found that in the absence of stress stimuli, NP exhibited a higher sensitivity to ABT-263 and WEHI-539 than hESCs and hiPSCs. Conversely, all tested cell types appeared to be highly resistant to the Bcl-2 specific inhibitor, ABT-199. However, in all cases we determined that ABT-263 or WEHI-539 treatment exacerbated camptothecin-induced apoptosis. Importantly, similar responses were observed after siRNA-mediated down-regulation of Bcl-xL or Bcl-2. Taken together, our results suggest that Bcl-xL contrary to Bcl-2 contributes to ensure cell survival and also functions as a primary suppressor of DNA double-strand brake induced apoptosis both in pluripotent and derived NP cells. The emerging knowledge of the relative dependence of pluripotent and progenitor cells on Bcl-2 and Bcl-xL activities may help to predict cellular responses and potentially manipulate these cells for therapeutic purposes in the near future.	[Paola Garcia, Carolina; Videla Richardson, Guillermo Agustin; Alexis Dimopoulos, Nicolas; Fernandez Espinosa, Damian Dario; Gabriel Miriuka, Santiago; Emilio Sevlever, Gustavo; Romorini, Leonardo; Elida Scassa, Maria] Consejo Nacl Invest Cient & Tecn, LIAN, Fdn FLENI, Ruta 9,Km 53,B1625XAF Escobar, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Scassa, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, LIAN, Fdn FLENI, Ruta 9,Km 53,B1625XAF Escobar, RA-1033 Buenos Aires, DF, Argentina.	mescassa@fleni.org.ar	Miriuka, Santiago/ABE-9614-2020; Romorini, Leonardo/AGK-7429-2022; Miriuka, Santiago/AAM-4051-2020; Sevlever, Gustavo/Q-2219-2015	Romorini, Leonardo/0000-0002-3972-0991; Miriuka, Santiago/0000-0003-2402-3920; Sevlever, Gustavo/0000-0002-9567-7553	ANPCyT [PICT 2011-2717]; Fundacion Perez Companc	ANPCyT(ANPCyT); Fundacion Perez Companc	This work was funded by grants from ANPCyT (PICT 2011-2717) and Fundacion Perez Companc.; This work was funded by grants from ANPCyT (PICT 2011-2717) and Fundacion Perez Companc. CPG and NAD are Graduate Fellows and LR and SGM are Research Members of CONICET. GAVR is a Graduate Fellow of Instituto Nacional del Cancer.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Crowther AJ, 2013, J NEUROSCI, V33, P18098, DOI 10.1523/JNEUROSCI.2602-13.2013; Davids MS, 2013, CANCER CELL, V23, P139, DOI 10.1016/j.ccr.2013.01.018; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Doerflinger M, 2015, FEBS J, V282, P1006, DOI 10.1111/febs.13190; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Kapinas K, 2013, J CELL PHYSIOL, V228, P9, DOI 10.1002/jcp.24104; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Lee MO, 2013, P NATL ACAD SCI USA, V110, pE3281, DOI 10.1073/pnas.1303669110; Lee Y, 2007, NEUROSCIENCE, V145, P1365, DOI 10.1016/j.neuroscience.2006.07.026; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Liu JC, 2014, TRENDS CELL BIOL, V24, P268, DOI 10.1016/j.tcb.2014.03.002; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Luzzani C, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt540; Madden DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028530; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mauro M, 2012, NUCLEIC ACIDS RES, V40, P8348, DOI 10.1093/nar/gks612; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1994, CANCER RES, V54, P3131; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Garcia CP, 2014, STEM CELL RES, V12, P400, DOI 10.1016/j.scr.2013.12.002; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sasaki M, 2001, MECH AGEING DEV, V122, P1695, DOI 10.1016/S0047-6374(01)00281-0; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Slagsvold HH, 2003, BRAIN RES, V984, P111, DOI 10.1016/S0006-8993(03)03119-6; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao RB, 2000, GENE DEV, V14, P981	49	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152607	10.1371/journal.pone.0152607	http://dx.doi.org/10.1371/journal.pone.0152607			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030982	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800102
J	Zhang, P; Weaver, JC; Chen, G; Beretov, J; Atsumi, T; Qi, M; Bhindi, R; Qi, JC; Madigan, MC; Giannakopoulos, B; Krilis, SA				Zhang, Peng; Weaver, James C.; Chen, Gang; Beretov, Julia; Atsumi, Tatsuya; Qi, Miao; Bhindi, Ravinay; Qi, Jian C.; Madigan, Michele C.; Giannakopoulos, Bill; Krilis, Steven A.			The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ANTIPHOSPHOLIPID SYNDROME; BETA(2)-GLYCOPROTEIN I; ISCHEMIA/REPERFUSION INJURY; PHOSPHOLIPID-BINDING; ENDOTHELIAL-CELLS; MURINE MODEL; ANTIBODIES; MICE; COMPLEMENT	Reperfusion after a period of ischemia results in reperfusion injury (IRI) which involves activation of the inflammatory cascade. In cardiac IRI, IgM natural antibodies (NAb) play a prominent role through binding to altered neoepitopes expressed on damaged cells. Beta 2 Glycoprotein I (beta 2GPI) is a plasma protein that binds to neoepitopes on damaged cells including anionic phospholipids through its highly conserved Domain V. Domain I of beta 2GPI binds circulating IgM NAbs and may provide a link between the innate immune system, IgM NAb binding and cardiac IRI. This study was undertaken to investigate the role of beta 2GPI and its Domain V in cardiac IRI using wild-type (WT), Rag-1(-/-) and beta 2GPI deficient mice. Compared with control, treatment with Domain V prior to cardiac IRI prevented binding of endogenous beta 2GPI to post-ischemic myocardium and resulted in smaller myocardial infarction size in both WT and beta 2GPI deficient mice. Domain V treatment in WT mice also resulted in less neutrophil infiltration, less apoptosis and improved ejection fraction at 24 h. Rag-1-/- antibody deficient mice reconstituted with IgM NAbs confirmed that Domain V prevented IgM NAb induced cardiac IRI. Domain V remained equally effective when delivered at the time of reperfusion which has therapeutic clinical relevance. Based upon this study Domain V may function as a universal inhibitor of IgM NAb binding in the setting of cardiac IRI, which offers promise as a new therapeutic strategy in the treatment of cardiac IRI.	[Zhang, Peng; Weaver, James C.; Chen, Gang; Qi, Miao; Qi, Jian C.; Giannakopoulos, Bill; Krilis, Steven A.] St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia; [Zhang, Peng; Weaver, James C.; Chen, Gang; Qi, Miao; Qi, Jian C.; Giannakopoulos, Bill; Krilis, Steven A.] Univ New S Wales, Dept Med, Sydney, NSW, Australia; [Zhang, Peng] Tianjin Med Univ, Gen Hosp, Dept Cardiothorac Surg, Tianjin, Peoples R China; [Weaver, James C.] St George Hosp, Dept Cardiol, Sydney, NSW, Australia; [Beretov, Julia] SEALS St George Hosp, Anat Pathol, Sydney, NSW, Australia; [Atsumi, Tatsuya] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan; [Bhindi, Ravinay] Royal N Shore Hosp, Dept Cardiol, Sydney, NSW, Australia; [Madigan, Michele C.] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [Madigan, Michele C.] Sydney Eye Hosp, Sydney, NSW, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Giannakopoulos, Bill] St George Hosp, Dept Rheumatol, Sydney, NSW, Australia	St George Hospital; University of New South Wales Sydney; Tianjin Medical University; St George Hospital; St George Hospital; Hokkaido University; Royal North Shore Hospital; University of Sydney; University of Sydney; University of New South Wales Sydney; St George Hospital	Krilis, SA (corresponding author), St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia.; Krilis, SA (corresponding author), Univ New S Wales, Dept Med, Sydney, NSW, Australia.	s.krilis@unsw.edu.au		Beretov, Julia/0000-0001-5582-0020	St George and Sutherland Medical Research Foundation; Japan Society for the Promotion of Science [S-15107]	St George and Sutherland Medical Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the St George and Sutherland Medical Research Foundation - do not use numbers - S Krilis (www.stgeorgemrf.com.au/) and the Japan Society for the Promotion of Science S-15107 - S Krilis (www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a grant from the St George and Sutherland Medical Research Foundation; and funding from the Japan Society for the Promotion of Science to SAK.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Agar C, 2011, THROMB HAEMOSTASIS, V106, P1069, DOI 10.1160/TH11-05-0333; Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Busche MN, 2009, AM J PHYSIOL-HEART C, V297, pH1853, DOI 10.1152/ajpheart.00049.2009; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Del Papa N, 1998, J IMMUNOL, V160, P5572; Dumont EAWJ, 2000, CIRCULATION, V102, P1564, DOI 10.1161/01.CIR.102.13.1564; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Elvington A, 2012, J IMMUNOL, V188, P1460, DOI 10.4049/jimmunol.1102132; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Fleming SD, 2004, J IMMUNOL, V173, P7055, DOI 10.4049/jimmunol.173.11.7055; Fleming SD, 2002, J IMMUNOL, V169, P2126, DOI 10.4049/jimmunol.169.4.2126; Fleming SD, 2010, J IMMUNOL, V185, P6168, DOI 10.4049/jimmunol.1002520; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frangogiannis NG, 2006, ANTIOXID REDOX SIGN, V8, P1907, DOI 10.1089/ars.2006.8.1907; Gandhi C, 2012, BLOOD, V120, P5224, DOI 10.1182/blood-2012-06-440255; Giannakopoulos B, 2014, ARTHRITIS RHEUMATOL, V66, P2270, DOI 10.1002/art.38646; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; Horkko S, 1997, P NATL ACAD SCI USA, V94, P10356, DOI 10.1073/pnas.94.19.10356; HUNT J, 1994, J IMMUNOL, V152, P653; HUNT JE, 1993, P NATL ACAD SCI USA, V90, P2141, DOI 10.1073/pnas.90.6.2141; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Iverson GM, 2002, J IMMUNOL, V169, P7097, DOI 10.4049/jimmunol.169.12.7097; Jones SP, 2015, CIRC RES, V116, P572, DOI 10.1161/CIRCRESAHA.116.305462; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Kulik L, 2009, J IMMUNOL, V182, P5363, DOI 10.4049/jimmunol.0803980; LEFER DJ, 1993, CIRCULATION, V88, P1779, DOI 10.1161/01.CIR.88.4.1779; Libby P, 2013, SEMIN IMMUNOPATHOL, V35, P553, DOI 10.1007/s00281-013-0387-3; MA XL, 1991, J CLIN INVEST, V88, P1237, DOI 10.1172/JCI115427; Maulik N, 1998, AM J PHYSIOL-HEART C, V274, pH242, DOI 10.1152/ajpheart.1998.274.1.H242; MILLER TD, 1995, CIRCULATION, V92, P334, DOI 10.1161/01.CIR.92.3.334; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Niessen HWM, 2000, J CLIN PATHOL, V53, P863, DOI 10.1136/jcp.53.11.863; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pope MR, 2012, J IMMUNOL, V189, P5047, DOI 10.4049/jimmunol.1200290; Reddel SW, 2000, J AUTOIMMUN, V15, P91, DOI 10.1006/jaut.2000.0427; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; Sheng YH, 2001, J BIOL CHEM, V276, P13817, DOI 10.1074/jbc.M010990200; Shishido SN, 2012, CLIN IMMUNOL, V144, P142, DOI 10.1016/j.clim.2012.06.002; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Van Os GMA, 2011, J THROMB HAEMOST, V9, P2447, DOI 10.1111/j.1538-7836.2011.04532.x; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang M, 2006, J EXP MED, V203, P141, DOI 10.1084/jem.20050390; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2006, J MOL CELL CARDIOL, V41, P62, DOI 10.1016/j.yjmcc.2006.02.006	50	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152681	10.1371/journal.pone.0152681	http://dx.doi.org/10.1371/journal.pone.0152681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031114	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800113
J	Fant, C; Schlosser, CA; Gao, X; Strzepek, K; Reilly, J				Fant, Charles; Schlosser, C. Adam; Gao, Xiang; Strzepek, Kenneth; Reilly, John			Projections of Water Stress Based on an Ensemble of Socioeconomic Growth and Climate Change Scenarios: A Case Study in Asia	PLOS ONE			English	Article							RESOURCES; DATASET	The sustainability of future water resources is of paramount importance and is affected by many factors, including population, wealth and climate. Inherent in current methods to estimate these factors in the future is the uncertainty of their prediction. In this study, we integrate a large ensemble of scenarios-internally consistent across economics, emissions, climate, and population-to develop a risk portfolio of water stress over a large portion of Asia that includes China, India, and Mainland Southeast Asia in a future with unconstrained emissions. We isolate the effects of socioeconomic growth from the effects of climate change in order to identify the primary drivers of stress on water resources. We find that water needs related to socioeconomic changes, which are currently small, are likely to increase considerably in the future, often overshadowing the effect of climate change on levels of water stress. As a result, there is a high risk of severe water stress in densely populated watersheds by 2050, compared to recent history. There is strong evidence to suggest that, in the absence of autonomous adaptation or societal response, a much larger portion of the region's population will live in water-stressed regions in the near future. Tools and studies such as these can effectively investigate large-scale system sensitivities and can be useful in engaging and informing decision makers.	[Fant, Charles; Schlosser, C. Adam; Gao, Xiang; Strzepek, Kenneth; Reilly, John] MIT, Joint Program Sci & Policy Global Change, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fant, C (corresponding author), MIT, Joint Program Sci & Policy Global Change, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chasfant@mit.edu			U.S. Department of Energy, Office of Science [DE-FG02-94ER61937, DE-FG02-93ER61677, DE-FG02-08ER64597, DE-FG02-06ER64320]; U.S. Environmental Protection Agency [XA-83344601-0, XA-83240101, XA-83042801-0, PI-83412601-0, RD-83096001, RD-83427901-0]; U.S. National Science Foundation [SES-0825915, EFRI-0835414, ATM-0120468, BCS-0410344, ATM-0329759, DMS-0426845]; U.S. National Aeronautics and Space Administration [NNX07AI49G, NNX08AY59A, NNX06AC30A, NNX09AK26G, NNX08AL73G, NNX09AI26G, NNG04GJ80G, NNG04GP30G, NNA06CN09A]; U.S. National Oceanic and Atmospheric Administration [DG1330-05-CN-1308, NA070AR4310050, NA16GP2290]; U.S. Federal Aviation Administration [06-C-NE-MIT]; Electric Power Research Institute [EP-P32616/C15124]	U.S. Department of Energy, Office of Science(United States Department of Energy (DOE)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); U.S. National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Federal Aviation Administration; Electric Power Research Institute	The Joint Program on the Science and Policy of Global Change, and therefore all authors, is funded by the U.S. Department of Energy, Office of Science under grants DE-FG02-94ER61937, DE-FG02-93ER61677, DE-FG02-08ER64597, and DE-FG02-06ER64320; the U.S. Environmental Protection Agency under grants XA-83344601-0, XA-83240101, XA-83042801-0, PI-83412601-0, RD-83096001, and RD-83427901-0; the U.S. National Science Foundation under grants SES-0825915, EFRI-0835414, ATM-0120468, BCS-0410344, ATM-0329759, and DMS-0426845; the U.S. National Aeronautics and Space Administration under grants NNX07AI49G, NNX08AY59A, NNX06AC30A, NNX09AK26G, NNX08AL73G, NNX09AI26G, NNG04GJ80G, NNG04GP30G, and NNA06CN09A; the U.S. National Oceanic and Atmospheric Administration under grants DG1330-05-CN-1308, NA070AR4310050, and NA16GP2290; the U.S. Federal Aviation Administration under grant 06-C-NE-MIT; the Electric Power Research Institute under grant EP-P32616/C15124; and a consortium of 40 industrial and foundation sponsors (for the complete list see http://globalchange.mit.edu/sponsors/all). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2010, HYDROLOGIC SCI J DES, V52; Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; [Anonymous], 2008, INT MODEL POLICY ANA; Arndt C, CLIMATIC CH IN PRESS; Arnell NW, 2011, GLOBAL ENVIRON CHANG, V21, P592, DOI 10.1016/j.gloenvcha.2011.01.015; Blanc E, 2014, EARTHS FUTURE, V2, P197, DOI 10.1002/2013EF000214; Fant C, 2012, 214 MIT JPSPGC; FAO, FAO STAT YB 2013 WOR; Forest CE, 2008, TELLUS A, V60, P911, DOI 10.1111/j.1600-0870.2008.00346.x; Georgakakos A., 2014, CLIMATE CHANGE IMPAC, P69, DOI [10.7930/J0G44N6T, DOI 10.7930/J0G44N6T]; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); Huffman GJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040000; Jimenez Cisneros BE, CLIMATE CHANGE 201 A; Kumar KR, 2006, CURR SCI INDIA, V90, P334; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; O'Brien K, 2004, GLOBAL ENVIRON CHANG, V14, P303, DOI 10.1016/j.gloenvcha.2004.01.001; Oleson KW, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000563; Paltsev S, 2004, 125 MIT JPSPGC; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Ramirez-Villegas J, 2010, DECISION POLICY ANAL; Revanga C, 2005, ACCOUNT ENV WATER RE; Schlosser CA, 2013, J CLIMATE, V26, P3394, DOI 10.1175/JCLI-D-11-00730.1; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Shen YJ, 2008, HYDROLOG SCI J, V53, P11, DOI 10.1623/hysj.53.1.11; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Siebert S, 2013, UPDATE DIGITAL GLOBA, P1; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Sokolov A. P., 2005, JOINT PROGRAM REPORT, P40; Strzepek K, 2009, WATER PAPERS WORLD B; Strzepek K, 2013, J ADV MODEL EARTH SY, V5, P638, DOI 10.1002/jame.20044; Tchakaloff V., 1957, B SCI MATH, V81, P123; Thenkabail P.S., 2008, GLOBAL IRRIGATED ARE; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Webster MD, 2008, 165 MIT JPSPGC; Webster M, 2012, CLIMATIC CHANGE, V112, P569, DOI 10.1007/s10584-011-0260-0; WILLMOTT CJ, 1992, PROF GEOGR, V44, P84, DOI 10.1111/j.0033-0124.1992.00084.x; World Commission on Dams (WCOD), 2000, DAMS DEV NEW FRAM DE; Xiong W, 2009, GLOBAL ENVIRON CHANG, V19, P34, DOI 10.1016/j.gloenvcha.2008.10.006	39	30	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150633	10.1371/journal.pone.0150633	http://dx.doi.org/10.1371/journal.pone.0150633			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27028871	Green Published, gold, Green Submitted			2022-12-26	WOS:000373116500008
J	Malavasi, V; Skaloud, P; Rindi, F; Tempesta, S; Paoletti, M; Pasqualetti, M				Malavasi, Veronica; Skaloud, Pavel; Rindi, Fabio; Tempesta, Sabrina; Paoletti, Michela; Pasqualetti, Marcella			DNA-Based Taxonomy in Ecologically Versatile Microalgae: A Re-Evaluation of the Species Concept within the Coccoid Green Algal Genus Coccomyxa (Trebouxiophyceae, Chlorophyta)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DELIMITATION METHOD; CULTURE COLLECTION; LICHEN PHOTOBIONT; COALESCENT; BIODIVERSITY; COMPLEX; PRASIOLALES; WIDESPREAD; SPECIATION	Coccomyxa is a genus of unicellular green algae of the class Trebouxiophyceae, well known for its cosmopolitan distribution and great ecological amplitude. The taxonomy of this genus has long been problematic, due to reliance on badly-defined and environmentally variable morphological characters. In this study, based on the discovery of a new species from an extreme habitat, we reassess species circumscription in Coccomyxa, a unicellular genus of the class Trebouxiophyceae, using a combination of ecological and DNA sequence data (analyzed with three different methods of algorithmic species delineation). Our results are compared with those of a recent integrative study of Darienko and colleagues that reassessed the taxonomy of Coccomyxa, recognizing 7 species in the genus. Expanding the dataset from 43 to 61 sequences (SSU + ITS rDNA) resulted in a different delimitation, supporting the recognition of a higher number of species (24 to 27 depending on the analysis used, with the 27-species scenario receiving the strongest support). Among these, C. melkonianii sp. nov. is described from material isolated from a river highly polluted by heavy metals (Rio Irvi, Sardinia, Italy). Analyses performed on ecological characters detected a significant phylogenetic signal in six different characters. We conclude that the 27-species scenario is presently the most realistic for Coccomyxa and we suggest that well-supported lineages distinguishable by ecological preferences should be recognized as different species in this genus. We also recommend that for microbial lineages in which the overall diversity is unknown and taxon sampling is sparse, as is often the case for green microalgae, the results of analyses for algorithmic DNA-based species delimitation should be interpreted with extreme caution.	[Malavasi, Veronica] Univ Cagliari, Interdept Ctr Environm Sci & Engn CINSA, Cagliari, Italy; [Skaloud, Pavel] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Rindi, Fabio] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Tempesta, Sabrina; Paoletti, Michela; Pasqualetti, Marcella] Univ Tuscia, Dept Biol & Ecol Sci, Viterbo, Italy	University of Cagliari; Charles University Prague; Marche Polytechnic University; Tuscia University	Skaloud, P (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	skaloud@natur.cuni.cz	Skaloud, Pavel/F-3103-2011; Malavasi, Veronica/K-8495-2019; Pasqualetti, Marcella/AAA-6047-2020; Rindi, Fabio/H-7147-2019	Skaloud, Pavel/0000-0003-1201-3290; Malavasi, Veronica/0000-0003-3270-2261; RINDI, Fabio/0000-0002-7392-3653	Sardinia Regional Government; POR Sardegna FSE [L.R.7/2007]; Mobility Fund of Charles University in Prague; Institutional Funds of Charles University in Prague	Sardinia Regional Government(Regione Sardegna); POR Sardegna FSE(Regione Sardegna); Mobility Fund of Charles University in Prague; Institutional Funds of Charles University in Prague	VM gratefully acknowledges Sardinia Regional Government for the financial support (research grant cofinanced by POR Sardegna FSE 2007-2013 L.R.7/2007 "Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna") and the Mobility Fund of Charles University in Prague for supporting her research stay in Czech Republic. The study was also supported by Institutional Funds of Charles University in Prague (PS).	ALBERTANO P, 1990, ARCH HYDROBIOL, P81; [Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Belton GS, 2014, J PHYCOL, V50, P32, DOI 10.1111/jpy.12132; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BRUNNER U, 1985, CAN J BOT, V63, P2221, DOI 10.1139/b85-315; Caisova L, 2015, AM J BOT, V102, P1482, DOI 10.3732/ajb.1500199; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Coesel PFM, 2008, BIODIVERS CONSERV, V17, P381, DOI 10.1007/s10531-007-9256-5; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Darienko T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127838; Darienko T, 2015, J PHYCOL, V51, P394, DOI 10.1111/jpy.12279; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dellicour S, 2015, SYST BIOL, V64, P900, DOI 10.1093/sysbio/syu130; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duminil J, 2010, MOL ECOL, V19, P5469, DOI 10.1111/j.1365-294X.2010.04917.x; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Ettl H, 1995, SYLLABUS BODEN LUFT; Florio AM, 2012, J EVOLUTION BIOL, V25, P1399, DOI 10.1111/j.1420-9101.2012.02528.x; Fucikova K, 2014, PHYCOL RES, V62, P294, DOI 10.1111/pre.12062; Fucikova K, 2014, J PHYCOL, V50, P14, DOI 10.1111/jpy.12118; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Garbayo I, 2012, J PHYCOL, V48, P607, DOI 10.1111/j.1529-8817.2012.01160.x; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heesch S, 2016, EUR J PHYCO IN PRESS; Hoef-Emden K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043652; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Huss VAR, 1999, J PHYCOL, V35, P587, DOI 10.1046/j.1529-8817.1999.3530587.x; Jaag O, 1933, BEITR KRYPTOGAM SCHW, V8, P1; Jones G., 2015, SPECIESDELIMITATIONA; Jones G.R., 2015, BIORXIV, DOI 10.1101/010199; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krienitz L, 2012, HYDROBIOLOGIA, V698, P295, DOI 10.1007/s10750-012-1079-z; Leavitt S.D., 2015, RECENT ADV LICHENOLO, P11, DOI 10.1007/978-81-322-2235-4_2; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Lewis LA, 2005, SYST BIOL, V54, P936, DOI 10.1080/10635150500354852; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Lopez-Bautista Juan M., 2007, V11; Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.006; Malavasi V, 2015, NOVA HEDWIGIA, V101, P273, DOI 10.1127/nova_hedwigia/2015/0269; MCFADDEN GI, 1986, PHYCOLOGIA, V25, P551, DOI 10.2216/i0031-8884-25-4-551.1; Meudt HM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-111; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mikhailyuk T, 2015, J PHYCOL, V51, P750, DOI 10.1111/jpy.12316; Miller M.A., 2010, P GAT COMP ENV WORKS; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moniz MBJ, 2012, J PHYCOL, V48, P940, DOI 10.1111/j.1529-8817.2012.01172.x; Naciri Y, 2015, TAXON, V64, P3, DOI 10.12705/641.24; Nemjova K., 2009, THESIS CHARLES U PRA; Novis PM, 2006, PHYCOLOGIA, V45, P293, DOI 10.2216/04-70.1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pardo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104073; Pasqualetti M, 2015, J ENVIRON PROT ECOL, V16, P1262; Payo DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2660; Peksa O, 2011, MOL ECOL, V20, P3936, DOI 10.1111/j.1365-294X.2011.05168.x; Pollio A, 2005, PROTIST, V156, P287, DOI 10.1016/j.protis.2005.04.004; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Proschold Thomas, 2007, Systematics Association Special Volume Series, V75, P123; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos GJP, 2015, BRAZ J BOT, V38, P171, DOI 10.1007/s40415-014-0118-6; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rindi F, 2004, J PHYCOL, V40, P977, DOI 10.1111/j.1529-8817.2004.04012.x; Rindi F, 2002, J PHYCOL, V38, P39, DOI 10.1046/j.1529-8817.2002.01193.x; Rindi F, 2011, MOL PHYLOGENET EVOL, V58, P218, DOI 10.1016/j.ympev.2010.11.030; Rivasseau C, 2013, ENERG ENVIRON SCI, V6, P1230, DOI 10.1039/c2ee23129h; Ruiz-Sanchez E, 2010, MOL PHYLOGENET EVOL, V54, P344, DOI 10.1016/j.ympev.2009.10.035; Rysanek D, 2016, PHYCOLOGIA IN PRESS; Rysanek D, 2015, ENVIRON MICROBIOL, V17, P689, DOI 10.1111/1462-2920.12501; Sadowska-Des AD, 2014, MOL PHYLOGENET EVOL, V76, P202, DOI 10.1016/j.ympev.2014.03.020; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; Skaloud P, 2015, J PHYCOL, V51, P507, DOI 10.1111/jpy.12295; Skaloud P, 2014, PLANT ECOL EVOL, V147, P333, DOI 10.5091/plecevo.2014.989; Skaloud P, 2014, FOTTEA, V14, P53, DOI 10.5507/fot.2014.004; Skaloud P, 2013, J EUKARYOT MICROBIOL, V60, P350, DOI 10.1111/jeu.12040; Su X, 2015, ANN BOT-LONDON, V116, P35, DOI 10.1093/aob/mcv062; Surek B, 2004, NOVA HEDWIGIA, V79, P77, DOI 10.1127/0029-5035/2004/0079-0077; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tsarenko PM, 2011, FRESHWATER ALGAL FLO, P418; Vancurova L, 2015, PHYTOTAXA, V219, P118; Verma V, 2009, J PHYCOL, V45, P847, DOI 10.1111/j.1529-8817.2009.00718.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhou WW, 2012, MOL ECOL, V21, P960, DOI 10.1111/j.1365-294X.2011.05411.x; Zoller S, 2003, MOL PHYLOGENET EVOL, V29, P629, DOI 10.1016/S1055-7903(03)00215-X; Zwickl D. J, 2006, GENETIC ALGORITHM AP	97	47	47	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151137	10.1371/journal.pone.0151137	http://dx.doi.org/10.1371/journal.pone.0151137			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028195	gold, Green Published, Green Submitted			2022-12-26	WOS:000373116500018
J	Ruiz-Ojeda, FJ; Gomez-Llorente, C; Aguilera, CM; Gil, A; Ruperez, AI				Javier Ruiz-Ojeda, Francisco; Gomez-Llorente, Carolina; Maria Aguilera, Concepcion; Gil, Angel; Iris Ruperez, Azahara			Impact of 3-Amino-1,2,4-Triazole (3-AT)-Derived Increase in Hydrogen Peroxide Levels on Inflammation and Metabolism in Human Differentiated Adipocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-KAPPA-B; OXIDATIVE STRESS; INSULIN-RESISTANCE; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; CATALASE INHIBITION; GLOBULAR DOMAIN; UP-REGULATION; ADIPONECTIN	Obesity is characterized by an excessive accumulation of fat in adipose tissue, which is associated with oxidative stress and chronic inflammation. Excessive H2O2 levels are degraded by catalase (CAT), the activity of which is decreased in obesity. We investigated the effects of inhibition of catalase activity on metabolism and inflammation by incubating human differentiated adipocytes with 10 mM 3-amino-1,2,4-triazole (3-AT) for 24 h. As expected, the treatment decreased CAT activity and increased intracellular H2O2 levels significantly. Glutathione peroxidase (GPX) activity was also reduced, and the gene expression levels of the antioxidant enzymes GPX4 and peroxiredoxins (1, 3 and 5) were inhibited. Interestingly, this occurred along with lower mRNA levels of the transcription factors nuclear factor (erythroid 2-like 2) and forkhead box O, which are involved in redox homeostasis. However, superoxide dismutase activity and expression were increased. Moreover, 3-AT led to nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) activation and increased tumor necrosis alpha and interleukin 6 protein and gene expression levels, while lowering peroxisome proliferator-activated receptor gamma (PPAR gamma) mRNA and protein levels. These alterations were accompanied by an altered glucose and lipid metabolism. Indeed, adipocytes treated with 3-AT showed reduced basal glucose uptake, reduced glucose transporter type 4 gene and protein expression, reduced lipolysis, reduced AMP-activated protein kinase activation and reduced gene expression of lipases. Our results indicate that increased H2O2 levels caused by 3-AT treatment impair the antioxidant defense system, lower PPAR gamma expression and initiate inflammation, thus affecting glucose and lipid metabolism in human differentiated adipocytes.	[Javier Ruiz-Ojeda, Francisco; Gomez-Llorente, Carolina; Maria Aguilera, Concepcion; Gil, Angel; Iris Ruperez, Azahara] Univ Granada, Dept Biochem & Mol Biol 2, Inst Nutr & Food Technol Jose Mataix, Ctr Biomed Res, Avda Conocimiento S-N, Granada 18016, Spain; [Gomez-Llorente, Carolina; Maria Aguilera, Concepcion; Gil, Angel] Inst Invest Biosanitaria IBS GRANADA, Granada, Spain; [Gomez-Llorente, Carolina; Maria Aguilera, Concepcion; Gil, Angel] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Ruperez, AI (corresponding author), Univ Granada, Dept Biochem & Mol Biol 2, Inst Nutr & Food Technol Jose Mataix, Ctr Biomed Res, Avda Conocimiento S-N, Granada 18016, Spain.	azahararuperez@ugr.es	Gil, Angel/ABA-7621-2020; Gil, Angel/L-2275-2014; Aguilera, Concepcion M/M-1663-2014; Llorente, Carolina Gomez/K-7484-2015; Ojeda, Francisco Javier Ruiz/D-1228-2016; Rupérez, Azahara/L-3771-2019	Gil, Angel/0000-0001-7663-0939; Gil, Angel/0000-0001-7663-0939; Aguilera, Concepcion M/0000-0002-1451-4788; Llorente, Carolina Gomez/0000-0003-3948-1473; Ojeda, Francisco Javier Ruiz/0000-0002-4452-0855; Rupérez, Azahara/0000-0002-3850-8235	Junta de Andalucia (Secretaria General de Universidades, Investigacion y Tecnologia. Consejeria de Economia, Innovacion y Ciencia) [CTS-6770]; Instituto de Salud Carlos III; Fondo de Investigaciones Sanitarias; Redes tematicas de investigacion cooperativa RETIC [Red SAMID RD08/0072/0028]; Formacion de Profesorado Universitario from the Ministry of Education and Science of the Spanish Government [AP2012-02068]; University of Granada Plan Propio	Junta de Andalucia (Secretaria General de Universidades, Investigacion y Tecnologia. Consejeria de Economia, Innovacion y Ciencia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Redes tematicas de investigacion cooperativa RETIC; Formacion de Profesorado Universitario from the Ministry of Education and Science of the Spanish Government; University of Granada Plan Propio	This work was supported by Junta de Andalucia (Project number CTS-6770; Secretaria General de Universidades, Investigacion y Tecnologia. Consejeria de Economia, Innovacion y Ciencia), and Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias, Redes tematicas de investigacion cooperativa RETIC (Red SAMID RD08/0072/0028). FJRO was funded by a Formacion de Profesorado Universitario stipend from the Ministry of Education and Science of the Spanish Government (AP2012-02068). CGL and AIR are recipients of fellowships from the University of Granada Plan Propio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2009, REDOX REP, V14, P34, DOI 10.1179/135100009X392467; Ahmed M, 2010, OBESITY, V18, P27, DOI 10.1038/oby.2009.208; Amirkhizi F, 2014, OBES RES CLIN PRACT, V8, pE26, DOI 10.1016/j.orcp.2012.07.004; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Andreeva ER, 2014, CELLS TISSUES ORGANS, V200, P307, DOI 10.1159/000438921; Atashi F, 2015, STEM CELLS DEV, V24, P1150, DOI 10.1089/scd.2014.0484; Than A, 2014, J BIOL CHEM, V289, P3763, DOI 10.1074/jbc.M113.526210; Bagnyukova TV, 2005, BRAIN RES, V1052, P180, DOI 10.1016/j.brainres.2005.06.002; Barbosa DS, 2003, NUTRITION, V19, P837, DOI 10.1016/S0899-9007(03)00162-X; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BHUYAN KC, 1977, BIOCHIM BIOPHYS ACTA, V497, P641, DOI 10.1016/0304-4165(77)90284-7; Boyle KE, 2015, DIABETES; Brinkmann C, 2013, J PHYSIOL SCI, V63, P1, DOI 10.1007/s12576-012-0237-4; Chang E, 2015, LIFE SCI, V132, P93, DOI 10.1016/j.lfs.2015.02.013; Chen BY, 2009, ARCH MED RES, V40, P241, DOI 10.1016/j.arcmed.2009.03.007; Chen BY, 2006, BIOCHEM BIOPH RES CO, V341, P549, DOI 10.1016/j.bbrc.2006.01.004; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; Comim CM, 2009, NEUROCHEM INT, V55, P802, DOI 10.1016/j.neuint.2009.08.003; Djordjevic D, 2011, MOL CELL BIOCHEM, V351, P251, DOI 10.1007/s11010-011-0732-6; DONI MG, 1983, HAEMOSTASIS, V13, P240; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; D'Alessandro ME, 2015, FOOD FUNCT, V6, P1299, DOI [10.1039/c4fo00903g, 10.1039/C4FO00903G]; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127; Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huh JY, 2012, ANTIOXID REDOX SIGN, V16, P229, DOI [10.1089/ars.2010.3766, 10.1089/ars.2011.3952]; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Korswagen HC, 2006, DEV CELL, V10, P687, DOI 10.1016/j.devcel.2006.05.007; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; LITTLE SA, 1980, J BIOL CHEM, V255, P888; MARGOLIASH E, 1960, BIOCHEM J, V74, P339, DOI 10.1042/bj0740339; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; MAY JM, 1982, HORM METAB RES, V14, P634, DOI 10.1055/s-2007-1019105; Monickaraj F, 2013, J BIOSCIENCES, V38, P113, DOI 10.1007/s12038-012-9289-0; MUKHERJEE SP, 1982, BIOCHEM PHARMACOL, V31, P3163, DOI 10.1016/0006-2952(82)90545-7; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Okuno Y, 2008, BIOCHEM BIOPH RES CO, V366, P698, DOI 10.1016/j.bbrc.2007.12.001; Pedruzzi LM, 2012, BIOCHIMIE, V94, P2461, DOI 10.1016/j.biochi.2012.07.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodriguez-Cuenca S, 2012, FASEB J, V26, P1835, DOI 10.1096/fj.11-193631; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Ruperez AI, 2014, INT J MOL SCI, V15, P3118, DOI 10.3390/ijms15023118; Ruperez AI, 2013, ANTIOXID REDOX SIGN, V19, P1970, DOI 10.1089/ars.2013.5386; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; Shin MJ, 2006, CLIN CHIM ACTA, V365, P200, DOI 10.1016/j.cca.2005.08.019; Sinha S, 2009, RESP PHYSIOL NEUROBI, V167, P255, DOI 10.1016/j.resp.2009.05.003; Soares AF, 2005, FREE RADICAL BIO MED, V38, P882, DOI 10.1016/j.freeradbiomed.2004.12.010; Stefan N, 2002, HORM METAB RES, V34, P469, DOI 10.1055/s-2002-34785; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Sugino N, 2002, J CLIN ENDOCR METAB, V87, P3845, DOI 10.1210/jc.87.8.3845; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Truong TH, 2013, CRIT REV BIOCHEM MOL, V48, P332, DOI 10.3109/10409238.2013.790873; Vazquez-Meza H, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-13; Walton PA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00108; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Yajima H, 2007, BIOCHEM BIOPH RES CO, V352, P526, DOI 10.1016/j.bbrc.2006.11.054; Yang ZC, 2009, CELL PHYSIOL BIOCHEM, V24, P115, DOI 10.1159/000227819; Yeh CH, 2015, J CELL PHYSIOL, V230, P1840, DOI 10.1002/jcp.24900	68	25	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152550	10.1371/journal.pone.0152550	http://dx.doi.org/10.1371/journal.pone.0152550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023799	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900074
J	Kang, HY; Lee, YJ; Choi, KS; Park, HJ; Yun, SG; Kang, CK				Kang, Hee Yoon; Lee, Young-Jae; Choi, Kwang-Sik; Park, Hyun Je; Yun, Sung-Gyu; Kang, Chang-Keun			Combined Effects of Temperature and Seston Concentration on the Physiological Energetics of the Manila Clam Ruditapes philippinarum	PLOS ONE			English	Article							GROSS BIOCHEMICAL-COMPOSITION; CRASSOSTREA-GIGAS THUNBERG; OXYGEN-CONSUMPTION RATES; FEEDING BIVALVE MOLLUSKS; CERASTODERMA-EDULE L; LAGOON-OF-VENICE; TAPES-PHILIPPINARUM; ENERGY-BALANCE; ANADARA-TUBERCULOSA; GAMETOGENIC CYCLE	The suspension-feeding Manila clam Ruditapes philippinarum is a native species of the western Pacific that is now widely distributed around the globe because of its commercial importance. To determine the adaptive physiological responses to changing thermal and nutritional conditions, clearance, filtration, feces production, ammonium excretion, respiration rates, and scope for growth (SFG) were measured in adult clams. The clams were exposed to 24 treatments involving the combination of four water temperatures (8, 13, 18, and 23 degrees C) and six concentrations of suspended particulatematter (SPM: 9.5 to 350.5 mg L-1). Physiological rates were standardized by using the mean (480 mg) of tissue dry weights of experimental clams using allometric equations between physiological variables and tissue dry weight. Higher clearance rates were recorded at higher temperatures and lower SPM concentrations, and these rates decreased with increasing SPM concentration at individual temperatures. Consumed energy increased with increasing temperature and SPM concentration, peaking at around 100-200 mg L-1 at 18-23 degrees C. Whereas fecal energy was largely determined by SPM concentration, ammonia excretion was mainly governed by temperature. Respiration rate studies revealed a predominant quadratic effect of temperature on the metabolism, indicating a lack of acclimatory adjustment of metabolic rate to rising temperature. SFG values were positive under almost all the treatment conditions and were much higher at higher SPM concentrations (> 45 mg L-1), with the highest level being recorded at 18 degrees C and 100-200 mg L-1 SPM. Increased filtration rate offset the increased metabolic cost at warm temperatures. Our holistic findings suggest that a high degree of physiological plasticity allows R. philippinarum to tolerate the wide range of temperatures and SPM concentrations that are found in tidal flats, accounting in part for the successful distribution of this species over a wide variety of geographical areas.	[Kang, Hee Yoon; Lee, Young-Jae; Kang, Chang-Keun] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Gwangju, South Korea; [Choi, Kwang-Sik] Jeju Natl Univ, Sch Marine Biomed Sci BK PLUS 21, Jeju, South Korea; [Park, Hyun Je] Gangneung Wonju Natl Univ, Dept Marine Biosci, Kangnung, South Korea; [Yun, Sung-Gyu] Daegu Univ, Dept Sci Educ, Gyongsan, South Korea	Gwangju Institute of Science & Technology (GIST); Jeju National University; Kangnung Wonju National University; Daegu University	Kang, CK (corresponding author), Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Gwangju, South Korea.	ckkang@gist.ac.kr	Choi, Kwang-Sik Albert/B-5367-2011; Kang, Chang-Keun/GLR-8512-2022		project titled "Long-term change of structure and function in marine ecosystems of Korea" - Ministry of Oceans and Fisheries, Korea	project titled "Long-term change of structure and function in marine ecosystems of Korea" - Ministry of Oceans and Fisheries, Korea	This research was supported by the project titled "Long-term change of structure and function in marine ecosystems of Korea," funded by the Ministry of Oceans and Fisheries, Korea.	Baek MJ, 2014, MAR POLLUT BULL, V78, P137, DOI 10.1016/j.marpolbul.2013.10.050; BAYNE BL, 1988, AM ZOOL, V28, P147; BAYNE BL, 1983, MOLLUSCA 1, V4, P407; BENINGER PG, 1984, J EXP MAR BIOL ECOL, V79, P19, DOI 10.1016/0022-0981(84)90028-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOUGRIER S, 1995, AQUACULTURE, V134, P143, DOI 10.1016/0044-8486(95)00036-2; Bougrier S, 1998, J EXP MAR BIOL ECOL, V219, P205, DOI 10.1016/S0022-0981(97)00181-0; BOURNE N, 1982, Journal of Shellfish Research, V2, P47; Brockington S, 2001, J EXP MAR BIOL ECOL, V258, P87, DOI 10.1016/S0022-0981(00)00347-6; Chew K.K., 1989, Developments in Aquaculture and Fisheries Science, V19, P243; Collins S, 2009, ECOL LETT, V12, P744, DOI 10.1111/j.1461-0248.2009.01340.x; COUTTEAU P, 1994, J SHELLFISH RES, V13, P47; Dame R. F., 2012, ECOLOGY MARINE BIVAL; Delgado M, 2007, AQUACULTURE, V264, P398, DOI 10.1016/j.aquaculture.2006.11.009; Dong Bo, 2000, Oceanologia et Limnologia Sinica, V31, P636; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELLIOTT JM, 1975, OECOLOGIA, V19, P195, DOI 10.1007/BF00345305; Filgueira R, 2006, LIMNOL OCEANOGR-METH, V4, P284, DOI 10.4319/lom.2006.4.284; FLASSCH JP, 1992, ICES MAR SC, V194, P92; Flye-Sainte-Marie J, 2007, AQUACULTURE, V266, P130, DOI 10.1016/j.aquaculture.2007.02.017; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; GOULLETQUER P, 1989, J EXP MAR BIOL ECOL, V132, P85, DOI 10.1016/0022-0981(89)90217-7; Han KN, 2008, AQUACULT INT, V16, P143, DOI 10.1007/s10499-007-9133-y; Haure J, 1998, AQUACULTURE, V169, P211, DOI 10.1016/S0044-8486(98)00383-4; Hawkins AJS, 1998, J EXP MAR BIOL ECOL, V219, P87, DOI 10.1016/S0022-0981(97)00176-7; Hawkins AJS, 1999, MAR ECOL PROG SER, V191, P217, DOI 10.3354/meps191217; Iglesias JIP, 1996, J EXP MAR BIOL ECOL, V197, P121, DOI 10.1016/0022-0981(95)00149-2; Kang CK, 2015, J EXP MAR BIOL ECOL, V462, P105, DOI 10.1016/j.jembe.2014.10.026; Kang CK, 2011, AQUACULTURE, V319, P168, DOI 10.1016/j.aquaculture.2011.06.016; KOH C, 2001, KOREAN TIDAL FLAT EN; Lassudrie M, 2014, AQUAT TOXICOL, V154, P27, DOI 10.1016/j.aquatox.2014.05.002; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacDonald B., 2006, SCALLOPS BIOL ECOLOG, P417, DOI DOI 10.1016/S0167-9309(06)80034-7; MACDONALD BA, 1986, MAR BIOL, V93, P37, DOI 10.1007/BF00428653; MANN R, 1979, J EXP MAR BIOL ECOL, V38, P121, DOI 10.1016/0022-0981(79)90016-9; Marin MG, 2003, AQUACULTURE, V219, P859, DOI 10.1016/S0044-8486(03)00035-8; MARSH JB, 1966, J LIPID RES, V7, P574; Meneghetti F, 2004, AQUACULTURE, V240, P473, DOI 10.1016/j.aquaculture.2004.04.011; Nakamura Y, 2004, FISHERIES SCI, V70, P215, DOI 10.1111/j.1444-2906.2003.00794.x; Nakamura Y, 2001, J EXP MAR BIOL ECOL, V266, P181, DOI 10.1016/S0022-0981(01)00354-9; National Fisheries Research & Development Institute (NFRDI), 2012, NEWSL MAR ENV FISH R; National Fisheries Research & Development Institute(NFRDI), 2004, KOR US AQ MAIN SPEC; NAVARRO E, 1992, J EXP MAR BIOL ECOL, V156, P69, DOI 10.1016/0022-0981(92)90017-5; NAVARRO E., 1995, HALIOTIS, V24, P43; Navarro JM, 1996, MAR ECOL PROG SER, V138, P135, DOI 10.3354/meps138135; Navarro JM, 1997, MAR ECOL PROG SER, V152, P175, DOI 10.3354/meps152175; Newell R.C., 1980, Advances in Marine Biology, V17, P329, DOI 10.1016/S0065-2881(08)60304-1; Newell RC., 1979, BIOL INTERTIDAL ANIM; NEWELL RIE, 1980, MAR BIOL, V56, P11, DOI 10.1007/BF00390589; Nieves-Soto M, 2011, AQUACULTURE, V318, P434, DOI 10.1016/j.aquaculture.2011.05.041; Packard G.C., 1987, P216; Park KI, 2004, AQUACULTURE, V241, P667, DOI 10.1016/j.aquaculture.2004.08.017; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Peck LS, 2002, POLAR BIOL, V25, P31, DOI 10.1007/s003000100308; Pena-Messina E, 2009, AQUAC RES, V40, P1750, DOI 10.1111/j.1365-2109.2009.02280.x; ROBERT R, 1993, MAR BIOL, V116, P291, DOI 10.1007/BF00350019; Rueda JL, 2004, J EXP MAR BIOL ECOL, V301, P141, DOI 10.1016/j.jembe.2003.09.018; Sara G, 2008, J EXP MAR BIOL ECOL, V363, P130, DOI 10.1016/j.jembe.2008.06.030; Saucedo PE, 2004, AQUACULTURE, V229, P377, DOI 10.1016/S0044-8486(03)00327-2; SHICK JM, 1988, AM ZOOL, V28, P161; SHUMWAY SE, 1985, J EXP MAR BIOL ECOL, V91, P77, DOI 10.1016/0022-0981(85)90222-9; SHUMWAY SE, 1982, MAR BIOL LETT, V3, P1; Sladonja B, 2011, AQUACULTURE AND THE ENVIRONMENT - A SHARED DESTINY, P51; Sobral PJA, 1997, SCI MAR, V61, P163; SOROKIN YI, 1995, ICES J MAR SCI, V52, P853, DOI 10.1006/jmsc.1995.0082; Velasco LA, 2003, J EXP MAR BIOL ECOL, V296, P79, DOI 10.1016/S0022-0981(03)00316-2; Velasco LA, 2005, MAR ECOL PROG SER, V291, P115, DOI 10.3354/meps291115; WIDDOWS J, 1979, MAR BIOL, V50, P195, DOI 10.1007/BF00394201; WIDDOWS J, 1989, PHYSIOL ZOOL, V62, P764, DOI 10.1086/physzool.62.3.30157926; WILBUR AE, 1989, J EXP MAR BIOL ECOL, V131, P161, DOI 10.1016/0022-0981(89)90005-1; Winberg G.G., 1956, FISH RES BOARD CAN, V251; Yukihira H, 1998, MAR ECOL PROG SER, V170, P119, DOI 10.3354/meps170119	72	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152427	10.1371/journal.pone.0152427	http://dx.doi.org/10.1371/journal.pone.0152427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022726	gold, Green Published, Green Submitted			2022-12-26	WOS:000373113900056
J	Yu, JS; Chen, WC; Tseng, CK; Lin, CK; Hsu, YC; Chen, YH; Lee, JC				Yu, Jung-Sheng; Chen, Wei-Chun; Tseng, Chin-Kai; Lin, Chun-Kuang; Hsu, Yao-Chin; Chen, Yen-Hsu; Lee, Jin-Ching			Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; BROCCOLI SPROUTS; IN-VIVO; INDUCTION; INFECTION; CELLS; PROTECTS; TARGETS; HO-1; EPIGALLOCATECHIN-3-GALLATE	Hepatitis C virus (HCV) infection-induced oxidative stress is a major risk factor for the development of HCV-associated liver disease. Sulforaphane (SFN) is an antioxidant phytocompound that acts against cellular oxidative stress and tumorigenesis. However, there is little known about its anti-viral activity. In this study, we demonstrated that SFN significantly suppressed HCV protein and RNA levels in HCV replicon cells and infectious system, with an IC50 value of 5.7 +/- 0.2 mu M. Moreover, combination of SFN with anti-viral drugs displayed synergistic effects in the suppression of HCV replication. In addition, we found nuclear factor erythroid 2-related factor 2 (Nrf2)/HO-1 induction in response to SFN and determined the signaling pathways involved in this process, including inhibition of NS3 protease activity and induction of IFN response. In contrast, the anti-viral activities were attenuated by knockdown of HO-1 with specific inhibitor (SnPP) and shRNA, suggesting that anti-HCV activity of SFN is dependent on HO-1 expression. Otherwise, SFN stimulated the phosphorylation of phosphoinositide 3-kinase (PI3K) leading Nrf2-mediated HO-1 expression against HCV replication. Overall, our results indicated that HO-1 is essential in SFN-mediated anti-HCV activity and provide new insights in the molecular mechanism of SFN in HCV replication.	[Yu, Jung-Sheng; Hsu, Yao-Chin] Chi Mei Med Ctr, Dept Chinese Med, Tainan 71004, Taiwan; [Yu, Jung-Sheng] China Med Univ, Grad Inst Integrated Med, Taichung 40402, Taiwan; [Chen, Wei-Chun] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Lin, Chun-Kuang] Natl Sun Yat Sen Univ, Coll Marine Sci, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Grad Inst Med, Sch Med,Sepsis Res Ctr, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Dept Biotechnol, Coll Life Sci, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Res Ctr Nat Prod & Drug Dev, Kaohsiung, Taiwan	Chi Mei Hospital; China Medical University Taiwan; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Chen, YH (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.; Chen, YH (corresponding author), Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Grad Inst Med, Sch Med,Sepsis Res Ctr, Kaohsiung, Taiwan.; Chen, YH (corresponding author), Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Chen, YH (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.; Lee, JC (corresponding author), Kaohsiung Med Univ, Dept Biotechnol, Coll Life Sci, Kaohsiung, Taiwan.; Lee, JC (corresponding author), Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan.; Lee, JC (corresponding author), Kaohsiung Med Univ, Res Ctr Nat Prod & Drug Dev, Kaohsiung, Taiwan.	infchen@gmail.com; jclee@kmu.edu.tw		Lee, Jin-Ching/0000-0003-0729-9589; Chen, Yen-hsu/0000-0002-8667-4844	Ministry of Science and Techonology of Taiwan [MOST104-2320-B-037-025-MY3, MOST103-2622-B-037-007-CC3, MOST103-2314-B-037-039-MY3]; Kaohsiung Medical University [NSYSU-KMU 104-I011, KMU-TP103H12, KMU-TP104E02, KMU-TP104H03, 102CM-KMU-07]	Ministry of Science and Techonology of Taiwan; Kaohsiung Medical University	This work was funded by grants from Ministry of Science and Techonology of Taiwan (http://www.most.gov.tw/mp.aspx) (MOST104-2320-B-037-025-MY3, MOST103-2622-B-037-007-CC3 and MOST103-2314-B-037-039-MY3) and Kaohsiung Medical University (http://www2.kmu.edu.tw/index.phtml) (NSYSU-KMU 104-I011, KMU-TP103H12, KMU-TP104E02, and KMU-TP104H03), 102CM-KMU-07, (http://www2.kmu.edu. tw/front/bin/home.phtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MY, 2012, EUR J INTERN MED, V23, P649, DOI 10.1016/j.ejim.2012.05.001; Abdalla MY, 2004, J INFECT DIS, V190, P1109, DOI 10.1086/423488; Alcaraz MJ, 2004, BRIT J PHARMACOL, V142, P1191, DOI 10.1038/sj.bjp.0705821; Anggakusuma, 2014, GUT, V63, P1137, DOI 10.1136/gutjnl-2012-304299; Arciello M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/971024; Atwell LL, 2015, MOL NUTR FOOD RES, V59, P424, DOI 10.1002/mnfr.201400674; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chang M, 2015, CELL MOL LIFE SCI, V72, P1161, DOI 10.1007/s00018-014-1790-1; Chen MH, 2012, INT J MOL MED, V30, P1021, DOI 10.3892/ijmm.2012.1096; Chen WC, 2013, ANTIMICROB AGENTS CH, V57, P1180, DOI 10.1128/AAC.02053-12; Chen X, 2013, BRIT J PHARMACOL, V169, P437, DOI 10.1111/bph.12133; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Clarke JD, 2011, PHARM RES-DORDR, V28, P3171, DOI 10.1007/s11095-011-0500-z; Clement S, 2009, VIRUSES-BASEL, V1, P126, DOI 10.3390/v1020126; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Davinelli S, 2014, BIOGERONTOLOGY, V15, P449, DOI 10.1007/s10522-014-9511-6; Deng C, 2012, MOL MED REP, V5, P847, DOI 10.3892/mmr.2011.731; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Fredenburgh LE, 2015, EUR HEART J, V36, P1512, DOI 10.1093/eurheartj/ehv114; Ghaziani T, 2006, J HEPATOL, V45, P5, DOI 10.1016/j.jhep.2005.12.020; Greenlee Heather, 2012, Semin Oncol Nurs, V28, P29, DOI 10.1016/j.soncn.2011.11.004; Gupta P, 2014, MOL NUTR FOOD RES, V58, P1685, DOI 10.1002/mnfr.201300684; Han O, 2011, METALLOMICS, V3, P103, DOI 10.1039/c0mt00043d; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; He YP, 2007, DRUG DISCOV TODAY, V12, P209, DOI 10.1016/j.drudis.2007.01.009; Hu R, 2004, J PHARMACOL EXP THER, V310, P263, DOI 10.1124/jpet.103.064261; Ivanov AV, 2015, VIRUSES-BASEL, V7, P2745, DOI 10.3390/v7062745; Jahan S, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-2; Kanzaki H, 2015, J DENT RES, V94, P787, DOI 10.1177/0022034515577814; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; Kim DY, 2014, GUT LIVER, V8, P471, DOI 10.5009/gnl14083; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; Kumar KJS, 2012, TOXICOL IN VITRO, V26, P700, DOI 10.1016/j.tiv.2012.03.012; Lee JC, 2011, J VIRAL HEPATITIS, V18, pE315, DOI 10.1111/j.1365-2893.2010.01424.x; Lee JC, 2014, BRIT J PHARMACOL, V171, P237, DOI 10.1111/bph.12440; Lee JC, 2010, ANAL BIOCHEM, V403, P52, DOI 10.1016/j.ab.2010.04.004; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lee YJ, 2012, FOOD CHEM TOXICOL, V50, P116, DOI 10.1016/j.fct.2011.10.035; Lehmann E, 2010, HEPATOLOGY, V51, P398, DOI 10.1002/hep.23339; Li XL, 2014, J VIROL, V88, P612, DOI 10.1128/JVI.02068-13; Lin LT, 2015, J HEPATOL, V62, P541, DOI 10.1016/j.jhep.2014.10.040; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Mullins Caitlin, 2015, Nurse Pract, V40, P22, DOI 10.1097/01.NPR.0000472253.59198.1c; Myzak MC, 2006, CANCER LETT, V233, P208, DOI 10.1016/j.canlet.2005.02.033; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Pan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114186; Polyak SJ, 2013, ANTIVIR THER, V18, P141, DOI 10.3851/IMP2402; Prawan A, 2008, PHARM RES-DORDR, V25, P836, DOI 10.1007/s11095-007-9370-9; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Reshi Mohammad Latif, 2014, Int J Cell Biol, V2014, P467452, DOI 10.1155/2014/467452; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tarozzi A, 2009, J NEUROCHEM, V111, P1161, DOI 10.1111/j.1471-4159.2009.06394.x; Wu CC, 2013, MOL CARCINOGEN, V52, P946, DOI 10.1002/mc.21926; Xu X, 2015, MEDIAT INFLAMM, V2015, DOI [10.1155/2015/810798, 10.1155/2015/380218]; Yeh CT, 2005, CARCINOGENESIS, V26, P2138, DOI 10.1093/carcin/bgi185; Yin F, 2010, BIOL PHARM BULL, V33, P1841, DOI 10.1248/bpb.33.1841; Zampino R, 2013, WORLD J HEPATOL, V5, P528, DOI 10.4254/wjh.v5.i10.528; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147; Zhu W, 2014, J RADIAT RES, V55, P1056, DOI 10.1093/jrr/rru047; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491; Zhu ZW, 2010, HEPATOLOGY, V52, P1897, DOI 10.1002/hep.23921	67	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152236	10.1371/journal.pone.0152236	http://dx.doi.org/10.1371/journal.pone.0152236			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023634	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900033
J	Yu, JR; Haldar, M; Mallik, S; Srivastava, DK				Yu, Junru; Haldar, Manas; Mallik, Sanku; Srivastava, D. K.			Role of the Substrate Specificity-Defining Residues of Human SIRT5 in Modulating the Structural Stability and Inhibitory Features of the Enzyme	PLOS ONE			English	Article							SELECTIVE INHIBITORS; LIFE-SPAN; NICOTINAMIDE; SIRTUINS; MECHANISM; BINDING; DEACETYLATION; ACTIVATION; POTENT; EXTENSION	Sirtuins are emerging as the key regulators of metabolism and aging, and their potential activators and inhibitors are being explored as therapeutics for improving health and treating associated diseases. Despite the global structural similarity among all seven isoforms of sirtuins (of which most of them catalyze the deacetylation reaction), SIRT5 is the only isoform that catalyzes the cleavage of negatively charged acylated substrates, and the latter feature appears to be encoded by the presence of Tyr102 and Arg105 residues at the active site pocket of the enzyme. To determine the contributions of the above residues in SIRT5 (vis a vis the corresponding residues of SIRT1) on substrate selectivity, inhibition by EX527 and nicotinamide, secondary structural features and thermal stability of the enzymes, we created single and double mutations (viz. Y102A, R105l, and Y102A/R105I) in SIRT5. The kinetic data revealed that while Y102A mutant enzyme catalyzed both deacetylation and desuccinylation reactions with comparable efficiencies, R105I and Y102A/R105I mutant enzymes favored the deacetylase reaction. Like SIRT1, the nicotinamide inhibition of SIRT5 double mutant (Y102A/R105I) exhibited the mixed non-competitive behavior. On the other hand, the desuccinylation reaction of both wild-type and Y102A mutant enzymes conformed to the competitive inhibition model. The inhibitory potency of EX527 progressively increased from Y102A, R105I, to Y102A/R105 mutant enzymes in SIRT5, but it did not reach to the level obtained with SIRT1. The CD spectroscopic data for the wild-type and mutant enzymes revealed changes in the secondary structural features of the enzymes, and such changes were more pronounced on examining their thermal denaturation patterns. A cumulative account of our experimental data reveal mutual cooperation between Y102 and R105 residues in promoting the desuccinylation versus deacetylation reaction in SIRT5, and the overall catalytic feature of the enzyme is manifested via the mutation induced modulation in the protein structure.	[Yu, Junru; Srivastava, D. K.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58105 USA; [Haldar, Manas; Mallik, Sanku] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	North Dakota State University Fargo; North Dakota State University Fargo	Srivastava, DK (corresponding author), N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58105 USA.	dk.srivastava@ndsu.edu	Srivastava, Deo Kumar/P-2435-2017	Srivastava, Deo Kumar/0000-0001-6693-8120; Mallik, Sanku/0000-0003-4236-2512	NIH [GM110367]; NSF [DMR1306154]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was funded by NIH (GM110367) and NSF (DMR1306154) grants to DKS and SM.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Banerjee AL, 2005, CHEM COMMUN, P2549, DOI 10.1039/b501780g; Berg AK, 2010, BBA-PROTEINS PROTEOM, V1804, P704, DOI 10.1016/j.bbapap.2009.11.006; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; CLELAND WW, 1979, ANAL BIOCHEM, V99, P142, DOI 10.1016/0003-2697(79)90055-1; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Fischer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045098; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Gertz M, 2010, BBA-PROTEINS PROTEOM, V1804, P1658, DOI 10.1016/j.bbapap.2009.09.011; Guan D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.185; Guan XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107729; Haldar MK, 2008, BIOORG MED CHEM LETT, V18, P2373, DOI 10.1016/j.bmcl.2008.02.066; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Madsen AS, 2012, J MED CHEM, V55, P5582, DOI 10.1021/jm300526r; Matsushita N, 2011, GENES CELLS, V16, P190, DOI 10.1111/j.1365-2443.2010.01475.x; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Morris BJ, 2013, FREE RADICAL BIO MED, V56, P133, DOI 10.1016/j.freeradbiomed.2012.10.525; Myung JI, 2009, METHOD ENZYMOL, V454, P287, DOI 10.1016/S0076-6879(08)03811-1; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Roth M, 2014, ONCOGENE, V33, P1609, DOI 10.1038/onc.2013.120; Roy BC, 2003, CHEM COMMUN, P2328, DOI 10.1039/b305179j; Roy BC, 2004, J AM CHEM SOC, V126, P13206, DOI 10.1021/ja047271k; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Singh RK, 2015, J BIOL CHEM, V290, P6607, DOI 10.1074/jbc.M114.600627; Singh RK, 2014, BIOCHEMISTRY-US, V53, P7445, DOI 10.1021/bi500711x; Singh RK, 2013, BIOCHEMISTRY-US, V52, P8139, DOI 10.1021/bi400740x; Singh RK, 2011, BIOORG MED CHEM LETT, V21, P5920, DOI 10.1016/j.bmcl.2011.07.080; Subramaniam R, 2008, BIOORG MED CHEM LETT, V18, P3333, DOI 10.1016/j.bmcl.2008.04.035; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zhou YY, 2012, J BIOL CHEM, V287, P28307, DOI 10.1074/jbc.M112.384511	56	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152467	10.1371/journal.pone.0152467	http://dx.doi.org/10.1371/journal.pone.0152467			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023330	gold, Green Published, Green Submitted			2022-12-26	WOS:000373113900061
J	Kriebel, J; Herder, C; Rathmann, W; Wahl, S; Kunze, S; Molnos, S; Volkova, N; Schramm, K; Carstensen-Kirberg, M; Waldenberger, M; Gieger, C; Peters, A; Illig, T; Prokisch, H; Roden, M; Grallert, H				Kriebel, Jennifer; Herder, Christian; Rathmann, Wolfgang; Wahl, Simone; Kunze, Sonja; Molnos, Sophie; Volkova, Nadezda; Schramm, Katharina; Carstensen-Kirberg, Maren; Waldenberger, Melanie; Gieger, Christian; Peters, Annette; Illig, Thomas; Prokisch, Holger; Roden, Michael; Grallert, Harald			Association between DNA Methylation in Whole Blood and Measures of Glucose Metabolism: KORA F4 Study	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; HEPATIC INSULIN ACTION; DIET-INDUCED OBESITY; DIABETES-MELLITUS; ADIPOSE-TISSUE; HIGH-FAT; TYPE-2; INFLAMMATION; RESISTANCE; POPULATION	Epigenetic regulation has been postulated to affect glucose metabolism, insulin sensitivity and the risk of type 2 diabetes. Therefore, we performed an epigenome-wide association study for measures of glucose metabolism in whole blood samples of the population-based Cooperative Health Research in the Region of Augsburg F4 study using the Illumina HumanMethylation 450 BeadChip. We identified a total of 31 CpG sites where methylation level was associated with measures of glucose metabolism after adjustment for age, sex, smoking, and estimated white blood cell proportions and correction for multiple testing using the Benjamini-Hochberg (B-H) method (four for fasting glucose, seven for fasting insulin, 25 for homeostasis model assessment-insulin resistance [HOMA-IR]; B-H-adjusted p-values between 9.2x10(-5) and 0.047). In addition, DNA methylation at cg06500161 (annotated to ABCG1) was associated with all the aforementioned phenotypes and 2-hour glucose (B-H-adjusted p-values between 9.2x10(-5) and 3.0x10(-3)). Methylation status of additional three CpG sites showed an association with fasting insulin only after additional adjustment for body mass index (BMI) (B-H-adjusted p-values = 0.047). Overall, effect strengths were reduced by around 30% after additional adjustment for BMI, suggesting that this variable has an influence on the investigated phenotypes. Furthermore, we found significant associations between methylation status of 21 of the aforementioned CpG sites and 2-hour insulin in a subset of samples with seven significant associations persisting after additional adjustment for BMI. In a subset of 533 participants, methylation of the CpG site cg06500161 (ABCG1) was inversely associated with ABCG1 gene expression (B-H-adjusted p-value = 1.5x10(-9)). Additionally, we observed an enrichment of the top 1,000 CpG sites for diabetes-related canonical pathways using Ingenuity Pathway Analysis. In conclusion, our study indicates that DNA methylation and diabetes-related traits are associated and that these associations are partially BMI-dependent. Furthermore, the interaction of ABCG1 with glucose metabolism is modulated by epigenetic processes.	[Kriebel, Jennifer; Wahl, Simone; Kunze, Sonja; Molnos, Sophie; Volkova, Nadezda; Waldenberger, Melanie; Gieger, Christian; Peters, Annette; Grallert, Harald] Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Kriebel, Jennifer; Wahl, Simone; Kunze, Sonja; Molnos, Sophie; Volkova, Nadezda; Waldenberger, Melanie; Gieger, Christian; Peters, Annette; Grallert, Harald] Helmholtz Zentrum Muenchen, Inst Epidemiol 2, German Res Ctr Environm Hlth, Neuherberg, Germany; [Kriebel, Jennifer; Herder, Christian; Wahl, Simone; Molnos, Sophie; Carstensen-Kirberg, Maren; Peters, Annette; Roden, Michael; Grallert, Harald] German Ctr Diabet Res DZD, Munich, Germany; [Herder, Christian; Carstensen-Kirberg, Maren; Roden, Michael] Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Rathmann, Wolfgang] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Schramm, Katharina; Prokisch, Holger] Helmholtz Zentrum Muenchen, Inst Human Genet, German Res Ctr Environm Hlth, Neuherberg, Germany; [Schramm, Katharina; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Illig, Thomas] Hannover Med Sch, Inst Human Genet, Hannover, Germany; [Roden, Michael] Univ Hosp Duesseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Hannover Medical School; Hannover Medical School	Grallert, H (corresponding author), Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany.; Grallert, H (corresponding author), Helmholtz Zentrum Muenchen, Inst Epidemiol 2, German Res Ctr Environm Hlth, Neuherberg, Germany.; Grallert, H (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	harald.grallert@helmholtz-muenchen.de	Kriebel, Jennifer/N-4782-2017; Waldenberger, Melanie/B-5355-2014; Peters, Annette/A-6117-2011; Grallert, Harald/B-3424-2013; Roden, Michael/AAD-3843-2019	Kriebel, Jennifer/0000-0003-4270-018X; Waldenberger, Melanie/0000-0003-0583-5093; Peters, Annette/0000-0001-6645-0985; Prokisch, Holger/0000-0003-2379-6286; Volkova, Nadezda/0000-0003-3368-3920; Kunze, Sonja/0000-0002-9685-2675; Gieger, Christian/0000-0001-6986-9554	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ; Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Research Foundation (DFG) [RA 459/3-1]; German Center for Diabetes Research (DZD e.V.)	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ; Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for Diabetes Research (DZD e.V.)	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. This work was supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW) and the German Federal Ministry of Health (BMG). The diabetes part of the KORA F4 study was funded by a grant from the German Research Foundation (DFG; RA 459/3-1). This study was supported by the German Center for Diabetes Research (DZD e.V.).	Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; An WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132721; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Basile KJ, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/769671; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Chambers JC, 2015, LANCET DIABETES ENDO, V3, P526, DOI 10.1016/S2213-8587(15)00127-8; Chen X, 2014, EXP THER MED, V8, P856, DOI 10.3892/etm.2014.1832; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Choudhuri S, 2010, TOXICOL APPL PHARM, V245, P378, DOI 10.1016/j.taap.2010.03.022; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Diaz M, 2012, OBESITY, V20, P2157, DOI 10.1038/oby.2012.101; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; FEINGOLD KR, 1989, J CLIN INVEST, V83, P1116, DOI 10.1172/JCI113991; Fernandez-Veledo S, 2009, J CLIN ENDOCR METAB, V94, P3583, DOI 10.1210/jc.2009-0558; Fiume R, 2012, FASEB J, V26, P203, DOI 10.1096/fj.11-186510; Gonzalez-Muniesa P, 2013, INT J MOL SCI, V14, P17238, DOI 10.3390/ijms140917238; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Henninger AMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105262; Herder C, 2015, EUR J ENDOCRINOL, V172, P423, DOI 10.1530/EJE-14-0879; Herder C, 2011, EUR J CLIN INVEST, V41, P679, DOI 10.1111/j.1365-2362.2010.02454.x; Hidalgo B, 2014, DIABETES, V63, P801, DOI 10.2337/db13-1100; Hirata M, 2011, DIABETES, V60, P1926, DOI 10.2337/db10-1500; Hirota Y, 2007, METABOLISM, V56, P656, DOI 10.1016/j.metabol.2006.12.014; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jain R, 2009, DIABETES OBES METAB, V11, P159, DOI 10.1111/j.1463-1326.2009.01102.x; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Kalninova J, 2014, BRATISL MED J, V115, P457, DOI 10.4149/BLL_2014_089; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kruit JK, 2012, DIABETES, V61, P659, DOI 10.2337/db11-1341; Kulkarni RN, 2007, CELL, V129, P241, DOI 10.1016/j.cell.2007.04.006; Langevin SM, 2013, ENVIRON MOL MUTAGEN, V54, P533, DOI 10.1002/em.21762; Leong GM, 2010, INT J OBESITY, V34, P524, DOI 10.1038/ijo.2009.265; Marker T, 2012, DIABETES, V61, P615, DOI 10.2337/db10-1574; Marques-Vidal P, 2013, CLIN ENDOCRINOL, V78, P232, DOI 10.1111/j.1365-2265.2012.04384.x; Marullo L, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0551-8; Mauldin JP, 2008, CIRCULATION, V117, P2785, DOI 10.1161/CIRCULATIONAHA.107.741314; Meng ZX, 2012, DIABETOLOGIA, V55, P1733, DOI 10.1007/s00125-012-2516-2; Meta-analysis C, 2014, NAT GENET, V46, P234, DOI [10.1038/ng.2897, DOI 10.1038/NG.2897]; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Na YK, 2014, MOL CELLS, V37, P467, DOI 10.14348/molcells.2014.0073; Nyman LR, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.11; Volpe CMO, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/479587; Orellana-Gavalda JM, 2011, HEPATOLOGY, V53, P821, DOI 10.1002/hep.24140; Ozaki KI, 2016, AM J PHYSL ENDOCRINO; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Poulsen P, 2005, DIABETES, V54, P275, DOI 10.2337/diabetes.54.1.275; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Rathmann W, 2013, DTSCH ARZTEBL INT, V110, P331, DOI 10.3238/arztebl.2013.0331; Rathmann W, 2012, ANN MED, V44, P170, DOI 10.3109/07853890.2010.531759; Rivera RM, 2010, CURR OPIN ENDOCRINOL, V17, P493, DOI 10.1097/MED.0b013e3283404f4b; Rondas D, 2012, J BIOL CHEM, V287, P2423, DOI 10.1074/jbc.M111.279885; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schousboe K, 2003, DIABETOLOGIA, V46, P1276, DOI 10.1007/s00125-003-1165-x; Schramm K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093844; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Schwenk RW, 2013, MOL METAB, V2, P337, DOI 10.1016/j.molmet.2013.09.002; Solak N, 2014, JOURNAL OF OBSTETRIC, P1; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Stepanow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017711; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Sturek JM, 2010, J CLIN INVEST, V120, P2575, DOI 10.1172/JCI41280; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Travers ME, 2011, HUM GENET, V130, P41, DOI 10.1007/s00439-011-1023-8; Vitto MF, 2012, HORM METAB RES, V44, P885, DOI 10.1055/s-0032-1321819; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; von Eckardstein A, 2000, J CLIN ENDOCR METAB, V85, P3101, DOI 10.1210/jc.85.9.3101; Waki H, 2012, CURR DIABETES REP, V12, P673, DOI 10.1007/s11892-012-0328-x; Wang ZC, 2006, BIOCHEM BIOPH RES CO, V345, P976, DOI 10.1016/j.bbrc.2006.04.173; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; WILSON PW, 1981, AM J EPIDEMIOL, V114, P697, DOI 10.1093/oxfordjournals.aje.a113240; XU J, 2014, THESCIENTIFICWORLDJO, P26932, DOI DOI 10.1155/2014/926932; Yu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065013; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002429; Zhou HL, 2012, PANCREAS, V41, P934, DOI 10.1097/MPA.0b013e318243a5e3; Zhu L, 2014, MOL BIOL REP, V41, P757, DOI 10.1007/s11033-013-2915-6	93	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152314	10.1371/journal.pone.0152314	http://dx.doi.org/10.1371/journal.pone.0152314			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019061	gold, Green Published, Green Submitted			2022-12-26	WOS:000372807800044
J	Welter, KC; Martins, CMDR; de Palma, ASV; Martins, MM; dos Reis, BR; Schmidt, BLU; Netto, AS				Welter, Katieli Caroline; de Magalhaes Rodrigues Martins, Cristian Marlon; Vizeu de Palma, Andre Soligo; Martins, Mellory Martinson; dos Reis, Barbara Roqueto; Unglaube Schmidt, Barbara Lais; Netto, Arlindo Saran			Canola Oil in Lactating Dairy Cow Diets Reduces Milk Saturated Fatty Acids and Improves Its Omega-3 and Oleic Fatty Acid Content	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; TISSUES	To produce milk that is healthier for human consumption, the present study evaluated the effect of including canola oil in the diet of dairy cows on milk production and composition as well as the nutritional quality of this milk fat. Eighteen Holstein cows with an average daily milk yield of 22 (+/- 4) kg/d in the middle stage of lactation were used. The cows were distributed in 6 contemporary 3x3 Latin squares consisting of 3 periods and 3 treatments: control diet (without oil), 3% inclusion of canola oil in the diet and 6% inclusion of canola oil in the diet (dry matter basis). The inclusion of 6% canola oil in the diet of lactating cows linearly reduced the milk yield by 2.51 kg/d, short-chain fatty acids (FA) by 41.42%, medium chain FA by 27.32%, saturated FA by 20.24%, saturated/unsaturated FA ratio by 39.20%, omega-6/omega-3 ratio by 39.45%, and atherogenicity index by 48.36% compared with the control treatment. Moreover, with the 6% inclusion of canola oil in the diet of cows, there was an increase in the concentration of long chain FA by 45.91%, unsaturated FA by 34.08%, monounsaturated FA by 40.37%, polyunsaturated FA by 17.88%, milk concentration of omega-3 by 115%, rumenic acid (CLA) by 16.50%, oleic acid by 44.87% and h/H milk index by 94.44% compared with the control treatment. Thus, the inclusion of canola oil in the diet of lactating dairy cows makes the milk fatty acid profile nutritionally healthier for the human diet; however, the lactating performance of dairy cows is reduce.	[Welter, Katieli Caroline; Vizeu de Palma, Andre Soligo; Martins, Mellory Martinson; dos Reis, Barbara Roqueto; Unglaube Schmidt, Barbara Lais; Netto, Arlindo Saran] Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Anim Sci, Sao Paulo, Brazil; [de Magalhaes Rodrigues Martins, Cristian Marlon] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Nutr & Anim Prod, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Netto, AS (corresponding author), Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Anim Sci, Sao Paulo, Brazil.	saranetto@usp.br	Netto, Arlindo SN saran/E-4978-2012; Welter, Katiéli/ABE-2936-2021; Welter, Katiéli Caroline/AAG-1133-2019; Martins, Cristian/I-2330-2018; Netto, Arlindo Saran/X-6180-2019	Netto, Arlindo SN saran/0000-0003-0170-8134; Welter, Katiéli/0000-0002-3445-0160; Martins, Cristian/0000-0002-3476-3458; Netto, Arlindo Saran/0000-0003-0170-8134	Sao Paulo Research Foundation (FAPESP) Sao Paulo, Brazil (FAPESP) [2012/22402-0, 2012 / 15050-0]	Sao Paulo Research Foundation (FAPESP) Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Sao Paulo Research Foundation (FAPESP) Sao Paulo, Brazil, research funding (FAPESP Process 2012/22402-0) and for scholarships (FAPESP Process 2012 / 15050-0)) to KW.	Barros PAV, 2013, ARQ BRAS MED VET ZOO, V65, P1545, DOI 10.1590/S0102-09352013000500036; Bauman DE, 2011, ANNU REV NUTR, V31, P299, DOI 10.1146/annurev.nutr.012809.104648; Bentes A.S., 2009, REV BRAS TECNOL AGRO, V3, P97, DOI DOI 10.3895/S1981-36862009000200011; Bentley Instruments, 1998, CHEMSP 150 US GUID; Bentley instruments, 1995, BENTL 2000 OP MAN; Bentley Instruments, 1995, SOM 300 OP MAN; Broughton KS, 1997, AM J CLIN NUTR, V65, P1011, DOI 10.1093/ajcn/65.4.1011; Caroprese M, 2010, J DAIRY SCI, V93, P2580, DOI 10.3168/jds.2008-2003; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024; de Silva PSA, 2014, EUR J GASTROEN HEPAT, V26, P11, DOI 10.1097/MEG.0b013e328365c372; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Dilzer A, 2012, CRIT REV FOOD SCI, V52, P488, DOI 10.1080/10408398.2010.501409; Freire SC, 2011, INGESTION OMEGA 3 6; Hall M. B., 2000, NEUTRAL DETERGENT SO, V339; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Haug A., 2007, Lipids in Health and Disease, V6; Ing SW, 2011, NUTR REV, V69, P123, DOI 10.1111/j.1753-4887.2011.00376.x; Lim JH, 2013, J BIOL CHEM, V288, P7117, DOI 10.1074/jbc.M112.415729; LOUGH DS, 1992, J ANIM SCI, V70, P1153, DOI 10.2527/1992.7041153x; Martin Clayton Antunes, 2006, Rev. Nutr., V19, P761, DOI 10.1590/S1415-52732006000600011; National Research Council, 2001, NUTR REQ DAIR CATTL, V7th; Palmquist D.L., 2006, RUMINANT NUTR, P287; Rodriguez-Ruiz J, 1998, BIOTECHNOL TECH, V12, P689, DOI 10.1023/A:1008812904017; Sales-Campos H, 2013, MINI-REV MED CHEM, V13, P201; Santos-Silva J, 2002, LIVEST PROD SCI, V77, P187, DOI 10.1016/S0301-6226(02)00059-3; Santos-Zago LF, 2008, REV NUTR, V21, P195, DOI 10.1590/S1415-52732008000200008; Simopoulos AP, 2002, ASIA PAC J CLIN NUTR, V11, pS163, DOI 10.1046/j.1440-6047.11.s.6.5.x; Simopoulos AP, 2004, FOOD REV INT, V20, P77, DOI 10.1081/FRI-120028831; SKLAN D, 1994, J DAIRY SCI, V77, P1652, DOI 10.3168/jds.S0022-0302(94)77107-1; SNIFFEN CJ, 1992, J ANIM SCI, V70, P3562, DOI 10.2527/1992.70113562x; Statistical Analysis System Institute-SAS, 2001, STAT AN US GUID VERS; Tanaka Keiichi, 2005, Animal Science Journal, V76, P291, DOI 10.1111/j.1740-0929.2005.00268.x; Teres S, 2008, P NATL ACAD SCI USA, V105, P13811, DOI 10.1073/pnas.0807500105; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25	36	30	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151876	10.1371/journal.pone.0151876	http://dx.doi.org/10.1371/journal.pone.0151876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015405	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900031
J	Yang, M; Lewinska, M; Fan, X; Zhu, J; Yuan, ZM				Yang, M.; Lewinska, M.; Fan, X.; Zhu, J.; Yuan, Z-M			PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis	ONCOGENE			English	Article							PROTEIN-KINASE B/AKT; TERMINAL SH3 DOMAIN; PROLINE-RICH MOTIFS; PHOSPHATIDYLINOSITOL 3-KINASE; CELLULAR-SURVIVAL; CRYSTAL-STRUCTURE; RAS; GRB2; SUBUNIT; SRC	Chromosomal focal amplifications often cause an increase in gene copy number, contributing to the pathogenesis of cancer. PRR14 overexpression is associated with recurrent locus amplification in lung cancer, and it correlates with a poor prognosis. We show that increased PRR14 expression promoted and reduced PRR14 expression impeded lung cancer cell proliferation. Interestingly, PRR14 cells were markedly enlarged in size and exhibited an elevated activity of the PI3-kinase/Akt/mTOR pathway, which was associated with a heightened sensitivity to the inhibitors of PI3K and mammalian target of rapamycin (mTOR). Biochemical analysis revealed that PRR14, as a proline-rich protein, binds to the Src homology 3 (SH3) domains of GRB2 resulting in PI3K activation. Significantly, two cancer patient-derived PRR14 mutants displayed considerably augmented GRB2-binding and an enhanced ability of promoting cell proliferation. Together with the in vivo data demonstrating a strong tumor-promoting activity of PRR14 and the mutants, our work uncovered this proline-rich protein as a novel activator of the PI3K pathway that promoted tumorigenesis in lung cancer.	[Yang, M.; Lewinska, M.; Fan, X.; Zhu, J.; Yuan, Z-M] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Yuan, ZM (corresponding author), Harvard Sch Publ Hlth, Dept Genet & Complex Dis, 655 Huntington Ave, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu	Lewinska, Monika/N-9919-2017	Lewinska, Monika/0000-0002-5275-992X; yang, mei/0000-0001-9574-2282	Morningside Foundation; Zhu Fund; National Cancer Institute at the National Institutes of Health [R01CA085679, RO1CA167814, RO1CA125144]; NATIONAL CANCER INSTITUTE [R01CA085679, R01CA125144, R01CA167814, R01CA183074] Funding Source: NIH RePORTER	Morningside Foundation; Zhu Fund; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to current and former members of the Yuan laboratory for support, advice and helpful discussions. We thank Dr Brendan Manning for reagents. This work was supported in part by the Morningside Foundation, the Zhu Fund and grants from the National Cancer Institute at the National Institutes of Health (R01CA085679, RO1CA167814 and RO1CA125144).	Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; BOOKER GW, 1993, CELL, V73, P813, DOI 10.1016/0092-8674(93)90259-S; Brognard J, 2001, CANCER RES, V61, P3986; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Cheng HY, 2014, LUNG CANCER MANAG, V3, P67, DOI 10.2217/LMT.13.72; DALY RJ, 1994, ONCOGENE, V9, P2723; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; GURUPRASAD L, 1995, J MOL BIOL, V248, P856, DOI 10.1006/jmbi.1995.0266; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Job B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015145; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Lin XB, 2001, LANGENBECK ARCH SURG, V386, P293, DOI 10.1007/s004230100203; Liu AX, 1998, CANCER RES, V58, P2973; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Meili R, 1998, ONCOGENE, V16, P903, DOI 10.1038/sj.onc.1201605; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Poleshko A, 2013, CELL REP, V5, P292, DOI 10.1016/j.celrep.2013.09.024; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Shen XC, 2010, J BIOL CHEM, V285, P29416, DOI 10.1074/jbc.M110.155325; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Spoerke JM, 2012, CLIN CANCER RES, V18, P6771, DOI 10.1158/1078-0432.CCR-12-2347; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Wissmueller S, 2011, PROTEINS, V79, P2365, DOI 10.1002/prot.23068; Yang XL, 2011, CELL RES, V21, P715, DOI 10.1038/cr.2011.63; YANG YS, 1994, EMBO J, V13, P1270, DOI 10.1002/j.1460-2075.1994.tb06379.x; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	40	13	15	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 20	2016	35	42					5527	5538		10.1038/onc.2016.93	http://dx.doi.org/10.1038/onc.2016.93			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XO	27041574	Green Accepted			2022-12-26	WOS:000386998200007
J	Wagener, BM; Hu, M; Zheng, AN; Zhao, XK; Che, PL; Brandon, A; Anjum, N; Snapper, S; Creighton, J; Guan, JL; Han, QM; Cai, GQ; Han, XS; Pittet, JF; Ding, Q				Wagener, Brant M.; Hu, Meng; Zheng, Anni; Zhao, Xueke; Che, Pulin; Brandon, Angela; Anjum, Naseem; Snapper, Scott; Creighton, Judy; Guan, Jun-Lin; Han, Qimei; Cai, Guo-Qiang; Han, Xiaosi; Pittet, Jean-Francois; Ding, Qiang			Neuronal Wiskott-Aldrich syndrome protein regulates TGF-beta 1-mediated lung vascular permeability	FASEB JOURNAL			English	Article						acute lung injury; FAK; small Rho GTPases; cytoskeletal dynamics; IL-1 beta	FOCAL ADHESION KINASE; RESPIRATORY-DISTRESS-SYNDROME; ENDOTHELIAL GROWTH-FACTOR; N-WASP; PSEUDOMONAS-AERUGINOSA; ACTIN-FILAMENTS; PULMONARY-EDEMA; RAT LUNG; TRANSFORMING GROWTH-FACTOR-BETA-1; MYOFIBROBLAST DIFFERENTIATION	TGF-beta 1 induces an increase in paracellular permeability and actin stress fiber formation in lung microvascular endothelial and alveolar epithelial cells via small Rho GTPase. The molecular mechanism involved is not fully understood. Neuronal Wiskott-Aldrich syndrome protein (N-WASP) has an essential role in actin structure dynamics. We hypothesized that N-WASP plays a critical role in these TGF-beta 1-induced responses. In these cell monolayers, we demonstrated that N-WASP down-regulation by short hairpin RNA prevented TGF-beta 1-mediated disruption of the cortical actin structure, actin stress filament formation, and increased permeability. Furthermore, N-WASP down-regulation blocked TGF-beta 1 activation mediated by IL-1 beta in alveolar epithelial cells, which requires actin stress fiber formation. Control short hairpin RNA had no effect on these TGF-beta 1-induced responses. TGF-beta 1-induced phosphorylation of Y256 of N-WASP via activation of small Rho GTPase and focal adhesion kinase mediates TGF-beta 1-induced paracellular permeability and actin cytoskeleton dynamics. In vivo, compared with controls, N-WASP down-regulation increases survival and prevents lung edema in mice induced by bleomycin exposure-a lung injury model in which TGF-beta 1 plays a critical role. Our data indicate that N-WASP plays a crucial role in the development of TGF-beta 1-mediated acute lung injury by promoting pulmonary edema via regulation of actin cytoskeleton dynamics.	[Wagener, Brant M.; Pittet, Jean-Francois] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Crit Care, Birmingham, AL 35294 USA; [Wagener, Brant M.; Brandon, Angela; Anjum, Naseem; Creighton, Judy; Pittet, Jean-Francois] Univ Alabama Birmingham, Div Mol & Translat Biomed, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Hu, Meng; Zheng, Anni; Zhao, Xueke; Han, Qimei; Cai, Guo-Qiang; Ding, Qiang] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Dept Med, Birmingham, AL 35294 USA; [Che, Pulin; Han, Xiaosi] Univ Alabama Birmingham, Dept Med, Div Neurol, Birmingham, AL 35294 USA; [Pittet, Jean-Francois] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Pittet, Jean-Francois; Ding, Qiang] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Zhao, Xueke] Guizhou Med Univ, Affiliated Hosp, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Snapper, Scott] Harvard Univ, Dept Pathol, Boston, MA 02115 USA; [Guan, Jun-Lin] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Guizhou Medical University; Harvard University; University System of Ohio; University of Cincinnati	Pittet, JF (corresponding author), Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Crit Care, Birmingham, AL 35294 USA.; Ding, Q (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Dept Med, Birmingham, AL 35294 USA.	jpittet@uabmc.edu; qding@uab.edu	Wagener, Brant/AAI-7480-2020	Han, Qimei/0000-0003-4874-8862	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant [R01-HL085324]; Flight Attendant Medical Research Institute; Mentored Research Training Grant from Foundation for Anesthesia Education and Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095451, R01HL127338, R01HL085324] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant; Flight Attendant Medical Research Institute; Mentored Research Training Grant from Foundation for Anesthesia Education and Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant R01-HL085324, the Flight Attendant Medical Research Institute (to Q.D.), and by a Mentored Research Training Grant from the Foundation for Anesthesia Education and Research (to B.M.W.).	Bai YS, 2014, INT J MOL MED, V34, P1473, DOI 10.3892/ijmm.2014.1946; Bechara RI, 2004, AM J RESP CRIT CARE, V170, P188, DOI 10.1164/rccm.200304-478OC; Bhattacharya S, 2003, AM J RESP CELL MOL, V28, P218, DOI 10.1165/rcmb.4763; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; Cai GQ, 2012, AM J PHYSIOL-LUNG C, V303, pL692, DOI 10.1152/ajplung.00390.2011; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Carles M, 2010, ANESTHESIOLOGY, V113, P1134, DOI 10.1097/ALN.0b013e3181f4171b; Che PL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08453; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Chesnutt AN, 1997, AM J RESP CRIT CARE, V156, P840, DOI 10.1164/ajrccm.156.3.9701124; Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Ding Q, 2002, CANCER RES, V62, P5336; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Duluc L, 2014, CELL TISSUE RES, V355, P675, DOI 10.1007/s00441-014-1805-0; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Frank J, 2003, J BIOL CHEM, V278, P43939, DOI 10.1074/jbc.M304882200; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Ganter MT, 2009, AM J RESP CELL MOL, V40, P108, DOI 10.1165/rcmb.2007-0454OC; Goldberg PL, 2002, AM J PHYSIOL-LUNG C, V282, pL146, DOI 10.1152/ajplung.2002.282.1.L146; Goolaerts A, 2011, THORAX, V66, P788, DOI 10.1136/thx.2010.155788; Greenlee MM, 2013, AM J PHYSIOL-LUNG C, V305, pL878, DOI 10.1152/ajplung.00008.2013; Infante JR, 2012, J CLIN ONCOL, V30, P1527, DOI 10.1200/JCO.2011.38.9346; Infusino GA, 2012, MICROVASC RES, V83, P89, DOI 10.1016/j.mvr.2011.09.011; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Jian MY, 2013, AM J PHYSIOL-LUNG C, V305, pL844, DOI 10.1152/ajplung.00173.2013; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kaner RJ, 2000, AM J RESP CELL MOL, V22, P657, DOI 10.1165/ajrcmb.22.6.3779; Konrad FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121725; LEWIS JF, 1993, AM REV RESPIR DIS, V147, P218, DOI 10.1164/ajrccm/147.1.218; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; Misra A, 2007, BIOCHEM BIOPH RES CO, V364, P908, DOI 10.1016/j.bbrc.2007.10.086; Olman MA, 2004, J IMMUNOL, V172, P2668, DOI 10.4049/jimmunol.172.4.2668; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Pittet JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063907; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pugin J, 1996, AM J RESP CRIT CARE, V153, P1850, DOI 10.1164/ajrccm.153.6.8665045; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Roux J, 2010, J BIOL CHEM, V285, P4278, DOI 10.1074/jbc.M109.036731; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Sturge J, 2002, J CELL SCI, V115, P699; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; Usatyuk PV, 2005, AM J PHYSIOL-LUNG C, V289, pL999, DOI 10.1152/ajplung.00211.2005; Wagener BM, 2015, ANESTHESIOLOGY, V122, P1084, DOI 10.1097/ALN.0000000000000595; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Wu MH, 2003, J PHYSIOL-LONDON, V552, P691, DOI 10.1113/jphysiol.2003.048405; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200	68	7	7	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2557	2569		10.1096/fj.201600102R	http://dx.doi.org/10.1096/fj.201600102R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27025963	Green Published			2022-12-26	WOS:000379249500011
J	Ahn, S; Jung, J; Jang, IA; Madsen, EL; Park, W				Ahn, Sungeun; Jung, Jaejoon; Jang, In-Ae; Madsen, Eugene L.; Park, Woojun			Role of Glyoxylate Shunt in Oxidative Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINETOBACTER-OLEIVORANS DR1; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; ISOCITRATE LYASE; MYCOBACTERIUM-TUBERCULOSIS; MAMMALIAN-CELLS; METABOLISM; VIRULENCE; ENZYME; PATHOGENESIS	The glyoxylate shunt (GS) is a two-step metabolic pathway (isocitrate lyase, aceA; and malate synthase, glcB) that serves as an alternative to the tricarboxylic acid cycle. The GS bypasses the carbon dioxide-producing steps of the tricarboxylic acid cycle and is essential for acetate and fatty acid metabolism in bacteria. GS can be up-regulated under conditions of oxidative stress, antibiotic stress, and host infection, which implies that it plays important but poorly explored roles in stress defense and pathogenesis. In many bacterial species, including Pseudomonas aeruginosa, aceA and glcB are not in an operon, unlike in Escherichia coli. In P. aeruginosa, we explored relationships between GS genes and growth, transcription profiles, and biofilm formation. Contrary to our expectations, deletion of aceA in P. aeruginosa improved cell growth under conditions of oxidative and antibiotic stress. Transcriptome data suggested that aceA mutants underwent a metabolic shift toward aerobic denitrification; this was supported by additional evidence, including up-regulation of denitrification-related genes, decreased oxygen consumption without lowering ATP yield, increased production of denitrification intermediates (NO and N2O), and increased cyanide resistance. The aceA mutants also produced a thicker exopolysaccharide layer; that is, a phenotype consistent with aerobic denitrification. A bioinformatic survey across known bacterial genomes showed that only microorganisms capable of aerobic metabolism possess the glyoxylate shunt. This trend is consistent with the hypothesis that the GS plays a previously unrecognized role in allowing bacteria to tolerate oxidative stress.	[Ahn, Sungeun; Jung, Jaejoon; Jang, In-Ae; Park, Woojun] Korea Univ, Dept Environm Sci & Ecol Engn, Lab Mol Environm Microbiol, Seoul 02841, South Korea; [Madsen, Eugene L.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Korea University; Cornell University	Park, W (corresponding author), Korea Univ, Dept Environm Sci & Ecol Engn, Seoul 02841, South Korea.	wpark@korea.ac.kr			National Research Foundation of Korea (NRF) by the Korea government (MSIP) [NRF-2014R1A2A2A05007010]	National Research Foundation of Korea (NRF) by the Korea government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant supported by the Korea government (MSIP) (NRF-2014R1A2A2A05007010). The authors declare that they have no conflicts of interest with the contents of this article.	Akhova AV, 2014, FEMS MICROBIOL LETT, V353, P69, DOI 10.1111/1574-6968.12405; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; ANDRAE U, 1985, TOXICOL LETT, V28, P93, DOI 10.1016/0378-4274(85)90015-3; Bedhomme M, 2009, J BIOL CHEM, V284, P36282, DOI 10.1074/jbc.M109.064428; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Bryantseva I, 1999, INT J SYST BACTERIOL, V49, P697, DOI 10.1099/00207713-49-2-697; Chen F, 2003, APPL ENVIRON MICROB, V69, P6715, DOI 10.1128/AEM.69.11.6715-6722.2003; Chung JCS, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120131; CLAASSEN PAM, 1987, ARCH MICROBIOL, V147, P30, DOI 10.1007/BF00492901; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; Diaz-Perez AL, 2007, FEMS MICROBIOL LETT, V269, P309, DOI 10.1111/j.1574-6968.2007.00654.x; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Grostern A, 2012, APPL ENVIRON MICROB, V78, P3298, DOI 10.1128/AEM.00067-12; GUNSALUS RP, 1992, J BACTERIOL, V174, P7069, DOI 10.1128/jb.174.22.7069-7074.1992; Hamada M, 2014, J BACTERIOL, V196, P3881, DOI 10.1128/JB.01978-14; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110215; IKEDA T, 1991, J BACTERIOL, V173, P1801, DOI 10.1128/jb.173.5.1801-1806.1991; Jung J, 2013, APPL ENVIRON MICROB, V79, P6351, DOI 10.1128/AEM.02350-13; Jung J, 2011, APPL ENVIRON MICROB, V77, P7418, DOI 10.1128/AEM.05231-11; Jung J, 2011, J MICROBIOL, V49, P208, DOI 10.1007/s12275-011-0395-8; Kim EJ, 2003, MICROBIOL-SGM, V149, P2627, DOI 10.1099/mic.0.26276-0; Kim J, 2013, FEMS MICROBIOL LETT, V343, P89, DOI 10.1111/1574-6968.12135; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Kretzschmar U, 2008, ARCH MICROBIOL, V190, P151, DOI 10.1007/s00203-008-0381-7; LAWLEY PD, 1970, BIOCHEM J, V116, P693, DOI 10.1042/bj1160693; Lee Y, 2010, MICROBIOL-SGM, V156, P3762, DOI 10.1099/mic.0.041095-0; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; MALOY SR, 1980, J BACTERIOL, V143, P720, DOI 10.1128/JB.143.2.720-725.1980; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Nandakumar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5306; Olivares J, 2014, ANTIMICROB AGENTS CH, V58, P3904, DOI 10.1128/AAC.00121-14; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; Resnik E, 1996, J BACTERIOL, V178, P2715, DOI 10.1128/jb.178.9.2715-2717.1996; Rock JD, 2005, BIOCHEM SOC T, V33, P134, DOI 10.1042/BST0330134; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; SPIRO S, 1991, TRENDS BIOCHEM SCI, V16, P310, DOI 10.1016/0968-0004(91)90125-F; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; VANNI P, 1990, COMP BIOCHEM PHYS B, V95, P431, DOI 10.1016/0305-0491(90)90002-B; Wall DM, 2005, INFECT IMMUN, V73, P6736, DOI 10.1128/IAI.73.10.6736-6741.2005; Wang WW, 2013, AMINO ACIDS, V45, P463, DOI 10.1007/s00726-013-1493-1; White D., 2012, PHYSL BIOCH PROKARYO, P214; Whittaker JW, 2012, ARCH BIOCHEM BIOPHYS, V525, P111, DOI 10.1016/j.abb.2011.12.008; Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13	55	118	118	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11928	11938		10.1074/jbc.M115.708149	http://dx.doi.org/10.1074/jbc.M115.708149			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27036942	hybrid, Green Published			2022-12-26	WOS:000377264800040
J	Morrill, SA; Exner, AE; Babokhov, M; Reinfeld, BI; Fuchs, SM				Morrill, Summer A.; Exner, Alexandra E.; Babokhov, Michael; Reinfeld, Bradley I.; Fuchs, Stephen M.			DNA Instability Maintains the Repeat Length of the Yeast RNA Polymerase II C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-QUADRUPLEX MOTIFS; SACCHAROMYCES-CEREVISIAE; MINISATELLITE STABILITY; EVOLUTION; REPLICATION; MUTATIONS; SEQUENCES; HELICASE; PROTEIN; REPAIR	The C-terminal domain (CTD) of RNA polymerase II in eukaryotes is comprised of tandemly repeating units of a conserved seven-amino acid sequence. The number of repeats is, however, quite variable across different organisms. Furthermore, previous studies have identified evidence of rearrangements within the CTD coding region, suggesting that DNA instability may play a role in regulating or maintaining CTD repeat number. The work described here establishes a clear connection between DNA instability and CTD repeat number in Saccharomyces cerevisiae. First, analysis of 36 diverse S. cerevisiae isolates revealed evidence of numerous past rearrangements within the DNA sequence that encodes the CTD. Interestingly, the total number of CTD repeats was relatively static (24-26 repeats in all strains), suggesting a balancing act between repeat expansion and contraction. In an effort to explore the genetic plasticity within this region, we measured the rates of repeat expansion and contraction using novel reporters and a doxycycline-regulated expression system for RPB1. In efforts to determine the mechanisms leading to CTD repeat variability, we identified the presence of DNA secondary structures, specifically G-quadruplex-like DNA, within the CTD coding region. Furthermore, we demonstrated that mutating PIF1, a G-quadruplex-specific helicase, results in increased CTD repeat length polymorphisms. We also determined that RAD52 is necessary for CTD repeat expansion but not contraction, identifying a role for recombination in repeat expansion. Results from these DNA rearrangements may help explain the CTD copy number variation seen across eukaryotes, as well as support a model of CTD expansion and contraction to maintain CTD integrity and overall length.	[Morrill, Summer A.; Exner, Alexandra E.; Babokhov, Michael; Reinfeld, Bradley I.; Fuchs, Stephen M.] Tufts Univ, Dept Biol, 200 Boston Ave,Ste 4700, Medford, MA 02155 USA	Tufts University	Fuchs, SM (corresponding author), Tufts Univ, Dept Biol, 200 Boston Ave,Ste 4700, Medford, MA 02155 USA.	stephen.fuchs@tufts.edu		/0000-0002-1938-1486; Reinfeld, Bradley/0000-0003-4161-8301; Fuchs, Stephen/0000-0001-7261-9214	Tufts University; Russell L. Carpenter scholarship; Tufts Summer Scholars program	Tufts University; Russell L. Carpenter scholarship; Tufts Summer Scholars program	This work was supported by startup funds and a Tufts Collaborates! grant from Tufts University (to S. M. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a Russell L. Carpenter scholarship.; Supported in part by the Tufts Summer Scholars program.	Akada R, 2000, BIOTECHNIQUES, V28, P668, DOI 10.2144/00284st02; Aksenova AY, 2013, P NATL ACAD SCI USA, V110, P19866, DOI 10.1073/pnas.1319313110; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fuchs SM, 2012, J BIOL CHEM, V287, P3249, DOI 10.1074/jbc.M111.273953; Fuchs SM, 2009, BBA-GENE REGUL MECH, V1789, P26, DOI 10.1016/j.bbagrm.2008.07.008; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JARMAN AP, 1989, TRENDS GENET, V5, P367, DOI 10.1016/0168-9525(89)90171-6; Kelly MK, 2012, G3-GENES GENOM GENET, V2, P1185, DOI 10.1534/g3.112.003673; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kishore SP, 2009, J MOL EVOL, V68, P706, DOI 10.1007/s00239-009-9245-2; LeClere AR, 2013, FUNGAL GENET BIOL, V50, P33, DOI 10.1016/j.fgb.2012.10.007; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Liu PD, 2008, MOL BIOL EVOL, V25, P719, DOI 10.1093/molbev/msn017; Liu PD, 2010, MOL BIOL EVOL, V27, P2628, DOI 10.1093/molbev/msq151; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; McDaniel JR, 2010, BIOMACROMOLECULES, V11, P944, DOI 10.1021/bm901387t; MITANI K, 1990, J BIOL CHEM, V265, P15203; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; NONET ML, 1989, GENETICS, V123, P715; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Preston CR, 2002, GENETICS, V161, P711; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SIKORSKI RS, 1989, GENETICS, V122, P19; Simonti CN, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0327-z; Stump AD, 2013, TRANSCR-AUSTIN, V4, P77, DOI 10.4161/trns.23305; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wang GL, 2014, DNA REPAIR, V19, P143, DOI 10.1016/j.dnarep.2014.03.017; Weitzmann MN, 1997, J BIOL CHEM, V272, P9517; WEST ML, 1995, GENETICS, V140, P1223; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585; Yang CL, 2014, P NATL ACAD SCI USA, V111, P5920, DOI 10.1073/pnas.1323616111; Zumwalt M, 2007, RNA BIOL, V4, P93, DOI 10.4161/rna.4.2.5039	48	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11540	11550		10.1074/jbc.M115.696252	http://dx.doi.org/10.1074/jbc.M115.696252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27026700	hybrid, Green Published			2022-12-26	WOS:000377264800007
J	Yosef, E; Katz, A; Peleg, Y; Mehlman, T; Karlish, SJD				Yosef, Eliyahu; Katz, Adriana; Peleg, Yoav; Mehlman, Tevie; Karlish, Steven J. D.			Do Src Kinase and Caveolin Interact Directly with Na,K-ATPase?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; SIGNAL-TRANSDUCING FUNCTION; NA/K-ATPASE; TYROSINE KINASES; OUABAIN; PROTEIN; PURIFICATION; STABILIZATION; NA+,K+-ATPASE; EXPRESSION	Much evidence points to a role of Na,K-ATPase in ouabain-dependent signal transduction. Based on experiments with different cell lines and native tissue membranes, a current hypothesis postulates direct interactions between the Na, K-ATPase and Src kinase (non-receptor tyrosine kinase). Na, K-ATPase is proposed to bind Src kinase and inhibit its activity, whereas ouabain, the specific Na, K-ATPase inhibitor, binds and stabilizes the E2 conformation, thus exposing the Src kinase domain and its active site Tyr-418 for activation. Ouabain-dependent signaling is thought to be mediated within caveolae by a complex consisting of Na, K-ATPase, caveolin, and Src kinase. In the current work, we have looked for direct interactions utilizing purified recombinant Na, K-ATPase (human alpha 1 beta 1FXYD1 or porcine alpha 1D369N beta 1FXYD1) and purified human Src kinase and human caveolin 1 or interactions between these proteins in native membrane vesicles isolated from rabbit kidney. By several independent criteria and techniques, no stable interactions were detected between Na, K-ATPase and purified Src kinase. Na,K-ATPase was found to be a substrate for Src kinase phosphorylation at Tyr-144. Clear evidence for a direct interaction between purified human Na, K-ATPase and human caveolin was obtained, albeit with a low molar stoichiometry (1:15-30 caveolin 1/Na,K-ATPase). In native renal membranes, a specific caveolin 14-5 oligomer (95 kDa) was found to be in direct interaction with Na, K-ATPase. We inferred that a small fraction of the renal Na, K-ATPase molecules is in a similar to 1:1 complex with a caveolin 14-5 oligomer. Thus, overall, whereas a direct caveolin 1/Na, K-ATPase interaction is confirmed, the lack of direct Src kinase/Na,K-ATPase binding requires reassessment of the mechanism of ouabain-dependent signaling.	[Yosef, Eliyahu; Katz, Adriana; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Peleg, Yoav] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-7610001 Rehovot, Israel; [Mehlman, Tevie] Weizmann Inst Sci, Biol Serv Dept, Mass Spectrometry Unit, IL-7610001 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il						Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Aperia A, 2016, AM J PHYSIOL-CELL PH, V310, pC491, DOI 10.1152/ajpcell.00359.2015; Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Belogus T, 2009, J BIOL CHEM, V284, P31038, DOI 10.1074/jbc.M109.050054; Bozulic LD, 2005, INVEST OPHTH VIS SCI, V46, P618, DOI 10.1167/iovs.04-0809; Clifford RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084306; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Ferrandi M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001815; Ferrari P, 2006, AM J PHYSIOL-REG I, V290, pR529, DOI 10.1152/ajpregu.00518.2005; Ferrari P, 2010, BBA-MOL BASIS DIS, V1802, P1254, DOI 10.1016/j.bbadis.2010.01.009; Fontana JM, 2013, FEBS J, V280, P5450, DOI 10.1111/febs.12448; Gable ME, 2014, BIOCHEM BIOPH RES CO, V446, P1151, DOI 10.1016/j.bbrc.2014.03.071; Gottlieb-Abraham E, 2013, MOL BIOL CELL, V24, P3881, DOI 10.1091/mbc.E13-03-0163; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; Habeck M, 2015, J BIOL CHEM, V290, P4829, DOI 10.1074/jbc.M114.611384; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; KARLISH SJD, 1993, J BIOL CHEM, V268, P3471; Karni R, 2003, FEBS LETT, V537, P47, DOI 10.1016/S0014-5793(03)00069-3; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Lai FF, 2013, J BIOL CHEM, V288, P13295, DOI 10.1074/jbc.M113.467381; LAZARO I, 1991, ANAL BIOCHEM, V192, P257, DOI 10.1016/0003-2697(91)90533-Y; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu J, 2000, J BIOL CHEM, V275, P27838; Liu LJ, 2011, BIOCHEMISTRY-US, V50, P8664, DOI 10.1021/bi2009008; Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Moroco JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105629; Reinhard L, 2013, CELL MOL LIFE SCI, V70, P205, DOI 10.1007/s00018-012-1039-9; Schoner W, 2002, EUR J BIOCHEM, V269, P2440, DOI 10.1046/j.1432-1033.2002.02911.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; Susa M, 2000, PROTEIN EXPRES PURIF, V19, P99, DOI 10.1006/prep.2000.1221; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Weigand KM, 2012, BBA-BIOMEMBRANES, V1818, P1269, DOI 10.1016/j.bbamem.2012.01.015; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051	49	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11736	11750		10.1074/jbc.M116.721084	http://dx.doi.org/10.1074/jbc.M116.721084			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27022017	Green Published, hybrid			2022-12-26	WOS:000377264800024
J	Cecil, JD; O'Brien-Simpson, NM; Lenzo, JC; Holden, JA; Chen, YY; Singleton, W; Gause, KT; Yan, Y; Caruso, F; Reynolds, EC				Cecil, Jessica D.; O'Brien-Simpson, Neil M.; Lenzo, Jason C.; Holden, James A.; Chen, Yu-Yen; Singleton, William; Gause, Katelyn T.; Yan, Yan; Caruso, Frank; Reynolds, Eric C.			Differential Responses of Pattern Recognition Receptors to Outer Membrane Vesicles of Three Periodontal Pathogens	PLOS ONE			English	Article							PROTEINASE-ADHESIN COMPLEXES; PORPHYROMONAS-GINGIVALIS; TREPONEMA-DENTICOLA; BACTEROIDES-GINGIVALIS; SOLUBLE PEPTIDOGLYCAN; EPITHELIAL-CELLS; VIRULENCE; BACTERIA; DNA; RELEASE	Highly purified outer membrane vesicles (OMVs) of the periodontal pathogens, Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia were produced using tangential flow ultrafiltration, ultracentrifugation and Optiprep density gradient separation. Cryo-TEM and light scattering showed OMVs to be single lipid-bilayers with modal diameters of 75 to 158 nm. Enumeration of OMVs by nanoparticle flow-cytometry at the same stage of late exponential culture indicated that P. gingivalis was the most prolific OMV producer. P. gingivalis OMVs induced strong TLR2 and TLR4-specific responses and moderate responses in TLR7, TLR8, TLR9, NOD1 and NOD2 expressing-HEK-Blue cells. Responses to T. forsythia OMVs were less than those of P. gingivalis and T. denticola OMVs induced only weak responses. Compositional analyses of OMVs from the three pathogens demonstrated differences in protein, fatty acids, lipopolysaccharide, peptidoglycan fragments and nucleic acids. Periodontal pathogen OMVs induced differential pattern recognition receptor responses that have implications for their role in chronic periodontitis.	[Cecil, Jessica D.; O'Brien-Simpson, Neil M.; Lenzo, Jason C.; Holden, James A.; Chen, Yu-Yen; Singleton, William; Reynolds, Eric C.] Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia; [Gause, Katelyn T.; Yan, Yan; Caruso, Frank] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu.au	Yan, Yan/A-3720-2009; Caruso, Frank/A-9587-2011; O'Brien-Simpson, Neil/B-2901-2009	Yan, Yan/0000-0003-2938-4063; Caruso, Frank/0000-0002-0197-497X; O'Brien-Simpson, Neil/0000-0001-8462-5603; Lenzo, Jason/0000-0002-0564-9250	Australian Government, Department of Industry, Innovation and Science	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by the Australian Government, Department of Industry, Innovation and Science.	Asai Y, 2003, INFECT IMMUN, V71, P717, DOI 10.1128/IAI.71.2.717-725.2003; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Chi B, 2003, RES MICROBIOL, V154, P637, DOI 10.1016/j.resmic.2003.08.001; Chua BY, 2007, VACCINE, V25, P92, DOI 10.1016/j.vaccine.2006.07.012; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Draghi JA, 2006, MICROBIOL-SGM, V152, P2683, DOI 10.1099/mic.0.29013-0; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Friedrich V, 2015, MOL ORAL MICROBIOL, V30, P451, DOI 10.1111/omi.12104; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; GMUR R, 1989, J PERIODONTAL RES, V24, P113, DOI 10.1111/j.1600-0765.1989.tb00865.x; GRAHAM J, 1994, ANAL BIOCHEM, V220, P367, DOI 10.1006/abio.1994.1351; Graunaite I., 2012, J ORAL MAXILLOFAC RE, V2, pE1, DOI DOI 10.5037/jomr.2011.2401; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Ho MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123448; Imayoshi R, 2011, ORAL DIS, V17, P83, DOI 10.1111/j.1601-0825.2010.01708.x; Jain S, 2013, INFECT IMMUN, V81, P1277, DOI 10.1128/IAI.01036-12; Jervoe-Storm PM, 2007, J PERIODONTOL, V78, P909, DOI 10.1902/jop.2007.060218; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kim J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/s10266-006-0060-6; Kim PD, 2015, INFECT IMMUN, V83, P2992, DOI 10.1128/IAI.00424-15; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kumada H, 2008, ORAL MICROBIOL IMMUN, V23, P60, DOI 10.1111/j.1399-302X.2007.00392.x; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McCaig WD, 2013, J BACTERIOL, V195, P1120, DOI 10.1128/JB.02007-12; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Nonnenmacher C, 2003, INFECT IMMUN, V71, P850, DOI 10.1128/IAI.71.2.850-856.2003; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; O'Brien-Simpson NM, 2009, INFECT IMMUN, V77, P1246, DOI 10.1128/IAI.01038-08; Orth RKH, 2011, MOL ORAL MICROBIOL, V26, P229, DOI 10.1111/j.2041-1014.2011.00612.x; Orth R, 2010, J MICROBIOL METH, V80, P123, DOI 10.1016/j.mimet.2009.11.006; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Posch G, 2013, CLIN VACCINE IMMUNOL, V20, P945, DOI 10.1128/CVI.00139-13; Prates TP, 2014, J DENT RES, V93, P1155, DOI 10.1177/0022034514551770; Qi MS, 2003, MICROB PATHOGENESIS, V35, P259, DOI 10.1016/j.micpath.2003.07.002; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; ROSEN G, 1995, INFECT IMMUN, V63, P3973, DOI 10.1128/IAI.63.10.3973-3979.1995; ROSENTHAL RS, 1979, INFECT IMMUN, V24, P869, DOI 10.1128/IAI.24.3.869-878.1979; ROSENTHAL RS, 1987, INFECT IMMUN, V55, P2117, DOI 10.1128/IAI.55.9.2117-2120.1987; Ruby J, 2007, INFECT IMMUN, V75, P5763, DOI 10.1128/IAI.01117-07; Schultz CP, 1998, J BIOL CHEM, V273, P15661, DOI 10.1074/jbc.273.25.15661; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Silva TA, 2007, J DENT RES, V86, P306, DOI 10.1177/154405910708600403; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Srisatjaluk R, 1999, MICROB PATHOGENESIS, V27, P81, DOI 10.1006/mpat.1999.0287; Stashenko P, 1998, CRIT REV ORAL BIOL M, V9, P498, DOI 10.1177/10454411980090040701; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; Tan KH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003955; TSAI CC, 1995, J PERIODONTOL, V66, P852, DOI 10.1902/jop.1995.66.10.852; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Wieser A, 2014, INT J MED MICROBIOL, V304, P1032, DOI 10.1016/j.ijmm.2014.07.012; Woodhams KL, 2013, INFECT IMMUN, V81, P3490, DOI 10.1128/IAI.00279-13; Yonezawa H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-197; Yoshimura A, 1997, J PERIODONTAL RES, V32, P279, DOI 10.1111/j.1600-0765.1997.tb00535.x; Zhou L, 1998, FEMS MICROBIOL LETT, V163, P223, DOI 10.1111/j.1574-6968.1998.tb13049.x; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071727	73	48	51	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0151967	10.1371/journal.pone.0151967	http://dx.doi.org/10.1371/journal.pone.0151967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035339	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200008
J	Liang, ZX; Yuan, RY; Chen, L; Zhu, XL; Dou, YX				Liang, Zhongxiang; Yuan, Ruyi; Chen, Lei; Zhu, Xueliang; Dou, Yongxi			Molecular Evolution and Characterization of Hemagglutinin (H) in Peste des Petits Ruminants Virus	PLOS ONE			English	Article							AMINO-ACID SITES; NEURAMINIDASE PROTEIN; PHYLOGENETIC ANALYSIS; RINDERPEST VIRUS; IMMUNE; SELECTION; GLYCOPROTEIN; SEQUENCE; EPIDEMIOLOGY; INTERFACE	Peste des Petits Ruminants (PPR) is an acute, highly contagious, and febrile viral disease that affects both domestic and wild small ruminants. The disease has become a major obstacle to the development of sustainable Agriculture. Hemagglutinin (H), the envelope glycoprotein of Peste des Petits Ruminants Virus (PPRV), plays a crucial role in regulating viral adsorption and entry, thus determining pathogenicity, and release of newly produced viral particles. In order to accurately understand the epidemic of the disease and the interactions between the virus and host, we launch the work. Here, we examined H gene from all four lineages of the PPRV to investigate evolutionary and epidemiologic dynamics of PPRV by the Bayesian method. In addition, we predicted positive selection sites due to selective pressures. Finally, we studied the interaction between H protein and SLAM receptor based on homology model of the complex. Phylogenetic analysis suggested that H gene can also be used to investigate evolutionary and epidemiologic dynamics of PPRV. Positive selection analysis identified four positive selection sites in H gene, in which only one common site (aa246) was detected by two methods, suggesting strong operation structural and/or functional constraint of changes on the H protein. This target site may be of interest for future mutagenesis studies. The results of homology modeling showed PPRVHv-shSLAM binding interface and MVH-maSLAM binding interface were consistent, wherein the groove in the B4 blade and B5 of the head domain of PPRVHv bound to the AGFCC' beta-sheets of the membrane-distal ectodomain of shSLAM. The binding regions could provide insight on the nature of the protein for epitope vaccine design, novel drug discovery, and rational drug design against PPRV.	[Liang, Zhongxiang; Yuan, Ruyi; Chen, Lei; Zhu, Xueliang; Dou, Yongxi] CAAS, Lanzhou Vet Res Inst, Minist Agr, State Key Lab Vet Etiol Biol,Key Lab Epizoot Dis, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Dou, YX (corresponding author), CAAS, Lanzhou Vet Res Inst, Minist Agr, State Key Lab Vet Etiol Biol,Key Lab Epizoot Dis, Lanzhou, Gansu, Peoples R China.	douyongxi@caas.cn			Special Fund for Agro-scientific Research in the Public Interest [201303059]; earmarked fund for China Agriculture Research System [CARS-40-10]	Special Fund for Agro-scientific Research in the Public Interest; earmarked fund for China Agriculture Research System	This work was financially sponsored by Special Fund for Agro-scientific Research in the Public Interest (201303059) and supported by the earmarked fund for China Agriculture Research System (CARS-40-10).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adombi CM, 2011, J VIROL METHODS, V173, P306, DOI 10.1016/j.jviromet.2011.02.024; Anandakrishnan R, 2015, BIOPHYS J, V108, P1153, DOI 10.1016/j.bpj.2014.12.047; Bailey D, 2005, VIRUS RES, V110, P119, DOI 10.1016/j.virusres.2005.01.013; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; BRUNHAM RC, 1993, INFECT IMMUN, V61, P2273, DOI 10.1128/IAI.61.6.2273-2276.1993; Carugo O, 2013, AMINO ACIDS, V44, P781, DOI 10.1007/s00726-012-1402-z; Colf LA, 2007, NAT STRUCT MOL BIOL, V14, P1227, DOI 10.1038/nsmb1342; Combes C, 1997, INT J PARASITOL, V27, P1, DOI 10.1016/S0020-7519(96)00168-3; Couacy-Hymann E, 2002, J VIROL METHODS, V100, P17, DOI 10.1016/S0166-0934(01)00386-X; Das SC, 2000, J VIROL, V74, P9039, DOI 10.1128/JVI.74.19.9039-9047.2000; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dhar P, 2002, VET MICROBIOL, V88, P153, DOI 10.1016/S0378-1135(02)00102-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammouchi M, 2012, VET MICROBIOL, V160, P240, DOI 10.1016/j.vetmic.2012.04.043; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00247; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Khamehchian S, 2007, CAN J MICROBIOL, V53, P720, DOI 10.1139/W07-035; Kimura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11648; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Kwiatek O, 2007, J COMP PATHOL, V136, P111, DOI 10.1016/j.jcpa.2006.12.002; Langedijk JPM, 1997, J VIROL, V71, P6155, DOI 10.1128/JVI.71.8.6155-6167.1997; Lu Guangwen, 2013, Sheng Wu Gong Cheng Xue Bao, V29, P1; Ma GJ, 2013, STAT METHODS MED RES; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Mizuta K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-533; Munir M, 2012, EMERG INFECT DIS, V18, P193, DOI 10.3201/eid1801.111304; Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684; Parida S, 2015, VET MICROBIOLOGY; Pawar RM, 2008, ACTA VIROL, V52, P231; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada David, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0605s00; Renukaradhya GJ, 2002, VIRUS RES, V90, P171, DOI 10.1016/S0168-1702(02)00151-X; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Seth S, 2001, VIRUS RES, V75, P169, DOI 10.1016/S0168-1702(01)00238-6; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Sinnathamby G, 2001, VACCINE, V19, P4816, DOI 10.1016/S0264-410X(01)00210-9; Sinnathamby G, 2004, VIRAL IMMUNOL, V17, P401, DOI 10.1089/vim.2004.17.401; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; Woelk CH, 2001, J GEN VIROL, V82, P2463, DOI 10.1099/0022-1317-82-10-2463; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	50	15	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152587	10.1371/journal.pone.0152587	http://dx.doi.org/10.1371/journal.pone.0152587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035347	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200024
J	Makhoba, XH; Burger, A; Coertzen, D; Zininga, T; Birkholtz, LM; Shonhai, A				Makhoba, Xolani Henry; Burger, Adelle; Coertzen, Dina; Zininga, Tawanda; Birkholtz, Lyn-Marie; Shonhai, Addmore			Use of a Chimeric Hsp70 to Enhance the Quality of Recombinant Plasmodium falciparum S-Adenosylmethionine Decarboxylase Protein Produced in Escherichia coli	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE; HETEROLOGOUS EXPRESSION; MOLECULAR CHAPERONES; SUBSTRATE-BINDING; TRIGGER FACTOR; IN-VITRO; DNAK; GENE; MECHANISM; SUPPRESS	S-adenosylmethionine decarboxylase (PfAdoMetDC) from Plasmodium falciparum is a prospective antimalarial drug target. The production of recombinant PfAdoMetDC for biochemical validation as a drug target is important. The production of PfAdoMetDC in Escherichia coli has been reported to result in unsatisfactory yields and poor quality product. The co-expression of recombinant proteins with molecular chaperones has been proposed as one way to improve the production of the former in E. coli. E. coli heat shock proteins DnaK, GroEL-GroES and DnaJ have previously been used to enhance production of some recombinant proteins. However, the outcomes were inconsistent. An Hsp70 chimeric protein, KPf, which is made up of the ATPase domain of E. coli DnaK and the substrate binding domain of P. falciparum Hsp70 (PfHsp70) has been previously shown to exhibit chaperone function when it was expressed in E. coli cells whose resident Hsp70 (DnaK) function was impaired. We proposed that because of its domain constitution, KPf would most likely be recognised by E. coli Hsp70 co-chaperones. Furthermore, because it possesses a substrate binding domain of plasmodial origin, KPf would be primed to recognise recombinant PfAdoMetDC expressed in E. coli. First, using site-directed mutagenesis, followed by complementation assays, we established that KPf with a mutation in the hydrophobic residue located in its substrate binding cavity was functionally compromised. We further co-expressed PfAdoMetDC with KPf, PfHsp70 and DnaK in E. coli cells either in the absence or presence of over-expressed GroEL-GroES chaperonin. The folded and functional status of the produced PfAdoMetDC was assessed using limited proteolysis and enzyme assays. PfAdoMetDC co-expressed with KPf and PfHsp70 exhibited improved activity compared to protein co-expressed with over-expressed DnaK. Our findings suggest that chimeric KPf may be an ideal Hsp70 co-expression partner for the production of recombinant plasmodial proteins in E. coli.	[Makhoba, Xolani Henry] Univ Zululand, Dept Biochem & Microbiol, Kwa Dlangezwa, South Africa; [Burger, Adelle; Zininga, Tawanda; Shonhai, Addmore] Univ Venda, Sch Math & Nat Sci, Dept Biochem, Thohoyandou, South Africa; [Coertzen, Dina; Birkholtz, Lyn-Marie] Univ Pretoria, Ctr Sustainable Malaria Control, Dept Biochem, ZA-0002 Pretoria, South Africa	University of Zululand; University of Venda; University of Pretoria	Shonhai, A (corresponding author), Univ Venda, Sch Math & Nat Sci, Dept Biochem, Thohoyandou, South Africa.	adshon@gmail.com	Birkholtz, Lyn-Marie/AAF-8481-2019; Coertzen, Dina/ABG-8897-2020; Shonhai, Addmore/AAS-4506-2021; Zininga, Tawanda/AAY-1428-2021; Zininga, Tawanda/Q-4131-2019	Birkholtz, Lyn-Marie/0000-0001-5888-2905; Coertzen, Dina/0000-0002-8408-244X; Zininga, Tawanda/0000-0001-8689-0152; Makhoba, Xolani Henry/0000-0002-7238-4619	National Research Foundation [75464]; Alexander von Humboldt Foundation of Germany; National Research Foundation (South Africa); University of Zululand Research Committee; NRF	National Research Foundation; Alexander von Humboldt Foundation of Germany(Alexander von Humboldt Foundation); National Research Foundation (South Africa)(National Research Foundation - South Africa); University of Zululand Research Committee; NRF	The authors wish to acknowledge the National Research Foundation for an equipment grant (UID, 75464) awarded to AS. AS is a recipient of a Georg Foster research fellowship awarded by the Alexander von Humboldt Foundation of Germany. XHM is a recipient of a National Research Foundation (South Africa) scarce skills scholarship and also received a grant from the University of Zululand Research Committee. AB is a recipient of a postdoctoral fellowship awarded by the NRF.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Birkholtz LM, 2004, BIOCHEM J, V377, P439, DOI 10.1042/BJ20030614; Birkholtz LM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Buchberger A, 1999, J BIOL CHEM, V274, P38017, DOI 10.1074/jbc.274.53.38017; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Bukau B, 2006, CELL, V4; Burger Adelle, 2014, Journal of Parasitology Research, P172582, DOI 10.1155/2014/172582; Cabrera R, 2002, ARCH BIOCHEM BIOPHYS, V406, P289, DOI 10.1016/S0003-9861(02)00435-6; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; de Marco A, 2007, NAT PROTOC, V2, P2632, DOI 10.1038/nprot.2007.400; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; Etchells SA, 2005, J BIOL CHEM, V280, P28118, DOI 10.1074/jbc.M504110200; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; GEORGOPOULOS CP, 1979, MOL GEN GENET, V172, P143, DOI 10.1007/BF00268275; Gitau GW, 2012, CELL STRESS CHAPERON, V17, P191, DOI 10.1007/s12192-011-0299-x; Han KG, 1999, PROTEIN EXPRES PURIF, V16, P103, DOI 10.1006/prep.1999.1061; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kolaj O, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-9; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Luthuli SD, 2013, IUBMB LIFE, V65, P454, DOI 10.1002/iub.1146; Makumire S, 2014, TOXICOL LETT, DOI [10.1016/j.toxilet.2014.02.027, DOI 10.1016/J.TOXILET.2014.02.027]; Martinez-Alonso M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-64; Matambo TS, 2004, PROTEIN EXPRES PURIF, V33, P214, DOI 10.1016/j.pep.2003.09.010; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Muller S, 2000, J BIOL CHEM, V275, P8097, DOI 10.1074/jbc.275.11.8097; Muller S, 2001, TRENDS PARASITOL, V17, P242, DOI 10.1016/S1471-4922(01)01908-0; Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Ratelade J, 2009, APPL ENVIRON MICROB, V75, P3803, DOI 10.1128/AEM.00255-09; Rudiger S, 2000, J MOL BIOL, V304, P245, DOI 10.1006/jmbi.2000.4193; Shonhai A, 2005, MOL GENET GENOMICS, V274, P70, DOI 10.1007/s00438-005-1150-9; Shonhai A., 2014, HEAT SHOCK PROTEINS, P47, DOI [10.1007/978-94-007-7438-4_3, DOI 10.1007/978-94-007-7438-4_3]; Shonhai A, 2008, PROTEIN PEPTIDE LETT, V15, P1117, DOI 10.2174/092986608786071067; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Slepenkov SV, 1998, BIOCHEMISTRY-US, V37, P16749, DOI 10.1021/bi981738k; Stephens LL, 2011, PROTEIN EXPRES PURIF, V77, P159, DOI 10.1016/j.pep.2011.01.005; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Wells GA, 2006, J MOL GRAPH MODEL, V24, P307, DOI 10.1016/j.jmgm.2005.09.011; Williams M, 2011, MOL BIOCHEM PARASIT, V180, P17, DOI 10.1016/j.molbiopara.2011.07.004; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	53	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152626	10.1371/journal.pone.0152626	http://dx.doi.org/10.1371/journal.pone.0152626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031344	gold, Green Submitted, Green Published			2022-12-26	WOS:000373121800105
J	Mookerjee, SA; Nicholls, DG; Brand, MD				Mookerjee, Shona A.; Nicholls, David G.; Brand, Martin D.			Determining Maximum Glycolytic Capacity Using Extracellular Flux Measurements	PLOS ONE			English	Article							OXIDATIVE STRESS; RESPIRATION; BIOENERGETICS	Measurements of glycolytic rate and maximum glycolytic capacity using extracellular flux analysis can give crucial information about cell status and phenotype during normal operation, development of pathology, differentiation, and malignant transformation. They are also of great use when assessing the effects of chemical or drug treatments. Here, we experimentally define maximum glycolytic capacity, demonstrate how it differs from glycolytic rate, and provide a protocol for determining the basal glycolytic rate and maximum glycolytic capacity in cells using extracellular flux measurements. The results illustrate the power of extracellular flux analysis to describe the energetics of adherent cells in culture in a fully quantitative way.	[Mookerjee, Shona A.; Brand, Martin D.] Touro Univ, Calif Coll Pharm, 1310 Club Dr, Vallejo, CA 94592 USA; [Mookerjee, Shona A.; Nicholls, David G.; Brand, Martin D.] Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA	Touro University California; Buck Institute for Research on Aging	Mookerjee, SA (corresponding author), Touro Univ, Calif Coll Pharm, 1310 Club Dr, Vallejo, CA 94592 USA.; Mookerjee, SA (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	shona.mookerjee@tu.edu	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153				Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BROWN GC, 1990, EUR J BIOCHEM, V192, P355, DOI 10.1111/j.1432-1033.1990.tb19234.x; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Epstein T, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-7; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Garrett R.H., 2012, BIOCHEMISTRY; IBSEN KH, 1961, CANCER RES, V21, P829; Issaq SH, 2014, CELL CYCLE, V13, P1152, DOI 10.4161/cc.28010; Kumagai S, 2008, BIOCHEM BIOPH RES CO, V365, P362, DOI 10.1016/j.bbrc.2007.10.199; Malinarich F, 2015, J IMMUNOL, V194, P5174, DOI 10.4049/jimmunol.1303316; Mookerjee SA, 2015, JOVE-J VIS EXP, DOI 10.3791/53464; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; NOBES CD, 1990, J BIOL CHEM, V265, P12903; Papkovsky Dmitri B, 2015, Methods Mol Biol, V1265, P333, DOI 10.1007/978-1-4939-2288-8_23; Pelletier M, 2014, METHOD ENZYMOL, V542, P125, DOI 10.1016/B978-0-12-416618-9.00007-8; Pfiffer Vanessa, 2015, Methods Mol Biol, V1264, P279, DOI 10.1007/978-1-4939-2257-4_25; Phillips D, 2010, J MOL CELL CARDIOL, V48, P582, DOI 10.1016/j.yjmcc.2009.10.033; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003; Winer LSP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109916	28	78	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152016	10.1371/journal.pone.0152016	http://dx.doi.org/10.1371/journal.pone.0152016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031845	Green Published, gold			2022-12-26	WOS:000373121800029
J	Nelson, RE; Jones, M; Leecaster, M; Samore, MH; Ray, W; Huttner, A; Huttner, B; Khader, K; Stevens, VW; Gerding, D; Schweizer, ML; Rubin, MA				Nelson, Richard E.; Jones, Makoto; Leecaster, Molly; Samore, Matthew H.; Ray, William; Huttner, Angela; Huttner, Benedikt; Khader, Karim; Stevens, Vanessa W.; Gerding, Dale; Schweizer, Marin L.; Rubin, Michael A.			An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; COMBINED ANDROGEN BLOCKADE; HEALTH-CARE-SYSTEM; COST-EFFECTIVENESS; UNITED-STATES; GOWN-USE; HOSPITALS; SURVEILLANCE; VANCOMYCIN; ENTEROCOCCUS	Background A number of strategies exist to reduce Clostridium difficile (C. difficile) transmission. We conducted an economic evaluation of "bundling" these strategies together. Methods We constructed an agent-based computer simulation of nosocomial C. difficile transmission and infection in a hospital setting. This model included the following components: interactions between patients and health care workers; room contamination via C. difficile shedding; C. difficile hand carriage and removal via hand hygiene; patient acquisition of C. difficile via contact with contaminated rooms or health care workers; and patient antimicrobial use. Six interventions were introduced alone and "bundled" together: (a) aggressive C. difficile testing; (b) empiric isolation and treatment of symptomatic patients; (c) improved adherence to hand hygiene and (d) contact precautions; (e) improved use of soap and water for hand hygiene; and (f) improved environmental cleaning. Our analysis compared these interventions using values representing 3 different scenarios: (1) base-case (BASE) values that reflect typical hospital practice, (2) intervention (INT) values that represent implementation of hospital-wide efforts to reduce C. diff transmission, and (3) optimal (OPT) values representing the highest expected results from strong adherence to the interventions. Cost parameters for each intervention were obtained from published literature. We performed our analyses assuming low, normal, and high C. difficile importation prevalence and transmissibility of C. difficile. Results INT levels of the "bundled" intervention were cost-effective at a willingness-to-pay threshold of $100,000/quality-adjusted life-year in all importation prevalence and transmissibility scenarios. OPT levels of intervention were cost-effective for normal and high importation prevalence and transmissibility scenarios. When analyzed separately, hand hygiene compliance, environmental decontamination, and empiric isolation and treatment were the interventions that had the greatest impact on both cost and effectiveness. Conclusions A combination of available interventions to prevent CDI is likely to be cost-effective but the cost-effectiveness varies for different levels of intensity of the interventions depending on epidemiological conditions such as C. difficile importation prevalence and transmissibility.	[Nelson, Richard E.; Jones, Makoto; Leecaster, Molly; Samore, Matthew H.; Ray, William; Khader, Karim; Stevens, Vanessa W.; Rubin, Michael A.] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Nelson, Richard E.; Jones, Makoto; Leecaster, Molly; Samore, Matthew H.; Ray, William; Khader, Karim; Rubin, Michael A.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Huttner, Angela; Huttner, Benedikt] Geneva Hosp, Infect Control Program, Geneva, Switzerland; [Stevens, Vanessa W.] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Gerding, Dale] Edward Hines Jr VA Hosp, Hines, IL USA; [Schweizer, Marin L.] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA USA; [Schweizer, Marin L.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University of Geneva; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Nelson, RE (corresponding author), Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA.	richard.nelson@utah.edu	Huttner, Benedikt/M-5616-2014; Huttner, Angela/AAM-1197-2020	Huttner, Benedikt/0000-0002-1749-9464; Huttner, Angela/0000-0002-8380-368X; Stevens, Vanessa/0000-0001-8933-5453; Schweizer, Marin/0000-0002-3604-0093	GOJO Industries, Inc.; VA Health Services Research and Development Service [REA 08-264, VA HSR CDA 10-030-2, VA CDA 11-210]; U.S. Centers for Disease Control and Prevention (VA Epicenter) [CDC 07FED706506]; Veterans Affairs [IK2HX001165] Funding Source: NIH RePORTER	GOJO Industries, Inc.; VA Health Services Research and Development Service(US Department of Veterans Affairs); U.S. Centers for Disease Control and Prevention (VA Epicenter); Veterans Affairs(US Department of Veterans Affairs)	This material is the result of work supported with resources and the use of facilities at the George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah. This study was supported with funding from GOJO Industries, Inc. (http://www.gojo.com/), the VA Health Services Research and Development Service (REA 08-264, VA HSR CDA 10-030-2, and VA CDA 11-210), and the U.S. Centers for Disease Control and Prevention (VA Epicenter, CDC 07FED706506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TRENDS IN INPATIENT; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Bartsch SM, 2012, EUR J CLIN MICROBIOL, V31, P3163, DOI 10.1007/s10096-012-1681-z; Bartsch SM, 2013, CLIN INFECT DIS, V57, P555, DOI 10.1093/cid/cit346; Briggs A, 2006, DECISION MODELLING F; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Burckhardt F, 2008, EMERG INFECT DIS, V14, P691, DOI 10.3201/eid1404.071023; Burger T, 2006, AM J INFECT CONTROL, V34, P458, DOI 10.1016/j.ajic.2005.08.010; Campbell RJ, 2009, INFECT CONT HOSP EP, V30, P526, DOI 10.1086/597507; Curry SR, 2011, J CLIN MICROBIOL, V49, P3788, DOI 10.1128/JCM.00679-11; Doan L, 2012, J HOSP INFECT, V82, P114, DOI 10.1016/j.jhin.2012.06.014; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Duggan JM, 2008, INFECT CONT HOSP EP, V29, P534, DOI 10.1086/588164; Eckstein BC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-61; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Farbman L, 2013, CLIN MICROBIOL INFEC, V19, pE582, DOI 10.1111/1469-0691.12280; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Frenz MB, 2003, QJM-INT J MED, V96, P579, DOI 10.1093/qjmed/hcg098; Gase KA, 2013, INFECT CONT HOSP EP, V34, P284, DOI 10.1086/669509; Golan Y, 2006, CLIN INFECT DIS, V42, P370, DOI 10.1086/498906; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Hacek DM, 2010, AM J INFECT CONTROL, V38, P350, DOI 10.1016/j.ajic.2009.11.003; Haley VB, 2014, INFECT CONT HOSP EP, V35, P1, DOI 10.1086/674389; Hayes JL, 2007, ANZ J SURG, V77, P782, DOI 10.1111/j.1445-2197.2007.04226.x; Hsu J, 2010, AM J GASTROENTEROL, V105, P2327, DOI 10.1038/ajg.2010.254; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kundrapu S, 2012, CLIN INFECT DIS, V55, P1527, DOI 10.1093/cid/cis707; Larson EL, 2001, CRIT CARE MED, V29, P944, DOI 10.1097/00003246-200105000-00007; Lee BY, 2010, VACCINE, V28, P5245, DOI 10.1016/j.vaccine.2010.05.062; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Lugner AK, 2010, HEALTH ECON, V19, P518, DOI 10.1002/hec.1485; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Muder RR, 2008, INFECT CONT HOSP EP, V29, P702, DOI 10.1086/589981; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Penson DF, 2005, J UROLOGY, V174, P547, DOI 10.1097/01.ju.0000165569.48372.4c; Perez J, 2005, AM J INFECT CONTROL, V33, P320, DOI 10.1016/j.ajic.2005.04.240; Pitman R, 2012, VALUE HEALTH, V15, P828, DOI 10.1016/j.jval.2012.06.011; Pittet D, 2004, INFECT CONT HOSP EP, V25, P264, DOI 10.1086/502389; Puzniak LA, 2004, INFECT CONT HOSP EP, V25, P418, DOI 10.1086/502416; Ramsey S, 2005, UROLOGY, V66, P835, DOI 10.1016/j.urology.2005.04.028; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Robotham JV, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5694; Rupp ME, 2008, INFECT CONT HOSP EP, V29, P8, DOI 10.1086/524333; Saint S, 2009, AM J INFECT CONTROL, V37, P306, DOI 10.1016/j.ajic.2008.08.004; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Scheurer D, 2008, J HOSP MED, V3, P156, DOI 10.1002/jhm.277; Schneider K, 2014, CLIN INFECT DIS; Schweizer ML, 2014, US COSTS AND OUTCOME; Shaughnessy MK, 2011, INFECT CONT HOSP EP, V32, P201, DOI 10.1086/658669; Speight S, 2011, J HOSP INFECT, V79, P18, DOI 10.1016/j.jhin.2011.05.016; Stranges PM, 2013, VALUE HEALTH, V16, P297, DOI 10.1016/j.jval.2012.11.004; Zilberberg MD, 2011, INFECT CONT HOSP EP, V32, P649, DOI 10.1086/660360; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	59	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152248	10.1371/journal.pone.0152248	http://dx.doi.org/10.1371/journal.pone.0152248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031464	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800045
J	Binder, ZA; Wilson, KM; Salmasi, V; Orr, BA; Eberhart, CG; Siu, IM; Lim, M; Weingart, JD; Quinones-Hinojosa, A; Bettegowda, C; Kassam, AB; Olivi, A; Brem, H; Riggins, GJ; Gallia, GL				Binder, Zev A.; Wilson, Kelli M.; Salmasi, Vafi; Orr, Brent A.; Eberhart, Charles G.; Siu, I-Mei; Lim, Michael; Weingart, Jon D.; Quinones-Hinojosa, Alfredo; Bettegowda, Chetan; Kassam, Amin B.; Olivi, Alessandro; Brem, Henry; Riggins, Gregory J.; Gallia, Gary L.			Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines	PLOS ONE			English	Article							STEM-CELLS; CROSS-CONTAMINATION; TUMOR; RESISTANCE; PHENOTYPE; GENOTYPE; CULTURE; GROWTH	Objective Human tumor cell lines form the basis of the majority of present day laboratory cancer research. These models are vital to studying the molecular biology of tumors and preclinical testing of new therapies. When compared to traditional adherent cell lines, suspension cell lines recapitulate the genetic profiles and histologic features of glioblastoma multiforme (GBM) with higher fidelity. Using a modified neural stem cell culture technique, here we report the characterization of GBM cell lines including GBM variants. Methods Tumor tissue samples were obtained intra-operatively and cultured in neural stem cell conditions containing growth factors. Tumor lines were characterized in vitro using differentiation assays followed by immunostaining for lineage-specific markers. In vivo tumor formation was assayed by orthotopic injection in nude mice. Genetic uniqueness was confirmed via short tandem repeat (STR) DNA profiling. Results Thirteen oncosphere lines derived from GBM and GBM variants, including a GBM with PNET features and a GBM with oligodendroglioma component, were established. All unique lines showed distinct genetic profiles by STR profiling. The lines assayed demonstrated a range of in vitro growth rates. Multipotency was confirmed using in vitro differentiation. Tumor formation demonstrated histologic features consistent with high grade gliomas, including invasion, necrosis, abnormal vascularization, and high mitotic rate. Xenografts derived from the GBM variants maintained histopathological features of the primary tumors. Conclusions We have generated and characterized GBM suspension lines derived from patients with GBMs and GBM variants. These oncosphere cell lines will expand the resources available for preclinical study.	[Binder, Zev A.; Wilson, Kelli M.; Salmasi, Vafi; Siu, I-Mei; Lim, Michael; Weingart, Jon D.; Quinones-Hinojosa, Alfredo; Bettegowda, Chetan; Olivi, Alessandro; Brem, Henry; Riggins, Gregory J.; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Binder, Zev A.] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Binder, Zev A.] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA; [Orr, Brent A.; Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Lim, Michael; Weingart, Jon D.; Quinones-Hinojosa, Alfredo; Bettegowda, Chetan; Olivi, Alessandro; Brem, Henry; Riggins, Gregory J.; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Kassam, Amin B.] Aurora Neurosci Innovat Inst, Dept Neurosurg, Milwaukee, WI USA; [Binder, Zev A.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Wilson, Kelli M.] NIH, Div Preclin Innovat, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Salmasi, Vafi] Cleveland Clin, Inst Anesthesiol, Cleveland, OH 44106 USA; [Orr, Brent A.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Cleveland Clinic Foundation; St Jude Children's Research Hospital	Gallia, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.; Gallia, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	ggallia1@jhmi.edu	Olivi, Alessandro/K-6531-2016; Orr, Brent/N-8068-2018; Salmasi, Vafi/O-9908-2019	Olivi, Alessandro/0000-0002-4489-7564; Orr, Brent/0000-0003-0997-4728; Salmasi, Vafi/0000-0002-1288-4531; Lim, Michael/0000-0003-0523-3076	Brain Tumor Funding Collaborative; Virginia and D.K. Ludwig Fund for Cancer Research; National Institutes of Health [5R01NS070024]; Department of Neurosurgery at Johns Hopkins School of Medicine; Postdoctoral Training Program in Nanotechnology for Cancer Medicine - National Institutes of Health [T32CA130840]; NATIONAL CANCER INSTITUTE [T32CA130840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070024] Funding Source: NIH RePORTER	Brain Tumor Funding Collaborative; Virginia and D.K. Ludwig Fund for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurosurgery at Johns Hopkins School of Medicine; Postdoctoral Training Program in Nanotechnology for Cancer Medicine - National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Brain Tumor Funding Collaborative, http://www.braintumorfunders.org/, GJR), the Virginia and D.K. Ludwig Fund for Cancer Research, http://www.ludwigcancerresearch.org/, GJR), National Institutes of Health Grant 5R01NS070024, http://www.nih.gov/, AQH), the Department of Neurosurgery at Johns Hopkins School of Medicine, http://www.hopkinsmedicine.org/neurology_neurosurgery/, GJR, GLG), and the Postdoctoral Training Program in Nanotechnology for Cancer Medicine supported by National Institutes of Health grant T32CA130840, http://www.nih.gov/, (ZAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Caldera V, 2011, J ONCOL, V2011, DOI 10.1155/2011/314962; Chaichana K, 2006, STEM CELLS, V24, P2851, DOI 10.1634/stemcells.2006-0399; DeCarvalho AC, 2010, STEM CELLS, V28, P181, DOI 10.1002/stem.264; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Di Tomaso E, 2000, NEUROPATH APPL NEURO, V26, P22, DOI 10.1046/j.1365-2990.2000.00214.x; Dirks WG, 1999, IN VITRO CELL DEV-AN, V35, P558; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; FISCHER H, 1985, CANCER GENET CYTOGEN, V17, P257, DOI 10.1016/0165-4608(85)90017-2; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leek RD, 2005, CANCER RES, V65, P4147, DOI 10.1158/0008-5472.CAN-04-2184; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; LOO DT, 1987, SCIENCE, V236, P200, DOI 10.1126/science.3494308; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MacLeod RAF, 1999, INT J CANCER, V83, P555; Markovic O, 1998, IN VITRO CELL DEV-AN, V34, P1; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Onda K, 1999, J NEURO-ONCOL, V41, P247, DOI 10.1023/A:1006172608019; Perry A, 2009, BRAIN PATHOL, V19, P81, DOI 10.1111/j.1750-3639.2008.00167.x; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Rodriguez-Enriquez S, 2008, J CELL PHYSIOL, V216, P189, DOI 10.1002/jcp.21392; RUTKA JT, 1986, CANCER RES, V46, P5893; Scudiero DA, 1998, J NATL CANCER I, V90, P862, DOI 10.1093/jnci/90.11.862; Shin KH, 2001, IN VITRO CELL DEV-AN, V37, P625; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Siu IM, 2010, J NEUROSURG-PEDIATR, V6, P92, DOI 10.3171/2010.3.PEDS09366; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Teicher BA, 2006, MOL CANCER THER, V5, P2435, DOI 10.1158/1535-7163.MCT-06-0391; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wang J, 2008, CELL MOL NEUROBIOL, V28, P991, DOI 10.1007/s10571-008-9273-2; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	40	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150271	10.1371/journal.pone.0150271	http://dx.doi.org/10.1371/journal.pone.0150271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028405	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500004
J	Plotz, RD; Grecian, WJ; Kerley, GIH; Linklater, WL				Plotz, Roan D.; Grecian, W. James; Kerley, Graham I. H.; Linklater, Wayne L.			Standardising Home Range Studies for Improved Management of the Critically Endangered Black Rhinoceros	PLOS ONE			English	Article							DICEROS-BICORNIS; SAMPLING REGIME; NATIONAL-PARK; HABITAT USE; CONSERVATION; RESERVE; MOVEMENTS; BEHAVIOR; SPACE; SIZE	Comparisons of recent estimations of home range sizes for the critically endangered black rhinoceros in Hluhluwe-iMfolozi Park (HiP), South Africa, with historical estimates led reports of a substantial (54%) increase, attributed to over-stocking and habitat deterioration that has far-reaching implications for rhino conservation. Other reports, however, suggest the increase is more likely an artefact caused by applying various home range estimators to non-standardised datasets. We collected 1939 locations of 25 black rhino over six years (2004-2009) to estimate annual home ranges and evaluate the hypothesis that they have increased in size. A minimum of 30 and 25 locations were required for accurate 95% MCP estimation of home range of adult rhinos, during the dry and wet seasons respectively. Forty and 55 locations were required for adult female and male annual MCP home ranges, respectively, and 30 locations were necessary for estimating 90% bivariate kernel home ranges accurately. Average annual 95% bivariate kernel home ranges were 20.4 +/- 1.2 km(2), 53 +/- 1.9% larger than 95% MCP ranges (9.8 km(2) +/- 0.9). When home range techniques used during the late-1960s in HiP were applied to our dataset, estimates were similar, indicating that ranges have not changed substantially in 50 years. Inaccurate, non-standardised, home range estimates and their comparison have the potential to mislead black rhino population management. We recommend that more care be taken to collect adequate numbers of rhino locations within standardized time periods (i.e., season or year) and that the comparison of home ranges estimated using dissimilar procedures be avoided. Home range studies of black rhino have been data deficient and procedurally inconsistent. Standardisation of methods is required.	[Plotz, Roan D.; Linklater, Wayne L.] Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand; [Grecian, W. James] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Plotz, Roan D.; Kerley, Graham I. H.; Linklater, Wayne L.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Plotz, Roan D.] Australian Bur Meteorol, Climate & Oceans Support Program Pacific, Melbourne, Vic, Australia	Victoria University Wellington; University of Glasgow; Nelson Mandela University; Bureau of Meteorology - Australia	Plotz, RD (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand.; Plotz, RD (corresponding author), Australian Bur Meteorol, Climate & Oceans Support Program Pacific, Melbourne, Vic, Australia.	r.plotz@bom.gov.au	Kimanzi, Johnstone/AAD-2750-2019; Plotz, Roan/I-3878-2019; Grecian, James/A-7689-2012	Plotz, Roan/0000-0001-7192-9931; Grecian, James/0000-0002-6428-719X; Linklater, Wayne/0000-0003-2627-693X	Australian Geographic Society; Rufford Small Grants for Nature Conservation; U.S. Fish & Wildlife Service administered Rhinoceros and Tiger Conservation Act [98210-6-G102, 98218-8-G690]; Victoria University of Wellington Summer Scholarship Scheme Grant	Australian Geographic Society; Rufford Small Grants for Nature Conservation; U.S. Fish & Wildlife Service administered Rhinoceros and Tiger Conservation Act; Victoria University of Wellington Summer Scholarship Scheme Grant	This research was made possible through funding grants awarded to RDP and WLL from the Australian Geographic Society (http://www.australiangeographic.com.au/society/sponsored-projects), Rufford Small Grants for Nature Conservation (http://www.rufford.org), U.S. Fish & Wildlife Service administered Rhinoceros and Tiger Conservation Act of 1994 (grant agreement numbers 98210-6-G102, 98218-8-G690; http://www.fws.gov/international/wildlife-without-borders/rhino-and-tiger-conservation-fund.html). RDP was also awarded a Victoria University of Wellington Summer Scholarship Scheme Grant (http://www.victoria.ac.nz/students/money/scholarships/summer-scholarships) that helped with analysing data and developing the manuscript. The authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock K, 2009, STATUS MANAGEMENT BL; Adcock K., 2001, ANNOUNCING RMG CARRY, P99; Adcock K, 2001, RMG BLACK R IN PRESS, P1; Adcock K., 1996, STATUS MANAGEMENT BL; Alibhai SK, 2001, ORYX, V35, P284, DOI 10.1017/S0030605300032014; Anderson F., 1971, Journal Sth Afr Willdl Mgmt Ass, V1, P26; Balfour D, 2001, P SADC RHIN MAN GROU, P35; Balfour D. A., 2002, African Journal of Range & Forage Science, V19, P45, DOI 10.2989/10220110209485773; Berkeley EV, 2010, S AFR J WILDL RES, V40, P53, DOI 10.3957/056.040.0102; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Boyle SA, 2009, FOLIA PRIMATOL, V80, P33, DOI 10.1159/000201092; Brookes PM, 1983, HLUHLUWE UMFOLOZI RE, P51; Buckle AP, 1997, CROP PROT, V16, P467, DOI 10.1016/S0261-2194(97)00010-0; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Clinning G., 2009, BLACK RHINO HLUHLUWE; Downs JA, 2008, J WILDLIFE MANAGE, V72, P1813, DOI 10.2193/2007-454; Emslie R., 2001, P SADC RHIN MAN GROU, P86; Emslie R, 2012, DICEROS BICORNIS IUC; Emslie R.H., 1999, THESIS U STELLENBOSC; Emslie RH, 2009, GUIDELINES SITU REIN; ESRI Inc, 2010, ESRI ARCMAP REL 10; Fanayo L, 2006, KZN BLACK RHINO STAT; Garnier JN, 2001, MOL ECOL, V10, P2031, DOI 10.1046/j.0962-1083.2001.01338.x; Gottert T, 2010, MAMMALIA, V74, P35, DOI 10.1515/MAMM.2010.012; Gula R, 2013, EUR J WILDLIFE RES, V59, P713, DOI 10.1007/s10344-013-0726-7; Harless ML, 2010, HERPETOL CONSERV BIO, V5, P374; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hayward MW, 2009, BIODIVERS CONSERV, V18, P887, DOI 10.1007/s10531-008-9452-y; Hitchins P. M., 1969, Lammergeyer, VNo. 10, P81; Hitchins PM, 1971, P S BIOT CSIR PRET S, P79; Hooge PN, 1997, ANIMAL EXTENSION ARC; JENNRICH RI, 1969, J THEOR BIOL, V22, P227, DOI 10.1016/0022-5193(69)90002-2; JEWELL P. A., 1966, SYMP ZOOL SOC LONDON, V18, P85; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lent PC, 2003, S AFR J WILDL RES, V33, P109; Lewin-Koh NJ, 2011, MAPTOOLS TOOLS READI; Lewis Timothy L., 1999, Chelonian Conservation and Biology, V3, P430; Linklater WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030664; Linklater WL, 2010, S AFR J WILDL RES, V40, P58, DOI 10.3957/056.040.0107; Linklater WL, 2010, ORYX, V44, P16, DOI 10.1017/S0030605309990986; Linklater WL, 2000, NEW ZEAL J ECOL, V24, P139; Loutit BD, 1984, QUAGGA, V7, P4; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Morgan S, 2009, BIOL CONSERV, V142, P384, DOI 10.1016/j.biocon.2008.10.033; Nams V., 2006, LOCATE 3 SOFTWARE VE; Odendaal-Holmes K, 2014, S AFR J WILDL RES, V44, P148, DOI 10.3957/056.044.0208; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Plotz RD, 2014, THESIS VICTORIA U WE; Plotz RD, 2009, AFR ZOOL, V44, P283, DOI 10.3377/004.044.0216; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reid C, 2007, ORYX, V41, P247, DOI 10.1017/S0030605307001780; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Shrader Adrian M., 2001, Pachyderm, V30, P81; Slotow R, 2010, ORYX, V44, P18, DOI 10.1017/S0030605309991025; Tatman SC, 2000, AFR J ECOL, V38, P163, DOI 10.1046/j.1365-2028.2000.00235.x; Thomas B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003902; Walters Michele, 2004, BMC Ecology, V4, P3, DOI 10.1186/1472-6785-4-3; White G. C., 1990, ANAL RADIO TRACKING; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	63	15	16	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150571	10.1371/journal.pone.0150571	http://dx.doi.org/10.1371/journal.pone.0150571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028728	Green Published, Green Accepted, gold			2022-12-26	WOS:000373116500007
J	Cesarano, G; Incerti, G; Bonanomi, G				Cesarano, Gaspare; Incerti, Guido; Bonanomi, Giuliano			The Influence of Plant Litter on Soil Water Repellency: Insight from C-13 NMR Spectroscopy	PLOS ONE			English	Article							ORGANIC-COMPOUNDS; AGGREGATE STABILITY; DECOMPOSITION; VEGETATION; DYNAMICS; QUALITY; FOREST; PHYTOTOXICITY; EXTRACTION; RESIDUES	Soil water repellency (SWR, i.e. reduced affinity for water owing to the presence of organic hydrophobic coatings on soil particles) has relevant hydrological implications because low rates of infiltration enhance water runoff, and untargeted diffusion of fertilizers and pesticides. Previous studies investigated the occurrence of SWR in ecosystems with different vegetation cover but did not clarify its relationships with litter biochemical quality. Here, we investigated the capability of different plant litter types to induce SWR by using fresh and decomposed leaf materials from 12 species, to amend a model sandy soil over a year-long microcosm experiment. Water repellency, measured by the Molarity of an Ethanol Droplet (MED) test, was tested for the effects of litter species and age, and compared with litter quality assessed by C-13-CPMAS NMR in solid state and elemental chemical parameters. All litter types were highly water repellent, with MED values of 18% or higher. In contrast, when litter was incorporated into the soil, only undecomposed materials induced SWR, but with a large variability of onset and peak dynamics among litter types. Surprisingly, SWR induced by litter addition was unrelated to the aliphatic fraction of litter. In contrast, lignin-poor but labile C-rich litter, as defined by O-alkyl C and N-alkyl and methoxyl C of C-13-CPMAS NMR spectral regions, respectively, induced a stronger SWR. This study suggests that biochemical quality of plant litter is a major controlling factor of SWR and, by defining litter quality with C-13-CPMAS NMR, our results provide a significant novel contribution towards a full understanding of the relationships between plant litter biochemistry and SWR.	[Cesarano, Gaspare; Incerti, Guido; Bonanomi, Giuliano] Univ Naples Federico II, Dipartimento Agr, Via Univ 100, I-80055 Naples, Italy	University of Naples Federico II	Cesarano, G (corresponding author), Univ Naples Federico II, Dipartimento Agr, Via Univ 100, I-80055 Naples, Italy.	gaspare.cesarano@unina.it	Incerti, Guido/O-5870-2019; Incerti, Guido/B-5106-2017	Incerti, Guido/0000-0003-1288-8708; Incerti, Guido/0000-0003-1288-8708; BONANOMI, Giuliano/0000-0002-1831-4361				Almendros G, 2000, SOIL BIOL BIOCHEM, V32, P793, DOI 10.1016/S0038-0717(99)00202-3; An M, 2001, J CHEM ECOL, V27, P395, DOI 10.1023/A:1005692724885; Arcenegui V, 2008, CATENA, V74, P219, DOI 10.1016/j.catena.2007.12.008; Atanassova I, 2010, EUR J SOIL SCI, V61, P298, DOI 10.1111/j.1365-2389.2009.01224.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg B., 2008, PLANT LITTER DECOMPO, DOI DOI 10.1007/978-3-540-74923-3; Bodi MB, 2011, GEODERMA, V160, P599, DOI 10.1016/j.geoderma.2010.11.009; Bonanomi G, 2015, COMMUNITY ECOL, V16, P167, DOI 10.1556/168.2015.16.2.4; Bonanomi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117393; Bonanomi G, 2014, BIOL CONTROL, V72, P38, DOI 10.1016/j.biocontrol.2014.02.005; Bonanomi G, 2013, APPL SOIL ECOL, V72, P135, DOI 10.1016/j.apsoil.2013.06.007; Bonanomi G, 2013, SOIL BIOL BIOCHEM, V56, P40, DOI 10.1016/j.soilbio.2012.03.003; Bonanomi G, 2011, NEW PHYTOL, V191, P1018, DOI 10.1111/j.1469-8137.2011.03765.x; Bonanomi G, 2010, PLANT SOIL, V331, P481, DOI 10.1007/s11104-009-0269-6; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Czarnes S, 2000, EUR J SOIL SCI, V51, P435, DOI 10.1046/j.1365-2389.2000.00327.x; DeBano L. F., 1981, U.S. Forest Service, Pacific Southwest Forest and Range Experiment Station, General Technical Report; DeBano LF, 2000, J HYDROL, V231, P195, DOI 10.1016/S0022-1694(00)00194-3; Doerr SH, 2000, EARTH-SCI REV, V51, P33, DOI 10.1016/S0012-8252(00)00011-8; Ferreira AJD, 2000, J HYDROL, V231, P165, DOI 10.1016/S0022-1694(00)00192-X; Franco CMM, 2000, J HYDROL, V231, P47, DOI 10.1016/S0022-1694(00)00182-7; Gabarron-Galeote MA, 2013, SOLID EARTH, V4, P497, DOI 10.5194/se-4-497-2013; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gessner Mark O., 2005, P189, DOI 10.1007/1-4020-3466-0_25; Gillon D, 1999, ECOLOGY, V80, P175, DOI 10.1890/0012-9658(1999)080[0175:CLDBPB]2.0.CO;2; Graber ER, 2009, SOIL SCI SOC AM J, V73, P541, DOI 10.2136/sssaj2008.0131; Hallett PD, 2007, INTRO SOIL WATER REP; Horne DJ, 2000, J HYDROL, V231, P35, DOI 10.1016/S0022-1694(00)00181-5; Huang Y, 1998, SOIL BIOL BIOCHEM, V30, P1517, DOI 10.1016/S0038-0717(97)00234-4; Incerti G, 2013, MYCOSCIENCE, V54, P449, DOI 10.1016/j.myc.2013.02.006; Jordan A, 2008, CATENA, V74, P137, DOI 10.1016/j.catena.2008.03.015; Jordan A, 2013, CATENA, V108, P1, DOI 10.1016/j.catena.2013.05.005; Keiluweit M, 2015, P NATL ACAD SCI USA, V112, pE5253, DOI 10.1073/pnas.1508945112; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Leelamanie D. A. L., 2010, Tropical Agricultural Research and Extension, V13, P6; Legendre P., 1998, NUMER ECOL 2 ENGLISH, V20, P870, DOI [10.1021/ic050220j, DOI 10.1021/IC050220J]; LETEY J., 1969, Water-repellent soils. Proceedings of the symposium on water-repellent soils held at the University of California, Riverside, May 6-10, 1968., P43; Li YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15783; Lundesanstalt B, 1997, HYDROPHOBICITY ORGAN, V48, P457; Mainwaring K, 2013, EUR J SOIL SCI, V64, P667, DOI 10.1111/ejss.12078; Mainwaring KA, 2004, ENVIRON CHEM LETT, V2, P35, DOI 10.1007/s10311-004-0064-9; Martinez-Zavala L, 2009, CATENA, V76, P215, DOI 10.1016/j.catena.2008.12.002; MASHUM M, 1988, J SOIL SCI, V39, P99, DOI 10.1111/j.1365-2389.1988.tb01198.x; Mataix-Solera J, 2007, HYDROL PROCESS, V21, P2300, DOI 10.1002/hyp.6750; Mataix-Solera J, 2004, GEODERMA, V118, P77, DOI 10.1016/S0016-7061(03)00185-X; Mathers NJ, 2007, SOIL BIOL BIOCHEM, V39, P993, DOI 10.1016/j.soilbio.2006.11.009; Mazzoleni S, 2014, NEW PHYTOL, DOI 10.111; MCGHIE DA, 1981, AUST J AGR RES, V32, P609, DOI 10.1071/AR9810609; Morales VL, 2010, J HYDROL, V393, P29, DOI 10.1016/j.jhydrol.2009.12.048; Olorunfemi I. E., 2014, Journal of Scientific Research and Reports, V3, P1003, DOI 10.9734/JSRR/2014/7325; Ono K, 2011, PLANT SOIL, V338, P171, DOI 10.1007/s11104-010-0397-z; Pane C, 2011, BIOL CONTROL, V56, P115, DOI 10.1016/j.biocontrol.2010.10.002; Preston CM, 2009, ECOSYSTEMS, V12, P1053, DOI 10.1007/s10021-009-9266-0; Roper MM, 2005, AUST J SOIL RES, V43, P803, DOI 10.1071/SR05061; Roper MM, 2004, AUST J SOIL RES, V42, P427, DOI 10.1071/SR03153; Schaumann GE, 2007, HYDROL PROCESS, V21, P2276, DOI 10.1002/hyp.6746; Schnabel S, 2013, CATENA, V103, P53, DOI 10.1016/j.catena.2011.11.006; VOGT KA, 1986, ADV ECOL RES, V15, P303, DOI 10.1016/S0065-2504(08)60122-1; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Zavala LM, 2009, GEODERMA, V152, P361, DOI 10.1016/j.geoderma.2009.07.011	61	32	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152565	10.1371/journal.pone.0152565	http://dx.doi.org/10.1371/journal.pone.0152565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022916	gold, Green Published, Green Submitted			2022-12-26	WOS:000373113900077
J	Wang, OH; Azizian, N; Guo, M; Capello, M; Deng, DF; Zang, FL; Fry, J; Katz, MH; Fleming, JB; Lee, JE; Wolff, RA; Hanash, S; Wang, HM; Maitra, A				Wang, Oliver H.; Azizian, Nancy; Guo, Ming; Capello, Michela; Deng, Defeng; Zang, Fenglin; Fry, Jason; Katz, Matthew H.; Fleming, Jason B.; Lee, Jeffrey E.; Wolff, Robert A.; Hanash, Samir; Wang, Huamin; Maitra, Anirban			Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR KINASE; DUCTAL ADENOCARCINOMA; MESENCHYMAL TRANSITION; DRUG-RESISTANCE; SAPK ACTIVATION; GCKR; GEMCITABINE; DEGRADATION; EXPRESSION; SURVIVAL	Objectives MAP4K5 plays an important role in regulating a range of cellular responses and is involved in Wnt signaling in hematopoietic cells. However, its functions in human malignancies have not been studied. The major objectives of this study are to examine the expression, functions and clinical significance of MAP4K5 in pancreatic ductal adenocarcinoma (PDAC). Materials and Methods The expression levels of MAP4K5, E-cadherin, vimentin, and carboxylesterase 2 (CES2) were examined by immunohistochemistry in 105 PDAC and matched non-neoplastic pancreas samples from our institution. The RNA sequencing data of 112 PDAC patients were downloaded from the TCGA data portal. Immunoblotting and RNA sequencing analysis were used to examine the expression of MAP4K5 and E-cadherin in pancreatic cancer cell lines. The effect of knockdown MAP4K5 using siRNA on the expression of CDH1 and vimentin were examined by Real-time RT-PCR in Panc-1 and AsPC-1 cells. Statistical analyses were performed using IBM SPSS Statistics. Results MAP4K5 protein is expressed at high levels specifically in the pancreatic ductal cells of 100% non-neoplastic pancreas samples, but is decreased or lost in 77.1% (81/105) of PDAC samples. MAP4K5-low correlated with the loss of E-cadherin (P = 0.001) and reduced CES2 expression (P = 0.002) in our patient populations. The expression levels of MAP4K5 mRNA directly correlated with the expression levels of CDH1 mRNA (R = 0.2490, P = 0.008) in the second cohort of 112 PDAC patients from The Cancer Genome Atlas (TCGA) RNA-seq dataset. Similar correlations between the expression of MAP4K5 and E-cadherin were observed both at protein and mRNA levels in multiple pancreatic cancer cell lines. Knockdown MAP4K5 led to decreased CDH1 mRNA expression in Panc-1 and AsPC-1 cells. MAP4K5-low correlated significantly with reduced overall survival and was an independent prognosticator in patients with stage II PDAC. Conclusions MAP4K5 expression is decreased or lost in majority of PDACs. The strong associations between low MAP4K5 expression and loss of E-cadherin, reduced CES2 expression and decreased overall survival may suggest an important role of MAP4K5 in epithelial-to-mesenchymal transition, chemotherapy resistance and tumor progression in pancreatic cancer. Targeting impaired MAP4K5 signaling may represent a new therapeutic strategy for pancreatic cancer.	[Wang, Oliver H.; Azizian, Nancy; Guo, Ming; Zang, Fenglin; Fry, Jason; Wang, Huamin; Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Capello, Michela; Hanash, Samir] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Deng, Defeng] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Katz, Matthew H.; Fleming, Jason B.; Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Wolff, Robert A.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Wang, Huamin; Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Maitra, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.; Maitra, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA.	amaitra@mdanderson.org		azizian, nancy/0000-0002-1158-0608; Capello, Michela/0000-0001-5810-6375	Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at the University of Texas M.D. Anderson Cancer Center	Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at the University of Texas M.D. Anderson Cancer Center	This work was supported by Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at the University of Texas M.D. Anderson Cancer Center. The authors received no specific funding for this work.	Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Barriere G, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0055-4; Beuran M, 2015, PANCREATOLOGY, V15, P217, DOI 10.1016/j.pan.2015.02.011; Capello M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv132; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Guo RJ, 2014, HUM PATHOL, V45, P1015, DOI 10.1016/j.humpath.2013.12.016; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; JEMAL A, 2008, CA CANC J CLIN; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Li ZJ, 2014, ONCOTARGET, V5, P3197, DOI 10.18632/oncotarget.1900; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Mizuuchi Y, 2015, LAB INVEST, V95, P193, DOI 10.1038/labinvest.2014.138; Neesse A, 2015, GUT, V64, P1842, DOI 10.1136/gutjnl-2015-309503; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ramjaun AR, 2001, J BIOL CHEM, V276, P28913, DOI 10.1074/jbc.M103198200; Shi CS, 2006, MOL CELL BIOL, V26, P6511, DOI 10.1128/MCB.00209-06; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Shi CS, 2000, BLOOD, V95, P776, DOI 10.1182/blood.V95.3.776.003k23_776_782; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang HM, 2002, BRAIN PATHOL, V12, P95; Wang H, 2014, J BIOL CHEM, V289, P4009, DOI 10.1074/jbc.M113.520106; Wang H, 2009, CANCER RES, V69, P1063, DOI 10.1158/0008-5472.CAN-08-1751; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003	30	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152300	10.1371/journal.pone.0152300	http://dx.doi.org/10.1371/journal.pone.0152300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023625	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900043
J	Pappalardo, F; Russo, G; Candido, S; Pennisi, M; Cavalieri, S; Motta, S; McCubrey, JA; Nicoletti, F; Libra, M				Pappalardo, Francesco; Russo, Giulia; Candido, Saverio; Pennisi, Marzio; Cavalieri, Salvatore; Motta, Santo; McCubrey, James A.; Nicoletti, Ferdinando; Libra, Massimo			Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; MUTATIONS; NEURONS	Background Malignant melanoma is an aggressive tumor of the skin and seems to be resistant to current therapeutic approaches. Melanocytic transformation is thought to occur by sequential accumulation of genetic and molecular alterations able to activate the Ras/Raf/MEK/ERK (MAPK) and/or the PI3K/AKT (AKT) signalling pathways. Specifically, mutations of B-RAF activate MAPK pathway resulting in cell cycle progression and apoptosis prevention. According to these findings, MAPK and AKT pathways may represent promising therapeutic targets for an otherwise devastating disease. Result Here we show a computational model able to simulate the main biochemical and metabolic interactions in the PI3K/AKT and MAPK pathways potentially involved in melanoma development. Overall, this computational approach may accelerate the drug discovery process and encourages the identification of novel pathway activators with consequent development of novel antioncogenic compounds to overcome tumor cell resistance to conventional therapeutic agents. The source code of the various versions of the model are available as S1 Archive.	[Pappalardo, Francesco; Russo, Giulia] Univ Catania, Dept Drug Sci, I-95125 Catania, Italy; [Candido, Saverio; Nicoletti, Ferdinando; Libra, Massimo] Univ Catania, Dept Biomed & Biotechnol Sci, I-95125 Catania, Italy; [Pennisi, Marzio; Motta, Santo] Univ Catania, Dept Math & Comp Sci, I-95125 Catania, Italy; [Cavalieri, Salvatore] Univ Catania, Dept Engn, I-95125 Catania, Italy; [McCubrey, James A.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	University of Catania; University of Catania; University of Catania; University of Catania; University of North Carolina; East Carolina University	Pappalardo, F (corresponding author), Univ Catania, Dept Drug Sci, I-95125 Catania, Italy.	francesco.pappalardo@unict.it	Libra, Massimo/ABF-6654-2020; Cavalieri, Salvatore/ABH-9801-2020; Cavalieri, Salvatore/K-7391-2015; Pennisi, Marzio/G-4618-2015; Libra, Massimo/L-8241-2018; Pennisi, Marzio/AAC-7947-2019; Pappalardo, Francesco/C-5832-2011; Nicoletti, Ferdinando/M-4428-2016; Candido, Saverio/K-5987-2016	Libra, Massimo/0000-0002-7232-7737; Cavalieri, Salvatore/0000-0001-9077-3688; Cavalieri, Salvatore/0000-0001-9077-3688; Pennisi, Marzio/0000-0003-0231-7653; Libra, Massimo/0000-0002-7232-7737; Pennisi, Marzio/0000-0003-0231-7653; Pappalardo, Francesco/0000-0003-1668-3320; Nicoletti, Ferdinando/0000-0002-4570-8462; Russo, Giulia/0000-0001-6616-7856; Joyce, Melinda/0000-0002-2791-5425; McCubrey, James/0000-0001-6027-3156; Candido, Saverio/0000-0003-1255-6666	FIR University of Catania, Italy grant; FIR	FIR University of Catania, Italy grant; FIR(Ministry of Education, Universities and Research (MIUR))	This work has been partially supported by the FIR 2014 University of Catania, Italy grant. There were no other funding sources supporting this work. FIR 2014 partially supported the work. The remaining effort comes from internal personnel work.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Bajzer Z, 2012, BIOCHEM BIOPH RES CO, V417, P982, DOI 10.1016/j.bbrc.2011.12.051; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Castiglione F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/902545; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gullo F, 2015, BIOINFORMATICS, V31, P2514, DOI 10.1093/bioinformatics/btv172; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Libra M, 2005, CELL CYCLE, V4, P1382, DOI 10.4161/cc.4.10.2026; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Pappalardo F, 2012, MATH MODEL NAT PHENO, V7, P186, DOI 10.1051/mmnp/20127312; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Vennepureddy Adarsh, 2016, J Clin Med Res, V8, P63, DOI 10.14740/jocmr2424w; Wolchok JD, 2007, CURR OPIN ONCOL, V19, P116, DOI 10.1097/CCO.0b013e32801497c6; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	20	43	45	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152104	10.1371/journal.pone.0152104	http://dx.doi.org/10.1371/journal.pone.0152104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015094	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900040
J	Sandlers, Y; Mercier, K; Pathmasiri, W; Carlson, J; McRitchie, S; Sumner, S; Vernon, HJ				Sandlers, Yana; Mercier, Kelly; Pathmasiri, Wimal; Carlson, Jim; McRitchie, Susan; Sumner, Susan; Vernon, Hilary J.			Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function	PLOS ONE			English	Article							PLASMA SEROTONIN; NITRIC-OXIDE; PALMITOYLATION; RECEPTOR; LOCALIZATION; DYSFUNCTION; RATIO; NMR	Barth Syndrome is the only known Mendelian disorder of cardiolipin remodeling, with characteristic clinical features of cardiomyopathy, skeletal myopathy, and neutropenia. While the primary biochemical defects of reduced mature cardiolipin and increased monolysocardiolipin are well-described, much of the downstream biochemical dysregulation has not been uncovered, and biomarkers are limited. In order to further expand upon the knowledge of the biochemical abnormalities in Barth Syndrome, we analyzed metabolite profiles in plasma from a cohort of individuals with Barth Syndrome compared to age-matched controls via H-1 nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry. A clear distinction between metabolite profiles of individuals with Barth Syndrome and controls was observed, and was defined by an array of metabolite classes including amino acids and lipids. Pathway analysis of these discriminating metabolites revealed involvement of mitochondrial and extra-mitochondrial biochemical pathways including: insulin regulation of fatty acid metabolism, lipid metabolism, biogenic amine metabolism, amino acid metabolism, endothelial nitric oxide synthase signaling, and tRNA biosynthesis. Taken together, this data indicates broad metabolic dysregulation in Barth Syndrome with wide cellular effects.	[Sandlers, Yana] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Mercier, Kelly; Pathmasiri, Wimal; Carlson, Jim; McRitchie, Susan; Sumner, Susan] Res Triangle Int, Durham, NC USA; [Vernon, Hilary J.] Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA; [Vernon, Hilary J.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA	University System of Ohio; Cleveland State University; Kennedy Krieger Institute; Johns Hopkins University	Vernon, HJ (corresponding author), Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA.; Vernon, HJ (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA.	hvernon1@jhmi.edu	Sandlers, Yana/AAH-9698-2019	Sumner, Susan/0000-0003-3381-6084; Pathmasiri, Wimal/0000-0002-5199-5744; Vernon, Hilary/0000-0001-9940-9866	Eastern Regional Comprehensive Metabolomics Resource Core (RTI RCMRC), a NIH Common Fund Award through NIDDK [1U24DK097193-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097193] Funding Source: NIH RePORTER	Eastern Regional Comprehensive Metabolomics Resource Core (RTI RCMRC), a NIH Common Fund Award through NIDDK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This metabolomics study was performed as a pilot and feasibility project through the Eastern Regional Comprehensive Metabolomics Resource Core (RTI RCMRC), a NIH Common Fund Award through NIDDK, project number 1U24DK097193-01.	ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309; Amici SA, 2012, J BIOL CHEM, V287, P23119, DOI 10.1074/jbc.M111.328294; Ayme-Dietrich E, 2015, J HYPERTENS, V33, P2310, DOI 10.1097/HJH.0000000000000695; Banerjee R, 2012, METABOLOMICS, V8, P1012, DOI 10.1007/s11306-011-0396-y; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; Brand T, 2011, CLIN CHEM, V57, P1376, DOI 10.1373/clinchem.2011.163824; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Church RJ, 2014, TOXICOL SCI, V140, P481, DOI 10.1093/toxsci/kfu094; Feillet-Coudray C, 2014, J BIOENERG BIOMEMBR, V46, P447, DOI 10.1007/s10863-014-9555-y; Ferreira C., 1993, GENEREVIEWS; Fuchs B, 2005, CLIN BIOCHEM, V38, P925, DOI 10.1016/j.clinbiochem.2005.06.006; GIBSON KM, 1993, PEDIATR NEUROL, V9, P120, DOI 10.1016/0887-8994(93)90046-F; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gorinski N, 2013, BIOCHEM SOC T, V41, P89, DOI 10.1042/BST20120235; He Q, 2014, CHEM PHYS LIPIDS, V179, P75, DOI 10.1016/j.chemphyslip.2013.10.007; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Jang D, 2015, J CELL SCI, V128, P2179, DOI 10.1242/jcs.169409; Jia LJ, 2014, J BIOL CHEM, V289, P6249, DOI 10.1074/jbc.M113.531475; Kahle M, 2015, MOL METAB, V4, P39, DOI 10.1016/j.molmet.2014.11.004; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006; Kulik W, 2008, CLIN CHEM, V54, P371, DOI 10.1373/clinchem.2007.095711; Liu SL, 2014, J BIOL CHEM, V289, P18163, DOI 10.1074/jbc.M113.521203; Marziliano N, 2007, AM J MED GENET A, V143A, P907, DOI 10.1002/ajmg.a.31653; Milner JJ, 2015, J IMMUNOL, V194, P4846, DOI 10.4049/jimmunol.1402295; Mulder C, 2003, J NEURAL TRANSM, V110, P949, DOI 10.1007/s00702-003-0007-9; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Pathmasiri W, 2012, METABOLOMICS, V8, P1037, DOI 10.1007/s11306-012-0404-x; Pathmasiri W, 2009, GEN APPL SYSTEMS TOX, DOI [10.1002/9780470744307.gat219, DOI 10.1002/9780470744307.GAT219]; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Reynolds Stacey, 2015, J Rare Disord, V3, P1; Rigaud C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-70; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Schmidt MR, 2004, ACTA PAEDIATR, V93, P419, DOI 10.1080/08035250410022837; Tatsuta T, 2014, TRENDS CELL BIOL, V24, P44, DOI 10.1016/j.tcb.2013.07.011; Toda N, 2003, PHARMACOL REV, V55, P271, DOI 10.1124/pr.55.2.3; Trygg, 2013, MULTIMEGAVARIATE DAT; Tyurina YY, 2013, MOL NUTR FOOD RES, V57, P1410, DOI 10.1002/mnfr.201200801; Vernon HJ, 2014, MOL GENET METAB, V112, P143, DOI 10.1016/j.ymgme.2014.03.007; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wei N, 2014, MOL CELL, V56, P323, DOI 10.1016/j.molcel.2014.09.006; Zukunft S, 2013, CHROMATOGRAPHIA, V76, P1295, DOI 10.1007/s10337-013-2429-3	45	28	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151802	10.1371/journal.pone.0151802	http://dx.doi.org/10.1371/journal.pone.0151802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015085	gold, Green Submitted, Green Published			2022-12-26	WOS:000372708900029
J	Tan, XD; Liu, P; Huang, YP; Zhou, L; Yang, YF; Wang, HT; Yu, BQ; Meng, XL; Zhang, XB; Gao, F				Tan, Xiaodong; Liu, Peng; Huang, Yinpeng; Zhou, Lei; Yang, Yifan; Wang, Huaitao; Yu, Boqiang; Meng, Xiangli; Zhang, Xiaobo; Gao, Feng			Phosphoproteome Analysis of Invasion and Metastasis-Related Factors in Pancreatic Cancer Cells	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; FINE-NEEDLE-ASPIRATION; ENDOSCOPIC ULTRASOUND; PHOSPHORYLATION; DISSOCIATION; INHIBITION; INVOLVEMENT; INDUCTION; RESIDUES; RECEPTOR	Mechanisms of abnormal protein phosphorylation that regulate cell invasion and metastasis in pancreatic cancer remain obscure. In this study, we used high-throughput phosphorylation array to test two pancreatic cancer cell lines (PC-1 cells with a low, and PC-1.0 cells with a high potential for invasion and metastasis). We noted that a total of 57 proteins revealed a differential expression (fold change >= 2.0). Six candidate proteins were further validated by western blot with results found to be accordance with the array. Of 57 proteins, 32 up-regulated proteins (e.g. CaMK1-alpha and P90RSK) were mainly involved in ErbB and neurotrophin signaling pathways as determined using DAVID software, while 25 down-regulated proteins (e.g. BID and BRCA1) were closely involved in apoptosis and p53 signaling pathways. Moreover, four proteins (AKT1, Chk2, p53 and P70S6K) with different phosphorylation sites were found, not only among up-regulated, but also among down-regulated proteins. Importantly, specific phosphorylation sites can affect cell biological functions. CentiScaPe software calculated topological characteristics of each node in the protein-protein interaction (PPI) network: we found that AKT1 owns the maximum node degrees and betweenness in the up-regulation protein PPI network (26 nodes, average path length: 1.89, node degrees: 6.62 +/- 4.18, betweenness: 22.23 +/- 35.72), and p53 in the down-regulation protein PPI network (17 nodes, average path length: 2.04, node degrees: 3.65 +/- 2.47, betweenness: 16.59 +/- 29.58). In conclusion, the identification of abnormal protein phosphorylation related to invasion and metastasis may allow us to identify new biomarkers in an effort to develop novel therapeutic drug targets for pancreatic cancer treatment.	[Tan, Xiaodong; Liu, Peng; Huang, Yinpeng; Zhou, Lei; Yang, Yifan; Wang, Huaitao; Yu, Boqiang; Meng, Xiangli; Zhang, Xiaobo; Gao, Feng] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Tan, XD (corresponding author), China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang 110001, Liaoning, Peoples R China.	tarixdcmu@163.com		Liu, Peng/0000-0001-8193-8997; Tan, Xiaodong/0000-0003-0862-1306	Liaoning Natural Science Foundation of China [2014021006]	Liaoning Natural Science Foundation of China	This work was supported by the Liaoning Natural Science Foundation of China (No. 2014021006).	Batchu RB, 2015, SURGERY, V158, P981, DOI 10.1016/j.surg.2015.05.019; Costache MI, 2013, ENDOSC ULTRASOUND, V2, P77, DOI [10.4103/2303-9027.117691, 10.7178/eus.05.004]; Del Re DP, 2014, MOL CELL, V54, P639, DOI 10.1016/j.molcel.2014.04.007; Dong QM, 2014, BIOCHEM BIOPH RES CO, V449, P449, DOI 10.1016/j.bbrc.2014.05.046; Guo H, 2014, ONCOGENE, V33, P3463, DOI 10.1038/onc.2013.301; Guo XZ, 2013, ENDOSC ULTRASOUND, V2, P181, DOI 10.4103/2303-9027.121238; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Kwak DH, 2014, MOL CELL BIOCHEM, V385, P257, DOI 10.1007/s11010-013-1834-0; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Okasha HH, 2013, ENDOSC ULTRASOUND, V2, P190, DOI 10.4103/2303-9027.121239; Rocha AG, 2014, BIOCHEM J, V458, P313, DOI 10.1042/BJ20130631; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Tan X, 2005, INT J ONCOL, V26, P1283; Tan XD, 2004, INT J ONCOL, V25, P1303; Tan XD, 2004, INT J ONCOL, V24, P65; Tan XD, 2010, EXP THER MED, V1, P211, DOI 10.3892/etm_00000034; Thorarensen A, 2014, ACS CHEM BIOL, V9, P1552, DOI 10.1021/cb5002125; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang X, 2013, PROG MOL BIOL TRANSL, V117, P531, DOI 10.1016/B978-0-12-386931-9.00020-9; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yip YY, 2014, J BIOL CHEM, V289, P2157, DOI 10.1074/jbc.M113.470682; Zanivan S, 2013, CELL REP, V3, P552, DOI 10.1016/j.celrep.2013.01.003; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84	31	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152280	10.1371/journal.pone.0152280	http://dx.doi.org/10.1371/journal.pone.0152280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27014871	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708900050
J	Ellert-Miklaszewska, A; Wisniewski, P; Kijewska, M; Gajdanowicz, P; Pszczolkowska, D; Przanowski, P; Dabrowski, M; Maleszewska, M; Kaminska, B				Ellert-Miklaszewska, A.; Wisniewski, P.; Kijewska, M.; Gajdanowicz, P.; Pszczolkowska, D.; Przanowski, P.; Dabrowski, M.; Maleszewska, M.; Kaminska, B.			Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression	ONCOGENE			English	Article							INFILTRATING MICROGLIA/MACROPHAGES; CELLS; MACROPHAGES; EXPRESSION; INVASION; STEM; ALPHA(9)BETA(1); METASTASIS; INHIBITION; PHENOTYPE	Tumour tissue is infiltrated by myeloid cells that are reprogrammed into alternatively activated/regenerative (M2) macrophages. The contribution of major signalling pathways and their modulators/targets involved in the macrophage reprogramming is poorly known. Glioblastoma (malignant brain tumour) attracts and reprograms brain-resident microglia and peripheral macrophages into cells that increase invasion, angiogenesis and suppress antitumour immunity. Using a 'function-first' approach and glioma secretome proteomics we identified osteopontin and lactadherin as proteins that cooperatively activate amoeboid transformation, phagocytosis and motility of primary microglia cultures via integrins and FAK-Akt (focal adhesion kinase-Akt) signalling. A synthetic peptide interfering with integrin ligands blocks glioma-microglia communication, functional activation and M2 gene expression. We found that osteopontin/secreted phosphoprotein 1 (Spp1) produced by non-transformed cells acts as a proinflammatory factor inducing inflammatory signalling and M1 genes, and counteracts the action of lactadherin. Using constructs encoding functional mutants of osteopontin, we demonstrated sequential processing of Spp1 by thrombin and matrix metalloproteinase-3 and/or -7 (MMP-3 and/or -7) in glioma cells, which generates a microglia-activating form devoid of the inflammatory activity, while retaining the M2 reprogramming potential. A similar form of osteopontin is secreted by human glioma cells but not normal human astrocytes. Knockdown of osteopontin or lactadherin in glioma cells reduces intracranial glioma growth, blocks amoeboid transformation of myeloid cells and affects M2 reprogramming of microglia/macrophages. Our findings demonstrate how glioma cells misuse macrophage-activating signals and redesign primarily proinflammatory signals towards their advantage to induce M2 reprogramming of tumour-infiltrating brain macrophages.	[Ellert-Miklaszewska, A.; Wisniewski, P.; Kijewska, M.; Gajdanowicz, P.; Pszczolkowska, D.; Przanowski, P.; Dabrowski, M.; Maleszewska, M.; Kaminska, B.] Nencki Inst Expt Biol, Neurobiol Ctr, Mol Neurobiol Lab, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Kaminska, B (corresponding author), Nencki Inst Expt Biol, Mol Neurobiol Lab, 3 Pasteur St, PL-02093 Warsaw, Poland.	bozenakk@nencki.gov.pl	Kaminska, Bozena/H-4592-2011; Kaminska, Bozena/B-2915-2014; Ellert-Miklaszewska, Aleksandra/AAX-8715-2020; Ellert-Miklaszewska, Aleksandra/H-4423-2011; Dąbrowski, Michał/K-4384-2012	Kaminska, Bozena/0000-0002-2642-4616; Ellert-Miklaszewska, Aleksandra/0000-0002-7947-5660; Ellert-Miklaszewska, Aleksandra/0000-0002-7947-5660; Gajdanowicz, Pawel/0000-0003-3075-5992; Dabrowski, Michal/0000-0002-5335-158X; Maleszewska, Marta/0000-0001-8695-374X	National Science Center (Poland) [2012/04/A/NZ3/00630]; Ministry of Science and Higher Education [264173 Bio-Imagine, IP2011013171]	National Science Center (Poland)(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	We thank Beata Kaza and Marcin Sliwa for technical assistance. This work was supported by the Grant 2012/04/A/NZ3/00630 (to BK) from the National Science Center (Poland). PG was supported by GA no. 264173 Bio-Imagine and IP2011013171 from the Ministry of Science and Higher Education.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Anborgh PH, 2010, J CELL MOL MED, V14, P2037, DOI 10.1111/j.1582-4934.2010.01115.x; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Cook AC, 2005, MOL CARCINOGEN, V43, P225, DOI 10.1002/mc.20105; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Ellert-Miklaszewska A, 2013, GLIA, V61, P1178, DOI 10.1002/glia.22510; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Held-Feindt J, 2010, EXP CELL RES, V316, P1553, DOI 10.1016/j.yexcr.2010.02.018; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Hussain SF, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-15; Hussain SF, 2005, EXPERT REV ANTICANC, V5, P777, DOI 10.1586/14737140.5.5.777; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Ku MC, 2013, ACTA NEUROPATHOL, V125, P609, DOI 10.1007/s00401-013-1079-8; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Murray P.J., 2014, OSTEOARTHR CARTILAGE, V41, P14; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Okada M, 2009, INT J ONCOL, V34, P1621, DOI 10.3892/ijo_00000292; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Platten M, 2003, ANN NEUROL, V54, P388, DOI 10.1002/ana.10679; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Shao ZF, 2014, J BIOL CHEM, V289, P27146, DOI 10.1074/jbc.M114.572172; Sielska M, 2013, J PATHOL, V230, P310, DOI 10.1002/path.4192; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Sliwa M, 2007, BRAIN, V130, P476, DOI 10.1093/brain/awl263; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Wei J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/285246; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Yamaguchi Y, 2013, J BIOL CHEM, V288, P3097, DOI 10.1074/jbc.M112.362954; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	41	57	57	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 15	2016	35	50					6366	6377		10.1038/onc.2016.55	http://dx.doi.org/10.1038/onc.2016.55			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TP	27041573				2022-12-26	WOS:000390247600002
J	Vodnala, M; Ranjbarian, F; Pavlova, A; de Koning, HP; Hofer, A				Vodnala, Munender; Ranjbarian, Farahnaz; Pavlova, Anna; de Koning, Harry P.; Hofer, Anders			Trypanosoma brucei Methylthioadenosine Phosphorylase Protects the Parasite from the Antitrypanosomal Effect of Deoxyadenosine IMPLICATIONS FOR THE PHARMACOLOGY OF ADENOSINE ANTIMETABOLITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; AFRICAN TRYPANOSOMIASIS; RIBONUCLEOTIDE REDUCTASE; DNTP POOLS; IN-VIVO; PURINE; NUCLEOSIDE; DEAMINASE; TRANSPORTERS; EXPRESSION	Trypanosoma brucei causes African sleeping sickness for which no vaccine exists and available treatments are of limited use due to their high toxicity or lack of efficacy. T. brucei cultivated in the presence of deoxyadenosine accumulates high levels of dATP in an adenosine kinase-dependent process and dies within a few hours. Here we show that T. brucei treated with 1 mM deoxyadenosine accumulates higher dATP levels than mammalian cells but that this effect diminishes quickly as the concentration of the deoxynucleoside decreases. Radioactive tracer studies showed that the parasites are partially protected against lower concentrations of deoxyadenosine by the ability to cleave it and use the adenine for ATP synthesis. T. brucei methylthioadenosine phosphorylase (TbMTAP) was found to be responsible for the cleavage as indicated by the phosphate dependence of deoxyadenosine cleavage in T. brucei cell extracts and increased deoxyadenosine sensitivity in TbMTAP knockdown cells. Recombinant TbMTAP exhibited higher turnover number (k(cat)) and K-m values for deoxyadenosine than for the regular substrate, methylthioadenosine. One of the reaction products, adenine, inhibited the enzyme, which might explain why TbMTAP-mediated protection is less efficient at higher deoxyadenosine concentrations. Consequently, T. brucei grown in the presence of adenine demonstrated increased sensitivity to deoxyadenosine. For deoxyadenosine/adenosine analogues to remain intact and be active against the parasite, they need to either be resistant to TbMTAP-mediated cleavage, which is the case with the three known antitrypanosomal agents adenine arabinoside, tubercidin, and cordycepin, or they need to be combined with TbMTAP inhibitors.	[Vodnala, Munender; Ranjbarian, Farahnaz; Pavlova, Anna; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [de Koning, Harry P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland	Umea University; University of Glasgow	Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	anders.hofer@umu.se		Vodnala, Munender/0000-0002-6219-6243; De Koning, Harry/0000-0002-9963-1827; Hofer, Anders/0000-0003-2890-2957	Swedish Research Council [2012-1932]; Swedish International Development Cooperation Agency [2008-069]; Kempe Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Kempe Foundation	This work was supported by Swedish Research Council Grant 2012-1932, Swedish International Development Cooperation Agency Grant 2008-069, and the Kempe Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Salabi MI, 2007, MOL PHARMACOL, V71, P921, DOI 10.1124/mol.106.031559; Berg M, 2010, ANTIMICROB AGENTS CH, V54, P1900, DOI 10.1128/AAC.01787-09; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; BRUN R, 1979, ACTA TROP, V36, P289; CHELLO PL, 1972, COMP BIOCHEM PHYSIOL, V43, P543, DOI 10.1016/0305-0491(72)90138-1; Da Silva AS, 2011, PARASITOLOGY, V138, P201, DOI 10.1017/S003118201000123X; Da Silva AS, 2011, EXP PARASITOL, V127, P173, DOI 10.1016/j.exppara.2010.07.010; DAVIES MJ, 1983, PARASITOLOGY, V87, P211, DOI 10.1017/S0031182000052574; De Koning HP, 1999, MOL PHARMACOL, V56, P1162, DOI 10.1124/mol.56.6.1162; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; de Koning HP, 2000, MOL BIOCHEM PARASIT, V106, P93, DOI 10.1016/S0166-6851(99)00203-0; de Koning HP, 1998, J BIOL CHEM, V273, P9486, DOI 10.1074/jbc.273.16.9486; el Kouni MH, 2003, PHARMACOL THERAPEUT, V99, P283, DOI 10.1016/S0163-7258(03)00071-8; Geiser F, 2005, MOL PHARMACOL, V68, P589, DOI 10.1124/mol.104.010298; GHODA LY, 1988, MOL BIOCHEM PARASIT, V27, P109, DOI 10.1016/0166-6851(88)90030-8; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Holmes P, 2013, J INVERTEBR PATHOL, V112, pS11, DOI 10.1016/j.jip.2012.07.014; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Luscher A, 2014, INT J PARASITOL-DRUG, V4, P55, DOI 10.1016/j.ijpddr.2013.12.001; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; OGBUNUDE POJ, 1985, ANN TROP MED PARASIT, V79, P7, DOI 10.1080/00034983.1985.11811883; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; Pelle R, 1998, J BIOL CHEM, V273, P2118, DOI 10.1074/jbc.273.4.2118; Ranjbarian F, 2012, J BIOL CHEM, V287, P17628, DOI 10.1074/jbc.M112.340059; Rottenberg ME, 2005, J INFECT DIS, V192, P1658, DOI 10.1086/496896; SLOWIACZEK P, 1982, ANAL BIOCHEM, V125, P6, DOI 10.1016/0003-2697(82)90376-1; Vodnala M, 2008, J BIOL CHEM, V283, P5380, DOI 10.1074/jbc.M705603200; Vodnala SK, 2013, J MED CHEM, V56, P9861, DOI 10.1021/jm401530a; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Ward CP, 2011, ANTIMICROB AGENTS CH, V55, P2352, DOI 10.1128/AAC.01551-10; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	35	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11717	11726		10.1074/jbc.M116.715615	http://dx.doi.org/10.1074/jbc.M116.715615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27036940	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000377264800022
J	Alves, AV; Argandona, EJS; Linzmeier, AM; Cardoso, CAL; Macedo, MLR				Alves, Ariana Vieira; Sanjinez Argandona, Eliana Janet; Linzmeier, Adelita Maria; Lima Cardoso, Claudia Andrea; Rodrigues Macedo, Maria Ligia			Chemical Composition and Food Potential of Pachymerus nucleorum Larvae Parasitizing Acrocomia aculeata Kernels	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; ANTIOXIDANT CAPACITY	Insect consumption as food is culturally practiced in various regions of the world. In Brazil, there are more than 130 species of edible insects registered, from nine orders, among which stands out the Coleoptera. The larva of the beetle Pachymerus nucleorum Fabricius, 1792, grows into the bocaiuva fruit (Acrocomia aculeata (Jacq.) Lodd. Ex Mart., 1845), which has proven nutritional quality. The aim of this work was to evaluate the nutritional potential of P. nucleorum larvae compared to bocaiuva kernels for human consumption. Proteins were the second largest portion of the larvae nutritional composition (33.13%), with percentage higher than the bocaiuva kernels (14.21%). The larval lipid content (37.87%) was also high, very close to the kernels (44.96%). The fraction corresponding to fatty acids in the oil extracted from the larvae was 40.17% for the saturated and 46.52% for the unsaturated. The antioxidant activity value was 24.3 uM trolox/g of oil extracted from larvae. The larvae tryptic activity was 0.032 +/- 0.006 nmol BAPNA/min. Both the larvae and the bocaiuva kernel presented absence of anti-nutritional factors. These results favor the use of P. nucleorum larvae as food, which are a great protein and lipid sources with considerable concentrations of unsaturated fatty acids compared to the bocaiuva kernel.	[Alves, Ariana Vieira; Sanjinez Argandona, Eliana Janet] Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dourados, MS, Brazil; [Linzmeier, Adelita Maria] Fed Univ Fronteira Sul, Realeza, Parana, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Course Chem, Dourados, MS, Brazil; [Rodrigues Macedo, Maria Ligia] Univ Fed Mato Grosso do Sul, Dept Nat Sci, Lab Prot Purificat & Biol Funct, Campo Grande, MS, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Fronteira Sul; Universidade Estadual de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Alves, AV (corresponding author), Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dourados, MS, Brazil.	arianavieiralves@gmail.com	Linzmeier, Adelita/A-9239-2013; Argandoña, Eliana Janet EJSA Sanjinez/J-6524-2012; Cardoso, Claudia Andrea Lima/AAK-5578-2020	Argandoña, Eliana Janet EJSA Sanjinez/0000-0001-9377-8839; Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Macedo, Maria Ligia/0000-0001-6969-6307; Linzmeier, Adelita Maria/0000-0002-2979-8728	Fundacao de Apoio ao Desenvolvimento ao Ensino, Ciencia a Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Apoio ao Desenvolvimento ao Ensino, Ciencia a Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by a Masters scholarship (Benefitted: AVA) from Fundacao de Apoio ao Desenvolvimento ao Ensino, Ciencia a Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) [http://fundect.ledes.net/]. Financial support for equipment (Benefitted: EJSA) was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [http://www.capes.gov.br/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, FAO Food Nutr Pap, V91, P1; [Anonymous], 2011, TACO TAB BRAS COMP A; [Anonymous], 1999, GRAPHPAD PRISM VERSI; [Anonymous], 2003, OFFICIAL METHODS ANA, P17; AOAC Association of Official Analytical Chemists, 2005, OFFICIAL METHODS ANA, P18; Aranceta J, 2012, BRIT J NUTR, V107, pS8, DOI 10.1017/S0007114512001444; Atwater WO, 1896, FARMERS B, V28; BLIGH E. G., CANADIAN J BIOCH PHY, V37, P911; Costa Neto Eraldo M., 2006, Boletin de la SEA, V38, P423; Dessimoni-Pinto N. A. V., 2010, Alimentos e Nutricao, V21, P79; Drin G, 2014, ANNU REV BIOCHEM, V83, P51, DOI 10.1146/annurev-biochem-060713-035307; Dutra-De-Oliveira JED, 2008, CIENCIAS NUTR APREND; Estevan AO, 2010, S BRAS JAP; FAO, 2010, FOR INS FOOD HUM BIT; FAO, 2013, STATE HUNGER BUILDIN; Ingram J, 2011, FOOD SECUR, V3, P417, DOI 10.1007/s12571-011-0149-9; Innocenti A, 2014, J BASIC APPL SCI, V10, P96; Jongema Y, 2012, LIST EDIBLE INSECTS; Karasov WH., 1997, HDB COMP PHYSL, P409, DOI 10.1002/cphy.cp130107; Lescano CH, 2014, J MED FOOD, V00, P1; Ramos MIL, 2008, CIENCIA TECNOL ALIME, V28, P90, DOI 10.1590/S0101-20612008000500015; Longvah T, 2011, FOOD CHEM, V128, P400, DOI 10.1016/j.foodchem.2011.03.041; Luan YB, 2013, FOOD SECUR, V5, P393, DOI 10.1007/s12571-013-0260-1; Marineli RD, 2012, FOOD RES INT, V49, P487, DOI 10.1016/j.foodres.2012.07.022; Mitsuhashi J., 2010, Forest insects as food: humans bite back. Proceedings of a workshop on Asia-Pacific resources and their potential for development, Chiang Mai, Thailand, 19-21 February, 2008, P115; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Prinz WA, 2014, NAT REV MOL CELL BIO, V15, DOI 10.1038/nrm3825; de Oliveira CFR, 2011, PROCESS BIOCHEM, V46, P498, DOI 10.1016/j.procbio.2010.09.025; Ramos-Elorduy J, 2006, INTERCIENCIA, V31, P512; Ramos-Elorduy Julieta, 2009, Entomological Research, V39, P271, DOI 10.1111/j.1748-5967.2009.00238.x; Rodriguez-Amaya DB, 2010, J FOOD COMPOS ANAL, V23, P726, DOI 10.1016/j.jfca.2010.03.008; Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037; Sanjinez-Argandona EJ, 2011, REV BRAS FRUTIC, V33, P1023, DOI 10.1590/S0100-29452011000300040; Shockley M, 2013, MASS PRODUCTION BENE, P764; STATSOFT, 2008, STAT DAT AN SOFTW SY; Willhelm F. F., 2014, Nutrire - Revista da Sociedade Brasileira de Alimentacao e Nutricao, V39, P179, DOI 10.4322/nutrire.2014.016; Zuo RT, 2013, BRIT J NUTR, V110, P1220, DOI 10.1017/S0007114513000378	38	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152125	10.1371/journal.pone.0152125	http://dx.doi.org/10.1371/journal.pone.0152125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031500	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800036
J	Liu, JJ; Li, G; Zhang, Y				Liu, Jianjun; Li, Guang; Zhang, Yue			Numerical Simulation of CO2 Flooding of Coalbed Methane Considering the Fluid-Solid Coupling Effect	PLOS ONE			English	Article							BASIN; SEQUESTRATION; PERMEABILITY	CO2 flooding of coalbed methane (CO2-ECBM) not only stores CO2 underground and reduces greenhouse gas emissions but also enhances the gas production ratio. This coupled process involves multi-phase fluid flow and coal-rock deformation, as well as processes such as competitive gas adsorption and diffusion from the coal matrix into fractures. A dual-porosity medium that consists of a matrix and fractures was built to simulate the flooding process, and a mathematical model was used to consider the competitive adsorption, diffusion and seepage processes and the interaction between flow and deformation. Due to the effects of the initial pressure and the differences in pressure variation during the production process, permeability changes caused by matrix shrinkage were spatially variable in the reservoir. The maximum value of permeability appeared near the production well, and the degree of rebound decreased with increasing distance from the production well.	[Liu, Jianjun; Li, Guang] Southwest Petr Univ, Sch Geosci & Technol, Chengdu, Peoples R China; [Liu, Jianjun; Li, Guang] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Zhang, Yue] Jidong Oilfield Co, PetroChina, Tangshan, Hebei, Peoples R China	Southwest Petroleum University; Southwest Petroleum University; China National Petroleum Corporation	Li, G (corresponding author), Southwest Petr Univ, Sch Geosci & Technol, Chengdu, Peoples R China.; Li, G (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	li_1616@163.com	Liu, Jianjun/K-8732-2015	Liu, Jianjun/0000-0003-4935-219X	National Natural Science Foundation of China [51174170]; National Science and Technology Support Program Project [2012BAC26B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program Project	The research is financially supported by National Natural Science Foundation of China (Grant No. 51174170) and the National Science and Technology Support Program Project (Grant No. 2012BAC26B05). Jianjun Liu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The research is financially supported by National Natural Science Foundation of China (Grant No. 51174170) and the National Science and Technology Support Program Project (Grant No. 2012BAC26B05).	An H, 2015, INT J COAL GEOL, V152, P15, DOI 10.1016/j.coal.2015.09.013; Dutta P, 2012, INT J GREENH GAS CON, V9, P103, DOI 10.1016/j.ijggc.2012.03.004; Enever J., 1997, RELATIONSHIP PERMEAB; Gray I., 1987, SPE RESERVOIR ENG, V2, P28, DOI DOI 10.2118/12514-PA; Hol S, 2014, INT J COAL GEOL, V128, P119, DOI 10.1016/j.coal.2014.04.010; Karacan CO, 2003, ENERG FUEL, V17, P1595, DOI 10.1021/ef0301349; Kumar H, 2014, FUEL, V135, P509, DOI 10.1016/j.fuel.2014.07.002; Li DY, 2010, FUEL, V89, P569, DOI 10.1016/j.fuel.2009.06.008; Massarotto P, 2010, INT J COAL GEOL, V82, P269, DOI 10.1016/j.coal.2009.11.002; Mavor MJ, 1998, SPE RESERV EVAL ENG, V1, P201, DOI 10.2118/39105-PA; Mazumder S, 2008, INT J COAL GEOL, V74, P123, DOI 10.1016/j.coal.2007.11.001; Merkel A, 2015, INT J COAL GEOL, V150, P181, DOI 10.1016/j.coal.2015.09.006; Palmer I., 1998, SPE RESERV EVAL ENG, V1, P539, DOI [DOI 10.2118/52607-PA, 10.2118/52607-pa]; Ronny P, 2011, ENERGY PROCEDIA, V4, P2157, DOI [10.1016/j.egypro.2011.02.101, DOI 10.1016/J.EGYPRO.2011.02.101]; Sayyafzadeh M, 2015, J NAT GAS SCI ENG, V27, P1205, DOI 10.1016/j.jngse.2015.09.071; Syed A, 2011, ENRGY PROCED, V4, P2137, DOI 10.1016/j.egypro.2011.02.098; Tang G.Q., 2005, SPE 95947 ANN TECH C, DOI [10.2118/95947-MS, DOI 10.2118/95947-MS]; Zhou FD, 2013, INT J GREENH GAS CON, V19, P26, DOI 10.1016/j.ijggc.2013.08.011	18	4	4	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152066	10.1371/journal.pone.0152066	http://dx.doi.org/10.1371/journal.pone.0152066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031096	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800033
J	Sondo, P; Derra, K; Nakanabo, SD; Tarnagda, Z; Kazienga, A; Zampa, O; Valea, I; Sorgho, H; Owusu-Dabo, E; Ouedraogo, JB; Guiguemde, TR; Tinto, H				Sondo, Paul; Derra, Karim; Nakanabo, Seydou Diallo; Tarnagda, Zekiba; Kazienga, Adama; Zampa, Odile; Valea, Innocent; Sorgho, Hermann; Owusu-Dabo, Ellis; Ouedraogo, Jean-Bosco; Guiguemde, Tinga Robert; Tinto, Halidou			Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso	PLOS ONE			English	Article							CHLOROQUINE RESISTANCE TRANSPORTER; IN-VIVO SELECTION; UNCOMPLICATED FALCIPARUM-MALARIA; DIHYDROARTEMISININ-PIPERAQUINE; POLYMORPHISMS; GENE; ASSOCIATION; SENSITIVITY; PARASITES; PROFILE	The adoption of Artemisinin based combination therapies (ACT) constitutes a basic strategy for malaria control in sub-Saharan Africa. Moreover, since cases of ACT resistance have been reported in South-East Asia, the need to understand P. falciparum resistance mechanism to ACT has become a global research goal. The selective pressure of ACT and the possibility that some specific Pfcrt and Pfmdr1 alleles are associated with treatment failures was assessed in a clinical trial comparing ASAQ to AL in Nanoro. Dried blood spots collected on Day 0 and on the day of recurrent parasitaemia during the 28-day follow-up were analyzed using the restriction fragments length polymorphism (PCR-RFLP) method to detect single nucleotide polymorphisms (SNPs) in Pfcrt (codon76) and Pfmdr1 (codons 86, 184, 1034, 1042, and 1246) genes. Multivariate analysis of the relationship between the presence of Pfcrt and Pfmdr1 alleles and treatment outcome was performed. AL and ASAQ exerted opposite trends in selecting Pfcrt K76T and Pfmdr1-N86Y alleles, raising the potential beneficial effect of using diverse ACT at the same time as first line treatments to reduce the selective pressure by each treatment regimen. No clear association between the presence of Pfcrt and Pfmdr1 alleles carried at baseline and treatment failure was observed.	[Sondo, Paul; Derra, Karim; Nakanabo, Seydou Diallo; Tarnagda, Zekiba; Kazienga, Adama; Valea, Innocent; Sorgho, Hermann; Ouedraogo, Jean-Bosco; Tinto, Halidou] IRSS, CRUN, Nanoro, Burkina Faso; [Nakanabo, Seydou Diallo; Zampa, Odile; Valea, Innocent; Guiguemde, Tinga Robert; Tinto, Halidou] Ctr Muraz Bobo Dioulasso, Bobo Dioulasso, Burkina Faso; [Owusu-Dabo, Ellis] Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana	Centre Muraz; Kumasi Center for Collaborative Research	Sondo, P (corresponding author), IRSS, CRUN, Nanoro, Burkina Faso.	paulsondo@yahoo.fr	Derra, Karim/AAC-1323-2022; Valea, Innocent/ABE-6694-2020; Kazienga, Adama/HGB-6079-2022	Derra, Karim/0000-0002-2090-9698; Sondo, Paul/0000-0003-4161-3367; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Valea, Innocent/0000-0002-3085-0490; Tinto, Halidou/0000-0002-0472-3586; Kazienga, Adama/0000-0002-6093-9648	Sanofi Aventis; WHO-TDR (World Health Organisation Special Programme for Research and Training in Tropical Diseases); Institute of Tropical Medicine, Belgium (FA3 - DGCD program)	Sanofi Aventis(Sanofi-Aventis); WHO-TDR (World Health Organisation Special Programme for Research and Training in Tropical Diseases); Institute of Tropical Medicine, Belgium (FA3 - DGCD program)	Sanofi Aventis and WHO-TDR (World Health Organisation Special Programme for Research and Training in Tropical Diseases) provided financial support for study samples collection. The Institute of Tropical Medicine, Belgium (FA3 - DGCD program) provided financial support for laboratory work.	[Anonymous], 2001, ANT DRUG COMB THER; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Baraka V, 2015, ANTIMICROB AGENTS CH, V59, P734, DOI 10.1128/AAC.03647-14; Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005; Dahlstrom S, 2009, J INFECT DIS, V200, P1456, DOI 10.1086/606009; Derra K, 2012, INT J EPIDEMIOL, V41, P1293, DOI 10.1093/ije/dys159; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dorsey G, 2001, J INFECT DIS, V183, P1417, DOI 10.1086/319865; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Ministry of health of Burkina Faso/DSN, 2013, PLAN ACT 2014 DISTR; Ministry of health of Burkina Faso/PNLP, 2006, NAT GUID MAL CAS MAN; Mungthin M, 2010, AM J TROP MED HYG, V83, P1005, DOI 10.4269/ajtmh.2010.10-0339; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Ochong EO, 2003, AM J TROP MED HYG, V69, P184, DOI 10.4269/ajtmh.2003.69.184; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Ranford-Cartwright LC, 1997, T ROY SOC TROP MED H, V91, P719, DOI 10.1016/S0035-9203(97)90539-3; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Some AF, 2010, ANTIMICROB AGENTS CH, V54, P1949, DOI 10.1128/AAC.01413-09; Sondo P, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.101.6437; Sondo P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0843-8; Tinto H, 2005, AM J TROP MED HYG, V73, P171, DOI 10.4269/ajtmh.2005.73.171; Tinto H, 2008, TROP MED INT HEALTH, V13, P238, DOI 10.1111/j.1365-3156.2007.01995.x; Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-207; Tinto H, 2014, TROP MED INT HEALTH, V19, P469, DOI 10.1111/tmi.12274; Venkatesan M, 2014, AM J TROP MED HYG, V91, P833, DOI 10.4269/ajtmh.14-0031; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6	30	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151565	10.1371/journal.pone.0151565	http://dx.doi.org/10.1371/journal.pone.0151565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031231	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800014
J	Chen, Y; Liu, Q; Su, QQ; Sun, YX; Peng, XW; He, XY; Zhang, LB				Chen, Yi; Liu, Qi; Su, Qianqian; Sun, Yunxiao; Peng, Xingwen; He, Xiangyang; Zhang, Libiao			'Compromise' in Echolocation Calls between Different Colonies of the Intermediate Leaf-Nosed Bat (Hipposideros larvatus)	PLOS ONE			English	Article							SOCIAL CALLS; BROWN BATS; EPTESICUS-FUSCUS; COMMUNICATION; CHIROPTERA; BEHAVIOR; VARIABILITY; FREQUENCIES; DIVERGENCE	Each animal population has its own acoustic signature which facilitates identification, communication and reproduction. The sonar signals of bats can convey social information, such as species identity and contextual information. The goal of this study was to determine whether bats adjust their echolocation call structures to mutually recognize and communicate when they encounter the bats from different colonies. We used the intermediate leafnosed bats (Hipposideros larvatus) as a case study to investigate the variations of echolocation calls when bats from one colony were introduced singly into the home cage of a new colony or two bats from different colonies were cohabitated together for one month. Our experiments showed that the single bat individual altered its peak frequency of echolocation calls to approach the call of new colony members and two bats from different colonies adjusted their call frequencies toward each other to a similar frequency after being chronically cohabitated. These results indicate that the 'compromise' in echolocation calls might be used to ensure effective mutual communication among bats.	[Chen, Yi; Liu, Qi; Su, Qianqian; Sun, Yunxiao; Peng, Xingwen; He, Xiangyang; Zhang, Libiao] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Chen, Yi; Zhang, Libiao] Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Chen, Yi; Zhang, Libiao] Guangdong Key Lab Integrated Pest Management Agr, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Zhang, LB (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.; Zhang, LB (corresponding author), Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China.; Zhang, LB (corresponding author), Guangdong Key Lab Integrated Pest Management Agr, Guangzhou, Guangdong, Peoples R China.	zhanglb@gdei.gd.cn		Chen, Yi/0000-0001-9989-2165	Science & Technology Planning Project of Guangdong [2015A020209093, 2013B050800024]; Guangdong Province [2012B091100260]; Chinese Academy of Sciences [2012B091100260]; Funds for Environment Construction & Capacity Building of GDAS' Research Platform [2016GDASPT-0215]	Science & Technology Planning Project of Guangdong; Guangdong Province; Chinese Academy of Sciences(Chinese Academy of Sciences); Funds for Environment Construction & Capacity Building of GDAS' Research Platform	Funding was provided by Science & Technology Planning Project of Guangdong (2015A020209093, 2013B050800024), The Project of Comprehensive Strategic Cooperation between Guangdong Province and Chinese Academy of Sciences (2012B091100260), and Funds for Environment Construction & Capacity Building of GDAS' Research Platform (2016GDASPT-0215).	Altringham JD, 1985, BATS BIOL BEHAV, P79; Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P61; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; Bates P., 1998, BIODIVERS CONSERV, V7, P1383, DOI [10.1023/A:1017113501563, DOI 10.1023/A:1017113501563]; Becker P.H., 1982, P213; BELWOOD JJ, 1984, CAN J ZOOL, V62, P2113, DOI 10.1139/z84-306; Berger-Tal O, 2008, J ZOOL, V274, P59, DOI 10.1111/j.1469-7998.2007.00357.x; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Bradshaw John W. S., 1995, P115; Broders HG, 2004, J MAMMAL, V85, P273, DOI 10.1644/BWG-102; Busnel R-G, 1967, ANIMAL SONAR SYSTEMS, VII, P939; Chen Y, 2015, BEHAVIOUR, V152, P1083, DOI 10.1163/1568539X-00003269; Corcoran AJ, 2014, SCIENCE, V346, P745, DOI 10.1126/science.1259512; Fenton M.B., 1985, COMMUNICATION CHIROP; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; FENTON MB, 1994, ANIM BEHAV, V47, P757, DOI 10.1006/anbe.1994.1108; Gillam Erin H, 2007, Proc Biol Sci, V274, P651, DOI 10.1098/rspb.2006.0047; GOULD E, 1971, Communications in Behavioral Biology Part A Original Articles, V5, P263; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Griffin DR, 1958, LISTENING DARK; HILL JH, 1978, J ANTHROPOL RES, V34, P1; Hiryu S, 2006, J COMP PHYSIOL A, V192, P807, DOI 10.1007/s00359-006-0118-5; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Kastein HB, 2013, ANIM COGN, V16, P945, DOI 10.1007/s10071-013-0628-9; Kingston T, 2001, P ROY SOC B-BIOL SCI, V268, P1381, DOI 10.1098/rspb.2001.1630; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; MASTERS WM, 1995, ANIM BEHAV, V50, P1243, DOI 10.1016/0003-3472(95)80041-7; MASTERS WM, 1991, J ACOUST SOC AM, V89, P1402, DOI 10.1121/1.400660; Melendez KV, 2010, J ACOUST SOC AM, V128, P919, DOI 10.1121/1.3455835; NYBY J, 1978, NEUROSCI BIOBEHAV R, V2, P1, DOI 10.1016/0149-7634(78)90003-9; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; Pfalzer G, 2003, J ZOOL, V261, P21, DOI 10.1017/S0952836903003935; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Siemers BM, 2001, BEHAV ECOL SOCIOBIOL, V50, P317, DOI 10.1007/s002650100379; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Thabah A, 2006, BIOL J LINN SOC, V88, P119, DOI 10.1111/j.1095-8312.2006.00602.x; Vaughan Nancy, 1997, Bioacoustics, V7, P189; Wright GS, 2014, CURR BIOL, V24, P885, DOI 10.1016/j.cub.2014.02.058; Wund MA, 2006, AM MIDL NAT, V156, P99, DOI 10.1674/0003-0031(2006)156[99:VITECO]2.0.CO;2; ZBINDEN K, 1989, REV SUISSE ZOOL, V96, P335, DOI 10.5962/bhl.part.117768	43	3	4	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151382	10.1371/journal.pone.0151382	http://dx.doi.org/10.1371/journal.pone.0151382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029005	Green Submitted, gold, Green Published			2022-12-26	WOS:000373116500025
J	Le Bomin, S; Lecointre, G; Heyer, E				Le Bomin, Sylvie; Lecointre, Guillaume; Heyer, Evelyne			The Evolution of Musical Diversity: The Key Role of Vertical Transmission	PLOS ONE			English	Article							POPULATIONS; LANGUAGE; SUPPORT; HISTORY; AFRICA; PYGMY	Music, like languages, is one of the key components of our culture, yet musical evolution is still poorly known. Numerous studies using computational methods derived from evolutionary biology have been successfully applied to varied subset of linguistic data. One of the major drawback regarding musical studies is the lack of suitable coded musical data that can be analysed using such evolutionary tools. Here we present for the first time an original set of musical data coded in a way that enables construction of trees classically used in evolutionary approaches. Using phylogenetic methods, we test two competing theories on musical evolution: vertical versus horizontal transmission. We show that, contrary to what is currently believed, vertical transmission plays a key role in shaping musical diversity. The signal of vertical transmission is particularly strong for intrinsic musical characters such as metrics, rhythm, and melody. Our findings reveal some of the evolutionary mechanisms at play for explaining musical diversity and open a new field of investigation in musical evolution.	[Le Bomin, Sylvie; Heyer, Evelyne] Univ Paris 04, Univ Paris Diderot, MNHN,Musee Homme, Ecoanthropol & Ethnobiol,UMR CNRS 7206, Paris, France; [Lecointre, Guillaume] Univ Paris 04, Inst Systemat Evolut & Biodivers, UMR CNRS MNHN UPMC EPHE 7205, Dept Systemat & Evolut,Museum Natl Hist Nat, Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Le Bomin, S (corresponding author), Univ Paris 04, Univ Paris Diderot, MNHN,Musee Homme, Ecoanthropol & Ethnobiol,UMR CNRS 7206, Paris, France.	lebomin@mnhn.fr	Heyer, Evelyne/K-9184-2013	Heyer, Evelyne/0000-0002-0266-3196	ACI Prosodie Histoire et diversite des Pygmees de l'Afrique Centrale et de leurs voisins, Research Ministry; La mobilite ancestrale face a la percee des routes forestieres en Afrique centrale : le cas des chasseurs cueilleurs pygmees [ANR-05-BLAN-0400-001]; CORUS program 6144 (MAE/IRD) Patrimoines musicaux et Societes (Gabon - Sud Cameroun)	ACI Prosodie Histoire et diversite des Pygmees de l'Afrique Centrale et de leurs voisins, Research Ministry; La mobilite ancestrale face a la percee des routes forestieres en Afrique centrale : le cas des chasseurs cueilleurs pygmees; CORUS program 6144 (MAE/IRD) Patrimoines musicaux et Societes (Gabon - Sud Cameroun)	This research benefited from three research programs: ACI Prosodie Histoire et diversite des Pygmees de l'Afrique Centrale et de leurs voisins, Research Ministry, directed by E. Heyer (Pr. MNHN). 2004-2007; ANR-05-BLAN-0400-001, La mobilite ancestrale face a la percee des routes forestieres en Afrique centrale : le cas des chasseurs cueilleurs pygmees directed by S. Bahuchet (Pr. MNHN). 2006-2009; CORUS program 6144 (MAE/IRD) Patrimoines musicaux et Societes (Gabon - Sud Cameroun) directed by S. Le Bomin (MNHN) and J.E. Mbot (Omar Bongo university). The funders had no role in analysis, decision to publish or preparation of the manuscript.	Alewijnse Bart, 2007, P RANLP WORKSH COMP, P3; Arom S., ANTHOLOGIE MUSIQUE; Arom S, 1972, MUSIQUE PYGMEES BAKA; Arom S, 2008, CATEGORIES CATEGORIS, P273; Arom S., 1991, AFRICAN POLYPHONY PO; Arom S, 2007, MUSISUES ENCY 21 SIE, VV, P1088; Bahuchet S., 1993, FORET AFRIQUE CENTRA, P322; Bahuchet S, 2012, HUM BIOL, V84, P11, DOI 10.3378/027.084.0101; Ben Hamed M., 2005, J QUANT LINGUIST, V12, P79, DOI DOI 10.1080/09296170500055467; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; BROWN S, 2014, P R SOC B, V281, P2013; Charbonnat P, 2014, APPARENTE LA PENSEE; Collard M, 2004, EVOLUTION CULTURAL D, P109; Collard M, 2006, EVOL HUM BEHAV, V27, P169, DOI 10.1016/j.evolhumbehav.2005.07.003; DARLU P, 1993, RECONSTRUCTION PHYLO; DEPINNA MCC, 1991, CLADISTICS, V7, P367; Doumon G, 1981, TECHNICAL HDB MUSEUM, V5; Fisler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068814; Furniss S, 2006, ANAL STUDIES WORLD M, P163; Furniss S, 2008, AFRICAN MUSIC, V8, P94; Furniss S, 2013, J AFRICANISTES, V82, P107; Furniss S, 2011, DYNAMIC CULTURE RITU; Furniss Suzanne, 1991, CAHIERS MUSIQUE TRAD, V4, P167; Graf W., 1965, SCHRIFTEN VEREINS VE, P2; Grauer VA, 2009, ETHNOMUSICOLOGY, V53, P396; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Greenhill SJ, 2004, EVOLUTION CULTURAL D, P31; GUTHRIE M, 1953, BANTU LANGUAGES W EQ; Holden CJ, 2003, P ROY SOC B-BIOL SCI, V270, P2425, DOI 10.1098/rspb.2003.2535; Howe CJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001069; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Le Bomin S, 2005, MUSIQUES MYENE DE PO; Le Bomin S, 2011, MISE SCENE TERRITOIR, P329; Le Bomin Sylvie., 2004, MUSIQUES BATEKE MPA; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062243; Lomax A., 1968, FOLK SONG STYLE CULT; Lycett SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007404; Maho JF, 2007, REFERENTIAL CLASSIFI; Molino Jean, 2009, SINGE MUSICIEN ESSAI; Mulder MB, 2006, EVOL ANTHROPOL, V15, P52, DOI 10.1002/evan.20088; Nunn CL, 2010, PHILOS T R SOC B, V365, P3807, DOI 10.1098/rstb.2010.0009; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pamjav H, 2012, MOL GENET GENOMICS, V287, P337, DOI 10.1007/s00438-012-0683-y; Rogers DS, 2009, P ROY SOC B-BIOL SCI, V276, P3835, DOI 10.1098/rspb.2009.1088; Roubeau B, 2009, J VOICE, V23, P425, DOI 10.1016/j.jvoice.2007.10.014; Rzeszutek T, 2012, P ROY SOC B-BIOL SCI, V279, P1606, DOI 10.1098/rspb.2011.1750; Sallee P, 1985, THESIS U PARIS X NAN; Steele J, 2010, PHILOS T R SOC B, V365, P3781, DOI 10.1098/rstb.2010.0202; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tehrani JJ, 2010, PHILOS T R SOC B, V365, P3865, DOI 10.1098/rstb.2010.0020; Temkin I, 2007, CURR ANTHROPOL, V48, P146, DOI 10.1086/510463; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049	53	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151570	10.1371/journal.pone.0151570	http://dx.doi.org/10.1371/journal.pone.0151570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DH9LB	27027305	Green Submitted, gold, Green Published			2022-12-26	WOS:000373116500027
J	Ovari, A; Nemenyi, D; Just, T; Schuldt, T; Buhr, A; Mlynski, R; Csokay, A; Pau, HW; Valalik, I				Ovari, Attila; Nemenyi, Dora; Just, Tino; Schuldt, Tobias; Buhr, Anne; Mlynski, Robert; Csokay, Andras; Pau, Hans-Wilhelm; Valalik, Istvan			Positioning Accuracy in Otosurgery Measured with Optical Tracking	PLOS ONE			English	Article							TEMPORAL BONE SIMULATOR; MIDDLE-EAR SURGERY; FINGERTIP SUPPORT; STAPES FOOTPLATE; SURGICAL ROBOT; HAND TREMOR; MICROMANIPULATOR; INSTRUMENT; COCHLEOSTOMY; FORCES	Objectives To assess positioning accuracy in otosurgery and to test the impact of the two-handed instrument holding technique and the instrument support technique on surgical precision. To test an otologic training model with optical tracking. Study Design In total, 14 ENT surgeons in the same department with different levels of surgical experience performed static and dynamic tasks with otologic microinstruments under simulated otosurgical conditions. Methods Tip motion of the microinstrument was registered in three dimensions by optical tracking during 10 different tasks simulating surgical steps such as prosthesis crimping and dissection of the middle ear using formalin-fixed temporal bone. Instrument marker trajectories were compared within groups of experienced and less experienced surgeons performing uncompensated or compensated exercises. Results Experienced surgeons have significantly better positioning accuracy than novice ear surgeons in terms of mean displacement values of marker trajectories. The instrument support and the two-handed instrument holding techniques significantly reduce surgeons' tremor. The laboratory set-up presented in this study provides precise feedback for otosurgeons about their surgical skills and proved to be a useful device for otosurgical training. Conclusions Simple tremor compensation techniques may offer trainees the potential to improve their positioning accuracy to the level of more experienced surgeons. Training in an experimental otologic environment with optical tracking may aid acquisition of technical skills in middle ear surgery and potentially shorten the learning curve. Thus, simulated exercises of surgical steps should be integrated into the training of otosurgeons.	[Ovari, Attila; Schuldt, Tobias; Buhr, Anne; Mlynski, Robert; Pau, Hans-Wilhelm] Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany; [Nemenyi, Dora] Univ Med Ctr, Dept Neurol, Rostock, Germany; [Just, Tino] KMG Klinikum Gustrow GmbH, Dept Otorhinolaryngol, Gustrow, Germany; [Csokay, Andras] Mil Hosp, Dept Neurosurg, Budapest, Hungary; [Valalik, Istvan] St Johns Hosp, Dept Neurosurg, Budapest, Hungary	University of Rostock; University of Rostock	Ovari, A (corresponding author), Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany.	atiova@gmail.com		Schuldt, Tobias/0000-0001-9278-4954; Mlynski, Robert/0000-0001-6404-6364; Ovari, Attila/0000-0003-4610-6890				Armstrong WB, 2005, OTOLARYNG HEAD NECK, V132, P471, DOI 10.1016/j.otohns.2004.10.012; Beleites T, 2011, LARYNGO RHINO OTOL, V90, P672, DOI 10.1055/s-0031-1284373; Bergin M, 2014, OTOL NEUROTOL, V35, pE77, DOI 10.1097/MAO.0000000000000173; Brett PN, 2007, P ANN INT IEEE EMBS, P1229, DOI 10.1109/IEMBS.2007.4352519; Choi DY, 2005, P ANN INT IEEE EMBS, P2325, DOI 10.1109/IEMBS.2005.1616932; Clifton N, 2011, EUR ARCH OTO-RHINO-L, V268, P949, DOI 10.1007/s00405-011-1554-6; Coulson CJ, 2008, CLIN OTOLARYNGOL, V33, P343, DOI 10.1111/j.1749-4486.2008.01703.x; Coulson CJ, 2007, INT J MED ROBOT COMP, V3, P91, DOI 10.1002/rcs.132; Coulson CJ, 2010, MICROSURG, V30, P565, DOI 10.1002/micr.20776; Csokay Andras, 2006, Orvosi Hetilap, V147, P1921; Francis HW, 2012, LARYNGOSCOPE, V122, P1385, DOI 10.1002/lary.22378; Growdon W, 2000, CLIN NEUROPHYSIOL, V40, P295; Hofer M, 2012, HNO, V60, P109, DOI 10.1007/s00106-011-2374-0; Jobbagy A, 2005, J NEUROSCI METH, V141, P29, DOI 10.1016/j.jneumeth.2004.05.009; Khemani S, 2012, OTOL NEUROTOL, V33, P1225, DOI 10.1097/MAO.0b013e31825e7977; Klenzner T, 2009, EUR ARCH OTO-RHINO-L, V266, P955, DOI 10.1007/s00405-008-0825-3; Lauxmann M, 2012, OTOL NEUROTOL, V33, P1077, DOI 10.1097/MAO.0b013e318259b34b; Maier T, 2008, LARYNGO RHINO OTOL, V87, P620, DOI 10.1055/s-0028-1086164; Manrique MJ, 2007, ACTA OTO-LARYNGOL, V127, P122, DOI 10.1080/00016480600827063; Miroir M, 2012, SCI WORLD J, DOI 10.1100/2012/907372; Grande GM, 2012, IEEE ENG MED BIO, P1422, DOI 10.1109/EMBC.2012.6346206; Murbe D, 2001, OTOL NEUROTOL, V22, P672; Nash R, 2012, J LARYNGOL OTOL, V126, P663, DOI 10.1017/S0022215112000734; Ovari A, 2010, CLIN OTOLARYNGOL, V35, P343, DOI 10.1111/j.1749-4486.2010.02160.x; Owa AO, 2003, J LARYNGOL OTOL, V117, P490, DOI 10.1258/002221503321892361; Rothbaum DL, 2002, OTOLARYNG HEAD NECK, V127, P417, DOI 10.1067/mhn.2002.129729; Runge A, 2001, STUD HLTH TECHNOL IN, V163, P524; Sandoval R, 2007, P ANN INT IEEE EMBS, P206, DOI 10.1109/IEMBS.2007.4352259; Savall J, 2006, C P IEEE ENG MED BIO, V1, P335; Slack PS, 2009, EUR ARCH OTO-RHINO-L, V266, P137, DOI 10.1007/s00405-008-0714-9; Sowerby LJ, 2010, J OTOLARYNGOL-HEAD N, V39, P122, DOI 10.2310/7070.2009.090079; Ucar C, 2007, LARYNGOSCOPE, V117, P1223, DOI 10.1097/MLG.0b013e31805c945c	32	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152623	10.1371/journal.pone.0152623	http://dx.doi.org/10.1371/journal.pone.0152623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027500	Green Published, gold			2022-12-26	WOS:000373116500060
J	Senevirathne, G; Garg, S; Kerney, R; Meegaskumbura, M; Biju, SD				Senevirathne, Gayani; Garg, Sonali; Kerney, Ryan; Meegaskumbura, Madhava; Biju, S. D.			Unearthing the Fossorial Tadpoles of the Indian Dancing Frog Family Micrixalidae	PLOS ONE			English	Article							CRANIAL ONTOGENY; ANURA; AMPHIBIA; MORPHOLOGY; EVOLUTION; CENTROLENIDAE; MICROHYLIDAE; MANTELLIDAE; OSTEOLOGY; CAMEROON	Tadpoles of the monotypic Indian dancing frog family Micrixalidae have remained obscure for over 125 years. Here we report the discovery of the elusive tadpoles of Micrixalus herrei from the sand beds of a forested stream in southern Western Ghats, and confirm their identity through DNA barcoding. These actively burrowing tadpoles lead an entirely fossorial life from eggs to late metamorphic stages. We describe their internal and external morphological characters while highlighting the following features: eel-like appearance, extensively muscularized body and tail, reduced tail fins, skin-covered eyes, delayed development of eye pigmentation in early pre-metamorphic stages (Gosner stages 25-29), prominent tubular sinistral spiracle, large transverse processes on vertebrae II and III, ankylosed ribs on transverse processes of vertebra II, notochord terminating before the atlantal cotyle-occipital condyle junction, absence of keratodonts, serrated well-formed jaw sheaths, and extensive calcified endolymphatic sacs reaching sacrum posteriorly. The tadpole gut contains mostly fine sediments and sand. We discuss the eel-like morphology and feeding habits of M. herrei in the context of convergence with other well-known fossorial tadpoles. This discovery builds the knowledge base for further comparative analyses and conservation of Micrixalus, an ancient and endemic lineage of Indian frogs.	[Senevirathne, Gayani; Meegaskumbura, Madhava] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka; [Garg, Sonali; Biju, S. D.] Univ Delhi, Dept Environm Studies, Systemat Lab, Delhi 110007, India; [Kerney, Ryan] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA	University of Peradeniya; University of Delhi; Gettysburg College	Meegaskumbura, M (corresponding author), Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka.; Biju, SD (corresponding author), Univ Delhi, Dept Environm Studies, Systemat Lab, Delhi 110007, India.	madhava88m@gmail.com; sdbiju@es.du.ac.in	Senevirathne, Gayani/ABD-5713-2021; Meegaskumbura, Madhava/F-8782-2013	Meegaskumbura, Madhava/0000-0002-4599-6724; Kerney, Ryan/0000-0002-4740-7735	DU/DST (Government of India) [2009/868]; MoEF (Government of India) [23/3/2007-RE]; CEPF (USA) [55918/2009]; University of Delhi 'RD' [2012/917]; National Research Council [NRC-11-124]; Council for Scientific and Industrial Research, India (CSIR) [9/45(1381)/2015-EMR-I]	DU/DST (Government of India); MoEF (Government of India)(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India); CEPF (USA); University of Delhi 'RD'; National Research Council; Council for Scientific and Industrial Research, India (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This research was funded by DU/DST '2009/868' (Government of India); MoEF '23/3/2007-RE' (Government of India); CEPF 'Project 55918/2009' (USA); and University of Delhi 'R&D 2012/917' grants to SDB. MM is supported by the National Research Council (NRC-11-124). SG is supported by a research fellowship from the Council for Scientific and Industrial Research, India (CSIR No. 9/45(1381)/2015-EMR-I).	ALTIG R, 1970, Herpetologica, V26, P180; ALTIG R, 1989, HERPETOL MONOGR, V3, P81, DOI [DOI 10.2307/1466987, 10.2307/1466987]; Altig R, 2006, P BIOL SOC WASH, V119, P418, DOI 10.2988/0006-324X(2006)119[418:DABNOT]2.0.CO;2; Biju SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145727; Biju S.D., 2014, Ceylon Journal of Science Biological Sciences, V43, P37; Blackburn DC, 2008, ZOOL J LINN SOC-LOND, V154, P611, DOI 10.1111/j.1096-3642.2008.00397.x; Blanco MJ, 2000, J MORPHOL, V244, P57, DOI 10.1002/(SICI)1097-4687(200004)244:1<57::AID-JMOR6>3.0.CO;2-7; BREDER C. M., 1926, ZOOLOGICA, V4, P159; CADLE JE, 1990, P BIOL SOC WASH, V103, P746; Cannatella D, 1999, TADPOLES, P52; Clarke BT, 1988, THESIS CITY LONDON P; Dempster WT, 1930, J MORPHOL, V50, P71, DOI 10.1002/jmor.1050500104; Dubois A, 1992, B MENS SOC LINN LYON, V61, P321; Dubois Alain, 2001, Alytes (Paris), V19, P53; Duellman W. E., 1986, BIOL AMPHIBIANS; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gosner K. L., 1960, Herpetologica, V16, P183; Grosjean S., 2006, CONTRIBUTIONS ZOOLOG, V74, P61; Grosjean S, 2011, SALAMANDRA, V47, P63; Gururaja Kotambylu Vasudeva, 2010, Zootaxa, V2642, P45; Haas A, 2006, ZOOLOGY, V109, P26, DOI 10.1016/j.zool.2005.09.008; Handrigan GR, 2007, EVOL DEV, V9, P190, DOI 10.1111/j.1525-142X.2007.00149.x; HANKEN J, 1992, J MORPHOL, V211, P95, DOI 10.1002/jmor.1052110111; HANKEN J, 1988, J MORPHOL, V195, P247, DOI 10.1002/jmor.1051950303; Hanken J., 1981, Functional Photography, V16, P22; Hanken James, 1999, P61, DOI 10.1016/B978-012730935-4/50004-3; Hirschfeld M, 2012, SALAMANDRA, V48, P147; Hoff KV, 1999, TADPOLES, P215; Hoffmann H, 2004, REV BIOL TROP, V52, P219; Hoffmann H, 2010, REV BIOL TROP, V58, P1467; Jairo Ospina-Sarria Jhon, 2011, South American Journal of Herpetology, V6, P79; Jaramillo FE, 1997, REV BIOL TROP, V45, P867; Kerney R, 2007, J MORPHOL, V268, P715, DOI 10.1002/jmor.10545; Krishna SN, 2006, AMPHIBIA-REPTILIA, V27, P143, DOI 10.1163/156853806776052056; Lamotte M., 1961, Bull Inst franY Afr noire, V23A, P211; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Malkmus Rudolf, 1999, Herpetozoa, V12, P17; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; Mercurio Vincenzo, 2006, Alytes (Paris), V23, P81; MIJARESURRUTIA A, 1990, J HERPETOL, V24, P410, DOI 10.2307/1565060; PERRET JEAN-LUC, 1966, ZOOL JAHRB ABT SYST OKOL GEOGR TIERE, V93, P289; PILKINGT.J, 1966, J EXP BIOL, V45, P329; Preininger Doris, 2012, Amphibian & Reptile Conservation, V5, P45; Preininger D, 2013, BEHAV ECOL SOCIOBIOL, V67, P1449, DOI 10.1007/s00265-013-1489-6; Preininger D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055367; Pugener LA, 2009, J MORPHOL, V270, P52, DOI 10.1002/jmor.10665; PYBURN W F, 1980, Papeis Avulsos de Zoologia (Sao Paulo), V33, P231; Rada Marco, 2007, Pap. Avulsos Zool., V47, P259; Roelants K, 2004, MOL PHYLOGENET EVOL, V31, P730, DOI 10.1016/j.ympev.2003.09.011; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schoch RR, 2009, ANNU REV EARTH PL SC, V37, P135, DOI 10.1146/annurev.earth.031208.100113; Senevirathne G, 2015, ZOOTAXA, V4032, P241, DOI 10.11646/zootaxa.4032.2.12; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 1924, REC INDIAN MUS, V26, P140; Starrett P, 1960, DESCRIPTIONS TADPOLE, P11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR W R, 1985, Cybium, V9, P107; Teran-Valdez Andrea, 2009, PHYLLOMEDUSA, V8, P105; Trueb L., 1973, P65; Vasudevan Karthikeyan, 2001, Cobra (Chennai), V44, P25; Villa J., 1982, Brenesia, V19-20, P1; Vitt LJ, 2013, HERPETOLOGY INTRO BI; WASSERSUG RJ, 1987, ZOOL J LINN SOC-LOND, V91, P137, DOI 10.1111/j.1096-3642.1987.tb01726.x; WASSERSUG RJ, 1979, BIOL J LINN SOC, V12, P225, DOI 10.1111/j.1095-8312.1979.tb00056.x; Wells K.D., 2007, ECOLOGY BEHAV AMPHIB, DOI 10.7208/chicago/9780226893334.001.0001; WORTHY TH, 1987, J ROY SOC NEW ZEAL, V17, P201, DOI 10.1080/03036758.1987.10418160	67	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151781	10.1371/journal.pone.0151781	http://dx.doi.org/10.1371/journal.pone.0151781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027870	Green Published, gold			2022-12-26	WOS:000373116500031
J	Shariff, M; Quik, M; Holgate, J; Morgan, M; Patkar, OL; Tam, V; Belmer, A; Bartlett, SE				Shariff, Masroor; Quik, Maryka; Holgate, Joan; Morgan, Michael; Patkar, Omkar L.; Tam, Vincent; Belmer, Arnauld; Bartlett, Selena E.			Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; PARTIAL AGONIST; EXTRACELLULAR DOPAMINE; GENE-EXPRESSION; INCENTIVE MOTIVATION; ETHANOL-CONSUMPTION; OPIOID RECEPTORS; CHRONIC MORPHINE; CORE DOPAMINE; NOSE-POKING	Excess sugar consumption has been shown to contribute directly to weight gain, thus contributing to the growing worldwide obesity epidemic. Interestingly, increased sugar consumption has been shown to repeatedly elevate dopamine levels in the nucleus accumbens (NAc), in the mesolimbic reward pathway of the brain similar to many drugs of abuse. We report that varenicline, an FDA-approved nicotinic acetylcholine receptor (nAChR) partial agonist that modulates dopamine in the mesolimbic reward pathway of the brain, significantly reduces sucrose consumption, especially in a long-term consumption paradigm. Similar results were observed with other nAChR drugs, namely mecamylamine and cytisine. Furthermore, we show that long-term sucrose consumption increases alpha 4 beta 2 * and decreases alpha 6 beta 2* nAChRs in the nucleus accumbens, a key brain region associated with reward. Taken together, our results suggest that nAChR drugs such as varenicline may represent a novel treatment strategy for reducing sugar consumption.	[Shariff, Masroor; Holgate, Joan; Morgan, Michael; Patkar, Omkar L.; Belmer, Arnauld; Bartlett, Selena E.] Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Quik, Maryka] SRI Int, Ctr Hlth Sci, Biosci Div, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA; [Tam, Vincent] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); SRI International; Queensland University of Technology (QUT)	Bartlett, SE (corresponding author), Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	selena.bartlett@qut.edu.au	Morgan, Michael/AAC-2044-2021; Morgan, Michael/C-1323-2015; Bartlett, Selena/J-1345-2012; Belmer, Arnauld/AAE-2554-2019	Morgan, Michael/0000-0002-3641-2774; Morgan, Michael/0000-0002-3641-2774; Bartlett, Selena/0000-0002-1741-3958; Belmer, Arnauld/0000-0001-6640-5631; Holgate, Joan/0000-0002-7953-0180; Shariff, Masroor/0000-0002-2677-8692	Australian Research Council [FT1110884]; National Health & Medical Research Council [1049427]; National Institute of Health [NS59910]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059910] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were funded by the following: 1. Australian Research Council - grant ID FT1110884 (to SEB), www.arc.gov.au; 2. National Health & Medical Research Council - grant ID 1049427 (to SEB), www.nhmrc.gov.au; and 3. National Institute of Health - grant ID NS59910 (to MQ), www.nih.gov.	ALBURGES ME, 1993, SYNAPSE, V14, P314, DOI 10.1002/syn.890140409; Aosaki T, 2010, GERIATR GERONTOL INT, V10, pS148, DOI 10.1111/j.1447-0594.2010.00588.x; Avena NM, 2006, NEUROSCIENCE, V139, P813, DOI 10.1016/j.neuroscience.2005.12.037; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Bassareo V, 2015, BEHAV BRAIN RES, V294, P215, DOI 10.1016/j.bbr.2015.08.006; Bassareo V, 2015, EUR J NEUROSCI, V41, P802, DOI 10.1111/ejn.12839; Bassareo V, 2015, BEHAV BRAIN RES, V287, P200, DOI 10.1016/j.bbr.2015.03.056; Bello NT, 2002, NEUROREPORT, V13, P1575, DOI 10.1097/00001756-200208270-00017; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Biala G, 2010, N-S ARCH PHARMACOL, V381, P361, DOI 10.1007/s00210-010-0498-5; Buccafusco JJ, 2009, J PHARMACOL EXP THER, V328, P364, DOI 10.1124/jpet.108.145292; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Crunelle CL, 2011, EUR NEUROPSYCHOPHARM, V21, P205, DOI 10.1016/j.euroneuro.2010.11.001; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; De Vries TJ, 2002, J NEUROSCI, V22, P3321; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Exley R, 2013, EUR J NEUROSCI, V38, P3036, DOI 10.1111/ejn.12298; Feduccia AA, 2014, BRIT J PHARMACOL, V171, P3420, DOI 10.1111/bph.12690; Ford MM, 2009, NEUROPHARMACOLOGY, V57, P250, DOI 10.1016/j.neuropharm.2009.05.012; Garrison GD, 2009, CLIN THER, V31, P463, DOI 10.1016/j.clinthera.2009.03.021; Georges F, 1999, EUR J NEUROSCI, V11, P481, DOI 10.1046/j.1460-9568.1999.00462.x; Goutier W, 2015, ADDICT BIOL, V20, P248, DOI 10.1111/adb.12108; Grady SR, 2010, NEUROPHARMACOLOGY, V58, P1054, DOI 10.1016/j.neuropharm.2010.01.013; Hebebrand J, 2014, NEUROSCI BIOBEHAV R, V47, P295, DOI 10.1016/j.neubiorev.2014.08.016; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Hoebel BG, 2007, CURR OPIN PHARMACOL, V7, P617, DOI 10.1016/j.coph.2007.10.014; HURD YL, 1988, J NEUROCHEM, V51, P1314, DOI 10.1111/j.1471-4159.1988.tb03103.x; Igari M, 2014, NEUROPSYCHOPHARMACOL, V39, P445, DOI 10.1038/npp.2013.216; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Leslie FM, 2013, MOL PHARMACOL, V83, P753, DOI 10.1124/mol.112.083659; Levin ED, 2000, PHYSIOL BEHAV, V71, P565, DOI 10.1016/S0031-9384(00)00382-6; Liu X, 2006, PSYCHOPHARMACOLOGY, V184, P417, DOI 10.1007/s00213-005-0134-0; Madsen HB, 2015, ADDICT BIOL, V20, P500, DOI 10.1111/adb.12148; MARK GP, 1992, J NEUROCHEM, V58, P2269, DOI 10.1111/j.1471-4159.1992.tb10973.x; Mark GP, 2011, PHYSIOL BEHAV, V104, P76, DOI 10.1016/j.physbeh.2011.04.052; McCallum SE, 2011, PSYCHOPHARMACOLOGY, V215, P247, DOI 10.1007/s00213-010-2132-0; McCarthy MJ, 2011, PSYCHOPHARMACOLOGY, V213, P735, DOI 10.1007/s00213-010-2028-z; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; Mineur YS, 2010, TRENDS PHARMACOL SCI, V31, P580, DOI 10.1016/j.tips.2010.09.004; Moore RJ, 1998, SYNAPSE, V30, P88, DOI 10.1002/(SICI)1098-2396(199809)30:1<88::AID-SYN11>3.0.CO;2-L; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Nickell JR, 2013, PHARMACOL BIOCHEM BE, V108, P28, DOI 10.1016/j.pbb.2013.04.005; Ortells MO, 2010, INT J BIOCHEM CELL B, V42, P1931, DOI 10.1016/j.biocel.2010.08.019; Ostlund SB, 2014, NEUROPSYCHOPHARMACOL, V39, P1490, DOI 10.1038/npp.2013.348; Palotai M, 2013, NEUROCHEM INT, V63, P239, DOI 10.1016/j.neuint.2013.06.014; Perez XA, 2013, J NEUROCHEM, V127, P762, DOI 10.1111/jnc.12442; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Picciotto MR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012112; Picciotto MR, 2002, J NEUROSCI, V22, P3338; POTHOS E, 1991, BRAIN RES, V566, P348, DOI 10.1016/0006-8993(91)91724-F; Quik M, 2001, J NEUROSCI, V21, P5494, DOI 10.1523/JNEUROSCI.21-15-05494.2001; Quik M, 2000, NEUROSCIENCE, V100, P63, DOI 10.1016/S0306-4522(00)00244-X; Quik M, 2011, PHARMACOL REV, V63, P938, DOI 10.1124/pr.110.003269; Quik M, 2011, BIOCHEM PHARMACOL, V82, P873, DOI 10.1016/j.bcp.2011.06.001; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Rada P, 2004, PHARMACOL BIOCHEM BE, V79, P599, DOI 10.1016/j.pbb.2004.09.011; Rada P, 2001, PSYCHOPHARMACOLOGY, V157, P105, DOI 10.1007/s002130100781; RADA P, 1991, BRAIN RES, V561, P354, DOI 10.1016/0006-8993(91)91616-9; Rada PV, 1996, PHARMACOL BIOCHEM BE, V53, P809, DOI 10.1016/0091-3057(95)02078-0; Rahman S, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00426; Renda A, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-89; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Rollema H, 2010, BRIT J PHARMACOL, V160, P334, DOI 10.1111/j.1476-5381.2010.00682.x; Sajja RK, 2011, PROG NEURO-PSYCHOPH, V35, P257, DOI 10.1016/j.pnpbp.2010.11.020; Shaffer CL, 2010, DRUG METAB DISPOS, V38, P292, DOI 10.1124/dmd.109.030171; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Spangler R, 2003, MOL BRAIN RES, V111, P74, DOI 10.1016/S0169-328X(02)00671-X; Spangler R, 2004, MOL BRAIN RES, V124, P134, DOI 10.1016/j.molbrainres.2004.02.013; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Tindell AJ, 2005, EUR J NEUROSCI, V22, P2617, DOI 10.1111/j.1460-9568.2005.04411.x; Turchan J, 1997, NEUROPEPTIDES, V31, P24, DOI 10.1016/S0143-4179(97)90015-9; Tutka P, 2006, PHARMACOL REP, V58, P777; Tutka P, 2013, PHARMACOL REP, V65, P195, DOI 10.1016/S1734-1140(13)70978-2; UHL GR, 1988, BRAIN RES, V459, P391, DOI 10.1016/0006-8993(88)90658-0; Unterwald EM, 2001, BRAIN RES, V900, P103, DOI 10.1016/S0006-8993(01)02269-7; UNTERWALD EM, 1994, NEUROREPORT, V5, P1613, DOI 10.1097/00001756-199408150-00018; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zaniewska M, 2008, SYNAPSE, V62, P935, DOI 10.1002/syn.20564; Zhang JH, 2012, EUR J PHARM SCI, V47, P813, DOI 10.1016/j.ejps.2012.09.014; Zubieta JK, 1996, NAT MED, V2, P1225, DOI 10.1038/nm1196-1225	85	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150270	10.1371/journal.pone.0150270	http://dx.doi.org/10.1371/journal.pone.0150270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028298	Green Published, gold			2022-12-26	WOS:000373116500003
J	Yagdiran, Y; Oskarsson, A; Knight, CH; Tallkvist, J				Yagdiran, Yagmur; Oskarsson, Agneta; Knight, Christopher H.; Tallkvist, Jonas			ABC- and SLC-Transporters in Murine and Bovine Mammary Epithelium - Effects of Prochloraz	PLOS ONE			English	Article							BETA-CASEIN GENE; IN-VITRO MODEL; REAL-TIME PCR; FUNGICIDE PROCHLORAZ; ORGANIC ANION; CELL LINE; EXPRESSION; RESISTANCE; PROTEIN; CANCER	Some chemicals are ligands to efflux transporters which may result in high concentrations in milk. Limited knowledge is available on the influence of maternal exposure to chemicals on the expression and function of transporters in the lactating mammary gland. We determined gene expression of ABC and SLC transporters in murine mammary tissue of different gestation and lactation stages, in murine mammary cells (HC11) featuring resting and secreting phenotypes and in bovine mammary tissue and cells (BME-UV). Effects on transporter expression and function of the imidazole fungicide prochloraz, previously reported to influence BCRP in mammary cells, was investigated on transporter expression and function in the two cell lines. Transporters studied were BCRP, MDR1, MRP1, OATP1A5/OATP1A2, OCTN1 and OCT1. Gene expressions of BCRP and OCT1 in murine mammary glands were increased during gestation and lactation, whereas MDR1, MRP1, OATP1A5 and OCTN1 were decreased, compared to expressions in virgins. All transporters measured in mammary glands of mice were detected in bovine mammary tissue and in HC11 cells, while only MDR1 and MRP1 were detected in BME-UV cells. Prochloraz treatment induced MDR1 gene and protein expression in both differentiated HC11 and BME-UV cells and increased protein function in HC11 cells, resulting in decreased accumulation of the MDR1 substrate digoxin. In conclusion, our results demonstrate that murine (HC11) and bovine (BME-UV) mammary epithelial cells can be applied to characterize expression and function of transporters as well as effects of contaminants on the mammary transporters. An altered expression, induced by a drug or toxic chemical, on any of the transporters expressed in the mammary epithelial cells during lactation may modulate the well-balanced composition of nutrients and/or secretion of contaminants in milk with potential adverse effects on breast-fed infants and dairy consumers.	[Yagdiran, Yagmur; Oskarsson, Agneta; Tallkvist, Jonas] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, SE-75007 Uppsala, Sweden; [Knight, Christopher H.] Univ Copenhagen, Dept Vet Clin & Anim Sci, DK-1870 Frederiksberg C, Denmark	Swedish University of Agricultural Sciences; University of Copenhagen	Tallkvist, J (corresponding author), Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, SE-75007 Uppsala, Sweden.	Jonas.Tallkvist@slu.se		Oskarsson, Agneta/0000-0002-3134-7811	TvarLivs; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Sweden's Innovation Agency (Vinnova); Swedish Farmer's Foundation for Agricultural Research; Swedish Food Federation; Swedish Food Retailer's Federation	TvarLivs; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Sweden's Innovation Agency (Vinnova)(Vinnova); Swedish Farmer's Foundation for Agricultural Research; Swedish Food Federation; Swedish Food Retailer's Federation	This study was funded by a grant from the research program TvarLivs, which is co-founded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), Sweden's Innovation Agency (Vinnova), Swedish Farmer's Foundation for Agricultural Research, the Swedish Food Federation and the Swedish Food Retailer's Federation.	Abcam, ANTI P GLYCOPROTEIN; Al-Bataineh MM, 2009, J VET PHARMACOL THER, V32, P422, DOI 10.1111/j.1365-2885.2009.01057.x; Al-Bataineh MM, 2010, BIOPHARM DRUG DISPOS, V31, P506, DOI 10.1002/bdd.731; Alcorn J, 2002, J PHARMACOL EXP THER, V303, P487, DOI 10.1124/jpet.102.038315; Assaraf YG, 2006, DRUG RESIST UPDATE, V9, P227, DOI 10.1016/j.drup.2006.09.001; Atlas THP, PYR CARB; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; BLUM JL, 1989, ENVIRON HEALTH PERSP, V80, P71, DOI 10.2307/3430733; Breitzka R L, 1997, J Hum Lact, V13, P155, DOI 10.1177/089033449701300219; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Desrivieres S, 2003, MOL CELL PROTEOMICS, V2, P1039, DOI 10.1074/mcp.M300032-MCP200; European Food Safety Authority, 2011, EFSA Journal, V9, P2323; Gilchrist SE, 2010, FUND CLIN PHARMACOL, V24, P205, DOI 10.1111/j.1472-8206.2009.00760.x; Graber-Maier A, 2010, MOL PHARMACEUT, V7, P1618, DOI 10.1021/mp100040f; Hallen Ira Palminger, 1998, Natural Toxins, V6, P43, DOI 10.1002/(SICI)1522-7189(199802)6:1<43::AID-NT12>3.0.CO;2-4; Halwachs S, 2014, TOXICOL IN VITRO, V28, P432, DOI 10.1016/j.tiv.2013.12.015; Halwachs S, 2013, TOXICOL SCI, V131, P491, DOI 10.1093/toxsci/kfs304; Han LQ, 2010, GENET MOL RES, V9, P449, DOI 10.4238/vol9-1gmr724; Haug A, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-25; HYNES NE, 1990, MOL CELL BIOL, V10, P4027, DOI 10.1128/MCB.10.8.4027; Ito N, 2014, J PHARM SCI-US, V103, P3342, DOI 10.1002/jps.24138; Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186; Kindla J, 2011, CANCER BIOL THER, V11, P584, DOI 10.4161/cbt.11.6.14533; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kwok B, 2006, AM J PHYSIOL-REG I, V290, pR793, DOI 10.1152/ajpregu.00087.2005; LARSON BL, 1976, J DAIRY SCI, V59, P1881, DOI 10.3168/jds.S0022-0302(76)84457-8; Liu WJ, 2006, EXP BIOL MED, V231, P599; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maliepaard M, 2001, CANCER RES, V61, P3458; MARTE BM, 1994, CELL GROWTH DIFFER, V5, P239; Monzani PS, 2011, GENET MOL RES, V10, P604, DOI 10.4238/vol10-2gmr1034; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Ohlsson A, 2009, TOXICOL LETT, V191, P174, DOI 10.1016/j.toxlet.2009.08.020; OSKARSSON A, 1995, ANALYST, V120, P765, DOI 10.1039/an9952000765; Oskarsson A, 1998, ANALYST, V123, P19, DOI 10.1039/a705136k; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Shi HB, 2015, FUNCT INTEGR GENOMIC, V15, P309, DOI 10.1007/s10142-014-0420-1; Shukla S, 2007, MOL CANCER THER, V6, P3279, DOI 10.1158/1535-7163.MCT-07-0564; Tallkvist J, 2015, CELL BIOL TOXICOL, V31, P111, DOI 10.1007/s10565-015-9298-5; Tan KP, 2010, MOL PHARMACOL, V78, P175, DOI 10.1124/mol.110.065078; van Herwaarden AE, 2007, MOL CELL BIOL, V27, P1247, DOI 10.1128/MCB.01621-06; Vinggaard AM, 2006, INT J ANDROL, V29, P186, DOI 10.1111/j.1365-2605.2005.00604.x; Vinggaard AM, 2005, TOXICOL SCI, V85, P886, DOI 10.1093/toxsci/kfi150; Vlaming MLH, 2009, ADV DRUG DELIVER REV, V61, P14, DOI 10.1016/j.addr.2008.08.007; Zavizion B, 1996, IN VITRO CELL DEV-AN, V32, P138, DOI 10.1007/BF02723679	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151904	10.1371/journal.pone.0151904	http://dx.doi.org/10.1371/journal.pone.0151904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028005	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500032
J	Zhao, YC; Luo, J; Xu, S; Wang, W; Liu, TT; Han, C; Chen, YJ; Kong, LY				Zhao, Yucheng; Luo, Jun; Xu, Sheng; Wang, Wei; Liu, Tingting; Han, Chao; Chen, Yijun; Kong, Lingyi			Selection of Reference Genes for Gene Expression Normalization in Peucedanum praeruptorum Dunn under Abiotic Stresses, Hormone Treatments and Different Tissues	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; POLYMERASE-CHAIN-REACTION; INTERNAL CONTROL GENES; REAL-TIME PCR; TRANSCRIPT NORMALIZATION; HOUSEKEEPING GENES; VALIDATION; BIOSYNTHESIS; COUMARINS; MODEL	Peucedanum praeruptorum Dunn is one of the main traditional Chinese medicines producing coumarins and plenty of literatures are focused on the biosynthesis of coumarins. Quantitative real-time reverse transcription PCR (qRT-PCR) is a widely used method in studying the biosynthesis pathway and the selection of reference genes plays a crucial role in accurate normalization. To facilitate biosynthesis study of coumarins, twelve candidate reference genes were selected from the transcriptome database of P. praeruptorum according to previous studies. Then, BestKeeper, geNoFrm and NormFinder were used for selecting stably expressed reference genes in different tissues and under various stress treatments. The results indicated that, among the twelve candidate reference genes, the SAND family protein (SAND), actin 2 (ACT2), ubiquitin-conjugating enzyme 9 (UBC9), protein phosphatase 2A gene (PP2A) and polypyrimidine tract-binding protein (PTBP1) were the most stable reference genes under different experimental treatments, while glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and tubulin beta-6 (TUB6) were the least stable genes. In addition, the suitability of SAND, TIP41-like protein (TIP41), UBC9, ACT2, TUB6 and their combination as reference genes were confirmed by normalizing the expression of 1-aminocyclopropane-1-carboxylate oxidase (ACO) in different treatments. This work is the first survey of the stability of reference genes in P. praeruptorum and provides guidelines to obtain more accurate qRT-PCR results in P. praeruptorum and other plant species.	[Zhao, Yucheng; Luo, Jun; Wang, Wei; Liu, Tingting; Han, Chao; Chen, Yijun; Kong, Lingyi] China Pharmaceut Univ, Dept Nat Med Chem, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Xu, Sheng] Inst Bot, Nanjing, Jiangsu, Peoples R China; [Xu, Sheng] Chinese Acad Sci, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Chinese Academy of Sciences	Kong, LY (corresponding author), China Pharmaceut Univ, Dept Nat Med Chem, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	cpu_lykong@126.com	Chen, Yijun/H-3209-2019; liu, ting/GZM-3326-2022	Chen, Yijun/0000-0002-4920-152X; Luo, Jun/0000-0002-7892-011X	National Natural Science Foundation of China [81430092]; Program for New Century Excellent Talents in University [NCET-2013-1035]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University [IRT_15R63]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was supported in part by the National Natural Science Foundation of China (81430092), the Program for New Century Excellent Talents in University (NCET-2013-1035) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). This research was also supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT_15R63).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bourgaud F., 2006, Phytochemistry Reviews, V5, P293, DOI 10.1007/s11101-006-9040-2; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Cusick KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131015; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Ketelaere A, 2006, J DAIRY SCI, V89, P4066, DOI 10.3168/jds.S0022-0302(06)72450-X; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Hou ZG, 2010, SEP PURIF TECHNOL, V75, P132, DOI 10.1016/j.seppur.2010.08.007; Huang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093724; Ishikawa A, 2009, PLANT CELL REP, V28, P257, DOI 10.1007/s00299-008-0631-9; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Karamat F, 2014, PLANT J, V77, P627, DOI 10.1111/tpj.12409; Kawai Y, 2014, PLANT J, V78, P328, DOI 10.1111/tpj.12479; Kong LY, 1996, PHYTOCHEMISTRY, V41, P1423, DOI 10.1016/0031-9422(95)00783-0; Kumar A, 2009, BIOORG MED CHEM LETT, V19, P6447, DOI 10.1016/j.bmcl.2009.09.031; Larbat R, 2009, J BIOL CHEM, V284, P4776, DOI 10.1074/jbc.M807351200; Leal MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133323; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li CQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00439; Li DH, 2015, PLANT CELL PHYSIOL, V56, P843, DOI 10.1093/pcp/pcv008; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Li XS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00038; Lin YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095445; Lin YH, 2013, METAB ENG, V18, P69, DOI 10.1016/j.ymben.2013.04.004; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Nakashima A, 2013, FEBS LETT, V587, P2924, DOI 10.1016/j.febslet.2013.07.027; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Pollier J, 2014, PLANT PHYSIOL BIOCH, V83, P20, DOI 10.1016/j.plaphy.2014.07.004; Qua Y, 2015, P NATL ACAD SCI USA, V112, P6224, DOI 10.1073/pnas.1501821112; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sun YZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-533; Tian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117569; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verbeke J, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0197-9; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wan XL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00519; Wang HJ, 2015, EXP MOL PATHOL, V98, P375, DOI 10.1016/j.yexmp.2014.10.014; Wu JYC, 2003, EUR J PHARMACOL, V473, P9, DOI 10.1016/S0014-2999(03)01946-0; Xiao L, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00388, 10.3389/fpls.2014.00788]; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yu PJ, 2012, INFLAMMATION, V35, P967, DOI 10.1007/s10753-011-9400-y; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhao YC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00996; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zhuang HH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00475	60	39	40	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152356	10.1371/journal.pone.0152356	http://dx.doi.org/10.1371/journal.pone.0152356			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022972	gold, Green Published			2022-12-26	WOS:000373113900048
J	Fowler, DB; N'Diaye, A; Laudencia-Chingcuanco, D; Pozniak, CJ				Fowler, D. B.; N'Diaye, A.; Laudencia-Chingcuanco, D.; Pozniak, C. J.			Quantitative Trait Loci Associated with Phenological Development, Low-Temperature Tolerance, Grain Quality, and Agronomic Characters in Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							DOUBLED HAPLOID POPULATION; CONSENSUS GENETIC MAPS; WINTER-WHEAT; FROST-TOLERANCE; IDENTIFICATION; YIELD; VERNALIZATION; SELECTION; WINTERHARDINESS; REGISTRATION	Plants must respond to environmental cues and schedule their development in order to react to periods of abiotic stress and commit fully to growth and reproduction under favorable conditions. This study was initiated to identify SNP markers for characters expressed from the seedling stage to plant maturity in spring and winter wheat (Triticum aestivum L.) genotypes adapted to western Canada. Three doubled haploid populations with the winter cultivar 'Norstar' as a common parent were developed and genotyped with a 90K Illumina iSelect SNP assay and a 2,998.9 cM consensus map with 17,541 markers constructed. High heritability's reflected large differences among the parents and relatively low genotype by environment interactions for all characters considered. Significant QTL were detected for the 15 traits examined. However, different QTL for days to heading in controlled environments and the field provided a strong reminder that growth and development are being orchestrated by environmental cues and caution should be exercised when extrapolating conclusions from different experiments. A QTL on chromosome 6A for minimum final leaf number, which determines the rate of phenological development in the seedling stage, was closely linked to QTL for low-temperature tolerance, grain quality, and agronomic characters expressed up to the time of maturity. This suggests phenological development plays a critical role in programming subsequent outcomes for many traits. Transgressive segregation was observed for the lines in each population and QTL with additive effects were identified suggesting that genes for desirable traits could be stacked using Marker Assisted Selection. QTL were identified for characters that could be transferred between the largely isolated western Canadian spring and winter wheat gene pools demonstrating the opportunities offered by Marker Assisted Selection to act as bridges in the identification and transfer of useful genes among related genetic islands while minimizing the drag created by less desirable genes.	[Fowler, D. B.; N'Diaye, A.; Pozniak, C. J.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK S7N 5A8, Canada; [Fowler, D. B.; N'Diaye, A.; Pozniak, C. J.] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK S7N 5A8, Canada; [Laudencia-Chingcuanco, D.] USDA ARS WRRC, Crop Improvement & Genet Res Unit, 800 Buchanan St, Albany, CA 94710 USA	University of Saskatchewan; University of Saskatchewan; United States Department of Agriculture (USDA)	Fowler, DB (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK S7N 5A8, Canada.; Fowler, DB (corresponding author), Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK S7N 5A8, Canada.	Brian.Fowler@usask.ca		N'Diaye, Amidou/0000-0001-7769-7801; Laudencia-Chingcuanco, Debbie/0000-0002-9192-8255; Fowler, David Brian/0000-0002-2692-3116	Ducks Unlimited Canada; Saskatchewan Agriculture and Food; Genome Canada	Ducks Unlimited Canada; Saskatchewan Agriculture and Food; Genome Canada(Genome Canada)	Ducks Unlimited Canada, Saskatchewan Agriculture and Food, and Genome Canada provided long-term financial support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baga M, 2007, FUNCT INTEGR GENOMIC, V7, P53, DOI 10.1007/s10142-006-0030-7; Baga M, 2009, J EXP BOT, V60, P3575, DOI 10.1093/jxb/erp199; BAUER A, 1984, AGRON J, V76, P829, DOI 10.2134/agronj1984.00021962007600050027x; Bogard M, 2013, MOL BREEDING, V31, P587, DOI 10.1007/s11032-012-9817-5; Borojevic K, 2005, J HERED, V96, P455, DOI 10.1093/jhered/esi060; BRULEBABEL AL, 1988, CROP SCI, V28, P879, DOI 10.2135/cropsci1988.0011183X002800060001x; CAMPBELL AB, 1967, CROP SCI, V7, P406, DOI 10.2135/cropsci1967.0011183X000700040058x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cui F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-57; Duggan BL, 2006, CROP SCI, V46, P1479, DOI 10.2135/cropsci2005.06-0126; ENTZ MH, 1988, AGRON J, V80, P987, DOI 10.2134/agronj1988.00021962008000060030x; FAO, 2013, STAT YB 2013 WORLD 3, P123; FISHER JE, 1973, CAN J PLANT SCI, V53, P7, DOI 10.4141/cjps73-002; Fowler DB, 2014, CROP SCI, V54, P2395, DOI 10.2135/cropsci2014.03.0196; Fowler DB, 2008, CROP SCI, V48, P1147, DOI 10.2135/cropsci2007.10.0581; Fowler DB, 1996, CAN J PLANT SCI, V76, P37, DOI 10.4141/cjps96-007; FOWLER DB, 1983, CAN J PLANT SCI, V63, P109, DOI 10.4141/cjps83-010; Fowler DB, 1999, CROP SCI, V39, P626, DOI 10.2135/cropsci1999.0011183X003900020002x; FOWLER DB, 1981, CROP SCI, V21, P896, DOI 10.2135/cropsci1981.0011183X002100060023x; Fowler DB, 1996, THEOR APPL GENET, V93, P554, DOI 10.1007/BF00417947; FOWLER DB, 1979, CROP SCI, V19, P769, DOI 10.2135/cropsci1979.0011183X001900060005x; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Gao LF, 2004, THEOR APPL GENET, V108, P1392, DOI 10.1007/s00122-003-1554-z; GILLILAND DJ, 1988, CAN J PLANT SCI, V68, P301, DOI 10.4141/cjps88-040; GRANT MN, 1980, CROP SCI, V20, P552, DOI 10.2135/cropsci1980.0011183X002000040042x; Groos C, 2002, THEOR APPL GENET, V104, P39, DOI 10.1007/s001220200004; Heidari B, 2011, GENOME, V54, P517, DOI [10.1139/g11-017, 10.1139/G11-017]; Jackson BN, 2008, IEEE ACM T COMPUT BI, V5, P161, DOI 10.1109/TCBB.2007.70221; Jackson BN, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P35, DOI 10.1109/CSB.2005.26; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Laudencia-Chingcuanco D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-299; LAURIE DA, 1991, PLANT BREEDING, V106, P182, DOI 10.1111/j.1439-0523.1991.tb00499.x; Limin AE, 2002, ANN BOT-LONDON, V89, P579, DOI 10.1093/aob/mcf102; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; McMaster GS, 1997, ADV AGRON, V59, P63, DOI 10.1016/S0065-2113(08)60053-X; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Pearson CJ, 1984, CONTROL CROP PRODUCT, P91; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Raman R, 2009, GENOME, V52, P701, DOI [10.1139/G09-045, 10.1139/g09-045]; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sosnowski O, 2012, BIOINFORMATICS, V28, P2082, DOI 10.1093/bioinformatics/bts313; SUTKA J, 1989, EUPHYTICA, V42, P41, DOI 10.1007/BF00042613; Vagujfalvi A, 2003, MOL GENET GENOMICS, V269, P60, DOI 10.1007/s00438-003-0806-6; Verma V, 2005, PLANT BREEDING, V124, P234, DOI 10.1111/j.1439-0523.2005.01070.x; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu YH, 2011, IEEE ACM T COMPUT BI, V8, P381, DOI 10.1109/TCBB.2010.35; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xue SL, 2008, THEOR APPL GENET, V117, P181, DOI 10.1007/s00122-008-0764-9; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yap IV, 2003, GENETICS, V165, P2235; Zanke C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00217; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x	62	34	36	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152185	10.1371/journal.pone.0152185	http://dx.doi.org/10.1371/journal.pone.0152185			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019468	Green Published, gold, Green Submitted			2022-12-26	WOS:000372807800031
J	Sacristan, HJ; Ansaldo, M; Franco-Tadic, LM; Gimenez, AVF; Greco, LSL				Javier Sacristan, Hernan; Ansaldo, Martin; Marcelo Franco-Tadic, Luis; Fernandez Gimenez, Analia Veronica; Lopez Greco, Laura Susana			Long-Term Starvation and Posterior Feeding Effects on Biochemical and Physiological Responses of Midgut Gland of Cherax quadricarinatus Juveniles (Parastacidae)	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; DIGESTIVE ENZYME-ACTIVITIES; WHITE SHRIMP; OXIDATIVE STRESS; REDCLAW CRAYFISH; HIGH-PROTEIN; HEPATOPANCREAS STRUCTURE; REPRODUCTIVE-SYSTEM; ANTIOXIDANT STATUS; PALAEMON-SERRATUS	We investigated the effect of long-term starvation and posterior feeding on energetic reserves, oxidative stress, digestive enzymes, and histology of C. quadricarinatus midgut gland. The crayfish (6.27 g) were randomly assigned to one of three feeding protocols: continuous feeding throughout 80 day, continuous starvation until 80 day, and continuous starvation throughout 50 day and then feeding for the following 30 days. Juveniles from each protocol were weighed, and sacrificed at day 15, 30, 50 or 80. The lipids, glycogen, reduced glutathione (GSH), soluble protein, lipid peroxidation (TBARS), protein oxidation (PO), catalase (CAT), lipase and proteinase activities, and histology were measured on midgut gland. Starved crayfish had a lower hepatosomatic index, number ofmolts, specific growth rate, lipids, glycogen, and GSH levels than fed animals at all assay times. The starvation did not affect the soluble protein, TBARS, PO levels and CAT. In starved juveniles the lipase activity decreased as starvation time increased, whereas proteinase activity decreased only at day 80. The histological analysis of the starved animals showed several signs of structural alterations. After 30 days of feeding, the starved-feeding animals exhibited a striking recovery of hepatosomatic index, number of molts, lipids and glycogen, GSH, lipase activity andmidgut gland structure.	[Javier Sacristan, Hernan; Marcelo Franco-Tadic, Luis; Lopez Greco, Laura Susana] Univ Buenos Aires, Biol Reprod & Growth Crustaceans, Dept Biodivers & Expt Biol, Buenos Aires, DF, Argentina; [Javier Sacristan, Hernan; Lopez Greco, Laura Susana] CONICET UBA, IBBEA, Buenos Aires, DF, Argentina; [Ansaldo, Martin] Argentinian Antarctic Inst, Ecophysiol & Ecotoxicol Lab, Buenos Aires, DF, Argentina; [Fernandez Gimenez, Analia Veronica] Univ Mar del Plata, CONICET, Inst Marine & Coastal Res, Physiol Aquat Organisms, Mar Del Plata, Buenos Aires, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata	Greco, LSL (corresponding author), Univ Buenos Aires, Biol Reprod & Growth Crustaceans, Dept Biodivers & Expt Biol, Buenos Aires, DF, Argentina.; Greco, LSL (corresponding author), CONICET UBA, IBBEA, Buenos Aires, DF, Argentina.	laura@bg.fcen.uba.ar		Franco Tadic, Luis Marcelo/0000-0002-2986-5628; Sacristan, Hernan/0000-0003-2331-8487; Fernandez-Gimenez, Analia/0000-0001-9232-4560	Agencia Nacional de Promocion Cientifica y Tecnologica (PICT) [01333]; CONICET (PIP) [129]; UBACYT [2011-2014 20020100100003, 2014-2017 020130100186BA]; MINCYT-CONACYT (Mexico) [MX/09/07]; MINCYT- CAPES [BR/11/21]; ANPCYT; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica (PICT)(ANPCyT); CONICET (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACYT; MINCYT-CONACYT (Mexico); MINCYT- CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ANPCYT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2012 project 01333), CONICET (PIP 2009-2011, number 129 and PIP 2012-2014), UBACYT (projects 2011-2014 20020100100003 and 2014-2017 020130100186BA), MINCYT-CONACYT (Mexico) MX/09/07 and MINCYT- CAPES BR/11/21.; This study is part of Hernan Javier Sacristan's postgraduate scholarships (ANPCYT and CONICET) and Ph.D. dissertation (University of Buenos Aires, Argentina). We are grateful to Lic. Amir Dyzenchauz for language revision, and to Centro Nacional de Desarrollo Acuicola (CENADAC, Argentina) for providing the reproductive stock. Laura S. Lopez Greco is grateful to Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2012 project 01333), CONICET (PIP 2009-2011, number 129 and PIP 2012-2014), UBACYT (projects 2011-2014 20020100100003 and 2014-2017 20020130100186BA), MINCYT-CONACYT (Mexico) MX/09/07 and MINCYT-CAPES BR/11/21 that funded this research.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Almeida EA, 2005, J EXP MAR BIOL ECOL, V318, P21, DOI 10.1016/j.jembe.2004.12.007; ALMOHANNA S, 1987, J MAR BIOL ASSOC UK, V67, P803, DOI 10.1017/S0025315400057040; Ansaldo M, 2007, COMP BIOCHEM PHYS C, V146, P118, DOI 10.1016/j.cbpc.2006.11.004; BARCLAY MC, 1983, J EXP MAR BIOL ECOL, V68, P229, DOI 10.1016/0022-0981(83)90055-2; BENUCK M, 1995, BRAIN RES, V678, P259, DOI 10.1016/0006-8993(95)00204-4; BIESIOT PM, 1990, COMP BIOCHEM PHYS A, V95, P47, DOI 10.1016/0300-9629(90)90008-G; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buege J A, 1978, Methods Enzymol, V52, P302; Bugnot AB, 2009, AQUACULTURE, V295, P292, DOI 10.1016/j.aquaculture.2009.07.021; Calvo NS, 2013, AQUACULTURE, V416, P85, DOI 10.1016/j.aquaculture.2013.08.017; Calvo NS, 2012, AQUAT BIOL, V16, P287, DOI 10.3354/ab00451; Calvo NS, 2011, AQUACULTURE, V319, P355, DOI 10.1016/j.aquaculture.2011.06.033; Comoglio L, 2008, REV BIOL MAR OCEANOG, V43, P345; Comoglio LI, 2004, J SHELLFISH RES, V23, P243; Diaz AC, 2010, BRAZ ARCH BIOL TECHN, V53, P599, DOI 10.1590/S1516-89132010000300013; Cuzon G., 1980, Proceedings of the Annual Meeting of the World Mariculture Society, V11, P410; Fagan JM, 1999, INT J BIOCHEM CELL B, V31, P751, DOI 10.1016/S1357-2725(99)00034-5; Gimenez AVF, 2009, ISR J AQUACULT-BAMID, V61, P48; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRINGS CS, 1970, AM J CLIN PATHOL, V53, P89; GARCIACARRENO FL, 1992, COMP BIOCHEM PHYS B, V103, P575, DOI 10.1016/0305-0491(92)90373-Y; Gillespie J, 1990, AUST FISH, V49, P2; GU HN, 1994, AQUACULTURE, V123, P249, DOI 10.1016/0044-8486(94)90063-9; Halliwell B.G.J.M.C., 2007, FREE RADICALS BIOL M; Hermes-Lima M., 2004, FUNCTIONAL METABOLIS, P319, DOI DOI 10.1002/047167558X.CH12; Hernandez-Cortes P., 1999, Journal of Applied Aquaculture, V9, P35, DOI 10.1300/J028v09n01_03; Hidalgo MC, 2002, INT J BIOCHEM CELL B, V34, P183, DOI 10.1016/S1357-2725(01)00105-4; Icely J.D., 1992, P147; Jones CM, 1995, AQUACULTURE, V138, P221, DOI 10.1016/0044-8486(95)00068-2; Jones PL, 2000, J CRUSTACEAN BIOL, V20, P431, DOI 10.1651/0278-0372(2000)020[0431:EOSASR]2.0.CO;2; Levi T, 1999, J CRUSTACEAN BIOL, V19, P477, DOI 10.2307/1549256; Li EC, 2008, AQUACULTURE, V274, P80, DOI 10.1016/j.aquaculture.2007.11.001; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Greco LSL, 2007, ACTA ZOOL-STOCKHOLM, V88, P223, DOI 10.1111/j.1463-6395.2007.00269.x; Lopez Greco LS, 2011, P 1 JORN CIENC MORF; Lopez-Lopez S, 2005, AQUACULT NUTR, V11, P79, DOI 10.1111/j.1365-2095.2004.00305.x; LOYAJAVELLANA GN, 1995, AQUACULTURE, V134, P295, DOI 10.1016/0044-8486(95)00050-C; Fanjul-Moles ML, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P208; MENDEZ G, 1993, ENVIRON BIOL FISH, V36, P73, DOI 10.1007/BF00005981; Merrick J.R., 1991, YABBY MARRON RED CLA; Morales AE, 2004, COMP BIOCHEM PHYS C, V139, P153, DOI 10.1016/j.cca.2004.10.008; Morales AE, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P281; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Muhlia-Almazan A, 2002, COMP BIOCHEM PHYS B, V133, P383, DOI 10.1016/S1096-4959(02)00163-X; NEILAND KENNETH A., 1953, PHYSIOL COMP ET OECOL, V3, P321; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira GT, 2004, COMP BIOCHEM PHYS A, V137, P383, DOI 10.1016/j.cbpb.2003.10.017; Ong BL, 2006, J SHELLFISH RES, V25, P113, DOI 10.2983/0730-8000(2006)25[113:IOFOHS]2.0.CO;2; Papadopoulos MC, 1997, BRAIN RES, V748, P151, DOI 10.1016/S0006-8993(96)01293-0; PAPATHANASSIOU E, 1984, COMP BIOCHEM PHYS A, V77, P243, DOI 10.1016/0300-9629(84)90055-0; Pascual C, 2006, AQUACULTURE, V251, P416, DOI 10.1016/j.aquaculture.2005.06.001; Pascual C, 2003, AQUACULTURE, V218, P637, DOI 10.1016/S0044-8486(02)00300-9; Reynolds J. D., 2002, P152; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rivera-Perez C, 2011, MAR GENOM, V4, P273, DOI 10.1016/j.margen.2011.07.002; Rivera-Perez C, 2011, MAR BIOTECHNOL, V13, P284, DOI 10.1007/s10126-010-9298-7; Robinson MK, 1997, J SURG RES, V69, P325, DOI 10.1006/jsre.1997.5062; Sacristan HJ, 2015, AQUAT BIOL, V23, P87, DOI 10.3354/ab00611; Sacristan HJ, 2011, P 1 JORN CIENC MORF; Sainz JC, 2004, J CRUSTACEAN BIOL, V24, P266, DOI 10.1651/C-2423; De Bock MS, 2010, AQUACULT INT, V18, P231, DOI 10.1007/s10499-008-9239-x; Sanchez-Paz A, 2006, INSECT BIOCHEM MOLEC, V36, P241, DOI 10.1016/j.ibmb.2006.01.002; SIES H, 1986, ANGEW CHEM INT EDIT, V25, P1058, DOI 10.1002/anie.198610581; SMITH DM, 1991, MAR BIOL, V110, P85, DOI 10.1007/BF01313095; STORCH V, 1983, HELGOLANDER MEERESUN, V36, P67, DOI 10.1007/BF01995796; Stuck KC, 1996, MAR BIOL, V125, P33, DOI 10.1007/BF00350758; Stumpf L, 2014, AQUACULTURE, V433, P404, DOI 10.1016/j.aquaculture.2014.06.037; Stumpf L, 2011, AQUACULTURE, V319, P98, DOI 10.1016/j.aquaculture.2011.06.029; Stumpf L, 2010, AQUACULTURE, V304, P34, DOI 10.1016/j.aquaculture.2010.03.011; Tropea C, 2010, AQUACULTURE, V302, P49, DOI 10.1016/j.aquaculture.2010.01.027; VANWORMHOUDT A, 1974, COMP BIOCHEM PHYSIOL, V49, P707, DOI 10.1016/0300-9629(74)90899-8; Vazquez FJ, 2008, INVERTEBR BIOL, V127, P433, DOI 10.1111/j.1744-7410.2008.00148.x; Vendemiale G, 2001, HEPATOLOGY, V33, P808, DOI 10.1053/jhep.2001.23060; VERSAW WK, 1989, J FOOD SCI, V54, P1557, DOI 10.1111/j.1365-2621.1989.tb05159.x; Vijayavel K, 2004, MAR POLLUT BULL, V48, P429, DOI 10.1016/j.marpolbul.2003.08.017; VINAGRE AS, 1992, COMP BIOCHEM PHYS A, V102, P579, DOI 10.1016/0300-9629(92)90213-A; VOGT G, 1986, AQUACULTURE, V59, P209, DOI 10.1016/0044-8486(86)90005-0; WHYTE JNC, 1986, CAN J FISH AQUAT SCI, V43, P1142, DOI 10.1139/f86-142; Yudkovski Y, 2007, INSECT MOL BIOL, V16, P661, DOI 10.1111/j.1365-2583.2007.00762.x; Zar J.H., 2010, BIOSTAT ANAL; Zhang PD, 2010, AQUACULT INT, V18, P1191, DOI 10.1007/s10499-010-9333-8; Zuur Alain F., 2009, P1	85	43	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0150854	10.1371/journal.pone.0150854	http://dx.doi.org/10.1371/journal.pone.0150854			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018793	Green Published, gold, Green Submitted			2022-12-26	WOS:000372807800007
J	Luo, H; Xiao, SJ; Ye, H; Zhang, ZS; Lv, CH; Zheng, SM; Wang, ZY; Wang, XQ				Luo, Hui; Xiao, Shijun; Ye, Hua; Zhang, Zhengshi; Lv, Changhuan; Zheng, Shuming; Wang, Zhiyong; Wang, Xiaoqing			Identification of Immune-Related Genes and Development of SSR/SNP Markers from the Spleen Transcriptome of Schizothorax prenanti	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; PATHOGEN RECOGNITION; EXPRESSION ANALYSIS; PROFILING ANALYSIS; COMPLEMENT-SYSTEM; MOLECULAR-CLONING; TISSUE EXPRESSION; ANALYSIS REVEALS; INNATE IMMUNITY; CXC CHEMOKINE	Schizothorax prenanti (S. prenanti) is mainly distributed in the upstream regions of the Yangtze River and its tributaries in China. This species is indigenous and commercially important. However, in recent years, wild populations and aquacultures have faced the serious challenges of germplasm variation loss and an increased susceptibility to a range of pathogens. Currently, the genetics and immune mechanisms of S. prenanti are unknown, partly due to a lack of genome and transcriptome information. Here, we sought to identify genes related to immune functions and to identify molecular markers to study the function of these genes and for trait mapping. To this end, the transcriptome from spleen tissues of S. prenanti was analyzed and sequenced. Using paired-end reads from the Illumina Hiseq2500 platform, 48,517 transcripts were isolated from the spleen transcriptome. These transcripts could be clustered into 37,785 unigenes with an N50 length of 2,539 bp. The majority of the unigenes (35,653, 94.4%) were successfully annotated using non-redundant nucleotide sequence analysis (nt), and the non-redundant protein (nr), Swiss-Prot, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. KEGG pathway assignment identified more than 500 immune-related genes. Furthermore, 7,545 putative simple sequence repeats (SSRs), 857,535 single nucleotide polymorphisms (SNPs), and 53,481 insertion/deletion (InDels) were detected from the transcriptome. This is the first reported high-throughput transcriptome analysis of S. prenanti, and it provides valuable genetic resources for the investigation of immune mechanisms, conservation of germplasm, and molecular marker-assisted breeding of S. prenanti.	[Luo, Hui; Wang, Xiaoqing] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China; [Luo, Hui; Ye, Hua; Zhang, Zhengshi; Zheng, Shuming] Southwest Univ, Fisheries Breeding & Hlth Cultivat Res Ctr, Chongqing, Peoples R China; [Luo, Hui; Xiao, Shijun; Lv, Changhuan; Wang, Zhiyong] Jimei Univ, Coll Fisheries, Minist Agr, Key Lab Hlth Mariculture East China Sea, Xiamen, Fujian, Peoples R China; [Luo, Hui; Wang, Xiaoqing] Collaborat Innovat Ctr Efficient & Hlth Prod Fish, Changde, Hunan, Peoples R China	Hunan Agricultural University; Southwest University - China; Jimei University; Ministry of Agriculture & Rural Affairs	Wang, XQ (corresponding author), Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China.; Zheng, SM (corresponding author), Southwest Univ, Fisheries Breeding & Hlth Cultivat Res Ctr, Chongqing, Peoples R China.; Wang, ZY (corresponding author), Jimei Univ, Coll Fisheries, Minist Agr, Key Lab Hlth Mariculture East China Sea, Xiamen, Fujian, Peoples R China.; Wang, XQ (corresponding author), Collaborat Innovat Ctr Efficient & Hlth Prod Fish, Changde, Hunan, Peoples R China.	zhsm199@163.com; zywang@jmu.edu.cn; wangxiao@hunau.net	luo, hui/D-2425-2017	luo, hui/0000-0003-1522-5002	National Natural Science Foundation of China [31402302, U1205122]; Scientific Research Fund of Hunan Provincial Education Department [15A087]; Fundamental Research Funds for the Central Universities [XDJK2015C034, XDJK2014C152]; Southwest university Rongchang campus [20700208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Southwest university Rongchang campus	This research was supported by the National Natural Science Foundation of China (31402302, U1205122), Scientific Research Fund of Hunan Provincial Education Department (15A087), Fundamental Research Funds for the Central Universities (XDJK2015C034, XDJK2014C152), and the project Supported by Scientific research initiation project aided by special fund, Southwest university Rongchang campus (20700208). The authors thank Meishan Aquaculture Company for providing S. prenanti. Thanks also to Lingbing Zeng, in Yangtze River Fisheries Research Institute Chinese Academy of Fishery Sciences, and Bin Chen, in College of Animal Science & Technology, Hunan Agricultural University, for providing constructive suggestions on experiments.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ali A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00348; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao BL, 2006, DEV COMP IMMUNOL, V30, P783, DOI 10.1016/j.dci.2005.10.007; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Lanes CFC, 2013, MAR BIOTECHNOL, V15, P677, DOI 10.1007/s10126-013-9527-y; Chapman RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096818; Che RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094046; Chen X, 2015, MAR BIOTECHNOL, V17, P190, DOI 10.1007/s10126-014-9607-7; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092502; [代应贵 Dai Yinggui], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P38; Ding R., 1994, FISHES SICHUAN; Dodds AW, 1998, IMMUNOL REV, V166, P15; [杜宗君 DU Zongjun], 2011, [四川农业大学学报, Journal of Sichuan Agricultural University], V29, P274; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Geng Y, 2012, TRANSBOUND EMERG DIS, V59, P369, DOI 10.1111/j.1865-1682.2011.01280.x; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo H, 2013, FISH SHELLFISH IMMUN, V35, P2008, DOI 10.1016/j.fsi.2013.09.019; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; He DK, 2004, CHINESE SCI BULL, V49, P39, DOI 10.1360/03wc0212; Huang QS, 2012, AQUAT TOXICOL, V120, P54, DOI 10.1016/j.aquatox.2012.04.013; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Li CJ, 2015, GENE, V557, P201, DOI 10.1016/j.gene.2014.12.034; Li CJ, 2011, MOL BIOL REP, V38, P4595, DOI 10.1007/s11033-010-0592-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang JJ, 2011, BIOCHEM SYST ECOL, V39, P361, DOI 10.1016/j.bse.2011.05.005; Liu Y, 2007, FISH SHELLFISH IMMUN, V23, P711, DOI 10.1016/j.fsi.2007.01.008; Luo Hui, 2015, Journal of Fisheries of China, V39, P598; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MULLEREBERHARD HJ, 1985, J INVEST DERMATOL, V85, pS47; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nakao M, 2011, DEV COMP IMMUNOL, V35, P1296, DOI 10.1016/j.dci.2011.03.003; Nakasugi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091776; Tran NT, 2015, FISH SHELLFISH IMMUN, V45, P72, DOI 10.1016/j.fsi.2015.01.034; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Pope MR, 2010, MOL IMMUNOL, V48, P356, DOI 10.1016/j.molimm.2010.07.004; Rebl A, 2014, MAR BIOTECHNOL, V16, P333, DOI 10.1007/s10126-013-9552-x; Rebl A, 2013, MAR BIOTECHNOL, V15, P445, DOI 10.1007/s10126-013-9501-8; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Roozendaal R, 2006, CELL, V125, P29, DOI 10.1016/j.cell.2006.03.018; Sellars MJ, 2015, MAR BIOTECHNOL, V17, P252, DOI 10.1007/s10126-015-9613-4; Song J, 2006, ENVIRON BIOL FISH, V77, P79, DOI 10.1007/s10641-006-9056-x; Takano T., 2011, DIS ASIAN AQUACULTUR, VVII; Tong C, 2015, FISH SHELLFISH IMMUN, V46, P366, DOI 10.1016/j.fsi.2015.06.025; Ulloa PE, 2015, MAR BIOTECHNOL, V17, P353, DOI 10.1007/s10126-015-9624-1; Vera M, 2013, INT J MOL SCI, V14, P5694, DOI 10.3390/ijms14035694; Wan X, 2009, VET IMMUNOL IMMUNOP, V127, P156, DOI 10.1016/j.vetimm.2008.09.009; Wang RJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-929; Wang T, 2014, FISH PHYSIOL BIOCHEM, V40, P1407, DOI 10.1007/s10695-014-9935-6; Wu JY, 2013, CONSERV GENET RESOUR, V5, P891, DOI 10.1007/s12686-013-9926-4; Wu JY, 2013, CONSERV GENET RESOUR, V5, P545, DOI 10.1007/s12686-012-9848-6; Wu Y, 1992, FISHES QINGHAI XIZAN; Xia JH, 2014, AQUACULTURE, V432, P67, DOI 10.1016/j.aquaculture.2014.04.028; Xiao SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124432; Yang LD, 2015, GENOME BIOL EVOL, V7, P251, DOI 10.1093/gbe/evu279; Yang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-33; [叶华 Ye Hua], 2014, [淡水渔业, Freshwater Fisheries], V44, P14; Yuan DY, 2014, REGUL PEPTIDES, V190, P32, DOI 10.1016/j.regpep.2014.03.004; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang RY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09780; Zhang X, 2015, FISH SHELLFISH IMMUN, V43, P209, DOI 10.1016/j.fsi.2014.11.018; Zhang X, 2015, ENVIRON BIOL FISH, V98, P261, DOI 10.1007/s10641-014-0257-4; Zhu LY, 2013, DEV COMP IMMUNOL, V39, P39, DOI 10.1016/j.dci.2012.04.001	69	24	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152572	10.1371/journal.pone.0152572	http://dx.doi.org/10.1371/journal.pone.0152572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019203	Green Published, gold, Green Submitted			2022-12-26	WOS:000372807800060
J	Soubeyrand, S; Martinuk, A; Lau, P; McPherson, R				Soubeyrand, Sebastien; Martinuk, Amy; Lau, Paulina; McPherson, Ruth			TRIB1 Is Regulated Post-Transcriptionally by Proteasomal and Non-Proteasomal Pathways	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; LIVER-CANCER CELLS; MESSENGER-RNA; HEPATIC LIPOGENESIS; JAPANESE PATIENTS; MULTIPLE-MYELOMA; C/EBP-ALPHA; BETA-TRCP; TRIBBLES; PROTEIN	The TRIB1 gene has been associated with multiple malignancies, plasma triglycerides and coronary artery disease (CAD). Despite the clinical significance of this pseudo-kinase, there is little information on the regulation of TRIB1. Previous studies reported TRIB1 mRNA to be unstable, hinting that TRIB1 might be subject to post-transcriptional regulation. This work explores TRIB1 regulation, focusing on its post-transcriptional aspects. In 3 distinct model systems (HEK293T, HeLa and arterial smooth muscle cells) TRIB1 was undetectable as assessed by western blot. Using recombinant TRIB1 as a proxy, we demonstrate TRIB1 to be highly unstable at the protein and RNA levels. By contrast, recombinant TRIB1 was stable in cellular extracts. Blocking proteasome function led to increased protein steady state levels but failed to rescue protein instability, demonstrating that the 2 processes are uncoupled. Unlike as shown for TRIB2, CUL1 and TRCP beta did not play a role in mediating TRIB1 instability although TRCP beta suppression increased TRIB1 expression. Lastly, we demonstrate that protein instability is independent of TRIB1 subcellular localization. Following the identification of TRIB1 nuclear localization signal, a cytosolic form was engineered. Despite being confined to the cytosol, TRIB1 remained unstable, suggesting that instability occurs at a stage that precedes its nuclear translocation and downstream nuclear function. These results uncover possible avenues of intervention to regulate TRIB1 function by identifying two distinct regulatory axes that control TRIB1 at the post-transcriptional level.	[Soubeyrand, Sebastien; Martinuk, Amy; Lau, Paulina; McPherson, Ruth] Univ Ottawa, Inst Heart, Atherogen Lab, Ottawa, ON, Canada; [McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute	Soubeyrand, S; McPherson, R (corresponding author), Univ Ottawa, Inst Heart, Atherogen Lab, Ottawa, ON, Canada.; McPherson, R (corresponding author), Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada.	ssoubeyrand@ottawaheart.ca; rmcpherson@ottawaheart.ca		soubeyrand, sebastien/0000-0002-9317-301X	Heart & Stroke Foundation of Canada [T-7268]	Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was supported by the Heart & Stroke Foundation of Canada # T-7268, http://www.hsf.ca/research/en/personnel-award-programs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bailey FP, 2015, BIOCHEM J, V467, P47, DOI 10.1042/BJ20141441; Bauer RC, 2015, BIOCHEM SOC T, V43, P1079, DOI 10.1042/BST20150101; Bauer RC, 2015, J CLIN INVEST, V125, P3809, DOI 10.1172/JCI77095; Bozaykut P, 2014, FREE RADICAL BIO MED, V77, P195, DOI 10.1016/j.freeradbiomed.2014.08.012; Briffa R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144708; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Dedhia PH, 2010, BLOOD, V116, P1321, DOI 10.1182/blood-2009-07-229450; Douvris A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000884; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Huch S, 2014, WIRES RNA, V5, P747, DOI 10.1002/wrna.1244; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishizuka Y, 2014, J MOL ENDOCRINOL, V52, P145, DOI 10.1530/JME-13-0243; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kiss-Toth E, 2006, CELL SIGNAL, V18, P202, DOI 10.1016/j.cellsig.2005.04.012; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; Lin ZY, 2014, INT J CANCER, V135, P541, DOI 10.1002/ijc.28707; Lohan F, 2013, BIOCHEM SOC T, V41, P1096, DOI 10.1042/BST20130105; Mashima T, 2014, CANCER RES, V74, P4888, DOI 10.1158/0008-5472.CAN-13-3718; Murphy JM, 2015, STRUCTURE, V23, P2111, DOI 10.1016/j.str.2015.08.017; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Ogawa Y, 2008, CANCER SCI, V99, P140, DOI 10.1111/j.1349-7006.2007.00638.x; Prudente S, 2013, BLOOD, V282, P122, DOI [10.1507/endocrj.K07E-110, DOI 10.1507/ENDOCRJ.KO7E-110]; Qiao YX, 2013, BIOCHEM BIOPH RES CO, V441, P555, DOI 10.1016/j.bbrc.2013.10.123; Richter JD, 2015, CELL, V163, P292, DOI 10.1016/j.cell.2015.09.041; Rorth P, 2000, MOL CELL, V6, P23; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Soubeyrand S, 2016, BBA-MOL BASIS DIS, V1862, P223, DOI 10.1016/j.bbadis.2015.12.003; Soubeyrand S, 2013, BBA-MOL CELL RES, V1833, P3405, DOI 10.1016/j.bbamcr.2013.10.001; Sung HY, 2007, J BIOL CHEM, V282, P18379, DOI 10.1074/jbc.M610792200; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vabulas RM, 2007, CURR OPIN CLIN NUTR, V10, P24, DOI 10.1097/MCO.0b013e328011645b; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Wang JY, 2013, J BIOL CHEM, V288, P33667, DOI 10.1074/jbc.M113.503292; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wilkin F, 1997, EUR J BIOCHEM, V248, P660, DOI 10.1111/j.1432-1033.1997.t01-1-00660.x; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xu SS, 2014, FEBS LETT, V588, P4334, DOI 10.1016/j.febslet.2014.09.042; Yokoyama T, 2012, BLOOD, V119, P2608, DOI 10.1182/blood-2010-12-324806; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264; Yoshizawa K, 2014, CANCER SCI, V105, P195, DOI 10.1111/cas.12335	50	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152346	10.1371/journal.pone.0152346	http://dx.doi.org/10.1371/journal.pone.0152346			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019349	Green Published, Green Submitted, gold			2022-12-26	WOS:000372807800047
J	Reese, A; List, NH; Kongsted, J; Solov'yov, IA				Reese, Anna; List, Nanna Holmgaard; Kongsted, Jacob; Solov'yov, Ilia A.			How Far Does a Receptor Influence Vibrational Properties of an Odorant?	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; FORCE-FIELD; OLFACTORY RECEPTOR; ELECTRON-TRANSFER; PROTEINS; RECOGNITION; ACCURATE; DENSITY; MODEL; PARAMETERIZATION	The biophysical mechanism of the sense of smell, or olfaction, is still highly debated. The mainstream explanation argues for a shape-based recognition of odorant molecules by olfactory receptors, while recent investigations suggest the primary olfactory event to be triggered by a vibrationally-assisted electron transfer reaction. We consider this controversy by studying the influence of a receptor on the vibrational properties of an odorant in atomistic details as the coupling between electronic degrees of freedom of the receptor and the vibrations of the odorant is the key parameter of the vibrationally-assisted electron transfer. Through molecular dynamics simulations we elucidate the binding specificity of a receptor towards acetophenone odorant. The vibrational properties of acetophenone inside the receptor are then studied by the polarizable embedding density functional theory approach, allowing to quantify protein-odorant interactions. Finally, we judge whether the effects of the protein provide any indications towards the existing theories of olfaction.	[Reese, Anna; List, Nanna Holmgaard; Kongsted, Jacob; Solov'yov, Ilia A.] Univ Southern Denmark, Dept Phys Chem & Pharm, Campusvej 55, DK-5230 Odense M, Denmark	University of Southern Denmark	Solov'yov, IA (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Campusvej 55, DK-5230 Odense M, Denmark.	ilia@sdu.dk	List, Nanna Holmgaard/L-4049-2016; Kongsted, Jacob/AAD-3458-2022; Solov'yov, Ilia/GLU-8851-2022	List, Nanna Holmgaard/0000-0002-0246-3995; Solov'yov, Ilia/0000-0002-8626-145X; Kongsted, Jacob/0000-0002-7725-2164; Ebeling, Anna/0000-0002-9449-5723	Texas Advanced Computing Center (TACC) at the University of Texas at Austin through Extreme Science and Engineering Discovery Environment (XSEDE) Grant [XSEDE MCB-120160]; Lundbeck Foundation; Russian Scientific Foundation [14-12-00342]; Danish Councils for Independent Research; Villum foundation; Lundbeck Foundation [R163-2013-16265] Funding Source: researchfish	Texas Advanced Computing Center (TACC) at the University of Texas at Austin through Extreme Science and Engineering Discovery Environment (XSEDE) Grant; Lundbeck Foundation(Lundbeckfonden); Russian Scientific Foundation(Russian Science Foundation (RSF)); Danish Councils for Independent Research; Villum foundation(Villum Fonden); Lundbeck Foundation(Lundbeckfonden)	The authors acknowledge supercomputer time on Stampede provided by the Texas Advanced Computing Center (TACC) at the University of Texas at Austin through Extreme Science and Engineering Discovery Environment (XSEDE) Grant XSEDE MCB-120160. The authors also thank DelC for providing computational resources. I. A. S. is grateful for the financial support from Lundbeck Foundation, and the Russian Scientific Foundation (grant no 14-12-00342). N. H. L. and J. K. acknowledge the Lundbeck Foundation and the Danish Councils for Independent Research for financial support. J. K. thanks the Villum foundation for financial support.	Aidas K, 2014, WIRES COMPUT MOL SCI, V4, P269, DOI 10.1002/wcms.1172; [Anonymous], 2009, SCHROD SUIT 2009 PRO; Barragan AM, 2015, J PHYS CHEM B, V119, P433, DOI 10.1021/jp510022w; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bittner ER, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4767067; Block E, 2015, P NATL ACAD SCI USA, V112, pE3155, DOI 10.1073/pnas.1508443112; Block E, 2015, P NATL ACAD SCI USA, V112, pE2766, DOI 10.1073/pnas.1503054112; Brookes JC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.038101; Brookes JC, 2012, SENSORS-BASEL, V12, P15709, DOI 10.3390/s121115709; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Checinska A, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4905377; Chipot C., 2007, SPRINGER SERIES CHEM; Cohen R.S., 2013, CELL BIOL SYNAPSE NE, P309; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; de March CA, 2015, PROTEIN SCI, V24, P1543, DOI 10.1002/pro.2717; de March CA, 2015, J AM CHEM SOC, V137, P8611, DOI 10.1021/jacs.5b04659; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Dyson GM., 1938, CHEM IND, V57, P647, DOI [10.1002/jctb.5000572802, DOI 10.1002/JCTB.5000572802]; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; Franco MI, 2011, P NATL ACAD SCI USA, V108, P3797, DOI 10.1073/pnas.1012293108; Freindorf M, 2005, J COMPUT CHEM, V26, P1270, DOI 10.1002/jcc.20264; Gagliardi L, 2004, J CHEM PHYS, V121, P4494, DOI 10.1063/1.1778131; Gane S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055780; Gelis L, 2012, ANGEW CHEM INT EDIT, V51, P1274, DOI 10.1002/anie.201103980; Hettinger TP, 2011, P NATL ACAD SCI USA, V108, pE349, DOI 10.1073/pnas.1103992108; HUANG K, 1950, PROC R SOC LON SER-A, V204, P406, DOI 10.1098/rspa.1950.0184; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Karlstrom G, 2003, COMP MATER SCI, V28, P222, DOI 10.1016/S0927-0256(03)00109-5; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Lai PC, 2005, CHEM SENSES, V30, P781, DOI 10.1093/chemse/bji070; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; List NH, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4905909; Lupieri P, 2009, HFSP J, V3, P228, DOI 10.2976/1.3092784; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maestro, 2009, MAESTR VERS 9 0; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Mayne CG, 2013, J COMPUT CHEM, V34, P2757, DOI 10.1002/jcc.23422; Moncrieff R. W., 1949, AM PERFUMER, V54, P453; MONCRIEFF RW, 1949, PERF ESSENT OIL REC, V40, P279; Nelson D.L, 2013, LEHNINGER PRINCIPLES, V6th; Olsen J.M.H, 2012, DEV QUANTUM CHEM MET; Olsen JMH, 2011, ADV QUANTUM CHEM, V61, P107, DOI 10.1016/B978-0-12-386013-2.00003-6; Park JH, 2013, ANGEW CHEM INT EDIT, V52, P11021, DOI 10.1002/anie.201302374; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pilme J, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2368-4; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schrodinger LLC N, 2014, SMALL MOL DRUG DISC; Sjulstok E, 2015, SCI REP-UK, V5, DOI 10.1038/srep18446; Soderhjelm P, 2009, J PHYS CHEM A, V113, P617, DOI 10.1021/jp8073514; Solov'yov IA, 2014, SCI REP-UK, V4, DOI 10.1038/srep03845; Solov'yov IA, 2012, J AM CHEM SOC, V134, P18046, DOI 10.1021/ja3074819; Solov'yov IA, 2012, PHYS CHEM CHEM PHYS, V14, P13861, DOI 10.1039/c2cp41436h; STONEHAM AM, 1979, J PHYS C SOLID STATE, V12, P891, DOI 10.1088/0022-3719/12/5/018; Turin L, 2005, CHEMISTRY AND TECHNOLOGY OF FLAVORS AND FRAGRANCES, P261; Turin L, 1996, CHEM SENSES, V21, P773, DOI 10.1093/chemse/21.6.773; Turin L, 2015, P NATL ACAD SCI USA, V112, pE3154, DOI 10.1073/pnas.1508035112; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wang M, 2009, ANGEW CHEM INT EDIT, V48, P4232, DOI 10.1002/anie.200900827; WRIGHT RH, 1977, J THEOR BIOL, V64, P473, DOI 10.1016/0022-5193(77)90283-1; Zhang DW, 2003, J CHEM PHYS, V119, P3599, DOI 10.1063/1.1591727; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057	70	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152345	10.1371/journal.pone.0152345	http://dx.doi.org/10.1371/journal.pone.0152345			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27014869	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708900056
J	Tellaroli, P; Bazzi, M; Donato, M; Brazzale, AR; Draghici, S				Tellaroli, Paola; Bazzi, Marco; Donato, Michele; Brazzale, Alessandra R.; Draghici, Sorin			Cross-Clustering: A Partial Clustering Algorithm with Automatic Estimation of the Number of Clusters	PLOS ONE			English	Article							DATA SET; IDENTIFICATION; PREDICTION; CRITERIA; PACKAGE	Four of the most common limitations of the many available clustering methods are: i) the lack of a proper strategy to deal with outliers; ii) the need for a good a priori estimate of the number of clusters to obtain reasonable results; iii) the lack of a method able to detect when partitioning of a specific data set is not appropriate; and iv) the dependence of the result on the initialization. Here we propose Cross-clustering (CC), a partial clustering algorithm that overcomes these four limitations by combining the principles of two well established hierarchical clustering algorithms: Ward's minimum variance and Complete-linkage. We validated CC by comparing it with a number of existing clustering methods, including Ward's and Complete-linkage. We show on both simulated and real datasets, that CC performs better than the other methods in terms of: the identification of the correct number of clusters, the identification of outliers, and the determination of real cluster memberships. We used CC to cluster samples in order to identify disease subtypes, and on gene profiles, in order to determine groups of genes with the same behavior. Results obtained on a non-biological dataset show that the method is general enough to be successfully used in such diverse applications. The algorithm has been implemented in the statistical language R and is freely available from the CRAN contributed packages repository.	[Tellaroli, Paola; Bazzi, Marco; Brazzale, Alessandra R.] Univ Padua, Dept Stat Sci, Padua, Italy; [Donato, Michele; Draghici, Sorin] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Draghici, Sorin] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA	University of Padua; Wayne State University; Wayne State University	Tellaroli, P (corresponding author), Univ Padua, Dept Stat Sci, Padua, Italy.	paola.tellaroli@unipd.it	Draghici, Sorin/B-3074-2013; Tellaroli, Paola/T-1384-2017; Tellaroli, Paola/AAG-5027-2020; Brazzale, Alessandra R./AAN-7617-2021	Draghici, Sorin/0000-0002-0786-8377; Tellaroli, Paola/0000-0002-5112-9256; Tellaroli, Paola/0000-0002-5112-9256; Brazzale, Alessandra R./0000-0003-1989-2697	Fondazione Cassa di Risparmio di Padova e Rovigo [PARO112419]; National Institute of Health [RO1 RDK089167, R42 GM087013]; National Science Foundation [DBI-0965741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R42GM087013] Funding Source: NIH RePORTER	Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Fondazione Cassa di Risparmio di Padova e Rovigo (http://www.fondazionecariparo.net/) grant number PARO112419 (grant recipient: ARB), National Institute of Health (http://www.nih.gov/) grant number RO1 RDK089167 (grant recipient: SD), National Institute of Health (http://www.nih.gov/) grant number R42 GM087013 (grant recipient: SD), and National Science Foundation (http://www.nsf.gov/) grant number DBI-0965741 (grant recipient: SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barenco M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r25; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Beale E. M. L, 1969, EUCLIDEAN CLUSTER AN; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradley P. S., 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P9; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chang F, 2010, J STAT SOFTW, V33, P1; Draghici S., 2011, STAT DATA ANAL MICRO, V2nd Edn; DUBES RC, 1987, PATTERN RECOGN, V20, P645, DOI 10.1016/0031-3203(87)90034-3; Duda RO, 1973, PATTERN RECOGNITION; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Everitt B. S., 2001, CLUSTER ANAL; FORGY EW, 1965, BIOMETRICS, V21, P768; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gordon A.D., 1996, DATA KNOWLEDGE, P32, DOI DOI 10.1007/978-3-642-79999-0_3; Hartigan J., 1975, CLUSTERING ALGORITHM; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hennig C., 2014, FPC FLEXIBLE PROCEDU; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Howlader N, 2013, SEER CANC STAT REV 1; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; HUBERT L, 1976, BRIT J MATH STAT PSY, V29, P190, DOI 10.1111/j.2044-8317.1976.tb00714.x; HUBERT LJ, 1976, PSYCHOL BULL, V83, P1072, DOI 10.1037/0033-2909.83.6.1072; International Agency for Research on Cancer and others, GLOBOCAN 2012 EST CA; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kohonen T, 1995, SELF ORGANIZING MAPS; KRZANOWSKI WJ, 1988, BIOMETRICS, V44, P23, DOI 10.2307/2531893; Liu B, 2011, DATA CENTRIC SYST AP, P1, DOI 10.1007/978-3-642-19460-3; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma SQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117135; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; MILLIGAN GW, 1986, MULTIVAR BEHAV RES, V21, P441, DOI 10.1207/s15327906mbr2104_5; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MILLIGAN GW, 1987, APPL PSYCH MEAS, V11, P329, DOI 10.1177/014662168701100401; MURTAGH F, 1983, INFORM PROCESS LETT, V16, P237, DOI 10.1016/0020-0190(83)90095-9; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Romanski P, 2014, FSELECTOR SELECTING; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sorensen T., 1948, BIOL SKAR, V5, P1; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Steinley D, 2004, PSYCHOL METHODS, V9, P386, DOI 10.1037/1082-989X.9.3.386; Straume M, 2004, METHOD ENZYMOL, V383, P149; Sugar CA, 2003, J AM STAT ASSOC, V98, P750, DOI 10.1198/016214503000000666; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tomancak P., 2002, GENOME BIOL, V3, P81; Vollebergh MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103177; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wehrens R, 2007, J STAT SOFTW, V21, P1; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	56	21	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152333	10.1371/journal.pone.0152333	http://dx.doi.org/10.1371/journal.pone.0152333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015427	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708900053
J	Wang, WP; Zhang, K; Deng, DG; Zhang, YN; Peng, SX; Xu, XX				Wang, Wenping; Zhang, Kun; Deng, Daogui; Zhang, Ya-Nan; Peng, Shuixiu; Xu, Xiaoxue			Genetic Diversity of Daphnia pulex in the Middle and Lower Reaches of the Yangtze River	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; CLADOCERA DAPHNIIDAE; PHYLOGENY; CRUSTACEA; ENDEMISM; SEQUENCE; NORTH; BIOGEOGRAPHY; ZOOPLANKTON; HISTORY	Increased human activities and environmental changes may lead to genetic diversity variations of Cladocerans in water. Daphnia pulex are distributed throughout the world and often regarded as a model organism. The 16S rDNA, cytochrome c oxidase subunit I (COI), and 18S genes were used as molecular marks. The genetic diversity and phylogeny of D. pulex obtained from 10 water bodies in the middle and lower reaches of the Yangtze River were studied. For 16S rDNA, COI gene, and 18S gene, the A+ T content (65.4%, 58.4%, and 54.6%) was significantly higher than the G+ C content (34.6%, 41.6% and 45.4%). This result was consistent with higher A and T contents among invertebrates. Based on the genetic distances of 16S rDNA and COI genes, the genetic differences of D. pulex from 10 water bodies located in the middle and lower reaches of the Yangtze River in China was minimal (0%-0.8% for 16S rDNA and 0%-1.5% for COI gene). However, D. pulex evolved into two branches in the phylogenetic trees, which coincided with its geographical distribution. Compared with D. pulex from other countries, the average genetic distance of D. pulex obtained from 10 water bodies in the middle and lower reaches of the Yangtze River reached 9.1%-10.5%, thereby indicating that D. pulex may have evolved into different subspecies.	[Wang, Wenping; Zhang, Kun; Deng, Daogui; Zhang, Ya-Nan; Peng, Shuixiu; Xu, Xiaoxue] Huaibei Normal Univ, Sch Life Sci, Anhui Key Lab Resource & Plant Biol, Huaibei 235000, Peoples R China	Huaibei Normal University	Deng, DG (corresponding author), Huaibei Normal Univ, Sch Life Sci, Anhui Key Lab Resource & Plant Biol, Huaibei 235000, Peoples R China.	dengdg@263.net			National Natural Science Foundation of China [31370470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (31370470).	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Adamowicz SJ, 2004, ZOOL J LINN SOC-LOND, V140, P171, DOI 10.1111/j.1096-3642.2003.00089.x; Ambrose CD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-13; Anderson FE, 2000, MOL PHYLOGENET EVOL, V15, P191, DOI 10.1006/mpev.1999.0753; Benzie J.A.H, 2005, CLADOCERA GENUS DAPH; BOUCHON D, 1994, AQUACULTURE, V127, P131, DOI 10.1016/0044-8486(94)90420-0; Briski E, 2011, BIOL INVASIONS, V13, P1325, DOI 10.1007/s10530-010-9892-7; Bunioto SC, 2007, AQUAT ECOL, V41, P569, DOI 10.1007/s10452-007-9114-2; Chen W.M., 1998, J LAKE SCI, V10, P10; Colbourne JK, 2006, BIOL J LINN SOC, V89, P469, DOI 10.1111/j.1095-8312.2006.00687.x; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Crease TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046620; Crease TJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-212; Crease TJ, 1999, GENE, V233, P89, DOI 10.1016/S0378-1119(99)00151-1; Dai Yan-Ju, 2010, Zhongguo Haiyang Daxue Xuebao, V40, P54; Damme KV, 2007, ZOOLOGICA SCRIPTA, V36, P465; Deng DG, 2008, LIMNOLOGY, V9, P1, DOI 10.1007/s10201-007-0229-x; deWaard JR, 2006, MOL PHYLOGENET EVOL, V39, P491, DOI 10.1016/j.ympev.2005.11.003; Elias-gutierrez M, 2008, ZOOTAXA, V1839, P31; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; Gao Tianxiang, 2000, Journal of Ocean University of Qingdao, V30, P43; Geng Xuexia, 2014, Nanjing Nongye Daxue Xuebao, V37, P44; Gewin V, 2005, PLOS BIOL, V3, P949, DOI 10.1371/journal.pbio.0030219; Hebert PDN, 2003, LIMNOL OCEANOGR, V48, P261, DOI 10.4319/lo.2003.48.1.0261; Huang XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112808; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; Jeffery Nicholas W., 2011, PLoS ONE, V6, P1; Jiang XZ., 1979, FAUNA SINICA CRUSTAC; Kotov AA, 2010, J PLANKTON RES, V32, P937, DOI 10.1093/plankt/fbq018; Kotov AA, 2009, ZOOL J LINN SOC-LOND, V156, P1, DOI 10.1111/j.1096-3642.2008.00475.x; Liady MND, 2015, WATER SCI TECHNOL, V71, P1436, DOI 10.2166/wst.2015.107; Lu M, 2008, ACTA HYDROBIOL, V26, P123; Markova S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069497; McTaggart SJ, 2005, MOL BIOL EVOL, V22, P1309, DOI 10.1093/molbev/msi119; Mergeay J, 2008, MOL ECOL, V17, P1789, DOI 10.1111/j.1365-294X.2007.03679.x; Miner BE, 2013, FRESHWATER BIOL, V58, P1512, DOI 10.1111/fwb.12152; Oosterhout FV, 2013, HYDROBIOLOGIA, V710, P267; Prosser S, 2013, MOL ECOL RESOUR, V13, P1151, DOI 10.1111/1755-0998.12132; Richter S, 2007, CLADISTICS, V23, P301, DOI 10.1111/j.1096-0031.2007.00148.x; Sharma P, 2013, ZOOTAXA, V3702, P79, DOI 10.11646/zootaxa.3702.1.5; Spears T, 2000, J CRUSTACEAN BIOL, V20, P1, DOI 10.1651/0278-0372(2000)020[0001:BMAIPI]2.0.CO;2; Stenderup JT, 2006, MOL PHYLOGENET EVOL, V41, P182, DOI 10.1016/j.ympev.2006.06.006; Taylor DJ, 1998, EVOLUTION, V52, P1648, DOI 10.1111/j.1558-5646.1998.tb02245.x; Toyota K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1392-9; Weider LJ, 2003, MOL ECOL, V12, P463, DOI 10.1046/j.1365-294X.2003.01746.x; [徐敏 Xu Min], 2014, [水生生物学报, Acta Hydrobiologica Sinica], V38, P1040; Xu S, 2009, MOL ECOL, V18, P5161, DOI 10.1111/j.1365-294X.2009.04422.x; Zhang L, 2007, J LAKE SCI, V20, P263; Zuykova EI, 2013, RUSS J GENET+, V49, P206, DOI 10.1134/S1022795412120186	50	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152436	10.1371/journal.pone.0152436	http://dx.doi.org/10.1371/journal.pone.0152436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015539	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708900066
J	Kim, CS; Mitchell, IP; Desotell, AW; Kreeger, PK; Masters, KS				Kim, Chloe S.; Mitchell, Isaiah P.; Desotell, Anthony W.; Kreeger, Pamela K.; Masters, Kristyn S.			Immobilized epidermal growth factor stimulates persistent, directed keratinocyte migration via activation of PLC gamma 1	FASEB JOURNAL			English	Article						collective migration; EGFR trafficking; PLC gamma 1 signaling; wound healing	MESENCHYMAL STEM-CELLS; HUMAN SKIN; EXTRACELLULAR-MATRIX; CHRONIC WOUNDS; TISSUE-REPAIR; FACTOR-BETA; RECEPTOR; REGENERATION; PROTEIN; EGFR	Epidermal growth factor (EGF) is a critical element in dermal repair, but EGF-containing wound dressings have not been successful clinically. However, these dressings have delivered only soluble EGF, and the native environment provides both soluble and matrix-bound EGF. To address our hypothesis that tethered EGF can stimulate cell behaviors not achievable with soluble EGF, we examined single-cell movement and signaling in human immortalized HaCaT keratinocytes treated with soluble or immobilized EGF. Although both EGF treatments increased collective sheet displacement and individual cell speed, only cells treated with immobilized EGF exhibited directed migration, as well as 2-fold greater persistence compared with soluble EGF. Immunofluorescence showed altered EGF receptor (EGFR) trafficking, where EGFR remained membrane-localized in the immobilized EGF condition. Cells treated with soluble EGF demonstrated higher phosphorylated ERK1/2, and cells on immobilized EGF exhibited higher pPLC gamma 1, which was localizedat the leading edge. Treatment with U0126 inhibited migration in both conditions, demonstrating that ERK1/2 activity was necessary but not responsible for the observed differences. In contrast, PLC gamma 1 inhibition with U73122 significantly decreased persistence on immobilized EGF. Combined, these results suggest that immobilized EGF increases collective keratinocyte displacement via an increase in single-cell migration persistence resulting from altered EGFR trafficking and PLCg1 activation.	[Kim, Chloe S.; Mitchell, Isaiah P.; Desotell, Anthony W.; Kreeger, Pamela K.; Masters, Kristyn S.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Kreeger, PK (corresponding author), 4553 Wisconsin Inst Med Res, 1111 Highland Ave, Madison, WI 53705 USA.; Masters, KS (corresponding author), 1550 Engn Dr,ECB 2152, Madison, WI 53706 USA.	kreeger@wisc.edu; kmasters@wisc.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [R01-GM099031]; Wisconsin Distinguished Graduate Fellowship Award; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099031] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wisconsin Distinguished Graduate Fellowship Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge Min Sung Kim (Department of Biomedical Engineering, University of Wisconsin-Madison) for her assistance with cell culture and fluorescent immunostaining and the University of Wisconsin-Madison Vision Research Core (P30 EY0166650) for use of the confocal microscope. This work was supported by a grant from the U.S. National Institutes of Health, National Institute of General Medical Sciences (R01-GM099031), and a Wisconsin Distinguished Graduate Fellowship Award.	Anderson SM, 2011, BIOMATERIALS, V32, P7432, DOI 10.1016/j.biomaterials.2011.06.027; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Braund Rhiannon, 2007, Current Drug Delivery, V4, P195; BROWN GL, 1986, J EXP MED, V163, P1319; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Chambon JP, 2007, DEVELOPMENT, V134, P1203, DOI 10.1242/dev.002220; Clarke DC, 2009, MOL CELL BIOL, V29, P2443, DOI 10.1128/MCB.01443-08; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Doukas J, 2001, HUM GENE THER, V12, P783, DOI 10.1089/104303401750148720; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; GAME SM, 1992, INT J CANCER, V52, P461, DOI 10.1002/ijc.2910520322; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haase I, 1997, J INVEST DERMATOL, V108, P748, DOI 10.1111/1523-1747.ep12292135; Haugh JM, 1999, J BIOL CHEM, V274, P8958, DOI 10.1074/jbc.274.13.8958; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Iyer AKV, 2008, J CELL PHYSIOL, V214, P504, DOI 10.1002/jcp.21232; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; JIN WZ, 1994, BRAIN RES, V642, P237, DOI 10.1016/0006-8993(94)90927-X; Jones S, 2014, INT J BIOCHEM CELL B, V51, P23, DOI 10.1016/j.biocel.2014.03.014; Koria P, 2012, BIODRUGS, V26, P163, DOI 10.2165/11631850-000000000-00000; Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022; Kuhlman W, 2007, BIOMACROMOLECULES, V8, P3206, DOI 10.1021/bm070237o; Li SW, 2009, MOL ENDOCRINOL, V23, P901, DOI 10.1210/me.2008-0368; Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505; McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2; Mehta G, 2010, BIOMATERIALS, V31, P4657, DOI 10.1016/j.biomaterials.2010.01.138; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Papanas N, 2010, DRUG SAFETY, V33, P455, DOI 10.2165/11534570-000000000-00000; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; Puccinelli TJ, 2010, ACTA BIOMATER, V6, P3415, DOI 10.1016/j.actbio.2010.04.006; Reddy CC, 1996, J CELL PHYSIOL, V166, P512, DOI 10.1002/(SICI)1097-4652(199603)166:3<512::AID-JCP6>3.0.CO;2-S; Robson Martin C., 1997, Wound Repair and Regeneration, V5, P12, DOI 10.1046/j.1524-475X.1997.50106.x; Rodrigues M, 2013, STEM CELLS, V31, P104, DOI 10.1002/stem.1215; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Seeger MA, 2015, ADV WOUND CARE, V4, P213, DOI 10.1089/wound.2014.0540; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sridhar BV, 2014, J BIOMED MATER RES A, V102, P4464, DOI 10.1002/jbm.a.35115; Stefonek-Puccinelli TJ, 2009, IEEE ENG MED BIO, P1167, DOI 10.1109/IEMBS.2009.5332607; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Tian D, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0098-y; Wang Y, 2003, TRAFFIC, V4, P618, DOI 10.1034/j.1600-0854.2003.00121.x; Wang Y, 2014, CELL RES, V24, P959, DOI 10.1038/cr.2014.89; Wickert LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep20139; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; YU W, 1994, LASER SURG MED, V15, P281, DOI 10.1002/lsm.1900150308	54	9	9	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2580	2590		10.1096/fj.201600252	http://dx.doi.org/10.1096/fj.201600252			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27025961	Green Published			2022-12-26	WOS:000379249500013
J	Patel, A; Mohl, BP; Roy, P				Patel, Avnish; Mohl, Bjorn-Patrick; Roy, Polly			Entry of Bluetongue Virus Capsid Requires the Late Endosome-specific Lipid Lysobisphosphatidic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEINS; CELL ENTRY; FUNCTIONAL-CHARACTERIZATION; CHOLESTEROL TRANSPORT; NONENVELOPED VIRUS; GLYCOPROTEIN-G; VIRAL FUSION; PARTICLES; REOVIRUS; ENDOCYTOSIS	The entry of viruses into host cells is one of the key processes of infection. The mechanisms of cellular entry for enveloped virus have been well studied. The fusion proteins as well as the facilitating cellular lipid factors involved in the viral fusion entry process have been well characterized. The process of non-enveloped virus cell entry, in comparison, remains poorly defined, particularly for large complex capsid viruses of the family Reoviridae, which comprises a range of mammalian pathogens. These viruses enter cells without the aid of a limiting membrane and thus cannot fuse with host cell membranes to enter cells. Instead, these viruses are believed to penetrate membranes of the host cell during endocytosis. However, the molecular mechanism of this process is largely undefined. Here we show, utilizing an in vitro liposome penetration assay and cell biology, that bluetongue virus (BTV), an archetypal member of the Reoviridae, utilizes the late endosome-specific lipid lysobisphosphatidic acid for productive membrane penetration and viral entry. Further, we provide preliminary evidence that lipid lysobisphosphatidic acid facilitates pore expansion during membrane penetration, suggesting a mechanism for lipid factor requirement of BTV. This finding indicates that despite the lack of a membrane envelope, the entry process of BTV is similar in specific lipid requirements to enveloped viruses that enter cells through the late endosome. These results are the first, to our knowledge, to demonstrate that a large non-enveloped virus of the Reoviridae has specific lipid requirements for membrane penetration and host cell entry.	[Patel, Avnish; Mohl, Bjorn-Patrick; Roy, Polly] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roy, P (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.	polly.roy@lshtm.ac.uk		Roy, Polly/0000-0001-6535-6911	Wellcome Trust; National Institutes of Health	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded in part by the Wellcome Trust and the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agosto MA, 2006, P NATL ACAD SCI USA, V103, P16496, DOI 10.1073/pnas.0605835103; Belnap DM, 2000, J VIROL, V74, P1342, DOI 10.1128/JVI.74.3.1342-1354.2000; Boisvert M, 2010, J VIROL, V84, P7782, DOI 10.1128/JVI.00479-10; Bowne J G, 1971, Adv Vet Sci Comp Med, V15, P1; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Celma CC, 2014, VET MICROBIOL, V174, P139, DOI 10.1016/j.vetmic.2014.09.012; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Diaz-Salinas MA, 2014, J VIROL, V88, P4389, DOI 10.1128/JVI.03457-13; Dowling W, 2000, J VIROL, V74, P6368, DOI 10.1128/JVI.74.14.6368-6376.2000; Du JZ, 2014, J VIROL, V88, P12656, DOI 10.1128/JVI.01815-14; EATON BT, 1990, CURR TOP MICROBIOL, V162, P89; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Forzan M, 2007, J VIROL, V81, P4819, DOI 10.1128/JVI.02284-06; FRENCH TJ, 1990, J VIROL, V64, P1530, DOI 10.1128/JVI.64.4.1530-1536.1990; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Grover A, 2012, ANGEW CHEM INT EDIT, V51, P4838, DOI 10.1002/anie.201108107; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hassan SS, 1999, J VIROL, V73, P9832, DOI 10.1128/JVI.73.12.9832-9842.1999; HUGHSON FM, 1995, CURR BIOL, V5, P265, DOI 10.1016/S0960-9822(95)00057-1; HUISMANS H, 1987, VIROLOGY, V157, P180, DOI 10.1016/0042-6822(87)90327-8; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Jenckel M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00016-15; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KIELIAN MC, 1984, J VIROL, V52, P281, DOI 10.1128/JVI.52.1.281-283.1984; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Lins B, 2014, FUTURE VIROL, V9, P1105, DOI 10.2217/FVL.14.82; LIU HM, 1992, J GEN VIROL, V73, P2577, DOI 10.1099/0022-1317-73-10-2577; Maclachlan NJ, 2011, PREV VET MED, V102, P107, DOI 10.1016/j.prevetmed.2011.04.005; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARTIN SA, 1972, VIROLOGY, V50, P495, DOI 10.1016/0042-6822(72)90400-X; Matos PM, 2013, J BIOL CHEM, V288, P12416, DOI 10.1074/jbc.M113.462028; Matsuda M, 2014, J GEN VIROL, V95, P2658, DOI 10.1099/vir.0.068528-0; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mertens PPC., 2005, VIRUS TAXONOMY, P466; NANDI P, 1992, J VIROL, V66, P3363, DOI 10.1128/JVI.66.6.3363-3367.1992; Nason EL, 2004, J VIROL, V78, P8059, DOI 10.1128/JVI.78.15.8059-8067.2004; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Panjwani A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004294; Pattanakitsakul SN, 2010, J PROTEOME RES, V9, P4640, DOI 10.1021/pr100357f; Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014; PRASAD BVV, 1992, J VIROL, V66, P2135, DOI 10.1128/JVI.66.4.2135-2142.1992; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Schulz WL, 2012, J VIROL, V86, P12665, DOI 10.1128/JVI.01861-12; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VERWOERD D W, 1972, Onderstepoort Journal of Veterinary Research, V39, P185; VERWOERD DW, 1972, J VIROL, V10, P783, DOI 10.1128/JVI.10.4.783-794.1972; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang X, 2016, NAT STRUCT MOL BIOL, V23, P74, DOI 10.1038/nsmb.3134; Zhang X, 2010, P NATL ACAD SCI USA, V107, P6292, DOI 10.1073/pnas.0913403107; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	67	23	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12408	12419		10.1074/jbc.M115.700856	http://dx.doi.org/10.1074/jbc.M115.700856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27036941	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000378092800038
J	Lamech, LT; Saoji, M; Paukstelis, PJ; Lambowitz, AM				Lamech, Lilian T.; Saoji, Maithili; Paukstelis, Paul J.; Lambowitz, Alan M.			Structural Divergence of the Group I Intron Binding Surface in Fungal Mitochondrial Tyrosyl-tRNA Synthetases That Function in RNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIBOSOMAL-RNA; KMSKS LOOP; PROTEIN; DOMAIN; SEQUENCE; REVEALS; EVOLUTION; ELECTROSTATICS; INVOLVEMENT	The mitochondrial tyrosyl-tRNA synthetases (mtTyrRSs) of Pezizomycotina fungi, a subphylum that includes many pathogenic species, are bifunctional proteins that both charge mitochondrial tRNATyr and act as splicing cofactors for autocatalytic group I introns. Previous studies showed that one of these proteins, Neurospora crassa CYT-18, binds group I introns by using both its N-terminal catalytic and C-terminal anticodon binding domains and that the catalytic domain uses a newly evolved group I intron binding surface that includes an N-terminal extension and two small insertions (insertions 1 and 2) with distinctive features not found in non-splicing mtTyrRSs. To explore how this RNA binding surface diverged to accommodate different group I introns in other Pezizomycotina fungi, we determined x-ray crystal structures of C-terminally truncated Aspergillus nidulans and Coccidioides posadasii mtTyrRSs. Comparisons with previous N. crassa CYT-18 structures and a structural model of the Aspergillus fumigatus mtTyrRS showed that the overall topology of the group I intron binding surface is conserved but with variations in key intron binding regions, particularly the Pezizomycotina-specific insertions. These insertions, which arose by expansion of flexible termini or internal loops, show greater variation in structure and amino acids potentially involved in group I intron binding than do neighboring protein core regions, which also function in intron binding but may be more constrained to preserve mtTyrRS activity. Our results suggest a structural basis for the intron specificity of different Pezizomycotina mtTyrRSs, highlight flexible terminal and loop regions as major sites for enzyme diversification, and identify targets for therapeutic intervention by disrupting an essential RNA-protein interaction in pathogenic fungi.	[Lamech, Lilian T.; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Lamech, Lilian T.; Lambowitz, Alan M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Saoji, Maithili; Paukstelis, Paul J.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University System of Maryland; University of Maryland College Park	Lambowitz, AM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.; Lambowitz, AM (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu			Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037949, R01GM037951, R37GM037951] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Instrumentation for x-ray crystallography and technical assistance for this work were provided by the Macromolecular Crystallography Facility of the Institute for Cellular and Molecular Biology at the University of Texas at Austin. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bonnefond L, 2005, RNA, V11, P558, DOI 10.1261/rna.7246805; Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Caprara MG, 1996, J MOL BIOL, V257, P512, DOI 10.1006/jmbi.1996.0182; CARTER P, 1986, P NATL ACAD SCI USA, V83, P1189, DOI 10.1073/pnas.83.5.1189; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen X, 2004, RNA, V10, P634, DOI 10.1261/rna.5212604; CHERNIACK AD, 1990, CELL, V62, P745, DOI 10.1016/0092-8674(90)90119-Y; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dewal MB, 2011, CURR MED CHEM, V18, P2420; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards TA, 2011, AMINO ACIDS, V41, P743, DOI 10.1007/s00726-011-0880-8; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; Geng C, 2014, BIOCHEMISTRY-US, V53, P1311, DOI 10.1021/bi401614h; Gerstner RB, 2001, BIOCHEMISTRY-US, V40, P7165, DOI 10.1021/bi010026i; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; GUO QB, 1992, GENE DEV, V6, P1357, DOI 10.1101/gad.6.8.1357; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hougland J. L., 2005, RNA WORLD, P133; JAKES R, 1975, BIOCHEMISTRY-US, V14, P3344, DOI 10.1021/bi00686a009; Joardar V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-698; KAMPER U, 1992, MOL CELL BIOL, V12, P499; KITTLE JD, 1991, GENE DEV, V5, P1009, DOI 10.1101/gad.5.6.1009; Kobayashi T, 2005, J MOL BIOL, V346, P105, DOI 10.1016/j.jmb.2004.11.034; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Lamech LT, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002028; MANNELLA CA, 1979, P NATL ACAD SCI USA, V76, P2635, DOI 10.1073/pnas.76.6.2635; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOHR G, 1992, CELL, V69, P483, DOI 10.1016/0092-8674(92)90449-M; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oren I, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12642; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paukstelis PJ, 2008, P NATL ACAD SCI USA, V105, P6010, DOI 10.1073/pnas.0801722105; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Paukstelis PJ, 2011, BIOCHEMISTRY-US, V50, P3816, DOI 10.1021/bi200189u; Paukstelis PJ, 2005, MOL CELL, V17, P417, DOI 10.1016/j.molcel.2004.12.026; Qiu XY, 2001, PROTEIN SCI, V10, P2008, DOI 10.1110/ps.18001; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saldanha R, 1996, J MOL BIOL, V261, P23, DOI 10.1006/jmbi.1996.0439; SALDANHA RJ, 1995, BIOCHEMISTRY-US, V34, P1275, DOI 10.1021/bi00004a022; Smirnova EV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P15, DOI 10.1134/S0006297912010026; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Stahley MR, 2007, J MOL BIOL, V372, P89, DOI 10.1016/j.jmb.2007.06.026; Staker BL, 2000, EMBO J, V19, P749, DOI 10.1093/emboj/19.4.749; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Verweij P. E., 2006, Manual of clinical microbiology: Volume 2, P1802; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wallweber GJ, 1997, RNA, V3, P114; Wheat LJ, 2009, CLIN CHEST MED, V30, P379, DOI 10.1016/j.ccm.2009.02.011; Wilke CO, 2010, CURR OPIN STRUC BIOL, V20, P385, DOI 10.1016/j.sbi.2010.03.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolf YI, 1999, GENOME RES, V9, P689; Xin Y, 2000, J MOL BIOL, V303, P287, DOI 10.1006/jmbi.2000.4125; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	71	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11911	11927		10.1074/jbc.M116.725390	http://dx.doi.org/10.1074/jbc.M116.725390			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27036943	hybrid, Green Published			2022-12-26	WOS:000377264800039
J	Perez, RE; Shen, H; Duan, L; Kim, RH; Kim, T; Park, NH; Maki, CG				Perez, Ricardo E.; Shen, Hong; Duan, Lei; Kim, Reuben H.; Kim, Terresa; Park, No-Hee; Maki, Carl G.			Modeling the Etiology of p53-mutated Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPOLYPOSIS COLON-CANCER; SPORADIC COLORECTAL CARCINOMAS; REPAIR-GENE DEFECTS; MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; P53 GENE; TUMOR-CELLS; HPRT LOCUS; MUTATION; LINES	p53 gene mutations are among the most common alterations in cancer. In most cases, missense mutations in one TP53 allele are followed by loss-of-heterozygosity (I,OH), so tumors express only mutant p53. TP5.3 mutations and LOH have been linked, in many cases, with poor therapy response and worse outcome. Despite this, remarkably little is known about how TP53 point mutations are acquired, how LOH occurs, or the cells involved. Nutlin-3a occupies the p53-binding site in MDM2 and blocks p53-MDM2 interaction, resulting in the stabilization and activation of p53 and subsequent growth arrest or apoptosis. We leveraged the powerful growth inhibitory activity of Nutlin-3a to select p53-mutated cells and examined how TP53 mutations arise and how the remaining wild-type allele is lost or inactivated. Mismatch repair (MMR)-deficient colorectal cancer cells formed heterozygote (p53 wild-type/mutant) colonies when cultured in low doses of Nutlin-3a, whereas MMR-corrected counterparts did not. Placing these heterozygotes in higher Nutlin-3a doses selected clones in which the remaining wild-type TP53 was silenced. Our data suggest silencing occurred through a novel mechanism that does not involve DNA methylation, his tone methylation, or histone deacetylation. These data indicate MMR deficiency in colorectal cancer can give rise to initiating TP53 mutations and that TP53 silencing occurs via a copy-neutral mechanism. Moreover, the data highlight the use of MDM2 antagonists as tools to study mechanisms of TP53 mutation acquisition and wild-type allele loss or silencing in cells with defined genetic backgrounds.	[Maki, Carl G.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Kim, Reuben H.; Kim, Terresa; Park, No-Hee] Univ Calif Los Angeles, Shapiro Family Lab Viral Oncol & Aging Res, Sch Dent, Los Angeles, CA 90095 USA; [Kim, Reuben H.; Kim, Terresa; Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Rush University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Maki, CG (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	carl_maki@rush.edu			National Institutes of Health from NCI [1R01CA137598-01A1, 1R21CA178733-01]; NIDCR [R01DE023874]; NATIONAL CANCER INSTITUTE [R01CA137598, R21CA178733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023874] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants 1R01CA137598-01A1 and 1R21CA178733-01 from NCI (to C. G. M.) and Grant R01DE023874 from NIDCR (to R. H. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Amatya VJ, 2005, ACTA NEUROPATHOL, V110, P178, DOI 10.1007/s00401-005-1041-5; BAKER SJ, 1990, CANCER RES, V50, P7717; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Barrera LN, 2013, EUR J NUTR, V52, P1327, DOI 10.1007/s00394-012-0442-1; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; Buglioni S, 2001, AM J CLIN PATHOL, V116, P360, DOI 10.1309/V7UW-UT2E-JVYH-DGWK; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cottu PH, 1996, ONCOGENE, V13, P2727; Done SJ, 2001, J NATL CANCER I, V93, P700, DOI 10.1093/jnci/93.9.700; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fulci G, 2002, CANCER RES, V62, P2897; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Glaab WE, 1998, CARCINOGENESIS, V19, P1931, DOI 10.1093/carcin/19.11.1931; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hasegawa A, 2004, ANTICANCER RES, V24, P2047; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Holstege H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-654; Hurt EM, 2006, CANCER BIOL THER, V5, P1154, DOI 10.4161/cbt.5.9.3001; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; KIKUCHIYANOSHITA R, 1992, CANCER RES, V52, P3965; KIM HG, 1994, AM J PATHOL, V145, P148; Kim RH, 2015, AGING CELL, V14, P838, DOI 10.1111/acel.12364; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KOI M, 1994, CANCER RES, V54, P4308; Konishi M, 1996, GASTROENTEROLOGY, V111, P307, DOI 10.1053/gast.1996.v111.pm8690195; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Mancuso T, 1997, NUCLEIC ACIDS RES, V25, P3643, DOI 10.1093/nar/25.18.3643; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Peltonen K, 2005, PIGM CELL RES, V18, P196, DOI 10.1111/j.1600-0749.2005.00225.x; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; Simms LA, 1998, ONCOGENE, V17, P2003, DOI 10.1038/sj.onc.1202109; Sjogren S, 1996, J NATL CANCER I, V88, P173, DOI 10.1093/jnci/88.3-4.173; Soong R, 1996, BRIT J CANCER, V74, P562, DOI 10.1038/bjc.1996.401; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Takahashi M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198804; Tindall KR, 1998, MUTAT RES-FUND MOL M, V402, P15, DOI 10.1016/S0027-5107(97)00277-7; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Umar A, 1998, GENETICS, V148, P1637; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Walker DR, 1999, ONCOGENE, V18, P211, DOI 10.1038/sj.onc.1202298; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81	59	8	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10131	10147		10.1074/jbc.M116.724781	http://dx.doi.org/10.1074/jbc.M116.724781			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27022024	hybrid, Green Published			2022-12-26	WOS:000375602800024
J	Oppenheimer, BW; Berger, KI; Ali, S; Segal, LN; Donnino, R; Katz, S; Parikh, M; Goldring, RM				Oppenheimer, Beno W.; Berger, Kenneth I.; Ali, Saleem; Segal, Leopoldo N.; Donnino, Robert; Katz, Stuart; Parikh, Manish; Goldring, Roberta M.			Pulmonary Vascular Congestion: A Mechanism for Distal Lung Unit Dysfunction in Obesity	PLOS ONE			English	Article							MEMBRANE DIFFUSING-CAPACITY; CAPILLARY BLOOD-VOLUME; CHRONIC HEART-FAILURE; MORBIDLY OBESE; RESPIRATORY RESISTANCE; CIRCULATORY CONGESTION; BARIATRIC SURGERY; CARBON MONOXIDE; AIRWAY FUNCTION; WEIGHT-LOSS	Rationale Obesity is characterized by increased systemic and pulmonary blood volumes (pulmonary vascular congestion). Concomitant abnormal alveolar membrane diffusion suggests subclinical interstitial edema. In this setting, functional abnormalities should encompass the entire distal lung including the airways. Objectives We hypothesize that in obesity: 1) pulmonary vascular congestion will affect the distal lung unit with concordant alveolar membrane and distal airway abnormalities; and 2) the degree of pulmonary congestion and membrane dysfunction will relate to the cardiac response. Methods 54 non-smoking obese subjects underwent spirometry, impulse oscillometry (IOS), diffusion capacity (D-LCO) with partition into membrane diffusion (D-M) and capillary blood volume (V-C), and cardiac MRI (n = 24). Alveolar-capillary membrane efficiency was assessed by calculation of D-M/V-C. Measurements and Main Results Mean age was 45 +/- 12 years; mean BMI was 44.8 +/- 7 kg/m(2). Vital capacity was 88 +/- 13% predicted with reduction in functional residual capacity (58 +/- 12% predicted). Despite normal D-LCO (98 +/- 18% predicted), V-C was elevated (135 +/- 31% predicted) while D-M averaged 94 +/- 22% predicted. D-M/V-C varied from 0.4 to 1.4 with high values reflecting recruitment of alveolar membrane and low values indicating alveolar membrane dysfunction. The most abnormal IOS (R-5 and X-5) occurred in subjects with lowest D-M/V-C (r(2) = 0.31, p<0.001; r(2) = 0.34, p<0.001). Cardiac output and index (cardiac output / body surface area) were directly related to D-M/V-C (r(2) = 0.41, p<0.001; r(2) = 0.19, p = 0.03). Subjects with lower D-M/V-C demonstrated a cardiac output that remained in the normal range despite presence of obesity. Conclusions Global dysfunction of the distal lung (alveolar membrane and distal airway) is associated with pulmonary vascular congestion and failure to achieve the high output state of obesity. Pulmonary vascular congestion and consequent fluid transudation and/or alterations in the structure of the alveolar capillary membrane may be considered often unrecognized causes of airway dysfunction in obesity.	[Oppenheimer, Beno W.; Berger, Kenneth I.; Ali, Saleem; Segal, Leopoldo N.; Goldring, Roberta M.] NYU, Sch Med, Andre Cournand Pulm Physiol Lab, Div Pulm Crit Care & Sleep,Bellevue Hosp, New York, NY USA; [Parikh, Manish] NYU, Dept Surg, Sch Med, Bellevue Hosp,Bariatr Ctr, New York, NY 10016 USA; [Donnino, Robert; Katz, Stuart] NYU, Leon H Charney Div Cardiol, Sch Med, New York, NY USA	Bellevue Hospital Center; New York University; Bellevue Hospital Center; New York University; New York University	Oppenheimer, BW (corresponding author), NYU, Sch Med, Andre Cournand Pulm Physiol Lab, Div Pulm Crit Care & Sleep,Bellevue Hosp, New York, NY USA.	beno.oppenheimer@nyumc.org		Berger, Kenneth/0000-0003-4879-6071; Stuart, Katz/0000-0003-2340-2021; Parikh, Manish/0000-0002-8612-5407; Segal, Leopoldo/0000-0003-3559-9431; goldring, roberta/0000-0003-3319-4932	Empire Clinical Research Investigator Program (ECRIP), NY State Department of Health [7002001]	Empire Clinical Research Investigator Program (ECRIP), NY State Department of Health	This work was supported by the Empire Clinical Research Investigator Program (ECRIP), NY State Department of Health, Grant #7002001 (Investigators: MP and BWO), http://www.health.ny.gov/professionals/doctors/graduate_medical_education/ecrip/regulation.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan A, 2014, AM J RESP CRIT CARE, V189, P1494, DOI 10.1164/rccm.201401-0178OC; ALEXANDE.JK, 1965, J CHRON DIS, V18, P895, DOI 10.1016/0021-9681(65)90136-0; Alexander JK, 1998, HEART AND LUNG IN OBESITY, P133; ALEXANDER JK, 1967, GERIATRICS, V22, P101; Alpert MA, 1997, AM J CARDIOL, V80, P736, DOI 10.1016/S0002-9149(97)00505-5; Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Brown NJ, 2010, RESP PHYSIOL NEUROBI, V172, P162, DOI 10.1016/j.resp.2010.05.013; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Chapman DG, 2014, RESPIROLOGY, V19, P1170, DOI 10.1111/resp.12368; Cotes JE, 1993, LUNG FUNCTION ASSESS, V5 th; DEDIVITIIS O, 1981, CIRCULATION, V64, P477, DOI 10.1161/01.CIR.64.3.477; DINAKARA P, 1970, AM REV RESPIR DIS, V102, P965; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; FORSTER RE, 1957, PHYSIOL REV, V37, P391, DOI 10.1152/physrev.1957.37.4.391; Goldman MD, 2005, RESP PHYSIOL NEUROBI, V148, P179, DOI 10.1016/j.resp.2005.05.026; Guazzi M, 2003, CHEST, V124, P1090, DOI 10.1378/chest.124.3.1090; Guazzi M, 2002, EUR HEART J, V23, P467, DOI 10.1053/euhj.2001.2803; Guazzi M, 1997, CIRCULATION, V95, P1930; Hsia CCW, 2002, CHEST, V122, P1774, DOI 10.1378/chest.122.5.1774; JOHNSON RL, 1965, J CLIN INVEST, V44, P789, DOI 10.1172/JCI105191; KALTMAN AJ, 1976, AM J MED, V60, P645, DOI 10.1016/0002-9343(76)90499-X; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; King GG, 2005, EUR RESPIR J, V25, P896, DOI 10.1183/09031936.05.00104504; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Kohlhaufl M, 2001, J AEROSOL MED, V14, P1, DOI 10.1089/08942680152007855; KRUMHOLZ RA, 1966, AM REV RESPIR DIS, V94, P195; LANDSER FJ, 1982, CHEST, V81, P586, DOI 10.1378/chest.81.5.586; Mancuso P, 2010, J APPL PHYSIOL, V108, P722, DOI 10.1152/japplphysiol.00781.2009; MCNEILL RS, 1958, CLIN SCI, V17, P465; Mercer R.R., 2015, COMP BIOL NORMAL LUN, P93; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; OGILVIE CM, 1957, J CLIN INVEST, V36, P1, DOI 10.1172/JCI103402; Oostveen E, 2013, EUR RESPIR J, V42, P1513, DOI 10.1183/09031936.00126212; Oppenheimer BW, 2007, CHEST, V132, P1275, DOI 10.1378/chest.07-0913; Oppenheimer BW, 2006, OBESITY, V14, P1172, DOI 10.1038/oby.2006.134; Oppenheimer BW, 2006, RESP MED, V100, P1247, DOI 10.1016/j.rmed.2005.10.015; Oppenheimer BW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088015; Oppenheimer BW, 2012, SURG OBES RELAT DIS, V8, P582, DOI 10.1016/j.soard.2011.08.004; OTIS AB, 1956, J APPL PHYSIOL, V8, P427, DOI 10.1152/jappl.1956.8.4.427; PURI S, 1995, CIRCULATION, V91, P2769, DOI 10.1161/01.CIR.91.11.2769; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Shiota S, 2005, RESPIROLOGY, V10, P310, DOI 10.1111/j.1440-1843.2005.00703.x; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P925, DOI 10.1016/j.jaci.2005.01.064; Sideleva O, PULMONARY PHARM THER, V26, P455; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Tamhane RM, 2001, CHEST, V120, P1850, DOI 10.1378/chest.120.6.1850; Wagner P.D., 2015, COMP BIOL NORMAL LUN, P143; Zavorsky G. S., 2014, PHYSL REP, V2; Zavorsky GS, 2008, OBES SURG, V18, P256, DOI 10.1007/s11695-007-9294-9; Zavorsky GS, 2008, OBES SURG, V18, P1587, DOI 10.1007/s11695-008-9527-6; ZERAH F, 1993, CHEST, V103, P1470, DOI 10.1378/chest.103.5.1470	54	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152769	10.1371/journal.pone.0152769	http://dx.doi.org/10.1371/journal.pone.0152769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035663	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200035
J	Bi, XW; Wang, L; Zhang, WW; Sun, P; Yan, SM; Liu, PP; Li, ZM; Jiang, WQ				Bi, Xi-wen; Wang, Liang; Zhang, Wen-wen; Sun, Peng; Yan, Shu-mei; Liu, Pan-pan; Li, Zhi-ming; Jiang, Wen-qi			High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma	PLOS ONE			English	Article							INTERNATIONAL PROGNOSTIC INDEX; NASAL-TYPE; BREAST-CANCER; T-CELL; VENOUS THROMBOEMBOLISM; DISEASE PROGRESSION; COLORECTAL-CANCER; RADIATION-THERAPY; HODGKINS-DISEASE; L-ASPARAGINASE	Pretreatment plasma D-dimer levels have been reported to predict survival in several types of malignancies. The aim of this study was to evaluate the prognostic value of D-dimer levels in patients with newly diagnosed natural killer/T-cell lymphoma (NKTCL). The cut-off value of D-dimer to predict survival was set as 1.2 mu g/mL based on the receiver operating curve analysis. Patients with a D-dimer level >= 1.2 mu g/mL had significantly more adverse clinical features, including poor performance status, advanced stage diseases, B symptoms, elevated serum lactic dehydrogenase levels, involvement of regional lymph nodes, more extranodal diseases, and higher International Prognostic Index and natural killer/Tcell lymphoma prognostic index scores. A D-dimer level >= 1.2 mu g/mL was significantly associated with inferior 3-year overall survival (OS, 13.0 vs. 68.5%, P < 0.001). In the multivariate analysis, a D-dimer level >= 1.2 mu g/mL remained an independent predictor for worse OS (HR: 3.13, 95% CI: 1.47-6.68, P = 0.003) after adjusting for other confounding prognostic factors. Among patients with Ann Arbor stage I-II diseases, those with a D-dimer level >= 1.2 mu g/mL had a significantly worse survival than those with a D-dimer level < 1.2 mu g/mL (3 year-OS: 76.2 vs. 22.2%, P < 0.001). Survival of early-stage patients with a high D-dimer level was similar to that of the advanced-stage patients. In conclusion, pretreatment plasma D-dimer level may serve as a simple but effective predictor of prognosis in patients with NKTCL.	[Bi, Xi-wen; Sun, Peng; Liu, Pan-pan; Li, Zhi-ming; Jiang, Wen-qi] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Liang] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Wen-wen] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Yan, Shu-mei] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Bi, Xi-wen; Wang, Liang; Zhang, Wen-wen; Sun, Peng; Yan, Shu-mei; Liu, Pan-pan; Li, Zhi-ming; Jiang, Wen-qi] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China	Jiang, WQ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.; Jiang, WQ (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	wenqi_jiang@163.com	jiang, wen/GYI-9662-2022		National-Eleventh Five Technology Major Project [2008ZX09312-002, 2012ZX09301]	National-Eleventh Five Technology Major Project	This study was funded by the National-Eleventh Five Technology Major Project (No. 2008ZX09312-002 to WQJ, 2012ZX09301 to WQJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia G, 2009, BLOOD COAGUL FIBRIN, V20, P170, DOI 10.1097/MBC.0b013e32831bc2de; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; Batschauer APB, 2010, ANN ONCOL, V21, P1267, DOI 10.1093/annonc/mdp474; Bi XW, 2015, ANN HEMATOL, V94, P1515, DOI 10.1007/s00277-015-2390-3; Bi XW, 2015, ANN HEMATOL, V94, P1525, DOI 10.1007/s00277-015-2395-y; Bi XW, 2015, ANN HEMATOL, V94, P1175, DOI 10.1007/s00277-015-2336-9; Bi XW, 2013, INT J RADIAT ONCOL, V87, P1086, DOI 10.1016/j.ijrobp.2013.08.040; BICK RL, 1992, SEMIN THROMB HEMOST, V18, P353, DOI 10.1055/s-2007-1002575; Blackwell K, 2004, CANCER-AM CANCER SOC, V101, P77, DOI 10.1002/cncr.20336; Blackwell K, 2000, J CLIN ONCOL, V18, P600, DOI 10.1200/JCO.2000.18.3.600; Buller HR, 2007, J THROMB HAEMOST, V5, P246, DOI 10.1111/j.1538-7836.2007.02497.x; CARBONE PP, 1971, CANCER RES, V31, P1860; Chan JC, 2008, WHO CLASSIFICATION T, P285; CHAN JKC, 2001, WHO CLASSIFICATION T, P204; Chim CS, 2004, BLOOD, V103, P216, DOI 10.1182/blood-2003-05-1401; Chuang HC, 2007, CANCER SCI, V98, P1281, DOI 10.1111/j.1349-7006.2007.00549.x; Dirix LY, 2002, BRIT J CANCER, V86, P389, DOI 10.1038/sj.bjc.6600069; Fukumoto K, 2015, SURG TODAY, V45, P63, DOI 10.1007/s00595-014-0894-4; Go SI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000951; Jaccard A, 2011, BLOOD, V117, P1834, DOI 10.1182/blood-2010-09-307454; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Kim BS, 2009, ANN ONCOL, V20, P121, DOI 10.1093/annonc/mdn551; Kim TM, 2005, BLOOD, V106, P3785, DOI 10.1182/blood-2005-05-2056; Kwong YL, 2012, BLOOD, V120, P2973, DOI 10.1182/blood-2012-05-431460; Lee J, 2006, J CLIN ONCOL, V24, P612, DOI 10.1200/JCO.2005.04.1384; Li YX, 2006, J CLIN ONCOL, V24, P181, DOI 10.1200/JCO.2005.03.2573; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Nagato T, 2005, CLIN CANCER RES, V11, P8250, DOI 10.1158/1078-0432.CCR-05-1426; Oya M, 2001, JPN J CLIN ONCOL, V31, P388, DOI 10.1093/jjco/hye075; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Wang BY, 2008, AM J HEMATOL, V83, P795, DOI 10.1002/ajh.21256; Wang H, 2015, ONCOTARGETS THER, V8, P2589, DOI 10.2147/OTT.S91077; Wang L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0860-4; Wang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0723-4; Wang L, 2013, CANCER-AM CANCER SOC, V119, P348, DOI 10.1002/cncr.27752; Yamaguchi M, 2011, J CLIN ONCOL, V29, P4410, DOI 10.1200/JCO.2011.35.6287; Yamamoto M, 2012, ONCOLOGY-BASEL, V83, P10, DOI 10.1159/000338329; Zhang PP, 2013, EJSO-EUR J SURG ONC, V39, P951, DOI 10.1016/j.ejso.2013.06.008	39	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152842	10.1371/journal.pone.0152842	http://dx.doi.org/10.1371/journal.pone.0152842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032016	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800150
J	Lathlean, JA; Seuront, L; McQuaid, CD; Ng, TPT; Zardi, GI; Nicastro, KR				Lathlean, Justin A.; Seuront, Laurent; McQuaid, Christopher D.; Ng, Terence P. T.; Zardi, Gerardo I.; Nicastro, Katy R.			Cheating the Locals: Invasive Mussels Steal and Benefit from the Cooling Effect of Indigenous Mussels	PLOS ONE			English	Article							BEHAVIORAL THERMOREGULATION; TEMPERATURE VARIABILITY; PERNA-PERNA; PATTERNS; EXPOSURE; SURVIVAL; HISTORY; COAST; COLD	The indigenous South African mussel Perna perna gapes during periods of aerial exposure to maintain aerobic respiration. This behaviour has no effect on the body temperatures of isolated individuals, but when surrounded by conspecifics, beneficial cooling effects of gaping emerge. It is uncertain, however, whether the presence of the invasive mussel Mytilus galloprovincialis limits the ability of P. perna for collective thermoregulation. We investigated whether varying densities of P. perna and M. galloprovincialis influences the thermal properties of both natural and artificial mussel beds during periods of emersion. Using infrared thermography, body temperatures of P. perna within mixed artificial beds were shown to increase faster and reach higher temperatures than individuals in conspecific beds, indicating that the presence of M. galloprovincialis limits the group cooling effects of gaping. In contrast, body temperatures of M. galloprovincialis within mixed artificial mussel beds increased slower and exhibited lower temperatures than for individuals in beds comprised entirely of M. galloprovincialis. Interestingly, differences in bed temperatures and heating rates were largely dependent on the size of mussels, with beds comprised of larger individuals experiencing less thermal stress irrespective of species composition. The small-scale patterns of thermal stress detected within manipulated beds were not observed within naturally occurring mixed mussel beds. We propose that small-scale differences in topography, size-structure, mussel bed size and the presence of organisms encrusting the mussel shells mask the effects of gaping behaviour within natural mussel beds. Nevertheless, the results from our manipulative experiment indicate that the invasive species M. galloprovincialis steals thermal properties as well as resources from the indigenous mussel P. perna. This may have significant implications for predicting how the co-existence of these two species may change as global temperatures continue to rise.	[Lathlean, Justin A.; McQuaid, Christopher D.; Zardi, Gerardo I.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Seuront, Laurent] CNRS, UMR 8187, LOG, 28 Ave Foch,BP 80, F-62930 Wimereux, France; [Ng, Terence P. T.] Univ Hong Kong, Swire Inst Marine Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Ng, Terence P. T.] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Nicastro, Katy R.] Univ Algarve, CCMAR Ctr Ciencias Mar, CIMAR Lab Associado, Campus Gambelas, P-8005139 Faro, Portugal	Rhodes University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); University of Hong Kong; University of Hong Kong; Universidade do Algarve	Lathlean, JA (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa.	jlathlean@gmail.com	Nicastro, Katy/AAY-3692-2021; McQuaid, Christopher/AAT-3725-2020; Nicastro, Katy R/ABI-1531-2020; Zardi, Gerardo/M-4026-2013	McQuaid, Christopher/0000-0002-3473-8308; Nicastro, Katy R/0000-0002-7071-141X; Seuront, Laurent/0000-0002-0051-5202; Zardi, Gerardo/0000-0001-8798-5794	NRF Postdoctoral Fellowship; Rhodes University Research Council Grant; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Australian Research Council's Discovery Project [DP0988554]; Fundacao para a Ciencia e a Tecnologia (FCT) [IF/01413/201 IF/01413/2014/CP1217/CT0004]; NERC [NE/L003074/1] Funding Source: UKRI; Natural Environment Research Council [NE/L003074/1] Funding Source: researchfish	NRF Postdoctoral Fellowship; Rhodes University Research Council Grant; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Australian Research Council's Discovery Project(Australian Research Council); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a NRF Postdoctoral Fellowship to JAL, a Rhodes University Research Council Grant and was further supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation, an Australian Research Council's Discovery Project (project number DP0988554), and by Fundacao para a Ciencia e a Tecnologia (FCT; IF/01413/201 IF/01413/2014/CP1217/CT0004).	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bauwens D, 1996, ECOLOGY, V77, P1818, DOI 10.2307/2265786; BOGERT CM, 1949, EVOLUTION, V3, P195, DOI 10.2307/2405558; Bownes SJ, 2006, J EXP MAR BIOL ECOL, V338, P140, DOI 10.1016/j.jembe.2006.07.006; Branch GM, 2004, J EXP MAR BIOL ECOL, V300, P189, DOI 10.1016/j.jembe.2003.12.007; Caddy-Retalic S, 2011, MOLLUSCAN RES, V31, P106; Chapperon C, 2012, J THERM BIOL, V37, P640, DOI 10.1016/j.jtherbio.2012.08.001; Chapperon C, 2011, GLOBAL CHANGE BIOL, V17, P1740, DOI 10.1111/j.1365-2486.2010.02356.x; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; Hayford HA, 2015, MAR ECOL PROG SER, V518, P165, DOI 10.3354/meps11053; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Helmuth B, 2011, J EXP MAR BIOL ECOL, V400, P191, DOI 10.1016/j.jembe.2011.02.004; Helmuth BST, 1998, ECOL MONOGR, V68, P51, DOI 10.1890/0012-9615(1998)068[0051:IMMPTB]2.0.CO;2; Jackson AC, 2011, J EXP MAR BIOL ECOL, V400, P314, DOI 10.1016/j.jembe.2011.02.012; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Kearney Michael, 2001, Herpetological Review, V32, P11; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lathlean J, 2014, MAR ECOL PROG SER, V514, P263, DOI 10.3354/meps10995; Lathlean JA, 2015, MAR FRESHWATER RES, V66, P86, DOI 10.1071/MF13287; Lathlean JA, 2013, MAR ECOL PROG SER, V475, P155, DOI 10.3354/meps10105; Lathlean JA, 2012, LIMNOL OCEANOGR, V57, P1279, DOI 10.4319/lo.2012.57.5.1279; Lathlean JA, 2011, MAR ECOL PROG SER, V439, P83, DOI 10.3354/meps09317; Marshall DJ, 2012, J EXP MAR BIOL ECOL, V430, P25, DOI 10.1016/j.jembe.2012.06.011; McQuaid CD, 1988, NATO ASI ADV SCI I A, P212; McQuaid CD, 2015, OCEANOGR MAR BIOL, V53, P127; Navas CA, 1996, OECOLOGIA, V108, P617, DOI 10.1007/BF00329034; Nicastro KR, 2010, BIOL INVASIONS, V12, P2165, DOI 10.1007/s10530-009-9619-9; Nicastro KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047382; Pincebourde S, 2013, J EXP BIOL, V216, P2183, DOI 10.1242/jeb.083881; Pincebourde S, 2009, AM NAT, V174, P890, DOI 10.1086/648065; Reiserer RS, 2008, J ZOOL, V274, P277, DOI 10.1111/j.1469-7998.2007.00383.x; Seabra R, 2011, J EXP MAR BIOL ECOL, V400, P200, DOI 10.1016/j.jembe.2011.02.010; Zardi GI, 2006, MAR BIOL, V150, P79, DOI 10.1007/s00227-006-0328-y	35	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152556	10.1371/journal.pone.0152556	http://dx.doi.org/10.1371/journal.pone.0152556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030975	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800092
J	Nyamweya, C; Desjardins, C; Sigurdsson, S; Tomasson, T; Taabu-Munyaho, A; Sitoki, L; Stefansson, G				Nyamweya, Chrispine; Desjardins, Christopher; Sigurdsson, Sven; Tomasson, Tumi; Taabu-Munyaho, Anthony; Sitoki, Lewis; Stefansson, Gunnar			Simulation of Lake Victoria Circulation Patterns Using the Regional Ocean Modeling System (ROMS)	PLOS ONE			English	Article							EAST-AFRICA; STRATIFICATION; CLIMATE; BASIN	Lake Victoria provides important ecosystem services including transport, water for domestic and industrial uses and fisheries to about 33 million inhabitants in three East African countries. The lake plays an important role in modulating regional climate. Its thermodynamics and hydrodynamics are also influenced by prevailing climatic and weather conditions on diel, seasonal and annual scales. However, information on water temperature and circulation in the lake is limited in space and time. We use a Regional Oceanographic Model System (ROMS) to simulate these processes from 1st January 2000 to 31st December 2014. The model is based on real bathymetry, river runoff and atmospheric forcing data using the bulk flux algorithm. Simulations show that the water column exhibits annual cycles of thermo-stratification (September-May) and mixing (June-August). Surface water currents take different patterns ranging from a lake-wide northward flow to gyres that vary in size and number. An under flow exists that leads to the formation of upwelling and downwelling regions. Current velocities are highest at the center of the lake and on the western inshore waters indicating enhanced water circulation in those areas. However, there is little exchange of water between the major gulfs (especially Nyanza) and the open lake, a factor that could be responsible for the different water quality reported in those regions. Findings of the present study enhance understanding of the physical processes (temperature and currents) that have an effect on diel, seasonal, and annual variations in stratification, vertical mixing, inshore-offshore exchanges and fluxes of nutrients that ultimately influence the biotic distribution and trophic structure. For instance information on areas/timing of upwelling and vertical mixing obtained from this study will help predict locations/seasons of high primary production and ultimately fisheries productivity in Lake Victoria.	[Nyamweya, Chrispine] Kenya Marine & Fisheries Res Inst, Kisumu, Kenya; [Nyamweya, Chrispine; Desjardins, Christopher; Sigurdsson, Sven; Stefansson, Gunnar] Univ Iceland, Fac Phys Sci, Sch Engn & Nat Sci, Reykjavik, Iceland; [Tomasson, Tumi] United Nations Univ, Fisheries Training Programme, Marine Res Inst, Reykjavik, Iceland; [Taabu-Munyaho, Anthony] Natl Fisheries Res Inst, Jinja, Uganda; [Sitoki, Lewis] Tech Univ Kenya, Nairobi, Kenya	University of Iceland; Marine & Freshwater Research Institute (MFRI); Technical University of Kenya	Nyamweya, C (corresponding author), Kenya Marine & Fisheries Res Inst, Kisumu, Kenya.; Nyamweya, C (corresponding author), Univ Iceland, Fac Phys Sci, Sch Engn & Nat Sci, Reykjavik, Iceland.	sanychris@yahoo.com	Stefansson, Gunnar/AAV-9432-2020; Nyamweya, Chrispine Sangara/I-5429-2019; Stefansson, Gunnar/A-2209-2008	Stefansson, Gunnar/0000-0002-2693-9142; Nyamweya, Chrispine Sangara/0000-0002-7135-7379; Stefansson, Gunnar/0000-0002-2693-9142; Desjardins, Christopher/0000-0002-8234-9665	United Nations University - Fisheries Training Program (UNU-FTP) PhD scholarship	United Nations University - Fisheries Training Program (UNU-FTP) PhD scholarship	This work was supported by the United Nations University - Fisheries Training Program (UNU-FTP) PhD scholarship to CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyah RO, 2009, INT J CLIMATOL, V29, P971, DOI 10.1002/joc.1795; Crul RCM, 1995, LIMNOLOGY AND HYDROL; Fairall CW, 2003, J CLIMATE, V16, P571, DOI 10.1175/1520-0442(2003)016<0571:BPOASF>2.0.CO;2; KENDALL RL, 1969, ECOL MONOGR, V39, P121, DOI 10.2307/1950740; MacIntyre S, 2014, LIMNOL OCEANOGR, V59, P1805, DOI 10.4319/lo.2014.59.6.1805; Ochumba PBO, 1996, LIMNOLOGY CLIMATOLOG, P55; Okely P, 2010, LIMNOL OCEANOGR, V55, P1865, DOI 10.4319/lo.2010.55.5.1865; Rocha C, 2013, J COASTAL RES, P117, DOI 10.2112/SI65-021a.1; Sitoki L, 2010, INT REV HYDROBIOL, V95, P209, DOI 10.1002/iroh.201011226; Song Y, 2004, INT J CLIMATOL, V24, P57, DOI 10.1002/joc.983; Sun X, 2014, MODEL; Swenson S, 2009, J HYDROL, V370, P163, DOI 10.1016/j.jhydrol.2009.03.008; Taabu-Munyaho A, 2013, J GREAT LAKES RES, V39, P466, DOI 10.1016/j.jglr.2013.06.009; TALLING J. F., 1965, INT REV GESAMTEN HYDROBIOL, V50, P1, DOI 10.1002/iroh.19650500102; TALLING J. F., 1966, INT REV GESAMTEN HYDROBIOL, V51, P545, DOI 10.1002/iroh.19660510402; Talling JF, 1969, INT VEREINIGUNG THEO, V17, P998; Tate E, 2004, HYDROLOG SCI J, V49, P563, DOI 10.1623/hysj.49.4.563.54422; Taylor JR, 2008, J PHYS OCEANOGR, V38, P2535, DOI 10.1175/2008JPO3942.1; TEMPLE P H, 1969, Biological Journal of the Linnean Society, V1, P363, DOI 10.1111/j.1095-8312.1969.tb00126.x; Warner JC, 2005, OCEAN MODEL, V8, P81, DOI 10.1016/j.ocemod.2003.12.003	20	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151272	10.1371/journal.pone.0151272	http://dx.doi.org/10.1371/journal.pone.0151272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030983	gold, Green Submitted, Green Published			2022-12-26	WOS:000373121800012
J	Smayda, KE; Van Engen, KJ; Maddox, WT; Chandrasekaran, B				Smayda, Kirsten E.; Van Engen, Kristin J.; Maddox, W. Todd; Chandrasekaran, Bharath			Audio-Visual and Meaningful Semantic Context Enhancements in Older and Younger Adults	PLOS ONE			English	Article							SPEECH RECOGNITION; VISUAL ENHANCEMENT; PERCEPTION; NOISE; HEARING	Speech perception is critical to everyday life. Oftentimes noise can degrade a speech signal; however, because of the cues available to the listener, such as visual and semantic cues, noise rarely prevents conversations from continuing. The interaction of visual and semantic cues in aiding speech perception has been studied in young adults, but the extent to which these two cues interact for older adults has not been studied. To investigate the effect of visual and semantic cues on speech perception in older and younger adults, we recruited forty-five young adults (ages 18-35) and thirty-three older adults (ages 60-90) to participate in a speech perception task. Participants were presented with semantically meaningful and anomalous sentences in audio-only and audio-visual conditions. We hypothesized that young adults would outperform older adults across SNRs, modalities, and semantic contexts. In addition, we hypothesized that both young and older adults would receive a greater benefit from a semantically meaningful context in the audio-visual relative to audio-only modality. We predicted that young adults would receive greater visual benefit in semantically meaningful contexts relative to anomalous contexts. However, we predicted that older adults could receive a greater visual benefit in either semantically meaningful or anomalous contexts. Results suggested that in the most supportive context, that is, semantically meaningful sentences presented in the audiovisual modality, older adults performed similarly to young adults. In addition, both groups received the same amount of visual and meaningful benefit. Lastly, across groups, a semantically meaningful context provided more benefit in the audio-visual modality relative to the audio-only modality, and the presence of visual cues provided more benefit in semantically meaningful contexts relative to anomalous contexts. These results suggest that older adults can perceive speech as well as younger adults when both semantic and visual cues are available to the listener.	[Smayda, Kirsten E.; Maddox, W. Todd; Chandrasekaran, Bharath] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Van Engen, Kristin J.] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO USA; [Chandrasekaran, Bharath] Univ Texas Austin, Commun Sci & Disorders Dept, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Washington University (WUSTL); University of Texas System; University of Texas Austin	Smayda, KE (corresponding author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.	ksmayda@utexas.edu		Van Engen, Kristin/0000-0001-9069-5464; Chandrasekaran, Bharath/0000-0002-3673-9435	National Institute of Drug Abuse from the National Institutes of Health [DA032457]; National Institute on Deafness and Other Communication Disorders from the National Institutes of Health [R01DC013315]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032457] Funding Source: NIH RePORTER	National Institute of Drug Abuse from the National Institutes of Health; National Institute on Deafness and Other Communication Disorders from the National Institutes of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute of Drug Abuse Grant No. DA032457 from the National Institutes of Health awarded to WTM, and National Institute on Deafness and Other Communication Disorders Grant No. R01DC013315 from the National Institutes of Health awarded to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2014, NEUROPSYCHOLOGIA, V62, P286, DOI 10.1016/j.neuropsychologia.2014.07.034; Anderson S, 2013, HEARING RES, V300, P18, DOI 10.1016/j.heares.2013.03.006; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2012, LME4 LINEAR MIXED EF; Boersma P, 2021, PRAAT DOING PHONETIC; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Calandruccio L, 2012, J SPEECH LANG HEAR R, V55, P1342, DOI 10.1044/1092-4388(2012/11-0260); Delis DC., 2000, CALIFORNIA VERBAL LE; Dubno JR, 2000, J ACOUST SOC AM, V107, P538, DOI 10.1121/1.428322; Frisina DR, 1997, HEARING RES, V106, P95, DOI 10.1016/S0378-5955(97)00006-3; Gilbert RC, 2014, J ACOUST SOC AM, V135, P389, DOI 10.1121/1.4838975; Heaton R.K., 1993, WISCONSIN CARD SORTI; Helfer K S, 1998, J Am Acad Audiol, V9, P234; Helfer KS, 1997, J SPEECH LANG HEAR R, V40, P432, DOI 10.1044/jslhr.4002.432; Helfer KS, 2007, AGING SPEECH ON SPEE; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Nye PW, 1974, SR3738 HASK LAB; Rogers CS, 2012, PSYCHOL AGING, V27, P33, DOI 10.1037/a0026231; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Schneider Bruce A., 2001, Seminars in Hearing, V22, P227, DOI 10.1055/s-2001-15628; SCHNEIDER PF, 1995, J ACOUST SOC AM, V97, P593; Smiljanic R, 2013, J SPEECH LANG HEAR R, V56, P1085, DOI 10.1044/1092-4388(2012/12-0097); Sommers MS, 2005, EAR HEARING, V26, P263, DOI 10.1097/00003446-200506000-00003; Stevenson RA, 2015, NEUROBIOL AGING, V36, P283, DOI 10.1016/j.neurobiolaging.2014.08.003; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sumby W.H., 1954, JASA EXPRESS; Van Engen KJ, 2014, J SPEECH LANG HEAR R, V57, P1908, DOI 10.1044/JSLHR-H-13-0076; Venables WN., 2002, MODERN APPL STAT S 4; WALDEN BE, 1993, J SPEECH HEAR RES, V36, P431, DOI 10.1044/jshr.3602.431; Wechsler D., 1997, WECHSLER ADULT INTEL	32	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152773	10.1371/journal.pone.0152773	http://dx.doi.org/10.1371/journal.pone.0152773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031343	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800135
J	Jones, CHD; Ward, A; Hodkinson, PW; Reid, SJ; Wallis, LA; Harrison, S; Argent, AC				Jones, Caroline H. D.; Ward, Alison; Hodkinson, Peter W.; Reid, Stephen J.; Wallis, Lee A.; Harrison, Sian; Argent, Andrew C.			Caregivers' Experiences of Pathways to Care for Seriously Ill Children in Cape Town, South Africa: A Qualitative Investigation	PLOS ONE			English	Article							HEALTH-CARE; MORTALITY; TRIAGE; MOTHERS	Purpose Understanding caregivers' experiences of care can identify barriers to timely and good quality care, and support the improvement of services. We aimed to explore caregivers' experiences and perceptions of pathways to care, from first access through various levels of health service, for seriously ill and injured children in Cape Town, South Africa, in order to identify areas for improvement. Methods Semi-structured, qualitative interviews were conducted with primary caregivers of children who were admitted to paediatric intensive care or died in the health system prior to intensive care admission. Interviews explored caregivers' experiences from when their child first became ill, through each level of health care to paediatric intensive care or death. A maximum variation sample of transcripts was purposively sampled from a larger cohort study based on demographic characteristics, child diagnosis, and outcome at 30 days; and analysed using the method of constant comparison. Results Of the 282 caregivers who were interviewed in the larger cohort study, 45 interviews were included in this qualitative analysis. Some caregivers employed 'tactics' to gain quicker access to care, including bypassing lower levels of care, and negotiating or demanding to see a healthcare professional ahead of other patients. It was sometimes unclear how to access emergency care within facilities; and non-medical personnel informally judged illness severity and helped or hindered quicker access. Caregivers commonly misconceived ambulances to be slow to arrive, and were concerned when ambulance transfers were seemingly not prioritised by illness severity. Communication was often good, but some caregivers experienced language difficulties and/or criticism. Conclusions Interventions to improve child health care could be based on: reorganising the reception of seriously ill children and making the emergency route within healthcare facilities clear; promoting caregivers' use of ambulances and prioritising transfers according to illness severity; addressing language barriers, and emphasising the importance of effective communication to healthcare providers.	[Jones, Caroline H. D.; Ward, Alison; Harrison, Sian] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Hodkinson, Peter W.; Wallis, Lee A.] Univ Cape Town, Div Emergency Med, ZA-7925 Cape Town, South Africa; [Reid, Stephen J.] Univ Cape Town, Primary Hlth Care Directorate, ZA-7925 Cape Town, South Africa; [Argent, Andrew C.] Univ Cape Town, Dept Paediat, ZA-7925 Cape Town, South Africa	University of Oxford; University of Cape Town; University of Cape Town; University of Cape Town	Ward, A (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	alison.ward@phc.ox.ac.uk	Reid, Stephen/AAY-6101-2020; Hodkinson, PW W/N-3122-2018; Argent, Andrew/J-1605-2019	Hodkinson, PW W/0000-0002-0376-7982; Argent, Andrew/0000-0001-9333-2036; Wallis, Lee/0000-0003-2711-3139; Reid, Steve/0000-0003-2826-2304	Wellcome Trust [WT091107MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust (WT091107MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argent AC, 2009, SOUTH AFR J CRIT CAR, V25, P4; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bradshaw D., 2014, RAPID MORTALITY SURV; Brockerhoff M, 2000, B WORLD HEALTH ORGAN, V78, P30; Buys H, 2013, SAMJ S AFR MED J, V103, P161, DOI [10.7196/samj.6020, 10.7196/SAMJ.6020]; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Herxheimer A, 2000, LANCET, V355, P1540, DOI 10.1016/S0140-6736(00)02174-7; Kahabuka C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-315; Kahabuka C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-158; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Kissoon N, 2011, PEDIATR CRIT CARE ME, V12, P73, DOI 10.1097/PCC.0b013e3181ce74ef; Kissoon N, 2011, PEDIATR CRIT CARE ME, V12, P494, DOI 10.1097/PCC.0b013e318207096c; Krug A, 2008, S AFR MED J, V94, P202; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Molyneux EM, 2013, SAMJ S AFR MED J, V103, P158, DOI [10.7196/SAMJ.6531, 10.7196/samj.6531]; Molyneux E, 2009, T ROY SOC TROP MED H, V103, P11, DOI 10.1016/j.trstmh.2008.07.002; Neill SJ, 2013, INT J NURS STUD, V50, P757, DOI 10.1016/j.ijnurstu.2011.11.007; Samuelsen H, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-67; Schneider H, 2002, HEALTH POLICY PLANN, V17, P32, DOI 10.1093/heapol/17.1.32; Schneider H, 2010, J HEALTH SERV RES PO, V15, P137, DOI 10.1258/jhsrp.2010.008174; Scribante J, 2008, SAMJ, V97, P1323; Sobo EJ, 2006, HEALTH SERV RES, V41, P148, DOI 10.1111/j.1475-6773.2005.00455.x; Statistics South Africa, 2011, CENS 2011 MUN REP W; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thandrayen K, 2010, S AFR J CHILD HEALTH, V4, P73; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Twomey M, 2013, SAMJ S AFR MED J, V103, P304, DOI 10.7196/SAMJ.6877; Wallis LA, 2008, S AFR MED J, V96, P53; Watermeyer J, 2012, EVAL HEALTH PROF, V35, P360, DOI 10.1177/0163278712445472; Ziebland S, 2014, J HEALTH SERV RES PO; Ziebland S., 2013, UNDERSTANDING USING, P39, DOI [10.1093/acprof:oso/9780199665372.001.0001, DOI 10.1093/ACPROF:OSO/9780199665372.001.0001]; Ziebland S, 2013, UNDERSTANDING USING	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151606	10.1371/journal.pone.0151606	http://dx.doi.org/10.1371/journal.pone.0151606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27027499	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500028
J	Yang, PL; Pei, Q; Yu, TY; Chang, QX; Wang, D; Gao, M; Zhang, X; Liu, Y				Yang, Peilang; Pei, Qing; Yu, Tianyi; Chang, Qingxuan; Wang, Di; Gao, Min; Zhang, Xiong; Liu, Yan			Compromised Wound Healing in Ischemic Type 2 Diabetic Rats	PLOS ONE			English	Article							EDUCATION-PROGRAM RECOMMENDATIONS; ANIMAL-MODELS; FOOT ULCERS; PPAR-GAMMA; MICE; MOUSE; CHOLESTEROL; CONTRIBUTES; DYSFUNCTION; GENERATION	Ischemia is one of the main epidemic factors and characteristics of diabetic chronic wounds, and exerts a profound effect on wound healing. To explore the mechanism of and the cure for diabetic impaired wound healing, we established a type 2 diabetic rat model. We used an 8weeks high fat diet (HFD) feeding regimen followed by multiple injections of streptozotocin (STZ) at a dose of 10mg/kg to induce Wister rat to develop type 2 diabetes. Metabolic characteristics were assessed at the 5th week after the STZ injections to confirm the establishment of diabetes mellitus on the rodent model. A bipedicle flap, with length to width ratio 1.5, was performed on the back of the rat to make the flap area ischemic. Closure of excisional wounds on this bipedicle flap and related physiological and pathological changes were studied using histological, immunohistochemical, real time PCR and protein immunoblot approaches. Our results demonstrated that a combination of HFD feeding and a low dose of STZ is capable of inducing the rats to develop type 2 diabetes with noticeable insulin resistance, persistent hyperglycemia, moderate degree of insulinemia, as well as high serum cholesterol and high triglyceride levels. The excision wounds on the ischemic double pedicle flap showed deteriorative healing features comparing with non-ischemic diabetic wounds, including: delayed healing, exorbitant wound inflammatory response, excessive and prolonged ROS production and excessive production of MMPs. Our study suggested that HFD feeding combined with STZ injection could induce type 2 diabetes in rat. Our ischemic diabetic wound model is suitable for the investigation of human diabetic related wound repair; especically for diabetic chronic wounds.	[Yang, Peilang; Pei, Qing; Yu, Tianyi; Chang, Qingxuan; Wang, Di; Gao, Min; Zhang, Xiong; Liu, Yan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Burn & Plast Surg, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Liu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Burn & Plast Surg, Shanghai 200025, Peoples R China.	rjliuyan@126.com	刘, 琰/GVT-3050-2022		National Natural Science Fund of China [81170761, 81270909]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Fund of China 81170761 and 81270909. There are two fundings involved in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahangarpour A, 2015, MALAYS J MED SCI, V22, P25; Algenstaedt P, 2003, DIABETES, V52, P542, DOI 10.2337/diabetes.52.2.542; Alikhani M, 2007, AM J PHYSIOL-CELL PH, V292, pC850, DOI 10.1152/ajpcell.00356.2006; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Arad Y, 2011, DIABETES CARE, V34, P1041, DOI 10.2337/dc10-1666; Acosta JB, 2008, INT WOUND J, V5, P530, DOI 10.1111/j.1742-481X.2008.00457.x; Bishop A, 2008, J Wound Care, V17, P399; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Chatzigeorgiou A, 2009, IN VIVO, V23, P245; Chen C, 1999, WOUND REPAIR REGEN, V7, P486, DOI 10.1046/j.1524-475X.1999.00486.x; Chien S, 2007, WOUND REPAIR REGEN, V15, P928, DOI 10.1111/j.1524-475X.2007.00285.x; Elliott JI, 1997, CLIN EXP IMMUNOL, V109, P116, DOI 10.1046/j.1365-2249.1997.4241319.x; Fujita M, 2007, WOUND REPAIR REGEN, V15, P58, DOI 10.1111/j.1524-475X.2006.00185.x; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gupta M, 2015, J DIABETES, V7, P573, DOI 10.1111/1753-0407.12223; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kang S, 2013, WOUND REPAIR REGEN, V21, P730, DOI 10.1111/wrr.12081; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kopal C, 2007, ANN PLAS SURG, V58, P449, DOI 10.1097/01.sap.0000241681.57965.35; KRONCKE KD, 1995, BIOL CHEM H-S, V376, P179, DOI 10.1515/bchm3.1995.376.3.179; Kushner JA, 2002, J CLIN INVEST, V109, P1193, DOI 10.1172/JCI200214439; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Levraut J, 2003, AM J PHYSIOL-HEART C, V284, pH549, DOI 10.1152/ajpheart.00708.2002; Li HH, 2008, J SURG RES, V145, P41, DOI 10.1016/j.jss.2007.02.044; Liechty KW, 1999, J INVEST DERMATOL, V113, P375, DOI 10.1046/j.1523-1747.1999.00705.x; Lupachyk S, 2013, EXP NEUROL, V247, P342, DOI 10.1016/j.expneurol.2012.11.001; MAGEE PN, 1969, BRIT MED BULL, V25, P240, DOI 10.1093/oxfordjournals.bmb.a070711; McNair ED, 2010, CLIN CARDIOL, V33, P678, DOI 10.1002/clc.20815; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; PALJARVI L, 1984, ACTA NEUROPATHOL, V64, P89, DOI 10.1007/BF00695571; Poonawala T, 2005, WOUND REPAIR REGEN, V13, P165, DOI 10.1111/j.1067-1927.2005.130207.x; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157; Reid RR, 2004, J AM COLL SURGEONS, V199, P578, DOI 10.1016/j.jamcollsurg.2004.05.262; Roy S, 2009, PHYSIOL GENOMICS, V37, P211, DOI 10.1152/physiolgenomics.90362.2008; Sarkar K, 2009, P NATL ACAD SCI USA, V106, P18769, DOI 10.1073/pnas.0910561106; Sharma K, 2003, AM J PHYSIOL-RENAL, V284, pF1138, DOI 10.1152/ajprenal.00315.2002; Sheikh BA, 2015, BIOCHIMIE, V112, P57, DOI 10.1016/j.biochi.2015.02.008; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Srinivasan S, 2000, DIABETES, V49, P1932, DOI 10.2337/diabetes.49.11.1932; STEIN EA, 1995, CLIN CHEM, V41, P1421; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Trujillo AN, 2015, JOVE-J VIS EXP, DOI 10.3791/52637; Ueki K, 2000, J CLIN INVEST, V105, P1437, DOI 10.1172/JCI7656; WARNICK GR, 1995, CLIN CHEM, V41, P1427; Watcho P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/268547; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yotsumoto T, 2003, METABOLISM, V52, P1633, DOI 10.1016/j.metabol.2003.06.002; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	57	25	26	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152068	10.1371/journal.pone.0152068	http://dx.doi.org/10.1371/journal.pone.0152068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028201	Green Submitted, gold, Green Published			2022-12-26	WOS:000373116500034
J	Chapa, J; An, G; Kulkarni, SA				Chapa, Joaquin; An, Gary; Kulkarni, Swati A.			Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model	PLOS ONE			English	Article							CARCINOMA IN-SITU; ESTROGEN-RECEPTOR-ALPHA; PROGESTERONE-RECEPTOR; CANCER-RISK; SIGNALING PATHWAYS; ENDOCRINE THERAPY; GENE-EXPRESSION; MUTATIONS; BRCA1; RESISTANCE	Introduction Breast cancer, the product of numerous rare mutational events that occur over an extended time period, presents numerous challenges to investigators interested in studying the transformation from normal breast epithelium to malignancy using traditional laboratory methods, particularly with respect to characterizing transitional and pre-malignant states. Dynamic computational modeling can provide insight into these pathophysiological dynamics, and as such we use a previously validated agent-based computational model of the mammary epithelium (the DEABM) to investigate the probabilistic mechanisms by which normal populations of ductal cells could transform into states replicating features of both pre-malignant breast lesions and a diverse set of breast cancer subtypes. Methods The DEABM consists of simulated cellular populations governed by algorithms based on accepted and previously published cellular mechanisms. Cells respond to hormones, undergo mitosis, apoptosis and cellular differentiation. Heritable mutations to 12 genes prominently implicated in breast cancer are acquired via a probabilistic mechanism. 3000 simulations of the 40-year period of menstrual cycling were run in wild-type (WT) and BRCA1-mutated groups. Simulations were analyzed by development of hyperplastic states, incidence of malignancy, hormone receptor and HER-2 status, frequency of mutation to particular genes, and whether mutations were early events in carcinogenesis. Results Cancer incidence in WT (2.6%) and BRCA1-mutated (45.9%) populations closely matched published epidemiologic rates. Hormone receptor expression profiles in both WT and BRCA groups also closely matched epidemiologic data. Hyperplastic populations carried more mutations than normal populations and mutations were similar to early mutations found in ER+ tumors (telomerase, E-cadherin, TGFB, RUNX3, p < .01). ER-tumors carried significantly more mutations and carried more early mutations in BRCA1, c-MYC and genes associated with epithelial-mesenchymal transition. Conclusions The DEABM generates diverse tumors that express tumor markers consistent with epidemiologic data. The DEABM also generates non-invasive, hyperplastic populations, analogous to atypia or ductal carcinoma in situ (DCIS), via mutations to genes known to be present in hyperplastic lesions and as early mutations in breast cancers. The results demonstrate that agent-based models are well-suited to studying tumor evolution through stages of carcinogenesis and have the potential to be used to develop prevention and treatment strategies.	[Chapa, Joaquin] Univ Chicago, Pritzker Sch Med, 924 East 57th St 104, Chicago, IL 60637 USA; [An, Gary] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kulkarni, Swati A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Dept Surg, 303 E Super St,Lurie 4-105, Chicago, IL 60611 USA	University of Chicago; University of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Kulkarni, SA (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Dept Surg, 303 E Super St,Lurie 4-105, Chicago, IL 60611 USA.	skulkarn@nm.org		An, Gary/0000-0003-4549-9004	NCI NIH HHS [P30 CA060553] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alluri PG, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0494-7; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G MQ, 2009, WILEY INTERDISCIPLIN; An G, 2015, MATH BIOSCI, V260, P16, DOI 10.1016/j.mbs.2014.07.009; An GC, 2009, MATH BIOSCI, V217, P53, DOI 10.1016/j.mbs.2008.08.013; Ang DC, 2014, MODERN PATHOL, V27, P740, DOI 10.1038/modpathol.2013.197; Arthur WB, 2013, COMPLEXITY IN PRESS; Aulmann S, 2002, BREAST CANCER RES TR, V74, P25, DOI 10.1023/A:1016061327812; Bankes SC, 2002, P NATL ACAD SCI USA, V99, P7199, DOI 10.1073/pnas.072081299; Bankhead A, 2007, J THEOR BIOL, V246, P491, DOI 10.1016/j.jtbi.2007.01.011; Barbara D, 2014, J EVOLUTIONARY MED, V2014; Barone I, 2010, CLIN CANCER RES, V16, P2702, DOI 10.1158/1078-0432.CCR-09-1753; Boonyaratanakornkit V, 2007, SEMIN REPROD MED, V25, P139, DOI 10.1055/s-2007-973427; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Cancer IAfRo, 2015, MOST TYP CANC NOT DU; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Carlson JJ, 2013, BREAST CANCER RES TR, V141, P13, DOI 10.1007/s10549-013-2666-z; Chapa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064091; Clarke RB, 1997, BREAST CANCER RES TR, V45, P121, DOI 10.1023/A:1005805831460; Collins LC, 2007, CANCER, V109, P180, DOI 10.1002/cncr.22408; Cronin M, 2007, CLIN CHEM, V53, P1084, DOI 10.1373/clinchem.2006.076497; Davidson NE, 2015, JAMA-J AM MED ASSOC, V313, P1109, DOI 10.1001/jama.2015.1945; EASTON DF, 1995, AM J HUM GENET, V56, P265; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; ELMORE JG, 2015, JAMA J AM MED ASSOC, V313, P1122; Eppstein MJ, 2011, ENERG POLICY, V39, P3789, DOI 10.1016/j.enpol.2011.04.007; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Gobbi H, 1999, J NATL CANCER I, V91, P2096, DOI 10.1093/jnci/91.24.2096; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gruvberger-Saal SK, 2007, CLIN CANCER RES, V13, P1987, DOI 10.1158/1078-0432.CCR-06-1823; Hannemann J, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1613; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Howlader N, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju055; Janssen MA, 2006, ECOL SOC, V11; Jin L, 1997, CANCER, V79, P749, DOI 10.1002/(SICI)1097-0142(19970215)79:4<749::AID-CNCR12>3.0.CO;2-#; Kaiser MI, 2011, LIMITS REDUCTIONISM; Keohavong P, 2004, CANCER LETT, V212, P121, DOI 10.1016/j.canlet.2004.03.010; Khan SA, 2002, INT J CANCER, V102, P334, DOI 10.1002/ijc.10737; Kim M, 2012, SURG INFECT, V13, P18, DOI 10.1089/sur.2011.057; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawton TJ, 2013, MANAGEMENT PATIENT H, P61; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Mi Q, 2007, WOUND REPAIR REGEN, V15, P671, DOI 10.1111/j.1524-475X.2007.00271.x; Moelans CB, 2011, CELL ONCOL, V34, P475, DOI 10.1007/s13402-011-0043-7; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Naidu R, 2002, INT J MOL MED, V9, P189; National Comprehensive Cancer Network, 2015, CLIN PRACT GUID BREA; Norton KA, 2010, J THEOR BIOL, V263, P393, DOI 10.1016/j.jtbi.2009.11.024; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; O'Donoghue C, 2013, BRIT J CANCER, V108, P2200, DOI 10.1038/bjc.2013.256; Olayioye MA, 2001, BREAST CANCER RES, V3, P385, DOI 10.1186/bcr327; Ozanne EM, 2011, BREAST CANCER RES TR, V129, P165, DOI 10.1007/s10549-011-1430-5; Pai R, 2011, BREAST SURGICAL TECHNIQUES AND INTERDISCIPLINARY MANAGEMENT, P613, DOI 10.1007/978-1-4419-6076-4_51; Pires MM, 2013, CANCER BIOL THER, V14, P246, DOI 10.4161/cbt.23297; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; RAVDIN PM, 1992, J CLIN ONCOL, V10, P1284, DOI 10.1200/JCO.1992.10.8.1284; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Shoker BS, 1999, AM J PATHOL, V155, P1811, DOI 10.1016/S0002-9440(10)65498-3; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; SODERQVIST G, 1993, AM J OBSTET GYNECOL, V168, P874; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; SUNSHINE JA, 1985, AM J SURG, V150, P44, DOI 10.1016/0002-9610(85)90008-X; Tan HN, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-31; Tice JA, 2013, JNCI-J NATL CANCER I; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Tsao JI, 1997, CLIN CANCER RES, V3, P627; Umekita Y, 2007, IN VIVO, V21, P535; VandenBussche CJ, 2013, AM J SURG PATHOL, V37, P913, DOI 10.1097/PAS.0b013e31828ba25c; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang ZH, 2015, SEMIN CANCER BIOL, V30, P70, DOI [10.1016/j.semcancer.2014.04.001, 10.1007/978-3-662-43514-4]; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691	81	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152298	10.1371/journal.pone.0152298	http://dx.doi.org/10.1371/journal.pone.0152298			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023391	Green Submitted, Green Published, gold			2022-12-26	WOS:000373113900042
J	Havranek, S; Fiala, M; Bulava, A; Sknouril, L; Dorda, M; Bulkova, V; Fingrova, Z; Souckova, L; Palecek, T; Simek, J; Linhart, A; Wichterle, D				Havranek, Stepan; Fiala, Martin; Bulava, Alan; Sknouril, Libor; Dorda, Miroslav; Bulkova, Veronika; Fingrova, Zdenka; Souckova, Lucie; Palecek, Tomas; Simek, Jan; Linhart, Ales; Wichterle, Dan			Multivariate Analysis of Correspondence between Left Atrial Volumes Assessed by Echocardiography and 3-Dimensional Electroanatomic Mapping in Patients with Atrial Fibrillation	PLOS ONE			English	Article							2-DIMENSIONAL ECHOCARDIOGRAPHY; COMPUTED-TOMOGRAPHY; CATHETER ABLATION; PREDICTIVE-VALUE; SIZE; RECOMMENDATIONS; QUANTIFICATION; ASSOCIATION; RECURRENCE; SHAPE	Background Left atrial (LA) enlargement is a predictor of worse outcome after catheter ablation for atrial fibrillation (AF). Widely used two-dimensional (2D)-echocardiography is inaccurate and underestimates real LA volume (LAV). We hypothesized that baseline clinical characteristics of patients can be used to adjust 2D-ECHO indices of LAV in order to minimize this disagreement. Methods The study enrolled 535 patients (59 +/- 9 years; 67% males; 43% paroxysmal AF) who underwent catheter ablation for AF in three specialized centers. We investigated multivariately the relationship between 2D-echocardiographic indices of LA size, specifically LA diameter in M-mode in the parasternal long-axis view (LAD), LAV assessed by the prolate-ellipsoid method (LAV(Ellipsoid)), LAV by the planimetric method (LAV(Planimetry)), and LAV derived from 3D-electroanatomic mapping (LAV(CARTO)). Results Cubed LAD of 106 +/- 45 ml, LAV(Ellipsoid) of 72 +/- 24 ml and LAV(Planimetry) of 88 +/- 30 ml correlated only modestly (r = 0.60, 0.69, and 0.53, respectively) with LAV(CARTO) of 137 +/- 46 ml, which was significantly underestimated with a bias (+/- 1.96 standard deviation) of -31 (-111; +49) ml, -64(-132; +2) ml, and -49(-125; +27) ml, respectively; p < 0.0001 for their mutual difference. LA enlargement itself, age, gender, type of AF, and the presence of structural heart disease were independent confounders of measurement error of 2D-echocardiographic LAV. Conclusion Accuracy and precision of all 2D-echocardiographic LAV indices are poor. Their agreement with true LAV can be significantly improved by multivariate adjustment to clinical characteristics of patients.	[Havranek, Stepan; Bulkova, Veronika; Fingrova, Zdenka; Souckova, Lucie; Palecek, Tomas; Simek, Jan; Linhart, Ales; Wichterle, Dan] Charles Univ Prague, Dept Med 2, Dept Cardiovasc Med, Fac Med 1, Prague, Czech Republic; [Havranek, Stepan; Bulkova, Veronika; Fingrova, Zdenka; Souckova, Lucie; Palecek, Tomas; Simek, Jan; Linhart, Ales; Wichterle, Dan] Gen Univ Hosp Prague, Prague, Czech Republic; [Fiala, Martin; Sknouril, Libor; Dorda, Miroslav] Hosp Podlesi, Dept Cardiol, Ctr Heart, Trinec, Czech Republic; [Fiala, Martin] Masaryk Univ, Dept Internal Med & Cardiol, Univ Hosp, Brno, Czech Republic; [Bulava, Alan] Univ South Bohemia, Dept Cardiol, Hosp Ceske Budejovice, Ceske Budejovice, Czech Republic; [Bulava, Alan] Univ South Bohemia, Fac Hlth & Social Studies, Ceske Budejovice, Czech Republic; [Bulkova, Veronika] St Annes Univ Hosp, Dept Cardiol & Angiol, Brno, Czech Republic; [Bulkova, Veronika] Int Clin Res Ctr, Brno, Czech Republic; [Wichterle, Dan] Inst Clin & Expt Med, Dept Cardiol, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Masaryk University Brno; University Hospital Brno; Hospital Ceske Budejovice; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; St Anne's University Hospital Brno (FNUSA-ICRC); St Anne's University Hospital Brno (FNUSA-ICRC); Institute for Clinical & Experimental Medicine (IKEM)	Havranek, S (corresponding author), Charles Univ Prague, Dept Med 2, Dept Cardiovasc Med, Fac Med 1, Prague, Czech Republic.; Havranek, S (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	stepan.havranek@lf1.cuni.cz	Wichterle, Dan/G-7611-2017; Bulava, Alan/E-1834-2016; Šimek, Jan/O-5140-2017; Fingrova, Zdenka/G-6776-2017; Havranek, Stepan/G-6768-2017; Linhart, Ales/O-2375-2017	Wichterle, Dan/0000-0002-0448-5143; Bulava, Alan/0000-0002-1742-207X; Šimek, Jan/0000-0002-5060-1643; Fingrova, Zdenka/0000-0002-1259-6644; Havranek, Stepan/0000-0001-9694-0344; Linhart, Ales/0000-0002-3372-7850; Bulkova, Veronika/0000-0003-0384-1895	Charles University [PRVOUK-P35/LF1/5]; OP Prague Competitiveness [CZ.2.16/3.1.00/21565]	Charles University; OP Prague Competitiveness	The work was supported by the following: Charles University supporting program: PRVOUK-P35/LF1/5, URL: http://www.cuni.cz/UK-3885.html; and OP Prague Competitiveness: CZ.2.16/3.1.00/21565, URL: http://www.prahafondy.eu/cz/oppk.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by PRVOUK-P35/LF1/5 and by project reg. no. CZ.2.16/3.1.00/21565 from OP Prague Competitiveness. We thank Barbara A. Danek for proofreading and editing assistance.	Badano LP, 2008, J CARDIOVASC MED, V9, P476, DOI 10.2459/JCM.0b013e3282f194f0; Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027; Bisbal F, 2013, J CARDIOVASC ELECTR, V24, P752, DOI 10.1111/jce.12116; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Cozma D, 2007, PACE, V30, pS147; Douglas PS, 2011, J AM SOC ECHOCARDIOG, V24, P229, DOI 10.1016/j.echo.2010.12.008; Ejima K, 2010, EUROPACE, V12, P45, DOI 10.1093/europace/eup371; Hof I, 2009, J CARDIOVASC ELECTR, V20, P159, DOI 10.1111/j.1540-8167.2008.01310.x; Kurotobi T, 2011, EUROPACE, V13, P803, DOI 10.1093/europace/eur039; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lester SJ, 1999, AM J CARDIOL, V84, P829, DOI 10.1016/S0002-9149(99)00446-4; Maceira AM, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-65; Mor-Avi V, 2012, JACC-CARDIOVASC IMAG, V5, P769, DOI 10.1016/j.jcmg.2012.05.011; Muller H, 2010, EUROPACE, V12, P792, DOI 10.1093/europace/euq031; Nedios S, 2011, J INTERV CARD ELECTR, V32, P87, DOI 10.1007/s10840-011-9591-z; Nikitin NP, 2013, EUR J ECHOCARDIOGR, V4, P36; Patel VV, 2003, AM J CARDIOL, V91, P351, DOI 10.1016/S0002-9149(02)03169-7; Piorkowski C, 2006, HEART RHYTHM, V3, P317, DOI 10.1016/j.hrthm.2005.11.027; Rodevand O, 1999, INT J CARDIAC IMAG, V15, P397, DOI 10.1023/A:1006276513186; Tsao HM, 2001, J CARDIOVASC ELECTR, V12, P809, DOI 10.1046/j.1540-8167.2001.00809.x; Ujino K, 2006, AM J CARDIOL, V98, P1185, DOI 10.1016/j.amjcard.2006.05.040; VANDENBERG BF, 1995, AM J CARDIOL, V75, P754, DOI 10.1016/S0002-9149(99)80676-6; von Bary C, 2012, J INTERV CARD ELECTR, V34, P181, DOI 10.1007/s10840-011-9641-6; Zhuang JH, 2012, EUROPACE, V14, P638, DOI 10.1093/europace/eur364	25	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152553	10.1371/journal.pone.0152553	http://dx.doi.org/10.1371/journal.pone.0152553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023918	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900075
J	Imai, T; Takimoto, Y; Takeda, N; Uno, A; Inohara, H; Shimada, S				Imai, Takao; Takimoto, Yasumitsu; Takeda, Noriaki; Uno, Atsuhiko; Inohara, Hidenori; Shimada, Shoichi			High-Speed Video-Oculography for Measuring Three-Dimensional Rotation Vectors of Eye Movements in Mice	PLOS ONE			English	Article							SCLERAL SEARCH COIL; DYNAMIC CHARACTERISTICS; OPTOKINETIC RESPONSE; 3 DIMENSIONS; ACCURACY; REFLEX; SYSTEM	Background The mouse is the most commonly used animal model in biomedical research because of recent advances in molecular genetic techniques. Studies related to eye movement in mice are common in fields such as ophthalmology relating to vision, neuro-otology relating to the vestibulo-ocular reflex (VOR), neurology relating to the cerebellum's role in movement, and psychology relating to attention. Recording eye movements in mice, however, is technically difficult. Methods We developed a new algorithm for analyzing the three-dimensional (3D) rotation vector of eye movement in mice using high-speed video-oculography (VOG). The algorithm made it possible to analyze the gain and phase of VOR using the eye's angular velocity around the axis of eye rotation. Results When mice were rotated at 0.5 Hz and 2.5 Hz around the earth's vertical axis with their heads in a 30 degrees nose-down position, the vertical components of their left eye movements were in phase with the horizontal components. The VOR gain was 0.42 at 0.5 Hz and 0.74 at 2.5 Hz, and the phase lead of the eye movement against the turntable was 16.1 degrees at 0.5 Hz and 4.88 degrees at 2.5 Hz. Conclusions To the best of our knowledge, this is the first report of this algorithm being used to calculate a 3D rotation vector of eye movement in mice using high-speed VOG. We developed a technique for analyzing the 3D rotation vector of eye movements in mice with a high-speed infrared CCD camera. We concluded that the technique is suitable for analyzing eye movements in mice. We also include a C++ source code that can calculate the 3D rotation vectors of the eye position from two-dimensional coordinates of the pupil and the iris freckle in the image to this article.	[Imai, Takao; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan; [Takimoto, Yasumitsu] Suita Municipal Hosp, Dept Otolaryngol, Osaka, Japan; [Takeda, Noriaki] Univ Tokushima, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Tokushima, Japan; [Uno, Atsuhiko] Osaka Gen Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan; [Shimada, Shoichi] Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, Osaka, Japan	Osaka University; Tokushima University; Osaka University	Imai, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan.	timai@ent.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24791772]; Japan Agency for Medical Research and Development	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant-in-Aid for Scientific Research (no. 24791772) from the Japan Society for the Promotion of Science (JSPS) - Grant-in-Aid from the Japan Agency for Medical Research and Development.	Beraneck M, 2008, J NEUROPHYSIOL, V100, P945, DOI 10.1152/jn.90319.2008; Calabrese DR, 2006, JARO-J ASSOC RES OTO, V7, P151, DOI 10.1007/s10162-006-0031-1; Harrod CG, 2003, BRAIN RES, V972, P75, DOI 10.1016/S0006-8993(03)02505-8; HASLWANTER T, 1995, VISION RES, V35, P1727, DOI 10.1016/0042-6989(94)00257-M; Imai T, 2005, AURIS NASUS LARYNX, V32, P3, DOI 10.1016/j.anl.2004.11.009; Imai T, 1999, ACTA OTO-LARYNGOL, V119, P24; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Kaneko CRS, 2010, J NEUROSCI METH, V193, P126, DOI 10.1016/j.jneumeth.2010.08.023; Katoh A, 1998, P NATL ACAD SCI USA, V95, P7705, DOI 10.1073/pnas.95.13.7705; Koekkoek Sebastiaan K. E., 1997, Genes and Function, V1, P175; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Migliaccio AA, 2011, EXP BRAIN RES, V210, P489, DOI 10.1007/s00221-010-2521-y; Naoi K, 2003, IEICE T INF SYST, VE86D, P2452; Raphan T, 1998, J NEUROPHYSIOL, V79, P2653, DOI 10.1152/jn.1998.79.5.2653; Sakatani T, 2004, NEUROSCI RES, V49, P123, DOI 10.1016/j.neures.2004.02.002; Sekine K, 2004, ACTA OTO-LARYNGOL, V124, P1046, DOI 10.1080/00016480410018061; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2004, J NEUROPHYSIOL, V91, P2066, DOI 10.1152/jn.01068.2003; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2	19	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152307	10.1371/journal.pone.0152307	http://dx.doi.org/10.1371/journal.pone.0152307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023859	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900045
J	Lim, D; Strucken, EM; Choi, BH; Chai, HH; Cho, YM; Jang, GW; Kim, TH; Gondro, C; Lee, SH				Lim, Dajeong; Strucken, Eva M.; Choi, Bong Hwan; Chai, Han Ha; Cho, Yong Min; Jang, Gul Won; Kim, Tae-Hun; Gondro, Cedric; Lee, Seung Hwan			Genomic Footprints in Selected and Unselected Beef Cattle Breeds in Korea	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; RECENT POSITIVE SELECTION; ARTIFICIAL SELECTION; SKELETAL-MUSCLE; CARCASS TRAITS; DAIRY; MODEL; GENE; IDENTIFICATION; ASSOCIATION	Korean Hanwoo cattle have been subjected to intensive artificial selection over the past four decades to improve meat production traits. Another three cattle varieties very closely related to Hanwoo reside in Korea (Jeju Black and Brindle) and in China (Yanbian). These breeds have not been part of a breeding scheme to improve production traits. Here, we compare the selected Hanwoo against these similar but presumed to be unselected populations to identify genomic regions that have been under recent selection pressure due to the breeding program. Rsb statistics were used to contrast the genomes of Hanwoo versus a pooled sample of the three unselected population (UN). We identified 37 significant SNPs (FDR corrected) in the HW/UN comparison and 21 known protein coding genes were within 1 MB to the identified SNPs. These genes were previously reported to affect traits important for meat production (14 genes), reproduction including mammary gland development (3 genes), coat color (2 genes), and genes affecting behavioral traits in a broader sense (2 genes). We subsequently sequenced (Illumina HiSeq 2000 platform) 10 individuals of the brown Hanwoo and the Chinese Yanbian to identify SNPs within the candidate genomic regions. Based on allele frequency differences, haplotype structures, and literature research, we singled out one non-synonymous SNP in the APP gene (APP:c.569C>T, Ala199Val) and predicted the mutational effect on the protein structure. We found that protein-protein interactions might be impaired due to increased exposed hydrophobic surfaces of the mutated protein. The APP gene has also been reported to affect meat tenderness in pigs and obesity in humans. Meat tenderness has been linked to intramuscular fat content, which is one of the main breeding goals for brown Hanwoo, potentially supporting a causal influence of the herein described nsSNP in the APP gene.	[Lim, Dajeong; Choi, Bong Hwan; Chai, Han Ha; Cho, Yong Min; Jang, Gul Won; Kim, Tae-Hun] RDA, Natl Inst Anim Sci, Div Anim Genom & Bioinformat, Jeonju 565851, South Korea; [Strucken, Eva M.; Gondro, Cedric] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Lee, Seung Hwan] Chung Nam Natl Univ, Div Anim & Dairy Sci, Daejeon 305764, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; University of New England; Chungnam National University	Lee, SH (corresponding author), Chung Nam Natl Univ, Div Anim & Dairy Sci, Daejeon 305764, South Korea.	slee46@cnu.ac.kr	gondro, cedric/B-4362-2010	gondro, cedric/0000-0003-0666-656X; Lee, Seung Hwan/0000-0003-1508-4887; Strucken, Eva/0000-0002-2715-0733; , Han-ha/0000-0001-7752-3967	Post-Genome project, Rural Development Administration (RDA), Korea [PJ010406]	Post-Genome project, Rural Development Administration (RDA), Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Post-Genome project, Rural Development Administration (RDA), Korea, Grant Nummber: PJ010406.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Avinun R, 2012, BIOL LETT; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosques J, 2007, J ANIM SCI, V85, P65; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Cheong HS, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-35; Cheong HS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-33; Choi TJ, 2009, ESTABLISHMENT PHYLOG; Chung H, 2012, MEAT SCI, V90, P711, DOI 10.1016/j.meatsci.2011.10.017; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; de Koning DJ, 2001, J ANIM SCI, V79, P2812; F.A.O, 2014, DOM AN DIV INF SERV; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; FU YX, 1993, GENETICS, V133, P693; Fukuchi K, 1998, AM J PATHOL, V153, P1687, DOI 10.1016/S0002-9440(10)65682-9; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gautier M, 2011, MOL ECOL, V20, P3128, DOI 10.1111/j.1365-294X.2011.05163.x; Golimbet V, 2015, PSYCHIAT RES, V225, P739, DOI 10.1016/j.psychres.2014.11.043; Haskell MJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00368; Hayes BJ, 2009, ANIM GENET, V40, P176, DOI 10.1111/j.1365-2052.2008.01815.x; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Jo C., 2012, Animal Frontiers, V2, P32, DOI 10.2527/af.2012-0060; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim JH, 2013, ASIAN AUSTRAL J ANIM, V26, P163, DOI 10.5713/ajas.2012.12499; Kim JB, 2000, ASIAN AUSTRAL J ANIM, V13, P1467, DOI 10.5713/ajas.2000.1467; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kunej T, 2012, J GENOMICS, V1, P45; Lee HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066267; Lee Seung-Hwan, 2014, J Anim Sci Technol, V56, P2, DOI 10.1186/2055-0391-56-2; Lee SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-623; Lee YH, 2008, OBESITY, V16, P1493, DOI 10.1038/oby.2008.267; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim D, 2013, ASIAN AUSTRAL J ANIM, V26, P603, DOI 10.5713/ajas.2012.12456; Lindholm-Perry AK, 2015, ANIM GENET, V46, P60, DOI 10.1111/age.12244; Lobjois V, 2008, ANIM GENET, V39, P147, DOI 10.1111/j.1365-2052.2007.01695.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-181; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mattevi VS, 2006, AM J HUM BIOL, V18, P182, DOI 10.1002/ajhb.20486; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Novichkova S, 2003, BIOINFORMATICS, V19, P1699, DOI 10.1093/bioinformatics/btg207; Onteru SK, 2012, ANIM GENET, V43, P18, DOI 10.1111/j.1365-2052.2011.02213.x; Pangalos MN, 1996, NEURODEGENERATION, V5, P445, DOI 10.1006/neur.1996.0061; Pintus E, 2013, ANIMAL GENETICS; Porto-Neto LR, 2014, ANIM GENET, V45, P180, DOI 10.1111/age.12119; Porto-Neto LR, 2012, ANIM GENET; Quigley IK, 2002, MICROSC RES TECHNIQ, V58, P442, DOI 10.1002/jemt.10162; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Safus P, 2006, CZECH J ANIM SCI, V51, P285, DOI 10.17221/3941-CJAS; Sassi C, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.06.002; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schwarzenbacher H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-48; SEIDEMAN SC, 1987, MEAT SCI, V20, P281, DOI 10.1016/0309-1740(87)90083-0; Skaar DA, 2005, MOL PSYCHIATR, V10, P563, DOI 10.1038/sj.mp.4001614; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; Stella R, 2011, J PROTEOME RES, V10, P2744, DOI 10.1021/pr101255c; Sugarman MC, 2002, P NATL ACAD SCI USA, V99, P6334, DOI 10.1073/pnas.082545599; TAJIMA F, 1989, GENETICS, V123, P585; Takeshita S, 2012, GENES GENET SYST, V87, P253, DOI 10.1266/ggs.87.253; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Tang K, 2003, EUR J NEUROSCI, V18, P102, DOI 10.1046/j.1460-9568.2003.02731.x; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Terenina E, 2012, 44 JOURN RECH PORC F; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040736; Zhang YY, 2011, LIVEST SCI, V135, P76, DOI 10.1016/j.livsci.2010.06.070	75	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0151324	10.1371/journal.pone.0151324	http://dx.doi.org/10.1371/journal.pone.0151324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023061	Green Published, gold			2022-12-26	WOS:000373113900009
J	Bouchard, KE; Conant, DF; Anumanchipalli, GK; Dichter, B; Chaisanguanthum, KS; Johnson, K; Chang, EF				Bouchard, Kristofer E.; Conant, David F.; Anumanchipalli, Gopala K.; Dichter, Benjamin; Chaisanguanthum, Kris S.; Johnson, Keith; Chang, Edward F.			High-Resolution, Non-Invasive Imaging of Upper Vocal Tract Articulators Compatible with Human Brain Recordings	PLOS ONE			English	Article							SENSORIMOTOR CORTEX; SPEECH; LIP; VARIABILITY; CONSONANTS; DYNAMICS	A complete neurobiological understanding of speech motor control requires determination of the relationship between simultaneously recorded neural activity and the kinematics of the lips, jaw, tongue, and larynx. Many speech articulators are internal to the vocal tract, and therefore simultaneously tracking the kinematics of all articulators is nontrivial-especially in the context of human electrophysiology recordings. Here, we describe a noninvasive, multi-modal imaging system to monitor vocal tract kinematics, demonstrate this system in six speakers during production of nine American English vowels, and provide new analysis of such data. Classification and regression analysis revealed considerable variability in the articulator-to-acoustic relationship across speakers. Non-negative matrix factorization extracted basis sets capturing vocal tract shapes allowing for higher vowel classification accuracy than traditional methods. Statistical speech synthesis generated speech from vocal tract measurements, and we demonstrate perceptual identification. We demonstrate the capacity to predict lip kinematics from ventral sensorimotor cortical activity. These results demonstrate a multi-modal system to non-invasively monitor articulator kinematics during speech production, describe novel analytic methods for relating kinematic data to speech acoustics, and provide the first decoding of speech kinematics from electrocorticography. These advances will be critical for understanding the cortical basis of speech production and the creation of vocal prosthetics.	[Bouchard, Kristofer E.] Lawrence Berkeley Natl Labs, Biol Syst & Engn Div, Berkeley, CA USA; [Bouchard, Kristofer E.] Lawrence Berkeley Natl Labs, Computat Res Div, Berkeley, CA USA; [Bouchard, Kristofer E.; Conant, David F.; Anumanchipalli, Gopala K.; Dichter, Benjamin; Chaisanguanthum, Kris S.; Chang, Edward F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Conant, David F.; Anumanchipalli, Gopala K.; Dichter, Benjamin; Chaisanguanthum, Kris S.; Chang, Edward F.] UCSF, Ctr Integrat Neurosci, San Francisco, CA USA; [Johnson, Keith] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Chang, EF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA.; Chang, EF (corresponding author), UCSF, Ctr Integrat Neurosci, San Francisco, CA USA.	changed@neurosurg.ucsf.edu	Johnson, Keith/AAM-6322-2020	Johnson, Keith/0000-0002-2569-8121; Dichter, Benjamin/0000-0001-5725-6910	National Institutes of Health [DP2-OD00862, R01-DC012379]; DARPA SUBNETS; Bowes Foundation; Curci Foundation; McKnight Foundation; New York Stem Cell Foundation; Laboratory Directed Research and Development (LDRD) from Berkeley Lab; U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA SUBNETS; Bowes Foundation; Curci Foundation; McKnight Foundation; New York Stem Cell Foundation; Laboratory Directed Research and Development (LDRD) from Berkeley Lab; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	E.F.C. was supported by National Institutes of Health grants DP2-OD00862 and R01-DC012379, DARPA SUBNETS, Bowes Foundation, Curci Foundation, and McKnight Foundation. Edward Chang is a New York Stem Cell Foundation-Robertson Investigator. This research was supported by The New York Stem Cell Foundation. KEB was supported by a Laboratory Directed Research and Development (LDRD) funding from Berkeley Lab, provided by the Director, Office of Science, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The author(s) received no specific funding for this work.	ALFONSO PJ, 1982, LANG SPEECH, V25, P151, DOI 10.1177/002383098202500203; Arce FI, 2013, J NEUROPHYSIOL, V110, P1357, DOI 10.1152/jn.00144.2013; Arce-McShane FI, 2014, J NEUROSCI, V34, P5985, DOI 10.1523/JNEUROSCI.4367-13.2014; BAER T, 1983, J ACOUST SOC AM, V73, P1304, DOI 10.1121/1.389279; BAER T, 1991, J ACOUST SOC AM, V90, P799, DOI 10.1121/1.401949; Black AW, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P1762; BORDEN GJ, 1979, PHONETICA, V36, P21, DOI 10.1159/000259943; Bouchard KE, 2015, BOOTSTRAPPED ADAPTIV, P1; Bouchard KE, 2014, J NEUROSCI, V34, P12662, DOI 10.1523/JNEUROSCI.1219-14.2014; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BROWMAN CP, 1990, J PHONETICS, V18, P299, DOI 10.1016/S0095-4470(19)30376-6; Brumberg JS, 2010, SPEECH COMMUN, V52, P367, DOI 10.1016/j.specom.2010.01.001; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Gick B, 2012, ARTICULATORY PHONETI; GRACCO VL, 1986, EXP BRAIN RES, V65, P156; GRACCO VL, 1994, J NEUROSCI, V14, P6585; Guenther FH, 1999, J ACOUST SOC AM, V105, P2854, DOI 10.1121/1.426900; HARSHMAN R, 1977, J ACOUST SOC AM, V62, P693, DOI 10.1121/1.381581; Hastie T., 2009, UNSUPERVISED LEARNIN; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Hirayama M, 1994, ADV NEURAL INF PROCE, P1043; JOHNSON K, 1993, J ACOUST SOC AM, V94, P701, DOI 10.1121/1.406887; Kellis S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056007; KENT R D, 1972, Folia Phoniatrica, V24, P278; Kim J., 2008, SPARSE NONNEGATIVE M; Ladefoged P., 2011, COURSE PHONETICS, V6th; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LEHISTE I, 1961, J ACOUST SOC AM, V33, P419, DOI 10.1121/1.1908681; Levelt WJM, 1999, PRODUCING SPOKEN LAN, P94; Li M, 2005, CLIN LINGUIST PHONET, V19, P545, DOI 10.1080/02699200500113616; LINDBLOM BE, 1971, J ACOUST SOC AM, V50, P1166, DOI 10.1121/1.1912750; Lofqvist A, 1999, J ACOUST SOC AM, V105, P1864, DOI 10.1121/1.426723; Lotte F, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00097; MacNeilage P, 2011, PRODUCTION SPEECH; Maddieson I., 1984, PATTERNS SOUNDS; Mugler EM, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035015; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; NARAYANAN SS, 1995, J ACOUST SOC AM, V98, P1325, DOI 10.1121/1.413469; Naylor PA, 2007, IEEE T AUDIO SPEECH, V15, P34, DOI 10.1109/TASL.2006.876878; Noiray A, 2011, J ACOUST SOC AM, V129, P340, DOI 10.1121/1.3518452; Pei XM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046028; PERKELL JS, 1993, J ACOUST SOC AM, V93, P2948, DOI 10.1121/1.405814; PERKELL JS, 1992, J ACOUST SOC AM, V92, P3078, DOI 10.1121/1.404204; PERKELL JS, 1985, J ACOUST SOC AM, V77, P1889, DOI 10.1121/1.391940; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Ramanarayanan V, 2011, INTERSPEECH, P61; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Stone M, 1996, J ACOUST SOC AM, V99, P3728, DOI 10.1121/1.414969; Story BH, 1996, J ACOUST SOC AM, V100, P537, DOI 10.1121/1.415960; Thomas MRP, 2009, IEEE T AUDIO SPEECH, V17, P1557, DOI 10.1109/TASL.2009.2022430; Toda T, 2008, SPEECH COMMUN, V50, P215, DOI 10.1016/j.specom.2007.09.001; Ueda Y, 2007, ACOUST SCI TECHNOL, V28, P271, DOI 10.1250/ast.28.271; Vatikiotis-bateson E, 1992, ADV NEUR IN, P191; von Luhmann A, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00617; Watanabe A, 2001, IEEE T SPEECH AUDI P, V9, P317, DOI 10.1109/89.917677; Yamagishi J, 2009, IEEE T AUDIO SPEECH, V17, P1208, DOI 10.1109/TASL.2009.2016394; Yehia HC, 2002, J PHONETICS, V30, P555, DOI 10.1006/jpho.2002.0165; Zen H, 2009, SPEECH COMMUN, V51, P1039, DOI 10.1016/j.specom.2009.04.004	60	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151327	10.1371/journal.pone.0151327	http://dx.doi.org/10.1371/journal.pone.0151327			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019106	Green Published, gold			2022-12-26	WOS:000372807800010
J	Khan, IA; Pilli, S; Surendranath, A; Rampal, R; Chauhan, SK; Tiwari, V; Mouli, VP; Kedia, S; Nayak, B; Das, P; Makharia, GK; Ahuja, V				Khan, Imteyaz Ahmad; Pilli, Sucharita; Surendranath, A.; Rampal, Ritika; Chauhan, Sudhir Kumar; Tiwari, Veena; Mouli, Venigalla Pratap; Kedia, Saurabh; Nayak, Baibaswata; Das, Prasenjit; Makharia, Govind K.; Ahuja, Vineet			Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; ESCHERICHIA-COLI; TISSUE; DNA; PCR	Background Association of Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn's disease (CD) has been controversial due to contradictory reports. Therefore, we determined the prevalence of MAP in patients with CD and intestinal tuberculosis (ITB) and its association with clinical course. Methodology Blood and intestinal biopsies were taken from 69 CD, 32 ITB patients and 41 patients with haemorrhoidal bleed who served as controls. qPCR targeting of MAP-specific IS900 gene was used to detect the presence of MAP DNA. qPCR results were further validated by sequencing. Immunohistochemistry (IHC) was used to detect the presence of MAP antigen in biopsy specimens. CD and ITB patients were followed-up for disease course and response to therapy. Principal Findings The frequency of MAP-specific DNA in biopsies by qPCR was significantly higher in CD patients (23.2%, p = 0.03) as compared to controls (7.3%). No significant difference in intestinal MAP presence was observed between ITB patients (12.5%, p = 0.6) and controls (7.3%). MAP presence in blood of CD patients was 10.1% as compared to 4.9% in controls while no patients with ITB were found to be positive (p = 0.1). Using IHC for detection of MAP antigen, the prevalence of MAP in CD was 2.9%, 12.5% in ITB patients and 2.4% in controls. However, long-term follow-up of the patients revealed no significant associations between clinical characteristics and treatment outcomes with MAP positivity. Conclusion We report significantly high prevalence of MAP in intestinal biopsies of CD patients. However, the presence of MAP does not affect the disease course and treatment outcomes in either CD or ITB patients.	[Khan, Imteyaz Ahmad; Pilli, Sucharita; Surendranath, A.; Rampal, Ritika; Chauhan, Sudhir Kumar; Tiwari, Veena; Mouli, Venigalla Pratap; Kedia, Saurabh; Nayak, Baibaswata; Makharia, Govind K.; Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India; [Das, Prasenjit] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Ahuja, V (corresponding author), All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India.	vins_ahuja@hotmail.com	Ahuja, Vineet/N-1705-2019; Nayak, Baibaswata/L-6156-2016; Kedia, Saurabh/AAD-7227-2020	Ahuja, Vineet/0000-0002-5474-9709; 	Indian Council of Medical Research, New Delhi, India [30/3/2008/25-ECD-II]; Indian Council of Medical Research (ICMR) [30/03/25/2008/ECD II]	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	The study was supported by a grant (30/3/2008/25-ECD-II) from the Indian Council of Medical Research (www.icmr.nic.in), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Dr. B.N. Tripathi, Dr. S.K. Dixit, and Dr. G.G Sonawane from Central Sheep and Wool Research Institute (CSWRI) for providing sheep serum and MAP positive tissue. We also thank Indian Council of Medical Research (ICMR) for funding this research (Ref No.: 30/03/25/2008/ECD II)	Ahuja V, 2012, INDIAN J GASTROENTER, V31, P294, DOI 10.1007/s12664-012-0272-3; Ahuja V, 2010, J DIGEST DIS, V11, P134, DOI 10.1111/j.1751-2980.2010.00429.x; Autschbach F, 2005, GUT, V54, P944, DOI 10.1136/gut.2004.045526; Beran V, 2006, VET MED-CZECH, V51, P365, DOI 10.17221/5557-VETMED; Bernstein CN, 2003, J CLIN MICROBIOL, V41, P4986, DOI 10.1128/JCM.41.11.4986-4990.2003; Bull TJ, 2000, MICROBIOL-SGM, V146, P2185, DOI 10.1099/00221287-146-9-2185; BUTCHER PD, 1988, GUT, V29, P1222, DOI 10.1136/gut.29.9.1222; Cellier C, 1998, GASTROEN CLIN BIOL, V22, P675; CHIODINI RJ, 1984, DIGEST DIS SCI, V29, P1073, DOI 10.1007/BF01317078; CHIODINI RJ, 1989, CLIN MICROBIOL REV, V2, P90, DOI 10.1128/CMR.2.1.90-117.1989; CHIODINI RJ, 1984, J CLIN MICROBIOL, V20, P966, DOI 10.1128/JCM.20.5.966-971.1984; Collins MT, 2000, J CLIN MICROBIOL, V38, P4373, DOI 10.1128/JCM.38.12.4373-4381.2000; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Delgado Fernando, 2011, Vet Med Int, V2011, P267102, DOI 10.4061/2011/267102; Ellingson Jay L E, 2003, Clin Med Res, V1, P217; Fujita H, 2002, J GASTROENTEROL, V37, P509, DOI 10.1007/s005350200079; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Kirkwood CD, 2009, INFLAMM BOWEL DIS, V15, P1643, DOI 10.1002/ibd.20967; Schwartz D, 2000, CLIN MICROBIOL INFEC, V6, P303, DOI 10.1046/j.1469-0691.2000.00093.x; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Xu XR, 2014, WORLD J GASTROENTERO, V20, P3255, DOI 10.3748/wjg.v20.i12.3255	23	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152063	10.1371/journal.pone.0152063	http://dx.doi.org/10.1371/journal.pone.0152063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019109	Green Published, gold			2022-12-26	WOS:000372807800027
J	Paoletti, MG; Blakemore, RJ; Csuzdi, C; Dorigo, L; Dreon, AL; Gavinelli, F; Lazzarini, F; Manno, N; Moretto, E; Porco, D; Ruzzier, E; Toniello, V; Squartini, A; Concheri, G; Zanardo, M; Alba-Tercedor, J				Paoletti, Maurizio G.; Blakemore, Robert J.; Csuzdi, Csaba; Dorigo, Luca; Dreon, Angelo Leandro; Gavinelli, Federico; Lazzarini, Francesca; Manno, Nicola; Moretto, Enzo; Porco, David; Ruzzier, Enrico; Toniello, Vladimiro; Squartini, Andrea; Concheri, Giuseppe; Zanardo, Marina; Alba-Tercedor, Javier			Barcoding Eophila crodabepis sp nov (Annelida, Oligochaeta, Lumbricidae), a Large Stripy Earthworm from Alpine Foothills of Northeastern Italy Similar to Eophila tellinii (Rosa, 1888)	PLOS ONE			English	Article								A new Italian earthworm morphologically close to the similarly large and anecic Eophila tellinii (Rosa, 1888) is described. Distribution of Eophila crodabepis sp. nov. extends over 750 km(2) from East to West on the Asiago Plateau and Vittorio Veneto Hills, from North to South on mounts Belluno Prealps (Praderadego and Cesen), Asiago, Grappa and onto the Montello foothills. This range abuts that of Eophila tellinii in northern Friuli Venezia Giulia region. Known localities of both E. tellinii and E. crodabepis sp. nov. are mapped. mtDNA barcoding definitively separates the new western species from classical Eophila tellinii (Rosa, 1888).	[Paoletti, Maurizio G.; Dreon, Angelo Leandro; Gavinelli, Federico; Lazzarini, Francesca; Manno, Nicola] Univ Padua, Dipartimento Biol, Padua, Italy; [Blakemore, Robert J.] Hanyang Univ, Coll Nat Sci, Seoul 133791, South Korea; [Csuzdi, Csaba] Eszterhazy Karoly Coll, Dept Zool, Eger, Hungary; [Dorigo, Luca] Museo Friulano Storia Nat, Udine, Italy; [Moretto, Enzo] ESAPOLIS, Padua, Italy; [Porco, David] Univ Rouen, Lab ECODIV, Mont St Aignan, France; [Ruzzier, Enrico] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England; [Toniello, Vladimiro] Federaz Speleol Veneta GSCAI, Lab Biospeleol Villa Papadopoli, Vittorio Veneto, Italy; [Squartini, Andrea; Concheri, Giuseppe; Zanardo, Marina] Univ Padua, Dipartimento Agron Anim Alimenti Risorse Nat & Am, Padua, Italy; [Alba-Tercedor, Javier] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain	University of Padua; Hanyang University; Universite de Rouen Normandie; Natural History Museum London; University of Padua; University of Granada	Paoletti, MG (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	paoletti@bio.unipd.it	Ruzzier, Enrico/GQO-8861-2022; Alba-Tercedor, Javier/C-3679-2015; Csuzdi, Csaba/A-8619-2010; Ruzzier, Enrico/M-4602-2019; Gavinelli, Federico/AAA-2838-2020; Squartini, Andrea/AAX-9942-2020; Dorigo, Luca/HGD-3354-2022; Concheri, Giuseppe/L-4151-2015	Ruzzier, Enrico/0000-0003-1020-1247; Csuzdi, Csaba/0000-0002-0319-7836; Ruzzier, Enrico/0000-0003-1020-1247; Squartini, Andrea/0000-0002-1961-1165; Dorigo, Luca/0000-0003-4637-8896; Concheri, Giuseppe/0000-0002-5812-8504; Gavinelli, Federico/0000-0001-5379-5845; Blakemore, Robert/0000-0001-9797-8328				Blakemore RJ, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.41.374; Blakemore RJ, 2008, LIST VALID INVALID S; Blakemore RJ, 2012, COSMOPOLITAN EARTHWO; Blakemore RJ, 2008, ADV EARTHWORM TAXONO, VIII, P129; Blakemore RJ, 2000, CD ROM MONOGRAPH REV, P800; Blakemore RJ, 1867, AFRICAN INVERTEBRATE; Blakemore RJ, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.285.4502; Bouche MB, 1972, LOMBRICIENS FRANCE E; Braido V, 1997, SPELEOLOGIA VENETA, P122; Braido V, 1993, THESIS U STUDI PADOV; CEJKA Z, 1989, J ULTRA MOL STRUCT R, V102, P71, DOI 10.1016/0889-1605(89)90035-9; Cernosvitov L, 1935, ARCH PROPRIRODOVEDEC, P1; Cernosvitov L, 1934, MITT KON NATURWISS I, P71; DARWIN C, 1881, FORMATION VEGETABLE; De Ribaucourt E, 1896, REV SUISSE ZOOL; Easton E.G., 1983, P475; Grainger C, 2006, PROTOCOLS COI AMPLIF; Grasse, 1959, TRAITE ZOOL, V1, P224; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Ivanova NV, 2006, HEBERT PDN PROTOCOLS; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lavelle P., 1983, P449; LEE K. E., 1959, NEW ZEALAND DEPT SCI AND INDUST REA BULL, V130, P1; Lee KE, 1985, EARTHWORMS THEIR ECO, P1; Michaelsen W, 1900, TIERREICH 10 OLIGOCH, V10; OMODEO P., 1956, ARCH ZOOL ITAL, V41, P129; OMODEO P, 1988, B ZOOL, V55, P73; Paoletti MG, 1999, AGR ECOSYST ENVIRON, V74, P137, DOI 10.1016/S0167-8809(99)00034-1; Paoletti MG, 2006, ANN ARID ZONE, V45, P309; Paoletti MG, 1978, GROTTE ITALIA, P45; Paoletti MG, 2013, AGROECOSISTEMI BIOL, V27, P25; Paoletti MG, 1988, REDIA, V2, P501; Pelosi C, 2009, EUR J SOIL BIOL, V45, P176, DOI 10.1016/j.ejsobi.2008.09.013; Porco D, 2013, BIOL INVASIONS, V15, P899, DOI 10.1007/s10530-012-0338-2; Rosa D, 1888, B MUS ZOOL ANAT COMP, V3, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith F., 1928, Rep Scient Res Norwegian Exped Novaya Zemblya (1921), V2, P1; Stephenson J. L, 1930, OLIGOCHAETA; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Viaggi del E, 1893, B MUSEI ZOOLOGIA ANA, V8, P1	43	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151799	10.1371/journal.pone.0151799	http://dx.doi.org/10.1371/journal.pone.0151799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019284	Green Submitted, Green Published, gold			2022-12-26	WOS:000372807800020
J	Peterson, SW; Knox, NC; Golding, GR; Tyler, SD; Tyler, AD; Mabon, P; Embree, JE; Fleming, F; Fanella, S; Van Domselaar, G; Mulvey, MR; Graham, MR				Peterson, Shelley W.; Knox, Natalie C.; Golding, George R.; Tyler, Shaun D.; Tyler, Andrea D.; Mabon, Philip; Embree, Joanne E.; Fleming, Fiona; Fanella, Sergio; Van Domselaar, Gary; Mulvey, Michael R.; Graham, Morag R.			A Study of the Infant Nasal Microbiome Development over the First Year of Life and in Relation to Their Primary Adult Caregivers Using cpn60 Universal Target (UT) as a Phylogenetic Marker	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; STAPHYLOCOCCUS-AUREUS; NASOPHARYNGEAL COLONIZATION; STREPTOCOCCUS-PNEUMONIAE; DYNAMICS; COMMUNITIES; AGE; MICROFLORA; DIVERSITY; INFECTION	Whereas the infant gut microbiome is the subject of intense study, relatively little is known regarding the nares microbiome in newborns and during early life. This study aimed to survey the typical composition and diversity of human anterior nare microflora for developing infants over time, and to explore how these correlate to their primary caregivers. Single nare swabs were collected at five time points over a one-year period for each subject from infant-caregiver pairs. Our study comprised of 50 infants (recruited at 2 weeks, post delivery) and their 50 primary caregivers. Applying the chaperonin-60 (cpn60) universal target (UT) amplicon as our molecular barcoding marker to census survey the microbial communities, we longitudinally surveyed infant nares microbiota at 5 time points over the course of the first year of life. The inter-and intra-subject diversity was catalogued and compared, both longitudinally and relative to their adult primary caregivers. Although within-subject variability over time and inter-subject variability were both observed, the assessment detected only one or two predominant genera for individual infant samples, belonging mainly to phyla Actinobacteria, Firmicutes, and Proteobacteria. Consistent with previously observed microbial population dynamics in other body sites, the diversity of nares microflora increased over the first year of life and infants showed differential operational taxonomic units (OTUs) relative to their matched primary caregiver. The collected evidence also support that both temporal and seasonal changes occur with respect to carriage of potentially pathogenic bacteria (PPBs), which may influence host predisposition to infection. This pilot study surveying paired infant/caregiver nare microbiomes provides novel longitudinal diversity information that is pertinent to better understanding nare microbiome development in infants.	[Peterson, Shelley W.; Golding, George R.; Embree, Joanne E.; Fleming, Fiona; Fanella, Sergio; Van Domselaar, Gary; Mulvey, Michael R.; Graham, Morag R.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Peterson, Shelley W.; Golding, George R.; Tyler, Andrea D.; Mulvey, Michael R.] Publ Hlth Agcy Canada, Bacteriol Div, Natl Microbiol Lab, Winnipeg, MB, Canada; [Knox, Natalie C.; Tyler, Shaun D.; Mabon, Philip; Van Domselaar, Gary; Graham, Morag R.] Publ Hlth Agcy Canada, Sci Technol Cores & Serv Div, Natl Microbiol Lab, Winnipeg, MB, Canada; [Embree, Joanne E.; Fanella, Sergio] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Fleming, Fiona] Manitoba Clin, Pediat Urgent Care, Winnipeg, MB, Canada; [Van Domselaar, Gary] Univ Manitoba, Dept Comp Sci, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba; University of Manitoba	Graham, MR (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.; Graham, MR (corresponding author), Publ Hlth Agcy Canada, Sci Technol Cores & Serv Div, Natl Microbiol Lab, Winnipeg, MB, Canada.	morag.graham@phac-aspc.gc.ca	Peterson, Shelley/AAU-2028-2021	Peterson, Shelley/0000-0002-6432-9257; Knox, Natalie/0000-0001-6133-7799	Public Health Agency of Canada; Canadian federal Genomics Research and Development Initiative (GRDI); GRDI	Public Health Agency of Canada; Canadian federal Genomics Research and Development Initiative (GRDI); GRDI	This work was funded by the Public Health Agency of Canada (to MRM and MRG), and an intramural grant from the Canadian federal Genomics Research and Development Initiative (GRDI) (awarded to MRM). SWP was supported by GRDI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Avershina E, 2014, FEMS MICROBIOL ECOL, V87, P280, DOI 10.1111/1574-6941.12223; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bassis CM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-27; Bergstrom A, 2014, APPL ENVIRON MICROB, V80, P2889, DOI 10.1128/AEM.00342-14; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P298, DOI 10.1164/rccm.201401-0073OC; Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Camarinha-Silva A, 2012, ENV MICROBIOL REP, V4, P126, DOI 10.1111/j.1758-2229.2011.00313.x; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Dumonceaux TJ, 2006, J MICROBIOL METH, V64, P46, DOI 10.1016/j.mimet.2005.04.006; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Erturk-Hasdemir D, 2013, CURR OPIN IMMUNOL, V25, P450, DOI 10.1016/j.coi.2013.06.001; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Fouhy F, 2012, GUT MICROBES, V3, P203, DOI 10.4161/gmic.20169; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Gao Zhancheng, 2014, Genomics Proteomics & Bioinformatics, V12, P144, DOI 10.1016/j.gpb.2014.06.001; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Government of Canada, CAN CLIM NORM AV 197; Hanage WP, 2014, NATURE, V512, P247, DOI 10.1038/512247a; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Hill JE, 2006, ENVIRON MICROBIOL, V8, P741, DOI 10.1111/j.1462-2920.2005.00944.x; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hull MW, 2007, INFECT DIS CLIN N AM, V21, P265, DOI 10.1016/j.idc.2007.03.015; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jian WY, 2001, INT J SYST EVOL MICR, V51, P1633, DOI 10.1099/00207713-51-5-1633; Johnson RC, 2015, INFECT IMMUN, V83, P802, DOI 10.1128/IAI.02664-14; Kononen E, 2005, ANAEROBES UPPER RESP; Kwok AYC, 2003, INT J SYST EVOL MICR, V53, P87, DOI 10.1099/ijs.0.02210-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebon A, 2008, J CLIN MICROBIOL, V46, P3517, DOI 10.1128/JCM.00641-08; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Links MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049755; Lutsar I, 2014, EUR J PEDIATR, V173, P997, DOI 10.1007/s00431-014-2279-5; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Manitoba Health, 2015, REC IMM SCHED INF CH; Marques TM, 2010, CURR OPIN BIOTECH, V21, P149, DOI 10.1016/j.copbio.2010.03.020; McInnes P, MANUAL PROCEDURES HU; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Public Health Agency of Canada, 2015, NACI REC STAT UPD; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rasmussen TT, 2000, APMIS, V108, P663, DOI 10.1034/j.1600-0463.2000.d01-13.x; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shilts MH, 2016, MICROB ECOL, V71, P233, DOI 10.1007/s00248-015-0663-y; Shitaye Demissie, 2010, Ethiop Med J, V48, P11; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Vermette CJ, 2010, MICROB ECOL, V59, P14, DOI 10.1007/s00248-009-9601-1; Vissers M, 2014, MUCOSAL IMMUNOL, V7, P227, DOI 10.1038/mi.2013.93; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Walls T, 2003, J MED MICROBIOL, V52, P829, DOI 10.1099/jmm.0.05259-0; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yan ML, 2013, CELL HOST MICROBE, V14, P631, DOI 10.1016/j.chom.2013.11.005; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhou YJ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r66	71	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152493	10.1371/journal.pone.0152493	http://dx.doi.org/10.1371/journal.pone.0152493			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019455	Green Submitted, gold, Green Published			2022-12-26	WOS:000372807800054
J	Karsten, B; Larumbe-Zabala, E; Kandemir, G; Hazir, T; Klose, A; Naclerio, F				Karsten, Bettina; Larumbe-Zabala, Eneko; Kandemir, Gokhan; Hazir, Tahir; Klose, Andreas; Naclerio, Fernando			The Effects of a 6-Week Strength Training on Critical Velocity, Anaerobic Running Distance, 30-M Sprint and Yo-Yo Intermittent Running Test Performances in Male Soccer Players	PLOS ONE			English	Article							RECOVERY TEST; CRITICAL POWER; ENDURANCE; RELIABILITY; VALIDITY; SPEED; MODEL	The objectives of this study were to examine the effects of a moderate intensity strength training on changes in critical velocity (CV), anaerobic running distance (D'), sprint performance and Yo-Yo intermittent running test (Yo-Yo IR1) performances. Methods: two recreational soccer teams were divided in a soccer training only group (SO; n = 13) and a strength and soccer training group (ST; n = 13). Both groups were tested for values of CV, D', Yo-Yo IR1 distance and 30-m sprint time on two separate occasions (pre and post intervention). The ST group performed a concurrent 6-week upper and lower body strength and soccer training, whilst the SO group performed a soccer only training. Results: after the re-test of all variables, the ST demonstrated significant improvements for both, YoYo IR1 distance (p = 0.002) and CV values (p< 0.001) with no significant changes in the SO group. 30-m sprint performance were slightly improved in the ST group with significantly decreased performance times identified in the SO group (p< 0.001). Values for D' were slightly reduced in both groups (ST -44.5 m, 95% CI = -90.6 to 1.6; SO -42.6 m, 95% CI = -88.7 to 3.5). Conclusions: combining a 6-week moderate strength training with soccer training significantly improves CV, Yo-Yo IR1 whilst moderately improving 30-m sprint performances in non-previously resistance trained male soccer players. Critical Velocity can be recommended to coaches as an additional valid testing tool in soccer.	[Karsten, Bettina; Kandemir, Gokhan; Naclerio, Fernando] Univ Greenwich, Dept Life & Sports Sci, Greenwich, Kent, England; [Larumbe-Zabala, Eneko] Texas Tech Univ, Hlth Sci Ctr, Clin Res Inst, Lubbock, TX 79430 USA; [Hazir, Tahir] Hacettepe Univ, Fac Sports Sci, Ankara, Turkey; [Klose, Andreas] Univ Munster, Arbeitsbereich Sportpadag, D-48149 Munster, Germany	University of Greenwich; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Hacettepe University; University of Munster	Karsten, B (corresponding author), Univ Greenwich, Dept Life & Sports Sci, Greenwich, Kent, England.	B.Karsten@gre.ec.uk	Larumbe-Zabala, Eneko/I-1648-2013; HAZIR, TAHIR/J-2360-2013; Naclerio, Fernando/G-4407-2013; Larumbe-Zabala, Eneko/I-7519-2019	Larumbe-Zabala, Eneko/0000-0002-8949-0602; Naclerio, Fernando/0000-0001-7405-4894; Larumbe-Zabala, Eneko/0000-0002-8949-0602; Karsten, Bettina/0000-0001-7336-9472				[Anonymous], 2008, ESSENTIALS STRENGTH; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bangsbo J, 1994, Acta Physiol Scand Suppl, V619, P1; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Barr MJ, 2014, J STRENGTH COND RES, V28, P2585, DOI 10.1519/JSC.0000000000000423; Bishop D, 1996, Aust J Sci Med Sport, V28, P101; Clark IE, 2013, J STRENGTH COND RES, V27, P3335, DOI 10.1519/JSC.0b013e31828f9d87; Clarke AC, 2014, J SCI MED SPORT, V17, P144, DOI 10.1016/j.jsams.2013.03.008; Damasceno M., 2012, EUR J APPL PHYSL, V115, P1513; Dekerle J, 2006, EUR J APPL PHYSIOL, V96, P257, DOI 10.1007/s00421-005-0074-8; Deprez D, 2014, J SPORT SCI, V32, P903, DOI 10.1080/02640414.2013.876088; Fanchini M, 2014, J SPORT SCI, V32, P1950, DOI 10.1080/02640414.2014.969295; GAESSER GA, 1995, MED SCI SPORT EXER, V27, P1430; Galbraith A, 2011, J SPORTS MED DOPING, V1, P1, DOI [10.4172/2161-0673.1000101, DOI 10.4172/2161-0673.1000101]; Galbraith A, 2014, INT J SPORT PHYSIOL, V9, P931, DOI 10.1123/ijspp.2013-0507; Haugen TA, 2014, INT J SPORT PHYSIOL, V9, P432, DOI [10.1123/IJSPP.2013-0121, 10.1123/ijspp.2013-0121]; Helgerud J, 2011, INT J SPORTS MED, V32, P677, DOI 10.1055/s-0031-1275742; Hoff J, 2004, SPORTS MED, V34, P165, DOI 10.2165/00007256-200434030-00003; Impellizzeri FM, 2006, INT J SPORTS MED, V27, P483, DOI 10.1055/s-2005-865839; Jenkins D, 1998, J Sci Med Sport, V1, P213; Jones A. M., 2009, OLYMPIC TXB SCI SPOR; Karsten B, 2015, INT J SPORTS PHYSL P; Kotzamanidis C, 2005, J STRENGTH COND RES, V19, P369; Markovic G, 2011, J STRENGTH COND RES, V25, P2931, DOI 10.1519/JSC.0b013e318207ed8c; Mikkola J, 2011, J SPORT SCI, V29, P1359, DOI 10.1080/02640414.2011.589467; POOLE DC, 1988, ERGONOMICS, V31, P1265, DOI 10.1080/00140138808966766; Robertson RJ, 2003, MED SCI SPORT EXER, V35, P333, DOI 10.1249/01.MSS.0000048831.15016.2A; Ronnestad BR, 2008, J STRENGTH COND RES, V22, P773, DOI 10.1519/JSC.0b013e31816a5e86; Rosch D, 2000, AM J SPORT MED, V28, pS29, DOI 10.1177/28.suppl_5.s-29; Sawyer BJ, 2014, J STRENGTH COND RES, V28, P601, DOI 10.1519/JSC.0b013e31829e113b; Shalfawi SAI, 2013, J STRENGTH COND RES, V27, P2966, DOI 10.1519/JSC.0b013e31828c2889; Silva JR, 2015, SPORTS MED OPEN, V2; Smith CGM, 2001, EUR J APPL PHYSIOL, V85, P19, DOI 10.1007/s004210100384; STICKLAND MK, 2000, SPORTS MED TRAIN REH, V9, P289, DOI DOI 10.1080/15438620009512563; Stolen T, 2005, SPORTS MED, V35, P501; Storen O, 2008, MED SCI SPORT EXER, V40, P1087, DOI 10.1249/MSS.0b013e318168da2f; Taipale RS, 2010, INT J SPORTS MED, V31, P468, DOI 10.1055/s-0029-1243639; Vanhatalo A, 2011, INT J SPORT PHYSIOL, V6, P128, DOI 10.1123/ijspp.6.1.128; Wisloff U, 1998, MED SCI SPORT EXER, V30, P462, DOI 10.1097/00005768-199803000-00019	39	18	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151448	10.1371/journal.pone.0151448	http://dx.doi.org/10.1371/journal.pone.0151448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015418	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000372708900025
J	Murray-Stewart, T; Sierra, JC; Piazuelo, MB; Mera, RM; Chaturvedi, R; Bravo, LE; Correa, P; Schneider, BG; Wilson, KT; Casero, RA				Murray-Stewart, T.; Sierra, J. C.; Piazuelo, M. B.; Mera, R. M.; Chaturvedi, R.; Bravo, L. E.; Correa, P.; Schneider, B. G.; Wilson, K. T.; Casero, R. A.			Epigenetic silencing of miR-124 prevents spermine oxidase regulation: implications for Helicobacter pylori-induced gastric cancer	ONCOGENE			English	Article							ABERRANT DNA METHYLATION; HUMAN POLYAMINE OXIDASE; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; INHIBITS PROLIFERATION; HYDROGEN-PEROXIDE; PROSTATE-CANCER; MICRORNA GENES; FIELD DEFECT; RISK	Chronic inflammation contributes to the development of various forms of cancer. The polyamine catabolic enzyme spermine oxidase (SMOX) is induced in chronic inflammatory conditions, including Helicobacter pylori-associated gastritis, where its production of hydrogen peroxide contributes to DNA damage and subsequent tumorigenesis. MicroRNA expression levels are also altered in inflammatory conditions; specifically, the tumor suppressor miR-124 becomes silenced by DNA methylation. We sought to determine if this repression of miR-124 is associated with elevated SMOX activity and concluded that miR-124 is indeed a negative regulator of SMOX. In gastric adenocarcinoma cells harboring highly methylated and silenced mir-124 gene loci, 5-azacytidine treatment allowed miR-124 re-expression and decreased SMOX expression. Overexpression of an exogenous miR-124-3p mimic repressed SMOX mRNA and protein expression as well as H2O2 production by >50% within 24 h. Reporter assays indicated that direct interaction of miR-124 with the 3 '-untranslated region of SMOX mRNA contributes to this negative regulation. Importantly, overexpression of miR-124 before infection with H. pylori prevented the induction of SMOX believed to contribute to inflammation-associated tumorigenesis. Compelling human in vivo data from H. pylori-positive gastritis tissues indicated that the mir-124 gene loci are more heavily methylated in a Colombian population characterized by elevated SMOX expression and a high risk for gastric cancer. Furthermore, the degree of mir-124 methylation significantly correlated with SMOX expression throughout the population. These results indicate a protective role for miR-124 through the inhibition of SMOX-mediated DNA damage in the etiology of H. pylori-associated gastric cancer.	[Murray-Stewart, T.; Casero, R. A.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Bunting Blaustein Bldg,Room 551,1650 Orleans St, Baltimore, MD 21287 USA; [Sierra, J. C.; Piazuelo, M. B.; Mera, R. M.; Chaturvedi, R.; Correa, P.; Schneider, B. G.; Wilson, K. T.] Vanderbilt Univ, Med Ctr, Div Gastroenterol, Nashville, TN USA; [Chaturvedi, R.] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India; [Bravo, L. E.] Univ Valle, Sch Med, Dept Pathol, Cali, Colombia; [Wilson, K. T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Johns Hopkins University; Johns Hopkins Medicine; Vanderbilt University; Jawaharlal Nehru University, New Delhi; Universidad del Valle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Casero, RA (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Bunting Blaustein Bldg,Room 551,1650 Orleans St, Baltimore, MD 21287 USA.	rcasero@jhmi.edu	Stewart, Tracy Murray/B-6137-2017; Bravo, Luis Eduardo/G-9671-2013; Bravo, Luis Eduardo/AAB-7209-2019	Stewart, Tracy Murray/0000-0001-8679-6414; Bravo, Luis Eduardo/0000-0002-9708-0312; Casero, Robert/0000-0001-5653-3306; Wilson, Keith/0000-0003-4421-1830	National Institutes of Health [R01CA051085, R01CA098454, R01DK053620, R01CA190612, P01CA028842, P01CA116087, K01AT007324]; Samuel Waxman Cancer Research Foundation; Vanderbilt Digestive Disease Research Center [P30DK058404, UL1RR024975]; Office of Medical Research, Department of Veterans Affairs [1I01BX001453]; NATIONAL CANCER INSTITUTE [P01CA028842, P01CA116087, R01CA051085, R01CA190612, R01CA098454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K01AT007324] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053620, P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; Vanderbilt Digestive Disease Research Center; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Alberto Delgado for his technical expertise and performance of SMOX immunohistochemistry studies. This study was supported by National Institutes of Health Grants R01CA051085 and R01CA098454 (to RAC), R01DK053620 and R01CA190612 (to KTW), P01CA028842 (to PC and KTW), P01CA116087 (to KTW), K01AT007324 (to RC), the Samuel Waxman Cancer Research Foundation (to RAC), the Vanderbilt Digestive Disease Research Center grant (P30DK058404), UL1RR024975 (Vanderbilt CTSA, Pilot Project to KTW) and Merit Review Grant 1I01BX001453 from the Office of Medical Research, Department of Veterans Affairs (to KTW).	Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Asada K, 2015, GUT, V64, P388, DOI 10.1136/gutjnl-2014-307094; Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo MC, 2004, HELICOBACTER, V9, P262, DOI 10.1111/j.1083-4389.2004.00221.x; Cervelli M, 2004, EUR J BIOCHEM, V271, P760, DOI 10.1111/j.1432-1033.2004.03979.x; Chaturvedi R, 2015, ONCOGENE, V34, P3429, DOI 10.1038/onc.2014.273; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2014, GASTROENTEROLOGY, V146, P1739, DOI 10.1053/j.gastro.2014.02.005; Chaturvedi R, 2011, GASTROENTEROLOGY, V141, P1696, DOI 10.1053/j.gastro.2011.07.045; CORREA P, 1976, JNCI-J NATL CANCER I, V57, P1027, DOI 10.1093/jnci/57.5.1027; Dalal RS, 2014, J LEUKOCYTE BIOL, V96, P213, DOI 10.1189/jlb.4BT0214-100R; de Sablet T, 2011, GUT, V60, P1189, DOI 10.1136/gut.2010.234468; Ford Alexander C, 2014, BMJ, V348, pg3174, DOI 10.1136/bmj.g3174; Goodwin AC, 2008, PROSTATE, V68, P766, DOI 10.1002/pros.20735; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Goodwin CS, 1997, CLIN INFECT DIS, V25, P1017, DOI 10.1086/516077; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hardbower DM, 2013, GUT MICROBES, V4, P475, DOI 10.4161/gmic.25583; Hong SKS, 2010, INFLAMM BOWEL DIS, V16, P1557, DOI 10.1002/ibd.21224; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Murray-Stewart T, 2008, FEBS J, V275, P2795, DOI 10.1111/j.1742-4658.2008.06419.x; Nakajima T, 2006, CANCER EPIDEM BIOMAR, V15, P2317, DOI 10.1158/1055-9965.EPI-06-0436; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pegg AE, 1998, BIOCHEM SOC T, V26, P580, DOI 10.1042/bst0260580; Plummer M, 2015, INT J CANCER, V136, P487, DOI 10.1002/ijc.28999; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Schneider BG, 2013, EPIGENETICS-US, V8, P1153, DOI 10.4161/epi.26072; Schneider BG, 2010, INT J CANCER, V127, P2588, DOI 10.1002/ijc.25274; Shi XB, 2013, ONCOGENE, V32, P4130, DOI 10.1038/onc.2012.425; Shimizu T, 2013, EUR UROL, V63, P1091, DOI 10.1016/j.eururo.2012.11.030; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Ueda Y, 2014, DIGEST DIS SCI, V59, P2444, DOI 10.1007/s10620-014-3193-4; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Wang HY, 2015, ADV DRUG DELIVER REV, V81, P142, DOI 10.1016/j.addr.2014.10.031; Wang YL, 2001, CANCER RES, V61, P5370; Wang YL, 2003, BIOCHEM BIOPH RES CO, V304, P605, DOI 10.1016/S0006-291X(03)00636-3; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Xie LM, 2014, MOL CELL BIOCHEM, V392, P153, DOI 10.1007/s11010-014-2028-0; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511	50	39	43	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 20	2016	35	42					5480	5488		10.1038/onc.2016.91	http://dx.doi.org/10.1038/onc.2016.91			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XO	27041578	Green Accepted			2022-12-26	WOS:000386998200003
J	Graziano, S; Johnston, R; Deng, O; Zhang, J; Gonzalo, S				Graziano, S.; Johnston, R.; Deng, O.; Zhang, J.; Gonzalo, S.			Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence	ONCOGENE			English	Article							CATHEPSIN-L EXPRESSION; A-TYPE LAMINS; HOMOLOGOUS RECOMBINATION; BREAST-CANCER; DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; GENOMIC INSTABILITY; CYSTEINE CATHEPSINS; CELLULAR SENESCENCE; CRITICAL MEDIATOR	Oncogenic Ras expression is associated with activation of the DNA damage response (DDR) pathway, as evidenced by elevated DNA damage, primarily DNA double-strand breaks (DSBs), and activation of DNA damage checkpoints, which in primary human cells leads to entry into senescence. DDR activation is viewed as a physiological barrier against uncontrolled proliferation in oncogenic Ras-expressing cells, and arises in response to genotoxic stress due to the production of reactive oxygen species that damage DNA and to hyper-replication stress. Although oncogene-induced senescence (OIS) is considered a tumor suppressor mechanism, the accumulation of DNA damage in senescent cells is thought to cause genomic instability, eventually allowing secondary hits in the genome that promote tumorigenesis. To date, the molecular mechanisms behind DNA repair defects during OIS remain poorly understood. Here, we show that oncogenic Ras expression in human primary cells results in the downregulation of BRCA1 and 53BP1, two key factors in DNA DSB repair by homologous recombination and non-homologous end joining, respectively. As a consequence, Ras-induced senescent cells are hindered in their ability to recruit BRCA1 and 53BP1 to DNA damage sites. Whereas BRCA1 is downregulated at transcripts levels, 53BP1 loss is caused by activation of cathepsin L-mediated degradation of 53BP1 protein. Moreover, we discovered a marked downregulation of vitamin D receptor (VDR) during OIS, and a role for the vitamin D/VDR axis regulating the levels of these DNA repair factors during OIS. This study reveals a new functional relationship between the oncogene Ras, the vitamin D/VDR axis and the expression of DNA repair factors, in the context of OIS. The observed deficiencies in DNA repair factors in senescent cells could contribute to the genomic instability that allows senescence bypass and tumorigenesis.	[Graziano, S.; Johnston, R.; Gonzalo, S.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, 1100S Grand Ave, St Louis, MO 63104 USA; [Deng, O.; Zhang, J.] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH 44106 USA	Saint Louis University; Case Western Reserve University	Gonzalo, S (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, 1100S Grand Ave, St Louis, MO 63104 USA.	sgonzalo@slu.edu	Gonzalo, Susana/T-8275-2019	Graziano, Simona/0000-0003-2661-1240; Gonzalo, Susana/0000-0001-9631-1206; Johnston, Rachel/0000-0002-6738-813X; Deng, Ou/0000-0002-9933-1832	NATIONAL CANCER INSTITUTE [R01CA154625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094513] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA154625] Funding Source: Medline; NIGMS NIH HHS [R01 GM094513] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Aly A, 2011, J MOL CELL BIOL, V3, P66, DOI 10.1093/jmcb/mjq055; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Campbell MJ, 2000, ONCOGENE, V19, P5091, DOI 10.1038/sj.onc.1203888; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Collette J, 2004, INT J CANCER, V112, P190, DOI 10.1002/ijc.20398; Croke M, 2013, CELL CYCLE, V12, P3629, DOI 10.4161/cc.26582; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Deng CH, 2009, MOL ENDOCRINOL, V23, P226, DOI 10.1210/me.2008-0075; DENHARDT DT, 1987, ONCOGENE, V2, P55; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gonzalo S, 2014, J STEROID BIOCHEM, V144, P59, DOI 10.1016/j.jsbmb.2013.09.009; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Grotsky DA, 2013, J CELL BIOL, V200, P187, DOI 10.1083/jcb.201204053; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Helleday T, 2005, CELL CYCLE, V4, P1176, DOI 10.4161/cc.4.9.2031; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Kass EM, 2010, CANCER CELL, V17, P423, DOI 10.1016/j.ccr.2010.04.021; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lowndes NF, 2010, DNA REPAIR, V9, P1112, DOI 10.1016/j.dnarep.2010.07.012; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Mannava S, 2013, AM J PATHOL, V182, P142, DOI 10.1016/j.ajpath.2012.09.011; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Narvaez CJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00213; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Redwood AB, 2011, CELL CYCLE, V10, P3652, DOI 10.4161/cc.10.21.18201; Redwood AB, 2011, CELL CYCLE, V10, P2549, DOI 10.4161/cc.10.15.16531; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Rozenchan PB, 2004, J STEROID BIOCHEM, V92, P89, DOI 10.1016/j.jsbmb.2004.05.007; Salomon DG, 2014, J NEURO-ONCOL, V118, P49, DOI 10.1007/s11060-014-1416-3; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Skrzydlewska E, 2005, WORLD J GASTROENTERO, V11, P1251, DOI 10.3748/wjg.v11.i9.1251; Srinivasan M, 2011, J STEROID BIOCHEM, V123, P30, DOI 10.1016/j.jsbmb.2010.10.002; Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132; Taber LM, 2009, J NUTR BIOCHEM, V20, P629, DOI 10.1016/j.jnutbio.2008.06.008; Tu ZG, 2013, CELL CYCLE, V12, P1653, DOI 10.4161/cc.24986; Tu ZG, 2011, DEV CELL, V21, P1077, DOI 10.1016/j.devcel.2011.10.010; Urbanelli L, 2010, MOL CELL BIOCHEM, V343, P49, DOI 10.1007/s11010-010-0497-3; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Yao S, 2013, J STEROID BIOCHEM, V136, P337, DOI 10.1016/j.jsbmb.2012.09.010; Yuan SSF, 2003, MUTAT RES-FUND MOL M, V525, P85, DOI 10.1016/S0027-5107(03)00009-5; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	61	31	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 13	2016	35	41					5362	5376		10.1038/onc.2016.77	http://dx.doi.org/10.1038/onc.2016.77			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA5QU	27041576	Green Accepted			2022-12-26	WOS:000386677800003
J	Krauson, AJ; Carattino, MD				Krauson, Aram J.; Carattino, Marcelo D.			The Thumb Domain Mediates Acid-sensing Ion Channel Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acid sensing ion channel (ASIC); conformational change; epithelial sodium channel (ENaC); ion channel; receptor desensitization	RECEPTOR DESENSITIZATION; ASIC1A CHANNELS; CATION CHANNEL; SODIUM-CHANNEL; CONTRIBUTES; SUBUNIT; PAIN; EXPRESSION; AMILORIDE; CLONING	Acid-sensing ion channels (ASICs) are cation-selective proton-gated channels expressed in neurons that participate in diverse physiological processes, including nociception, synaptic plasticity, learning, and memory. ASIC subunits contain intracellular N and C termini, two transmembrane domains that constitute the pore, and a large extracellular loop with defined domains termed the finger, -ball, thumb, palm, and knuckle. Here we examined the contribution of the finger, -ball, and thumb domains to activation and desensitization through the analysis of chimeras and the assessment of the effect of covalent modification of introduced Cys at the domain-domain interfaces. Our studies with ASIC1a-ASIC2a chimeras showed that swapping the thumb domain between subunits results in faster channel desensitization. Likewise, the covalent modification of Cys residues at selected positions in the -ball-thumb interface accelerates the desensitization of the mutant channels. Studies of accessibility with thiol-reactive reagents revealed that the -ball and thumb domains reside apart in the resting state but that they become closer to each other in response to extracellular acidification. We propose that the thumb domain moves upon continuous exposure to an acidic extracellular milieu, assisting with the closing of the pore during channel desensitization.	[Krauson, Aram J.; Carattino, Marcelo D.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S935 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S935 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu	Krauson, Aram/ABH-1593-2021; Krauson, Aram J/M-4866-2013	Krauson, Aram/0000-0001-7948-5730; Krauson, Aram J/0000-0001-7948-5730	National Institutes of Health [R01 DK084060, T32 DK061296]; Cellular Physiology Core of the Pittsburgh Center for Kidney Research Grant [P30-DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061296, R01DK084060, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular Physiology Core of the Pittsburgh Center for Kidney Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK084060, T32 DK061296, and by Cellular Physiology Core of the Pittsburgh Center for Kidney Research Grant P30-DK079307. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Arias RL, 2008, NEUROBIOL DIS, V31, P334, DOI 10.1016/j.nbd.2008.05.008; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Bonifacio G, 2014, J GEN PHYSIOL, V143, P105, DOI 10.1085/jgp.201311053; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Duan B, 2011, J NEUROSCI, V31, P2101, DOI 10.1523/JNEUROSCI.4351-10.2011; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gautam M, 2013, FASEB J, V27, P793, DOI 10.1096/fj.12-220400; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 2000, NEUROREPORT, V11, P1607; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hu R, 2011, ANN SURG, V254, P353, DOI 10.1097/SLA.0b013e31822645b4; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Kusama N, 2013, AM J PHYSIOL-CELL PH, V304, pC89, DOI 10.1152/ajpcell.00216.2012; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Langlhofer G, 2015, NEUROSCI LETT, V600, P176, DOI 10.1016/j.neulet.2015.06.017; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; McKinnon NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035563; Meiselbach H, 2014, J BIOL CHEM, V289, P29135, DOI 10.1074/jbc.M114.559138; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Ramaswamy SS, 2013, J BIOL CHEM, V288, P35896, DOI 10.1074/jbc.M113.478982; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhang JL, 2013, MOL NEUROBIOL, V48, P97, DOI 10.1007/s12035-013-8420-z; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	56	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11407	11419		10.1074/jbc.M115.702316	http://dx.doi.org/10.1074/jbc.M115.702316			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27015804	Green Published, hybrid			2022-12-26	WOS:000377042100038
J	Sankhala, RS; Lokareddy, RK; Cingolani, G				Sankhala, Rajeshwer S.; Lokareddy, Ravi K.; Cingolani, Gino			Divergent Evolution of Nuclear Localization Signal Sequences in Herpesvirus Terminase Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						herpesvirus; nuclear translocation; nuclear transport; virus assembly; virus entry; genome packaging motor; importin; terminase	SIMPLEX-VIRUS TYPE-1; IMPORTIN-ALPHA ISOFORMS; HUMAN CYTOMEGALOVIRUS; STRUCTURAL BASIS; PORTAL PROTEIN; DNA-RECOGNITION; GENE-PRODUCT; CRYSTALLOGRAPHIC ANALYSIS; FUNCTIONAL DOMAINS; CRYSTAL-STRUCTURE	The tripartite terminase complex of herpesviruses assembles in the cytoplasm of infected cells and exploits the host nuclear import machinery to gain access to the nucleus, where capsid assembly and genome-packaging occur. Here we analyzed the structure and conservation of nuclear localization signal (NLS) sequences previously identified in herpes simplex virus 1 (HSV-1) large terminase and human cytomegalovirus (HCMV) small terminase. We found a monopartite NLS at the N terminus of large terminase, flanking the ATPase domain, that is conserved only in -herpesviruses. In contrast, small terminase exposes a classical NLS at the far C terminus of its helical structure that is conserved only in two genera of the -subfamily and absent in - and -herpesviruses. In addition, we predicted a classical NLS in the third terminase subunit that is partially conserved among herpesviruses. Bioinformatic analysis revealed that both location and potency of NLSs in terminase subunits evolved more rapidly than the rest of the amino acid sequence despite the selective pressure to keep terminase gene products active and localized in the nucleus. We propose that swapping NLSs among terminase subunits is a regulatory mechanism that allows different herpesviruses to regulate the kinetics of terminase nuclear import, reflecting a mechanism of virus:host adaptation.	[Sankhala, Rajeshwer S.; Lokareddy, Ravi K.; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA; [Cingolani, Gino] CNR, Inst Biomembranes & Bioenerget, Via Amendola 165-A, I-70126 Bari, Italy	Jefferson University; Consiglio Nazionale delle Ricerche (CNR)	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu			National Institutes of Health [R01GM100888, P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100888] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01GM100888 (to G. C.). Research in this publication includes work carried out at the Sidney Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility, which is supported in part by National Institutes of Health Grant P30 CA56036 (NCI). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ADDISON C, 1990, J GEN VIROL, V71, P2377, DOI 10.1099/0022-1317-71-10-2377; Adelman K, 2001, P NATL ACAD SCI USA, V98, P3086, DOI 10.1073/pnas.061555698; Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1, DOI 10.2277/ 0521827140; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baines Joel D., 2005, P135; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Bhardwaj A, 2014, CURR OPIN STRUC BIOL, V25, P1, DOI 10.1016/j.sbi.2013.10.005; BOGNER E, 1993, VIROLOGY, V196, P290, DOI 10.1006/viro.1993.1477; Bogner E, 1998, J VIROL, V72, P2259, DOI 10.1128/JVI.72.3.2259-2264.1998; Borst EM, 2013, J VIROL, V87, P1720, DOI 10.1128/JVI.01955-12; Brown J, 2002, STRUCTURE FUNCTION R, P111; Brown JC, 2011, CURR OPIN VIROL, V1, P142, DOI 10.1016/j.coviro.2011.06.003; Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Champier G, 2008, ANTIVIR THER, V13, P643; Champier G, 2007, ANTIVIR THER, V12, P217; Chang CW, 2013, TRAFFIC, V14, P1144, DOI 10.1111/tra.12098; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Barros AC, 2016, J MOL BIOL, V428, P2120, DOI 10.1016/j.jmb.2016.01.019; de Beer T, 2002, MOL CELL, V9, P981, DOI 10.1016/S1097-2765(02)00537-3; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dittmer A, 2005, J VIROL, V79, P14660, DOI 10.1128/JVI.79.23.14660-14667.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Giesen K, 2000, J GEN VIROL, V81, P2231, DOI 10.1099/0022-1317-81-9-2231; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Guo PX, 2014, BIOTECHNOL ADV, V32, P853, DOI 10.1016/j.biotechadv.2014.01.006; Heming JD, 2014, J VIROL, V88, P225, DOI 10.1128/JVI.02632-13; Higgs MR, 2008, J GEN VIROL, V89, P1709, DOI 10.1099/vir.0.2008/000448-0; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Koerner C, 2003, J BIOL CHEM, V278, P16216, DOI 10.1074/jbc.M301137200; Koslowski KM, 1997, J VIROL, V71, P9118, DOI 10.1128/JVI.71.12.9118-9123.1997; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Liu SX, 2014, CELL, V157, P702, DOI 10.1016/j.cell.2014.02.034; Lokareddy RK, 2015, STRUCTURE, V23, P1305, DOI 10.1016/j.str.2015.04.017; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Lott K, 2010, J BIOL CHEM, V285, P13769, DOI 10.1074/jbc.M109.095760; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McGeoch DJ, 2005, J VIROL, V79, P725, DOI 10.1128/JVI.79.2.725-731.2005; McNulty R, 2015, J MOL BIOL, V427, P3285, DOI 10.1016/j.jmb.2015.08.013; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Mocarski ES, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P44; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Ostapchuk P, 2005, J CELL BIOCHEM, V96, P25, DOI 10.1002/jcb.20523; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Pumroy RA, 2015, STRUCTURE, V23, P374, DOI 10.1016/j.str.2014.11.015; Rao JH, 1998, SCIENCE, V280, P708, DOI 10.1126/science.280.5364.708; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Roman N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082038; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; Roy A, 2012, J BIOL CHEM, V287, P28196, DOI 10.1074/jbc.M112.349894; Sankhala RS, 2015, STRUCTURE, V23, P1777, DOI 10.1016/j.str.2015.09.002; Savva CGW, 2004, FEBS LETT, V563, P135, DOI 10.1016/S0014-5793(04)00283-2; Sigamani SS, 2013, J VIROL, V87, P7140, DOI 10.1128/JVI.00311-13; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Trus BL, 2004, J VIROL, V78, P12668, DOI 10.1128/JVI.78.22.12668-12671.2004; White CA, 2003, J VIROL, V77, P6351, DOI 10.1128/JVI.77.11.6351-6358.2003; Yang K, 2007, J VIROL, V81, P6419, DOI 10.1128/JVI.00047-07; Yu D, 1998, J VIROL, V72, P7428, DOI 10.1128/JVI.72.9.7428-7439.1998; Zhao HY, 2013, P NATL ACAD SCI USA, V110, P8075, DOI 10.1073/pnas.1301133110; Zhao HY, 2010, P NATL ACAD SCI USA, V107, P1971, DOI 10.1073/pnas.0908569107	92	18	20	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11420	11433		10.1074/jbc.M116.724393	http://dx.doi.org/10.1074/jbc.M116.724393			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033706	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000377042100039
J	Arend, I; Weiss, PH; Timpert, DC; Fink, GR; Henik, A				Arend, Isabel; Weiss, Peter H.; Timpert, David C.; Fink, Gereon R.; Henik, Avishai			Spatial Coding as a Function of Handedness and Responding Hand: Theoretical and Methodological Implications	PLOS ONE			English	Article							S-R COMPATIBILITY; 2-FINGER CHOICE REACTIONS; HUNTINGTONS-DISEASE; IRRELEVANT CUE; ATTENTION; STIMULUS; INFORMATION; ASYMMETRIES; CORTEX; CODES	The Simon effect shows that choice reactions are faster if the location of the stimulus and the response correspond, even when stimulus location is task-irrelevant. The Simon effect raises the question of what factors influence spatial coding. Until now, the effects of handedness, responding hand, and visual field were addressed in separate studies that used bimanual and unimanual tasks, providing inconclusive results. Here we aimed to close this empirical gap by looking at the effects of these variables in the same study. We used a unimanual version of a Simon task with four groups of participants: left-handed and right-handed, responding with the dominant or nondominant hand. Our results show that the Simon effect is substantially reduced in the field of the responding hand for all groups of participants, except for left-handed individuals responding with the left-hand. These findings highlight the importance of attention mechanisms in stimulus-response coding. They reflect that stimulus-response interference is influenced by hierarchical activation of response units. At a practical level, these findings call for a number of methodological considerations (e.g., handedness, responding hand, and visual field) when using stimulus-response conflict to address spatial coding and cognitive control functions in neurological populations.	[Arend, Isabel; Henik, Avishai] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel; [Arend, Isabel; Henik, Avishai] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Weiss, Peter H.; Timpert, David C.] Res Ctr Juelich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany; [Weiss, Peter H.; Timpert, David C.; Fink, Gereon R.] Univ Hosp Cologne, Dept Neurol, Cologne, Germany	Ben Gurion University; Ben Gurion University; Helmholtz Association; Research Center Julich; University of Cologne	Arend, I (corresponding author), Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel.; Arend, I (corresponding author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel.	arend.psy@gmail.com	HENIK, AVISHAI/F-1176-2012; Fink, Gereon R./AFW-9377-2022; Weiss, Peter H./H-8983-2013; Fink, Gereon R./E-1616-2012	Fink, Gereon R./0000-0002-8230-1856; Weiss, Peter H./0000-0002-5230-9080; Fink, Gereon R./0000-0002-8230-1856; Henik, Avishai/0000-0002-5665-6004	German-Israel Foundation [1110-93.4/2010]	German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development)	This research was funded by the German-Israel Foundation (grant# 1110-93.4/2010) awarded to AH and PHW.	Adam JJ, 2005, VIS COGN, V12, P1444, DOI 10.1080/13506280444000779; Adam JJ, 2003, COGNITIVE PSYCHOL, V46, P302, DOI 10.1016/S0010-0285(02)00516-9; Bobath B., 1990, ADULT HEMIPLEGIA EVA; Buckingham G, 2011, CORTEX, V47, P432, DOI 10.1016/j.cortex.2009.11.003; COHEN A, 1995, NEUROPSYCHOLOGY, V9, P165, DOI 10.1037/0894-4105.9.2.165; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Coull JT, 2001, CEREB CORTEX, V11, P73, DOI 10.1093/cercor/11.1.73; Danziger S, 2004, COGN AFFECT BEHAV NE, V4, P89, DOI 10.3758/CABN.4.1.89; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Floel A, 2005, BEHAV BRAIN RES, V158, P269, DOI 10.1016/j.bbr.2004.09.016; Galfano G, 2008, ACTA PSYCHOL, V127, P186, DOI 10.1016/j.actpsy.2007.04.004; GEORGIOU N, 1995, BRAIN, V118, P1305, DOI 10.1093/brain/118.5.1305; Georgiou-Karistianis N, 2007, NEUROPSYCHOLOGIA, V45, P1791, DOI 10.1016/j.neuropsychologia.2006.12.023; GOODALE MA, 1990, VISION ACTION CONTRO, P14; HEISTER G, 1986, PERCEPT PSYCHOPHYS, V40, P271, DOI 10.3758/BF03211507; HEISTER G, 1987, PERCEPT PSYCHOPHYS, V42, P195, DOI 10.3758/BF03210508; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P208, DOI 10.1007/BF00419608; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P270, DOI 10.1007/BF00419687; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Ivanoff J, 2000, PSYCHOL RES-PSYCH FO, V64, P117, DOI 10.1007/s004260000033; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; MILLER J, 1982, J EXP PSYCHOL HUMAN, V8, P273, DOI 10.1037/0096-1523.8.2.273; NICOLETTI R, 1989, J EXP PSYCHOL HUMAN, V15, P164, DOI 10.1037/0096-1523.15.1.164; NICOLETTI R, 1994, PSYCHOL RES-PSYCH FO, V56, P144, DOI 10.1007/BF00419701; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rafal R, 1996, NEUROPSYCHOLOGIA, V34, P1197, DOI 10.1016/0028-3932(96)00045-0; RIGGIO L, 1986, ACTA PSYCHOL, V62, P89, DOI 10.1016/0001-6918(86)90006-5; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rubichi S, 1997, J EXP PSYCHOL HUMAN, V23, P1353, DOI 10.1037/0096-1523.23.5.1353; Rubichi S, 2006, PERCEPT PSYCHOPHYS, V68, P1059, DOI 10.3758/BF03193709; Schneider W., 2002, E PRIME USERS GUIDE; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Spironelli C, 2009, EXP PSYCHOL, V56, P274, DOI 10.1027/1618-3169.56.4.274; Stoffer TH, 1997, ADV PSYCHOL, V118, P181; Tagliabue M, 2007, BEHAV RES METHODS, V39, P50, DOI 10.3758/BF03192843; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; UMILTA C, 1987, PSYCHOL RES-PSYCH FO, V49, P81, DOI 10.1007/BF00308672; UMILTA C, 1985, ATTENTION PERFORM, V11, P457; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151979	10.1371/journal.pone.0151979	http://dx.doi.org/10.1371/journal.pone.0151979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031523	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800026
J	Cao, G; Gonzalez, J; Muller, A; Ottaviano, G; Ambrosio, G; Toblli, JE; Milei, J				Cao, Gabriel; Gonzalez, Julian; Mueller, Angelica; Ottaviano, Graciela; Ambrosio, Giuseppe; Toblli, Jorge E.; Milei, Jose			Beneficial Effect of Moderate Exercise in Kidney of Rat after Chronic Consumption of Cola Drinks	PLOS ONE			English	Article							OXIDATIVE STRESS; MECHANISMS; DISEASE; RISK; TRIGLYCERIDES; ANTIOXIDANTS; NEPHROPATHY; DYSFUNCTION; PROGRESSION; ASSOCIATION	Aim The purpose of this study was to investigate the effect of moderate intensity exercise on kidney in an animal model of high consumption of cola soft drinks. Methods Forty-eight Wistar Kyoto rats (age: 16 weeks; weight: 350-400 g) were assigned to the following groups: WR (water runners) drank water and submitted to aerobic exercise; CR (cola runners) drank cola and submitted to aerobic exercise; WS (water sedentary) and CS (cola sedentary), not exercised groups. The aerobic exercise was performed for 5 days per week throughout the study (24 weeks) and the exercise intensity was gradually increased during the first 8 weeks until it reached 20 meters / minute for 30 minutes. Body weight, lipid profile, glycemia, plasma creatinine levels, atherogenic index of plasma (AIP) and systolic blood pressure (SBP) were determined. After 6 months all rats were sacrificed. A kidney histopathological score was obtained using a semiquantitative scale. Glomerular size and glomerulosclerosis were estimated by point-counting. The oxidative stress and proinflammatory status were explored by immunohistochemistry. A one way analysis of variance (ANOVA) with Tukey-Kramer post-hoc test or the Kruskal-Wallis test with Dunn's post-hoc test was used for statistics. A value of p < 0.05 was considered significant. Results At 6 months, an increased consumption of cola soft drink was shown in CS and CR compared with water consumers (p<0.0001). Chronic cola consumption was associated with increased plasma triglycerides, AIP, heart rate, histopathological score, glomerulosclerosis, oxidative stress and pro-inflammatory status. On the other hand, moderate exercise prevented these findings. No difference was observed in the body weight, SBP, glycemia, cholesterol and plasma creatinine levels across experimental groups. Conclusions This study warns about the consequences of chronic consumption of cola drinks on lipid metabolism, especially regarding renal health. Additionally, these findings emphasize the protective role of exercise training on renal damage.	[Cao, Gabriel; Gonzalez, Julian; Mueller, Angelica; Ottaviano, Graciela; Toblli, Jorge E.; Milei, Jose] ININCA UBA CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini, Buenos Aires, DF, Argentina; [Ambrosio, Giuseppe] Univ Perugia, Sch Med, Div Cardiol, I-06100 Perugia, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Perugia	Cao, G (corresponding author), ININCA UBA CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini, Buenos Aires, DF, Argentina.	gabrielcao@fibertel.com.ar	Ambrosio, Giuseppe/C-6596-2013	Ambrosio, Giuseppe/0000-0002-9677-980X	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina [PIP 6549]; Universidad de Buenos Aires, Argentina [UBACYT M052]; University of Buenos Aires - Instituto de Investigaciones Cardiologicas; University of Perugia - Division of Cardiology; CONICET [PIP 6549]; University of Buenos Aires, Argentina [UBACYT M052]; Institute S. Paolo, Turin, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Argentina(University of Buenos Aires); University of Buenos Aires - Instituto de Investigaciones Cardiologicas; University of Perugia - Division of Cardiology; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires, Argentina(University of Buenos Aires); Institute S. Paolo, Turin, Italy	This work was funded by PIP 6549, http://www.conicet.gov.ar/, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina, to JM; UBACYT M052, http://www.uba.ar/, Universidad de Buenos Aires, Argentina, to JM; and Framework Agreement between the University of Buenos Aires - Instituto de Investigaciones Cardiologicas and the University of Perugia - Division of Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study received financial support from PIP 6549, CONICET and UBACYT M052, University of Buenos Aires, Argentina, and from Institute S. Paolo, Turin, Italy. This work has been performed under a Framework Agreement between the University of Buenos Aires-Instituto de Investigaciones Cardiologicas- and the University of Perugia-Division of Cardiology.	Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; Canadian Council on Animal Care, 1993, GUIDE CARE USE EXPT; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; Dauchy RT, 2010, COMPARATIVE MED, V60, P348; de Lemos ET, 2009, NUTRITION, V25, P330, DOI 10.1016/j.nut.2008.08.014; de Lemos ET, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/253061; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Fraser TB, 2001, CLIN EXP PHARMACOL P, V28, P831, DOI 10.1046/j.1440-1681.2001.03531.x; Gad SC, 2014, BIOMARKERS IN TOXICOLOGY, P7, DOI 10.1016/B978-0-12-404630-6.00002-6; Godoy JR, 2011, FREE RADICAL BIO MED, V51, P552, DOI 10.1016/j.freeradbiomed.2011.04.036; Hadjadj S, 2004, DIABETES METAB, V30, P43, DOI 10.1016/S1262-3636(07)70088-5; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; Hill GS, 2003, KIDNEY INT, V63, P1027, DOI 10.1046/j.1523-1755.2003.00831.x; Hughson MD, 2002, AM J KIDNEY DIS, V39, P679, DOI 10.1053/ajkd.2002.31980; Hussain MM, 2015, J LIPID RES, V56, P761, DOI 10.1194/jlr.R051573; Joles JA, 2000, J AM SOC NEPHROL, V11, P669, DOI 10.1681/ASN.V114669; Kaplan A., 1995, TERPRETATION TECHNIQ, P220; KAYSER K, 1994, PATHOL RES PRACT, V190, P1031, DOI 10.1016/S0344-0338(11)80898-8; KIMURA K, 1991, HYPERTENSION, V18, P101, DOI 10.1161/01.HYP.18.1.101; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Lachance D, 2009, CIRC-HEART FAIL, V2, P437, DOI 10.1161/CIRCHEARTFAILURE.108.845487; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; Lehnen AM, 2013, AUTON NEUROSCI-BASIC, V176, P64, DOI 10.1016/j.autneu.2013.02.011; Madrigal-Matute J, 2015, FREE RADICAL BIO MED, V86, P352, DOI 10.1016/j.freeradbiomed.2015.06.001; Malik VS, 2006, AM J CLIN NUTR, V84, P274; McCullough PA, 2004, AM HEART J, V148, P243, DOI 10.1016/j.ahj.2004.03.042; Mei WJ, 2015, NEPHROLOGY, V20, P832, DOI 10.1111/nep.12515; Milei J, 2011, WORLD J CARDIOL, V3, P111, DOI 10.4330/wjc.v3.i4.111; Mizuno M, 2011, AM J PHYSIOL-REG I, V300, pR969, DOI 10.1152/ajpregu.00768.2010; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nseir W, 2010, WORLD J GASTROENTERO, V16, P2579, DOI 10.3748/wjg.v16.i21.2579; Otero-Losada ME, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-57; Otero-Losada ME, 2011, INT J CARDIOL, V146, P106, DOI 10.1016/j.ijcard.2010.09.066; Pagtalunan ME, 2000, KIDNEY INT, V57, P2644, DOI 10.1046/j.1523-1755.2000.00125.x; Pal GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078072; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Roshan VD, 2011, INT J TOXICOL, V30, P190, DOI 10.1177/1091581810392809; Rovin BH, 1998, AM J KIDNEY DIS, V31, P1065, DOI 10.1053/ajkd.1998.v31.pm9631856; Samuelsson O, 1998, J AM SOC NEPHROL, V9, P1482; Seely JC, 2002, TOXICOL PATHOL, V30, P681, DOI 10.1080/01926230290166779; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Soleimani M, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/392708; Teixeira-Lemos E, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-12; Tsuruya K, 2014, ATHEROSCLEROSIS, V233, P260, DOI 10.1016/j.atherosclerosis.2013.12.037; Tucker PS, 2015, FREE RADICAL BIO MED, V89, P466, DOI 10.1016/j.freeradbiomed.2015.07.162; Tucker PS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/156584; Tucker PS, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/806358; Yu F, 2013, NEUROREPORT, V24, P342, DOI 10.1097/WNR.0b013e3283606c5e	54	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152461	10.1371/journal.pone.0152461	http://dx.doi.org/10.1371/journal.pone.0152461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031710	gold, Green Submitted, Green Published			2022-12-26	WOS:000373121800078
J	Simons, RD; Page, HM; Zaleski, S; Miller, R; Dugan, JE; Schroeder, DM; Doheny, B				Simons, Rachel D.; Page, Henry M.; Zaleski, Susan; Miller, Robert; Dugan, Jenifer E.; Schroeder, Donna M.; Doheny, Brandon			The Effects of Anthropogenic Structures on Habitat Connectivity and the Potential Spread of Non-Native Invertebrate Species in the Offshore Environment	PLOS ONE			English	Article							BRYOZOAN WATERSIPORA-SUBTORQUATA; SOUTHERN CALIFORNIA BIGHT; DISTANCE SEED DISPERSAL; GULF-OF-MEXICO; LARVAL TRANSPORT; POPULATION CONNECTIVITY; BENTHIC INVERTEBRATES; MARINE ORGANISMS; OIL PLATFORMS; DURATION	Offshore structures provide habitat that could facilitate species range expansions and the introduction of non-native species into new geographic areas. Surveys of assemblages of seven offshore oil and gas platforms in the Santa Barbara Channel revealed a change in distribution of the non-native sessile invertebrate Watersipora subtorquata, a bryozoan with a planktonic larval duration (PLD) of 24 hours or less, from one platform in 2001 to four platforms in 2013. We use a three-dimensional biophysical model to assess whether larval dispersal via currents from harbors to platforms and among platforms is a plausible mechanism to explain the change in distribution of Watersipora and to predict potential spread to other platforms in the future. Hull fouling is another possible mechanism to explain the change in distribution of Watersipora. We find that larval dispersal via currents could account for the increase in distribution of Watersipora from one to four platforms and that Watersipora is unlikely to spread from these four platforms to additional platforms through larval dispersal. Our results also suggest that larvae with PLDs of 24 hours or less released from offshore platforms can attain much greater dispersal distances than larvae with PLDs of 24 hours or less released from nearshore habitat. We hypothesize that the enhanced dispersal distance of larvae released from offshore platforms is driven by a combination of the offshore hydrodynamic environment, larval behavior, and larval release above the seafloor.	[Simons, Rachel D.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Page, Henry M.; Miller, Robert; Dugan, Jenifer E.; Doheny, Brandon] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Zaleski, Susan; Schroeder, Donna M.] Bur Ocean Energy Management, Pacific Reg, Camarillo, CA USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Simons, RD (corresponding author), Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA.	simons@eri.ucsb.edu		Miller, Robert/0000-0002-8350-3759	U.S. Department of Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington D.C. [M13AC00007]; SZ DMS; Division Of Ocean Sciences [1232779] Funding Source: National Science Foundation	U.S. Department of Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington D.C.; SZ DMS; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Study collaboration and funding was provided by the U.S. Department of Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington D.C. under Co-Op Agreement # M13AC00007. Authors who received funding: HMP JED RDS. Funders: SZ DMS. The funders participated in the field work and proofed the paper.	Adams TP, 2014, J APPL ECOL, V51, P330, DOI 10.1111/1365-2664.12207; Anderson CM, 2007, APPL ENVIRON MICROB, V73, P303, DOI 10.1128/AEM.00604-06; Atchison AD, 2008, J EXP MAR BIOL ECOL, V365, P1, DOI 10.1016/j.jembe.2008.07.002; Bradbury IR, 2001, CAN J FISH AQUAT SCI, V58, P811, DOI 10.1139/cjfas-58-4-811; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carr SD, 2008, FISH OCEANOGR, V17, P1, DOI 10.1111/j.1365-2419.2007.00447.x; CHIA FS, 1984, CAN J ZOOL, V62, P1205, DOI 10.1139/z84-176; Cohen AN, 2005, BIOL INVASIONS, V7, P995, DOI 10.1007/s10530-004-3121-1; Cohen AN, 2011, THE EXOTICS GUIDE NO; Continental Shelf Associates, 2005, SURV INV ALG COMM OF; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Coyer J, 1999, GUIDE METHODS UNDERW; Davidson IC, 2010, AQUAT BIOL, V11, P179, DOI 10.3354/ab00302; Dong CM, 2007, CONT SHELF RES, V27, P1233, DOI 10.1016/j.csr.2007.01.016; Dong CM, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006578; Dong CM, 2009, PROG OCEANOGR, V82, P168, DOI 10.1016/j.pocean.2009.07.005; Floerl O, 2005, BIOL INVASIONS, V7, P589, DOI 10.1007/s10530-004-0952-8; Foss S., 2008, SUBMITTED TO THE CAL; Gallaway BJ, 1981, 10BS8227 FWS; Gawarkiewicz G, 2007, OCEANOGRAPHY, V20, P40, DOI 10.5670/oceanog.2007.28; Harms S, 1998, J GEOPHYS RES-OCEANS, V103, P3041, DOI 10.1029/97JC02393; Hellberg ME, 2002, B MAR SCI, V70, P273; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Mackie JA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00871; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Miller RG, 2013, FRONT ECOL ENVIRON, V11, P433, DOI 10.1890/120089; Miller TJ, 2007, MAR ECOL PROG SER, V347, P127, DOI 10.3354/meps06973; Mineur F, 2012, OCEANOGR MAR BIOL, V50, P189; Mitarai S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005166; Needles LA, 2013, BIOL INVASIONS, V15, P1231, DOI 10.1007/s10530-012-0362-2; Ng TYT, 2003, MAR ECOL PROG SER, V257, P77, DOI 10.3354/meps257077; Ohlmann JC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044436; Page H. M., 2010, BIOFOULING, P252, DOI [10.1002/9781444315462, DOI 10.1002/9781444315462]; Page HM, 2008, ICES J MAR SCI, V65, P851, DOI 10.1093/icesjms/fsn060; Page HM, 2006, MAR ECOL PROG SER, V325, P101, DOI 10.3354/meps325101; Pergl J, 2011, DIVERS DISTRIB, V17, P725, DOI 10.1111/j.1472-4642.2011.00771.x; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Ruiz GM, 1997, AM ZOOL, V37, P621; RYLAND JS, 1960, J EXP BIOL, V37, P783; Sammarco PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030144; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sams MA, 2015, MAR ECOL PROG SER, V531, P179, DOI 10.3354/meps11339; Santschi CA, 2012, SPATIAL PATTERNS REC; Sellheim K, 2010, MAR ECOL PROG SER, V398, P69, DOI 10.3354/meps08341; Shanks AL, 2009, BIOL BULL-US, V216, P373; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Sheehy DJ, 2010, ECOL ENG, V36, P1, DOI 10.1016/j.ecoleng.2009.09.012; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Simons RD, 2015, DEEP-SEA RES PT I, V100, P34, DOI 10.1016/j.dsr.2015.02.002; Simons RD, 2013, J MARINE SYST, V119, P19, DOI 10.1016/j.jmarsys.2013.03.004; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Verling E, 2005, P ROY SOC B-BIOL SCI, V272, P2659, DOI 10.1098/rspb.2005.2001; Vieira LM, 2014, ZOOTAXA, V3857, P151, DOI 10.11646/zootaxa.3857.2.1; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Wendt DE, 1998, BIOL BULL-US, V195, P126, DOI 10.2307/1542820; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; WOOLLACOTT RM, 1989, MAR BIOL, V102, P57, DOI 10.1007/BF00391323	61	20	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152261	10.1371/journal.pone.0152261	http://dx.doi.org/10.1371/journal.pone.0152261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031827	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800048
J	Manriquez, PH; Jara, ME; Seguel, ME; Torres, R; Alarcon, E; Lee, MR				Manriquez, Patricio H.; Elisa Jara, Maria; Seguel, Mylene E.; Torres, Rodrigo; Alarcon, Emilio; Lee, Matthew R.			Ocean Acidification and Increased Temperature Have Both Positive and Negative Effects on Early Ontogenetic Traits of a Rocky Shore Keystone Predator Species	PLOS ONE			English	Article							CONCHOLEPAS-CONCHOLEPAS; PHYSIOLOGICAL ENERGETICS; LARVAL DEVELOPMENT; CLIMATE-CHANGE; CARBONIC-ACID; SEAWATER; IMPACT; HABITAT; CORAL; DISSOCIATION	The combined effect of ocean acidification and warming is expected to have significant effects on several traits of marine organisms. The gastropod Concholepas concholepas is a rocky shore keystone predator characteristic of the south-eastern Pacific coast of South America and an important natural resource exploited by small-scale artisanal fishermen along the coast of Chile and Peru. In this study, we used small juveniles of C. concholepas collected from the rocky intertidal habitats of southern Chile (39 degrees S) to evaluate under laboratory conditions the potential consequences of projected near-future levels of ocean acidification and warming for important early ontogenetic traits. The individuals were exposed long-term (5.8 months) to contrasting pCO(2) (ca. 500 and 1400 mu atm) and temperature (15 and 19 degrees C) levels. After this period we compared body growth traits, dislodgement resistance, predator-escape response, self-righting and metabolic rates. With respect to these traits there was no evidence of a synergistic interaction between pCO(2) and temperature. Shell growth was negatively affected by high pCO(2) levels only at 15 degrees C. High pCO(2) levels also had a negative effect on the predator-escape response. Conversely, dislodgement resistance and self-righting were positively affected by high pCO(2) levels at both temperatures. High tenacity and fast self-righting would reduce predation risk in nature and might compensate for the negative effects of high pCO(2) levels on other important defensive traits such as shell size and escape behaviour. We conclude that climate change might produce in C. concholepas positive and negative effects in physiology and behaviour. In fact, some of the behavioural responses might be a consequence of physiological effects, such as changes in chemosensory capacity (e.g. predator-escape response) or secretion of adhesive mucous (e.g. dislodgement resistance). Moreover, we conclude that positive behavioural responses may assist in the adaptation to negative physiological impacts, and that this may also be the case for other benthic organisms.	[Manriquez, Patricio H.; Elisa Jara, Maria; Seguel, Mylene E.] CEAZA, LECOT, Coquimbo, Chile; [Torres, Rodrigo; Alarcon, Emilio] CIEP, Coyhaique, Chile; [Torres, Rodrigo] Ctr Invest Dinam Ecosistemas Marinos Altas Latitu, Punta Arenas, Chile; [Lee, Matthew R.] Univ Los Lagos, Ctr I Mar, Puerto Montt, Chile	Universidad de Los Lagos	Manriquez, PH (corresponding author), CEAZA, LECOT, Coquimbo, Chile.	patriciohmanriquez@gmail.com	Torres, Rodrigo/J-8442-2019; Lee, Matthew/B-6360-2008	Lee, Matthew/0000-0001-9675-9908; Seguel, Mylene/0000-0002-7234-6129; Manriquez, Patricio/0000-0001-6586-764X	Fondecyt [1130839]; Direccion de Investigacion, Universidad de Los Lagos [R09/15]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion, Universidad de Los Lagos	This study was funded by the Project Fondecyt No 1130839 to PHM and RT. PHM acknowledge Celulosa Arauco and Constitucion S. A. for an economic support that allowed equipment acquisition and pay for research space in the Universidad Catolica del Norte (UCN, Coquimbo) and supported field work at Valdivia and Antofagasta. The work of MRL on ocean acidification is supported by grant R09/15 Direccion de Investigacion, Universidad de Los Lagos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne M, 2013, INTEGR COMP BIOL, V53, P582, DOI 10.1093/icb/ict049; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Castilla JC, 1985, BIOL PESQUERA, V14, P46; Castilla JC, 1997, DEV SUSTAINING WORLD, P130; Conover WJ, 2012, WIRES COMPUT STAT, V4, P432, DOI 10.1002/wics.1216; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DAVIES MS, 1990, J MOLLUS STUD, V56, P499, DOI 10.1093/mollus/56.4.499; de Zwaan A., 1985, Symposia of the Society for Experimental Biology, P33; Dickson A. G., 1994, ORNLCDIAC74 DOE; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doncaster CP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0108; Dorey N, 2013, GLOBAL CHANGE BIOL, V19, P3355, DOI 10.1111/gcb.12276; Duarte C, 2014, J SEA RES, V85, P308, DOI 10.1016/j.seares.2013.06.002; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Findlay HS, 2010, MAR BIOL, V157, P725, DOI 10.1007/s00227-009-1356-1; Findlay HS, 2010, ESTUAR COAST SHELF S, V86, P675, DOI 10.1016/j.ecss.2009.11.036; Gazeau F, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00062; Godbold JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0186; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Haraldsson C, 1997, DEEP-SEA RES PT I, V44, P2031, DOI 10.1016/S0967-0637(97)00088-5; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Jackson AC, 2008, AUSTRAL ECOL, V33, P307, DOI 10.1111/j.1442-9993.2007.01818.x; Lardies MA, 2014, J SEA RES, V90, P127, DOI 10.1016/j.seares.2014.03.010; Leiva GE, 2002, REV FISH BIOL FISHER, V11, P283; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Manriquez PH, 2008, AQUACULTURE, V279, P99, DOI 10.1016/j.aquaculture.2008.03.031; Manriquez PH, 2014, MAR ECOL PROG SER, V502, P157, DOI 10.3354/meps10703; Manriquez PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068643; Manriquez PH, 2013, MAR ECOL PROG SER, V472, P169, DOI 10.3354/meps10055; Manriquez PH, 2009, P NATL ACAD SCI USA, V106, P16298, DOI 10.1073/pnas.0908655106; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Melatunan S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P583, DOI 10.1086/662680; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; MORENO CA, 1993, J EXP MAR BIOL ECOL, V171, P51, DOI 10.1016/0022-0981(93)90139-F; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nagelkerken I, 2016, GLOBAL CHANGE BIOL, V22, P974, DOI 10.1111/gcb.13167; NAVARRO JM, 1995, REV CHIL HIST NAT, V68, P61; Navarro JM, 2013, CHEMOSPHERE, V90, P1242, DOI 10.1016/j.chemosphere.2012.09.063; Paganini AW, 2014, J EXP BIOL, V217, P3974, DOI 10.1242/jeb.109801; Pan TCF, 2015, P NATL ACAD SCI USA, V112, P4696, DOI 10.1073/pnas.1416967112; Peck LS, 2010, MAR BIOL, V157, P2051, DOI 10.1007/s00227-010-1473-x; Peck LS, 2009, POLAR BIOL, V32, P399, DOI 10.1007/s00300-008-0532-y; Peck LS, 2002, MAR BIOL, V141, P271, DOI 10.1007/s00227-002-0834-5; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; R Development Core Team R, 2013, R LANG ENV STAT COMP; Ramajo L, 2013, J MAR BIOL ASSOC UK, V93, P2167, DOI 10.1017/S0025315413000891; Reyes-Nivia C, 2013, GLOBAL CHANGE BIOL, V19, P1919, DOI 10.1111/gcb.12158; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; SMITH AM, 1991, J EXP BIOL, V161, P151; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stillman JH, 2009, MOL ECOL, V18, P4206, DOI 10.1111/j.1365-294X.2009.04354.x; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Torres R, 2002, DEEP-SEA RES PT I, V49, P1413, DOI 10.1016/S0967-0637(02)00034-1; Torres R, 2013, REV CHIL HIST NAT, V86, P443, DOI 10.4067/S0716-078X2013000400006; Torres R, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006344; TRUCHOT JP, 1980, RESP PHYSIOL, V39, P241, DOI 10.1016/0034-5687(80)90056-0; TRUSSELL GC, 1993, MAR ECOL PROG SER, V100, P135, DOI 10.3354/meps100135; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Van Holt T, 2012, GLOBAL CHANGE BIOL, V18, P2147, DOI 10.1111/j.1365-2486.2012.02674.x; Walther K, 2010, MAR ECOL PROG SER, V417, P159, DOI 10.3354/meps08807; Wolfe K, 2013, GLOBAL CHANGE BIOL, V19, P2698, DOI 10.1111/gcb.12249; Zar J.H., 2010, BIOSTAT ANAL	72	22	23	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151920	10.1371/journal.pone.0151920	http://dx.doi.org/10.1371/journal.pone.0151920			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028118	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500033
J	Prado, NDR; Pereira, SS; da Silva, MP; Morais, MSS; Kayano, AM; Moreira-Dill, LS; Luiz, MB; Zanchi, FB; Fuly, AL; Huacca, MEF; Fernandes, CF; Calderon, LA; Zuliani, JP; da Silva, LHP; Soares, AM; Stabeli, RG; Fernandes, CFC				Prado, Nidiane D. R.; Pereira, Soraya S.; da Silva, Michele P.; Morais, Michelle S. S.; Kayano, Anderson M.; Moreira-Dill, Leandro S.; Luiz, Marcos B.; Zanchi, Fernando B.; Fuly, Andre L.; Huacca, Maribel E. F.; Fernandes, Cleberson F.; Calderon, Leonardo A.; Zuliani, Juliana P.; Pereira da Silva, Luiz H.; Soares, Andreimar M.; Stabeli, Rodrigo G.; Fernandes, Carla F. C.			Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A(2) by Specific Camelid Single-Domain Antibody Fragments	PLOS ONE			English	Article							CROSS-NEUTRALIZATION; SNAKE; METALLOPROTEINASE; IDENTIFICATION; NANOBODIES; ANTIVENOM; ALIGNMENT; PROTEINS; SEQUENCE; ASPER	Antivenoms, produced using animal hyperimmune plasma, remains the standard therapy for snakebites. Although effective against systemic damages, conventional antivenoms have limited efficacy against local tissue damage. Additionally, the hypersensitivity reactions, often elicited by antivenoms, the high costs for animal maintenance, the difficulty of producing homogeneous lots, and the instability of biological products instigate the search for innovative products for antivenom therapy. In this study, camelid antibody fragments (VHH) with specificity to Bothropstoxin I and II (BthTX-I and BthTX-II), two myotoxic phospholipases from Bothrops jararacussu venom, were selected from an immune VHH phage display library. After biopanning, 28 and 6 clones recognized BthTX-I and BthTX-II by ELISA, respectively. Complementarity determining regions (CDRs) and immunoglobulin frameworks (FRs) of 13 VHH-deduced amino acid sequences were identified, as well as the camelid hallmark amino acid substitutions in FR2. Three VHH clones (KF498607, KF498608, and KC329718) were capable of recognizing BthTX-I by Western blot and showed affinity constants in the nanomolar range against both toxins. VHHs inhibited the BthTX-II phospholipase A(2) activity, and when tested for cross-reactivity, presented specificity to the Bothrops genus in ELISA. Furthermore, two clones (KC329718 and KF498607) neutralized the myotoxic effects induced by B. jararacussu venom, BthTX-I, BthTX-II, and by a myotoxin from Bothrops brazili venom (MTX-I) in mice. Molecular docking revealed that VHH CDRs are expected to bind the C-terminal of both toxins, essential for myotoxic activity, and to epitopes in the BthTX-II enzymatic cleft. Identified VHHs could be a biotechnological tool to improve the treatment for snake envenomation, an important and neglected world public health problem.	[Prado, Nidiane D. R.; Pereira, Soraya S.; da Silva, Michele P.; Morais, Michelle S. S.; Kayano, Anderson M.; Moreira-Dill, Leandro S.; Luiz, Marcos B.; Zanchi, Fernando B.; Calderon, Leonardo A.; Zuliani, Juliana P.; Pereira da Silva, Luiz H.; Soares, Andreimar M.; Stabeli, Rodrigo G.; Fernandes, Carla F. C.] Fiocruz Rondonia, Fundacao Oswaldo Cruz, Porto Velho, RO, Brazil; [Fuly, Andre L.] Univ Fed Fluminense, Rio De Janeiro, RJ, Brazil; [Huacca, Maribel E. F.; Calderon, Leonardo A.; Zuliani, Juliana P.; Stabeli, Rodrigo G.] Univ Fed Rondonia, UNIR, Porto Velho, RO, Brazil; [Fernandes, Cleberson F.] EMBRAPA, Empresa Brasileira Pesquisa Agr, Porto Velho, RO, Brazil; [Fernandes, Carla F. C.] CEPEM, Ctr Pesquisa Med Trop, Porto Velho, RO, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade Federal de Rondonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Fernandes, CFC (corresponding author), Fiocruz Rondonia, Fundacao Oswaldo Cruz, Porto Velho, RO, Brazil.; Fernandes, CFC (corresponding author), CEPEM, Ctr Pesquisa Med Trop, Porto Velho, RO, Brazil.	carlaceledonio@fiocruz.br	Soares, Andrei/ABG-3545-2020; Zuliani, JP/P-3633-2019; Zanchi, Fernando Berton/R-2291-2019; Zuliani, Juliana P/G-2329-2015; Soares, Andreimar/AAE-4657-2021; Pereira, Soraya Santos/ABA-2753-2020; de A Calderon, Leonardo/K-8515-2012; Fuly, Andre/U-1538-2019; Soares, Andreimar M/K-5556-2014; S. Moreira-Dill, Leandro/D-5024-2015; Fernandes, Cleberson/C-9973-2013; Stabeli, Rodrigo Guerino/G-1721-2017	Zuliani, JP/0000-0001-9221-7749; Zanchi, Fernando Berton/0000-0003-3386-0069; Pereira, Soraya Santos/0000-0003-2116-7670; de A Calderon, Leonardo/0000-0003-2669-092X; Fuly, Andre/0000-0002-5265-5258; S. Moreira-Dill, Leandro/0000-0003-2977-0001; Funes Huacca, Maribel Elizabeth/0000-0002-3878-0722; Soares, Andreimar/0000-0003-1032-2188; Fernandes, Cleberson/0000-0001-5269-1139; Stabeli, Rodrigo Guerino/0000-0002-0476-920X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477760/2012-0, 459046/2014-4]; CFCF-Programa Primeiros Projetos Secretaria de Estado de Planejamento de> Rondonia-SEPLAN/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Rede de Biodiversidade e Biotecnologia da Amazonia Legal (BIONORTE/CNPq/MCT); Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas e a Pesquisa de Rondonia (FAPERO); CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CFCF-Programa Primeiros Projetos Secretaria de Estado de Planejamento de> Rondonia-SEPLAN/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Rede de Biodiversidade e Biotecnologia da Amazonia Legal (BIONORTE/CNPq/MCT); Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas e a Pesquisa de Rondonia (FAPERO)(Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas e a Pesquisa do Estado de Rondonia (FAPERO)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) -www.cnpq.br/RGS-Grant Number: 477760/2012-0, CFCF-Grant Number: 459046/2014-4, CFCF-Programa Primeiros Projetos Secretaria de Estado de Planejamento de> Rondonia-SEPLAN/CNPq, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP), Rede de Biodiversidade e Biotecnologia da Amazonia Legal (BIONORTE/CNPq/MCT) and Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas e a Pesquisa de Rondonia (FAPERO). Nidiane D. R. Prado, student of Postgraduate Program in Experimental Biology, was supported by a fellowship of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarenga LM, 2014, TOXINS, V6, P2541, DOI 10.3390/toxins6082541; Andersson K, 1999, ANAL CHEM, V71, P2475, DOI 10.1021/ac981271j; Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bakherad H, 2013, MOL BIOTECHNOL, V55, P159, DOI 10.1007/s12033-013-9669-1; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Cardoso D. F., 2009, ANIMAIS PECONHENTOS, P419; Cardoso DF, 2000, SCAND J IMMUNOL, V51, P337; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Chotwiwatthanakun C, 2001, TOXICON, V39, P1487, DOI 10.1016/S0041-0101(01)00108-8; Cintra-Francischinelli M, 2010, P NATL ACAD SCI USA, V107, P14140, DOI 10.1073/pnas.1009128107; Dart RC, 2005, CLIN PRACTICE EMERGE, P1624; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Fernandes CAH, 2014, BBA-PROTEINS PROTEOM, V1844, P2265, DOI 10.1016/j.bbapap.2014.09.015; Fernandes CAH, 2010, J STRUCT BIOL, V171, P31, DOI 10.1016/j.jsb.2010.03.019; Fernandes I, 2010, TOXICON, V56, P1059, DOI 10.1016/j.toxicon.2010.07.014; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Govaert J, 2012, J BIOL CHEM, V287, P1970, DOI 10.1074/jbc.M111.242818; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guimaraes CLS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981923; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; Gutierrez JM, 2003, CLIN PHARMACOKINET, V42, P721, DOI 10.2165/00003088-200342080-00002; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Hansson E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002009; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Helma J, 2015, J CELL BIOL, V209, P633, DOI 10.1083/jcb.201409074; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; JANSSEN M, 1990, TOXICON, V28, P975, DOI 10.1016/0041-0101(90)90026-4; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kashima S, 2004, BIOCHIMIE, V86, P211, DOI 10.1016/j.biochi.2004.02.002; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kornhauser R, 2013, BASIC CLIN PHARMACOL, V112, P138, DOI 10.1111/j.1742-7843.2012.00925.x; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; LOMONTE B, 1992, TOXICON, V30, P239, DOI 10.1016/0041-0101(92)90866-4; Mora-Obando D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109846; Mousli M, 1999, FEBS LETT, V442, P183, DOI 10.1016/S0014-5793(98)01647-0; Otten EJ, 2013, ROSENS EMERGENCY MED, P794; Pereira MF, 1998, J PROTEIN CHEM, V17, P381, DOI 10.1023/A:1022563401413; Pereira SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108067; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Richard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069495; Rodrigues RS, 2007, TOXICON, V50, P153, DOI 10.1016/j.toxicon.2007.03.005; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Tan CH, 2015, TOXINS, V7, P572, DOI 10.3390/toxins7020572; Thanongsaksrikul J, 2010, J BIOL CHEM, V285, P9657, DOI 10.1074/jbc.M109.073163; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; (WHO), 2015, SNAK ANT	56	35	37	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151363	10.1371/journal.pone.0151363	http://dx.doi.org/10.1371/journal.pone.0151363			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028872	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500024
J	Solounias, N; Danowitz, M				Solounias, Nikos; Danowitz, Melinda			Astragalar Morphology of Selected Giraffidae	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; ECOMORPHOLOGY	The artiodactyl astragalus has been modified to exhibit two trochleae, creating a double pullied structure allowing for significant dorso-plantar motion, and limited mediolateral motion. The astragalus structure is partly influenced by environmental substrates, and correspondingly, morphometric studies can yield paleohabitat information. The present study establishes terminology and describes detailed morphological features on giraffid astragali. Each giraffid astragalus exhibits a unique combination of anatomical characteristics. The giraffid astragalar morphologies reinforce previously established phylogenetic relationships. We find that the enlargement of the navicular head is a feature shared by all giraffids, and that the primitive giraffids possess exceptionally tall astragalar heads in relation to the total astragalar height. The sivatheres and the okapi share a reduced notch on the lateral edge of the astragalus. We find that Samotherium is more primitive in astragalar morphologies than Palaeotragus, which is reinforced by tooth characteristics and ossicone position. Diagnostic anatomical characters on the astragalus allow for giraffid species identifications and a better understanding of Giraffidae.	[Solounias, Nikos; Danowitz, Melinda] New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Solounias, Nikos] Amer Museum Nat Hist, Dept Paleontol, Cent Pk West & 79th St, New York, NY 10024 USA	New York Institute Technology; American Museum of Natural History (AMNH)	Solounias, N (corresponding author), New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.; Solounias, N (corresponding author), Amer Museum Nat Hist, Dept Paleontol, Cent Pk West & 79th St, New York, NY 10024 USA.	nsolouni@nyit.edu						Barr WA, 2014, J MORPHOL, V275, P1201, DOI 10.1002/jmor.20279; Colbert EH, 1933, AM MUS NOVIT, V632, P1; Danowitz M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150521; Danowitz M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150393; Davis EB, 2012, PALAEONTOL ELECTRON, V15; DeGusta D, 2003, J ARCHAEOL SCI, V30, P1009, DOI 10.1016/S0305-4403(02)00286-8; GERAADS D, 1985, Palaeontologische Zeitschrift, V59, P311; HAMILTON WR, 1978, PHILOS T R SOC B, V283, P165, DOI 10.1098/rstb.1978.0019; Hou Sukuan, 2014, Zitteliana Reihe B, V32, P91; Janis CM., 1987, AM MUS NOVIT, V2893, P1; KLEIN RG, 1989, J ARCHAEOL SCI, V16, P363, DOI 10.1016/0305-4403(89)90012-5; Mazza PPA, 2013, GEOBIOS-LYON, V46, P33, DOI 10.1016/j.geobios.2012.10.009; Mitchell G., 2003, Transactions of the Royal Society of South Africa, V58, P51; Plummer TW, 2008, J ARCHAEOL SCI, V35, P3016, DOI 10.1016/j.jas.2008.06.015; SCHAEFFER B, 1948, EVOLUTION, V2, P164, DOI 10.2307/2405375; Schaeffer B., 1947, AM MUS NOVIT, V1367, P1; SCOTT KM, 1985, B AM MUS NAT HIST, V179, P197; Solounias Nikos, 2007, P257; Szalay F.S., 1980, P133; Tassy P., 1996, EVOLUTION PALAEOECOL, P39; Thewissen JGM, 1999, SYST BIOL, V48, P21, DOI 10.1080/106351599260418	21	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151310	10.1371/journal.pone.0151310	http://dx.doi.org/10.1371/journal.pone.0151310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27028515	Green Published, gold, Green Submitted			2022-12-26	WOS:000373116500021
J	Du, YH; Li, R; Lau, WB; Zhao, JL; Lopez, B; Christopher, TA; Ma, XL; Wang, YJ				Du, Yunhui; Li, Rui; Lau, Wayne Bigond; Zhao, Jianli; Lopez, Bernard; Christopher, Theodore A.; Ma, Xin-Liang; Wang, Yajing			Adiponectin at Physiologically Relevant Concentrations Enhances the Vasorelaxative Effect of Acetylcholine via Cav-1/AdipoR-1 Signaling	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; GENDER-DIFFERENCES; HYPERTENSION; CAVEOLIN-1; PROTEIN; ATHEROSCLEROSIS; MECHANISMS; INSULIN; DEFICIENCY	Clinical studies have identified hypoadiponectinemia as an independent hypertension risk factor. It is known that adiponectin (APN) can directly cause vasodilation, but the doses required exceed physiologic levels several fold. In the current study, we determine the effect of physiologically relevant APN concentrations upon vascular tone, and investigate the mechanism(s) responsible. Physiologic APN concentrations alone induced no significant vasorelaxation. Interestingly, pretreatment of wild type mouse aortae with physiologic APN levels significantly enhanced acetylcholine (ACh)-induced vasorelaxation (P<0.01), an endothelium-dependent and nitric oxide (NO)-mediated process. Knockout of adiponectin receptor 1 (AdipoR1) or caveolin-1 (Cav-1, a cell signaling facilitating molecule), but not adiponectin receptor 2 (AdipoR2) abolished APN-enhanced ACh-induced vasorelaxation. Immunoblot assay revealed APN promoted the AdipoR1/Cav1 signaling complex in human endothelial cells. Treatment of HUVECs with physiologic APN concentrations caused significant eNOS phosphorylation and nitric oxide (NO) production (P<0.01), an effect abolished in knockdown of either AdipoR1 or Cav-1. Taken together, these data demonstrate for the first time physiologic APN levels enhance the vasorelaxative response to ACh by inducing NO production through AdipoR1/Cav-1 mediated signaling. In physiologic conditions, APN plays an important function of maintaining vascular tone.	[Du, Yunhui; Ma, Xin-Liang] Capital Med Univ, Dept Physiol & Pathophysiol, Beijing 100069, Peoples R China; [Li, Rui; Wang, Yajing] Shanxi Med Univ, Dept Physiol, Natl Key Discipline, Taiyuan 030001, Shanxi, Peoples R China; [Li, Rui; Wang, Yajing] Shanxi Med Univ, Key Lab Cytophysiol Shanxi Prov, Taiyuan 030001, Shanxi, Peoples R China; [Du, Yunhui; Lau, Wayne Bigond; Zhao, Jianli; Lopez, Bernard; Christopher, Theodore A.; Ma, Xin-Liang; Wang, Yajing] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA	Capital Medical University; Shanxi Medical University; Shanxi Medical University; Jefferson University	Ma, XL (corresponding author), Capital Med Univ, Dept Physiol & Pathophysiol, Beijing 100069, Peoples R China.; Wang, YJ (corresponding author), Shanxi Med Univ, Dept Physiol, Natl Key Discipline, Taiyuan 030001, Shanxi, Peoples R China.; Wang, YJ (corresponding author), Shanxi Med Univ, Key Lab Cytophysiol Shanxi Prov, Taiyuan 030001, Shanxi, Peoples R China.; Ma, XL; Wang, YJ (corresponding author), Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA.	xin.ma@jefferson.edu; Yajing.Wang@jefferson.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	American Diabetes Association [1-14-BS-218, 1-15-BS-122]; Natural Science Foundation of China [81170199, 31322026, 81270185, 81470020, 81300180]; National Institutes of Health [HL-96686, HL-123404]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123404, R01HL096686, R56HL123404] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the following grants: American Diabetes Association 1-14-BS-218, Natural Science Foundation of China 81170199, 31322026 (Y. Wang), 81270185, 81470020 (J. Zhao), 81300180 (Y. Du), National Institutes of Health HL-96686, HL-123404, and American Diabetes Association 1-15-BS-122 (X.L. Ma). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Cao Y, 2009, J MOL CELL CARDIOL, V46, P413, DOI 10.1016/j.yjmcc.2008.10.014; Celoria Bruno M J, 2010, Clin Cardiol, V33, pE61, DOI 10.1002/clc.20657; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Innamorati G, 2006, CELL SIGNAL, V18, P761, DOI 10.1016/j.cellsig.2005.11.004; KANNEL WB, 1989, J CARDIOVASC PHARM, V13, pS4, DOI 10.1097/00005344-198900131-00003; Katusic ZS, 2014, EUR HEART J, V35, P888, DOI 10.1093/eurheartj/eht544; Kraehling JR, 2016, CIRC RES, V118, P48, DOI 10.1161/CIRCRESAHA.115.307767; Li R, 2010, J MOL CELL CARDIOL, V49, P508, DOI 10.1016/j.yjmcc.2010.03.002; Liu GZ, 2015, FREE RADICAL BIO MED, V89, P473, DOI 10.1016/j.freeradbiomed.2015.09.005; London GM, 2002, AM J HYPERTENS, V15, P754, DOI 10.1016/S0895-7061(02)02966-7; Martinez-Outschoorn UE, 2015, NAT REV CANCER, V15, P225, DOI 10.1038/nrc3915; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Nien JK, 2007, J PERINAT MED, V35, P522, DOI 10.1515/JPM.2007.123; Ntaios G, 2013, ATHEROSCLEROSIS, V227, P216, DOI 10.1016/j.atherosclerosis.2012.12.029; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; Papadopoulos DP, 2008, BLOOD PRESSURE, V17, P50, DOI 10.1080/08037050701876307; Pavlides S, 2014, CELL TISSUE RES, V356, P147, DOI 10.1007/s00441-013-1767-7; Pavlides S, 2012, ADV EXP MED BIOL, V729, P127, DOI 10.1007/978-1-4614-1222-9_9; Perez-Lopez FR, 2010, REPROD SCI, V17, P511, DOI 10.1177/1933719110367829; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schmid PM, 2011, AM J HYPERTENS, V24, P270, DOI 10.1038/ajh.2010.239; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Tanigawa T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.140; Trane AE, 2014, J BIOL CHEM, V289, P13273, DOI 10.1074/jbc.M113.528695; Wang N, 2015, DRUG DES DEV THER, V9, P4965, DOI 10.2147/DDDT.S77646; Wang YJ, 2015, CIRCULATION, V131, P1392, DOI 10.1161/CIRCULATIONAHA.114.015248; White RM, 2000, J PHARMACOL EXP THER, V292, P375; Zhao LN, 2013, CIRC RES, V112, P1263, DOI 10.1161/CIRCRESAHA.111.300388; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	34	13	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152247	10.1371/journal.pone.0152247	http://dx.doi.org/10.1371/journal.pone.0152247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023866	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900035
J	Shen, XL; Bourg, NA; McShea, WJ; Turner, BL				Shen, Xiaoli; Bourg, Norman A.; McShea, William J.; Turner, Benjamin L.			Long-Term Effects of White-Tailed Deer Exclusion on the Invasion of Exotic Plants: A Case Study in a Mid-Atlantic Temperate Forest	PLOS ONE			English	Article							PENNSYLVANIA; UNDERSTORY; BIODIVERSITY; VEGETATION; INTRODUCTIONS; DIVERSITY; DISTANCE; NITROGEN; IMPACTS; INDIANA	Exotic plant invasions and chronic high levels of herbivory are two of the major biotic stressors impacting temperate forest ecosystems in eastern North America, and the two problems are often linked. We used a 4-ha deer exclosure maintained since 1991 to examine the influence of a generalist herbivore, white-tailed deer (Odocoileus virginianus), on the abundance of four exotic invasive (Rosa multiflora, Berberis thunbergii, Rubus phoenicolasius and Microstegium vimineum) and one native (Cynoglossum virginianum) plant species, within a 25.6-ha mature temperate forest dynamics plot in Virginia, USA. We identified significant predictors of the abundance of each focal species using generalized linear models incorporating 10 environmental and landscape variables. After controlling for those predictors, we applied our models to a 4-ha deer exclusion site and a 4-ha reference site, both embedded within the larger plot, to test the role of deer on the abundance of the focal species. Slope, edge effects and soil pH were the most frequent predictors of the abundance of the focal species on the larger plot. The abundance of C. virginianum, known to be deer-dispersed, was significantly lower in the exclosure. Similar patterns were detected for B. thunbergii, R. phoenicolasius and M. vimineum, whereas R. multiflora was more abundant within the exclosure. Our results indicate that chronic high deer density facilitates increased abundances of several exotic invasive plant species, with the notable exception of R. multiflora. We infer that the invasion of many exotic plant species that are browse-tolerant to whitetailed deer could be limited by reducing deer populations.	[Shen, Xiaoli; Bourg, Norman A.; McShea, William J.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA USA; [Turner, Benjamin L.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Shen, Xiaoli] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Bourg, Norman A.] US Geol Survey, Natl Res Program, Eastern Branch, 959 Natl Ctr, Reston, VA 22092 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian Tropical Research Institute; Chinese Academy of Sciences; Institute of Botany, CAS; United States Department of the Interior; United States Geological Survey	Shen, XL (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA USA.; Shen, XL (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	xlshen.pku@gmail.com	Turner, Benjamin L/E-5940-2011	Turner, Benjamin L/0000-0002-6585-0722; McShea, William/0000-0002-8102-0200; Bourg, Norman/0000-0002-7443-1992	Smithsonian Global Earth Observatory initiative; Smithsonian Institution; HSBC; National Zoo; Earthwatch Foundation	Smithsonian Global Earth Observatory initiative; Smithsonian Institution(Smithsonian Institution); HSBC; National Zoo(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Earthwatch Foundation	The Smithsonian Global Earth Observatory initiative (http://www.forestgeo.si.edu/), the Smithsonian Institution (http://www.si.edu/), and the HSBC Climate Partnership (http://www.theclimategroup.org/programs/hsbc-climate-partnership/) provided the funding for establishing the SCBI Large Forest Dynamics Plot. The Friends of the National Zoo (https://nationalzoo.si.edu/JoinFONZ/Join/) and Earthwatch Foundation (http://earthwatch.org/) supported the original exclosure fence installation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas F, 2012, OIKOS, V121, P1271, DOI 10.1111/j.1600-0706.2011.20103.x; Abrams MD, 2012, J TORREY BOT SOC, V139, P167, DOI 10.3159/TORREY-D-11-00075.1; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; Anderson DR, 2002, PRACTICAL INFORM THE; BEERS TW, 1966, J FOREST, V64, P691; Beguin J, 2011, ECOL APPL, V21, P439, DOI 10.1890/09-2100.1; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bourg N. A., 2013, Ecology, V94, P2111, DOI 10.1890/13-0010.1; BROTHERS TS, 1992, CONSERV BIOL, V6, P91, DOI 10.1046/j.1523-1739.1992.610091.x; Bushway L, 2008, RASPBERRY BLACKBEERY; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Cronquist A., 1988, EVOLUTION CLASSIFICA; Dilts T., 2010, TOPOGRAPHY TOOLS ARC; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Drickamer L. C., 1970, J. Mammal., V51, P191, DOI 10.2307/1378564; Ehrenfeld JG, 2001, ECOL APPL, V11, P1287, DOI 10.2307/3060920; Ehrenfeld JG, 1997, J TORREY BOT SOC, V124, P210, DOI 10.2307/2996586; Elton C., 1958; Eschtruth AK, 2011, ECOLOGY, V92, P1314, DOI 10.1890/10-0857.1; Eschtruth AK, 2009, CONSERV BIOL, V23, P388, DOI 10.1111/j.1523-1739.2008.01122.x; Flory SL, 2006, PLANT ECOL, V184, P131, DOI 10.1007/s11258-005-9057-4; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Goetsch C, 2011, J TORREY BOT SOC, V138, P220, DOI 10.3159/TORREY-D-11-00013.1; Gorchov DL, 2011, PLANT SPEC BIOL, V26, P221, DOI 10.1111/j.1442-1984.2011.00317.x; Handley DT, 2006, GROWING RASPBERRIES; Heckel CD, 2010, ECOLOGY, V91, P319, DOI 10.1890/09-0628.1; Innis AF, 2005, THESIS U MARYLAND; Jenkins LH, 2014, BIOL CONSERV, V175, P119, DOI 10.1016/j.biocon.2014.04.022; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kalisz S, 2014, P NATL ACAD SCI USA, V111, P4501, DOI 10.1073/pnas.1310121111; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Knight TM, 2009, NAT AREA J, V29, P110, DOI 10.3375/043.029.0202; Kuebbing S, 2013, J PLANT ECOL, V6, P141, DOI 10.1093/jpe/rts018; Martin PH, 2009, FRONT ECOL ENVIRON, V7, P142, DOI 10.1890/070096; McGarvey JC, 2013, NORTHEAST NAT, V20, P451, DOI 10.1656/045.020.0301; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; McShea WJ, 2000, CONSERV BIOL, V14, P1161, DOI 10.1046/j.1523-1739.2000.99210.x; Mehrhoff LJ, 2000, J TORREY BOT SOC, V127, P251, DOI 10.2307/3088762; Merriam RW, 2003, J TORREY BOT SOC, V130, P283, DOI 10.2307/3557546; Messier C, 1998, J VEG SCI, V9, P511, DOI 10.2307/3237266; Myers JA, 2004, OECOLOGIA, V139, P35, DOI 10.1007/s00442-003-1474-2; Oswalt CM, 2007, FOREST ECOL MANAG, V249, P199, DOI 10.1016/j.foreco.2007.05.007; Peterson Paul M., 1999, Castanea, V64, P201; Qian H, 2006, ECOL LETT, V9, P1293, DOI 10.1111/j.1461-0248.2006.00982.x; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Rodgers VL, 2008, BIOSCIENCE, V58, P426, DOI 10.1641/B580510; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Rooney TP, 1997, NAT AREA J, V17, P297; Seagle SW, 2003, OIKOS, V103, P230, DOI 10.1034/j.1600-0706.2003.12287.x; Stiles E.W., 1982, American Birds, V36, P358; Urban DL, 2000, ECOL APPL, V10, P1820, DOI 10.1890/1051-0761(2000)010[1820:UMATDM]2.0.CO;2; USDA Forest Service, 2005, CONS ASS NO WILD COM; Vavra M, 2007, FOREST ECOL MANAG, V246, P66, DOI 10.1016/j.foreco.2007.03.051; Von Holle B, 2003, J VEG SCI, V14, P425, DOI 10.1111/j.1654-1103.2003.tb02168.x; Whigham D.F., 1988, PLANT FORM VEGETATIO, P243; Whigham Dennis F., 1993, Plant Species Biology, V8, P107, DOI 10.1111/j.1442-1984.1993.tb00062.x; Wiegmann SM, 2006, BIOL CONSERV, V129, P109, DOI 10.1016/j.biocon.2005.10.027; Williams SC, 2008, FOREST ECOL MANAG, V255, P940, DOI 10.1016/j.foreco.2007.10.003	60	18	20	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151825	10.1371/journal.pone.0151825	http://dx.doi.org/10.1371/journal.pone.0151825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019356	Green Published, gold, Green Submitted			2022-12-26	WOS:000372807800021
J	Martinez-Rovira, I; Boisgard, R; Pottier, G; Kuhnast, B; Jan, S				Martinez-Rovira, Immaculada; Boisgard, Raphael; Pottier, Geraldine; Kuhnast, Bertrand; Jan, Sebastien			Experimental Approach to Evaluate the C-11 Perfusion and Diffusion in Small Animal Tissues for HadronPET Applications	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RANGE VERIFICATION; PROTON THERAPY; TUMOR-THERAPY; BEAMS; WASHOUT; PATIENT; RABBIT	The development of a reliable dose monitoring system in hadron therapy is essential in order to control the treatment plan delivery. Positron Emission Tomography (PET) is the only method used in clinics nowadays for quality assurance. However, the accuracy of this method is limited by the loss of signal due to the biological washout processes. Up to the moment, very few studies measured the washout processes and there is no database of washout data as a function of the tissue and radioisotope. One of the main difficulties is related to the complexity of such measurements, along with the limited time slots available in hadron therapy facilities. Thus, in this work, we proposed an alternative in vivo methodology for the measurement and modeling of the biological washout parameters without any radiative devices. It consists in the implementation of a point-like radioisotope source by direct injection on the tissues of interest and its measurement by means of high-resolution preclinical PET systems. In particular, the washout of C-11 carbonate radioisotopes was assessed, considering that C-11 is is the most abundant beta(+) emitter produced by carbon beams. C-11 washout measurements were performed in several tissues of interest (brain, muscle and 9L tumor xenograf) in rodents (Wistar rat). Results show that the methodology presented is sensitive to the washout variations depending on the selected tissue. Finally, a first qualitative correlation between C-11 tumor washout properties and tumor metabolism (via F-18-FDG tracer uptake) was found.	[Martinez-Rovira, Immaculada] Univ Paris 07, Univ Paris 11, CNRS, IMNC,UMR 8165, Orsay, France; [Martinez-Rovira, Immaculada; Boisgard, Raphael; Pottier, Geraldine; Kuhnast, Bertrand; Jan, Sebastien] Univ Paris 11, CNRS, INSERM, CEA,I2BM,SHFJ,IMIV,UMR 1023,CEA,ERL 9218, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Jan, S (corresponding author), Univ Paris 11, CNRS, INSERM, CEA,I2BM,SHFJ,IMIV,UMR 1023,CEA,ERL 9218, F-91405 Orsay, France.	sebastien.jan@cea.fr	Martínez-Rovira, Immaculada/E-9154-2016	Martínez-Rovira, Immaculada/0000-0002-2918-489X; Kuhnast, Bertrand/0000-0002-5035-4072	CEA national institut	CEA national institut	This work was funded by the CEA national institut.	Enghardt W, 2004, RADIOTHER ONCOL, V73, pS96, DOI 10.1016/S0167-8140(04)80024-0; Enghardt W, 2014, NUCL INSTR METH PH A; Fiedler F, 2008, ACTA ONCOL, V47, P1077, DOI 10.1080/02841860701769743; Helmbrecht S, 2013, MED PHYS, V40, DOI 10.1118/1.4818424; Iseki Y, 2004, PHYS MED BIOL, V49, P3179, DOI 10.1088/0031-9155/49/14/012; Knopf A, 2009, PHYS MED BIOL, V54, P4477, DOI 10.1088/0031-9155/54/14/008; Kraft G, 2000, PROG PART NUCL PHYS, V45, pS473, DOI 10.1016/S0146-6410(00)00112-5; Martinez-Rovira I, 2015, MED PHYS, V42, P1773, DOI 10.1118/1.4914449; Mizuno H, 2003, PHYS MED BIOL, V48, P2269, DOI 10.1088/0031-9155/48/15/302; Moteabbed M, 2011, PHYS MED BIOL, V56, P1063, DOI 10.1088/0031-9155/56/4/012; Parodi K, 2007, INT J RADIAT ONCOL, V68, P920, DOI 10.1016/j.ijrobp.2007.01.063; Pshenichnov I, 2007, PHYS MED BIOL, V52, P7295, DOI 10.1088/0031-9155/52/24/007; Schardt D, 2010, REV MOD PHYS, V82, P383, DOI 10.1103/RevModPhys.82.383; SHIELDS AF, 1992, J NUCL MED, V33, P581; STENSTROM T, 1970, THESIS UPPSALA; Tomitani T, 2003, PHYS MED BIOL, V48, P875, DOI 10.1088/0031-9155/48/7/305; WILSON RR, 1946, RADIOLOGY, V47, P487, DOI 10.1148/47.5.487	17	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151212	10.1371/journal.pone.0151212	http://dx.doi.org/10.1371/journal.pone.0151212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015269	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708900024
J	Heier, C; Taschler, U; Radulovic, M; Aschauer, P; Eichmann, TO; Grond, S; Wolinski, H; Oberer, M; Zechner, R; Kohlwein, SD; Zimmermann, R				Heier, Christoph; Taschler, Ulrike; Radulovic, Maja; Aschauer, Philip; Eichmann, Thomas O.; Grond, Susanne; Wolinski, Heimo; Oberer, Monika; Zechner, Rudolf; Kohlwein, Sepp D.; Zimmermann, Robert			Monoacylglycerol Lipases Act as Evolutionarily Conserved Regulators of Non-oxidative Ethanol Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID ETHYL-ESTERS; YEAST SACCHAROMYCES-CEREVISIAE; RAT-LIVER MICROSOMES; MITOCHONDRIAL DYSFUNCTION; LIPID PARTICLES; GENES ENCODE; FATTY-ACIDS; ALCOHOL; ACYLTRANSFERASE; PURIFICATION	Fatty acid ethyl esters (FAEEs) are non-oxidative metabolites of ethanol that accumulate in human tissues upon ethanol intake. Although FAEEs are considered as toxic metabolites causing cellular dysfunction and tissue damage, the enzymology of FAEE metabolism remains poorly understood. In this study, we used a biochemical screen in Saccharomyces cerevisiae to identify and characterize putative hydrolases involved in FAEE catabolism. We found that Yju3p, the functional orthologue of mammalian monoacylglycerol lipase (MGL), contributes >90% of cellular FAEE hydrolase activity, and its loss leads to the accumulation of FAEE. Heterologous expression of mammalian MGL in yju3 Delta mutants restored cellular FAEE hydrolase activity and FAEE catabolism. Moreover, overexpression or pharmacological inhibition of MGL in mouse AML-12 hepatocytes decreased or increased FAEE levels, respectively. FAEEs were transiently incorporated into lipid droplets (LDs) and both Yju3p and MGL co-localized with these organelles. We conclude that the storage of FAEE in inert LDs and their mobilization by LD-resident FAEE hydrolases facilitate a controlled metabolism of these potentially toxic lipid metabolites.	[Heier, Christoph; Taschler, Ulrike; Radulovic, Maja; Aschauer, Philip; Eichmann, Thomas O.; Grond, Susanne; Wolinski, Heimo; Oberer, Monika; Zechner, Rudolf; Kohlwein, Sepp D.; Zimmermann, Robert] Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria; [Wolinski, Heimo; Kohlwein, Sepp D.] BioTechMed Graz, A-8010 Graz, Austria	University of Graz	Heier, C; Zimmermann, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria.	christoph.heier@uni-graz.at; robert.zimmermann@uni-graz.at		Wolinski, Heimo/0000-0002-1583-6092; Taschler, Ulrike/0000-0001-9000-1602; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Eichmann, Thomas O./0000-0002-8521-2795; Grond, Susanne/0000-0002-7121-9013; Oberer, Monika/0000-0003-2525-9513; Zechner, Rudolf/0000-0001-5483-1182; Zimmermann, Robert/0000-0002-7354-870X; Heier, Christoph/0000-0001-6858-408X	Austrian Science Fund (FWF) [P21296, P24294, P24857]; SFB Lipotox [F3002]; DK Molecular Enzymology [W901]; Wittgenstein Award [Z136]; Austrian Science Fund (FWF) [W 901, F 3002, P 24857] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); SFB Lipotox(German Research Foundation (DFG)); DK Molecular Enzymology(Austrian Science Fund (FWF)); Wittgenstein Award(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) Grants P21296, P24294, and P24857, SFB Lipotox F3002, the DK Molecular Enzymology W901, and Wittgenstein Award Z136. The authors declare that they have no conflicts of interest with the contents of this article.	Aschauer P, 2016, BBA-MOL CELL BIOL L, V1861, P462, DOI 10.1016/j.bbalip.2016.02.005; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Auwarter V, 2001, CLIN CHEM, V47, P2114; BORA PS, 1989, FEBS LETT, V258, P236, DOI 10.1016/0014-5793(89)81662-X; Bora PS, 1996, J MOL CELL CARDIOL, V28, P2027, DOI 10.1006/jmcc.1996.0195; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Currie E, 2014, J LIPID RES, V55, P1465, DOI 10.1194/jlr.M050229; Debelyy MO, 2011, EUKARYOT CELL, V10, P776, DOI 10.1128/EC.05040-11; Diczfalusy MA, 2001, J LIPID RES, V42, P1025; Diczfalusy MA, 1999, EUR J BIOCHEM, V259, P404, DOI 10.1046/j.1432-1327.1999.00052.x; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Doyle KM, 1996, JAMA-J AM MED ASSOC, V276, P1152, DOI 10.1001/jama.276.14.1152; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; GRIGOR MR, 1973, BIOCHIM BIOPHYS ACTA, V306, P26, DOI 10.1016/0005-2760(73)90204-X; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HADVARY P, 1991, J BIOL CHEM, V266, P2021; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Huang W, 2014, GUT, V63, P1313, DOI 10.1136/gutjnl-2012-304058; Iglesias J, 2016, J LIPID RES, V57, P131, DOI 10.1194/jlr.D058438; Jandrositz A, 2005, BBA-MOL CELL BIOL L, V1735, P50, DOI 10.1016/j.bbalip.2005.04.005; Khor VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105047; Knight MJ, 2014, YEAST, V31, P463, DOI 10.1002/yea.3046; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LANGE LG, 1983, J CLIN INVEST, V72, P724, DOI 10.1172/JCI111022; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; LAPOSATA EA, 1990, J BIOL CHEM, V265, P9688; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; MOGELSON S, 1984, BIOCHEMISTRY-US, V23, P4075, DOI 10.1021/bi00313a010; Mohan SS, 2015, ALCOHOL CLIN EXP RES, V39, P434, DOI 10.1111/acer.12647; Molina PE, 2014, PHYSIOLOGY, V29, P203, DOI 10.1152/physiol.00055.2013; Neal A, 2006, BBA-MOL CELL BIOL L, V1761, P757, DOI 10.1016/j.bbalip.2006.04.009; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Piano MR, 2014, CARDIOVASC TOXICOL, V14, P291, DOI 10.1007/s12012-014-9252-4; POLOKOFF MA, 1978, J BIOL CHEM, V253, P7173; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; RILEY DJS, 1990, BIOCHEMISTRY-US, V29, P3848, DOI 10.1021/bi00468a007; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Schiabor KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113899; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schneider A, 2005, DIGEST DIS, V23, P222, DOI 10.1159/000090169; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Selvaraju K, 2014, BBA-MOL CELL BIOL L, V1841, P1383, DOI 10.1016/j.bbalip.2014.06.013; Shield KD, 2013, ALCOHOL RES-CURR REV, V35, P155; Subbanna S, 2015, J NEUROCHEM, V134, P276, DOI 10.1111/jnc.13120; SZCZEPIORKOWSKI ZM, 1995, GASTROENTEROLOGY, V108, P515, DOI 10.1016/0016-5085(95)90081-0; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Treloar T, 1996, BBA-LIPID LIPID MET, V1299, P160, DOI 10.1016/0005-2760(95)00199-9; Valachovic M, 2016, BIOCHEM BIOPH RES CO, V469, P1123, DOI 10.1016/j.bbrc.2015.12.050; Varthini LV, 2015, FEBS LETT, V589, P23, DOI 10.1016/j.febslet.2014.11.019; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Werner J, 1997, GASTROENTEROLOGY, V113, P286, DOI 10.1016/S0016-5085(97)70106-9; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Zelner I, 2013, DRUG METAB REV, V45, P277, DOI 10.3109/03602532.2013.795584; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c	69	12	12	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11865	11875		10.1074/jbc.M115.705541	http://dx.doi.org/10.1074/jbc.M115.705541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27036938	Green Published, hybrid			2022-12-26	WOS:000377264800035
J	Miura, K; Ishioka, M; Minami, S; Horie, Y; Ohshima, S; Goto, T; Ohnishi, H				Miura, Kouichi; Ishioka, Mitsuaki; Minami, Shinichiro; Horie, Yasuo; Ohshima, Shigetoshi; Goto, Takashi; Ohnishi, Hirohide			Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE AMINOTRANSFERASE LEVELS; VIRUS-ASSOCIATED CIRRHOSIS; FATTY LIVER-DISEASE; CANCER STEM-CELLS; NONALCOHOLIC STEATOHEPATITIS; HEPATITIS-C; INNATE IMMUNITY; TLR4; MICROBIOTA; EXPRESSION	The role of Toll-like receptor (TLR) signaling has attracted much attention in the development of hepatic inflammation and hepatocellular carcinoma (HCC). We herein sought to determine the role of TLRs and responsible cells in steatohepatitis-related HCC. We used hepatocyte-specific Pten-deficient (Pten(Delta hep)) mice, which exhibit steatohepatitis followed by liver tumor formation, including HCC. We then generated Pten(Delta hep)/Tlr4(-/-) and Pten(Delta hep)/Tlr2(-/-) double-mutant mice and investigated the role of macrophages using reconstitution of bone marrow (BM)-derived cells, chemical depletion of macrophages, and isolated macrophages. Tlr4 but not Tlr2 deficiency in the Pten(Delta hep) mice suppressed tumor growth as well as hepatic inflammation. Gut sterilization by an antibiotic mixture reduced the portal LPS levels as well as tumor growth in the Pten(Delta hep) mice. Tumor growth was also decreased by reconstitution of BM-derived cells to Tlr4(-/-) BM cells. In addition, chemical depletion of macrophages significantly reduced tumor size and numbers. Macrophages expressing Ly6C were increased in number, which was associated with inflammation and tumor progression in the Pten(Delta hep) mice. Hepatic macrophages isolated from the Pten(Delta hep) mice abundantly expressed the Ly6C gene and produced much more IL-6 and TNF alpha in response to LPS. These proinflammatory cytokines induced the proliferation of HCC cells as well as oval cells, putative cancer progenitor cells. Indeed, putative cancer progenitor cells emerged before the development of macroscopic liver tumors and then increased in number under sustained inflammation. TLR4 on macrophages contributes to the development of steatohepatitis-related HCC in mice.	[Miura, Kouichi; Ishioka, Mitsuaki; Minami, Shinichiro; Horie, Yasuo; Ohshima, Shigetoshi; Goto, Takashi; Ohnishi, Hirohide] Akita Univ, Grad Sch Med, Dept Gastroenterol & Hepatobiliary Pancreatol, 1-1-1 Hondo, Akita, Akita 0108543, Japan	Akita University	Miura, K (corresponding author), Akita Univ, Grad Sch Med, Dept Gastroenterol & Hepatobiliary Pancreatol, 1-1-1 Hondo, Akita, Akita 0108543, Japan.	miura116@doc.med.akita-u.ac.jp		Ishioka, Mitsuaki/0000-0002-7853-4454	Japan Society for the Promotion of Science; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Foundation for Promotion of Cancer Research in Japan; Mishima Kaiun Memorial Foundation; Nakayama Cancer Research Institute (Gastrointestinal Cancer Project)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Foundation for Promotion of Cancer Research in Japan; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Nakayama Cancer Research Institute (Gastrointestinal Cancer Project)	Supported by a grant-in-aid for scientific research from Japan Society for the Promotion of Science, Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Foundation for Promotion of Cancer Research in Japan, Mishima Kaiun Memorial Foundation, and Nakayama Cancer Research Institute (Gastrointestinal Cancer Project).	Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Himes RW, 2010, FASEB J, V24, P731, DOI 10.1096/fj.09-141929; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kirillova I, 1999, CELL GROWTH DIFFER, V10, P819; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kudo H, 2009, J HEPATOL, V51, P168, DOI 10.1016/j.jhep.2009.02.032; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Matthews VB, 2004, WOUND REPAIR REGEN, V12, P650, DOI 10.1111/j.1067-1927.2004.12605.x; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Osawa Y, 2013, J CLIN INVEST, V123, P834, DOI 10.1172/JCI65188; Paik YH, 2006, LAB INVEST, V86, P676, DOI 10.1038/labinvest.3700422; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Rivera CA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-52; Romics L, 2004, HEPATOLOGY, V40, P555, DOI 10.1002/hep.20350; Rountree CB, 2009, STEM CELLS, V27, P290, DOI 10.1634/stemcells.2008-0332; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tarao K, 1999, CANCER, V86, P589, DOI 10.1002/(SICI)1097-0142(19990815)86:4<589::AID-CNCR7>3.0.CO;2-K; Tarao K, 1997, CANCER, V79, P688, DOI 10.1002/(SICI)1097-0142(19970215)79:4<688::AID-CNCR5>3.0.CO;2-A; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Wang ZY, 2013, HEPATOLOGY, V57, P1869, DOI 10.1002/hep.26234; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	44	39	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11504	11517		10.1074/jbc.M115.709048	http://dx.doi.org/10.1074/jbc.M115.709048			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27022031	Green Published, hybrid			2022-12-26	WOS:000377264800004
J	Czikora, A; Lundberg, DJ; Abramovitz, A; Lewin, NE; Kedei, N; Peach, ML; Zhou, XL; Merritt, RC; Craft, EA; Braun, DC; Blumberg, PM				Czikora, Agnes; Lundberg, Daniel J.; Abramovitz, Adelle; Lewin, Nancy E.; Kedei, Noemi; Peach, Megan L.; Zhou, Xiaoling; Merritt, Raymond C., Jr.; Craft, Elizabeth A.; Braun, Derek C.; Blumberg, Peter M.			Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cloning; guanine nucleotide exchange factor (GEF); phorbol ester; protein kinase C (PKC); Ras-related protein 1 (Rap1); C1 domain; RasGRP2	KINASE-C; CALDAG-GEFI; EXCHANGE FACTOR; MOLECULAR-DYNAMICS; DIACYLGLYCEROL BINDING; MEMBRANE INTERACTIONS; CRYSTAL-STRUCTURE; SWISS-MODEL; ACTIVATION; LIGAND	The C1 domain represents the recognition module for diacylglycerol and phorbol esters in protein kinase C, Ras guanine nucleotide releasing protein (RasGRP), and related proteins. RasGRP2 is exceptional in that its C1 domain has very weak binding affinity (K-d = 2890 +/- 240 nm for [H-3]phorbol 12,13-dibutyrate. We have identified four amino acid residues responsible for this lack of sensitivity. Replacing Asn(7), Ser(8), Ala(19), and Ile(21) with the corresponding residues from RasGRP1/3 (Thr(7), Tyr(8), Gly(19), and Leu(21), respectively) conferred potent binding affinity (K-d = 1.47 +/- 0.03 nm) in vitro and membrane translocation in response to phorbol 12-myristate 13-acetate in LNCaP cells. Mutant C1 domains incorporating one to three of the four residues showed intermediate behavior with S8Y making the greatest contribution. Binding activity for diacylglycerol was restored in parallel. The requirement for anionic phospholipid for [H-3]phorbol 12,13-dibutyrate binding was determined; it decreased in going from the single S8Y mutant to the quadruple mutant. The full-length RasGRP2 protein with the mutated C1 domains also showed strong phorbol ester binding, albeit modestly weaker than that of the C1 domain alone (K-d = 8.2 +/- 1.1 nm for the full-length protein containing all four mutations), and displayed translocation in response to phorbol ester. RasGRP2 is a guanyl exchange factor for Rap1. Consistent with the ability of phorbol ester to induce translocation of the full-length RasGRP2 with the mutated C1 domain, phorbol ester enhanced the ability of the mutated RasGRP2 to activate Rap1. Modeling confirmed that the four mutations helped the binding cleft maintain a stable conformation.	[Czikora, Agnes; Abramovitz, Adelle; Lewin, Nancy E.; Kedei, Noemi; Zhou, Xiaoling; Blumberg, Peter M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lundberg, Daniel J.; Merritt, Raymond C., Jr.; Craft, Elizabeth A.; Braun, Derek C.] Gallaudet Univ, Dept Sci Technol & Math, Washington, DC 20002 USA; [Peach, Megan L.] Frederick Natl Lab Canc Res, Basic Sci Program, Leidos Biomed Res Inc, Biol Chem Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumberg, PM (corresponding author), NCI, Bldg 37,Rm 4048,37 Convent Dr MSC4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov	zhou, xuan/GZA-8157-2022	Peach, Megan/0000-0002-4290-5268	Intramural Research Program; Center for Cancer Research; NCI; National Institutes of Health [Z1A BC 005270]; NCI, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [Z01BC005270, ZIABC005270] Funding Source: NIH RePORTER	Intramural Research Program; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program, Center for Cancer Research, NCI, National Institutes of Health Project Z1A BC 005270 and in part with federal funds from the NCI, National Institutes of Health under Contract HHSN261200800001E. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alon R, 2003, BLOOD, V101, P4437, DOI 10.1182/blood-2002-11-3427; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertolini TM, 2003, J ORG CHEM, V68, P5028, DOI 10.1021/jo030029w; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Braun DC, 2005, MOL CANCER THER, V4, P141; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Canault M, 2014, J EXP MED, V211, P1346, DOI 10.1084/jem.20130477; Carbo C, 2010, J LEUKOCYTE BIOL, V88, P313, DOI 10.1189/jlb.0110049; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Dupuy AJ, 2001, J BIOL CHEM, V276, P11804, DOI 10.1074/jbc.M008970200; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fuller DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038796; Geczy T, 2012, J BIOL CHEM, V287, P13137, DOI 10.1074/jbc.M111.320010; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; HERMANS J, 1969, NATURE, V224, P175, DOI 10.1038/224175a0; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley JH, 1997, PROTEIN SCI, V6, P477; Igumenova TI, 2015, BIOCHEMISTRY-US, V54, P4953, DOI 10.1021/acs.biochem.5b00565; Irie K, 2004, BIOORGAN MED CHEM, V12, P4575, DOI 10.1016/j.bmc.2004.07.008; Irie K, 2002, PHARMACOL THERAPEUT, V93, P271, DOI 10.1016/S0163-7258(02)00196-1; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Kelsey JS, 2014, CHEMBIOCHEM, V15, P1131, DOI 10.1002/cbic.201400041; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lewin Nancy E, 2003, Methods Mol Biol, V233, P129; Li JN, 2014, J AM CHEM SOC, V136, P11757, DOI 10.1021/ja505369r; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Lorenzo PS, 2001, CANCER RES, V61, P943; Lucic I, 2016, J MOL BIOL, V428, P121, DOI 10.1016/j.jmb.2015.11.001; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pasvolsky R, 2007, J EXP MED, V204, P1571, DOI 10.1084/jem.20070058; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pu YM, 2014, J MED CHEM, V57, P3835, DOI 10.1021/jm500165n; Riches JC, 2014, BLOOD, V123, P4101, DOI 10.1182/blood-2014-01-552307; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shindo M, 2003, J BIOL CHEM, V278, P18448, DOI 10.1074/jbc.M300400200; Shindo M, 2001, BIOORGAN MED CHEM, V9, P2073, DOI 10.1016/S0968-0896(01)00100-6; Sosa MS, 2009, BIOCHEMISTRY-US, V48, P8171, DOI 10.1021/bi9010623; Stadtmann A, 2011, EUR J IMMUNOL, V41, P2074, DOI 10.1002/eji.201041196; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Stefanini L, 2010, PLATELETS, V21, P239, DOI 10.3109/09537101003639931; Stewart MD, 2014, J BIOL CHEM, V289, P27653, DOI 10.1074/jbc.M114.585570; Stewart MD, 2011, J MOL BIOL, V408, P949, DOI 10.1016/j.jmb.2011.03.020; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Subramanian H, 2013, J THROMB HAEMOST, V11, P1574, DOI 10.1111/jth.12271; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Zahedi B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.189605; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Ziemba BP, 2014, BIOCHEMISTRY-US, V53, P1697, DOI 10.1021/bi4016082	72	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11133	11147		10.1074/jbc.M116.725333	http://dx.doi.org/10.1074/jbc.M116.725333			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022025	hybrid, Green Published			2022-12-26	WOS:000377042100017
J	Wu, W; Chen, GM; Fan, BX; Liu, JY				Wu, Wei; Chen, Guiming; Fan, Boxuan; Liu, Jianyou			Effect of Groove Surface Texture on Tribological Characteristics and Energy Consumption under High Temperature Friction	PLOS ONE			English	Article							RECIPROCATING AUTOMOTIVE COMPONENTS; PERFORMANCE; STEEL; DRY; BEHAVIOR; LUBRICATION; WATER; WEAR; TOOL	Energy consumption and tribological properties could be improved by proper design of surface texture in friction. However, some literature focused on investigating their performance under high temperature. In the study, different groove surface textures were fabricated on steels by a laser machine, and their tribological behaviors were experimentally studied with the employment of the friction and wear tester under distinct high temperature and other working conditions. The friction coefficient was recorded, and wear performance were characterized by double light interference microscope, scanning electron microscope (SEM) and x-ray energy dispersive spectrometry (EDS). Then, the performances of energy consumptions were carefully estimated. Results showed that friction coefficient, wear, and energy consumption could almost all be reduced by most textures under high temperature conditions, but to a different extent which depends on the experimental conditions and texture parameters. The main improvement mechanisms were analyzed, such as the hardness change, wear debris storage, thermal stress release and friction induced temperature reduction by the textures. Finally, a scattergram of the relatively reduced ratio of the energy consumption was drawn for different surface textures under four distinctive experimental conditions to illustrate the comprehensive energy consumption improving ability of textures, which was of benefit for the application of texture design.	[Wu, Wei; Chen, Guiming; Liu, Jianyou] Xian Res Inst Hitech, Xian, Peoples R China; [Fan, Boxuan] CASC, Acad 4, Xian, Peoples R China	China Aerospace Science & Technology Corporation (CASC)	Wu, W (corresponding author), Xian Res Inst Hitech, Xian, Peoples R China.	foterlk@163.com			Science and Technology Innovation Fund [2014kct-03]	Science and Technology Innovation Fund	Support was provided by the Science and Technology Innovation Fund (2014kct-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archard JF, 1958, WEAR, V2, P438, DOI DOI 10.1016/0043-1648(59)90159-0; Blatter A, 1999, WEAR, V232, P226, DOI 10.1016/S0043-1648(99)00150-7; Borghi A, 2008, WEAR, V265, P1046, DOI 10.1016/j.wear.2008.02.011; Chang WL, 2011, WEAR, V271, P2433, DOI 10.1016/j.wear.2010.12.026; Deng JX, 2013, SURF COAT TECH, V222, P135, DOI 10.1016/j.surfcoat.2013.02.015; Etsion I, 1999, TRIBOL T, V42, P511, DOI 10.1080/10402009908982248; Etsion I, 2013, FRICTION, V1, P195, DOI 10.1007/s40544-013-0018-y; Flatters IJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032770; Ibatan T, 2015, SURF COAT TECH, V272, P102, DOI 10.1016/j.surfcoat.2015.04.017; Kawasegi N, 2009, PRECIS ENG, V33, P248, DOI 10.1016/j.precisioneng.2008.07.005; Kligerman Y, 2005, J TRIBOL-T ASME, V127, P632, DOI 10.1115/1.1866171; Klocker A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079085; Li G, 2015, J FUNCTION MAT, V44, P2033; Ma HY, 2010, MANUFACTURE INFORM E, V39, P30; Min J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137566; Mufti RA, 2009, P I MECH ENG J-J ENG, V223, P629, DOI 10.1243/13506501JET487; NAKADA M, 1994, TRIBOL INT, V27, P3, DOI 10.1016/0301-679X(94)90056-6; Pettersson U, 2003, TRIBOL INT, V36, P857, DOI 10.1016/S0301-679X(03)00104-X; Qiu Y, 2011, TRIBOL INT, V44, P635, DOI 10.1016/j.triboint.2011.01.003; Qu JQ, 2011, TECHNOLOGY HIGHWAY T, V3, P80; Ronen A, 2001, TRIBOL T, V44, P359, DOI 10.1080/10402000108982468; Ryk G, 2002, TRIBOL T, V45, P444, DOI 10.1080/10402000208982572; Sinanoglu C, 2005, J MATER PROCESS TECH, V168, P344, DOI 10.1016/j.jmatprotec.2005.02.252; Sugihara T, 2012, PRECIS ENG, V36, P229, DOI 10.1016/j.precisioneng.2011.10.002; Tala-Ighil N, 2015, TRIBOL INT, V90, P228, DOI 10.1016/j.triboint.2015.02.032; TIAN XF, 1993, J TRIBOL-T ASME, V115, P411, DOI 10.1115/1.2921652; Tong X, 2013, APPL SURF SCI, V271, P373, DOI 10.1016/j.apsusc.2013.01.209; UETZ H, 1978, WEAR, V49, P253, DOI 10.1016/0043-1648(78)90091-1; Wang XL, 2006, APPL SURF SCI, V253, P1282, DOI 10.1016/j.apsusc.2006.01.076; Wang XL, 2001, TRIBOL INT, V34, P703, DOI 10.1016/S0301-679X(01)00063-9; Wu Z, 2012, WEAR, V292, P135, DOI 10.1016/j.wear.2012.05.021; Xie J, 2013, INT J MACH TOOL MANU, V73, P25, DOI 10.1016/j.ijmachtools.2013.05.006; Xing YQ, 2013, MATER DESIGN, V52, P234, DOI 10.1016/j.matdes.2013.05.077; Yu XQ, 2002, J MATER PROCESS TECH, V129, P463, DOI 10.1016/S0924-0136(02)00611-8; Zhang ZH, 2007, THESIS JILIN U JILIN; Zhang ZH, 2010, J BIONIC ENG, V7, P390, DOI 10.1016/S1672-6529(10)60271-5; Zhou H, 2006, SURF COAT TECH, V200, P6758, DOI 10.1016/j.surfcoat.2005.10.019	37	14	17	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152100	10.1371/journal.pone.0152100	http://dx.doi.org/10.1371/journal.pone.0152100			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035658	gold, Green Submitted, Green Published			2022-12-26	WOS:000373201200011
J	Sedova, L; Pravenec, M; Krenova, D; Kazdova, L; Zidek, V; Krupkova, M; Liska, F; Kren, V; Seda, O				Sedova, Lucie; Pravenec, Michal; Krenova, Drahomira; Kazdova, Ludmila; Zidek, Vyclav; Krupkova, Michaela; Liska, Frantisek; Kren, Vladimir; Seda, Ondrej			Isolation of a Genomic Region Affecting Most Components of Metabolic Syndrome in a Chromosome-16 Congenic Rat Model	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BLOOD-PRESSURE; GENETIC-DETERMINANTS; GLUCOSE-TOLERANCE; HYPERTENSIVE-RAT; STRAINS; REVEALS; IDENTIFICATION; MECHANISMS; PHENOTYPES	Metabolic syndrome is a highly prevalent human disease with substantial genomic and environmental components. Previous studies indicate the presence of significant genetic determinants of several features of metabolic syndrome on rat chromosome 16 (RNO16) and the syntenic regions of human genome. We derived the SHR. BN16 congenic strain by introgression of a limited RNO16 region from the Brown Norway congenic strain (BN-Lx) into the genomic background of the spontaneously hypertensive rat (SHR) strain. We compared the morphometric, metabolic, and hemodynamic profiles of adult male SHR and SHR. BN16 rats. We also compared in silico the DNA sequences for the differential segment in the BN-Lx and SHR parental strains. SHR. BN16 congenic rats had significantly lower weight, decreased concentrations of total triglycerides and cholesterol, and improved glucose tolerance compared with SHR rats. The concentrations of insulin, free fatty acids, and adiponectin were comparable between the two strains. SHR. BN16 rats had significantly lower systolic (18-28 mmHg difference) and diastolic (10-15 mmHg difference) blood pressure throughout the experiment (repeated-measures ANOVA, P < 0.001). The differential segment spans approximately 22 Mb of the telomeric part of the short arm of RNO16. The in silico analyses revealed over 1200 DNA variants between the BN-Lx and SHR genomes in the SHR. BN16 differential segment, 44 of which lead to missense mutations, and only eight of which (in Asb14, Il17rd, Itih1, Syt15, Ercc6, RGD1564958, Tmem161a, and Gatad2a genes) are predicted to be damaging to the protein product. Furthermore, a number of genes within the RNO16 differential segment associated with metabolic syndrome components in human studies showed polymorphisms between SHR and BN-Lx (including Lpl, Nrg3, Pbx4, Cilp2, and Stab1). Our novel congenic rat model demonstrates that a limited genomic region on RNO16 in the SHR significantly affects many of the features of metabolic syndrome.	[Sedova, Lucie; Pravenec, Michal; Krenova, Drahomira; Krupkova, Michaela; Liska, Frantisek; Kren, Vladimir; Seda, Ondrej] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Sedova, Lucie; Pravenec, Michal; Krenova, Drahomira; Krupkova, Michaela; Liska, Frantisek; Kren, Vladimir; Seda, Ondrej] Gen Teaching Hosp, Prague, Czech Republic; [Sedova, Lucie; Seda, Ondrej] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic; [Pravenec, Michal; Zidek, Vyclav; Kren, Vladimir] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic; [Kazdova, Ludmila] Inst Clin & Expt Med, Dept Metab & Diabet, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Institute for Clinical & Experimental Medicine (IKEM)	Seda, O (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.; Seda, O (corresponding author), Gen Teaching Hosp, Prague, Czech Republic.; Seda, O (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic.	oseda@lf1.cuni.cz	Liska, Frantisek/N-9192-2017; Pravenec, Michal/B-1666-2012; Krupkova, Michaela/L-2373-2017; Seda, Ondrej/A-2058-2008; Sedova, Lucie/D-1089-2017	Liska, Frantisek/0000-0002-9588-806X; Pravenec, Michal/0000-0001-9197-5871; Krupkova, Michaela/0000-0002-9371-2511; Seda, Ondrej/0000-0001-8498-5895; Sedova, Lucie/0000-0003-3783-2946	Ministry of Education, Youth and Sports of the Czech Republic [LK11217, LL1204]; Charles University in Prague [PRVOUK-P25/LF1/2, UNCE 204022]; project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" [CZ.1.05/1.1.0/02.0109]; European Regional Development Fund; Czech Science Foundation [301/12/0696]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University"; European Regional Development Fund(European Commission); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by Project LK11217 and LL1204 (within ERC CZ program) from the Ministry of Education, Youth and Sports of the Czech Republic; Charles University in Prague [PRVOUK-P25/LF1/2, UNCE 204022] and by the project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" (CZ.1.05/1.1.0/02.0109), from the European Regional Development Fund. MP was supported by grants 301/12/0696 from Czech Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Aneas I, 2009, PHYSIOL GENOMICS, V37, P52, DOI 10.1152/physiolgenomics.90299.2008; Baguhl R, 2009, OBESITY, V17, P1215, DOI 10.1038/oby.2008.658; Bergholdt R, 2012, DIABETES, V61, P954, DOI 10.2337/db11-1263; Bonne ACM, 2002, ARTERIOSCL THROM VAS, V22, P2072, DOI 10.1161/01.ATV.0000040225.16592.CE; Bureau A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00248; Chauvet C, 2013, HUM MOL GENET, V22, P4451, DOI 10.1093/hmg/ddt294; Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575; Fukuda M, 2003, BIOCHEM BIOPH RES CO, V306, P64, DOI 10.1016/S0006-291X(03)00911-2; Gesualdi NM, 2006, FREE RADICAL RES, V40, P467, DOI 10.1080/10715760600570547; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hoffman MJ, 2013, HYPERTENSION, V62, P557, DOI 10.1161/HYPERTENSIONAHA.113.01708; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Hull RL, 2012, J HISTOCHEM CYTOCHEM, V60, P749, DOI 10.1369/0022155412457048; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P819, DOI 10.1152/physiolgenomics.00175.2011; Langley SR, 2013, CARDIOVASC RES, V97, P653, DOI 10.1093/cvr/cvs329; Mashimo T, 2007, PHYSIOL GENOMICS, V30, P95, DOI 10.1152/physiolgenomics.00211.2006; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Moujahidine M, 2004, HYPERTENS RES, V27, P203, DOI 10.1291/hypres.27.203; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Pravenec M, 2010, METHODS MOL BIOL, V597, P415, DOI 10.1007/978-1-60327-389-3_28; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; SCHORK NJ, 1995, GENOME RES, V5, P164, DOI 10.1101/gr.5.2.164; Seda O, 2002, FOLIA BIOL-PRAGUE, V48, P81; Seda O, 2008, HYPERTENSION, V51, P1156, DOI 10.1161/HYPERTENSIONAHA.107.105247; Seda O, 2006, PHYSIOL GENOMICS, V27, P95, DOI 10.1152/physiolgenomics.00039.2006; Sedova L, 2012, HEREDITY, V109, P63, DOI 10.1038/hdy.2012.14; Sedova L, 2007, AM J PHYSIOL-ENDOC M, V292, pE1318, DOI 10.1152/ajpendo.00526.2006; Shimoyama M, 2015, NUCLEIC ACIDS RES, V43, pD743, DOI 10.1093/nar/gku1026; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Sugiura K, 1999, MAMM GENOME, V10, P1126, DOI 10.1007/s003359901177; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; Ueno T, 2003, PHYSIOL RES, V52, P689; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; Wang JK, 2015, CIRC-CARDIOVASC GENE, V8, P316, DOI 10.1161/CIRCGENETICS.114.000520; Ways JA, 2007, PHYSIOL GENOMICS, V29, P91, DOI 10.1152/physiolgenomics.00027.2006; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	38	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152708	10.1371/journal.pone.0152708	http://dx.doi.org/10.1371/journal.pone.0152708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031336	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800125
J	Singer, RH; Stoutenberg, M; Gellman, MD; Archer, E; Davis, SM; Gotman, N; Marquez, DX; Buelna, C; Deng, Y; Hosgood, HD; Zambrana, RE				Singer, Richard H.; Stoutenberg, Mark; Gellman, Marc D.; Archer, Edward; Davis, Sonia M.; Gotman, Nathan; Marquez, David X.; Buelna, Christina; Deng, Yu; Hosgood, H. Dean; Zambrana, Ruth E.			Occupational Physical Activity and Body Mass Index: Results from the Hispanic Community Health Study/Study of Latinos	PLOS ONE			English	Article							CANADIAN ADULTS; UNITED-STATES; SOCIAL-CLASS; US ADULTS; OBESITY; OVERWEIGHT; PREVALENCE; TIME; ASSOCIATIONS; TRENDS	Purpose To examine the associations between overweight/obesity and occupation among Hispanics/Latinos, the largest minority population in the U.S. Methods This study included 7,409 employed individuals in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), a prospective study of Hispanic/Latino individuals aged 18-74 in four communities in the U.S. We independently examined the relationships between BMI, Occupational Activity (OA), and Total Hours Worked, quantified via self-reported hours worked per week and occupation-assigned Metabolic Equivalents (METs). Results More than three quarters of the participants were either overweight (39.3%) or obese (37.8%). Individuals with a primary occupation and those employed in a secondary occupation worked an average of 36.8 and 14.6 hrs/wk, respectively. The overall adjusted odds for being obese compared to normal weight were 3.2% (AOR = 1.03, 95% CI 1.01, 1.05) and 14.4% (AOR = 1.14 95% Cl 1.07, 1.23) greater for each 10 MET.hrs/wk unit of increased OA, and each 10-hrs/wk unit of Total Hours Worked, respectively. Conclusion This study presents the first findings on the association between OA with overweight/obesity among Hispanic/Latino individuals in the U.S. Increasing OA and Total Hours Worked per week were independently associated with increasing odds of overweight/obesity suggesting that the workplace is only one part of the overall energy expenditure dynamic. Our findings point to the need to emphasize engaging employed individuals in greater levels of PA outside of the work environment to impact overweight/obesity.	[Singer, Richard H.; Stoutenberg, Mark] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Singer, Richard H.] Nova SE Univ, Coll Dent Med, Ft Lauderdale, FL 33314 USA; [Gellman, Marc D.] Univ Miami, Dept Psychol, Miami, FL USA; [Archer, Edward] Univ Alabama Birmingham, Nutr Obes Res Ctr, Off Energet, Birmingham, AL USA; [Davis, Sonia M.; Gotman, Nathan; Deng, Yu] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Marquez, David X.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Buelna, Christina] San Diego State Univ, Grad Sch Publ Hlth, Inst Behav & Community Hlth, San Diego, CA 92182 USA; [Hosgood, H. Dean] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Zambrana, Ruth E.] Univ Maryland, Dept Womens Studies, Consortium Race Gender & Ethn, College Pk, MD 20742 USA	University of Miami; Nova Southeastern University; University of Miami; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; California State University System; San Diego State University; Yeshiva University; Albert Einstein College of Medicine; University System of Maryland; University of Maryland College Park	Singer, RH (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.; Singer, RH (corresponding author), Nova SE Univ, Coll Dent Med, Ft Lauderdale, FL 33314 USA.	rsinger@med.miami.edu	Archer, Edward/J-9567-2017; Singer, D.M.D., M.S., Ph.D., Richard/AAE-8195-2022; Zambrana, Ruth Enid/ABD-5509-2020	Archer, Edward/0000-0002-9339-6918; Singer, D.M.D., M.S., Ph.D., Richard/0000-0002-1754-7438; Thomas, Sonia/0000-0003-1362-5627	NCATS NIH HHS [KL2 TR000461] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000461] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Ali SM, 2006, EUR J PUBLIC HEALTH, V16, P324, DOI 10.1093/eurpub/cki187; Allman-Farinelli MA, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-14; Archer E, 2013, MAYO CLIN PROC, V88, P1398, DOI 10.1016/j.mayocp.2013.08.019; Archer E, 2013, MAYO CLIN PROC, V88, P1368, DOI 10.1016/j.mayocp.2013.09.009; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076632; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056620; Barberio A, 2011, CAN J PUBLIC HEALTH, V102, P169, DOI 10.1007/BF03404888; Bonauto DK, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130219; Caban-Martinez AJ, 2007, PREV MED, V44, P432, DOI 10.1016/j.ypmed.2006.12.017; Centers for Disease Control and Prevention, 2010, 1988 2008 NO LEISURE; Centers for Disease Control and Prevention (CDC), 2009, DIFFERENCES IN PREVA; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Duffey KJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001050; Finkelstein EA, 2003, HLTH AFF MILLWOOD S; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Ham S. A., 2004, Morbidity and Mortality Weekly Report, V53, P82; Hasselbalch AL, 2010, INT J OBESITY, V34, P892, DOI 10.1038/ijo.2010.1; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Imai K, 2008, OBESITY, V16, P402, DOI 10.1038/oby.2007.70; Ioannidis JPA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6698; Jang TW, 2013, J OCCUP HEALTH, V55, P359, DOI 10.1539/joh.13-0043-OA; Jitnarin N, 2010, NUTRIENTS, V2, P60, DOI [10.3390/nu20100060, 10.3390/nu2010060]; Kaleta Dorota, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P9, DOI 10.2478/v10001-007-0009-1; King GA, 2001, INT J OBESITY, V25, P606, DOI 10.1038/sj.ijo.0801583; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Luckhaupt SE, 2014, AM J PREV MED, V46, P237, DOI 10.1016/j.amepre.2013.11.002; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; McLaren L, 2009, OBESITY, V17, P290, DOI 10.1038/oby.2008.539; National Cancer Institute U.S. NIH, 2013, USUAL DIETARY INTAKE; National Cancer Institute U.S. NIH, 2014, METABOLIC EQUIVALENT; National Heart Lung and Blood Institute, 2012, AIM FOR A HEALTHY WE; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Panasiuk L, 2008, ANN AGR ENV MED, V15, P149; Patterson E., 2010, GUIDELINES FOR DATA; Physical Activity Guidelines Advisory Committee, 2008, PHYSICAL ACTIVITY GU; Proper KI, 2010, INT ARCH OCC ENV HEA, V83, P61, DOI 10.1007/s00420-009-0438-1; Martin AR, 2008, APPETITE, V51, P266, DOI 10.1016/j.appet.2008.02.021; Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125; Shao Q, 2011, NUTR RES PRACT, V5, P253, DOI 10.4162/nrp.2011.5.3.253; Singh GK, 2011, J COMMUN HEALTH, V36, P94, DOI 10.1007/s10900-010-9287-9; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Steeves JA, 2012, INT J OBESITY, V36, P100, DOI 10.1038/ijo.2011.50; Thomas DM, 2009, MATH BIOSCI ENG, V6, P873, DOI 10.3934/mbe.2009.6.873; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Trivedi T, 2015, RURAL REMOTE HEALTH, V15; Tudor-Locke C, 2011, J PHYS ACT HEALTH, V8, P581, DOI 10.1123/jpah.8.4.581; U.S. Bureau of Labor Statistics, 2014, LABOR FORCE STATISTI; US Department of Health and Human Services, 2014, HLTH PEOPL 2020; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	52	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152339	10.1371/journal.pone.0152339	http://dx.doi.org/10.1371/journal.pone.0152339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031996	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800060
J	Tedde, V; Rosini, R; Galeotti, CL				Tedde, Vittorio; Rosini, Roberto; Galeotti, Cesira L.			Zn2+ Uptake in Streptococcus pyogenes: Characterization of adcA and lmb Null Mutants	PLOS ONE			English	Article							HISTIDINE TRIAD PROTEIN; LAMININ-BINDING PROTEIN; ZINC HOMEOSTASIS; METAL HOMEOSTASIS; ACQUISITION; TRANSPORTERS; INTERFACE; VIRULENCE; ADHESION; AFFINITY	An effective regulation of metal ion homeostasis is essential for the growth of microorganisms in any environment and in pathogenic bacteria is strongly associated with their ability to invade and colonise their hosts. To gain a better insight into zinc acquisition in Group A Streptococcus (GAS) we characterized null deletion mutants of the adcA and lmb genes of Streptococcus pyogenes strain MGAS5005 encoding the orthologues of AdcA and AdcAII, the two surface lipoproteins with partly redundant roles in zinc homeostasis in Streptococcus pneumoniae. Null adcA and lmb mutants were analysed for their capability to grow in zinc-depleted conditions and were found to be more susceptible to zinc starvation, a phenotype that could be rescued by the addition of Zn2+ ions to the growth medium. Expression of AdcA, Lmb and HtpA, the polyhistidine triad protein encoded by the gene adjacent to lmb, during growth under conditions of limited zinc availability was examined by Western blot analysis in wild type and null mutant strains. In the wild type strain, AdcA was always present with little variation in expression levels between conditions of excess or limited zinc availability. In contrast, Lmb and HtpA were expressed at detectable levels only during growth in the presence of low zinc concentrations or in the null adcA mutant, when expression of lmb is required to compensate for the lack of adcA expression. In the latter case, Lmb and HtpA were overexpressed by several fold, thus indicating that also in GAS AdcA is a zinc-specific importer and, although it shares this function with Lmb, the two substrate-binding proteins do not show fully overlapping roles in zinc homeostasis.	[Tedde, Vittorio; Rosini, Roberto; Galeotti, Cesira L.] GlaxoSmithKline Vaccines Srl, Res Ctr, Siena, Italy; [Galeotti, Cesira L.] Univ Siena, Dept Med Biotechnol, Via Laterina 8, I-53100 Siena, Italy; [Tedde, Vittorio] Porto Conte Ric, Alghero, SS, Italy	GlaxoSmithKline; University of Siena; Porto Conte Ricerche	Galeotti, CL (corresponding author), GlaxoSmithKline Vaccines Srl, Res Ctr, Siena, Italy.; Galeotti, CL (corresponding author), Univ Siena, Dept Med Biotechnol, Via Laterina 8, I-53100 Siena, Italy.	cesira.galeotti@gmail.com		Tedde, Vittorio/0000-0001-8025-0437	GSK Vaccines S.r.l.	GSK Vaccines S.r.l.	This study was funded by GSK Vaccines S.r.l. The authors confirm that the GSK Vaccines S.r.l funder provided support in the form of salaries for authors VT RR CLG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	ACHEN MG, 1986, GENE, V45, P45, DOI 10.1016/0378-1119(86)90130-7; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; Braymer JJ, 2014, CURR OPIN CHEM BIOL, V19, P59, DOI 10.1016/j.cbpa.2013.12.021; Brenot A, 2007, MOL MICROBIOL, V63, P1185, DOI 10.1111/j.1365-2958.2006.05577.x; Carroll RK, 2011, EPIDEMICS-NETH, V3, P159, DOI 10.1016/j.epidem.2011.07.001; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Elsner A, 2002, INFECT IMMUN, V70, P4859, DOI 10.1128/IAI.70.9.4859-4869.2002; Gabbianelli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-36; Galeotti CL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015206; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kimoto H, 2003, BIOSCI BIOTECH BIOCH, V67, P2203, DOI 10.1271/bbb.67.2203; Kunitomo E, 2008, MICROBES INFECT, V10, P414, DOI 10.1016/j.micinf.2008.01.003; LAKSHMIDEVI G, 1990, APPL ENVIRON MICROB, V56, P934, DOI 10.1128/AEM.56.4.934-942.1990; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Lo Sapio M, 2012, J BIOTECHNOL, V157, P279, DOI 10.1016/j.jbiotec.2011.11.011; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; Ong CLY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10799; Ong CLY, 2014, J INFECT DIS, V209, P1500, DOI 10.1093/infdis/jiu053; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Plumptre CD, 2014, INFECT IMMUN, V82, P4315, DOI 10.1128/IAI.02155-14; Plumptre CD, 2014, MOL MICROBIOL, V91, P834, DOI 10.1111/mmi.12504; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Shao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060116; Shumaker DK, 1998, CELL CALCIUM, V23, P151, DOI 10.1016/S0143-4160(98)90114-2; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Terao Y, 2002, INFECT IMMUN, V70, P993; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0	39	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152835	10.1371/journal.pone.0152835	http://dx.doi.org/10.1371/journal.pone.0152835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031880	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800149
J	Zheng, GA; Li, YX; Takayama, T; Nishida, T; Sudo, M; Haruta, H; Fukamachi, D; Okubo, K; Higuchi, Y; Hiro, T; Saito, S; Hirayama, A				Zheng, Guian; Li, Yuxin; Takayama, Tadateru; Nishida, Toshihiko; Sudo, Mitsumasa; Haruta, Hironori; Fukamachi, Daisuke; Okubo, Kimie; Higuchi, Yoshiharu; Hiro, Takafumi; Saito, Satoshi; Hirayama, Atsushi			The Spatial Distribution of Plaque Vulnerabilities in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ACUTE CORONARY SYNDROMES; INTRAVASCULAR ULTRASOUND ASSESSMENT; OCCLUDED CULPRIT ARTERIES; THIN-CAP FIBROATHEROMA; LONG-TERM MORTALITY; ST-ELEVATION; TASK-FORCE; RUPTURE; LESION	Objective Although the plaque characteristics have been recognized in patients with acute myocardial infarction (AMI), the plaque spatial distribution is not well clarified. Using color-mapping intravascular ultrasound (iMAP-IVUS), we examined culprit lesions to clarify plaque morphology, composition and spatial distribution of the sites of potential vulnerability. Methods Sixty-eight culprit lesions in 64 consecutive AMI patients who underwent angiography and IVUS examinations before intervention were analyzed. Plaque morphology and composition were quantified with iMAP-IVUS. The spatial distribution of the sites of potential vulnerability was assessed with longitudinal reconstruction of the consecutive IVUS images. The plaque characteristics were also compared between ruptured and non-ruptured lesions, and between totally occlusive (TO) and non-TO lesions. Results The sites with maximum necrotic area (maxNA), maximum plaque burden (maxPB) and most severely narrowed (minimal luminal area, MLA) were recognized vulnerability. In the majority of cases, maxNA sites were proximal to the maxPB sites, and MLA sites were distal to the maxNA and maxPB sites. Ruptures usually occurred close to maxNA sites and proximal to maxPB and MLA sites. The average distance from the site of rupture to the maxNA site was 0.33 +/- 4.04 mm. Ruptured lesions showed significant vessel remodeling, greater plaque volume, and greater lipidic volume compared to those of non-ruptured lesions. Both the length and plaque burden (PB) of TO lesions were greater than those of non-TO lesions. Conclusions Instead of overlapping on maxPB sites, most maxNA sites are proximal to the maxPB sites and are the sites most likely to rupture. Plaque morphology and composition play critical roles in plaque rupture and coronary occlusion.	[Zheng, Guian; Li, Yuxin; Takayama, Tadateru; Hiro, Takafumi; Saito, Satoshi; Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Adv Cardiovasc Imaging, Tokyo 1738610, Japan; [Zheng, Guian] Fujian Med Univ, Zhangzhou Hosp, Dept Cardiol, Zhangzhou 363000, Fujian, Peoples R China; [Takayama, Tadateru; Nishida, Toshihiko; Sudo, Mitsumasa; Haruta, Hironori; Fukamachi, Daisuke; Okubo, Kimie; Higuchi, Yoshiharu; Hiro, Takafumi; Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 1738610, Japan	Nihon University; Fujian Medical University; Nihon University	Li, YX (corresponding author), Nihon Univ, Sch Med, Dept Adv Cardiovasc Imaging, Tokyo 1738610, Japan.	li.yuxin@nihon-u.ac.jp	Li, yuxin/GSD-1668-2022; Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022					Arbustini E, 1999, HEART, V82, P269, DOI 10.1136/hrt.82.3.269; Bahrmann P, 2011, CLIN RES CARDIOL, V100, P457, DOI 10.1007/s00392-010-0269-9; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Chan MY, 2009, CIRCULATION, V119, P3110, DOI 10.1161/CIRCULATIONAHA.108.799981; Davies MJ, 2000, HEART, V83, P361, DOI 10.1136/heart.83.3.361; de Graaf MA, 2013, HEART VESSELS, V28, P166, DOI 10.1007/s00380-012-0236-7; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Fishbein MC, 2010, CARDIOVASC PATHOL, V19, P6, DOI 10.1016/j.carpath.2008.08.004; Garcia-Garcia HM, 2011, INT J CARDIOVAS IMAG, V27, P215, DOI 10.1007/s10554-010-9789-7; Heo JH, 2014, CATHETER CARDIO INTE, V83, pE233, DOI 10.1002/ccd.23335; Kaple RK, 2009, ULTRASOUND MED BIOL, V35, P550, DOI 10.1016/j.ultrasmedbio.2008.09.024; Kim MC, 2012, INT HEART J, V53, P160, DOI 10.1536/ihj.53.160; Kim SW, 2012, AM J CARDIOL, V109, P794, DOI 10.1016/j.amjcard.2011.10.042; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Kusama I, 2012, HEART VESSELS, V27, P541, DOI 10.1007/s00380-011-0184-7; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Legutko J, 2013, AM J CARDIOL, V112, P1854, DOI 10.1016/j.amjcard.2013.08.011; Li ZY, 2008, J AM COLL CARDIOL, V52, P499, DOI 10.1016/j.jacc.2008.04.040; Li ZY, 2006, STROKE, V37, P1195, DOI 10.1161/01.STR.0000217331.61083.3b; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2001, CIRCULATION, V103, P604, DOI 10.1161/01.CIR.103.4.604; Ouldzein H, 2012, ANN CARDIOL ANGEIOL, V61, P20, DOI 10.1016/j.ancard.2011.07.011; Piccolo R, 2014, AM J CARDIOL, V114, P1145, DOI 10.1016/j.amjcard.2014.07.030; Plutzky J, 1999, AM J CARDIOL, V84, p15J; Pride YB, 2010, JACC-CARDIOVASC INTE, V3, P806, DOI 10.1016/j.jcin.2010.05.012; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Shin DI, 2014, J INTERV CARDIOL, V27, P12, DOI 10.1111/joic.12078; Shin ES, 2011, EUROINTERVENTION, V6, P1017, DOI 10.4244/EIJV6I8A175; Speelman L, 2011, J BIOMECH, V44, P2376, DOI 10.1016/j.jbiomech.2011.07.004; Takumi T, 2007, J AM COLL CARDIOL, V50, P2197, DOI 10.1016/j.jacc.2007.07.079; Tanaka A, 2008, CIRC J, V72, P1276, DOI 10.1253/circj.72.1276; Tang DL, 2009, STROKE, V40, P3258, DOI 10.1161/STROKEAHA.109.558676; Tian JW, 2014, J AM COLL CARDIOL, V63, P2209, DOI 10.1016/j.jacc.2014.01.061; Topaz O, 2001, AM J CARDIOL, V87, P849, DOI 10.1016/S0002-9149(00)01525-3; Toutouzas K, 2012, EUROINTERVENTION, V8, P477, DOI 10.4244/EIJV8I4A75; Toutouzas K, 2011, AM HEART J, V161, P1192, DOI 10.1016/j.ahj.2011.03.005; Uemura S, 2012, EUR HEART J, V33, P78, DOI 10.1093/eurheartj/ehr284; van Leeuwen MAH, 2013, INT J CARDIOL, V167, P2082, DOI 10.1016/j.ijcard.2012.05.064; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; von Birgelen C, 2001, J AM COLL CARDIOL, V37, P1864, DOI 10.1016/S0735-1097(01)01234-7; Wang TY, 2009, AM HEART J, V157, P716, DOI 10.1016/j.ahj.2009.01.004; Wykrzykowska JJ, 2012, JACC-CARDIOVASC IMAG, V5, pS10, DOI 10.1016/j.jcmg.2012.01.006; Xie Y, 2014, JACC-CARDIOVASC IMAG, V7, P397, DOI 10.1016/j.jcmg.2013.10.010; Yamada R, 2013, J CARDIOL, V61, P149, DOI 10.1016/j.jjcc.2012.10.008	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152825	10.1371/journal.pone.0152825	http://dx.doi.org/10.1371/journal.pone.0152825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031514	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800146
J	Barebring, L; Bullarbo, M; Glantz, A; Agelii, ML; Jagner, A; Ellis, J; Hulthen, L; Schoenmakers, I; Augustin, H				Barebring, Linnea; Bullarbo, Maria; Glantz, Anna; Agelii, Monica Leu; Jagner, Ase; Ellis, Joy; Hulthen, Lena; Schoenmakers, Inez; Augustin, Hanna			Preeclampsia and Blood Pressure Trajectory during Pregnancy in Relation to Vitamin D Status	PLOS ONE			English	Article							WOMEN; OUTCOMES; SERUM; ASSOCIATIONS; HYPERTENSION; DISEASE; SWEDEN; RISK	Every tenth pregnancy is affected by hypertension, one of the most common complications and leading causes of maternal death worldwide. Hypertensive disorders in pregnancy include pregnancy-induced hypertension and preeclampsia. The pathophysiology of the development of hypertension in pregnancy is unknown, but studies suggest an association with vitamin D status, measured as 25-hydroxyvitamin D (25(OH) D). The aim of this study was to investigate the association between gestational 25(OH) D concentration and preeclampsia, pregnancy-induced hypertension and blood pressure trajectory. This cohort study included 2000 women. Blood was collected at the first (T1) and third (T3) trimester (mean gestational weeks 10.8 and 33.4). Blood pressure at gestational weeks 10, 25, 32 and 37 as well as symptoms of preeclampsia and pregnancy-induced hypertension were retrieved from medical records. Serum 25(OH) D concentrations (LC-MS/MS) in T1 was not significantly associated with preeclampsia. However, both 25(OH) D in T3 and change in 25 (OH) D from T1 to T3 were significantly and negatively associated with preeclampsia. Women with a change in 25(OH) D concentration of >= 30 nmol/L had an odds ratio of 0.22 (p = 0.002) for preeclampsia. T1 25(OH) D was positively related to T1 systolic (beta = 0.03, p = 0.022) and T1 diastolic blood pressure (beta = 0.02, p = 0.016), and to systolic (beta = 0.02, p = 0.02) blood pressure trajectory during pregnancy, in adjusted analyses. There was no association between 25(OH) D and pregnancy-induced hypertension in adjusted analysis. In conclusion, an increase in 25(OH) D concentration during pregnancy of at least 30 nmol/L, regardless of vitamin D status in T1, was associated with a lower odds ratio for preeclampsia. Vitamin D status was significantly and positively associated with T1 blood pressure and gestational systolic blood pressure trajectory but not with pregnancy-induced hypertension.	[Barebring, Linnea; Hulthen, Lena; Augustin, Hanna] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Bullarbo, Maria] Sodra Alvsborgs Hosp, Dept Obstet & Gynecol, Boras, Sweden; [Bullarbo, Maria] Univ Gothenburg, Dept Obstet & Gynaecol, Sahlgrenska Acad, Gothenburg, Sweden; [Glantz, Anna; Jagner, Ase] Narhalsan, Primary Care, Dept Antenatal Care, Gothenburg, Sweden; [Agelii, Monica Leu] Univ Gothenburg, Dept Publ Hlth & Community Med, Sahlgrenska Acad, Gothenburg, Sweden; [Ellis, Joy] Narhalsan, Primary Care, Dept Antenatal Care, Sodra Bohuslan, Sweden; [Schoenmakers, Inez] Nutr & Bone Hlth Grp, MRC Human Nutr Res, Cambridge, England	University of Gothenburg; University of Gothenburg; University of Gothenburg; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Barebring, L (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden.	linnea.barebring@gu.se		Bullarbo, Maria/0000-0002-3954-7228	Swedish Research Council for Health, Working Life and Welfare [2012-0793]; Regional Research and Development grants [VGFOUREG-388201, VGFOUREG-229331]; Medical Research Council [U105960371]; MRC [MC_U105960371] Funding Source: UKRI; Medical Research Council [MC_U105960371] Funding Source: researchfish	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Regional Research and Development grants; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Swedish Research Council for Health, Working Life and Welfare (HA, Forte, Dnr 2012-0793) and Regional Research and Development grants (MB, FoU, Dnr VGFOUREG-388201 and VGFOUREG-229331). Inez Schoenmakers was funded by the Medical Research Council, programme U105960371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi P, 2014, MATERN CHILD NUTR, V10, P206, DOI 10.1111/mcn.12058; Achkar M, 2014, AM J OBSTET GYNECOL; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bodnar LM, 2014, EPIDEMIOLOGY, V25, P207, DOI 10.1097/EDE.0000000000000039; Brembeck Petra, 2013, Br J Nutr, V110, P856, DOI 10.1017/S0007114512005855; Burris HH, 2014, ANN EPIDEMIOL, V24, P399, DOI 10.1016/j.annepidem.2014.02.001; Darj Elisabeth, 2002, Lakartidningen, V99, P41; De-Regil LM, 2012, COCHRANE DATABASE SY, V2; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; Hossain N, 2014, J CLIN ENDOCR METAB, V99, P2448, DOI 10.1210/jc.2013-3491; Hypponen E, 2005, NUTR REV, V63, P225, DOI 10.1111/j.1753-4887.2005.tb00378.x; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lechtermann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105558; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Rebelo F, 2015, ARQ BRAS CARDIOL, V104, P284, DOI 10.5935/abc.20150007; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Schneuer FJ, 2014, AM J CLIN NUTR, V99, P287, DOI 10.3945/ajcn.113.065672; Scholl TO, 2013, AM J CLIN NUTR, V98, P787, DOI 10.3945/ajcn.112.055871; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; The National Board of Health and Welfare, 2013, 14003511 NAT BOARD H; Uzan J, 2011, VASC HEALTH RISK MAN, V7, P467, DOI 10.2147/VHRM.S20181; Wei SQ, 2012, BJOG-INT J OBSTET GY, V119, P832, DOI 10.1111/j.1471-0528.2012.03307.x; Wielders JPM, 2009, CLIN CHEM, V55, P1584, DOI 10.1373/clinchem.2008.117366; World Health Organization, 2011, WHO REC PREV TREATM; Zhou J, 2014, EUR J CLIN NUTR, V68, P925, DOI 10.1038/ejcn.2014.99	27	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152198	10.1371/journal.pone.0152198	http://dx.doi.org/10.1371/journal.pone.0152198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022948	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000373113900028
J	Chen, XL; Serrano, D; Ghobadi, F; Mayhue, M; Hoebe, K; Ilangumaran, S; Ramanathan, S				Chen, Xi-Lin; Serrano, Daniel; Ghobadi, Farnaz; Mayhue, Marian; Hoebe, Kasper; Ilangumaran, Subburaj; Ramanathan, Sheela			TCR and IL-7 Signaling Are Altered in the Absence of Functional GTPase of the Immune Associated Nucleotide Binding Protein 5 (GIMAP5)	PLOS ONE			English	Article							PRONE BB RAT; T-CELLS; NITRIC-OXIDE; MUTATION; LYMPHOCYTES; ACTIVATION; MOUSE; LYMPHOPENIA; MACROPHAGES; SURVIVAL	GTPase of the immune associated nucleotide binding protein (GIMAP) family of proteins are expressed essentially in cells of the hematopoietic system. Mutation in the founding member of this gene family, Gimap5, results in the lymphopenic phenotype in Bio-Breeding diabetes prone rats. In mice, deletion of functional Gimap5 gene affects the survival and renewal of hematopoietic stem cells in addition to the defects observed in T cells. Here we show that T cells from OTII TCR-transgenic Gimap5(sph/sph) mice do not proliferate in response to its cognate antigen. Furthermore, T cells from Gimap5 mutant rats and mice show decreased phosphorylation of STAT5 following stimulation with IL-7. Our results suggest that functional Gimap5 is required for optimal signaling through TCR and IL-7R in T cells.	[Chen, Xi-Lin; Serrano, Daniel; Ghobadi, Farnaz; Mayhue, Marian; Ilangumaran, Subburaj; Ramanathan, Sheela] Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; [Hoebe, Kasper] Cincinnati Childrens Hosp Med Ctr, Div Cellular & Mol Immunol, Dept Pediat, Cincinnati, OH 45229 USA; [Ilangumaran, Subburaj; Ramanathan, Sheela] Univ Sherbrooke, Ctr Rech Clin, Sherbrooke, PQ J1H 5N4, Canada; [Chen, Xi-Lin] Univ Montreal, Inst Res Immunol & Canc, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada	University of Sherbrooke; Cincinnati Children's Hospital Medical Center; University of Sherbrooke; Universite de Montreal	Ramanathan, S (corresponding author), Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada.; Ramanathan, S (corresponding author), Univ Sherbrooke, Ctr Rech Clin, Sherbrooke, PQ J1H 5N4, Canada.	Sheela.Ramanathan@Usherbrooke.ca		Ilangumaran, Subburaj/0000-0002-7563-576X	Natural Sciences and Engineering Research Council of Canada-NSERC-Discovery Grant [312777]; Fonds de recherche du Quebec - Sante (FRQS)-Doctoral fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR070549, P30AR047363] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada-NSERC-Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Sante (FRQS)-Doctoral fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Natural Sciences and Engineering Research Council of Canada-NSERC-Discovery Grant No. 312777 to SR, and Fonds de recherche du Quebec - Sante (FRQS)-Doctoral fellowship to XLC.	Aksoylar HI, 2012, J IMMUNOL, V188, P146, DOI 10.4049/jimmunol.1101206; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Chen XL, 2013, BIOCHEM J, V449, P353, DOI 10.1042/BJ20120516; Chen XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139019; Chen YH, 2011, J EXP MED, V208, P923, DOI 10.1084/jem.20101192; Ciucci T, 2014, EUR J IMMUNOL, V44, P348, DOI 10.1002/eji.201344375; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gagnon J, 2008, J IMMUNOL, V180, P7958, DOI 10.4049/jimmunol.180.12.7958; Heinonen MT, 2015, J IMMUNOL, V194, P5885, DOI 10.4049/jimmunol.1500016; Hernandez-Hoyos G, 1999, EUR J IMMUNOL, V29, P1832, DOI 10.1002/(SICI)1521-4141(199906)29:06&lt;1832::AID-IMMU1832&gt;3.0.CO;2-F; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Ilangumaran S, 2009, MOL IMMUNOL, V46, P1256, DOI 10.1016/j.molimm.2008.09.031; Keita M, 2007, BIOCHEM BIOPH RES CO, V361, P481, DOI 10.1016/j.bbrc.2007.07.048; Kurgonaite K, 2015, J CELL SCI, V128, P3781, DOI 10.1242/jcs.170969; Lau A, 1998, DIABETES, V47, P197, DOI 10.2337/diabetes.47.2.197; LEE KU, 1994, DIABETES, V43, P1218, DOI 10.2337/diabetes.43.10.1218; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Malissen B, 2014, NAT IMMUNOL, V15, P790, DOI 10.1038/ni.2959; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; PLAMONDON C, 1990, J IMMUNOL, V144, P923; Ramanathan S, 2001, IMMUNOL REV, V184, P161, DOI 10.1034/j.1600-065x.2001.1840115.x; Ramanathan S, 1998, J IMMUNOL, V160, P5757; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Schwefel D, 2013, STRUCTURE, V21, P550, DOI 10.1016/j.str.2013.01.014; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tamarit B, 2013, J BIOL CHEM, V288, P8691, DOI 10.1074/jbc.M113.449918; Wong Vivian Wy, 2010, Self Nonself, V1, P259, DOI 10.4161/self.1.3.12819; Yano K, 2014, EUR J IMMUNOL, V44, P561, DOI 10.1002/eji.201343750	29	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0151837	10.1371/journal.pone.0151837	http://dx.doi.org/10.1371/journal.pone.0151837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023180	gold, Green Published, Green Submitted			2022-12-26	WOS:000373113900020
J	Gruenert, AK; Czugala, M; Mueller, C; Schmeer, M; Schleef, M; Kruse, FE; Fuchsluger, TA				Gruenert, Anja K.; Czugala, Marta; Mueller, Chris; Schmeer, Marco; Schleef, Martin; Kruse, Friedrich E.; Fuchsluger, Thomas A.			Self-Complementary Adeno-Associated Virus Vectors Improve Transduction Efficiency of Corneal Endothelial Cells	PLOS ONE			English	Article							RATE-LIMITING STEP; GENE-TRANSFER; TRANSGENE EXPRESSION; TRABECULAR MESHWORK; EX-VIVO; THERAPY; RABBIT; TRANSPLANTATION; DELIVERY; MUSCLE	Transplantation of a donor cornea to restore vision is the most frequently performed transplantation in the world. Corneal endothelial cells (CEC) are crucial for the outcome of a graft as they maintain corneal transparency and avoid graft failure due to corneal opaqueness. Given the characteristic of being a monolayer and in direct contact with culture medium during cultivation in eye banks, CEC are specifically suitable for gene therapeutic approaches prior to transplantation. Recombinant adeno-associated virus 2 (rAAV2) vectors represent a promising tool for gene therapy of CEC. However, high vector titers are needed to achieve sufficient gene expression. One of the rate-limiting steps for transgene expression is the conversion of single-stranded (ss-) DNA vector genome into double-stranded (ds-) DNA. This step can be bypassed by using self-complementary (sc-) AAV2 vectors. Aim of this study was to compare for the first time transduction efficiencies of ss-and scAAV2 vectors in CEC. For this purpose AAV2 vectors containing enhanced green fluorescent protein (GFP) as transgene were used. Both in CEC and in donor corneas, transduction with scAAV2 resulted in significantly higher transgene expression compared to ssAAV2. The difference in transduction efficiency decreased with increasing vector titer. In most cases, only half the vector titer of scAAV2 was required for equal or higher gene expression rates than those of ssAAV2. In human donor corneas, GFP expression was 64.7 +/- 11.3%(scAAV) and 38.0 +/- 8.6% (ssAAV) (p<0.001), respectively. Furthermore, transduced cells maintained their viability and showed regular morphology. Working together with regulatory authorities, a translation of AAV2 vector-mediated gene therapy to achieve a temporary protection of corneal allografts during cultivation and transplantation could therefore become more realistic.	[Gruenert, Anja K.; Czugala, Marta; Kruse, Friedrich E.; Fuchsluger, Thomas A.] Univ Erlangen Nurnberg, Dept Ophthalmol, Schwabachanlage 6, Erlangen, Germany; [Mueller, Chris] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Mueller, Chris] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA USA; [Schmeer, Marco; Schleef, Martin] PlasmidFactory GmbH & Co KG, Bielefeld, Germany	University of Erlangen Nuremberg; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Gruenert, AK; Fuchsluger, TA (corresponding author), Univ Erlangen Nurnberg, Dept Ophthalmol, Schwabachanlage 6, Erlangen, Germany.	Anja.Gruenert@uk-erlangen.de; Thomas.Fuchsluger@uk-erlangen.de		Mueller, Christian/0000-0003-3589-8749; Czugala, Marta/0000-0001-7733-0882	Deutsche Forschungsgemeinschaft (DFG) [INST 410/45-1 FUGG]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Two of the authors [M. Schleef and M. Schmeer] are employed by a commercial company: PlasmidFactory GmbH & Co (http://www.plasmidfactory.com). The funder provided support in the form of salaries for authors [MS and MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The confocal microscope (Zeiss LSM 780) used in our studies was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de, DFG grant INST 410/45-1 FUGG).	Ali RR, 1996, HUM MOL GENET, V5, P591, DOI 10.1093/hmg/5.5.591; Armitage WJ, 1997, INVEST OPHTH VIS SCI, V38, P16; Barcia RN, 2007, AM J TRANSPLANT, V7, P2082, DOI 10.1111/j.1600-6143.2007.01897.x; Bogner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128759; Borras T, 2006, J GENE MED, V8, P589, DOI 10.1002/jgm.886; Bourne W M, 1998, Trans Am Ophthalmol Soc, V96, P229; Bourne WM, 2001, CORNEA, V20, P560, DOI 10.1097/00003226-200108000-00002; Buie LK, 2010, INVEST OPHTH VIS SCI, V51, P236, DOI 10.1167/iovs.09-3847; Chen KH, 2001, CORNEA, V20, P731, DOI 10.1097/00003226-200110000-00012; Chung DC, 2009, CURR OPIN OPHTHALMOL, V20, P377, DOI 10.1097/ICU.0b013e32832f802a; Claerhout Ilse, 2008, International Ophthalmology, V28, P165, DOI 10.1007/s10792-007-9087-0; Conlon TJ, 2004, EXPERT OPIN BIOL TH, V4, P1093, DOI 10.1517/14712598.4.7.1093; Coura RD, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-99; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; FISCHBARG J, 1974, J PHYSIOL-LONDON, V241, P647, DOI 10.1113/jphysiol.1974.sp010676; Fisher KJ, 1996, J VIROL, V70, P520, DOI 10.1128/JVI.70.1.520-532.1996; FLOTTE TR, 1993, P NATL ACAD SCI USA, V90, P10613, DOI 10.1073/pnas.90.22.10613; Fu HY, 2003, MOL THER, V8, P911, DOI 10.1016/j.ymthe.2003.08.021; Fuchsluger TA, 2011, GENE THER, V18, P778, DOI 10.1038/gt.2011.20; Fuchsluger TA, 2011, KLIN MONATSBL AUGENH, V228, P498, DOI 10.1055/s-0031-1273399; Fuchsluger TA, 2011, HUM GENE THER, V22, P549, DOI 10.1089/hum.2010.079; Girod A, 1999, NAT MED, V5, P1052, DOI 10.1038/12491; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; Hippert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035318; Hori Junko, 2008, J Ocul Biol Dis Infor, V1, P94, DOI 10.1007/s12177-008-9010-6; Hudde T, 2000, CORNEA, V19, P369, DOI 10.1097/00003226-200005000-00022; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Kampik D, 2012, EXP EYE RES, V95, P54, DOI 10.1016/j.exer.2011.07.001; Koilkonda RD, 2009, MOL VIS, V15; Lai CM, 2002, DNA CELL BIOL, V21, P895, DOI 10.1089/104454902762053855; Lai LJ, 2005, CURR EYE RES, V30, P213, DOI 10.1080/02713680590927515; Lo WD, 1999, HUM GENE THER, V10, P201, DOI 10.1089/10430349950018995; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maina N, 2008, HUM GENE THER, V19, P376, DOI 10.1089/hum.2007.143; MAURICE DM, 1972, J PHYSIOL-LONDON, V221, P43, DOI 10.1113/jphysiol.1972.sp009737; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Nakai H, 2000, J VIROL, V74, P9451, DOI 10.1128/JVI.74.20.9451-9463.2000; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; Ponnazhagan S, 1997, J VIROL, V71, P8262, DOI 10.1128/JVI.71.11.8262-8267.1997; RAYMOND GM, 1986, INVEST OPHTH VIS SCI, V27, P474; Ren C, 2005, HUM GENE THER, V16, P1047, DOI 10.1089/hum.2005.16.1047; Sarra GM, 2002, VISION RES, V42, P541, DOI 10.1016/S0042-6989(01)00230-9; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; Tsai ML, 2002, INVEST OPHTH VIS SCI, V43, P751; VANHORN DL, 1977, INVEST OPHTH VIS SCI, V16, P597; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yokoi K, 2007, INVEST OPHTH VIS SCI, V48, P3324, DOI 10.1167/iovs.06-1306; Zhou R, 2010, F1000 BIOL REP, V2; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152589	10.1371/journal.pone.0152589	http://dx.doi.org/10.1371/journal.pone.0152589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023329	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900081
J	Keane, A; Gurd, H; Kaelo, D; Said, MY; de Leeuw, J; Rowcliffe, JM; Homewood, K				Keane, Aidan; Gurd, Heather; Kaelo, Dickson; Said, Mohammed Y.; de Leeuw, Jan; Rowcliffe, J. Marcus; Homewood, Katherine			Gender Differentiated Preferences for a Community-Based Conservation Initiative	PLOS ONE			English	Article							WILDLIFE CONSERVATION; MAASAI MARA; KENYA; MANAGEMENT; TANZANIA; CHOICE; LAND; EXCLUSION; ECOSYSTEM; BUSHMEAT	Community-based conservation (CBC) aims to benefit local people as well as to achieve conservation goals, but has been criticised for taking a simplistic view of "community" and failing to recognise differences in the preferences and motivations of community members. We explore this heterogeneity in the context of Kenya's conservancies, focussing on the livelihood preferences of men and women living adjacent to the Maasai Mara National Reserve. Using a discrete choice experiment we quantify the preferences of local community members for key components of their livelihoods and conservancy design, differentiating between men and women and existing conservancy members and non-members. While Maasai preference for pastoralism remains strong, non-livestock-based livelihood activities are also highly valued and there was substantial differentiation in preferences between individuals. Involvement with conservancies was generally perceived to be positive, but only if households were able to retain some land for other purposes. Women placed greater value on conservancy membership, but substantially less value on wage income, while existing conservancy members valued both conservancy membership and livestock more highly than did non-members. Our findings suggest that conservancies can make a positive contribution to livelihoods, but care must be taken to ensure that they do not unintentionally disadvantage any groups. We argue that conservation should pay greater attention to individual-level differences in preferences when designing interventions in order to achieve fairer and more sustainable outcomes for members of local communities.	[Keane, Aidan] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Keane, Aidan; Gurd, Heather; Kaelo, Dickson; Homewood, Katherine] UCL, Dept Anthropol, London, England; [Keane, Aidan; Gurd, Heather; Kaelo, Dickson; Rowcliffe, J. Marcus] ZSL Inst Zool, Regents Pk, London, England; [Kaelo, Dickson] Kenya Wildlife Conservancies Assoc KWCA, POB 1038 000517, Nairobi, Kenya; [Said, Mohammed Y.; de Leeuw, Jan] Int Livestock Res Inst ILRI, POB 30709 00100, Nairobi, Kenya; [Said, Mohammed Y.] Univ Nairobi, Ctr Sustainable Drylands Ecosyst & Soc, POB 30297 00100, Nairobi, Kenya; [de Leeuw, Jan] World Agroforestry Ctr ICRAF, POB 30677 00100, Nairobi, Kenya	University of Edinburgh; University of London; University College London; CGIAR; International Livestock Research Institute (ILRI); University of Nairobi; CGIAR; World Agroforestry (ICRAF)	Keane, A (corresponding author), Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland.; Keane, A (corresponding author), UCL, Dept Anthropol, London, England.; Keane, A (corresponding author), ZSL Inst Zool, Regents Pk, London, England.	aidan.keane@ed.ac.uk	Keane, Aidan/Q-5153-2019; Rowcliffe, Marcus/G-3713-2018; Homewood, Katherine/K-6151-2019; said, mohammed/E-4932-2019	Keane, Aidan/0000-0002-9704-5576; Rowcliffe, Marcus/0000-0002-4286-6887; Homewood, Katherine/0000-0001-7391-985X; said, mohammed/0000-0001-9278-3193; de Leeuw, Jan/0000-0001-7020-2503	Ecosystem Services for Poverty Alleviation (ESPA) programme [NE/I003673/1]; Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC); CGIAR research program on Dry lands [CRP 1.1]; CGIAR research program on Forest, Trees and Agroforestry; NERC [NE/I003673/1] Funding Source: UKRI; Natural Environment Research Council [NE/I003673/1] Funding Source: researchfish	Ecosystem Services for Poverty Alleviation (ESPA) programme; Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CGIAR research program on Dry lands(CGIAR); CGIAR research program on Forest, Trees and Agroforestry(CGIAR); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work [Biodiversity, Ecosystem services, Social sustainability and Tipping points in African drylands NE/I003673/1], was funded with support from the Ecosystem Services for Poverty Alleviation (ESPA) programme (www.espa.ac.uk). The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC). MS and JdL were supported by the CGIAR research program on Dry lands (CRP 1.1). JdL was also supported by CGIAR research program on Forest, Trees and Agroforestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 1999, WORLD DEV, V27, P629, DOI 10.1016/S0305-750X(98)00161-2; Agrawal A, 2001, COMMUNITIES AND THE; Ahluwalia M, 1997, IDS BULL-I DEV STUD, V28, P23, DOI 10.1111/j.1759-5436.1997.mp28004004.x; Archambault C, 2014, EUR J DEV RES, V26, P204, DOI 10.1057/ejdr.2013.59; Bedelian C, 2012, CONSERVATION AND ECO; Bedelian C.E., 2014, CONSERVATION TOURISM; Brooks J, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-2; Butt B, 2011, HUM ECOL, V39, P289, DOI 10.1007/s10745-011-9399-6; Butt B, 2009, ANN ASSOC AM GEOGR, V99, P309, DOI 10.1080/00045600802685895; Coast E, 2002, HUM ECOL, V30, P79, DOI 10.1023/A:1014567029853; Cochrane K, 2005, FINAL PROJECT REPORT; de Leeuw JM, 2014, ECOSYST SERV, V8, P16, DOI 10.1016/j.ecoser.2014.01.003; Dressler W, 2010, ENVIRON CONSERV, V37, P5, DOI 10.1017/S0376892910000044; Fratkin E., 2001, AFR STUD REV, V44, P1, DOI [10.2307/525591, DOI 10.2307/525591]; Glew L, 2010, EVALUATING THE EFFEC; Goldman M, 2003, DEV CHANGE, V34, P833, DOI 10.1111/j.1467-7660.2003.00331.x; Homewood K, 2004, AFRICA, V74, P567, DOI 10.3366/afr.2004.74.4.567; Homewood K, 2009, STUD HUM ECOL ADAPT, V5, P1, DOI 10.1007/978-0-387-87492-0; HOMEWOOD KM, 1991, MAASAILAND ECOLOGY P; Hoyos D, 2010, ECOL ECON, V69, P1595, DOI 10.1016/j.ecolecon.2010.04.011; Hulme D., 1999, Journal of International Development, V11, P277, DOI 10.1002/(SICI)1099-1328(199903/04)11:2&lt;277::AID-JID582&gt;3.0.CO;2-T; Igoe J., 2007, CONSERV SOC, V5, P534; Kosoy N, 2010, ECOL ECON, V69, P1228, DOI 10.1016/j.ecolecon.2009.11.002; Lamprey RH, 2004, J BIOGEOGR, V31, P997, DOI 10.1111/j.1365-2699.2004.01062.x; Leslie P, 2013, CURR ANTHROPOL, V54, P114, DOI 10.1086/669563; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Moro M, 2013, CONSERV LETT, V6, P37, DOI 10.1111/j.1755-263X.2012.00284.x; Neumann RP, 1997, DEV CHANGE, V28, P559, DOI 10.1111/1467-7660.00054; Nielsen MR, 2014, CONSERV BIOL, V28, P382, DOI 10.1111/cobi.12197; Norton-Griffiths M, 2009, SERENGETI III HUMAN; Nyariki D. M., 2009, Journal of Human Ecology, V26, P163; Odote C, 2013, NOMAD PEOPLES, V17, P87, DOI 10.3167/np.2013.170105; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Osano PM, 2013, NAT RESOUR FORUM, V37, P242, DOI 10.1111/1477-8947.12027; R Core Team, 2014, R A LANGUAGE AND ENV; Razavi, 2002, SHIFTING BURDENS GEN; Roe D., 2009, COMMUNITY MANAGEMENT; SCHROEDER RA, 1995, ANTIPODE, V27, P325, DOI 10.1111/j.1467-8330.1995.tb00283.x; Seno SK, 2002, SOC NATUR RESOUR, V15, P79, DOI 10.1080/089419202317174039; Sikor T, 2013, THE JUSTICES AND INJ; Spencer P., 1992, BEING MAASAI, P140; Stan Development Team, 2015, STAN A C LIBRARY FOR; Stan Development Team, 2015, RSTAN THE R INTERFAC; Suich H, 2010, ENVIRON CONSERV, V37, P45, DOI 10.1017/S0376892910000202; Thompson DM, 2009, STUD HUM ECOL ADAPT, V5, P77, DOI 10.1007/978-0-387-87492-0_4; Thompson M, 2002, HUM ECOL, V30, P107, DOI 10.1023/A:1014519113923; Wheeler B, 2014, ALGDESIGN ALGORITHMI	49	21	22	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152432	10.1371/journal.pone.0152432	http://dx.doi.org/10.1371/journal.pone.0152432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9KB	27022918	Green Submitted, Green Published, gold			2022-12-26	WOS:000373113900057
J	Kreuter, M; Ehlers-Tenenbaum, S; Palmowski, K; Bruhwyler, J; Oltmanns, U; Muley, T; Heussel, CP; Warth, A; Kolb, M; Herth, FJF				Kreuter, Michael; Ehlers-Tenenbaum, Svenja; Palmowski, Karin; Bruhwyler, Jacques; Oltmanns, Ute; Muley, Thomas; Heussel, Claus Peter; Warth, Arne; Kolb, Martin; Herth, Felix J. F.			Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; LUNG-CANCER; SURVIVAL; EMPHYSEMA; HYPERTENSION; COMMON	Introduction Comorbidities significantly influence the clinical course of idiopathic pulmonary fibrosis (IPF). However, their prognostic impact is not fully understood. We therefore aimed to determine the impact of comorbidities, as individual and as whole, on survival in IPF. Methods The database of a tertiary referral centre for interstitial lung diseases was reviewed for comorbidities, their treatments, their frequency and survival in IPF patients. Results 272 patients were identified of which 12% had no, 58% 1-3 and 30% 4-7 comorbidities, mainly cardiovascular, pulmonary and oncologic comorbidities. Median survival according to the frequency of comorbidities differed significantly with 66 months for patients without comorbidities, 48 months when 1-3 comorbidities were reported and 35 months when 4-7 comorbidities were prevalent (p = 0.004). A multivariate Cox proportional hazard analyses identified other cardiac diseases and lung cancer as significant predictors of death, gastro-oesophageal reflux disease (GERD) and diastolic dysfunction had a significant positive impact on survival. A significant impact of comorbidities associated therapies on survival was not discovered. This included the use of proton pump inhibitors at baseline, which was not associated with a survival benefit (p = 0.718). We also established a predictive tool for highly prevalent comorbidities, termed IPF comorbidome which demonstrates a new relationship of IPF and comorbidities. Conclusion Comorbidities are frequent in IPF patients. Some comorbidities, especially lung cancer, mainly influence survival in IPF, while others such as GERD may inherit a more favourable effect. Moreover, their cumulative incidence impacts survival.	[Kreuter, Michael; Ehlers-Tenenbaum, Svenja; Palmowski, Karin; Oltmanns, Ute; Herth, Felix J. F.] Heidelberg Univ, Ctr Interstitial & Rare Lung Dis, Pneumol & Resp Crit Care Med, Thoraxklin, Heidelberg, Germany; [Bruhwyler, Jacques] ECSOR Dept Biostat, Gembloux, Belgium; [Muley, Thomas] Heidelberg Univ, Dept Translat Res, Thoraxklin, Heidelberg, Germany; [Heussel, Claus Peter] Heidelberg Univ, Diagnost & Intervent Radiol, Thoraxklin, Heidelberg, Germany; [Heussel, Claus Peter] Heidelberg Univ, Dept Radiol, Heidelberg, Germany; [Warth, Arne] Heidelberg Univ, Inst Pathol, Neuenheimer Feld 220, Heidelberg, Germany; [Kolb, Martin] McMaster Univ, Hamilton, ON, Canada	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; McMaster University	Kreuter, M (corresponding author), Heidelberg Univ, Ctr Interstitial & Rare Lung Dis, Pneumol & Resp Crit Care Med, Thoraxklin, Heidelberg, Germany.	kreuter@uni-heidelberg.de	Muley, Thomas/AAY-9200-2020		German Centre for Lung research; F. Hoffmann-La Roche Ltd.; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	German Centre for Lung research; F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This work was supported by the German Centre for Lung research and by an unrestricted grant from InterMune which is now F. Hoffmann-La Roche Ltd. The funder provided support in the form of funding the statistical analyses, which were performed by Jacques Bruhwyler who is an employee of CRO ECSOR, Belgium and for further research material. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section. Furthermore, we acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	Alder JK, 2011, AM J RESP CRIT CARE, V184, P904, DOI 10.1164/rccm.201103-0520OC; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Behr J, 2015, EUR RESPIR J, V46, P186, DOI 10.1183/09031936.00217614; Calado Rodrigo, 2012, F1000 Med Rep, V4, P8, DOI 10.3410/M4-8; Colombi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130653; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; De Vries J, 2001, EUR RESPIR J, V17, P954, DOI 10.1183/09031936.01.17509540; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Dowman L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006322.pub3; GREENFIE.LJ, 1969, ANN SURG, V170, P74, DOI 10.1097/00000658-196907000-00009; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Hunt WR, 2014, AM J PHYSIOL-LUNG C, V306, pL43, DOI 10.1152/ajplung.00224.2013; Huppmann P, 2013, EUR RESPIR J, V42, P444, DOI 10.1183/09031936.00081512; Hyldgaard C, 2014, RESP MED, V108, P647, DOI 10.1016/j.rmed.2014.01.008; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kizer JR, 2004, ARCH INTERN MED, V164, P551, DOI 10.1001/archinte.164.5.551; Kreuter M, 2016, LANCET RESP MED IN P; Kreuter M, 2016, EUR RESPIR J, V47, P1776, DOI 10.1183/13993003.02087-2015; Krishnan V, 2008, CHEST, V134, P693, DOI 10.1378/chest.08-0173; Kromberger H, 1985, PRAX KLIN PNEUMOL, V39, P241; Kyung SY, 2014, INT J CLIN EXP PATHO, V7, P221; Lancaster LH, 2009, CHEST, V136, P772, DOI 10.1378/chest.08-2776; Lee Joyce S, 2014, Clin Pulm Med, V21, P81; Lee JS, 2013, LANCET RESP MED, V1, P369, DOI 10.1016/S2213-2600(13)70105-X; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Ley Brett, 2013, Clin Epidemiol, V5, P483, DOI 10.2147/CLEP.S54815; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Mermigkis C, 2007, LUNG, V185, P173, DOI 10.1007/s00408-007-9004-3; Mertens V, 2010, J CLIN GASTROENTEROL, V44, pE230, DOI 10.1097/MCG.0b013e3181d47dc4; MITSUHASHI T, 1985, EXP MOL PATHOL, V42, P261, DOI 10.1016/0014-4800(85)90032-2; Nathan SD, 2010, RESP MED, V104, P1035, DOI 10.1016/j.rmed.2010.02.008; Ozawa Y, 2009, RESPIROLOGY, V14, P723, DOI 10.1111/j.1440-1843.2009.01547.x; Papadopoulos CE, 2008, EUR RESPIR J, V31, P701, DOI 10.1183/09031936.00102107; Patel NM, 2007, CHEST, V132, P998, DOI 10.1378/chest.06-3087; Raghu G, 2015, EUR RESPIR J, V46, P1113, DOI 10.1183/13993003.02316-2014; Raghu G, 2015, AM J RESP CRIT CARE, V191, P252, DOI 10.1164/rccm.201411-2044ED; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Tomassetti S, 2015, CHEST, V147, P157, DOI 10.1378/chest.14-0359; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vancheri C, 2013, EUR RESPIR REV, V22, P265, DOI 10.1183/09059180.00003613; Wuyts WA, 2016, AM J RESP CRIT CARE, V193, P340, DOI 10.1164/rccm.201509-1763LE	44	175	176	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0151425	10.1371/journal.pone.0151425	http://dx.doi.org/10.1371/journal.pone.0151425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023440	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900012
J	Lee, J; Gregory, SM; Nelson, EA; White, JM; Tamm, LK				Lee, Jinwoo; Gregory, Sonia M.; Nelson, Elizabeth A.; White, Judith M.; Tamm, Lukas K.			The Roles of Histidines and Charged Residues as Potential Triggers of a Conformational Change in the Fusion Loop of Ebola Virus Glycoprotein	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; FILOVIRUS ENTRY; DOMAIN; GP2; REQUIRES; STABILITY; PEPTIDES; PROTEINS	Ebola virus (EBOV) enters cells from late endosomes/lysosomes under mildly acidic conditions. Entry by fusion with the endosomal membrane requires the fusion loop (FL, residues 507-560) of the EBOV surface glycoprotein to undergo a pH-dependent conformational change. To find the pH trigger for this reaction we mutated multiple conserved histidines and charged and uncharged hydrophilic residues in the FL and measured their activity by liposome fusion and cell entry of virus-like particles. The FL location in the membrane was assessed by NMR using soluble and lipid-bound paramagnetic relaxation agents. While we could not identify a single residue to be alone responsible for pH triggering, we propose that a distributed pH effect over multiple residues induces the conformational change that enhances membrane insertion and triggers the fusion activity of the EBOV FL.	[Lee, Jinwoo; Gregory, Sonia M.; White, Judith M.; Tamm, Lukas K.] Univ Virginia, Ctr Membrane & Cell Physiol, Charlottesville, VA 22908 USA; [Lee, Jinwoo; Gregory, Sonia M.; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Nelson, Elizabeth A.; White, Judith M.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Tamm, LK (corresponding author), Univ Virginia, Ctr Membrane & Cell Physiol, Charlottesville, VA 22908 USA.; Tamm, LK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	lkt2e@virginia.edu		Lee, Jinwoo/0000-0002-1433-2810	NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, T32GM080186] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	There are no funders other than NIH that have supported this work.	Bale S, 2012, VIRUSES-BASEL, V4, P447, DOI 10.3390/v4040447; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Brecher M, 2012, J VIROL, V86, P364, DOI 10.1128/JVI.05708-11; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delos SE, 2010, J VIROL, V84, P5687, DOI 10.1128/JVI.02583-09; DeMarco ML, 2010, J AM CHEM SOC, V132, P1334, DOI 10.1021/ja907518x; Dube D, 2008, J VIROL, V82, P7238, DOI 10.1128/JVI.00425-08; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Goddard T.D., 2008, SPARKY NMR ASSIGNMEN; Gregory SM, 2014, J VIROL, V88, P6636, DOI 10.1128/JVI.00396-14; Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Harrison JS, 2013, STRUCTURE, V21, P1085, DOI 10.1016/j.str.2013.05.009; Harrison JS, 2012, BIOCHEMISTRY-US, V51, P2515, DOI 10.1021/bi3000353; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hoenen T, 2006, TRENDS MOL MED, V12, P206, DOI 10.1016/j.molmed.2006.03.006; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; Hunt CL, 2012, VIRUSES-BASEL, V4, P258, DOI 10.3390/v4020258; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Koellhoffer JF, 2012, BIOCHEMISTRY-US, V51, P7665, DOI 10.1021/bi300976m; Kreutzberger AJB, 2015, BIOPHYS J, V109, P319, DOI 10.1016/j.bpj.2015.06.022; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lai AL, 2007, J BIOL CHEM, V282, P23946, DOI 10.1074/jbc.M704008200; Lai AL, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P279; Lai AL, 2012, J MOL BIOL, V418, P3, DOI 10.1016/j.jmb.2012.02.010; Lai AL, 2010, J BIOL CHEM, V285, P37467, DOI 10.1074/jbc.M110.153700; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Liu NN, 2015, J INFECT DIS, V212, pS146, DOI 10.1093/infdis/jiv030; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Miller EH, 2012, CURR OPIN VIROL, V2, P206, DOI 10.1016/j.coviro.2012.02.015; Mingo RM, 2015, J VIROL, V89, P2931, DOI 10.1128/JVI.03398-14; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Shoemaker CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056265; Tamm LK, 2000, BIOSCIENCE REP, V20, P501, DOI 10.1023/A:1010406920417; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; White JM, 2012, NAT REV MICROBIOL, V10, P317, DOI 10.1038/nrmicro2764; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005	45	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152527	10.1371/journal.pone.0152527	http://dx.doi.org/10.1371/journal.pone.0152527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023721	Green Published, gold			2022-12-26	WOS:000373113900073
J	Ros-Freixedes, R; Gol, S; Pena, RN; Tor, M; Ibanez-Escriche, N; Dekkers, JCM; Estany, J				Ros-Freixedes, Roger; Gol, Sofia; Pena, Ramona N.; Tor, Marc; Ibanez-Escriche, Noelia; Dekkers, Jack C. M.; Estany, Joan			Genome-Wide Association Study Singles Out SCD and LEPR as the Two Main Loci Influencing Intramuscular Fat Content and Fatty Acid Composition in Duroc Pigs	PLOS ONE			English	Article							GENE POLYMORPHISMS; BACKFAT THICKNESS; MELTING-POINT; LEPTIN; QTL; MC4R; IDENTIFICATION; PREDICTION; NUTRITION	Intramuscular fat (IMF) content and fatty acid composition affect the organoleptic quality and nutritional value of pork. A genome-wide association study was performed on 138 Duroc pigs genotyped with a 60k SNP chip to detect biologically relevant genomic variants influencing fat content and composition. Despite the limited sample size, the genome-wide association study was powerful enough to detect the association between fatty acid composition and a known haplotypic variant in SCD (SSC14) and to reveal an association of IMF and fatty acid composition in the LEPR region (SSC6). The association of LEPR was later validated with an independent set of 853 pigs using a candidate quantitative trait nucleotide. The SCD gene is responsible for the biosynthesis of oleic acid (C18:1) from stearic acid. This locus affected the stearic to oleic desaturation index (C18:1/C18:0), C18: 1, and saturated (SFA) and monounsaturated (MUFA) fatty acids content. These effects were consistently detected in gluteus medius, longissimus dorsi, and subcutaneous fat. The association of LEPR with fatty acid composition was detected only in muscle and was, at least in part, a consequence of its effect on IMF content, with increased IMF resulting in more SFA, less polyunsaturated fatty acids (PUFA), and greater SFA/PUFA ratio. Marker substitution effects estimated with a subset of 65 animals were used to predict the genomic estimated breeding values of 70 animals born 7 years later. Although predictions with the whole SNP chip information were in relatively high correlation with observed SFA, MUFA, and C18: 1/C18: 0 (0.48-0.60), IMF content and composition were in general better predicted by using only SNPs at the SCD and LEPR loci, in which case the correlation between predicted and observed values was in the range of 0.36 to 0.54 for all traits. Results indicate that markers in the SCD and LEPR genes can be useful to select for optimum fatty acid profiles of pork.	[Ros-Freixedes, Roger; Gol, Sofia; Pena, Ramona N.; Tor, Marc; Ibanez-Escriche, Noelia; Estany, Joan] Univ Lleida, Agrotecnio Ctr, Dept Ciencia Anim, Lleida, Catalonia, Spain; [Ibanez-Escriche, Noelia] IRTA, Genet & Millora Anim, Lleida, Catalonia, Spain; [Dekkers, Jack C. M.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	Centre de Recerca en Agrotecnologia (Agrotecnio); Universitat de Lleida; IRTA; Iowa State University	Ros-Freixedes, R; Estany, J (corresponding author), Univ Lleida, Agrotecnio Ctr, Dept Ciencia Anim, Lleida, Catalonia, Spain.	rros@ca.udl.cat; jestany@ca.udl.cat	Ibanez, Noelia/H-2988-2014; Pena, Romi/C-7756-2011; Ros-Freixedes, Roger/M-5247-2013; Estany, Joan/D-3228-2013; Ibañez-Escriche, Noelia/Q-5155-2018	Ibanez, Noelia/0000-0002-6221-3576; Pena, Romi/0000-0002-3558-7302; Ros-Freixedes, Roger/0000-0002-3745-6736; Estany, Joan/0000-0002-5660-5709; Ibañez-Escriche, Noelia/0000-0002-6221-3576; GOL Parera, sofia/0000-0003-0960-9026	Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2012-33529, AGL2015-65846-R]	Spanish Ministry of Economy and Competitiveness (MINECO)	This research was funded by the Spanish Ministry of Economy and Competitiveness (MINECO; grants AGL2012-33529 and AGL2015-65846-R).	Amills M, 2008, J ANIM BREED GENET, V125, P228, DOI 10.1111/j.1439-0388.2007.00715.x; [Anonymous], 2009, GENSEL USER MANUAL P; AOAC, 1997, AOAC OFF METH AN S, P18; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bosch L, 2009, MEAT SCI, V82, P432, DOI 10.1016/j.meatsci.2009.02.013; Bouwman Aniek C, 2011, BMC Proc, V5 Suppl 3, pS4, DOI 10.1186/1753-6561-5-S3-S4; Cameron ND, 2000, MEAT SCI, V55, P187, DOI 10.1016/S0309-1740(99)00142-4; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen LH, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0290-0; Christophersen OA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-16; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Clop A, 2003, MAMM GENOME, V14, P650, DOI 10.1007/s00335-002-2210-7; Dekkers JCM, 2012, CURR GENOMICS, V13, P207, DOI 10.2174/138920212800543057; Dubern B, 2012, BIOCHIMIE, V94, P2111, DOI 10.1016/j.biochi.2012.05.010; Estany J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086177; Galve A, 2012, LIVEST SCI, V145, P145, DOI 10.1016/j.livsci.2012.01.010; Guo T, 2009, ANIM GENET, V40, P185, DOI 10.1111/j.1365-2052.2008.01819.x; Hirose K, 2014, ANIM SCI J, V85, P198, DOI 10.1111/asj.12134; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kim ES, 2015, J ANIM SCI, V93, P3292, DOI 10.2527/jas.2015-8879; Kim Y, 2006, J HERED, V97, P535, DOI 10.1093/jhered/esl026; Legarra A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0087-7; Li X, 2010, MOL BIOL REP, V37, P3931, DOI 10.1007/s11033-010-0050-1; Lim KS, 2015, ASIAN AUSTRAL J ANIM, V28, P151, DOI 10.5713/ajas.14.0529; Lopez-Buesa P, 2014, ANIM GENET, V45, P133, DOI 10.1111/age.12091; Mackowski M, 2005, ANIM GENET, V36, P135, DOI 10.1111/j.1365-2052.2005.01247.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Munoz G, 2011, MEAT SCI, V88, P169, DOI 10.1016/j.meatsci.2010.12.018; Munoz M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-845; Muraoka O, 2003, NEUROCHEM INT, V42, P591, DOI 10.1016/S0197-0186(02)00160-2; Ntawubizi M, 2010, J ANIM SCI, V88, P1286, DOI 10.2527/jas.2009-2355; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ovilo C, 2010, MAMM GENOME, V21, P583, DOI 10.1007/s00335-010-9307-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Ros-Freixedes R, 2012, J ANIM SCI, V90, P4230, DOI 10.2527/jas.2011-5063; Saatchi M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-730; Sanchez MP, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-55; Tyra M, 2011, LIVEST SCI, V142, P114, DOI 10.1016/j.livsci.2011.07.003; Uemoto Y, 2012, ANIM GENET, V43, P225, DOI 10.1111/j.1365-2052.2011.02236.x; Uemoto Y, 2012, ANIM GENET, V43, P27, DOI 10.1111/j.1365-2052.2011.02218.x; Uemoto Y, 2012, ANIM SCI J, V83, P375, DOI 10.1111/j.1740-0929.2011.00963.x; Wolc A, 2012, ANIM GENET, V43, P87, DOI 10.1111/j.1365-2052.2012.02381.x; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065554; Zhang WC, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0184-2	47	58	61	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152496	10.1371/journal.pone.0152496	http://dx.doi.org/10.1371/journal.pone.0152496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023885	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900065
J	Burtscher, D; Van den Bergh, R; Toktosunov, U; Angmo, N; Samieva, N; Arechaga, EPR				Burtscher, Doris; Van den Bergh, Rafael; Toktosunov, Ulan; Angmo, Nilza; Samieva, Nazgul; Arechaga, Eva P. Rocillo			"My Favourite Day Is Sunday": Community Perceptions of (Drug-Resistant) Tuberculosis and Ambulatory Tuberculosis Care in Kara Suu District, Osh Province, Kyrgyzstan	PLOS ONE			English	Article							HEALTH-CARE; SEEKING; HIV; PREVALENCE; ADHERENCE; PATHWAYS; BARRIERS; BEHAVIOR; ACCESS	Objectives Kyrgyzstan is one of the 27 high multidrug-resistant tuberculosis (MDR-TB) burden countries listed by the WHO. In 2012, Medecins Sans FrontiSres (MSF) started a drug-resistant tuberculosis (DR-TB) project in Kara Suu District. A qualitative study was undertaken to understand the perception of TB and DR-TB in order to improve the effectiveness and acceptance of the MSF intervention and to support advocacy strategies for an ambulatory model of care. Methods This paper reports findings from 63 interviews with patients, caregivers, health care providers and members of communities. Data was analysed using a qualitative content analysis. Validation was ensured by triangulation and a 'thick' description of the research context, and by presenting deviant cases. Results Findings show that the general population interprets TB as the 'lungs having a cold' or as a 'family disease' rather than as an infectious illness. From their perspective, individuals facing poor living conditions are more likely to get TB than wealthier people. Vulnerable groups such as drug and alcohol users, homeless persons, ethnic minorities and young women face barriers in accessing health care. As also reported in other publications, TB is highly stigmatised and possible side effects of the long treatment course are seen as unbearable; therefore, people only turn to public health care quite late. Most patients prefer ambulatory treatment because of the much needed emotional support from their social environment, which positively impacts treatment concordance. Health care providers favour inpatient treatment only for a better monitoring of side effects. Health staff increasingly acknowledges the central role they play in supporting DR-TB patients, and the importance of assuming a more empathic attitude. Conclusions Health promotion activities should aim at improving knowledge on TB and DR-TB, reducing stigma, and fostering the inclusion of vulnerable populations. Health seeking delays and adherence problems will be countered by further implementation of shortened treatment regimens. An ambulatory model of care is proposed when convenient for the patient; hospitalisation is favoured only when seen as more appropriate for the respective individual.	[Burtscher, Doris] Med Sans Frontieres, Vienna Evaluat Unit, Vienna, Austria; [Van den Bergh, Rafael] Med Sans Frontieres, Brussels, Belgium; [Toktosunov, Ulan] Minist Hlth, Bishkek, Kyrgyzstan; [Angmo, Nilza; Samieva, Nazgul] Med Sans Frontieres, Bishkek, Kyrgyzstan; [Arechaga, Eva P. Rocillo] Med Sans Frontieres, Osh, Kyrgyzstan	Doctors Without Borders; Doctors Without Borders; Ministry of Health - Kyrgyzstan	Burtscher, D (corresponding author), Med Sans Frontieres, Vienna Evaluat Unit, Vienna, Austria.	doris.burtscher@vienna.msf.org		Van den Bergh, Rafael/0000-0001-6277-8713				Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Agboatwalla M, 2003, East Mediterr Health J, V9, P732; Aitpeva Gulnara., 2007, MAZAR WORSHIP KYRGYZ; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Awofeso N., 2008, B WORLD HEALTH ORGAN, V86; Bissell P, 2004, SOC SCI MED, V58, P851, DOI 10.1016/S0277-9536(03)00259-4; Bond V, 2006, J COMMUNITY APPL SOC, V16, P452, DOI 10.1002/casp.893; Brikci N., 2007, GUIDE USING QUALITAT; Burgess R. G, 1984, FIELD INTRO FIELD RE; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Daftary A, 2012, SOC SCI MED, V74, P1512, DOI 10.1016/j.socscimed.2012.01.027; Dimitrova B, 2006, HEALTH POLICY PLANN, V21, P265, DOI 10.1093/heapol/czl014; Dowell J, 1997, FAM PRACT, V14, P369, DOI 10.1093/fampra/14.5.369; Falkingham J, 2004, SOC SCI MED, V58, P247, DOI 10.1016/S0277-9536(03)00008-X; Geertz C., 1973, THICK DESCRIPTION TO; Green J., 2018, QUALITATIVE METHODS, VFourth; Hancock B., 2002, INTRO QUALITATIVE RE; Helman, 2000, CULTURE HLTH ILLNESS; Hermosilla S, 2015, PUBLIC HEALTH, V129, P569, DOI 10.1016/j.puhe.2015.01.022; Horter S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-81; Huffman S., 2009, AWARENESS TUBERCULOS; Huffman SA, 2012, SOC SCI MED, V74, P864, DOI 10.1016/j.socscimed.2011.07.019; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Isakova Zh T, 2008, Mol Gen Mikrobiol Virusol, P36; Khan JA, 2008, PAK J PHARM SCI, V21, P311; Kleinman A., 1984, PATIENTS HEALERS CON; Kozhamkulov U, 2011, JPN J INFECT DIS, V64, P253; Liefooghe R, 1995, SOC SCI MED, V41, P1685, DOI 10.1016/0277-9536(95)00129-U; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; Mayring P., 2010, QUALITATIVE INHALTSA, V2nd Aufl, DOI [10.1007/978-3-531-92052-8_42, DOI 10.1007/978-3-531-92052-8_42]; Miller JA., 2007, PERCEPTION BELIEFS H; Molchanova E., 2009, J TRANSPERSONAL RES, V1, P6; Moller LF, 2008, INT J PRISON HEALTH, V4, P124, DOI 10.1080/17449200802264654; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Patton Michael Quinn., 2002, QUALITATIVE RES EVAL, P453; Pool R., 2005, MED ANTHROPOL; Pope C, 2006, QUALITATIVE RES HLTH; Steen TW, 1999, SOC SCI MED, V48, P163, DOI 10.1016/S0277-9536(98)00329-3; Stickley A, 2013, BMC COMPLEM ALTERN M, V13, P9; Stoffels K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063128; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Terlikbayeva A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-262; TheGlobalFund, 2013, GFOIG13023; Thomas Stefan, 2012, FORUM QUALITATIVE SO, V13; ULMASOVA DJ, 2013, EUROSURVEILLANCE, V18, P18; van den Hof S, 2013, INT J TUBERC LUNG D, V17, P526, DOI 10.5588/ijtld.12.0703; Wang JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-354; Wang WB, 2007, INT J TUBERC LUNG D, V11, P386; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Woith WM, 2008, INT J NURS STUD, V45, P1163, DOI 10.1016/j.ijnurstu.2007.07.014; World Health Organization, 2011, GUID PROGR MAN DRUG; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	55	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152283	10.1371/journal.pone.0152283	http://dx.doi.org/10.1371/journal.pone.0152283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH5EH	27019454	Green Published, Green Submitted, gold			2022-12-26	WOS:000372807800039
J	Iosue, CL; Attanasio, N; Sheik, NF; Neal, EM; Leone, SG; Cali, BJ; Peel, MT; Grannas, AM; Wykoff, DD				Iosue, Christine L.; Attanasio, Nicholas; Sheik, Noor F.; Neal, Erin M.; Leone, Sarah G.; Cali, Brian J.; Peel, Michael T.; Grannas, Amanda M.; Wykoff, Dennis D.			Partial Decay of Thiamine Signal Transduction Pathway Alters Growth Properties of Candida glabrata	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC-REGULATION; ACID-PHOSPHATASE; TRANSPORTER GENE; GENOME DATABASE; YEAST; BIOSYNTHESIS; EVOLUTION; DUPLICATION; EXPRESSION	The phosphorylated form of thiamine (Vitamin B1), thiamine pyrophosphate (TPP) is essential for the metabolism of amino acids and carbohydrates in all organisms. Plants and microorganisms, such as yeast, synthesize thiamine de novo whereas animals do not. The thiamine signal transduction (THI) pathway in Saccharomyces cerevisiae is well characterized. The similar to 10 genes required for thiamine biosynthesis and uptake are transcriptionally upregulated during thiamine starvation by THI2, THI3, and PDC2. Candida glabrata, a human commensal and opportunistic pathogen, is closely related to S. cerevisiae but is missing half of the biosynthetic pathway, which limits its ability to make thiamine. We investigated the changes to the THI pathway in C. glabrata, confirming orthologous functions. We found that C. glabrata is unable to synthesize the pyrimidine subunit of thiamine as well as the thiamine precursor vitamin B-6. In addition, THI2 (the gene encoding a transcription factor) is not present in C. glabrata, indicating a difference in the transcriptional regulation of the pathway. Although the pathway is upregulated by thiamine starvation in both species, C. glabrata appears to upregulate genes involved in thiamine uptake to a greater extent than S. cerevisiae. However, the altered regulation of the THI pathway does not alter the concentration of thiamine and its vitamers in the two species as measured by HPLC. Finally, we demonstrate potential consequences to having a partial decay of the THI biosynthetic and regulatory pathway. When the two species are co-cultured, the presence of thiamine allows C. glabrata to rapidly outcompete S. cerevisiae, while absence of thiamine allows S. cerevisiae to outcompete C. glabrata. This simplification of the THI pathway in C. glabrata suggests its environment provides thiamine and/or its precursors to cells, whereas S. cerevisiae is not as reliant on environmental sources of thiamine.	[Iosue, Christine L.; Attanasio, Nicholas; Sheik, Noor F.; Neal, Erin M.; Leone, Sarah G.; Cali, Brian J.; Peel, Michael T.; Wykoff, Dennis D.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Grannas, Amanda M.] Villanova Univ, Dept Chem, Villanova, PA 19085 USA	Villanova University; Villanova University	Wykoff, DD (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	dennis.wykoff@villanova.edu	Grannas, Amanda/F-4804-2010	Grannas, Amanda/0000-0003-4719-348X; Shaik, Noor/0000-0002-9336-4238	National Science Foundation [MCB-1412582]; Dennis M. Cook Endowed Gregor Mendel Chair in Genetics Endowment; Villanova College of Liberal Art and Sciences; Villanova Department of Biology; Div Of Molecular and Cellular Bioscience [1412582] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Dennis M. Cook Endowed Gregor Mendel Chair in Genetics Endowment; Villanova College of Liberal Art and Sciences; Villanova Department of Biology; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation grant MCB-1412582, the Dennis M. Cook Endowed Gregor Mendel Chair in Genetics Endowment, the Villanova College of Liberal Art and Sciences, and the Villanova Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batifoulier F, 2005, J CHROMATOGR B, V816, P67, DOI 10.1016/j.jchromb.2004.11.004; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; Chatterjee A, 2011, NATURE, V478, P542, DOI 10.1038/nature10503; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Coquille S, 2012, J BIOL CHEM, V287, P42333, DOI 10.1074/jbc.M112.397240; Cormack BP, 1999, GENETICS, V151, P979; Corrigan MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069628; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Fitzpatrick TB, 2012, PLANT CELL, V24, P395, DOI 10.1105/tpc.111.093120; Gabaldon T, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fov110; Gabaldon T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-623; Goddard MR, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov009; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; Hittinger CT, 2013, TRENDS GENET, V29, P309, DOI 10.1016/j.tig.2013.01.002; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Huang SD, 2005, GENETICS, V169, P1859, DOI 10.1534/genetics.104.038695; Huang ZW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003083; Huerta-Cepas J, 2014, NUCLEIC ACIDS RES, V42, pD897, DOI 10.1093/nar/gkt1177; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; IWASHIMA A, 1986, J GEN MICROBIOL, V132, P1541; IWASHIMA A, 1990, BIOCHIM BIOPHYS ACTA, V1028, P161, DOI 10.1016/0005-2736(90)90150-M; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; KAWASAKI Y, 1990, J BACTERIOL, V172, P6145, DOI 10.1128/jb.172.10.6145-6147.1990; Kawasaki Y, 2005, CURR GENET, V47, P156, DOI 10.1007/s00294-004-0557-x; Kerwin CL, 2009, GENETICS, V182, P471, DOI 10.1534/genetics.109.101063; Lai RY, 2012, J AM CHEM SOC, V134, P9157, DOI 10.1021/ja302474a; McGary KL, 2013, P NATL ACAD SCI USA, V110, P11481, DOI 10.1073/pnas.1304461110; Mojzita D, 2006, MOL GENET GENOMICS, V276, P147, DOI 10.1007/s00438-006-0130-z; Muller EH, 1999, FEBS LETT, V449, P245, DOI 10.1016/S0014-5793(99)00449-4; NOSAKA K, 1993, J BIOL CHEM, V268, P17440; NOSAKA K, 1994, J BIOL CHEM, V269, P30510; Nosaka K, 2005, MOL MICROBIOL, V58, P467, DOI 10.1111/j.1365-2958.2005.04835.x; NOSAKA K, 1984, Acta Vitaminologica et Enzymologica, V6, P137; NOSAKA K, 1989, FEMS MICROBIOL LETT, V60, P55, DOI 10.1016/0378-1097(89)90077-3; NOSAKA K, 1989, YEAST, V5, P447; Nosaka K, 2006, APPL MICROBIOL BIOT, V72, P30, DOI 10.1007/s00253-006-0464-9; Nosaka K, 2012, FEMS MICROBIOL LETT, V330, P140, DOI 10.1111/j.1574-6968.2012.02543.x; Orkwis BR, 2010, GENETICS, V186, P885, DOI 10.1534/genetics.110.120824; PRAEKELT UM, 1994, YEAST, V10, P481, DOI 10.1002/yea.320100407; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton CK, 1997, GENE, V199, P111, DOI 10.1016/S0378-1119(97)00354-5; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wightman R, 2003, MICROBIOL-SGM, V149, P1447, DOI 10.1099/mic.0.26194-0; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022	52	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152042	10.1371/journal.pone.0152042	http://dx.doi.org/10.1371/journal.pone.0152042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015653	gold, Green Submitted, Green Published			2022-12-26	WOS:000372708900039
J	Eclarinal, JD; Zhu, SY; Baker, MS; Piyarathna, DB; Coarfa, C; Fiorotto, ML; Waterland, RA				Eclarinal, Jesse D.; Zhu, Shaoyu; Baker, Maria S.; Piyarathna, Danthasinghe B.; Coarfa, Cristian; Fiorotto, Marta L.; Waterland, Robert A.			Maternal exercise during pregnancy promotes physical activity in adult offspring	FASEB JOURNAL			English	Article						developmental programming; activity-stat; metabolic imprinting	ENERGY-EXPENDITURE; VOLUNTARY EXERCISE; LOCOMOTOR-ACTIVITY; OBESITY; LIFE; DETERMINANTS; HIPPOCAMPUS; EXPRESSION; PHENOTYPES; PREVENTS	Previous rodent studies have shown that maternal voluntary exercise during pregnancy leads to metabolic changes in adult offspring. We set out to test whether maternal voluntary exercise during pregnancy also induces persistent changes in voluntary physical activity in the offspring. Adult C57BL/6J female mice were randomly assigned to be caged with an unlocked (U) or locked (L) running wheel before and during pregnancy. Maternal running behavior was monitored during pregnancy, and body weight, body composition, food intake, energy expenditure, total cage activity, and running wheel activity were measured in the offspring at various ages. U offspring were slightly heavier at birth, but no group differences in body weight or composition were observed at later ages (when mice were caged without access to running wheels). Consistent with our hypothesis, U offspring were more physically active as adults. This effect was observed earlier in female offspring (at sexual maturation). Remarkably, at 300 d of age, U females achieved greater fat loss in response to a 3-wk voluntary exercise program. Our findings show for the first time that maternal physical activity during pregnancy affects the offspring's lifelong propensity for physical activity and may have important implications for combating the worldwide epidemic of physical inactivity and obesity.	[Eclarinal, Jesse D.; Zhu, Shaoyu; Baker, Maria S.; Fiorotto, Marta L.; Waterland, Robert A.] USDA ARS, Childrens Nutr Res Ctr, Houston, TX USA; [Eclarinal, Jesse D.; Zhu, Shaoyu; Baker, Maria S.; Fiorotto, Marta L.; Waterland, Robert A.] Baylor Coll Med, Dept Pediat, Houston, TX USA; [Piyarathna, Danthasinghe B.; Coarfa, Cristian] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX USA; [Waterland, Robert A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX USA	United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Waterland, RA (corresponding author), USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Dept Pediat, 1100 Bates St,Suite 5080, Houston, TX 77030 USA.; Waterland, RA (corresponding author), USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Dept Mol & Human Genet, 1100 Bates St,Suite 5080, Houston, TX 77030 USA.	waterland@bcm.edu		Piyarathna, Danthasinghe Waduge Badrajee/0000-0002-7240-216X	U.S. Department of Agriculture (USDA) Grants [CRIS 6250-51000-055, CRIS 3092-5-001-059]; U.S. National Institutes of Health (NIH) Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [AR46308]; USDA/Agricultural Research Service (ARS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR046308, R01AR046308] Funding Source: NIH RePORTER	U.S. Department of Agriculture (USDA) Grants; U.S. National Institutes of Health (NIH) Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; USDA/Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Mr. Firoz Vohra [U.S. Department of Agriculture (USDA) Children's National Research Center (CNRC), Baylor College of Medicine] for expert assistance with the CLAMS studies, and Mr. Adam Gillum (USDA CNRC) for assistance in creating the figures. This work was funded by U.S. Department of Agriculture (USDA) Grants CRIS 6250-51000-055 and CRIS 3092-5-001-059 (to R.A.W.) and U.S. National Institutes of Health (NIH) Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR46308 (to M.L.F.). Measurements of body composition, energy expenditure, and food intake were conducted in the Mouse Metabolic Research Unit (USDA CNRC), which is supported by funds from the USDA/Agricultural Research Service (ARS) (www.bcm.edu/cnrc/mmru). The authors declare no conflicts of interest.	Acosta W, 2015, PHYSIOL BEHAV, V149, P279, DOI 10.1016/j.physbeh.2015.06.020; Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Atkinson RL, 2012, INT J OBESITY, V36, P1259, DOI 10.1038/ijo.2012.149; Baker MS, 2015, INT J OBESITY, V39, P98, DOI 10.1038/ijo.2013.146; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Carter LG, 2013, MED SCI SPORT EXER, V45, P832, DOI 10.1249/MSS.0b013e31827de953; Carter LG, 2012, AM J PHYSIOL-ENDOC M, V303, pE1061, DOI 10.1152/ajpendo.00213.2012; CEDERHOLM J, 1985, ACTA MED SCAND, V217, P373; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; Dorner G, 1974, Prog Brain Res, V41, P221; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gluckman PD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002554; Guth LM, 2013, EXP PHYSIOL, V98, P1469, DOI 10.1113/expphysiol.2012.070300; Hesketh KR, 2014, PEDIATRICS, V133, pE973, DOI 10.1542/peds.2013-3153; Hopkins SA, 2010, J CLIN ENDOCR METAB, V95, P2080, DOI 10.1210/jc.2009-2255; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kelly SA, 2015, J NEGAT RESULTS BIOM, V14, DOI 10.1186/s12952-015-0032-x; Kelly SA, 2013, TRENDS GENET, V29, P348, DOI 10.1016/j.tig.2012.12.007; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kriska AM, 2001, DIABETES CARE, V24, P1787, DOI 10.2337/diacare.24.10.1787; Laker RC, 2014, DIABETES, V63, P1605, DOI [10.2337/db14-0135, 10.2337/db13-1614]; Lee HH, 2006, BRAIN DEV-JPN, V28, P147, DOI 10.1016/j.braindev.2005.05.007; Li G, 2013, DIABETES, V62, P2773, DOI 10.2337/db12-1306; Mattocks C, 2008, BRIT J SPORT MED, V42, P721; Murashov AK, 2016, FASEB J, V30, P775, DOI 10.1096/fj.15-274274; Parnpiansil P, 2003, NEUROSCI LETT, V352, P45, DOI 10.1016/j.neulet.2003.08.023; Pollock KE, 2015, ENDOCRINOLOGY, V156, P3777, DOI 10.1210/en.2015-1247; Ronca AE, 2008, BEHAV NEUROSCI, V122, P224, DOI 10.1037/0735-7044.122.1.224; Rowland TW, 1998, MED SCI SPORT EXER, V30, P392, DOI 10.1097/00005768-199803000-00009; Stanford KI, 2015, DIABETES, V64, P427, DOI 10.2337/db13-1848; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; Takito MY, 2010, REV SAUDE PUBL, V44, P90, DOI 10.1590/S0034-89102010000100010; Vega CC, 2015, INT J OBESITY, V39, P712, DOI 10.1038/ijo.2013.150; Vickers MH, 2014, ANN NUTR METAB, V64, P26, DOI 10.1159/000360506; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Waterland RA, 2014, ANNU REV NUTR, V34, P337, DOI 10.1146/annurev-nutr-071813-105315; Wiebe HW, 2015, OBSTET GYNECOL, V125, P1185, DOI 10.1097/AOG.0000000000000801; Yin MM, 2013, BEHAV BRAIN RES, V253, P297, DOI 10.1016/j.bbr.2013.07.040	42	41	43	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2541	2548		10.1096/fj.201500018R	http://dx.doi.org/10.1096/fj.201500018R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27033262	Green Published			2022-12-26	WOS:000379249500009
J	Jensen, DD; Zhao, PS; Jimenez-Vargas, NN; Lieu, T; Gerges, M; Yeatman, HR; Canals, M; Vanner, SJ; Poole, DP; Bunnett, NW				Jensen, Dane D.; Zhao, Peishen; Jimenez-Vargas, Nestor N.; Lieu, TinaMarie; Gerges, Marina; Yeatman, Holly R.; Canals, Meritxell; Vanner, Stephen J.; Poole, Daniel P.; Bunnett, Nigel W.			Protein Kinase D and G Subunits Mediate Agonist-evoked Translocation of Protease-activated Receptor-2 from the Golgi Apparatus to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-helix receptor; Golgi; protein kinase D (PKD); protein trafficking (Golgi); receptor desensitization	ARRESTIN-DEPENDENT ENDOCYTOSIS; BETA-GAMMA COMPLEX; CELL-SURFACE; SUBSTANCE-P; PARACELLULAR PERMEABILITY; TRAFFICKING; ENDOSOMES; INFLAMMATION; TRANSPORT; NEURONS	Agonist-evoked endocytosis of G protein-coupled receptors has been extensively studied. The mechanisms by which agonists stimulate mobilization and plasma membrane translocation of G protein-coupled receptors from intracellular stores are unexplored. Protease-activated receptor-2 (PAR(2)) traffics to lysosomes, and sustained protease signaling requires mobilization and plasma membrane trafficking of PAR(2) from Golgi stores. We evaluated the contribution of protein kinase D (PKD) and G to this process. In HEK293 and KNRK cells, the PAR(2) agonists trypsin and 2-furoyl-LIGRLO-NH2 activated PKD in the Golgi apparatus, where PKD regulates protein trafficking. PAR(2) activation induced translocation of G, a PKD activator, to the Golgi apparatus, determined by bioluminescence resonance energy transfer between G-Venus and giantin-Rluc8. Inhibitors of PKD (CRT0066101) and G (gallein) prevented PAR(2)-stimulated activation of PKD. CRT0066101, PKD1 siRNA, and gallein all inhibited recovery of PAR(2)-evoked Ca2+ signaling. PAR(2) with a photoconvertible Kaede tag was expressed in KNRK cells to examine receptor translocation from the Golgi apparatus to the plasma membrane. Irradiation of the Golgi region (405 nm) induced green-red photo-conversion of PAR(2)-Kaede. Trypsin depleted PAR(2)-Kaede from the Golgi apparatus and repleted PAR(2)-Kaede at the plasma membrane. CRT0066101 inhibited PAR(2)-Kaede translocation to the plasma membrane. CRT0066101 also inhibited sustained protease signaling to colonocytes and nociceptive neurons that naturally express PAR(2) and mediate protease-evoked inflammation and nociception. Our results reveal a major role for PKD and G in agonist-evoked mobilization of intracellular PAR(2) stores that is required for sustained signaling by extracellular proteases.	[Jensen, Dane D.; Zhao, Peishen; Lieu, TinaMarie; Gerges, Marina; Yeatman, Holly R.; Canals, Meritxell; Poole, Daniel P.; Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia; [Jensen, Dane D.; Zhao, Peishen; Lieu, TinaMarie; Canals, Meritxell; Poole, Daniel P.; Bunnett, Nigel W.] Monash Univ, Australian Res Council, Ctr Excellence Convergent Bionano Sci & Technol, Parkville, Vic 3052, Australia; [Poole, Daniel P.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia; [Jimenez-Vargas, Nestor N.; Vanner, Stephen J.] Queens Univ, Div Gastroenterol, Gastrointestinal Dis Res Unit, Kingston, ON K7L 3N6, Canada	Monash University; University of Melbourne; University of Melbourne; Queens University - Canada	Poole, DP; Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	daniel.poole@monash.edu; nigel.bunnett@monash.edu	Zhao, Peishen/AFQ-6840-2022; Lieu, TinaMarie/AAM-7691-2020; Poole, Daniel/AET-6645-2022	Poole, Daniel/0000-0002-6168-8422; Bunnett, Nigel W./0000-0003-3367-0644; Jimenez-Vargas, Nestor N/0000-0001-6595-1884; Canals, Meritxell/0000-0002-7942-5006; Jensen, Dane D./0000-0001-6540-2375	National Health and Medical Research Council; Australian Research Council; Monash University; Takeda Pharmaceuticals, Inc.	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Monash University(Monash University); Takeda Pharmaceuticals, Inc.(Takeda Pharmaceutical Company Ltd)	This work was supported by the National Health and Medical Research Council, The Australian Research Council, and Monash University. Research in the authors' laboratory was funded in part by Takeda Pharmaceuticals, Inc.	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Amadesi S, 2009, J COMP NEUROL, V516, P141, DOI 10.1002/cne.22104; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Cottrell GS, 2007, GASTROENTEROLOGY, V132, P2422, DOI 10.1053/j.gastro.2007.03.101; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Gupta A, 2015, BRIT J PHARMACOL, V172, P704, DOI 10.1111/bph.12833; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jensen DD, 2014, J BIOL CHEM, V289, P20283, DOI 10.1074/jbc.M114.578179; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059821; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Oh P, 2012, J BIOL CHEM, V287, P17353, DOI 10.1074/jbc.M111.338897; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Poole DP, 2011, GASTROENTEROLOGY, V141, P982, DOI 10.1053/j.gastro.2011.05.042; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Coria AS, 2014, BIOL CELL, V106, P30, DOI 10.1111/boc.201300052; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; Wang HY, 2010, FASEB J, V24, P1971, DOI 10.1096/fj.09-137646; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712; Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067	55	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11285	11299		10.1074/jbc.M115.710681	http://dx.doi.org/10.1074/jbc.M115.710681			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27030010	Green Published, hybrid			2022-12-26	WOS:000377042100028
J	Saito, S; Ohkita, M; Saito, CT; Takahashi, K; Tominaga, M; Ohta, T				Saito, Shigeru; Ohkita, Masashi; Saito, Claire T.; Takahashi, Kenji; Tominaga, Makoto; Ohta, Toshio			Evolution of Heat Sensors Drove Shifts in Thermosensation between Xenopus Species Adapted to Different Thermal Niches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; molecular evolution; receptor structure-function; transient receptor potential channels (TRP channels); Xenopus; functional evolution; molecular basis; thermal sensor	CAPSAICIN RECEPTOR; MOLECULAR-BASIS; TRPV1; TROPICALIS; CHANNEL; TRPA1; GENOME; SENSITIVITIES; DETERMINANTS; MECHANISMS	Temperature is one of the most critical environmental factors affecting survival, and thus species that inhabit different thermal niches have evolved thermal sensitivities suitable for their respective habitats. During the process of shifting thermal niches, various types of genes expressed in diverse tissues, including those of the peripheral to central nervous systems, are potentially involved in the evolutionary changes in thermosensation. To elucidate the molecular mechanisms behind the evolution of thermosensation, thermal responses were compared between two species of clawed frogs (Xenopus laevis and Xenopus tropicalis) adapted to different thermal environments. X. laevis was much more sensitive to heat stimulation than X. tropicalis at the behavioral and neural levels. The activity and sensitivity of the heat-sensing TRPA1 channel were higher in X. laevis compared with those of X. tropicalis. The thermal responses of another heat-sensing channel, TRPV1, also differed between the two Xenopus species. The species differences in Xenopus TRPV1 heat responses were largely determined by three amino acid substitutions located in the first three ankyrin repeat domains, known to be involved in the regulation of rat TRPV1 activity. In addition, Xenopus TRPV1 exhibited drastic species differences in sensitivity to capsaicin, contained in chili peppers, between the two Xenopus species. Another single amino acid substitution within Xenopus TRPV1 is responsible for this species difference, which likely alters the neural and behavioral responses to capsaicin. These combined subtle amino acid substitutions in peripheral thermal sensors potentially serve as a driving force for the evolution of thermal and chemical sensation.	[Saito, Shigeru; Saito, Claire T.; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Saito, Shigeru; Tominaga, Makoto] SOKENDAI, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan; [Ohkita, Masashi; Takahashi, Kenji; Ohta, Toshio] Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Tottori University	Saito, S (corresponding author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan.; Ohta, T (corresponding author), Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan.	sshigeru@nips.ac.jp; tohta@muses.tottori-u.ac.jp	Saito, Shigeru/B-4698-2015	Saito, Shigeru/0000-0002-6237-8979	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H05927, 16K07470, 26292150]; Grants-in-Aid for Scientific Research [16K07470] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 15H05927 (to M. T.), 16K07470 (to S. S.), and 26292150 (to T. O.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3501; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gau P, 2013, J NEUROSCI, V33, P5249, DOI 10.1523/JNEUROSCI.5403-12.2013; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Joseph J, 2013, J BIOL CHEM, V288, P35690, DOI 10.1074/jbc.M113.513374; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Ohkita M, 2012, J BIOL CHEM, V287, P2388, DOI 10.1074/jbc.M111.305698; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Saito S, 2015, CELL CALCIUM, V57, P214, DOI 10.1016/j.ceca.2014.12.001; Saito S, 2014, MOL BIOL EVOL, V31, P708, DOI 10.1093/molbev/msu001; Saito S, 2012, J BIOL CHEM, V287, P30743, DOI 10.1074/jbc.M112.362194; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tinsley RC, 1996, BIOL XENOPUS; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yokoyama S, 2013, MOL BIOL EVOL, V30, P1495, DOI 10.1093/molbev/mst075	40	23	23	1	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11446	11459		10.1074/jbc.M115.702498	http://dx.doi.org/10.1074/jbc.M115.702498			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022021	Green Published, hybrid			2022-12-26	WOS:000377042100041
J	Hossain, ST; Deutscher, MP				Hossain, Sk Tofajjen; Deutscher, Murray P.			Helicase Activity Plays a Crucial Role for RNase R Function in Vivo and for RNA Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; STRUCTURED RNA; NUCLEASE DOMAIN; RIBOSOMAL-RNA; DEGRADOSOME; DEGRADATION; PROTEIN; DECAY; CSDA	RNase R is a 3' to 5' hydrolytic exoribonuclease that has the unusual ability to digest highly structured RNA. The enzyme possesses an intrinsic, ATP-dependent RNA helicase activity that is essential in vitro for efficient nuclease activity against double-stranded RNA substrates, particularly at lower temperatures, with more stable RNA duplexes, and for duplexes with short 3' overhangs. Here, we inquired whether the helicase activity was also important for RNase R function in vivo and for RNA metabolism. We find that strains containing a helicase-deficient RNase R due to mutations in its ATP-binding Walker motifs exhibit growth defects at low temperatures. Most importantly, cells also lacking polynucleotide phosphorylase ( PNPase), and dependent for growth on RNase R, grow extremely poorly at 34, 37, and 42 degrees C and do not grow at all at 31 degrees C. Northern analysis revealed that in these cells, fragments of 16S and 23S rRNA accumulate to high levels, leading to interference with ribosome maturation and ultimately to cell death. These findings indicate that the intrinsic helicase activity of RNase R is required for its proper functioning in vivo and for effective RNA metabolism.	[Hossain, Sk Tofajjen; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu		Hossain, Sk Tofajjen/0000-0002-1448-1015	National Institutes of Health [GM 16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant GM 16317 (to M. P. D.) from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Awano N, 2007, J BACTERIOL, V189, P5808, DOI 10.1128/JB.00655-07; Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Hossain ST, 2016, J BIOL CHEM, V291, P7877, DOI 10.1074/jbc.M116.717991; Hossain ST, 2015, J BIOL CHEM, V290, P15697, DOI 10.1074/jbc.M115.650176; HUANG S, 1992, J BIOL CHEM, V267, P25609; Jagessar KL, 2010, RNA, V16, P1386, DOI 10.1261/rna.2015610; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Purusharth RI, 2007, J BIOL CHEM, V282, P16267, DOI 10.1074/jbc.M605588200; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; Yamanaka K, 2001, J BACTERIOL, V183, P2808, DOI 10.1128/JB.183.9.2808-2816.2001; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	23	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9438	9443		10.1074/jbc.C116.726091	http://dx.doi.org/10.1074/jbc.C116.726091			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	27022019	Green Published, hybrid			2022-12-26	WOS:000375602300005
J	Lu, Q; Schnitzler, GR; Ueda, K; Iyer, LK; Diomede, OI; Andrade, T; Karas, RH				Lu, Qing; Schnitzler, Gavin R.; Ueda, Kazutaka; Iyer, Lakshmanan K.; Diomede, Olga I.; Andrade, Tiffany; Karas, Richard H.			ER Alpha Rapid Signaling Is Required for Estrogen Induced Proliferation and Migration of Vascular Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; RECEPTOR-ALPHA; GENE-EXPRESSION; POSTMENOPAUSAL WOMEN; IN-VITRO; MICE; BETA; INFLAMMATION; NUCLEAR	Estrogen promotes the proliferation and migration of vascular endothelial cells (ECs), which likely underlies its ability to accelerate re-endothelialization and reduce adverse remodeling after vascular injury. In previous studies, we have shown that the protective effects of E2 (the active endogenous form of estrogen) in vascular injury require the estrogen receptor alpha (ER alpha). ER alpha transduces the effects of estrogen via a classical DNA binding, "genomic" signaling pathway and via a more recently-described "rapid" signaling pathway that is mediated by a subset of ER alpha localized to the cell membrane. However, which of these pathways mediates the effects of estrogen on endothelial cells is poorly understood. Here we identify a triple point mutant version of ER alpha (KRR ER alpha) that is specifically defective in rapid signaling, but is competent to regulate transcription through the "genomic" pathway. We find that in ECs expressing wild type ER alpha, E2 regulates many genes involved in cell migration and proliferation, promotes EC migration and proliferation, and also blocks the adhesion of monocytes to ECs. ECs expressing KRR mutant ER alpha, however, lack all of these responses. These observations establish KRR ER alpha as a novel tool that could greatly facilitate future studies into the vascular and non-vascular functions of ER alpha rapid signaling. Further, they support that rapid signaling through ER alpha is essential for many of the transcriptional and physiological responses of ECs to E2, and that ER alpha rapid signaling in ECs, in vivo, may be critical for the vasculoprotective and anti-inflammatory effects of estrogen.	[Lu, Qing; Schnitzler, Gavin R.; Ueda, Kazutaka; Iyer, Lakshmanan K.; Diomede, Olga I.; Andrade, Tiffany; Karas, Richard H.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA	Tufts Medical Center	Schnitzler, GR; Karas, RH (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA.	gschnitzler@tuftsmedicalcenter.org; rkaras@tuftsmedicalcenter.org		ueda, kazutaka/0000-0002-0509-1840	NIH [R01-HL061298]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061298] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16K20174] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by an NIH grant to RHK, number R01-HL061298. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlanmerini M, 2014, P NATL ACAD SCI USA, V111, pE283, DOI 10.1073/pnas.1322057111; Alam M, 2013, J BIOL CHEM, V288, P30892, DOI 10.1074/jbc.M113.477158; Bhalla RC, 1997, AM J PHYSIOL-HEART C, V272, pH1996, DOI 10.1152/ajpheart.1997.272.4.H1996; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bobik A, 2012, CIRCULATION, V126, P1941, DOI 10.1161/CIRCULATIONAHA.112.138958; Brouchet L, 2001, CIRCULATION, V103, P423; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; COLLINS P, 1995, CIRCULATION, V92, P24, DOI 10.1161/01.CIR.92.1.24; Di Giorgio E, 2013, MOL CELL BIOL, V33, P4473, DOI 10.1128/MCB.01050-13; Duan RQ, 2002, BIOCHEM BIOPH RES CO, V294, P384, DOI 10.1016/S0006-291X(02)00499-0; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gao H, 2006, INFLAMM RES, V55, P349, DOI 10.1007/s00011-006-5194-z; Gordon FK, 2014, MOL ENDOCRINOL, V28, P1337, DOI 10.1210/me.2013-1395; Hodgin JB, 2001, J CLIN INVEST, V107, P333, DOI 10.1172/JCI11320; Jiang HM, 2004, J BIOL CHEM, V279, P55905, DOI 10.1074/jbc.M406094200; Karas RH, 1999, P NATL ACAD SCI USA, V96, P15133, DOI 10.1073/pnas.96.26.15133; Karas RH, 1998, J CLIN INVEST, V101, P2851, DOI 10.1172/JCI1416; Kulkarni J, 2013, INT J ENDOCRINOL MET, V11, P129, DOI 10.5812/ijem.6615; Lengyel F, 2007, STEROIDS, V72, P422, DOI 10.1016/j.steroids.2007.03.001; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Lu Q, 2003, J BIOL CHEM, V278, P4639, DOI 10.1074/jbc.M210949200; MacRitchie AN, 1997, CIRC RES, V81, P355, DOI 10.1161/01.RES.81.3.355; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Matter CM, 2006, STROKE, V37, P2625, DOI 10.1161/01.STR.0000241068.50156.82; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mendelsohn ME, 2007, NEW ENGL J MED, V356, P2639, DOI 10.1056/NEJMe078072; Meyer MR, 2009, MOL CELL ENDOCRINOL, V308, P9, DOI 10.1016/j.mce.2009.03.009; Miller AP, 2004, CIRCULATION, V110, P1664, DOI 10.1161/01.CIR.0000142050.19488.C7; Moens SJB, 2012, CIRCULATION, V126, P1993, DOI 10.1161/CIRCULATIONAHA.112.124529; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; Nishishita T, 2004, J CELL BIOCHEM, V91, P584, DOI 10.1002/jcb.10718; Nuedling S, 1999, CARDIOVASC RES, V43, P666, DOI 10.1016/S0008-6363(99)00093-0; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; Pedram A, 2014, DEV CELL, V29, P482, DOI 10.1016/j.devcel.2014.04.016; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Rauch C, 2005, AM J PHYSIOL-CELL PH, V288, pC593, DOI 10.1152/ajpcell.00346.2004; REIS SE, 1994, CIRCULATION, V89, P52, DOI 10.1161/01.CIR.89.1.52; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Saxena A, 2013, MOL IMAGING BIOL, V15, P282, DOI 10.1007/s11307-012-0599-2; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Shifren JL, 2010, OBSTET GYNECOL, V115, P839, DOI 10.1097/AOG.0b013e3181d41191; Simon DI, 2000, J CLIN INVEST, V105, P293, DOI 10.1172/JCI7811; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Studd John, 2010, Menopause Int, V16, P44, DOI 10.1258/mi.2010.010001; Ueda K, 2013, ARTERIOSCL THROM VAS, V33, P1837, DOI 10.1161/ATVBAHA.112.300752; Utian WH, 2010, MENOPAUSE, V17, P242, DOI 10.1097/gme.0b013e3181d0f6b9; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Xing DQ, 2004, CIRCULATION, V109, P234, DOI 10.1161/01.CIR.0000105700.95607.49; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zhang LL, 2011, CARDIOVASC RES, V92, P484, DOI 10.1093/cvr/cvr238; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	62	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152807	10.1371/journal.pone.0152807	http://dx.doi.org/10.1371/journal.pone.0152807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035664	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200043
J	Reins, RY; Hanlon, SD; Magadi, S; McDermott, AM				Reins, Rose Y.; Hanlon, Samuel D.; Magadi, Sri; McDermott, Alison M.			Effects of Topically Applied Vitamin D during Corneal Wound Healing	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN CATHELICIDIN LL-37; DELTA-T-CELLS; PSEUDOMONAS-AERUGINOSA; EPITHELIAL-CELLS; OCULAR SURFACE; IN-VITRO; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; MULTIFUNCTIONAL PEPTIDE; HOST-DEFENSE	Vitamin D is an important regulator of immune function and largely acts to dampen chronic inflammatory events in a variety of tissues. There is also accumulating evidence that vitamin D acts to enhance initial inflammation, beneficial during both infection and wound healing, and then promotes resolution and prevention of chronic, damaging inflammation. The current study examines the effect of topical vitamin D in a mouse of model of corneal epithelial wound healing, where acute inflammation is necessary for efficient wound closure. At 12 and 18 hours post-wounding, vitamin D treatment significantly delayed wound closure by similar to 17% and increased infiltration of neutrophils into the central cornea. Basal epithelial cell division, corneal nerve density, and levels of VEGF, TGF beta, IL-1 beta, and TNF alpha were unchanged. However, vitamin D increased the production of the anti-microbial peptide CRAMP 12 hours after wounding. These data suggest a possible role for vitamin D in modulating corneal wound healing and have important implications for therapeutic use of vitamin D at the ocular surface.	[Reins, Rose Y.; Hanlon, Samuel D.; Magadi, Sri; McDermott, Alison M.] Univ Houston, Coll Optometry, Houston, TX USA	University of Houston System; University of Houston	McDermott, AM (corresponding author), Univ Houston, Coll Optometry, Houston, TX USA.	amcdermott@central.uh.edu			National Institutes of Health [EY13175, EY07551, T3207024]; NATIONAL EYE INSTITUTE [R01EY013175, P30EY007551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors received funding from the following grants to support this work: National Institutes of Health EY13175 (AMM), National Institutes of Health Grant EY07551 (UHCO Core Grant), and National Institutes of Health Grant T3207024 (RYR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Biggs David S C, 2010, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1219s52; Byeseda SE, 2009, AM J PATHOL, V175, P571, DOI 10.2353/ajpath.2009.090112; Cantorna MT, 2015, NUTRIENTS, V7, P3011, DOI 10.3390/nu7043011; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Carlson EC, 2010, J LEUKOCYTE BIOL, V88, P517, DOI 10.1189/jlb.0310134; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Chen LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016132; Dekaris I, 1999, J IMMUNOL, V162, P4235; DeLuca H F, 1986, Adv Exp Med Biol, V196, P361; Elizondo RA, 2014, INVEST OPHTH VIS SCI, V55, P5245, DOI 10.1167/iovs.13-13553; Gao N, 2011, AM J PATHOL, V179, P2243, DOI 10.1016/j.ajpath.2011.07.050; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; He JC, 2010, EXP EYE RES, V91, P513, DOI 10.1016/j.exer.2010.07.007; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Hong JW, 2001, INVEST OPHTH VIS SCI, V42, P2795; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Huang LC, 2007, CURR EYE RES, V32, P595, DOI 10.1080/02713680701446653; Huang LC, 2006, INVEST OPHTH VIS SCI, V47, P2369, DOI 10.1167/iovs.05-1649; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jung MK, 2015, LIFE SCI, V128, P39, DOI 10.1016/j.lfs.2015.02.018; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Kubilus JK, 2010, INVEST OPHTH VIS SCI, V51, P782, DOI 10.1167/iovs.09-3942; Lam FW, 2011, AM J PHYSIOL-HEART C, V300, pH468, DOI 10.1152/ajpheart.00491.2010; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2006, AM J PATHOL, V169, P1590, DOI 10.2353/ajpath.2006.060415; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu Q, 2012, AM J PATHOL, V181, P452, DOI 10.1016/j.ajpath.2012.04.010; MARFURT CF, 1993, J COMP NEUROL, V336, P517, DOI 10.1002/cne.903360405; McDermott Alison M, 2004, Ocul Surf, V2, P229; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Murphy CJ, 2001, INVEST OPHTH VIS SCI, V42, P2252; Reins RY, 2015, EXP EYE RES, V134, P101, DOI 10.1016/j.exer.2015.02.019; Ren ZG, 2012, DIABETES RES CLIN PR, V98, P474, DOI 10.1016/j.diabres.2012.09.028; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Sel S, 2016, GRAEF ARCH CLIN EXP, V254, P717, DOI 10.1007/s00417-016-3267-4; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Steinstraesser L, 2008, MOL MED, V14, P528, DOI 10.2119/2008-00002.Steinstraesser; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Suzuki T, 2000, CURR EYE RES, V20, P127, DOI 10.1076/0271-3683(200002)20:2;1-D;FT127; Terai K, 2011, INVEST OPHTH VIS SCI, V52, P8208, DOI 10.1167/iovs.11-8017; TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weeres MA, 2014, J IMMUNOL, V193, P3456, DOI 10.4049/jimmunol.1400698; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Xue ML, 2002, IMMUNOL CELL BIOL, V80, P340, DOI 10.1046/j.1440-1711.80.4august.1.x; Xue ML, 2002, IMMUNOL CELL BIOL, V80, P323, DOI 10.1046/j.1440-1711.2002.01094.x; Yildirim B, 2014, POSTGRAD MED, V126, P104, DOI 10.3810/pgm.2014.01.2730; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024	63	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152889	10.1371/journal.pone.0152889	http://dx.doi.org/10.1371/journal.pone.0152889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035345	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000373201200048
J	Ene, RD; Marinca, V; Marinca, B				Ene, Remus-Daniel; Marinca, Vasile; Marinca, Bogdan			Analytic Approximate Solutions to the Boundary Layer Flow Equation over a Stretching Wall with Partial Slip at the Boundary	PLOS ONE			English	Article							STAGNATION-POINT FLOW; HOMOTOPY PERTURBATION METHOD; NAVIER-STOKES EQUATIONS; HEAT-TRANSFER; ELECTRICAL MACHINE; VISCOELASTIC FLUID; POROUS CHANNEL; ROTATING-DISK; MASS-TRANSFER; SHEET	Analytic approximate solutions using Optimal Homotopy Perturbation Method (OHPM) are given for steady boundary layer flow over a nonlinearly stretching wall in presence of partial slip at the boundary. The governing equations are reduced to nonlinear ordinary differential equation by means of similarity transformations. Some examples are considered and the effects of different parameters are shown. OHPM is a very efficient procedure, ensuring a very rapid convergence of the solutions after only two iterations.	[Ene, Remus-Daniel] Univ Politehn Timisoara, Dept Math, Timisoara, Romania; [Marinca, Vasile] Univ Politehn Timisoara, Dept Mech & Vibrat, Timisoara, Romania; [Marinca, Vasile] Romania Acad, Ctr Adv & Fundamental Tech Res, Dept Electromech & Vibrat, Timisoara 300223, Romania; [Marinca, Bogdan] Univ Politehn Timisoara, Dept Appl Elect, Timisoara, Romania	Polytechnic University of Timisoara; Polytechnic University of Timisoara; Romanian Academy of Sciences; Polytechnic University of Timisoara	Ene, RD (corresponding author), Univ Politehn Timisoara, Dept Math, Timisoara, Romania.	remus.ene@upt.ro	Marinca, Bogdan Valentin/ABG-9480-2020; MARINCA, VASILE/AAA-1750-2021	Marinca, Bogdan Valentin/0000-0003-2340-1280; MARINCA, VASILE/0000-0002-0947-1322				Adomian G, 1998, J MATH ANAL APPL, V135, P507; Ariel PD, 2008, ZAMM-Z ANGEW MATH ME, V88, P320, DOI 10.1002/zamm.200700041; Boutros YZ, 2006, MECCANICA, V41, P681, DOI 10.1007/s11012-006-9014-x; Butt AS, 2015, J TAIWAN INST CHEM E, V48, P8, DOI 10.1016/j.jtice.2014.10.021; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Ene RD, 2014, MATER PLAST, V51, P194; Fang TG, 2011, INT J NONLIN MECH, V46, P1116, DOI 10.1016/j.ijnonlinmec.2011.04.014; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hassan H, 2014, INT J NUMER METHOD H, V24, P419, DOI 10.1108/HFF-08-2011-0158; He JH, 1999, INT J NONLINEAR MECH, V34, P699, DOI 10.1016/S0020-7462(98)00048-1; He JH, 2000, INT J NONLINEAR MECH, V35, P37, DOI 10.1016/S0020-7462(98)00085-7; Herisanu N, 2012, Z NATURFORSCH A, V67, P509, DOI 10.5560/ZNA.2012-0047; Ishak A, 2008, MECCANICA, V43, P411, DOI 10.1007/s11012-007-9103-5; Mahapatra TR, 2007, MECCANICA, V42, P263, DOI 10.1007/s11012-006-9040-8; Marinca V, 2011, COMPUT MATH APPL, V61, P2019, DOI 10.1016/j.camwa.2010.08.056; Marinca V., 2011, NONLINEAR DYNAMICAL; Marinca V, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/139314; Mehmood A, 2010, J TAIWAN INST CHEM E, V41, P29, DOI 10.1016/j.jtice.2009.03.011; Mehmood A, 2006, INT COMMUN HEAT MASS, V33, P1243, DOI 10.1016/j.icheatmasstransfer.2006.08.001; Misra JC, 2008, COMPUT FLUIDS, V37, P1, DOI 10.1016/j.compfluid.2006.09.005; Mukhopadhyay S, 2013, ALEX ENG J, V52, P563, DOI 10.1016/j.aej.2013.07.004; Munawar S, 2012, COMPUT MATH APPL, V64, P1575, DOI 10.1016/j.camwa.2012.01.003; Pal D, 2009, MECCANICA, V44, P145, DOI 10.1007/s11012-008-9155-1; Parsa AB, 2013, COMPUT BIOL MED, V43, P1142, DOI 10.1016/j.compbiomed.2013.05.019; Rashidi MM, 2012, ENG COMPUTATION, V29, P562, DOI 10.1108/02644401211246283; Rashidi MM, 2009, MOD PHYS LETT B, V23, P3147, DOI 10.1142/S0217984909021193; SAKIADIS BC, 1961, AICHE J, V7, P221, DOI 10.1002/aic.690070211; Turkyilmazoglu M, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/05/055004; Turkyilmazoglu M, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/01/015301; Turkyilmazoglu M, 2011, MATH COMPUT MODEL, V53, P1929, DOI 10.1016/j.mcm.2011.01.022; Turkyilmazoglu M, 2010, INT J MECH SCI, V52, P1735, DOI 10.1016/j.ijmecsci.2010.09.007; Van Gorder RA, 2010, ARCH APPL MECH, V80, P1329, DOI 10.1007/s00419-009-0370-6; Yao SS, 2011, COMMUN NONLINEAR SCI, V16, P752, DOI 10.1016/j.cnsns.2010.05.028	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0149334	10.1371/journal.pone.0149334	http://dx.doi.org/10.1371/journal.pone.0149334			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031232	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800004
J	Kato, Y; Ogasawara, S; Oki, H; Goichberg, P; Honma, R; Fujii, Y; Kaneko, MK				Kato, Yukinari; Ogasawara, Satoshi; Oki, Hiroharu; Goichberg, Polina; Honma, Ryusuke; Fujii, Yuki; Kaneko, Mika K.			LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; MEMBRANE-PROTEIN; RECEPTOR CLEC-2; MARKER; EXPRESSION; AGGRUS; AGGRUS/PODOPLANIN; RECOGNIZES; BINDING; TUMORS	Podoplanin (PDPN), also known as Aggrus, possesses three tandem repeat of platelet aggregation-stimulating (PLAG) domains in its N-terminus. Among the PLAG domains, sialylated O-glycan on Thr52 of PLAG3 is essential for the binding to C-type lectin-like receptor-2 (CLEC-2) and the platelet-aggregating activity of human PDPN (hPDPN). Although various anti-hPDPN monoclonal antibodies (mAbs) have been generated, no specific mAb has been reported to target the epitope containing glycosylated Thr52. We recently established CasMab technology to develop mAbs against glycosylated membrane proteins. Herein, we report the development of a novel anti-glycopeptide mAb (GpMab), LpMab-12. LpMab-12 detected endogenous hPDPN by flow cytometry. Immunohistochemical analyses also showed that hPDPN-expressing lymphatic endothelial and cancer cells were clearly labeled by LpMab-12. The minimal epitope of LpMab-12 was identified as Asp49-Pro53 of hPDPN. Furthermore, LpMab-12 reacted with the synthetic glycopeptide of hPDPN, corresponding to 38-54 amino acids (hpp3854: (38)-EGGVAMPGAEDDVVTPG-(54)), which carries alpha 2-6 sialylated N-acetyl-D-galactosamine (GalNAc) on Thr52. LpMab-12 did not recognize non-sialylated GalNAc-attached glycopeptide, indicating that sialylated GalNAc on Thr52 is necessary for the binding of LpMab-12 to hPDPN. Thus, LpMab-12 could serve as a new diagnostic tool for determining whether hPDPN possesses the sialylation on Thr52, a site-specific post-translational modification critical for the hPDPN association with CLEC-2.	[Kato, Yukinari; Ogasawara, Satoshi; Oki, Hiroharu; Honma, Ryusuke; Fujii, Yuki; Kaneko, Mika K.] Tohoku Univ, Grad Sch Med, Dept Reg Innovat, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Goichberg, Polina] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesia, 75 Francis St, Boston, MA 02115 USA	Tohoku University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kato, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Reg Innovat, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yukinari-k@bea.hi-ho.ne.jp		Kato, Yukinari/0000-0001-5385-8201; K. Kaneko, Mika/0000-0002-4158-9208	Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from Japan Agency for Medical Research and development, AMED; Basic Science and Platform Technology Program for Innovative Biological Medicine from AMED; Japan Society for the Promotion of Science (JSPS) KAKENHI [25462242, 26440019]; Takeda Science Foundation; American Heart Association	Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Basic Science and Platform Technology Program for Innovative Biological Medicine from AMED; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); American Heart Association(American Heart Association)	This work was supported in part by the Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Y.K.); by the Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from Japan Agency for Medical Research and development, AMED (Y.K.); by the Basic Science and Platform Technology Program for Innovative Biological Medicine from AMED (Y.K.); by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number Grant Number 25462242 (Y.K.) and 26440019 (M.K.K.); by Takeda Science Foundation (S.O.); and by the Grant-in-Aid from the American Heart Association (P.G.).	Abe S, 2013, J IMMUNOL, V190, P6239, DOI 10.4049/jimmunol.1300448; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Honma R, 2016, CRITICAL EPITOPE ANT; Honma Ryusuke, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V35, P41, DOI 10.1089/mab.2015.0066; Kaji C, 2012, ACTA HISTOCHEM CYTOC, V45, P227, DOI 10.1267/ahc.12008; Kaneko M, 2004, J BIOL CHEM, V279, P38838, DOI 10.1074/jbc.M407210200; Kaneko Mika K., 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P310, DOI 10.1089/mab.2015.0022; Kaneko Mika K., 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P154, DOI 10.1089/mab.2014.0091; Kaneko MK, 2007, FEBS LETT, V581, P331, DOI 10.1016/j.febslet.2006.12.044; Kaneko MK, 2006, GENE, V378, P52, DOI 10.1016/j.gene.2006.04.023; Kato Y, 2005, TUMOR BIOL, V26, P195, DOI 10.1159/000086952; Kato Y, 2004, ONCOGENE, V23, P8552, DOI 10.1038/sj.onc.1207869; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2016, MONOCLON ANTIB IMMUN; Kato Y, 2014, BRAIN TUMOR PATHOL, V31, P23, DOI [10.1007/s10014-014-0202-4, 10.1007/s10014-012-0127-8]; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kato Y, 2006, BIOCHEM BIOPH RES CO, V349, P1301, DOI 10.1016/j.bbrc.2006.08.171; Kato Y, 2015, ONCOTARGET, V6, P36003, DOI 10.18632/oncotarget.5339; Kato Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05924; Kato Y, 2010, NUCL MED BIOL, V37, P785, DOI 10.1016/j.nucmedbio.2010.03.010; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Kunita A, 2011, AM J PATHOL, V179, P1041, DOI 10.1016/j.ajpath.2011.04.027; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Matsui K, 1998, J AM SOC NEPHROL, V9, P2013; Mishima K, 2006, ACTA NEUROPATHOL, V111, P483, DOI 10.1007/s00401-006-0063-y; Mishima K, 2006, ACTA NEUROPATHOL, V111, P563, DOI 10.1007/s00401-006-0033-4; Nagae M, 2014, STRUCTURE, V22, P1711, DOI 10.1016/j.str.2014.09.009; Ogasawara S, 2016, ESTABLISHMENT MOUSE; Ogasawara S, 2008, HYBRIDOMA, V27, P259, DOI 10.1089/hyb.2008.0017; Ogasawara Satoshi, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P318, DOI 10.1089/mab.2015.0018; Oki Hiroharu, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P396, DOI 10.1089/mab.2015.0041; Oki Hiroharu, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P174, DOI 10.1089/mab.2014.0090; Oki Hiroharu, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P44, DOI 10.1089/mab.2014.0087; RISHI AK, 1995, DEV BIOL, V167, P294, DOI 10.1006/dbio.1995.1024; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Sekiguchi T., 2015, ONCOTARGET; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200	39	11	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152912	10.1371/journal.pone.0152912	http://dx.doi.org/10.1371/journal.pone.0152912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031228	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800154
J	Martin, CM; Parthsarathy, V; Hasib, A; Ng, MT; McClean, S; Flatt, PR; Gault, VA; Irwin, N				Martin, Christine M.; Parthsarathy, Vadivel; Hasib, Annie; Ng, Ming T.; McClean, Stephen; Flatt, Peter R.; Gault, Victor A.; Irwin, Nigel			Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin	PLOS ONE			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; DIABETES-MELLITUS; GLUCOSE; SECRETION; MICE; DEGRADATION; GIP; RESISTANCE; HUMANS	Xenin is a peptide that is co-secreted with the incretin hormone, glucose-dependent insulinotropic polypeptide (GIP), from intestinal K-cells in response to feeding. Studies demonstrate that xenin has appetite suppressive effects and modulates glucose-induced insulin secretion. The present study was undertaken to determine the bioactivity and antidiabetic properties of two C-terminal fragment xenin peptides, namely xenin 18-25 and xenin 18-25 Gln. In BRIN-BD11 cells, both xenin fragment peptides concentration-dependently stimulated insulin secretion, with similar efficacy as the parent peptide. Neither fragment peptide had any effect on acute feeding behaviour at elevated doses of 500 nmol/kg bw. When administered together with glucose to normal mice at 25 nmol/kg bw, the overall insulin secretory effect was significantly enhanced in both xenin 18-25 and xenin 18-25 Gln treated mice, with better moderation of blood glucose levels. Twice daily administration of xenin 18-25 or xenin 18-25 Gln for 21 days in high fat fed mice did not affect energy intake, body weight, circulating blood glucose or body fat stores. However, circulating plasma insulin concentrations had a tendency to be elevated, particularly in xenin 18-25 Gln mice. Both treatment regimens significantly improved insulin sensitivity by the end of the treatment period. In addition, sustained treatment with xenin 18-25 Gln significantly reduced the overall glycaemic excursion and augmented the insulinotropic response to an exogenous glucose challenge on day 21. In harmony with this, GIP-mediated glucose-lowering and insulin-releasing effects were substantially improved by twice daily xenin 18-25 Gln treatment. Overall, these data provide evidence that C-terminal octapeptide fragments of xenin, such as xenin 18-25 Gln, have potential therapeutic utility for type 2 diabetes.	[Martin, Christine M.; Parthsarathy, Vadivel; Hasib, Annie; Ng, Ming T.; McClean, Stephen; Flatt, Peter R.; Gault, Victor A.; Irwin, Nigel] Univ Ulster, Biomed Sci Res Inst, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	Irwin, N (corresponding author), Univ Ulster, Biomed Sci Res Inst, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland.	n.irwin@ulster.ac.uk	Irwin, Nigel/H-9696-2019	Irwin, Nigel/0000-0003-4855-964X; Flatt, Peter/0000-0001-8548-7943; HASIB, ANNIE/0000-0002-5388-6461; /0000-0002-1610-9663; Parthsarathy, Vadivel/0000-0002-2037-7804; McClean, Stephen/0000-0001-9718-6689	Department of Education and Learning, Northern Ireland; European Foundation; European Regional Development Fund/Invest Northern Ireland (ERDF/INI)	Department of Education and Learning, Northern Ireland; European Foundation(European Science Foundation (ESF)); European Regional Development Fund/Invest Northern Ireland (ERDF/INI)	Studies were supported by the Department of Education and Learning, Northern Ireland, the European Foundation for the Study of Diabetes and a research grant from the European Regional Development Fund/Invest Northern Ireland (ERDF/INI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chowdhury S, 2014, AM J PHYSIOL-GASTR L, V306, pG301, DOI 10.1152/ajpgi.00383.2013; Cline MA, 2007, BEHAV BRAIN RES, V179, P28, DOI 10.1016/j.bbr.2007.01.008; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Feurle GE, 1998, PEPTIDES, V19, P609, DOI 10.1016/S0196-9781(97)00378-1; FLATT PR, 1981, HORM METAB RES, V13, P556, DOI 10.1055/s-2007-1019334; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gault VA, 2015, ACTA DIABETOL, V52, P461, DOI 10.1007/s00592-014-0681-0; Hamscher G, 1996, PEPTIDES, V17, P889; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Holst JJ, 2011, DIABETES CARE, V34, pS251, DOI 10.2337/dc11-s227; Kim ER, 2010, NEUROSCI LETT, V481, P59, DOI 10.1016/j.neulet.2010.06.055; Kim ER, 2014, BEHAV BRAIN RES, V261, P60, DOI 10.1016/j.bbr.2013.12.005; Leckstrom A, 2009, DIABETES, V58, P87, DOI 10.2337/db08-0260; Martin CMA, 2014, J ENDOCRINOL, V221, P193, DOI 10.1530/JOE-13-0617; Martin CMA, 2012, BIOCHEM PHARMACOL, V84, P312, DOI 10.1016/j.bcp.2012.04.015; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Nandar W, 2008, GEN COMP ENDOCR, V157, P58, DOI 10.1016/j.ygcen.2008.03.012; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Novakovic ZM, 2013, PEPTIDES, V43, P167, DOI 10.1016/j.peptides.2013.02.023; Park JW, 2015, CURR PHARM DESIGN, V21, P3097, DOI 10.2174/1381612821666150531163944; Parthsarathy V, 2016, BIOCH BIOPH IN PRESS; Piteau S, 2007, BIOCHEM BIOPH RES CO, V362, P1007, DOI 10.1016/j.bbrc.2007.08.115; Schiavo-Cardozo D, 2013, CLIN ENDOCRINOL, V79, P807, DOI 10.1111/cen.12114; Silvestre RA, 2003, REGUL PEPTIDES, V115, P25, DOI 10.1016/S0167-0115(03)00147-2; Taylor AI, 2010, J ENDOCRINOL, V207, P87, DOI 10.1677/JOE-10-0085; Tewari N, 2015, INT J OBESITY, V39, P1575, DOI 10.1038/ijo.2015.100; WARD WK, 1984, J CLIN INVEST, V74, P1318, DOI 10.1172/JCI111542; Wice BM, 2012, DIABETES, V61, P1793, DOI 10.2337/db11-1451; Wice BM, 2010, J BIOL CHEM, V285, P19842, DOI 10.1074/jbc.M110.129304	29	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152818	10.1371/journal.pone.0152818	http://dx.doi.org/10.1371/journal.pone.0152818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032106	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800141
J	Pava, MJ; Makriyannis, A; Lovinger, DM				Pava, Matthew J.; Makriyannis, Alexandros; Lovinger, David M.			Endocannabinoid Signaling Regulates Sleep Stability	PLOS ONE			English	Article							PENTOBARBITAL-INDUCED SLEEP; C-FOS EXPRESSION; TOLERANCE DEVELOPMENT; LATERAL HYPOTHALAMUS; EXTRACELLULAR LEVELS; RECEPTOR ANTAGONIST; MODULATES SLEEP; CROSS-TOLERANCE; CB1 RECEPTORS; WAKE CYCLE	The hypnogenic properties of cannabis have been recognized for centuries, but endogenous cannabinoid (endocannabinoid) regulation of vigilance states is poorly characterized. We report findings from a series of experiments in mice measuring sleep with polysomnography after various systemic pharmacological manipulations of the endocannabinoid system. Rapid, unbiased scoring of vigilance states was achieved using an automated algorithm that we devised and validated. Increasing endocannabinoid tone with a selective inhibitor of monoacyglycerol lipase (JZL184) or fatty acid amide hydrolase (AM3506) produced a transient increase in non-rapid eye movement (NREM) sleep due to an augmentation of the length of NREM bouts (NREM stability). Similarly, direct activation of type 1 cannabinoid (CB1) receptors with CP47,497 increased NREM stability, but both CP47,497 and JZL184 had a secondary effect that reduced NREM sleep time and stability. This secondary response to these drugs was similar to the early effect of CB1 blockade with the antagonist/inverse agonist AM281, which fragmented NREM sleep. The magnitude of the effects produced by JZL184 and AM281 were dependent on the time of day this drug was administered. While activation of CB1 resulted in only a slight reduction in gamma power, CB1 blockade had dramatic effects on broadband power in the EEG, particularly at low frequencies. However, CB1 blockade did not significantly reduce the rebound in NREM sleep following total sleep deprivation. These results support the hypothesis that endocannabinoid signaling through CB1 is necessary for NREM stability but it is not necessary for sleep homeostasis.	[Pava, Matthew J.; Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, Div Intramural Biol & Clin Res,NIH, Rockville, MD 20852 USA; [Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Makriyannis, Alexandros] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Makriyannis, Alexandros] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Northeastern University; Northeastern University; Northeastern University	Lovinger, DM (corresponding author), NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, Div Intramural Biol & Clin Res,NIH, Rockville, MD 20852 USA.	lovindav@mail.nih.gov	Makriyannis, Alexandros/GRF-1518-2022	Makriyannis, Alexandros/0000-0003-3272-3687	United States National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism's Division of Intramural Clinical and Biological Research [ZIA AA000416]; National Institute on Drug Abuse Grant [DA003801]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA003801, R01DA003801] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism's Division of Intramural Clinical and Biological Research; National Institute on Drug Abuse Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the United States National Institutes of Health. DML and MJP received support from the National Institute on Alcohol Abuse and Alcoholism's Division of Intramural Clinical and Biological Research, award number ZIA AA000416 (http://www.niaaa.nih.gov/). AM received support from National Institute on Drug Abuse Grant DA003801 (http://www.drugabuse.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2010, J NEUROSCI, V30, P10061, DOI 10.1523/JNEUROSCI.5838-09.2010; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bastianini S, 2014, J NEUROSCI METH, V235, P277, DOI 10.1016/j.jneumeth.2014.07.018; Baud MO, 2015, SLEEP, V38, P567, DOI 10.5665/sleep.4572; Behn CGD, 2010, SLEEP, V33, P297, DOI 10.1093/sleep/33.3.297; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Bradbury J B, 1899, Br Med J, V2, P134; BUONAMICI M, 1982, NEUROPHARMACOLOGY, V21, P825, DOI 10.1016/0028-3908(82)90071-5; Ceccarini J, 2015, ADDICT BIOL, V20, P357, DOI 10.1111/adb.12116; Clendinning J, 1843, Med Chir Trans, V26, P188; COMPTON DR, 1992, J PHARMACOL EXP THER, V260, P201; Cortes-Briones J, 2015, NEUROPSYCHOPHARMACOL, V40, P2124, DOI 10.1038/npp.2015.53; Davis CJ, 2011, J CLIN SLEEP MED, V7, pS16, DOI 10.5664/JCSM.1346; DIJK DJ, 1990, SLEEP, V13, P430, DOI 10.1093/sleep/13.5.430; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Rueda-Orozco PE, 2010, NEUROSCI LETT, V473, P158, DOI 10.1016/j.neulet.2010.02.044; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; FEINBERG I, 1976, CLIN PHARMACOL THER, V19, P782; Fernandez-Mendoza J, 2015, J SLEEP RES, V24, P390, DOI 10.1111/jsr.12285; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; FUJIMORI M, 1973, PHYSIOL BEHAV, V11, P291, DOI 10.1016/0031-9384(73)90003-6; Garzon J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-11; Gates P, 2016, SUBST ABUS, V37, P255, DOI 10.1080/08897077.2015.1023484; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Goonawardena AV, 2015, BEHAV PHARMACOL, V26, P289, DOI 10.1097/FBP.0000000000000108; Goonawardena Anushka V, 2011, Sleep Disord, V2011, P178469, DOI 10.1155/2011/178469; Gunduz-Cinar O, 2013, MOL PSYCHIATR, V18, P813, DOI 10.1038/mp.2012.72; Hajos M, 2008, BIOL PSYCHIAT, V63, P1075, DOI 10.1016/j.biopsych.2007.12.005; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; He JY, 2015, J MOL NEUROSCI, V55, P644, DOI 10.1007/s12031-014-0403-7; Huitron-Resendiz S, 2004, SLEEP, V27, P857, DOI 10.1093/sleep/27.5.857; Jacobs J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0304; Jacobson LH, 2011, N-S ARCH PHARMACOL, V384, P565, DOI 10.1007/s00210-011-0686-y; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kim D, 2015, SLEEP, V38, P85, DOI 10.5665/sleep.4330; Kim T, 2015, NEUROSCIENCE, V303, P211, DOI 10.1016/j.neuroscience.2015.06.037; Kucewicz MT, 2011, J NEUROSCI, V31, P15560, DOI 10.1523/JNEUROSCI.2970-11.2011; Liedhegner ES, 2014, J NEUROCHEM, V128, P491, DOI 10.1111/jnc.12495; Lin Shih-Chieh, 2008, P145; MACKIE K, 1993, MOL PHARMACOL, V44, P498; Mang Geraldine Morgane, 2012, Curr Protoc Mouse Biol, V2, P55, DOI 10.1002/9780470942390.mo110126; Martinez-Vargas M, 2013, INT J MOL SCI, V14, P23341, DOI 10.3390/ijms141223341; MELVIN LS, 1993, MOL PHARMACOL, V44, P1008; Mendelson WB, 1999, NEUROREPORT, V10, P3237, DOI 10.1097/00001756-199910190-00021; MORETON JE, 1973, NEUROPHARMACOLOGY, V12, P897, DOI 10.1016/0028-3908(73)90042-7; Murillo-Rodriguez E, 2008, NEUROSCIENCE, V157, P1, DOI 10.1016/j.neuroscience.2008.08.056; Murillo-Rodriguez E, 2003, SLEEP, V26, P943, DOI 10.1093/sleep/26.8.943; Murillo-Rodriguez E, 2001, NEUROREPORT, V12, P2131, DOI 10.1097/00001756-200107200-00018; Murillo-Rodriguez E, 1998, BRAIN RES, V812, P270, DOI 10.1016/S0006-8993(98)00969-X; Murillo-Rodriguez E, 2007, EUR J PHARMACOL, V562, P82, DOI 10.1016/j.ejphar.2007.01.076; Murillo-Rodriguez E, 2013, PHYSIOL BEHAV, V109, P88, DOI 10.1016/j.physbeh.2012.11.007; Murillo-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020766; Nathan PJ, 2011, CNS NEUROSCI THER, V17, P490, DOI 10.1111/j.1755-5949.2010.00172.x; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; OShaughnessy WB, 1843, PROV MED J RETROSPEC, V5, P363, DOI DOI 10.1136/BMJ.S1-5.123.363; Pava MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088672; Perez-Morales M, 2013, PHARMACOL BIOCHEM BE, V108, P1, DOI 10.1016/j.pbb.2013.04.006; Perez-Morales M, 2012, NEUROREPORT, V23, P814, DOI 10.1097/WNR.0b013e328357615a; Ringgold KM, 2013, J NEUROSCI METH, V219, P104, DOI 10.1016/j.jneumeth.2013.07.008; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Russo E, 2005, MIL DRUG TH, P1; RYAN LJ, 1984, BRAIN RES BULL, V13, P549, DOI 10.1016/0361-9230(84)90037-6; Sales-Carbonell C, 2013, P NATL ACAD SCI USA, V110, P719, DOI 10.1073/pnas.1217144110; Sanford AE, 2008, BRAIN RES, V1222, P141, DOI 10.1016/j.brainres.2008.05.048; Santucci V, 1996, LIFE SCI, V58, pPL103, DOI 10.1016/0024-3205(95)02319-4; Savinainen JR, 2001, BRIT J PHARMACOL, V134, P664, DOI 10.1038/sj.bjp.0704297; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089432; Sim LJ, 1996, J NEUROSCI, V16, P8057; Srinivasan BV, 2010, GPUML GRAPHICAL PROC; Steinberg BA, 2007, AM J CARDIOL, V100, p27P, DOI [10.1016/j.amjcard.2007.10.011, 10.1016/.j.amjcard.2007.10.011]; Sunagawa GA, 2013, GENES CELLS, V18, P502, DOI 10.1111/gtc.12053; TURKANIS SA, 1982, NEUROPHARMACOLOGY, V21, P7, DOI 10.1016/0028-3908(82)90204-0; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Vaughn LK, 2010, BRIT J PHARMACOL, V160, P530, DOI 10.1111/j.1476-5381.2010.00790.x; Vyazovskiy VV, 2007, SLEEP, V30, P1631, DOI 10.1093/sleep/30.12.1631; WALLACH MB, 1973, EUR J PHARMACOL, V24, P172, DOI 10.1016/0014-2999(73)90068-X; Wallich G C, 1883, Br Med J, V1, P1224; WATANABE K, 1982, EUR J PHARMACOL, V77, P53, DOI 10.1016/0014-2999(82)90535-0; WATANABE K, 1987, J PHARM PHARMACOL, V39, P945, DOI 10.1111/j.2042-7158.1987.tb03136.x; Weber F, 2015, NATURE, V526, P435, DOI 10.1038/nature14979; Wu CS, 2010, EUR J NEUROSCI, V32, P693, DOI 10.1111/j.1460-9568.2010.07337.x; Yasuo S, 2010, CELL TISSUE RES, V340, P127, DOI 10.1007/s00441-010-0930-7; ZARCONE VP, 1973, PSYCHIAT MED, V4, P201, DOI 10.2190/BA5B-1LVX-0LQ5-XV02; Zhuang SY, 1998, MOL BRAIN RES, V62, P141, DOI 10.1016/S0169-328X(98)00232-0; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	86	43	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152473	10.1371/journal.pone.0152473	http://dx.doi.org/10.1371/journal.pone.0152473			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031992	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800080
J	van Dijk, LV; Steenbakkers, RJHM; ten Haken, B; van der Laan, HP; van 't Veld, AA; Langendijk, JA; Korevaar, EW				van Dijk, Lisanne V.; Steenbakkers, Roel J. H. M.; ten Haken, Bennie; van der Laan, Hans Paul; van 't Veld, Aart A.; Langendijk, Johannes A.; Korevaar, Erik W.			Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients	PLOS ONE			English	Article							SET-UP ERRORS; RANGE UNCERTAINTIES; TREATMENT PLANS; RADIOTHERAPY; OPTIMIZATION; MARGINS; PROBABILITY; SENSITIVITY; ACCOUNT; IMPACT	Purpose To compare the clinical benefit of robust optimized Intensity Modulated Proton Therapy (minimax IMPT) with current photon Intensity Modulated Radiation Therapy (IMRT) and PTV-based IMPT for head and neck cancer (HNC) patients. The clinical benefit is quantified in terms of both Normal Tissue Complication Probability (NTCP) and target coverage in the case of setup and range errors. Methods and Materials For 10 HNC patients, PTV-based IMRT (7 fields), minimax and PTV-based IMPT (2, 3, 4, 5 and 7 fields) plans were tested on robustness. Robust optimized plans differed from PTV-based plans in that they target the CTV and penalize possible error scenarios, instead of using the static isotropic CTV-PTV margin. Perturbed dose distributions of all plans were acquired by simulating in total 8060 setup (+/- 3.5 mm) and range error (+/- 3%) combinations. NTCP models for xerostomia and dysphagia were used to predict the clinical benefit of IMPT versus IMRT. Results The robustness criterion was met in the IMRT and minimax IMPT plans in all error scenarios, but this was only the case in 1 of 40 PTV-based IMPT plans. Seven (out of 10) patients had relatively large NTCP reductions in minimax IMPT plans compared to IMRT. For these patients, xerostomia and dysphagia NTCP values were reduced by 17.0% (95% CI; 13.0-21.1) and 8.1% (95% CI; 4.9-11.2) on average with minimax IMPT. Increasing the number of fields did not contribute to plan robustness, but improved organ sparing. Conclusions The estimated clinical benefit in terms of NTCP of robust optimized (minimax) IMPT is greater than that of IMRT and PTV-based IMPT in HNC patients. Furthermore, the target coverage of minimax IMPT plans in the presence of errors was comparable to IMRT plans.	[van Dijk, Lisanne V.; Steenbakkers, Roel J. H. M.; van der Laan, Hans Paul; van 't Veld, Aart A.; Langendijk, Johannes A.; Korevaar, Erik W.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands; [van Dijk, Lisanne V.; ten Haken, Bennie] Univ Twente, Inst Biomed Technol & Tech Med MIRA, POB 217, NL-7500 AE Enschede, Netherlands	University of Groningen; University of Twente	van Dijk, LV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands.; van Dijk, LV (corresponding author), Univ Twente, Inst Biomed Technol & Tech Med MIRA, POB 217, NL-7500 AE Enschede, Netherlands.	l.v.van.dijk@umcg.nl	van Dijk, Lisanne/AAA-2199-2021; Haken, Bennie ten/AAI-9083-2020; Korevaar, Erik/N-2912-2013	Langendijk, Johannes A./0000-0003-1083-372X				Albertini F, 2011, PHYS MED BIOL, V56, P4399, DOI 10.1088/0031-9155/56/14/011; [Anonymous], 1993, 50 ICRU; [Anonymous], 2010, 83 ICRU; Christianen MEMC, 2012, RADIOTHER ONCOL, V105, P107, DOI 10.1016/j.radonc.2011.08.009; Cochran DM, 2008, INT J RADIAT ONCOL, V70, P1336, DOI 10.1016/j.ijrobp.2007.08.027; Dionisi F, 2013, INT J CLIN ONCOL, V18, P418, DOI 10.1007/s10147-012-0395-7; Dirix P, 2010, LANCET ONCOL, V11, P85, DOI 10.1016/S1470-2045(09)70231-1; Engelsman M, 2005, MED PHYS, V32, P3549, DOI 10.1118/1.2126187; Fontanarosa D, 2013, RADIOTHER ONCOL, V109, P430, DOI 10.1016/j.radonc.2013.07.012; Fredriksson A, 2014, MED PHYS, V41, P48, DOI 10.1118/1.4883837; Fredriksson A, 2011, MED PHYS, V38, P1672, DOI 10.1118/1.3556559; Hansen DC, 2015, ACTA ONCOL, P1; Harding R, 2014, MED PHYS, V41, DOI 10.1118/1.4897571; Hopfgartner J, 2013, ACTA ONCOL, V52, P570, DOI 10.3109/0284186X.2012.744874; Houweling AC, 2010, INT J RADIAT ONCOL, V76, P1259, DOI 10.1016/j.ijrobp.2009.07.1685; Jakobi A, 2015, INT J RADIAT ONCOL, V92, P1165, DOI 10.1016/j.ijrobp.2015.04.031; Kraan AC, 2013, INT J RADIAT ONCOL, V87, P888, DOI 10.1016/j.ijrobp.2013.09.014; Langendijk JA, 2008, J CLIN ONCOL, V26, P3770, DOI 10.1200/JCO.2007.14.6647; Langendijk JA, 2013, RADIOTHER ONCOL, V107, P267, DOI 10.1016/j.radonc.2013.05.007; Lomax A, 1999, PHYS MED BIOL, V44, P185, DOI 10.1088/0031-9155/44/1/014; Lomax AJ, 2008, PHYS MED BIOL, V53, P1027, DOI 10.1088/0031-9155/53/4/014; Moyers MF, 2010, MED DOSIM, V35, P179, DOI 10.1016/j.meddos.2009.05.004; Park Peter C, 2012, Int J Radiat Oncol Biol Phys, V82, pe329, DOI 10.1016/j.ijrobp.2011.05.011; Pflugfelder D, 2008, PHYS MED BIOL, V53, P1689, DOI 10.1088/0031-9155/53/6/013; Rischin D, 2002, J CLIN ONCOL, V20, P1845, DOI 10.1200/JCO.2002.07.011; Simone CB, 2011, RADIOTHER ONCOL, V101, P376, DOI 10.1016/j.radonc.2011.05.028; Stuschke M, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-145; Unkelbach J, 2007, PHYS MED BIOL, V52, P2755, DOI 10.1088/0031-9155/52/10/009; Unkelbach J, 2009, MED PHYS, V36, P149, DOI 10.1118/1.3021139; van de Water TA, 2011, INT J RADIAT ONCOL, V79, P1216, DOI 10.1016/j.ijrobp.2010.05.012; van de Water TA, 2011, ONCOLOGIST, V16, P366, DOI 10.1634/theoncologist.2010-0171; van der Laan HP, 2012, RADIOTHER ONCOL, V103, P76, DOI 10.1016/j.radonc.2011.11.001; van Herk M, 2000, INT J RADIAT ONCOL, V47, P1121, DOI 10.1016/S0360-3016(00)00518-6; Widesott L, 2008, INT J RADIAT ONCOL, V72, P589, DOI 10.1016/j.ijrobp.2008.05.065	34	40	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152477	10.1371/journal.pone.0152477	http://dx.doi.org/10.1371/journal.pone.0152477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030987	gold, Green Submitted, Green Published			2022-12-26	WOS:000373121800082
J	Zhou, B; Zhang, L; Ullah, A; Jin, X; Yang, XY; Zhang, XL				Zhou, Bin; Zhang, Lin; Ullah, Abid; Jin, Xin; Yang, Xiyan; Zhang, Xianlong			Identification of Multiple Stress Responsive Genes by Sequencing a Normalized cDNA Library from Sea-Land Cotton (Gossypium barbadense L.)	PLOS ONE			English	Article							ABIOTIC STRESS; ABSCISIC-ACID; PROTEIN-KINASES; TRANSCRIPTION FACTORS; VERTICILLIUM-DAHLIAE; SALT-STRESS; FUNCTIONAL-CHARACTERIZATION; SIGNALING PATHWAYS; OXIDATIVE STRESS; CHILLING STRESS	Background Plants often face multiple stresses including drought, extreme temperature, salinity, nutrition deficiency and biotic stresses during growth and development. All the stresses result in a series of physiological and metabolic reactions and then generate reversible inhibition of metabolism and growth and can cause seriously irreversible damage, even death. At each stage of cotton growth, environmental stress conditions pose devastating threats to plant growth and development, especially yield and quality. Due to the complex stress conditions and unclear molecular mechanisms of stress response, there is an urgent need to explore the mechanisms of cotton response against abiotic stresses. Methodology and Principal Findings A normalized cDNA library was constructed using Gossypium barbadense Hai-7124 treated with different stress conditions (heat, cold, salt, drought, potassium and phosphorus deficit and Verticillium dahliae infection). Random sequencing of this library generated 6,047 high-quality expressed sequence tags (ESTs). The ESTs were clustered and assembled into 3,135 uniESTs, composed of 2,497 contigs and 638 singletons. The blastx results demonstrated 2,746 unigenes showing significant similarity to known genes, 74 uniESTs displaying significant similarity to genes of predicted proteins, and 315 uniESTs remain uncharacterized. Functional classification unveiled the abundance of uniESTs in binding, catalytic activity, and structural molecule activity. Annotations of the uniESTs by the plant transcription factor database (PlantTFDB) and Plant Stress Protein Database (PSPDB) disclosed that transcription factors and stress-related genes were enriched in the current library. The expression of some transcription factors and specific stress-related genes were verified by RT-PCR under various stress conditions. Conclusions/Significance Annotation results showed that a huge number of genes respond to stress in our study, such as MYB-related, C2H2, FAR1, bHLH, bZIP, MADS, and mTERF. These results will improve our knowledge of stress tolerance in cotton. In addition, they are also helpful in discovering candidate genes related to stress tolerance. The publicly available ESTs from G. barbadense are a valuable genomic resource that will facilitate further molecular study and breeding of stress-tolerant cotton.	[Zhou, Bin; Zhang, Lin; Ullah, Abid; Jin, Xin; Yang, Xiyan; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University	Yang, XY (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China.	yxy@mail.hzau.edu.cn	Ullah, Abid/AAD-1241-2020	Ullah, Abid/0000-0003-2389-3916	National Natural Science Foundation of China [31371675]; Fundamental Research Funds for the Central Universities [2014PY028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported through funding from the National Natural Science Foundation of China (31371675) (XY) http://www.nsfc.gov.cn/ and the Fundamental Research Funds for the Central Universities (2014PY028)(XY). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bailey-Serres J, 2006, PLANT PHYSIOL, V141, P311, DOI 10.1104/pp.104.900191; Chaudhary B, 2008, EVOL DEV, V10, P567, DOI 10.1111/j.1525-142X.2008.00272.x; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Das R, 2010, CURR GENOMICS, V11, P2, DOI 10.2174/138920210790217981; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Gai YP, 2008, J AGRON CROP SCI, V194, P278, DOI 10.1111/j.1439-037X.2008.00311.x; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; He LR, 2013, BIOCHEM BIOPH RES CO, V435, P209, DOI 10.1016/j.bbrc.2013.04.080; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Jiang ZQ, 2010, J GENET GENOMICS, V37, P219, DOI 10.1016/S1673-8527(09)60040-0; KEBEDE H, 2015, INT J PLANT GENOMICS, DOI [10.1155/2015/892716, DOI 10.1155/2015/892716]; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Kumar SA, 2014, PLANT MOL BIOL REP, V32, P940, DOI 10.1007/s11105-014-0698-0; Lehti-Shiu MD, 2012, PHILOS T R SOC B, V367, P2619, DOI 10.1098/rstb.2012.0003; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu WW, 2014, NEW PHYTOL, V201, P1192, DOI 10.1111/nph.12607; Loka DA, 2014, S AFR J BOT, V93, P131, DOI 10.1016/j.sajb.2014.03.019; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mehrotra R, 2014, J PLANT PHYSIOL, V171, P486, DOI 10.1016/j.jplph.2013.12.007; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Min L, 2014, PLANT PHYSIOL, V164, P1293, DOI 10.1104/pp.113.232314; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nam SH, 2009, BIOINFORMATICS, V25, P1846, DOI 10.1093/bioinformatics/btp293; Nobili A, 2016, CONSTR BUILD MATER, V105, P465, DOI 10.1016/j.conbuildmat.2015.12.173; Noctor G, 2014, PLANT PHYSIOL, V164, P1636, DOI 10.1104/pp.113.233478; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliveira EJ, 2006, GENET MOL BIOL, V29, P294, DOI 10.1590/S1415-47572006000200018; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Parkinson J, 2003, BIOINFORMATICS, V19, P390, DOI 10.1093/bioinformatics/btf870; Pastori GM, 2002, PLANT PHYSIOL, V129, P460, DOI 10.1104/pp.011021; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Saavedra X, 2010, PLANT PHYSIOL, V152, P133, DOI 10.1104/pp.109.146381; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; SHANNON MC, 1977, AGRON J, V69, P619, DOI 10.2134/agronj1977.00021962006900040024x; Shi GY, 2015, PLANT CELL REP, V34, P1005, DOI 10.1007/s00299-015-1761-5; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Tian MM, 2015, PLANT J, V82, P81, DOI 10.1111/tpj.12797; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Wang H, 2016, CHINESE GEOGR SCI, V26, P35, DOI 10.1007/s11769-015-0762-1; Wei XZ, 2009, PROG NAT SCI-MATER, V19, P173, DOI 10.1016/j.pnsc.2008.06.016; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Wu CA, 2004, PLANT CELL PHYSIOL, V45, P600, DOI 10.1093/pcp/pch071; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Xu L, 2014, J EXP BOT, V65, P6679, DOI 10.1093/jxb/eru393; Yang HJ, 2015, PLANT PHYSIOL, V167, P1604, DOI 10.1104/pp.114.255216; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yuan DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022758; Zhang F, 2015, PLANT MOL BIOL, V87, P47, DOI 10.1007/s11103-014-0260-3; Zhang Ling, 2009, BMC Res Notes, V2, P120, DOI 10.1186/1756-0500-2-120; Zhang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-637; Zhao J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-110; Zhu LongFu, 2005, Acta Agronomica Sinica, V31, P1657	86	25	26	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152927	10.1371/journal.pone.0152927	http://dx.doi.org/10.1371/journal.pone.0152927			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031331	Green Submitted, gold, Green Published			2022-12-26	WOS:000373121800155
J	Chomicki, G; Renner, SS				Chomicki, Guillaume; Renner, Susanne S.			Evolutionary Relationships and Biogeography of the Ant-Epiphytic Genus Squamellaria (Rubiaceae: Psychotrieae) and Their Taxonomic Implications	PLOS ONE			English	Article							TUBEROUS EPIPHYTES; REVISION; MODEL; PHYLOGENETICS; REVEAL; PLANTS	Ecological research on ant/plant symbioses in Fiji, combined with molecular phylogenetics, has brought to light four new species of Squamellaria in the subtribe Hydnophytinae of the Rubiaceae tribe Psychotrieae and revealed that four other species, previously in Hydnophytum, need to be transferred to Squamellaria. The diagnoses of the new species are based on morphological and DNA traits, with further insights from microCT scanning of flowers and leaf delta C-13 ratios (associated with Crassulacean acid metabolism). Our field and phylogenetic work results in a new circumscription of the genus Squamellaria, which now contains 12 species (to which we also provide a taxonomic key), not 3 as in the last revision. A clock-dated phylogeny and a model-testing biogeographic framework were used to infer the broader geographic history of rubiaceous ant plants in the Pacific, specifically the successive expansion of Squamellaria to Vanuatu, the Solomon Islands, and Fiji. The colonization of Vanuatu may have occurred from Fiji, when these islands were still in the same insular arc, while the colonization of the Solomon islands may have occurred after the separation of this island from the Fiji/Vanuatu arc. Some of these ant-housing epiphytes must have dispersed with their specialized ants, for instance attached to floating timber. Others acquired new ant symbionts on different islands.	[Chomicki, Guillaume; Renner, Susanne S.] Univ Munich LMU, Systemat Bot & Mycol, Menzinger Str 67, D-80638 Munich, Germany	University of Munich	Chomicki, G (corresponding author), Univ Munich LMU, Systemat Bot & Mycol, Menzinger Str 67, D-80638 Munich, Germany.	guillaume.chomicki@gmail.com		Chomicki, Guillaume/0000-0003-4547-6195	German Research Foundation (DFG) [RE 603/20]; Society of Systematic Biologists; American Association of Plant Taxonomy; Stavros Niarchos Foundation; French Fonds Pacifique; Total Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Society of Systematic Biologists; American Association of Plant Taxonomy; Stavros Niarchos Foundation; French Fonds Pacifique; Total Foundation(Total SA)	This work was supported by a grant from the German Research Foundation (DFG), RE 603/20, and grants from the Society of Systematic Biologists and the American Association of Plant Taxonomy to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jeremy Aroles for help in the field; Two anonymous reviewers for comments on the manuscript; Bruno Corbara and Derrick Rowe for photographs; Alivereti Naikatini and Marika Tuiwawa from the University of South Pacific and the herbarium SUVA for technical support and advice; Gudrun Kadereit, University of Mainz, for the isotope-ratio mass spectrometry analyses carried out at the University of Mainz; Matthew Jebb and Sylvain Razafimandimbison for taxonomic advice, and Yannick Staedler for providing the microCT scanning images in Fig 3. Yasumin S. Lermer from the Botanical Institute in Munich drew two plates (S. huxleyana and S. grayi), and Rosemary Wise from Oxford drew the S. vanuatensis plate. Curators at Dublin (DUB), Kew (K), Leiden (L), Munich (M and MSB), Oxford (FHO), Paris (P), Sydney (NSW), and SUVA provided access to relevant collections. Material from Vanuatu was collected during "SANTO 2006", an international expedition organized by the Paris Natural History Museum, Pro-Natura International, and the Institut de Recherche pour le Developpement, and sponsored by the Stavros Niarchos Foundation, the French Fonds Pacifique and the Total Foundation. The expedition operated under a permit granted to Prof. P. Bouchet by the Environment Unit of the Government of Vanuatu. This work was supported by a grant from the German Research Foundation (DFG), RE 603/20, and grants from the Society of Systematic Biologists and the American Association of Plant Taxonomy to GC.	[Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baker JG, 1884, J LINN SOC LOND BOT, V20, P358; Barosi F., 2010, GEOSTORIE, V18, P7; Barrabe L, 2014, MOL PHYLOGENET EVOL, V71, P15, DOI 10.1016/j.ympev.2013.10.020; Beccari O, 1884, MALESIA GENOA, VII; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Chomicki G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2200; Chomicki G, 2015, NEW PHYTOL, V207, P411, DOI 10.1111/nph.13271; Chomicki G, 2015, NEW PHYTOL, V205, P526, DOI 10.1111/nph.13163; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ewart FT, 1988, CICADAS FIJI SAMOA T; Gray A, 1858, P AM ACAD ARTS SCI, V4, P31; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Heim DR, 1988, 1896 SMITHS, P411; Horne J., 1881, YEAR FIJI INQUIRY BO; HUXLEY CR, 1978, NEW PHYTOL, V80, P231, DOI 10.1111/j.1469-8137.1978.tb02285.x; HUXLEY CR, 1993, BLUMEA, V37, P271; HUXLEY CR, 1991, BLUMEA, V36, P1; HUXLEY CR, 1991, BLUMEA, V36, P21; HUXLEY CR, 1991, BLUMEA, V36, P43; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; JANZEN D H, 1974, Biotropica, V6, P237, DOI 10.2307/2989668; JEBB M, 1991, ANT - PLANT INTERACTIONS, P374; JEBB MHP, 1991, BLUMEA, V36, P53; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Lin H-L, 2012, PACIFIC ASIA INQUIRY, V3, P41; Maddison WP, 2009, MESQUITE MODULAR SYS; Matzke N.J., 2012, FRONTIERS BIOGEOGRAP, V4, P210; Matzke NJ, 2014, SYST BIOL, V63, P951, DOI 10.1093/sysbio/syu056; Miehe H, 1991, BIOL ZBL, V31, P73; Rambaut A, 2012, FIGTREE V 1 4 0; Razafimandimbison SG, 2014, AM J BOT, V101, P1102, DOI 10.3732/ajb.1400076; RODDA P, 1994, SOPAC TECHNICAL B, V8, P131; RODDA P., 1984, CENOZOIC TECTONIC DE, V6, P87; Smith AC, 1967, CONTRIB US NATL HERB, V37, P67; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taylor GK, 2000, J GEOPHYS RES-SOL EA, V105, P5771, DOI 10.1029/1999JB900305; Treub MM, 1888, ANN JARDIN BOT BUITE, V7, P191; Treub MM, 1883, ANN JARD BOT BUITENZ, V3, P129; Wagner Warren L., 2001, Allertonia, V8, P329	41	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151317	10.1371/journal.pone.0151317	http://dx.doi.org/10.1371/journal.pone.0151317			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028599	Green Published, gold, Green Submitted			2022-12-26	WOS:000373116500022
J	Cirillo, G; Colangelo, AM; De Luca, C; Savarese, L; Barillari, MR; Alberghina, L; Papa, M				Cirillo, Giovanni; Colangelo, Anna Maria; De Luca, Ciro; Savarese, Leonilde; Barillari, Maria Rosaria; Alberghina, Lilia; Papa, Michele			Modulation of Matrix Metalloproteinases Activity in the Ventral Horn of the Spinal Cord Re-stores Neuroglial Synaptic Homeostasis and Neurotrophic Support following Peripheral Nerve Injury	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EXTRACELLULAR-MATRIX; GROWTH-FACTOR; MALADAPTIVE PLASTICITY; NEUROPATHIC PAIN; EXPRESSION; DISEASE; MODEL; REGENERATION; ASTROGLIOSIS	Modulation of extracellular matrix (ECM) remodeling after peripheral nerve injury (PNI) could represent a valid therapeutic strategy to prevent maladaptive synaptic plasticity in central nervous system (CNS). Inhibition of matrix metalloproteinases (MMPs) and maintaining a neurotrophic support could represent two approaches to prevent or reduce the maladaptive plastic changes in the ventral horn of spinal cord following PNI. The purpose of our study was to analyze changes in the ventral horn produced by gliopathy determined by the suffering of motor neurons following spared nerve injury (SNI) of the sciatic nerve and how the intrathecal (i.t.) administration of GM6001 (a MMPs inhibitor) or the NGF mimetic peptide BB14 modulate these events. Immunohistochemical analysis of spinal cord sections revealed that motor neuron disease following SNI was associated with increased microglial (Iba1) and astrocytic (GFAP) response in the ventral horn of the spinal cord, indicative of reactive gliosis. These changes were paralleled by decreased glial aminoacid transporters (glutamate GLT1 and glycine GlyT1), increased levels of the neuronal glutamate transporter EAAC1, and a net increase of the Glutamate/GABA ratio, as measured by HPLC analysis. These molecular changes correlated to a significant reduction of mature NGF levels in the ventral horn. Continuous i.t. infusion of both GM6001 and BB14 reduced reactive astrogliosis, recovered the expression of neuronal and glial transporters, lowering the Glutamate/GABA ratio. Inhibition of MMPs by GM6001 significantly increased mature NGF levels, but it was absolutely ineffective in modifying the reactivity of microglia cells. Therefore, MMPs inhibition, although supplies neurotrophic support to ECM components and restores neuro-glial transporters expression, differently modulates astrocytic and microglial response after PNI.	[Cirillo, Giovanni; De Luca, Ciro; Savarese, Leonilde; Barillari, Maria Rosaria; Papa, Michele] Univ Naples 2, Lab Neuronal Networks, Dept Mental & Phys Hlth & Prevent Med, I-80138 Naples, Italy; [Colangelo, Anna Maria; Alberghina, Lilia] Univ Milano Bicocca, Lab Neurosci R Levi Montalcini, Dept Biotechnol & Biosci, Milan, Italy; [Colangelo, Anna Maria; Savarese, Leonilde; Alberghina, Lilia; Papa, Michele] Univ Milano Bicocca, Ctr Syst Biol, SYSBIO, Milan, Italy	Universita della Campania Vanvitelli; University of Milano-Bicocca; University of Milano-Bicocca	Cirillo, G (corresponding author), Univ Naples 2, Lab Neuronal Networks, Dept Mental & Phys Hlth & Prevent Med, I-80138 Naples, Italy.	giovannicirillosun@gmail.com	Papa, Michele/A-7228-2017; Colangelo, Anna Maria AM/Q-3597-2017; Barillari, Maria Rosaria/AHH-9643-2022; Papa, Michele/AAB-1759-2021	Papa, Michele/0000-0003-4834-7970; Colangelo, Anna Maria AM/0000-0002-7971-4289; Papa, Michele/0000-0002-6609-7453; Alberghina, Lilia/0000-0003-1694-931X; BARILLARI, Maria Rosaria/0000-0002-5457-1509; De Luca, Ciro/0000-0002-8146-5736; Cirillo, Giovanni/0000-0003-3183-8773	Italian Ministry of University and Research (MIUR):PRIN; SYSBIONET-Italian ROADMAP ESFRI Infrastructures; FIRB-ITALBIONET; NEDD; Blueprint Pharma s.r.l.; PRIMM, s.r.l.; Regione Campania (L.R. N.5 Bando); Regione Campania (Prog. Spec art 12 E.F.); CNR (Neurobiotecnologie); Associazione Levi-Montalcini	Italian Ministry of University and Research (MIUR):PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); SYSBIONET-Italian ROADMAP ESFRI Infrastructures; FIRB-ITALBIONET(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); NEDD; Blueprint Pharma s.r.l.; PRIMM, s.r.l.; Regione Campania (L.R. N.5 Bando); Regione Campania (Prog. Spec art 12 E.F.); CNR (Neurobiotecnologie); Associazione Levi-Montalcini	This work was supported by grants from the Italian Ministry of University and Research (MIUR):PRIN2007 to MP and to AMC; SYSBIONET-Italian ROADMAP ESFRI Infrastructures to LA, AMC, MP (fellowship to LS); and FIRB-ITALBIONET and NEDD to LA. Work was also supported by Blueprint Pharma s.r.l. and PRIMM, s.r.l.. Research work in authors' laboratory was funded by grants from Regione Campania (L.R. N.5 Bando 2003 to MP), Regione Campania (Prog. Spec art 12 E.F. 2000 to MP), CNR (Neurobiotecnologie 2003 to MP), and Associazione Levi-Montalcini (fellowship to GC).	Arbat-Plana A, 2015, EXP NEUROL, V263, P293, DOI 10.1016/j.expneurol.2014.10.009; Benkler C, 2013, GLIA, V61, P312, DOI 10.1002/glia.22428; Bjerke M, 2011, J ALZHEIMERS DIS, V27, P665, DOI 10.3233/JAD-2011-110566; Blanco-Mezquita T, 2013, INVEST OPHTH VIS SCI, V54, P3880, DOI 10.1167/iovs.12-10816; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Cavaliere C, 2007, NEURON GLIA BIOL, V3, P141, DOI 10.1017/S1740925X07000695; Cirillo G, 2012, BIOTECHNOL ADV, V30, P223, DOI 10.1016/j.biotechadv.2011.05.008; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Colangelo AM, 2014, NEUROSCI LETT, V565, P59, DOI 10.1016/j.neulet.2014.01.014; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; De Luca C, 2016, NEUROCHEM RES, V41, P1507, DOI 10.1007/s11064-016-1876-2; De Luca C, 2016, CELL MOL NEUROBIOL, V36, P37, DOI 10.1007/s10571-015-0218-2; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Faissner A, 2015, GLIA, V63, P1330, DOI 10.1002/glia.22839; Fawcett JW, 2015, PROG BRAIN RES, V218, P213, DOI 10.1016/bs.pbr.2015.02.001; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; Foscarin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016666; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Glas M, 2007, EXP NEUROL, V207, P350, DOI 10.1016/j.expneurol.2007.07.007; Gordon T, 2015, EXP NEUROL, V264, P26, DOI 10.1016/j.expneurol.2014.10.022; Heikkinen A, 2014, PROG BRAIN RES, V214, P29, DOI 10.1016/B978-0-444-63486-3.00002-5; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Jayanth P, 2010, CELL SIGNAL, V22, P1193, DOI 10.1016/j.cellsig.2010.03.011; Lepeta K, 2015, SCHIZOPHRENIA BULL, V41, P1003, DOI 10.1093/schbul/sbv036; Li Y, 2011, NEUROPHARMACOLOGY, V60, P1168, DOI 10.1016/j.neuropharm.2010.10.016; Lukaszewicz-Zajac M, 2014, J NEURAL TRANSM, V121, P1387, DOI 10.1007/s00702-014-1205-3; Lv MM, 2014, BIOCHEM BIOPH RES CO, V450, P1568, DOI 10.1016/j.bbrc.2014.07.044; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; MORRIS DC, 2006, ACAD EMERG MED, V13, pS194; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nyati KK, 2010, J NEUROSCI RES, V88, P3540, DOI 10.1002/jnr.22514; Papa M, 2014, NEUROSCI BIOBEHAV R, V42, P35, DOI 10.1016/j.neubiorev.2014.01.010; Romi F, 2012, EUR NEUROL, V67, P121, DOI 10.1159/000334862; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Verkhratsky A, 2007, J ANAT, V210, P651, DOI 10.1111/j.1469-7580.2007.00734.x	39	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152750	10.1371/journal.pone.0152750	http://dx.doi.org/10.1371/journal.pone.0152750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028103	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500065
J	Kajiura, SM; Tellman, SL				Kajiura, Stephen M.; Tellman, Shari L.			Quantification of Massive Seasonal Aggregations of Blacktip Sharks (Carcharhinus limbatus) in Southeast Florida	PLOS ONE			English	Article							FEMALE LEOPARD SHARKS; GULF-OF-MEXICO; RHINCODON-TYPUS; AERIAL SURVEYS; WHALE SHARKS; HABITAT USE; BEHAVIORAL THERMOREGULATION; NEGAPRION-BREVIROSTRIS; TRIAKIS-SEMIFASCIATA; EXPLOITATION RATES	Southeast Florida witnesses an enormous seasonal influx of upper trophic level marine predators each year as massive aggregations of migrating blacktip sharks (Carcharhinus limbatus) overwinter in nearshore waters. The narrow shelf and close proximity of the Gulf Stream current to the Palm Beach County shoreline drive tens of thousands of sharks to the shallow, coastal environment. This natural bottleneck provides a unique opportunity to estimate relative abundance. Over a four year period from 2011-2014, an aerial survey was flown approximately biweekly along the length of Palm Beach County. A high definition video camera and digital still camera mounted out of the airplane window provided a continuous record of the belt transect which extended 200 m seaward from the shoreline between Boca Raton Inlet and Jupiter Inlet. The number of sharks within the survey transect was directly counted from the video. Shark abundance peaked in the winter (January-March) with a maximum in 2011 of 12,128 individuals counted within the 75.6 km(-2) belt transect. This resulted in a maximum density of 803.2 sharks km(-2). By the late spring (April-May), shark abundance had sharply declined to 1.1% of its peak, where it remained until spiking again in January of the following year. Shark abundance was inversely correlated with water temperature and large numbers of sharks were found only when water temperatures were less than 25 degrees C. Shark abundance was also correlated with day of the year but not with barometric pressure. Although shark abundance was not correlated with photoperiod, the departure of the sharks from southeast Florida occurred around the vernal equinox. The shark migration along the United States eastern seaboard corresponds spatially and temporally with the spawning aggregations of various baitfish species. These baseline abundance data can be compared to future studies to determine if shark population size is changing and if sharks are restricting their southward migration as global water temperatures increase.	[Kajiura, Stephen M.; Tellman, Shari L.] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Kajiura, SM (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.	kajiura@fau.edu		Kajiura, Stephen/0000-0003-3009-8419	Colgan Foundation; Florida Atlantic University Division of Research; Southeast National Marine Renewable Energy Center at Florida Atlantic University; State of Florida; U.S. Department of Energy [DE-EE0000319]	Colgan Foundation; Florida Atlantic University Division of Research; Southeast National Marine Renewable Energy Center at Florida Atlantic University; State of Florida; U.S. Department of Energy(United States Department of Energy (DOE))	Funding for this project was provided by the Colgan Foundation (www.colganfoundation.org), the Florida Atlantic University Division of Research (www.fau.edu/research), and the Southeast National Marine Renewable Energy Center at Florida Atlantic University (snmrec.fau.edu) with funding provided by the State of Florida and The U.S. Department of Energy (science.energy.gov) under funding award DE-EE0000319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, HMS COMMERCIAL COMPL; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beckley LE, 1997, ENVIRON BIOL FISH, V50, P343, DOI 10.1023/A:1007355709632; BIGELOW H. B., 1948, MEM SEARS FOUND MARINE RES [NEW HAVEN], V1, P59; BLAYLOCK RA, 1989, COPEIA, P744; BRANSTETTER S, 1982, COPEIA, P461; Branstetter S, 1996, COMMERCIAL SHARK FIS; Burgess GH, 2009, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2009-2.RLTS.T3851A10124862.en, DOI 10.2305/IUCN.UK.2009-2.RLTS.T3851A10124862.EN]; Burks CM, 2006, FISH B-NOAA, V104, P579; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Camhi M., 1998, SHARKS LINE STATE BY; Perez-Jimenez JC, 2015, FISH RES, V172, P96, DOI 10.1016/j.fishres.2015.07.004; Castro J. I, 2011, SHARKS N AM; Castro JI, 1996, B MAR SCI, V59, P508; CASTRO JI, 1999, 380 FAO; Certain G, 2008, REMOTE SENS ENVIRON, V112, P3314, DOI 10.1016/j.rse.2008.01.019; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; CLARK EUGENIE, 1963, ZOOLOGICA [NEW YORK], V48, P61; Cliff G, 2007, FISH RES, V84, P41, DOI 10.1016/j.fishres.2006.11.012; Compagno LJV., 1984, FAO FISH SYNOP, P20; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Dodrill JW., 1977, THESIS FLORIDA I TEC; DRYFOOS RL, 1973, FISH B-NOAA, V71, P719; Dudley SFJ, 2010, AFR J MAR SCI, V32, P383, DOI 10.2989/1814232X.2010.502641; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Edwards HH, 2007, J WILDLIFE MANAGE, V71, P2052, DOI 10.2193/2005-645; EPPERLY SP, 1995, FISH B-NOAA, V93, P254; Gaskell T. E, 1972, GULF STREAM; Grubbs RD, SHARK NURSERY GROUND, P87; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; GRUBER SH, 1988, B MAR SCI, V43, P61; Guttridge TL, 2012, MAR ECOL PROG SER, V445, P279, DOI 10.3354/meps09423; Hanfee F., 1996, WORLD TRADE SHARKS C, VII, P605; Harvey-Clark CJ, 1999, COPEIA, P780, DOI 10.2307/1447614; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Henderson AC, 2009, AFR J MAR SCI, V31, P233, DOI 10.2989/AJMS.2009.31.2.11.883; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Jean C, 2010, ORYX, V44, P223, DOI 10.1017/S003060530999072X; Jennings R.D., 1985, Copeia, V1985, P223, DOI 10.2307/1444814; KENNEY RD, 1985, COPEIA, P220, DOI 10.2307/1444813; Kneebone J, 2012, MAR ECOL PROG SER, V471, P165, DOI 10.3354/meps09989; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lauriano G, 2011, MAR ECOL PROG SER, V437, P291, DOI 10.3354/meps09261; LEAMAN KD, 1989, J PHYS OCEANOGR, V19, P36, DOI 10.1175/1520-0485(1989)019<0036:TADOVT>2.0.CO;2; LEGGETT WC, 1972, FISH BULL NATL OC AT, V70, P659; Lydersen C, 2012, POLAR BIOL, V35, P1555, DOI 10.1007/s00300-012-1195-2; Lynch PD, 2015, ICES J MAR SCI, V72, P374, DOI 10.1093/icesjms/fsu134; Manojkumar PP, 2012, INDIAN J FISH, V59, P35; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nosal AP, 2014, MAR ECOL PROG SER, V499, P157, DOI 10.3354/meps10632; Ovenden JR, 2010, MAR FRESHWATER RES, V61, P253, DOI 10.1071/MF09151; Papastamatiou YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127807; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; PETERSON CH, 1976, EVOLUTION, V30, P393, DOI 10.1111/j.1558-5646.1976.tb00916.x; Rowat D, 2009, J EXP MAR BIOL ECOL, V368, P1, DOI 10.1016/j.jembe.2008.09.001; Schlaff AM, 2014, REV FISH BIOL FISHER, V24, P1089, DOI 10.1007/s11160-014-9364-8; Smultea MA, 2014, AQUAT MAMM, V40, P32, DOI 10.1578/AM.40.1.2014.32; Speed CW, 2012, MAR ECOL PROG SER, V463, P231, DOI 10.3354/meps09864; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Tavares R, 2009, INTERCIENCIA, V34, P463; Taylor JG, 1996, MAR FRESHWATER RES, V47, P637, DOI 10.1071/MF9960637; Tobin AJ, 2014, ENVIRON BIOL FISH, V97, P821, DOI 10.1007/s10641-013-0182-y; Walker Paddy, 2005, P71; Weeks SJ, 2015, REMOTE SENS-BASEL, V7, P3138, DOI 10.3390/rs70303138; Weideli OC, 2015, CORAL REEFS, V34, P835, DOI 10.1007/s00338-015-1290-2; Wilson SG, 2004, FISH OCEANOGR, V13, P283, DOI 10.1111/j.1365-2419.2004.00292.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	73	36	36	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150911	10.1371/journal.pone.0150911	http://dx.doi.org/10.1371/journal.pone.0150911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027502	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500012
J	Cai, KD; Luo, Q; Dai, ZW; Zhu, BX; Fei, JP; Xue, CP; Wu, D				Cai, Kedan; Luo, Qun; Dai, Zhiwei; Zhu, Beixia; Fei, Jinping; Xue, Congping; Wu, Dan			Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients	PLOS ONE			English	Article							LOW SERUM MAGNESIUM; CARDIOVASCULAR-DISEASE; CALCIUM; RISK; ATHEROSCLEROSIS; RECEPTOR; PROTEIN	Objective Hypomagnesemia has been associated with an increase in mortality among the general population as well as patients with chronic kidney disease or those on hemodialysis. However, this association has not been thoroughly studied in patients undergoing peritoneal dialysis. The aim of this study was to evaluate the association between serum magnesium concentrations and all-cause and cardiovascular mortalities in peritoneal dialysis patients. Methods This single-center retrospective study included 253 incident peritoneal dialysis patients enrolled between July 1, 2005 and December 31, 2014 and followed to June 30, 2015. Patient's demographic characteristics as well as clinical and laboratory measurements were collected. Results Of 253 patients evaluated, 36 patients (14.2%) suffered from hypomagnesemia. During a median follow-up of 29 months (range: 4-120 months), 60 patients (23.7%) died, and 35 (58.3%) of these deaths were attributed to cardiovascular causes. Low serum magnesium was positively associated with peritoneal dialysis duration (r = 0.303, p < 0.001) as well as serum concentrations of albumin (r = 0.220, p < 0.001), triglycerides (r = 0.160, p = 0.011), potassium (r = 0.156, p = 0.013), calcium(r = 0.299, p < 0.001) and phosphate (r = 0.191, p = 0.002). Patients in the hypomagnesemia group had a lower survival rate than those in the normal magnesium groups (p < 0.001). In a multivariate Cox proportional hazards regression analysis, serum magnesium was an independent negative predictor of all-cause mortality (hazard ratio [HR] = 0.075, p = 0.011) and cardiovascular mortality (HR = 0.003, p < 0.001), especially in female patients. However, in univariate and multivariate Cox analysis, Delta Mg(difference between 1-year magnesium and baseline magnesium) was not an independent predictor of all-cause mortality and cardiovascular mortality. Conclusion Hypomagnesemia was common among peritoneal dialysis patients and was independently associated with all-cause mortality and cardiovascular mortality.	[Cai, Kedan; Luo, Qun; Dai, Zhiwei; Zhu, Beixia; Fei, Jinping; Xue, Congping; Wu, Dan] Ningbo Univ, Sch Med, Ningbo Hosp 2, Dept Nephrol, Ningbo, Zhejiang, Peoples R China	Ningbo University	Luo, Q (corresponding author), Ningbo Univ, Sch Med, Ningbo Hosp 2, Dept Nephrol, Ningbo, Zhejiang, Peoples R China.	nbluoqun@163.com			Ningbo social-development fund [2015C50038]	Ningbo social-development fund	This work was supported by Ningbo social-development fund (2015C50038). Website: http://www.nbsti.gov.cn/gb/Project/ContentByXml.aspx? CID=00671&CID1=00441&CID2=00442&CID3=00448&CID4=00671&Info_ID=6612706f-2380-4261-b858-eee50c1698ea&Page=1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANNAN PG, 1976, J CLIN INVEST, V57, P1412, DOI 10.1172/JCI108410; Chang WH, 1998, J BONE MINER RES, V13, P570, DOI 10.1359/jbmr.1998.13.4.570; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chiuve SE, 2011, AM J CLIN NUTR, V93, P253, DOI 10.3945/ajcn.110.002253; Cho Min Seok, 2002, Korean Journal of Internal Medicine, V17, P114; Dmitrieva NI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128870; EJAZ AA, 1995, PERITON DIALYSIS INT, V15, P61; Fein Paul, 2010, Adv Perit Dial, V26, P112; Fein Paula, 2014, Adv Perit Dial, V30, P90; FERMENT O, 1987, J ENDOCRINOL, V113, P117, DOI 10.1677/joe.0.1130117; Fouque D, 2011, KIDNEY INT, V80, P348, DOI 10.1038/ki.2011.118; Han SH, 2008, PERITON DIALYSIS INT, V28, pS21; Kanbay M, 2012, AM J NEPHROL, V36, P228, DOI 10.1159/000341868; Matias PJ, 2014, BLOOD PURIFICAT, V38, P244, DOI 10.1159/000366124; Navarro-Gonzalez JF, 2009, SEMIN DIALYSIS, V22, P37, DOI 10.1111/j.1525-139X.2008.00530.x; Qu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057720; Reffelmann T, 2011, ATHEROSCLEROSIS, V219, P280, DOI 10.1016/j.atherosclerosis.2011.05.038; ROSEN EU, 1970, J PEDIATR-US, V77, P709, DOI 10.1016/S0022-3476(70)80220-7; Ruat M, 1996, J BIOL CHEM, V271, P5972, DOI 10.1074/jbc.271.11.5972; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Silva AP, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/308190; Stenvinkel P, 2001, PERITON DIALYSIS INT, V21, pS157; Suzuki K, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/231018; Tin A, 2015, KIDNEY INT, V87, P820, DOI 10.1038/ki.2014.331; Van Laecke S, 2013, AM J MED, V126, P825, DOI 10.1016/j.amjmed.2013.02.036; van Zuijdewijn CLMD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143104; Wang AYM, 2003, J AM SOC NEPHROL, V14, P159, DOI 10.1097/01.ASN.0000038685.95946.83; Ye HJ, 2013, PERITON DIALYSIS INT, V33, P450, DOI 10.3747/pdi.2012.00164; Zhang F, 2015, PERITON DIALYSIS INT, V35, P199, DOI 10.3747/pdi.2013.00164; Zhang W, 2012, ATHEROSCLEROSIS, V221, P587, DOI 10.1016/j.atherosclerosis.2012.01.034	30	35	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152488	10.1371/journal.pone.0152488	http://dx.doi.org/10.1371/journal.pone.0152488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023783	gold, Green Published, Green Submitted			2022-12-26	WOS:000373113900064
J	Vikram, P; Swamy, BPM; Dixit, S; Trinidad, J; Cruz, MTS; Maturan, PC; Amante, M; Kumar, A				Vikram, Prashant; Swamy, B. P. Mallikarjuna; Dixit, Shalabh; Trinidad, Jennylyn; Cruz, Ma Teresa Sta; Maturan, Paul C.; Amante, Modesto; Kumar, Arvind			Linkages and Interactions Analysis of Major Effect Drought Grain Yield QTLs in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC ARCHITECTURE; REPRODUCTIVE-STAGE; COMPLEX TRAITS; TOLERANCE; IDENTIFICATION; STRESS; RESISTANCE	Quantitative trait loci conferring high grain yield under drought in rice are important genomic resources for climate resilient breeding. Major and consistent drought grain yield QTLs usually co-locate with flowering and/or plant height QTLs, which could be due to either linkage or pleiotropy. Five mapping populations used for the identification of major and consistent drought grain yield QTLs underwent multiple-trait, multiple-interval mapping test (MT-MIM) to estimate the significance of pleiotropy effects. Results indicated towards possible linkages between the drought grain yield QTLs with co-locating flowering and/or plant height QTLs. Linkages of days to flowering and plant height were eliminated through a markerassisted breeding approach. Drought grain yield QTLs also showed interaction effects with flowering QTLs. Drought responsiveness of the flowering locus on chromosome 3 (qDTY(3.2)) has been revealed through allelic analysis. Considering linkage and interaction effects associated with drought QTLs, a comprehensive marker-assisted breeding strategy was followed to develop rice genotypes with improved grain yield under drought stress.	[Vikram, Prashant; Swamy, B. P. Mallikarjuna; Dixit, Shalabh; Trinidad, Jennylyn; Cruz, Ma Teresa Sta; Maturan, Paul C.; Amante, Modesto; Kumar, Arvind] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Metro Manila, Philippines; [Vikram, Prashant] CIMMYT, Genet Resource Program, El Batan, Texcoco, Mexico	CGIAR; International Rice Research Institute (IRRI); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Vikram, P; Kumar, A (corresponding author), Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Metro Manila, Philippines.; Vikram, P (corresponding author), CIMMYT, Genet Resource Program, El Batan, Texcoco, Mexico.	p.vikram@cgiar.org; a.kumar@irri.org	Kumar, Arvind/N-3181-2017	Kumar, Arvind/0000-0002-5488-9410; Vikram, Prashant/0000-0002-3740-6608	Bill & Mellinda Gates Foundation (BMGF)	Bill & Mellinda Gates Foundation (BMGF)	Bill & Mellinda Gates Foundation (BMGF) funded Project: Stress Tolerant Rice for Poor Farmers of South Asia and Africa (STRASA), http://strasa.irri.org/.	Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Comstock R.E., 1978, MAIZE BREEDING GENET, P191; Deng SM, 2011, THEOR APPL GENET, V122, P281, DOI 10.1007/s00122-010-1443-1; Dixit S, 2012, MOL BREEDING, V30, P1767, DOI 10.1007/s11032-012-9760-5; Ghimire KH, 2012, FIELD CROP RES, V131, P88, DOI 10.1016/j.fcr.2012.02.028; Gomez SM, 2010, ACTA PHYSIOL PLANT, V32, P355, DOI 10.1007/s11738-009-0413-1; Hittalmani S, 2002, EUPHYTICA, V125, P207, DOI 10.1023/A:1015890125247; JIANG CJ, 1995, GENETICS, V140, P1111; Joehanes R, 2009, THESIS; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Kao CH, 1999, GENETICS, V152, P1203; Kumar R, 2007, FIELD CROP RES, V103, P42, DOI 10.1016/j.fcr.2007.04.013; Kumawat G, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-84; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; LANDER ES, 1989, GENETICS, V121, P185; LEBRETON C, 1995, J EXP BOT, V46, P853, DOI 10.1093/jxb/46.7.853; Lin HX, 2002, BREEDING SCI, V52, P35, DOI 10.1270/jsbbs.52.35; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Mishra KK, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-12; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Shashidhar H. E., 1999, Genetic improvement of rice for water-limited environments., P239; Swamy BPM, 2011, IRRIGATION SYSTEMS P, P149; Tuberosa R, 2006, TRENDS PLANT SCI, V11, P405, DOI 10.1016/j.tplants.2006.06.003; Venuprasad R, 2007, CROP SCI, V47, P285, DOI 10.2135/cropsci2006.03.0181; Venuprasad R, 2012, MOL BREEDING, V30, P535, DOI 10.1007/s11032-011-9642-2; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Vikram P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14799; Vikram P, 2012, FIELD CROP RES, V134, P185, DOI 10.1016/j.fcr.2012.05.012; Vikram P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-89; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1996, ACTA AGRON SIN, V22, P535	34	34	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151532	10.1371/journal.pone.0151532	http://dx.doi.org/10.1371/journal.pone.0151532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018583	Green Published, gold, Green Submitted			2022-12-26	WOS:000372807800015
J	Worrillow, L; Baskaran, P; Care, MA; Varghese, A; Munir, T; Evans, PA; O'Connor, SJ; Rawstron, A; Hazelwood, L; Tooze, RM; Hillmen, P; Newton, DJ				Worrillow, L.; Baskaran, P.; Care, M. A.; Varghese, A.; Munir, T.; Evans, P. A.; O'Connor, S. J.; Rawstron, A.; Hazelwood, L.; Tooze, R. M.; Hillmen, P.; Newton, D. J.			An ultra-deep sequencing strategy to detect sub-clonal TP53 mutations in presentation chronic lymphocytic leukaemia cases using multiple polymerases	ONCOGENE			English	Article							SUBCLONAL MUTATIONS; 17P DELETION; MUTANT P53; EVOLUTION; THERAPY; ALEMTUZUMAB; FLUDARABINE; RESISTANCE; SURVIVAL; IMPACT	Chronic lymphocytic leukaemia (CLL) is the most common clonal B-cell disorder characterized by clonal diversity, a relapsing and remitting course, and in its aggressive forms remains largely incurable. Current front-line regimes include agents such as fludarabine, which act primarily via the DNA damage response pathway. Key to this is the transcription factor p53. Mutations in the TP53 gene, altering p53 functionality, are associated with genetic instability, and are present in aggressive CLL. Furthermore, the emergence of clonal TP53 mutations in relapsed CLL, refractory to DNA-damaging therapy, suggests that accurate detection of sub-clonal TP53 mutations prior to and during treatment may be indicative of early relapse. In this study, we describe a novel deep sequencing workflow using multiple polymerases to generate sequencing libraries (MuPol-Seq), facilitating accurate detection of TP53 mutations at a frequency as low as 0.3%, in presentation CLL cases tested. As these mutations were mostly clustered within the regions of TP53 encoding DNA-binding domains, essential for DNA contact and structural architecture, they are likely to be of prognostic relevance in disease progression. The workflow described here has the potential to be implemented routinely to identify rare mutations across a range of diseases.	[Worrillow, L.; Care, M. A.; Tooze, R. M.; Hillmen, P.; Newton, D. J.] Univ Leeds, Leeds Inst Canc & Pathol, Sect Expt Haematol, Leeds LS9 7TF, W Yorkshire, England; [Baskaran, P.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany; [Varghese, A.; Munir, T.; Evans, P. A.; O'Connor, S. J.; Rawstron, A.] Leeds Teaching Hosp Natl Hlth Serv Trust, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England; [Hazelwood, L.] Univ Cambridge, Canc Res UK, Ling Ka Shing Ctr, Cambridge, England	University of Leeds; Max Planck Society; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Newton, DJ (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Sect Expt Haematol, Leeds LS9 7TF, W Yorkshire, England.	D.J.Newton@leeds.ac.uk	Newton, Darren/CAA-0475-2022; Care, Matthew/P-2987-2019	Care, Matthew/0000-0001-6584-5889; Tooze, Reuben/0000-0003-2915-7119; Baskaran, Praveen/0000-0003-2275-3516	Kay Kendall Leukaemia Fund	Kay Kendall Leukaemia Fund	This project was funded by the Kay Kendall Leukaemia Fund (www.kklf.org.uk). We would also like to thank the staff in the Haematological Malignancy Diagnostic Services Unit at Leeds Teaching Hospital who provided information on diagnostic patient data and samples for the study, and the sequencing facility at the University of Leeds who provided a technical service running the Illumina next-generation sequencing systems.	Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Delgado J, 2012, BRIT J HAEMATOL, V157, P67, DOI 10.1111/j.1365-2141.2011.09000.x; Dicker F, 2009, LEUKEMIA, V23, P117, DOI 10.1038/leu.2008.274; DOHNER H, 1995, BLOOD, V85, P1580, DOI 10.1182/blood.V85.6.1580.bloodjournal8561580; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Gonzalez D, 2011, J CLIN ONCOL, V29, P2223, DOI 10.1200/JCO.2010.32.0838; Gravanis I, 2010, ONCOLOGIST, V15, P1335, DOI 10.1634/theoncologist.2010-0255; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grollman AP, 2007, P NATL ACAD SCI USA, V104, P12129, DOI 10.1073/pnas.0701248104; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Huggett JF, 2015, CLIN CHEM, V61, P79, DOI 10.1373/clinchem.2014.221366; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jethwa A, 2013, BRIT J HAEMATOL, V163, P496, DOI 10.1111/bjh.12539; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; KNUDSON AG, 1991, MUTAT RES, V247, P185, DOI 10.1016/0027-5107(91)90013-E; Komarova NL, 2014, P NATL ACAD SCI USA, V111, P13906, DOI 10.1073/pnas.1409362111; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lozanski G, 2004, BLOOD, V103, P3278, DOI 10.1182/blood-2003-10-3729; Malcikova J, 2015, LEUKEMIA, V29, P877, DOI 10.1038/leu.2014.297; Mclnerney P, 2014, MOL BIOL INT, V2014; Mohr J, 2011, BLOOD, V117, P1622, DOI 10.1182/blood-2010-08-300160; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; Ojha J, 2015, BLOOD, V125, P492, DOI 10.1182/blood-2014-06-580563; Olivier M, 2009, CANCER GENE THER, V16, P1, DOI 10.1038/cgt.2008.69; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Rossi D, 2014, BLOOD, V123, P2139, DOI 10.1182/blood-2013-11-539726; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Stieglitz E, 2015, BLOOD, V125, P516, DOI 10.1182/blood-2014-09-601690; Stilgenbauer S, 2009, J CLIN ONCOL, V27, P3994, DOI 10.1200/JCO.2008.21.1128; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Tian K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072303; Tsao SCH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11198; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wawrzyniak E, 2014, EUR J HAEMATOL, V92, P91, DOI 10.1111/ejh.12215; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Zenz T, 2010, J CLIN ONCOL, V28, P4473, DOI 10.1200/JCO.2009.27.8762; Zenz T, 2009, BLOOD, V114, P2589, DOI 10.1182/blood-2009-05-224071; Zenz T, 2008, CELL CYCLE, V7, P3810, DOI 10.4161/cc.7.24.7245	48	3	3	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5328	5336		10.1038/onc.2016.73	http://dx.doi.org/10.1038/onc.2016.73			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	27041575	Green Accepted			2022-12-26	WOS:000386053000011
J	Udwan, K; Brideau, G; Fila, M; Edwards, A; Vogt, B; Doucet, A				Udwan, Khalil; Brideau, Gaelle; Fila, Marc; Edwards, Aurelie; Vogt, Bruno; Doucet, Alain			Oxidative Stress and Nuclear Factor B (NF-B) Increase Peritoneal Filtration and Contribute to Ascites Formation in Nephrotic Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						albumin; NF-kappa B (NF-KB); oxidative stress; permeability; water channel	TUMOR-NECROSIS-FACTOR; KAPPA-B; INTRAPERITONEAL PRESSURE; HYDRAULIC CONDUCTIVITY; ALPHA; ACTIVATION; TRANSPORT; MECHANISM; REVEALS; FLUID	Water accumulation in the interstitium (edema) and the peritoneum (ascites) of nephrotic patients is classically thought to stem from the prevailing low plasma albumin concentration and the decreased transcapillary oncotic pressure gradient. However, several clinical and experimental observations suggest that it might also stem from changes in capillary permeability. We addressed this hypothesis by studying the peritoneum permeability of rats with puromycin aminonucleoside-induced nephrotic syndrome. The peritoneum of puromycin aminonucleoside rats displayed an increase in the water filtration coefficient of paracellular and transcellular pathways, and a decrease in the reflection coefficient to proteins. It also displayed oxidative stress and subsequent activation of NF-B. Scavenging of reactive oxygen species and inhibition of NF-B prevented the changes in the water permeability and reflection coefficient to proteins and reduced the volume of ascites by over 50%. Changes in water permeability were associated with the overexpression of the water channel aquaporin 1, which was prevented by reactive oxygen species scavenging and inhibition of NF-B. In conclusion, nephrotic syndrome is associated with an increased filtration coefficient of the peritoneum and a decreased reflection coefficient to proteins. These changes, which account for over half of ascite volume, are triggered by oxidative stress and subsequent activation of NF-B.	[Udwan, Khalil; Brideau, Gaelle; Fila, Marc; Edwards, Aurelie; Doucet, Alain] Univ Paris 05, Univ Paris 06, Sorbonne Univ,Ctr Rech Cordeliers,ERL8228, INSERM,Sorbonne Paris Cite,UMR S 1138,CNRS, F-75006 Paris, France; [Fila, Marc] Univ Paris 07, Ctr Hosp Univ CHU Robert Debre, APHP, Dept Pediat Nephrol, F-75020 Paris, France; [Vogt, Bruno] Univ Hosp Bern, Inselspital, Dept Nephrol & Hypertens, CH-3010 Bern, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Bern; University Hospital of Bern	Doucet, A (corresponding author), Ctr Rech Cordeliers, ERL8228, 15 Rue Ecole Med, F-75270 Paris 06, France.	alain.doucet@crc.jussieu.fr	Vogt, Bruno/AAS-2876-2020	Vogt, Bruno/0000-0002-1548-6387	Fondation du Rein (Prix Syndrome Nephrotique FDR/FRM Alain Doucet); An-Najah University (Nablus, Palestine); UPMC (Paris, France)	Fondation du Rein (Prix Syndrome Nephrotique FDR/FRM Alain Doucet); An-Najah University (Nablus, Palestine); UPMC (Paris, France)	This work was supported in part by a grant from the Fondation du Rein (Prix Syndrome Nephrotique 2012 FDR/FRM Alain Doucet). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by grants from An-Najah University (Nablus, Palestine) and UPMC (Paris, France).	Adamson RH, 2014, AM J PHYSIOL-HEART C, V306, pH1011, DOI 10.1152/ajpheart.00829.2013; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; Broyer M., 1998, OXFORD TXB CLIN NEPH, P493; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Cameron J., 1998, OXFORD TXB CLIN NEPH, P461; Cheng XL, 2015, BIOCHEM BIOPH RES CO, V461, P275, DOI 10.1016/j.bbrc.2015.04.015; Dechenes G, 2000, J AM SOC NEPHROL, V11, P604, DOI 10.1681/ASN.V114604; Devuyst O, 2014, KIDNEY INT, V85, P750, DOI 10.1038/ki.2013.250; Ece A, 2005, PEDIATR NEPHROL, V20, P1279, DOI 10.1007/s00467-005-1956-z; Evans TW, 2002, ALIMENT PHARM THER, V16, P6, DOI 10.1046/j.1365-2036.16.s5.2.x; FAUCHALD P, 1985, ACTA MED SCAND, V217, P127; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Flessner MF, 2005, AM J PHYSIOL-RENAL, V288, pF433, DOI 10.1152/ajprenal.00313.2004; Granqvist A, 2010, AM J PHYSIOL-RENAL, V299, pF898, DOI 10.1152/ajprenal.00124.2010; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; KOOMANS HA, 1985, NEPHRON, V40, P391, DOI 10.1159/000183505; Kumar A, 2011, DIABETES OBES METAB, V13, P750, DOI 10.1111/j.1463-1326.2011.01402.x; Lewis DM, 1998, KIDNEY INT, V54, P1261, DOI 10.1046/j.1523-1755.1998.00100.x; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Ma T, 2013, INT UROL NEPHROL, V45, P1187, DOI 10.1007/s11255-012-0355-1; MALIK AB, 1985, FED PROC, V44, P36; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Matsumura H, 2006, CLIN NEPHROL, V66, P405; Minnear FL, 2005, AM J PHYSIOL-HEART C, V289, pH840, DOI 10.1152/ajpheart.00026.2005; Mishra OP, 2011, PEDIATR NEPHROL, V26, P251, DOI 10.1007/s00467-010-1696-6; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; NITTA S, 1981, TOHOKU J EXP MED, V135, P43, DOI 10.1620/tjem.135.43; OLIVER WJ, 1963, J LAB CLIN MED, V62, P449; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Rippe B, 2006, PERITON DIALYSIS INT, V26, P317; Rusthoven E, 2005, PERITON DIALYSIS INT, V25, P352; SCHIEVEN GL, 1993, BLOOD, V82, P1212, DOI 10.1182/blood.V82.4.1212.bloodjournal8241212; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Skinner RA, 1999, J TRAUMA, V47, P486, DOI 10.1097/00005373-199909000-00009; Su X, 2004, RESP PHYSIOL NEUROBI, V142, P1, DOI 10.1016/j.resp.2004.05.001; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Waniewski J, 2009, AM J PHYSIOL-HEART C, V296, pH1960, DOI 10.1152/ajpheart.00121.2009; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Zhang CX, 2014, ONCOTARGET, V5, P4392, DOI 10.18632/oncotarget.2025; Zhao LX, 2012, J CELL MOL MED, V16, P1840, DOI 10.1111/j.1582-4934.2011.01479.x	42	8	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11105	11113		10.1074/jbc.M116.724690	http://dx.doi.org/10.1074/jbc.M116.724690			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033704	Green Published, hybrid			2022-12-26	WOS:000377042100014
J	Kahana, SY; Jenkins, RA; Bruce, D; Fernandez, MI; Hightow-Weidman, LB; Bauermeister, JA				Kahana, Shoshana Y.; Jenkins, Richard A.; Bruce, Douglas; Fernandez, Maria I.; Hightow-Weidman, Lisa B.; Bauermeister, Jose A.		Adolescent Med Trials Network HIV	Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIV	PLOS ONE			English	Article							RESIDENTIAL SEGREGATION; UNITED-STATES; RACIAL DISPARITIES; HEALTH; ADHERENCE; PEOPLE; YOUTH; RISK; NONADHERENCE; HIV/AIDS	Background The authors examined associations between structural characteristics and HIV disease management among a geographically diverse sample of behaviorally and perinatally HIV-infected adolescents and young adults in the United States. Methods The sample included 1891 adolescents and young adults living with HIV (27.8% perinatally infected; 72.2% behaviorally infected) who were linked to care through 20 Adolescent Medicine Trials Network for HIV/AIDS Interventions Units. All completed audio computer-assisted self-interview surveys. Chart abstraction or blood draw provided viral load data. Geographic-level variables were extracted from the United States Census Bureau (e.g., socioeconomic disadvantage, percent of Black and Latino households, percent rural) and Esri Crime (e.g., global crime index) databases as Zip Code Tabulation Areas. AIDSVu data (e.g., prevalence of HIV among youth) were extracted at the county-level. Using HLM v.7, the authors conducted means-as-outcomes random effects multi-level models to examine the association between structural-level and individual-level factors and (1) being on antiretroviral therapy (ART) currently; (2) being on ART for at least 6 months; (3) missed HIV care appointments (not having missed any vs. having missed one or more appointments) over the past 12 months; and (4) viral suppression (defined by the corresponding assay cutoff for the lower limit of viral load at each participating site which denoted nondetectability vs. detectability). Results Frequencies for the 4 primary outcomes were as follows: current ART use (n = 1120, 59.23%); ART use for >= 6 months (n = 861, 45.53%); at least one missed HIV care appointment (n = 936, 49.50); and viral suppression (n = 577, 30.51%). After adjusting for individual-level factors, youth living in more disadvantaged areas (defined by a composite score derived from 2010 Census indicators including percent poverty, percent receiving public assistance, percent of female, single-headed households, percent unemployment, and percent of people with less than a high school degree) were less likely to report current ART use (OR: 0.85, 95% CI: 0.72-1.00, p = .05). Among current ART users, living in more disadvantaged areas was associated with greater likelihood of having used ART for >= 6 months. Participants living in counties with greater HIV prevalence among 13-24 year olds were more likely to report current ART use (OR: 1.32, 95% CI: 1.05-1.65, p = .02), >= 6 months ART use (OR: 1.32, 95% CI: 1.05-1.65, p = .02), and to be virally suppressed (OR: 1.50, 95% CI: 1.20-1.87, p = .001); however, youth in these areas were also more likely to report missed medical appointments (OR: 1.32, 95% CI: 1.07-1.63, p = .008). Conclusions The findings underscore the multi-level and structural factors associated with ART use, missed HIV care appointments, and viral suppression for adolescents and young adults in the United States. Consideration of these factors is strongly recommended in future intervention, clinical practice, and policy research that seek to understand the contextual influences on individuals' health behaviors.	[Kahana, Shoshana Y.; Jenkins, Richard A.] NIDA, Div Epidemiol Serv & Prevent Res, NIH, Bethesda, MD 20892 USA; [Bruce, Douglas] Depaul Univ, Dept Hlth Sci, Chicago, IL 60604 USA; [Fernandez, Maria I.] Nova SE Univ, Dept Prevent Med, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Fernandez, Maria I.] Nova SE Univ, Dept Publ Hlth Program, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Hightow-Weidman, Lisa B.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Bauermeister, Jose A.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); DePaul University; Nova Southeastern University; Nova Southeastern University; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan	Kahana, SY (corresponding author), NIDA, Div Epidemiol Serv & Prevent Res, NIH, Bethesda, MD 20892 USA.	kahanas@mail.nih.gov	Bauermeister, Jose/X-8960-2018	Bauermeister, Jose/0000-0002-9276-2306; Bruce, Douglas/0000-0002-2137-7099	Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) from National Institutes of Health through National Institute of Child Health and Human Development [U01 HD 040533, U01 HD 040474]; National Institutes on Drug Abuse and Mental Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD040533, U01HD040474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069415] Funding Source: NIH RePORTER	Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) from National Institutes of Health through National Institute of Child Health and Human Development; National Institutes on Drug Abuse and Mental Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) from the National Institutes of Health [U01 HD 040533 and U01 HD 040474] through the National Institute of Child Health and Human Development, with supplemental funding from the National Institutes on Drug Abuse and Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2003, AM J PUBLIC HEALTH, V93, P215, DOI 10.2105/AJPH.93.2.215; Ali R, 2002, ADDICTION, V97, P1183; Allison PD, 2009, FIXED EFFECT REGRESS; Bauermeister JA, 2015, AIDS BEHAV; Bauermeister JA, BEHAV MED IN PRESS; Bauermeister JA, 2011, J URBAN HEALTH, V88, P66, DOI 10.1007/s11524-010-9506-9; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Bowleg L, 2014, AIDS BEHAV, V18, P2207, DOI 10.1007/s10461-014-0803-2; Bruce D, 2015, DRUG ALCOHOL DEPEN, V151, P173, DOI 10.1016/j.drugalcdep.2015.03.017; Bundock H, 2011, AIDS PATIENT CARE ST, V25, P465, DOI 10.1089/apc.2010.0279; Charania MR, 2011, AIDS BEHAV, V15, P1283, DOI 10.1007/s10461-010-9812-y; Cooper HLF, 2016, INT J DRUG POLICY, V27, P43, DOI 10.1016/j.drugpo.2015.07.015; Davies G, 2006, AIDS CARE, V18, P895, DOI 10.1080/09540120500329556; Eaton LA, 2015, AM J PUBLIC HEALTH, V105, pE75, DOI 10.2105/AJPH.2014.302322; Eberhart MG, 2015, JAIDS-J ACQ IMM DEF, V69, pS37, DOI 10.1097/QAI.0000000000000587; Fair CD, 2010, PSYCHOL HEALTH MED, V15, P515, DOI 10.1080/13548506.2010.493944; Friedman SR, 2005, J URBAN HEALTH, V82, P434, DOI 10.1093/jurban/jti088; Gaston GB, 2013, AIDS BEHAV, V17, P31, DOI 10.1007/s10461-012-0323-x; Glaeser E.L., 2010, AGGLOMERATION EC, P1, DOI DOI 10.7208/CHICAGO/9780226297927.001.0001; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Hartzell JD, 2007, JAIDS-J ACQ IMM DEF, V44, P411, DOI 10.1097/QAI.0b013e31802f83a6; Health Resources and Services Administration (HRSA), 2013, CREAT JAIL LINK PROG; Heslin KC, 2005, J GEN INTERN MED, V20, P283, DOI 10.1111/j.1525-1497.2005.40109.x; Hosek Sybil G, 2005, Psychol Health Med, V10, P166; Johns MM, 2010, AIDS EDUC PREV, V22, P509, DOI 10.1521/aeap.2010.22.6.509; Kahana SY, 2015, JAIDS-J ACQ IMM DEF, V68, P169, DOI 10.1097/QAI.0000000000000408; Kahn JG, 2002, PUBLIC HEALTH REP, V117, P252, DOI 10.1016/S0033-3549(04)50159-0; Kalichman SC, 2014, J COMMUN HEALTH, V39, P1133, DOI 10.1007/s10900-014-9868-0; Kim SH, 2015, AIDS PATIENT CARE ST, V29, P354, DOI 10.1089/apc.2014.0335; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075878; Latkin CA, 2013, AM PSYCHOL, V68, P210, DOI 10.1037/a0032704; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Mavedzenge SN, 2013, EFFECTIVENESS HIV PR; Mellins CA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18593; Mellins CA, 2011, AIDS PATIENT CARE ST, V25, P413, DOI 10.1089/apc.2011.0025; Millett G, 2013, INT C HIV TREATM PRE; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Park WB, 2007, J INTERN MED, V261, P268, DOI 10.1111/j.1365-2796.2006.01762.x; Philbin MM, 2014, AIDS CARE, V26, P12, DOI 10.1080/09540121.2013.808730; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Raymond HF, 2014, AIDS BEHAV, V18, P346, DOI 10.1007/s10461-013-0508-y; Ribaudo HJ, 2013, CLIN INFECT DIS, V57, P1607, DOI 10.1093/cid/cit595; Riley ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035207; Saha S, 2013, J GEN INTERN MED, V28, P622, DOI 10.1007/s11606-012-2298-8; Schackman BR, 2007, JAIDS-J ACQ IMM DEF, V46, P547, DOI 10.1097/QAI.0b013e31815ac499; Shacham E, 2013, HIV MED, V14, P624, DOI 10.1111/hiv.12067; Sheppard S, 2014, WILLIAMS COLL EC DEP, P1; Spector SA, 2000, J INFECT DIS, V182, P1769, DOI 10.1086/317621; Sprague C, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-28; Trepka MJ, 2013, AM J PUBLIC HEALTH, V103, P717, DOI 10.2105/AJPH.2012.300930; US Department of Health and Human Services, PROF BLACK AFR AM; White K, 2012, HEALTH SERV RES, V47, P1278, DOI 10.1111/j.1475-6773.2012.01410.x; Whitmore Suzanne K., 2012, Morbidity and Mortality Weekly Report, V61, P971; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Wolitski RJ, 2010, AIDS BEHAV, V14, P493, DOI 10.1007/s10461-009-9643-x; Zanoni BC, 2014, AIDS PATIENT CARE ST, V28, P128, DOI 10.1089/apc.2013.0345; Zierler S, 2000, AM J PUBLIC HEALTH, V90, P1064, DOI 10.2105/AJPH.90.7.1064	60	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0151106	10.1371/journal.pone.0151106	http://dx.doi.org/10.1371/journal.pone.0151106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035905	Green Published, gold, Green Submitted			2022-12-26	WOS:000373201200006
J	Cai, SX; Yang, H; Zeng, KW; Zhang, J; Zhong, N; Wang, YZ; Ye, J; Tu, PF; Liu, ZH				Cai, Shuxian; Yang, Heng; Zeng, Kewu; Zhang, Jing; Zhong, Ni; Wang, Yingzi; Ye, Jing; Tu, Pengfei; Liu, Zhonghua			EGCG Inhibited Lipofuscin Formation Based on Intercepting Amyloidogenic beta-Sheet-Rich Structure Conversion	PLOS ONE			English	Article							PROTEINS; PATHWAY; BINDING; P62; AGGREGATION; ACTIVATION; OLIGOMERS; DISEASES; FIBRILS; DAMAGE	Background Lipofuscin (LF) is formed during lipid peroxidation and sugar glycosylation by carbonylamino crosslinks with biomacrolecules, and accumulates slowly within postmitotic cells. The environmental pollution, modern dietary culture and lifestyle changes have been found to be the major sources of reactive carbonyl compounds in vivo. Irreversible carbonyl-amino crosslinks induced by carbonyl stress are essentially toxiferous for aging-related functional losses in modern society. Results show that (-)-epigallocatechin gallate (EGCG), the main polyphenol in green tea, can neutralize the carbonyl-amino cross-linking reaction and inhibit LF formation, but the underlying mechanism is unknown. Methods and Results We explored the mechanism of the neutralization process from protein, cell, and animal levels using spectrofluorometry, infrared spectroscopy, conformation antibodies, and electron microscopy. LF demonstrated an amyloidogenic beta-sheet-rich with antiparallel structure, which accelerated the carbonyl-amino crosslinks formation and disrupted proteolysis in both PC12 cells and D-galactose (D-gal)-induced brain aging mice models. Additionally, EGCG effectively inhibited the formation of the amyloidogenic beta-sheet-rich structure of LF, and prevented its conversion into toxic and on-pathway aggregation intermediates, thereby cutting off the carbonyl-amino crosslinks. Conclusions Our study indicated that the amyloidogenic beta-sheet structure of LF may be the core driving force for carbonyl-amino crosslinks further formation, which mediates the formation of amyloid fibrils from native state of biomacrolecules. That EGCG exhibits anti-amyloidogenic beta-sheet-rich structure properties to prevent the LF formation represents a novel strategy to impede the development of degenerative processes caused by ageing or stress-induced premature senescence in modern environments.	[Cai, Shuxian; Zeng, Kewu; Ye, Jing; Tu, Pengfei] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Yang, Heng; Zhang, Jing; Zhong, Ni; Wang, Yingzi; Liu, Zhonghua] Hunan Agr Univ, Coinnovat Ctr Utilizat Bot Funct Ingredients, Changsha 410128, Hunan, Peoples R China	Peking University; Hunan Agricultural University	Tu, PF (corresponding author), Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Hlth Sci Ctr, Beijing 100191, Peoples R China.; Liu, ZH (corresponding author), Hunan Agr Univ, Coinnovat Ctr Utilizat Bot Funct Ingredients, Changsha 410128, Hunan, Peoples R China.	pengfeitu@bjmu.edu.cn; larkin-liu@163.com	Tu, Peng Fei/E-2089-2018; Ke-wu, Zeng/U-6930-2019		National Natural Science Foundation of China [31471590, 31100501, 81172944]; China Postdoctoral Science Foundation [2014M560024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Natural Science Foundation of China (Nos. 31471590, 31100501 and 81172944), the China Postdoctoral Science Foundation (No. 2014M560024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Burcham PC, 1996, BIOCHEM BIOPH RES CO, V220, P996, DOI 10.1006/bbrc.1996.0521; Cai SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075687; Cai SX, 2011, J MED PLANTS RES, V5, P5470; Cai ShuXian, 2010, Journal of Tea Science, V30, P1; Caine S, 2012, NEUROIMAGE, V59, P3624, DOI 10.1016/j.neuroimage.2011.11.033; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; Davis CM, 2014, BIOCHEMISTRY-US, V53, P5476, DOI 10.1021/bi500556h; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Di Domizio J, 2012, J BIOL CHEM, V287, P736, DOI 10.1074/jbc.M111.238477; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fukunaga S, 2012, BIOCHEMISTRY-US, V51, P8125, DOI 10.1021/bi300839u; Goh BC, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12027-8; Hohn A, 2014, FREE RADICAL BIO MED, V71, P70, DOI 10.1016/j.freeradbiomed.2014.02.028; Hohn A, 2011, FREE RADICAL BIO MED, V50, P585, DOI 10.1016/j.freeradbiomed.2010.12.011; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; KIKUGAWA K, 1980, CHEM PHARM BULL, V28, P3323; Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002; Lu J, 2010, BRAIN PATHOL, V20, P952, DOI 10.1111/j.1750-3639.2010.00397.x; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Peyroux J, 2006, PATHOL BIOL, V54, P405, DOI 10.1016/j.patbio.2006.07.006; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Wu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050483; Yin DZ, 2016, CURR TOP MED CHEM, V16, P503, DOI 10.2174/1568026615666150813142854; Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zeng KW, 2014, CANCER LETT, V353, P220, DOI 10.1016/j.canlet.2014.07.022	39	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152064	10.1371/journal.pone.0152064	http://dx.doi.org/10.1371/journal.pone.0152064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030967	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800032
J	Elisia, I; Nakamura, H; Lam, V; Hofs, E; Cederberg, R; Cait, J; Hughes, MR; Lee, L; Jia, W; Adomat, HH; Guns, ES; McNagny, KM; Samudio, I; Krystal, G				Elisia, Ingrid; Nakamura, Hisae; Lam, Vivian; Hofs, Elyse; Cederberg, Rachel; Cait, Jessica; Hughes, Michael R.; Lee, Leora; Jia, William; Adomat, Hans H.; Guns, Emma S.; McNagny, Kelly M.; Samudio, Ismael; Krystal, Gerald			DMSO Represses Inflammatory Cytokine Production from Human Blood Cells and Reduces Autoimmune Arthritis	PLOS ONE			English	Article							DIMETHYL-SULFOXIDE DMSO; GENE-EXPRESSION; K/BXN MOUSE; DIMETHYLSULFOXIDE; MODEL; ABSORPTION; METABOLISM; EXCRETION; MELANOMA; GROWTH	Dimethyl sulfoxide (DMSO) is currently used as an alternative treatment for various inflammatory conditions as well as for cancer. Despite its widespread use, there is a paucity of data regarding its safety and efficacy as well as its mechanism of action in human cells. Herein, we demonstrate that DMSO has ex-vivo anti-inflammatory activity using Escherichia coli-(E. coli) and herpes simplex virus-1 (HSV-1)-stimulated whole human blood. Specifically, we found that between 0.5%-2%, DMSO significantly suppressed the expression of many pro-inflammatory cytokines/chemokines and prostaglandin E-2 (PGE(2)). However, a significant reduction in monocyte viability was also observed at 2% DMSO, suggesting a narrow window of efficacy. Anti-inflammatory concentrations of DMSO suppressed E. coli-induced ERK1/2, p38, JNK and Akt phosphorylation, suggesting DMSO acts on these signaling pathways to suppress inflammatory cytokine/chemokine production. Although DMSO induces the differentiation of B16/F10 melanoma cells in vitro, topical administration of DMSO to mice subcutaneously implanted with B16 melanoma cells was ineffective at reducing tumor growth, DMSO was also found to block mouse macrophages from polarizing to either an M1- or an M2-phenotype, which may contribute to its inability to slow tumor growth. Topical administration of DMSO, however, significantly mitigated K/BxN serum-induced arthritis in mice, and this was associated with reduced levels of pro-inflammatory cytokines in the joints and white blood cell levels in the blood. Thus, while we cannot confirm the efficacy of DMSO as an anti-cancer agent, the use of DMSO in arthritis warrants further investigation to ascertain its therapeutic potential.	[Elisia, Ingrid; Nakamura, Hisae; Lam, Vivian; Hofs, Elyse; Cederberg, Rachel; Lee, Leora; Samudio, Ismael; Krystal, Gerald] British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Cait, Jessica; Hughes, Michael R.; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Jia, William] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Adomat, Hans H.; Guns, Emma S.] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Krystal, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	gkrystal@bccrc.ca	McNagny, Kelly/P-5239-2014; Hughes, Michael/N-6039-2015; JIA, WILLIAM/AAE-4322-2020; Samudio, Ismael/D-3581-2013	McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070; Krystal, Gerald/0000-0002-1961-6281; Samudio, Ismael/0000-0001-8676-1035	Lotte and John Hecht Memorial Foundation [3693]	Lotte and John Hecht Memorial Foundation	This work was funded by the Lotte and John Hecht Memorial Foundation to GK, Hecht Grant ID #3693 (http://www.hecht.org). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Ahn H, 2014, IMMUNOBIOLOGY, V219, P315, DOI 10.1016/j.imbio.2013.11.003; Aita K, 2005, EXP MOL PATHOL, V79, P265, DOI 10.1016/j.yexmp.2005.07.001; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; [Anonymous], 1966, JAMA-J AM MED ASSOC, V195, pA33, DOI [10.1001/jama.1966.03100010017005, DOI 10.1001/JAMA.1966.03100010017005]; ANTONY VB, 1983, INFLAMMATION, V7, P377, DOI 10.1007/BF00916302; Becker K, 2014, PHYTOMEDICINE, V21, P164, DOI 10.1016/j.phymed.2013.08.008; Blanchet MR, 2010, J IMMUNOL, V184, P1292, DOI 10.4049/jimmunol.0900808; Capriotti Kara, 2012, J Clin Aesthet Dermatol, V5, P24; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Colucci M, 2008, PHARMACOL RES, V57, P419, DOI 10.1016/j.phrs.2008.04.004; Cox Media Group, 2014, CAM CANC CAR SHUT DO; Da Violante G, 2002, BIOL PHARM BULL, V25, P1600, DOI 10.1248/bpb.25.1600; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; Deng R, 2014, J BREAST CANCER, V17, P25, DOI 10.4048/jbc.2014.17.1.25; Ditzel HJ, 2004, TRENDS MOL MED, V10, P40, DOI 10.1016/j.molmed.2003.11.004; Ehrlich G E, 1965, Pa Med, V68, P51; GOROG P, 1968, CURR THER RES CLIN E, V10, P486; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P10453, DOI 10.1021/jp073113e; Hollebeeck S, 2011, TOXICOL LETT, V206, P268, DOI 10.1016/j.toxlet.2011.08.010; HOSOI J, 1985, CANCER RES, V45, P1474; HUCKER HB, 1967, J PHARMACOL EXP THER, V155, P309; JACOB SW, 1964, CURR THER RES CLIN E, V6, P134; JIMENEZ RAH, 1982, J LAB CLIN MED, V100, P489; JONES RJ, 1982, JAMA-J AM MED ASSOC, V248, P1369; Kloesch B, 2011, LIFE SCI, V89, P473, DOI 10.1016/j.lfs.2011.07.015; KOLB KH, 1967, ANN NY ACAD SCI, V141, P85, DOI 10.1111/j.1749-6632.1967.tb34869.x; Kyburz D, 2003, SPRINGER SEMIN IMMUN, V25, P79, DOI 10.1007/s00281-003-0131-5; LAYMAN DL, 1985, LIFE SCI, V37, P2431, DOI 10.1016/0024-3205(85)90111-0; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MATSUMOT.J, 1967, ANN NY ACAD SCI, V141, P560, DOI 10.1111/j.1749-6632.1967.tb34925.x; Monach Paul, 2007, V136, P269; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Muir M., 1996, ALTERN COMPLEMENT TH, V2, P230, DOI [10.1089/act.1996.2.230, DOI 10.1089/ACT.1996.2.230]; MYRER JW, 1986, AM J SPORT MED, V14, P165, DOI 10.1177/036354658601400214; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Nigrovic PA, 2015, METHODS MOL BIOL, V1220, P423, DOI 10.1007/978-1-4939-1568-2_26; NORDENBERG J, 1986, EXP CELL RES, V162, P77, DOI 10.1016/0014-4827(86)90427-1; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Pegg David E, 2007, Methods Mol Biol, V368, P39; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; PREZIOSI P, 1966, CURR THER RES CLIN E, V8, P261; REED K W, 1985, Journal of Parenteral Science and Technology, V39, P64; ROSENBAUM EDWARD E., 1964, NW MED, V63, P227; ROSENBAUM EE, 1965, J AMER MED ASSOC, V192, P309, DOI 10.1001/jama.1965.03080170037009; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; SIRACKY J, 1985, NEOPLASMA, V32, P685; STEINBER.A, 1967, ANN NY ACAD SCI, V141, P532, DOI 10.1111/j.1749-6632.1967.tb34922.x; Stolevik SB, 2011, TOXICOL IN VITRO, V25, P555, DOI 10.1016/j.tiv.2010.11.021; SULZBERG.MB, 1967, ANN NY ACAD SCI, V141, P437, DOI 10.1111/j.1749-6632.1967.tb34908.x; TEIGLAND.MB, 1967, ANN NY ACAD SCI, V141, P471, DOI 10.1111/j.1749-6632.1967.tb34913.x; TRICE JM, 1985, SEMIN ARTHRITIS RHEU, V15, P45, DOI 10.1016/0049-0172(85)90009-5; U.S. Food and Drug Administration, 2009, 187 FAK CANC CUR CON; Weisser Shelley B, 2013, Methods Mol Biol, V946, P225, DOI 10.1007/978-1-62703-128-8_14; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	57	47	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152538	10.1371/journal.pone.0152538	http://dx.doi.org/10.1371/journal.pone.0152538			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031833	gold, Green Published			2022-12-26	WOS:000373121800089
J	Lin, F; Liu, JH; Zeng, B; Pan, XJ; Su, XL				Lin, Feng; Liu, Jianhui; Zeng, Bo; Pan, Xiaojiao; Su, Xiaolei			Submergence Tolerance and Germination Dynamics of Roegneria nutans Seeds in Water-Level Fluctuation Zones with Different Water Rhythms in the Three Gorges Reservoir	PLOS ONE			English	Article							WETLAND VEGETATION; RIPARIAN; CHINA; DRAWDOWN; RESTORATION; RESPONSES; ECOLOGY; RIVER; DAM; ESTABLISHMENT	The Three Gorges Dam features two water-level fluctuation zones (WLFZs): the preupland drawdown zone (PU-DZ) and the preriparian drawdown zone (PR-DZ). To investigate the vegetation potential of Roegneria nutans in WLFZs, we compared the submergence tolerance and germination dynamics in the natural riparian zone (NRZ), PU-DZ and PR-DZ. We found that the NRZ seeds maintained an 81.3% intactness rate and >91% germination rate. The final seed germination rate and germination dynamics were consistent with those of the controls. Meanwhile, the PU-DZ seeds submerged at 5 m, 10 m, 15 m, and 20 m exhibited intactness rates of 70.5%, 79.95%, 40.75%, and 39.87%, respectively, and >75% germination. Furthermore, the PR-DZ seeds exhibited intactness rates of 22.44%, 61.13%, 81.87%, and 15.36% at 5 m, 10 m, 15 m, and 17 m, respectively, and 80% germination. The germination rates of the intact seeds submerged > 10 m were > 80%. Finally, the intact seeds germinated quickly in all WLFZs. The high proportion of intact seeds, rapid germination capacity, and high germination rate permit R. nutans seeds to adapt to the complicated water rhythms of the PU-DZ and PR-DZ and indicate the potential for their use in vegetation restoration and recovery. Thus, perennial seeds can be used for vegetation restoration in the WLFZs of large reservoirs and in other regions with water rhythms similar to the Three Gorges Reservoir.	[Lin, Feng; Liu, Jianhui; Zeng, Bo; Pan, Xiaojiao; Su, Xiaolei] Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Res Gorg, Sch Life Sci, Key Lab Ecoenvironm Gorges Reservoir Reg 3,Minist, Chongqing 400715, Peoples R China	Southwest University - China	Zeng, B (corresponding author), Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Res Gorg, Sch Life Sci, Key Lab Ecoenvironm Gorges Reservoir Reg 3,Minist, Chongqing 400715, Peoples R China.	bzeng@swu.edu.cn	Liu, Jianhui/X-6679-2019		National Natural Science Foundation of China [31370443, 31070474]; Ministry of Finance & State Council Executive Office of Three Gorges Project Construction Committee of China [5000002013BB5200001, 5000002013BB5200002]; Research Grant for Disciplines Conferring Doctorate in China [20100182110022]; Fundamental Research Funds for the Central Universities [XDJK2013A003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Finance & State Council Executive Office of Three Gorges Project Construction Committee of China; Research Grant for Disciplines Conferring Doctorate in China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was financed by the National Natural Science Foundation of China (31370443, 31070474), the Ministry of Finance & State Council Executive Office of Three Gorges Project Construction Committee of China (5000002013BB5200001, 5000002013BB5200002), the Research Grant for Disciplines Conferring Doctorate in China (20100182110022), and the Fundamental Research Funds for the Central Universities (XDJK2013A003).	Baskin CC, 2004, ACTA OECOL, V26, P9, DOI 10.1016/j.actao.2004.03.001; Baskin CC, 2002, WETLANDS, V22, P661, DOI 10.1672/0277-5212(2002)022[0661:EOFATO]2.0.CO;2; Baskin CC, 1996, AQUAT BOT, V54, P51, DOI 10.1016/0304-3770(96)01028-5; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; Cornaglia PS, 2009, AUSTRAL ECOL, V34, P343, DOI 10.1111/j.1442-9993.2009.01935.x; Crawford RMM, 2003, CAN J BOT, V81, P1224, DOI [10.1139/B03-127, 10.1139/b03-127]; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; Holzel N, 2004, PLANT ECOL, V174, P279, DOI 10.1023/B:VEGE.0000049108.04955.e2; Ismail AM, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls019; Jiao F, 2011, CATENA, V86, P110, DOI 10.1016/j.catena.2011.03.001; Lu Zhi-Jun, 2010, Wuhan Zhiwuxue Yanjiu, V28, P303, DOI 10.3724/SP.J.1142.2010.30303; Luo Fang-Li, 2007, Zhiwu Shengtai Xuebao, V31, P910; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Martin DW, 2001, J RANGE MANAGE, V54, P284, DOI 10.2307/4003249; Merritt DM, 2006, RIVER RES APPL, V22, P1, DOI 10.1002/rra.890; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Nilsson C, 1997, SCIENCE, V276, P798, DOI 10.1126/science.276.5313.798; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Odland A, 2002, PLANT ECOL, V162, P185, DOI 10.1023/A:1020388910724; Peng CR, 2014, ECOL ENG, V71, P574, DOI 10.1016/j.ecoleng.2014.07.078; Shafroth PB, 2005, ENVIRON MANAGE, V35, P231, DOI 10.1007/s00267-004-0099-5; Shen Jian-Hong, 2011, Chinese Journal of Plant Ecology, V35, P237, DOI 10.3724/SP.J.1258.2011.00237; Su XL, 2012, ECOL ENG, V44, P123, DOI 10.1016/j.ecoleng.2012.03.001; [汤显强 Tang Xianqiang], 2012, [长江科学院院报, Journal of Yangtze River Scientific Research Institute], V29, P13; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Vidal DB, 2014, J FORESTRY RES, V25, P903, DOI 10.1007/s11676-014-0537-z; [王海锋 WANG HaiFeng], 2008, [生态学报, Acta Ecologica Sinica], V28, P2571; [王建超 WANG Jianchao], 2011, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V20, P603; Wang Q, 2014, POL J ECOL, V62, P25, DOI 10.3161/104.062.0104; [韦红波 Wei Hongbo], 2002, [植物生态学报, Acta Phytoecologica Sinica], V26, P489; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.1890/1540-9295(2004)002[0241:TTGDAE]2.0.CO;2; Yang F, 2015, AQUAT ECOSYST HEALTH, V18, P240, DOI 10.1080/14634988.2015.1040332; [袁慎鸿 Yuan Shenhong], 2014, [生态学报, Acta Ecologica Sinica], V34, P6481; Zhang H, 2008, RESOUR ENV YANGTZE B, V3, P374, DOI DOI 10.3969/J.ISSN.1004-8227.2008.03.009; Zhong ZC, 2009, ILLUSTRATED SPECIES	35	6	7	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151318	10.1371/journal.pone.0151318	http://dx.doi.org/10.1371/journal.pone.0151318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031104	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800013
J	Longo, G; Ioannidu, CA; d'Abusco, AS; Superti, F; Misiano, C; Zanoni, R; Politi, L; Mazzola, L; Iosi, F; Mura, F; Scandurra, R				Longo, Giovanni; Ioannidu, Caterina Alexandra; d'Abusco, Anna Scotto; Superti, Fabiana; Misiano, Carlo; Zanoni, Robertino; Politi, Laura; Mazzola, Luca; Iosi, Francesca; Mura, Francesco; Scandurra, Roberto			Improving Osteoblast Response In Vitro by a Nanostructured Thin Film with Titanium Carbide and Titanium Oxides Clustered around Graphitic Carbon	PLOS ONE			English	Article							SURFACE FREE-ENERGY; CELL-ADHESION; EXTRACELLULAR-MATRIX; INTEGRIN; MODULATION; PROLIFERATION; WETTABILITY; EXPRESSION; ROUGHNESS; ALLOYS	Introduction Recently, we introduced a new deposition method, based on Ion Plating Plasma Assisted technology, to coat titanium implants with a thin but hard nanostructured layer composed of titanium carbide and titanium oxides, clustered around graphitic carbon. The nanostructured layer has a double effect: protects the bulk titanium against the harsh conditions of biological tissues and in the same time has a stimulating action on osteoblasts. Results The aim of this work is to describe the biological effects of this layer on osteoblasts cultured in vitro. We demonstrate that the nanostructured layer causes an overexpression of many early genes correlated to proteins involved in bone turnover and an increase in the number of surface receptors for alpha 3 beta 1 integrin, talin, paxillin. Analyses at single-cell level, by scanning electron microscopy, atomic force microscopy, and single cell force spectroscopy, show how the proliferation, adhesion and spreading of cells cultured on coated titanium samples are higher than on uncoated titanium ones. Finally, the chemistry of the layer induces a better formation of blood clots and a higher number of adhered platelets, compared to the uncoated cases, and these are useful features to improve the speed of implant osseointegration. Conclusion In summary, the nanostructured TiC film, due to its physical and chemical properties, can be used to protect the implants and to improve their acceptance by the bone.	[Longo, Giovanni] CNR, Ist Struttura Mat, Via Fosso del Cavaliere 100, I-00133 Rome, Italy; [Longo, Giovanni] Ecole Polytech Fed Lausanne, SB IPSB LPMV, BSP 409 Cubotron UNIL, CH-1015 Lausanne, Switzerland; [Ioannidu, Caterina Alexandra; d'Abusco, Anna Scotto; Politi, Laura; Mazzola, Luca; Scandurra, Roberto] Univ Roma La Sapienza, Dipartimento Sci Biochim, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Superti, Fabiana; Iosi, Francesca] Ist Super Sanita, Dipartimento Tecnol & Salute, Viale Regina Elena 299, I-00161 Rome, Italy; [Misiano, Carlo] Romana Film Sottili, Rome, Italy; [Zanoni, Robertino; Mura, Francesco] Univ Roma La Sapienza, Dipartimento Chim, Piazzale Aldo Moro 5, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Struttura della Materia (ISM-CNR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome	Longo, G (corresponding author), CNR, Ist Struttura Mat, Via Fosso del Cavaliere 100, I-00133 Rome, Italy.; Longo, G (corresponding author), Ecole Polytech Fed Lausanne, SB IPSB LPMV, BSP 409 Cubotron UNIL, CH-1015 Lausanne, Switzerland.	longo@ism.cnr.it	Zanoni, Robertino/A-1742-2008; IOSI, FRANCESCA/F-2106-2015; Longo, G./K-8923-2016; Scotto d'Abusco, Anna/E-9978-2011; Mura, Francesco/AAD-5114-2020; Superti, Fabiana/F-2100-2015; Zanoni, Robertino/N-7001-2019	Zanoni, Robertino/0000-0003-2419-309X; IOSI, FRANCESCA/0000-0002-5929-6833; Longo, G./0000-0003-2434-2155; Mura, Francesco/0000-0001-8490-9438; Superti, Fabiana/0000-0003-4909-7598; Zanoni, Robertino/0000-0003-2419-309X; scotto d'abusco, anna/0000-0002-3323-6015	Italian Department of Health [GR-2009-1305007]	Italian Department of Health	This work has been supported by the Italian Department of Health through the grant n. GR-2009-1305007.	Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009; Anselme K, 2014, SCANNING, V36, P11, DOI 10.1002/sca.21067; Anselme K, 2011, OSTEOPOROSIS INT, V22, P2037, DOI 10.1007/s00198-011-1618-x; Ashby MF., 1980, ENG MAT INTRO THEIR; Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brama M, 2007, BIOMATERIALS, V28, P595, DOI 10.1016/j.biomaterials.2006.08.018; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]; Della Volpe C, 1997, J COLLOID INTERF SCI, V195, P121; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; dos Santos EA, 2008, J MATER SCI-MATER M, V19, P2307, DOI 10.1007/s10856-007-3347-4; Farrugia BL, 2014, BIOMATERIALS, V35, P1462, DOI 10.1016/j.biomaterials.2013.10.068; Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Marquez-Ramirez SG, 2012, TOXICOLOGY, V302, P146, DOI 10.1016/j.tox.2012.09.005; GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KANDASAMY K, 1980, J PHYS C SOLID STATE, V13, P689, DOI 10.1088/0022-3719/13/4/024; Kasas S, 2013, MICROSC RES TECHNIQ, V76, P357, DOI 10.1002/jemt.22174; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E; Lawrence WT, 1998, CLIN PLAST SURG, V25, P321; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8; Longo G, 2010, SURF COAT TECH, V204, P2605, DOI 10.1016/j.surfcoat.2010.02.007; Mazzola L, 2011, J NANOSCI NANOTECHNO, V11, P8754, DOI 10.1166/jnn.2011.3508; Mazzola L, 2012, MEASUREMENT, V45, P317, DOI 10.1016/j.measurement.2011.11.016; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Mohanty M, 1996, BIO-MED MATER ENG, V6, P165; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6; Pesakova V, 2007, J MATER SCI-MATER M, V18, P465, DOI 10.1007/s10856-007-2006-0; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032; Rama KA, 2011, TRENDS BIOMATER ARTI, V25, P112, DOI DOI 10.1007/S11056-007-9051-X; Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003; SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311; Saldana L, 2010, ACTA BIOMATER, V6, P1649, DOI 10.1016/j.actbio.2009.10.033; Santiago-Medina P, 2015, INT J DENT, V2015, P9; SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006; Wu WH, 2008, BIOCHEM BIOPH RES CO, V373, P315, DOI 10.1016/j.bbrc.2008.06.035; Yang GH, 2015, NANOSCALE, V7, P14217, DOI 10.1039/c5nr03398e; YOUNG WC, 1985, J CELL SCI, V73, P19; Zanoni R, 2015, MAT SCI ENG C-MATER, V46, P409, DOI 10.1016/j.msec.2014.10.073; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320	57	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152566	10.1371/journal.pone.0152566	http://dx.doi.org/10.1371/journal.pone.0152566			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031101	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800093
J	Nagy, A; Cernikova, L; Vitaskova, E; Krivda, V; Dan, A; Dirbakova, Z; Jirincova, H; Prochazka, B; Sedlak, K; Havlickova, M				Nagy, Alexander; Cernikova, Lenka; Vitaskova, Eliska; Krivda, Vlastimil; Dan, Adam; Dirbakova, Zuzana; Jirincova, Helena; Prochazka, Bohumir; Sedlak, Kamil; Havlickova, Martina			MeltMan: Optimization, Evaluation, and Universal Application of a qPCR System Integrating the TaqMan qPCR and Melting Analysis into a Single Assay	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SYBR-GREEN-I; AFRICAN-SWINE-FEVER; RT-PCR; CURVE ANALYSIS; BURKHOLDERIA-MALLEI; DYE CONCENTRATION; RAPID DETECTION; VIRUS	In the present work, we optimised and evaluated a qPCR system integrating 6-FAM (6-carboxyfluorescein)-labelled TaqMan probes and melting analysis using the SYTO 82 (S82) DNA binding dye in a single reaction. We investigated the influence of the S82 on various TaqMan and melting analysis parameters and defined its optimal concentration. In the next step, the method was evaluated in 36 different TaqMan assays with a total of 729 paired reactions using various DNA and RNA templates, including field specimens. In addition, the melting profiles of interest were correlated with the electrophoretic patterns. We proved that the S82 is fully compatible with the FAM-TaqMan system. Further, the advantages of this approach in routine diagnostic TaqMan qPCR were illustrated with practical examples. These included solving problems with flat or other atypical amplification curves or even false negativity as a result of probe binding failure. Our data clearly show that the integration of the TaqMan qPCR and melting analysis into a single assay provides an additional control option as well as the opportunity to perform more complex analyses, get more data from the reactions, and obtain analysis results with higher confidence.	[Nagy, Alexander; Cernikova, Lenka; Vitaskova, Eliska; Krivda, Vlastimil] State Vet Inst Prague, Lab Mol Methods, Prague, Czech Republic; [Dan, Adam] Natl Food Chain Safety Off, Vet Diagnost Directorate, Mol Biol Lab, Budapest, Hungary; [Dirbakova, Zuzana] State Vet Inst Zvolen, Dept Virol, Zvolen, Slovakia; [Nagy, Alexander; Jirincova, Helena; Havlickova, Martina] Natl Inst Publ Hlth, Natl Reference Lab Influenza, Prague, Czech Republic; [Prochazka, Bohumir] Natl Inst Publ Hlth, Dept Informat & Biostat, Prague, Czech Republic; [Krivda, Vlastimil; Sedlak, Kamil] State Vet Inst Prague, Dept Virol & Serol, Prague, Czech Republic	National Institute of Public Health (SZU) - Czech Republic; National Institute of Public Health (SZU) - Czech Republic	Nagy, A (corresponding author), State Vet Inst Prague, Lab Mol Methods, Prague, Czech Republic.; Nagy, A (corresponding author), Natl Inst Publ Hlth, Natl Reference Lab Influenza, Prague, Czech Republic.	alexandernagy17@hotmail.com	Dán, Ádám/G-6018-2012; Jirincova, Helena/GRJ-0968-2022	Dán, Ádám/0000-0001-7849-7721; 	Ministry of Health, Czech Republic-conceptual development of research organization (NIPH) [IN 75010330]	Ministry of Health, Czech Republic-conceptual development of research organization (NIPH)	Funding for this work was provided by the Ministry of Health, Czech Republic-conceptual development of research organization (NIPH, IN 75010330).	Abril C, 2004, J VIROL, V78, P3644, DOI 10.1128/JVI.78.7.3644-3653.2004; Achazi K, 2011, J VIROL METHODS, V171, P34, DOI 10.1016/j.jviromet.2010.09.026; Armstrong PM, 2012, VECTOR-BORNE ZOONOT, V12, P872, DOI 10.1089/vbz.2012.1008; Avian Influenza EU Reference Laboratory Animal and Plant Health Agency UK, 2007, H7 EUR REAL TIM PCRS; Balasuriya UBR, 2002, J VIROL METHODS, V101, P21, DOI 10.1016/S0166-0934(01)00416-5; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Callison SA, 2006, J VIROL METHODS, V138, P60, DOI 10.1016/j.jviromet.2006.07.018; Cattoli G, 2009, J CLIN MICROBIOL, V47, P3791, DOI 10.1128/JCM.00895-09; Cheah ESG, 2010, J MOL DIAGN, V12, P250, DOI 10.2353/jmoldx.2010.090030; Colborn JM, 2008, AM J TROP MED HYG, V79, P887, DOI 10.4269/ajtmh.2008.79.887; Decaro N, 2008, J VIROL METHODS, V147, P67, DOI 10.1016/j.jviromet.2007.08.006; Diallo IS, 2007, VET MICROBIOL, V123, P93, DOI 10.1016/j.vetmic.2007.02.004; Dorak M.T., 2007, REAL TIME PCR, P1, DOI [10.4324/9780203967317, DOI 10.4324/9780203967317]; Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; European Union Reference Laboratory for Animal Proteins in Feedingstuffs, 2013, DET HORS DNA US REAL; Evans JJ, 2007, J FORENSIC SCI, V52, P93, DOI 10.1111/j.1556-4029.2006.00305.x; Everett KDE, 1999, J CLIN MICROBIOL, V37, P575, DOI 10.1128/JCM.37.3.575-580.1999; Fernandez-Pinero J, 2013, TRANSBOUND EMERG DIS, V60, P48, DOI 10.1111/j.1865-1682.2012.01317.x; Garson JA, 2012, J VIROL METHODS, V186, P157, DOI 10.1016/j.jviromet.2012.07.027; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Gilad O, 2004, DIS AQUAT ORGAN, V60, P179, DOI 10.3354/dao060179; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Hakhverdyan M, 2005, J VIROL METHODS, V123, P195, DOI 10.1016/j.jviromet.2004.09.016; Hinshaw JV, 2004, LC GC N AM, V22, P252; Hole K, 2010, J VET DIAGN INVEST, V22, P428, DOI 10.1177/104063871002200315; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Hupfer C, 2007, EUR FOOD RES TECHNOL, V225, P329, DOI 10.1007/s00217-006-0418-6; King DP, 2003, J VIROL METHODS, V107, P53, DOI 10.1016/S0166-0934(02)00189-1; Koppel R, 2011, EUR FOOD RES TECHNOL, V232, P151, DOI 10.1007/s00217-010-1371-y; Koppel R, 2009, EUR FOOD RES TECHNOL, V230, P125, DOI 10.1007/s00217-009-1154-5; Lee DH, 2005, J CLIN MICROBIOL, V43, P5111, DOI 10.1128/JCM.43.10.5111-5116.2005; Letellier C, 2003, J VIROL METHODS, V114, P21, DOI 10.1016/j.jviromet.2003.08.004; Lind K, 2006, BIOTECHNIQUES, V40, P315, DOI 10.2144/000112101; Liu Y, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00096; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Mehndiratta M, 2008, BIOTECHNIQUES, V45, P625, DOI 10.2144/000112994; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Molecular Probes, 2001, MOL PROBES SYTO ORAN; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Monne I, 2008, J CLIN MICROBIOL, V46, P1769, DOI 10.1128/JCM.02204-07; Nagy A, 2010, ARCH VIROL, V155, P665, DOI 10.1007/s00705-010-0636-x; Nitsche A, 2006, CLIN CHEM, V52, P316, DOI 10.1373/clinchem.2005.060335; Papin JF, 2004, J CLIN MICROBIOL, V42, P1511, DOI 10.1128/JCM.42.4.1511-1518.2004; Payungporn S, 2006, J VIROL METHODS, V131, P143, DOI 10.1016/j.jviromet.2005.08.004; Qiagen, 2010, REAL TIME PCR BROCHU, V07, P1; Reid SM, 2004, J VIROL METHODS, V116, P169, DOI 10.1016/j.jviromet.2003.11.007; Reid SM, 2002, J VIROL METHODS, V105, P67, DOI 10.1016/S0166-0934(02)00081-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stormer M, 2009, INT J MED MICROBIOL, V299, P291, DOI 10.1016/j.ijmm.2008.08.002; Thibault FM, 2004, J CLIN MICROBIOL, V42, P5871, DOI 10.1128/JCM.42.12.5871-5874.2004; Tomaso H, 2006, CLIN CHEM, V52, P307, DOI 10.1373/clinchem.2005.059196; Traul DL, 2007, J VET DIAGN INVEST, V19, P405, DOI 10.1177/104063870701900412; Van Poucke M, 2012, BIOTECHNIQUES, V52, P81, DOI 10.2144/000113808; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; WHO Collaborating Centre for influenza at CDC Atlanta USA, 2009, CDC PROT REAL TIM RT; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	60	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151204	10.1371/journal.pone.0151204	http://dx.doi.org/10.1371/journal.pone.0151204			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031831	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800009
J	ter Beek, J; Krause, N; Adelroth, P				ter Beek, Josy; Krause, Nils; Adelroth, Pia			Investigating the Proton Donor in the NO Reductase from Paracoccus denitrificans	PLOS ONE			English	Article							NITRIC-OXIDE REDUCTASE; CYTOCHROME-C-OXIDASE; THERMUS-THERMOPHILUS; STRUCTURAL BASIS; N2O GENERATION; PATHWAY; MECHANISM; PROTEINS; RESIDUES; ENZYME	Variant nomenclature: the variants were made in the NorB subunit if not indicated by the superscript(c), which are variants in the NorC subunit (e.g. E122A = exchange of Glu-122 in NorB for an Ala, E71(c)D; exchange of Glu-71 in NorC for an Asp). Bacterial NO reductases (NORs) are integral membrane proteins from the heme-copper oxidase superfamily. Most heme-copper oxidases are proton-pumping enzymes that reduce O-2 as the last step in the respiratory chain. With electrons from cytochrome c, NO reductase (cNOR) from Paracoccus (P.) denitrificans reduces NO to N2O via the following reaction: 2NO+2e(-)+2H(+) -> N2O+H2O. Although this reaction is as exergonic as O-2-reduction, cNOR does not contribute to the electrochemical gradient over the membrane. This means that cNOR does not pump protons and that the protons needed for the reaction are taken from the periplasmic side of the membrane (since the electrons are donated from this side). We previously showed that the P. denitrificans cNOR uses a single defined proton pathway with residues Glu-58 and Lys-54 from the NorC subunit at the entrance. Here we further strengthened the evidence in support of this pathway. Our further aim was to define the continuation of the pathway and the immediate proton donor for the active site. To this end, we investigated the region around the calcium-binding site and both propionates of heme b(3) by site directed mutagenesis. Changing single amino acids in these areas often had severe effects on cNOR function, with many variants having a perturbed active site, making detailed analysis of proton transfer properties difficult. Our data does however indicate that the calcium ligation sphere and the region around the heme b(3) propionates are important for proton transfer and presumably contain the proton donor. The possible evolutionary link between the area for the immediate donor in cNOR and the proton loading site (PLS) for pumped protons in oxygen-reducing heme-copper oxidases is discussed.	[ter Beek, Josy; Krause, Nils; Adelroth, Pia] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [ter Beek, Josy] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Krause, Nils] Free Univ Berlin, Dept Expt Phys, Berlin, Germany	Stockholm University; Umea University; Free University of Berlin	Adelroth, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	pia.adelroth@dbb.su.se	Beek, Josy ter/AAG-8291-2021	Beek, Josy ter/0000-0003-4165-9277	Vetenskapsradet; Stockholm University	Vetenskapsradet(Swedish Research Council); Stockholm University	This work was supported y Vetenskapsradet, http://www.vr.se. JB was supported by a post-doctoral grant from Stockholm University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelroth P, 2004, BBA-BIOENERGETICS, V1655, P102, DOI 10.1016/j.bbabio.2003.10.018; Beekter J, 2013, J BIOL CHEM, DOI [10.1074/jbc.M113.497347, DOI 10.1074/JBC.M113.497347]; Blomberg MRA, 2012, BIOCHEMISTRY-US, V51, P5173, DOI 10.1021/bi300496e; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Chang HY, 2012, P NATL ACAD SCI USA, V109, P5259, DOI 10.1073/pnas.1107345109; Flock U, 2005, BIOCHEMISTRY-US, V44, P10711, DOI 10.1021/bi050524h; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Flock U, 2009, J INORG BIOCHEM, V103, P845, DOI 10.1016/j.jinorgbio.2009.02.008; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Gribaldo S, 2009, TRENDS BIOCHEM SCI, V34, P375, DOI 10.1016/j.tibs.2009.04.002; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hendriks JHM, 2001, BIOCHEMISTRY-US, V40, P13361, DOI 10.1021/bi011428t; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P80, DOI 10.1016/j.bbabio.2010.08.014; Koutny M, 1999, BIOCHEM BIOPH RES CO, V262, P562, DOI 10.1006/bbrc.1999.1245; Lachmann P, 2010, J BIOL CHEM, V285, P25531, DOI 10.1074/jbc.M110.123984; Matsumoto Y, 2012, NAT STRUCT MOL BIOL, V19, P238, DOI 10.1038/nsmb.2213; Pisliakov AV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002674; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; Schurig-Briccio LA, 2013, P NATL ACAD SCI USA, V110, P12613, DOI 10.1073/pnas.1301731110; Shiro Y, 2012, PHILOS T R SOC B, V367, P1195, DOI 10.1098/rstb.2011.0310; Silverman DN, 2000, BBA-BIOENERGETICS, V1458, P88, DOI 10.1016/S0005-2728(00)00061-X; Terasaka E, 2014, BBA-BIOENERGETICS, V1837, P1019, DOI 10.1016/j.bbabio.2014.02.017; Thorndycroft FH, 2007, BIOCHEM J, V401, P111, DOI 10.1042/BJ20060856; Wraight CA, 2006, BBA-BIOENERGETICS, V1757, P886, DOI 10.1016/j.bbabio.2006.06.017	29	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152745	10.1371/journal.pone.0152745	http://dx.doi.org/10.1371/journal.pone.0152745			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030968	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800132
J	Zewde, N; Gorham, RD; Dorado, A; Morikis, D				Zewde, Nehemiah; Gorham, Ronald D., Jr.; Dorado, Angel; Morikis, Dimitrios			Quantitative Modeling of the Alternative Pathway of the Complement System	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; DECAY-ACCELERATING FACTOR; BINDING-SITE; MOLECULAR-ORGANIZATION; POSITIVE REGULATOR; PROPERDIN BINDS; RECEPTOR CR-1; C3 CONVERTASE; 3RD COMPONENT; T-CELLS	The complement system is an integral part of innate immunity that detects and eliminates invading pathogens through a cascade of reactions. The destructive effects of the complement activation on host cells are inhibited through versatile regulators that are present in plasma and bound to membranes. Impairment in the capacity of these regulators to function in the proper manner results in autoimmune diseases. To better understand the delicate balance between complement activation and regulation, we have developed a comprehensive quantitative model of the alternative pathway. Our model incorporates a system of ordinary differential equations that describes the dynamics of the four steps of the alternative pathway under physiological conditions: (i) initiation (fluid phase), (ii) amplification (surfaces), (iii) termination (pathogen), and (iv) regulation (host cell and fluid phase). We have examined complement activation and regulation on different surfaces, using the cellular dimensions of a characteristic bacterium (E. coli) and host cell (human erythrocyte). In addition, we have incorporated neutrophil-secreted properdin into the model highlighting the cross talk of neutrophils with the alternative pathway in coordinating innate immunity. Our study yields a series of time-dependent response data for all alternative pathway proteins, fragments, and complexes. We demonstrate the robustness of alternative pathway on the surface of pathogens in which complement components were able to saturate the entire region in about 54 minutes, while occupying less than one percent on host cells at the same time period. Our model reveals that tight regulation of complement starts in fluid phase in which propagation of the alternative pathway was inhibited through the dismantlement of fluid phase convertases. Our model also depicts the intricate role that properdin released from neutrophils plays in initiating and propagating the alternative pathway during bacterial infection.	[Zewde, Nehemiah; Gorham, Ronald D., Jr.; Morikis, Dimitrios] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Dorado, Angel] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Morikis, D (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	dmorikis@ucr.edu	Morikis, Dimitrios/L-8527-2013	Morikis, Dimitrios/0000-0003-0083-4665; Gorham, Ronald/0000-0002-0261-6699				Agarwal S, 2010, J IMMUNOL, V185, P507, DOI 10.4049/jimmunol.0903598; AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; BOTTO M, 1992, J IMMUNOL, V149, P1348; Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; Brodbeck WG, 2000, J IMMUNOL, V165, P3999, DOI 10.4049/jimmunol.165.7.3999; Camous L, 2011, BLOOD, V117, P1340, DOI 10.1182/blood-2010-05-283564; Charles A Janeway J, 2001, COMPLEMENT SYSTEM IN; Chauhan AK, 2006, CLIN EXP IMMUNOL, V145, P398, DOI 10.1111/j.1365-2249.2006.03135.x; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Choi J, 1998, J HYDROL, V209, P297, DOI 10.1016/S0022-1694(98)00093-6; COCHRANE CG, 1968, J EXP MED, V127, P371, DOI 10.1084/jem.127.2.371; COOPER NR, 1970, J EXP MED, V132, P775, DOI 10.1084/jem.132.4.775; Cortes C, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00412; Cortes C, 2011, INFECT IMMUN, V79, P724, DOI 10.1128/IAI.00980-10; DASILVA WD, 1967, J EXP MED, V126, P1027, DOI 10.1084/jem.126.6.1027; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Ember JA, 1997, IMMUNOPHARMACOLOGY, V38, P3, DOI 10.1016/S0162-3109(97)00088-X; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Ferreira VP, 2010, IMMUNOBIOLOGY, V215, P932, DOI 10.1016/j.imbio.2010.02.002; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; FODOR WL, 1995, J IMMUNOL, V155, P4135; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; Gizeli E, 2003, BIOMOLECULAR SENSORS; Greer JP, 2009, WINTROBES CLIN HEMAT; Gupta-Bansal R, 2000, MOL IMMUNOL, V37, P191, DOI 10.1016/S0161-5890(00)00047-X; Harris CL, 2007, J IMMUNOL, V178, P352, DOI 10.4049/jimmunol.178.1.352; Hirayama H, 1996, BIOSYSTEMS, V39, P173, DOI 10.1016/0303-2647(96)01617-6; HOGASEN AKM, 1995, J IMMUNOL, V154, P4734; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; HOURCADE D, 1989, PROGRESS IN IMMUNOLOGY, VOL 7, P171; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Hugli T, CURR TOP MICROBIOL I, V153, P181; HUNSICKE.LG, 1973, J IMMUNOL, V110, P128; Jozsi M, 2002, J IMMUNOL, V168, P2782, DOI 10.4049/jimmunol.168.6.2782; Kavanagh D, 2013, SEMIN NEPHROL, V33, P508, DOI 10.1016/j.semnephrol.2013.08.003; KELLOGG JA, 1984, J CLIN MICROBIOL, V20, P618, DOI 10.1128/JCM.20.4.618-623.1984; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Korotaevskiy AA, 2009, MATH BIOSCI, V222, P127, DOI 10.1016/j.mbs.2009.10.003; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; LAW SK, 1979, J IMMUNOL, V123, P1388; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Liddington R, 2005, NATURE, V437, P484, DOI 10.1038/437484a; Liu B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001059; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; MEDICUS RG, 1976, J EXP MED, V144, P1076, DOI 10.1084/jem.144.4.1076; MEDOF ME, 1982, J EXP MED, V156, P1739, DOI 10.1084/jem.156.6.1739; MONAHAN JB, 1981, J BIOL CHEM, V256, P3258; MORGAN BP, 1994, SPRINGER SEMIN IMMUN, V15, P369, DOI 10.1007/BF01837366; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003; Nataf S, 1999, J IMMUNOL, V162, P4018; NELSON RA, 1958, J EXP MED, V108, P515, DOI 10.1084/jem.108.4.515; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Ottonello L, 1999, J IMMUNOL, V162, P6510; PANGBURN MK, 1989, J IMMUNOL, V142, P202; PANGBURN MK, 1983, BIOCHEMISTRY-US, V22, P178, DOI 10.1021/bi00270a026; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1983, J IMMUNOL, V131, P1930; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; PILLEMER L, 1954, SCIENCE, V120, P279, DOI 10.1126/science.120.3112.279; PODACK ER, 1982, J EXP MED, V156, P268, DOI 10.1084/jem.156.1.268; PORTEU F, 1988, J BIOL CHEM, V263, P5091; PREISSNER KT, 1985, J IMMUNOL, V135, P445; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Rawal N, 2000, J IMMUNOL, V164, P1379, DOI 10.4049/jimmunol.164.3.1379; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Ross D, 1982, CR COFACTOR ACTIVITY; Saggu G, 2013, J IMMUNOL, V190, P6457, DOI 10.4049/jimmunol.1300610; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schrier R. W., 2008, MANUAL OF NEPHROLOGY; SCHWAEBLE W, 1993, J IMMUNOL, V151, P2521; SEYA T, 1995, MICROBIOL IMMUNOL, V39, P295, DOI 10.1111/j.1348-0421.1995.tb02205.x; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; STEWART JL, 1987, J IMMUNOL, V139, P1960; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; TSCHOPP J, 1993, J IMMUNOL, V151, P2159; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Wirthmueller U, 1997, J IMMUNOL, V158, P4444; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	95	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152337	10.1371/journal.pone.0152337	http://dx.doi.org/10.1371/journal.pone.0152337			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031863	Green Published, gold			2022-12-26	WOS:000373121800059
J	Huang, YL; Yang, S; Long, GX; Zhao, ZK; Li, XF; Gu, MH				Huang, Yu Lan; Yang, Shu; Long, Guang Xia; Zhao, Zun Kang; Li, Xiao Feng; Gu, Ming Hua			Manganese Toxicity in Sugarcane Plantlets Grown on Acidic Soils of Southern China	PLOS ONE			English	Article							MN TOXICITY; IRON; TEMPERATURE; PHOTOSYNTHESIS; DEFICIENCY; SILICON; COPPER	Ratoon sugarcane plantlets in southern China have suffered a serious chlorosis problem in recent years. To reveal the causes of chlorosis, plant nutrition in chlorotic sugarcane plantlets and the role of manganese (Mn) in this condition were investigated. The study results showed that the pH of soils growing chlorotic plantlets ranged from 3.74 to 4.84. The symptoms of chlorosis were similar to those of iron (Fe) deficiency while the chlorotic and non-chlorotic plantlets contained similar amount of Fe. Chlorotic plantlets had 6.4-times more Mn in their leaf tissues compared to the control plants. There was a significantly positive correlation between Mn concentration in the leaves and the exchangeable Mn concentration in the soils. Moreover, leaf Mn concentration was related to both seasonal changes in leaf chlorophyll concentration and to the occurrence of chlorosis. Basal stalks of mature sugarcanes contained up to 564.36 mg.kg(-1) DW Mn. Excess Mn in the parent stalks resulted in a depress of chlorophyll concentration in the leaves of sugarcanes as indicated by lower chlorophyll concentration in the leaves of plantlets emerged from basal stalks. Ratoon sugarcane plantlets were susceptible to chlorosis due to high Mn accumulation in their leaves (456.90-1626.95 mg.kg(-1) DW), while in planted canes chlorosis did not occur because of low Mn accumulation (94.64-313.41 mg.kg-1 DW). On the other hand, active Fe content in chlorotic plantlets (3.39 mg kg(-1) FW) was only equivalent to 28.2% of the concentration found in the control. These results indicate that chlorosis in ratoon sugarcane plantlets results from excessive Mn accumulated in parent stalks of planted cane sugarcanes grown on excessive Mn acidic soils, while active Fe deficiency in plantlets may play a secondary role in the chlorosis.	[Huang, Yu Lan; Yang, Shu; Long, Guang Xia; Zhao, Zun Kang; Li, Xiao Feng; Gu, Ming Hua] Guangxi Univ, Coll Agr, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China	Guangxi University	Li, XF (corresponding author), Guangxi Univ, Coll Agr, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.	lxf@gxu.edu.cn		Yang, Shu/0000-0002-6479-4722	National Natural Science Foundation of China [31260497]; Guangxi Natural Science Foundation [2012GXNSFDA053010]; Innovation Project of Guangxi Graduate Education [YCBZ2013005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Innovation Project of Guangxi Graduate Education	This work was funded in part by the National Natural Science Foundation of China (grant No. 31260497), Guangxi Natural Science Foundation (grant No. 2012GXNSFDA053010) and Innovation Project of Guangxi Graduate Education (YCBZ2013005).	ABADIA J, 1992, J PLANT NUTR, V15, P1699, DOI 10.1080/01904169209364432; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BACHMAN GR, 1995, J PLANT NUTR, V18, P1917, DOI 10.1080/01904169509365033; Bogorad L., 1976, CHEM BIOCH PLANT PIG, V1, P64; CHENG BT, 1977, AGROCHIMICA, V21, P170; CLAIRMONT KB, 1986, PLANT PHYSIOL, V80, P291, DOI 10.1104/pp.80.1.291; CSATORDAY K, 1984, P NATL ACAD SCI-BIOL, V81, P476, DOI 10.1073/pnas.81.2.476; Demirevska-Kepova K, 2004, ENVIRON EXP BOT, V52, P253, DOI 10.1016/j.envexpbot.2004.02.004; El-Jaoual T, 1998, J PLANT NUTR, V21, P353, DOI 10.1080/01904169809365409; Fecht-Christoffers MM, 2003, PLANT PHYSIOL, V133, P1935, DOI 10.1104/pp.103.029215; Feng JP, 2009, AGR SCI CHINA, V8, P40, DOI 10.1016/S1671-2927(09)60007-9; Ferroni L, 2004, PROTOPLASMA, V224, P167, DOI 10.1007/s00709-004-0072-4; Foy C. D., 1984, Soil acidity and liming, P57; GERRETSEN FC, 1950, PLANT SOIL, V2, P323, DOI 10.1007/BF01344136; Gonzalez A, 1998, PLANT PHYSIOL, V118, P493, DOI 10.1104/pp.118.2.493; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hauck M, 2003, ENVIRON EXP BOT, V49, P181, DOI 10.1016/S0098-8472(02)00069-2; Hauck M, 2002, ENVIRON EXP BOT, V47, P127, DOI 10.1016/S0098-8472(01)00121-6; HEENAN DP, 1983, PLANT SOIL, V70, P317, DOI 10.1007/BF02374888; HEENAN DP, 1977, PLANT SOIL, V47, P219, DOI 10.1007/BF00010381; HORST WJ, 1978, Z PFLANZ BODENKUNDE, V141, P129, DOI 10.1002/jpln.19781410202; Hue NV, 2001, SOIL SCI SOC AM J, V65, P153, DOI 10.2136/sssaj2001.651153x; Kovacik J, 2014, PLANT SCI, V215, P1, DOI 10.1016/j.plantsci.2013.10.015; LUCAS R. E., 1961, SOIL SCI, V92, P177, DOI 10.1097/00010694-196109000-00005; MAAS FM, 1988, PLANT PHYSIOL, V87, P167, DOI 10.1104/pp.87.1.167; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; McCray JM, SSAGR335 U FLOR IFAS, P1; McCray JM, SSAGR128 U FLOR IFAS, P1; MEHROTRA SC, 1990, PLANT PHYSIOL, V93, P1017, DOI 10.1104/pp.93.3.1017; Morales F, 1998, J PLANT NUTR, V21, P815, DOI 10.1080/01904169809365444; Mou DL, 2011, ECOTOX ENVIRON SAFE, V74, P776, DOI 10.1016/j.ecoenv.2010.10.040; MUKHOPADHYAY MJ, 1991, BOT REV, V57, P117, DOI 10.1007/BF02858767; NABLE RO, 1988, PLANT PHYSIOL, V86, P1136, DOI 10.1104/pp.86.4.1136; NIAN LS, 1989, Z PFLANZ BODENKUNDE, V152, P125, DOI 10.1002/jpln.19891520122; PANDA S, 1987, PHYTOCHEMISTRY, V26, P3217, DOI 10.1016/S0031-9422(00)82472-3; RAO JK, 1987, PLANT SOIL, V97, P353, DOI 10.1007/BF02383225; RUFTY TW, 1979, AGRON J, V71, P638, DOI 10.2134/agronj1979.00021962007100040029x; Shen Alin, 1996, Pedosphere, V6, P355; Shi QH, 2005, PHYTOCHEMISTRY, V66, P1551, DOI 10.1016/j.phytochem.2005.05.006; Shi QH, 2008, ENVIRON EXP BOT, V63, P317, DOI 10.1016/j.envexpbot.2007.11.003; SONNEVELD C, 1977, PLANT SOIL, V46, P487, DOI 10.1007/BF00010103; Srivastava S, 2011, PLANT GROWTH REGUL, V64, P1, DOI 10.1007/s10725-010-9526-1; St Clair SB, 2004, FUNCT PLANT BIOL, V31, P1005, DOI 10.1071/FP04049; Subrahmanyam D, 2000, PHOTOSYNTHETICA, V38, P449, DOI 10.1023/A:1010998226323; THOMAS RL, 1967, AGRON J, V59, P240, DOI 10.2134/agronj1967.00021962005900030010x; WU SH, 1994, J PLANT NUTR, V17, P991, DOI 10.1080/01904169409364783	46	22	24	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0148956	10.1371/journal.pone.0148956	http://dx.doi.org/10.1371/journal.pone.0148956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023702	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900003
J	Coleman, MA; Cappuccio, JA; Blanchette, CD; Gao, TJ; Arroyo, ES; Hinz, AK; Bourguet, FA; Segelke, B; Hoeprich, PD; Huser, T; Laurence, TA; Motin, VL; Chromy, BA				Coleman, Matthew A.; Cappuccio, Jenny A.; Blanchette, Craig D.; Gao, Tingjuan; Arroyo, Erin S.; Hinz, Angela K.; Bourguet, Feliza A.; Segelke, Brent; Hoeprich, Paul D.; Huser, Thomas; Laurence, Ted A.; Motin, Vladimir L.; Chromy, Brett A.			Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles	PLOS ONE			English	Article							CELL-FREE EXPRESSION; MEMBRANE-PROTEIN; OUTER PROTEINS; V-ANTIGEN; SECRETION; PSEUDOTUBERCULOSIS; INFECTION; SYSTEM; PLAGUE; LCRV	Yersinia pestis enters host cells and evades host defenses, in part, through interactions between Yersinia pestis proteins and host membranes. One such interaction is through the type III secretion system, which uses a highly conserved and ordered complex for Yersinia pestis outer membrane effector protein translocation called the injectisome. The portion of the injectisome that interacts directly with host cell membranes is referred to as the translocon. The translocon is believed to form a pore allowing effector molecules to enter host cells. To facilitate mechanistic studies of the translocon, we have developed a cell-free approach for expressing translocon pore proteins as a complex supported in a bilayer membrane mimetic nano-scaffold known as a nanolipoprotein particle (NLP) Initial results show cell-free expression of Yersinia pestis outer membrane proteins YopB and YopD was enhanced in the presence of liposomes. However, these complexes tended to aggregate and precipitate. With the addition of co-expressed (NLP) forming components, the YopB and/or YopD complex was rendered soluble, increasing the yield of protein for biophysical studies. Biophysical methods such as Atomic Force Microscopy and Fluorescence Correlation Spectroscopy were used to confirm that the soluble YopB/D complex was associated with NLPs. An interaction between the YopB/D complex and NLP was validated by immunoprecipitation. The YopB/D translocon complex embedded in a NLP provides a platform for protein interaction studies between pathogen and host proteins. These studies will help elucidate the poorly understood mechanism which enables this pathogen to inject effector proteins into host cells, thus evading host defenses.	[Coleman, Matthew A.; Blanchette, Craig D.; Arroyo, Erin S.; Hinz, Angela K.; Bourguet, Feliza A.; Segelke, Brent; Hoeprich, Paul D.; Laurence, Ted A.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Coleman, Matthew A.; Gao, Tingjuan; Huser, Thomas; Chromy, Brett A.] Univ Calif Davis, NSF, Ctr Biophoton, Sacramento, CA 95817 USA; [Cappuccio, Jenny A.] Humboldt State Univ, Dept Chem, Arcata, CA 95521 USA; [Motin, Vladimir L.] Univ Texas Med Branch, Galveston, TX 77555 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Science Foundation (NSF); University of California System; University of California Davis; California State University System; California State Polytechnic University, Humboldt; University of Texas System; University of Texas Medical Branch Galveston	Coleman, MA (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.; Coleman, MA; Chromy, BA (corresponding author), Univ Calif Davis, NSF, Ctr Biophoton, Sacramento, CA 95817 USA.	coleman16@llnl.gov; bachromy@ucdavis.edu	Motin, Vladimir L/O-1535-2013; Huser, Thomas/K-7291-2019	Huser, Thomas/0000-0003-2348-7416; Segelke, Brent/0000-0003-3358-5028; Motin, Vladimir/0000-0002-4762-457X; Coleman, Matthew/0000-0003-1389-4018; Bourguet, Feliza/0000-0003-3557-404X	Laboratory Directed Research and Development Office [06-SI-003, 01-ERD-045]; National Science Foundation through the Center for Biophotonics Science and Technology Center [PHY 0120999]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Laboratory Directed Research; NSF [PHY 0120999]	Laboratory Directed Research and Development Office; National Science Foundation through the Center for Biophotonics Science and Technology Center; U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Laboratory Directed Research; NSF(National Science Foundation (NSF))	Laboratory Directed Research and Development Office Grants 06-SI-003 and 01-ERD-045. National Science Foundation through the Center for Biophotonics Science and Technology Center, managed by the University of California Davis under Cooperative Agreement No. PHY 0120999.; This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344 and support from the Laboratory Directed Research. Part of the work was also performed at the NSF Center for Biophotonics, an NSF Science and Technology Center, which is managed by the University of California, Davis, under cooperative agreement no. PHY 0120999 with the NSF. The authors are grateful to Dr. Gregory Plano for his generous donation of the YopD antibodies.	Andrews GP, 1999, INFECT IMMUN, V67, P1533, DOI 10.1128/IAI.67.3.1533-1537.1999; Anisimov AP, 2010, INFECT GENET EVOL, V10, P137, DOI 10.1016/j.meegid.2009.10.003; Baker SE, 2009, J AM CHEM SOC, V131, P7508, DOI 10.1021/ja809251f; Benner GE, 1999, INFECT IMMUN, V67, P1922; Blanchette CD, 2009, BBA-BIOMEMBRANES, V1788, P724, DOI 10.1016/j.bbamem.2008.11.019; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; CAPPUCCIO JA, 2008, MOL CELL PROTEOMICS; Cappuccio Jenny A., 2009, V498, P273, DOI 10.1007/978-1-59745-196-3_18; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chromy BA, 2007, J AM CHEM SOC, V129, P14348, DOI 10.1021/ja074753y; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Edqvist PJ, 2007, MICROBES INFECT, V9, P224, DOI 10.1016/j.micinf.2006.11.010; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; Gao TJ, 2011, PROTEIN SCI, V20, P437, DOI 10.1002/pro.577; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x; Ivanov MI, 2008, INFECT IMMUN, V76, P5181, DOI 10.1128/IAI.00189-08; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Ly S, 2014, BIOPHYS J, V106, pL5, DOI 10.1016/j.bpj.2013.12.014; Mota LJ, 2006, TRENDS MICROBIOL, V14, P197, DOI 10.1016/j.tim.2006.02.010; MOTIN VL, 1992, MICROB PATHOGENESIS, V12, P165, DOI 10.1016/0882-4010(92)90050-X; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Plano GV, 2001, MOL MICROBIOL, V40, P284, DOI 10.1046/j.1365-2958.2001.02354.x; Raab R, 2008, PROTEIN EXPRES PURIF, V58, P53, DOI 10.1016/j.pep.2007.11.001; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Scherer CA, 2000, MOL MICROBIOL, V37, P1133, DOI 10.1046/j.1365-2958.2000.02066.x; Segelke Brent W., 2004, Journal of Structural and Functional Genomics, V5, P147, DOI 10.1023/B:JSFG.0000029193.82120.d1; Smiley ST, 2008, IMMUNOL REV, V225, P256, DOI 10.1111/j.1600-065X.2008.00674.x; Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793; Tengel T, 2002, EUR J BIOCHEM, V269, P3659, DOI 10.1046/j.1432-1033.2002.03051.x	35	8	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0150166	10.1371/journal.pone.0150166	http://dx.doi.org/10.1371/journal.pone.0150166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015536	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708900020
J	Danilowicz-Szymanowicz, L; Suchecka, J; Niemirycz-Makurat, A; Rozwadowska, K; Raczak, G				Danilowicz-Szymanowicz, Ludmila; Suchecka, Justyna; Niemirycz-Makurat, Agnieszka; Rozwadowska, Katarzyna; Raczak, Grzegorz			Autonomic Predictors of Hospitalization Due to Heart Failure Decompensation in Patients with Left Ventricular Systolic Dysfunction	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; RATE-VARIABILITY; BAROREFLEX SENSITIVITY; PARASYMPATHETIC ACTIVITY; SUDDEN-DEATH; RISK; MORTALITY	Introduction Autonomic nervous system balance can be significantly deteriorated during heart failure exacerbation. However, it is still unknown whether these changes are only the consequence of heart failure decompensation or can also predict development thereof. Objectives were to verify if simple, non-invasive autonomic parameters, such as baroreflex sensitivity and short-term heart rate variability can provide independent of other well-known clinical parameters information on the risk of heart failure decompensation in patients with left ventricular systolic dysfunction. Methods In 142 stable patients with left ventricular ejection fraction <= 40%, baroreflex sensitivity and short-term heart rate variability, as well as other well-known clinical parameters, were analyzed. During 23 +/- 9 months of follow-up 19 patients were hospitalized due to the heart failure decompensation (EVENT). Results Pre-specified cut-off values of baroreflex sensitivity (<= 2.4 ms/mmHg) and low frequency power index of heart rate variability (<= 19 ms(2)) were significantly associated with the EVENTs (hazard ratio 4.43, 95% confidence interval [CI] 1.35-14.54 and 5.41, 95% CI 1.87-15.65 respectively). EVENTs were also associated with other parameters, such as left ventricular ejection fraction, NYHA class, diuretic use, renal function, brain natriuretic peptide and hemoglobin level, left atrial size, left and right ventricular heart failure signs. After adjusting baroreflex sensitivity and low frequency power index for each of the abovementioned parameters, autonomic parameters were still significant predictors of hospitalization due to the heart failure decompensation. Conclusion Simple, noninvasive autonomic indices can be helpful in identifying individuals with increased risk of hospitalization due to the heart failure decompensation among clinically stable patients with left ventricular systolic dysfunction, even when adjusted for other well-known clinical parameters.	[Danilowicz-Szymanowicz, Ludmila; Suchecka, Justyna; Niemirycz-Makurat, Agnieszka; Rozwadowska, Katarzyna; Raczak, Grzegorz] Med Univ Gdansk, Dept Cardiol & Electrotherapy, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk	Danilowicz-Szymanowicz, L (corresponding author), Med Univ Gdansk, Dept Cardiol & Electrotherapy, Gdansk, Poland.	ludwik@gumed.edu.pl	Danilowicz-Szymanowicz, Ludmila/AAG-7732-2019	Danilowicz-Szymanowicz, Ludmila/0000-0002-2269-1880; Rozwadowska, Katarzyna/0000-0002-8712-801X				Alvarez-Garcia J, 2015, EUR J HEART FAIL, V17, P818, DOI 10.1002/ejhf.287; BINKLEY PF, 1991, J AM COLL CARDIOL, V18, P464, DOI 10.1016/0735-1097(91)90602-6; Braga SS, 2006, INT J CARDIOL, V109, P118, DOI 10.1016/j.ijcard.2005.03.072; Camm AJ, 1996, EUR HEART J, V17, P354; Eckberg D, 1992, HUMAN BAROREFLEXES H; ELLENBOGEN KA, 1989, CIRCULATION, V79, P51, DOI 10.1161/01.CIR.79.1.51; Fauchier L, 1999, J AM COLL CARDIOL, V33, P1203, DOI 10.1016/S0735-1097(99)00021-2; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Gademan MGJ, 2008, AM J PHYSIOL-HEART C, V295, pH755, DOI 10.1152/ajpheart.00170.2008; Galinier M, 2000, EUR HEART J, V21, P475, DOI 10.1053/euhj.1999.1875; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Huikuri HV, 1999, J AM COLL CARDIOL, V34, P1878, DOI 10.1016/S0735-1097(99)00468-4; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Kishi T, 2012, J CARDIOL, V59, P117, DOI 10.1016/j.jjcc.2011.12.006; La Rovere MT, 2009, J AM COLL CARDIOL, V53, P193, DOI 10.1016/j.jacc.2008.09.034; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; La Rovere MT, 1998, LANCET, V351, P478; Maestri R, 1998, COMPUT METH PROG BIO, V56, P37, DOI 10.1016/S0169-2607(98)00004-2; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mortara A, 1997, CIRCULATION, V96, P3450; Nolan J, 1996, AM J CARDIOL, V77, P154, DOI 10.1016/S0002-9149(96)90587-1; NOLAN J, 1992, BRIT HEART J, V67, P482; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Perkiomaki JS, 2010, ANN NONINVAS ELECTRO, V15, P250, DOI 10.1111/j.1542-474X.2010.00372.x; Piepoli MF, 2008, PACE, V31, P701, DOI 10.1111/j.1540-8159.2008.01073.x; Pinna GD, 2005, J AM COLL CARDIOL, V46, P1314, DOI 10.1016/j.jacc.2005.06.062; Pinna GD, 2002, CLIN SCI, V103, P81; Rydlewska A, 2011, CLIN AUTON RES, V21, P47, DOI 10.1007/s10286-010-0089-z; Sanchez-Lazaro IJ, 2011, INT J CARDIOL, V152, P83, DOI 10.1016/j.ijcard.2010.07.010; Shah SA, 2013, AM J CARDIOL, V112, P533, DOI 10.1016/j.amjcard.2013.04.018; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015	31	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152372	10.1371/journal.pone.0152372	http://dx.doi.org/10.1371/journal.pone.0152372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015089	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708900057
J	Tuo, SH; Zhang, JY; Yuan, XG; Zhang, YY; Liu, ZW				Tuo, Shouheng; Zhang, Junying; Yuan, Xiguo; Zhang, Yuanyuan; Liu, Zhaowen			FHSA-SED: Two-Locus Model Detection for Genome-Wide Association Study with Harmony Search Algorithm	PLOS ONE			English	Article							EPISTATIC INTERACTIONS; HUMAN-DISEASES; CUCKOO SEARCH; GENE; LOCI	Motivation Two-locus model is a typical significant disease model to be identified in genome-wide association study (GWAS). Due to intensive computational burden and diversity of disease models, existing methods have drawbacks on low detection power, high computation cost, and preference for some types of disease models. Method In this study, two scoring functions (Bayesian network based K2-score and Gini-score) are used for characterizing two SNP locus as a candidate model, the two criteria are adopted simultaneously for improving identification power and tackling the preference problem to disease models. Harmony search algorithm (HSA) is improved for quickly finding the most likely candidate models among all two-locus models, in which a local search algorithm with two-dimensional tabu table is presented to avoid repeatedly evaluating some disease models that have strong marginal effect. Finally G-test statistic is used to further test the candidate models. Results We investigate our method named FHSA-SED on 82 simulated datasets and a real AMD dataset, and compare it with two typical methods (MACOED and CSE) which have been developed recently based on swarm intelligent search algorithm. The results of simulation experiments indicate that our method outperforms the two compared algorithms in terms of detection power, computation time, evaluation times, sensitivity (TPR), specificity (SPC), positive predictive value (PPV) and accuracy (ACC). Our method has identified two SNPs (rs3775652 and rs10511467) that may be also associated with disease in AMD dataset.	[Tuo, Shouheng; Zhang, Junying; Yuan, Xiguo; Zhang, Yuanyuan; Liu, Zhaowen] Xidian Univ, Sch Comp Sci & Technol, Xian 710071, Peoples R China; [Tuo, Shouheng] Shaanxi Univ Technol, Sch Math & Comp Sci, Hanzhong 723000, Peoples R China	Xidian University; Shaanxi University of Technology	Zhang, JY (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian 710071, Peoples R China.	tuo_sh@126.com; jyzhang@mail.xidian.edu.cn	Liu, Zhaowen/AAM-6710-2021	Zhang, Yuanyuan/0000-0003-3935-3201	Natural Science Foundation of China [61571341, 61201312, 91530113, 11401357]; Research Fund for the Doctoral Program of Higher Education of China [2013 0203110017]; Fundamental Research Funds for the Central Universities of China [BDY171416, JB140306]; Natural Science Foundation of Shaanxi Province in China [2015JM6275]; Scientific Research Program - Projects Program of Shaanxi University of Technology Academician Workstation [fckt201509]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Shaanxi Province in China(Natural Science Foundation of Shaanxi Province); Scientific Research Program - Projects Program of Shaanxi University of Technology Academician Workstation	This work was supported by the Natural Science Foundation of China under Grants 61571341, 61201312, 91530113, 11401357, Research Fund for the Doctoral Program of Higher Education of China ( No. 2013 0203110017), the Fundamental Research Funds for the Central Universities of China ( Nos. BDY171416 and JB140306), the Natural Science Foundation of Shaanxi Province in China ( 2015JM6275).; This work was supported by the Natural Science Foundation of China under Grants 61571341, 61201312, 91530113 and 11401357, Research Fund for the Doctoral Program of Higher Education of China ( No. 2013 0203110017), the Fundamental Research Funds for the Central Universities of China ( Nos. BDY171416 and JB140306), the Natural Science Foundation of Shaanxi Province in China (2015JM6275), and the Scientific Research Program funded by the Projects Program of Shaanxi University of Technology Academician Workstation ( No. fckt201509).	Aflakparast M, 2014, HEREDITY, V112, P666, DOI 10.1038/hdy.2014.4; Aflakparast M, 2014, MOL BIOSYST, V10, P2654, DOI 10.1039/c4mb00123k; Bergmann C, 2006, AM J HUM GENET, V79, P1105, DOI 10.1086/509789; Breiman L., 1984, CLASSIFICATION REGRE; Ceriani L, 2012, J ECON INEQUAL, V10, P421, DOI 10.1007/s10888-011-9188-x; Chen X, 2007, P NATL ACAD SCI USA, V104, P19199, DOI 10.1073/pnas.0709868104; Chuang Li-Yeh, 2013, J Clin Bioinforma, V3, P4, DOI 10.1186/2043-9113-3-4; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Crow JF, 1999, GENETICS, V152, P821; Fontanesi L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-583; Gayan J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-360; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Guo X, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-102; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Han B, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S14; Han B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S9; Harremoes P., 2012, P ISIT, V2012, P538; Harremoes P, 2008, IEEE T INFORM THEORY, V54, P321, DOI 10.1109/TIT.2007.911155; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoey J, 2012, 2 WAY LIKELIHOOD RAT, V6; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Jiang X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-89; Jing PJ, 2014, BIOINFORMATICS; Kam-Thong T, 2011, EUR J HUM GENET, V19, P465, DOI 10.1038/ejhg.2010.196; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li S, 2013, ACS APPL MATER INTER, V6, P9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Piriyapongsa J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S2; Prabhu S, 2012, GENOME RES, V22, P2230, DOI 10.1101/gr.137885.112; QUINE MP, 1985, ANN STAT, V13, P727, DOI 10.1214/aos/1176349550; Raileanu LE, 2014, ANN MATH ARTIFICIAL, V41, P77; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Schildkraut JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010061; Shah SC, 2004, ARTIF INTELL MED, V31, P183, DOI 10.1016/j.artmed.2004.04.002; Shang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/604972; Shang JL, 2014, DIGIT SIGNAL PROCESS, V24, P1, DOI 10.1016/j.dsp.2013.08.007; Shang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-475; Tang WW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000464; Urbanowicz RJ, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-16; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Visweswaran Shyam, 2009, AMIA Annu Symp Proc, V2009, P673; Walton S, 2011, CHAOS SOLITON FRACT, V44, P710, DOI 10.1016/j.chaos.2011.06.004; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wang JX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2217-6; Wang MH, 2009, STAT BIOPHARM RES, V1, P424, DOI 10.1198/sbr.2009.0046; Wang YD, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-S3-S34, 10.1186/1471-2164-10-S1-S2]; Wang Yupeng, 2010, BMC Res Notes, V3, P117, DOI 10.1186/1756-0500-3-117; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; Yang G, 2014, BIOINFORMATICS; Yang PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-524; Yitzhaki S., 2012, GINI METHODOLOGY PRI; Yucebas SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091404; Yung LS, 2011, BIOINFORMATICS, V27, P1309, DOI 10.1093/bioinformatics/btr114; Zhang QR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003627; Zhang X, 2010, BIOINFORMATICS, V26, pi217, DOI 10.1093/bioinformatics/btq186; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zhang Y, 2011, ANN APPL STAT, V5, P2052, DOI 10.1214/11-AOAS469	62	36	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0150669	10.1371/journal.pone.0150669	http://dx.doi.org/10.1371/journal.pone.0150669			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27014873	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708900022
J	Vidal, BD; Mello, MLS				Vidal, Benedicto de Campos; Mello, Maria Luiza S.			FT-IR Microspectroscopy of Rat Ear Cartilage	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; MACROMOLECULAR ORIENTATION; INFRARED-SPECTROSCOPY; COLLAGEN BUNDLES; TENDON; PROTEOGLYCANS; SPECIFICITY; PROTEINS; SULFATE; FIBERS	Rat ear cartilage was studied using Fourier transform-infrared (FT-IR) microspectroscopy to expand the current knowledge which has been established for relatively more complex cartilage types. Comparison of the FT-IR spectra of the ear cartilage extracellular matrix (ECM) with published data on articular cartilage, collagen II and 4-chondroitin-sulfate standards, as well as of collagen type I-containing dermal collagen bundles (CBs) with collagen type II, was performed. Ear cartilage ECM glycosaminoglycans (GAGs) were revealed histochemically and as a reduction in ECM FT-IR spectral band heights (1140-820 cm(-1)) after testicular hyaluronidase digestion. Although ear cartilage is less complex than articular cartilage, it contains ECM components with a macromolecular orientation as revealed using polarization microscopy. Collagen type II and GAGs, which play a structural role in the stereo-arrangement of the ear cartilage, contribute to its FT-IR spectrum. Similar to articular cartilage, ear cartilage showed that proteoglycans add a contribution to the collagen amide I spectral region, a finding that does not recommend this region for collagen type II quantification purposes. In contrast to articular cartilage, the symmetric stretching vibration of -SO3- groups at 1064 cm-1 appeared under-represented in the FT-IR spectral profile of ear cartilage. Because the band corresponding to the asymmetric stretching vibration of -SO3- groups (1236-1225 cm(-1)) overlapped with that of amide III bands, it is not recommended for evaluation of the -SO3--contribution to the FT-IR spectrum of the ear cartilage ECM. Instead, a peak (or shoulder) at 1027-1016 cm(-1) could be better considered for this intent. Amide I/amide II ratios as calculated here and data from the literature suggest that protein complexes of the ear cartilage ECM are arranged with a lower helical conformation compared to pure collagen II. The present results could motivate further studies on this tissue under pathological or experimental states involving ear cartilage.	[Vidal, Benedicto de Campos; Mello, Maria Luiza S.] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, BR-13083862 Campinas, SP, Brazil	Universidade Estadual de Campinas	Vidal, BD (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, BR-13083862 Campinas, SP, Brazil.	camposvi@unicamp.br	Vidal, Benedicto/I-3227-2012; Mello, Maria Luiza Silveira/D-9158-2012; de Campos Vidal, Benedicto/ABH-6617-2020	Vidal, Benedicto/0000-0003-1629-5619; Mello, Maria Luiza Silveira/0000-0003-1629-5619; de Campos Vidal, Benedicto/0000-0003-0285-1653	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2003/04597-0, 2007/058251-8, 2013/1078-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants no. 2003/04597-0, 2007/058251-8 and 2013/1078-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro AA, 2013, LIFE SCI, V92, P799, DOI 10.1016/j.lfs.2013.02.011; Aygit AC, 2010, J BURN CARE RES, V31, P803, DOI 10.1097/BCR.0b013e3181e4c888; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; BRADAMANTE Z, 1991, International Journal of Developmental Biology, V35, P311; Bryan MA, 2007, J AM CHEM SOC, V129, P7877, DOI 10.1021/ja071154i; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; Hanifi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064822; ISHIDA KP, 1993, APPL SPECTROSC, V47, P584, DOI 10.1366/0003702934067306; JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V; KIERNAN JA, 1974, J ANAT, V117, P397; Kolostova K, 2012, EUR ARCH OTO-RHINO-L, V269, P1763, DOI 10.1007/s00405-011-1821-6; MEINGASSNER JG, 1991, LAB ANIM, V25, P68, DOI 10.1258/002367791780808103; MELLO MLS, 1973, ANN HISTOCHIM, V18, P103; Mello MLS, 2003, CELL MOL BIOL, V49, P579; Ribeiro JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054724; Rieppo L, 2012, OSTEOARTHR CARTILAGE, V20, P451, DOI 10.1016/j.joca.2012.01.010; Rieppo L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.097006; Saarakkala S, 2010, CARTILAGE, V1, P262, DOI 10.1177/1947603510368689; Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871; Servaty R, 2001, INT J BIOL MACROMOL, V28, P121, DOI 10.1016/S0141-8130(00)00161-6; Tian HL, 2012, CARBOHYD POLYM, V89, P542, DOI 10.1016/j.carbpol.2012.03.042; Tomiosso TC, 2005, BIOCELL, V29, P47; VIDAL BC, 1970, HISTOCHEMISTRY, V23, P176; VIDAL BC, 2005, BRAZ J MORPHOL SCI, V22, P149; Vidal BD, 2003, MICRON, V34, P423, DOI 10.1016/S0968-4328(03)00039-8; VIDAL BD, 1980, CELL MOL BIOL, V26, P415; VIDAL BD, 1988, ACTA HISTOCHEM, V83, P189; VIDAL BDC, 1977, CELL MOL BIOL, V22, P45; Vidal BDC, 2014, ACTA HISTOCHEM, V116, P1359, DOI 10.1016/j.acthis.2014.08.007; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Vidal BD, 2010, ACTA HISTOCHEM, V112, P53, DOI 10.1016/j.acthis.2008.07.005; West PA, 2004, APPL SPECTROSC, V58, P376, DOI 10.1366/000370204773580194; Youn JI, 2008, LASER MED SCI, V23, P229, DOI 10.1007/s10103-007-0464-8	33	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151989	10.1371/journal.pone.0151989	http://dx.doi.org/10.1371/journal.pone.0151989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015280	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708900036
J	Deuis, JR; Dekan, Z; Inserra, MC; Lee, TH; Aguilar, MI; Craik, DJ; Lewis, RJ; Alewood, PF; Mobli, M; Schroeder, CI; Henriques, ST; Vetter, I				Deuis, Jennifer R.; Dekan, Zoltan; Inserra, Marco C.; Lee, Tzong-Hsien; Aguilar, Marie-Isabel; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.; Mobli, Mehdi; Schroeder, Christina I.; Henriques, Sonia Troeira; Vetter, Irina			Development of a mu O-Conotoxin Analogue with Improved Lipid Membrane Interactions and Potency for the Analgesic Sodium Channel Na(V)1.8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; VOLTAGE SENSORS; PAIN; INHIBITION; PROGRAM; BINDING; MRVIB; ELECTROGENESIS; PRP(106-126); SPECTROSCOPY	The mu O-conotoxins MrVIA, MrVIB, and MfVIA inhibit the voltage-gated sodium channel Na(V)1.8, a well described target for the treatment of pain; however, little is known about the residues or structural elements that define this activity. In this study, we determined the three-dimensional structure of MfVIA, examined its membrane binding properties, performed alanine-scanning mutagenesis, and identified residues important for its activity at human Na(V)1.8. Asecond round of mutations resulted in (E5K,E8K)MfVIA, a double mutant with greater positive surface charge and greater affinity for lipid membranes compared with MfVIA. This analogue had increased potency at Na(V)1.8 and was analgesic in the mouse formalin assay.	[Deuis, Jennifer R.; Dekan, Zoltan; Inserra, Marco C.; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.; Schroeder, Christina I.; Henriques, Sonia Troeira; Vetter, Irina] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld 4072, Australia; [Deuis, Jennifer R.; Inserra, Marco C.; Vetter, Irina] Univ Queensland, Sch Pharm, Woolloongabba, Qld 4102, Australia; [Lee, Tzong-Hsien; Aguilar, Marie-Isabel] Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia	University of Queensland; University of Queensland; University of Queensland; Monash University	Schroeder, CI; Henriques, ST; Vetter, I (corresponding author), Univ Queensland, Inst Mol Biosci, 306 Carmody Rd,Bldg 80, St Lucia, Qld 4067, Australia.	c.schroeder@imb.uq.edu.au; s.henriques@imb.uq.edu.au; i.vetter@uq.edu.au	Schroeder, Cristina I./K-2042-2014; Vetter, Irina/A-6035-2010; Henriques, Sonia Troeira/J-3500-2016; Craik, David/B-1695-2010; Mobli, Mehdi/O-7244-2014; Lewis, Richard/T-8763-2019; Deuis, Jennifer/R-2440-2017	Schroeder, Cristina I./0000-0002-6737-6374; Vetter, Irina/0000-0002-3594-9588; Henriques, Sonia Troeira/0000-0001-9564-9651; Craik, David/0000-0003-0007-6796; Mobli, Mehdi/0000-0003-2420-4262; Lewis, Richard/0000-0003-3470-923X; Deuis, Jennifer/0000-0002-5107-8938; Alewood, Paul/0000-0001-7454-6522; Dekan, Zoltan/0000-0002-6841-4176	Australian postgraduate award; Australian Future Fellowships [FT130101215, FT10100925]; University of Queensland; National Health and Medical Research Council (NHMRC) [APP1080405]	Australian postgraduate award(Australian Government); Australian Future Fellowships; University of Queensland(University of Queensland); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by an Australian postgraduate award (to J. R. D.), Australian Future Fellowships FT130101215 (to I. V.) and FT10100925 (to M. M.), a University of Queensland early career researcher grant (to I. V.), and National Health and Medical Research Council (NHMRC) Project Grant APP1080405 (to C. I. S., S. T. H., and M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbadie C, 1997, PAIN, V69, P101, DOI 10.1016/S0304-3959(96)03285-X; Adams DJ, 2003, J BIOL CHEM, V278, P4057, DOI 10.1074/jbc.M209969200; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Blair NT, 2002, J NEUROSCI, V22, P10277; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulaj G, 2006, BIOCHEMISTRY-US, V45, P7404, DOI 10.1021/bi060159+; Cardoso FC, 2015, MOL PHARMACOL, V88, P291, DOI 10.1124/mol.115.098178; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; CODERRE TJ, 1990, BRAIN RES, V535, P155, DOI 10.1016/0006-8993(90)91835-5; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; de Araujo AD, 2011, ANGEW CHEM INT EDIT, V50, P6527, DOI 10.1002/anie.201101642; DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711; Deuis JR, 2013, PAIN, V154, P1749, DOI 10.1016/j.pain.2013.05.032; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Gingras J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105895; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hall K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05479; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Henriques ST, 2005, BBA-BIOMEMBRANES, V1669, P75, DOI 10.1016/j.bbamem.2004.11.017; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Knapp O, 2012, BRIT J PHARMACOL, V166, P2148, DOI 10.1111/j.1476-5381.2012.01955.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laird JMA, 2002, J NEUROSCI, V22, P8352; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Lee TH, 2015, BBA-BIOMEMBRANES, V1848, P1868, DOI 10.1016/j.bbamem.2015.05.012; Lee TH, 2010, BBA-BIOMEMBRANES, V1798, P1977, DOI 10.1016/j.bbamem.2010.06.023; Leipold E, 2007, CHANNELS, V1, P253, DOI 10.4161/chan.4847; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Liu ZH, 2013, J BIOL CHEM, V288, P20392, DOI 10.1074/jbc.M112.426627; Mashaghi A, 2008, ANAL CHEM, V80, P3666, DOI 10.1021/ac800027s; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Scanlon MJ, 1997, STRUCTURE, V5, P1585, DOI 10.1016/S0969-2126(97)00307-9; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shields SD, 2012, PAIN, V153, P2017, DOI 10.1016/j.pain.2012.04.022; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Vetter I, 2012, BIOCHEM PHARMACOL, V84, P540, DOI 10.1016/j.bcp.2012.05.008; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wilson MJ, 2011, J PHARMACOL EXP THER, V338, P687, DOI 10.1124/jpet.110.178343; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880; Zorn S, 2006, FEBS LETT, V580, P1360, DOI 10.1016/j.febslet.2006.01.057	62	33	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11829	11842		10.1074/jbc.M116.721662	http://dx.doi.org/10.1074/jbc.M116.721662			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27026701	Green Published, hybrid			2022-12-26	WOS:000377264800032
J	Smagris, E; Gilyard, S; BasuRay, S; Cohen, JC; Hobbs, HH				Smagris, Eriks; Gilyard, Shenise; BasuRay, Soumik; Cohen, Jonathan C.; Hobbs, Helen H.			Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; SUPERFAMILY MEMBER 2; HEPATOCELLULAR-CARCINOMA; HEPATIC STEATOSIS; CONFERS SUSCEPTIBILITY; WIDE ASSOCIATION; PNPLA3 RS738409; VARIANT; RISK; CHOLESTEROL	A missense mutation (E167K) in TM6SF2 (transmembrane 6 superfamily member 2), a polytopic protein of unknown function, is associated with the full spectrum of fatty liver disease. To investigate the role of TM6SF2 in hepatic triglyceride (TG) metabolism, we inactivated the gene in mice. Chronic inactivation of Tm6sf2 in mice is associated with hepatic steatosis, hypocholesterolemia, and transaminitis, thus recapitulating the phenotype observed in humans. No dietary challenge was required to elicit the phenotype. Immunocytochemical and cell fractionation studies revealed that TM6SF2 was present in the endoplasmic reticulum and Golgi complex, whereas the excess neutral lipids in the Tm6sf2(-/-) mice were located in lipid droplets. Plasma VLDL-TG levels were reduced in the KO animals due to a 3-fold decrease in VLDL-TG secretion rate without any associated reduction in hepatic apoB secretion. Both VLDL particle size and plasma cholesterol levels were significantly reduced in KO mice. Despite levels of TM6SF2 protein being 10-fold higher in the small intestine than in the liver, dietary lipid absorption was only modestly reduced in the KO mice. Our data, taken together, reveal that TM6SF2 is required to mobilize neutral lipids for VLDL assembly but is not required for secretion of apoB-containing lipoproteins. Despite TM6SF2 being located in the endoplasmic reticulum and Golgi complex, the lipids that accumulate in its absence reside in lipid droplets.	[Smagris, Eriks; Gilyard, Shenise; BasuRay, Soumik; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Smagris, Eriks; Gilyard, Shenise; Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cohen, JC; Hobbs, HH (corresponding author), Dept Mol Genet, L5-134,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu			National Institute of Health [PO1 HL20948, R01 DK090066]; American Liver Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090066] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health Grants PO1 HL20948 and R01 DK090066. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a postdoctoral research fellowship award from the American Liver Foundation.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Browning JD, 2004, AM J GASTROENTEROL, V99, P292, DOI 10.1111/j.1572-0241.2004.04059.x; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Burza MA, 2014, LIVER INT, V34, P514, DOI 10.1111/liv.12310; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dongiovanni P, 2015, HEPATOLOGY, V61, P506, DOI 10.1002/hep.27490; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Engelking LJ, 2012, J LIPID RES, V53, P1359, DOI 10.1194/jlr.M027599; Falleti E, 2016, DIGEST LIVER DIS, V48, P69, DOI 10.1016/j.dld.2015.09.009; Falleti E, 2011, LIVER INT, V31, P1137, DOI 10.1111/j.1478-3231.2011.02534.x; Fan YB, 2016, GASTROENTEROLOGY, V150, P1208, DOI 10.1053/j.gastro.2016.01.005; FISHER RM, 1995, CLIN CHIM ACTA, V236, P7, DOI 10.1016/0009-8981(95)06032-3; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goffredo M, 2016, HEPATOLOGY, V63, P117, DOI 10.1002/hep.28283; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Jones C, 2007, J CLIN INVEST, V117, P165, DOI 10.1172/JCI29415; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Li JZ, 2012, J CLIN INVEST, V122, P4130, DOI 10.1172/JCI65179; Li ZQ, 2015, GASTROENTEROLOGY, V149, P1519, DOI 10.1053/j.gastro.2015.07.012; LIN MCM, 1994, J BIOL CHEM, V269, P29138; Liu YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5309; Manchekar M, 2015, J BIOL CHEM, V290, P8196, DOI 10.1074/jbc.M114.602748; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Nischalke HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027087; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Ouguerram K, 2012, ARTERIOSCL THROM VAS, V32, P1520, DOI 10.1161/ATVBAHA.112.245076; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Sanchez-Pulido L, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00439; Schumacher MM, 2015, ELIFE, V4, DOI [10.7554/eLife.05560, 10.7554/eLife.04490]; Smagris E, 2015, HEPATOLOGY, V61, P108, DOI 10.1002/hep.27242; Sookoian S, 2015, HEPATOLOGY, V61, P515, DOI 10.1002/hep.27556; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2014, HEPATOLOGY, V59, P2170, DOI 10.1002/hep.26767; Vitale N, 1998, P NATL ACAD SCI USA, V95, P8613, DOI 10.1073/pnas.95.15.8613; Wang J, 2015, J LIPID RES, V56, P319, DOI 10.1194/jlr.M054544; Wang Y, 2015, P NATL ACAD SCI USA, V112, P11630, DOI 10.1073/pnas.1515374112; Wang Y, 2015, J LIPID RES, V56, P1296, DOI 10.1194/jlr.M054882; WETTERAU JR, 1992, SCIENCE, V258, P999; Yao ZM, 2013, CURR OPIN LIPIDOL, V24, P160, DOI 10.1097/MOL.0b013e32835aebe7	57	125	127	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10659	10676		10.1074/jbc.M116.719955	http://dx.doi.org/10.1074/jbc.M116.719955			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27013658	Green Published, hybrid			2022-12-26	WOS:000377042600019
J	Hansen, RW; Wang, XL; Golab, A; Bornert, O; Oswald, C; Wagner, R; Martinez, KL				Hansen, Randi Westh; Wang, Xiaole; Golab, Agnieszka; Bornert, Olivier; Oswald, Christine; Wagner, Renaud; Martinez, Karen Laurence			Functional Stability of the Human Kappa Opioid Receptor Reconstituted in Nanodiscs Revealed by a Time-Resolved Scintillation Proximity Assay	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; NANOSCALE LIPID-BILAYERS; PLASMON RESONANCE SPECTROSCOPY; MEMBRANE-PROTEINS; DRUG DISCOVERY; PHOSPHOLIPID-BILAYER; MONOMERIC RHODOPSIN; LIGAND-BINDING; TRANSDUCIN; DETERGENT	Long-term functional stability of isolated membrane proteins is crucial for many in vitro applications used to elucidate molecular mechanisms, and used for drug screening platforms in modern pharmaceutical industry. Compared to soluble proteins, the understanding at the molecular level of membrane proteins remains a challenge. This is partly due to the difficulty to isolate and simultaneously maintain their structural and functional stability, because of their hydrophobic nature. Here we show, how scintillation proximity assay can be used to analyze time-resolved high-affinity ligand binding to membrane proteins solubilized in various environments. The assay was used to establish conditions that preserved the biological function of isolated human kappa opioid receptor. In detergent solution the receptor lost high-affinity ligand binding to a radiolabelled ligand within minutes at room temperature. After reconstitution in Nanodiscs made of phospholipid bilayer the half-life of high-affinity ligand binding to the majority of receptors increased 70-fold compared to detergent solubilized receptors-a level of stability that is appropriate for further downstream applications. Time-resolved scintillation proximity assay has the potential to screen numerous conditions in parallel to obtain high levels of stable and active membrane proteins, which are intrinsically unstable in detergent solution, and with minimum material consumption.	[Hansen, Randi Westh; Wang, Xiaole; Golab, Agnieszka; Martinez, Karen Laurence] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Hansen, Randi Westh; Wang, Xiaole; Golab, Agnieszka; Martinez, Karen Laurence] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Bornert, Olivier; Wagner, Renaud] Univ Strasbourg, CNRS, UMR7242, Lab Excellence MEDALIS,Inst Rech ESBS,Biotechnol, Illkirch Graffenstaden, France; [Oswald, Christine] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Oswald, Christine] Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England	University of Copenhagen; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Copenhagen; Heptares Therapeutics Ltd.	Martinez, KL (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.; Martinez, KL (corresponding author), Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark.	martinez@nano.ku.dk	martinez, karen L/J-5933-2013; Martinez, Karen/W-3709-2019	martinez, karen L/0000-0003-0932-8080; Martinez, Karen/0000-0003-0932-8080; Hansen, Randi Westh/0000-0001-5547-683X; Wagner, Renaud/0000-0002-4249-9853	Lundbeck Foundation Center for Biomembranes in Nanomedicine	Lundbeck Foundation Center for Biomembranes in Nanomedicine	UNIK Synthetic Biology founded by the Danish Ministry of Science and the Lundbeck Foundation Center for Biomembranes in Nanomedicine supported this work.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Alkhalfioui F, 2009, CURR OPIN PHARMACOL, V9, P629, DOI 10.1016/j.coph.2009.04.002; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; Andrews SP, 2014, CHEMMEDCHEM, V9, P256, DOI 10.1002/cmdc.201300382; Aristotelous T, 2013, ACS MED CHEM LETT, V4, P1005, DOI 10.1021/ml400312j; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bjorneras J, 2013, BIOCHEMISTRY-US, V52, P4157, DOI 10.1021/bi4004205; Borch J, 2008, ANAL CHEM, V80, P6245, DOI 10.1021/ac8000644; BOSWORTH N, 1989, NATURE, V341, P167, DOI 10.1038/341167a0; Bradford CS, 2005, J MOL ENDOCRINOL, V34, P809, DOI 10.1677/jme.1.01711; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; Butelman ER, 2012, TRENDS NEUROSCI, V35, P587, DOI 10.1016/j.tins.2012.05.005; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen D, 2012, ACS CHEM BIOL, V7, P2064, DOI 10.1021/cb300436c; Christopher JA, 2013, J MED CHEM, V56, P3446, DOI 10.1021/jm400140q; Civjan NR, 2003, BIOTECHNIQUES, V35, P556, DOI 10.2144/03353rr02; Cooke RM, 2013, BIOCHEM SOC T, V41, P185, DOI 10.1042/BST20120240; D'Antona AM, 2014, BIOCHEMISTRY-US, V53, P127, DOI 10.1021/bi4012995; Das A, 2009, ANAL CHEM, V81, P3754, DOI 10.1021/ac802612z; de Jong LAA, 2005, J CHROMATOGR B, V829, P1, DOI 10.1016/j.jchromb.2005.10.002; Fang Y, 2012, EXPERT OPIN DRUG DIS, V7, P969, DOI 10.1517/17460441.2012.715631; Fiez-Vandal C, 2012, BIOPHYS CHEM, V165, P56, DOI 10.1016/j.bpc.2012.03.005; Fox DA, 2014, J AM CHEM SOC, V136, P9938, DOI 10.1021/ja503093y; Glickman JF, 2008, ASSAY DRUG DEV TECHN, V6, P433, DOI 10.1089/adt.2008.135; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Howell SC, 2010, BIOCHEMISTRY-US, V49, P9572, DOI 10.1021/bi101334j; Jamshad Mohammed, 2015, Biosci Rep, V35, DOI 10.1042/BSR20140171; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Lindert S, 2014, BIOCHEM BIOPH RES CO, V445, P724, DOI 10.1016/j.bbrc.2014.01.179; Locatelli-Hoops S, 2013, BIOMED SPECTROSC IMA, V2, P155, DOI 10.3233/BSI-130045; Magnin T, 2009, PROTEIN EXPRES PURIF, V64, P1, DOI 10.1016/j.pep.2008.09.007; Marty MT, 2013, ANAL BIOANAL CHEM, V405, P4009, DOI 10.1007/s00216-013-6790-8; Mayr LM, 2008, J BIOMOL SCREEN, V13, P443, DOI 10.1177/1087057108319644; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Mitra N, 2013, ACS CHEM BIOL, V8, P617, DOI 10.1021/cb300466n; Nasr ML, 2014, BIOCHEMISTRY-US, V53, P4, DOI 10.1021/bi401412e; Patching SG, 2014, BBA-BIOMEMBRANES, V1838, P43, DOI 10.1016/j.bbamem.2013.04.028; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rich RL, 2011, ANAL BIOCHEM, V409, P267, DOI 10.1016/j.ab.2010.10.008; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774; Schwarzer C, 2009, PHARMACOL THERAPEUT, V123, P353, DOI 10.1016/j.pharmthera.2009.05.006; Shepherd CA, 2014, PROG BIOPHYS MOL BIO, V116, P113, DOI 10.1016/j.pbiomolbio.2014.09.008; Shibata Y, 2013, BBA-BIOMEMBRANES, V1828, P1293, DOI 10.1016/j.bbamem.2013.01.008; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Tribet C, 2009, LANGMUIR, V25, P12623, DOI 10.1021/la9018772; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu W, 2000, BIOCHEMISTRY-US, V39, P13904, DOI 10.1021/bi001099p; Yao ZP, 2005, ANAL BIOCHEM, V343, P344, DOI 10.1016/j.ab.2005.05.002; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yoshiura C, 2010, J AM CHEM SOC, V132, P6768, DOI 10.1021/ja100830f; Zoonens M, 2014, J MEMBRANE BIOL, V247, P759, DOI 10.1007/s00232-014-9666-8	58	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0150658	10.1371/journal.pone.0150658	http://dx.doi.org/10.1371/journal.pone.0150658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035823	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200005
J	Disanto, G; Benkert, P; Lorscheider, J; Mueller, S; Vehoff, J; Zecca, C; Ramseier, S; Achtnichts, L; Findling, O; Nedeltchev, K; Radue, EW; Sprenger, T; Stippich, C; Derfuss, T; Louvion, JF; Kamm, CP; Mattle, HP; Lotter, C; Du Pasquier, R; Schluep, M; Pot, C; Lalive, PH; Yaldizli, O; Gobbi, C; Kappos, L; Kuhle, J				Disanto, Giulio; Benkert, Pascal; Lorscheider, Johannes; Mueller, Stefanie; Vehoff, Jochen; Zecca, Chiara; Ramseier, Simon; Achtnichts, Lutz; Findling, Oliver; Nedeltchev, Krassen; Radue, Ernst-Wilhelm; Sprenger, Till; Stippich, Christoph; Derfuss, Tobias; Louvion, Jean-Francois; Kamm, Christian P.; Mattle, Heinrich P.; Lotter, Christoph; Du Pasquier, Renaud; Schluep, Myriam; Pot, Caroline; Lalive, Patrice H.; Yaldizli, Oezuer; Gobbi, Claudio; Kappos, Ludwig; Kuhle, Jens		SMSC Sci Board	The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options	PLOS ONE			English	Article							PRIMARY PROGRESSIVE MS; DIAGNOSTIC-CRITERIA; DOUBLE-BLIND; IMMUNOLOGY; MECHANISMS; THERAPY; RISK	The mechanisms leading to disability and the long-term efficacy and safety of disease modifying drugs (DMDs) in multiple sclerosis (MS) are unclear. We aimed at building a prospective cohort of MS patients with standardized collection of demographic, clinical, MRI data and body fluids that can be used to develop prognostic indicators and biomarkers of disease evolution and therapeutic response. The Swiss MS Cohort (SMSC) is a prospective observational study performed across seven Swiss MS centers including patients with MS, clinically isolated syndrome (CIS), radiologically isolated syndrome or neuromyelitis optica. Neurological and radiological assessments and biological samples are collected every 6-12 months. We recruited 872 patients (clinically isolated syndrome [CIS] 5.5%, relapsing-remitting MS [RRMS] 85.8%, primary progressive MS [PPMS] 3.5%, secondary progressive MS [SPMS] 5.2%) between June 2012 and July 2015. We performed 2,286 visits (median follow-up 398 days) and collected 2,274 serum, plasma and blood samples, 152 cerebrospinal fluid samples and 1,276 brain MRI scans. 158 relapses occurred and expanded disability status scale (EDSS) scores increased in PPMS, SPMS and RRMS patients experiencing relapses. Most RRMS patients were treated with fingolimod (33.4%), natalizumab (24.5%) or injectable DMDs (13.6%). The SMSC will provide relevant information regarding DMDs efficacy and safety and will serve as a comprehensive infrastructure available for nested research projects.	[Disanto, Giulio; Zecca, Chiara; Gobbi, Claudio] Reg Hosp Lugano EOC, Dept Neurol, Lugano, Switzerland; [Benkert, Pascal] Univ Basel Hosp, Clin Trial Unit, Basel, Switzerland; [Lorscheider, Johannes; Sprenger, Till; Derfuss, Tobias; Yaldizli, Oezuer; Kappos, Ludwig; Kuhle, Jens] Univ Basel Hosp, Dept Med, Neurol, CH-4031 Basel, Switzerland; [Lorscheider, Johannes; Sprenger, Till; Derfuss, Tobias; Yaldizli, Oezuer; Kappos, Ludwig; Kuhle, Jens] Univ Basel Hosp, Dept Biomed, Neurol, CH-4031 Basel, Switzerland; [Lorscheider, Johannes; Sprenger, Till; Derfuss, Tobias; Yaldizli, Oezuer; Kappos, Ludwig; Kuhle, Jens] Univ Basel Hosp, Dept Clin Res, Neurol, CH-4031 Basel, Switzerland; [Mueller, Stefanie; Vehoff, Jochen] Cantonal Hosp St Gallen, Dept Neurol, St Gallen, Switzerland; [Ramseier, Simon; Achtnichts, Lutz; Findling, Oliver; Nedeltchev, Krassen] Cantonal Hosp Aarau, Dept Neurol, Aarau, Switzerland; [Radue, Ernst-Wilhelm; Sprenger, Till] Univ Basel, Med Image Anal Ctr, Basel, Switzerland; [Stippich, Christoph] Univ Basel Hosp, Dept Radiol, Neuroradiol, CH-4031 Basel, Switzerland; [Louvion, Jean-Francois] RodanoTech, Geneva, Switzerland; [Kamm, Christian P.; Mattle, Heinrich P.] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Kamm, Christian P.; Mattle, Heinrich P.] Univ Bern, Bern, Switzerland; [Lotter, Christoph] Swiss Multiple Sclerosis Soc, Zurich, Switzerland; [Du Pasquier, Renaud; Schluep, Myriam] Univ Hosp Lausanne CHUV, Dept Neurol, Lausanne, Switzerland; [Pot, Caroline; Lalive, Patrice H.] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; Kantonsspital St. Gallen; Kantonsspital Aarau AG (KSA); University of Basel; University of Basel; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva	Kappos, L; Kuhle, J (corresponding author), Univ Basel Hosp, Dept Med, Neurol, CH-4031 Basel, Switzerland.; Kappos, L; Kuhle, J (corresponding author), Univ Basel Hosp, Dept Biomed, Neurol, CH-4031 Basel, Switzerland.; Kappos, L; Kuhle, J (corresponding author), Univ Basel Hosp, Dept Clin Res, Neurol, CH-4031 Basel, Switzerland.	ludwig.kappos@usb.ch; jens.kuhle@usb.ch	Zecca, Chiara/L-3406-2013; Yaldizli, Özgür/AAN-3351-2021; Findling, Oliver/AAE-3815-2019; Benkert, Pascal/C-3895-2009; Lorscheider, Johannes/AAU-2509-2020; Haller, Sven/AAY-2564-2020; Pot, Caroline/O-8590-2016; Du Pasquier, Renaud/O-8588-2016; Kuhle, Jens/AGE-3474-2022; Yaldizli, Özgür/AAV-1423-2020; Yaldizli, Özgür/AAP-5585-2021; Lalive, Patrice/AAM-5861-2020	Haller, Sven/0000-0001-7433-0203; Pot, Caroline/0000-0002-1146-3129; Du Pasquier, Renaud/0000-0002-2786-3434; Yaldizli, Özgür/0000-0002-0800-4845; Chan, Andrew/0000-0003-3434-7283; Gobbi, Claudio/0000-0002-7554-0664; Zecca, Chiara/0000-0002-9990-3431; Derfuss, Tobias/0000-0001-8656-4250; Lorscheider, Johannes/0000-0003-1100-2506; Sprenger, Till/0000-0002-5390-819X; lovblad, karl-olof/0000-0003-2768-9779; Granziera, Cristina/0000-0002-4917-8761	Swiss MS Society; Biogen; Genzyme GmbH; Hoffmann-La Roche Ltd; Novartis Pharma Switzerland; Teva Pharma AG	Swiss MS Society; Biogen(Biogen); Genzyme GmbH(Sanofi-AventisGenzyme Corporation); Hoffmann-La Roche Ltd(Hoffmann-La Roche); Novartis Pharma Switzerland; Teva Pharma AG(Teva Pharmaceutical Industries)	This study received funding from the Swiss MS Society and also by grants from Biogen, Genzyme GmbH, Hoffmann-La Roche Ltd, Novartis Pharma Switzerland, and Teva Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rodano Tech provided support in the form of salaries for authors [JFL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen O, 2012, ACTA NEUROL SCAND, V126, P13, DOI 10.1111/ane.12023; Armstrong K, 2012, J CLIN ONCOL, V30, P4208, DOI 10.1200/JCO.2012.42.2659; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bronnum-Hansen H, 2011, SCAND J PUBLIC HEALT, V39, P62, DOI 10.1177/1403494810390729; Butzkueven H, 2006, MULT SCLER, V12, P769, DOI 10.1177/1352458506070775; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2014, LANCET NEUROL, V13, P247, DOI 10.1016/S1474-4422(13)70308-9; Derfuss T, 2013, SEMIN NEUROL, V33, P26, DOI 10.1055/s-0033-1343793; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Granberg T, 2013, MULT SCLER J, V19, P271, DOI 10.1177/1352458512451943; Hartung HP, 2015, MULT SCLER J, V21, P22, DOI 10.1177/1352458514549398; Havrdova E, 2013, EXPERT OPIN PHARMACO, V14, P2145, DOI 10.1517/14656566.2013.826190; Jurynczyk M, 2015, J NEUROL NEUROSUR PS, V86, P20, DOI 10.1136/jnnp-2014-308984; Kasper LH, 2010, NEUROLOGY, V74, pS2, DOI 10.1212/WNL.0b013e3181c97c8f; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Kuhlmann T, 2013, MULT SCLER J, V19, P268, DOI 10.1177/1352458513476563; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lassmann H, 2013, MULT SCLER J, V19, P266, DOI 10.1177/1352458512474091; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Mackenzie IS, 2014, J NEUROL NEUROSUR PS, V85, P76, DOI 10.1136/jnnp-2013-305450; Maercker A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13751; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Scalfari A, 2011, NEUROLOGY, V77, P1246, DOI 10.1212/WNL.0b013e318230a17d; Scalfari A, 2014, J NEUROL NEUROSUR PS, V85, P67, DOI 10.1136/jnnp-2012-304333; Steinman L, 2014, ANNU REV IMMUNOL, V32, P257, DOI 10.1146/annurev-immunol-032713-120227; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Wingerchuk DM, 2014, MAYO CLIN PROC, V89, P225, DOI 10.1016/j.mayocp.2013.11.002	34	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152347	10.1371/journal.pone.0152347	http://dx.doi.org/10.1371/journal.pone.0152347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032105	Green Submitted, gold, Green Published			2022-12-26	WOS:000373121800061
J	Foley, RC; Kidd, BN; Hane, JK; Anderson, JP; Singh, KB				Foley, Rhonda C.; Kidd, Brendan N.; Hane, James K.; Anderson, Jonathan P.; Singh, Karam B.			Reactive Oxygen Species Play a Role in the Infection of the Necrotrophic Fungi, Rhizoctonia solani in Wheat	PLOS ONE			English	Article							OXALATE OXIDASE GENE; SCLEROTINIA-SCLEROTIORUM; BOTRYTIS-CINEREA; NADPH OXIDASES; BRASSICA-NAPUS; GERMIN GENE; NICOTIANA-BENTHAMIANA; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; NONHOST RESISTANCE	Rhizoctonia solani is a nectrotrophic fungal pathogen that causes billions of dollars of damage to agriculture worldwide and infects a broad host range including wheat, rice, potato and legumes. In this study we identify wheat genes that are differentially expressed in response to the R. solani isolate, AG8, using microarray technology. A significant number of wheat genes identified in this screen were involved in reactive oxygen species (ROS) production and redox regulation. Levels of ROS species were increased in wheat root tissue following R. solani infection as determined by Nitro Blue Tetrazolium (NBT), 3,3'-diaminobenzidine (DAB) and titanium sulphate measurements. Pathogen/ROS related genes from R. solani were also tested for expression patterns upon wheat infection. TmpL, a R. solani gene homologous to a gene associated with ROS regulation in Alternaria brassicicola, and OAH, a R. solani gene homologous to oxaloacetate acetylhydrolase which has been shown to produce oxalic acid in Sclerotinia sclerotiorum, were highly induced in R. solani when infecting wheat. We speculate that the interplay between the wheat and R. solani ROS generating proteins may be important for determining the outcome of the wheat/R. solani interaction.	[Foley, Rhonda C.; Kidd, Brendan N.; Hane, James K.; Anderson, Jonathan P.; Singh, Karam B.] CSIRO Agr, Ctr Environm & Life Sci, Floreat, WA, Australia; [Anderson, Jonathan P.; Singh, Karam B.] Univ Western Australia, UWA Inst Agr, Crawley, WA, Australia; [Hane, James K.] Curtin Univ, Dept Environm & Agr, Bentley Campus, Perth, WA 6845, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Curtin University	Singh, KB (corresponding author), CSIRO Agr, Ctr Environm & Life Sci, Floreat, WA, Australia.; Singh, KB (corresponding author), Univ Western Australia, UWA Inst Agr, Crawley, WA, Australia.	Karam.Singh@csiro.au	Anderson, Jonathan P/A-7244-2008; Hane, James/A-7062-2011; Kidd, Brendan N/D-9801-2017; Singh, Karam B/C-3235-2012; Kidd, Brendan N/J-9672-2014; Foley, Rhonda C/G-6716-2012	Anderson, Jonathan P/0000-0002-4783-5393; Hane, James/0000-0002-7651-0977; Singh, Karam B/0000-0002-2777-7448; Kidd, Brendan N/0000-0003-1770-1404; 	GRDC [UWA00145]; CSIRO	GRDC; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was supported by GRDC (UWA00145), www.grdc.com.au, and CSIRO, www.csiro.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDER P, 1976, ARCH MICROBIOL, V109, P1, DOI 10.1007/BF00425105; [Anonymous], 2002, PLANT VARIETIES J, V15, P53; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Bailey A, 2000, J BIOL CHEM, V275, P14242, DOI 10.1074/jbc.275.19.14242; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Beracochea VC, 2015, PLANT CELL REP, V34, P1717, DOI 10.1007/s00299-015-1819-4; Berna A, 1999, PLANT MOL BIOL, V39, P539, DOI 10.1023/A:1006123432157; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Burhenne K, 2003, J BIOL CHEM, V278, P13919, DOI 10.1074/jbc.M213041200; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Chamoun R, 2015, MOL GENET GENOMICS, V290, P877, DOI 10.1007/s00438-014-0962-x; Daudi A., 2012, BIOPROTOCOL, V2, pe263, DOI DOI 10.1016/j.envexpbot.2012.08.003; Dobon A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004800; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P359, DOI 10.1016/0048-4059(83)90020-6; Donaldson PA, 2001, PHYSIOL MOL PLANT P, V59, P297, DOI 10.1006/pmpp.2001.0369; Dong XB, 2008, PLANTA, V228, P331, DOI 10.1007/s00425-008-0740-2; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Foley RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056814; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Gardiner DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-289; Gkarmiri K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1758-z; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gleason C, 2011, P NATL ACAD SCI USA, V108, P10768, DOI 10.1073/pnas.1016060108; Hane JK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004281; Hurkman WJ, 1996, PLANT PHYSIOL, V111, P735, DOI 10.1104/pp.111.3.735; Kamara S, 2008, AQUAT SCI, V70, P204, DOI 10.1007/s00027-008-8048-7; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HJ, 2011, APPL ENVIRON MICROB, V77, P7721, DOI 10.1128/AEM.05472-11; Kim KH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000653; LANE BG, 1993, J BIOL CHEM, V268, P12239; Larroque M, 2013, J EXP BOT, V64, P3615, DOI 10.1093/jxb/ert195; Lehmann S, 2015, PHYTOCHEMISTRY, V112, P54, DOI 10.1016/j.phytochem.2014.08.027; Li XH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00463; Liang XF, 2015, MOL PLANT PATHOL, V16, P559, DOI 10.1111/mpp.12211; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACNISH GC, 1993, AUST J AGR RES, V44, P1175, DOI 10.1071/AR9931175; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Molla KA, 2013, MOL PLANT PATHOL, V14, P910, DOI 10.1111/mpp.12055; Nagarajkumara M, 2005, MICROBIOL RES, V160, P291, DOI 10.1016/j.micres.2005.02.002; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Novakova M, 2014, PLANT PHYSIOL BIOCH, V80, P308, DOI 10.1016/j.plaphy.2014.04.019; Nozaki M, 2013, BIOSCI BIOTECH BIOCH, V77, P1323, DOI 10.1271/bbb.130092; Nussbaumer T, 2013, NUCLEIC ACIDS RES, V41, pD1144, DOI 10.1093/nar/gks1153; Okubara PA, 2014, PLANT SCI, V228, P61, DOI 10.1016/j.plantsci.2014.02.001; Oliveira MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01162; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Perl-Treves R, 2004, MOL PLANT MICROBE IN, V17, P70, DOI 10.1094/MPMI.2004.17.1.70; Pietrowska E, 2015, PROTOPLASMA, V252, P307, DOI 10.1007/s00709-014-0680-6; Pogany M, 2009, PLANT PHYSIOL, V151, P1459, DOI 10.1104/pp.109.141994; Rietz S, 2012, J EXP BOT, V63, P5507, DOI 10.1093/jxb/ers203; Rioux R, 2011, CURR GENET, V57, P391, DOI 10.1007/s00294-011-0353-3; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanchez-Vallet A, 2010, PLANT J, V63, P115, DOI 10.1111/j.1365-313X.2010.04224.x; Sarkar TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107348; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Serrano-Carreon L, 2004, BIOTECHNOL LETT, V26, P1403, DOI 10.1023/B:BILE.0000045640.71840.b5; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Shu CW, 2015, FUNCT INTEGR GENOMIC, V15, P449, DOI 10.1007/s10142-015-0435-2; Snell FD, 1949, COLORIMETRIC METHODS; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Toyomasu T, 2009, BIOSCI BIOTECH BIOCH, V73, P772, DOI 10.1271/bbb.80781; Tudzynski P, 2012, CURR OPIN MICROBIOL, V15, P653, DOI 10.1016/j.mib.2012.10.002; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Wang XJ, 2010, PHYSIOL PLANTARUM, V139, P27, DOI 10.1111/j.1399-3054.2009.01338.x; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Xu LS, 2013, MOL PLANT MICROBE IN, V26, P431, DOI 10.1094/MPMI-07-12-0177-R; Yang SL, 2012, MOL PLANT PATHOL, V13, P900, DOI 10.1111/j.1364-3703.2012.00799.x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang G, 2010, AGR SCI CHINA, V9, P549, DOI 10.1016/S1671-2927(09)60128-0; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078348, 10.1371/journal.pone.0082079]; Zhang ZY, 2012, NEW PHYTOL, V196, P1155, DOI 10.1111/j.1469-8137.2012.04353.x; Zhao J, 2015, J EXP BOT, V66, P1721, DOI 10.1093/jxb/eru540; Zhou FS, 1998, PLANT PHYSIOL, V117, P33, DOI 10.1104/pp.117.1.33	77	45	49	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152548	10.1371/journal.pone.0152548	http://dx.doi.org/10.1371/journal.pone.0152548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031952	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800090
J	Gutierrez, Y; Santos, HP; Serrao, JE; Oliveira, EE				Gutierrez, Yeisson; Santos, Helen P.; Serrao, Jose Eduardo; Oliveira, Eugenio E.			Deltamethrin-Mediated Toxicity and Cytomorphological Changes in the Midgut and Nervous System of the Mayfly Callibaetis radiatus	PLOS ONE			English	Article							PARTICLE-ASSOCIATED FENVALERATE; CERAEOCHRYSA-CLAVERI NAVAS; PYRETHROID INSECTICIDE; DAPHNIA-MAGNA; STREAM MACROINVERTEBRATES; NEUROPTERA CHRYSOPIDAE; SPODOPTERA-LITURA; MOSQUITO-CONTROL; CLOEON-DIPTERUM; ION CHANNELS	Immature instars of mayflies are important constituents of the food web in aquatic ecosystems (especially in Neotropical regions) and they are among the most susceptible arthropods to pyrethroid insecticides. These insecticides have been recognized as important stressors of freshwater ecosystems, but their cellular effects in aquatic insects have been neglected. Here, we assessed the susceptibility to deltamethrin (a typical type II pyrethroid) as well as the deltamethrin-mediated cytomorphological changes in the central nervous system and midgut of the mayfly Callibaetis radiatus. While the deltamethrin LC50 for 24h of exposure was of 0.60 (0.46-0.78) mu g of a.i/L, the survival of C. radiatus was significantly reduced in deltamethrin concentrations >= 0.25 mu g a.i/L at 96h of exposure. Sub-lethal deltamethrin exposure severely affected the cytomorphology of C. radiatus midgut (e.g., muscle layer retraction, cytoplasm vacuolation, nucleus and striated border disorganization) and also induced slight cytomorphological changes in the brain (e.g., presence of pyknotic nuclei) and in the thoracic ganglia (e.g., vacuolation of neurons and presence of pyknotic nuclei) of these insects. However, DNA damage was absent in all of these organs, suggesting that the sublethal cellular stress induced by deltamethrin might disrupt physiological processes (e.g., metabolism or electrical signal transmission) rather than cause cell death (e.g., apoptosis) in C. radiatus. Thus, our findings indicated that deltamethrin actions at cellular levels represent a clear indication of sublethal effects on the C. radiatus survival abilities.	[Gutierrez, Yeisson; Oliveira, Eugenio E.] Univ Fed Vicosa, Dept Entomol, BR-36570000 Vicosa, MG, Brazil; [Santos, Helen P.; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, BR-36570000 Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Oliveira, EE (corresponding author), Univ Fed Vicosa, Dept Entomol, BR-36570000 Vicosa, MG, Brazil.	eugenio@ufv.br	de Oliveira, Eugênio Eduardo/F-4045-2016; Santos, Helen C P/AAD-3479-2019; de Oliveira, Eugenio Eduardo/ABE-8935-2021	de Oliveira, Eugenio Eduardo/0000-0003-1174-6564; Gutierrez Lopez, Yeisson/0000-0002-0166-2933; Pinto Santos, Helen Cristina/0000-0003-2234-5280	Minas Gerais State Foundation for Research Aid (FAPEMIG); CAPES Foundation; Arthur Bernardes Foundation (FUNARBE); National Council of Scientific and Technological Development (CNPq)	Minas Gerais State Foundation for Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Arthur Bernardes Foundation (FUNARBE); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants to all co-authors from the Minas Gerais State Foundation for Research Aid (FAPEMIG) and the CAPES Foundation; grants from Arthur Bernardes Foundation (FUNARBE) to EEO and from National Council of Scientific and Technological Development (CNPq) for YG (PEC-PG).	Alves SN, 2010, MICRON, V41, P592, DOI 10.1016/j.micron.2010.04.004; Amweg EL, 2006, ENVIRON SCI TECHNOL, V40, P1700, DOI 10.1021/es051407c; Ballan-Dufrancais CN, 2002, MICROSC RES TECHNIQ, V56, P403, DOI 10.1002/jemt.10041; Beketov MA, 2005, ENVIRON TOXICOL CHEM, V24, P1281, DOI 10.1897/04-256R1.1; Beketov MA, 2004, RUSS J ECOL+, V35, P200, DOI 10.1023/B:RUSE.0000025972.29638.46; Beketov MA, 2008, ARCH ENVIRON CON TOX, V55, P247, DOI 10.1007/s00244-007-9104-3; Bengoa M, 2014, J AM MOSQUITO CONTR, V30, P42, DOI 10.2987/13-6378.1; Bereswill R, 2013, ENVIRON TOXICOL CHEM, V32, P1254, DOI 10.1002/etc.2170; Burr SA, 2004, TOXICOL SCI, V77, P341, DOI 10.1093/toxsci/kfh027; Buss DF, 2007, ENVIRON MONIT ASSESS, V130, P365, DOI 10.1007/s10661-006-9403-6; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Clark JM, 2012, TOP CURR CHEM, V314, P49, DOI 10.1007/128_2011_268; Costa MS, 2012, NEOTROP ENTOMOL, V41, P311, DOI 10.1007/s13744-012-0050-z; Cristofoletti PT, 2001, J INSECT PHYSIOL, V47, P143, DOI 10.1016/S0022-1910(00)00098-6; Cruz PV, 2014, J NAT HIST, V48, P591, DOI 10.1080/00222933.2013.791883; Csoknya M, 1977, Acta Biol Szeged, V23, P89; Darlington C. D., 1960, HANDLING CHROMOSOMES; DOMINGUEZ E, 2006, EPHEMEROPTERA S AM; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Feo ML, 2010, J HYDROL, V393, P156, DOI 10.1016/j.jhydrol.2010.08.012; Franzetti E, 2012, APOPTOSIS, V17, P305, DOI 10.1007/s10495-011-0675-0; Fu KY, 2014, PESTIC BIOCHEM PHYS, V114, P16, DOI 10.1016/j.pestbp.2014.07.009; Harker JE, 1999, J ZOOL, V248, P243; Huang J-H, 2015, INSECT BIOCH MOL BIO; KING DG, 1987, MAR POLLUT BULL, V18, P40, DOI 10.1016/0025-326X(87)90657-6; Konus M, 2013, COMP BIOCHEM PHYS D, V8, P152, DOI 10.1016/j.cbd.2013.04.001; Lawler SP, 2008, PEST MANAG SCI, V64, P843, DOI 10.1002/ps.1575; Levy SM, 2004, BRAZILIAN J BIOL; Li FC, 2016, CHEMOSPHERE, V146, P478, DOI 10.1016/j.chemosphere.2015.12.032; Licht O, 2004, ECOTOX ENVIRON SAFE, V58, P246, DOI 10.1016/j.ecoenv.2003.08.021; Mohr S, 2012, AQUAT TOXICOL, V110, P25, DOI 10.1016/j.aquatox.2011.11.016; Narahashi T, 2000, J PHARMACOL EXP THER, V294, P1; Narahashi T, 1988, NEUROTOX, V88, P563; Norum U, 2010, AQUAT TOXICOL, V98, P328, DOI 10.1016/j.aquatox.2010.03.004; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pawlisz AV, 1998, ENVIRON TOXIC WATER, V13, P175, DOI 10.1002/(SICI)1098-2256(1998)13:3<175::AID-TOX1>3.3.CO;2-F; Pearse A.G.E., 1985, HISTOCHEMISTRY THEOR, Vfourth; Pinto LZ, 2003, INT J DEV BIOL, V47, P385; Rasmussen JJ, 2012, PESTICIDE EFFECTS ST; Ray DE, 2006, PHARMACOL THERAPEUT, V111, P174, DOI 10.1016/j.pharmthera.2005.10.003; Reichenberger S, 2007, SCI TOTAL ENVIRON, V384, P1, DOI 10.1016/j.scitotenv.2007.04.046; Rharrabe K, 2007, PESTIC BIOCHEM PHYS, V89, P137, DOI 10.1016/j.pestbp.2007.05.002; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Roma GC, 2014, ACTA TROP, V136, P19, DOI 10.1016/j.actatropica.2014.04.004; Roma GC, 2013, VET PARASITOL, V196, P482, DOI 10.1016/j.vetpar.2013.02.025; Rossi CD, 2013, MICROSC RES TECHNIQ, V76, P552, DOI 10.1002/jemt.22199; Rozilawati H, 2005, Trop Biomed, V22, P143; Santos DE, 2015, PROTOPLASMA, V252, P619, DOI 10.1007/s00709-014-0707-z; SAS Institute, 2008, SAS STAT US GUID; Schulz R, 2001, ARCH ENVIRON CON TOX, V40, P481, DOI 10.1007/s002440010200; Schulz R, 2001, CHEMOSPHERE, V45, P543, DOI 10.1016/S0045-6535(00)00601-9; Schulz R, 2001, ENVIRON TOXICOL CHEM, V20, P185, DOI [10.1897/1551-5028(2001)020&lt;0185:TOAPAS&gt;2.0.CO;2, 10.1002/etc.5620200121]; Scudeler EL, 2014, NEOTROP ENTOMOL, V43, P154, DOI 10.1007/s13744-013-0191-8; Scudeler EL, 2013, MICRON, V44, P125, DOI 10.1016/j.micron.2012.05.009; SERRAO JE, 1995, ENTOMOL GEN, V19, P261; Silver KS, 2014, ADV INSECT PHYSIOL, V46, P389, DOI 10.1016/B978-0-12-417010-0.00005-7; Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Toumi H, 2013, SCI TOTAL ENVIRON, V458, P47, DOI 10.1016/j.scitotenv.2013.03.085; Unkiewicz-Winiarczyk A, 2012, B ENVIRON CONTAM TOX, V89, P960, DOI 10.1007/s00128-012-0814-5; Van den Brink PJ, 2015, ENV TOXICOLOGY CHEM; Vishwanathreddy H, 2014, TOXICON, V78, P47, DOI 10.1016/j.toxicon.2013.11.012; Volland JM, 2012, MICROSC RES TECHNIQ, V75, P425, DOI 10.1002/jemt.21073; Wang YH, 2013, PESTIC BIOCHEM PHYS, V105, P13, DOI 10.1016/j.pestbp.2012.11.001; Weston DP, 2006, ENVIRON SCI TECHNOL, V40, P5817, DOI 10.1021/es0601540; Wheelock CE, 2005, AQUAT TOXICOL, V74, P47, DOI 10.1016/j.aquatox.2005.04.007; Xu ZB, 2015, INSECT SCI, V22, P503, DOI 10.1111/1744-7917.12142; Zagariya AM, 2012, EXP CELL RES, V318, P861, DOI 10.1016/j.yexcr.2012.02.001	69	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152383	10.1371/journal.pone.0152383	http://dx.doi.org/10.1371/journal.pone.0152383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031238	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800064
J	Little, MP; Hendry, JH; Puskin, JS				Little, Mark P.; Hendry, Jolyon H.; Puskin, Jerome S.			Lack of Correlation between Stem-Cell Proliferation and Radiation-or Smoking-Associated Cancer Risk	PLOS ONE			English	Article							COLON-CANCER; RELATIVE RISK; CARCINOGENESIS; MODEL; INSTABILITY; MORTALITY; LUNG; MUTATIONS; ARMITAGE; EXPOSURE	Background A recent paper by Tomasetti and Vogelstein (Science 2015 347 78-81) suggested that the variation in natural cancer risk was largely explained by the total number of stem-cell divisions, and that most cancers arose by chance. They proposed an extra-risk score as way of distinguishing the effects of the stochastic, replicative component of cancer risk from other causative factors, specifically those due to the external environment and inherited mutations. Objectives We tested the hypothesis raised by Tomasetti and Vogelstein by assessing the degree of correlation of stem cell divisions and their extra-risk score with radiation-and tobacco-associated cancer risk. Methods We fitted a variety of linear and log-linear models to data on stem cell divisions per year and cumulative stem cell divisions over lifetime and natural cancer risk, some taken from the paper of Tomasetti and Vogelstein, augmented using current US lifetime cancer risk data, and also radiation-and tobacco-associated cancer risk. Results The data assembled by Tomasetti and Vogelstein, as augmented here, are inconsistent with the power-of-age relationship commonly observed for cancer incidence and the predictions of a multistage carcinogenesis model, if one makes the strong assumption of homogeneity of numbers of driver mutations across cancer sites. Analysis of the extra-risk score and various other measures (number of stem cell divisions per year, cumulative number of stem cell divisions over life) considered by Tomasetti and Vogelstein suggests that these are poorly predictive of currently available estimates of radiation- or smoking-associated cancer risk-for only one out of 37 measures or logarithmic transformations thereof is there a statistically significant correlation (p<0.05) with radiation-or smoking-associated risk. Conclusions The data used by Tomasetti and Vogelstein are in conflict with predictions of a multistage model of carcinogenesis, under the assumption of homogeneity of numbers of driver mutations across most cancer sites. Their hypothesis that if the extra-risk score for a tissue type is high then one would expect that environmental factors would play a relatively more important role in that cancer's risk is in conflict with the lack of correlation between the extra-risk score and other stem-cell proliferation indices and radiation-or smoking-related cancer risk.	[Little, Mark P.] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Rockville, MD USA; [Hendry, Jolyon H.] Christie Hosp, Christie Med Phys & Engn, Manchester, Lancs, England; [Hendry, Jolyon H.] Univ Manchester, Manchester, Lancs, England; [Puskin, Jerome S.] US EPA, Radiat Protect Div, Washington, DC 20460 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Christie NHS Foundation Trust; Christie Hospital; University of Manchester; United States Environmental Protection Agency	Little, MP (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Rockville, MD USA.	mark.little@nih.gov	Matsuo, Keitaro/H-6758-2019	Matsuo, Keitaro/0000-0003-1761-6314	Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics	Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics	The work of MPL was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics.	Annex A, 2008, UNSCEAR 2006 REP, P13; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Armstrong B, 2012, RADIATION VOLUME 100, P1; BROWN CC, 1983, ENVIRON HEALTH PERSP, V50, P293, DOI 10.2307/3429561; Committee on Health Risks of Exposure to Radon (BEIR VI), 1999, HLTH EFF EXP RAD; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; DAY NE, 1980, JNCI-J NATL CANCER I, V64, P977; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Doll R, 2005, BRIT J CANCER, V92, P426, DOI 10.1038/sj.bjc.6602359; DOLL R, 1971, J R STAT SOC SER A-G, V134, P133, DOI 10.2307/2343871; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; International Commission on Radiological Protection, 2015, ANN ICRP, V44, P1; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Little MP, 2008, J THEOR BIOL, V254, P229, DOI 10.1016/j.jtbi.2008.05.027; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Little MP, 2013, RADIAT ENVIRON BIOPH, V52, P147, DOI 10.1007/s00411-012-0442-9; LITTLE MP, 1992, RADIAT RES, V132, P207, DOI 10.2307/3578528; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Little MP, 1995, BIOMETRICS, V51, P1278, DOI 10.2307/2533259; MAZUMDAR S, 1989, RISK ANAL, V9, P551, DOI 10.1111/j.1539-6924.1989.tb01266.x; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; O'Callaghan M, 2015, SCIENCE, V347, P729, DOI 10.1126/science.aaa6212; Otsuka K, 2013, RADIAT RES, V179, P637, DOI 10.1667/RR3253.1; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Peto R, 1977, ORIGINS HUMAN CANC C, P1403; Potter JD, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6507; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; PUSKIN JS, 1988, HEALTH PHYS, V54, P635, DOI 10.1097/00004032-198806000-00004; Rao CR, 2002, LINEAR STAT INFERENC; Song MY, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6094; THOMAS DC, 1990, ENVIRON HEALTH PERSP, V87, P163, DOI 10.2307/3431021; Tomasetti C, 2015, ARXIV150105035V3STAT, P1; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; US. Surgeon General, 2004, THE HEALTH CONSEQUEN; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0150335	10.1371/journal.pone.0150335	http://dx.doi.org/10.1371/journal.pone.0150335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031507	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800006
J	Matta, J; Morales, L; Ortiz, C; Adams, D; Vargas, W; Casbas, P; Dutil, J; Echenique, M; Suarez, E				Matta, Jaime; Morales, Luisa; Ortiz, Carmen; Adams, Damian; Vargas, Wanda; Casbas, Patricia; Dutil, Julie; Echenique, Miguel; Suarez, Erick			Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer	PLOS ONE			English	Article							CELL REACTIVATION ASSAY; ENDOCRINE RESISTANCE; PROGESTERONE-RECEPTOR; EXCISION-REPAIR; THERAPEUTIC TARGET; AMERICAN SOCIETY; SKIN-CANCER; CHEMOTHERAPY; MECHANISMS; DAMAGE	Estrogen-receptor-positive (ER+) tumors employ complex signaling that engages in crosstalk with multiple pathways through genomic and non-genomic regulation. A greater understanding of these pathways is important for developing improved biomarkers that can better determine treatment choices, risk of recurrence and cancer progression. Deficiencies in DNA repair capacity (DRC) is a hallmark of breast cancer (BC); therefore, in this work we tested whether ER signaling influences DRC. We analyzed the association between ER positivity (% receptor activation) and DRC in 270 BC patients, then further stratified our analysis by HER2 receptor status. Our results show that among HER2 negative, the likelihood of having low DRC values among ER-women is 1.92 (95% CI: 1.03, 3.57) times the likelihood of having low DRC values among ER+ women, even adjusting for different potential confounders (p<0.05); however, a contrary pattern was observed among HER2 positives women. In conclusion, there is an association between DRC levels and ER status, and this association is modified by HER2 receptor status. Adding a DNA repair capacity test to hormone receptor testing may provide new information on defective DNA repair phenotypes, which could better stratify BC patients who have ER+ tumors. ER+/HER2-tumors are heterogeneous, incompletely defined, and clinically challenging to treat; the addition of a DRC test could better characterize and classify these patients as well as help clinicians select optimal therapies, which could improve outcomes and reduce recurrences.	[Matta, Jaime; Ortiz, Carmen; Adams, Damian; Vargas, Wanda] Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Pharmacol & Toxicol, Ponce, PR USA; [Matta, Jaime; Ortiz, Carmen; Adams, Damian; Vargas, Wanda; Casbas, Patricia; Dutil, Julie] Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Canc Biol, Ponce, PR USA; [Morales, Luisa] Ponce Hlth Sci Univ, Publ Hlth Program, Ponce, PR USA; [Casbas, Patricia; Dutil, Julie] Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Biochem, Ponce, PR USA; [Echenique, Miguel] Auxilio Mutuo Hosp, San Juan, PR 00919 USA; [Suarez, Erick] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Biostat & Epidemiol, Med Sci Campus, San Juan, PR 00936 USA	Ponce Health Sciences University; Ponce Health Sciences University; Ponce Health Sciences University; Ponce Health Sciences University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Matta, J (corresponding author), Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Pharmacol & Toxicol, Ponce, PR USA.; Matta, J (corresponding author), Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Canc Biol, Ponce, PR USA.	jmatta@psm.edu		Ortiz-Sanchez, Carmen/0000-0003-3567-7866	NCI Center; NIH-MBRS Program grant [S06 GM008239-20, 9SC1CA182846-04]; PSM-MCC Partnership grant [5U54CA163071-04]; MBRS-RISE [GM082406]; NATIONAL CANCER INSTITUTE [U54CA163068, U54CA163071, SC1CA182846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008239, R25GM082406] Funding Source: NIH RePORTER	NCI Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-MBRS Program grant; PSM-MCC Partnership grant; MBRS-RISE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the NCI Center to Reduce Health Disparities and NIH-MBRS Program grant # S06 GM008239-20 and 9SC1CA182846-04 to Ponce School of Medicine through Dr. J. Matta and PSM-MCC Partnership grant # 5U54CA163071-04. Carmen Ortiz was supported by MBRS-RISE GM082406 [NIH-NIGMS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2014, CANCER MANAG RES, V6, P77, DOI 10.2147/CMAR.S50497; Abdel-Fatah TMA, 2014, ANTIOXID REDOX SIGN, V21, P2262, DOI 10.1089/ars.2014.6077; Alli E, 2012, DNA REPAIR, V11, P522, DOI 10.1016/j.dnarep.2012.02.003; American Cancer Society, 2013, BREAST CANC FACTS FI; Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; ATHAS WF, 1991, CANCER RES, V51, P5786; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bonastre J, 2014, J CLIN ONCOL, V32, P3513, DOI 10.1200/JCO.2013.54.9931; Caldoe CE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00106; Chen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095185; Cheng L, 1998, CANCER EPIDEM BIOMAR, V7, P465; CLARK GM, 1984, J CLIN ONCOL, V2, P1102, DOI 10.1200/JCO.1984.2.10.1102; Curtis CD, 2009, MOL ENDOCRINOL, V23, P1346, DOI 10.1210/me.2009-0093; D'Errico M, 1999, CANCER EPIDEM BIOMAR, V8, P553; Davis NM, 2014, ONCOTARGET, V5, P4603, DOI 10.18632/oncotarget.2209; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Ellis MJ, 2013, CANCER DISCOV, V3, P27, DOI 10.1158/2159-8290.CD-12-0462; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Gnant M, 2012, EXPERT REV ANTICANC, V12, P1579, DOI [10.1586/ERA.12.138, 10.1586/era.12.138]; Good P, 2006, RESAMPLING METHODS A; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hilakivi-Clarke L, 2000, CANCER RES, V60, P4993; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hu JJ, 2004, CANCER RES, V64, P1197, DOI 10.1158/0008-5472.CAN-03-2670; Huynh KT, 2012, EXPERT REV MOL DIAGN, V12, P371, DOI [10.1586/erm.12.26, 10.1586/ERM.12.26]; Issa-Nummer Y, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27926; Jemal A, 2012, BREAST CANCER RES TR, V135, P867, DOI 10.1007/s10549-012-2214-2; Jerusalem G, 2014, BREAST CANCER-TARGET, V6, P43, DOI 10.2147/BCTT.S38679; Jeselsohn R, 2015, NAT REV CLIN ONCOL, V12, P573, DOI 10.1038/nrclinonc.2015.117; Kelley MR, 2012, DNA REPAIR IN CANCER THERAPY: MOLECULAR TARGETS AND CLINICAL APPLICATIONS, P1, DOI 10.1016/B978-0-12-384999-1.10001-0; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Latimer JJ, 2010, P NATL ACAD SCI USA, V107, P21725, DOI 10.1073/pnas.0914772107; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Likhite VS, 2004, J BIOL CHEM, V279, P16875, DOI 10.1074/jbc.M313155200; Lips EH, 2012, BREAST CANCER RES TR, V131, P827, DOI 10.1007/s10549-011-1488-0; Magnani L, 2012, EPIGENOMICS-UK, V4, P675, DOI [10.2217/EPI.12.64, 10.2217/epi.12.64]; Martin HL, 2014, BREAST CANCER-TARGET, V6, P1, DOI 10.2147/BCTT.S37638; Matta J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-490; Matta JL, 2003, J AM ACAD DERMATOL, V49, P433, DOI 10.1067/S0190-9622(03)00918-6; Medunjanin S, 2010, MOL BIOL CELL, V21, P1620, DOI 10.1091/mbc.E09-08-0724; Mendez P, 2011, DNA REPAIR, V10, P603, DOI 10.1016/j.dnarep.2011.04.001; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Morales L, 2013, J EPIDEMIOL GLOB HEA, V3, P205, DOI 10.1016/j.jegh.2013.08.003; Murray DM, 2004, CANC DRUG DISC DEV, P211; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Partridge AH, 2014, J CLIN ONCOL, V32, P3307, DOI 10.1200/JCO.2014.56.7479; Pedram A, 2009, MOL BIOL CELL, V20, P3374, DOI 10.1091/mbc.E09-01-0085; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Qiao YW, 2002, MUTAT RES-FUND MOL M, V509, P165, DOI 10.1016/S0027-5107(02)00219-1; Raha P, 2011, EPIGENOMICS-UK, V3, P451, DOI [10.2217/epi.11.72, 10.2217/EPI.11.72]; Rahal OM, 2011, ENDOCRINOLOGY, V152, P3409, DOI 10.1210/en.2011-1085; Ramos JM, 2004, CANCER-AM CANCER SOC, V100, P1352, DOI 10.1002/cncr.20135; Robertson NM, 2014, WIRES RNA, V5, P823, DOI 10.1002/wrna.1248; Rosa FE, 2008, HUM PATHOL, V39, P720, DOI 10.1016/j.humpath.2007.09.019; Ross DD, 2010, METHODS MOL BIOL, V596, P251, DOI 10.1007/978-1-60761-416-6_12; Santarpia L, 2013, ONCOLOGIST, V18, P1063, DOI 10.1634/theoncologist.2013-0163; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Stone A, 2013, MOL CANCER THER, V12, P1874, DOI 10.1158/1535-7163.MCT-13-0012; Sullivan I, 2014, CANCER LETT, V353, P160, DOI 10.1016/j.canlet.2014.07.023; Sutherland RL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2878; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; Trimarchi Michael P, 2011, Chin J Cancer, V30, P749, DOI 10.5732/cjc.011.10128; Van Belle V, 2010, J CLIN ONCOL, V28, P4129, DOI 10.1200/JCO.2009.26.4200; Vergne Yeidyly, 2013, Integr Med (Encinitas), V12, P38; Wajed SA, 2001, ANN SURG, V234, P10, DOI 10.1097/00000658-200107000-00003; Wang DY, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3017; Wang L, 2007, CARCINOGENESIS, V28, P1430, DOI 10.1093/carcin/bgm029; Wei QY, 1996, CANCER RES, V56, P4103; WEI QY, 1993, P NATL ACAD SCI USA, V90, P1614, DOI 10.1073/pnas.90.4.1614; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Zhang MH, 2014, BIOMED REP, V2, P41, DOI 10.3892/br.2013.187	74	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152422	10.1371/journal.pone.0152422	http://dx.doi.org/10.1371/journal.pone.0152422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032101	Green Published, gold			2022-12-26	WOS:000373121800071
J	Sapkota, S; Conner, JA; Hanna, WW; Simon, B; Fengler, K; Deschamps, S; Cigan, M; Ozias-Akins, P				Sapkota, Sirjan; Conner, Joann A.; Hanna, Wayne W.; Simon, Bindu; Fengler, Kevin; Deschamps, Stephane; Cigan, Mark; Ozias-Akins, Peggy			In Silico and Fluorescence In Situ Hybridization Mapping Reveals Collinearity between the Pennisetum squamulatum Apomixis Carrier-Chromosome and Chromosome 2 of Sorghum and Foxtail Millet	PLOS ONE			English	Article							GENOMIC REGION; CENCHRUS-CILIARIS; PEARL-MILLET; APOMICTIC GRASSES; APOSPORY; PASPALUM; SEQUENCE; LOCUS; RECOMBINATION; CONSTRUCTION	Apomixis, or clonal propagation through seed, is a trait identified within multiple species of the grass family (Poaceae). The genetic locus controlling apomixis in Pennisetum squamulatum (syn Cenchrus squamulatus) and Cenchrus ciliaris (syn Pennisetum ciliare, buffelgrass) is the apospory-specific genomic region (ASGR). Previously, the ASGR was shown to be highly conserved but inverted in marker order between P. squamulatum and C. ciliaris based on fluorescence in situ hybridization (FISH) and varied in both karyotype and position of the ASGR on the ASGR-carrier chromosome among other apomictic Cenchrus/Pennisetum species. Using in silico transcript mapping and verification of physical positions of some of the transcripts via FISH, we discovered that the ASGR-carrier chromosome from P. squamulatum is collinear with chromosome 2 of foxtail millet and sorghum outside of the ASGR. The in silico ordering of the ASGR-carrier chromosome markers, previously unmapped in P. squamulatum, allowed for the identification of a backcross line with structural changes to the P. squamulatum ASGR-carrier chromosome derived from gamma irradiated pollen.	[Sapkota, Sirjan; Conner, Joann A.; Simon, Bindu; Ozias-Akins, Peggy] Univ Georgia, Dept Hort, Tifton Campus, Tifton, GA 31793 USA; [Hanna, Wayne W.] Univ Georgia, Dept Crop & Soil Sci, Tifton Campus, Tifton, GA 31793 USA; [Fengler, Kevin; Cigan, Mark] DuPont Pioneer, Johnston, IA 50131 USA; [Deschamps, Stephane] DuPont Expt Stn, Wilmington, DE 19803 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; DuPont; Pioneer Hi-Bred International, Inc.; DuPont	Conner, JA (corresponding author), Univ Georgia, Dept Hort, Tifton Campus, Tifton, GA 31793 USA.	jconner@uga.edu	Conner, Joann/AAF-1852-2020; Deschamps, Stephane/R-3806-2019	Sapkota, Sirjan/0000-0002-5718-3544; Conner, Joann/0000-0003-3825-0147	Peggy Ozias-Akins/UGA; Pioneer Hi-Bred	Peggy Ozias-Akins/UGA; Pioneer Hi-Bred	This study was partially funded by a Sponsored Research Agreement between Peggy Ozias-Akins/UGA and Pioneer Hi-Bred. Pioneer Hi-Bred provided financial support for research materials, in kind support, and had intellectual input into the design, analysis and interpretation of the results.	Akiyama Y, 2004, PLANT PHYSIOL, V134, P1733, DOI 10.1104/pp.103.033969; Akiyama Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-289; Andres R. J., 2013, Journal of Cotton Science, V17, P149; Bennetzen JL, 2007, CURR OPIN PLANT BIOL, V10, P176, DOI 10.1016/j.pbi.2007.01.010; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Conner JA, 2008, PLANT PHYSIOL, V147, P1396, DOI 10.1104/pp.108.119081; Conner JA, 2013, PLANTA, V238, P51, DOI 10.1007/s00425-013-1873-5; Devos KM, 2000, THEOR APPL GENET, V100, P190, DOI 10.1007/s001220050026; Fukui Kiichi, 1996, P1; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Goel S, 2006, GENETICS, V173, P389, DOI 10.1534/genetics.105.054429; HANNA WW, 1992, J HERED, V83, P386, DOI 10.1093/oxfordjournals.jhered.a111236; Hojsgaard DH, 2011, THEOR APPL GENET, V123, P959, DOI 10.1007/s00122-011-1639-z; INGHAM LD, 1993, MOL GEN GENET, V238, P350, DOI 10.1007/BF00291993; Jessup RW, 2002, CROP SCI, V42, P1688, DOI 10.2135/cropsci2002.1688; Johri, 1984, EMBRYOLOGY ANGIOSPER, P475, DOI DOI 10.1007/978-3-642-69302-1_10; Kirov I, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-21; Ozias-Akins P, 1998, P NATL ACAD SCI USA, V95, P5127, DOI 10.1073/pnas.95.9.5127; Paterson AH, 2012, PLANT GEN DIVER, V1, P195, DOI DOI 10.1007/978-3-7091-1130-7_13; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Podio M, 2012, GENET MOL BIOL, V35, P827, DOI 10.1590/S1415-47572012005000070; Pupilli F, 2004, MOL GENET GENOMICS, V270, P539, DOI 10.1007/s00438-003-0949-5; Pupilli F, 2001, MOL BREEDING, V8, P53, DOI 10.1023/A:1011966922301; Roche D, 2002, THEOR APPL GENET, V104, P804, DOI 10.1007/s00122-001-0795-y; Roche D, 1999, PLANT J, V19, P203, DOI 10.1046/j.1365-313X.1999.00514.x; Singh M, 2010, CROP SCI, V50, P892, DOI 10.2135/cropsci2009.05.0263; Wang XY, 2015, MOL PLANT, V8, P885, DOI 10.1016/j.molp.2015.04.004; YOUNG BA, 1979, CAN J BOT, V57, P1668, DOI 10.1139/b79-204; Zeng YJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-206; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31; Zhong XB, 1996, PLANT MOL BIOL REP, V14, P232, DOI 10.1007/BF02671658	31	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152411	10.1371/journal.pone.0152411	http://dx.doi.org/10.1371/journal.pone.0152411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031857	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800069
J	Spadafora, D; Kozhukhar, N; Alexeyev, MF				Spadafora, Domenico; Kozhukhar, Natalia; Alexeyev, Mikhail F.			Presequence-Independent Mitochondrial Import of DNA Ligase Facilitates Establishment of Cell Lines with Reduced mtDNA Copy Number	PLOS ONE			English	Article							SKELETAL-MUSCLE; DEPLETION; DEGRADATION; DYSFUNCTION; PROGRESSION; PROTEIN; CANCER	Due to the essential role played by mitochondrial DNA (mtDNA) in cellular physiology and bioenergetics, methods for establishing cell lines with altered mtDNA content are of considerable interest. Here, we report evidence for the existence in mammalian cells of a novel, low-efficiency, presequence-independent pathway for mitochondrial protein import, which facilitates mitochondrial uptake of such proteins as Chlorella virus ligase (ChVlig) and Escherichia coli LigA. Mouse cells engineered to depend on this pathway for mitochondrial import of the LigA protein for mtDNA maintenance had severely (up to >90%) reduced mtDNA content. These observations were used to establish a method for the generation of mouse cell lines with reduced mtDNA copy number by, first, transducing them with a retrovirus encoding LigA, and then inactivating in these transductants endogenous Lig3 with CRISPR-Cas9. Interestingly, mtDNA depletion to an average level of one copy per cell proceeds faster in cells engineered to maintain mtDNA at low copy number. This makes a low-mtDNA copy number phenotype resulting from dependence on mitochondrial import of DNA ligase through presequence-independent pathway potentially useful for rapidly shifting mtDNA heteroplasmy through partial mtDNA depletion.	[Spadafora, Domenico] Univ S Alabama, Dept Pharmacol, 307 Univ Blvd, Mobile, AL 36688 USA; [Kozhukhar, Natalia; Alexeyev, Mikhail F.] Univ S Alabama, Dept Physiol & Cell Biol, 307 Univ Blvd, Mobile, AL 36688 USA; [Alexeyev, Mikhail F.] Univ S Alabama, Ctr Lung Biol, 307 Univ Blvd, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama	Alexeyev, MF (corresponding author), Univ S Alabama, Dept Physiol & Cell Biol, 307 Univ Blvd, Mobile, AL 36688 USA.; Alexeyev, MF (corresponding author), Univ S Alabama, Ctr Lung Biol, 307 Univ Blvd, Mobile, AL 36688 USA.	malexeye@southalabama.edu			National Institutes of Health [HL66299, OD010944]; DoD award [PR150220]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066299] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health HL66299 and OD010944, DoD award PR150220. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Barthelemy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs; Blackstone NW, 2015, CELL CALCIUM, V57, P133, DOI 10.1016/j.ceca.2014.11.006; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Cha MY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.122; Chen H, 2001, STROKE, V32, P2382, DOI 10.1161/hs1001.097099; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6; Elkholi R, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-16; Fayzulin RZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv140; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Hsu CC, 2013, WORLD J GASTROENTERO, V19, P8880, DOI 10.3748/wjg.v19.i47.8880; Lee HC, 2014, WORLD J GASTROENTERO, V20, P3950, DOI 10.3748/wjg.v20.i14.3950; Li HZ, 2014, FRONT BIOSCI-LANDMRK, V19, P777, DOI 10.2741/4244; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Mansouri A, 1999, GASTROENTEROLOGY, V117, P181, DOI 10.1016/S0016-5085(99)70566-4; Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Nakano Y, 2011, PEDIATR INT, V53, P240, DOI 10.1111/j.1442-200X.2010.03183.x; Nogueira C, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-34; OLIVERA BM, 1967, P NATL ACAD SCI USA, V57, P1700, DOI 10.1073/pnas.57.6.1700; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Sambrook J., 2001, MOL CLONING LAB MANU; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Shokolenko IN, 2015, BBA-MOL BASIS DIS, V1852, P1805, DOI 10.1016/j.bbadis.2015.05.016; Shokolenko IN, 2013, J BIOL CHEM, V288, P26594, DOI 10.1074/jbc.M113.472977; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023; van Leeuwen N, 2014, AGE, V36, P1463, DOI 10.1007/s11357-014-9629-0; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang DD, 2012, ACM T KNOWL DISCOV D, V6, DOI 10.1145/2362383.2362386; Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098282; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	36	4	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152705	10.1371/journal.pone.0152705	http://dx.doi.org/10.1371/journal.pone.0152705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031233	Green Published, gold			2022-12-26	WOS:000373121800124
J	Torssander, J; Ahlbom, A; Modig, K				Torssander, Jenny; Ahlbom, Anders; Modig, Karin			Four Decades of Educational Inequalities in Hospitalization and Mortality among Older Swedes	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; EUROPEAN COUNTRIES; LIFE EXPECTANCY; HEALTH; NORWAY	Background The inverse association between education and mortality has grown stronger the last decades in many countries. During the same period, gains in life expectancy have been concentrated to older ages; still, old-age mortality is seldom the focus of attention when analyzing trends in the education-mortality gradient. It is further unknown if increased educational inequalities in mortality are preceded by increased inequalities in morbidity of which hospitalization may be a proxy. Methods Using administrative population registers from 1971 and onwards, education-specific annual changes in the risk of death and hospital admission were estimated with complimentary log-log models. These risk changes were supplemented by estimations of the ages at which 25, 50, and 75% of the population had been hospitalized or died (after age 60). Results The mortality decline among older people increasingly benefitted the well-educated over the less well-educated. This inequality increase was larger for the younger old, and among men. Educational inequalities in the age of a first hospital admission generally followed the development of growing gaps, but at a slower pace than mortality and inequalities did not increase among the oldest individuals. Conclusions Education continues to be a significant predictor of health and longevity into old age. That the increase in educational inequalities is greater for mortality than for hospital admissions (our proxy of overall morbidity) may reflect that well-educated individuals gradually have obtained more possibilities or resources to survive a disease than less well-educated individuals have the last four decades.	[Torssander, Jenny] Stockholm Univ, Swedish Inst Social Res, S-10691 Stockholm, Sweden; [Ahlbom, Anders; Modig, Karin] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Stockholm University; Karolinska Institutet	Torssander, J (corresponding author), Stockholm Univ, Swedish Inst Social Res, S-10691 Stockholm, Sweden.	jenny.torssander@sofi.su.se	Modig, Karin/H-1542-2014	Modig, Karin/0000-0002-5151-4867	Swedish Research Council for Health, Working Life and Welfare [20140445, 2014-0231]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	Funding was received from the Swedish Research Council for Health, Working Life and Welfare (http://forte.se/en/), Grant numbers 20140445 (JT) and 2014-0231 (AA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1995, SURVIVAL ANAL USING; Bronnum-Hansen H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-994; Bygren LO., 2001, J PUBLIC HLTH POLICY; Cutler DM, 2011, J HEALTH ECON, V30, P1174, DOI 10.1016/j.jhealeco.2011.06.009; Fors S., 2007, EUROPEAN J PUBLIC HL, V18, P138; Fritzell J, 2007, HLTH INEQUALITIES WE; Glied S., 2003, HLTH INEQUALITY ED M; Karampampa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099034; Karampampa K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003447; Kinge JM, 2015, AGE AGEING, V44, P1040, DOI 10.1093/ageing/afv128; Kunst AE, 2005, INT J EPIDEMIOL, V34, P295, DOI 10.1093/ije/dyh342; Lagergren M, 2016, SCAND J PUBLIC HEALT, V44, P55, DOI 10.1177/1403494815605195; Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319; Majer IM, 2011, J EPIDEMIOL COMMUN H, V65, P972, DOI 10.1136/jech.2010.111492; Meinow Bettina, 2006, Eur J Ageing, V3, P98, DOI 10.1007/s10433-006-0027-z; Montez JK, 2013, J HEALTH SOC BEHAV, V54, P165, DOI [10.1177/0022146513491066, 10.1177/0022146513481230]; National Board of Health and Welfare, 2009, FOLKH 2009; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ostergren O, 2015, SCAND J PUBLIC HEALT, V43, P563, DOI 10.1177/1403494815585401; Shkolnikov VM, 2012, J EPIDEMIOL COMMUN H, V66, P372, DOI 10.1136/jech.2009.104786; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4	22	3	3	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152369	10.1371/journal.pone.0152369	http://dx.doi.org/10.1371/journal.pone.0152369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031107	Green Submitted, gold, Green Published			2022-12-26	WOS:000373121800063
J	Zhang, QS; Zhang, XQ; Wang, SB; Tan, C; Zhou, GF; Li, CD				Zhang, Qisen; Zhang, Xiaoqi; Wang, Songbo; Tan, Cong; Zhou, Gaofeng; Li, Chengdao			Involvement of Alternative Splicing in Barley Seed Germination	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; LANDSCAPE; STRESS; ABI3; RNA; TRANSCRIPTION; VIVIPAROUS-1; METABOLISM; COMPLEXITY	Seed germination activates many new biological processes including DNA, membrane and mitochondrial repairs and requires active protein synthesis and sufficient energy supply. Alternative splicing (AS) regulates many cellular processes including cell differentiation and environmental adaptations. However, limited information is available on the regulation of seed germination at post-transcriptional levels. We have conducted RNA-sequencing experiments to dissect AS events in barley seed germination. We identified between 552 and 669 common AS transcripts in germinating barley embryos from four barley varieties (Hordeum vulgare L. Bass, Baudin, Harrington and Stirling). Alternative 3' splicing (34%-45%), intron retention (32%-34%) and alternative 5' splicing (16%-21%) were three major AS events in germinating embryos. The AS transcripts were predominantly mapped onto ribosome, RNA transport machineries, spliceosome, plant hormone signal transduction, glycolysis, sugar and carbon metabolism pathways. Transcripts of these genes were also very abundant in the early stage of seed germination. Correlation analysis of gene expression showed that AS hormone responsive transcripts could also be co-expressed with genes responsible for protein biosynthesis and sugar metabolisms. Our RNA-sequencing data revealed that AS could play important roles in barley seed germination.	[Zhang, Qisen] Australian Export Grains Innovat Ctr, 3 Baron Hay Court, S Perth, WA 6155, Australia; [Zhang, Xiaoqi; Tan, Cong; Zhou, Gaofeng; Li, Chengdao] Murdoch Univ, Western Barley Genet Alliance, 90 South St, Murdoch, WA 6150, Australia; [Wang, Songbo] BGI Shenzhen, Beishan Ind Zone, Shenzhen 518083, Peoples R China; [Li, Chengdao] Dept Agr & Food Western Australia, 3 Baron Hay Court, S Perth, WA 6155, Australia	Murdoch University; Beijing Genomics Institute (BGI); Government of Western Australia; Department of Agriculture & Food - Western Australia	Li, CD (corresponding author), Murdoch Univ, Western Barley Genet Alliance, 90 South St, Murdoch, WA 6150, Australia.; Li, CD (corresponding author), Dept Agr & Food Western Australia, 3 Baron Hay Court, S Perth, WA 6155, Australia.	c.li@murdoch.edu.au		tan, cong/0000-0003-0158-4442	Australian Grain Research and Development Corporation; AEGIC research funding	Australian Grain Research and Development Corporation(Grains R&D Corp); AEGIC research funding	This research was funded by Australian Grain Research and Development Corporation to CL and AEGIC research funding to QZ.	Aghamirzaie Delasa, 2013, Biology (Basel), V2, P1311, DOI 10.3390/biology2041311; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIALEK K, 1992, PLANT PHYSIOL, V100, P509, DOI 10.1104/pp.100.1.509; BOTHA FC, 1992, PLANT GROWTH REGUL, V11, P211, DOI 10.1007/BF00024560; Bournay AS, 1996, NUCLEIC ACIDS RES, V24, P2347, DOI 10.1093/nar/24.12.2347; Brummell DA, 2011, J EXP BOT, V62, P3519, DOI 10.1093/jxb/err043; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Chang CY, 2014, PLANT PHYSIOL, V165, P826, DOI 10.1104/pp.113.230540; Crowe J.H., 1992, WATER LIFE, P87, DOI DOI 10.1007/978-3-642-76682-4_7; Eckardt NA, 2013, PLANT CELL, V25, P3639, DOI 10.1105/tpc.113.251013; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; HATTORI T, 1994, PLANT MOL BIOL, V24, P805, DOI 10.1007/BF00029862; Huang Songbo, 2011, Frontiers in Genetics, V2, P46, DOI 10.3389/fgene.2011.00046; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WF, 2013, PLANT PHYSIOL, V162, P1750, DOI 10.1104/pp.113.217778; Liu JJ, 2013, PLANT PHYSIOL, V162, P512, DOI 10.1104/pp.112.205864; Liu XD, 2013, P NATL ACAD SCI USA, V110, P15485, DOI 10.1073/pnas.1304651110; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; Min XJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1914-5; Pease J, 2012, NAT METH, V9; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Rohde A, 1998, J EXP BOT, V49, P1059, DOI 10.1093/jexbot/49.323.1059; SANDOVAL JA, 1995, PLANT PHYSIOL, V109, P269, DOI 10.1104/pp.109.1.269; Seo PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1303; Shen YT, 2014, PLANT CELL, V26, P996, DOI 10.1105/tpc.114.122739; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Sugliani M, 2010, PLANT CELL, V22, P1936, DOI 10.1105/tpc.110.074674; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Thatcher SR, 2016, PLANT PHYSIOL, V170, P586, DOI 10.1104/pp.15.01267; Thatcher SR, 2014, PLANT CELL, V26, P3472, DOI 10.1105/tpc.114.130773; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Wu HP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r10; Zhang QS, 2016, J PLANT PHYSIOL, V191, P127, DOI 10.1016/j.jplph.2015.12.007	44	42	44	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152824	10.1371/journal.pone.0152824	http://dx.doi.org/10.1371/journal.pone.0152824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031341	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800145
J	Hoffmann, M; Kruger, N; Zmora, P; Wrensch, F; Herrler, G; Pohlmann, S				Hoffmann, Markus; Krueger, Nadine; Zmora, Pawel; Wrensch, Florian; Herrler, Georg; Poehlmann, Stefan			The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; VESICULAR STOMATITIS-VIRUS; A-VIRUSES; PROTEOLYTIC CLEAVAGE; ENDOSOMAL PROTEOLYSIS; ENVELOPE PROTEINS; SERINE PROTEASES; FUSION PROTEIN; B VIRUSES; NEURAMINIDASE	New World bats have recently been discovered to harbor influenza A virus (FLUAV)-related viruses, termed bat-associated influenza A-like viruses (batFLUAV). The internal proteins of batFLUAV are functional in mammalian cells. In contrast, no biological functionality could be demonstrated for the surface proteins, hemagglutinin (HA)-like (HAL) and neuraminidase (NA)-like (NAL), and these proteins need to be replaced by their human counterparts to allow spread of batFLUAV in human cells. Here, we employed rhabdoviral vectors to study the role of HAL and NAL in viral entry. Vectors pseudotyped with batFLUAV-HAL and -NAL were able to enter bat cells but not cells from other mammalian species. Host cell entry was mediated by HAL and was dependent on prior proteolytic activation of HAL and endosomal low pH. In contrast, sialic acids were dispensable for HAL-driven entry. Finally, the type II transmembrane serine protease TMPRSS2 was able to activate HAL for cell entry indicating that batFLUAV can utilize human proteases for HAL activation. Collectively, these results identify viral and cellular factors governing host cell entry driven by batFLUAV surface proteins. They suggest that the absence of a functional receptor precludes entry of batFLUAV into human cells while other prerequisites for entry, HAL activation and protonation, are met in target cells of human origin.	[Hoffmann, Markus; Zmora, Pawel; Wrensch, Florian; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Krueger, Nadine; Herrler, Georg] Univ Vet Med Hannover, Inst Virol, Hannover, Germany	Deutsches Primatenzentrum (DPZ); University of Veterinary Medicine Hannover, Foundation	Hoffmann, M; Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.	mhoffmann@dpz.eu; spoehlmann@dpz.eu	Pöhlmann, Stefan/H-2395-2011; Krüger, Nadine/V-2282-2019; Hoffmann, Markus/J-7836-2018; Zmora, Pawel/V-3843-2019	Pöhlmann, Stefan/0000-0001-6086-9136; Krüger, Nadine/0000-0002-4413-8699; Hoffmann, Markus/0000-0003-4603-7696; Zmora, Pawel/0000-0002-2012-7223; Wrensch, Florian/0000-0002-7258-5453	Deutsche Forschungsgemeinschaft (DFG) [PO 716/6-1, GSC 226/1, GSC 226/2]; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant PO 716/6-1, Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences, Deutsche Forschungsgemeinschaft (DFG) grants GSC 226/1 and GSC 226/2 (www.dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; CARROLL SM, 1981, J BIOL CHEM, V256, P8357; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cheng ZS, 2015, J INFECT DIS, V212, P1214, DOI 10.1093/infdis/jiv246; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Diederich S, 2005, J BIOL CHEM, V280, P29899, DOI 10.1074/jbc.M504598200; Diederich S, 2012, J VIROL, V86, P3736, DOI 10.1128/JVI.06628-11; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Garcia-Sastre A, 2012, P NATL ACAD SCI USA, V109, P18635, DOI 10.1073/pnas.1215857109; Garten W, 2015, EUR J CELL BIOL, V94, P375, DOI 10.1016/j.ejcb.2015.05.013; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Hofmann H, 2013, J VIROL, V87, P4384, DOI 10.1128/JVI.02628-12; Jung C, 2008, BIOTECHNOL BIOENG, V99, P1016, DOI 10.1002/bit.21622; Juozapaitis M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5448; Kawase M, 2009, J VIROL, V83, P712, DOI 10.1128/JVI.01933-08; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; KLENK HD, 1977, J GEN VIROL, V36, P151, DOI 10.1099/0022-1317-36-1-151; Kruger N, 2015, J VIROL, V89, P4539, DOI 10.1128/JVI.03693-14; Kruger N, 2013, J VIROL, V87, P13889, DOI 10.1128/JVI.02458-13; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; LAZAROWITZ SG, 1973, VIROLOGY, V56, P172, DOI 10.1016/0042-6822(73)90296-1; Li Q, 2012, P NATL ACAD SCI USA, V109, P18897, DOI 10.1073/pnas.1211037109; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Maruyama J, 2016, VIROLOGY, V488, P43, DOI 10.1016/j.virol.2015.11.002; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Okumura Y, 2010, J VIROL, V84, P5089, DOI 10.1128/JVI.02605-09; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Poole DS, 2014, J VIROL, V88, P12572, DOI 10.1128/JVI.01857-14; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Roberts NA, 2001, PROG DRUG RES, V56, P195; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Steffen I, 2016, CURR GENE THER, V16, P47, DOI 10.2174/1566523216666160119093948; Sun XM, 2013, CELL REP, V3, P769, DOI 10.1016/j.celrep.2013.01.025; SUZUKI Y, 1989, J VIROL, V63, P4298, DOI 10.1128/JVI.63.10.4298-4302.1989; SUZUKI Y, 1985, VACCINE, V3, P201, DOI 10.1016/0264-410X(85)90104-5; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tefsen B, 2014, J VIROL, V88, P1935, DOI 10.1128/JVI.03270-13; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Turkington HL, 2015, J VIROL, V89, P10696, DOI 10.1128/JVI.01430-15; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wu Y, 2014, TRENDS MICROBIOL, V22, P183, DOI 10.1016/j.tim.2014.01.010; Zhou B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004420; Zhu XY, 2013, P NATL ACAD SCI USA, V110, P1458, DOI 10.1073/pnas.1218509110; Zhu XY, 2012, P NATL ACAD SCI USA, V109, P18903, DOI 10.1073/pnas.1212579109; Zimmer G, 2014, J GEN VIROL, V95, P1634, DOI 10.1099/vir.0.065201-0; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	68	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152134	10.1371/journal.pone.0152134	http://dx.doi.org/10.1371/journal.pone.0152134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028521	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500037
J	Clemente, FM; Nikolaidis, PT; Martins, FML; Mendes, RS				Clemente, Filipe Manuel; Nikolaidis, Pantelis Theodoros; Lourenco Martins, Fernando Manuel; Mendes, Rui Sousa			Physical Activity Patterns in University Students: Do They Follow the Public Health Guidelines?	PLOS ONE			English	Article							COLLEGE-STUDENTS; LIFE-STYLE; ACCELEROMETER; COUNTRIES; YOUTH; ADULTS; METAANALYSIS; ASSOCIATION; PREFERENCES; PREVALENCE	Physical activity is associated with health. The aim of this study was (a) to access if Portuguese university students meet the public health recommendations for physical activity and (b) the effect of gender and day of the week on daily PA levels of university students. This observational cross-sectional study involved 126 (73 women) healthy Portuguese university students aged 18-23 years old. Participants wore the ActiGraph wGT3X-BT accelerometer for seven consecutive days. Number of steps, time spent sedentary and in light, moderate and vigorous physical activity were recorded. The two-way MANOVA revealed that gender (p-value = 0.001; eta(2) = 0.038; minimum effect) and day of the week (p-value = 0.001; eta(2) = 0.174; minimum effect) had significant main effects on the physical activity variables. It was shown that during weekdays, male students walked more steps (65.14%), spent less time sedentary (6.77%) and in light activities (3.11%) and spent more time in moderate (136.67%) and vigorous activity (171.29%) in comparison with weekend days (p < 0.05). The descriptive analysis revealed that female students walked more steps (51.18%) and spent more time in moderate (125.70%) and vigorous (124.16%) activities during weekdays than in weekend days (p < 0.05). Women students did not achieve the recommended 10,000 steps/day on average during weekdays and weekend days. Only male students achieved this recommendation during weekdays. In summary, this study showed a high incidence of sedentary time in university students, mainly on weekend days. New strategies must be adopted to promote physical activity in this population, focusing on the change of sedentary behaviour.	[Clemente, Filipe Manuel] Escola Super Desporto & Lazer, Inst Politecn Viana Castelo, Melgaco, Portugal; [Clemente, Filipe Manuel; Lourenco Martins, Fernando Manuel] Delegacao Covilha, Inst Telecomunicacoes, Covilha, Portugal; [Nikolaidis, Pantelis Theodoros] Hellen Army Acad, Dept Phys & Cultural Educ, Athens, Greece; [Lourenco Martins, Fernando Manuel; Mendes, Rui Sousa] ASSERT, RoboCorp, Coimbra Coll Educ, Polytech Inst Coimbra, Coimbra, Portugal	Polytechnic Institute of Viana do Castelo	Clemente, FM (corresponding author), Escola Super Desporto & Lazer, Inst Politecn Viana Castelo, Melgaco, Portugal.; Clemente, FM (corresponding author), Delegacao Covilha, Inst Telecomunicacoes, Covilha, Portugal.	Filipe.clemente5@gmail.com	Clemente, Filipe Manuel/AAN-6545-2020; Mendes, Rui/V-6841-2017; Nikolaidis, Pantelis Theodoros/K-8664-2017; Martins, Fernando Manuel Lourenço/AAK-6934-2020; Clemente, Filipe Manuel/G-2625-2012	Mendes, Rui/0000-0002-2433-5193; Nikolaidis, Pantelis Theodoros/0000-0001-8030-7122; Martins, Fernando Manuel Lourenço/0000-0002-1812-2300; Clemente, Filipe Manuel/0000-0001-9813-2842	FCT [PEst-OE/EEI/LA0008/2013]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the FCT project PEst-OE/EEI/LA0008/2013.	Baptista F, 2012, MED SCI SPORT EXER, V44, P466, DOI 10.1249/MSS.0b013e318230e441; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Burke SM, 2006, PSYCHOL SPORT EXERC, V7, P1, DOI 10.1016/j.psychsport.2005.03.002; Cocca A, 2014, PERCEPT MOTOR SKILL, V118, P247, DOI 10.2466/10.06.PMS.118k16w1; Comte M, 2013, APPL PHYSIOL NUTR ME, V38, P115, DOI 10.1139/apnm-2012-0100; Corder K, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-69; Cradock AL, 2004, MED SCI SPORT EXER, V36, P525, DOI 10.1249/01.MSS.0000117112.76067.D3; DEHGHAN M, 2008, NUTR J, V7, DOI DOI 10.1186/1475-2891-7-26; Dinger M, 1999, AM J HLTH STUDIES, V15, P139; Dinger MK, 2006, MED SCI SPORT EXER, V38, P774, DOI 10.1249/01.mss.0000210191.72081.43; Evenson KR, 2009, RES Q EXERCISE SPORT, V80, P355, DOI 10.1080/02701367.2009.10599570; Fedewa MV, 2014, AM J PREV MED, V47, P641, DOI 10.1016/j.amepre.2014.07.035; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fernandez-Aranda F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104534; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gallardo-Escudero A, 2015, NUTR HOSP, V31, P975, DOI 10.3305/nh.2015.31.2.8303; Gropper SS, 2012, APPL PHYSIOL NUTR ME, V37, P1118, DOI [10.1139/h2012-139, 10.1139/H2012-139]; Haase A, 2004, PREV MED, V39, P182, DOI 10.1016/j.ypmed.2004.01.028; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Kang B, 2013, MED SCI SPORT EXER, V45, P1419, DOI 10.1249/MSS.0b013e318285f202; Keating XFD, 2005, J AM COLL HEALTH, V54, P116, DOI 10.3200/JACH.54.2.116-126; Loney T, 2011, J PHYS ACT HEALTH, V8, P62, DOI 10.1123/jpah.8.1.62; Loprinzi PD, 2013, AM J HEALTH PROMOT, V27, P143, DOI 10.4278/ajhp.110916-QUAN-348; Arias-Palencia NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141977; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; O'Donoghue, 2013, STAT SPORT EXERCISE; Pengpid S, 2015, INT J PUBLIC HEALTH, V60, P539, DOI 10.1007/s00038-015-0680-0; Peterson NE, 2015, RES NURS HEALTH, V38, P492, DOI 10.1002/nur.21694; Resnick PJ, 2010, J MED INTERNET RES, V12, P154, DOI 10.2196/jmir.1339; Shapcott KM, 2007, J SPORT EXERCISE PSY, V29, P201; Steptoe A, 2002, PREV MED, V35, P97, DOI 10.1006/pmed.2002.1048; Strain GW, 2008, OBESITY, V16, P1953, DOI 10.1038/oby.2008.321; Troiano RP, 2007, MED SCI SPORT EXER, V39, P1501, DOI 10.1097/mss.0b013e318150d42e; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Varela-Mato V, 2012, INT J ENV RES PUB HE, V9, P2728, DOI 10.3390/ijerph9082728; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilcox S, 1999, J AGING PHYS ACTIV, V7, P386, DOI 10.1123/japa.7.4.386	38	67	69	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152516	10.1371/journal.pone.0152516	http://dx.doi.org/10.1371/journal.pone.0152516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9KB	27022993	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900068
J	Kaczmarek, MC; Ware, RS; Coulthard, MG; McEniery, J; Lambert, SB				Kaczmarek, Marlena C.; Ware, Robert S.; Coulthard, Mark G.; McEniery, Julie; Lambert, Stephen B.			Epidemiology of Australian Influenza-Related Paediatric Intensive Care Unit Admissions, 1997-2013	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; CONFIRMED INFLUENZA; PANDEMIC INFLUENZA; SEASONAL INFLUENZA; PREGNANT-WOMEN; VACCINE; BURDEN; STATES	Background Influenza virus predictably causes an annual epidemic resulting in a considerable burden of illness in Australia. Children are disproportionately affected and can experience severe illness and complications, which occasionally result in death. Methods We conducted a retrospective descriptive study using data collated in the Australian and New Zealand Paediatric Intensive Care (ANZPIC) Registry of influenza-related intensive care unit (ICU) admissions over a 17-year period (1997-2013, inclusive) in children < 16 years old. National laboratory-confirmed influenza notifications were used for comparison. Results Between 1997 and 2013, a total of 704 influenza-related ICU admissions were recorded, at a rate of 6.2 per 1,000 all-cause ICU admissions. Age at admission ranged from 0 days and 15.9 years (median = 2.1 years), with 135 (19.2%) aged < 6 months. Pneumonia/pneumonitis and bronchiolitis were the most common primary diagnoses among influenza-related admissions (21.9% and 13.6%, respectively). More than half of total cases (59.2%) were previously healthy (no co-morbidities recorded), and in the remainder, chronic lung disease (16.7%) and asthma (12.5%) were the most common co-morbidities recorded. Pathogen co-detection occurred in 24.7% of cases, most commonly with respiratory syncytial virus or a staphylococcal species. Median length of all ICU admissions was 3.2 days (range 2.0 hours-107.4 days) and 361 (51.3%) admissions required invasive respiratory support for a median duration of 4.3 days (range 0.2 hours-107.5 days). There were 27 deaths recorded, 14 (51.9%) in children without a recorded co-morbidity. Conclusion Influenza causes a substantial number of ICU admissions in Australian children each year with the majority occurring in previously healthy children.	[Kaczmarek, Marlena C.; Ware, Robert S.; Lambert, Stephen B.] Univ Queensland, Sch Med, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Kaczmarek, Marlena C.; Ware, Robert S.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Kaczmarek, Marlena C.; Ware, Robert S.; Lambert, Stephen B.] Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Coulthard, Mark G.; McEniery, Julie] Lady Cilento Childrens Hosp, Paediat Intens Care Unit, Brisbane, Qld, Australia; [Coulthard, Mark G.] Univ Queensland, Sch Med, Acad Discipline Paediat & Child Hlth, Brisbane, Qld, Australia; [Lambert, Stephen B.] Queensland Hlth, Communicable Dis Unit, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Queensland Health	Kaczmarek, MC (corresponding author), Univ Queensland, Sch Med, Child Hlth Res Ctr, Brisbane, Qld, Australia.; Kaczmarek, MC (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.; Kaczmarek, MC (corresponding author), Queensland Childrens Med Res Inst, Brisbane, Qld, Australia.	m.kaczmarek@uq.edu.au	McEniery, Julie/M-8492-2015; Ware, Robert S./B-2024-2014; Coulthard, Mark G/AAT-7735-2021; Lambert, Stephen/N-7819-2019; Coulthard, Mark Graeme/E-9444-2010	McEniery, Julie/0000-0002-7136-8043; Ware, Robert S./0000-0002-6129-6736; Coulthard, Mark G/0000-0001-7400-5582; Lambert, Stephen/0000-0002-2709-193X; Coulthard, Mark Graeme/0000-0001-7400-5582; Kaczmarek, Marlena/0000-0002-5556-276X	Sidney Myer Health Scholarship; Australian Government National Health and Medical Research Council; Queensland Children's Hospital Foundation	Sidney Myer Health Scholarship; Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland Children's Hospital Foundation	The authors received no specific funding for this work. Ms Kaczmarek is the recipient of a Sidney Myer Health Scholarship and receives student support from the Queensland Children's Medical Research Institute and The University of Queensland School of Public Health. A/Prof Lambert is supported by an Early Career Fellowship from the Australian Government National Health and Medical Research Council and a people support grant from the Queensland Children's Hospital Foundation.	Alexander J, 2014, REPORT AUSTR NZ PAED; Australian Government Department of Health, 2014, PUBL SUMM DOC JUL 20; Australian Government Department of Health, 2013, AUSTR IMM HDB; Australian Government Department of Health, 2008, AUSTR NAT NOT DIS CA; Bagdure D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015173; Blyth CC, 2014, PEDIATRICS, V133, pE1218, DOI 10.1542/peds.2013-3707; Chiu SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092914; D'Onise K, 2008, MED J AUSTRALIA, V188, P510, DOI 10.5694/j.1326-5377.2008.tb01763.x; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Dawood FS, 2014, J INFECT DIS, V209, P686, DOI 10.1093/infdis/jit473; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Dixon GA, 2010, INFLUENZA OTHER RESP, V4, P231, DOI 10.1111/j.1750-2659.2010.00141.x; Ferdinands JM, 2014, J INFECT DIS, V210, P674, DOI 10.1093/infdis/jiu185; Flood EM, 2010, CLIN THER, V32, P1448, DOI 10.1016/j.clinthera.2010.06.020; Fraaij PLA, 2011, VACCINE, V29, P7524, DOI 10.1016/j.vaccine.2011.08.010; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI 10.1111/ajt.13505; Heininger U, 2013, PEDIATR INFECT DIS J, V32, P293, DOI 10.1097/INF.0b013e318279ce4b; Iskander M, 2007, CURR OPIN INFECT DIS, V20, P259, DOI 10.1097/QCO.0b013e3280ad4687; Kaczmarek M, 2010, COMMUN DIS INTELL, V34, P8; Kaczmarek MC, 2013, MED J AUSTRALIA, V198, P624, DOI 10.5694/mja13.10044; Khandaker G, 2014, INFLU OTHER RESP VIR, V8, P636, DOI DOI 10.1111/IRV.12286; Lester-Smith D, 2009, COMMUN DIS INTELL, V33, P209; Li Z, 2013, PERINATAL STAT SERIE, V28; Lu AB, 2012, VACCINE, V30, P4055, DOI 10.1016/j.vaccine.2012.04.012; Maher L, 2013, VACCINE, V31, P5557, DOI 10.1016/j.vaccine.2013.08.081; Morris SK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000310; National Centre for Immunisation Research & Surveillance, 2014, SIGN EV INFL VACC PR; O'Grady KAF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005676; Owen R, 2008, COMMUN DIS INTELL, V32, P208; Pebody R, 2015, EUROSURVEILLANCE, V20, P21025; PEBODY R, 2014, EURO SURVEILL, V19; Public Health England, 2015, NAT CHILDH FLU IMM P; Ruf BR, 2014, EUR J PEDIATR, V173, P265, DOI 10.1007/s00431-013-2023-6; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Slater A, 2003, INTENS CARE MED, V29, P271, DOI 10.1007/s00134-002-1600-3; Song XY, 2012, INFLUENZA OTHER RESP, V6, P25, DOI 10.1111/j.1750-2659.2011.00258.x; Streng A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-233; Wiley KE, 2013, MED J AUSTRALIA, V198, P373, DOI 10.5694/mja12.11849	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152305	10.1371/journal.pone.0152305	http://dx.doi.org/10.1371/journal.pone.0152305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023740	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900044
J	Mohammad, O; Kaur, J; Singh, G; Faisal, SM; Azhar, A; Rauf, MA; Gupta, UD; Gupta, P; Pal, R; Zubair, S				Mohammad, Owais; Kaur, Jagdeep; Singh, Gurpreet; Faisal, Syed Mohd; Azhar, Asim; Rauf, Mohd Ahmar; Gupta, Umesh Dutt; Gupta, Pushpa; Pal, Rahul; Zubair, Swaleha			TLR Agonist Augments Prophylactic Potential of Acid Inducible Antigen Rv3203 against Mycobacterium tuberculosis H37Rv in Experimental Animals	PLOS ONE			English	Article							BCG VACCINE; BALB/C MICE; T-CELLS; PROTECTION; MEMORY; PROTEINS; IMMUNITY; INFECTIONS; RESPONSES; EFFICACY	In general, the members of Lip gene family of Mycobacterium tuberculosis evoke strong immune response in the host. Keeping this fact into consideration, we investigated role of Rv3203, a cell wall associated protein with lipolytic activity, in imparting protection against experimental murine tuberculosis. The data of the present study suggested that archaeosome encapsulated Rv3203 induce strong lymphocyte proliferation, up-regulated Th-1 biased cytokines profile, increased expression of co-stimulatory markers on both antigen presenting cells and T lymphocytes. The immuno-prophylactic response was further modulated by exposure of the animals to zymosan, a TLR2/6 agonist, prior to immunization with archaeosome encapsulated Rv3203. Interestingly, pre-treatment of experimental animals with zymosan boosted strong immunological memory as compared to archaeosome encapsulated Rv3203 as well as BCG vaccine. We conclude that priming of immunized animal with TLR agonist followed by immunization with archaeosomes encapsulated Rv3203 offer substantial protection against tuberculosis infection and could be a potential subunit vaccine based prophylactic strategy.	[Mohammad, Owais; Faisal, Syed Mohd; Azhar, Asim; Rauf, Mohd Ahmar] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Mol Immunol Lab, Aligarh, Uttar Pradesh, India; [Kaur, Jagdeep; Singh, Gurpreet] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India; [Gupta, Umesh Dutt; Gupta, Pushpa] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Pal, Rahul] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Zubair, Swaleha] Aligarh Muslim Univ, Womens Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Panjab University; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Aligarh Muslim University	Mohammad, O (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Mol Immunol Lab, Aligarh, Uttar Pradesh, India.; Zubair, S (corresponding author), Aligarh Muslim Univ, Womens Coll, Aligarh, Uttar Pradesh, India.	owais_lakhnawi@yahoo.com; swalehazubair@yahoo.com	Rauf, Mohd Ahmar/Y-3968-2019; Rauf, Mohd Ahmar/AAJ-9434-2021; Syed, Mohammad Faisal/AAM-7496-2020	Syed, Mohammad Faisal/0000-0002-3968-7810; Azhar, Asim/0000-0001-9884-7645; Mohammad, Owais/0000-0001-7377-7388; Kaur, Jagdeep/0000-0002-2252-2489; Rauf, Mohd Ahmar/0000-0001-5639-2208	Department of Biotechnology, Govt. of India; UGC-DS Kothari Post-Doctoral Fellowship; UGC, Govt of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); UGC-DS Kothari Post-Doctoral Fellowship; UGC, Govt of India(University Grants Commission, India)	SMF is grateful to Department of Biotechnology, Govt. of India, for granting Junior Research Fellowship (JRF). AA acknowledges financial support in the form of UGC-DS Kothari Post-Doctoral Fellowship.; The authors are thankful to the Co-ordinator, Interdisciplinary Biotechnology Unit, Aligarh Muslim University for providing the institute's research facilities. We are also thankful to Director of National JALMA institute for leprosy and other mycobacterial diseases for providing M. tuberculosis H37Rv, BCG strain and access to the Biosafety Level 3 facility of the institute. We are thankful to Dr. Anshu Agarwal, (Professor University of California, Irvine CA 92697) for her help in critical reading, editing and language assistance of the manuscript. Syed Mohd Faisal is grateful to Department of Biotechnology, Govt. of India for granting Junior Research Fellowship (JRF). Dr. Asim Azhar acknowledges UGC, Govt of India for UGC-DS Kothari Post-Doctoral Fellowship.	Ahmad E, 2012, VACCINE, V30, P6851, DOI 10.1016/j.vaccine.2012.09.010; Al-Attiyah R, 2004, CLIN EXP IMMUNOL, V138, P139, DOI 10.1111/j.1365-2249.2004.02609.x; Ansari Mairaj Ahmed, 2012, Int J Nanomedicine, V7, P2433, DOI 10.2147/IJN.S25875; Ansari MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022889; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Arlehamn CSL, 2012, J IMMUNOL, V188, P5020, DOI 10.4049/jimmunol.1103556; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; Atif SM, 2006, FEBS LETT, V580, P2183, DOI 10.1016/j.febslet.2006.03.015; Bosio CM, 1998, INFECT IMMUN, V66, P5048, DOI 10.1128/IAI.66.10.5048-5051.1998; Brust B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025078; Canaan S, 2004, EUR J BIOCHEM, V271, P3953, DOI 10.1111/j.1432-1033.2004.04335.x; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Coker RJ, 2004, TROP MED INT HEALTH, V9, P25, DOI 10.1046/j.1365-3156.2003.01156.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Dedieu L, 2013, BIOCHIMIE, V95, P66, DOI 10.1016/j.biochi.2012.07.008; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Franco-Paredes C, 2006, INT J INFECT DIS, V10, P93, DOI 10.1016/j.ijid.2005.06.002; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garcia-Pelayo MC, 2015, TUBERCULOSIS, V95, P48, DOI 10.1016/j.tube.2014.10.012; Garg R, 2015, INFECT IMMUN, V83, P120, DOI 10.1128/IAI.02274-14; GETZOFF ED, 1988, ADV IMMUNOL, V43, P1; Gupta UD, 2007, VACCINE, V25, P3742, DOI 10.1016/j.vaccine.2007.01.112; Keyser A, 2011, VACCINE, V29, P9308, DOI 10.1016/j.vaccine.2011.10.019; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MILICH DR, 1989, ADV IMMUNOL, V45, P195, DOI 10.1016/S0065-2776(08)60694-X; Olivier A, 2011, EUR J IMMUNOL, V41, P2303, DOI 10.1002/eji.201041387; Petricevich VL, 2001, BRAZ J MED BIOL RES, V34, P81, DOI 10.1590/S0100-879X2001000100010; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; SEPULVEDA RL, 1992, TUBERCLE LUNG DIS, V73, P372, DOI 10.1016/0962-8479(92)90043-J; Shanahan ER, 2010, VACCINE, V28, P1341, DOI 10.1016/j.vaccine.2009.11.010; Singh G, 2014, MOL BIOL REP, V41, P285, DOI 10.1007/s11033-013-2861-3; Singh S, 2014, VACCINE, V32, P712, DOI 10.1016/j.vaccine.2013.11.065; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; von Reyn CF, 2002, CLIN INFECT DIS, V35, P465, DOI 10.1086/341901; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; World Health Organisation, 2014, IMPR DAT REV HIGH GL; World Health Organization, 2015, GLOB TUB REP 2015	42	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152240	10.1371/journal.pone.0152240	http://dx.doi.org/10.1371/journal.pone.0152240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023750	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900034
J	Sanchez, SE; Islam, S; Zhong, QY; Gelaye, B; Williams, MA				Sanchez, Sixto E.; Islam, Suhayla; Zhong, Qiu-Yue; Gelaye, Bizu; Williams, Michelle A.			Intimate Partner Violence Is Associated with Stress-Related Sleep Disturbance and Poor Sleep Quality during Early Pregnancy	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE; PERUVIAN WOMEN; DEPRESSION; INSOMNIA; PREVALENCE; VALIDITY; RISK; VICTIMIZATION; VULNERABILITY; REACTIVITY	Objectives To examine the associations of Intimate partner violence (IPV) with stress-related sleep disturbance (measured using the Ford Insomnia Response to Stress Test [FIRST]) and poor sleep quality (measured using the Pittsburgh Sleep Quality Index [PSQI]) during early pregnancy. Methods This cross-sectional study included 634 pregnant Peruvian women. In-person interviews were conducted in early pregnancy to collect information regarding IPV history, and sleep traits. Adjusted odds ratios (aOR) and 95% confidence intervals (95% CIs) were calculated using logistic regression procedures. Results Lifetime IPV was associated with a 1.54-fold increased odds of stress-related sleep disturbance (95% CI: 1.08-2.17) and a 1.93-fold increased odds of poor sleep quality (95% CI: 1.33-2.81). Compared with women experiencing no IPV during lifetime, the aOR (95% CI) for stress-related sleep disturbance associated with each type of IPV were: physical abuse only 1.24 (95% CI: 0.84-1.83), sexual abuse only 3.44 (95% CI: 1.07-11.05), and physical and sexual abuse 2.51 (95% CI: 1.27-4.96). The corresponding aORs (95% CI) for poor sleep quality were: 1.72 (95% CI: 1.13-2.61), 2.82 (95% CI: 0.99-8.03), and 2.50 (95% CI: 1.30-4.81), respectively. Women reporting any IPV in the year prior to pregnancy had increased odds of stress-related sleep disturbance (aOR = 2.07; 95% CI: 1.17-3.67) and poor sleep quality (aOR = 2.27; 95% CI: 1.30-3.97) during pregnancy. Conclusion Lifetime and prevalent IPV exposures are associated with stress-related sleep disturbance and poor sleep quality during pregnancy. Our findings suggest that sleep disturbances may be important mechanisms that underlie the lasting adverse effects of IPV on maternal and perinatal health.	[Sanchez, Sixto E.] Univ Peruana Ciencias Aplicadas, Lima, Peru; [Sanchez, Sixto E.] Asociac Civil PROESA, Lima, Peru; [Islam, Suhayla] Wellesley Coll, Wellesley, MA 02181 USA; [Zhong, Qiu-Yue; Gelaye, Bizu; Williams, Michelle A.] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Universidad Peruana de Ciencias Aplicadas (UPC); Wellesley College; Harvard University; Harvard T.H. Chan School of Public Health	Gelaye, B (corresponding author), Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	bgelaye@hsph.harvard.edu		Gelaye, Bizu/0000-0001-7934-548X; Sanchez, Sixto/0000-0003-0354-0523	National Institutes of Health [R01-HD-059835, T37-MD000149]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059835] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [T37MD001449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Support was provided by the National Institutes of Health (R01-HD-059835 and T37-MD000149).	Barrios YV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116609; Breiding MJ, 2015, AM J PUBLIC HEALTH, V105, pE11, DOI 10.2105/AJPH.2014.302321; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Campbell J, 2004, VIOLENCE AGAINST WOM, V10, P770, DOI 10.1177/1077801204265551; Cripe SM, 2011, HEADACHE, V51, P208, DOI 10.1111/j.1526-4610.2010.01777.x; Drake C, 2004, SLEEP, V27, P285, DOI 10.1093/sleep/27.2.285; Drake CL, 2008, SLEEP MED, V9, P297, DOI 10.1016/j.sleep.2007.04.012; Drake CL, 2006, SLEEP MED, V7, P567, DOI 10.1016/j.sleep.2006.03.019; Drake CL, 2011, SLEEP, V34, P1179, DOI 10.5665/SLEEP.1234; Ellsberg MC, 2001, J EPIDEMIOL COMMUN H, V55, P547, DOI 10.1136/jech.55.8.547; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gelaye B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116383; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Gomez-Beloz A, 2009, VIOLENCE VICTIMS, V24, P380, DOI 10.1891/0886-6708.24.3.380; Han A, 2014, INT J GYNECOL OBSTET, V124, P6, DOI 10.1016/j.ijgo.2013.06.037; Humphreys J, 1999, Issues Ment Health Nurs, V20, P319; Hurwitz Elizabeth J Himelfarb, 2006, J Immigr Minor Health, V8, P251, DOI 10.1007/s10903-006-9330-1; Johri M, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-49; Kishor S., DOMESTIC VIOLENCE ME, P1; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Moraes CL, 2009, ACTA OBSTET GYN SCAN, V88, P1041, DOI 10.1080/00016340903128439; Nakajima S, 2014, SLEEP MED, V15, P196, DOI 10.1016/j.sleep.2013.09.022; Newton TL, 2016, J INTERPERS VIOLENCE, V31, P1430, DOI 10.1177/0886260514567961; Perales MT, 2009, VIOLENCE AGAINST WOM, V15, P224, DOI 10.1177/1077801208329387; Pigeon WR, 2011, J WOMENS HEALTH, V20, P1923, DOI 10.1089/jwh.2011.2781; Rallis S, 2014, WOMEN BIRTH, V27, pE36, DOI 10.1016/j.wombi.2014.08.002; Sanchez SE, 2008, EUR J OBSTET GYN R B, V137, P50, DOI 10.1016/j.ejogrb.2007.05.013; Sanchez Sixto E, 2013, Health (Irvine Calif), V5, P26; Sarkar NN, 2008, J OBSTET GYNAECOL, V28, P266, DOI 10.1080/01443610802042415; Saunders D G, 1994, Violence Vict, V9, P31; Sinha SS., SLEEP MED REV, DOI [10.1016/i.smrv.2015.01.008, DOI 10.1016/I.SMRV.2015.01.008]; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; Svavarsdottir EK, 2009, J ADV NURS, V65, P1452, DOI 10.1111/j.1365-2648.2009.05006.x; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787; Walker R, 2011, J INTERPERS VIOLENCE, V26, P2004, DOI 10.1177/0886260510372932; Woods SJ, 2010, J TRAUMA STRESS, V23, P141, DOI 10.1002/jts.20495; World Health Organization, PROM MENT HLTH CONC; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004; Zhong Q. Y., 2015, J CLIN SLEEP MED JCS; Zhong QY, 2014, J AFFECT DISORDERS, V158, P148, DOI 10.1016/j.jad.2014.02.012	41	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152199	10.1371/journal.pone.0152199	http://dx.doi.org/10.1371/journal.pone.0152199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9KB	27023005	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900029
J	Han, MH; Yi, HJ; Kim, YS; Ko, Y; Kim, YS				Han, Myung-Hoon; Yi, Hyeong-Joong; Kim, Young-Seo; Ko, Yong; Kim, Young-Soo			Association between Diurnal Variation of Ozone Concentration and Stroke Occurrence: 24-Hour Time Series Study	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; CASE-CROSSOVER ANALYSIS; ISCHEMIC-STROKE; CIRCADIAN VARIATION; RISK-FACTOR; EXPOSURE; ADMISSIONS; MORTALITY; REGISTRY; QUALITY	Background and Purpose Increasing ozone concentrations have been known to damage human health and ecosystems. Although ozone tends to display diurnal variation, most studies have reported only on the association between daily ozone concentrations and ischemic stroke occurrence on the same day, or with a 1-day lag. We investigated the effect of the diurnal variation of ozone on ischemic stroke occurrence during the same day. Methods We included a consecutive series of 1,734 patients from January 1, 2008, to December 31, 2014, at a single tertiary hospital in Seoul, South Korea. We evaluated differences between temperature and pollutants at the time of stroke onset for each time interval and averaged those parameters across the 7-year study period. Results During the interval from 13: 00 to 16: 59, we found a positive association between ischemic stroke occurrence and ozone concentration relative to other time periods. Upper median ozone levels from 13: 00 to 16: 59 were positively correlated with ischemic stroke (odds ratio, 1.550; 95% confidence intervals, 1.220 to 1.970; P = < 0.001) when compared with lower median levels. Conclusions The results show diurnal patterns of ischemic stroke occurrence based on upper and lower median ozone levels for a 24-hour period, which extends understanding of the association between stroke occurrence and environmental influences.	[Yi, Hyeong-Joong; Ko, Yong; Kim, Young-Soo] Hanyang Univ, Med Ctr, Dept Neurosurg, 222-1 Wangsimni Ro, Seoul 133791, South Korea; [Kim, Young-Seo] Hanyang Univ, Med Ctr, Dept Neurol, 222-1 Wangsimni Ro, Seoul 133791, South Korea; [Han, Myung-Hoon] Hanyang Univ, Guri Hosp, Dept Neurosurg, 153 Gyeongchun Ro, Guri 471701, Gyonggi Do, South Korea	Hanyang University; Hanyang University; Hanyang University	Yi, HJ (corresponding author), Hanyang Univ, Med Ctr, Dept Neurosurg, 222-1 Wangsimni Ro, Seoul 133791, South Korea.	hjyi8499@hanyang.ac.kr	Yi, Hyeong-Joong/AAR-2685-2020					Amancio CT, 2014, SAO PAULO MED J, V132, P353, DOI 10.1590/1516-3180.2014.1326733; Bae S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129423; BERGINER VM, 1989, STROKE, V20, P65, DOI 10.1161/01.STR.20.1.65; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Carlsen HK, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-28; Casetta I, 2002, ARCH NEUROL-CHICAGO, V59, P48, DOI 10.1001/archneur.59.1.48; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; Chen L, 2014, J EXPO SCI ENV EPID, V24, P358, DOI 10.1038/jes.2013.82; Corea F, 2012, NEUROL INT, V4, P44, DOI 10.4081/ni.2012.e11; Dales RE, 2010, J THROMB HAEMOST, V8, P669, DOI 10.1111/j.1538-7836.2010.03760.x; Darrow LA, 2011, J EXPO SCI ENV EPID, V21, P10, DOI 10.1038/jes.2009.49; Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359; Finlayson-Pitts B.J., 1999, CHEM UPPER LOWER ATM; Han MH, 2015, STROKE, V46, P927, DOI 10.1161/STROKEAHA.114.007950; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Henrotin JB, 2007, OCCUP ENVIRON MED, V64, P439, DOI 10.1136/oem.2006.029306; Hong KS, 2013, J STROKE, V15, P67, DOI 10.5853/jos.2013.15.2.67; Hong YC, 2002, STROKE, V33, P2165, DOI 10.1161/01.STR.0000026865.52610.5B; Johnson JYM, STROKE; Karnosky DF, 2007, ENVIRON POLLUT, V147, P489, DOI 10.1016/j.envpol.2006.08.043; Kent ST, 2013, ANN NEUROL, V73, P32, DOI 10.1002/ana.23737; Kinney PL, 2008, AM J PREV MED, V35, P459, DOI 10.1016/j.amepre.2008.08.025; Lago A, 1998, STROKE, V29, P1873, DOI 10.1161/01.STR.29.9.1873; Lisabeth LD, 2008, ANN NEUROL, V64, P53, DOI 10.1002/ana.21403; Ljungman PL, 2014, STROKE, V45, P3734, DOI 10.1161/STROKEAHA.114.003130; Maheswaran R, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-23; Mechtouff L, 2012, INT J STROKE, V7, P669, DOI 10.1111/j.1747-4949.2011.00737.x; Moolgavkar SH, 2013, ENVIRON HEALTH PERSP, V121, P73, DOI 10.1289/ehp.1104507; Mostofsky E, 2014, CEREBROVASC DIS EXTR, V4, P9, DOI 10.1159/000357352; Omama S, 2006, J NEUROL NEUROSUR PS, V77, P1345, DOI 10.1136/jnnp.2006.090373; Ren C, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-3; Rudez G, 2009, ENVIRON HEALTH PERSP, V117, P995, DOI 10.1289/ehp.0800437; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.i4851, 10.1136/bmj.h1295]; Shan WP, 2009, ENVIRON MONIT ASSESS, V151, P127, DOI 10.1007/s10661-008-0255-0; SHINKAWA A, 1990, STROKE, V21, P1262, DOI 10.1161/01.STR.21.9.1262; Sorensen M, 2014, ENVIRON RES, V133, P49, DOI 10.1016/j.envres.2014.05.011; Suissa L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004060; Tsai SS, 2003, STROKE, V34, P2612, DOI 10.1161/01.STR.0000095564.33543.64; Turin TC, 2009, EUR J NEUROL, V16, P843, DOI 10.1111/j.1468-1331.2009.02605.x; Turin TC, 2008, STROKE, V39, P745, DOI 10.1161/STROKEAHA.107.495929; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080381; Wang Y., 2014, J AM HEART ASSOC, V3; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Xiang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061168; Xu XH, 2013, NEUROEPIDEMIOLOGY, V41, P2, DOI 10.1159/000345138; Yang WS, 2014, INT J CARDIOL, V175, P307, DOI 10.1016/j.ijcard.2014.05.044	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152433	10.1371/journal.pone.0152433	http://dx.doi.org/10.1371/journal.pone.0152433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015421	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900065
J	Hussein, HM; Habustova, OS; Puza, V; Zemek, R				Hussein, Hany M.; Habustova, Oxana Skokova; Puza, Vladimir; Zemek, Rostislav			Laboratory Evaluation of Isaria fumosorosea CCM 8367 and Steinernema feltiae Ustinov against Immature Stages of the Colorado Potato Beetle	PLOS ONE			English	Article							LEPTINOTARSA-DECEMLINEATA SAY; ENTOMOPATHOGENIC NEMATODES STEINERNEMA; BLACK VINE WEEVIL; PAECILOMYCES-FUMOSOROSEUS; METARHIZIUM-ANISOPLIAE; BEAUVERIA-BASSIANA; HETERORHABDITIS-BACTERIOPHORA; HYPOCREALES CORDYCIPITACEAE; NEONICOTINOID INSECTICIDES; COLEOPTERA-CHRYSOMELIDAE	The Colorado potato beetle, Leptinotarsa decemlineata, has developed resistance to most registered pesticides and has become one of the most difficult insect pests to control. Development of new biopesticides targeting this pest might solve the resistance problem and contribute to sustainable crop production. Laboratory experiments were conducted to assess the efficacy of Isaria fumosorosea (syn. Paecilomyces fumosoroseus) strain CCM 8367 against L. decemlineata when applied alone or combined with the entomopathogenic nematode Steinernema feltiae. The last-instar larvae of the Colorado potato beetle showed the highest susceptibility to I. fumosorosea followed by pre-pupae and pupae. The median lethal concentration (LC50) was estimated to be 1.03x10(6) blastospores/ml. The strain CCM 8367 was more virulent, causing 92.6% mortality of larvae (LT50 = 5.0 days) compared to the reference strain Apopka 97, which caused 54.5% mortality (LT50 = 7.0 days). The combined application of the fungus with the nematodes increased the mortality up to 98.0%. The best results were obtained when S. feltiae was applied simultaneously with I. fumosorosea (LT50 = 2.0 days); later application negatively affected both the penetration rate and the development of the nematodes. We can conclude that the strain CCM 8367 of I. fumosorosea is a prospective biocontrol agent against immature stages of L. decemlineata. For higher efficacy, application together with an entomopathogenic nematode is recommended.	[Hussein, Hany M.; Habustova, Oxana Skokova] Biol Ctr CAS, Inst Entomol, Dept Biochem & Physiol, Ceske Budejovice, Czech Republic; [Puza, Vladimir; Zemek, Rostislav] Biol Ctr CAS, Inst Entomol, Dept Biosystemat & Ecol, Ceske Budejovice, Czech Republic; [Hussein, Hany M.] Natl Res Ctr, Pests & Plant Protect Dept, Cairo, Egypt	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Zemek, R (corresponding author), Biol Ctr CAS, Inst Entomol, Dept Biosystemat & Ecol, Ceske Budejovice, Czech Republic.	rosta@entu.cas.cz	Zemek, Rostislav/G-8989-2014; Habustova, Oxana Skokova/H-1412-2014; Puza, Vladimir/G-9248-2014	Zemek, Rostislav/0000-0001-7640-1503; Skokova Habustova, Oxana/0000-0002-7628-317X; Puza, Vladimir/0000-0002-0019-009X; Hussein, Hany/0000-0002-4618-0874	European Social Fund; National budget of the Czech Republic (project TTM) [CZ.1.07/2.4.00/12.0082]; National budget of the Czech Republic (project Postdok BIOGLOBE) [CZ.1.07/2.3.00/30.0032]; Ministry of Agriculture [206553/2011-MZE-17253];  [RVO:60077344]	European Social Fund(European Social Fund (ESF)); National budget of the Czech Republic (project TTM); National budget of the Czech Republic (project Postdok BIOGLOBE); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); 	This research was conducted with institutional support RVO:60077344 (www.cas.cz) (HMH OH VP RZ) and co-financed by the European Social Fund and National budget of the Czech Republic (projects TTM, reg. No. CZ.1.07/2.4.00/12.0082 and Postdok BIOGLOBE, reg. No. CZ.1.07/2.3.00/30.0032) (www.msmt.cz) (RZ) and Ministry of Agriculture, reg. No. 206553/2011-MZE-17253 (eagri.cz/public/web/en/mze/ministry/) (OH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adel Manal M., 2010, Archives of Phytopathology and Plant Protection, V43, P1485, DOI 10.1080/03235400802538473; Ali S, 2010, J PEST SCI, V83, P361, DOI 10.1007/s10340-010-0305-6; Alyokhin A, 2007, PEST MANAG SCI, V63, P32, DOI 10.1002/ps.1305; [Anonymous], 1988, SO COOPERATIVE SERIE; Ansari MA, 2008, ENTOMOL EXP APPL, V129, P340, DOI 10.1111/j.1570-7458.2008.00783.x; Ansari MA, 2010, BIOCONTROL SCI TECHN, V20, P99, DOI 10.1080/09583150903420031; Ansari MA, 2004, BIOL CONTROL, V31, P172, DOI 10.1016/j.biocontrol.2004.04.002; Armer CA, 2004, ENTOMOL EXP APPL, V111, P47, DOI 10.1111/j.0013-8703.2004.00152.x; Arthurs S, 2004, B ENTOMOL RES, V94, P297, DOI 10.1079/BER2003309; Arthurs SP, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.3101; Avery PB, 2011, BIOCONTROL SCI TECHN, V21, P1065, DOI 10.1080/09583157.2011.596927; BAJAN C, 1972, Ekologia polska, V20, P423; BAJAN C, 1978, B ACAD POL SCI BIOL, V26, P715; BAJAN C, 1973, Ekologia polska, V21, P705; BARBERCHECK ME, 1990, J INVERTEBR PATHOL, V55, P225, DOI 10.1016/0022-2011(90)90058-E; BARBERCHECK ME, 1991, ENVIRON ENTOMOL, V20, P707, DOI 10.1093/ee/20.2.707; Bathon H, 1996, BIOCONTROL SCI TECHN, V6, P421, DOI 10.1080/09583159631398; Belair G, 2005, NEMATODES AS BIOCONTROL AGENTS, P255, DOI 10.1079/9780851990170.0255; Blackburn MB, 2007, BIOL CONTROL, V42, P207, DOI 10.1016/j.biocontrol.2007.04.008; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Bolckmans K, 1995, MEDEDELINGEN VAN DE FACULTEIT LANDBOUWWETENSCHAPPEN - UNIVERSITEIT GENT, VOL 60, NOS 2A-3B, 1995, P707; Campos-Herrera R, 2009, J PEST SCI, V82, P305, DOI 10.1007/s10340-009-0247-z; CANTELO WW, 1992, J ENTOMOL SCI, V27, P37, DOI 10.18474/0749-8004-27.1.37; Cantone FA, 1998, MYCOL RES, V102, P209, DOI 10.1017/S0953756297004590; Castellan NJ., 2003, NONPARAMETRIC STAT B; Chang GC, 1996, ENVIRON ENTOMOL, V25, P207, DOI 10.1093/ee/25.1.207; Dalleau-Clouet C, 2005, MOL ECOL NOTES, V5, P496, DOI 10.1111/j.1471-8286.2005.00968.x; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Dunlap CA, 2007, BIOCONTROL SCI TECHN, V17, P513, DOI 10.1080/09583150701311614; Ehlers RU, 1996, BIOCONTROL SCI TECHN, V6, P295, DOI 10.1080/09583159631280; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; EPSKY ND, 1993, J NEMATOL, V25, P173; FARGUES J, 1994, J ECON ENTOMOL, V87, P67, DOI 10.1093/jee/87.1.67; Fargues J, 2002, MYCOL RES, V106, P1066, DOI 10.1017/S0953756202006408; Gauthier N, 2007, MYCOLOGIA, V99, P693, DOI 10.3852/mycologia.99.5.693; Georgis R., 2002, Entomopathogenic nematology, P357, DOI 10.1079/9780851995670.0357; Grafius Edward J., 2008, V5, P195, DOI 10.1007/978-1-4020-8373-0_7; Guetsky R, 2001, PHYTOPATHOLOGY, V91, P621, DOI 10.1094/PHYTO.2001.91.7.621; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; HARE JD, 1990, ANNU REV ENTOMOL, V35, P81, DOI 10.1146/annurev.en.35.010190.000501; HAYDAK M. H., 1936, Journal of Economic Entomology, V29, pp, DOI 10.1093/jee/29.5.870; HOLM S, 1979, SCAND J STAT, V6, P65; Hoy MA, 2010, FLA ENTOMOL, V93, P24, DOI 10.1653/024.093.0103; Hussein H. M., 2013, Archives of Phytopathology and Plant Protection, V46, P1307, DOI 10.1080/03235408.2013.765677; ISHIBASHI N, 1991, J NEMATOL, V23, P175; JOLIVET P, 1991, Entomologiste (Paris), V47, P29; Jorg E, KARTOFFELBAU, V51, P202; Kaya HK, 1996, BIOCONTROL SCI TECHN, V6, P357, DOI 10.1080/09583159631334; Kim JS, 2010, J IND MICROBIOL BIOT, V37, P419, DOI 10.1007/s10295-010-0692-y; Koppenhofer AM, 1997, BIOL CONTROL, V8, P131, DOI 10.1006/bcon.1996.0498; Koppenhofer AM, 1999, BIOL CONTROL, V14, P37, DOI 10.1006/bcon.1998.0663; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; Lacey LA, 2012, J NEMATOL, V44, P218; LAUMOND C, 1979, ENTOMOPHAGA, V24, P13, DOI 10.1007/BF02377505; Laznik Z, 2010, J PLANT DIS PROTECT, V117, P129; LEBECK LM, 1993, J INVERTEBR PATHOL, V62, P58, DOI 10.1006/jipa.1993.1074; Luangsa-Ard JJ, 2009, MYCOL RES, V113, P1389, DOI 10.1016/j.mycres.2009.08.017; Acevedo JPM, 2007, J INVERTEBR PATHOL, V96, P187, DOI 10.1016/j.jip.2007.04.003; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Osborne LS, 2002, ISTRO C BRNO SESS 2, P195; Osborne LS., 1993, Biological control of whiteflies and other pests with a fungal pathogen, Patent No. [WO_ 1990_ 010388_ A1, 1990010388]; Otsuki H, 2014, ENTOMOL EXP APPL, V151, P27, DOI 10.1111/eea.12164; Poinar G. O., 1979, NEMATODES BIOL CONTR; Preserve E., 2009, IOBC/WPRS Bulletin, V45, P321; Ramisch I., 1976, Nova Hedwigia, V27, P199; SAMSINAKOVA A, 1977, ACTA ENTOMOL BOHEMOS, V74, P76; Sefrova Hana, 2001, Entomologische Zeitschrift, V111, P194; Shapiro-Ilan DI, 2004, BIOL CONTROL, V30, P119, DOI 10.1016/j.biocontrol.2003.09.014; Smith P., 1993, Biocontrol News and Information, V14, p71N; Stauderman K, 2012, BIOCONTROL SCI TECHN, V22, P747, DOI 10.1080/09583157.2012.686599; Stewart JG, 1998, CAN ENTOMOL, V130, P509, DOI 10.4039/Ent130509-4; Szendrei Z, 2012, PEST MANAG SCI, V68, P941, DOI 10.1002/ps.3258; Tarasco E, 2011, BIOCONTROL SCI TECHN, V21, P693, DOI 10.1080/09583157.2011.570428; THURSTON GS, 1993, J INVERTEBR PATHOL, V61, P167, DOI 10.1006/jipa.1993.1030; THURSTON GS, 1994, BIOL CONTROL, V4, P67, DOI 10.1006/bcon.1994.1012; Trdan S, 2009, HELMINTHOLOGIA, V46, P14, DOI 10.2478/s11687-009-0003-1; Vacek Z., 1974, HISTOLOGIA HISTOLOGI; Vidal C, 1998, BIOL CONTROL, V12, P191, DOI 10.1006/bcon.1998.0625; Weber D., 2003, Pesticide Outlook, V14, P256, DOI 10.1039/b314847p; WELCH H. E., 1961, CANADIAN ENTOMOL, V93, P759; Weyda F., 2013, US Patent, Patent No. 08574566; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Wolf J, 1954, MIKROSKOPICKA TECHNI; Wraight SP, 2002, BIOL CONTROL, V23, P164, DOI 10.1006/bcon.2001.1004; Zemek R, 2012, Commun Agric Appl Biol Sci, V77, P685; Zemek R., 2012, Acta Fytotechnica et Zootechnica, V15, P79; Zemek Rostislav, 2007, Entomological Research, V37, pA135; Zichova T, 2010, PEST MANAG SCI, V66, P853, DOI 10.1002/ps.1952; Zimmermann G, 2008, BIOCONTROL SCI TECHN, V18, P865, DOI 10.1080/09583150802471812; [No title captured]	91	22	23	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152399	10.1371/journal.pone.0152399	http://dx.doi.org/10.1371/journal.pone.0152399			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015633	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708900061
J	Johnson, AR; Bucks, RS; Kane, RT; Thomas, MG; Gasson, N; Loftus, AM				Johnson, Andrew R.; Bucks, Romola S.; Kane, Robert T.; Thomas, Meghan G.; Gasson, Natalie; Loftus, Andrea M.			Motor Subtype as a Predictor of Future Working Memory Performance in Idiopathic Parkinson's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MINI-MENTAL-STATE; RATING-SCALE; DYSFUNCTION; CANTAB; TREMOR; GAIT	Parkinson's disease is a progressive neurodegenerative disorder associated with reduced spatial and verbal working memory ability. There are two established motor subtypes of PD, tremor dominant (TD) and postural instability and gait difficulty (PIGD). This study used structural equation modelling to explore the longitudinal relationship between the two subtypes and working memory assessed at a 2-year follow-up. The study comprised 84 males and 30 females (N = 114), aged between 39 and 85 (M = 64.82, SD = 9.23) with confirmed PD. There was no significant relationship between motor subtype at Time 1 and working memory at Time 2. Postural symptom severity at Time 1 predicted Time 2 spatial working memory for the PIGD subtype (p =.011) but not the TD subtype. Tremor symptoms were not associated with Time 2 working memory in either subtype. Predictive significance of Time 1 postural symptoms only in the PIGD subtype suggests an interaction between symptom dominance (subtype) and symptom severity that future subtyping should consider. This study demonstrates a predictive relationship between postural difficulties and working memory performance assessed at a 2-year follow-up. Establishing physical symptoms as predictors of cognitive change could have significant clinical importance.	[Johnson, Andrew R.; Kane, Robert T.; Gasson, Natalie; Loftus, Andrea M.] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia; [Johnson, Andrew R.; Bucks, Romola S.; Kane, Robert T.; Thomas, Meghan G.; Gasson, Natalie; Loftus, Andrea M.] Curtin Univ, Sch Psychol & Speech Pathol, ParkC Collaborat, Perth, WA 6845, Australia; [Bucks, Romola S.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Thomas, Meghan G.] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Perth, WA 6009, Australia; [Thomas, Meghan G.] Edith Cowan Univ, Parkinsons Ctr Sci, Sch Med Sci, Perth, WA, Australia	Curtin University; Curtin University; University of Western Australia; University of Western Australia; Edith Cowan University	Johnson, AR (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.; Johnson, AR (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, ParkC Collaborat, Perth, WA 6845, Australia.	andrew.r.johnson@postgrad.curtin.edu.au	Bucks, Romola Starr/B-9164-2011; Johnson, Andrew Robert/H-6282-2019	Bucks, Romola Starr/0000-0002-4207-4724; Johnson, Andrew Robert/0000-0001-7000-8065; Thomas, Meghan/0000-0003-4374-1039				Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Beato R, 2008, ARQ NEURO-PSIQUIAT, V66, P147, DOI 10.1590/S0004-282X2008000200001; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Bohnen NI, 2006, J NEUROL, V253, P242, DOI 10.1007/s00415-005-0971-0; Bohnen NI, 2011, BEHAV BRAIN RES, V221, P564, DOI 10.1016/j.bbr.2009.12.048; Bohnen NI, 2010, BRAIN, V133, P1747, DOI 10.1093/brain/awq079; Buschkuehl M, 2014, COGN AFFECT BEHAV NE, V14, P147, DOI 10.3758/s13415-013-0244-9; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Costa A, 2009, NEUROPSYCHOLOGIA, V47, P1374, DOI 10.1016/j.neuropsychologia.2009.01.039; Domellof ME, 2011, MOVEMENT DISORD, V26, P2183, DOI 10.1002/mds.23814; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fu R., 2015, CHANGE SCORE FOLLOWU; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; HOLM S, 1979, SCAND J STAT, V6, P65; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Kline R.B., 2010, PRINCIPLES PRACTICE; Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868; Lewis SJG, 2005, NEUROPSYCHOLOGIA, V43, P823, DOI 10.1016/j.neuropsychologia.2004.10.001; Loane C, 2013, NEUROLOGY, V80, P1850, DOI 10.1212/WNL.0b013e318292a31d; Loftus AM, 2015, J INT NEUROPSYCH SOC, V21, P137, DOI 10.1017/S1355617715000041; Lord S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00249; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; Martinez-Horta S, 2015, NEUROPSYCHIATRIC SYM, P29; McKinlay A, 2010, J INT NEUROPSYCH SOC, V16, P268, DOI 10.1017/S1355617709991299; Munck I. M. E., 1979, MODEL BUILDING COMP; Nocera JR, 2010, PARKINSONISM RELAT D, V16, P590, DOI 10.1016/j.parkreldis.2010.08.008; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Rochester L, 2012, BRAIN, V135, P2779, DOI 10.1093/brain/aws207; Rosenthal R, 1991, METAANALYTIC PROCEDU; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Stebbins GT, 2013, MOVEMENT DISORD, V28, P668, DOI 10.1002/mds.25383; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Stepankova H, 2014, DEV PSYCHOL, V50, P1049, DOI 10.1037/a0034913; Tabachnick B. G., 2013, USING MULTIVARIATE S; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Williams J, 2008, STRUCT EQU MODELING, V15, P23, DOI 10.1080/10705510701758166; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245	45	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152534	10.1371/journal.pone.0152534	http://dx.doi.org/10.1371/journal.pone.0152534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3TE	27015637	Green Published, gold			2022-12-26	WOS:000372708900073
J	Strauss, A; Guilhaumon, F; Randrianiaina, RD; Valero, KCW; Vences, M; Glos, J				Strauss, Axel; Guilhaumon, Francois; Randrianiaina, Roger Daniel; Valero, Katharina C. Wollenberg; Vences, Miguel; Glos, Julian			Opposing Patterns of Seasonal Change in Functional and Phylogenetic Diversity of Tadpole Assemblages	PLOS ONE			English	Article							RAIN-FOREST; NICHE CONSERVATISM; SPECIES RICHNESS; TRAIT DIVERSITY; BODY-SIZE; COMMUNITIES; ECOLOGY; FROGS; BIODIVERSITY; COMPETITION	Assemblages that are exposed to recurring temporal environmental changes can show changes in their ecological properties. These can be expressed by differences in diversity and assembly rules. Both can be identified using two measures of diversity: functional (FD) and phylogenetic diversity (PD). Frog communities are understudied in this regard, especially during the tadpole life stage. We utilised tadpole assemblages from Madagascan rainforest streams to test predictions of seasonal changes on diversity and assemblage composition and on diversity measures. From the warm-wet to the cool-dry season, species richness (SR) of tadpole assemblages decreased. Also FD and PD decreased, but FD less and PD more than expected by chance. During the dry season, tadpole assemblages were characterised by functional redundancy (among assemblages-with increasing SR), high FD (compared to a null model), and low PD (phylogenetic clustering; compared to a null model). Although mutually contradictory at first glance, these results indicate competition as tadpole community assembly driving force. This is true during the limiting cool-dry season but not during the more suitable warm-wet season. We thereby show that assembly rules can strongly depend on season, that comparing FD and PD can reveal such forces, that FD and PD are not interchangeable, and that conclusions on assembly rules based on FD alone are critical.	[Strauss, Axel; Randrianiaina, Roger Daniel; Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Mendelssohnstr 4, D-38106 Braunschweig, Germany; [Strauss, Axel] Univ Munich, Inst Genet, Grosshaderner Str 2-4, D-82152 Munich, Germany; [Guilhaumon, Francois] Univ Montpellier, IRD, MARBEC, F-34059 Montpellier, France; [Randrianiaina, Roger Daniel] Univ Antananarivo, Dept Biol Anim, Antananarivo 101, Madagascar; [Valero, Katharina C. Wollenberg] Bethune Cookman Univ, Dept Nat Sci, Coll Sci Engn & Math, 640 Dr Mary McLeod Bethune Blvd, Daytona Beach, FL 32114 USA; [Glos, Julian] Univ Hamburg, Inst Zool, Martin Luther King Pl 3, D-20146 Hamburg, Germany	Braunschweig University of Technology; University of Munich; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University Antananarivo; Bethune-Cookman University; University of Hamburg	Strauss, A (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Mendelssohnstr 4, D-38106 Braunschweig, Germany.; Strauss, A (corresponding author), Univ Munich, Inst Genet, Grosshaderner Str 2-4, D-82152 Munich, Germany.	axel@tsiboboka.de	Strauß, Axel/G-8473-2013; Guilhaumon, francois/GPX-7180-2022	Guilhaumon, francois/0000-0003-4707-8932; Vences, Miguel/0000-0003-0747-0817; Wollenberg Valero, Katharina/0000-0001-8858-1804	Volkswagen Foundation; Deutsche Forschungsgemeinschaft [VE247/2-1]; DFG [Glos 665/1-1]; Deutscher Akademischer Austauschdienst	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	Financial support was granted by the Volkswagen Foundation to MV and RDR, by the Deutsche Forschungsgemeinschaft (grant VE247/2-1) to MV, AS and JG, and grant DFG Glos 665/1-1 to JG, and by the Deutscher Akademischer Austauschdienst to RDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso LG, 2007, J NAT HIST, V41, P949, DOI 10.1080/00222930701311680; Alford RA, 1999, TADPOLES, P240; Andreone F, 1996, COLLOQ SEMI, P397; [Anonymous], 2012, CLUSTER CLUSTER ANAL; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Best RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057550; Bletz MC, 2015, SCI REPORTS, P5, DOI 10.1038/srep08633; Both C, 2009, HYDROBIOLOGIA, P1; Brunbjerg AK, 2012, J VEG SCI, V23, P1082, DOI 10.1111/j.1654-1103.2012.01433.x; Bryant JA, 2012, ECOLOGY, V93, P1659, DOI 10.1890/11-1204.1; Burnham K. P., 1998, MODEL SELECTION INFE; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Choi WI, 2010, BIODIVERS CONSERV, V19, P2291, DOI 10.1007/s10531-010-9842-9; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Dinnage R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007071; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Ernst R, 2006, BIOL CONSERV, V133, P143, DOI 10.1016/j.biocon.2006.05.028; Eterovick PC, 2006, HERPETOLOGICA, V62, P365, DOI 10.1655/0018-0831(2006)62[365:DOTWAA]2.0.CO;2; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fox J., 2019, R COMPANION APPL REG, V.; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Grimbacher PS, 2009, BIOTROPICA, V41, P328, DOI 10.1111/j.1744-7429.2008.00477.x; Grosjean S, 2011, SALAMANDRA, V47, P63; Grosjean S, 2011, ZOOL J LINN SOC-LOND, V162, P149, DOI 10.1111/j.1096-3642.2010.00667.x; Haas A, 2003, CLADISTICS, V19, P23, DOI 10.1111/j.1096-0031.2003.tb00405.x; Halpern BS, 2008, MAR ECOL PROG SER, V364, P147, DOI 10.3354/meps07553; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Heinermann J, 2015, J NAT HIST, V49, P2213, DOI 10.1080/00222933.2015.1009513; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Hornik K, 2012, CLUE CLUSTER ENSEMBL; Hornik K, 2005, J STAT SOFTWARE, V14; Huston M. A., 1995, BIOL DIVERSITY COEXI, DOI DOI 10.1016/0022-0981(95)90069-1; INGER R F, 1986, Journal of Tropical Ecology, V2, P193; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Joshi J, 2000, J ECOL, V88, P634, DOI 10.1046/j.1365-2745.2000.00487.x; Kluge J, 2011, J BIOGEOGR, V38, P394, DOI 10.1111/j.1365-2699.2010.02433.x; Knapp S, 2008, ECOL LETT, V11, P1054, DOI 10.1111/j.1461-0248.2008.01217.x; Kopp K, 2006, J NAT HIST, V40, P1813, DOI 10.1080/00222930601017403; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Moretti M, 2009, J ANIM ECOL, V78, P98, DOI 10.1111/j.1365-2656.2008.01462.x; MORIN PJ, 1988, OIKOS, V53, P398, DOI 10.2307/3565542; MORIN PJ, 1983, COPEIA, P628, DOI 10.2307/1444327; Mouchet M, 2008, OIKOS, V117, P794, DOI 10.1111/j.0030-1299.2008.16594.x; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; R Core Team, 2012, R LANG ENV STAT COMP; Randrianiaina RD, 2012, ZOOKEYS, P59, DOI 10.3897/zookeys.178.1410; Randrianiaina RD, 2011, CONTRIB ZOOL, V80, P17, DOI 10.1163/18759866-08001002; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Scherer-Lorenzen M, 2008, FUNCT ECOL, V22, P547, DOI 10.1111/j.1365-2435.2008.01389.x; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Strauss A, 2013, HYDROBIOLOGIA, V702, P27, DOI 10.1007/s10750-012-1301-z; Strauss Axel, 2010, BMC Ecology, V10, P12, DOI 10.1186/1472-6785-10-12; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vences Miguel, 2008, Museo Regionale di Scienze Naturali Monografie (Turin), V45, P233; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Warnes GR, 2012, GTOOLS VARIOUS R PRO; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Weiblen GD, 2006, ECOLOGY, V87, pS62, DOI 10.1890/0012-9658(2006)87[62:PDOHUI]2.0.CO;2; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Werner EE, 1999, COPEIA, P1, DOI 10.2307/1447379; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217; Wollenberg Katharina C., 2008, Museo Regionale di Scienze Naturali Monografie (Turin), V45, P85	86	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151744	10.1371/journal.pone.0151744	http://dx.doi.org/10.1371/journal.pone.0151744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27014867	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900028
J	Bernard, V; Bouilly, J; Kramer, P; Carre, N; Schlumberger, M; Visser, JA; Young, J; Binart, N				Bernard, Valerie; Bouilly, Justine; Kramer, Piet; Carre, Nadege; Schlumberger, Martin; Visser, Jenny A.; Young, Jacques; Binart, Nadine			The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical Study	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; ANTI-MULLERIAN HORMONE; RENAL-CELL CARCINOMA; MALE GYNECOMASTIA; SOLID TUMORS; IMATINIB; THERAPY; RECEPTOR; CANCER; MICE	The aim of the study was to evaluate ovarian toxicity of tyrosine kinase inhibitor (TKI) sunitinib, since only scarce data are available on gonadal function after this treatment. Six-weekold female mice received orally, once daily, vehicle or sunitinib (50 mg/kg/d) during 5 weeks. Fertility parameters were analyzed from ovulation to litter assessment. Sunitinib exposure significantly reduced (i) corpora lutea number per ovary (1.1 +/- 0.38 in sunitinib group versus 4 +/- 0.79 in control group, p<0.01) and (ii) serum Anti Mullerian hormone (AMH) levels in sunitinib treated mice (12.01 +/- 1.16) compared to control mice (14.33 +/- 0.87 ng/ml, p<0.05). However, primordial and growing follicles numbers per ovary were not different in both groups. After treatment withdrawal, female mice in both groups were able to obtain litters. These data could be helpful to counsel clinicians and patients, when fertility preservation methods are discussed, before TKI treatment in girls and young women.	[Bernard, Valerie; Bouilly, Justine; Carre, Nadege; Young, Jacques; Binart, Nadine] Univ Paris Saclay, Univ Paris 11, Inserm U1185, F-94276 Le Kremlin Bicetre, France; [Kramer, Piet; Visser, Jenny A.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Schlumberger, Martin] Univ Paris 11, Inst Gustave Roussy, Dept Med Nucl & Oncol Endocrinienne, F-94800 Villejuif, France; [Young, Jacques] Univ Paris 11, AP HP, Fac Med Paris Sud, Serv Endocrinol & Malad Reprod, F-94276 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Binart, N (corresponding author), Univ Paris Saclay, Univ Paris 11, Inserm U1185, F-94276 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Young, Jacques/N-5251-2019; Binart, Nadine/F-2949-2013; Visser, Jenny A./F-8156-2011; Young, Jacques/T-2976-2018	Young, Jacques/0000-0001-9286-5631; Binart, Nadine/0000-0002-5606-3866; Young, Jacques/0000-0001-9286-5631	Inserm; Societe francaise d'Endocrinologie	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Societe francaise d'Endocrinologie	This work was supported by Inserm, Societe francaise d'Endocrinologie (VB).	Ault P, 2006, J CLIN ONCOL, V24, P1204, DOI 10.1200/JCO.2005.04.6557; Baker SD, 2013, CLIN CANCER RES, V19, P5758, DOI 10.1158/1078-0432.CCR-13-1323; Ballardini P, 2009, CLIN DRUG INVEST, V29, P487, DOI 10.2165/00044011-200929070-00007; Brassard M, 2011, J CLIN ENDOCR METAB, V96, P2741, DOI 10.1210/jc.2010-2771; Broutin S, 2011, CLIN CANCER RES, V17, P2044, DOI 10.1158/1078-0432.CCR-10-2041; Caocci G, 2008, LEUKEMIA, V22, P2127, DOI 10.1038/leu.2008.106; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Chowdhury T, 2013, J PEDIAT HEMATOL ONC, V35, pE1, DOI 10.1097/MPH.0b013e318266bf34; Christopoulos C, 2008, NEW ENGL J MED, V358, P1079, DOI 10.1056/NEJMc0707841; DuBois SG, 2011, CLIN CANCER RES, V17, P5113, DOI 10.1158/1078-0432.CCR-11-0237; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Gambacorti-Passerini C, 2003, LANCET, V361, P1954, DOI 10.1016/S0140-6736(03)13554-4; Hoffman-La Roche Limited, 2015, AVASTIN MONOGRAPH; Hutt KJ, 2006, MOL HUM REPROD, V12, P61, DOI 10.1093/molehr/gal010; Kevenaar ME, 2006, ENDOCRINOLOGY, V147, P3228, DOI 10.1210/en.2005-1588; Kim H, 2005, J KOREAN MED SCI, V20, P512, DOI 10.3346/jkms.2005.20.3.512; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Le Tourneau C, 2008, CANCER TREAT REV, V34, P37, DOI 10.1016/j.ctrv.2007.09.003; Lodish MB, 2013, J CLIN ENDOCR METAB, V98, P1333, DOI 10.1210/jc.2012-4085; Lodish MB, 2010, ENDOCR-RELAT CANCER, V17, pR233, DOI 10.1677/ERC-10-0082; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Malozowski S, 2008, NEW ENGL J MED, V358, P2648, DOI 10.1056/NEJMc080707; Mariani S, 2008, LANCET, V372, P111, DOI 10.1016/S0140-6736(08)61023-5; Meirow D, 2007, HUM REPROD, V22, P1626, DOI 10.1093/humrep/dem027; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Nilsson EE, 2006, REPRODUCTION, V131, P1007, DOI 10.1530/rep.1.00978; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Sirotkin AV, 2011, J CELL PHYSIOL, V226, P2222, DOI 10.1002/jcp.22588; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Viengchareun S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001535; Visser JA, 2007, ENDOCRINOLOGY, V148, P2301, DOI 10.1210/en.2006-1265; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Zimmermann RC, 2003, J CLIN INVEST, V112, P659, DOI 10.1172/JCI200318740	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152872	10.1371/journal.pone.0152872	http://dx.doi.org/10.1371/journal.pone.0152872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035144	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200047
J	Cai, AD; Xu, H; Shao, XF; Zhu, P; Zhang, WJ; Xu, MG; Murphy, DV				Cai, Andong; Xu, Hu; Shao, Xingfang; Zhu, Ping; Zhang, Wenju; Xu, Minggang; Murphy, Daniel V.			Carbon and Nitrogen Mineralization in Relation to Soil Particle-Size Fractions after 32 Years of Chemical and Manure Application in a Continuous Maize Cropping System	PLOS ONE			English	Article							ORGANIC-MATTER; MICROBIAL BIOMASS; N-MINERALIZATION; FERTILIZER; AGGREGATE; CLAY; PARTICULATE; STABILIZATION; RESPIRATION; SATURATION	Long-term manure application is recognized as an efficient management practice to enhance soil organic carbon (SOC) accumulation and nitrogen (N) mineralization capacity. A field study was established in 1979 to understand the impact of long-term manure and/or chemical fertilizer application on soil fertility in a continuous maize cropping system. Soil samples were collected from field plots in 2012 from 9 fertilization treatments (M0CK, M0N, M0NPK, M30CK, M30N, M30NPK, M60CK, M60N, and M60NPK) where M-0, M-30, and M-60 refer to manure applied at rates of 0, 30, and 60 t ha(-1) yr(-1), respectively; CK indicates no fertilizer; N and NPK refer to chemical fertilizer in the forms of either N or N plus phosphorus (P) and potassium (K). Soils were separated into three particle-size fractions (2000-250, 250-53, and < 53 mu m) by dry-and wet-sieving. A laboratory incubation study of these separated particle-size fractions was used to evaluate the effect of long-term manure, in combination with/without chemical fertilization application, on the accumulation and mineralization of SOC and total N in each fraction. Results showed that long-term manure application significantly increased SOC and total N content and enhanced C and N mineralization in the three particle-size fractions. The content of SOC and total N followed the order 2000-250 mu m > 250-53 mu m > 53 mu m fraction, whereas the amount of C and N mineralization followed the reverse order. In the < 53 mu m fraction, the M60NPK treatment significantly increased the amount of C and N mineralized (7.0 and 10.1 times, respectively) compared to the M0CK treatment. Long-term manure application, especially when combined with chemical fertilizers, resulted in increased soil microbial biomass C and N, and a decreased microbial metabolic quotient. Consequently, long-term manure fertilization was beneficial to both soil C and N turnover and microbial activity, and had significant effect on the microbial metabolic quotient.	[Cai, Andong; Shao, Xingfang; Zhang, Wenju; Xu, Minggang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100081, Peoples R China; [Xu, Hu] Guizhou Univ, Coll Agr, Guiyang 550025, Peoples R China; [Zhu, Ping] Jilin Acad Agr Sci, Gongzhuling 136100, Peoples R China; [Murphy, Daniel V.] Univ Western Australia, Inst Agr, Sch Geog & Environm Sci, Soil Biol & Mol Ecol Grp, Crawley, WA 6009, Australia	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Guizhou University; Jilin Academy of Agricultural Sciences; University of Western Australia	Zhang, WJ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100081, Peoples R China.	zhangwenju01@caas.cn	Cai, Andong/J-8441-2019	Cai, Andong/0000-0001-6853-7558; Murphy, Daniel/0000-0002-4686-9276	12th National Technology R&D Program of the Ministry of Science and Technology [2014BAD14B02]; National Special Research Fund for Non-Profit Sector (Agriculture) [201203030, 201303126]; Australian Research Council Future Fellowship Scheme [FT110100246]; Chinese High-End Foreign Experts Visiting Professorship	12th National Technology R&D Program of the Ministry of Science and Technology; National Special Research Fund for Non-Profit Sector (Agriculture); Australian Research Council Future Fellowship Scheme(Australian Research Council); Chinese High-End Foreign Experts Visiting Professorship	This work received Financial support from the 12th National Technology R&D Program of the Ministry of Science and Technology (2014BAD14B02) the National Special Research Fund for Non-Profit Sector (Agriculture) (201203030, 201303126), the Australian Research Council Future Fellowship Scheme (FT110100246) and a Chinese High-End Foreign Experts Visiting Professorship is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli A, 2001, SOIL BIOL BIOCHEM, V33, P613, DOI 10.1016/S0038-0717(00)00203-0; Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P3245, DOI 10.1016/j.soilbio.2006.04.011; Aoyama M, 1999, CAN J SOIL SCI, V79, P295, DOI 10.4141/S98-049; Ashman MR, 2003, SOIL BIOL BIOCHEM, V35, P435, DOI 10.1016/S0038-0717(02)00295-X; Besnard E, 1996, EUR J SOIL SCI, V47, P495, DOI 10.1111/j.1365-2389.1996.tb01849.x; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P123, DOI 10.2136/sssaj1994.03615995005800010017x; Chen Y, 2010, J SOIL SEDIMENT, V10, P1018, DOI 10.1007/s11368-009-0123-8; COLLINS HP, 1992, SOIL SCI SOC AM J, V56, P783, DOI 10.2136/sssaj1992.03615995005600030018x; Ding XL, 2012, SOIL TILL RES, V122, P36, DOI 10.1016/j.still.2012.02.002; Du ZL, 2014, J INTEGR AGR, V13, P2276, DOI 10.1016/S2095-3119(14)60823-6; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1090, DOI 10.2136/sssaj1997.03615995006100040015x; GUPTA VVSR, 1988, SOIL BIOL BIOCHEM, V20, P777, DOI 10.1016/0038-0717(88)90082-X; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; HASSINK J, 1993, GEODERMA, V57, P105, DOI 10.1016/0016-7061(93)90150-J; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Hernandez-Hernandez RM, 2002, SOIL BIOL BIOCHEM, V34, P1563, DOI 10.1016/S0038-0717(02)00125-6; Huang S, 2010, GEODERMA, V154, P364, DOI 10.1016/j.geoderma.2009.11.009; Jiang GY, 2014, GLOBAL BIOGEOCHEM CY, V28, P319, DOI 10.1002/2013GB004746; John B, 2005, GEODERMA, V128, P63, DOI 10.1016/j.geoderma.2004.12.013; Johnson JMF, 2007, ENVIRON POLLUT, V150, P107, DOI 10.1016/j.envpol.2007.06.030; Kamaa M, 2011, BIOL FERT SOILS, V47, P315, DOI 10.1007/s00374-011-0539-3; Kleber M, 2004, EUR J SOIL SCI, V55, P381, DOI 10.1111/j.1365-2389.2004.00610.x; Liang B, 2012, PLANT SOIL, V353, P249, DOI 10.1007/s11104-011-1028-z; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Maillard E, 2014, GLOBAL CHANGE BIOL, V20, P666, DOI 10.1111/gcb.12438; Mendes IC, 1999, SOIL SCI SOC AM J, V63, P873, DOI 10.2136/sssaj1999.634873x; Meng QF, 2014, J SOIL SEDIMENT, V14, P1041, DOI 10.1007/s11368-014-0859-7; Mikha MM, 2004, SOIL SCI SOC AM J, V68, P809, DOI 10.2136/sssaj2004.0809; Pagliai M, 2004, SOIL TILL RES, V79, P131, DOI 10.1016/j.still.2004.07.002; Parfitt RL, 2001, AUST J SOIL RES, V39, P361, DOI 10.1071/SR00028; Pascual JA, 1997, BIOL FERT SOILS, V24, P429, DOI 10.1007/s003740050268; Puget P, 2000, EUR J SOIL SCI, V51, P595, DOI 10.1046/j.1365-2389.2000.00353.x; PUGET P, 1995, EUR J SOIL SCI, V46, P449, DOI 10.1111/j.1365-2389.1995.tb01341.x; SEECH AG, 1988, SOIL SCI SOC AM J, V52, P1616, DOI 10.2136/sssaj1988.03615995005200060019x; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Sposito G, 1999, P NATL ACAD SCI USA, V96, P3358, DOI 10.1073/pnas.96.7.3358; Steinweg JM, 2008, BIOL FERT SOILS, V45, P1, DOI 10.1007/s00374-008-0305-3; Suzuki C, 2009, SOIL SCI PLANT NUTR, V55, P80, DOI 10.1111/j.1747-0765.2008.00344.x; Triberti L, 2008, EUR J AGRON, V29, P13, DOI 10.1016/j.eja.2008.01.009; Wattel-Koekkoek EJW, 2003, EUR J SOIL SCI, V54, P269, DOI 10.1046/j.1365-2389.2003.00512.x; Whalen JK, 2002, SOIL SCI SOC AM J, V66, P1637, DOI 10.2136/sssaj2002.1637; Wu J., 2006, SOIL MICROBIAL BIOMA, V12, P54; Yu HY, 2012, BIOL FERT SOILS, V48, P325, DOI 10.1007/s00374-011-0629-2; Zhu P, 2007, J PLANT NUTR SOIL SC, V170, P219, DOI 10.1002/jpln.200620635	47	36	38	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152521	10.1371/journal.pone.0152521	http://dx.doi.org/10.1371/journal.pone.0152521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031697	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800088
J	Hosseini, SM; Moulavi, F; Tanhaie-Vash, N; Asgari, V; Ghanaei, HR; Abedi-Dorche, M; Jafarzadeh, N; Gourabi, H; Shahverdi, AH; Dizaj, AV; Shirazi, A; Nasr-Esfahani, MH				Hosseini, Sayyed-Morteza; Moulavi, Fariba; Tanhaie-Vash, Nima; Asgari, Vajihe; Ghanaei, Hamid-Reza; Abedi-Dorche, Maryam; Jafarzadeh, Naser; Gourabi, Hossein; Shahverdi, Abdol-Hossein; Dizaj, Ahmad Vosough; Shirazi, Abolfazl; Nasr-Esfahani, Mohammad-Hossein			The Principal Forces of Oocyte Polarity Are Evolutionary Conserved but May Not Affect the Contribution of the First Two Blastomeres to the Blastocyst Development in Mammals	PLOS ONE			English	Article							NORMAL MOUSE DEVELOPMENT; ANIMAL-VEGETAL AXIS; 2-CELL STAGE; POSTIMPLANTATION DEVELOPMENT; NUCLEAR TRANSFER; CLEAVAGE PLANE; NORMAL NUMBER; CELL FATE; IN-VITRO; EMBRYO	Oocyte polarity and embryonic patterning are well-established features of development in lower species. Whether a similar form of pre-patterning exists in mammals is currently under hot debate in mice. This study investigated this issue for the first time in ovine as a large mammal model. Microsurgical trisection of unfertilized MII-oocytes revealed that cortical cytoplasm around spindle (S) contained significant amounts of total maternal mRNAs and proteins compared to matched cytoplast hemispheres that were located either near (NS) or far (FS) -to-spindle. RT-qPCR provided striking examples of maternal mRNA localized to subcellular substructures S (NPM2, GMNN, H19, PCAF, DNMT3A, DNMT1, and STELLA), NS (SOX2, NANOG, POU5F1, and TET1), and FS (GCN) of MII oocyte. Immunoblotting revealed that specific maternal proteins DNMT3A and NANOG were asymmetrically enriched in MII-spindle-half of the oocytes. Topological analysis of sperm entry point (SEP) revealed that sperm preferentially entered via the MII-spindle-half of the oocytes. Even though, the topological position of first cleavage plane with regard to SEP was quite stochastic. Spatial comparison of lipid content revealed symmetrical distribution of lipids between 2-cell blastomeres. Lineage tracing using Dil, a fluorescent dye, revealed that while the progeny of leading blastomere of 2-cell embryos contributed to more cells in the developed blastocysts compared to lagging counterpart, the contributions of leading and lagging blastomeres to the embryonic-abembryonic parts of the developed blastocysts were almost unbiased. And finally, separated sister blastomeres of 2-cell embryos had an overall similar probability to arrest at any stage before the blastocyst (2-cell, 4-cell, 8-cell, and morula) or to achieve the blastocyst stage. It was concluded that the localization of maternal mRNAs and proteins at the spindle are evolutionarily conserved between mammals unfertilized ovine oocyte could be considered polar with respect to the spatial regionalization of maternal transcripts and proteins. Even though, the principal forces of this definitive oocyte polarity may not persist during embryonic cleavages.	[Hosseini, Sayyed-Morteza; Moulavi, Fariba; Tanhaie-Vash, Nima; Asgari, Vajihe; Ghanaei, Hamid-Reza; Abedi-Dorche, Maryam; Nasr-Esfahani, Mohammad-Hossein] ACECR, Royan Inst Biotechnol, Dept Reprod Biotechnol, Reprod Biomed Res Ctr, Esfahan, Iran; [Jafarzadeh, Naser] Tarbiat Modares Univ, Dept Med Phys, Tehran, Iran; [Gourabi, Hossein] ACECR, Royan Inst Reprod Biomed, Dept Genet, Reprod Biomed Res Ctr, POB 19395-4644, Tehran, Iran; [Shahverdi, Abdol-Hossein] ACECR, Royan Inst Reprod Med, Dept Embryol, Reprod Biomed Res Ctr, Tehran, Iran; [Dizaj, Ahmad Vosough] ACECR, Royan Inst Reprod Biomed, Dept Reprod Imaging, Reprod Biomed Res Ctr, Tehran, Iran; [Shirazi, Abolfazl] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran; [Shirazi, Abolfazl] Shahrekord Univ, Res Inst Anim Embryo Technol, Shahrekord, Iran	Academic Center for Education, Culture & Research (ACECR); Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Shahrekord University	Nasr-Esfahani, MH (corresponding author), ACECR, Royan Inst Biotechnol, Dept Reprod Biotechnol, Reprod Biomed Res Ctr, Esfahan, Iran.; Shirazi, A (corresponding author), ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran.; Shirazi, A (corresponding author), Shahrekord Univ, Res Inst Anim Embryo Technol, Shahrekord, Iran.	shiraziabbas@yahoo.com; mh.nasr-esfahani@royaninstitute.org	Nasr-Esfahani, Mohammad Hossein/AAN-2577-2020; asgari, vajihe/AAC-8528-2022; Husseini, Sayyed/AAK-8341-2021; , Nasr-Esfahani/AAR-2434-2021	Nasr-Esfahani, Mohammad Hossein/0000-0003-1983-3435; asgari, vajihe/0000-0002-0264-4198; Shahverdi, Abdolhossein/0000-0002-9615-4586; Tanhaeivash, Nima/0000-0002-2044-443X	Royan Institute [IRAN253658]	Royan Institute	This work was supported by IRAN253658, Royan Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon VB, 2005, MOL REPROD DEV, V72, P354, DOI 10.1002/mrd.20353; Alarcon VB, 2003, BIOL REPROD, V69, P1208, DOI 10.1095/biolreprod.103.018283; Alarcon VB, 2008, MOL REPROD DEV, V75, P1143, DOI 10.1002/mrd.20856; Antczak M, 1997, MOL HUM REPROD, V3, P1067, DOI 10.1093/molehr/3.12.1067; Au PCK, 2010, MOL REPROD DEV, V77, P373, DOI 10.1002/mrd.21158; Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Chroscicka A, 2004, MOL REPROD DEV, V68, P308, DOI 10.1002/mrd.20081; Ciemerych MA, 2000, DEVELOPMENT, V127, P3467; DUCIBELLA T, 1975, DEV BIOL, V47, P45, DOI 10.1016/0012-1606(75)90262-6; Duncan FE, 2005, DEV BIOL, V280, P38, DOI 10.1016/j.ydbio.2004.12.034; Edwards RG, 1997, MOL HUM REPROD, V3, P863, DOI 10.1093/molehr/3.10.863; Fulka J, 1998, HUM REPROD, V13, P3303, DOI 10.1093/humrep/13.12.3303; Gajda B, 2009, REPROD BIOL, V9, P97; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2001, DEVELOPMENT, V128, P839; Gardner RL, 1999, BIOESSAYS, V21, P271, DOI 10.1002/(SICI)1521-1878(199904)21:4<271::AID-BIES2>3.0.CO;2-C; Genicot G, 2005, THERIOGENOLOGY, V63, P1181, DOI 10.1016/j.theriogenology.2004.06.006; Hardarson T, 2000, HUM REPROD, V15, P1372, DOI 10.1093/humrep/15.6.1372; Held E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102921; Herr JC, 2008, DEV BIOL, V314, P300, DOI 10.1016/j.ydbio.2007.11.027; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Hiiragi T, 2006, INT J DEV BIOL, V50, P581, DOI 10.1387/ijdb.062181th; Hosseini SM, 2015, THERIOGENOLOGY, V83, P366, DOI 10.1016/j.theriogenology.2014.09.031; Hosseini SM, 2013, IN VITRO CELL DEV-AN, V49, P569, DOI 10.1007/s11626-013-9630-4; Hosseini SM, 2008, INT J FERTIL STERIL, V2, P66; JACKLE H, 1980, DEV BIOL, V75, P492, DOI 10.1016/0012-1606(80)90182-7; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; JOHNSON MH, 1975, NATURE, V257, P321, DOI 10.1038/257321a0; Katayama M, 2010, BIOL REPROD, V82, P1237, DOI 10.1095/biolreprod.109.082982; Khatib H, 2012, LIVESTOCK EPIGENETICS, P1, DOI 10.1002/9781119949930; Kikuchi K, 2002, ZYGOTE, V10, P355, DOI 10.1017/S0967199402004100; Kim K, 2012, ANIM REPROD SCI, V130, P91, DOI 10.1016/j.anireprosci.2011.12.011; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lee E, 2014, HUM REPROD; Liu ZC, 2012, DEV BIOL, V368, P304, DOI 10.1016/j.ydbio.2012.05.027; Louvet-Vallee S, 2005, CURR BIOL, V15, P464, DOI 10.1016/j.cub.2004.12.078; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Macaulay AD, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119867; Marlow F.L., 2010, MATERNAL CONTROL DEV; McMillen IC, 2001, ANZCCART NEWS, V14; Mitalipov SM, 2002, BIOL REPROD, V66, P1449, DOI 10.1095/biolreprod66.5.1449; MOEN TL, 1977, DEV BIOL, V58, P1, DOI 10.1016/0012-1606(77)90070-7; Morris SA, 2012, CELL REP, V2, P756, DOI 10.1016/j.celrep.2012.08.029; Motosugi N, 2006, PLOS BIOL, V4, P799, DOI 10.1371/journal.pbio.0040135; Moulavi F, 2013, REPRODUCTION, V145, P345, DOI 10.1530/REP-12-0318; Nicholas JS, 1942, J EXP ZOOL, V90, P441, DOI 10.1002/jez.1400900307; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; PAPAIOANNOU VE, 1995, DEV DYNAM, V203, P393, DOI 10.1002/aja.1002030402; Park SK, 2009, J VET MED SCI, V71, P569, DOI 10.1292/jvms.71.569; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Reinzi L, 2003, HUM REPROD, V18, P1289, DOI 10.1093/humrep/deg274; Roberts RM, 2011, BIOL REPROD, V84, P487, DOI 10.1095/biolreprod.110.086884; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schurmann A, 2006, REPRODUCTION, V132, P839, DOI 10.1530/REP-06-0054; Sirard MA, 2012, REPROD DOMEST ANIM, V47, P148, DOI 10.1111/j.1439-0531.2012.02069.x; Taei A, 2013, HUM REPROD, V28, P2661, DOI 10.1093/humrep/det309; Tagawa M, 2008, THERIOGENOLOGY, V69, P574, DOI 10.1016/j.theriogenology.2007.11.003; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; TSUNODA Y, 1983, J REPROD FERTIL, V69, P315, DOI 10.1530/jrf.0.0690315; Van der Westerlaken LAJ, 1999, HUM REPROD, V14, P2565, DOI 10.1093/humrep/14.10.2565; VanSoom A, 1997, MOL REPROD DEV, V47, P47, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;47::AID-MRD7&gt;3.0.CO;2-Q; VerMilyea MD, 2011, EMBO J, V30, P1841, DOI 10.1038/emboj.2011.92; Vinot S, 2004, CURR BIOL, V14, P520, DOI 10.1016/j.cub.2004.02.061; Waksmundzka M, 2006, BIOL REPROD, V75, P582, DOI 10.1095/biolreprod.106.053165; Weber RJ, 1999, DEVELOPMENT, V126, P5591; Wennekamp S, 2013, NAT REV MOL CELL BIO, V14, P452, DOI 10.1038/nrm3602; WILLADSEN SM, 1980, J REPROD FERTIL, V59, P357, DOI 10.1530/jrf.0.0590357; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	71	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0148382	10.1371/journal.pone.0148382	http://dx.doi.org/10.1371/journal.pone.0148382			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030988	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800002
J	Huang, W; Li, Q; Amiry-Moghaddam, M; Hokama, M; Sardi, SH; Nagao, M; Warman, ML; Olsen, BR				Huang, Wei; Li, Qing; Amiry-Moghaddam, Mahmood; Hokama, Madoka; Sardi, Sylvia H.; Nagao, Masashi; Warman, Matthew L.; Olsen, Bjorn R.			Critical Endothelial Regulation by LRP5 during Retinal Vascular Development	PLOS ONE			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; CRE-RECOMBINASE; TRANSGENIC MICE; LINEAGE ANALYSIS; NORRIE DISEASE; BONE MASS; IN-VIVO; ANGIOGENESIS; CELLS	Vascular abnormalities in the eye are the leading cause of many forms of inherited and acquired human blindness. Loss-of-function mutations in the Wnt-binding co-receptor LRP5 leads to aberrant ocular vascularization and loss of vision in genetic disorders such as osteoporosis-pseudoglioma syndrome. The canonical Wnt-beta-catenin pathway is known to regulate retinal vascular development. However, it is unclear what precise role LPR5 plays in this process. Here, we show that loss of LRP5 function in mice causes retinal hypovascularization during development as well as retinal neovascularization in adulthood with disorganized and leaky vessels. Using a highly specific Flk1-CreBreier line for vascular endothelial cells, together with several genetic models, we demonstrate that loss of endothelium-derived LRP5 recapitulates the retinal vascular defects in Lrp5(-/-) mice. In addition, restoring LRP5 function only in endothelial cells in Lrp5(-/-) mice rescues their retinal vascular abnormalities. Furthermore, we show that retinal vascularization is regulated by LRP5 in a dosage dependent manner and does not depend on LRP6. Our study provides the first direct evidence that endothelium-derived LRP5 is both necessary and sufficient to mediate its critical role in the development and maintenance of retinal vasculature.	[Huang, Wei; Sardi, Sylvia H.; Nagao, Masashi; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA; [Huang, Wei; Sardi, Sylvia H.; Nagao, Masashi; Olsen, Bjorn R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Li, Qing] GE Global Res Ctr, Translat Sci Lab, Diagnost Imaging & Biomed Technol, Niskayuna, NY USA; [Amiry-Moghaddam, Mahmood] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Hokama, Madoka] Okayama Univ, Sch Med, Okayama 700, Japan; [Warman, Matthew L.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Warman, Matthew L.] Boston Childrens Hosp, Orthopaed Res Labs, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Orthopaed Surg, Boston, MA USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; General Electric; University of Oslo; Okayama University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Olsen, BR (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA.; Olsen, BR (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA.	bjorn_olsen@hms.harvard.edu		Amiry-Moghaddam, Mahmood/0000-0003-1071-1247	National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR36819, AR36820]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR036819, R37AR036820, R01AR036820, R01AR036819, R37AR036819] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases [http://nih.gov/,http://www.niams.nih.gov/] grant numbers AR36819 and AR36820 to BO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; FRONTALI M, 1985, AM J MED GENET, V22, P35, DOI 10.1002/ajmg.1320220104; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; Grammas P, 2003, MICROVASC RES, V65, P18, DOI 10.1016/S0026-2862(02)00016-X; Hackett SF, 2002, J CELL PHYSIOL, V192, P182, DOI 10.1002/jcp.10128; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Licht AH, 2004, DEV DYNAM, V229, P312, DOI 10.1002/dvdy.10416; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Nikopoulos K, 2010, HUM MUTAT, V31, P656, DOI 10.1002/humu.21250; Ohlmann AV, 2004, INVEST OPHTH VIS SCI, V45, P2384, DOI 10.1167/iovs.03-1214; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI DOI 10.1016/J.0PHTHA.2013.05.025; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654; Tokunaga CC, 2013, INVEST OPHTH VIS SCI, V54, P222, DOI 10.1167/iovs.12-10127; TOOMES C, 2004, MUTATIONS LRP5 FZD4, V74, P721; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Warburg M., 1966, ACTA OPHTHALMOL SCAN, V89, P1; Xia C, 2010, LRP5 IS REQUIRED VAS, V5, DOI [10.1371/journal.pone.0011676, DOI 10.1371/JOURNAL.PONE.0011676]; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zhong ZD, 2012, J CELL BIOCHEM, V113, P31, DOI 10.1002/jcb.23324; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	42	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152833	10.1371/journal.pone.0152833	http://dx.doi.org/10.1371/journal.pone.0152833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031698	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800148
J	Plewan, T; Wascher, E; Falkenstein, M; Hoffmann, S				Plewan, Thorsten; Wascher, Edmund; Falkenstein, Michael; Hoffmann, Sven			Classifying Response Correctness across Different Task Sets: A Machine Learning Approach	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; BRAIN ACTIVITY; FUNCTIONAL-SIGNIFICANCE; PREFRONTAL CORTEX; COGNITIVE CONTROL; ERROR NEGATIVITY; ERP COMPONENTS; PERFORMANCE; POTENTIALS; ATTENTION	Erroneous behavior usually elicits a distinct pattern in neural waveforms. In particular, inspection of the concurrent recorded electroencephalograms (EEG) typically reveals a negative potential at fronto-central electrodes shortly following a response error (Ne or ERN) as well as an error-awareness-related positivity (Pe). Seemingly, the brain signal contains information about the occurrence of an error. Assuming a general error evaluation system, the question arises whether this information can be utilized in order to classify behavioral performance within or even across different cognitive tasks. In the present study, a machine learning approach was employed to investigate the outlined issue. Ne as well as Pe were extracted from the single-trial EEG signals of participants conducting a flanker and a mental rotation task and subjected to a machine learning classification scheme (via a support vector machine, SVM). Overall, individual performance in the flanker task was classified more accurately, with accuracy rates of above 85%. Most importantly, it was even feasible to classify responses across both tasks. In particular, an SVM trained on the flanker task could identify erroneous behavior with almost 70% accuracy in the EEG data recorded during the rotation task, and vice versa. Summed up, we replicate that the response-related EEG signal can be used to identify erroneous behavior within a particular task. Going beyond this, it was possible to classify response types across functionally different tasks. Therefore, the outlined methodological approach appears promising with respect to future applications.	[Plewan, Thorsten; Wascher, Edmund; Falkenstein, Michael] Leibniz Res Ctr Working Environm & Human Factors, Dept Ergon, Dortmund, Germany; [Hoffmann, Sven] German Sport Univ Cologne, Inst Psychol, Dept Performance Psychol, Cologne, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); German Sport University Cologne	Plewan, T (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dept Ergon, Dortmund, Germany.; Hoffmann, S (corresponding author), German Sport Univ Cologne, Inst Psychol, Dept Performance Psychol, Cologne, Germany.	plewan@ifado.de; s.hoffmann@dshs-koeln.de	Wascher, Edmund/B-8457-2019; Plewan, Thorsten/Y-2564-2019; Wascher, Edmund/N-6848-2019; Falkenstein, Michael/ABA-7497-2020	Wascher, Edmund/0000-0003-3616-9767; Plewan, Thorsten/0000-0001-5510-1181; Hoffmann, Sven/0000-0002-4521-8332				Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; Benjamini Y, 2001, ANN STAT, V29, P1165; Bode S, 2013, NEUROIMAGE, V65, P456, DOI 10.1016/j.neuroimage.2012.09.064; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Christ S, 2000, BIOL PSYCHOL, V51, P129, DOI 10.1016/S0301-0511(99)00034-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Eichele H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00065; Endrass T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00178; Endrass T, 2012, PSYCHOPHYSIOLOGY, V49, P733, DOI 10.1111/j.1469-8986.2012.01365.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 1995, EEG CL N SU, P261; Golland P, 2005, LECT NOTES COMPUT SC, V3559, P501, DOI 10.1007/11503415_34; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hoffmann S, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00050; Hoffmann S, 2014, BRAIN STRUCT FUNCT, V219, P595, DOI 10.1007/s00429-013-0521-y; Hoffmann S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00171; Hoffmann S, 2012, INT J PSYCHOPHYSIOL, V83, P208, DOI 10.1016/j.ijpsycho.2011.11.015; Hoffmann S, 2012, NEUROSCI LETT, V506, P225, DOI 10.1016/j.neulet.2011.11.011; Hoffmann S, 2010, HUM BRAIN MAPP, V31, P1305, DOI 10.1002/hbm.20937; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hsu W C, 2003, PRACTICAL GUIDE SUPP; Hughes G, 2011, NEUROPSYCHOLOGIA, V49, P405, DOI 10.1016/j.neuropsychologia.2010.11.036; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Maier ME, 2011, NEUROIMAGE, V56, P2339, DOI 10.1016/j.neuroimage.2011.03.083; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1996, ADV NEUR IN, V8, P145; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Masaki H, 2001, NEUROREPORT, V12, P1851, DOI 10.1097/00001756-200107030-00018; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; O'Connell RG, 2009, J NEUROSCI, V29, P8604, DOI 10.1523/JNEUROSCI.5967-08.2009; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Palmer JA, 2007, LECT NOTES COMPUT SC, V4666, P97; Parra L, 2002, NEUROIMAGE, V17, P223, DOI 10.1006/nimg.2002.1212; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Riesel A, 2013, BIOL PSYCHOL, V93, P377, DOI 10.1016/j.biopsycho.2013.04.007; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; Steinhauser M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00097; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; Ullsperger M, 2004, NAT NEUROSCI, V7, P1173, DOI 10.1038/nn1104-1173; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; Ventouras EM, 2011, COMPUT BIOL MED, V41, P98, DOI 10.1016/j.compbiomed.2010.12.004; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Wascher E, 1999, J COGNITIVE NEUROSCI, V11, P214, DOI 10.1162/089892999563346; Willemssen R, 2004, PSYCHOPHYSIOLOGY, V41, P762, DOI 10.1111/j.1469-8986.2004.00201.x	61	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152864	10.1371/journal.pone.0152864	http://dx.doi.org/10.1371/journal.pone.0152864			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27032108	Green Submitted, gold, Green Published			2022-12-26	WOS:000373121800151
J	Roth, A; Glaesener, S; Schutz, K; Meyer-Bahlburg, A				Roth, Alena; Glaesener, Stephanie; Schuetz, Katharina; Meyer-Bahlburg, Almut			Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax (R) 23	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; MARGINAL-ZONE; PERIPHERAL-BLOOD; ANTIBODY-RESPONSE; PNEUMOCOCCAL POLYSACCHARIDES; CAPSULAR POLYSACCHARIDES; IMMUNOGLOBULIN-A; REGION GENES; IGM; DISEASE	Protective immunity against T cell independent (TI) antigens such as Streptococcus pneumoniae is characterized by antibody production of B cells induced by the combined activation of T cell independent type 1 and type 2 antigens in the absence of direct T cell help. In mice, the main players in TI immune responses have been well defined as marginal zone (MZ) B cells and B-1 cells. However, the existence of human equivalents to these B cell subsets and the nature of the human B cell compartment involved in the immune reaction remain elusive. We therefore analyzed the effect of a TI antigen on the B cell compartment through immunization of healthy individuals with the pneumococcal polysaccharide (PnPS)-based vaccine Pneumovax (R) 23, and subsequent characterization of B cell subpopulations. Our data demonstrates a transient decrease of transitional and naive B cells, with a concomitant increase of IgA(+) but not IgM(+) or IgG(+) memory B cells and a predominant generation of PnPS-specific IgA(+) producing plasma cells. No alterations could be detected in T cells, or proposed human B-1 and MZ B cell equivalents. Consistent with the idea of a TI immune response, anti-genspecific memory responses could not be observed. Finally, BAFF, which is supposed to drive class switching to IgA, was unexpectedly found to be decreased in serum in response to Pneumovax (R) 23. Our results demonstrate that a characteristic TI response induced by Pneumovax (R) 23 is associated with distinct phenotypical and functional changes within the B cell compartment. Those modulations occur in the absence of any modulations of T cells and without the development of a specific memory response.	[Roth, Alena; Glaesener, Stephanie; Schuetz, Katharina; Meyer-Bahlburg, Almut] Hannover Med Sch, Pediat Pneumol Allergy & Neonatol, Hannover, Germany	Hannover Medical School	Meyer-Bahlburg, A (corresponding author), Hannover Med Sch, Pediat Pneumol Allergy & Neonatol, Hannover, Germany.	Meyer-Bahlburg.Almut@mh-hannover.de			German Research Foundation (DFG) [ME2709/2-3]; German Center for lung research (DZL); German Center for Infection Research (DZIF, project AA2.1)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for lung research (DZL); German Center for Infection Research (DZIF, project AA2.1)	This work was supported by the German Research Foundation (DFG ME2709/2-3) and the German Center for lung research (DZL, project AA2.1) to AMB and a student stipend to AR by the German Center for Infection Research (DZIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnara D, 2015, J IMMUNOL, V195, P3716, DOI 10.4049/jimmunol.1500753; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Calzas C, 2015, INFECT IMMUN, V83, P441, DOI 10.1128/IAI.02427-14; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cavaliere FM, 2013, J CLIN IMMUNOL, V33, P838, DOI 10.1007/s10875-012-9856-z; Chovancova Z, 2011, VACCINE, V29, P4142, DOI 10.1016/j.vaccine.2011.03.087; Covens K, 2013, BLOOD, V122, P3693, DOI 10.1182/blood-2013-09-528091; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; De Vos J, 2006, IMMUNOL REV, V210, P86, DOI 10.1111/j.0105-2896.2006.00362.x; Descatoire M, 2011, J EXP MED, V208, P2563, DOI 10.1084/jem.20112232; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Glaesener S, 2014, ARTHRITIS RHEUMATOL, V66, P2590, DOI 10.1002/art.38736; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hong R, 2010, J CLIN IMMUNOL, V30, P435, DOI 10.1007/s10875-010-9371-z; Iwajomo OH, 2015, J INFECTION, V70, P616, DOI 10.1016/j.jinf.2014.10.011; Johnson S, 1996, INFECT IMMUN, V64, P4339, DOI 10.1128/IAI.64.10.4339-4344.1996; Jolles S, 2013, J ALLER CL IMM-PRACT, V1, P545, DOI 10.1016/j.jaip.2013.09.015; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Khaskhely N, 2012, J IMMUNOL, V188, P2455, DOI 10.4049/jimmunol.1102809; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Leggat DJ, 2013, J INFECT DIS, V208, P101, DOI 10.1093/infdis/jit139; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; LUE C, 1988, J IMMUNOL, V140, P3793; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Melegaro A, 2006, J INFECTION, V52, P37, DOI 10.1016/j.jinf.2005.02.008; Moens L, 2008, J IMMUNOL, V181, P5306, DOI 10.4049/jimmunol.181.8.5306; Moens L, 2015, INFECT IMMUN, V83, P2889, DOI 10.1128/IAI.00068-15; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Neumann B, 2015, J LEUKOCYTE BIOL, V97, P19, DOI 10.1189/jlb.1HI0514-243R; Perez-Andres M, 2011, J EXP MED, V208, P2565, DOI 10.1084/jem.20112203; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Quach TD, 2016, J IMMUNOL, V196, P1060, DOI 10.4049/jimmunol.1501843; Quinti I, 2011, J CLIN IMMUNOL, V31, P315, DOI 10.1007/s10875-011-9511-0; Rothstein TL, 2015, ANN NY ACAD SCI, V1362, P143, DOI 10.1111/nyas.12790; Roy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082121; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schutz K, 2013, J CLIN IMMUNOL, V33, P288, DOI 10.1007/s10875-012-9792-y; Sen G, 2005, J IMMUNOL, V175, P3084, DOI 10.4049/jimmunol.175.5.3084; Sugalski JM, 2010, J IMMUNOL, V185, P3019, DOI 10.4049/jimmunol.1000879; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; TARKOWSKI A, 1990, J IMMUNOL, V144, P3770; Tierens A, 1999, BLOOD, V93, P226, DOI 10.1182/blood.V93.1.226.401a30_226_234; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Verbinnen B, 2012, J ALLERGY CLIN IMMUN, V130, P272, DOI 10.1016/j.jaci.2012.04.040; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166	61	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152215	10.1371/journal.pone.0152215	http://dx.doi.org/10.1371/journal.pone.0152215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031098	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800043
J	Strandberg, AY; Hoti, FJ; Strandberg, TE; Christopher, S; Haukka, J; Korhonen, P				Strandberg, Arto Y.; Hoti, Fabian J.; Strandberg, Timo E.; Christopher, Solomon; Haukka, Jari; Korhonen, Pasi			All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine	PLOS ONE			English	Article							ACTING INSULIN; CARDIOVASCULAR EVENTS; PROPENSITY SCORE; GLYCEMIC CONTROL; CANCER-RISK; HYPOGLYCEMIA; INTERMEDIATE; ASSOCIATION; OUTCOMES; ANALOGS	Background Insulin therapy in type 2 diabetes may increase mortality and cancer incidence, but the impact of different types of basal insulins on these endpoints is unclear. Compared to the traditional NPH insulin, the newer, longer-acting insulin analogues detemir and glargine have shown benefits in randomized controlled trials. Whether these advantages translate into lower mortality among users in real life is unknown. Objective To estimate the differences in all-cause and cause-specific mortality rates between new users of basal insulins in a population-based study in Finland. Methods 23 751 individuals aged >= 40 with type 2 diabetes, who initiated basal insulin therapy in 2006-2009 were identified from national registers, with comprehensive data for mortality, causes of death, and background variables. Propensity score matching was performed on characteristics. Follow-up time was up to 4 years (median 1.7 years). Results 2078 deaths incurred. With NPH as reference, the adjusted HRs for all-cause mortality were 0.39 (95% CI, 0.30-0.50) for detemir, and 0.55 (95% CI, 0.44-0.69) for glargine. As compared to glargine, the HR was 0.71 (95% CI, 0.54-0.93) among detemir users. Compared to NPH, the mortality risk for both cardiovascular causes as well as cancer were also significantly lower for glargine, and especially for detemir in adjusted analysis. Furthermore, the results were robust in various sensitivity analyses. Conclusion In real clinical practice, mortality was substantially higher among users of NPH insulin as compared to insulins detemir or glargine. Considering the large number of patients who require insulin therapy, this difference in risk may have major clinical and public health implications. Due to limitations of the observational study design, further investigation using an interventional study design is warranted.	[Strandberg, Arto Y.; Strandberg, Timo E.] Univ Helsinki, Clinicum, Helsinki, Finland; [Strandberg, Arto Y.] Aava Med Ctr, Kerava, Finland; [Hoti, Fabian J.; Christopher, Solomon; Haukka, Jari; Korhonen, Pasi] EPID Res, Espoo, Finland; [Strandberg, Timo E.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Strandberg, Timo E.] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu	Strandberg, AY (corresponding author), Univ Helsinki, Clinicum, Helsinki, Finland.; Strandberg, AY (corresponding author), Aava Med Ctr, Kerava, Finland.	arto.strandberg@aava.fi	Haukka, Jari/G-1484-2014	Haukka, Jari/0000-0003-1450-6208; Hoti, Fabian/0000-0002-7464-3549; strandberg, timo/0000-0001-6299-925X	Novo Nordisk Pharma; Gustaf V; Queen Victoria Frimurarestiftelse; EPID Research	Novo Nordisk Pharma(Novo Nordisk); Gustaf V; Queen Victoria Frimurarestiftelse; EPID Research	Retrieval of national register data by EPID Research was financially supported by Novo Nordisk Pharma. AYS's research is supported by the Gustaf V and Queen Victoria Frimurarestiftelse. FH, SC, JH and PK are employed by EPID Research and received funding in the form of salaries. The specific roles of these authors are articulated in the 'Author Contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; Colmers IN, 2012, DIABETES METAB, V38, P485, DOI 10.1016/j.diabet.2012.08.011; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; Dejgaard A, 2009, DIABETOLOGIA, V52, P2507, DOI 10.1007/s00125-009-1568-4; Fagot JP, 2013, DIABETES CARE, V36, P294, DOI 10.2337/dc12-0506; Gamble JM, 2010, DIABETES OBES METAB, V12, P47, DOI 10.1111/j.1463-1326.2009.01125.x; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Gissler M., 2004, NOR EPIDEMIOL, V14, P113; Goldman-Levine JD, 2005, ANN PHARMACOTHER, V39, P502, DOI 10.1345/aph.1E334; Gordon J, 2010, INT J CLIN PRACT, V64, P1609, DOI 10.1111/j.1742-1241.2010.02520.x; Haukka J, 2013, PHARMACOEPIDEM DR S, V22, P1326, DOI 10.1002/pds.3534; Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Karlstad O, 2013, CURR DRUG SAF, V8, P333, DOI 10.2174/15680266113136660067; Khunti K, 2015, DIABETES CARE, V38, P316, DOI 10.2337/dc14-0920; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Luo J, 2015, JAMA INTERN MED, V175, P1681, DOI 10.1001/jamainternmed.2015.4338; Meneghini LF, 2007, DIABETES OBES METAB, V9, P418, DOI 10.1111/j.1463-1326.2006.00674.x; Mikkola TS, 2015, MENOPAUSE, V22, P976, DOI 10.1097/GME.0000000000000450; Monami M, 2008, DIABETES RES CLIN PR, V81, P184, DOI 10.1016/j.diabres.2008.04.007; National institute for Health and Clinical Excellence (NICE), TYP 2 DIAB NEW AG; Price HI, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006341; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rossetti Paolo, 2008, Archives of Physiology and Biochemistry, V114, P3, DOI [10.1080/13813450801900777, 10.1080/13813450801900777 ]; Roumie CL, 2014, JAMA-J AM MED ASSOC, V311, P2288, DOI 10.1001/jama.2014.4312; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Tricco AC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5459; Tylee T, 2015, JAMA-J AM MED ASSOC, V314, P665, DOI 10.1001/jama.2015.7032; Yang XL, 2012, WORLD J DIABETES, V3, P60, DOI 10.4239/wjd.v3.i4.60; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	35	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151910	10.1371/journal.pone.0151910	http://dx.doi.org/10.1371/journal.pone.0151910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031113	gold, Green Published			2022-12-26	WOS:000373121800023
J	Ahire, JJ; Hattingh, M; Neveling, DP; Dicks, LMT				Ahire, Jayesh J.; Hattingh, Melanie; Neveling, Deon P.; Dicks, Leon M. T.			Copper-Containing Anti-Biofilm Nanofiber Scaffolds as a Wound Dressing Material	PLOS ONE			English	Article							IN-VITRO; 2,3-DIHYDROXYBENZOIC ACID; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; PEO NANOFIBERS; OXIDE) PEO; SURFACES; NANOPARTICLES; MECHANISMS	Copper particles were incorporated into nanofibers during the electrospinning of poly-D, Llactide (PDLLA) and poly(ethylene oxide) (PEO). The ability of the nanofibers to prevent Pseudomonas aeruginosa PA01 and Staphylococcus aureus (strain Xen 30) to form biofilms was tested. Nanofibers containing copper particles (Cu-F) were thinner (326 +/- 149 nm in diameter), compared to nanofibers without copper (CF; 445 +/- 93 nm in diameter). The crystalline structure of the copper particles in Cu-F was confirmed by X-ray diffraction (XRD). Copper crystals were encapsulated, but also attached to the surface of Cu-F, as shown scanning transmission electron microscopy (STEM) and transmission electron microscopy (TEM), respectively. The copper particles had no effect on the thermal degradation and thermal behaviour of Cu-F, as shown by thermogravimetric analysis (TGA) and differential scanning calorimeter (DSC). After 48 h in the presence of Cu-F, biofilm formation by P. aeruginosa PA01 and S. aureus Xen 30 was reduced by 41% and 50%, respectively. Reduction in biofilm formation was ascribed to copper released from the nanofibers. Copper-containing nanofibers may be incorporated into wound dressings.	[Ahire, Jayesh J.; Hattingh, Melanie; Neveling, Deon P.; Dicks, Leon M. T.] Univ Stellenbosch, Dept Microbiol, ZA-7602 Stellenbosch, South Africa	Stellenbosch University	Dicks, LMT (corresponding author), Univ Stellenbosch, Dept Microbiol, ZA-7602 Stellenbosch, South Africa.	LMTD@sun.ac.za	Neveling, Deon/AAH-3763-2020; Ahire, Jayesh J/Q-1632-2018; Dicks, Leon/X-6642-2019	Neveling, Deon/0000-0003-4090-9684; Ahire, Jayesh J/0000-0002-1142-8630; 	TraceXtec (Pty) Ltd, South Africa; Stellenbosch University, South Africa	TraceXtec (Pty) Ltd, South Africa; Stellenbosch University, South Africa	This work was supported by the TraceXtec (Pty) Ltd, South Africa, for financial support and Divann Robertson for assistance with DSC and TGA analyses. Jayesh J Ahire is grateful to Stellenbosch University, South Africa, for a postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahire JJ, 2015, CURR MICROBIOL, V71, P24, DOI 10.1007/s00284-015-0813-y; Ahire JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123648; Ahire JJ, 2015, PROBIOTICS ANTIMICRO, V7, P52, DOI 10.1007/s12602-014-9171-5; Ahire JJ, 2014, CURR MICROBIOL, V69, P587, DOI 10.1007/s00284-014-0635-3; Ahire JJ, 2014, ANTIMICROB AGENTS CH, V58, P2098, DOI 10.1128/AAC.02397-13; Ahmed Z, 2004, BIOMATERIALS, V25, P803, DOI 10.1016/S0142-9612(03)00596-9; Borkow G, 2010, WOUND REPAIR REGEN, V18, P266, DOI 10.1111/j.1524-475X.2010.00573.x; Casey AL, 2010, J HOSP INFECT, V74, P72, DOI 10.1016/j.jhin.2009.08.018; Chatterjee AK, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/13/135101; Christena LR, 2015, RSC ADV, V5, P12899, DOI 10.1039/c4ra15382k; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Denyer SP, 2002, J APPL MICROBIOL, V92, p35S, DOI 10.1046/j.1365-2672.92.5s1.19.x; Ding B, 2010, MATER TODAY, V13, P16, DOI 10.1016/S1369-7021(10)70200-5; Dolina J, 2013, IND ENG CHEM RES, V52, P13971, DOI 10.1021/ie303120j; Elguindi J, 2009, J APPL MICROBIOL, V106, P1448, DOI 10.1111/j.1365-2672.2009.04148.x; Faundez G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-19; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10; Harris E D, 1980, Ciba Found Symp, V79, P163; Heunis TDJ, 2010, PROBIOTICS ANTIMICRO, V2, P46, DOI 10.1007/s12602-009-9024-9; Heunis T, 2011, INT J MOL SCI, V12, P2158, DOI 10.3390/ijms12042158; Hostynek Jurij J, 2003, Rev Environ Health, V18, P153; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; LewisOscar F, 2015, BIOFOULING, V31, P379, DOI 10.1080/08927014.2015.1048686; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mehtar S, 2008, J HOSP INFECT, V68, P45, DOI 10.1016/j.jhin.2007.10.009; Molteni C, 2010, APPL ENVIRON MICROB, V76, P4099, DOI 10.1128/AEM.00424-10; Noyce JO, 2006, J HOSP INFECT, V63, P289, DOI 10.1016/j.jhin.2005.12.008; Palza H, 2015, INT J MOL SCI, V16, P2099, DOI 10.3390/ijms16012099; Quaranta D, 2011, APPL ENVIRON MICROB, V77, P416, DOI 10.1128/AEM.01704-10; Ren GG, 2009, INT J ANTIMICROB AG, V33, P587, DOI 10.1016/j.ijantimicag.2008.12.004; Rucker RB, 1998, AM J CLIN NUTR, V67, p996S, DOI 10.1093/ajcn/67.5.996S; Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821, DOI 10.1152/ajpheart.01015.2001; Sheikh FA, 2011, APPL SURF SCI, V257, P3020, DOI 10.1016/j.apsusc.2010.10.110; Tenaud I, 1999, BRIT J DERMATOL, V140, P26; Tian WX, 2012, J MICROBIOL, V50, P586, DOI 10.1007/s12275-012-2067-8; Uauy R, 1998, AM J CLIN NUTR, V67, p952S, DOI 10.1093/ajcn/67.5.952S; USEPA, 2008, EPA REG COPP CONT AL; Usman MS, 2013, INT J NANOMED, V8, P4467, DOI 10.2147/IJN.S50837; Wheeldon LJ, 2008, J ANTIMICROB CHEMOTH, V62, P522, DOI 10.1093/jac/dkn219; Wilks SA, 2005, INT J FOOD MICROBIOL, V105, P445, DOI 10.1016/j.ijfoodmicro.2005.04.021; Wu J, 2014, CARBOHYD POLYM, V102, P762, DOI 10.1016/j.carbpol.2013.10.093; Yousuf B, 2016, APPL MICROBIOL BIOT, V100, P5569, DOI 10.1007/s00253-016-7361-7	45	41	41	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152755	10.1371/journal.pone.0152755	http://dx.doi.org/10.1371/journal.pone.0152755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028292	Green Published, gold, Green Submitted			2022-12-26	WOS:000373116500067
J	Castro-Gomes, T; Corrotte, M; Tam, C; Andrews, NW				Castro-Gomes, Thiago; Corrotte, Matthias; Tam, Christina; Andrews, Norma W.			Plasma Membrane Repair Is Regulated Extracellularly by Proteases Released from Lysosomes	PLOS ONE			English	Article							HUMAN ACID SPHINGOMYELINASE; ACTIVITY-BASED PROBES; CATHEPSIN-D; MUSCULAR-DYSTROPHY; CYSTEINE CATHEPSINS; EXOCYTOSIS; DYSFERLIN; CELLS; ENDOCYTOSIS; PROTEINS	Eukaryotic cells rapidly repair wounds on their plasma membrane. Resealing is Ca(2+-)dependent, and involves exocytosis of lysosomes followed by massive endocytosis. Extracellular activity of the lysosomal enzyme acid sphingomyelinase was previously shown to promote endocytosis and wound removal. However, whether lysosomal proteases released during cell injury participate in resealing is unknown. Here we show that lysosomal proteases regulate plasma membrane repair. Extracellular proteolysis is detected shortly after cell wounding, and inhibition of this process blocks repair. Conversely, surface protein degradation facilitates plasma membrane resealing. The abundant lysosomal cysteine proteases cathepsin B and L, known to proteolytically remodel the extracellular matrix, are rapidly released upon cell injury and are required for efficient plasma membrane repair. In contrast, inhibition of aspartyl proteases or RNAi-mediated silencing of the lysosomal aspartyl protease cathepsin D enhances resealing, an effect associated with the accumulation of active acid sphingomyelinase on the cell surface. Thus, secreted lysosomal cysteine proteases may promote repair by facilitating membrane access of lysosomal acid sphingomyelinase, which promotes wound removal and is subsequently downregulated extracellularly by a process involving cathepsin D.	[Castro-Gomes, Thiago; Corrotte, Matthias; Tam, Christina; Andrews, Norma W.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Tam, Christina] ARS, USDA, Western Reg Res Ctr, Albany, CA 94710 USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Andrews, NW (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	andrewsn@umd.edu		Andrews, Norma/0000-0002-0611-2412	National Institutes of Health [GM064625]; Conselho Nacional de Pesquisas, Brazil; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Pesquisas, Brazil; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by at the National Institutes of Health grant GM064625 and a fellowship from the Conselho Nacional de Pesquisas, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NW, 2014, TRENDS CELL BIOL, V24, P734, DOI 10.1016/j.tcb.2014.07.008; Atanassoff AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089743; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brocklehurst K, 2013, CELL TISSUE RES, V351, P237, DOI 10.1007/s00441-013-1557-2; Caglic D, 2011, BIOORGAN MED CHEM, V19, P1055, DOI 10.1016/j.bmc.2010.10.028; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Corrotte M, 2013, ELIFE, V2, DOI 10.7554/eLife.00926; Defour A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.272; DIMENT S, 1988, J BIOL CHEM, V263, P6901; Draeger A, 2014, BIOCHIMIE, V107, P66, DOI 10.1016/j.biochi.2014.08.008; Edgington LE, 2011, CURR OPIN CHEM BIOL, V15, P798, DOI 10.1016/j.cbpa.2011.10.012; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; Fernandes MC, 2011, J EXP MED, V208, P909, DOI 10.1084/jem.20102518; Fonovic M, 2014, BBA-GEN SUBJECTS, V1840, P2560, DOI 10.1016/j.bbagen.2014.03.017; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Heinrich M, 2000, ADV EXP MED BIOL, V477, P305; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Jordans S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-23; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Lariccia V, 2011, J GEN PHYSIOL, V137, P111, DOI 10.1085/jgp.201010468; Lek A, 2013, J NEUROSCI, V33, P5085, DOI 10.1523/JNEUROSCI.3560-12.2013; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; POLGAR L, 1987, J BIOL CHEM, V262, P14448; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Qiu HW, 2003, J BIOL CHEM, V278, P32744, DOI 10.1074/jbc.M303022200; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Redpath GMI, 2014, MOL BIOL CELL, V25, P3037, DOI 10.1091/mbc.E14-04-0947; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Roy D, 2004, SCIENCE, V304, P1515, DOI 10.1126/science.1098371; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schuchman EH, 2009, INT J CLIN PHARM TH, V47, pS48; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Swaggart KA, 2014, P NATL ACAD SCI USA, V111, P6004, DOI 10.1073/pnas.1324242111; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; Tam C, 2013, JOVE-J VIS EXP, DOI 10.3791/50531; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; TURK B, 1994, BIOCHEMISTRY-US, V33, P14800, DOI 10.1021/bi00253a019; TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; XIE XY, 1991, J NEUROSCI, V11, P3257; Xu M, 2012, MOL BIOL CELL, V23, P1546, DOI 10.1091/mbc.E11-09-0821; Zebrakovska I, 2011, BBA-MOL CELL BIOL L, V1811, P1097, DOI 10.1016/j.bbalip.2011.09.005; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022	70	49	50	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152583	10.1371/journal.pone.0152583	http://dx.doi.org/10.1371/journal.pone.0152583			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028538	gold, Green Published			2022-12-26	WOS:000373116500053
J	Hernandez-Romieu, AC; del Rio, C; Hernandez-Avila, JE; Lopez-Gatell, H; Izazola-Licea, JA; Zuniga, PU; Hernandez-Avila, M				Hernandez-Romieu, Alfonso C.; del Rio, Carlos; Eugenio Hernandez-Avila, Juan; Lopez-Gatell, Hugo; Antonio Izazola-Licea, Jose; Zuniga, Patricia Uribe; Hernandez-Avila, Mauricio			CD4 Counts at Entry to HIV Care in Mexico for Patients under the "Universal Antiretroviral Treatment Program for the Uninsured Population," 2007-2014	PLOS ONE			English	Article							SOCIODEMOGRAPHIC CHARACTERISTICS; SEXUAL-BEHAVIORS; UNITED-STATES; HEALTH; PREVALENCE; INITIATION; DIAGNOSIS; TRENDS; RECOMMENDATIONS; INFECTIONS	In Mexico, public health services have provided universal access to antiretroviral therapy (ART) since 2004. For individuals receiving HIV care in public healthcare facilities, the data are limited regarding CD4 T-lymphocyte counts (CD4e) at the time of entry into care. Relevant population-based estimates of CD4e are needed to inform strategies to maximize the impact of Mexico's national ART program, and may be applicable to other countries implementing universal HIV treatment programs. For this study, we retrospectively analyzed the CD4e of persons living with HIV and receiving care at state public health facilities from 2007 to 2014, comparing CD4e by demographic characteristics and the marginalization index of the state where treatment was provided, and assessing trends in CD4e over time. Our sample included 66,947 individuals who entered into HIV care between 2007 and 2014, of whom 79% were male. During the study period, the male-to-female ratio increased from 3.0 to 4.3, reflecting the country's HIV epidemic; the median age at entry decreased from 34 years to 32 years. Overall, 48.6% of individuals entered care with a CD4 <= 200 cells/mu l, ranging from 42.2% in states with a very low marginalization index to 52.8% in states with a high marginalization index, and from 38.9% among individuals aged 18-29 to 56.5% among those older than 50. The adjusted geometric mean (95% confidence interval) CD4e increased among males from 135 (131,142) cells mu in 2007 to 148 (143,155) cells/mu l in 2014 (p-value<0.0001); no change was observed among women, with a geometric mean of 178 (171,186) and 171 (165,183) in 2007 and 2014, respectively. There have been important gains in access to HIV care and treatment; however, late entry into care remains an important barrier in achieving optimal outcomes of ART in Mexico. The geographic, socioeconomic, and demographic differences observed reflect important inequities in timely access to HIV prevention, care, and treatment services, and highlight the need to develop contextual and culturally appropriate prevention and HIV testing strategies and linkage programs.	[Hernandez-Romieu, Alfonso C.; del Rio, Carlos] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Hernandez-Romieu, Alfonso C.; del Rio, Carlos] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [del Rio, Carlos] Emory Univ, Ctr AIDS Res, Atlanta, GA 30322 USA; [Eugenio Hernandez-Avila, Juan; Lopez-Gatell, Hugo; Hernandez-Avila, Mauricio] Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico; [Antonio Izazola-Licea, Jose] Natl Ctr Prevent & Control HIV AIDS CENSIDA, Mexico City, DF, Mexico; [Antonio Izazola-Licea, Jose; Zuniga, Patricia Uribe] Evaluat & Econ Div, Joint United Nations Programme HIV AIDS UNAIDS, Geneva, Switzerland	Emory University; Rollins School Public Health; Emory University; Emory University; Instituto Nacional de Salud Publica; UNAIDS	Hernandez-Avila, M (corresponding author), Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico.	mhernan@insp.mx	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517; Hernandez-Avila, Juan Eugenio/0000-0001-9638-6718	National Institutes of Health/Fogarty International Center Emory AIDS International Training and Research Program [D43 TW01042]; National Institutes of Health/National Institute for Allergic and Infectious Diseases IAID Emory Center for AIDS Research [P30 AI050409]; Consejo Nacional de Ciencia y Tecnologia de Mexico Scholarship; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	National Institutes of Health/Fogarty International Center Emory AIDS International Training and Research Program; National Institutes of Health/National Institute for Allergic and Infectious Diseases IAID Emory Center for AIDS Research; Consejo Nacional de Ciencia y Tecnologia de Mexico Scholarship; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: National Institutes of Health/Fogarty International Center Emory AIDS International Training and Research Program (D43 TW01042) (CDR), http://www.fic.nih.gov/Pages/Default.aspx; National Institutes of Health/National Institute for Allergic and Infectious Diseases IAID Emory Center for AIDS Research (P30 AI050409) (CDR), http://www.niaid.nih.gov/Pages/default.aspx; Consejo Nacional de Ciencia y Tecnologia de Mexico (http://www.conacyt.gob.mx/) Scholarship (ACHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Antinori A, 2010, ANTIVIR THER, V15, P31, DOI 10.3851/IMP1525; Aracena-Genao B, 2011, SALUD PUBLICA MEXICO, V53, pS407, DOI 10.1590/S0036-36342011001000004; Colchero MA, 2015, SALUD PUBLICA MEXICO, V57, pS99; Bautista Arredondo S, 2012, RESULTADOS PRINCIPAL; Bautista-Arredondo S, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0286-4; Bautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616; Carrizosa CM, 2010, AIDS PATIENT CARE ST, V24, P333, DOI 10.1089/apc.2009.0138; CENSIDA, 2006, GUIA APL PRUEB RAP; CENSIDA/Secretaria de Salud, 2012, VIH SIDA EN MEX; Centro Nacional para la Prevencion y el Control del VIH/SIDA, 2014, GUIA MAN ANT PERS CO; Centro Nacional para la Prevencion y el Control del VIH/SIDA, 2009, GUIA MAN ANT PERS CO; Chaumont C, 2015, SALUD PUBLICA MEXICO, V57, pS171; Crabtree-Ramirez B, 2015, AIDS BEHAV, V19, P1599, DOI 10.1007/s10461-014-0974-x; Crabtree-Ramirez B, 2012, SALUD PUBLICA MEXICO, V54, P506, DOI 10.1590/S0036-36342012000500007; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; de la Vega Estrada S, 2010, INDICES MARGINACION; Desai S, 2015, EURO SURVEILLANCE B, V20; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Fleishman JA, 2010, MED CARE, V48, P1071, DOI 10.1097/MLR.0b013e3181f81c4a; Goldenberg SM, 2012, J IMMIGR MINOR HEALT, V14, P48, DOI 10.1007/s10903-011-9505-2; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077763; Hernandez-Avila JE, 2015, JAIDS-J ACQ IMM DEF, V69, pe100, DOI 10.1097/QAI.0000000000000645; Hoffmann CJ, 2013, JAIDS-J ACQ IMM DEF, V63, P105, DOI 10.1097/QAI.0b013e3182893fb4; Infante C, 2006, SALUD PUBLICA MEXICO, V48, P141, DOI 10.1590/S0036-36342006000200007; Kendall T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109912; Kiertiburanakul S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18804; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lesko CR, 2013, CLIN INFECT DIS, V57, P1027, DOI 10.1093/cid/cit421; Lozano R, 2011, SALUD PUBLICA MEXICO, V53, pS295; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Gutierrez JP, 2014, SALUD PUBLICA MEXICO, V56, P323; Pan American Health Organization, 2013, ANT TREATM SPOTL PUB; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Secretaria de Salud, 2010, NOM010SSA22010 SECR; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; Smit C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001949; Stanley B, 2003, BMJ-BRIT MED J, V326, P1174, DOI 10.1136/bmj.326.7400.1174; Wing C, 2009, AM J PUBLIC HEALTH, V99, P1087, DOI 10.2105/AJPH.2008.141069; World Health Organization, 2013, CONSOLIDATED GUIDELI; Zetola NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002591	50	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152444	10.1371/journal.pone.0152444	http://dx.doi.org/10.1371/journal.pone.0152444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27027505	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500044
J	Ishizuka, T; Kanmani, P; Kobayashi, H; Miyazaki, A; Soma, J; Suda, Y; Aso, H; Nochi, T; Iwabuchi, N; Xiao, JZ; Saito, T; Villena, J; Kitazawa, H				Ishizuka, Takamasa; Kanmani, Paulraj; Kobayashi, Hisakazu; Miyazaki, Ayako; Soma, Junichi; Suda, Yoshihito; Aso, Hisashi; Nochi, Tomonori; Iwabuchi, Noriyuki; Xiao, Jin-zhong; Saito, Tadao; Villena, Julio; Kitazawa, Haruki			Immunobiotic Bifidobacteria Strains Modulate Rotavirus Immune Response in Porcine Intestinal Epitheliocytes via Pattern Recognition Receptor Signaling	PLOS ONE			English	Article							LACTOBACILLUS-RHAMNOSUS GG; ANTIVIRAL SPECIFICITY; VIRUS-INFECTION; CELL-LINE; PROBIOTICS; CHILDREN; DIARRHEA; PATHOGENESIS; INFLAMMATION; EXPRESSION	In this work, we aimed to characterize the antiviral response of an originally established porcine intestinal epithelial cell line (PIE cells) by evaluating the molecular innate immune response to rotavirus (RVs). In addition, we aimed to select immunomodulatory bacteria with antiviral capabilities. PIE cells were inoculated with RVs isolated from different host species and the infective titers and the molecular innate immune response were evaluated. In addition, the protection against RVs infection and the modulation of immune response by different lactic acid bacteria (LAB) strains was studied. The RVs strains OSU (porcine) and UK (bovine) effectively infected PIE cells. Our results also showed that RVs infection in PIE cells triggered TLR3-, RIG-I-and MDA-5-mediated immune responses with activation of IRF3 and NF-kappa B, induction of IFN-beta and up-regulation of the interferon stimulated genes MxA and RNase L. Among the LAB strains tested, Bifidobacterium infantis MCC12 and B. breve MCC1274 significantly reduced RVs titers in infected PIE cells. The beneficial effects of both bifidobacteria were associated with reduction of A20 expression, and improvements of IRF-3 activation, IFN-beta production, and MxA and RNase L expressions. These results indicate the value of PIE cells for studying RVs molecular innate immune response in pigs and for the selection of beneficial bacteria with antiviral capabilities.	[Ishizuka, Takamasa; Kanmani, Paulraj; Kobayashi, Hisakazu; Saito, Tadao; Villena, Julio; Kitazawa, Haruki] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Prod Chem, Food & Feed Immunol Grp, Sendai, Miyagi 980, Japan; [Kanmani, Paulraj; Kobayashi, Hisakazu; Aso, Hisashi; Kitazawa, Haruki] Tohoku Univ, Grad Sch Agr Sci, Livestock Immunol Unit, Int Educ & Res Ctr Food & Agr Immunol CFAI, Sendai, Miyagi 980, Japan; [Miyazaki, Ayako] NARO, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki, Japan; [Soma, Junichi] JA Zen Noh Natl Federat Agr Cooperat Assoc, Inst Anim Hlth, Res & Dev Sect, Chiba, Japan; [Suda, Yoshihito] Miyagi Univ, Dept Food Agr & Environm, Sendai, Miyagi, Japan; [Aso, Hisashi; Nochi, Tomonori] Tohoku Univ, Grad Sch Agr Sci, Cell Biol Lab, Sendai, Miyagi 980, Japan; [Nochi, Tomonori] Tohoku Univ, Grad Sch Agr Sci, Infect Immunol Unit, Int Educ & Res Ctr Food Agr Immunol CFAI, Sendai, Miyagi 980, Japan; [Iwabuchi, Noriyuki; Xiao, Jin-zhong] Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, Zama, Kanagawa, Japan; [Villena, Julio] Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Argentina	Tohoku University; Tohoku University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Miyagi University; Tohoku University; Tohoku University; Morinaga Milk Industry Company, Ltd; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Villena, J; Kitazawa, H (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Lab Anim Prod Chem, Food & Feed Immunol Grp, Sendai, Miyagi 980, Japan.; Kitazawa, H (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Livestock Immunol Unit, Int Educ & Res Ctr Food & Agr Immunol CFAI, Sendai, Miyagi 980, Japan.; Villena, J (corresponding author), Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Argentina.	jcvillena@cerela.org.ar; haruki@bios.tohoku.ac.jp	Nochi, Tomonori/U-2533-2019; Iwabuchi, Noriyuki/H-9139-2019	Nochi, Tomonori/0000-0003-1800-6972; Kitazawa, Haruki/0000-0003-4586-5553	JSPS Bilateral Joint Research Projects from the Japanese Society for the Promotion of Science (JSPS) [24380146, 26660216]; JSPS [25-03397]; Morinaga Milk Industry Co., Ltd.; Grants-in-Aid for Scientific Research [13F03397, 16H06207, 26660217, 15H04586] Funding Source: KAKEN	JSPS Bilateral Joint Research Projects from the Japanese Society for the Promotion of Science (JSPS); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Morinaga Milk Industry Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (B)(2) (No. 24380146), Challenging Exploratory Research (No. 26660216) and Open Partnership Joint Projects of JSPS Bilateral Joint Research Projects from the Japanese Society for the Promotion of Science (JSPS) to Dr. H. Kitazawa, Dr. Paulraj Kanmani was supported by JSPS Postdoctoral Fellowship for Foreign Researchers, Program No. 25-03397. Morinaga Milk Industry Co., Ltd., provided support in the form of salaries for authors NI and JX, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064; Arnold MM, 2009, VIRUSES-BASEL, V1, P1035, DOI 10.3390/v1031035; Breckpot K, 2009, J IMMUNOL, V182, P860, DOI 10.4049/jimmunol.182.2.860; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; Casola A, 1998, GASTROENTEROLOGY, V114, P947, DOI 10.1016/S0016-5085(98)70314-2; Casola A, 2002, VIROLOGY, V298, P8, DOI 10.1006/viro.2002.1475; Chattha KS, 2013, J IMMUNOL, V191, P2446, DOI 10.4049/jimmunol.1300678; Chiba E, 2013, INT IMMUNOPHARMACOL, V17, P373, DOI 10.1016/j.intimp.2013.06.024; Estes MK, 2001, NOVART FDN SYMP, V238, P82; Estes MK, 1974, FIELDS VIROLOGY, V2, P1917; Fujie H, 2011, FEMS IMMUNOL MED MIC, V63, P129, DOI 10.1111/j.1574-695X.2011.00837.x; Guandalini S, 2000, J PEDIATR GASTR NUTR, V30, P54, DOI 10.1097/00005176-200001000-00018; Guandalini S, 2008, J CLIN GASTROENTEROL, V42, pS53, DOI 10.1097/MCG.0b013e3181674087; Guerrero CA, 2010, J VIROL METHODS, V168, P22, DOI 10.1016/j.jviromet.2010.04.010; Holloway G, 2013, J GEN VIROL, V94, P1151, DOI 10.1099/vir.0.051276-0; HOSHINO Y, 1985, J CLIN MICROBIOL, V21, P425, DOI 10.1128/JCM.21.3.425-430.1985; Hosoya S, 2013, J MICROBIOL IMMUNOL, V46, P474, DOI 10.1016/j.jmii.2012.04.005; Hosoya S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-111; Liang SL, 2006, IUBMB LIFE, V58, P508, DOI 10.1080/15216540600838232; Liu FN, 2013, J PEDIATR GASTR NUTR, V57, P750, DOI 10.1097/MPG.0b013e3182a356e1; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Liu KJ, 2009, IMMUNOL LETT, V127, P13, DOI 10.1016/j.imlet.2009.08.007; MacPherson C, 2014, APPL ENVIRON MICROB, V80, P1692, DOI 10.1128/AEM.03411-13; Maragkoudakis PA, 2010, INT J FOOD MICROBIOL, V141, pS91, DOI 10.1016/j.ijfoodmicro.2009.12.024; Mitchell PS, 2013, CURR OPIN MICROBIOL, V16, P493, DOI 10.1016/j.mib.2013.04.005; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Morelli M, 2015, VIROLOGY, V479, P75, DOI 10.1016/j.virol.2015.01.006; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Nandi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092126; Ning SB, 2010, J VIROL, V84, P6130, DOI 10.1128/JVI.00364-10; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Sheth R, 1996, VIROLOGY, V221, P251, DOI 10.1006/viro.1996.0374; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; Tomosada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059259; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Villena J., 2014, FRONT IMMUNOL, V4, P1; Villena J, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-126; Vlasova AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076962; Wakuda M, 2011, EMERG INFECT DIS, V17, P1491, DOI 10.3201/eid1708.101466; Wang J, 2014, J VIROL METHODS, V202, P87, DOI 10.1016/j.jviromet.2014.03.007; Zelaya H, 2014, INT IMMUNOPHARMACOL, V19, P161, DOI 10.1016/j.intimp.2013.12.020	44	43	46	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152416	10.1371/journal.pone.0152416	http://dx.doi.org/10.1371/journal.pone.0152416			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023883	gold, Green Published			2022-12-26	WOS:000373113900055
J	Pan, LL; Ke, JQ; Zhao, CC; Huang, SY; Shen, J; Jiang, XX; Wang, XT				Pan, Lu-Lu; Ke, Jiang-Qiong; Zhao, Cui-Cui; Huang, Shi-Yuan; Shen, Jie; Jiang, Xian-Xun; Wang, Xiao-Tong			Electrical Stimulation Improves Rat Muscle Dysfunction Caused by Chronic Intermittent Hypoxia-Hypercapnia via Regulation of miRNA-Related Signaling Pathways	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SKELETAL-MUSCLE; COPD; HDAC4; EXPRESSION; ENDURANCE; PHOSPHORYLATION; HYPERTROPHY; ADAPTATIONS; MICRORNAS	Skeletal muscle dysfunction in chronic obstructive pulmonary disease (COPD) patients is common. Neuromuscular Electrical Stimulation (NMES) is a powerful exercise training that may relieve muscle dysfunction in COPD. This study investigated whether electrical stimulation may have atypical adaptations via activation of miRNA related pathways in counteracting COPD muscle dysfunction. Forty-eight male Sprague-Dawley rats were randomly assigned to 3 groups. With the exception of the rats in the control group, the experimental rats were exposed to chronic intermittent hypoxia-hypercapnia (CIHH) (9 similar to 11% O-2,5.5 similar to 6.5% CO2) for 2 or 4 weeks. Electrical stimulation was performed immediately after each CIHH session. Following assessment of the running capacity, biopsy samples were obtained from the gastrocnemius of the rats. The miR-1, miR-133a and miR-133b levels were measured, as well as their related proteins: phosphorylation of Akt (p-AKT), PGC-1alpha (PGC-1 alpha), histone deacetylase 4 (HDAC4) and serum response factor (SRF). Myosin heavy chain. a (MHCIIa) and myosin heavy chain. b (MHCIIb) were also measured to assess fiber type changes. After 2 weeks, compared with the controls, only miR-1 and miR-133a were significantly increased (p<0.05) in the exposure group. After 4 weeks, the exposure group exhibited a decreased running distance (p = 0.054) and MHCIIa-to-MHCIIb shift (p<0.05). PGC-1 alpha (p = 0.051), nuclear HDAC4 (p = 0.058), HDAC4, p-AKT, PGC-1 alpha and SRF was also significantly decreased (p<0.05). In contrast, miR-1 and miR-133a were significantly increased (p<0.05). Four weeks of electrical stimulation can partly reversed those changes, and miR-133b exhibited a transient increase after 2 weeks electrical stimulation. Our study indicate miRNAs may have roles in the response of CIHH-impaired muscle to changes during electrical stimulation.	[Pan, Lu-Lu; Ke, Jiang-Qiong; Huang, Shi-Yuan; Shen, Jie; Jiang, Xian-Xun; Wang, Xiao-Tong] Wenzhou Med Univ, Ctr Neurol & Rehabil, Affiliated Hosp 2, Wenzhou, Peoples R China; [Pan, Lu-Lu] Tradit Chinese Med Hosp Wenzhou City, Dept Rehabil, Wenzhou, Peoples R China; [Zhao, Cui-Cui] Wenzhou Med Univ, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Wang, XT (corresponding author), Wenzhou Med Univ, Ctr Neurol & Rehabil, Affiliated Hosp 2, Wenzhou, Peoples R China.	wangxt22@163.com		Ke, Jiangqiong/0000-0003-0776-6060	Medical Science Research Foundation of Zhejiang Province [Y2080503]	Medical Science Research Foundation of Zhejiang Province	This research was supported by the Medical Science Research Foundation of Zhejiang Province grant (No. Y2080503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Barreiro E, 2015, TRANSL RES, V165, P61, DOI 10.1016/j.trsl.2014.04.006; Barreiro E, 2013, J APPL PHYSIOL, V114, P1263, DOI 10.1152/japplphysiol.01027.2012; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Clocchiatti A, 2013, CELL SIGNAL, V25, P269, DOI 10.1016/j.cellsig.2012.10.002; Cohen TJ, 2009, FASEB J, V23, P99, DOI 10.1096/fj.08-115931; den Hoed M, 2009, SCAND J MED SCI SPOR, V19, P373, DOI 10.1111/j.1600-0838.2008.00782.x; Donaldson A, 2013, THORAX, V68, P1140, DOI 10.1136/thoraxjnl-2012-203129; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Gea J, 2013, J APPL PHYSIOL, V114, P1222, DOI 10.1152/japplphysiol.00981.2012; Gondin J, 2011, J APPL PHYSIOL, V110, P433, DOI 10.1152/japplphysiol.00914.2010; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Huo XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094278; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Levine S, 2013, J APPL PHYSIOL, V114, P1235, DOI 10.1152/japplphysiol.01121.2012; Lewis A, 2012, THORAX, V67, P26, DOI 10.1136/thoraxjnl-2011-200309; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu YW, 2013, J PHYSIOL-LONDON, V591, P3605, DOI 10.1113/jphysiol.2013.256263; Lokireddy S, 2011, AM J PHYSIOL-CELL PH, V301, pC1316, DOI 10.1152/ajpcell.00114.2011; Min JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05555; Puente-Maestu L, 2013, J APPL PHYSIOL, V114, P1282, DOI 10.1152/japplphysiol.00815.2012; Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106; Roberts-Wilson TK, 2010, BBA-MOL CELL RES, V1803, P960, DOI 10.1016/j.bbamcr.2010.03.019; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Sillen MJH, 2011, LUNG, V189, P21, DOI 10.1007/s00408-010-9265-0; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tu WZ, 2012, NEUROCHEM INT, V60, P379, DOI 10.1016/j.neuint.2012.01.006; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vivodtzev I, 2013, CHEST, V143, P485, DOI 10.1378/chest.12-0584; Vivodtzev I, 2012, CHEST, V141, P716, DOI 10.1378/chest.11-0839; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200; Zheng GQ, 2008, MED HYPOTHESES, V71, P111, DOI 10.1016/j.mehy.2008.01.025	37	5	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152525	10.1371/journal.pone.0152525	http://dx.doi.org/10.1371/journal.pone.0152525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023369	Green Submitted, Green Published, gold			2022-12-26	WOS:000373113900071
J	Scott, BL; Hoppe, AD				Scott, Brandon L.; Hoppe, Adam D.			Three-Dimensional Reconstruction of Three-Way FRET Microscopy Improves Imaging of Multiple Protein-Protein Interactions	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; MOLECULAR-INTERACTIONS; MAXIMUM-LIKELIHOOD; DECONVOLUTION; BINDING; CELLS	Fluorescence resonance energy transfer (FRET) microscopy is a powerful tool for imaging the interactions between fluorescently tagged proteins in two-dimensions. For FRET microscopy to reach its full potential, it must be able to image more than one pair of interacting molecules and image degradation from out-of-focus light must be reduced. Here we extend our previous work on the application of maximum likelihood methods to the 3-dimensional reconstruction of 3-way FRET interactions within cells. We validated the new method (3D-3Way FRET) by simulation and fluorescent protein test constructs expressed in cells. In addition, we improved the computational methods to create a 2-log reduction in computation time over our previous method (3DFSR). We applied 3D-3Way FRET to image the 3D subcellular distributions of HIV Gag assembly. Gag fused to three different FPs (CFP, YFP, and RFP), assembled into viral-like particles and created punctate FRET signals that become visible on the cell surface when 3D-3Way FRET was applied to the data. Control experiments in which YFP-Gag, RFP-Gag and free CFP were expressed, demonstrated localized FRET between YFP and RFP at sites of viral assembly that were not associated with CFP. 3D-3Way FRET provides the first approach for quantifying multiple FRET interactions while improving the 3D resolution of FRET microscopy data without introducing bias into the reconstructed estimates. This method should allow improvement of widefield, confocal and superresolution FRET microscopy data.	[Scott, Brandon L.; Hoppe, Adam D.] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA; [Scott, Brandon L.; Hoppe, Adam D.] S Dakota State Univ, BioSNTR, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Hoppe, AD (corresponding author), S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA.; Hoppe, AD (corresponding author), S Dakota State Univ, BioSNTR, Brookings, SD 57007 USA.	adam.hoppe@sdstate.edu	Hoppe, Adam/U-8563-2019	Hoppe, Adam/0000-0003-4180-0840; Scott, Brandon/0000-0002-1950-0748	National Science Foundation/EPSCoR [IIA-1335423]; state of South Dakota's Governor's Office of Economic Development as a South Dakota Research Innovation Center; National Science Foundation [0953561]; US Department of Education GAANN Fellowship [P200A100103]	National Science Foundation/EPSCoR(National Science Foundation (NSF)); state of South Dakota's Governor's Office of Economic Development as a South Dakota Research Innovation Center; National Science Foundation(National Science Foundation (NSF)); US Department of Education GAANN Fellowship(US Department of Education)	This work was supported by National Science Foundation/EPSCoR (http://www.nsf.gov/od/iia/programs/epscor/index.jsp) Award #IIA-1335423 and by the state of South Dakota's Governor's Office of Economic Development as a South Dakota Research Innovation Center and National Science Foundation CAREER Award # 0953561 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503214) to ADH. Funding support from US Department of Education GAANN Fellowship #P200A100103 (http://www2.ed.gov/programs/gaann/index.html) supported BLS. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2013, DEV GROWTH DIFFER, V55, P515, DOI 10.1111/dgd.12039; Hogue IB, 2009, J VIROL, V83, P7322, DOI 10.1128/JVI.02545-08; Hoppe Adam D., 2007, P157, DOI 10.1007/978-3-540-71331-9_6; Hoppe AD, 2008, BIOPHYS J, V95, P400, DOI 10.1529/biophysj.107.125385; Hoppe AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064760; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; KAUFMAN L, 1993, IEEE T MED IMAGING, V12, P200, DOI 10.1109/42.232249; Kim J, 2013, OPT EXPRESS, V21, P27668, DOI 10.1364/OE.21.027668; Lakowicz, 2006, PRINCIPLES FLUORESCE; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Scott BL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10270; Shaw P., 2006, HDB BIOL CONFOCAL MI, P453, DOI DOI 10.1007/978-0-387-45524-2_23; Szolgay D, 2011, ELECTRON LETT, V47, P442, DOI 10.1049/el.2010.3692; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Verveer PJ, 1999, J MICROSC-OXFORD, V193, P50, DOI 10.1046/j.1365-2818.1999.00421.x	15	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152401	10.1371/journal.pone.0152401	http://dx.doi.org/10.1371/journal.pone.0152401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023704	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900053
J	Cassemiro, KMSD; Burlandy, FM; Barbosa, MRF; Chen, Q; Jorba, J; Hachich, EM; Sato, MIZ; Burns, CC; da Silva, EE				de Melo Cassemiro, Klecia Marilia S.; Burlandy, Fernanda M.; Barbosa, Mikaela R. F.; Chen, Qi; Jorba, Jaume; Hachich, Elayse M.; Sato, Maria I. Z.; Burns, Cara C.; da Silva, Edson E.			Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014	PLOS ONE			English	Article							ACTING REPLICATION ELEMENT; WILD POLIOVIRUS; MOSAIC STRUCTURE; IDENTIFICATION; RECOMBINATION; SEQUENCES; SEWAGE; POLIOMYELITIS; SURVEILLANCE; OUTBREAK	A type 2 vaccine-derived poliovirus (VDPV), differing from the Sabin 2 strain at 8.6% (78/903) of VP1 nucleotide positions, was isolated from seawater collected from a seaport in Sao Paulo State, Brazil. The P1/capsid region is related to the Sabin 2 strain, but sequences within the 5'-untranslated region and downstream of the P1 region were derived from recombination with other members of Human Enterovirus Species C (HEV-C). The two known attenuating mutations had reverted to wild-type (A481G in the 5'-UTR and Ile143Thr in VP1). The VDPV isolate had lost the temperature sensitive phenotype and had accumulated amino acid substitutions in neutralizing antigenic (NAg) sites 3a and 3b. The date of the initiating OPV dose, estimated from the number of synonymous substitutions in the capsid region, was approximately 8.5 years before seawater sampling, a finding consistent with a long time of virus replication and possible transmission among several individuals. Although no closely related type 2 VDPVs were detected in Brazil or elsewhere, this VDPV was found in an area with a mobile population, where conditions may favor both viral infection and spread. Environmental surveillance serves as an important tool for sensitive and early detection of circulating poliovirus in the final stages of global polio eradication.	[de Melo Cassemiro, Klecia Marilia S.; Burlandy, Fernanda M.; da Silva, Edson E.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Enterovirus Lab, Rio De Janeiro, Rio De Janeiro, Brazil; [Barbosa, Mikaela R. F.; Hachich, Elayse M.; Sato, Maria I. Z.] Environm Co Sao Paulo State, Environm Anal Dept, Sao Paulo, Sao Paulo, Brazil; [Chen, Qi; Jorba, Jaume; Burns, Cara C.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA	Fundacao Oswaldo Cruz; Centers for Disease Control & Prevention - USA	da Silva, EE (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Enterovirus Lab, Rio De Janeiro, Rio De Janeiro, Brazil.	edson@ioc.fiocruz.br	Sato, Maria Inês Zanoli/AFV-6255-2022		"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico"; "Fundacao Oswaldo Cruz"; CNPq	"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico"(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); "Fundacao Oswaldo Cruz"; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	KMSMC was supported by the "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (URL: http://cnpq.br/). The study was supported by the "Fundacao Oswaldo Cruz" (URL: http://fiocruz.br/) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu F, 2007, VIRUS RES, V127, P17, DOI 10.1016/j.virusres.2007.03.009; Al-Hello H, 2013, J VIROL, V87, P13076, DOI 10.1128/JVI.01174-13; Bellmunt A, 1998, J CLIN MICROBIOL, V265, P178; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; BOTTIGER M, 1968, ARCH GES VIRUSFORSCH, V25, P299, DOI 10.1007/BF01556558; BOTTIGER M, 1992, SCAND J INFECT DIS, V24, P151, DOI 10.3109/00365549209052605; Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; Burns CC, 2014, J INFECT DIS, V210, pS283, DOI 10.1093/infdis/jiu295; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Cai JJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-64; COUDERC T, 1989, EUR J EPIDEMIOL, V5, P270, DOI 10.1007/BF00144825; Deshpande JM, 2003, APPL ENVIRON MICROB, V69, P2919, DOI 10.1128/AEM.69.5.2919-2927.2003; DeVries AS, 2011, NEW ENGL J MED, V364, P2316, DOI 10.1056/NEJMoa1008677; Diop OM, 2015, MMWR-MORBID MORTAL W, V64, P640; Diop OM, 2014, MMWR-MORBID MORTAL W, V63, P242; Dragunsky EM, 2004, J INFECT DIS, V190, P1404, DOI 10.1086/424524; [Environmental Regulations and Technology USEPA], 2003, EPA 525 R 092 013; EQUESTRE M, 1991, J VIROL, V65, P2707, DOI 10.1128/JVI.65.5.2707-2710.1991; Famulare M, 2016, J VIROL, V90, P317, DOI 10.1128/JVI.01532-15; Gary HE, 1997, J INFECT DIS, V175, pS141, DOI 10.1093/infdis/175.Supplement_1.S141; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gnanashanmugam D, 2007, J CLIN MICROBIOL, V45, P2419, DOI 10.1128/JCM.02268-06; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hovi T, 2006, BIOLOGICALS, V34, P123, DOI 10.1016/j.biologicals.2006.02.009; Hovi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066849; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kew OM, 1998, J CLIN MICROBIOL, V36, P2893, DOI 10.1128/JCM.36.10.2893-2899.1998; Kilpatrick DR, 2014, J VIROL METHODS, V197, P25, DOI 10.1016/j.jviromet.2013.11.017; Korotkova EA, 2003, J VIROL, V77, P12460, DOI 10.1128/JVI.77.23.12460-12465.2003; LAMONICA N, 1986, J VIROL, V57, P515, DOI 10.1128/JVI.57.2.515-525.1986; Lentz KN, 1997, STRUCTURE, V5, P961, DOI 10.1016/S0969-2126(97)00249-9; Liu HM, 2003, J VIROL, V77, P10994, DOI 10.1128/JVI.77.20.10994-11005.2003; Liu XD, 2010, ARCH VIROL, V155, P685, DOI 10.1007/s00705-010-0631-2; MACADAM AJ, 1993, VIROLOGY, V192, P18, DOI 10.1006/viro.1993.1003; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MINOR PD, 1988, J GEN VIROL, V69, P1091, DOI 10.1099/0022-1317-69-5-1091; Nakano J H, 1978, Prog Med Virol, V24, P178; Nei M, 2000, MOLECULAR EVOLUTION; OTELEA D, 1993, DEV BIOL STAND, V78, P33; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pliaka V, 2010, VIRUS GENES, V40, P200, DOI 10.1007/s11262-010-0448-9; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Razafindratsimandresy R, 2013, EMERG INFECT DIS, V19, P1008, DOI 10.3201/eid1906.130080; REN R, 1991, J VIROL, V65, P1377, DOI 10.1128/JVI.65.3.1377-1382.1991; Ren RB, J VIROL MAR, V65, P1377; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Rieder E, 2000, J VIROL, V74, P10371, DOI 10.1128/JVI.74.22.10371-10380.2000; Rousset D, 2003, EMERG INFECT DIS, V9, P885; SATTAR SA, 1977, CAN MED ASSOC J, V116, P25; Shulman LM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000069; Shulman LM, 2000, J CLIN MICROBIOL, V38, P945, DOI 10.1128/JCM.38.3.945-952.2000; SMITH JM, 1992, J MOL EVOL, V34, P126; Sutter R.W., 1993, VACCINES-BASEL, V6th ed., P598, DOI DOI 10.1016/B978-1-4557-0090-5.00035-5; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083975; World Health Organization, 1997, MANUAL FOR THE VIROL; World Health Organization, 2006, NEW TEST ALGORITHM T, VXXXIII; World Health Organization, 2004, POLIO LABORATORY MAN; World Health Organization, 2014, DETECTION OF POLIOVI; Yakovenko ML, 2006, J VIROL, V80, P2641, DOI 10.1128/JVI.80.6.2641-2653.2006; Yan DM, 2014, CLIN VACCINE IMMUNOL, V21, P1012, DOI 10.1128/CVI.00196-14; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Yoshida H, 2002, J GEN VIROL, V83, P1107, DOI 10.1099/0022-1317-83-5-1107; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0	72	8	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152251	10.1371/journal.pone.0152251	http://dx.doi.org/10.1371/journal.pone.0152251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019095	Green Published, Green Submitted, gold			2022-12-26	WOS:000372807800036
J	Su, ZP; Zhu, JW; Xu, ZF; Xiao, R; Zhou, R; Li, L; Chen, HC				Su, Zhipeng; Zhu, Jiawen; Xu, Zhuofei; Xiao, Ran; Zhou, Rui; Li, Lu; Chen, Huanchun			A Transcriptome Map of Actinobacillus pleuropneumoniae at Single-Nucleotide Resolution Using Deep RNA-Seq	PLOS ONE			English	Article							TILING ARRAY ANALYSIS; ESCHERICHIA-COLI; NONCODING RNAS; RE-ANNOTATION; PROLINE DEHYDROGENASE; BIOFILM FORMATION; 6S RNA; EXPRESSION; OPERON; PROTEIN	Actinobacillus pleuropneumoniae is the pathogen of porcine contagious pleuropneumoniae, a highly contagious respiratory disease of swine. Although the genome of A. pleuropneumoniae was sequenced several years ago, limited information is available on the genome-wide transcriptional analysis to accurately annotate the gene structures and regulatory elements. High-throughput RNA sequencing (RNA-seq) has been applied to study the transcriptional landscape of bacteria, which can efficiently and accurately identify gene expression regions and unknown transcriptional units, especially small non-coding RNAs (sRNAs), UTRs and regulatory regions. The aim of this study is to comprehensively analyze the transcriptome of A. pleuropneumoniae by RNA-seq in order to improve the existing genome annotation and promote our understanding of A. pleuropneumoniae gene structures and RNA-based regulation. In this study, we utilized RNA-seq to construct a single nucleotide resolution transcriptome map of A. pleuropneumoniae. More than 3.8 million high-quality reads (average length similar to 90 bp) from a cDNA library were generated and aligned to the reference genome. We identified 32 open reading frames encoding novel proteins that were mis-annotated in the previous genome annotations. The start sites for 35 genes based on the current genome annotation were corrected. Furthermore, 51 sRNAs in the A. pleuropneumoniae genome were discovered, of which 40 sRNAs were never reported in previous studies. The transcriptome map also enabled visualization of 5'- and 3'-UTR regions, in which contained 11 sRNAs. In addition, 351 operons covering 1230 genes throughout the whole genome were identified. The RNA-Seq based transcriptome map validated annotated genes and corrected annotations of open reading frames in the genome, and led to the identification of many functional elements (e.g. regions encoding novel proteins, non-coding sRNAs and operon structures). The transcriptional units described in this study provide a foundation for future studies concerning the gene functions and the transcriptional regulatory architectures of this pathogen.	[Su, Zhipeng; Zhu, Jiawen; Xu, Zhuofei; Xiao, Ran; Zhou, Rui; Li, Lu; Chen, Huanchun] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Zhou, Rui; Li, Lu; Chen, Huanchun] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China; [Xu, Zhuofei] Katholieke Univ Leuven, Stem Cell Biol & Embryol, O&N 4 Herestr 49,Box 804, B-3000 Leuven, Belgium	Huazhong Agricultural University; KU Leuven	Li, L; Chen, HC (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.; Li, L; Chen, HC (corresponding author), Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China.	lilu@mail.hzau.edu.cn; chenhch@mail.hzau.edu.cn			National Natural Science Foundation of China [31201932, 31572535]; National Basic Research Program of China (973 Program) [2012CB518802]; Special Fund for Agro-scientific Research in the Public Interest [201303034-11]; Fundamental Research Funds for the Central Universities [2662014BQ021, 2662015PY161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31201932; 31572535), National Basic Research Program of China (973 Program, 2012CB518802), Special Fund for Agro-scientific Research in the Public Interest (201303034-11), and Fundamental Research Funds for the Central Universities (2662014BQ021, 2662015PY161).	Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bosse JT, 2010, J BACTERIOL, V192, P2414, DOI 10.1128/JB.01513-09; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-71; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Cavanagh AT, 2014, ANNU REV MICROBIOL, V68, P45, DOI 10.1146/annurev-micro-092611-150135; CHAN CL, 1989, J BIOL CHEM, V264, P20796; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Cho KY, 1996, MOL MICROBIOL, V22, P1025, DOI 10.1046/j.1365-2958.1996.01524.x; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Deslandes V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-98; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; Gao JX, 2012, CURR MICROBIOL, V64, P118, DOI 10.1007/s00284-011-0035-x; Gao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101229; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Gomez-Lozano M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-783; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Guo FB, 2014, CURR GENOMICS, V15, P95, DOI 10.2174/1389202915999140328162724; Guo FB, 2013, DNA RES, V20, P273, DOI 10.1093/dnares/dst009; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Ignatov D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074209; Kaufmann M, 2006, CURR BIOINFORM, V1, P291, DOI 10.2174/157489306777828017; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Klitgaard K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-698; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029435; Kumar Ranjit, 2011, Genomics Proteomics & Bioinformatics, V9, P56, DOI 10.1016/S1672-0229(11)60008-9; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Lee JH, 2003, J BACTERIOL, V185, P3842, DOI 10.1128/JB.185.13.3842-3852.2003; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2014, J MICROBIOL, V52, P473, DOI 10.1007/s12275-014-3456-y; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031121; Liu T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-931; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2010, NUCLEIC ACIDS RES, V38, P1504, DOI 10.1093/nar/gkp1121; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Marcellin E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-699; McArthur SD, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-52; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; Merino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055546; MUROPASTOR AM, 1995, J BIOL CHEM, V270, P9819, DOI 10.1074/jbc.270.17.9819; OLIVER H, 2009, BMC BIOINFORMATI S10, V10, DOI DOI 10.1186/1471-2164-10-641; Osmundson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076572; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pfeifer-Sancar K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-888; Pridmore A, 2011, VET MICROBIOL, V151, P409, DOI 10.1016/j.vetmic.2011.03.016; Pulvermacher SC, 2009, MICROBIOL-SGM, V155, P115, DOI 10.1099/mic.0.023432-0; Reddy JS, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S4; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Regulski EE, 2008, MOL MICROBIOL, V68, P918, DOI 10.1111/j.1365-2958.2008.06208.x; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Sabatti C, 2002, NUCLEIC ACIDS RES, V30, P2886, DOI 10.1093/nar/gkf388; Saito S, 2009, GENE, V428, P2, DOI 10.1016/j.gene.2008.09.024; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075828; WANG Y, 2011, BMC BIOINFORMATI S10, V12, DOI DOI 10.1186/1471-2164-12-479; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zeng Q, 2014, PHYTOPATHOLOGY, V104, P134; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e	80	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152363	10.1371/journal.pone.0152363	http://dx.doi.org/10.1371/journal.pone.0152363			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018591	gold, Green Published			2022-12-26	WOS:000372807800049
J	Marston, M; Nakiyingi-Miiro, J; Hosegood, V; Lutalo, T; Mtenga, B; Zaba, B				Marston, Milly; Nakiyingi-Miiro, Jessica; Hosegood, Victoria; Lutalo, Tom; Mtenga, Baltazar; Zaba, Basia		ALPHA Network	Measuring the Impact of Antiretroviral Therapy Roll-Out on Population Level Fertility in Three African Countries	PLOS ONE			English	Article							HIV-INFECTED WOMEN; RURAL-POPULATION; AIDS-PREVENTION; COHORT PROFILE; PREVALENCE; INTENTIONS; COMMUNITY; UGANDA; RAKAI; BIRTH	Background UNAIDS official estimates of national HIV prevalence are based on trends observed in antenatal clinic surveillance, after adjustment for the reduced fertility of HIV positive women. Uptake of ART may impact on the fertility of HIV positive women, implying a need to re-estimate the adjustment factors used in these calculations. We analyse the effect of antiretroviral therapy (ART) provision on population-level fertility in Southern and East Africa, comparing trends in HIV infected women against the secular trends observed in uninfected women. Methods We used fertility data from four community-based demographic and HIV surveillance sites: Kisesa (Tanzania), Masaka and Rakai (Uganda) and uMkhanyakude (South Africa). All births to women aged 15-44 years old were included in the analysis, classified by mother's age and HIV status at time of birth, and ART availability in the community. Calendar time period of data availability relative to ART Introduction varied across the sites, from 5 years prior to ART roll-out, to 9 years after. Calendar time was classified according to ART availability, grouped into pre ART, ART introduction (available in at least one health facility serving study site) and ART available (available in all designated health facilities serving study site). We used Poisson regression to calculate age adjusted fertility rate ratios over time by HIV status, and investigated the interaction between ART period and HIV status to ascertain whether trends over time were different for HIV positive and negative women. Results Age-adjusted fertility rates declined significantly over time for HIV negative women in all four studies. However HIV positives either had no change in fertility (Masaka, Rakai) or experienced a significant increase over the same period (Kisesa, uMkhanyakude). HIV positive fertility was significantly lower than negative in both the pre ART period (age adjusted fertility rate ratio (FRR) range 0.51 95% CI 0.42-0.61 to 0.73 95% CI 0.64-0.83) and when ART was widely available (FRR range 0.57 95% CI 0.52-0.62 to 0.83 95% CI 0.78-0.87), but the difference has narrowed. The interaction terms describing the difference in trends between HIV positives and negatives are generally significant. Conclusions Differences in fertility between HIV positive and HIV negative women are narrowing over time as ART becomes more widely available in these communities. Routine adjustment of ANC data for estimating national HIV prevalence will need to allow for the impact of treatment.	[Marston, Milly; Zaba, Basia] London Sch Hyg & Trop Med, London WC1, England; [Nakiyingi-Miiro, Jessica] MRC, Entebbe, Uganda; [Hosegood, Victoria] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Hosegood, Victoria] Univ Southampton, Fac Med, Fac Social & Human Sci, Southampton SO9 5NH, Hants, England; [Lutalo, Tom] Natl Inst Med Res, TAZAMA Project, Mwanza, Tanzania; [Mtenga, Baltazar] Rakai Hlth Sci Program, Kalisizo, Rakai, Uganda	University of London; London School of Hygiene & Tropical Medicine; University of Kwazulu Natal; University of Southampton; National Institute of Medical Research; Rakai Health Sciences Program	Marston, M (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	milly.marston@lshtm.ac.uk		Hosegood, Victoria/0000-0002-2244-2518	Wellcome Trust [WT090959MA]; ESRC [ES/K007394/1, ES/J021202/1, ES/J021881/1] Funding Source: UKRI; Economic and Social Research Council [ES/J021202/1, ES/K007394/1, ES/J021881/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The ALPHA network is core funded by Wellcome Trust WT090959MA.	Baggaley R, 2012, B WORLD HEALTH ORGAN, V90, P652, DOI 10.2471/BLT.11.100818; Biraro S, 2007, JAIDS-J ACQ IMM DEF, V44, P222, DOI 10.1097/QAI.0b013e31802e2954; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Floyd S, 2013, AIDS, V27, P233, DOI 10.1097/QAD.0b013e32835848ab; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469; Kasamba I, 2012, TROP MED INT HEALTH, V17, pe66, DOI 10.1111/j.1365-3156.2012.02841.x; Lee LM, 2000, AM J EPIDEMIOL, V151, P1020, DOI 10.1093/oxfordjournals.aje.a010130; Lewis JJC, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200406002-00005; Maher D, 2010, TROP MED INT HEALTH, V15, P321, DOI 10.1111/j.1365-3156.2009.02456.x; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Makumbi FE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/519492; Marsh K, 2014, AIDS, V28, pS497, DOI 10.1097/QAD.0000000000000453; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/00002030-200312050-00012; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Nguyen RHN, 2006, INT J STD AIDS, V17, P842, DOI 10.1258/095646206779307586; Porter L, 2004, DEMOGRAPHY, V41, P465, DOI 10.1353/dem.2004.0025; Reniers G, 2016, INT J EPIDEMIOL, V45, P83, DOI 10.1093/ije/dyv343; Reniers G, 2009, AIDS, V23, P621, DOI 10.1097/QAD.0b013e3283269e13; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Souza E, 2015, AJAR-AFR J AIDS RES, V14, P315, DOI 10.2989/16085906.2015.1093512; surveillance UWwgoGHAaS, 2003, GUID COND HIV SENT S; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Terceira N, 2003, POP STUD-J DEMOG, V57, P149, DOI 10.1080/0032472032000097074; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; WHO U, 2013, GLOB UPD HIV TREATM; Wringe A, 2012, TROP MED INT HEALTH, V17, pe38, DOI 10.1111/j.1365-3156.2011.02925.x; Zaba B, 1998, AIDS, V12, pS41	34	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151877	10.1371/journal.pone.0151877	http://dx.doi.org/10.1371/journal.pone.0151877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3TE	27015522	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000372708900032
J	Merino-Gracia, J; Costas-Insua, C; Canales, MA; Rodriguez-Crespo, I				Merino-Gracia, Javier; Costas-Insua, Carlos; Angeles Canales, Maria; Rodriguez-Crespo, Ignacio			Insights into the C-terminal Peptide Binding Specificity of the PDZ Domain of Neuronal Nitric-oxide Synthase CHARACTERIZATION OF THE INTERACTION WITH THE TIGHT JUNCTION PROTEIN CLAUDIN-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY; RECEPTOR INTERACTION; STRUCTURAL BASIS; TIGHT JUNCTIONS; PROTEIN; NNOS; RECOGNITION; COMPLEX; INHIBITORS; SEQUENCES	Neuronal nitric-oxide synthase, unlike its endothelial and inducible counterparts, displays a PDZ (PSD-95/Dlg/ZO-1) domain located at its N terminus involved in subcellular targeting. The C termini of various cellular proteins insert within the binding groove of this PDZ domain and determine the subcellular distribution of neuronal NOS (nNOS). The molecular mechanisms underlying these interactions are poorly understood because the PDZ domain of nNOS can apparently exhibit class I, class II, and class III binding specificity. In addition, it has been recently suggested that the PDZ domain of nNOS binds with very low affinity to the C termini of target proteins, and a necessary simultaneous lateral interaction must take place for binding to occur. We describe herein that the PDZ domain of nNOS can behave as a bona fide class III PDZ domain and bind to C-terminal sequences with acidic residues at the P-2 position with low micromolar binding constants. Binding to C-terminal sequences with a hydrophobic residue at the P-2 position plus an acidic residue at the P-3 position (class II) can also occur, although interactions involving residues extending up to the P-7 position mediate this type of binding. This promiscuous behavior also extends to its association to class I sequences, which must display a Glu residue at P-3 and a Thr residue at P-2. By means of site-directed mutagenesis and NMR spectroscopy, we have been able to identify the residues involved in each specific type of binding and rationalize the mechanisms used to recognize binding partners. Finally, we have analyzed the high affinity association of the PDZ domain of nNOS to claudin-3 and claudin-14, two tight junction tetraspan membrane proteins that are essential components of the paracellular barrier.	[Merino-Gracia, Javier; Costas-Insua, Carlos; Rodriguez-Crespo, Ignacio] Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain; [Angeles Canales, Maria] Univ Complutense Madrid, Fac Ciencias Quim, Dept Quim Organ, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Rodriguez-Crespo, I (corresponding author), Univ Complutense Madrid, Fac Quim, Dept Bioquim & Biol Mol, Ciudad Univ, E-28040 Madrid, Spain.	nacho@bbm1.ucm.es	Canales, Angeles/K-7499-2015; Rodriguez-Crespo, J. Ignacio/M-1966-2018	Canales, Angeles/0000-0003-0542-3080; Rodriguez-Crespo, J. Ignacio/0000-0002-2582-129X; Merino Gracia, Javier/0000-0003-3397-8171	Spanish "Ministerio de Ciencia e Innovacion" [BFU2012-37934]	Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Spanish "Ministerio de Ciencia e Innovacion" Grant BFU2012-37934. The authors declare that they have no conflicts of interest with the contents of this article.	Aicart-Ramos C, 2014, J CELL SCI, V127, P3360, DOI 10.1242/jcs.148601; Angulo I, 2011, GLYCOBIOLOGY, V21, P1349, DOI 10.1093/glycob/cwr074; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Bach A, 2008, J MED CHEM, V51, P6450, DOI 10.1021/jm800836w; Bach A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12157; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Courtney MJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00252; Erlendsson S, 2014, J BIOL CHEM, V289, P25327, DOI 10.1074/jbc.M114.548743; Ernst A, 2014, J MOL BIOL, V426, P3509, DOI 10.1016/j.jmb.2014.08.012; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Firestein BL, 1999, J BIOL CHEM, V274, P10545, DOI 10.1074/jbc.274.15.10545; Garcia-Mayoral MF, 2011, FEBS LETT, V585, P53, DOI 10.1016/j.febslet.2010.11.027; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Garcia-Mayoral MF, 2010, FEBS J, V277, P2340, DOI 10.1111/j.1742-4658.2010.07649.x; Gerber NC, 1997, J BIOL CHEM, V272, P6285, DOI 10.1074/jbc.272.10.6285; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jackson CL, 2015, NITRIC OXIDE-BIOL CH, V44, P3, DOI 10.1016/j.niox.2014.11.003; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Lai Y, 2013, P NATL ACAD SCI USA, V110, P525, DOI 10.1073/pnas.1211431109; Lemaire JF, 2006, FEBS LETT, V580, P6948, DOI 10.1016/j.febslet.2006.11.061; Li LL, 2015, J NEUROSCI, V35, P7349, DOI 10.1523/JNEUROSCI.0037-15.2015; Li LL, 2013, J NEUROSCI, V33, P8185, DOI 10.1523/JNEUROSCI.4578-12.2013; Liu J, 2016, MOL NEUROBIOL, V53, P5935, DOI 10.1007/s12035-015-9504-8; Mandal PK, 2002, MONATSH CHEM, V133, P205, DOI 10.1007/s706-002-8252-5; Merino-Gracia J, 2015, FEBS J, V282, P3945, DOI 10.1111/febs.13388; Mitchell LA, 2011, AM J PHYSIOL-LUNG C, V301, pL40, DOI 10.1152/ajplung.00299.2010; Molina-Jijon E, 2014, FREE RADICAL BIO MED, V72, P162, DOI 10.1016/j.freeradbiomed.2014.03.040; Navarro-Lerida I, 2006, J CELL SCI, V119, P1558, DOI 10.1242/jcs.02878; Navarro-Lerida I, 2004, J BIOL CHEM, V279, P55682, DOI 10.1074/jbc.M406621200; Navarro-Lerida I, 2007, MOL BIOL CELL, V18, P2768, DOI 10.1091/mbc.E06-12-1102; Nomme J, 2015, J BIOL CHEM, V290, P16595, DOI 10.1074/jbc.M115.646695; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Ort T, 2000, EUR J CELL BIOL, V79, P621, DOI 10.1078/0171-9335-00095; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Persichini T, 2005, NEUROSCI LETT, V384, P254, DOI 10.1016/j.neulet.2005.04.085; Riefler GM, 2001, J BIOL CHEM, V276, P48262, DOI 10.1074/jbc.M106503200; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodriguez-Crespo I, 1998, ARCH BIOCHEM BIOPHYS, V359, P297, DOI 10.1006/abbi.1998.0928; Saitoh F, 2004, J BIOL CHEM, V279, P29461, DOI 10.1074/jbc.M401471200; Sanchez-Ruiloba L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095191; Schepens J, 1997, FEBS LETT, V409, P53, DOI 10.1016/S0014-5793(97)00481-X; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Twiss F, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27425; Van Itallie CM, 2012, J CELL SCI, V125, P4902, DOI 10.1242/jcs.111237; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783	64	20	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11581	11595		10.1074/jbc.M116.724427	http://dx.doi.org/10.1074/jbc.M116.724427			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27030110	hybrid, Green Published			2022-12-26	WOS:000377264800011
J	Almeida-Paes, R; Figueiredo-Carvalho, MHG; Brito-Santos, F; Almeida-Silva, F; Oliveira, MME; Zancope-Oliveira, RM				Almeida-Paes, Rodrigo; Galdino Figueiredo-Carvalho, Maria Helena; Brito-Santos, Fabio; Almeida-Silva, Fernando; Evangelista Oliveira, Manoel Marques; Zancope-Oliveira, Rosely Maria			Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine	PLOS ONE			English	Article							INHIBITORY CONCENTRATION INDEX; IN-VITRO; CRYPTOCOCCUS-NEOFORMANS; PARACOCCIDIOIDES-BRASILIENSIS; CUTANEOUS SPOROTRICHOSIS; PENICILLIUM-MARNEFFEI; SUSCEPTIBILITY; MELANIZATION; INFECTION; ITRACONAZOLE	Terbinafine is a recommended therapeutic alternative for patients with sporotrichosis who cannot use itraconazole due to drug interactions or side effects. Melanins are involved in resistance to antifungal drugs and Sporothrix species produce three different types of melanin. Therefore, in this study we evaluated whether Sporothrix melanins impact the efficacy of antifungal drugs. Minimal inhibitory concentrations (MIC) and minimal fungicidal concentrations (MFC) of two Sporothrix brasiliensis and four Sporothrix schenckii strains grown in the presence of the melanin precursors L-DOPA and L-tyrosine were similar to the MIC determined by the CLSI standard protocol for S. schenckii susceptibility to amphotericin B, ketoconazole, itraconazole or terbinafine. When MICs were determined in the presence of inhibitors to three pathways of melanin synthesis, we observed, in four strains, an increase in terbinafine susceptibility in the presence of tricyclazole, a DHN-melanin inhibitor. In addition, one S. schenckii strain grown in the presence of L-DOPA had a higher MFC value when compared to the control. Growth curves in presence of 2xMIC concentrations of terbinafine showed that pyomelanin and, to a lesser extent, eumelanin were able to protect the fungi against the fungicidal effect of this antifungal drug. Our results suggest that melanin protects the major pathogenic species of the Sporothrix complex from the effects of terbinafine and that the development of new antifungal drugs targeting melanin synthesis may improve sporotrichosis therapies.	[Almeida-Paes, Rodrigo; Galdino Figueiredo-Carvalho, Maria Helena; Brito-Santos, Fabio; Almeida-Silva, Fernando; Evangelista Oliveira, Manoel Marques; Zancope-Oliveira, Rosely Maria] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Micol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Almeida-Paes, R (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Micol, Rio De Janeiro, Brazil.	rodrigo.paes@ini.fiocruz.br	Almeida-Paes, R/J-2976-2015; Oliveira, Manoel M E/P-8685-2014; Almeida-Paes, Rodrigo/Q-4933-2019	Oliveira, Manoel M E/0000-0001-7670-9225; Figueiredo-Carvalho, Maria Helena/0000-0002-1719-832X	Programa institucional de inducao a cioncia, tecnologia e inovacao em saude PAPES VI - CNPq/Fiocruz [407693/2012-2]; Conselho Nacional de desenvolvimento Cientifico e Tecnologico [304976/2013-0, 449184/2014-5]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/103.157/2011]	Programa institucional de inducao a cioncia, tecnologia e inovacao em saude PAPES VI - CNPq/Fiocruz(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Conselho Nacional de desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Programa institucional de inducao a cioncia, tecnologia e inovacao em saude PAPES VI - CNPq/Fiocruz (grant number 407693/2012-2), Conselho Nacional de desenvolvimento Cientifico e Tecnologico (grant numbers 304976/2013-0 to RMZ-O, and 449184/2014-5 to RA-P), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (grant number E-26/103.157/2011 to RMZ-O). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Paes R, 2012, MELANIN BIOSYNTHESIS, P77; Almeida-Paes R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/212308; Almeida-Paes R, 2012, APPL ENVIRON MICROB, V78, P8623, DOI 10.1128/AEM.02414-12; Almeida-Paes R, 2009, MICROBES INFECT, V11, P554, DOI 10.1016/j.micinf.2009.03.002; Baltazar LM, 2015, ANTIMICROB AGENTS CH, V59, P4003, DOI 10.1128/AAC.04917-14; Teixeira PAC, 2010, MED MYCOL, V48, P687, DOI 10.3109/13693780903453287; Chakrabarti A, 2015, MED MYCOL, V53, P3, DOI 10.1093/mmy/myu062; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; CLSI, 2008, M27A3 CLSI; da Silva MB, 2006, MICROBES INFECT, V8, P197, DOI 10.1016/j.micinf.2005.06.018; Barros MBD, 2011, CLIN MICROBIOL REV, V24, P633, DOI 10.1128/CMR.00007-11; Barros MBD, 2011, CLIN INFECT DIS, V52, pE200, DOI 10.1093/cid/cir245; Dias NM, 2011, EMERG INFECT DIS, V17, P1975, DOI 10.3201/eid1710.110737; Francesconi G, 2009, J EUR ACAD DERMATOL, V23, P1273, DOI 10.1111/j.1468-3083.2009.03306.x; Francesconi G, 2011, MYCOPATHOLOGIA, V171, P349, DOI 10.1007/s11046-010-9380-8; Garcia-Rivera J, 2005, FUNGAL GENET BIOL, V42, P989, DOI 10.1016/j.fgb.2005.09.003; Ikeda R, 2003, MICROBIOL IMMUNOL, V47, P271, DOI 10.1111/j.1348-0421.2003.tb03395.x; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Marcos-Zambrano LJ, 2013, ANTIMICROB AGENTS CH, V57, P5767, DOI 10.1128/AAC.01032-13; Kaewmalakul J, 2014, ANTON LEEUW INT J G, V106, P1011, DOI 10.1007/s10482-014-0270-9; Kauffman CA, 2007, CLIN INFECT DIS, V45, P1255, DOI 10.1086/522765; Koehling HL, 2015, J CLIN MICROBIOL, V53, P255, DOI 10.1128/JCM.02830-14; Lovero G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150218; Macedo PM, 2015, J EUR ACAD DERMATOL, V29, P719, DOI 10.1111/jdv.12667; Marimon R, 2008, MED MYCOL, V46, P621, DOI 10.1080/13693780801992837; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Morris-Jones R, 2003, INFECT IMMUN, V71, P4026, DOI 10.1128/IAI.71.7.4026-4033.2003; Morrison AS, 2013, MED MYCOL CASE REP, V2, P88, DOI 10.1016/j.mmcr.2013.03.002; Nosanchuk JD, 2007, FUNGAL GENET BIOL, V44, P517, DOI 10.1016/j.fgb.2006.09.006; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pereira SA, 2010, VET REC, V166, P290, DOI [10.1136/vr.b4752, 10.1136/vr.166.10.290]; RYDER NS, 1992, BRIT J DERMATOL, V126, P2, DOI 10.1111/j.1365-2133.1992.tb00001.x; Freitas DFS, 2010, CLIN INFECT DIS, V50, DOI 10.1086/649891; Song Y, 2013, J EUR ACAD DERMATOL, V27, P313, DOI 10.1111/j.1468-3083.2011.04389.x; Sun JF, 2011, MYCOPATHOLOGIA, V172, P373, DOI 10.1007/s11046-011-9439-1; Taborda CP, 2008, MYCOPATHOLOGIA, V165, P331, DOI 10.1007/s11046-007-9061-4; Tamura T, 2014, MICROBIOL IMMUNOL, V58, P1, DOI 10.1111/1348-0421.12109; Uran ME, 2011, CLIN VACCINE IMMUNOL, V18, P1680, DOI 10.1128/CVI.05099-11; van de Sande WWJ, 2007, MICROBES INFECT, V9, P1114, DOI 10.1016/j.micinf.2007.05.015; van Duin D, 2002, ANTIMICROB AGENTS CH, V46, P3394, DOI 10.1128/AAC.46.11.3394-3400.2002; Wheeler M, 2000, INFECT IMMUN, V68, P3696, DOI 10.1128/IAI.68.6.3696-3703.2000; Yamada K, 2011, REV INST MED TROP SP, V53, P89, DOI 10.1590/S0036-46652011000200006; Youngchim S, 2005, MICROBIOL-SGM, V151, P291, DOI 10.1099/mic.0.27433-0	44	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152796	10.1371/journal.pone.0152796	http://dx.doi.org/10.1371/journal.pone.0152796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031728	Green Submitted, gold, Green Published			2022-12-26	WOS:000373121800138
J	Okerberg, ES; Hainley, A; Brown, H; Aban, A; Alemayehu, S; Shih, A; Wu, J; Patricelli, MP; Kozarich, JW; Nomanbhoy, T; Rosenblum, JS				Okerberg, Eric S.; Hainley, Anna; Brown, Heidi; Aban, Arwin; Alemayehu, Senait; Shih, Ann; Wu, Jane; Patricelli, Matthew P.; Kozarich, John W.; Nomanbhoy, Tyzoon; Rosenblum, Jonathan S.			Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1 alpha by Chemical Proteomics	PLOS ONE			English	Article							SUPPRESSOR; INHIBITOR; RESISTANCE; LKB1	We describe the identification of a novel, tumor-specific missense mutation in the active site of casein kinase 1 alpha (CSNK1A1) using activity-based proteomics. Matched normal and tumor colon samples were analyzed using an ATP acyl phosphate probe in a kinase-targeted LC-MS2 platform. An anomaly in the active-site peptide from CSNK1A1 was observed in a tumor sample that was consistent with an altered catalytic aspartic acid. Expression and analysis of the suspected mutant verified the presence of asparagine in the probe-labeled, active-site peptide for CSNK1A1. Genomic sequencing of the colon tumor samples confirmed the presence of amissensemutation in the catalytic aspartic acid of CSNK1A1 (GAC -> AAC). To our knowledge, the D163N mutation in CSNK1A1 is a newly defined mutation to the conserved, catalytic aspartic acid of a protein kinase and the first missense mutation identified using activity-based proteomics. The tumorigenic potential of this mutation remains to be determined.	[Okerberg, Eric S.; Hainley, Anna; Brown, Heidi; Aban, Arwin; Alemayehu, Senait; Shih, Ann; Wu, Jane; Kozarich, John W.; Nomanbhoy, Tyzoon; Rosenblum, Jonathan S.] ActivX Biosci Inc, La Jolla, CA USA; [Patricelli, Matthew P.] Wellspring Biosci LLC, La Jolla, CA USA	Kyorin Pharmaceutical Co Ltd	Rosenblum, JS (corresponding author), ActivX Biosci Inc, La Jolla, CA USA.	jonr@activx.com			ActivX Biosciences	ActivX Biosciences	At the time the research was performed, all authors were employed by ActivX Biosciences. Accordingly, ActivX Biosciences paid their salaries, paid for supplies and had a role in every aspect of the research.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Arnato KR, 2014, J CLIN INVEST, V124, P2037, DOI 10.1172/JCI72522; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; BOJESEN G, 1987, J AM CHEM SOC, V109, P5557, DOI 10.1021/ja00252a060; Brognard J, 2001, CANCER RES, V71, P3152; Chamrad I, 2013, J PROTEOME RES, V12, P4005, DOI 10.1021/pr400309p; Choi HG, 2012, ACS MED CHEM LETT, V3, P658, DOI 10.1021/ml300123a; Dietel M, 2015, CANCER GENE THER, V22, P417, DOI 10.1038/cgt.2015.39; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Jessani N, 2007, CHEM BIOL, P403; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Martens L, 2013, PROTEOM CLIN APPL, V7, P388, DOI 10.1002/prca.201300020; Nordin BE, 2015, BIOCHEMISTRY-US, V54, P3024, DOI 10.1021/acs.biochem.5b00148; Okerberg ES, 2014, J AM CHEM SOC, V136, P4664, DOI 10.1021/ja4129907; Okerberg ES, 2005, P NATL ACAD SCI USA, V102, P4996, DOI 10.1073/pnas.0501205102; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Xiao YS, 2014, MOL CELL PROTEOMICS, V13, P1065, DOI 10.1074/mcp.M113.036905; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843; Zhang MC, 2004, CLIN PROTEOM, V1, P301	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152934	10.1371/journal.pone.0152934	http://dx.doi.org/10.1371/journal.pone.0152934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031502	Green Published, gold			2022-12-26	WOS:000373121800156
J	Pfortmueller, CA; Drexel, C; Krahenmann-Muller, S; Leichtle, AB; Fiedler, GM; Lindner, G; Exadaktylos, AK				Pfortmueller, Carmen Andrea; Drexel, Christian; Kraehenmann-Mueller, Simone; Leichtle, Alexander Benedikt; Fiedler, Georg Martin; Lindner, Gregor; Exadaktylos, Aristomenis Konstantinos			S-100 B Concentrations Are a Predictor of Decreased Survival in Patients with Major Trauma, Independently of Head Injury	PLOS ONE			English	Article							SERUM S100B LEVELS; BRAIN-DEATH; PROTEIN; SEVERITY; MARKER	Background Major trauma remains one of the principle causes of disability and death throughout the world. There is currently no satisfactory risk assessment to predict mortality in patients with major trauma. The aim of our study is to examine whether S-100 B protein concentrations correlate with injury severity and survival in patients with major trauma, with special emphasis on patients without head injury. Methods Our retrospective data analysis comprised adult patients admitted to our emergency department between 1.12. 2008 and 31.12 2010 with a suspected major trauma. S-100 B concentrations were routinely assessed in major trauma patients. Results A total of 27.7%(378) of all patients had major trauma. The median ISS was 24.6 (SD 8.4); 16.6% (63/378) of the patients died. S-100 B concentrations correlated overall with the ISS (p<0.0001). Patients who died had significantly higher S-100 B concentrations than survivors (8.2 mu g/l versus 2.2 mu g/l, p<0.0001). Polytraumatised patients with and without head trauma did not differ significantly with respect to S-100 B concentration (3.2 mu g/l (SD 5.3) versus 2.9 mu g/l (SD 3.8), respectively, p = 0.63) or with respect to Injury Severity Score (24.8 (SD 8.6) versus 24.2 (SD 8.1), respectively, p = 0.56). S-100 B concentrations correlated negatively with survival (p<0.0001) in all patients and in both subgroups (p = 0.001 and p = 0.006, respectively) Conclusions S-100 concentrations on admission correlate positively with greater injury severity and decreased survival in major trauma patients, independently of the presence of a head injury. S-100 B protein levels at admission in patients with major trauma may therefore be used to assess outcome in all polytraumatised patients. These measurements should be subject to further evaluation.	[Pfortmueller, Carmen Andrea] Vienna Gen Hosp, Clin Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria; [Pfortmueller, Carmen Andrea] Univ Vienna, Vienna, Austria; [Pfortmueller, Carmen Andrea; Drexel, Christian; Kraehenmann-Mueller, Simone; Lindner, Gregor; Exadaktylos, Aristomenis Konstantinos] Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen Andrea; Drexel, Christian; Kraehenmann-Mueller, Simone; Lindner, Gregor; Exadaktylos, Aristomenis Konstantinos] Univ Bern, Bern, Switzerland; [Leichtle, Alexander Benedikt; Fiedler, Georg Martin] Inselspital Bern, Univ Hosp Bern, Univ Inst Clin Chem, Ctr Lab Med, CH-3010 Bern, Switzerland; [Lindner, Gregor] Hirslandenklin Pk Zurich, Dept Emergency Med, Zurich, Switzerland	University of Vienna; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Vienna Gen Hosp, Clin Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria.; Pfortmueller, CA (corresponding author), Univ Vienna, Vienna, Austria.; Pfortmueller, CA (corresponding author), Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland.; Pfortmueller, CA (corresponding author), Univ Bern, Bern, Switzerland.	cpfortmueller@gmail.com	Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011; Lindner, Gregor/AAR-6761-2020	Fiedler, Georg Martin/0000-0001-5689-4574; Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770				Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; [Anonymous], 2012, INJURY SEVERITY SCOR; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Dang XB, 2014, INT J CLIN EXP PATHO, V7, P3818; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Genarelli T, 2008, ABBREVIATED INJURY S, P1; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Leigh JP, 2011, MILBANK Q, V89, P728, DOI 10.1111/j.1468-0009.2011.00648.x; Lomas JP, 2005, EMERG MED J, V22, P889, DOI 10.1136/emj.2005.031732; Mussack T, 2000, ACT NEUR S, V76, P393; Network BI, 2011, DEFINITION ABI TBI; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shakeril M, 2013, ARCH TRAUMA RES, V2, P76, DOI 10.5812/atr.8549; Soreide K, 2009, BRIT J SURG, V96, P697, DOI 10.1002/bjs.6643; Stamataki E, 2013, SHOCK, V40, P274, DOI 10.1097/SHK.0b013e3182a35de5; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Union E., INJ EUR UN SUMM INJ; Wolf H, 2014, J NEUROTRAUMA	25	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152822	10.1371/journal.pone.0152822	http://dx.doi.org/10.1371/journal.pone.0152822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031106	Green Published, gold			2022-12-26	WOS:000373121800143
J	Uysal, HK; Sohrabi, P; Habip, Z; Saribas, S; Kocazeybek, E; Seyhan, F; Caliskan, R; Bonabi, E; Yuksel, P; Birinci, I; Uysal, O; Kocazeybek, B				Uysal, Hayriye Kirkoyun; Sohrabi, Pari; Habip, Zafer; Saribas, Suat; Kocazeybek, Emre; Seyhan, Fatih; Caliskan, Reyhan; Bonabi, Esad; Yuksel, Pelin; Birinci, Ilhan; Uysal, Omer; Kocazeybek, Bekir			Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PREDICTS DISEASE PROGRESSION; ANTIRETROVIRAL THERAPY HAART; HIV-1/HIV-2 RAPID TEST; INTERFERON-GAMMA; SERUM NEOPTERIN; MICROBIAL TRANSLOCATION; PROGNOSTIC-SIGNIFICANCE; VIRAL LOAD; MARKERS	Background We aimed to evaluate the roles of the plasma immune activation biomarkers neopterin and soluble CD14 (sCD14) in the indirect assessment of the immune activation status of patients with the indeterminate HIV-1 (IHIV-1) pattern and a true HIV-1-positive infection (PCG). Methods This cross-sectional and descriptive study included eighty-eight patients with the IHIV-1 pattern, 100 patients in the PCG, and 100 people in a healthy control group (HCG). Neopterin and sCD14 levels were determined by competitive and sandwich ELISA methods, respectively. Results Mean neopterin and sCD14 levels among those with the IHIV-1 pattern were significantly lower than among the PCG (p < 0.001 and p = 0.001, respectively), but they were similiar to those in the HCG (p = 0.57 and p = 0.66, respectively. Mean neopterin and sCD14 levels among the PCG were found to be significantly higher than among those with the IHIV-1 pattern (p < 0.001 and p = 0.001, respectively) and among those in the HCG (p = 0.001, p < 0.001, respectively). Neopterin did not have adequate predictive value for identifying those in the PCG (area under the curve [AUC] = 0.534; 95% CI, 0.463-0.605; p = 0.4256); sCD14 also had poor predictive value but high specificity (100%) for identifying those in the PCG (AUC = 0.627; 95% CI, 0.556-0.694; p = 0.0036). Conclusions While low levels of these two biomarkers were detected among those with the IHIV-1 pattern, they were found in high levels among those in the PCG. These two markers obviously cannot be used as a sceening test because they have low sensitivies. Taken together, we suggest that neopterin and sCD14 may be helpful because they both have high specificity (92%-100%) as indirect non-specific markers for predicting the immune activation status of individuals, whether or not they have true positive HIV-1.	[Uysal, Hayriye Kirkoyun] Istanbul Univ, Istanbul Fac Med, Dept Med Microbiol, Istanbul, Turkey; [Sohrabi, Pari] Istanbul Publ Hlth Lab, Istanbul, Turkey; [Habip, Zafer; Saribas, Suat; Caliskan, Reyhan; Yuksel, Pelin; Kocazeybek, Bekir] Istanbul Univ, Cerrahpasa Med Fac, Dept Med Microbiol, Istanbul, Turkey; [Kocazeybek, Emre] Marmara Univ, Fac Med, Istanbul, Turkey; [Seyhan, Fatih] Istanbul Leprosy Dermatol & Venereol Hosp, Istanbul, Turkey; [Bonabi, Esad] Istanbul Aydin Univ, Hlth Serv Vocat Sch Higher Educ, Istanbul, Turkey; [Birinci, Ilhan] Turkish Red Crescent, Istanbul, Turkey; [Uysal, Omer] Bezmialem Vakif Univ, Sch Med, Deparment Biostat, Istanbul, Turkey	Istanbul University; Istanbul University; Istanbul University - Cerrahpasa; Marmara University; Istanbul Lepra Skin & Venereal Diseases Hospital; Istanbul Aydin University; Bezmialem Vakif University	Saribas, S (corresponding author), Istanbul Univ, Cerrahpasa Med Fac, Dept Med Microbiol, Istanbul, Turkey.	suatsaribas@gmail.com	habip, zafer/AAA-8496-2020; Uysal, Ömer/AAR-4220-2020; Kocazeybek, Bekir/D-8113-2018; Uysal, Hayriye Kırkoyun/A-7548-2016; Saribas, Suat/D-6440-2019	Uysal, Ömer/0000-0002-8833-697X; Saribas, Suat/0000-0002-4549-3887; Kocazeybek, Bekir S/0000-0003-1072-3846; sohrabi molla yousefi, peri/0000-0001-6346-1398	Istanbul University Research Fund [45694]	Istanbul University Research Fund(Istanbul University)	This work was supported by Istanbul University Research Fund with the project number 45694.	Amirayan-Chevillard N, 2000, CLIN DIAGN LAB IMMUN, V7, P832, DOI 10.1128/CDLI.7.5.832-834.2000; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Balakrishnan P, 2005, INDIAN J MED RES, V121, P345; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; BAZIL V, 1991, J IMMUNOL, V147, P1567; Bipath P, 2015, AFR HEALTH SCI, V15, P334, DOI 10.4314/ahs.v15i2.5; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chadha Sanjim, 2013, Interdiscip Perspect Infect Dis, V2013, P143648, DOI 10.1155/2013/143648; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Romero-Sanchez MC, 2012, J INFECTION, V65, P431, DOI 10.1016/j.jinf.2012.06.008; Cornett JK, 2013, CLIN INFECT DIS, V57, P712, DOI 10.1093/cid/cit281; Daniel V, 1999, IMMUNOL LETT, V69, P283, DOI 10.1016/S0165-2478(99)00105-4; DENZ H, 1990, EUR J HAEMATOL, V44, P186; Eisenhut Michael, 2013, J Biomark, V2013, P196432, DOI 10.1155/2013/196432; Eller MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018779; Fahey JL, 1998, AIDS, V12, P1581, DOI 10.1097/00002030-199813000-00004; Fisenk BI, 2005, SCAND J INFECT DIS, V37, P599, DOI 10.1080/00365540510043310; Fuchs D, 1992, Eur J Med, V1, P196; FUCHS D, 1992, CRIT REV CL LAB SCI, V29, P307, DOI 10.3109/10408369209114604; FUCHS D, 1991, IMMUNOL LETT, V28, P207, DOI 10.1016/0165-2478(91)90005-U; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Hoffmann G, 2004, PTERIDINES, V15, P107; HONLINGER M, 1989, DEUT MED WOCHENSCHR, V114, P172, DOI 10.1055/s-2008-1066571; Immanuel C, 2005, INDIAN J MED RES, V121, P220; LABETA MO, 1993, EUR J IMMUNOL, V23, P2144, DOI 10.1002/eji.1830230915; Lien E, 1998, BLOOD, V92, P2084, DOI 10.1182/blood.V92.6.2084.418k26_2084_2092; Linley L, 2013, J CLIN VIROL, V58, pE108, DOI 10.1016/j.jcv.2013.09.021; Malloch L, 2013, J CLIN VIROL, V58, pE85, DOI 10.1016/j.jcv.2013.08.008; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Mildvan D, 2005, CLIN INFECT DIS, V40, P853, DOI 10.1086/427877; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Nasrullah M, 2011, J CLIN VIROL, V52, pS23, DOI 10.1016/j.jcv.2011.09.020; Nubling CM, 2006, TRANSFUSION, V46, P1886, DOI 10.1111/j.1537-2995.2006.00994.x; Plaeger S, 1999, CLIN IMMUNOL, V90, P238, DOI 10.1006/clim.1998.4646; REIBNEGGER G, 1988, HEPATOLOGY, V8, P771, DOI 10.1002/hep.1840080412; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schroecksnadel K, 2004, PTERIDINES, V15, P75; Stein DS, 1997, J INFECT DIS, V176, P1161, DOI 10.1086/514108; Sucher R, 2010, CANCER LETT, V287, P13, DOI 10.1016/j.canlet.2009.05.008; TSOUKAS CM, 1994, CLIN MICROBIOL REV, V7, P14, DOI 10.1128/CMR.7.1.14-28.1994; WAHL LM, 1989, P NATL ACAD SCI USA, V86, P621, DOI 10.1073/pnas.86.2.621; Wirleitner B, 2005, MOL IMMUNOL, V42, P183, DOI 10.1016/j.molimm.2004.06.017	43	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152258	10.1371/journal.pone.0152258	http://dx.doi.org/10.1371/journal.pone.0152258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031691	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800047
J	An, FF; Chen, T; Stephanie, DMA; Li, KM; Li, QX; Carvalho, LJCB; Tomlins, K; Li, J; Gu, B; Chen, SB				An, Feifei; Chen, Ting; Stephanie, Djabou Mouafi Astride; Li, Kaimian; Li, Qing X.; Carvalho, Luiz J. C. B.; Tomlins, Keith; Li, Jun; Gu, Bi; Chen, Songbi			Domestication Syndrome Is Investigated by Proteomic Analysis between Cultivated Cassava (Manihot esculenta Crantz) and Its Wild Relatives	PLOS ONE			English	Article							ROOT PROTEOME; PHOTOSYNTHESIS; C-3	Cassava (Manihot esculenta Crantz) wild relatives remain a largely untapped potential for genetic improvement. However, the domestication syndrome phenomena from wild species to cultivated cassava remain poorly understood. The analysis of leaf anatomy and photosynthetic activity showed significantly different between cassava cultivars SC205, SC8 and wild relative M. esculenta ssp. Flabellifolia (W14). The dry matter, starch and amylose contents in the storage roots of cassava cultivars were significantly more than that in wild species. In order to further reveal the differences in photosynthesis and starch accumulation of cultivars and wild species, the globally differential proteins between cassava SC205, SC8 and W14 were analyzed using 2-DE in combination with MALDI-TOF tandem mass spectrometry. A total of 175 and 304 proteins in leaves and storage roots were identified, respectively. Of these, 122 and 127 common proteins in leaves and storage roots were detected in SC205, SC8 and W14, respectively. There were 11, 2 and 2 unique proteins in leaves, as well as 58, 9 and 12 unique proteins in storage roots for W14, SC205 and SC8, respectively, indicating proteomic changes in leaves and storage roots between cultivated cassava and its wild relatives. These proteins and their differential regulation across plants of contrasting leaf morphology, leaf anatomy pattern and photosynthetic related parameters and starch content could contribute to the footprinting of cassava domestication syndrome. We conclude that these global protein data would be of great value to detect the key gene groups related to cassava selection in the domestication syndrome phenomena.	[An, Feifei; Chen, Ting; Stephanie, Djabou Mouafi Astride; Li, Kaimian; Chen, Songbi] Chinese Acad Trop Agr Sci, Key Lab Minist Agr Germplasm Resources Conservat, Trop Crops Genet Resources Inst, Danzhou 571737, Peoples R China; [Stephanie, Djabou Mouafi Astride] Univ Yaounde I, Higher Teachers Training Coll, Lab Plant Physiol, POB 47, Yaounde, Cameroon; [Li, Qing X.] Univ Hawaii, Dept Mol Biosci & Bioengn, Manoa, HI 96822 USA; [Carvalho, Luiz J. C. B.] EMBRAPA, Genet Resources & Biotechnol, BR-02372 Brasilia, DF, Brazil; [Tomlins, Keith] Univ Greenwich, Nat Resources Inst, Chatham ME4 4TB, Kent, England; [Li, Jun] Jiangsu Univ, Anal & Testing Ctr, Zhenjiang 212013, Peoples R China; [Gu, Bi] Guangxi Univ, Chem Starch Inst, Nanning 300004, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; University of Yaounde I; University of Hawaii System; University of Hawaii Manoa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Greenwich; Jiangsu University; Guangxi University	Chen, SB (corresponding author), Chinese Acad Trop Agr Sci, Key Lab Minist Agr Germplasm Resources Conservat, Trop Crops Genet Resources Inst, Danzhou 571737, Peoples R China.; Li, QX (corresponding author), Univ Hawaii, Dept Mol Biosci & Bioengn, Manoa, HI 96822 USA.	qingl@hawaii.edu; songbichen@yahoo.com	Li, Qing/AAO-3938-2020	Tomlins, Keith/0000-0001-6897-5902	NSFC-CGIAR International (Regional) Cooperation and Exchange Programs [31361140366]; Initia Fund of High-level Creative Talents in Hainan Province; CATAS Key Technology Research and Development Program [1630032015005]; Natural science foundation project of Hainan province [20153053]; U.S. National Institute on Minority Health and Health Disparities [8G12MD007601]; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	NSFC-CGIAR International (Regional) Cooperation and Exchange Programs; Initia Fund of High-level Creative Talents in Hainan Province; CATAS Key Technology Research and Development Program; Natural science foundation project of Hainan province; U.S. National Institute on Minority Health and Health Disparities; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NSFC-CGIAR International (Regional) Cooperation and Exchange Programs (31361140366), the Initia Fund of High-level Creative Talents in Hainan Province, CATAS Key Technology Research and Development Program (1630032015005), Natural science foundation project of Hainan province (20153053), and the U.S. National Institute on Minority Health and Health Disparities (8G12MD007601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allem AC, 1999, EUPHYTICA, V107, P123, DOI 10.1023/A:1026422229054; Alves Alfredo Augusto Cunha, 2001, P67, DOI 10.1079/9780851995243.0067; An FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085991; ANGELOV MN, 1993, PHOTOSYNTH RES, V38, P61, DOI 10.1007/BF00015062; Brautigam A, 2008, PLANT PHYSIOL, V148, P568, DOI 10.1104/pp.108.121012; Calatayud PA, 2002, ANN BOT-LONDON, V89, P125, DOI 10.1093/aob/mcf016; Carvalho Luiz Joaquim Castelo Branco, 2012, Open Biochem J, V6, P116, DOI 10.2174/1874091X01206010116; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Chen SB, 2009, J EXP BOT, V60, P2005, DOI 10.1093/jxb/erp075; Dengler N., 1999, C4 PLANT BIOL; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; El-Sharkawy MA, 2004, J FOOD AGRIC ENVIRON, V7, P468; Gomes PTC, 2013, GENET MOL RES, V12, P1214, DOI 10.4238/2013.April.12.8; Gu B, 2013, STARCH-STARKE, V65, P253, DOI 10.1002/star.201200028; Gulick P, 1983, GENETIC RESOURCES CA; Halsey Chavarriaga-Aguirre, 2005, CASSAVA MANIHOT ESCU; Jansson C, 2009, APPL ENERG, V86, pS95, DOI 10.1016/j.apenergy.2009.05.011; Li KM, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-10; Medina RD, 2007, ANN BOT, P1; Nassar NMA, 2006, GENET MOL RES, V5, P536; Nassar NMA, 2007, GENET RESOUR CROP EV, V54, P1523, DOI 10.1007/s10722-006-9144-y; Owiti J, 2011, PLANT J, V67, P145, DOI 10.1111/j.1365-313X.2011.04582.x; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Raven P, 2006, SCIENCE, V311, P468; Sakurai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074056; Sarian FD, 2012, APPL MICROBIOL BIOT, V93, P645, DOI 10.1007/s00253-011-3436-7; Sheffield J, 2006, PROTEOMICS, V6, P1588, DOI 10.1002/pmic.200500503; Stein L, 2001, NAT REV GENET, V2, P493, DOI 10.1038/35080529; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Ueno O, 2001, PLANT PHYSIOL, V127, P1524, DOI 10.1104/pp.010704	30	10	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152154	10.1371/journal.pone.0152154	http://dx.doi.org/10.1371/journal.pone.0152154			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023871	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900025
J	Lu, YW; Zhang, HF; Liang, R; Xie, ZR; Luo, HY; Zeng, YJ; Xu, Y; Wang, LM; Kong, XY; Wang, KH				Lu, You-Wang; Zhang, Hui-Feng; Liang, Rui; Xie, Zhen-Rong; Luo, Hua-You; Zeng, Yu-Jian; Xu, Yu; Wang, La-Mei; Kong, Xiang-Yang; Wang, Kun-Hua			Colorectal Cancer Genetic Heterogeneity Delineated by Multi-Region Sequencing	PLOS ONE			English	Article							INTRATUMOR HETEROGENEITY; MUTATIONAL LANDSCAPE; CELL-MIGRATION; HUMAN COLON; METASTASIS; EXPRESSION; EVOLUTION; INVASION; MARKER; SMAD4	Intratumor heterogeneity (ITH) leads to an underestimation of the mutational landscape portrayed by a single needle biopsy and consequently affects treatment precision. The extent of colorectal cancer (CRC) genetic ITH is not well understood in Chinese patients. Thus, we conducted deep sequencing by using the OncoGxOne (TM) Plus panel, targeting 333 cancer-specific genes in multi-region biopsies of primary and liver metastatic tumors from three Chinese CRC patients. We determined that the extent of ITH varied among the three cases. On average, 65% of all the mutations detected were common within individual tumors. KMT2C aberrations and the NCOR1 mutation were the only ubiquitous events. Subsequent phylo-genetic analysis showed that the tumors evolved in a branched manner. Comparison of the primary and metastatic tumors revealed that PPP2R1A (E370X), SETD2 (I1608V), SMAD4 (G382T), and AR splicing site mutations may be specific to liver metastatic cancer. These mutations might contribute to the initiation and progression of distant metastasis. Collectively, our analysis identified a substantial level of genetic ITH in CRC, which should be considered for personalized therapeutic strategies.	[Lu, You-Wang; Zhang, Hui-Feng; Kong, Xiang-Yang; Wang, Kun-Hua] Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Yunnan, Peoples R China; [Lu, You-Wang; Wang, La-Mei; Kong, Xiang-Yang] Kunming Univ Sci & Technol, Fac Med, Kunming, Yunnan, Peoples R China; [Zhang, Hui-Feng] First Peoples Hosp Yunnan Prov, Dept Pharm, Kunming, Yunnan, Peoples R China; [Xie, Zhen-Rong; Luo, Hua-You; Zeng, Yu-Jian; Xu, Yu; Wang, Kun-Hua] Kunming Med Univ, Yunnan Inst Digest Dis, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Luo, Hua-You; Zeng, Yu-Jian; Xu, Yu; Wang, Kun-Hua] Kunming Med Univ, Dept Gastrointestinal & Hernia Surg, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Luo, Hua-You; Zeng, Yu-Jian; Xu, Yu; Wang, Kun-Hua] Jie Shou Li Acad Workstn, Kunming, Yunnan, Peoples R China; [Liang, Rui] First Peoples Hosp Yunnan Prov, Dept Pathol, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology; Kunming University of Science & Technology; Kunming Medical University; Kunming Medical University	Kong, XY; Wang, KH (corresponding author), Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Yunnan, Peoples R China.; Kong, XY (corresponding author), Kunming Univ Sci & Technol, Fac Med, Kunming, Yunnan, Peoples R China.; Wang, KH (corresponding author), Kunming Med Univ, Yunnan Inst Digest Dis, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.; Wang, KH (corresponding author), Kunming Med Univ, Dept Gastrointestinal & Hernia Surg, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.; Wang, KH (corresponding author), Jie Shou Li Acad Workstn, Kunming, Yunnan, Peoples R China.	kxy02@kmust.edu.cn; wangkunhua_group@163.com		Kong, xiangyang/0000-0001-8184-2493	Foundation of Medical Leading Talent of Yunnan Province [L-201205]; Foundation of Yunnan Institute of Digestive Disease [2014NS122]; Department of Science and Technology of Yunnan Province-Kunming Medical University [2015FB100]; National Natural Science Foundation of China [81460007]	Foundation of Medical Leading Talent of Yunnan Province; Foundation of Yunnan Institute of Digestive Disease; Department of Science and Technology of Yunnan Province-Kunming Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Foundation of Medical Leading Talent of Yunnan Province (No. L-201205) KHW, Foundation of Yunnan Institute of Digestive Disease (No. 2014NS122) KHW, Department of Science and Technology of Yunnan Province-Kunming Medical University (NO. 2015FB100) HFZ, National Natural Science Foundation of China (81460007) XYK. http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzouzi H, 2005, CLIN CANCER RES, V11, P2606, DOI 10.1158/1078-0432.CCR-04-1458; Berg KD, 2000, J MOL DIAGN, V2, P20, DOI 10.1016/S1525-1578(10)60611-3; Bluemn EG, 2013, MOL CANCER RES, V11, P568, DOI 10.1158/1541-7786.MCR-12-0710; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Brannon AR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0454-7; Chen S, 2011, ISRN Gastroenterol, V2011, P909121, DOI 10.5402/2011/909121; CHEN W, 2009, CHIN J CANCER RES, V25, P10, DOI DOI 10.3978/J.ISSN.1000-9604.2012.12.04; Christianson DR, 2015, P NATL ACAD SCI USA, V112, P2521, DOI 10.1073/pnas.1424994112; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kim TM, 2015, CLIN CANCER RES, V21, P4461, DOI 10.1158/1078-0432.CCR-14-2413; Kim TM, 2014, J PATHOL, V233, P425, DOI 10.1002/path.4380; Kogita A, 2015, BIOCHEM BIOPH RES CO, V458, P52, DOI 10.1016/j.bbrc.2015.01.064; Kong DJ, 2015, PROSTATE, V75, P161, DOI 10.1002/pros.22901; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XM, 2011, J GASTROINTEST SURG, V15, P2001, DOI 10.1007/s11605-011-1627-2; Losi L, 2007, ONCOL REP, V17, P1095; Ma WL, 2012, HEPATOLOGY, V56, P176, DOI 10.1002/hep.25644; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Merrell KW, 2011, ONCOGENE, V30, P1608, DOI 10.1038/onc.2010.528; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naxerova K, 2014, P NATL ACAD SCI USA, V111, pE1889, DOI 10.1073/pnas.1400179111; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Retief J D, 2000, Methods Mol Biol, V132, P243; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xiao DS, 2006, ACTA BIOCH BIOPH SIN, V38, P883, DOI 10.1111/j.1745-7270.2006.00233.x; Zhang BG, 2014, ONCOTARGET, V5, P10584, DOI 10.18632/oncotarget.2513; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	37	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152673	10.1371/journal.pone.0152673	http://dx.doi.org/10.1371/journal.pone.0152673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023146	Green Submitted, gold, Green Published			2022-12-26	WOS:000373113900089
J	Nakano, T; Inoue, I; Takenaka, Y; Ono, H; Katayama, S; Awata, T; Murakoshi, T				Nakano, Takanari; Inoue, Ikuo; Takenaka, Yasuhiro; Ono, Hiraku; Katayama, Shigehiro; Awata, Takuya; Murakoshi, Takayuki			Ezetimibe Promotes Brush Border Membrane-to-Lumen Cholesterol Efflux in the Small Intestine	PLOS ONE			English	Article							ABSORPTION INHIBITOR EZETIMIBE; NEUTRAL STEROL EXCRETION; CACO-2 CELLS; DIETARY-CHOLESTEROL; PLANT STEROLS; SECRETION; TRANSPORT; MICE; NPC1L1; ABCG8	Ezetimibe inhibits Niemann-Pick C1-like 1 (NPC1L1), an apical membrane cholesterol transporter of enterocytes, thereby reduces intestinal cholesterol absorption. This treatment also increases extrahepatic reverse cholesterol transport via an undefined mechanism. To explore this, we employed a trans-intestinal cholesterol efflux (TICE) assay, which directly detects circulation-to-intestinal lumen H-3-cholesterol transit in a cannulated jejunal segment, and found an increase of TICE by 45%. To examine whether such increase in efflux occurs at the intestinal brush border membrane(BBM)-level, we performed luminal perfusion assays, similar to TICE but the jejunal wall was labelled with orally-given H-3-cholesterol, and determined elevated BBM-to-lumen cholesterol efflux by 3.5-fold with ezetimibe. Such increased efflux probably promotes circulation-to-lumen cholesterol transit eventually; thus increases TICE. Next, we wondered how inhibition of NPC1L1, an influx transporter, resulted in increased efflux. When we traced orally-given H-3-cholesterol in mice, we found that lumen-to-BBM H-3-cholesterol transit was rapid and less sensitive to ezetimibe treatment. Comparison of the efflux and fractional cholesterol absorption revealed an inverse correlation, indicating the efflux as an opposite-regulatory factor for cholesterol absorption efficiency and counteracting to the naturally-occurring rapid cholesterol influx to the BBM. These suggest that the ezetimibe-stimulated increased efflux is crucial in reducing cholesterol absorption. Ezetimibe-induced increase in cholesterol efflux was approximately 2.5-fold greater in mice having endogenous ATP-binding cassette G5/G8 heterodimer, the major sterol efflux transporter of enterocytes, than the knockout counterparts, suggesting that the heterodimer confers additional rapid BBM-to-lumen cholesterol efflux in response to NPC1L1 inhibition. The observed framework for intestinal cholesterol fluxes may provide ways to modulate the flux to dispose of endogenous cholesterol efficiently for therapeutic purposes.	[Nakano, Takanari; Murakoshi, Takayuki] Saitama Med Univ, Fac Med, Dept Biochem, Saitama, Japan; [Inoue, Ikuo; Takenaka, Yasuhiro; Ono, Hiraku; Katayama, Shigehiro] Saitama Med Univ, Fac Med, Dept Diabet & Endocrinol, Moroyama, Saitama, Japan; [Awata, Takuya] Int Univ Hlth & Welf Hosp, Dept Diabet Endocrinol & Metab, Nasushiobara, Tochigi, Japan	Saitama Medical University; Saitama Medical University; International University of Health & Welfare	Nakano, T (corresponding author), Saitama Med Univ, Fac Med, Dept Biochem, Saitama, Japan.	tnakano@saitama-med.ac.jp	Takenaka, Yasuhiro/HDO-7290-2022	Awata, Takuya/0000-0003-2622-8129	JSPS KAKENHI [25504013]; Mitsukoshi Health and Welfare Foundation; Suzuken Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsukoshi Health and Welfare Foundation; Suzuken Memorial Foundation	This study was supported by JSPS KAKENHI (https://www.jsps.go.jp/english/index.html) Grant number 25504013, Research Fund of Mitsukoshi Health and Welfare Foundation 2014 (http://www.mhwf.or.jp/research-assist/medical-assist/application/), and Suzuken Memorial Foundation 2011 (http://www.suzuken.co.jp/english/index.html).	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Beaumier-Gallon G, 2001, AM J CLIN NUTR, V73, P870; Bonamassa B, 2013, TRENDS ENDOCRIN MET, V24, P120, DOI 10.1016/j.tem.2012.10.004; Breevoort SR, 2014, ARTERIOSCL THROM VAS, V34, P1650, DOI 10.1161/ATVBAHA.114.303383; Brufau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021576; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Chang TY, 2008, CELL METAB, V7, P469, DOI 10.1016/j.cmet.2008.05.001; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; Davidson MH, 2013, ATHEROSCLEROSIS, V230, P322, DOI 10.1016/j.atherosclerosis.2013.08.006; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Hawes BE, 2007, MOL PHARMACOL, V71, P19, DOI 10.1124/mol.106.027896; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; Igel M, 2003, J LIPID RES, V44, P533, DOI 10.1194/jlr.M200393-JLR200; Jakulj L, 2010, FEBS LETT, V584, P3625, DOI 10.1016/j.febslet.2010.07.035; Knoepfel M, 2007, BBA-MOL CELL BIOL L, V1771, P1140, DOI 10.1016/j.bbalip.2007.05.011; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Le May C, 2013, ARTERIOSCL THROM VAS, V33, P1484, DOI 10.1161/ATVBAHA.112.300263; Musliner T, 2008, INT J CLIN PRACT, V62, P995, DOI 10.1111/j.1742-1241.2008.01786.x; Nakano T, 2007, AM J PHYSIOL-GASTR L, V292, pG1439, DOI 10.1152/ajpgi.00331.2006; Nakano T, 2009, J CLIN BIOCHEM NUTR, V45, P227, DOI 10.3164/jcbn.09-25; Nakano T, 2009, BBA-BIOMEMBRANES, V1788, P2222, DOI 10.1016/j.bbamem.2009.07.015; Nakano T, 2009, AM J PHYSIOL-GASTR L, V297, pG207, DOI 10.1152/ajpgi.90590.2008; Orlowski S, 2007, EUR BIOPHYS J BIOPHY, V36, P869, DOI 10.1007/s00249-007-0193-8; Salen G, 2006, GASTROENTEROLOGY, V130, P1853, DOI 10.1053/j.gastro.2006.02.027; Salen G, 2004, CIRCULATION, V109, P966, DOI 10.1161/01.CIR.0000116766.31036.03; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sehayek E, 2008, ARTERIOSCL THROM VAS, V28, P1296, DOI 10.1161/ATVBAHA.108.165803; Tang WQ, 2009, J LIPID RES, V50, P293, DOI 10.1194/jlr.M800439-JLR200; Temel RE, 2015, TRENDS PHARMACOL SCI, V36, P440, DOI 10.1016/j.tips.2015.04.002; Uto-Kondo H, 2014, BBA-MOL CELL BIOL L, V1841, P1247, DOI 10.1016/j.bbalip.2014.05.009; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; van Heek M, 2000, BRIT J PHARMACOL, V129, P1748, DOI 10.1038/sj.bjp.0703235; von Bergmann K, 2005, AM J CARDIOL, V96, p10D, DOI 10.1016/j.amjcard.2005.03.014; Vrins CLJ, 2012, J LIPID RES, V53, P2017, DOI 10.1194/jlr.M022194; Vrins CLJ, 2009, J LIPID RES, V50, P2046, DOI 10.1194/jlr.M800579-JLR200; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Xie C, 2012, J LIPID RES, V53, P2092, DOI 10.1194/jlr.M027359; Yamanashi Y, 2007, J PHARMACOL EXP THER, V320, P559, DOI 10.1124/jpet.106.114181; Yu LQ, 2005, J LIPID RES, V46, P1739, DOI 10.1194/jlr.M500124-JLR200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	42	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152207	10.1371/journal.pone.0152207	http://dx.doi.org/10.1371/journal.pone.0152207			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023132	Green Submitted, Green Published, gold			2022-12-26	WOS:000373113900030
J	Gonzalez, PN; Gasperowicz, M; Barbeito-Andres, J; Klenin, N; Cross, JC; Hallgrimsson, B				Gonzalez, Paula N.; Gasperowicz, Malgorzata; Barbeito-Andres, Jimena; Klenin, Natasha; Cross, James C.; Hallgrimsson, Benedikt			Chronic Protein Restriction in Mice Impacts Placental Function and Maternal Body Weight before Fetal Growth	PLOS ONE			English	Article							RESOURCE-ALLOCATION; FOOD RESTRICTION; GESTATIONAL-AGE; GENE-EXPRESSION; SKULL; PHENOTYPE; NUTRITION; PREGNANCY; MODEL; RATS	Mechanisms of resource allocation are essential for maternal and fetal survival, particularly when the availability of nutrients is limited. We investigated the responses of feto-placental development to maternal chronic protein malnutrition to test the hypothesis that maternal low protein diet produces differential growth restriction of placental and fetal tissues, and adaptive changes in the placenta that may mitigate impacts on fetal growth. C57BL/6J female mice were fed either a low-protein diet (6% protein) or control isocaloric diet (20% protein). On embryonic days E10.5, 17.5 and 18.5 tissue samples were prepared for morphometric, histological and quantitative RT-PCR analyses, which included markers of trophoblast cell subtypes. Potential endocrine adaptations were assessed by the expression of Prolactin-related hormone genes. In the low protein group, placenta weight was significantly lower at E10.5, followed by reduction of maternal weight at E17.5, while the fetuses became significantly lighter no earlier than at E18.5. Fetal head at E18.5 in the low protein group, though smaller than controls, was larger than expected for body size. The relative size and shape of the cranial vault and the flexion of the cranial base was affected by E17.5 and more severely by E18.5. The junctional zone, a placenta layer rich in endocrine and energy storing glycogen cells, was smaller in low protein placentas as well as the expression of Pcdh12, a marker of glycogen trophoblast cells. Placental hormone gene Prl3a1 was altered in response to low protein diet: expression was elevated at E17.5 when fetuses were still growing normally, but dropped sharply by E18.5 in parallel with the slowing of fetal growth. This model suggests that nutrients are preferentially allocated to sustain fetal and brain growth and suggests the placenta as a nutrient sensor in early gestation with a role in mitigating impacts of poor maternal nutrition on fetal growth.	[Gonzalez, Paula N.; Barbeito-Andres, Jimena] CCT CONICET, Inst Genet Vet, La Plata, Buenos Aires, Argentina; [Gonzalez, Paula N.; Barbeito-Andres, Jimena] UNLP, Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina; [Gasperowicz, Malgorzata; Cross, James C.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Gasperowicz, Malgorzata; Cross, James C.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Klenin, Natasha; Cross, James C.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Hallgrimsson, Benedikt] Univ Calgary, Dept Cell Biol & Anat, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Hallgrimsson, Benedikt] Univ Calgary, McCaig Inst Bone & Joint Health, Calgary, AB, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Cross, JC (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada.; Cross, JC (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.; Cross, JC (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.; Hallgrimsson, B (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.; Hallgrimsson, B (corresponding author), Univ Calgary, McCaig Inst Bone & Joint Health, Calgary, AB, Canada.	jcross@ucalgary.ca; bhallgri@ucalgary.ca	Hallgrimsson, Benedikt/A-9616-2008; Cross, James/F-4814-2011; Cross, James/AAU-2973-2020	Hallgrimsson, Benedikt/0000-0002-7192-9103; Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378	Canadian Institutes of Health Research [37776]; National Institute of Health [1R01DE021708, 1R01DE01963]; Natural Sciences and Engineering Research Council of Canada [238992-12]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2014-1810]; COnsejo Nacional de Investigaciones Cientificas y Tecnicas [11220120100603]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021708] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); COnsejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Canadian Institutes of Health Research 37776 to JC, National Institute of Health 1R01DE021708 and 1R01DE01963 to BH, Natural Sciences and Engineering Research Council of Canada 238992-12 to BH, Agencia Nacional de Promocion Cientifica y Tecnologica PICT2014-1810 to PG, COnsejo Nacional de Investigaciones Cientificas y Tecnicas 11220120100603 to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baisden B, 2007, PLACENTA, V28, P1082, DOI 10.1016/j.placenta.2007.04.002; Baker J, 2010, AM J HUM BIOL, V22, P206, DOI 10.1002/ajhb.20979; Barbeito-Andr?s J., 2016, REV ARG ANTROP BIOL, V18, P1; Barker DJP, 2011, PLACENTA HUMAN DEV P, P5; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; BRASEL JA, 1972, ARCH DIS CHILD, V47, P479, DOI 10.1136/adc.47.254.479; Burton GJ, 2012, PLACENTA, V33, pS23, DOI 10.1016/j.placenta.2011.11.013; Cahill LS, 2014, J CEREBR BLOOD F MET, V34, P1082, DOI 10.1038/jcbfm.2014.62; Chen PY, 2013, PHYSIOL GENOMICS, V45, P565, DOI 10.1152/physiolgenomics.00034.2013; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Coan PM, 2011, J PHYSIOL-LONDON, V589, P3659, DOI 10.1113/jphysiol.2011.208629; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Coan PM, 2006, DEV DYNAM, V235, P3280, DOI 10.1002/dvdy.20981; Collins SL, 2013, ULTRASOUND MED BIOL, V39, P253, DOI 10.1016/j.ultrasmedbio.2012.09.003; Cross JC, 2006, NUTR REV, V64, pS12, DOI 10.1301/nr.may.S12-S18; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Damodaram M, 2010, PLACENTA, V31, P491, DOI 10.1016/j.placenta.2010.03.001; Dilworth MR, 2011, PLACENTA, V32, P914, DOI 10.1016/j.placenta.2011.08.007; Dressino V, 1997, AM J PHYS ANTHROPOL, V102, P545, DOI 10.1002/(SICI)1096-8644(199704)102:4<545::AID-AJPA8>3.0.CO;2-Q; EDELSTONE DI, 1980, AM J PHYSIOL, V238, pH656, DOI 10.1152/ajpheart.1980.238.5.H656; Elia M, 2012, NUTRITION, V28, P477, DOI 10.1016/j.nut.2011.11.009; Fernandez-Twinn DS, 2003, BRIT J NUTR, V90, P815, DOI 10.1079/BJN2003967; Fowden AL, 2012, PLACENTA, V33, pE11, DOI 10.1016/j.placenta.2012.05.002; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Gao H, 2013, FRONT BIOSCI ELITE E, V4, P1434; Gasperowicz M, 2013, DEV BIOL, V382, P1, DOI 10.1016/j.ydbio.2013.08.005; Gheorghe CP, 2009, PLACENTA, V30, P411, DOI 10.1016/j.placenta.2009.03.002; Gonzalez PN, 2014, AM J PHYS ANTHROPOL, V154, P544, DOI 10.1002/ajpa.22545; Gonzalez PN, 2013, EVOL DEV, V15, P133, DOI 10.1111/ede.12025; Gonzalez PN, 2011, J ANAT, V218, P243, DOI 10.1111/j.1469-7580.2010.01326.x; Gonzalez PN, 2011, J EXP ZOOL PART B, V316B, P547, DOI 10.1002/jez.b.21430; Gutierrez-Marcos JF, 2012, PLACENTA, V33, pE3, DOI 10.1016/j.placenta.2012.08.006; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; King JC, 2000, AM J CLIN NUTR, V71, p1218S, DOI 10.1093/ajcn/71.5.1218s; Knox K, 2011, PLACENTA, V32, P811, DOI 10.1016/j.placenta.2011.08.013; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; KRAMER MS, 1989, PEDIATRICS, V84, P717; Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x; Malandro MS, 1996, AM J PHYSIOL-CELL PH, V271, pC295, DOI 10.1152/ajpcell.1996.271.1.C295; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Morgane PJ, 2002, NEUROSCI BIOBEHAV R, V26, P471, DOI 10.1016/S0149-7634(02)00012-X; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Mu JW, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-34; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Prada JA, 1998, EUR J CLIN NUTR, V52, pS21; Proctor LK, 2009, ULTRASOUND OBST GYN, V34, P274, DOI 10.1002/uog.7308; PUCCIARELLI HM, 1987, AM J PHYS ANTHROPOL, V72, P67, DOI 10.1002/ajpa.1330720109; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Rebelato HJ, 2013, J MOL HISTOL, V44, P629, DOI 10.1007/s10735-013-9522-7; Reichling TD, 2000, J NUTR, V130, P2326, DOI 10.1093/jn/130.9.2326; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Roza SJ, 2008, AM J EPIDEMIOL, V168, P1145, DOI 10.1093/aje/kwn233; Rutland CS, 2007, PLACENTA, V28, P734, DOI 10.1016/j.placenta.2006.07.001; Salam RA, 2014, CURR OPIN CLIN NUTR, V17, P249, DOI 10.1097/MCO.0000000000000051; Schell LM, 2007, AM J HUM BIOL, V19, P606, DOI 10.1002/ajhb.20669; Schonfeldt HC, 2012, BRIT J NUTR, V108, pS69, DOI 10.1017/S0007114512002553; Schulz LC, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103218; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Strakovsky RS, 2010, J NUTR, V140, P2116, DOI 10.3945/jn.110.127803; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; Tunster SJ, 2010, MOL CELL BIOL, V30, P295, DOI 10.1128/MCB.00662-09; Vaughan OR, 2012, REPROD FERT DEVELOP, V24, P80, DOI 10.1071/RD11909; Wallace JM, 2013, PLACENTA, V34, P269, DOI 10.1016/j.placenta.2012.12.007; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wedegartner U, 2006, RADIOLOGY, V238, P872, DOI 10.1148/radiol.2383042213; Wiley DF, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P431; Willmore KE, 2006, EVOL DEV, V8, P550, DOI 10.1111/j.1525-142X.2006.00127.x; Wong MD, 2013, PLOS ONE, V13; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; Young NM, 2007, ANAT REC, V290, P123, DOI 10.1002/ar.20415; Zelditch ML, 2004, EVOL DEV, V6, P194, DOI 10.1111/j.1525-142X.2004.04025.x	75	37	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152227	10.1371/journal.pone.0152227	http://dx.doi.org/10.1371/journal.pone.0152227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018791	gold, Green Submitted, Green Published			2022-12-26	WOS:000372807800033
J	De Castro-Oros, I; Sola, R; Valls, RM; Brea, A; Mozas, P; Puzo, J; Pocovi, M				De Castro-Oros, Isabel; Sola, Rosa; Maria Valls, Rosa; Brea, Angel; Mozas, Pilar; Puzo, Jose; Pocovi, Miguel			Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine	PLOS ONE			English	Article							3' UNTRANSLATED REGION; RECEPTOR MESSENGER-RNA; CORONARY-HEART-DISEASE; RED YEAST RICE; SERUM-CHOLESTEROL; FAMILIAL HYPERCHOLESTEROLEMIA; METABOLIC SYNDROME; STATINS; PROTEIN; EXPRESSION	Background Armolipid Plus (AP) is a nutraceutical that contains policosanol, fermented rice with red yeast, berberine, coenzyme Q10, folic acid, and astaxanthin. It has been shown to be effective in reducing plasma LDL cholesterol (LDLc) levels. In the multicenter randomized trial NCT01562080, there was large interindividual variability in the plasma LDLc response to AP supplementation. We hypothesized that the variability in LDLc response to AP supplementation may be linked to LDLR and PCSK9 polymorphisms. Material and Methods We sequenced the LDLR 30 and 50 untranslated regions (UTR) and the PCSK9 5' UTR of 102 participants with moderate hypercholesterolemia in trial NCT01562080. In this trial, 50 individuals were treated with AP supplementation and the rest with placebo. Results Multiple linear regression analysis, using the response of LDLc levels to AP as the dependent variable, revealed that polymorphisms rs2149041 (c.-3383C>G) in the PCSK9 50 UTR and rs14158 (c.*52G>A) in the LDLR 30 UTR explained 14.1% and 6.4%, respectively, of the variability after adjusting for gender, age, and BMI of individuals. Combining polymorphisms rs2149041 and rs14158 explained 20.5% of this variability (p < 0.004). Conclusions Three polymorphisms in the 30 UTR region of LDLR, c.*52G>A, c.*504G>A, and c.*773A>G, and two at the 50 UTR region of PCSK9, c.-3383C>G and c.-2063A>G, were associated with response to AP. These results could explain the variability observed in the response to berberine among people with moderate hypercholesterolemia, and they may be useful in identifying patients who could potentially benefit from supplementation with AP.	[De Castro-Oros, Isabel; Mozas, Pilar; Pocovi, Miguel] Univ Zaragoza, IIS Aragon, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain; [Maria Valls, Rosa] Univ Rovira & Virgili, IISPV Fac Med, Unitat Recerca Lipids & Arteriosclerosi, CIBERDEM,Serv Med Interna,Hosp Univ San Joan, C St Llorenc 21, E-43201 Reus, Spain; [Sola, Rosa; Brea, Angel] Hosp Univ San Pedro, Med Interna Serv, Unidad Lipidos, Logrono, Spain; [Puzo, Jose] Hosp Univ Miguel Servet, Serv Bioquim Clin, Zaragoza, Spain	University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Miguel Servet University Hospital	De Castro-Oros, I (corresponding author), Univ Zaragoza, IIS Aragon, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain.	isadco@gmail.com	Puzo, Jose/AAE-5827-2021; MOZAS, PILAR/AAR-8624-2021; Valls, Rosa M/AAB-1163-2019	Puzo, Jose/0000-0002-1309-4363; Valls, Rosa M/0000-0002-3351-0942; SOLA, Rosa/0000-0002-8359-235X	Fondo de Investigacion Sanitaria (FIS) [PI12/01703]; Rottapharm S.L.	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Rottapharm S.L.	This work was supported by grants from the Fondo de Investigacion Sanitaria (FIS) PI12/01703 and Rottapharm S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affuso F, 2012, WORLD J CARDIOL, V4, P77, DOI 10.4330/wjc.v4.i3.77; BEYNEN AC, 1985, ATHEROSCLEROSIS, V57, P19, DOI 10.1016/0021-9150(85)90134-0; BEYNEN AC, 1987, ADV LIPID RES, V22, P115; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Chen W, 2008, INT J MOL MED, V21, P345; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; De Castro-Oros I, 2011, HUM MUTAT, V32, P868, DOI 10.1002/humu.21520; Dong B, 2015, J BIOL CHEM, V290, P4047, DOI 10.1074/jbc.M114.597229; Gerards MC, 2015, ATHEROSCLEROSIS, V240, P415, DOI 10.1016/j.atherosclerosis.2015.04.004; Guyton JR, 2014, J CLIN LIPIDOL, V8, pS72, DOI 10.1016/j.jacl.2014.03.002; Izzo R, 2010, J HYPERTENS, V28, P1482, DOI 10.1097/HJH.0b013e3283395208; JACOBS DR, 1983, ARTERIOSCLEROSIS, V3, P349, DOI 10.1161/01.ATV.3.4.349; KATAN MB, 1986, AM J EPIDEMIOL, V123, P221, DOI 10.1093/oxfordjournals.aje.a114231; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lee IT, 2012, NUTR RES, V32, P85, DOI 10.1016/j.nutres.2011.12.011; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Liu J, 2006, CHIN MED, V23, P1; Menendez R, 2001, ARCH MED RES, V32, P8, DOI 10.1016/S0188-4409(00)00265-4; PEDERSEN TR, 1994, LANCET, V344, P1383; Pisciotta L, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-123; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Singh AB, 2014, ARTERIOSCL THROM VAS, V34, P8, DOI 10.1161/ATVBAHA.112.301131; Singh DK, 2006, J PHARMACOL EXP THER, V318, P1020, DOI 10.1124/jpet.106.107144; Sirtori CR, 2012, ANN MED, V44, P419, DOI 10.3109/07853890.2011.582135; Sola R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101978; Tiwari A, 2006, EXPERT OPIN DRUG SAF, V5, P651, DOI 10.1517/14740338.5.5.651; Trimarco B, 2011, MEDITERR J NUTR META, V4, P133, DOI 10.1007/s12349-010-0043-6; Wilson GM, 1998, J LIPID RES, V39, P1025	29	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0150785	10.1371/journal.pone.0150785	http://dx.doi.org/10.1371/journal.pone.0150785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015087	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900023
J	Bhattacharya, S; Chalk, AM; Ng, AJM; Martin, TJ; Zannettino, AC; Purton, LE; Lu, J; Baker, EK; Walkley, CR				Bhattacharya, S.; Chalk, A. M.; Ng, A. J. M.; Martin, T. J.; Zannettino, A. C.; Purton, L. E.; Lu, J.; Baker, E. K.; Walkley, C. R.			Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death	ONCOGENE			English	Article							TARGETING ROCK1; POOR-PROGNOSIS; MOUSE MODEL; KINASE; MICRORNA-148A; PROGRESSION; RIP1; GENE; HYPERMETHYLATION; IDENTIFICATION	Osteosarcoma (OS) is the most common cancer of bone and the 5th leading cause of cancer-related death in young adults. Currently, 5-year survival rates have plateaued at similar to 70% for patients with localized disease. Those with disseminated disease have an similar to 20% 5-year survival. An improved understanding of the molecular genetics of OS may yield new approaches to improve outcomes for OS patients. To this end, we applied murine models that replicate human OS to identify and understand dysregulated microRNAs (miRNAs) in OS. miRNA expression patterns were profiled in murine primary osteoblasts, osteoblast cultures and primary OS cell cultures (from primary and paired metastatic locations) isolated from two genetically engineered murine models of OS. The differentially expressed miRNA were further assessed by a cross-species comparison with human osteoblasts and OS cultures. We identified miR-155-5p and miR-148a-3p as deregulated in OS. miR-155-5p suppression or miR-148a-3p overexpression potently reduced proliferation and induced apoptosis in OS cells, yet strikingly, did not impact normal osteoblasts. To define how these miRNAs regulated OS cell fate, we used an integrated computational approach to identify putative candidate targets and then correlated these with the cell biological impact. Although we could not resolve the mechanism through which miR-148a-3p impacts OS, we identified that miR-155-5p overexpression suppressed its target Ripk1 (receptor (TNFRSF)-interacting serine-threonine kinase 1) expression, and miR-155-5p inhibition elevated Ripk1 levels. Ripk1 is directly involved in apoptosis/necroptosis. In OS cells, small interfering RNA against Ripk1 prevented cell death induced by the sequestration of miR-155-5p. Collectively, we show that miR-148a-3p and miR-155-5p are species-conserved deregulated miRNA in OS. Modulation of these miRNAs was specifically toxic to tumor cells but not normal osteoblasts, raising the possibility that these may be tractable targets for miRNA-based therapies for OS.	[Bhattacharya, S.; Chalk, A. M.; Ng, A. J. M.; Martin, T. J.; Purton, L. E.; Baker, E. K.; Walkley, C. R.] Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic, Australia; [Zannettino, A. C.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic, Australia; [Zannettino, A. C.] Univ Adelaide, Fac Hlth Sci, Sch Med, Myeloma Res Lab, Adelaide, SA, Australia; [Purton, L. E.; Walkley, C. R.] South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia; [Lu, J.] St Vincents Inst Med Res, ACRF Rat Drug Discovery Ctr, Fitzroy, Vic, Australia; [Baker, E. K.; Walkley, C. R.] Yale Univ, Dept Genet, New Haven, CT USA; [Baker, E. K.; Walkley, C. R.] Yale Univ, Yale Stem Cell Ctr, New Haven, CT USA	St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); St. Vincent's Institute of Medical Research; Yale University; Yale University	Walkley, CR (corresponding author), St Vincents Inst, 9 Princes St, Fitzroy, Vic 3065, Australia.	cwalkley@svi.edu.au	Chalk, Alistair/O-3522-2019; Ng, Alvin/AAQ-5759-2020; Walkley, Carl/AAO-6021-2020; Purton, Louise/AAI-8956-2021	Chalk, Alistair/0000-0002-9630-6236; Walkley, Carl/0000-0002-4784-9031; Purton, Louise/0000-0001-6593-3168; Zannettino, Andrew/0000-0002-6646-6167	National Health and Medical Research Council (NHMRC), Australia; Cancer Council of Victoria; Cure Cancer Australia Foundation; 5point foundation; Zig Inge Foundation; NHMRC Career Development Award; NHMRC Dora Lush postgraduate scholarship; Victorian State Government OIS Program; Phillip Desbrow Senior Research Fellow of the Leukaemia Foundation	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cure Cancer Australia Foundation; 5point foundation; Zig Inge Foundation; NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Dora Lush postgraduate scholarship(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government OIS Program; Phillip Desbrow Senior Research Fellow of the Leukaemia Foundation	We thank A Pfeiffer (University of Bonn) for providing the miR-155-5p sponge, control sponge and miR-155-5p overexpression vector. We thank A Gupte for technical assistance; C Hawkins for discussion and comments; the BioResource Facility (St Vincent's Hospital) for housing and care of experimental animals, and M Thomson (SVI Flow Cytometry Facility) for help with FACS analysis. This work was supported by grants from the National Health and Medical Research Council (NHMRC), Australia (CW and TJM), Cancer Council of Victoria (CW and EB); Cure Cancer Australia Foundation (EB); 5point foundation (EB); Zig Inge Foundation (CW); NHMRC Career Development Award (CW); NHMRC Dora Lush postgraduate scholarship (SB); in part by the Victorian State Government OIS Program (to St. Vincent's Institute); CW was the Phillip Desbrow Senior Research Fellow of the Leukaemia Foundation.	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Atkins GJ, 2002, BONE, V31, P448, DOI 10.1016/S8756-3282(02)00858-X; Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batanian JR, 2002, J CLIN PATHOL-MOL PA, V55, P389, DOI 10.1136/mp.55.6.389; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Cheng CJ, 2015, NATURE, V518, P107, DOI 10.1038/nature13905; Dohi O, 2013, INT J ONCOL, V42, P411, DOI 10.3892/ijo.2012.1724; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Geller David S, 2010, Clin Adv Hematol Oncol, V8, P705; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; Grimm S, 1996, P NATL ACAD SCI USA, V93, P10923, DOI 10.1073/pnas.93.20.10923; Hanoun N, 2010, CLIN CHEM, V56, P1107, DOI 10.1373/clinchem.2010.144709; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Hu H, 2012, ONCOL LETT, V4, P1037, DOI 10.3892/ol.2012.866; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kelly AD, 2013, GENOME MED, V5, DOI 10.1186/gm406; Kim S, 2010, CANCER SCI, V101, P2425, DOI 10.1111/j.1349-7006.2010.01697.x; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Li JP, 2013, MOL CELL BIOCHEM, V380, P277, DOI 10.1007/s11010-013-1682-y; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Lv HC, 2014, EXP THER MED, V8, P1575, DOI 10.3892/etm.2014.1942; Ma WL, 2014, TUMOR BIOL, V35, P12467, DOI 10.1007/s13277-014-2565-x; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Mutsaers AJ, 2013, BONE, V55, P166, DOI 10.1016/j.bone.2013.02.016; Neale G, 2008, CLIN CANCER RES, V14, P4572, DOI 10.1158/1078-0432.CCR-07-5090; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; PARKIN DM, 1988, INT J CANCER, V42, P511, DOI 10.1002/ijc.2910420408; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Sarver AL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-7; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Sun JX, 2014, ONCOTARGETS THER, V7, P853, DOI 10.2147/OTT.S60888; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tang MJ, 2013, ONCOTARGETS THER, V6, P833, DOI 10.2147/OTT.S40080; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang Y, 2013, MOL CELL BIOCHEM, V384, P105, DOI 10.1007/s11010-013-1786-4; Wu XY, 2013, INT J MED SCI, V10, P676, DOI 10.7150/ijms.5528; Yang J, 2013, MOL CELL BIOCHEM, V381, P9, DOI 10.1007/s11010-013-1677-8; Yen CC, 2009, INT J ONCOL, V35, P775, DOI 10.3892/ijo_00000390; Yuan J, 2009, CANCER INVEST, V27, P435, DOI 10.1080/07357900802491477; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127386; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zhu A, 2012, MED ONCOL, V29, P2701, DOI 10.1007/s12032-011-0134-3	57	48	50	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5282	5294		10.1038/onc.2016.68	http://dx.doi.org/10.1038/onc.2016.68			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	27041566				2022-12-26	WOS:000386053000007
J	Cernvall, M; Hoven, E; Ljungman, L; Ljungman, G; Carlbring, P; von Essen, L				Cernvall, Martin; Hoven, Emma; Ljungman, Lisa; Ljungman, Gustaf; Carlbring, Per; von Essen, Louise			Posttraumatic Stress and Attentional Bias towards Cancer-Related Stimuli in Parents of Children Recently Diagnosed with Cancer	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; CHILDHOOD-CANCER; PTSD CHECKLIST; SYMPTOMS; INFORMATION; THREAT; DISORDERS; ANXIETY; TRAUMA	Objectives To investigate whether posttraumatic stress symptoms (PTSS) are related to attentional bias towards cancer-related stimuli among parents of children recently diagnosed with cancer. Methods Sixty-two parents completed questionnaires measuring PTSS, depression, and anxiety and the emotional Stroop task via the Internet. The emotional Stroop task included cancer-related words, cardiovascular disease-related words, and neutral words. Results Participants were split in two groups based on the median of PTSS: High-PTSS and Low-PTSS. There was a significant interaction between word-type and group and a planned contrast test of this interaction indicated that the High-PTSS group had longer response latencies on cancer-related words compared to the other word-type and group combinations. Conclusions Findings suggest that PTSS are related to attentional bias towards cancer-related stimuli among parents of children recently diagnosed with cancer. Implications of this finding for the understanding of PTSS in this population, future research, and clinical practice are discussed.	[Cernvall, Martin; Hoven, Emma; Ljungman, Lisa; von Essen, Louise] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Psychol Healthcare, Uppsala, Sweden; [Ljungman, Gustaf] Uppsala Univ, Dept Womens & Childrens Hlth, Pediat Oncol, Uppsala, Sweden; [Carlbring, Per] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	Uppsala University; Uppsala University; Stockholm University	Cernvall, M (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Psychol Healthcare, Uppsala, Sweden.	martin.cernvall@pubcare.uu.se	Carlbring, Per/D-3628-2009; Carlbring, Per/R-1220-2019	Carlbring, Per/0000-0002-2172-8813; Carlbring, Per/0000-0002-2172-8813; Ljungman, Lisa/0000-0002-4512-8900; Hoven, Emma/0000-0001-9335-9714; Ljungman, Gustaf/0000-0002-4949-2494	Swedish Research Council [K2008-70X-20836-01-3, K2011-70X-20836-04-4]; Swedish Cancer Society [2010/276]; Swedish Childhood Cancer Foundation [PROJ08/010, PROJ12/028]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission)	This research was supported by grants from the Swedish Research Council (www.vr.se, grant numbers K2008-70X-20836-01-3, K2011-70X-20836-04-4), the Swedish Cancer Society (www.cancerfonden.se, grant number 2010/276), and the Swedish Childhood Cancer Foundation (www.barncancerfonden.se, grant numbers PROJ08/010, PROJ12/028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andersson G, 2005, CYBERPSYCHOL BEHAV, V8, P32, DOI 10.1089/cpb.2005.8.32; Andersson Gerhard, 2006, Cognitive Behaviour Therapy, V35, P55, DOI 10.1080/16506070500372469; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Barakat LP, 1997, J PEDIATR PSYCHOL, V22, P843, DOI 10.1093/jpepsy/22.6.843; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Breslau N, 2004, PSYCHOL MED, V34, P1205, DOI 10.1017/S0033291704002594; Brown RT, 2003, J TRAUMA STRESS, V16, P309, DOI 10.1023/A:1024465415620; BRYANT RA, 1995, J ABNORM PSYCHOL, V104, P537, DOI 10.1037/0021-843X.104.3.537; Cernvall M, 2016, J CLIN PSYCHOL MED S, V23, P67, DOI 10.1007/s10880-015-9437-4; Cernvall M, 2015, PSYCHO-ONCOLOGY, V24, P1152, DOI 10.1002/pon.3788; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Dolgin MJ, 2007, J PEDIATR PSYCHOL, V32, P771, DOI 10.1093/jpepsy/jsm013; Dunn MJ, 2012, HEALTH PSYCHOL, V31, P176, DOI 10.1037/a0025545; Erblich J, 2003, HEALTH PSYCHOL, V22, P235, DOI 10.1037/0278-6133.22.3.235; Flory JD, 2015, DIALOGUES CLIN NEURO, V17, P141; FOA EB, 1991, J ABNORM PSYCHOL, V100, P156, DOI 10.1037/0021-843X.100.2.156; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; HALL M, 1995, J APPL SOC PSYCHOL, V25, P1215, DOI 10.1111/j.1559-1816.1995.tb02615.x; Harvey AG, 1996, COGNITIVE THER RES, V20, P613, DOI 10.1007/BF02227964; Johansson L, 2008, SCAND J PSYCHOL, V49, P69, DOI 10.1111/j.1467-9450.2007.00606.x; Karademas EC, 2008, J HEALTH PSYCHOL, V13, P28, DOI 10.1177/1359105307084309; KASPI SP, 1995, COGNITIVE THER RES, V19, P433, DOI 10.1007/BF02230410; Kazak AE, 2005, J CLIN ONCOL, V23, P7405, DOI 10.1200/JCO.2005.09.110; Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P211, DOI 10.1093/jpepsy/jsh022; Linnman C, 2006, COMPUT HUM BEHAV, V22, P448, DOI 10.1016/j.chb.2004.09.010; Ljungman L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103340; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MacLeod C, 2011, EMOT REV, V3, P62, DOI 10.1177/1754073910380970; Mundy E, 2004, CURR OPIN PSYCHIATR, V17, P123, DOI 10.1097/00001504-200403000-00009; Norberg AL, 2005, ACTA ONCOL, V44, P382, DOI 10.1080/02841860510029789; Pergamin-Hight L, 2015, CLIN PSYCHOL REV, V35, P10, DOI 10.1016/j.cpr.2014.10.005; Phipps S, 2006, J PEDIATR PSYCHOL, V31, P298, DOI 10.1093/jpepsy/jsj033; Phipps S, 2005, PEDIATR BLOOD CANCER, V45, P952, DOI 10.1002/pbc.20373; Phipps S, 2014, J CLIN ONCOL, V32, P641, DOI 10.1200/JCO.2013.49.8212; Poder U, 2008, PSYCHO-ONCOLOGY, V17, P430, DOI 10.1002/pon.1263; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127; Todd J, 2014, INT J BEHAV MED, V21, P470, DOI 10.1007/s12529-013-9328-8; VRANA SR, 1995, J ANXIETY DISORD, V9, P515, DOI 10.1016/0887-6185(95)00028-M; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	45	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152778	10.1371/journal.pone.0152778	http://dx.doi.org/10.1371/journal.pone.0152778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035912	gold, Green Published, Green Submitted			2022-12-26	WOS:000373201200038
J	Hoang, DT; Hara, M; Jo, J				Danh-Tai Hoang; Hara, Manami; Jo, Junghyo			Design Principles of Pancreatic Islets: Glucose-Dependent Coordination of Hormone Pulses	PLOS ONE			English	Article							INHIBITS GLUCAGON-SECRETION; POSITIVE AUTOCRINE SIGNAL; BETA-CELL FUNCTION; ALPHA-CELLS; INSULIN-SECRETION; CA2+ OSCILLATIONS; PULSATILE INSULIN; CANINE PANCREAS; SOMATOSTATIN; RELEASE	Pancreatic islets are functional units involved in glucose homeostasis. The multicellular system comprises three main cell types; beta and a cells reciprocally decrease and increase blood glucose by producing insulin and glucagon pulses, while the role of delta cells is less clear. Although their spatial organization and the paracrine/autocrine interactions between them have been extensively studied, the functional implications of the design principles are still lacking. In this study, we formulated a mathematical model that integrates the pulsatility of hormone secretion and the interactions and organization of islet cells and examined the effects of different cellular compositions and organizations in mouse and human islets. A common feature of both species was that islet cells produced synchronous hormone pulses under low-and high-glucose conditions, while they produced asynchronous hormone pulses under normal glucose conditions. However, the synchronous coordination of insulin and glucagon pulses at low glucose was more pronounced in human islets that had more a cells. When beta cells were selectively removed to mimic diabetic conditions, the anti-synchronicity of insulin and glucagon pulses was deteriorated at high glucose, but it could be partially recovered when the re-aggregation of remaining cells was considered. Finally, the third cell type, delta cells, which introduced additional complexity in the multicellular system, prevented the excessive synchronization of hormone pulses. Our computational study suggests that controllable synchronization is a design principle of pancreatic islets.	[Danh-Tai Hoang; Jo, Junghyo] Asia Pacific Ctr Theoret Phys, Pohang 36763, Gyeongbuk, South Korea; [Danh-Tai Hoang] Quang Binh Univ, Dept Nat Sci, Dong Hoi 510000, Quang Binh, Vietnam; [Hara, Manami] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Jo, Junghyo] Pohang Univ Sci & Technol, Dept Phys, Pohang 36763, Gyeongbuk, South Korea	Asia Pacific Center for Theoretical Physics; University of Chicago; Pohang University of Science & Technology (POSTECH)	Jo, J (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang 36763, Gyeongbuk, South Korea.; Jo, J (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Pohang 36763, Gyeongbuk, South Korea.	jojunghyo@apctp.org	Hara, Masayuki/AAH-4361-2019	Hoang, Danh-Tai/0000-0003-2640-4196	Basic Science Research Program through National Foundation of Korea - Ministry of Science, ICT & Future Planning [2013R1A1A1006655]; Max Planck Society; Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City;  [DK-020595];  [DK-072473];  [AG-042151]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P60DK020595, U01DK072473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042151] Funding Source: NIH RePORTER	Basic Science Research Program through National Foundation of Korea - Ministry of Science, ICT & Future Planning; Max Planck Society(Max Planck Society); Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by Basic Science Research Program through the National Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (No. 2013R1A1A1006655) and by the Max Planck Society, the Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J. J.), and DK-020595 to the University of Chicago Diabetes Research and Training Center (Animal Models Core), DK-072473, AG-042151, and a gift from the Kovler Family Foundation (M.H.).	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Almaca J, 2015, DIABETOLOGIA, V58, P2810, DOI 10.1007/s00125-015-3747-9; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; BERTRAND G, 1990, EUR J PHARMACOL, V182, P369, DOI 10.1016/0014-2999(90)90296-I; Berts A, 1996, BBA-MOL CELL RES, V1310, P212, DOI 10.1016/0167-4889(95)00173-5; Berts A, 1996, ENDOCRINOLOGY, V137, P693, DOI 10.1210/en.137.2.693; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Braun M, 2012, DIABETES OBES METAB, V14, P143, DOI 10.1111/j.1463-1326.2012.01642.x; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Brereton H, 2007, ENDOCRINE, V31, P61, DOI 10.1007/s12020-007-0004-0; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; CHERRINGTON AD, 1976, J CLIN INVEST, V58, P1407, DOI 10.1172/JCI108596; Cho JH, 2010, ENDOCRINOLOGY, V151, P1541, DOI 10.1210/en.2009-0362; DALEY ML, 1981, DIABETOLOGIA, V21, P238; Daunt M, 2006, ENDOCRINOLOGY, V147, P1527, DOI 10.1210/en.2005-0873; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Gilon P., 2015, ISLETS LANGERHANS, V2nd, P175; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; GRAPENGIESSER E, 1991, J BIOL CHEM, V266, P12207; GUILLEMIN R, 1976, ANNU REV MED, V27, P379, DOI 10.1146/annurev.me.27.020176.002115; Gylfe E, 2014, DIABETES OBES METAB, V16, P102, DOI 10.1111/dom.12345; HANSEN BC, 1982, J CLIN ENDOCR METAB, V54, P785, DOI 10.1210/jcem-54-4-785; Hellman B, 2012, BIOCHEM BIOPH RES CO, V417, P1219, DOI 10.1016/j.bbrc.2011.12.113; Hellman B, 2009, ENDOCRINOLOGY, V150, P5334, DOI 10.1210/en.2009-0600; Hoang DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110384; HONEY RN, 1979, LIFE SCI, V24, P1747, DOI 10.1016/0024-3205(79)90062-6; Hong H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032711; Hraha TH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003819; Hraha TH, 2014, BIOPHYS J, V106, P299, DOI 10.1016/j.bpj.2013.11.026; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; JASPAN JB, 1986, AM J PHYSIOL, V251, pE215, DOI 10.1152/ajpendo.1986.251.2.E215; Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x; KAWAI K, 1995, DIABETOLOGIA, V38, P274, DOI 10.1007/BF00400630; KOERKER DJ, 1974, SCIENCE, V184, P482, DOI 10.1126/science.184.4135.482; Koh DS, 2012, J MOL NEUROSCI, V48, P429, DOI 10.1007/s12031-012-9752-2; LANG DA, 1982, DIABETES, V31, P22, DOI 10.2337/diabetes.31.1.22; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Leibiger B, 2012, P NATL ACAD SCI USA, V109, P20925, DOI 10.1073/pnas.1212870110; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Li J, 2015, FASEB J, V29, P3379, DOI 10.1096/fj.14-265918; Liu YJ, 1996, ARCH BIOCHEM BIOPHYS, V334, P295, DOI 10.1006/abbi.1996.0458; Louzada VHP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00658; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Nittala A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000983; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; PATTON GS, 1976, METABOLISM, V25, P1499, DOI 10.1016/S0026-0495(76)80177-1; Pikovsky A., 2001, SYNCHRONIZATION UNIV, V12; Press W. H., 1992, ART SCI COMPUTING; Ramracheya R, 2010, DIABETES, V59, P2198, DOI 10.2337/db09-1505; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rohrer S, 2012, J CLIN ENDOCR METAB, V97, pE791, DOI 10.1210/jc.2011-3439; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SAMOLS E, 1976, METABOLISM, V25, P1443, DOI 10.1016/S0026-0495(76)80161-8; SAMOLS E, 1965, LANCET, V2, P415; SHERMAN A, 1991, BIOPHYS J, V59, P547, DOI 10.1016/S0006-3495(91)82271-8; STAGNER JI, 1980, J CLIN INVEST, V65, P939, DOI 10.1172/JCI109750; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Tuduri E, 2008, AM J PHYSIOL-ENDOC M, V294, pE952, DOI 10.1152/ajpendo.00641.2007; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Walker JN, 2011, DIABETES OBES METAB, V13, P95, DOI 10.1111/j.1463-1326.2011.01450.x; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; WEIR GC, 1978, METABOLISM, V27, P1223, DOI 10.1016/0026-0495(78)90047-1	70	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152446	10.1371/journal.pone.0152446	http://dx.doi.org/10.1371/journal.pone.0152446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035570	Green Published, gold, Green Submitted			2022-12-26	WOS:000373201200018
J	Hsu, YH; Hsu, YL; Liu, SH; Liao, HC; Lee, PX; Lin, CH; Lo, LC; Fu, SL				Hsu, Ya-Hsin; Hsu, Yu-Ling; Liu, Sheng-Hung; Liao, Hsin-Chia; Lee, Po-Xuan; Lin, Chao-Hsiung; Lo, Lee-Chiang; Fu, Shu-Ling			Development of a Bifunctional Andrographolide-Based Chemical Probe for Pharmacological Study	PLOS ONE			English	Article							NATURAL-PRODUCTS; V-SRC; INFLAMMATION; SUPPRESSION; INHIBITION; ACTIVATION; ANALOGS; TARGETS	Andrographolide (ANDRO) is a lactone diterpenoid compound present in the medicinal plant Andrographis paniculata which is clinically applied for multiple human diseases in Asia and Europe. The pharmacological activities of andrographolide have been widely demonstrated, including anti-inflammation, anti-cancer and hepatoprotection. However, the pharmacological mechanism of andrographolide remains unclear. Therefore, further characterization on the kinetics and molecular targets of andrographolide is essential. In this study, we described the synthesis and characterization of a novel fluorescent andrographolide derivative (ANDRO-NBD). ANDRO-NBD exhibited a comparable anti-cancer spectrum to andrographolide: ANDRO-NBD was cytotoxic to various types of cancer cells and suppressed the migration activity of melanoma cells; ANDRO-NBD treatment induced the cleavage of heat shock protein 90 (Hsp90) and the downregulation of its client oncoproteins, v-Src and Bcr-abl. Notably, ANDRO-NBD showed superior inhibitory effects to andrographolide in all anticancer assays we have performed. In addition, ANDRO-NBD was further used as a fluorescent probe to investigate the uptake kinetics, cellular distribution and molecular targets of andrographolide. Our data revealed that ANDRO-NBD entered cells rapidly and its fluorescent signal could be detected in nucleus, cytoplasm, mitochondria, and lysosome. Moreover, we demonstrated that ANDRO-NBD was covalently bound to several putative target proteins of andrographolide, including NF-kappa B and hnRNPK. In summary, we developed a fluorescent andrographolide probe with comparable bioactivity to andrographolide, which serves as a powerful tool to explore the pharmacological mechanism of andrographolide.	[Hsu, Ya-Hsin; Liao, Hsin-Chia; Lee, Po-Xuan; Fu, Shu-Ling] Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan; [Hsu, Yu-Ling; Lo, Lee-Chiang] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Liu, Sheng-Hung] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Liu, Sheng-Hung; Fu, Shu-Ling] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Liu, Sheng-Hung; Fu, Shu-Ling] Acad Sinica, Taipei 115, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Fu, SL (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan.; Lo, LC (corresponding author), Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan.; Fu, SL (corresponding author), Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan.; Fu, SL (corresponding author), Acad Sinica, Taipei 115, Taiwan.	lclo@ntu.edu.tw; slfu@ym.edu.tw		Fu, Shu-ling/0000-0003-2895-225X; LIN, CHAO-HSIUNG/0000-0001-6344-271X	Ministry of Science and Technology in Taiwan [MOST-102-2113-M-002-004-MY3, MOST 103-2320-B-010-007-MY3, MOST 104-3011-B-010-001, MOST-104-2311-B-010-005]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	Funded by Ministry of Science and Technology in Taiwan (https://www.most.gov.tw/en/public); Grant number: MOST-102-2113-M-002-004-MY3, MOST 103-2320-B-010-007-MY3, MOST 104-3011-B-010-001 and MOST-104-2311-B-010-005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER S, 1992, BIOCHEM PHARMACOL, V43, P301, DOI 10.1016/0006-2952(92)90292-Q; Barnes KR, 2008, BIOCONJUGATE CHEM, V19, P130, DOI 10.1021/bc7002204; Bottcher T, 2010, ANGEW CHEM INT EDIT, V49, P2680, DOI 10.1002/anie.200905352; Calabrese C, 2000, PHYTOTHER RES, V14, P333, DOI 10.1002/1099-1573(200008)14:5&lt;333::AID-PTR584&gt;3.0.CO;2-D; Chao HP, 2010, PLANTA MED, V76, P1827, DOI 10.1055/s-0030-1250039; Gersch M, 2012, NAT PROD REP, V29, P659, DOI 10.1039/c2np20012k; Haldar S, 2013, J ORG CHEM, V78, P10192, DOI 10.1021/jo401559t; Hsu YH, 2010, J BIOL CHEM, V285, P22630, DOI 10.1074/jbc.M109.096255; Jayakumar T, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/846740; Kligler B, 2006, EXPLORE-NY, V2, P25, DOI 10.1016/j.explore.2005.08.008; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Li L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11522; Liang FP, 2008, J BIOL CHEM, V283, P5023, DOI 10.1074/jbc.M705877200; Lim JCW, 2012, CLIN EXP PHARMACOL P, V39, P300, DOI 10.1111/j.1440-1681.2011.05633.x; Liu SH, 2014, BIOCHEM PHARMACOL, V87, P229, DOI 10.1016/j.bcp.2013.10.014; Liu SH, 2010, J AGR FOOD CHEM, V58, P10831, DOI 10.1021/jf1017093; Sirion U, 2012, BIOORG MED CHEM LETT, V22, P49, DOI 10.1016/j.bmcl.2011.11.085; Varma A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep135; Wang JG, 2014, MOL CELL PROTEOMICS, V13, P876, DOI 10.1074/mcp.M113.029793; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Ye JF, 2011, BIOL PHARM BULL, V34, P1666, DOI 10.1248/bpb.34.1666; Zhou B, 2013, MINI-REV MED CHEM, V13, P298	22	8	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152770	10.1371/journal.pone.0152770	http://dx.doi.org/10.1371/journal.pone.0152770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035713	gold, Green Published, Green Submitted			2022-12-26	WOS:000373201200036
J	Ohkubo, H; Kanemitsu, Y; Uemura, T; Takakuwa, O; Takemura, M; Maeno, K; Ito, Y; Oguri, T; Kazawa, N; Mikami, R; Niimi, A				Ohkubo, Hirotsugu; Kanemitsu, Yoshihiro; Uemura, Takehiro; Takakuwa, Osamu; Takemura, Masaya; Maeno, Ken; Ito, Yutaka; Oguri, Tetsuya; Kazawa, Nobutaka; Mikami, Ryuji; Niimi, Akio			Normal Lung Quantification in Usual Interstitial Pneumonia Pattern: The Impact of Threshold-based Volumetric CT Analysis for the Staging of Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							COMPUTER-AIDED DIAGNOSIS; PHYSIOLOGICAL TESTS; VISUAL SCORES; TOMOGRAPHY; INDEXES; DISEASE; PIRFENIDONE; SYSTEM; COPD	Background Although several computer-aided computed tomography (CT) analysis methods have been reported to objectively assess the disease severity and progression of idiopathic pulmonary fibrosis (IPF), it is unclear which method is most practical. A universal severity classification system has not yet been adopted for IPF. Objective The purpose of this study was to test the correlation between quantitative-CT indices and lung physiology variables and to determine the ability of such indices to predict disease severity in IPF. Methods A total of 27 IPF patients showing radiological UIP pattern on high-resolution (HR) CT were retrospectively enrolled. Staging of IPF was performed according to two classification systems: the Japanese and GAP (gender, age, and physiology) staging systems. CT images were assessed using a commercially available CT imaging analysis workstation, and the whole-lung mean CT value (MCT), the normally attenuated lung volume as defined from -950 HU to -701 Hounsfield unit (NL), the volume of the whole lung (WL), and the percentage of NL to WL (NL%), were calculated. Results CT indices (MCT, WL, and NL) closely correlated with lung physiology variables. Among them, NL strongly correlated with forced vital capacity (FVC) (r = 0.92, P < 0.0001). NL% showed a large area under the receiver operating characteristic curve for detecting patients in the moderate or advanced stages of IPF. Multivariable logistic regression analyses showed that NL% is significantly more useful than the percentages of predicted FVC and predicted diffusing capacity of the lungs for carbon monoxide (Japanese stage II/III/IV [odds ratio, 0.73; 95% confidence intervals (CI), 0.48 to 0.92; P < 0.01]; III/IV [odds ratio. 0.80; 95% CI 0.59 to 0.96; P < 0.01]; GAP stage II/III [odds ratio, 0.79; 95% CI, 0.56 to 0.97; P < 0.05]). Conclusion The measurement of NL% by threshold-based volumetric CT analysis may help improve IPF staging.	[Ohkubo, Hirotsugu; Kanemitsu, Yoshihiro; Uemura, Takehiro; Takakuwa, Osamu; Takemura, Masaya; Maeno, Ken; Ito, Yutaka; Oguri, Tetsuya; Niimi, Akio] Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan; [Kazawa, Nobutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi, Japan; [Mikami, Ryuji] Tokyo Med Univ, Dept Radiol, Tokyo 1608402, Japan	Nagoya City University; Nagoya City University; Tokyo Medical University	Ohkubo, H (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan.	hohkubo@med.nagoya-cu.ac.jp		Ohkubo, Hirotsugu/0000-0002-8538-1150				Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Colombi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130653; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Homma S, 2015, RESPIR INVESTIG, V53, P7, DOI 10.1016/j.resinv.2014.08.003; Iwano S, 2013, INTERACT CARDIOV TH, V17, P59, DOI 10.1093/icvts/ivt122; Iwasawa T, 2014, EUR J RADIOL, V83, P32, DOI 10.1016/j.ejrad.2012.02.014; Kauczor HU, 2000, AM J ROENTGENOL, V175, P1329, DOI 10.2214/ajr.175.5.1751329; Kim KG, 2005, RADIOLOGY, V237, P657, DOI 10.1148/radiol.2372041461; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kitano M, 2014, INT J CHRONIC OBSTR, V9, P1347, DOI 10.2147/COPD.S72616; Kubota M, 2014, RESPIR INVESTIG, V52, P242, DOI 10.1016/j.resinv.2014.03.003; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Lynch DA, 2013, J THORAC IMAG, V28, P284, DOI 10.1097/RTI.0b013e318298733c; Park SO, 2011, KOREAN J RADIOL, V12, P297, DOI 10.3348/kjr.2011.12.3.297; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Shin KE, 2011, J COMPUT ASSIST TOMO, V35, P266, DOI 10.1097/RCT.0b013e31820ccf18; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Zavaletta VA, 2007, ACAD RADIOL, V14, P772, DOI 10.1016/j.acra.2007.03.009	19	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152505	10.1371/journal.pone.0152505	http://dx.doi.org/10.1371/journal.pone.0152505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031615	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800087
J	Nair, SC; Welsing, PMJ; Choi, IYK; Roth, J; Holzinger, D; Bijlsma, JWJ; van Laar, JM; Gerlag, DM; Lafeber, FPJG; Tak, PP				Nair, S. C.; Welsing, P. M. J.; Choi, I. Y. K.; Roth, J.; Holzinger, D.; Bijlsma, J. W. J.; van Laar, J. M.; Gerlag, D. M.; Lafeber, F. P. J. G.; Tak, P. P.			A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; TNF-ALPHA THERAPY; CONCOMITANT METHOTREXATE; MONOCLONAL-ANTIBODY; DISEASE-ACTIVITY; DOUBLE-BLIND; PHASE-III; INFLIXIMAB; RITUXIMAB; PLACEBO	Objectives Measurement of MRP8/14 serum levels has shown potential in predicting clinical response to different biological agents in rheumatoid arthritis (RA). We aimed to develop a treatment algorithm based on a prediction score using MRP8/14 measurements and clinical parameters predictive for response to different biological agents. Methods Baseline serum levels of MRP8/14 were measured in 170 patients starting treatment with infliximab, adalimumab or rituximab. We used logistic regression analysis to develop a predictive score for clinical response at 16 weeks. MRP8/14 levels along with clinical variables at baseline were investigated. We also investigated how the predictive effect of MRP8/14 was modified by drug type. A treatment algorithm was developed based on categorizing the expected response per drug type as high, intermediate or low for each patient and optimal treatment was defined. Finally, we present the utility of using this treatment algorithm in clinical practice. Results The probability of response increased with higher baseline MRP8/14 complex levels (OR = 1.39), differentially between the TNF-blockers and rituximab (OR of interaction term = 0.78), and also increased with higher DAS28 at baseline (OR = 1.28). Rheumatoid factor positivity, functional disability (a higher HAQ), and previous use of a TNF-inhibitor decreased the probability of response. Based on the treatment algorithm 80 patients would have been recommended for anti-TNF treatment, 8 for rituximab, 13 for another biological treatment (other than TNFi or rituximab) and for 69 no recommendation was made. The predicted response rates matched the observed response in the cohort well. On group level the predicted response based on the algorithm resulted in a modest 10% higher response rate in our cohort with much higher differences in response probability in individual patients treated contrary to treatment recommendation. Conclusions Prediction of response using MRP8/14 levels along with clinical predictors has potential in personalizing treatment for RA patients starting biological anti-rheumatic treatment, and might increase cost-effectiveness.	[Nair, S. C.; Welsing, P. M. J.; Bijlsma, J. W. J.; van Laar, J. M.; Lafeber, F. P. J. G.] Univ Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Choi, I. Y. K.; Gerlag, D. M.; Tak, P. P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Roth, J.] Univ Hosp Muenster, Inst Immunol, Munster, Germany; [Holzinger, D.] Univ Childrens Hosp Muenster, Dept Pediat Rheumatol & Immunol, Munster, Germany; [Gerlag, D. M.] GSK, Clin Unit Cambridge, Cambridge, England; [Tak, P. P.] GSK Res Dev, Stevenage, Herts, England; [Tak, P. P.] Univ Cambridge, Cambridge, England; [Tak, P. P.] Univ Ghent, B-9000 Ghent, Belgium	Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Munster; University of Munster; GlaxoSmithKline; GlaxoSmithKline; University of Cambridge; Ghent University	Nair, SC (corresponding author), Univ Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	sandyn26@gmail.com		Holzinger, Dirk/0000-0002-8062-8820	Center for Translational Molecular Medicine [04I-202]; Innovative Medicines Initiative project BTCure [115142-1]; EU FP7 grant EUTRAIN; EU FP7 grant MIAMI; Interdisciplinary Centre of Clinical Research at the University of Muenster [IZKF CRA04]; ReumaFonds [LLP-9] Funding Source: researchfish	Center for Translational Molecular Medicine; Innovative Medicines Initiative project BTCure; EU FP7 grant EUTRAIN; EU FP7 grant MIAMI; Interdisciplinary Centre of Clinical Research at the University of Muenster; ReumaFonds	This research was supported by the Center for Translational Molecular Medicine (project TRACER, grant 04I-202), the Innovative Medicines Initiative project BTCure (grant agreement number 115142-1), EU FP7 grants EUTRAIN and MIAMI and the Interdisciplinary Centre of Clinical Research at the University of Muenster (IZKF CRA04).	Alessandri C, 2004, ANN RHEUM DIS, V63, P1218, DOI 10.1136/ard.2003.014647; Buch MH, 2011, ANN RHEUM DIS, V70, P909, DOI 10.1136/ard.2010.144998; Choi IY, 2015, ANN RHEUM DIS, V74, P499, DOI 10.1136/annrheumdis-2013-203923; Choi IY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106253; Coulthard LR, 2011, ANN RHEUM DIS, V70, P98, DOI 10.1136/ard.2010.133249; Daien CI, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/386148; Emery P, 2010, ANN RHEUM DIS, V69, P1629, DOI 10.1136/ard.2009.119933; Fabris M, 2012, AUTOIMMUN REV, V11, P315, DOI 10.1016/j.autrev.2010.06.012; Foell D, 2010, JAMA-J AM MED ASSOC, V303, P1266, DOI 10.1001/jama.2010.375; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Holzinger D, 2012, ANN RHEUM DIS, V71, P974, DOI 10.1136/annrheumdis-2011-200598; Hurnakova J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0764-5; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Isaacs JD, 2013, ANN RHEUM DIS, V72, P329, DOI 10.1136/annrheumdis-2011-201117; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; Klaasen R, 2011, RHEUMATOLOGY, V50, P1487, DOI 10.1093/rheumatology/ker010; Klaasen R, 2011, ARTHRITIS RHEUM-US, V63, P359, DOI 10.1002/art.30136; Kleinert S, 2012, RHEUMATOL INT, V32, P2759, DOI 10.1007/s00296-011-2033-5; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Quartuccio L, 2009, RHEUMATOLOGY, V48, P1557, DOI 10.1093/rheumatology/kep314; Schoels M, 2010, ANN RHEUM DIS, V69, P995, DOI 10.1136/ard.2009.126714; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Tak PP, 2012, RHEUMATOLOGY, V51, P600, DOI 10.1093/rheumatology/ker300; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van Gestel AM, 1999, J RHEUMATOL, V26, P705; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wijbrandts CA, 2008, ANN RHEUM DIS, V67, P1139, DOI 10.1136/ard.2007.080440; Wittkowski H, 2011, ANN RHEUM DIS, V70, P2075, DOI 10.1136/ard.2011.152496	38	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152362	10.1371/journal.pone.0152362	http://dx.doi.org/10.1371/journal.pone.0152362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029006	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500041
J	Leichsenring, A; Backer, I; Furtmuller, PG; Obinger, C; Lange, F; Flemmig, J				Leichsenring, Anna; Baecker, Ingo; Furtmueller, Paul G.; Obinger, Christian; Lange, Franziska; Flemmig, Joerg			Long-Term Effects of (-)-Epigallocatechin Gallate (EGCG) on Pristane-Induced Arthritis (PIA) in Female Dark Agouti Rats	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; RHEUMATOID-ARTHRITIS; HUMAN MYELOPEROXIDASE; CHLORINATING ACTIVITY; ALPHA-1-ACID GLYCOPROTEIN; ANTIINFLAMMATORY DRUGS; CHRONIC INFLAMMATION; ANTIRHEUMATIC DRUGS; IMMUNE-SYSTEM; MURINE MODEL	Rheumatoid arthritis (RA)-a widespread chronic inflammatory disease in industrialized countries-is characterized by a persistent and progressive joint destruction. The chronic pro-inflammatory state results from a mutual activation of the innate and the adaptive immune system, while the exact pathogenesis mechanism is still under discussion. New data suggest a role of the innate immune system and especially polymorphonuclear granulocytes (PMNs, neutrophils) not only during onset and the destructive phase of RA but also at the chronification of the disease. Thereby the enzymatic activity of myeloperoxidase (MPO), a peroxidase strongly abundant in neutrophils, may be important: While its peroxidase activity is known to contribute to cartilage destruction at later stages of RA the almost MPO-specific oxidant hypochlorous acid (HOCl) is also discussed for certain anti-inflammatory effects. In this study we used pristane-induced arthritis (PIA) in Dark Agouti rats as a model for the chronic course of RA in man. We were able to shown that a specific detection of the HOCl-producing MPO activity provides a sensitive new marker to evaluate the actual systemic inflammatory status which is only partially detectable by the evaluation of clinical symptoms (joint swelling and redness measurements). Moreover, we evaluated the long-term pharmacological effect of the well-known anti-inflammatory flavonoid epigallocatechin gallate (EGCG). Thereby only upon early and continuous oral application of this polyphenol the arthritic symptoms were considerably diminished both in the acute and in the chronic phase of the disease. The obtained results were comparable to the treatment control (application of methotrexate, MTX). As revealed by stopped-flow kinetic measurements, EGCG may regenerate the HOCl-production of MPO which is known to be impaired at chronic inflammatory diseases like RA. It can be speculated that this MPO activity-promoting effect of EGCG may contribute to the pharmacological mode of action of this polyphenol.	[Leichsenring, Anna; Baecker, Ingo; Lange, Franziska] Fraunhofer Inst Cell Therapy & Immunol IZI Leipzi, Perlickstr 1, D-04103 Leipzig, Germany; [Furtmueller, Paul G.; Obinger, Christian] Univ Nat Resources & Life Sci BOKU Vienna, Div Biochem, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria; [Flemmig, Joerg] Univ Leipzig, Inst Med Phys & Biophys, Fac Med, Hartelstr 16-18, D-04107 Leipzig, Germany; [Flemmig, Joerg] Translat Ctr Regenerat Med TRM Leipzig, Philipp Rosenthal Str 55, D-04103 Leipzig, Germany	Fraunhofer Gesellschaft; University of Natural Resources & Life Sciences, Vienna; Leipzig University	Flemmig, J (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Fac Med, Hartelstr 16-18, D-04107 Leipzig, Germany.; Flemmig, J (corresponding author), Translat Ctr Regenerat Med TRM Leipzig, Philipp Rosenthal Str 55, D-04103 Leipzig, Germany.	joerg.flemmig@medizin.uni-leipzig.de	Furtmüller, Paul G./Y-5819-2018; Obinger, Christian/AAV-3173-2021	Furtmüller, Paul G./0000-0002-1199-2469; Obinger, Christian/0000-0002-7133-3430; Flemmig, Jorg/0000-0001-5872-3373	German Federal Ministry of Education and Research (BMBF) [1315883]; Sachsische Aufbaubank (SAB) project from a European Regional Development Fund (ERDF) [100116526]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Sachsische Aufbaubank (SAB) project from a European Regional Development Fund (ERDF)	This work was made possible by funding from the German Federal Ministry of Education and Research (BMBF, 1315883) as well as by the Sachsische Aufbaubank (SAB) project 100116526 from a funding of the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, P NATL ACAD SCI USA, V105, P14692, DOI 10.1073/pnas.0802675105; Ahmed S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2982; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; BEERS RF, 1952, J BIOL CHEM, V195, P133; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P189, DOI 10.1016/0167-4838(84)90127-4; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; Brand DD, 2005, COMPARATIVE MED, V55, P114; Cai Y, 2013, PATHOG DIS, V67, P76, DOI 10.1111/2049-632X.12001; Flemmig J, 2015, FREE RADICAL RES, V49, P768, DOI 10.3109/10715762.2014.999676; Flemmig J, 2014, J IMMUNOL METHODS, V415, P46, DOI 10.1016/j.jim.2014.09.003; Flemmig J, 2014, J INORG BIOCHEM, V130, P84, DOI 10.1016/j.jinorgbio.2013.10.002; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Furtmuller PC, 2000, EUR J BIOCHEM, V267, P5858, DOI 10.1046/j.1432-1327.2000.01491.x; Furtmuller PG, 2000, FEBS LETT, V484, P139, DOI 10.1016/S0014-5793(00)02143-8; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2003, BIOCHEM BIOPH RES CO, V301, P551, DOI 10.1016/S0006-291X(02)03075-9; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; GEIGER T, 1993, AGENTS ACTIONS, V38, pC69, DOI 10.1007/BF01991141; Gillespie K, 2008, LIFE SCI, V83, P581, DOI 10.1016/j.lfs.2008.08.011; Gresnigt MS, 2012, J IMMUNOL, V189, P4806, DOI 10.4049/jimmunol.1103551; Guidelli GM, 2015, CLIN EXP RHEUMATOL, V33, P102; Haley PJ, 2003, TOXICOLOGY, V188, P49, DOI 10.1016/S0300-483X(03)00043-X; Hashizume M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3821; Holm BC, 2001, HUM MOL GENET, V10, P565, DOI 10.1093/hmg/10.6.565; Holmdahl R, 2001, IMMUNOL REV, V184, P184, DOI 10.1034/j.1600-065x.2001.1840117.x; Holmdahl R, 1998, HUMAN GENOME METHODS, P215; HOPKINS SJ, 1984, RHEUMATOL INT, V5, P21, DOI 10.1007/BF00541361; Hultqvist M, 2006, PLOS MED, V3, P1625, DOI 10.1371/journal.pmed.0030348; Itoh T, 2012, J NEURAL TRANSM; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kannan Krishnaswamy, 2005, Pathophysiology, V12, P167, DOI 10.1016/j.pathophys.2005.07.011; KETTLE AJ, 1991, BIOCHEM PHARMACOL, V41, P1485, DOI 10.1016/0006-2952(91)90565-M; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kirchner T, 2010, ARCH BIOCHEM BIOPHYS, V495, P21, DOI 10.1016/j.abb.2009.12.013; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kohri T, 2001, J AGR FOOD CHEM, V49, P4102, DOI 10.1021/jf001491+; Koyani CN, 2015, ARCH BIOCHEM BIOPHYS, V571, P1, DOI 10.1016/j.abb.2015.02.028; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Lange F, 2005, ANN RHEUM DIS, V64, P599, DOI 10.1136/ard.2004.026120; LEFKOWITZ DL, 1995, MED HYPOTHESES, V44, P58, DOI 10.1016/0306-9877(95)90303-8; Lefkowitz DL, 2001, IMMUNOL CELL BIOL, V79, P502, DOI 10.1046/j.1440-1711.2001.01020.x; Lin SK, 2008, ARTHRITIS RHEUM, V58, P3145, DOI 10.1002/art.23937; Longo UG, 2015, INT J RHEUMATOL, V2015, P1; Lu SM, 1999, CLIN IMMUNOL, V90, P119, DOI 10.1006/clim.1998.4615; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Neve J, 2001, EUR J PHARMACOL, V417, P37, DOI 10.1016/S0014-2999(01)00895-0; Odobasic D, 2014, ARTHRITIS RHEUMATOL, V66, P907, DOI 10.1002/art.38299; Olofsson P, 2002, ARTHRITIS RHEUM, V46, P259, DOI 10.1002/1529-0131(200201)46:1<259::AID-ART10035>3.0.CO;2-2; Olofsson Peter, 2007, V136, P255; PILLINGER MH, 1995, RHEUM DIS CLIN N AM, V21, P691; Pillukat MH, 2014, J ETHNOPHARMACOL, V155, P165, DOI 10.1016/j.jep.2014.05.015; Rowley MJ, 2008, MOD RHEUMATOL, V18, P429, DOI 10.1007/s10165-008-0080-x; Roy S, 2012, INFLAMMATION, V35, P1435, DOI 10.1007/s10753-012-9457-2; Fernandes RMSN, 2012, RHEUMATOL INT, V32, P1605, DOI 10.1007/s00296-011-1810-5; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sjogren B, 1997, OCCUP ENVIRON MED, V54, P66, DOI 10.1136/oem.54.1.66; Spalteholz H, 2008, BIOCHEM BIOPH RES CO, V371, P810, DOI 10.1016/j.bbrc.2008.04.139; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Straub RH, 1997, BRIT J RHEUMATOL, V36, P1298; Svelander L, 2004, ARTHRITIS RHEUM, V50, P297, DOI 10.1002/art.11488; Swierkot J, 2006, PHARMACOL REP, V58, P473; Van Eden W., 1996, CURR PROTOC IMMUNOL, V19, p15.4.1, DOI [10.1002/0471142735.im1504s19, DOI 10.1002/0471142735.IM1504S19]; Vingsbo C, 1996, AM J PATHOL, V149, P1675; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wright HL, 2014, NAT REV RHEUMATOL, V10, P593, DOI 10.1038/nrrheum.2014.80; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407; Zschaler J, 2014, CRIT REV IMMUNOL, V34, P433; ZUURBIER KWM, 1990, BIOCHIM BIOPHYS ACTA, V1037, P140, DOI 10.1016/0167-4838(90)90159-D	74	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152518	10.1371/journal.pone.0152518	http://dx.doi.org/10.1371/journal.pone.0152518			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023113	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900069
J	Weijerman, M; Fulton, EA; Brainard, RE				Weijerman, Mariska; Fulton, Elizabeth A.; Brainard, Russell E.			Management Strategy Evaluation Applied to Coral Reef Ecosystems in Support of Ecosystem-Based Management	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MARINE RESERVES; FISHERIES; BENEFITS; DISTURBANCE; RESILIENCE; DIVERSITY; SERVICES; DECLINE; MODELS	Ecosystem modelling is increasingly used to explore ecosystem-level effects of changing environmental conditions and management actions. For coral reefs there has been increasing interest in recent decades in the use of ecosystem models for evaluating the effects of fishing and the efficacy of marine protected areas. However, ecosystem models that integrate physical forcings, biogeochemical and ecological dynamics, and human induced perturbations are still underdeveloped. We applied an ecosystem model (Atlantis) to the coral reef ecosystem of Guam using a suite of management scenarios prioritized in consultation with local resource managers to review the effects of each scenario on performance measures related to the ecosystem, the reef-fish fishery (e.g., fish landings) and coral habitat. Comparing tradeoffs across the selected scenarios showed that each scenario performed best for at least one of the selected performance indicators. The integrated 'full regulation' scenario outperformed other scenarios with four out of the six performance metrics at the cost of reef-fish landings. This model application quantifies the socio-ecological costs and benefits of alternative management scenarios. When the effects of climate change were taken into account, several scenarios performed equally well, but none prevented a collapse in coral biomass over the next few decades assuming a business-as-usual greenhouse gas emissions scenario.	[Weijerman, Mariska] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Weijerman, Mariska] Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands; [Weijerman, Mariska; Brainard, Russell E.] NOAA, Coral Reef Ecosystem Program, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Fulton, Elizabeth A.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Fulton, Elizabeth A.] Univ Tasmania, Ctr Marine Socioecol, Hobart, Tas, Australia	University of Hawaii System; University of Hawaii Manoa; Wageningen University & Research; National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Weijerman, M (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.; Weijerman, M (corresponding author), Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands.; Weijerman, M (corresponding author), NOAA, Coral Reef Ecosystem Program, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA.	mariska.weijerman@noaa.gov	Fulton, Beth/A-2871-2008; Fulton, Beth/AAJ-1398-2021	Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917	National Oceanic and Atmospheric Administration; NOAA	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding was provided to MW though the National Oceanic and Atmospheric Administration. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided to MW through NOAA. We gratefully acknowledge the staff of NOAA PIFSC CREP and PIRO Habitat Division, and staff of Guam Division of Aquatic and Wildlife Resources, Coastal Management Program and Guam University for their contributions in data and/or discussions. We further would like to acknowledge Ivor Williams, Adel Heenan, John Rooney, Brett Taylor for their improvements to the manuscript.	Ainsworth CH, 2011, ATLANTIS MODEL DEV N; Alder J, 1996, ENVIRON MANAGE, V20, P541, DOI 10.1007/BF01474654; Armstrong CW, 2007, ECOL ECON, V62, P242, DOI 10.1016/j.ecolecon.2006.03.027; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; Brown CJ, 2014, FRONT ECOL ENVIRON, V12, P324, DOI 10.1890/130296; Burdick D., 2008, STATUS CORAL REEF EC; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Campbell SJ, 2012, ORYX, V46, P486, DOI 10.1017/S0030605312000348; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Castruccio FS, 2013, J GEOPHYS RES-OCEANS, V118, P6123, DOI 10.1002/2013JC009196; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Cinner J, 2014, CURR OPIN ENV SUST, V7, P65, DOI 10.1016/j.cosust.2013.11.025; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Edwards HJ, 2011, GLOBAL CHANGE BIOL, V17, P2033, DOI 10.1111/j.1365-2486.2010.02366.x; Evans RD, 2008, CORAL REEFS, V27, P179, DOI 10.1007/s00338-007-0309-8; Fulton EA, 2004, ECOL MODEL, V173, P371, DOI 10.1016/j.ecolmodel.2003.09.024; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Heenan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079604; Home P.J., 2010, NMFSNWFSC104 NOAA US, P140; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Johnson AE, 2013, FISH FISH, V14, P281, DOI 10.1111/j.1467-2979.2012.00468.x; Link JS, 2010, PROG OCEANOGR, V87, P214, DOI 10.1016/j.pocean.2010.09.020; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McClanahan TR, 2006, AQUAT CONSERV, V16, P147, DOI 10.1002/aqc.715; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Ortiz JC, 2014, NAT CLIM CHANGE, V4, P1090, DOI 10.1038/NCLIMATE2439; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Riegl B, 2013, ECOL EVOL, V3, P1050, DOI 10.1002/ece3.519; Rodgers K, 2003, ENVIRON MANAGE, V31, P377, DOI 10.1007/s00267-002-2831-3; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stow CA, 2009, J MARINE SYST, V76, P4, DOI 10.1016/j.jmarsys.2008.03.011; Taylor BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039599; Thompson AA, 2010, CORAL REEFS, V29, P637, DOI 10.1007/s00338-009-0562-0; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Viswanathan KK, 1997, ENFORCEMENT COMPLIAN; Weijerman M, FISHERIES B IN PRESS; Weijerman M, 2014, NOAATMNMFSPIFSC43 US; Weijerman M, 2013, REP H 13 3 PACIFIC I; Weijerman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144165; Wilkinson C. R., 1994, GLOBAL CLIMATE CHANG; Williams I, 2011, NOAATMNMFSPIFSC33 US; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516	54	24	24	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152577	10.1371/journal.pone.0152577	http://dx.doi.org/10.1371/journal.pone.0152577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023183	gold, Green Published			2022-12-26	WOS:000373113900080
J	Yoshihisa, Y; Andoh, T; Matsunaga, K; Rehman, MU; Maoka, T; Shimizu, T				Yoshihisa, Yoko; Andoh, Tsugunobu; Matsunaga, Kenji; Rehman, Mati Ur; Maoka, Takashi; Shimizu, Tadamichi			Efficacy of Astaxanthin for the Treatment of Atopic Dermatitis in a Murine Model	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; ENHANCED EXPRESSION; GENE-EXPRESSION; SKIN-LESIONS; NC/NGA MICE; IN-VIVO; CELLS; EOSINOPHILS; PROTECTS; BEHAVIOR	Atopic dermatitis (AD) is a common chronic inflammatory skin disease associated with various factors, including immunological abnormalities and exposure to allergens. Astaxanthin (AST) is a xanthophyll carotenoid that has recently been demonstrated to have anti-inflammatory effects and to regulate the expression of inflammatory cytokines. Thus, we investigated whether AST could improve the dermatitis and pruritus in a murine model of AD using NC/Nga mice. In addition to a behavioral evaluation, the effects of AST on the AD were determined by the clinical skin severity score, serum IgE level, histological analyses of skin, and by reverse transcription-PCR and Western blotting analyses for the expression of inflammation-related factors. AST (100 mg/kg) or vehicle (olive oil) was orally administered once day and three times a week for 26 days. When compared with vehicle-treated group, the administration of AST significantly reduced the clinical skin severity score. In addition, the spontaneous scratching in AD model mice was reduced by AST administration. Moreover, the serum IgE level was markedly decreased by the oral administration of AST compared to that in vehicle-treated mice. The number of eosinophils, total and degranulated mast cells all significantly decreased in the skin of AST-treated mice compared with vehicle-treated mice. The mRNA and protein levels of eotaxin, MIF, IL-4, IL-5 and L-histidine decarboxylase were significantly decreased in the skin of AST-treated mice compared with vehicle-treated mice. These results suggest that AST improves the dermatitis and pruritus in AD via the regulation of the inflammatory effects and the expression of inflammatory cytokines.	[Yoshihisa, Yoko; Matsunaga, Kenji; Rehman, Mati Ur; Shimizu, Tadamichi] Toyama Univ, Dept Dermatol, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama, Japan; [Andoh, Tsugunobu] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, Sugitani, Toyama, Japan; [Rehman, Mati Ur] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Sugitani, Toyama, Japan; [Maoka, Takashi] Res Inst Prod Dev, Div Food Funct & Chem, Sakyo Ku, Shimogamo Morimoto Cho, Kyoto, Japan	University of Toyama; University of Toyama; University of Toyama	Shimizu, T (corresponding author), Toyama Univ, Dept Dermatol, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama, Japan.	shimizut@med.u-toyama.ac.jp	Rehman, Mati Ur/AAE-6885-2019	Shimizu, Tadamichi/0000-0002-3231-0279	Japan Society for the Promotion of Science [15K19681, 15K09761]; Fuji Chemical Industry Co., Ltd.; Grants-in-Aid for Scientific Research [15K09761] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fuji Chemical Industry Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Scientific Research (No. 15K19681 and 15K09761) from the Japan Society for the Promotion of Science and research aid from Fuji Chemical Industry Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon Ulrich, 1994, Journal of Dermatological Science, V7, P63, DOI 10.1016/0923-1811(94)90023-X; Andoh T, 2011, EXP DERMATOL, V20, P894, DOI 10.1111/j.1600-0625.2011.01346.x; Beck Lisa A., 2000, Journal of Allergy and Clinical Immunology, V106, pS258; Bystrom J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-10; Chew BP, 1999, ANTICANCER RES, V19, P1849; Fassett RG, 2009, FUTUR CARDIOL, V5, P333, DOI 10.2217/FCA.09.19; HARVIMA IT, 1994, ARCH DERMATOL RES, V287, P61, DOI 10.1007/BF00370720; Ikeuchi M, 2007, BIOSCI BIOTECH BIOCH, V71, P893, DOI 10.1271/bbb.60521; Iwamoto T, 2000, J Atheroscler Thromb, V7, P216; Jang HY, 2010, REPROD DOMEST ANIM, V45, P967, DOI 10.1111/j.1439-0531.2009.01469.x; Jawaid P, 2014, APOPTOSIS, V19, P1006, DOI 10.1007/s10495-014-0972-5; JYONOUCHI H, 1995, J NUTR, V125, P2483; Kobayashi M, 2000, APPL MICROBIOL BIOT, V54, P550, DOI 10.1007/s002530000416; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Lampinen M, 2004, ALLERGY, V59, P793, DOI 10.1111/j.1398-9995.2004.00469.x; Lee SJ, 2003, MOL CELLS, V16, P97; Lennikov Anton, 2012, Mol Vis, V18, P455; Leung DYM, 2000, J ALLERGY CLIN IMMUN, V105, P860, DOI 10.1067/mai.2000.106484; Manabe E, 2008, J CELL BIOCHEM, V103, P1925, DOI 10.1002/jcb.21583; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Okayama Yoshimichi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P517, DOI 10.2174/1568010054526386; Omata N, 2001, LIFE SCI, V69, P223, DOI 10.1016/S0024-3205(01)01124-9; Pashkow FJ, 2008, AM J CARDIOL, V101, p58D, DOI 10.1016/j.amjcard.2008.02.010; Sanderson C J, 1992, Adv Pharmacol, V23, P163, DOI 10.1016/S1054-3589(08)60965-5; Simon D, 2004, ALLERGY, V59, P561, DOI 10.1111/j.1398-9995.2004.00476.x; Sivaranjani N, 2013, J CLIN DIAGN RES, V7, P2683, DOI 10.7860/JCDR/2013/6635.3732; Suzuki Y, 2006, EXP EYE RES, V82, P275, DOI 10.1016/j.exer.2005.06.023; Takizawa Y, 2011, EUR J DRUG METAB PH, V35, P89, DOI 10.1007/s13318-010-0020-y; Tsuboi H, 1998, BRIT J DERMATOL, V138, P1033; Tsukahara H, 2003, LIFE SCI, V72, P2509, DOI 10.1016/S0024-3205(03)00145-0; Yagi R, 2002, J IMMUNOL, V168, P2020, DOI 10.4049/jimmunol.168.4.2020; Yawalkar N, 1999, J INVEST DERMATOL, V113, P43, DOI 10.1046/j.1523-1747.1999.00619.x; Ye QY, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-156; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Yoshihisa Y, 2014, EXP DERMATOL, V23, P178, DOI 10.1111/exd.12347	35	34	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152288	10.1371/journal.pone.0152288	http://dx.doi.org/10.1371/journal.pone.0152288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023003	gold, Green Published			2022-12-26	WOS:000373113900039
J	Sanduja, S; Feng, Y; Mathis, RA; Sokol, ES; Reinhardt, F; Halaban, R; Gupta, PB				Sanduja, S.; Feng, Y.; Mathis, R. A.; Sokol, E. S.; Reinhardt, F.; Halaban, R.; Gupta, P. B.			AMPK promotes tolerance to Ras pathway inhibition by activating autophagy	ONCOGENE			English	Article							INITIATING KINASE ULK1; TUMOR-SUPPRESSOR LKB1; ADVANCED MELANOMA; BRAF; RESISTANCE; PROLIFERATION; BRAF(V600E); VEMURAFENIB; METABOLISM; SURVIVAL	Targeted inhibitors of oncogenic Ras (rat sarcoma viral oncogene)-Raf signaling have shown great promise in the clinic, but resistance remains a major challenge: 30% of tumors with pathway mutations do not respond to targeted inhibitors, and of the 70% that do respond, all eventually develop resistance. Before cancer cells acquire resistance, they respond to initial drug treatment either by undergoing apoptosis ('addiction') or by surviving treatment albeit with reduced growth ('tolerance'). As these drug-tolerant cells serve as a reservoir from which resistant cells eventually emerge, inhibiting the pathways that confer tolerance could potentially delay or even prevent recurrence. Here, we show that melanomas and other cancers acquire tolerance to Ras-Raf pathway inhibitors by activating autophagy, which is mediated by the cellular energy sensor AMP-activated protein kinase (AMPK). Blocking this AMPK-mediated autophagy sensitizes drug-tolerant melanomas to Ras-Raf pathway inhibitors. Conversely, activating AMPK signaling and autophagy enables melanomas that would otherwise be addicted to the Ras-Raf pathway to instead tolerate pathway inhibition. These findings identify a key mechanism of tolerance to Ras-Raf pathway inhibitors and suggest that blocking either AMPK or autophagy in combination with these targeted inhibitors could increase tumor regression and decrease the likelihood of eventual recurrence.	[Sanduja, S.; Feng, Y.; Mathis, R. A.; Sokol, E. S.; Reinhardt, F.; Gupta, P. B.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Mathis, R. A.; Sokol, E. S.; Gupta, P. B.] MIT, Dept Biol, Cambridge, MA USA; [Halaban, R.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Gupta, P. B.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gupta, P. B.] Harvard Stem Cell Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Yale University; Massachusetts Institute of Technology (MIT); Harvard University	Gupta, PB (corresponding author), Whitehead Inst Biomed Res, Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	pgupta@wi.mit.edu			Ellison Foundation; Melanoma Research Alliance [311800]; Yale SPORE in Skin Cancer - National Cancer Institute [1 P50 CA121974]; NSFGRFP [1122374]; NATIONAL CANCER INSTITUTE [P50CA121973, P50CA121974] Funding Source: NIH RePORTER	Ellison Foundation(Lawrence Ellison Foundation); Melanoma Research Alliance; Yale SPORE in Skin Cancer - National Cancer Institute; NSFGRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Tyler Jacks for providing us with mouse KRAS<SUP>mut</SUP>/p53<SUP>-/-</SUP> NSCLC line, the Whitehead flow cytometry facility, and Nicki Watson and Wendy Salmon at the Whitehead Keck Imaging Facility for microscopy services. We thank Dr David Pincus and Dr Luke Whitesell for critical reading of the manuscript. This research was supported by grants from the Ellison Foundation (PBG) and Melanoma Research Alliance (#311800; PBG), a Yale SPORE in Skin Cancer funded by the National Cancer Institute (#1 P50 CA121974; RH), and funds from the NSFGRFP (#1122374; ESS).	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Flaherty KT, 2010, ANN INTERN MED, V153, P587, DOI 10.7326/0003-4819-153-9-201011020-00008; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Gamrekelashvili J, 2007, J IMMUNOL, V178, P1573, DOI 10.4049/jimmunol.178.3.1573; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kawada K, 2012, CLIN CANCER RES, V18, P1696, DOI 10.1158/1078-0432.CCR-11-1909; Kim J, 2011, CELL CYCLE, V10, P1337, DOI 10.4161/cc.10.9.15291; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levy JMM, 2014, CANCER DISCOV, V4, P773, DOI 10.1158/2159-8290.CD-14-0049; Lock R, 2014, CANCER DISCOV, V4, P466, DOI 10.1158/2159-8290.CD-13-0841; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; McArthur GA, 2012, J CLIN ONCOL, V30, P1628, DOI 10.1200/JCO.2011.39.1938; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Petti C, 2012, MELANOMA RES, V22, P341, DOI 10.1097/CMR.0b013e3283544929; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Smalley KSM, 2010, CURR OPIN INVEST DR, V11, P699; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Strohecker AM, 2014, AUTOPHAGY, V10, P384, DOI 10.4161/auto.27320; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	44	34	34	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5295	5303		10.1038/onc.2016.70	http://dx.doi.org/10.1038/onc.2016.70			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	27041569	Green Submitted, Green Accepted			2022-12-26	WOS:000386053000008
J	Soderberg, C; Gillam, ME; Ahlgren, EC; Hunter, GA; Gakh, O; Isaya, G; Ferreira, GC; Al-Karadaghi, S				Soderberg, Christopher; Gillam, Mallory E.; Ahlgren, Eva-Christina; Hunter, Gregory A.; Gakh, Oleksandr; Isaya, Grazia; Ferreira, Gloria C.; Al-Karadaghi, Salam			The Structure of the Complex between Yeast Frataxin and Ferrochelatase CHARACTERIZATION AND PRE-STEADY STATE REACTION OF FERROUS IRON DELIVERY AND HEME SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; FRIEDREICH ATAXIA; BACTERIAL FRATAXIN; BINDING-PROPERTIES; REACTION-MECHANISM; METAL-BINDING; PROTEIN; METABOLISM; MITOFERRIN; SITES	Frataxin is a mitochondrial iron-binding protein involved in iron storage, detoxification, and delivery for iron sulfur-cluster assembly and heme biosynthesis. The ability of frataxin from different organisms to populate multiple oligomeric states in the presence of metal ions, e.g. Fe2+ and Co2+, led to the suggestion that different oligomers contribute to the functions of frataxin. Here we report on the complex between yeast frataxin and ferrochelatase, the terminal enzyme of heme biosynthesis. Protein-protein docking and cross-linking in combination with mass spectroscopic analysis and single-particle reconstruction from negatively stained electron microscopic images were used to verify the Yfh1-ferrochelatase interactions. The model of the complex indicates that at the 2: 1 Fe2+-to-protein ratio, when Yfh1 populates a trimeric state, there are two interaction interfaces between frataxin and the ferrochelatase dimer. Each interaction site involves one ferrochelatase monomer and one frataxin trimer, with conserved polar and charged amino acids of the two proteins positioned at hydrogen-bonding distances from each other. One of the subunits of the Yfh1 trimer interacts extensively with one subunit of the ferrochelatase dimer, contributing to the stability of the complex, whereas another trimer subunit is positioned for Fe2+ delivery. Single-turnover stopped-flow kinetics experiments demonstrate that increased rates of heme production result from monomers, dimers, and trimers, indicating that these forms are most efficient in delivering Fe2+ to ferrochelatase and sustaining porphyrin metalation. Furthermore, they support the proposal that frataxin-mediated delivery of this potentially toxic substrate overcomes formation of reactive oxygen species.	[Soderberg, Christopher; Ahlgren, Eva-Christina; Al-Karadaghi, Salam] Lund Univ, Dept Chem, Ctr Mol Prot Sci, SE-22100 Lund, Sweden; [Gillam, Mallory E.; Hunter, Gregory A.; Ferreira, Gloria C.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, Dept Chem, Tampa, FL 33612 USA; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Soderberg, Christopher; Gillam, Mallory E.; Ferreira, Gloria C.] Lund Univ, MAX IV Lab, SE-22100 Lund, Sweden	Lund University; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Mayo Clinic; Mayo Clinic; Lund University	Al-Karadaghi, S (corresponding author), Lund Univ, Dept Chem, Ctr Mol Prot Sci, SE-22100 Lund, Sweden.; Ferreira, GC (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, MDC 7, Tampa, FL 33612 USA.	gferreir@health.usf.edu; salam.al-karadaghi@biochemistry.lu.se	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	National Institutes of Health [GM080270, AG15709-19]; Swedish Research Council (Vetenskapsradet); American Heart Association, Greater SE Affiliate [10GRNT4300073, 13GRNT16970019]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); American Heart Association, Greater SE Affiliate(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080270 (to G. C. F.). This work was also supported by a grant from the Swedish Research Council (Vetenskapsradet) (to S. A.-K.) and the American Heart Association, Greater SE Affiliate, Grants 10GRNT4300073 and 13GRNT16970019 (to G. C. F.) and in part by National Institutes of Health Grant AG15709-19 (to G. I.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrahao A, 2015, NEUROGENETICS, V16, P151, DOI 10.1007/s10048-015-0439-z; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; Blow DM, 2002, ACTA CRYSTALLOGR D, V58, P792, DOI 10.1107/S0907444902003931; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; FERREIRA GC, 1994, J BIOL CHEM, V269, P4396; Ferreira GC, 2011, HANDB PORPHYR SCI, V15, P49; Fodje MN, 2002, PROTEIN ENG, V15, P353, DOI 10.1093/protein/15.5.353; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2002, BIOCHEMISTRY-US, V41, P6798, DOI 10.1021/bi025566+; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Hadzhieva M, 2014, NEUROPATH APPL NEURO, V40, P240, DOI 10.1111/nan.12096; Hales KG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-79; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; HEMPSTEAD PD, 1994, FEBS LETT, V350, P258, DOI 10.1016/0014-5793(94)00781-0; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Hunter GA, 2008, J BIOL CHEM, V283, P23685, DOI 10.1074/jbc.M803372200; Isaya G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00029; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Maliandi MV, 2011, FEBS J, V278, P470, DOI 10.1111/j.1742-4658.2010.07968.x; Metzendorf C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-68; Mielcarek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122538; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rawat S, 2011, CHEM-EUR J, V17, P746, DOI 10.1002/chem.201002143; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richardson DR, 2010, J MOL MED, V88, P323, DOI 10.1007/s00109-009-0565-x; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Segel I. H., 1993, ENZYME KINETICS BEHA, P18; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shen Y, 2005, CHEM-EUR J, V11, P1549, DOI 10.1002/chem.200400298; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Soderberg CAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038927; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Welch KD, 2002, ARCH BIOCHEM BIOPHYS, V397, P360, DOI 10.1006/abbi.2001.2694; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200	68	17	17	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11887	11898		10.1074/jbc.M115.701128	http://dx.doi.org/10.1074/jbc.M115.701128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27026703	Green Published, hybrid			2022-12-26	WOS:000377264800037
J	Beltrami-Moreira, M; Vromman, A; Sukhova, GK; Folco, EJ; Libby, P				Beltrami-Moreira, Marina; Vromman, Amelie; Sukhova, Galina K.; Folco, Eduardo J.; Libby, Peter			Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ATHEROSCLEROTIC PLAQUES; INTERLEUKIN-1-BETA INHIBITION; MATRIX METALLOPROTEINASES; COLLAGEN ACCUMULATION; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; HEART-FAILURE; INFLAMMATION; ANAKINRA	Aims Mice deficient in IL-1 receptor 1 (hence unresponsive to both IL-1 isoforms a and beta) have impaired expansive arterial remodeling due to diminished expression of matrix-degrading enzymes, especially MMP-3. Emergence of IL-1 as a target in cardiovascular disease prompted the investigation of the redundancy of IL-1 alpha and IL-1 beta in the induction of MMP-3 and other matrix-remodeling enzymes in human cells. Methods and Results Human primary vascular smooth muscle cells (VSMCs) and carotid endarterectomy specimens were stimulated with equimolar concentrations of IL-1 alpha or IL-1 beta and analyzed protease expression by immunoblot and ELISA. Either IL-1 alpha or IL-1 beta increased the expression of pro-MMP-3 in VSMCs, facilitated VSMC migration through Matrigel, and induced MMP-3 production in specimens from atheromatous plaques. VSMCs also secreted MMP-1 and Cathepsin S (CatS) upon stimulation with IL-1 alpha or IL-1 beta. IL-1 isoforms similarly increased MMP-1 and MMP-9 expression in carotid endarterectomy specimens. We examined the expression of MMP-3 and IL-1 isoforms by immunostaining of carotid atheromata, calculated the% positive areas, and tested associations by linear regression. MMP-3 colocalized with IL-1 isoforms in atheromata. MMP-3+ area in plaques positively associated with IL-1 alpha+ (R2 = 0.61, P < 0.001) and with IL-1 beta + areas (R2 = 0.68, P < 0.001). MMP-3+ area within atheroma also associated with CD68+ area, but not with a-smooth muscle actin area. Conclusions Either IL-1 alpha or IL-1 beta can induce the expression of enzymes implicated in remodeling of the arterial extracellular matrix, and facilitate human VSMC migration in vitro. Human atheromata contain both IL-1 isoforms in association with immunoreactive MMP-3. This redundancy of IL-1 isoforms suggests that selective blocking of one IL-1 isoform should not impair expansive arterial remodeling, a finding with important clinical implications for therapeutic targeting of IL-1 in atherosclerosis.	[Beltrami-Moreira, Marina; Vromman, Amelie; Sukhova, Galina K.; Folco, Eduardo J.; Libby, Peter] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Libby, P (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Beltrami Moreira, Marina/ADG-6570-2022; Libby, Peter/AAY-6404-2021; Beltrami Moreira, Marina/AGW-5591-2022	Libby, Peter/0000-0002-1502-502X; Beltrami Moreira, Marina/0000-0001-7449-9789	Novartis; Heart, Lung, and Blood Institute [HL080472]; Lemann Foundation; CNPq (National Council for Scientific and Technologic Development), Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080472] Funding Source: NIH RePORTER	Novartis(Novartis); Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lemann Foundation; CNPq (National Council for Scientific and Technologic Development), Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A sponsored research agreement from Novartis contributed to the support of this project. Dr. Libby's laboratory received funding from the Heart, Lung, and Blood Institute (HL080472). MBM received support from the Lemann Foundation and CNPq (National Council for Scientific and Technologic Development), Brazil. Dr. Libby is an unpaid consultant and involved in clinical trials sponsored by Novartis. Novartis had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbate A, 2013, AM J CARDIOL, V111, P1394, DOI 10.1016/j.amjcard.2013.01.287; Abbate A, 2010, AM J CARDIOL, V105, P1371, DOI 10.1016/j.amjcard.2009.12.059; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; CLINTON SK, 1991, AM J PATHOL, V138, P1005; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fearon WF, 2008, CIRCULATION, V117, P2577, DOI 10.1161/CIRCULATIONAHA.108.772491; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; Fukumoto Y, 2004, CIRCULATION, V110, P1953, DOI 10.1161/01.CIR.0000143174.41810.10; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Glagov S., 1987, NEW ENGL J MED, V316, P371; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; Ikonomidis I, 2008, CIRCULATION, V117, P2662, DOI 10.1161/CIRCULATIONAHA.107.731877; Ikonomidis I, 2014, CIRC-CARDIOVASC IMAG, V7, P619, DOI 10.1161/CIRCIMAGING.113.001193; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, P167, DOI DOI 10.1007/0-387-22440-8_8; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; LOPPNOW H, 1992, EXP CELL RES, V198, P283, DOI 10.1016/0014-4827(92)90381-H; Quillard T, 2014, ARTERIOSCL THROM VAS, V34, P1179, DOI 10.1161/ATVBAHA.114.303326; Rader DJ, 2012, J CLIN INVEST, V122, P27, DOI 10.1172/JCI61163; Rajavashisth TB, 1999, J BIOL CHEM, V274, P11924, DOI 10.1074/jbc.274.17.11924; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Schoenhagen P, 2002, AM J CARDIOL, V89, P1354, DOI 10.1016/S0002-9149(02)02346-9; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Van Tassell BW, 2014, AM J CARDIOL, V113, P321, DOI 10.1016/j.amjcard.2013.08.047	31	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152474	10.1371/journal.pone.0152474	http://dx.doi.org/10.1371/journal.pone.0152474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032103	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800081
J	Gaffney, LP; Franks, B; Weary, DM; von Keyserlingk, MAG				Gaffney, Leigh P.; Franks, Becca; Weary, Daniel M.; von Keyserlingk, Marina A. G.			Coho Salmon (Oncorhynchus kisutch) Prefer and Are Less Aggressive in Darker Environments	PLOS ONE			English	Article							VISUAL PIGMENT COMPOSITION; ATLANTIC SALMON; STOCKING DENSITY; COLOR-VISION; FISH; GOLDFISH; WELFARE; GROWTH; LIGHT; ENRICHMENT	Fish are capable of excellent vision and can be profoundly influenced by the visual properties of their environment. Ambient colours have been found to affect growth, survival, aggression and reproduction, but the effect of background darkness (i.e., the darkness vs. lightness of the background) on preference and aggression has not been evaluated systematically. One-hundred Coho salmon (Oncorhynchus kisutch), a species that is increasing in popularity in aquaculture, were randomly assigned to 10 tanks. Using a Latin-square design, every tank was bisected to allow fish in each tank to choose between all the following colour choices (8 choices in total): black vs. white, light grey, dark grey, and a mixed dark grey/black pattern, as well as industry-standard blue vs. white, light grey, dark grey, and black. Fish showed a strong preference for black backgrounds over all other options (p < 0.01). Across tests, preference strength increased with background darkness (p < 0.0001). Moreover, having darker backgrounds in the environment resulted in less aggressive behaviour throughout the tank (p < 0.0001). These results provide the first evidence that darker tanks are preferred by and decrease aggression in salmonids, which points to the welfare benefits of housing farmed salmon in enclosures containing dark backgrounds.	[Gaffney, Leigh P.; Franks, Becca; Weary, Daniel M.; von Keyserlingk, Marina A. G.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, 2357 Main Mall, Vancouver, BC V6T 1Z6, Canada	University of British Columbia	von Keyserlingk, MAG (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, 2357 Main Mall, Vancouver, BC V6T 1Z6, Canada.	nina@mail.ubc.ca	von Keyserlingk, Marina/AAB-6353-2019; Weary, Daniel M/A-8868-2010	von Keyserlingk, Marina/0000-0002-1427-3152; Weary, Daniel M/0000-0002-0917-3982	Killiam Postdoctoral Scholarship	Killiam Postdoctoral Scholarship	This work was funded through the generous donations to the UBC Animal Welfare Program. B.F. is supported through a Killiam Postdoctoral Scholarship.	ABBOTT JC, 1985, CAN J FISH AQUAT SCI, V42, P1702, DOI 10.1139/f85-213; [Anonymous], 2014, R LANG ENV STAT COMP; Ashley PJ, 2007, APPL ANIM BEHAV SCI, V104, P199, DOI 10.1016/j.applanim.2006.09.001; Batzina A, 2012, AQUACULTURE, V370, P54, DOI 10.1016/j.aquaculture.2012.10.005; Braithwaite VA, 2005, P ROY SOC B-BIOL SCI, V272, P1107, DOI 10.1098/rspb.2005.3062; Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Braithwaite VA, 1998, SPATIAL REPRESENTATION IN ANIMALS, P86; BROOM D, 1998, REPORT AQUAVISION 98, P89; Chandroo KP, 2004, FISH FISH, V5, P281, DOI 10.1111/j.1467-2679.2004.00163.x; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Chaouloff F, 1997, BEHAV BRAIN RES, V85, P27, DOI 10.1016/S0166-4328(96)00160-X; Cheng CL, 2004, NATURE, V428, P279, DOI 10.1038/428279a; Cott H.B., 1940, ADAPTIVE COLORATION; Davis NJ, 1999, ANIM WELFARE, V8, P193; DAWKINS M, 1977, ANIM BEHAV, V25, P1034, DOI 10.1016/0003-3472(77)90054-9; Duncan I. J. H., 1978, Applied Animal Ethology, P197, DOI 10.1016/0304-3762(78)90086-X; Dunlop R, 2005, J PAIN, V6, P561, DOI 10.1016/j.jpain.2005.02.010; Ellis T, 2002, J FISH BIOL, V61, P493, DOI [10.1006/jfbi.2002.2057, 10.1111/j.1095-8649.2002.tb00893.x]; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ O; Fraser D., 1997, Animal welfare., P159; Fraser D., 2008, UNDERSTANDING ANIMAL; FRASER NHC, 1993, P ROY SOC B-BIOL SCI, V252, P135, DOI 10.1098/rspb.1993.0057; FUJIMOTO M, 1991, PHYSIOL BEHAV, V50, P185, DOI 10.1016/0031-9384(91)90519-T; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Godin, 1997, BEHAV ECOLOGY TELEOS; Hoglund E, 2002, J EXP BIOL, V205, P2535; Hyvarinen P, 2013, CAN J FISH AQUAT SCI, V70, P1386, DOI 10.1139/cjfas-2013-0147; Karakatsouli N, 2010, AQUACULT ENG, V42, P121, DOI 10.1016/j.aquaeng.2010.01.001; KEENLEYSIDE MHA, 1962, J FISH RES BOARD CAN, V19, P625, DOI 10.1139/f62-042; KEENLEYSIDE MILES H. A., 1962, BEHAVIOUR, V19, P139, DOI 10.1163/156853961X00231; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Kjernsmo K, 2012, P ROY SOC B-BIOL SCI, V279, P4192, DOI 10.1098/rspb.2012.1547; Kuznetsova A., 2015, R PACKAGE VERSION, V2, P734; Laland KN, 2003, FISH FISH, V4, P199, DOI 10.1046/j.1467-2979.2003.00124.x; LEVINE JS, 1982, SCI AM, V246, P140, DOI 10.1038/scientificamerican0282-140; Luchiari AC, 2009, J APPL ICHTHYOL, V25, P162, DOI 10.1111/j.1439-0426.2008.01203.x; Marchesan M, 2005, FISH RES, V73, P171, DOI 10.1016/j.fishres.2004.12.009; McLean E., 2008, Ribarstvo, V66, P43; Naas K, 1996, AQUACULT ENG, V15, P291, DOI 10.1016/0144-8609(95)00019-4; Naslund J, 2013, CAN J FISH AQUAT SCI, V70, P585, DOI 10.1139/cjfas-2012-0302; O'Connor KI, 1999, ANIM BEHAV, V58, P1269, DOI 10.1006/anbe.1999.1260; Odling-Smee L, 2003, FISH FISH, V4, P235, DOI 10.1046/j.1467-2979.2003.00127.x; Phillips PA, 2000, APPL ANIM BEHAV SCI, V67, P59, DOI 10.1016/S0168-1591(99)00104-5; Portavella M, 2004, NEUROSCI LETT, V362, P75, DOI 10.1016/j.neulet.2004.01.083; Portavella M, 2004, J NEUROSCI, V24, P2335, DOI 10.1523/JNEUROSCI.4930-03.2004; Portavella M, 2003, PHYSIOL BEHAV, V80, P49, DOI 10.1016/S0031-9384(03)00208-7; Rabe-Hesketh S., 2008, MULTILEVEL LONDGITUD; Rodriguez F., 1994, ANIM LEARN BEHAV, V10, P108; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Sandercock F. K., 1991, PACIFIC SALMON LIFE, P397; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHNEIDER R, 1980, CAN J FISH AQUAT SCI, V37, P1505, DOI 10.1139/f80-195; Shapovalov L., 1954, Fishery Bulletin Sacramento, VNo. 98, P1; Smith A., 1978, COMPUT GRAPH-UK, V12, P12; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2, P354; Southgate P, 2001, IN PRACTICE, V23, P277, DOI 10.1136/inpract.23.5.277; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; STEIGER A, 1979, SCHWEIZ ARCH TIERH, V121, P109; STRADMEYER L, 1987, Aquaculture and Fisheries Management, V18, P33, DOI 10.1111/j.1365-2109.1987.tb00123.x; Temple SE, 2006, J COMP PHYSIOL A, V192, P301, DOI 10.1007/s00359-005-0068-3; Temple SE, 2008, J EXP BIOL, V211, P2134, DOI 10.1242/jeb.009365; Thorarensen H, 2011, AQUACULTURE, V312, P1, DOI 10.1016/j.aquaculture.2010.11.043; Tucker CB, 2003, J DAIRY SCI, V86, P521, DOI 10.3168/jds.S0022-0302(03)73630-3; Turnbull J, 2005, AQUACULTURE, V243, P121, DOI 10.1016/j.aquaculture.2004.09.022; Turnbull JF, 1998, AQUACULTURE, V159, P345, DOI 10.1016/S0044-8486(97)00233-0; Ullmann JFP, 2011, AQUACULTURE, V322, P235, DOI 10.1016/j.aquaculture.2011.10.005; VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152; Volpato GL, 2007, DIS AQUAT ORGAN, V75, P165, DOI 10.3354/dao075165; Volpato GL, 2001, BRAZ J MED BIOL RES, V34, P1041, DOI 10.1590/S0100-879X2001000800011; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; WIDOWSKI TM, 1992, CAN J ANIM SCI, V72, P203, DOI 10.4141/cjas92-027	75	21	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151325	10.1371/journal.pone.0151325	http://dx.doi.org/10.1371/journal.pone.0151325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028731	gold, Green Published, Green Submitted			2022-12-26	WOS:000373116500023
J	Carletti, G; Carra, A; Allegro, G; Vietto, L; Desiderio, F; Bagnaresi, P; Gianinetti, A; Cattivelli, L; Vale, G; Nervo, G				Carletti, Giorgia; Carra, Andrea; Allegro, Gianni; Vietto, Lorenzo; Desiderio, Francesca; Bagnaresi, Paolo; Gianinetti, Alberto; Cattivelli, Luigi; Vale, Giampiero; Nervo, Giuseppe			QTLs for Woolly Poplar Aphid (Phloeomyzus passerinii L.) Resistance Detected in an InterSpecific Populus deltoides x P. nigra Mapping Population	PLOS ONE			English	Article							GENETIC-LINKAGE MAPS; KINASE KINASE KINASE; SEGREGATION DISTORTION; MICROSATELLITE MARKERS; CONFERS RESISTANCE; MOLECULAR-GENETICS; DISEASE RESISTANCE; HYBRID POPLAR; PROTEIN; GENOME	The genus Populus represents one of the most economically important groups of forest trees. It is composed by approximately 30 species used for wood and non-wood products, phytoremediation and biomass. Poplar is subjected to several biological and environmental threats although, compared to annual crops, we know far less about the genetic bases of biotic stress resistance. Woolly poplar aphid (Phloeomyzus passerinii) is considered a main pest of cultivated poplars in European and American countries. In this work we present two high density linkage maps in poplar obtained by a genotyping by sequencing (GBS) approach and the identification of QTLs involved in Ph. passerinii resistance. A total of 5,667 polymorphic markers (5,606 SNPs and 61 SSRs) identified on expressed sequences have been used to genotype 131 plants of an F1 population P xcanadensis obtained by an interspecific mate between Populus deltoides (resistant to woolly poplar aphid) and Populus nigra (susceptible to woolly poplar aphid). The two linkage maps, obtained following the two-way pseudo-testcross mapping strategy, have been used to investigate the genetic bases of woolly poplar aphid resistance. One major QTL and two QTLs with minor effects (mapped on LGV, LGXVI and LG XIX) explaining the 65.8% of the genetic variance observed in the progeny in response to Ph. passerinii attack were found. The high density coverage of functional markers allowed the identification of three genes belonging to disease resistance pathway as putative candidates for P. deltoides resistance to woolly poplar aphid. This work is the first report on genetic of woolly poplar aphid genetic resistance and the resistant loci associated markers identified represent a valuable tool in resistance poplar breeding programs.	[Carletti, Giorgia; Carra, Andrea; Allegro, Gianni; Vietto, Lorenzo; Nervo, Giuseppe] CREA, Res Unit Intens Wood Prod, Casale Monferrato, AL, Italy; [Desiderio, Francesca; Bagnaresi, Paolo; Gianinetti, Alberto; Cattivelli, Luigi; Vale, Giampiero] CREA, Genom Res Ctr, Fiorenzuola Darda, PC, Italy; [Vale, Giampiero] CREA, Rice Res Unit, Vercelli, Italy; [Carra, Andrea] Natl Res Council Italy CNR, Inst Sustainable Plant Protect, Turin, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR)	Nervo, G (corresponding author), CREA, Res Unit Intens Wood Prod, Casale Monferrato, AL, Italy.	giuseppe.nervo@crea.gov.it	cattivelli, luigi/AAE-7046-2020; Gianinetti, Alberto/J-4839-2019; Carletti, Giorgia/HII-5693-2022; Valè, Giampiero/ABF-1492-2020	cattivelli, luigi/0000-0002-6067-4600; Gianinetti, Alberto/0000-0003-0919-3956; Valè, Giampiero/0000-0003-2158-9726; Bagnaresi, Paolo/0000-0001-8466-4805; Desiderio, Francesca/0000-0002-1991-5249	Project "ESPLORA" (The Italian Ministry of Agricultural, Food and Forestry Policies-MiPAAF DM) [14658-7303]	Project "ESPLORA" (The Italian Ministry of Agricultural, Food and Forestry Policies-MiPAAF DM)	This research was supported by the Project "ESPLORA" (The Italian Ministry of Agricultural, Food and Forestry Policies-MiPAAF DM 14658-7303).	Allegro G., 1996, Forest Genetics, V3, P23; Arru G., 1979, International Union of Forestry Research Organizations: Proceedings of the meeting concerning poplars in France and Belgium, 17-22 Sept. 1979., P11; Arru G. M., 1975, Cellulosa e Carta, V26, P47; Barabaschi D, 2016, PLANT SCI, V242, P3, DOI 10.1016/j.plantsci.2015.07.010; BRADSHAW HD, 1995, GENETICS, V139, P963; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P167, DOI 10.1007/BF00225137; Bresson A, 2011, NEW PHYTOL, V192, P151, DOI 10.1111/j.1469-8137.2011.03786.x; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Bus VGM, 2010, TREE GENET GENOMES, V6, P477, DOI 10.1007/s11295-009-0265-2; Caseys C, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0904-8; Cervera MT, 2001, GENETICS, V158, P787; Coppola V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-515; Dardeau F, 2014, TREES-STRUCT FUNCT, V28, P1007, DOI 10.1007/s00468-014-1014-1; Deng HQ, 2012, PLANT PHYSIOL, V158, P876, DOI 10.1104/pp.111.191379; Dogimont C, 2014, PLANT J, V80, P993, DOI 10.1111/tpj.12690; Fishman L, 2001, EVOLUTION, V55, P1932, DOI 10.1111/j.0014-3820.2001.tb01311.x; Gaudet M, 2008, TREE GENET GENOMES, V4, P25, DOI 10.1007/s11295-007-0085-1; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Jiang CX, 2000, EVOLUTION, V54, P798, DOI 10.1111/j.0014-3820.2000.tb00081.x; Klingler JP, 2009, J EXP BOT, V60, P4115, DOI 10.1093/jxb/erp244; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lattanzio V, 2000, J AGR FOOD CHEM, V48, P5316, DOI 10.1021/jf000229y; Lee JS, 2015, THEOR APPL GENET, V128, P1481, DOI 10.1007/s00122-015-2519-8; Lescot M, 2004, THEOR APPL GENET, V109, P10, DOI 10.1007/s00122-004-1621-0; Li ZK, 1997, GENETICS, V145, P1139; Liang HY, 2014, PLANT SCI, V223, P69, DOI 10.1016/j.plantsci.2014.03.004; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; Neves LG, 2013, PLANT J, V75, P146, DOI 10.1111/tpj.12193; Nishihama R, 2001, GENE DEV, V15, P352, DOI 10.1101/gad.863701; Pakull B, 2009, TREE GENET GENOMES, V5, P505, DOI 10.1007/s11295-009-0204-2; Pointeau S, 2013, J ECON ENTOMOL, V106, P473, DOI 10.1603/EC12127; Portis E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089499; Sadeghi SE, 2002, IRANIAN J FOREST POP, V7, P1; SANO Y, 1990, GENETICS, V125, P183; Sauge MH, 2012, HEREDITY, V108, P292, DOI 10.1038/hdy.2011.74; Scherer GFE, 2010, PLANT CELL MONOGR, V16, P3, DOI 10.1007/978-3-642-03873-0_1; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shou HX, 2004, P NATL ACAD SCI USA, V101, P3298, DOI 10.1073/pnas.0308095100; Smulders MJM, 2001, MOL ECOL NOTES, V1, P188, DOI 10.1046/j.1471-8278.2001.00071.x; Stettler RF, 1996, BIOL POPULUS ITS IMP, P113; Tsai C. J., 2011, Genetics, genomics and breeding of poplar, P112; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2004, PLANT BIOLOGY, V6, P2, DOI 10.1055/s-2003-44715; van der Schoot J, 2000, THEOR APPL GENET, V101, P317, DOI 10.1007/s001220051485; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Woolbright SA, 2008, HEREDITY, V100, P59, DOI 10.1038/sj.hdy.6801063; Wroblewski T, 2007, PLANT J, V51, P803, DOI 10.1111/j.1365-313X.2007.03182.x; Wu RL, 2000, THEOR APPL GENET, V100, P1249, DOI 10.1007/s001220051431; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yin TM, 2002, GENOME, V45, P541, DOI [10.1139/g02-013, 10.1139/G02-013]; Zhang J, 2008, INSECT MOL BIOL, V17, P209, DOI 10.1111/j.1365-2583.2008.00796.x; Zhou Y, 2002, BIOTECHNIQUES, V32, P46, DOI 10.2144/02321bm05	61	8	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152569	10.1371/journal.pone.0152569	http://dx.doi.org/10.1371/journal.pone.0152569			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022954	Green Published, gold			2022-12-26	WOS:000373113900078
J	Wang, HX; Qiu, YR; Zhong, XP				Wang, Hong-Xia; Qiu, Yu-Rong; Zhong, Xiao-Ping			Intercellular Protein Transfer from Thymocytes to Thymic Epithelial Cells	PLOS ONE			English	Article							CENTRAL TOLERANCE; NEGATIVE SELECTION; DENDRITIC CELLS; SELF-TOLERANCE; T-CELLS; MEDULLA; ANTIGEN; AIRE; MICROENVIRONMENT; INDUCTION	Promiscuous expression of tissue restricted antigens (TRAs) in medullary thymic epithelial cells (mTECs) is crucial for negative selection of self-reactive T cells to establish central tolerance. Intercellular transfer of self-peptide-MHC complexes from mTECs to thymic dendritic cells (DCs) allows DCs to acquire TRAs, which in turn contributes to negative selection and regulatory T cell generation. However, mTECs are unlikely to express all TRAs, such as immunoglobulins generated only in B cells after somatic recombination, hyper-mutation, or class-switches. We report here that both mTECs and cortical TECs can efficiently acquire not only cell surface but also intracellular proteins from thymocytes. This reveals a previously unappreciated intercellular sharing of molecules from thymocytes to TECs, which may broaden the TRA inventory in mTECs for establishing a full spectrum of central tolerance.	[Wang, Hong-Xia; Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA; [Wang, Hong-Xia; Qiu, Yu-Rong] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Hematol Malignancies & Cellular Therapies Program, Duke Canc Inst, Durham, NC 27710 USA	Duke University; Southern Medical University - China; Duke University; Duke University	Zhong, XP (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA.; Qiu, YR (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China.; Zhong, XP (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.; Zhong, XP (corresponding author), Duke Univ, Med Ctr, Hematol Malignancies & Cellular Therapies Program, Duke Canc Inst, Durham, NC 27710 USA.	qiuyuronggz@126.com; xiaoping.zhong@duke.edu		Wang, Hongxia/0000-0001-5082-003X	National Institutes of Health [R01AI079088, R01AI101206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101206, R01AI079088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health R01AI079088 to XPZ (https://projectreporter.nih.gov/project_info_details.cfm?aid=8965994&icde=28040570&ddparam=&ddvalue=&ddsub=&cr=4&csb=default&cs=ASC&MMOpt=), and National Institutes of Health R01AI101206 to XPZ (https://projectreporter.nih.gov/project_info_details.cfm?aid=8831584&icde=28040570&ddparam=&ddvalue=&ddsub=&cr=5&csb=default&cs=ASC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Coder BD, 2015, J IMMUNOL, V194, P5825, DOI 10.4049/jimmunol.1500082; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Gray DHD, 2008, J IMMUNOL METHODS, V329, P56, DOI 10.1016/j.jim.2007.09.010; Guo R, 2008, P NATL ACAD SCI USA, V105, P11909, DOI 10.1073/pnas.0711856105; Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klein L, 2011, TRENDS IMMUNOL, V32, P188, DOI 10.1016/j.it.2011.03.002; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Krangel MS, 1998, IMMUNOL REV, V165, P131, DOI 10.1111/j.1600-065X.1998.tb01236.x; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lopes N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00365; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manley NR, 2011, FRONT BIOSCI-LANDMRK, V16, P2461, DOI 10.2741/3866; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Millet V, 2008, EUR J IMMUNOL, V38, P1257, DOI 10.1002/eji.200737982; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; PALMER DB, 1993, DEV IMMUNOL, V3, P175, DOI 10.1155/1993/56290; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Roberts NA, 2012, IMMUNITY, V36, P427, DOI 10.1016/j.immuni.2012.01.016; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; Skogberg G, 2015, IMMUNOL CELL BIOL, V93, P727, DOI 10.1038/icb.2015.33; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Wang HX, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002370; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Yang Q, 2010, IMMUNOL REV, V238, P12, DOI 10.1111/j.1600-065X.2010.00956.x; Yang SJ, 2006, INT IMMUNOL, V18, P729, DOI 10.1093/intimm/dxl010; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152641	10.1371/journal.pone.0152641	http://dx.doi.org/10.1371/journal.pone.0152641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022746	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900086
J	Hennersdorf, P; Kleinertz, S; Theisen, S; Abdul-Aziz, MA; Mrotzek, G; Palm, HW; Saluz, HP				Hennersdorf, Philipp; Kleinertz, Sonja; Theisen, Stefan; Abdul-Aziz, Muslihudeen A.; Mrotzek, Grit; Palm, Harry W.; Saluz, Hans Peter			Microbial Diversity and Parasitic Load in Tropical Fish of Different Environmental Conditions	PLOS ONE			English	Article							INDICATORS; WATER; SEQUENCES; IMPACT; FAUNA	In this study we analysed fecal bacterial communities and parasites of three important Indonesian fish species, Epinephelus fuscoguttatus, Epinephelus sexfasciatus and Atule mate. We then compared the biodiversity of bacterial communities and parasites of these three fish species collected in highly polluted Jakarta Bay with those collected in less polluted Indonesian areas of Cilacap (E. sexfasciatus, A. mate) and Thousand Islands (E. fuscoguttatus). In addition, E. fuscoguttatus from net cages in an open water mariculture facility was compared with free living E. fuscoguttatus from its surroundings. Both core and shared microbiomes were investigated. Our results reveal that, while the core microbiomes of all three fish species were composed of fairly the same classes of bacteria, the proportions of these bacterial classes strongly varied. The microbial composition of phylogenetically distant fish species, i.e. A. mate and E. sexfasciatus from Jakarta Bay and Cilacap were more closely related than the microbial composition of more phylogentically closer species, i.e. E. fuscoguttatus, E. sexfasciatus from Jakarta Bay, Cilacap and Thousand Islands. In addition, we detected a weak negative correlation between the load of selected bacterial pathogens, i.e. Vibrio sp. and Photobacterium sp. and the number of endoparasites. In the case of Flavobacterium sp. the opposite was observed, i.e. a weak positive correlation. Of the three recorded pathogenic bacterial genera, Vibrio sp. was commonly found in E. fuscoguttatus from mariculture, and lessly in the vicinity of the net cages and rarely in the fishes from the heavily polluted waters from Jakarta Bay. Flavobacterium sp. showed higher counts in mariculture fish and Photobacteria sp. was the most prominent in fish inside and close to the net cages.	[Hennersdorf, Philipp; Mrotzek, Grit; Saluz, Hans Peter] Leibniz Inst Nat Prod Res & Infect Biol, Cell & Mol Biol, Jena, Germany; [Hennersdorf, Philipp; Saluz, Hans Peter] Univ Jena, Jena, Germany; [Kleinertz, Sonja; Theisen, Stefan; Palm, Harry W.] Univ Rostock, Fac Agr & Environm Sci, D-18055 Rostock, Germany; [Palm, Harry W.] Udayana Univ, Fac Vet Med, Kampus Bukit Jimbaran, Udayana, Indonesia; [Abdul-Aziz, Muslihudeen A.] Univ Adelaide, Sch Biol Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; University of Rostock; Universitas Udayana; University of Adelaide	Saluz, HP (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Cell & Mol Biol, Jena, Germany.; Saluz, HP (corresponding author), Univ Jena, Jena, Germany.	hanspeter.saluz@leibniz-hki.de		Abdul-Aziz, Muslih./0000-0001-5600-0972	German Academic Exchange Service (DAAD) German Federal Ministry for Education and Science [03F0641B, 03F0641D]	German Academic Exchange Service (DAAD) German Federal Ministry for Education and Science	Financial support was provided through the German Academic Exchange Service (DAAD) (ST) German Federal Ministry for Education and Science within the framework of the joint Indonesian-German research programs SPICE III - MABICO (Science for the Protection of Indonesian Coastal Marine Ecosystems, BMBF Grant Nos. 03F0641B, 03F0641D).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anderson RC, 2002, NEMATODE PARASITES V; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bray RA., 2008, KEYS TREMATODA, V3; Bray RA, 2009, ZOOTAXA, P1, DOI 10.11646/zootaxa.2223.1.1; Brown K, 2012, NUTRIENTS, V4, P1552, DOI [10.3390/nu4081095, 10.3390/nu4111552]; Bu SSH, 1999, J HELMINTHOL, V73, P301; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; CHAO A, 1984, SCAND J STAT, V11, P265; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; de SILVA P. H. D. H., 1963, SPOLIA ZEYLANICA, V30, P47; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewi K, 2013, ZOOTAXA, V3609, P49, DOI 10.11646/zootaxa.3609.1.3; Dsikowitzky L, 2011, MAR POLLUT BULL, V62, P851, DOI 10.1016/j.marpolbul.2011.02.023; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ENG CT, 1989, MAR POLLUT BULL, V20, P335, DOI 10.1016/0025-326X(89)90157-4; Gibson D. I., 2002, VVolume 1, P1, DOI [10.1079/9780851995472.0001, 10.1079/9780851995472.0000]; Givens CE, 2015, MAR ECOL PROG SER, V518, P209, DOI 10.3354/meps11034; Golvan YJ, 1969, SYSTEMATIQUE ACANTHO; Halsey SH, 2004, INTRO COPEPOD DIVERS, V1; Hechinger RF, 2007, OECOLOGIA, V151, P82, DOI 10.1007/s00442-006-0568-z; Hennersdorf P, 2015, MARINE POLL IN PRESS; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Hudson PJ, 2016, VEGAN COMMUNITY ECOL; Jones A., 2005, KEYS TREMATODA, V2; Kleinertz S, 2015, J HELMINTHOL, V89, P86, DOI 10.1017/S0022149X1300062X; Kleinertz S, 2014, J HELMINTHOL, V88, P50, DOI 10.1017/S0022149X12000715; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moravec F, 1989, NEMATODES FRESHWATER; MUNKITTRICK KR, 1994, ENVIRON TOXICOL CHEM, V13, P1089, DOI 10.1002/etc.5620130710; Nordhaus I, 2009, REG ENVIRON CHANGE, V9, P291, DOI 10.1007/s10113-009-0097-5; Palm HW, 2015, REG STUD MAR SCI, V2, P54, DOI 10.1016/j.rsma.2015.07.003; Palm HW, 2011, PARASITOLOGY, V138, P1793, DOI 10.1017/S0031182011000011; Palm HW, 2009, PARASITOL RES, V105, P539, DOI 10.1007/s00436-009-1423-z; Palm H. W, 2004, TRYPANORHYNCHA DIESI; PALM H.W., 2014, MARINE FISH PARASITO; Palm HW, 2011, PARASITOL RES MG, V2, P223, DOI 10.1007/978-3-642-21396-0_12; PILLAI N. K., 1985, FAUNA INDIA COPEPOD; R Core Team, 2021, R LANGUAGE ENV STAT; Rinawati, 2012, J HAZARD MATER, V217, P208, DOI 10.1016/j.jhazmat.2012.03.023; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Ruckert S, 2008, J APPL ICHTHYOL, V24, P321, DOI 10.1111/j.1439-0426.2008.01064.x; Ruckert S, 2009, PARASITOL RES, V104, P523, DOI 10.1007/s00436-008-1226-7; Ruckert S, 2010, AQUAC RES, V41, P1158, DOI 10.1111/j.1365-2109.2009.02403.x; Rueckert S, 2009, REG ENVIRON CHANGE, V9, P315, DOI 10.1007/s10113-008-0076-2; Sevellec M, 2014, J EVOLUTION BIOL, V27, P1029, DOI 10.1111/jeb.12374; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; van der Meij SET, 2009, MAR POLLUT BULL, V59, P101, DOI 10.1016/j.marpolbul.2009.02.021; van der Meij SET, 2010, MAR POLLUT BULL, V60, P1442, DOI 10.1016/j.marpolbul.2010.05.011; Whittington ID, 2004, FOLIA PARASIT, V51, P109, DOI 10.14411/fp.2004.016; Xia JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-266; Yamaguti S., 1960, Publications of the Seto Marine Biological Laboratory, V8, P141; Yamaguti S., 1963, P1; YAMAGUTI S, 1963, SYSTEMA HELMINTHUM, V4; YAMAGUTI SATYU, 1952, ACTA MED OKAYAMA, V8, P146	61	28	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151594	10.1371/journal.pone.0151594	http://dx.doi.org/10.1371/journal.pone.0151594			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018789	gold, Green Published, Green Submitted			2022-12-26	WOS:000372807800016
J	Lyons, JD; Mittal, R; Fay, KT; Chen, CW; Liang, Z; Margoles, LM; Burd, EM; Farris, AB; Ford, ML; Coopersmith, CM				Lyons, John D.; Mittal, Rohit; Fay, Katherine T.; Chen, Ching-Wen; Liang, Zhe; Margoles, Lindsay M.; Burd, Eileen M.; Farris, Alton B.; Ford, Mandy L.; Coopersmith, Craig M.			Murine Lung Cancer Increases CD4+T Cell Apoptosis and Decreases Gut Proliferative Capacity in Sepsis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; IMPROVES SURVIVAL; CECAL LIGATION; MORTALITY; PREVENTION; OUTCOMES; INJURY; MOTOR; MICE	Background Mortality is significantly higher in septic patients with cancer than in septic patients without a history of cancer. We have previously described a model of pancreatic cancer followed by sepsis from Pseudomonas aeruginosa pneumonia in which cancer septic mice have higher mortality than previously healthy septic mice, associated with increased gut epithelial apoptosis and decreased T cell apoptosis. The purpose of this study was to determine whether this represents a common host response by creating a new model in which both the type of cancer and the model of sepsis are altered. Methods C57Bl/6 mice received an injection of 250,000 cells of the lung cancer line LLC-1 into their right thigh and were followed three weeks for development of palpable tumors. Mice with cancer and mice without cancer were then subjected to cecal ligation and puncture and sacrificed 24 hours after the onset of sepsis or followed 7 days for survival. Results Cancer septic mice had a higher mortality than previously healthy septic mice (60% vs. 18%, p = 0.003). Cancer septic mice had decreased number and frequency of splenic CD4+ lymphocytes secondary to increased apoptosis without changes in splenic CD8+ numbers. Intestinal proliferation was also decreased in cancer septic mice. Cancer septic mice had a higher bacterial burden in the peritoneal cavity, but this was not associated with alterations in local cytokine, neutrophil or dendritic cell responses. Cancer septic mice had biochemical evidence of worsened renal function, but there was no histologic evidence of renal injury. Conclusions Animals with cancer have a significantly higher mortality than previously healthy animals following sepsis. The potential mechanisms associated with this elevated mortality differ significantly based upon the model of cancer and sepsis utilized. While lymphocyte apoptosis and intestinal integrity are both altered by the combination of cancer and sepsis, the patterns of these alterations vary greatly depending on the models used.	[Lyons, John D.; Mittal, Rohit; Fay, Katherine T.; Chen, Ching-Wen; Liang, Zhe; Ford, Mandy L.; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Lyons, John D.; Mittal, Rohit; Fay, Katherine T.; Chen, Ching-Wen; Liang, Zhe; Margoles, Lindsay M.; Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Crit Care Ctr, Atlanta, GA USA; [Margoles, Lindsay M.] Emory Univ, Sch Med, Dept Internal Med, Atlanta, GA USA; [Burd, Eileen M.; Farris, Alton B.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Ford, Mandy L.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA USA	Emory University; Emory University; Emory University; Emory University; Emory University	Coopersmith, CM (corresponding author), Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA.; Coopersmith, CM (corresponding author), Emory Univ, Sch Med, Emory Crit Care Ctr, Atlanta, GA USA.	cmcoop3@emory.edu	Chen, Ching-wen/ABH-8484-2020; Farris, Alton Brad/S-6041-2017	Farris, Alton Brad/0000-0001-5534-7763	National Institutes of Health [GM104323, GM095442, GM072808, GM109779, GM113228]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, R01GM113228, R01GM109779, R01GM104323, T32GM095442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (GM104323, GM095442, GM072808, GM109779, GM113228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BAKER CC, 1983, SURGERY, V94, P331; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Danai PA, 2006, CHEST, V129, P1432, DOI 10.1378/chest.129.6.1432; de Montmollin E, 2013, SHOCK, V39, P250, DOI 10.1097/SHK.0b013e3182866d32; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dominguez JA, 2013, CRIT CARE MED, V41, pE275, DOI 10.1097/CCM.0b013e31828a44ed; Dominguez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049159; Fox AC, 2011, J IMMUNOL, V187, P1950, DOI 10.4049/jimmunol.1003391; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Fry DE, 2008, CRIT CARE MED, V36, P1369, DOI 10.1097/CCM.0b013e31816a11e9; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Hotchkiss RS, 2015, SCIENCE, V347, P1201, DOI 10.1126/science.aaa8334; Hotchkiss RS, 2014, NEW ENGL J MED, V371, P380, DOI 10.1056/NEJMcibr1404664; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Iskander KN, 2013, CRIT CARE MED, V41, P159, DOI 10.1097/CCM.0b013e3182676322; Liang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101828; McConnell KW, 2010, CRIT CARE MED, V38, P223, DOI 10.1097/CCM.0b013e3181b4a76b; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; Mittal R, 2015, J SURG RES, V195, P541, DOI 10.1016/j.jss.2015.02.004; Mittal R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093523; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; Rosolem MM, 2012, J CRIT CARE, V27, P301, DOI 10.1016/j.jcrc.2011.06.014; Safdar A, 2001, CRIT CARE CLIN, V17, P531, DOI 10.1016/S0749-0704(05)70198-6; Sertaridou E, 2015, ANN GASTROENTEROL, V28, P309; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Torres VBL, 2015, ANN AM THORAC SOC, V12, P1185, DOI 10.1513/AnnalsATS.201501-046OC; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; Yoseph BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062792; Yu SL, 2004, AM J RESP CRIT CARE, V169, P1135, DOI 10.1164/rccm.200211-1278OC	37	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0149069	10.1371/journal.pone.0149069	http://dx.doi.org/10.1371/journal.pone.0149069			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018973	Green Submitted, Green Published, gold			2022-12-26	WOS:000372807800003
J	Tamuli, R; Deka, R; Borkovich, KA				Tamuli, Ranjan; Deka, Rekha; Borkovich, Katherine A.			Calcineurin Subunits A and B Interact to Regulate Growth and Asexual and Sexual Development in Neurospora crassa	PLOS ONE			English	Article							DEPENDENT PROTEIN PHOSPHATASE; GENE-EXPRESSION; CATALYTIC SUBUNIT; BINDING PROTEIN; CYCLOSPORINE-A; CALMODULIN; STRESS; CALCIUM; YEAST; MORPHOLOGY	Calcineurin is a calcium/calmodulin dependent protein phosphatase in eukaryotes that consists of a catalytic subunit A and a regulatory subunit B. Previous studies in the filamentous fungus Neurospora crassa had suggested that the catalytic subunit of calcineurin might be an essential protein. We generated N. crassa strains expressing the A (cna-1) and B (cnb1) subunit genes under the regulation of Ptcu-1, a copper-responsive promoter. In these strains, addition of bathocuproinedisulfonic acid (BCS), a copper chelator, results in induction of cna-1 and cnb-1, while excess Cu2+ represses gene expression. Through analysis of these strains under repressing and inducing conditions, we found that the calcineurin is required for normal growth, asexual development and female fertility in N. crassa. Moreover, we isolated and analyzed cnb-1 mutant alleles generated by repeat-induced point mutation (RIP), with the results further supporting roles for calcineurin in growth and fertility in N. crassa. We demonstrated a direct interaction between the CNA-1 and CNB-1 proteins using an assay system developed to study protein-protein interactions in N. crassa.	[Tamuli, Ranjan; Deka, Rekha; Borkovich, Katherine A.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Tamuli, Ranjan] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, India	University of California System; University of California Riverside; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Tamuli, R (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Inst Integrat Genome Biol, Riverside, CA 92521 USA.; Tamuli, R (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, India.	ranjantamuli@iitg.ernet.in			Indo-US Science and Technology Forum; National Institutes of Health	Indo-US Science and Technology Forum; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by Indo-US Science and Technology Forum (http://www.iusstf.org/) and National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVALOS J, 1989, CURR GENET, V16, P369, DOI 10.1007/BF00340716; Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Barman A, 2015, J MICROBIOL, V53, P226, DOI 10.1007/s12275-015-4465-1; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; CHAUDHURI B, 1995, FEBS LETT, V357, P221, DOI 10.1016/0014-5793(94)01365-8; Chen YL, 2010, CURR FUNGAL INFECT R, V4, P244, DOI 10.1007/s12281-010-0027-5; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Cruz MC, 2001, EMBO J, V20, P1020, DOI 10.1093/emboj/20.5.1020; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Deka R, 2013, J GENET, V92, P559, DOI 10.1007/s12041-013-0270-y; Deka R, 2011, GENETICA, V139, P885, DOI 10.1007/s10709-011-9592-y; Egan JD, 2009, MOL PLANT MICROBE IN, V22, P1293, DOI 10.1094/MPMI-22-10-1293; Fox DS, 2001, MOL MICROBIOL, V39, P835, DOI 10.1046/j.1365-2958.2001.02295.x; Gajewski KM, 2006, DEV BIOL, V289, P17, DOI 10.1016/j.ydbio.2005.09.039; Ghosh A, 2014, G3-GENES GENOM GENET, V4, P349, DOI 10.1534/g3.113.008813; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hays S., 2000, FUNGAL GENET NEWSL, V47, P107, DOI [10.4148/1941-4765.1221, DOI 10.4148/1941-4765.1221]; Hoffman C. S., 2001, CURR PROTOC MOL BIOL; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Ivey FD, 1996, MOL BIOL CELL, V7, P1283, DOI 10.1091/mbc.7.8.1283; Jinhee C, 2009, J MICROBIOL BIOTECHN, V19, P11, DOI 10.4014/jmb.0804.268; Jones CA, 2010, METHOD ENZYMOL, V471, P319, DOI 10.1016/S0076-6879(10)71017-X; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Korripally P, 2010, FUNGAL GENET BIOL, V47, P237, DOI 10.1016/j.fgb.2009.12.006; Kothe GO, 1998, FUNGAL GENET BIOL, V23, P248, DOI 10.1006/fgbi.1998.1037; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Krystofova S, 2005, EUKARYOT CELL, V4, P365, DOI 10.1128/EC.4.2.365-378.2005; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Kumar KS, 2006, BIOCHEM BIOPH RES CO, V345, P1010, DOI 10.1016/j.bbrc.2006.05.010; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; Kumar R, 2014, ARCH MICROBIOL, V196, P295, DOI 10.1007/s00203-014-0966-2; Lamb TM, 2013, G3-GENES GENOM GENET, V3, P2273, DOI 10.1534/g3.113.008821; Lee SC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003625; LIU Y, 1991, MOL GEN GENET, V227, P52, DOI 10.1007/BF00260706; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Mendoza I, 1996, J BIOL CHEM, V271, P23061, DOI 10.1074/jbc.271.38.23061; Musson REA, 2012, CLIN CHEM, V58, P511, DOI 10.1373/clinchem.2011.167296; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Ouyang SQ, 2015, G3-GENES GENOM GENET, V5, P1899, DOI 10.1534/g3.115.020073; Pall ML, 1993, FUNGAL GENET NEWSL, V40, P58; Perkins DD, 1963, NEUROSPORA NEWSL, Vl4, P21; Prokisch H, 1997, MOL GEN GENET, V256, P104, DOI 10.1007/s004380050551; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rumi-Masante J, 2012, J MOL BIOL, V415, P307, DOI 10.1016/j.jmb.2011.11.008; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; SIKKINK R, 1995, BIOCHEMISTRY-US, V34, P8348, DOI 10.1021/bi00026a016; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Vogel H.J., 1956, MICROB GENET B, V13, P42; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339; WINKLER MA, 1984, P NATL ACAD SCI-BIOL, V81, P3054, DOI 10.1073/pnas.81.10.3054; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006	61	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151867	10.1371/journal.pone.0151867	http://dx.doi.org/10.1371/journal.pone.0151867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019426	Green Submitted, Green Published, gold			2022-12-26	WOS:000372807800022
J	Biondo, LA; Lima, EA; Souza, CO; Cruz, MM; Cunha, RDC; Alonso-Vale, MI; Oyama, LM; Nascimento, CMO; Pimentel, GD; dos Santos, RVT; Lira, FS; Neto, JCR				Biondo, Luana Amorim; Lima Junior, Edson Alves; Souza, Camila Oliveira; Cruz, Maysa Mariana; Cunha, Roberta D. C.; Alonso-Vale, Maria Isabel; Oyama, Lila Missae; Oller Nascimento, Claudia M.; Pimentel, Gustavo Duarte; dos Santos, Ronaldo V. T.; Lira, Fabio Santos; Rosa Neto, Jose Cesar			Impact of Doxorubicin Treatment on the Physiological Functions of White Adipose Tissue	PLOS ONE			English	Article							PPAR-GAMMA; CANCER CACHEXIA; GLUCOSE-UPTAKE; GLUT4; MASS; ASSOCIATION; ADIPOCYTES; INHIBITION; MIMICKING; ATROPHY	White adipose tissue (WAT) plays a fundamental role in maintaining energy balance and important endocrine functions. The loss of WAT modifies adipokine secretion and disrupts homeostasis, potentially leading to severe metabolic effects and a reduced quality of life. Doxorubicin is a chemotherapeutic agent used clinically because of its good effectiveness against various types of cancer. However, doxorubicin has deleterious effects in many healthy tissues, including WAT, liver, and skeletal and cardiac muscles. Our objective was to investigate the effects of doxorubicin on white adipocytes through in vivo and in vitro experiments. Doxorubicin reduced the uptake of glucose by retroperitoneal adipocytes and 3T3-L1 cells via the inhibition of AMP-activated protein kinase Thr172 phosphorylation and glucose transporter 4 content. Doxorubicin also reduced the serum level of adiponectin and, to a greater extent, the expression of genes encoding lipogenic (Fas and Acc) and adipogenic factors (Pparg, C/ebpa, and Srebp1c) in retroperitoneal adipose tissue. In addition, doxorubicin inhibited both lipogenesis and lipolysis and reduced the hormone-sensitive lipase and adipose tissue triacylglycerol lipase protein levels. Therefore, our results demonstrate the impact of doxorubicin on WAT. These results are important to understand some side effects observed in patients receiving chemotherapy and should encourage new adjuvant treatments that aim to inhibit these side effects.	[Biondo, Luana Amorim; Lima Junior, Edson Alves; Souza, Camila Oliveira; Rosa Neto, Jose Cesar] Univ Sao Paulo, Inst Biomed Sci, Dept Cellular Biol & Dev, Immunometab Res Grp, Sao Paulo, SP, Brazil; [Cruz, Maysa Mariana; Cunha, Roberta D. C.; Alonso-Vale, Maria Isabel] Fed Univ Sao Paulo UNIFESP, Inst Environm Sci Chem & Pharmaceut, Dept Biol Sci, Sao Paulo, SP, Brazil; [Oyama, Lila Missae; Oller Nascimento, Claudia M.] Fed Univ Sao Paulo UNIFESP, Dept Physiol, Physiol Nutr Discipline, Sao Paulo, SP, Brazil; [Pimentel, Gustavo Duarte] Univ Fed Goias, Fac Nursing & Nutr, Goiania, Go, Brazil; [dos Santos, Ronaldo V. T.] Univ Fed Sao Paulo UNIFESP, Dept Psychobiol, Sao Paulo, SP, Brazil; [Lira, Fabio Santos] State Univ Sao Paulo Julio de Mesquita Filho UNES, Dept Phys Educ, Presidente Prudente, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Goias; Universidade Federal de Sao Paulo (UNIFESP)	Neto, JCR (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cellular Biol & Dev, Immunometab Res Grp, Sao Paulo, SP, Brazil.	josecesar23@hotmail.com	de souza, camila oliveira/M-4220-2019; Thomatieli-Santos, Ronaldo Vagner/C-8209-2012; Lira, Fábio Santos/Q-7581-2016; Alonso-Vale, Maria Isabel C/C-6108-2012; Neto, Jose Cesar Rosa/I-8145-2015; Thomatieli-Santos, ronaldo/ABC-1167-2021; Lira, Fábio/N-7299-2019; Oyama, Lila M/B-7609-2012; Souza, Camila Oliveira de/GYU-8640-2022; Neto, Jose Rosa/G-6336-2012; Nascimento, Claudia Maria Oller do/T-4151-2019	de souza, camila oliveira/0000-0001-6749-9545; Thomatieli-Santos, Ronaldo Vagner/0000-0001-7010-2799; Lira, Fábio Santos/0000-0002-9645-1003; Neto, Jose Cesar Rosa/0000-0001-7019-9762; Thomatieli-Santos, ronaldo/0000-0001-7010-2799; Lira, Fábio/0000-0002-9645-1003; Neto, Jose Rosa/0000-0001-7019-9762; Nascimento, Claudia Maria Oller do/0000-0001-5755-3392; Biondo, Luana/0000-0002-7506-6667; ALONSO-VALE, MARIA ISABEL/0000-0001-5847-8080	Sao Paulo Research Foundation (FAPESP) [2013/09367-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo Research Foundation (FAPESP) (www.fapesp.br), grants number: 2013/09367-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Arunachalam S, 2013, FEBS LETT, V587, P105, DOI 10.1016/j.febslet.2012.11.019; Arunachalam S, 2012, TOXICOL MECH METHOD, V22, P540, DOI 10.3109/15376516.2012.692110; Ayla Sule, 2011, Int J Cell Biol, V2011, P390238, DOI 10.1155/2011/390238; Belakhlef A, 2008, CLIN NUCL MED, V33, P271, DOI 10.1097/RLU.0b013e3181662bbf; BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO;2-M; Bing C, 2006, BRIT J CANCER, V95, P1028, DOI 10.1038/sj.bjc.6603360; Bing C, 2008, CURR OPIN CLIN NUTR, V11, P201, DOI 10.1097/MCO.0b013e3282f948e2; Bing C, 2009, P NUTR SOC, V68, P385, DOI 10.1017/S0029665109990267; Bolsoni-Lopes A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-199; Brunengraber DZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE917, DOI 10.1152/ajpendo.00128.2003; Cabeza L, 2015, INT J NANOMED, V10, P1291, DOI 10.2147/IJN.S74378; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Garcia JM, 2013, ENDOCRINOLOGY, V154, P3118, DOI 10.1210/en.2013-1179; Gorselink M, 2006, MUSCLE NERVE, V33, P691, DOI 10.1002/mus.20467; Halabi S, 2007, CANCER, V110, P1478, DOI 10.1002/cncr.22932; Hyvonen MT, 2014, INT J BIOCHEM CELL B, V56, P123, DOI 10.1016/j.biocel.2014.09.013; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Jing L, 2011, EUR J PHARMACOL, V659, P224, DOI 10.1016/j.ejphar.2011.03.031; Kelishomi RB, 2008, TOXICOLOGY, V243, P96, DOI 10.1016/j.tox.2007.09.026; Lanthier N, 2014, BEST PRACT RES CL GA, V28, P545, DOI 10.1016/j.bpg.2014.07.002; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Lieffers JR, 2009, AM J CLIN NUTR, V89, P1173, DOI 10.3945/ajcn.2008.27273; Lima EAL, J CACHEXIA IN PRESS; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; Obregon MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00479; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Schondorf Thomas, 2011, J Diabetes Sci Technol, V5, P426; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; Sheu SH, 2005, BIOCHEMISTRY-US, V44, P1193, DOI 10.1021/bi048032c; Singla Shivani, 2014, Toxicol Int, V21, P191, DOI 10.4103/0971-6580.139808; Stanford KI, 2015, DIABETES, V64, P2002, DOI 10.2337/db14-0704; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Takada I, 2015, EXPERT OPIN THER PAT, V25, P175, DOI 10.1517/13543776.2014.985206; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Trayhurn P, 2014, ANNU REV NUTR, V34, P207, DOI 10.1146/annurev-nutr-071812-161156; Tsoli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092966; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028335	44	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151548	10.1371/journal.pone.0151548	http://dx.doi.org/10.1371/journal.pone.0151548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015538	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708900026
J	Gilbert, MM; Snively, E; Cotton, J				Gilbert, Meagan M.; Snively, Eric; Cotton, John			The Tarsometatarsus of the Ostrich Struthio camelus: Anatomy, Bone Densities, and Structural Mechanics	PLOS ONE			English	Article							FINITE-ELEMENT MODELS; CANCELLOUS BONE; BIPEDAL LOCOMOTION; PELVIC LIMB; STRESS; STRAIN; BIRDS; REQUIREMENTS; MORPHOLOGY; BEHAVIOR	Background The ostrich Struthio camelus reaches the highest speeds of any extant biped, and has been an extraordinary subject for studies of soft-tissue anatomy and dynamics of locomotion. An elongate tarsometatarsus in adult ostriches contributes to their speed. The internal osteology of the tarsometatarsus, and its mechanical response to forces of running, are potentially revealing about ostrich foot function. Methods/Principal Findings Computed tomography (CT) reveals anatomy and bone densities in tarsometatarsi of an adult and a young juvenile ostrich. A finite element (FE) model for the adult was constructed with properties of compact and cancellous bone where these respective tissues predominate in the original specimen. The model was subjected to a quasi-static analysis under the midstance ground reaction and muscular forces of a fast run. Anatomy-Metatarsals are divided proximally and distally and unify around a single internal cavity in most adult tarsometatarsus shafts, but the juvenile retains an internal three-part division of metatarsals throughout the element. The juvenile has a sparsely ossified hypotarsus for insertion of the m. fibularis longus, as part of a proximally separate third metatarsal. Bone is denser in all regions of the adult tarsometatarsus, with cancellous bone concentrated at proximal and distal articulations, and highly dense compact bone throughout the shaft. Biomechanics-FE simulations show stress and strain are much greater at midshaft than at force applications, suggesting that shaft bending is the most important stressor of the tarsometatarsus. Contraction of digital flexors, inducing a posterior force at the TMT distal condyles, likely reduces buildup of tensile stresses in the bone by inducing compression at these locations, and counteracts bending loads. Safety factors are high for von Mises stress, consistent with faster running speeds known for ostriches. Conclusions/Significance High safety factors suggest that bone densities and anatomy of the ostrich tarsometatarsus confer strength for selectively critical activities, such as fleeing and kicking predators. Anatomical results and FE modeling of the ostrich tarsometatarsus are a useful baseline for testing the structure's capabilities and constraints for locomotion, through ontogeny and the full step cycle. With this foundation, future analyses can incorporate behaviorally realistic strain rates and distal joint forces, experimental validation, and proximal elements of the ostrich hind limb.	[Gilbert, Meagan M.] Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 0W0, Canada; [Snively, Eric] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA; [Cotton, John] Ohio Univ, Russ Coll Engn & Technol, Mech Engn & Biomed Engn, Athens, OH 45701 USA	University of Saskatchewan; University of Wisconsin System; University System of Ohio; Ohio University	Gilbert, MM (corresponding author), Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 0W0, Canada.	m.gilbert@usask.ca						Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; Abourachid A, 2011, ZOOLOGY, V114, P360, DOI 10.1016/j.zool.2011.07.002; ALEXANDER RM, 1979, J ZOOL, V187, P169; Baumel JJ, 1993, NOMIA ANATOMICA AVIU; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Beer F P, 1992, MECH MAT; Bright JA, 2011, J ANAT, V219, P456, DOI 10.1111/j.1469-7580.2011.01408.x; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; Brusatte SL, 2015, CURR BIOL, V25, pR888, DOI 10.1016/j.cub.2015.08.003; CARRASCAL LM, 1990, HOLARCTIC ECOL, V13, P105; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Cheung JTM, 2005, J BIOMECH, V38, P1045, DOI 10.1016/j.jbiomech.2004.05.035; Cotton JR, 2005, J BIOMECH ENG-T ASME, V127, P213, DOI 10.1115/1.1865188; Cowin SC, 1989, BONE MECH; Deeming DC, 1996, VET REC, V139, P210, DOI 10.1136/vr.139.9.210; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Eichenseer PH, 2011, SPINE, V36, pE1446, DOI 10.1097/BRS.0b013e31820bc705; Gangl D, 2004, ANAT HISTOL EMBRYOL, V33, P100, DOI 10.1111/j.1439-0264.2003.00522.x; Gangl D, 2001, THESIS VETERINARMEDI; GANS C, 1979, EVOLUTION, V33, P227, DOI 10.1111/j.1558-5646.1979.tb04677.x; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Gatesy SM, 2009, J VERTEBR PALEONTOL, V29, P535, DOI 10.1671/039.029.0213; Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6; Gu YD, 2011, INT J NUMER METH BIO, V27, P476, DOI 10.1002/cnm.1414; Hellmich C, 2008, ANN BIOMED ENG, V36, P108, DOI [10.1007/s10439-007-9393-8, 10.1016/S0021-9290(08)70202-1]; Hinterhofer C, 2009, J DAIRY SCI, V92, P972, DOI 10.3168/jds.2008-1605; Horner JR, 2004, J VERTEBR PALEONTOL, V20, P115; Hutchinson JR, 2015, PEERJ, V3, DOI 10.7717/peerj.1001; Jindrich DL, 2007, J EXP BIOL, V210, P1378, DOI 10.1242/jeb.001545; Keaveny T.M., 1942, LANCET, V240, P43; Liang J, 2011, SCI CHINA LIFE SCI, V54, P267, DOI 10.1007/s11427-011-4139-0; LINDE F, 1992, J BIOMECH, V25, P359, DOI 10.1016/0021-9290(92)90255-Y; Martin RB, 1998, SKELETAL TISSUE MECH; Meriam JL, 2002, ENG MECH, V2; NORBERG UM, 1979, PHILOS T ROY SOC B, V287, P131, DOI 10.1098/rstb.1979.0054; ODGAARD A, 1989, J BIOMECH, V22, P829, DOI 10.1016/0021-9290(89)90066-3; Panagiotopoulou O, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0854; Panagiotopoulou O, 2012, J R SOC INTERFACE, V9, P351, DOI 10.1098/rsif.2011.0323; Pfafrod GO, 1972, POLYM MECH, V4, P697; Rayfield EJ, 2008, PALEOBIOLOGY, V34, P494, DOI 10.1666/07006.1; Reed K L, 2001, Iowa Orthop J, V21, P53; RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D; RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F; Robertson D.G.E., 2004, RES METHODS BIOMECHA; Rubenson J, 2007, J EXP BIOL, V210, P2548, DOI 10.1242/jeb.02792; Rubenson J, 2011, J R SOC INTERFACE, V8, P740, DOI 10.1098/rsif.2010.0466; Schaller N. U., 2005, Proceedings of the 3rd International Ratite Science Symposium of the World's Poultry Science Association (WPSA) and 12th World Ostrich Congress, Madrid, Spain, 14th-16th October, 2005, P83; Schaller NU, 2009, J ANAT, V214, P830, DOI 10.1111/j.1469-7580.2009.01083.x; Schaller NU, 2008, THESIS U HEIDELBERG; Schneider U, 1996, PHYS MED BIOL, V41, P111, DOI 10.1088/0031-9155/41/1/009; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Snively E, 2012, THESIS OHIO U ATHENS; Snively E, 2013, 10 INT C VERT MORPH, P204; Snively E, 2012, SKELETAL ONTOGENY MI; Snively E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021422; Snively Eric, 2002, Senckenbergiana Lethaea, V82, P35; VAHEY JW, 1987, J BIOMECH, V20, P29, DOI 10.1016/0021-9290(87)90264-8; Varghese B, 2011, J BIOMECH, V44, P1374, DOI 10.1016/j.jbiomech.2010.12.028; Verwoerd DJ, 1999, OSTRICH: BIOLOGY, PRODUCTION AND HEALTH, P191; Wang QH, 2009, MED ENG PHYS, V31, P1228, DOI 10.1016/j.medengphy.2009.07.021; Wood SA, 2011, J BIOMECH, V44, P1831, DOI 10.1016/j.jbiomech.2011.03.022; Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594; Zeffer A, 2003, J EXP BIOL, V206, P1085, DOI 10.1242/jeb.00208	64	16	16	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0149708	10.1371/journal.pone.0149708	http://dx.doi.org/10.1371/journal.pone.0149708			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015416	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708900019
J	Mooses, K; Mastu, J; Riso, EM; Hannus, A; Mooses, M; Kaasik, P; Kull, M				Mooses, Kerli; Maestu, Jarek; Riso, Eva-Maria; Hannus, Aave; Mooses, Martin; Kaasik, Priit; Kull, Merike			Different Methods Yielded Two-Fold Difference in Compliance with Physical Activity Guidelines on School Days	PLOS ONE			English	Article							2014 REPORT CARD; YOUNG-PEOPLE; CHILDREN; PATTERNS; ADOLESCENTS; CANADA; FITNESS; WALK	Introduction The aim was to compare the average and the days method in exploring the compliance of children with physical activity guidelines and describe their physical activity patterns in different school day segments. Methods Physical activity was objectively measured in 472 children aged 6-13 for one school week. Children were compliant when fulfilling PA recommendations 1) on average over all measured days (average method) or 2) on at least four measured days (days method). To explore the difference in moderate to vigorous physical activity (MVPA) minutes between compliant and non-complaint children (using both the average and days method) in various day segments, linear mixed models was used. Results Compliance with physical activity guidelines was significantly higher with the average compared to the days method (51.7% and 23.7%, respectively). In segmented-day analysis, compliant children accrued more MVPA minutes in all day segments, especially during after-school. Gender differences appeared only during the in-school segments, where girls spent less time in MVPA (average method: -4.39 min, 95% CI = -5.36,-3.42, days method: -4.45 min, 95% CI = -5.46,-3.44). Older children accrued more MVPA minutes during physical education classes, but less during breaks, compared to younger children. Conclusions The used methods yielded remarkably different prevalence estimates for compliance to physical activity recommendations. To ensure comparability between studies, interventions and reports, there is a need for internationally agreed operationalization and assessment methods of physical activity guidelines. As non-compliant children had lower MVPA during all day segments, greater efforts should be made to provide physical activity opportunities both during and after school.	[Mooses, Kerli; Maestu, Jarek; Riso, Eva-Maria; Hannus, Aave; Mooses, Martin; Kaasik, Priit; Kull, Merike] Univ Tartu, Fac Med, Inst Sports Sci & Physiotherapy, Ulikooli 18, EE-50090 Tartu, Estonia	University of Tartu	Mooses, K (corresponding author), Univ Tartu, Fac Med, Inst Sports Sci & Physiotherapy, Ulikooli 18, EE-50090 Tartu, Estonia.	Kerli.Mooses@ut.ee	, jarek/AAG-5620-2021; , Merike/AAN-6371-2020; Hannus, Aave/AAY-9688-2021; Hannus, Aave/N-6259-2019	Hannus, Aave/0000-0002-0912-0661; Mooses, Kerli/0000-0002-3651-6063	Science Institutional Grant [IUT 20-58]; health promotion research programme TerVE project "Development of research-based physical activity program for children and youth" - European Regional Development Fund	Science Institutional Grant; health promotion research programme TerVE project "Development of research-based physical activity program for children and youth" - European Regional Development Fund	Publication of this article was funded by Science Institutional Grant IUT 20-58 and by the health promotion research programme TerVE project "Development of research-based physical activity program for children and youth", funded by the European Regional Development Fund and implemented by the Estonian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apete GK, 2012, PERSPECT PUBLIC HEAL, V132, P81, DOI 10.1177/1757913911419896; Atkin AJ, 2008, PEDIATR EXERC SCI, V20, P446, DOI 10.1123/pes.20.4.446; Bates D, 2014, J STAT SOFTW UNPUB; Beets MW, 2009, AM J PREV MED, V36, P527, DOI 10.1016/j.amepre.2009.01.033; Brooke HL, 2014, SPORTS MED, V44, P1427, DOI 10.1007/s40279-014-0215-5; Cavill N, 2001, PEDIATR EXERC SCI, V13, P12, DOI 10.1123/pes.13.1.12; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Collings PJ, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-23; Cooper AR, 2005, AM J PREV MED, V29, P179, DOI 10.1016/j.amepre.2005.05.009; Cooper AR, 2003, AM J PREV MED, V25, P273, DOI 10.1016/S0749-3797(03)00205-8; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fairclough SJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-406; Gidlow C, 2008, J SPORT SCI, V26, P1411, DOI 10.1080/02640410802277445; Gray CE, 2014, J PHYS ACT HEALTH, V11, pS26, DOI 10.1123/jpah.2014-0178; Groffik D, 2012, INT J PUBLIC HEALTH, V57, P711, DOI 10.1007/s00038-012-0355-z; Guinhouya BC, 2013, PUBLIC HEALTH, V127, P301, DOI 10.1016/j.puhe.2013.01.020; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kesaniemi A, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-41; Kettner S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-895; Konstabel K, 2014, INT J OBESITY, V38, pS135, DOI 10.1038/ijo.2014.144; Kriemler S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c785; Liukkonen J, 2014, J PHYS ACT HEALTH, V11, pS51, DOI 10.1123/jpah.2014-0168; Long MW, 2013, AM J PREV MED, V45, P150, DOI 10.1016/j.amepre.2013.03.011; Matthews JS, 2009, J EDUC PSYCHOL, V101, P689, DOI 10.1037/a0014240; Mckenzie TL, 2004, MED SCI SPORT EXER, V36, P1382, DOI 10.1249/01.MSS.0000135792.20358.4D; Mota J, 2003, AM J HUM BIOL, V15, P547, DOI 10.1002/ajhb.10163; Nettlefold L, 2011, BRIT J SPORT MED, V45, P813, DOI 10.1136/bjsm.2009.068072; Olds T, 2011, J PHYS ACT HEALTH, V8, P548, DOI 10.1123/jpah.8.4.548; Olds T, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-43; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Ridgers ND, 2011, J SCHOOL HEALTH, V81, P545, DOI 10.1111/j.1746-1561.2011.00625.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Smith L, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-134; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Tremblay MS, 2014, J PHYS ACT HEALTH, V11, pS3, DOI 10.1123/jpah.2014-0167; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Twisk J.W., 2010, APPL MULTILEVEL ANAL; Vale S, 2013, INT J OBESITY, V37, P1352, DOI 10.1038/ijo.2013.109; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yli-Piipari S, 2016, J PHYS ACT HEALTH, V13, P440, DOI 10.1123/jpah.2015-0335; Zitouni D, 2012, J SCI MED SPORT, V15, P327, DOI 10.1016/j.jsams.2011.11.254	45	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152323	10.1371/journal.pone.0152323	http://dx.doi.org/10.1371/journal.pone.0152323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015099	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900051
J	Na, TY; Ka, NL; Rhee, H; Kyeong, D; Kim, MH; Seong, JK; Park, YN; Lee, MO				Na, T-Y; Ka, N-L; Rhee, H.; Kyeong, D.; Kim, M-H; Seong, J. K.; Park, Y. N.; Lee, M-O			Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma	ONCOGENE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; DAMAGE RESPONSE; EXCISION-REPAIR; LIVER-CANCER; CHROMATIN; CELLS; TRANSCRIPTION; ACCUMULATION; INVOLVEMENT; INVASION	Hepatitis B virus X protein (HBx) contributes to the development of hepatocellular carcinoma (HCC), probably by regulating activities of many host or viral proteins through protein-protein interactions. In this study, we identified poly(ADP-ribose) polymerase (PARP1), a crucial factor in DNA repair, as an HBx-interacting protein using a proteomics approach. Coimmunoprecipitation and proximity ligation assays confirmed the binding and colocalization of HBx and PARP1 in the nucleus. The carboxyl-terminus of HBx protein bound to the catalytic domain of PARP1, and this binding reduced the enzymatic activity of PARP1 in both in vitro and in vivo assays. HBx interrupted the binding of PARP1 to Sirt6, which catalyzes the mono-ADP-ribosylation required for DNA repair. Consistently, overexpression of HBx inhibited the clearance of gamma H2AX DNA repair foci generated under oxidative stress in Chang liver cells. Recruitment of the DNA repair complex to the site-specific double-strand breaks was inhibited in the presence of HBx, when measured by laser microirradiation assay and damage-specific chromatin immunoprecipitation assays. Consequently, HBx increased signs of DNA damage such as accumulation of 8-hydroxy-2'-deoxyguanosine and comet formation, which were reversed by overexpression of PARP1 and/or Sirt6. Finally, the interaction between PARP1 and Sirt6 was markedly lower in the livers of HBx-transgenic mice and specimens obtained from HCC patients to compare with the corresponding control. Our data suggest that the physical interaction of HBx and PARP1 accelerates DNA damage by inhibiting recruitment of the DNA repair complex to the damaged DNA sites, which may lead to the onset of hepatocarcinogenesis.	[Na, T-Y; Ka, N-L; Kim, M-H; Lee, M-O] Seoul Natl Univ, Coll Pharm, San 56-1 Sillim Dong, Seoul 151742, South Korea; [Na, T-Y; Ka, N-L; Kim, M-H; Lee, M-O] Seoul Natl Univ, Bio MAX Inst, Seoul, South Korea; [Rhee, H.; Park, Y. N.] Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Dept Pathol, Seoul, South Korea; [Kyeong, D.; Seong, J. K.] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Coll Vet Med, Seoul, South Korea; [Kyeong, D.; Seong, J. K.] Seoul Natl Univ, Program Canc Biol, Seoul, South Korea; [Kyeong, D.; Seong, J. K.] Korea Mouse Phenotyping Ctr, Seoul, South Korea; [Park, Y. N.] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System	Lee, MO (corresponding author), Seoul Natl Univ, Coll Pharm, San 56-1 Sillim Dong, Seoul 151742, South Korea.	molee@snu.ac.kr	Rhee, Hyungjin/T-7619-2019	Seong, Je Kyung/0000-0003-1177-6958; Rhee, Hyungjin/0000-0001-7759-4458; Park, Young Nyun/0000-0003-0357-7967; Kyung, Dongsoo/0000-0003-2910-0120	National R&D Program for Cancer Control, Ministry of Health Welfare, Korea [1220110]; Bio & Medical Technology Development Program [2012M3A9B6055338];  [NRF-2014R1A2A1A10052265]	National R&D Program for Cancer Control, Ministry of Health Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Bio & Medical Technology Development Program; 	This work was supported by grants from NRF-2014R1A2A1A10052265, the National R&D Program for Cancer Control, Ministry of Health & Welfare, Korea (1220110) and the Bio & Medical Technology Development Program (2012M3A9B6055338).	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Becker SA, 1998, J VIROL, V72, P266, DOI 10.1128/JVI.72.1.266-272.1998; Bolukbas C, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-95; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Dandri M, 2002, HEPATOLOGY, V35, P217, DOI 10.1053/jhep.2002.30203; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Deng BA, 2015, GENE, V571, P292, DOI 10.1016/j.gene.2015.06.083; Di Giammartino DC, 2013, MOL CELL, V49, P7, DOI 10.1016/j.molcel.2012.11.005; Fujita N, 2008, J VIRAL HEPATITIS, V15, P498, DOI 10.1111/j.1365-2893.2008.00972.x; Gehrke R, 2004, DIGESTION, V70, P117, DOI 10.1159/000080930; Higgs MR, 2014, J GEN VIROL, V95, P991, DOI 10.1099/vir.0.059485-0; Hoare J, 2001, J MED VIROL, V64, P419, DOI 10.1002/jmv.1067; Iizuka N, 2006, J CANCER RES CLIN, V132, P473, DOI 10.1007/s00432-006-0094-8; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jia L, 1999, INT J CANCER, V80, P875, DOI 10.1002/(SICI)1097-0215(19990315)80:6<875::AID-IJC13>3.3.CO;2-Q; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; Ko HL, 2011, HEPATOLOGY, V54, P1190, DOI 10.1002/hep.24502; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lara-Pezzi E, 2001, ONCOGENE, V20, P3323, DOI 10.1038/sj.onc.1204451; Lee MH, 2012, ONCOGENE, V31, P5099, DOI 10.1038/onc.2012.2; Lee NS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10463; LEE TH, 1995, J VIROL, V69, P1107, DOI 10.1128/JVI.69.2.1107-1114.1995; Liu HO, 2012, CANCER SCI, V103, P2072, DOI 10.1111/cas.12017; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Lu H, 2011, J BIOL CHEM, V286, P20335, DOI 10.1074/jbc.M110.215632; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Marquardt JU, 2013, HEPATOLOGY, V58, P1054, DOI 10.1002/hep.26413; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Min S, 2014, CELL CYCLE, V13, P666, DOI 10.4161/cc.27548; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Ng SA, 2011, J GASTROENTEROL, V46, P974, DOI 10.1007/s00535-011-0415-9; Nomura F, 2000, J GASTROEN HEPATOL, V15, P529, DOI 10.1046/j.1440-1746.2000.02193.x; PATERLINI P, 1995, HEPATOLOGY, V21, P313, DOI 10.1002/hep.1840210208; Piskunova Tatiana S, 2008, Curr Gerontol Geriatr Res, P754190, DOI 10.1155/2008/754190; Qadri I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-48; Sala A, 2008, PLOS BIOL, V6, P2329, DOI 10.1371/journal.pbio.0060252; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shimizu S, 2004, ONCOL REP, V12, P821; SHIMODA R, 1994, CANCER RES, V54, P3171; Sousa FG, 2012, CARCINOGENESIS, V33, P1433, DOI 10.1093/carcin/bgs132; Srisuttee R, 2012, ONCOL REP, V28, P276, DOI 10.3892/or.2012.1798; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; van de Klundert MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048940; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; Xu C, 2014, CANCER LETT, V345, P216, DOI 10.1016/j.canlet.2013.08.035; Yoo YG, 2004, FEBS LETT, V577, P121, DOI 10.1016/j.febslet.2004.10.004; Zhang ZG, 2014, MOL MED REP, V9, P882, DOI 10.3892/mmr.2013.1879	52	31	32	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 13	2016	35	41					5435	5445		10.1038/onc.2016.82	http://dx.doi.org/10.1038/onc.2016.82			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA5QU	27041572				2022-12-26	WOS:000386677800009
J	Ko, C; Kim, YG; Le, TP; Choi, KW				Ko, C.; Kim, Y-G; Le, T. P.; Choi, K-W			Twinstar/cofilin is required for regulation of epithelial integrity and tissue growth in Drosophila	ONCOGENE			English	Article							ACTIN-CAPPING-PROTEIN; HIPPO PATHWAY; CELL POLARITY; F-ACTIN; SIGNALING PATHWAYS; COFILIN; APOPTOSIS; SLINGSHOT; MIGRATION; PROLIFERATION	Regulation of actin assembly and depolymerization is important for the organization of epithelia. Recent studies have shown that the actin-capping proteins are required to prevent cell extrusion and inappropriate activation of Yorkie (Yki) activity in Drosophila, implicating the importance of actin regulation for epithelial integrity and Yki-dependent tissue growth. However, the role of Twinstar (Tsr), the Drosophila homolog for cofilin/actin depolymerization factor (ADF), in epithelial integrity and Hippo signaling is unknown. Here we demonstrate that reduction of Tsr by RNA interference (RNAi) or mutant clones in wing imaginal disc induces not only F-actin accumulation but also ectopic expression of Wingless (Wg) and Yki target gene expanded (ex). Knockdown of Yki in Tsr-depleted cells reduced the level of ectopic Wg expression. Reduced Tsr also led to downregulation of cell junction proteins and extrusion of affected cells from the basal part of the epithelium. Rho GTPase 1 was upregulated in Tsr-depleted tissue, supporting the Tsr function in the inhibition of cell extrusion from the epithelium. Tsr is also required for blocking cell death and c-Jun N-terminal kinase (JNK) signaling. Ectopic JNK activation induced caspase activation but did not cause cell extrusion. Further, the invasiveness of Tsr-depleted cells was not suppressed by inhibition of cell death or JNK signaling. In contrast, Yki upregulation was significantly suppressed by cell death inhibition. Taken together, our data suggest that Tsr is required for cell survival and tissue growth by regulating JNK and Yki signaling while maintaining the epithelial integrity by controlling cell junctions. This study provides an insight into potential roles of ADF/cofilin in invasive cell migration and tumor suppression in higher animals.	[Ko, C.; Kim, Y-G; Le, T. P.; Choi, K-W] Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Choi, KW (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Taejon 305701, South Korea.	kchoi100@kaist.ac.kr	Choi, Kwang-Wook/C-1707-2011	Choi, Kwang-Wook/0000-0002-8997-3065	National Research Foundation of Korea - Korean, Ministry of Education, Science and Technology [NRF-2011-0028326, 2014K1A1A2042982]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	National Research Foundation of Korea - Korean, Ministry of Education, Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Drs David Helfman and Kyung-Ok Cho for critical comments on the manuscript. We thank Drs Florence Janody, Jongkyeong Chung and Kenneth Irvine for providing flies and antibodies mentioned in the text. We acknowledge the Bloomington Drosophila Stock Center, DGGC, the NIG-Fly Stock Center and the Developmental Studies Hybridoma Bank for fly stocks and antibodies. We thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks. This research was supported by a National Research Laboratory Grant (NRF-2011-0028326) and a Global Research Laboratory Grant (2014K1A1A2042982) through the National Research Foundation of Korea, funded by the Korean, Ministry of Education, Science and Technology.	Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Blair A, 2006, DEVELOPMENT, V133, P1789, DOI 10.1242/dev.02320; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; EDWARDS KA, 1994, P NATL ACAD SCI USA, V91, P4589, DOI 10.1073/pnas.91.10.4589; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Hsu FF, 2010, ONCOGENE, V29, P2864, DOI 10.1038/onc.2010.40; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Janody F, 2006, DEVELOPMENT, V133, P3349, DOI 10.1242/dev.02511; Jezowska B, 2011, DEV BIOL, V360, P143, DOI 10.1016/j.ydbio.2011.09.016; Lee YJ, 2005, CELL BIOL INT, V29, P877, DOI 10.1016/j.cellbi.2005.07.005; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lin CM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-46; Liu XF, 2000, DEV BIOL, V228, P287, DOI 10.1006/dbio.2000.9939; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Miles WO, 2011, DIS MODEL MECH, V4, P753, DOI 10.1242/dmm.006908; Nagai Shoichi, 2011, Genes Cancer, V2, P859, DOI 10.1177/1947601911431839; Nakajima Y, 2013, NATURE, V500, P359, DOI 10.1038/nature12335; Neumann CJ, 1996, DEVELOPMENT, V122, P1781; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Pham H, 2008, DEV BIOL, V318, P82, DOI 10.1016/j.ydbio.2008.03.006; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Rogers EM, 2005, MECH DEVELOP, V122, P1194, DOI 10.1016/j.mod.2005.07.002; Rudrapatna VA, 2014, ONCOGENE, V33, P2801, DOI 10.1038/onc.2013.232; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schlote, 1984, DROS INFORM SERV, V60, P210; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Tahtamouni LH, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-45; Tsai CH, 2009, CELL CYCLE, V8, P2365, DOI 10.4161/cc.8.15.9072; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; XU T, 1993, DEVELOPMENT, V117, P1223	40	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5144	5154		10.1038/onc.2016.46	http://dx.doi.org/10.1038/onc.2016.46			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	27041568				2022-12-26	WOS:000384433000006
J	Zhang, F; Yu, JW; Yang, T; Xu, D; Chi, ZX; Xia, YH; Xu, ZH				Zhang, Feng; Yu, Jingwen; Yang, Tao; Xu, Dan; Chi, Zhixia; Xia, Yanheng; Xu, Zhiheng			A Novel c-Jun N-terminal Kinase (JNK) Signaling Complex Involved in Neuronal Migration during Brain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING CEREBRAL-CORTEX; DEVELOPING NEOCORTEX; CELL-MIGRATION; IN-VIVO; KAPPA-B; PROTEIN; ACTIVATION; PATHWAYS; WDR62; POSH	Disturbance of neuronal migration may cause various neurological disorders. Both the transforming growth factor-beta (TGF-beta) signaling and microcephaly-associated protein WDR62 are important for neuronal migration during brain development; however, the underlying molecular mechanisms involved remain unclear. We show here that knock-out or knockdown of Tak1 (TGF beta-activated kinase 1) and Jnk2 (c-Jun N-terminal kinase 2) perturbs neuronal migration during cortical development and that the migration defects incurred by knock-out and/or knockdown of T beta r2 (type II TGF-beta receptor) or Tak1 can be partially rescued by expression of TAK1 and JNK2, respectively. Furthermore, TAK1 forms a protein complex with RAC1 and two scaffold proteins of the JNK pathway, the microcephaly-associated protein WDR62 and the RAC1-interacting protein POSH (plenty of Src homology). Components of the complex coordinate with each other in the regulation of TAK1 as well as JNK activities. We suggest that unique JNK protein complexes are involved in the diversified biological and pathological functions during brain development and pathogenesis of diseases.	[Zhang, Feng; Yu, Jingwen; Yang, Tao; Xu, Dan; Chi, Zhixia; Xia, Yanheng; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Xu, Zhiheng] Tongji Univ, Sch Med, Shanghai East Hosp, Translat Med Ctr Stem Cell Therapy, Shanghai 200120, Peoples R China; [Zhang, Feng; Xia, Yanheng] Univ Chinese Acad Sci, Beijing 100101, Peoples R China; [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Tongji University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.	zhxu@genetics.ac.cn	Yang, T/AFR-6763-2022	Xu, Zhiheng/0000-0002-4809-2851; Zhang, Feng/0000-0003-2887-8184	National Natural Science Foundation (China) [31430037, 31271156, 31270826, 31470845]; "973" program of the Ministry of Science and Technology (China) [2014CB942801, 2012CB517904, 2013DFA31990, 2012YQ03026006]	National Natural Science Foundation (China)(National Natural Science Foundation of China (NSFC)); "973" program of the Ministry of Science and Technology (China)	This work was supported by National Natural Science Foundation (China) Grants 31430037/31271156/31270826/31470845 and the "973" program of the Ministry of Science and Technology (China) Grants 2014CB942801/2012CB517904/2013DFA31990/2012YQ03026006). The authors declare that they have no conflicts of interest with the contents of this article.	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Chen L, 2007, J NEUROSCI, V27, P3884, DOI 10.1523/JNEUROSCI.3509-06.2007; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Govek EE, 2011, DEV NEUROBIOL, V71, P528, DOI 10.1002/dneu.20850; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; Kriegstein AR, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.1528-1167.2005.00304.x; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Tan X, 2013, WIRES DEV BIOL, V2, P443, DOI 10.1002/wdev.88; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yamasaki T, 2011, J NEUROSCI, V31, P16872, DOI 10.1523/JNEUROSCI.1111-11.2011; Yang T, 2012, CELL REP, V2, P640, DOI 10.1016/j.celrep.2012.08.007; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yu JW, 2014, J MOL CELL BIOL, V6, P349, DOI 10.1093/jmcb/mju030; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zhang F., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.3969/J.ISSN.1000-2324.2014.02.01	36	27	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11466	11475		10.1074/jbc.M116.716811	http://dx.doi.org/10.1074/jbc.M116.716811			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27026702	Green Published, hybrid			2022-12-26	WOS:000377264800001
J	Zou, HY; Wu, Y; Brew, K				Zou, Haiyin; Wu, Ying; Brew, Keith			Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1,-3, and-14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calorimetry; conformational change; enzyme inhibitor; matrix metalloproteinase (MMP); protein dynamic; protein engineering; protein-protein interaction; thermodynamics; tissue inhibitor of metalloproteinase (TIMP); zinc	CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; TERMINAL DOMAIN; HEAT-CAPACITY; BINDING; TIMP-1; ENTROPY; SITE; FLEXIBILITY; COMPLEX	The four tissue inhibitors of metalloproteinases (TIMPs) are potent inhibitors of the many matrixins (MMPs), except that TIMP1 weakly inhibits some MMPs, including MMP14. The broad-spectrum inhibition of MMPs by TIMPs and their N-domains (NTIMPs) is consistent with the previous isothermal titration calorimetric finding that their interactions are entropy-driven but differ in contributions from solvent and conformational entropy (S-solv, S-conf), estimated using heat capacity changes (C-p). Selective engineered NTIMPs have potential applications for treating MMP-related diseases, including cancer and cardiomyopathy. Here we report isothermal titration calorimetric studies of the effects of selectivity-modifying mutations in NTIMP1 and NTIMP2 on the thermodynamics of their interactions with MMP1, MMP3, and MMP14. The weak inhibition of MMP14 by NTIMP1 reflects a large conformational entropy penalty for binding. The T98L mutation, peripheral to the NTIMP1 reactive site, enhances binding by increasing S-solv but also reduces S-conf. However, the same mutation increases NTIMP1 binding to MMP3 in an interaction that has an unusual positive C-p. This indicates a decrease in solvent entropy compensated by increased conformational entropy, possibly reflecting interactions involving alternative conformers. The NTIMP2 mutant, S2D/S4A is a selective MMP1 inhibitor through electrostatic effects of a unique MMP-1 arginine. Asp-2 increases reactive site polarity, reducing C-p, but increases conformational entropy to maintain strong binding to MMP1. There is a strong negative correlation between S-solv and S-conf for all characterized interactions, but the data for each MMP have characteristic ranges, reflecting intrinsic differences in the structures and dynamics of their free and inhibitor-bound forms.	[Zou, Haiyin; Wu, Ying; Brew, Keith] Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Wu, Ying] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Wu, Ying] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	State University System of Florida; Florida Atlantic University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brew, K (corresponding author), Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.	kbrew@fau.edu	Brew, Keith/W-1643-2019	Brew, Keith/0000-0003-1306-1032	National Institutes of Health [RO1 AR40994]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant RO1 AR40994. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Arumugam S, 1998, BIOCHEMISTRY-US, V37, P9650, DOI 10.1021/bi980128h; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Baker BM, 1998, METHOD ENZYMOL, V295, P294; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chang CEA, 2008, P NATL ACAD SCI USA, V105, P7456, DOI 10.1073/pnas.0800452105; Chen LY, 1999, J MOL BIOL, V293, P545, DOI 10.1006/jmbi.1999.3147; EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Kumar S, 2000, PROTEIN SCI, V9, P10; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Liang XY, 2010, BIOPHYS J, V99, P273, DOI 10.1016/j.bpj.2010.04.002; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Negi SS, 2007, BIOINFORMATICS, V23, P3397, DOI 10.1093/bioinformatics/btm474; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Palde PB, 2015, P NATL ACAD SCI USA, V112, P7960, DOI 10.1073/pnas.1504376112; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Van Doren SR, 2008, BIOPOLYMERS, V89, P960, DOI 10.1002/bip.21043; Velazquez Campoy A., 2005, BIOPHYS CHEM, V115, P115, DOI DOI 10.1016/J.BPC.2004.12.015; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Wu B, 2000, J MOL BIOL, V295, P257, DOI 10.1006/jmbi.1999.3362; Wu Y, 2011, J BIOL CHEM, V286, P16891, DOI 10.1074/jbc.M111.222307	45	7	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11348	11358		10.1074/jbc.M116.720250	http://dx.doi.org/10.1074/jbc.M116.720250			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033700	hybrid, Green Published			2022-12-26	WOS:000377042100033
J	Brechbuhl, C; Girard, O; Millet, GP; Schmitt, L				Brechbuhl, Cyril; Girard, Olivier; Millet, Gregoire P.; Schmitt, Laurent			On the Use of a Test to Exhaustion Specific to Tennis (TEST) with Ball Hitting by Elite Players	PLOS ONE			English	Article							INCREMENTAL EXERCISE TEST; ON-COURT ENDURANCE; 20-M SHUTTLE RUN; AEROBIC FITNESS; SPORTS-MEDICINE; SQUASH PLAYERS; OXYGEN-UPTAKE; SCIENCE; PHYSIOLOGY; DRILLS	Purpose We aimed to a) introduce a new Test to Exhaustion Specific to Tennis (TEST) and compare performance (test duration) and physiological responses to those obtained during the 20-m multistage shuttle test (MSST), and b) determine to which extent those variables correlate with performance level (tennis competitive ranking) for both test procedures. Methods Twenty-seven junior players (8 males, 19 females) members of the national teams of the French Tennis Federation completed MSST and TEST, including elements of the game (ball hitting, intermittent activity, lateral displacement), in a randomized order. Cardiorespiratory responses were compared at submaximal (respiratory compensation point) and maximal loads between the two tests. Results At the respiratory compensation point oxygen uptake (50.1 +/- 4.7 vs. 47.5 +/- 4.3 mL.min(-1).kg(-1), p = 0.02), but not minute ventilation and heart rate, was higher for TEST compared to MSST. However, load increment and physiological responses at exhaustion did not differ between the two tests. Players' ranking correlated negatively with oxygen uptake measured at submaximal and maximal loads for both TEST (r = -0.41; p = 0.01 and -0.55; p = 0.004) and MSST (r = -0.38; P = 0.05 and -0.51; p = 0.1). Conclusion Using TEST provides a tennis-specific assessment of aerobic fitness and may be used to prescribe aerobic exercise in a context more appropriate to the game than MSST. Results also indicate that VO2 values both at submaximal and maximal load reached during TEST and MSST are moderate predictors of players competitive ranking.	[Brechbuhl, Cyril] French Tennis Federat, Natl Tech Direct, Paris, France; [Brechbuhl, Cyril; Girard, Olivier; Millet, Gregoire P.; Schmitt, Laurent] Univ Lausanne, Dept Physiol, Fac Biol & Med, Inst Sport Sci ISSUL, Lausanne, Switzerland; [Schmitt, Laurent] Natl Ctr Nord Ski, Dept Res & Performance, Premanon, France; [Brechbuhl, Cyril] Stade Roland Garros, Federat Francaise Tennis, Ctr Natl Entrainement, Paris, France; [Girard, Olivier; Millet, Gregoire P.] ISSUL, Batiment Geopolis, Lausanne, Switzerland; [Schmitt, Laurent] Ctr Natl Ski Nord, Premanon, France	University of Lausanne	Brechbuhl, C (corresponding author), French Tennis Federat, Natl Tech Direct, Paris, France.; Brechbuhl, C (corresponding author), Univ Lausanne, Dept Physiol, Fac Biol & Med, Inst Sport Sci ISSUL, Lausanne, Switzerland.; Brechbuhl, C (corresponding author), Stade Roland Garros, Federat Francaise Tennis, Ctr Natl Entrainement, Paris, France.	cyril.brechbuhl@unil.ch	Millet, Gregoire P/F-4104-2012; Millet, Grégoire/M-3220-2019	Millet, Gregoire P/0000-0001-8081-4423; Millet, Grégoire/0000-0001-8081-4423; girard, olivier/0000-0002-4797-182X				American College of Sports Medicine, 2006, ACMS GUID EX TEST PR; Baiget E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131304; Baiget E, 2014, J STRENGTH COND RES, V28, P256, DOI 10.1519/JSC.0b013e3182955dad; Balmer J, 2000, MED SCI SPORT EXER, V32, P1790, DOI 10.1097/00005768-200010000-00020; Banzer W, 2008, BRIT J SPORT MED, V42, P152, DOI 10.1136/bjsm.2007.036798; Bekraoui N, 2012, APPL PHYSIOL NUTR ME, V37, P982, DOI [10.1139/h2012-082, 10.1139/H2012-082]; Bentley DJ, 2007, SPORTS MED, V37, P575, DOI 10.2165/00007256-200737070-00002; BERGERON MF, 1991, INT J SPORTS MED, V12, P474, DOI 10.1055/s-2007-1024716; Buchheit M, 2012, J SPORT SCI, V30, P555, DOI 10.1080/02640414.2012.658079; Buchheit M, 2008, J STRENGTH COND RES, V22, P365, DOI 10.1519/JSC.0b013e3181635b2e; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Fargeas-Gluck MA, 2012, J STRENGTH COND RES, V26, P3036, DOI 10.1519/JSC.0b013e3182472fc3; Fernald DH, 2012, J AM BOARD FAM MED, V25, P83, DOI 10.3122/jabfm.2012.01.110019; Fernandez-Fernandez J, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093152; Fernandez-Fernandez J, 2012, J STRENGTH COND RES, V26, P53, DOI 10.1519/JSC.0b013e318220b4ff; Fernandez-Fernandez J, 2011, J SPORT SCI MED, V10, P540; Fernandez-Fernandez J, 2010, J STRENGTH COND RES, V24, P3255, DOI 10.1519/JSC.0b013e3181e8745f; Ferrauti A, 2011, J SPORT SCI, V29, P485, DOI 10.1080/02640414.2010.539247; Foster C, 2006, PHYSL ASSESSMENT HUM, P63; Gibson AS, 1998, J SPORT SCI, V16, P331, DOI 10.1080/02640419808559361; Girard O, 2006, BRIT J SPORT MED, V40, P791, DOI 10.1136/bjsm.2006.027680; Girard O, 2005, BRIT J SPORT MED, V39, P921, DOI 10.1136/bjsm.2005.018101; Girard O, 2005, MED SCI SPORT EXER, V37, P1021, DOI 10.1249/01.mss.0000171619.99391.bb; Girard O, 2008, J ELECTROMYOGR KINES, V18, P1038, DOI 10.1016/j.jelekin.2007.05.005; Guillot A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143331; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kovacs MS, 2007, SPORTS MED, V37, P189, DOI 10.2165/00007256-200737030-00001; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; LEGER L, 1989, CAN J SPORT SCI, V14, P21; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Midgley AW, 2008, SPORTS MED, V38, P441, DOI 10.2165/00007256-200838060-00001; Pialoux V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122718; Pierce S J, 1999, J Sci Med Sport, V2, P356, DOI 10.1016/S1440-2440(99)80008-5; Pyne DB, 2000, EUR J APPL PHYSIOL, V82, P112, DOI 10.1007/s004210050659; Reid M, 2008, BRIT J SPORT MED, V42, P146, DOI 10.1136/bjsm.2007.036426; Reid M, 2008, J SCI MED SPORT, V11, P248, DOI 10.1016/j.jsams.2007.05.002; Smekal G, 2000, INT J SPORTS MED, V21, P242, DOI 10.1055/s-2000-310; Vallier JM, 2000, SCI SPORT, V15, P133, DOI 10.1016/S0765-1597(00)80017-9; Wasserman K, 2005, PRINCIPLES EXERCISE	40	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152389	10.1371/journal.pone.0152389	http://dx.doi.org/10.1371/journal.pone.0152389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035342	Green Published, gold			2022-12-26	WOS:000373201200016
J	Ishihara, MI; Konno, Y; Umeki, K; Ohno, Y; Kikuzawa, K				Ishihara, Masae Iwamoto; Konno, Yasuo; Umeki, Kiyoshi; Ohno, Yasuyuki; Kikuzawa, Kihachiro			A New Model for Size-Dependent Tree Growth in Forests	PLOS ONE			English	Article							METABOLIC SCALING THEORY; YIELD-DENSITY DIAGRAM; PLANT-POPULATIONS; NORTHERN JAPAN; ASYMMETRIC COMPETITION; BIOMASS; DYNAMICS; MONOCULTURES; STANDS; LIGHT	Tree growth, especially diameter growth of tree stems, is an important issue for understanding the productivity and dynamics of forest stands. Metabolic scaling theory predicted that the 2/3 power of stem diameter at a certain time is a linear function of the 2/3 power of the initial diameter and that the diameter growth rate scales to the 1/3 power of the initial diameter. We tested these predictions of the metabolic scaling theory for 11 Japanese secondary forests at various growth stages. The predictions were not supported by the data, especially in younger stands. Alternatively, we proposed a new theoretical model for stem diameter growth on the basis of six assumptions. All these assumptions were supported by the data. The model produced a nearly linear to curvilinear relationship between the 2/3 power of stem diameters at two different times. It also fitted well to the curvilinear relationship between diameter growth rate and the initial diameter. Our model fitted better than the metabolic scaling theory, suggesting the importance of asymmetric competition among trees, which has not been incorporated in the metabolic scaling theory.	[Ishihara, Masae Iwamoto] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima, Hiroshima 724, Japan; [Konno, Yasuo] Obihiro Univ Agr & Vet Med, Dept Life Sci Agr, Obihiro, Hokkaido 080, Japan; [Umeki, Kiyoshi] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Ohno, Yasuyuki] Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido, Japan; [Kikuzawa, Kihachiro] Zushioku Onoecho, Yamashina Ku, Kyoto, Kyoto, Japan	Hiroshima University; Obihiro University of Agriculture & Veterinary Medicine; Chiba University	Ishihara, MI (corresponding author), Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima, Hiroshima 724, Japan.	masaish.n@gmail.com	Ishihara, Masae Iwamoto/AAU-8407-2020; Ishihara, Masae Iwamoto/P-7979-2014; Umeki, Kiyoshi/AAE-5992-2019	Ishihara, Masae Iwamoto/0000-0002-8365-7766; Ishihara, Masae Iwamoto/0000-0002-8365-7766; 	Environmental Research and Technology Development Fund of the Ministry of the Environment, Japan [S-9-3]	Environmental Research and Technology Development Fund of the Ministry of the Environment, Japan	MII was supported by the Environmental Research and Technology Development Fund (S-9-3) of the Ministry of the Environment, Japan.	AIKMAN DP, 1980, ANN BOT-LONDON, V45, P419, DOI 10.1093/oxfordjournals.aob.a085840; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Cheng XP, 2014, J FOREST RES-JPN, V19, P86, DOI 10.1007/s10310-012-0377-7; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Coomes DA, 2011, J ECOL, V99, P748, DOI 10.1111/j.1365-2745.2011.01811.x; Coomes DA, 2009, J ECOL, V97, P1369, DOI 10.1111/j.1365-2745.2009.01571.x; Damgaard C, 2008, J PLANT ECOL, V1, P111, DOI 10.1093/jpe/rtn008; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; Falster DS, 2015, ECOLOGY, V96, P1445, DOI 10.1890/14-1889.1; HARA T, 1988, TRENDS ECOL EVOL, V3, P129, DOI 10.1016/0169-5347(88)90175-9; HARA T, 1992, ANN BOT-LONDON, V69, P509, DOI 10.1093/oxfordjournals.aob.a088380; HOZUMI K, 1968, Japanese Journal of Ecology, V18, P10; Ishihara MI, 2015, ECOL APPL, V25, P1433, DOI 10.1890/14-0175.1; Kikuzawa K, 1999, ANN BOT-LONDON, V83, P11, DOI 10.1006/anbo.1998.0782; KIKUZAWA K, 1988, ANN BOT-LONDON, V61, P727, DOI 10.1093/oxfordjournals.aob.a087611; Kikuzawa K, 1996, ANN BOT-LONDON, V77, P565, DOI 10.1006/anbo.1996.0071; KIKUZAWA K, 1982, FOREST ECOL MANAG, V4, P341, DOI 10.1016/0378-1127(82)90034-2; KIKUZAWA K, 1993, FOREST ECOL MANAG, V58, P287, DOI 10.1016/0378-1127(93)90151-C; Kikuzawa K, 2016, ADV PHOTOSYNTH RESP, V42, P399, DOI 10.1007/978-94-017-7291-4_15; KING DA, 1994, AM J BOT, V81, P948, DOI 10.2307/2445287; Kira T, 1967, JAPANESE J ECOL; Kobayashi Y, 2000, J THEOR BIOL, V205, P253, DOI 10.1006/jtbi.2000.2058; KOYAMA HIROSI, 1956, JOUR INST POLYTECH OSAKA CITY UNIV SER D BIOL, V7, P73; KUBOTA Y, 1995, ANN BOT-LONDON, V76, P503, DOI 10.1006/anbo.1995.1126; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Niklas K.., 1994, PLANT ALLOMETRY; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Russo SE, 2007, ECOL LETT, V10, P889, DOI 10.1111/j.1461-0248.2007.01079.x; Schneider MK, 2006, J ECOL, V94, P310, DOI 10.1111/j.1365-2745.2005.01079.x; Sedmak R, 2015, IFOREST, V8, DOI 10.3832/ifor1243-007; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Umeki K, 2001, ECOL RES, V16, P435, DOI 10.1046/j.1440-1703.2001.00409.x; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WEINER J, 1986, OIKOS, V47, P211, DOI 10.2307/3566048; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; White Ethan P., 2012, P9; YOKOZAWA M, 1992, ANN BOT-LONDON, V70, P305, DOI 10.1093/oxfordjournals.aob.a088479; Zianis D, 2004, FOREST ECOL MANAG, V187, P311, DOI 10.1016/j.foreco.2003.07.007	45	7	8	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152219	10.1371/journal.pone.0152219	http://dx.doi.org/10.1371/journal.pone.0152219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035709	Green Published, gold, Green Submitted			2022-12-26	WOS:000373201200012
J	Taggar, JS; Coleman, T; Lewis, S; Jones, M				Taggar, Jaspal S.; Coleman, Tim; Lewis, Sarah; Jones, Matthew			Screening for Atrial Fibrillation - A Cross-Sectional Survey of Healthcare Professionals in Primary Care	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ROUTINE PRACTICE; NURSES VIEWS; AGED 65; METAANALYSIS	Introduction Screening for atrial fibrillation (AF) in primary care has been recommended; however, the views of healthcare professionals (HCPs) are not known. This study aimed to determine the opinions of HCP about the feasibility of implementing screening within a primary care setting. Methods A cross-sectional mixed methods census survey of 418 HCPs from 59 inner-city practices (Nottingham, UK) was conducted between October-December 2014. Postal and web-surveys ascertained data on existing methods, knowledge, skills, attitudes, barriers and facilitators to AF screening using Likert scale and open-ended questions. Responses, categorized according to HCP group, were summarized using proportions, adjusting for clustering by practice, with 95% C. Is and free-text responses using thematic analysis. Results At least one General Practitioner (GP) responded from 48 (81%) practices. There were 212/418 (51%) respondents; 118/229 GPs, 67/129 nurses [50 practice nurses; 17 Nurse Practitioners (NPs)], 27/60 healthcare assistants (HCAs). 39/48 (81%) practices had an ECG machine and diagnosed AF in-house. Non-GP HCPs reported having less knowledge about ECG interpretation, diagnosing and treating AF than GPs. A greater proportion of non-GP HCPs reported they would benefit from ECG training specifically for AF diagnosis than GPs [proportion (95% CI) GPs: 11.9%(6.8-20.0); HCAs: 37.0%(21.7-55.5); nurses: 44.0% (30.0-59.0); NPs 41.2%(21.9-63.7)]. Barriers included time, workload and capacity to undertake screening activities, although training to diagnose and manage AF was a required facilitator. Conclusion Inner-city general practices were found to have adequate access to resources for AF screening. There is enthusiasm by non-GP HCPs to up-skill in the diagnosis and management of AF and they may have a role in future AF screening. However, organisational barriers, such as lack of time, staff and capacity, should be overcome for AF screening to be feasibly implemented within primary care.	[Taggar, Jaspal S.; Coleman, Tim; Jones, Matthew] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Lewis, Sarah] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Taggar, JS (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England.	jaspal.taggar@nottingham.ac.uk		Jones, Matthew/0000-0002-4824-9724; Coleman, Tim/0000-0002-7303-4805; Taggar, Jaspal/0000-0002-5031-0977	NIHR/School for Primary Care Research GP Career Progression Fellowship [RC08E7]; Nottingham City Clinical Commissioning Group [PCT/UoN/01/RCF/12-13]; East Midlands CLAHRC	NIHR/School for Primary Care Research GP Career Progression Fellowship; Nottingham City Clinical Commissioning Group; East Midlands CLAHRC	The study was supported by an NIHR/School for Primary Care Research GP Career Progression Fellowship (RC08E7) and Research Capability Funding from Nottingham City Clinical Commissioning Group (PCT/UoN/01/RCF/12-13). Tim Coleman acknowledges support from East Midlands CLAHRC. The funding bodies had no role in the design, conduct, interpretation and writing of the report for this research. Views and Institute for Health Research (NIHR) or Nottingham City Clinical Commissioning Group (CCG).	Allaby M., 2014, SCREENING ATRIAL FIB; Atrial Fibrillation Association (AFA), 2012, AF REP ATR FIBR PREV; Barry Kristen L, 2004, Subst Abus, V25, P27, DOI 10.1300/J465v25n01_05; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Department of Health, 2010, ADV LEV NURS POS STA; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Furaker C, 2008, J NURS MANAGE, V16, P933, DOI 10.1111/j.1365-2834.2008.00872.x; Green J, 2014, QUALITATIVE METHODS; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Health Policy and Economic Research Unit, 2013, GPS VIEWS FUT GEN PR; Hobbs FDR, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9400; Hobbs FDR, 2002, FAM PRACT, V19, P596, DOI 10.1093/fampra/19.6.596; Hobbs FR, 2015, EUROPEAN J PREVENTIV; Majeed A, 2013, J ROY SOC MED, V106, P384, DOI 10.1177/0141076813504326; Majeed A, 2012, BRIT J GEN PRACT, V62, P625, DOI 10.3399/bjgp12X659150; Moran PS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009586.pub2; NHS Commissioning Board, 2012, PUBL HLTH ENGL NHS N; Nottingham City Clinical Commissioning Group, 2013, WORK TOG HLTH NOTT O; Public Health England, 2014, NAT GEN PRACT PROF; Robertson C, 2012, J AM ACAD NURSE PRAC, V24, P225, DOI 10.1111/j.1745-7599.2012.00719.x; Royal College of Physicians of Edinburgh, 2012, RCPE UK CONS C APPR; Shell R, 2004, J RURAL HEALTH, V20, P368, DOI 10.1111/j.1748-0361.2004.tb00051.x; Spiva L, 2012, J CONTIN EDUC NURS, V43, P81, DOI 10.3928/00220124-20111011-02; Stenner K, 2008, J ADV NURS, V63, P27, DOI 10.1111/j.1365-2648.2008.04644.x; Taggar JS, 2015, INT J CARDIOL, V184, P175, DOI 10.1016/j.ijcard.2015.02.014; Wakeford R, 2014, BMJ CLIN RES ED, P349; Whalley D, 2006, BRIT J GEN PRACT, V56, P87; Workforce and Facilities Team Health and Social Care Information Centre, 2015, GEN PERS MED SERV EN; Zhang HJ, 2013, INT EMERG NURS, V21, P247, DOI 10.1016/j.ienj.2012.11.001	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152086	10.1371/journal.pone.0152086	http://dx.doi.org/10.1371/journal.pone.0152086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035567	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000373201200010
J	Benazzi, S; Nguyen, HN; Kullmer, O; Kupczik, K				Benazzi, Stefano; Nguyen, Huynh Nhu; Kullmer, Ottmar; Kupczik, Kornelius			Dynamic Modelling of Tooth Deformation Using Occlusal Kinematics and Finite Element Analysis	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; STRESS-DISTRIBUTION; MASTICATORY PERFORMANCE; JAW MOVEMENT; HUMAN TEETH; BITE FORCE; BEHAVIOR; DENTIN; BIOMECHANICS; ENAMEL	Background Dental biomechanics based on finite element (FE) analysis is attracting enormous interest in dentistry, biology, anthropology and palaeontology. Nonetheless, several shortcomings in FE modeling exist, mainly due to unrealistic loading conditions. In this contribution we used kinematics information recorded in a virtual environment derived from occlusal contact detection between high resolution models of an upper and lower human first molar pair (M-1 and M-1, respectively) to run a non-linear dynamic FE crash colliding test. Methodology MicroCT image data of a modern human skull were segmented to reconstruct digital models of the antagonistic right M-1 and M-1 and the dental supporting structures. We used the Occlusal Fingerprint Analyser software to reconstruct the individual occlusal pathway trajectory during the power stroke of the chewing cycle, which was applied in a FE simulation to guide the M-1 3D-path for the crash colliding test. Results FE analysis results showed that the stress pattern changes considerably during the power stroke, demonstrating that knowledge about chewing kinematics in conjunction with a morphologically detailed FE model is crucial for understanding tooth form and function under physiological conditions. Conclusions/Significance Results from such advanced dynamic approaches will be applicable to evaluate and avoid mechanical failure in prosthodontics/endodontic treatments, and to test material behavior for modern tooth restoration in dentistry. This approach will also allow us to improve our knowledge in chewing-related biomechanics for functional diagnosis and therapy, and it will help paleoanthropologists to illuminate dental adaptive processes and morphological modifications in human evolution.	[Benazzi, Stefano] Univ Bologna, Dept Cultural Heritage, Ravenna, Italy; [Benazzi, Stefano] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Nguyen, Huynh Nhu] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Kullmer, Ottmar] Senckenberg Res Inst, Dept Palaeoanthropol & Messel Res, Frankfurt, Germany; [Kupczik, Kornelius] Max Planck Inst Evolutionary Anthropol, Max Planck Weizmann Ctr Integrat Archaeol & Anthr, Leipzig, Germany	University of Bologna; Max Planck Society; Max Planck Society; Senckenberg Gesellschaft fur Naturforschung (SGN); Max Planck Society	Benazzi, S (corresponding author), Univ Bologna, Dept Cultural Heritage, Ravenna, Italy.; Benazzi, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	stefano.benazzi@unibo.it	Benazzi, Stefano/AAH-3923-2020; Kupczik, Kornelius/E-9788-2011	Kupczik, Kornelius/0000-0003-1502-581X; Kullmer, Ottmar/0000-0002-5929-8070	Max Planck Society; German Science Foundation (DFG)	Max Planck Society(Max Planck Society); German Science Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the Max Planck Society and the German Science Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Vienna micro-CT Lab (University of Vienna, Austria) for micro-CT scanning of the modern human skull. We are grateful to Johannes Schoneich for help with the CT segmentation. This research was supported by the Max Planck Society and the German Science Foundation (DFG). This is publication no 84 of the DFG Research Unit 771 "Function and performance enhancement in the mammalian dentition-phylogenetic and ontogenetic impact on the masticatory apparatus".	Barak MM, 2009, J STRUCT BIOL, V168, P511, DOI 10.1016/j.jsb.2009.07.019; Benazzi S, 2015, J ANAT, V226, P180, DOI 10.1111/joa.12260; Benazzi S, 2014, CLIN ORAL INVEST, V18, P369, DOI 10.1007/s00784-013-0973-8; Benazzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069990; Benazzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062263; Benazzi S, 2012, AM J PHYS ANTHROPOL, V147, P128, DOI 10.1002/ajpa.21607; Benazzi S, 2011, J ANAT, V219, P259, DOI 10.1111/j.1469-7580.2011.01396.x; Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; Calderon Patrícia dos Santos, 2006, J. Appl. Oral Sci., V14, P448, DOI 10.1590/S1678-77572006000600011; Chattah NLT, 2011, J ANAT, V218, P87, DOI 10.1111/j.1469-7580.2010.01234.x; Cheng YY, 2010, DENT MATER, V26, pE211, DOI 10.1016/j.dental.2010.05.002; Commisso MS, 2015, J MECH BEHAV BIOMED, V41, P23, DOI 10.1016/j.jmbbm.2014.09.022; Daegling DJ, 2003, AM J PHYS ANTHROPOL, V122, P38, DOI 10.1002/ajpa.10225; Daegling DJ, 1998, AM J PHYS ANTHROPOL, V105, P73, DOI 10.1002/(SICI)1096-8644(199801)105:1<73::AID-AJPA7>3.3.CO;2-Y; Dejak B, 2015, DENT MATER, V31, pE77, DOI 10.1016/j.dental.2014.11.016; Duck F.A., 1990, MED PHYS, V18; Field C, 2010, J DENT BIOMECH, V2010, P1, DOI DOI 10.4061/2010/902537; Fu G, 2010, DENT TRAUMATOL, V26, P64, DOI 10.1111/j.1600-9657.2009.00829.x; Hall BK., 1992, BONE BONE GROWTH, V7; Hasegawa A, 2010, INT J BIOMATER, P1, DOI DOI 10.1155/2010/659802; Ho SP, 2007, BIOMATERIALS, V28, P5238, DOI 10.1016/j.biomaterials.2007.08.031; Holmes DC, 1996, J PROSTHET DENT, V75, P140, DOI 10.1016/S0022-3913(96)90090-6; Hughes K, 2014, P I MECH ENG G-J AER, V228, P1890, DOI 10.1177/0954410013506415; Hylander W.L., 2006, TEMPOROMANDIBULAR DI, P3; Jiang W, 2010, J PROSTHET DENT, V103, P6, DOI 10.1016/S0022-3913(09)60206-7; KO CC, 1992, J PROSTHET DENT, V68, P421, DOI 10.1016/0022-3913(92)90404-X; Kullmer O, 2013, J HUM EVOL, V64, P151, DOI 10.1016/j.jhevol.2012.10.009; Kuninori T, 2014, J ORAL REHABIL, V41, P338, DOI 10.1111/joor.12149; Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972; Kupczik K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097677; Kupczik K, 2012, BIOL J LINN SOC, V105, P456, DOI 10.1111/j.1095-8312.2011.01779.x; Li H, 2001, WEAR, V249, P980, DOI 10.1016/S0043-1648(01)00835-3; Lin TS, 2010, J MED BIOL ENG, V30, P79; Macho GA, 2005, ANAT REC PART A, V283A, P310, DOI 10.1002/ar.a.20175; Macho GA, 1999, AM J PHYS ANTHROPOL, V109, P211, DOI 10.1002/(SICI)1096-8644(199906)109:2<211::AID-AJPA6>3.3.CO;2-2; Magne P, 2007, DENT MATER, V23, P539, DOI 10.1016/j.dental.2006.03.013; Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z; McCormack SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102387; de Abreu RAM, 2014, ARCH ORAL BIOL, V59, P1065, DOI 10.1016/j.archoralbio.2014.05.005; Natali AN., 2003, DENT BIOMECHANICS, P1, DOI [10.1201/9780203514849, DOI 10.1201/9780203514849]; Okiyama S, 2003, J ORAL REHABIL, V30, P278, DOI 10.1046/j.1365-2842.2003.01009.x; Pacher HM, 1961, RUDOLF POCHS NACHL A, VXII; Park JC, 2015, J PERIODONTAL IMPLAN, V45, P8, DOI 10.5051/jpis.2015.45.1.8; Pascale AM, 2015, INT J COMPUT DENT, V18, P237; Pesqueira AA, 2014, J ORAL IMPLANTOL, V40, P217, DOI 10.1563/AAID-JOI-D-11-00066; Prombonas A, 2002, J PROSTHET DENT, V88, P415, DOI 10.1067/mpr.2002.128174; RUBIN C, 1983, J DENT RES, V62, P82, DOI 10.1177/00220345830620021701; Schmidt H, 2005, MODEL SIMUL MATER SC, V13, P77, DOI 10.1088/0965-0393/13/1/006; Shen LK, 2009, J DENT SCI, V4, P81, DOI 10.1016/S1991-7902(09)60012-X; Stamfelj I, 2008, ANN ANAT, V190, P129, DOI 10.1016/j.aanat.2007.10.006; Trujillo L, 2012, ENG, V4, P972; von Koenigswald W, 2013, PALAEONTOL Z, V87, P141, DOI 10.1007/s12542-012-0142-4; Vukicevic AM, 2015, J DENT, V43, P556, DOI 10.1016/j.jdent.2015.02.011; Watanabe Fumihiko, 2003, Odontology, V91, P31, DOI 10.1007/s10266-003-0029-7; WEIDMANN SM, 1967, ARCH ORAL BIOL, V12, P85, DOI 10.1016/0003-9969(67)90145-8; Zaslansky P, 2006, J STRUCT BIOL, V153, P188, DOI 10.1016/j.jsb.2005.10.010; Zaytsev D, 2014, MAT SCI ENG C-MATER, V34, P15, DOI 10.1016/j.msec.2013.10.009; Zelic K, 2015, INT ENDOD J, V48, P850, DOI 10.1111/iej.12381; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	59	39	43	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152663	10.1371/journal.pone.0152663	http://dx.doi.org/10.1371/journal.pone.0152663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031836	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800109
J	Celandroni, F; Salvetti, S; Gueye, SA; Mazzantini, D; Lupetti, A; Senesi, S; Ghelardi, E				Celandroni, Francesco; Salvetti, Sara; Gueye, Sokhna Aissatou; Mazzantini, Diletta; Lupetti, Antonella; Senesi, Sonia; Ghelardi, Emilia			Identification and Pathogenic Potential of Clinical Bacillus and Paenibacillus Isolates	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DESORPTION IONIZATION-TIME; MEMBRANE-DAMAGING TOXINS; MALDI-TOF-MS; CEREUS; THURINGIENSIS; LICHENIFORMIS; BACTEREMIA; SECRETION; SUSCEPTIBILITY	The soil-related Bacillus and Paenibacillus species have increasingly been implicated in various human diseases. Nevertheless, their identification still poses problems in the clinical microbiology laboratory and, with the exception of Bacillus anthracis and Bacillus cereus, little is known on their pathogenicity for humans. In this study, we evaluated the use of matrixassisted laser desorption-ionization time of flight mass spectrometry (MALDI-TOF MS) in the identification of clinical isolates of these genera and conducted genotypic and phenotypic analyses to highlight specific virulence properties. Seventy-five clinical isolates were subjected to biochemical and MALDI-TOF MS identification. 16S rDNA sequencing and supplemental tests were used to solve any discrepancies or failures in the identification results. MALDI-TOF MS significantly outperformed classical biochemical testing for correct species identification and no misidentification was obtained. One third of the collected strains belonged to the B. cereus species, but also Bacillus pumilus and Bacillus subtilis were isolated at high rate. Antimicrobial susceptibility testing showed that all the B. cereus, B. licheniformis, B. simplex, B. mycoides, Paenibacillus glucanolyticus and Paenibacillus lautus isolates are resistant to penicillin. The evaluation of toxin/enzyme secretion, toxinencoding genes, motility, and biofilm formation revealed that B. cereus displays the highest virulence potential. However, although generally considered nonpathogenic, most of the other species were shown to swim, swarm, produce biofilms, and secrete proteases that can have a role in bacterial virulence. In conclusion, MALDI-TOF MS appears useful for fast and accurate identification of Bacillus and Paenibacillus strains whose virulence properties make them of increasing clinical relevance.	[Celandroni, Francesco; Salvetti, Sara; Gueye, Sokhna Aissatou; Mazzantini, Diletta; Lupetti, Antonella; Ghelardi, Emilia] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Senesi, Sonia] Univ Pisa, Dept Biol, Pisa, Italy; [Ghelardi, Emilia] Univ Pisa, Interdept Res Ctr Nutraceut & Food Hlth, Pisa, Italy; [Salvetti, Sara] S Giuseppe Hosp USL 11, Empoli, Italy	University of Pisa; University of Pisa; University of Pisa	Ghelardi, E (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.; Ghelardi, E (corresponding author), Univ Pisa, Interdept Res Ctr Nutraceut & Food Hlth, Pisa, Italy.	emilia.ghelardi@med.unipi.it	Ghelardi, Emilia/ABH-6508-2020	GHELARDI, EMILIA/0000-0001-6863-1384; SALVETTI, SARA/0000-0001-7386-385X; Celandroni, Francesco/0000-0001-7920-7159				Abrishami M, 2015, J CLIN DIAGN RES, V9, pNC1, DOI 10.7860/JCDR/2015/10291.5733; AlMasoud N, 2014, ANAL CHIM ACTA, V840, P49, DOI 10.1016/j.aca.2014.06.032; Ameur MA, 2005, MED MALADIES INFECT, V35, P417, DOI 10.1016/j.medmal.2005.04.007; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Bohme K, 2011, ELECTROPHORESIS, V32, P2951, DOI 10.1002/elps.201100217; Brown KL, 2000, BRIT MED BULL, V56, P158, DOI 10.1258/0007142001902860; Caamano-Antelo S, 2015, FOOD MICROBIOL, V46, P288, DOI 10.1016/j.fm.2014.08.013; Castiaux V, 2015, INT J FOOD MICROBIOL, V211, P79, DOI 10.1016/j.ijfoodmicro.2015.06.020; Celandroni F, 2000, FEMS MICROBIOL LETT, V190, P247, DOI 10.1016/S0378-1097(00)00343-8; Celandroni F, 2014, FEMS MICROBIOL LETT, V361, P95, DOI 10.1111/1574-6968.12615; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Clinical and Laboratory Standards Institute, 2008, 18A MM CLIN LAB STAN; De Bellis P, 2015, INT J FOOD MICROBIOL, V197, P30, DOI 10.1016/j.ijfoodmicro.2014.12.017; Di Franco C, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-33; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Farfour E, 2012, J CLIN MICROBIOL, V50, P2702, DOI 10.1128/JCM.00368-12; Fernandez-No IC, 2013, FOOD MICROBIOL, V33, P235, DOI 10.1016/j.fm.2012.09.022; Ferrand J, 2013, J CLIN MICROBIOL, V51, P3439, DOI 10.1128/JCM.00864-13; FUNADA H, 1988, JPN J CLIN ONCOL, V18, P69, DOI 10.1093/jjco/18.1.69; Ghelardi E, 2002, FEMS MICROBIOL LETT, V208, P129, DOI [10.1016/S0378-1097(02)00450-0, 10.1111/j.1574-6968.2002.tb11072.x]; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Ghelardi E, 2007, APPL ENVIRON MICROB, V73, P4089, DOI 10.1128/AEM.02345-06; Ghelardi E, 2007, MICROBES INFECT, V9, P591, DOI 10.1016/j.micinf.2007.02.001; Ghelardi E, 2012, APPL ENVIRON MICROB, V78, P6540, DOI 10.1128/AEM.01341-12; Hotta Y, 2011, J AGR FOOD CHEM, V59, P5222, DOI 10.1021/jf2004095; HOULT B, 1991, J CLIN PATHOL, V44, P455, DOI 10.1136/jcp.44.6.455; Hsueh YH, 2006, APPL ENVIRON MICROB, V72, P5089, DOI 10.1128/AEM.00573-06; Idelevich EA, 2013, J MED MICROBIOL, V62, P940, DOI 10.1099/jmm.0.051987-0; Jessberger N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00560; Ki JS, 2009, J MICROBIOL METH, V77, P48, DOI 10.1016/j.mimet.2009.01.003; Kimouli M, 2012, J MED MICROBIOL, V61, P596, DOI 10.1099/jmm.0.033175-0; Kumar S, 2015, CARBOHYD POLYM, V117, P543, DOI 10.1016/j.carbpol.2014.10.017; Kuroki R, 2009, INTERNAL MED, V48, P791, DOI 10.2169/internalmedicine.48.1885; La Jeon Y, 2012, J MED MICROBIOL, V61, P1766, DOI 10.1099/jmm.0.042275-0; Luna VA, 2007, J ANTIMICROB CHEMOTH, V60, P555, DOI 10.1093/jac/dkm213; Padhi Sanghamitra, 2013, J Lab Physicians, V5, P133, DOI 10.4103/0974-2727.119872; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; Ramarao N, 2013, TOXINS, V5, P1119, DOI 10.3390/toxins5061119; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rieg S, 2010, EMERG INFECT DIS, V16, P487, DOI 10.3201/eid1603.091457; Rowan NJ, 2001, APPL ENVIRON MICROB, V67, P3873, DOI 10.1128/AEM.67.9.3873-3881.2001; Sahu C, 2013, INT OPHTHALMOL, V33, P611, DOI 10.1007/s10792-012-9697-z; Schafer MO, 2014, VET MICROBIOL, V170, P291, DOI 10.1016/j.vetmic.2014.02.006; Senesi S, 2010, TOXINS, V2, P1690, DOI 10.3390/toxins2071690; Senesi S, 2010, RES MICROBIOL, V161, P743, DOI 10.1016/j.resmic.2010.10.007; Starostin KV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16989; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Tourasse NJ, 2011, FOOD MICROBIOL, V28, P236, DOI 10.1016/j.fm.2010.06.014; WANDERSMAN C, 1986, J GEN MICROBIOL, V132, P899; Yim JH, 2015, J FOOD SCI, V80, pM1266, DOI 10.1111/1750-3841.12872	50	53	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152831	10.1371/journal.pone.0152831	http://dx.doi.org/10.1371/journal.pone.0152831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031639	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800147
J	Fahrenkrog, B; Martinelli, V; Nilles, N; Fruhmann, G; Chatel, G; Juge, S; Sauder, U; Di Giacomo, D; Mecucci, C; Schwaller, J				Fahrenkrog, Birthe; Martinelli, Valerie; Nilles, Nadine; Fruhmann, Gernot; Chatel, Guillaume; Juge, Sabine; Sauder, Ursula; Di Giacomo, Danika; Mecucci, Cristina; Schwaller, Juerg			Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype	PLOS ONE			English	Article							NUCLEOPORIN NUP98; PORE COMPLEX; C-TERMINUS; GENE; TRANSLOCATION; NUP98-HOXA9; LAP2-ALPHA; TRANSCRIPTION; CELLS; T(7/11)(P15,P15)	Chromosomal translocations involving the nucleoporin NUP98 have been described in several hematopoietic malignancies, in particular acute myeloid leukemia (AML). In the resulting chimeric proteins, Nup98's N-terminal region is fused to the C-terminal region of about 30 different partners, including homeodomain (HD) transcription factors. While transcriptional targets of distinct Nup98 chimeras related to immortalization are relatively well described, little is known about other potential cellular effects of these fusion proteins. By comparing the sub-nuclear localization of a large number of Nup98 fusions with HD and non-HD partners throughout the cell cycle we found that while all Nup98 chimeras were nuclear during interphase, only Nup98-HD fusion proteins exhibited a characteristic speckled appearance. During mitosis, only Nup98-HD fusions were concentrated on chromosomes. Despite the difference in localization, all tested Nup98 chimera provoked morphological alterations in the nuclear envelope (NE), in particular affecting the nuclear lamina and the lamina-associated polypeptide 2 alpha (LAP2 alpha). Importantly, such aberrations were not only observed in transiently transfected HeLa cells but also in mouse bone marrow cells immortalized by Nup98 fusions and in cells derived from leukemia patients harboring Nup98 fusions. Our findings unravel Nup98 fusion-associated NE alterations that may contribute to leukemogenesis.	[Fahrenkrog, Birthe; Martinelli, Valerie; Nilles, Nadine; Chatel, Guillaume] Univ Libre Bruxelles, Inst Mol Biol & Med, Charleroi, Belgium; [Fruhmann, Gernot; Juge, Sabine; Schwaller, Juerg] Univ Childrens Hosp Basel, Dept Biomed, Basel, Switzerland; [Sauder, Ursula] Univ Basel, Biozentrum, Microscopy Ctr, Basel, Switzerland; [Di Giacomo, Danika; Mecucci, Cristina] Univ Perugia, Hematol & Bone Marrow Transplantat Unit, I-06100 Perugia, Italy	Universite Libre de Bruxelles; University of Basel; University of Basel; University of Perugia	Fahrenkrog, B (corresponding author), Univ Libre Bruxelles, Inst Mol Biol & Med, Charleroi, Belgium.; Schwaller, J (corresponding author), Univ Childrens Hosp Basel, Dept Biomed, Basel, Switzerland.	bfahrenk@ulb.ac.be; j.schwaller@unibas.ch	Schwaller, Juerg/A-3044-2016	Schwaller, Juerg/0000-0001-8616-0096; Fahrenkrog, Birthe/0000-0003-4080-9413; Fruhmann, Gernot/0000-0002-4828-8301	Fonds de la Recherche Scientifique-FNRS [T.0237.13, 7.4595.14]; Swiss National Science Foundation [31003A 149714]; Swiss Cancer League [KFS-3019-08-2012]	Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League	This work was supported by Fonds de la Recherche Scientifique-FNRS: grant numbers T.0237.13 and 7.4595.14; (www.frs-fnrs.be); the Swiss National Science Foundation: grant number 31003A 149714, (www.sf.ch); and the Swiss Cancer League, grant number: KFS-3019-08-2012, (www.krebsliga.ch).	Ahuja HG, 2000, CANCER RES, V60, P6227; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; Becker M, 2010, CELL CYCLE, V9, P1360, DOI 10.4161/cc.9.7.11177; Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Bradley CM, 2007, STRUCTURE, V15, P643, DOI 10.1016/j.str.2007.04.007; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chatel G, 2012, J STRUCT BIOL, V177, P81, DOI 10.1016/j.jsb.2011.11.004; Chou WC, 2009, LEUKEMIA, V23, P1303, DOI 10.1038/leu.2009.25; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Cross MK, 2011, MOL BIOL CELL, V22, P661, DOI 10.1091/mbc.E10-06-0478; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Fahrenkrog B., 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/468306, DOI 10.1155/2014/468306]; Forrester AM, 2011, BRIT J HAEMATOL, V155, P167, DOI 10.1111/j.1365-2141.2011.08810.x; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Gotic I, 2010, NUCLEUS-PHILA, V1, P397, DOI 10.4161/nucl.1.5.12394; Gotic I, 2010, STEM CELLS, V28, P480, DOI 10.1002/stem.292; Gotic I, 2010, CIRC RES, V106, P346, DOI 10.1161/CIRCRESAHA.109.205724; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Grand FH, 2005, LEUKEMIA RES, V29, P1469, DOI 10.1016/j.leukres.2005.05.002; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Hirose K, 2008, ONCOGENE, V27, P6056, DOI 10.1038/onc.2008.210; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Jeganathan KB, 2006, CELL CYCLE, V5, P366, DOI 10.4161/cc.5.4.2483; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; La Starza R, 2004, GENE CHROMOSOME CANC, V41, P395, DOI 10.1002/gcc.20103; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003308; Light WH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001524; Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Nakamura T, 1999, BLOOD, V94, P741, DOI 10.1182/blood.V94.2.741.414k04_741_747; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Panarello C, 2002, GENE CHROMOSOME CANC, V35, P277, DOI 10.1002/gcc.10119; Pascual-Garcia P, 2014, CELL REP, V9, P433, DOI 10.1016/j.celrep.2014.09.002; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Qiu JJ, 2015, LEUKEMIA, V29, P1153, DOI 10.1038/leu.2014.334; Reader JC, 2007, LEUKEMIA, V21, P842, DOI 10.1038/sj.leu.2404579; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Singer S, 2012, MOL CELL, V48, P799, DOI 10.1016/j.molcel.2012.09.020; Snyers L, 2007, J BIOL CHEM, V282, P6308, DOI 10.1074/jbc.M605782200; Such E, 2011, BLOOD, V117, P242, DOI 10.1182/blood-2010-06-291658; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Taketani T, 2009, CANCER GENET CYTOGEN, V190, P108, DOI 10.1016/j.cancergencyto.2008.12.008; van Zutven LJCM, 2006, GENE CHROMOSOME CANC, V45, P437, DOI 10.1002/gcc.20308; Vlcek S, 2002, J BIOL CHEM, V277, P18898, DOI 10.1074/jbc.M200048200; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Xu SL, 2010, MOL BIOL CELL, V21, P1585, DOI 10.1091/mbc.E09-07-0561; Yassin ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006719; Zhang SF, 2013, J BIOL CHEM, V288, P18104, DOI 10.1074/jbc.C113.469544	70	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152321	10.1371/journal.pone.0152321	http://dx.doi.org/10.1371/journal.pone.0152321			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031510	gold, Green Submitted, Green Published			2022-12-26	WOS:000373121800056
J	Stoker, SD; Fles, R; Herdini, C; Rijntjes, FJF; Tjokronagoro, M; Dwidanarti, SR; Sikorska, K; Leemans, CR; Schmidt, MK; Al-Mamgani, A; Wildeman, MA; Haryana, SM; Indrasari, SR; Tan, IB				Stoker, S. D.; Fles, R.; Herdini, C.; Rijntjes, F. J. F.; Tjokronagoro, M.; Dwidanarti, S. R.; Sikorska, K.; Leemans, C. R.; Schmidt, M. K.; Al-Mamgani, A.; Wildeman, M. A.; Haryana, S. M.; Indrasari, S. R.; Tan, I. B.			The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FRACTIONATED RADIOTHERAPY; CONCURRENT CHEMOTHERAPY; CURRENT MANAGEMENT; LOCAL-CONTROL; HEAD; NECK; CANCER; INTERRUPTIONS; FAILURE	Purpose In Yogyakarta, nasopharyngeal carcinoma (NPC) shows a poor response to radiotherapy treatment. Previous study showed a prolonged overall treatment time (OTT), due to interruptions during treatment. This study explores the association between clinical outcome and OTT. Secondary, the relation between clinical outcome and disease stage, waiting time to radiation (WT) and chemotherapy schedule was explored. Methods In this retrospective cohort, 142 patients who started curative intent radiotherapy for NPC between March 2009 and May 2014, with or without chemotherapy, were included. The median follow up time was 1.9 years. Data was collected on WT, OTT, disease stage, and chemotherapy schedule. Time factors were log-transformed. Clinical outcome was defined as therapy response, loco-regional control (LRC), disease free survival (DFS) and overall survival (OS). Results The median WT was 117 days (range 12-581) and OTT was 58 days (43-142). OTT and disease stage were not associated to any of the clinical outcome parameters. The log-WT was associated to poor therapy outcome (HR 1.68; 95% ci: 1.09-2.61), LRC (HR 1.66; 95% ci: 1.15-2.39), and DFS (HR 1.4; 95% ci: 1.09-1.81). In the multivariable analysis, significant hazard risk for poor therapy response, LRC, DFS and OS were seen for patients who didn't received concurrent chemotherapy. Conclusion Not receiving concurrent chemotherapy showed the strongest risk for poor outcome. Since the choice of chemotherapy is related to a variety of factors, like the WT and patient's physical condition when radiation can start, careful interpretation is needed. Reason for not finding a relation between OTT and clinical outcome might be the low number of patients who finished radiotherapy within 7 weeks, or by a stronger detrimental effect of other factors.	[Stoker, S. D.; Fles, R.; Rijntjes, F. J. F.; Wildeman, M. A.; Tan, I. B.] Netherlands Canc Inst, Dept Head & Neck Surg & Oncol, Amsterdam, Netherlands; [Stoker, S. D.; Leemans, C. R.] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands; [Herdini, C.; Indrasari, S. R.; Tan, I. B.] Gadjah Mada Univ, Dr Sardjito Hosp, Dept Otolaryngol Head & Neck Surg, Yogyakarta, Indonesia; [Tjokronagoro, M.; Dwidanarti, S. R.] Gadjah Mada Univ, Dr Sardjito Hosp, Dept Radiotherapy, Yogyakarta, Indonesia; [Sikorska, K.] Netherlands Canc Inst, Dept Bioinformat, Amsterdam, Netherlands; [Schmidt, M. K.] Netherlands Canc Inst, Dept Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Schmidt, M. K.] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands; [Al-Mamgani, A.] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; [Wildeman, M. A.] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Haryana, S. M.] Gadjah Mada Univ, Dept Histol Cell & Tumour Biol, Fac Med, Yogyakarta, Indonesia; [Tan, I. B.] Univ Amsterdam, Acad Med Ctr, Dept Oral & Maxillofacial Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Central General Hospital Dr. Sardjito; Gadjah Mada University; Central General Hospital Dr. Sardjito; Gadjah Mada University; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Gadjah Mada University; University of Amsterdam	Tan, IB (corresponding author), Netherlands Canc Inst, Dept Head & Neck Surg & Oncol, Amsterdam, Netherlands.; Tan, IB (corresponding author), Gadjah Mada Univ, Dr Sardjito Hosp, Dept Otolaryngol Head & Neck Surg, Yogyakarta, Indonesia.; Tan, IB (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oral & Maxillofacial Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	i.tan@nki.nl	Schmidt, Marjanka K/G-9058-2011	Schmidt, Marjanka K/0000-0002-2228-429X; Leemans, C. Rene/0000-0001-7887-083X	Dutch Cancer Society [KWF2012-5423]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society, KWF2012-5423 (http://www.kwf.nl/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2012, CHIN J CANC; Adham M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102353; Akimoto T, 1997, JPN J CLIN ONCOL, V27, P240, DOI 10.1093/jjco/27.4.240; Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Cannon DM, 2014, HEAD NECK-J SCI SPEC, V36, P1120, DOI 10.1002/hed.23419; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Chua DTT, 2003, CANCER-AM CANCER SOC, V98, P74, DOI 10.1002/cncr.11485; Fatema CN, 2013, ANN NUCL MED, V27, P355, DOI 10.1007/s12149-013-0693-9; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kwong DLW, 1997, INT J RADIAT ONCOL, V39, P703, DOI 10.1016/S0360-3016(97)00339-8; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lee AWM, 2015, CANCER-AM CANCER SOC, V121, P1328, DOI 10.1002/cncr.29208; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lee AW, 2015, NPC 2015 YOG 7 INT N; LEE AWM, 1995, RADIOTHER ONCOL, V36, P24, DOI 10.1016/0167-8140(95)01579-6; Li PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141332; MARKS LB, 1991, INT J RADIAT ONCOL, V21, P1377, DOI 10.1016/0360-3016(91)90301-J; McCloskey SA, 2009, AM J CLIN ONCOL-CANC, V32, P587, DOI 10.1097/COC.0b013e3181967dd0; Overgaard J, 2003, LANCET, V362, P933, DOI 10.1016/S0140-6736(03)14361-9; Pan ZQ, 2012, AM J CLIN ONCOL-CANC, V35, P600, DOI 10.1097/COC.0b013e31822dfd55; Platek ME, 2012, HEAD NECK; Rades D, 2008, INT J RADIAT ONCOL, V70, P1108, DOI 10.1016/j.ijrobp.2007.07.2380; Sher DJ, 2011, INT J RADIAT ONCOL, V81, pE813, DOI 10.1016/j.ijrobp.2010.12.005; Song CH, 2008, LARYNGOSCOPE, V118, P663, DOI 10.1097/MLG.0b013e3181626cfe; Stoker SD, 2013, MC C 2013 IST; Su Sheng-fa, 2011, Zhonghua Yi Xue Za Zhi, V91, P469; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Teo PML, 2000, INT J RADIAT ONCOL, V48, P1311, DOI 10.1016/S0360-3016(00)00786-0; Wei WI, 2010, CLIN EXP OTORHINOLAR, V3, P1, DOI 10.3342/ceo.2010.3.1.1; Wildeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063706; Wildeman MA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-190; Yang J, 2014, ONCOL LETT, V7, P1755, DOI 10.3892/ol.2014.1990	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151899	10.1371/journal.pone.0151899	http://dx.doi.org/10.1371/journal.pone.0151899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030990	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800022
J	Wang, B; Franklin, JM; Eddings, W; Landon, J; Kesselheim, AS				Wang, Bo; Franklin, Jessica M.; Eddings, Wesley; Landon, Joan; Kesselheim, Aaron S.			Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis	PLOS ONE			English	Article							OPEN-LABEL; RISK; ADOLESCENTS; MEDICATIONS; OLANZAPINE; MONOTHERAPY; QUETIAPINE; DISORDER; COHORT	Background Following Food and Drug Administration (FDA) approval, many drugs are prescribed for non-FDA-approved ("off-label") uses. If substantial evidence supports the efficacy and safety of off-label indications, manufacturers can pursue formal FDA approval through supplemental new drug applications (sNDAs). We evaluated the effect of FDA determinations on pediatric sNDAs for antipsychotic drugs on prescribing of these products in children. Methods Retrospective, segmented time-series analysis using new prescription claims during 20032012 for three atypical antipsychotics (olanzapine, quetiapine, ziprasidone). FDA approved the sNDAs for pediatric use of olanzapine and quetiapine in December 2009, but did not approve the sNDA for pediatric use of ziprasidone. Results During the months before FDA approval of its pediatric sNDA, new prescriptions of olanzapine decreased for both children and adults. After FDA approval, the increase in prescribing trends was similar for both age groups (P = 0.47 for schizophrenia and bipolar disorder; P = 0.37 for other indications). Comparable decreases in use of quetiapine were observed between pediatrics and adults following FDA approval of its pediatric sNDA (P = 0.88; P = 0.63). Prescribing of ziprasidone decreased similarly for pediatric and adult patients after FDA non-approval of its pediatric sNDA (P = 0.61; P = 0.79). Conclusions The FDA's sNDA determinations relating to use of antipsychotics in children did not result in changes in use that favored the approved sNDAs and disfavored the unapproved sNDA. Improved communication may help translate the agency's expert judgments to clinical practice.	[Wang, Bo; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA; [Wang, Bo; Franklin, Jessica M.; Eddings, Wesley; Landon, Joan; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA; [Franklin, Jessica M.; Eddings, Wesley; Landon, Joan] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA.; Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Harvard Program in Therapeutic Science; Laura and John Arnold Foundation	Harvard Program in Therapeutic Science; Laura and John Arnold Foundation	Dr. Kesselheim's work is supported by the Harvard Program in Therapeutic Science and the Laura and John Arnold Foundation. The funders had no role in the conception, writing, or review of the manuscript.	Advisory meeting minutes: US Food and Drug Administration, 2009, SUMM MIN PSYCH DRUGS; Agency for Healthcare Research and Quality, 2011, OFF LAB US AT ANT UP; Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Barnett MS, 2004, J CHILD ADOL PSYCHOP, V14, P471, DOI 10.1089/cap.2004.14.471; Barry CL, 2012, J MENT HEALTH POLICY, V15, P119; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; Czaja AS, 2012, PHARMACOEPIDEM DR S, V21, P997, DOI 10.1002/pds.3312; Department of Health and Human Services and US Food and Drug Administration, FDA TRANSP IN IMPR T; Department of Health and Human Services and US Food and Drug Administration, FOOD DRUG ADM TRANSP; DiMasi JA, 2013, CLIN THER, V35, P808, DOI 10.1016/j.clinthera.2013.04.004; Dusetzina SB, 2012, MED CARE, V50, P466, DOI 10.1097/MLR.0b013e318245a160; Eli Lilly and Company, 2009, FDA APPR LILL ZYPR 2; Eng PM, 2005, PHARMACOEPIDEM DR S, V14, pS1; Findling RL, 2002, J CLIN PSYCHIAT, V63, P27; Food and Drug Administration, CLIN REV UNPUB; Frazier JA, 2001, J CHILD ADOL PSYCHOP, V11, P239, DOI 10.1089/10445460152595568; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Harris G., 2009, NY TIMES; Justice Department Press Release, 2022, JUST DEP INV LEADS S; Kemner C, 2002, J CLIN PSYCHOPHARM, V22, P455, DOI 10.1097/00004714-200210000-00003; Kesselheim AS, 2014, ANN INTERN MED, V161, P96, DOI 10.7326/M13-2381; Kesselheim AS, 2011, HEALTH AFFAIR, V30, P2318, DOI 10.1377/hlthaff.2011.0370; Lambert BL, 2006, AM J EPIDEMIOL, V164, P672, DOI 10.1093/aje/kwj289; Mack Alicia, 2003, J Manag Care Pharm, V9, P559; McIntyre RS, 2008, ARCH PEDIAT ADOL MED, V162, P929, DOI 10.1001/archpedi.162.10.929; Penfold RB, 2010, PEDIATRICS, V125, P475, DOI 10.1542/peds.2009-1288; Tarkan Laurie, 2008, NY TIMES; U.S. Department of Justice, 2010, PHARM GIANT ASTRAZEN; US Department of Justice, 2009, EL LILL COMP AGR PAY; US Food and Drug Administration, DRUG RES CHILDR; Vitiello B, 2009, EUR NEUROPSYCHOPHARM, V19, P629, DOI 10.1016/j.euroneuro.2009.04.008; Wang B, 2014, JAMA INTERN MED, V174, P1938, DOI 10.1001/jamainternmed.2014.5266; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wilson D., 2010, 520 MILLION ASTRAZEN; World Health Organization, PROM SAF MED CHILDR	35	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152195	10.1371/journal.pone.0152195	http://dx.doi.org/10.1371/journal.pone.0152195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032095	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800041
J	Yoon, SJ; Rahman, MS; Kwon, WS; Park, YJ; Pang, MG				Yoon, Sung-Jae; Rahman, Md Saidur; Kwon, Woo-Sung; Park, Yoo-Jin; Pang, Myung-Geol			Addition of Cryoprotectant Significantly Alters the Epididymal Sperm Proteome	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; 2 DIFFERENT EXTENDERS; BOVINE SPERMATOZOA; OXIDATIVE STRESS; BINDING-PROTEIN; SUPEROXIDE-DISMUTASE; MAMMALIAN SPERM; MALE-FERTILITY; BULL SPERM; CRYOPRESERVATION	Although cryopreservation has been developed and optimized over the past decades, it causes various stresses, including cold shock, osmotic stress, and ice crystal formation, thereby reducing fertility. During cryopreservation, addition of cryoprotective agent (CPA) is crucial for protecting spermatozoa from freezing damage. However, the intrinsic toxicity and osmotic stress induced by CPA cause damage to spermatozoa. To identify the effects of CPA addition during cryopreservation, we assessed the motility (%), motion kinematics, capacitation status, and viability of epididymal spermatozoa using computer-assisted sperm analysis and Hoechst 33258/chlortetracycline fluorescence staining. Moreover, the effects of CPA addition were also demonstrated at the proteome level using two-dimensional electrophoresis. Our results demonstrated that CPA addition significantly reduced sperm motility (%), curvilinear velocity, viability (%), and non-capacitated spermatozoa, whereas straightness and acrosome-reacted spermatozoa increased significantly (p < 0.05). Ten proteins were differentially expressed (two decreased and eight increased) (>3 fold, p < 0.05) after CPA, whereas NADH dehydrogenase flavoprotein 2, f-actin-capping protein subunit beta, superoxide dismutase 2, and outer dense fiber protein 2 were associated with several important signaling pathways (p < 0.05). The present study provides a mechanistic basis for specific cryostresses and potential markers of CPA-induced stress. Therefore, these might provide information about the development of safe biomaterials for cryopreservation and basic ground for sperm cryopreservation.	[Yoon, Sung-Jae; Rahman, Md Saidur; Kwon, Woo-Sung; Park, Yoo-Jin; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea	Chung Ang University	Pang, MG (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Rahman, Saidur/J-7855-2012; Pang, Myung-Geol/AAV-2014-2021; Rahman, Md Saidur/AAT-2972-2020; Kwon, Woo-Sung/J-6731-2019; Rahman, Mohammad Saifur/GZM-5483-2022; Rahman, Mohammad Sohelur/AAJ-7376-2020	Rahman, Saidur/0000-0003-4583-8731; Pang, Myung-Geol/0000-0003-2019-3789; Kwon, Woo-Sung/0000-0002-0848-7189; Rahman, Mohammad Saifur/0000-0002-9887-4456; Rahman, Mohammad Sohelur/0000-0002-4489-2202	National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF-2014R1A2A2A01002706]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (no. NRF-2014R1A2A2A01002706), http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none.	Alapati R, 2009, CRYOBIOLOGY, V59, P164, DOI 10.1016/j.cryobiol.2009.06.009; AMANN RP, 1974, J DAIRY SCI, V57, P212, DOI 10.3168/jds.S0022-0302(74)84862-9; Ardon F, 2013, REPRODUCTION, V146, P111, DOI 10.1530/REP-12-0468; Arnaud-Dabernat S, 2004, EXP CELL RES, V301, P293, DOI 10.1016/j.yexcr.2004.07.026; Awad MM, 2004, ANIM REPROD SCI, V84, P83, DOI 10.1016/j.anireprosci.2003.12.001; Ball BA, 2001, J ANDROL, V22, P1061; Barbas JP, 2009, CELL TISSUE BANK, V10, P49, DOI 10.1007/s10561-008-9081-4; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Borini A, 2009, SEMIN REPROD MED, V27, P443, DOI 10.1055/s-0029-1241053; Braun S, 2007, ONCOGENE, V26, P532, DOI 10.1038/sj.onc.1209822; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; Celeghini ECC, 2008, ANIM REPROD SCI, V104, P119, DOI 10.1016/j.anireprosci.2007.02.001; Chen J, 2011, J ANDROL, V32, P26, DOI 10.2164/jandrol.109.009662; Chen XL, 2012, J PROTEOMICS, V77, P59, DOI 10.1016/j.jprot.2012.07.004; Chiou SH, 2011, KAOHSIUNG J MED SCI, V27, P1, DOI 10.1016/j.kjms.2010.12.001; Cormier N, 1997, J ANDROL, V18, P461; Cui YG, 2008, J PROTEOME RES, V7, P3984, DOI 10.1021/pr800259t; Curry M R, 1995, Methods Mol Biol, V38, P189; D'Amours O, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100990; D'Amours O, 2010, REPRODUCTION, V139, P545, DOI 10.1530/REP-09-0375; Day JG, 2008, MOL BIOTECHNOL, V40, P202, DOI 10.1007/s12033-008-9099-7; Desai NR, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-114; Dvorakova K, 2005, REPRODUCTION, V130, P61, DOI 10.1530/rep.1.00549; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Fahy GM, 2010, CRYOBIOLOGY, V60, pS45, DOI 10.1016/j.cryobiol.2009.05.005; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Finkelstein M, 2013, DEV BIOL, V381, P62, DOI 10.1016/j.ydbio.2013.06.014; Fujii J, 2003, ASIAN J ANDROL, V5, P231; Fujita A, 2000, J CELL SCI, V113, P103; Glover M, 2014, ANTIVIR RES, V111, P136, DOI 10.1016/j.antiviral.2014.09.010; Goovaerts IGF, 2006, THERIOGENOLOGY, V66, P323, DOI 10.1016/j.theriogenology.2005.11.018; HAMMERSTEDT RH, 1990, J ANDROL, V11, P73; Ikeda T, 2010, CELL STRUCT FUNCT, V35, P23, DOI 10.1247/csf.09016; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Kaabi M, 2003, THERIOGENOLOGY, V60, P1249, DOI 10.1016/S0093-691X(03)00139-0; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kwon WS, 2015, SCI REP-UK, V5, DOI 10.1038/srep13821; Kwon WS, 2015, MOL CELL PROTEOMICS, V14, P1230, DOI 10.1074/mcp.M114.045369; Kwon WS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-897; Liu QH, 2015, FISH PHYSIOL BIOCHEM, V41, P413, DOI 10.1007/s10695-014-9993-9; Liu ZS, 1998, CRYOBIOLOGY, V37, P207, DOI 10.1006/cryo.1998.2116; Garcia BM, 2012, THERIOGENOLOGY, V77, P1280, DOI 10.1016/j.theriogenology.2011.10.033; Martins CF, 2009, ANIM REPROD SCI, V116, P50, DOI 10.1016/j.anireprosci.2008.12.018; Martins MIM, 2012, REPROD DOMEST ANIM, V47, P293, DOI 10.1111/rda.12042; Mazzilli F, 1995, Acta Eur Fertil, V26, P145; Mochida K, 2005, THERIOGENOLOGY, V64, P135, DOI 10.1016/j.theriogenology.2004.11.013; Mota AC, 2014, CRYOBIOLOGY, V69, P17, DOI 10.1016/j.cryobiol.2014.04.013; Mruk DD, 2002, CONTRACEPTION, V65, P305, DOI 10.1016/S0010-7824(01)00320-1; NAKAMURA M, 1988, BIOL REPROD, V39, P771, DOI 10.1095/biolreprod39.4.771; Oh JH, 2002, CRYOBIOLOGY, V44, P279, DOI 10.1016/S0011-2240(02)00034-2; Ohno K, 2002, CRYOBIOLOGY, V44, P142, DOI 10.1016/S0011-2240(02)00016-0; Olaciregui M, 2014, CRYOBIOLOGY, V68, P91, DOI 10.1016/j.cryobiol.2013.12.009; Oliva R, 2009, PROTEOMICS, V9, P1004, DOI 10.1002/pmic.200800588; Papa FO, 2008, ANIM REPROD SCI, V107, P293, DOI 10.1016/j.anireprosci.2008.05.003; Papa PM, 2015, ANIM REPROD SCI, V161, P58, DOI 10.1016/j.anireprosci.2015.08.004; Park YJ, 2012, J REPROD DEVELOP, V58, P461, DOI 10.1262/jrd.11-067H; Parrish JJ, 1999, THERIOGENOLOGY, V51, P461, DOI 10.1016/S0093-691X(98)00240-4; Peterson C, 1999, MOL HUM REPROD, V5, P627, DOI 10.1093/molehr/5.7.627; Rahman MS, 2014, ANDROLOGY-US, V2, P899, DOI 10.1111/j.2047-2927.2014.00273.x; Rahman MS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09169; Rahman MS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/360986; Rosato MP, 2013, THERIOGENOLOGY, V79, P508, DOI 10.1016/j.theriogenology.2012.11.008; SHABANOWITZ RB, 1987, BIOL REPROD, V36, P753, DOI 10.1095/biolreprod36.3.753; Shamonki MI, 2005, SEMIN REPROD MED, V23, P266, DOI 10.1055/s-2005-872455; Songsasen N, 1998, J EXP ZOOL, V280, P189, DOI 10.1002/(SICI)1097-010X(19980201)280:2&lt;189::AID-JEZ10&gt;3.0.CO;2-H; Sorrenti G, 2014, CRYOBIOLOGY, V68, P43, DOI 10.1016/j.cryobiol.2013.11.005; Wang XL, 2015, MOL HUM REPROD, V21, P136, DOI 10.1093/molehr/gau097; Wasinger V.C., 2013, INT J PROTEOMICS, V2013, DOI [10.1155/2013/180605, DOI 10.1155/2013/180605]; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Yoon SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126232	72	58	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152690	10.1371/journal.pone.0152690	http://dx.doi.org/10.1371/journal.pone.0152690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031703	Green Published, gold			2022-12-26	WOS:000373121800118
J	Kim, CS; Choi, JS; Joo, SY; Bae, EH; Ma, SK; Lee, J; Kim, SW				Kim, Chang Seong; Choi, Joon Seok; Joo, Soo Yeon; Bae, Eun Hui; Ma, Seong Kwon; Lee, JongUn; Kim, Soo Wan			Nicotine-Induced Apoptosis in Human Renal Proximal Tubular Epithelial Cells	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR GENES; SIGNALING PATHWAYS; CIGARETTE-SMOKING; OXIDATIVE STRESS; AMERICAN-INDIANS; KIDNEY-DISEASE; RISK-FACTORS; INJURY; PROGRESSION; DEATH	Background Nicotine is, to a large extent, responsible for smoking-mediated renal dysfunction. This study investigated nicotine's effects on renal tubular epithelial cell apoptosis in vitro and it explored the mechanisms underlying its effects. Methods Human proximal tubular epithelial (HK-2) cells were treated with nicotine. Cell viability was examined by using the WST-1 assay. Intracellular levels of reactive oxygen species (ROS) and the expression of mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-kappa B) proteins were determined. The messenger ribonucleic acid and the protein expression associated with the nicotine acetylcholine receptors (nAChRs) in HK-2 cells was examined, and apoptosis was detected using flow cytometry, cell cycle analysis, and immunoblot analysis. Results The HK-2 cells were endowed with nAChRs. Nicotine treatment reduced cell viability dose dependently, increased ROS levels, and increased extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK expression. Nicotine increased NF-kappa B activation, which was attenuated by N-acetyl-L-cysteine, and ERK and JNK inhibitors, but was not affected by a p38 MAPK inhibitor. Nicotine increased the Bax/Bcl-2 ratio, which was attenuated by N-acetyl-L-cysteine, the NF-kappa B inhibitor, Bay 11-7082, and hexamethonium, a non-specific nAChR blocker. Flow cytometry revealed nicotine-induced G2/M phase arrest. While nicotine treatment increased the expression of phosphorylated cdc2 and histone H3, a marker of G2/M phase arrest, hexamethonium and Bay 11-7082 pretreatment reduced their expression. Conclusions Nicotine caused apoptosis in HK-2 cells by inducing ROS generation that activated the NF-kappa B signaling pathway via the MAPK pathway and it arrested the cell cycle at the G2/M phase. Nicotine-induced apoptosis in HK-2 cells involves the nAChRs.	[Kim, Chang Seong; Choi, Joon Seok; Joo, Soo Yeon; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Joo, Soo Yeon; Lee, JongUn] Chonnam Natl Univ, Sch Med, Dept Physiol, Kwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.	skimw@chonnam.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2013R1A2A2A01067611]; National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2014M3C1A3053036]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2084]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2084).	Bae EH, 2011, NEPHROL DIAL TRANSPL, V26, P3866, DOI 10.1093/ndt/gfr386; BARTECCHI CE, 1994, NEW ENGL J MED, V330, P907, DOI 10.1056/NEJM199403313301307; Berger F, 1998, J NEUROSCI, V18, P6871; Bhatt K, 2008, AM J PHYSIOL-RENAL, V294, pF499, DOI 10.1152/ajprenal.00415.2007; Bleyer AJ, 2000, KIDNEY INT, V57, P2072, DOI 10.1046/j.1523-1755.2000.00056.x; Bonegio R, 2002, CURR OPIN NEPHROL HY, V11, P301, DOI 10.1097/00041552-200205000-00006; Graham A, 2002, NEUROSCIENCE, V113, P493, DOI 10.1016/S0306-4522(02)00223-3; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Heusch WL, 1998, CARCINOGENESIS, V19, P551, DOI 10.1093/carcin/19.4.551; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Hua P, 2010, AM J PHYSIOL-RENAL, V299, pF732, DOI 10.1152/ajprenal.00293.2010; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Jaimes EA, 2009, AM J NEPHROL, V29, P319, DOI 10.1159/000163593; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063186; Kim Seewan, 2011, Chonnam Med J, V47, P104, DOI 10.4068/cmj.2011.47.2.104; Lee KE, 2013, BIOCHEM BIOPH RES CO, V434, P527, DOI 10.1016/j.bbrc.2013.03.108; Ma Seong Kwon, 2013, Chonnam Med J, V49, P108, DOI 10.4068/cmj.2013.49.3.108; Macklin KD, 1998, J PHARMACOL EXP THER, V287, P435; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Onoda N, 2001, HEAD NECK-J SCI SPEC, V23, P860, DOI 10.1002/hed.1125; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Qiao D, 2005, TOXICOL APPL PHARM, V206, P17, DOI 10.1016/j.taap.2004.11.003; Regalado M, 2000, AM J KIDNEY DIS, V35, P687, DOI 10.1016/S0272-6386(00)70017-5; Rezonzew G, 2012, AM J PHYSIOL-RENAL, V303, pF304, DOI 10.1152/ajprenal.00661.2011; Rossing P, 2002, DIABETES CARE, V25, P859, DOI 10.2337/diacare.25.5.859; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Servais H, 2008, APOPTOSIS, V13, P11, DOI 10.1007/s10495-007-0151-z; STEGMAYR BG, 1990, J INTERN MED, V228, P121, DOI 10.1111/j.1365-2796.1990.tb00204.x; Takeda M, 1997, ARCH TOXICOL, V71, P612, DOI 10.1007/s002040050434; URAKAWA N, 1994, INT J LEGAL MED, V106, P232, DOI 10.1007/BF01225411; Vickers AEM, 2004, TOXICOL PATHOL, V32, P577, DOI 10.1080/01926230490508821; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Yang JY, 2012, DIABETES, V61, P1888, DOI 10.2337/db11-1393; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Zamai L, 1996, CYTOMETRY, V23, P303, DOI 10.1002/(SICI)1097-0320(19960401)23:4<303::AID-CYTO6>3.3.CO;2-B; Zeidler R, 2007, APOPTOSIS, V12, P1927, DOI 10.1007/s10495-007-0102-8; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278; Zhu Y, 2014, J HYPERTENS, V32, P1042, DOI 10.1097/HJH.0000000000000151	40	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152591	10.1371/journal.pone.0152591	http://dx.doi.org/10.1371/journal.pone.0152591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028622	gold, Green Submitted, Green Published			2022-12-26	WOS:000373116500054
J	Reuten, R; Nikodemus, D; Oliveira, MB; Patel, TR; Brachvogel, B; Breloy, I; Stetefeld, J; Koch, M				Reuten, Raphael; Nikodemus, Denise; Oliveira, Maria B.; Patel, Trushar R.; Brachvogel, Bent; Breloy, Isabelle; Stetefeld, Joerg; Koch, Manuel			Maltose-Binding Protein (MBP), a Secretion-Enhancing Tag for Mammalian Protein Expression Systems	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; FUSION PROTEINS; DOMAIN; CELLS; ACID	Recombinant proteins are commonly expressed in eukaryotic expression systems to ensure the formation of disulfide bridges and proper glycosylation. Although many proteins can be expressed easily, some proteins, sub-domains, and mutant protein versions can cause problems. Here, we investigated expression levels of recombinant extracellular, intracellular as well as transmembrane proteins tethered to different polypeptides in mammalian cell lines. Strikingly, fusion of proteins to the prokaryotic maltose-binding protein (MBP) generally enhanced protein production. MBP fusion proteins consistently exhibited the most robust increase in protein production in comparison to commonly used tags, e.g., the Fc, Glutathione S-transferase (GST), SlyD, and serum albumin (ser alb) tag. Moreover, proteins tethered to MBP revealed reduced numbers of dying cells upon transient transfection. In contrast to the Fc tag, MBP is a stable monomer and does not promote protein aggregation. Therefore, the MBP tag does not induce artificial dimerization of tethered proteins and provides a beneficial fusion tag for binding as well as cell adhesion studies. Using MBP we were able to secret a disease causing laminin beta 2 mutant protein (congenital nephrotic syndrome), which is normally retained in the endoplasmic reticulum. In summary, this study establishes MBP as a versatile expression tag for protein production in eukaryotic expression systems.	[Reuten, Raphael; Nikodemus, Denise; Koch, Manuel] Univ Cologne, Fac Med, Inst Dent Res & Oral Musculoskeletal Biol, D-50931 Cologne, Germany; [Reuten, Raphael; Nikodemus, Denise; Oliveira, Maria B.; Brachvogel, Bent; Breloy, Isabelle; Koch, Manuel] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Patel, Trushar R.; Stetefeld, Joerg] Univ Manitoba, Dept Chem, 144 Dysart Rd, Winnipeg, MB RT3 2N2, Canada; [Patel, Trushar R.] Univ Birmingham, Sch Biosci, Edgbaston B15 2TT, Middx, England; [Brachvogel, Bent] Univ Cologne, Fac Med, Dept Pediat & Adolescent Med, Expt Neonatol, D-50931 Cologne, Germany; [Koch, Manuel] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal	University of Cologne; University of Cologne; University of Manitoba; University of Birmingham; University of Cologne; Universidade de Lisboa	Reuten, R; Koch, M (corresponding author), Univ Cologne, Fac Med, Inst Dent Res & Oral Musculoskeletal Biol, D-50931 Cologne, Germany.; Reuten, R; Koch, M (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany.; Koch, M (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal.	rreuten@uni-koeln.de; Manuel.Koch@uni-koeln.de	Reuten, Raphael/AAA-3235-2022; Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011; Koch, Manuel/AAG-9914-2021; Stetefeld, Joerg/H-7630-2017	Reuten, Raphael/0000-0002-9434-4108; Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; Koch, Manuel/0000-0002-2962-7814; Stetefeld, Joerg/0000-0003-1478-3248; Nikodemus, Denise/0000-0003-4492-817X; Brachvogel, Bent/0000-0002-3923-0554	DFG [CRC829, DFG 2304/5-3, 2304/7-1, 2304/9-1]; KOLN FORTUNE program of the Medical Faculty; Multiple Sclerosis Society of Canada; Canadian Institute of Health Research [RPA-109759]; Canadian Institutes of Health Research Postdoctoral Fellowships; Marie Sklodowska-Curie Fellowship	DFG(German Research Foundation (DFG)); KOLN FORTUNE program of the Medical Faculty; Multiple Sclerosis Society of Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Postdoctoral Fellowships(Canadian Institutes of Health Research (CIHR)); Marie Sklodowska-Curie Fellowship	This work was supported by grants from the DFG (A2, CRC829 to M.K.; B04, CRC829, DFG 2304/5-3, 2304/7-1, 2304/9-1 to B.B.) and the KOLN FORTUNE program of the Medical Faculty. Jorg Stetefeld is partially supported by the Multiple Sclerosis Society of Canada and by the Canadian Institute of Health Research (RPA-109759). Trushar R. Patel was in receipt of Canadian Institutes of Health Research Postdoctoral Fellowships and a Marie Sklodowska-Curie Fellowship.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Baldi L, 2012, METHODS MOL BIOL, V801, P13, DOI 10.1007/978-1-61779-352-3_2; Bire S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082559; Chen YM, 2011, J AM SOC NEPHROL, V22, P849, DOI 10.1681/ASN.2010060632; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; Grandin M, 2016, CANCER CELL, V29, P173, DOI 10.1016/j.ccell.2016.01.001; Kaur J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048629; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Knappe TA, 2007, J MOL BIOL, V368, P1458, DOI 10.1016/j.jmb.2007.02.097; Kodama A, 2013, KIDNEY INT, V83, P446, DOI 10.1038/ki.2012.429; Korf U, 2005, PROTEOMICS, V5, P3571, DOI 10.1002/pmic.200401195; Li MC, 2006, BIOTECHNOL LETT, V28, P1141, DOI 10.1007/s10529-006-9066-y; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Lo KM, 1998, PROTEIN ENG, V11, P495, DOI 10.1093/protein/11.6.495; Patel TR, 2014, MATRIX BIOL, V33, P60, DOI 10.1016/j.matbio.2013.07.009; Patel TR, 2012, MATRIX BIOL, V31, P135, DOI 10.1016/j.matbio.2011.11.004; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Pennati A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106724; Rosenbaum S, 2011, J BIOL CHEM, V286, P5708, DOI 10.1074/jbc.M110.193086; Ruggiero F, 2008, METHODS, V45, P75, DOI 10.1016/j.ymeth.2008.01.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Scholz C, 2005, J MOL BIOL, V345, P1229, DOI 10.1016/j.jmb.2004.10.091; Wolper SA, 2014, ANAL BIOCHEM, V447, P64, DOI 10.1016/j.ab.2013.10.031	26	31	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152386	10.1371/journal.pone.0152386	http://dx.doi.org/10.1371/journal.pone.0152386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029048	Green Published, gold, Green Submitted			2022-12-26	WOS:000373116500042
J	Abd Razak, MRM; Sastu, UR; Norahmad, NA; Abdul-Karim, A; Muhammad, A; Muniandy, PK; Jelip, J; Rundi, C; Imwong, M; Mudin, RN; Abdullah, NR				Abd Razak, Mohd Ridzuan Mohd; Sastu, Umi Rubiah; Norahmad, Nor Azrina; Abdul-Karim, Abass; Muhammad, Amirrudin; Muniandy, Prem Kumar; Jelip, Jenarun; Rundi, Christina; Imwong, Mallika; Mudin, Rose Nani; Abdullah, Noor Rain			Genetic Diversity of Plasmodium falciparum Populations in Malaria Declining Areas of Sabah, East Malaysia	PLOS ONE			English	Article							MICROSATELLITE MARKERS REVEAL; POLYMERASE-CHAIN-REACTION; PAPUA-NEW-GUINEA; ANTIMALARIAL TRIALS; DRUG-RESISTANCE; HIGH PREVALENCE; GLURP GENES; ELIMINATION; REGION; TRANSMISSION	Malaysia has a national goal to eliminate malaria by 2020. Understanding the genetic diversity of malaria parasites in residual transmission foci can provide invaluable information which may inform the intervention strategies used to reach elimination targets. This study was conducted to determine the genetic diversity level of P. falciparum isolates in malaria residual foci areas of Sabah. Malaria active case detection was conducted in Kalabakan and Kota Marudu. All individuals in the study sites were screened for malaria infection by rapid diagnostic test. Blood from P. falciparum-infected individuals were collected on filter paper prior to DNA extraction. Genotyping was performed using merozoite surface protein-1 (MSP-1), merozoite surface protein-2 (MSP-2), glutamate rich protein (GLURP) and 10 neutral microsatellite loci markers. The size of alleles, multiplicity of infection (MOI), mean number of alleles (Na), expected heterozygosity (He), linkage disequilibrium (LD) and genetic differentiation (F-ST) were determined. In Kalabakan, the MSP-1 and MSP-2 alleles were predominantly K1 and FC27 family types, respectively. The GLURP genotype VI (751-800 bp) was predominant. The MOI for MSP-1 and MSP-2 were 1.65 and 1.20, respectively. The Na per microsatellite locus was 1.70. The He values for MSP-1, MSP-2, GLURP and neutral microsatellites were 0.17, 0.37, 0.70 and 0.33, respectively. In Kota Marudu, the MSP-1 and MSP-2 alleles were predominantly MAD20 and 3D7 family types, respectively. The GLURP genotype IV (651-700 bp) was predominant. The MOI for both MSP-1 and MSP-2 was 1.05. The Na per microsatellite locus was 3.60. The He values for MSP-1, MSP-2, GLURP and neutral microsatellites were 0.24, 0.25, 0.69 and 0.30, respectively. A significant LD was observed in Kalabakan (0.495, p<0.01) and Kota Marudu P. falciparum populations (0.601, p<0.01). High genetic differentiation between Kalabakan and Kota Marudu P. falciparum populations was observed (F-ST = 0.532). The genetic data from the present study highlighted the limited diversity and contrasting genetic pattern of P. falciparum populations in the malaria declining areas of Sabah.	[Abd Razak, Mohd Ridzuan Mohd; Sastu, Umi Rubiah; Norahmad, Nor Azrina; Muhammad, Amirrudin; Muniandy, Prem Kumar; Abdullah, Noor Rain] Inst Med Res, Herbal Med Res Ctr, Kuala Lumpur 50588, Malaysia; [Jelip, Jenarun; Rundi, Christina] Sabah State Hlth Dept, Kota Kinabalu, Sabah, Malaysia; [Abdul-Karim, Abass] Tamale Teaching Hosp, Zonal Publ Hlth Lab, Tamale, Northern Region, Ghana; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Mudin, Rose Nani] Fed Govt Adm Ctr, Minist Hlth, Dis Control Div, Vector Borne Dis Sect, Putrajaya, Malaysia	Kementerian Kesihatan Malaysia; Mahidol University; Kementerian Kesihatan Malaysia	Abd Razak, MRM (corresponding author), Inst Med Res, Herbal Med Res Ctr, Kuala Lumpur 50588, Malaysia.	ridzuan@imr.gov.my	Imwong, Mallika/ABE-6493-2020; Mohd Abd Razak, Mohd Ridzuan/GXZ-7049-2022	Mohd Abd Razak, Mohd Ridzuan/0000-0002-9589-5892	National Institute of Health, Ministry of Health Malaysia [JPPIMR 13-008]	National Institute of Health, Ministry of Health Malaysia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study (JPPIMR 13-008) was supported by the National Institute of Health, Ministry of Health Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-198; Akter J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-386; Alam MT, 2011, J INFECT DIS, V203, P220, DOI 10.1093/infdis/jiq038; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Anthony TG, 2005, J INFECT DIS, V191, P1558, DOI 10.1086/429338; Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Atroosh WM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-251; Atroosh WM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-233; BABIKER HA, 1994, PARASITOLOGY, V109, P413, DOI 10.1017/S0031182000080665; Barry AE, 2013, AM J TROP MED HYG, V88, P718, DOI 10.4269/ajtmh.12-0056; Chenet SM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0887-9; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-412; Congpuong Kanungnit, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P598, DOI 10.12980/APJTB.4.2014APJTB-2014-0156; Daniels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060780; Echeverry DF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-2; Escalante AA, 2015, AM J TROP MED HYG, V93, P79, DOI 10.4269/ajtmh.15-0005; Gatei W, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1003-x; Gosi P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-403; Griffing SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058984; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Haubold B, 1998, GENETICS, V150, P1341; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Iwagami M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-96; Juliano JJ, 2010, TRENDS PARASITOL, V26, P119, DOI 10.1016/j.pt.2009.12.007; Juliano JJ, 2009, J INFECT DIS, V200, P624, DOI 10.1086/600892; Juliano JJ, 2009, J INFECT DIS, V200, P5, DOI 10.1086/599379; Khaireh BA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-201; Lau TY, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-445; Mita T, 2015, PARASITOL INT, V64, P238, DOI 10.1016/j.parint.2014.09.007; Mobegi VA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-223; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; Nkhoma SC, 2013, MOL ECOL, V22, P273, DOI 10.1111/mec.12099; Norahmad NA, 2011, SE ASIAN J TROP MED, V42, P1322; Noviyanti R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003739; Oyebola MK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-493; Oyebola Muyiwa K., 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS87, DOI 10.12980/APJTB.4.2014C1301; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pumpaibool T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-155; Rebaudet S, 2010, EMERG INFECT DIS, V16, P1686, DOI 10.3201/eid1611.100694; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Shorthouse DP, 2010, SIMPLEMAPPR ONLINE T; Sisya TJ, 2015, ACTA TROP, V142, P108, DOI 10.1016/j.actatropica.2014.11.008; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Sulistyaningsih E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-80; Vardo-Zalik AM, 2013, AM J TROP MED HYG, V88, P29, DOI 10.4269/ajtmh.2012.12-0308; VIRIYAKOSOL S, 1995, B WORLD HEALTH ORGAN, V73, P85; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; World Health Organization, 2015, WORLD MAL REP 2015	51	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152415	10.1371/journal.pone.0152415	http://dx.doi.org/10.1371/journal.pone.0152415			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023787	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900054
J	Forder, L; Taylor, O; Mankin, H; Scott, RB; Franklin, A				Forder, Lewis; Taylor, Olivia; Mankin, Helen; Scott, Ryan B.; Franklin, Anna			Colour Terms Affect Detection of Colour and Colour-Associated Objects Suppressed from Visual Awareness	PLOS ONE			English	Article							BINOCULAR-RIVALRY; CATEGORIES; LANGUAGE; ATTENTION; FIELD; PERCEPTION; RESPONSES; COMPONENT; CORTEX; MEMORY	The idea that language can affect how we see the world continues to create controversy. A potentially important study in this field has shown that when an object is suppressed from visual awareness using continuous flash suppression (a form of binocular rivalry), detection of the object is differently affected by a preceding word prime depending on whether the prime matches or does not match the object. This may suggest that language can affect early stages of vision. We replicated this paradigm and further investigated whether colour terms likewise influence the detection of colours or colour-associated object images suppressed from visual awareness by continuous flash suppression. This method presents rapidly changing visual noise to one eye while the target stimulus is presented to the other. It has been shown to delay conscious perception of a target for up to several minutes. In Experiment 1 we presented greyscale photos of objects. They were either preceded by a congruent object label, an incongruent label, or white noise. Detection sensitivity (d') and hit rates were significantly poorer for suppressed objects preceded by an incongruent label compared to a congruent label or noise. In Experiment 2, targets were coloured discs preceded by a colour term. Detection sensitivity was significantly worse for suppressed colour patches preceded by an incongruent colour term as compared to a congruent term or white noise. In Experiment 3 targets were suppressed greyscale object images preceded by an auditory presentation of a colour term. On congruent trials the colour term matched the object's stereotypical colour and on incongruent trials the colour term mismatched. Detection sensitivity was significantly poorer on incongruent trials than congruent trials. Overall, these findings suggest that colour terms affect awareness of coloured stimuli and colour-associated objects, and provide new evidence for language-perception interaction in the brain.	[Forder, Lewis; Taylor, Olivia; Mankin, Helen; Franklin, Anna] Univ Sussex, Sch Psychol, Sussex Colour Grp, Brighton, E Sussex, England; [Scott, Ryan B.] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Sussex; University of Sussex	Forder, L (corresponding author), Univ Sussex, Sch Psychol, Sussex Colour Grp, Brighton, E Sussex, England.	L.Forder@sussex.ac.uk	Franklin, Anna/B-5812-2017	Franklin, Anna/0000-0003-2201-4377	European Research Council [283605]	European Research Council(European Research Council (ERC)European Commission)	This research was supported by a European Research Council Starting Grant (project "CATEGORIES") 283605 (to AF). http://erc.europa.eu/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulaki A, 2006, J GREEK LINGUIST, V7, P3; Arnold DH, 2008, VISION RES, V48, P994, DOI 10.1016/j.visres.2008.01.020; Bahrami B, 2010, PSYCHOL SCI, V21, P224, DOI 10.1177/0956797609360664; Baker DH, 2009, P NATL ACAD SCI USA, V106, P5436, DOI 10.1073/pnas.0812860106; Bannert MM, 2013, CURR BIOL, V23, P2268, DOI 10.1016/j.cub.2013.09.016; Becker E, 2007, STROKE, V38, P3172, DOI 10.1161/STROKEAHA.107.489096; Berlin B., 1969, BASIC COLOR TERMS TH; Bird CM, 2014, P NATL ACAD SCI USA, V111, P4590, DOI 10.1073/pnas.1315275111; Boutonnet B, 2015, J NEUROSCI, V35, P9329, DOI 10.1523/JNEUROSCI.5111-14.2015; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; Brouwer GJ, 2013, J NEUROSCI, V33, P15454, DOI 10.1523/JNEUROSCI.2472-13.2013; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; Cave CB, 1998, PSYCHOL SCI, V9, P299, DOI 10.1111/1467-9280.00059; Clifford A, 2012, BRAIN COGNITION, V80, P126, DOI 10.1016/j.bandc.2012.04.011; Clifford A, 2010, BIOL PSYCHOL, V85, P275, DOI 10.1016/j.biopsycho.2010.07.014; Conway BR, 2007, NEURON, V56, P560, DOI 10.1016/j.neuron.2007.10.008; Corballis MC, 1993, THE LOPSIDED APE EVO; Costello P, 2009, CONSCIOUS COGN, V18, P375, DOI 10.1016/j.concog.2009.02.003; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Drivonikou GV, 2007, P NATL ACAD SCI USA, V104, P1097, DOI 10.1073/pnas.0610132104; Duncan KJ, 2010, J COGNITIVE NEUROSCI, V22, P739, DOI 10.1162/jocn.2009.21207; Fletcher R., 1980, THE CITY UNIVERSITY; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hansen T, 2006, NAT NEUROSCI, V9, P1367, DOI 10.1038/nn1794; He X, 2014, J OPT SOC AM A, V31, pA322, DOI 10.1364/JOSAA.31.00A322; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Hopf JM, 2002, J NEUROPHYSIOL, V88, P2088, DOI 10.1152/jn.2002.88.4.2088; Ishihara S, 1987, ISHIHARA TEST FOR CO; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Kang MS, 2011, J NEUROSCI, V31, P13535, DOI 10.1523/JNEUROSCI.1691-11.2011; Kersten D, 2003, CURR OPIN NEUROBIOL, V13, P150, DOI 10.1016/S0959-4388(03)00042-4; KINCHLA RA, 1979, PERCEPT PSYCHOPHYS, V25, P225, DOI 10.3758/BF03202991; Konkle T, 2010, PSYCHOL SCI, V21, P1551, DOI 10.1177/0956797610385359; Kranjec A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098604; Kuehni RG, 2005, J COGN CULT, V5, P409, DOI 10.1163/156853705774648554; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lee P, 1996, THE WHORF THEORY COM; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Li HH, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004510; Luck S, 2005, AN INTRODUCTION TO T; Lucy JA, 1997, ANNU REV ANTHROPOL, V26, P291, DOI 10.1146/annurev.anthro.26.1.291; Lupyan G, 2008, COGNITION, V108, P566, DOI 10.1016/j.cognition.2008.03.009; Lupyan G, 2013, P NATL ACAD SCI USA, V110, P14196, DOI 10.1073/pnas.1303312110; Mancini F, 2011, J COGNITIVE NEUROSCI, V23, P1987, DOI 10.1162/jocn.2010.21561; Mather G, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150418; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Melloni L, 2012, CEREB CORTEX, V22, P2943, DOI 10.1093/cercor/bhr384; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Miyahara E, 2003, PERCEPT MOTOR SKILL, V97, P1038, DOI 10.2466/PMS.97.7.1038-1042; Morgan M, 2012, ATTEN PERCEPT PSYCHO, V74, P185, DOI 10.3758/s13414-011-0222-7; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Olkkonen M, 2008, J VISION, V8, DOI [10.1167/8.5.13, 10.1167/8.8.8]; Patel Salil H, 2005, Int J Med Sci, V2, P147; Persichetti AS, 2015, J VISION, V15, DOI 10.1167/15.6.18; Pinker S, 1995, THE LANGUAGE INSTINC; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ringman JM, 2004, NEUROLOGY, V63, P468, DOI 10.1212/01.WNL.0000133011.10689.CE; Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109; Stone GO, 1997, J MEM LANG, V36, P337, DOI 10.1006/jmla.1996.2487; STONE GO, 1993, J EXP PSYCHOL HUMAN, V19, P744, DOI 10.1037/0096-1523.19.4.744; STURGES J, 1995, COLOR RES APPL, V20, P364, DOI 10.1002/col.5080200605; Sun YL, 2015, CONSCIOUS COGN, V34, P16, DOI 10.1016/j.concog.2015.03.004; Thierry G, 2009, P NATL ACAD SCI USA, V106, P4567, DOI 10.1073/pnas.0811155106; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; WALKER ECT, 1977, BEHAV RES METH INSTR, V9, P3, DOI 10.3758/BF03202208; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104; Yuval-Greenberg S, 2013, J NEUROSCI, V33, P9635, DOI 10.1523/JNEUROSCI.4612-12.2013; ZEKI S, 1990, BRAIN, V113, P1721, DOI 10.1093/brain/113.6.1721; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; ZIMBA LD, 1983, J EXP PSYCHOL HUMAN, V9, P807, DOI 10.1037/0096-1523.9.5.807	78	7	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152212	10.1371/journal.pone.0152212	http://dx.doi.org/10.1371/journal.pone.0152212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9KB	27023274	gold, Green Published, Green Submitted			2022-12-26	WOS:000373113900031
J	Muys, BR; Lorenzi, JCC; Zanette, DL; Bueno, RDLE; de Araujo, LF; Dinarte-Santos, AR; Alves, CP; Ramao, A; de Molfetta, GA; Vidal, DO; Silva, WA				Muys, Bruna Rodrigues; Cetrulo Lorenzi, Julio Cesar; Zanette, Dalila Luciola; Lima e Bueno, Rafaela de Barros; de Araujo, Luza Ferreira; Dinarte-Santos, Anemari Ramos; Alves, Cleidson Padua; Ramao, Anelisa; de Molfetta, Greice Andreotti; Vidal, Daniel Onofre; Silva, Wilson Araujo, Jr.			Placenta-Enriched LincRNAs MIR503HG and LINC00629 Decrease Migration and Invasion Potential of JEG-3 Cell Line	PLOS ONE			English	Article							NONCODING RNAS; EXPRESSION; GENE; IDENTIFICATION	LINC00629 and MIR503HG are long intergenic non-coding RNAs (lincRNAs) mapped on chromosome X (Xq26), a region enriched for genes associated with human reproduction. Genes highly expressed in normal reproductive tissues and cancers (CT genes) are well known as potential tumor biomarkers. This study aimed to characterize the structure, expression, function and regulation mechanism of MIR503HG and LINC00629 lincRNAs. According to our data, MIR503HG expression was almost exclusive to placenta and LINC00629 was highly expressed in placenta and other reproductive tissues. Further analysis, using a cancer cell lines panel, showed that MIR503HG and LINC00629 were expressed in 50% and 100% of the cancer cell lines, respectively. MIR503HG was expressed predominantly in the nucleus of JEG-3 choriocarcinoma cells. We observed a positively correlated expression between MIR503HG and LINC00629, and between the lincRNAs and neighboring miRNAs. Also, both LINC00629 and MIR503GH could be negatively regulated by DNA methylation in an indirect way. Additionally, we identified new transcripts for MIR503HG and LINC00629 that are relatively conserved when compared to other primates. Furthermore, we found that overexpression of MIR503HG2 and the three-exon LINC00629 new isoforms decreased invasion and migration potential of JEG-3 tumor cell line. In conclusion, our results suggest that lincRNAs MIR503HG and LINC00629 impaired migration and invasion capacities in a choriocarcinoma in vitro model, indicating a potential role in human reproduction and tumorigenesis. Moreover, the MIR503HG expression pattern found here could indicate a putative new tumor biomarker.	[Muys, Bruna Rodrigues; Cetrulo Lorenzi, Julio Cesar; Lima e Bueno, Rafaela de Barros; de Araujo, Luza Ferreira; Alves, Cleidson Padua; Ramao, Anelisa; de Molfetta, Greice Andreotti; Silva, Wilson Araujo, Jr.] Univ Sao Paulo, Dept Genet, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, Brazil; [Muys, Bruna Rodrigues; Cetrulo Lorenzi, Julio Cesar; Lima e Bueno, Rafaela de Barros; de Araujo, Luza Ferreira; Dinarte-Santos, Anemari Ramos; Alves, Cleidson Padua; Ramao, Anelisa; de Molfetta, Greice Andreotti; Silva, Wilson Araujo, Jr.] Reg Blood Ctr Ribeirao Preto, Ctr Cell Based Therapy CEPID FAPESP, Natl Inst Sci & Technol Stem Cell & Cell Therapy, Ribeirao Preto, Brazil; [Muys, Bruna Rodrigues; Cetrulo Lorenzi, Julio Cesar; Lima e Bueno, Rafaela de Barros; de Araujo, Luza Ferreira; Dinarte-Santos, Anemari Ramos; Alves, Cleidson Padua; de Molfetta, Greice Andreotti; Silva, Wilson Araujo, Jr.] Ctr Integrat Syst Biol CISBi NAP USP, Ctr Med Genom HCFMRP USP, Ribeirao Preto, Brazil; [Zanette, Dalila Luciola] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, Brazil; [Vidal, Daniel Onofre] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil	Universidade de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao Oswaldo Cruz; Hospital de Cancer de Barretos	Silva, WA (corresponding author), Univ Sao Paulo, Dept Genet, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, Brazil.; Silva, WA (corresponding author), Reg Blood Ctr Ribeirao Preto, Ctr Cell Based Therapy CEPID FAPESP, Natl Inst Sci & Technol Stem Cell & Cell Therapy, Ribeirao Preto, Brazil.; Silva, WA (corresponding author), Ctr Integrat Syst Biol CISBi NAP USP, Ctr Med Genom HCFMRP USP, Ribeirao Preto, Brazil.	wilsonjr@usp.br	Lorenzi, Julio Cesar C.C. Cetrulo/B-5264-2008; Araujo, L. F./I-5586-2015; Lorenzi, Julio/S-2394-2019; Silva Jr, Wilson Araújo/E-9487-2011; ZANETTE, DALILA/Q-3541-2016; Vidal, Daniel/C-7203-2012	Lorenzi, Julio Cesar C.C. Cetrulo/0000-0003-2492-3961; Araujo, L. F./0000-0002-5199-619X; Lorenzi, Julio/0000-0003-2492-3961; Silva Jr, Wilson Araújo/0000-0001-9364-2886; zanette, dalila l./0000-0001-9397-4127; Vidal, Daniel/0000-0003-2117-3640; Muys, Bruna/0000-0002-3963-0865; Molfetta, Greice Andreotti/0000-0003-0946-5704	National Counsel of Technological and Scientific Development (CNPq) [573754/2008-0, 131371/2011-8, 2011/04154-7, 2013/08135-2]; Sao Paulo Research Foundation (FAPESP); University of Sao Paulo, CISBi-NAP/USP [12.1.25441.01.2]	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Sao Paulo, CISBi-NAP/USP	This work was funded by The National Counsel of Technological and Scientific Development (CNPq), grant #573754/2008-0 and #131371/2011-8; by grants #2011/04154-7 and #2013/08135-2, Sao Paulo Research Foundation (FAPESP); and by Research Support of the University of Sao Paulo, CISBi-NAP/USP #12.1.25441.01.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Fant M, 2010, PRENATAL DIAG, V30, P497, DOI 10.1002/pd.2506; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fiedler J, 2015, J AM COLL CARDIOL, V66, P2005, DOI 10.1016/j.jacc.2015.07.081; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Harmanci AO, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-108; Hurst LD, 1999, TRENDS GENET, V15, P383, DOI 10.1016/S0168-9525(99)01809-0; Jackman SM, 2012, MOL REPROD DEV, V79, P564, DOI 10.1002/mrd.22062; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koslowski M, 2007, CANCER RES, V67, P9528, DOI 10.1158/0008-5472.CAN-07-1350; Li N, 2014, BIOCHEM BIOPH RES CO, V444, P611, DOI 10.1016/j.bbrc.2014.01.103; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P991, DOI 10.1016/j.bbrc.2007.04.034; Silva Wilson A Jr, 2007, Cancer Immun, V7, P18; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Torarinsson E, 2006, GENOME RES, V16, P885, DOI 10.1101/gr.5226606; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013	29	27	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0151560	10.1371/journal.pone.0151560	http://dx.doi.org/10.1371/journal.pone.0151560			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023770	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900014
J	Zhang, MX; Tidwell, V; La Rosa, PS; Wilson, JD; Eswaran, H; Nehorai, A				Zhang, Mengxue; Tidwell, Vanessa; La Rosa, Patricio S.; Wilson, James D.; Eswaran, Hari; Nehorai, Arye			Modeling Magnetomyograms of Uterine Contractions during Pregnancy Using a Multiscale Forward Electromagnetic Approach	PLOS ONE			English	Article							ELECTRICAL-ACTIVITY; COMPUTER-MODEL; SMOOTH-MUSCLE; UTERUS; LABOR; TERM; PROPAGATION; RECORDINGS; PRETERM; CALCIUM	Understanding the mechanisms of uterine contractions during pregnancy is especially important in predicting the onset of labor and thus in forecasting preterm deliveries. Preterm birth can cause serious health problems in newborns, as well as large financial burdens to society. Various techniques such as electromyography (EMG) and magnetomyography (MMG) have been developed to quantify uterine contractions. However, no widely accepted method to predict labor based on electromagnetic measurement is available. Therefore, developing a biophysical model of EMG and MMG could help better understand uterine contractions, interpret real measurements, and detect labor. In this work, we propose a multiscale realistic model of uterine contractions during pregnancy. At the cellular level, building on bifurcation theory, we apply generalized FitzHugh-Nagumo (FHN) equations that produces both plateau-type and bursting-type action potentials. At the tissue level, we introduce a random fiber orientation model applicable to an arbitrary uterine shape. We also develop an analytical expression for the propagation speed of transmembrane potential. At the organ level, a realistic volume conductor geometry model is provided based on magnetic resonance images of a pregnant woman. To simulate the measurements from the SQUID Array for Reproductive Assessment (SARA) device, we propose a sensor array model. Our model is able to reproduce the characteristics of action potentials. Additionally, we investigate the sensitivity of MMG to model configuration aspects such as volume geometry, fiber orientation, and pacemaker location. Our numerical results show that fiber orientation and pacemaker location are the key aspects that greatly affect the MMG as measured by the SARA device. We conclude that sphere is appropriate as an approximation of the volume geometry. The initial step towards validating the model against real MMG measurement is also presented. Our results show that the model is flexible to mimic the limited-propagation magnetic signature during the emergence and decay of a uterine contraction.	[Zhang, Mengxue; Tidwell, Vanessa; Nehorai, Arye] Washington Univ, Dept Elect & Syst Engn, St Louis, MO USA; [La Rosa, Patricio S.] Monsanto Co, Res & Dev Technol Pipeline Solut, St Louis, MO USA; [La Rosa, Patricio S.] Univ Missouri, Joint Undergrad Engn Program, St Louis, MO 63121 USA; [La Rosa, Patricio S.] Washington Univ, St Louis, MO USA; [Wilson, James D.] Univ Arkansas, Grad Inst Technol, Little Rock, AR 72204 USA; [Eswaran, Hari] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA	Washington University (WUSTL); Monsanto; University of Missouri System; University of Missouri Saint Louis; Washington University (WUSTL); University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Medical Sciences	Nehorai, A (corresponding author), Washington Univ, Dept Elect & Syst Engn, St Louis, MO USA.	nehorai@wustl.edu			National Institute of Biomedical Imaging and Bioengineering [R01EB016567]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016567] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by National Institute of Biomedical Imaging and Bioengineering grant R01EB016567. This funding organization provided financial support in the form of authors' salaries (MZ, VT, JDW, HE, AN) and research materials, but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author (PSL) in Monsanto Company is also a member in the joint undergraduate Engineering program between University of Missouri and Washington University in St. Louis. The Monsanto Company did not play a role in the financial support, study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section of the online submission form.	ANDERSEN HF, 1995, OBSTET GYNECOL, V86, P108, DOI 10.1016/0029-7844(95)00111-4; [Anonymous], 2002, MATH BIOL; Bibin L, 2010, IEEE T BIO-MED ENG, V57, P2346, DOI 10.1109/TBME.2010.2053367; Bursztyn L, 2007, AM J PHYSIOL-CELL PH, V292, pC1816, DOI 10.1152/ajpcell.00478.2006; Ermentrout B., 2002, SIMULATING ANAL ANIM, DOI DOI 10.1137/1.9780898718195; Eswaran H, 2004, AM J OBSTET GYNECOL, V190, P1598, DOI 10.1016/j.ajog.2004.03.063; Eswaran H, 2002, AM J OBSTET GYNECOL, V187, P145, DOI 10.1067/mob.2002.123031; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Garfield RE, 2005, AM J OBSTET GYNECOL, V193, P23, DOI 10.1016/j.ajog.2005.01.050; GARFIELD RE, 1988, OXFORD REV REPROD B, V10, P436; GARFIELD RE, 1984, CLIN OBSTET GYNECOL, V27, P572, DOI 10.1097/00003081-198409000-00007; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Govindan RB, 2015, REPROD SCI, V22, P595, DOI 10.1177/1933719114556484; La Rosa Patricio S, 2012, BMC Med Phys, V12, P4, DOI 10.1186/1756-6649-12-4; Laforet J, 2013, IRBM, V34, P38, DOI 10.1016/j.irbm.2012.12.004; Laforet J, 2011, IEEE T BIO-MED ENG, V58, P3487, DOI 10.1109/TBME.2011.2167970; Lammers WJEP, 2008, AM J PHYSIOL-REG I, V294, pR919, DOI 10.1152/ajpregu.00704.2007; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; Lamont RF, 2003, BJOG-INT J OBSTET GY, V110, P131, DOI 10.1016/S1470-0328(03)00065-X; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Malmivuo P., 1995, BIOELECTROMAGNETISM, DOI [DOI 10.1093/ACPROF:OSO/9780195058239.001.0001, 10.1093/acprof:oso/9780195058239.001.0001]; Nagarajan R, 2003, J Matern Fetal Neonatal Med, V14, P8, DOI 10.1080/jmf.14.1.8.21; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Parkington HC, 1999, AM J OBSTET GYNECOL, V181, P1445, DOI 10.1016/S0002-9378(99)70390-X; PLONSEY R, 1967, B MATH BIOPHYS, V29, P657, DOI 10.1007/BF02476917; Ramon C, 2005, SYNCHRONIZATION ANAL; Rihana S, 2009, MED BIOL ENG COMPUT, V47, P665, DOI 10.1007/s11517-009-0433-4; Smith R, 2015, AM J OBSTET GYNECOL, V213, P181, DOI 10.1016/j.ajog.2015.06.040; Tong WC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0114034, DOI 10.1371/J0URNAL.PONE.0114034]; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Weiss S, 2006, ANAT REC PART A, V288A, P84, DOI 10.1002/ar.a.20274; WIKLAND M, 1985, EUR J OBSTET GYN R B, V20, P337, DOI 10.1016/0028-2243(85)90057-7; Young RC, 1997, OBSTET GYNECOL, V89, P604, DOI 10.1016/S0029-7844(96)00502-9; Young RC, 2004, J SOC GYNECOL INVEST, V11, P478, DOI 10.1016/j.jsgi.2004.05.005; Young RC, 2015, J BIOMECH, V48, P1614, DOI 10.1016/j.jbiomech.2015.02.002	35	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152421	10.1371/journal.pone.0152421	http://dx.doi.org/10.1371/journal.pone.0152421			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019202	Green Published, gold			2022-12-26	WOS:000372807800053
J	Prinz, F; Puetter, V; Holton, SJ; Andres, D; Stegmann, CM; Kwiatkowski, D; Prechtl, S; Petersen, K; Beckmann, G; Kreft, B; Mumberg, D; Fernandez-Montalvan, A				Prinz, Florian; Puetter, Vera; Holton, Simon J.; Andres, Dorothee; Stegmann, Christian M.; Kwiatkowski, Dennis; Prechtl, Stefan; Petersen, Kirstin; Beckmann, Georg; Kreft, Bertolt; Mumberg, Dominik; Fernandez-Montalvan, Amaury			Functional and Structural Characterization of Bub3 center dot BubR1 Interactions Required for Spindle Assembly Checkpoint Signaling in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kinetics; mitosis; protein-protein interaction; structure-function; thermodynamics; Bub3; BubR1; WD40; spindle assembly checkpoint	PROTEIN-PROTEIN INTERACTIONS; AGING-ASSOCIATED PHENOTYPES; BREAST-CANCER CELLS; MITOTIC CHECKPOINT; CHROMOSOME MISSEGREGATION; WDR5-MLL INTERACTION; SMALL MOLECULES; HIGH-AFFINITY; BUB3; MICE	The spindle assembly checkpoint (SAC) is an essential safeguarding mechanism devised to ensure equal chromosome distribution in daughter cells upon mitosis. The proteins Bub3 and BubR1 are key components of the mitotic checkpoint complex, an essential part of the molecular machinery on which the SAC relies. In the present work we have performed a detailed functional and biochemical characterization of the interaction between human Bub3 and BubR1 in cells and in vitro. Our results demonstrate that genetic knockdown of Bub3 abrogates the SAC, promotes apoptosis, and inhibits the proliferation of human cancer cells. We also show that the integrity of the human mitotic checkpoint complex depends on the specific recognition between BubR1 and Bub3, for which the BubR1 Gle2 binding sequence motif is essential. This 1:1 binding event is high affinity, enthalpy-driven and with slow dissociation kinetics. The affinity, kinetics, and thermodynamic parameters of the interaction are differentially modulated by small regions in the N and C termini of the Gle2 binding domain sequence, suggesting the existence of hotspots for this protein-protein interaction. Furthermore, we show that specific disruption of endogenous BubR1Bub3 complexes in human cancer cells phenocopies the effects observed in gene targeting experiments. Our work enhances the current understanding of key members of the SAC and paves the road for the pursuit of novel targeted cancer therapies based on SAC inhibition.	[Puetter, Vera; Holton, Simon J.; Andres, Dorothee; Stegmann, Christian M.; Kwiatkowski, Dennis; Prechtl, Stefan; Fernandez-Montalvan, Amaury] Bayer Pharma AG, Global Drug Discovery, Lead Discovery, D-13353 Berlin, Germany; [Beckmann, Georg] Bayer Pharma AG, Global Drug Discovery, Target Discovery, D-13353 Berlin, Germany; [Prinz, Florian; Petersen, Kirstin; Kreft, Bertolt; Mumberg, Dominik] Bayer Pharma AG, Global Drug Discovery, TRG Discovery, D-13353 Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Fernandez-Montalvan, A (corresponding author), Bayer Pharma AG, Global Drug Discovery, Lead Discovery, D-13353 Berlin, Germany.; Prinz, F (corresponding author), Bayer Pharma AG, Global Drug Discovery, TRG Discovery, D-13353 Berlin, Germany.	florian.prinz@bayer.com; amaury.fernandez@bayer.com		Fernandez-Montalvan, Amaury/0000-0001-9156-0000; Kwiatkowski, Dennis/0000-0002-8235-9716				Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Bolshan Y, 2013, ACS MED CHEM LETT, V4, P353, DOI 10.1021/ml300467n; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Chari A, 2015, NAT METHODS, V12, P859, DOI [10.1038/NMETH.3493, 10.1038/nmeth.3493]; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Hahn M, 2001, J MOL BIOL, V314, P293, DOI 10.1006/jmbi.2001.5135; Han JS, 2014, P NATL ACAD SCI USA, V111, pE4185, DOI 10.1073/pnas.1416277111; Harris L, 2005, EXP CELL RES, V308, P85, DOI 10.1016/j.yexcr.2005.03.036; Hutsell SQ, 2010, METHODS MOL BIOL, V627, P75, DOI 10.1007/978-1-60761-670-2_4; Jemaa M, 2013, CELL DEATH DIFFER, V20, P1532, DOI 10.1038/cdd.2013.105; Jemaa M, 2012, EMBO MOL MED, V4, P500, DOI 10.1002/emmm.201200228; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kalitsis P, 2005, GENE CHROMOSOME CANC, V44, P29, DOI 10.1002/gcc.20215; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Krenn V, 2012, J CELL BIOL, V196, P451, DOI 10.1083/jcb.201110013; Larsen NA, 2004, J MOL BIOL, V344, P885, DOI 10.1016/j.jmb.2004.09.094; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Layton CJ, 2011, PROTEIN SCI, V20, P1439, DOI 10.1002/pro.674; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; London N, 2013, CURR OPIN CHEM BIOL, V17, P952, DOI 10.1016/j.cbpa.2013.10.011; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; O'Brien R, 2000, PROTEIN SCI, V9, P570; Overlack K, 2015, ELIFE, V4, DOI 10.7554/eLife.05269; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Senisterra G, 2013, BIOCHEM J, V449, P151, DOI 10.1042/BJ20121280; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Slee RB, 2014, MOL CANCER THER, V13, P307, DOI 10.1158/1535-7163.MCT-13-0324; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tange Y, 2008, GENETICS, V179, P785, DOI 10.1534/genetics.107.081695; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wilson DK, 2005, J BIOL CHEM, V280, P13944, DOI 10.1074/jbc.M412919200; Windecker H, 2009, EMBO REP, V10, P1022, DOI 10.1038/embor.2009.183; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	59	7	7	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11252	11267		10.1074/jbc.M115.702142	http://dx.doi.org/10.1074/jbc.M115.702142			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27030009	Green Published, hybrid			2022-12-26	WOS:000377042100026
J	Zorzini, V; Mernik, A; Lah, J; Sterckx, YGJ; De Jonge, N; Garcia-Pino, A; De Greve, H; Versees, W; Loris, R				Zorzini, Valentina; Mernik, Andrej; Lah, Jurij; Sterckx, Yann G. J.; De Jonge, Natalie; Garcia-Pino, Abel; De Greve, Henri; Versees, Wim; Loris, Remy			Substrate Recognition and Activity Regulation of the Escherichia coli mRNA Endonuclease MazF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; ribonuclease; stress response; structure-function; substrate specificity; persistence; toxin-antitoxin	TOXIN-ANTITOXIN MODULES; PERSISTER CELLS; SELECTIVE TRANSLATION; FUNCTIONAL-ANALYSIS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; CLEAVAGE; INTERFERASE; PROTEIN; MECHANISMS	Escherichia coli MazF (EcMazF) is the archetype of a large family of ribonucleases involved in bacterial stress response. The crystal structure of EcMazF in complex with a 7-nucleotide substrate mimic explains the relaxed substrate specificity of the E. coli enzyme relative to its Bacillus subtilis counterpart and provides a framework for rationalizing specificity in this enzyme family. In contrast to a conserved mode of substrate recognition and a conserved active site, regulation of enzymatic activity by the antitoxin EcMazE diverges from its B. subtilis homolog. Central in this regulation is an EcMazE-induced double conformational change as follows: a rearrangement of a crucial active site loop and a relative rotation of the two monomers in the EcMazF dimer. Both are induced by the C-terminal residues Asp-78-Trp-82 of EcMazE, which are also responsible for strong negative cooperativity in EcMazE-EcMazF binding. This situation shows unexpected parallels to the regulation of the F-plasmid CcdB activity by CcdA and further supports a common ancestor despite the different activities of the MazF and CcdB toxins. In addition, we pinpoint the origin of the lack of activity of the E24A point mutant of EcMazF in its inability to support the substrate binding-competent conformation of EcMazF.	[Zorzini, Valentina; Sterckx, Yann G. J.; De Jonge, Natalie; Garcia-Pino, Abel; De Greve, Henri; Versees, Wim; Loris, Remy] Vrije Univ Brussel, Dept Biotechnol, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Zorzini, Valentina; Sterckx, Yann G. J.; De Jonge, Natalie; De Greve, Henri; Versees, Wim; Loris, Remy] VIB, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium; [Mernik, Andrej; Lah, Jurij] Univ Ljubljana, Fac Chem & Chem Technol, Vecna Pot 113, Ljubljana 1000, Slovenia; [Garcia-Pino, Abel] Univ Libre Bruxelles, Biol Struct & Biophys, Rue Prof Jeener & Brachet 12, B-6041 Gosselies, Belgium; [Zorzini, Valentina] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, B-3000 Leuven, Belgium; [De Jonge, Natalie] arGEN X, Technol Pk 30, B-9052 Zwijnaarde, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Ljubljana; Universite Libre de Bruxelles; KU Leuven	Loris, R (corresponding author), Vrije Univ Brussel, Dept Biotechnol, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium.; Loris, R (corresponding author), VIB, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium.	reloris@vub.ac.be	Loris, Remy/GPG-0894-2022; Sterckx, Yann G.-J./F-2269-2017; Versées, Wim/H-5518-2015	Sterckx, Yann G.-J./0000-0002-7420-0983; Versees, Wim/0000-0002-4695-696X; Zorzini, Valentina/0000-0002-8727-309X; Loris, Remy/0000-0002-8862-3338	ESRF, Grenoble, France [BM29]; SOLEIL, Gif-sur-Yvette, France [PROXIMA-1, PROXIMA-2a]	ESRF, Grenoble, France; SOLEIL, Gif-sur-Yvette, France	We thank the beamline scientists from BM29 (ESRF, Grenoble, France) and PROXIMA-1 and PROXIMA-2a (SOLEIL, Gif-sur-Yvette, France) for their support.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agarwal S, 2010, J BIOL CHEM, V285, P7254, DOI 10.1074/jbc.M109.073387; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen-Dalsgaard M, 2008, NUCLEIC ACIDS RES, V36, P6472, DOI 10.1093/nar/gkn667; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; D'Alessio G., 1997, RIBONUCLEASES STRUCT; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; De Jonge N, 2010, J BIOL CHEM, V285, P5606, DOI 10.1074/jbc.M109.068429; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Dunican BF, 2015, BIOCHEMISTRY-US, V54, P7048, DOI 10.1021/acs.biochem.5b00866; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Germain E, 2015, P NATL ACAD SCI USA, V112, P5171, DOI 10.1073/pnas.1423536112; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kamphuis MB, 2007, PROTEINS, V67, P219, DOI 10.1002/prot.21254; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Loris R, 2014, CHEM REV, V114, P6933, DOI 10.1021/cr400656f; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moll I, 2012, TRENDS BIOCHEM SCI, V37, P493, DOI 10.1016/j.tibs.2012.07.007; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; Park JH, 2011, FEBS LETT, V585, P2526, DOI 10.1016/j.febslet.2011.07.008; Rothenbacher FP, 2012, J BACTERIOL, V194, P3464, DOI 10.1128/JB.00217-12; Schifano JM, 2013, P NATL ACAD SCI USA, V110, P8501, DOI 10.1073/pnas.1222031110; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Simanshu DK, 2013, MOL CELL, V52, P447, DOI 10.1016/j.molcel.2013.09.006; Sterckx YGJ, 2015, PROTEIN EXPRES PURIF, V108, P30, DOI 10.1016/j.pep.2015.01.001; Steyaert J, 1997, EUR J BIOCHEM, V247, P1, DOI 10.1111/j.1432-1033.1997.t01-1-00001.x; Tripathi A, 2014, J BIOL CHEM, V289, P4191, DOI 10.1074/jbc.M113.510511; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zorzini V, 2014, NUCLEIC ACIDS RES, V42, P6709, DOI 10.1093/nar/gku266	49	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					10950	10960		10.1074/jbc.M116.715912	http://dx.doi.org/10.1074/jbc.M116.715912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27026704	hybrid, Green Published			2022-12-26	WOS:000377042100001
J	Tavares, CDJ; Sharabi, K; Dominy, JE; Lee, Y; Isasa, M; Orozco, JM; Jedrychowski, MP; Kamenecka, TM; Griffin, PR; Gygi, SP; Puigserver, P				Tavares, Clint D. J.; Sharabi, Kfir; Dominy, John E.; Lee, Yoonjin; Isasa, Marta; Orozco, Jose M.; Jedrychowski, Mark P.; Kamenecka, Theodore M.; Griffin, Patrick R.; Gygi, Steven P.; Puigserver, Pere			The Methionine Transamination Pathway Controls Hepatic Glucose Metabolism through Regulation of the GCN5 Acetyltransferase and the PGC-1 alpha Transcriptional Coactivator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-METABOLISM; HISTONE ACETYLTRANSFERASE; PROTEIN; RESTRICTION; GLUCONEOGENESIS; HOMOCYSTEINE; HOMEOSTASIS; EXPRESSION; REPRESSION; MECHANISM	Methionine is an essential sulfur amino acid that is engaged in key cellular functions such as protein synthesis and is a precursor for critical metabolites involved in maintaining cellular homeostasis. In mammals, in response to nutrient conditions, the liver plays a significant role in regulating methionine concentrations by altering its flux through the transmethylation, transsulfuration, and transamination metabolic pathways. A comprehensive understanding of how hepatic methionine metabolism intersects with other regulatory nutrient signaling and transcriptional events is, however, lacking. Here, we show that methionine and derived-sulfur metabolites in the transamination pathway activate the GCN5 acetyltransferase promoting acetylation of the transcriptional coactivator PGC-1 alpha to control hepatic gluconeogenesis. Methionine was the only essential amino acid that rapidly induced PGC-1 alpha acetylation through activating the GCN5 acetyltransferase. Experiments employing metabolic pathway intermediates revealed that methionine transamination, and not the transmethylation or transsulfuration pathways, contributed to methionine-induced PC4C-1 alpha acetylation. Moreover, aminooxyacetic acid, a transaminase inhibitor, was able to potently suppress PGC-1 alpha acetylation stimulated by methionine, which was accompanied by predicted alterations in PGC-1 alpha-mediated gluconeogenic gene expression and glucose production in primary murine hepatocytes. Methionine administration in mice likewise induced hepatic PGC-1 alpha acetylation, suppressed the gluconeogenic gene program, and lowered glycemia, indicating that a similar phenomenon occurs in vivo. These results highlight a communication between methionine metabolism and PGC-1 alpha-mediated hepatic gluconeogenesis, suggesting that influencing methionine metabolic flux has the potential to be therapeutically exploited for diabetes treatment.	[Tavares, Clint D. J.; Sharabi, Kfir; Dominy, John E.; Lee, Yoonjin; Orozco, Jose M.; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, 450 Brookline Ave,CLSB 11144, Boston, MA 02115 USA; [Tavares, Clint D. J.; Sharabi, Kfir; Dominy, John E.; Lee, Yoonjin; Isasa, Marta; Orozco, Jose M.; Jedrychowski, Mark P.; Gygi, Steven P.; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kamenecka, Theodore M.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Scripps Research Institute	Puigserver, P (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,CLSB 11144, Boston, MA 02215 USA.	pere_puigserver@dfci.harvard.edu			National Institutes of Health [RO11069966, R24DK080261-06]; American Diabetes Association [1-16-PDF-111]; American Heart Association [15POST22880002]; National Research Service Award Kirschstein fellowship from the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); National Research Service Award Kirschstein fellowship from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO11069966 (NIDDK; to P. P.) and R24DK080261-06 (NIDDK; to P. P. and P. R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a mentor-based American Diabetes Association postdoctoral fellowship and also by a postdoctoral fellowship from the American Diabetes Association (Grant 1-16-PDF-111).r Supported by a postdoctoral fellowship from the American Heart Association (15POST22880002).r Supported by a National Research Service Award Kirschstein fellowship from the National Institutes of Health.	Ables GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051357; Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; BENEVENGA NJ, 1974, J AGR FOOD CHEM, V22, P2, DOI 10.1021/jf60191a036; BLOM HJ, 1989, CLIN SCI, V76, P43, DOI 10.1042/cs0760043; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; CHERRINGTON A D, 1987, Diabetes Metabolism Reviews, V3, P307; Dever JT, 2008, J PHARMACOL EXP THER, V326, P809, DOI 10.1124/jpet.108.141044; Dever TE, 1999, TRENDS BIOCHEM SCI, V24, P398, DOI 10.1016/S0968-0004(99)01457-7; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; FINKELSTEIN JD, 1986, J BIOL CHEM, V261, P1582; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Fukagawa NK, 2000, AM J CLIN NUTR, V72, P22; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Gietzen DW, 2006, TRENDS NEUROSCI, V29, P91, DOI 10.1016/j.tins.2005.12.007; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P366; HARPER AE, 1970, PHYSIOL REV, V50, P428, DOI 10.1152/physrev.1970.50.3.428; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Korendyaseva TK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000076; Lee BC, 2016, ANN NY ACAD SCI, V1363, P116, DOI 10.1111/nyas.12973; Lee YJ, 2014, NATURE, V510, P547, DOI 10.1038/nature13267; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lin WC, 2008, DEV DYNAM, V237, P928, DOI 10.1002/dvdy.21479; Livesey G, 1980, BIOCHEM SOC T, V8, P540, DOI 10.1042/bst0080540; MARCHESINI G, 1992, HEPATOLOGY, V16, P149; MITCHELL AD, 1978, J NUTR, V108, P67, DOI 10.1093/jn/108.1.67; Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Riss A, 2015, J BIOL CHEM, V290, P28997, DOI 10.1074/jbc.M115.668533; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SCISLOWSKI PWD, 1993, MOL CELL BIOCHEM, V129, P39, DOI 10.1007/BF00926574; SCISLOWSKI PWD, 1989, ARCH BIOCHEM BIOPHYS, V273, P602, DOI 10.1016/0003-9861(89)90521-3; STEELE RD, 1978, J BIOL CHEM, V253, P7844; Sternglanz R, 1999, P NATL ACAD SCI USA, V96, P8807, DOI 10.1073/pnas.96.16.8807; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464; Toue S, 2006, J NUTR, V136, p1716S, DOI 10.1093/jn/136.6.1716S; Wang L, 2014, EPIGENOMICS-UK, V6, P329, DOI [10.2217/EPI.14.22, 10.2217/epi.14.22]; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Xu JY, 2014, J BIOL CHEM, V289, P27034, DOI 10.1074/jbc.M114.579078; Yamada H, 2012, FREE RADICAL BIO MED, V52, P1716, DOI 10.1016/j.freeradbiomed.2012.02.033; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	46	21	22	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10635	10645		10.1074/jbc.M115.706200	http://dx.doi.org/10.1074/jbc.M115.706200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27022023	Green Published, hybrid			2022-12-26	WOS:000377042600017
J	Gloersen, O; Federolf, P				Gloersen, Oyvind; Federolf, Peter			Predicting Missing Marker Trajectories in Human Motion Data Using Marker Intercorrelations	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; SOFT-TISSUE ARTIFACT; CLINICAL GAIT; STEREOPHOTOGRAMMETRY	Missing information in motion capture data caused by occlusion or detachment of markers is a common problem that is difficult to avoid entirely. The aim of this study was to develop and test an algorithm for reconstruction of corrupted marker trajectories in datasets representing human gait. The reconstruction was facilitated using information of marker inter-correlations obtained from a principal component analysis, combined with a novel weighting procedure. The method was completely data-driven, and did not require any training data. We tested the algorithm on datasets with movement patterns that can be considered both well suited (healthy subject walking on a treadmill) and less suited (transitioning from walking to running and the gait of a subject with cerebral palsy) to reconstruct. Specifically, we created 50 copies of each dataset, and corrupted them with gaps in multiple markers at random temporal and spatial positions. Reconstruction errors, quantified by the average Euclidian distance between predicted and measured marker positions, was <= 3 mm for the well suited dataset, even when there were gaps in up to 70% of all time frames. For the less suited datasets, median reconstruction errors were in the range 5-6 mm. However, a few reconstructions had substantially larger errors (up to 29 mm). Our results suggest that the proposed algorithm is a viable alternative both to conventional gap-filling algorithms and state-of-the-art reconstruction algorithms developed for motion capture systems. The strengths of the proposed algorithm are that it can fill gaps anywhere in the dataset, and that the gaps can be considerably longer than when using conventional interpolation techniques. Limitations are that it does not enforce musculoskeletal constraints, and that the reconstruction accuracy declines if applied to datasets with less predictable movement patterns.	[Gloersen, Oyvind; Federolf, Peter] Univ Oslo, Dept Phys, Oslo, Norway; [Gloersen, Oyvind; Federolf, Peter] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Federolf, Peter] Norwegian Univ Sci & Technol, Fac Med, Dept Neurosci, N-7034 Trondheim, Norway; [Federolf, Peter] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria	University of Oslo; Norwegian School of Sport Sciences; Norwegian University of Science & Technology (NTNU); University of Innsbruck	Gloersen, O (corresponding author), Univ Oslo, Dept Phys, Oslo, Norway.; Gloersen, O (corresponding author), Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway.	o.n.gloersen@fys.uio.no	Federolf, Peter/H-4481-2019	Federolf, Peter/0000-0002-0266-6813				Begon M, 2008, J BIOMECH, V41, P581, DOI 10.1016/j.jbiomech.2007.10.005; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Federolf PA, 2013, J BIOMECH, V46, P2173, DOI 10.1016/j.jbiomech.2013.06.032; Federolf P, 2014, J BIOMECH, V47, P1555, DOI 10.1016/j.jbiomech.2014.02.013; Federolf PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078689; Feng YF, 2014, INFORM SCIENCES, V277, P777, DOI 10.1016/j.ins.2014.03.013; Herda L, 2001, HUM MOVEMENT SCI, V20, P313, DOI 10.1016/S0167-9457(01)00050-1; Howarth SJ, 2010, COMPUT METHOD BIOMEC, V13, P847, DOI 10.1080/10255841003664701; Junhui H, 2014, 2014 IEEE INT C MULT; Li L, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P507; Liu GD, 2006, VISUAL COMPUT, V22, P721, DOI 10.1007/s00371-006-0080-9; Liu X, 2014, SIGNAL PROCESS, V105, P350, DOI 10.1016/j.sigpro.2014.06.009; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; Richards JG, 1999, HUM MOVEMENT SCI, V18, P589, DOI 10.1016/S0167-9457(99)00023-8; Stagni R, 2005, CLIN BIOMECH, V20, P320, DOI 10.1016/j.clinbiomech.2004.11.012; Tan CH, 2015, VISUAL COMPUT, V31, P1521, DOI 10.1007/s00371-014-1031-5; Xiao J, 2011, COMPUT ANIMAT VIRT W, V22, P221, DOI 10.1002/cav.413	18	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152616	10.1371/journal.pone.0152616	http://dx.doi.org/10.1371/journal.pone.0152616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031243	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800104
J	Hu, SD; Luebberstedt, T; Zhao, GW; Lee, M				Hu, Shuaidong; Luebberstedt, Thomas; Zhao, Guangwu; Lee, Michael			QTL Mapping of Low-Temperature Germination Ability in the Maize IBM Syn4 RIL Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ORYZA-SATIVA L.; ZEA-MAYS L.; COLD STRESS; RICE; GERMINABILITY; TOLERANCE; IDENTIFICATION; SELECTION; SEEDLINGS	Low temperature is the primary factor to affect maize sowing in early spring. It is, therefore, vital for maize breeding programs to improve tolerance to low temperatures at seed germination stage. However, little is known about maize QTL involved in low-temperature germination ability. 243 lines of the intermated B73xMo17 (IBM) Syn4 recombinant inbred line (RIL) population was used for QTL analysis of low-temperature germination ability. There were significant differences in germination-related traits under both conditions of low temperature (12 degrees C/16h, 18 degrees C/8h) and optimum temperature (28 degrees C/24h) between the parental lines. Only three QTL were identified for controlling optimum-temperature germination rate. Six QTL controlling low-temperature germination rate were detected on chromosome 4, 5, 6, 7 and 9, and contribution rate of single QTL explained between 3.39%similar to 11.29%. In addition, six QTL controlling low-temperature primary root length were detected in chromosome 4, 5, 6, and 9, and the contribution rate of single QTL explained between 3.96%similar to 8.41%. Four pairs of QTL were located at the same chromosome position and together controlled germination rate and primary root length under low temperature condition. The nearest markers apart from the corresponding QTL (only 0.01 cM) were umc1303 (265.1 cM) on chromosome 4, umc1 (246.4 cM) on chromosome 5, umc62 (459.1 cM) on chromosome 6, bnl14.28a (477.4 cM) on chromosome 9, respectively. A total of 3155 candidate genes were extracted from nine separate intervals based on the Maize Genetics and Genomics Database (http://www.maizegdb.org). Five candidate genes were selected for analysis as candidates putatively affecting seed germination and seedling growth at low temperature. The results provided a basis for further fine mapping, molecular marker assisted breeding and functional study of cold-tolerance at the stage of seed germination in maize.	[Hu, Shuaidong; Zhao, Guangwu] Zhejiang Agr & Forestry Univ, Coll Agr & Food Sci, Key Lab Qual Improvement Agr Prod Zhejiang Prov, Linan 311300, Zhejiang, Peoples R China; [Luebberstedt, Thomas; Lee, Michael] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Zhejiang A&F University; Iowa State University	Zhao, GW (corresponding author), Zhejiang Agr & Forestry Univ, Coll Agr & Food Sci, Key Lab Qual Improvement Agr Prod Zhejiang Prov, Linan 311300, Zhejiang, Peoples R China.	gwuzhao@126.com		Lubberstedt, Thomas/0000-0002-0526-0798	Zhejiang Natural Science Foundation [LY13C130011]; National Natural Science Foundation of China [31371712]; Special Fund for Agro-scientific Research in the Public Interest of China [201303002]; Crop Germplasm Resources Protection Project of Zhejiang [2015004]; Key Project for Breeding of Agricultural New Variety of Zhejiang [2012C12902]; USDA's National Institute of Food and Agriculture [IOW04314, IOW01018]; RF Baker Center for Plant Breeding	Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China; Crop Germplasm Resources Protection Project of Zhejiang; Key Project for Breeding of Agricultural New Variety of Zhejiang; USDA's National Institute of Food and Agriculture; RF Baker Center for Plant Breeding	This research was supported by Zhejiang Natural Science Foundation (LY13C130011), National Natural Science Foundation of China (31371712), Special Fund for Agro-scientific Research in the Public Interest of China (201303002), Crop Germplasm Resources Protection Project of Zhejiang (2015004), the Key Project for Breeding of Agricultural New Variety of Zhejiang (2012C12902). The authors would also like to thank USDA's National Institute of Food and Agriculture (project numbers: IOW04314, IOW01018), as well as the RF Baker Center for Plant Breeding and K. J. Frey Chair in Agronomy at Iowa State University for funding this work.	Baga M, 2007, FUNCT INTEGR GENOMIC, V7, P53, DOI 10.1007/s10142-006-0030-7; Basten C, 2005, QTL CARTOGRAPHER VER; CHURCHILL GA, 1994, GENETICS, V138, P963; Dong YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143181; Frascaroli E, 2013, THEOR APPL GENET, V126, P733, DOI 10.1007/s00122-012-2014-4; Fujino K, 2004, THEOR APPL GENET, V108, P794, DOI 10.1007/s00122-003-1509-4; Hund A, 2004, THEOR APPL GENET, V109, P618, DOI 10.1007/s00122-004-1665-1; Hyun DY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0298-1; Iwata N, 2010, GENOME, V53, P763, DOI [10.1139/G10-060, 10.1139/g10-060]; Ji SL, 2009, PLANT BREEDING, V128, P387, DOI 10.1111/j.1439-0523.2008.01533.x; Jiang L, 2006, FIELD CROP RES, V98, P68, DOI 10.1016/j.fcr.2005.12.015; Jompuk C, 2005, J EXP BOT, V56, P1153, DOI 10.1093/jxb/eri108; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Miura K, 2001, BREEDING SCI, V51, P293, DOI 10.1270/jsbbs.51.293; NYQUIST WE, 1991, CRIT REV PLANT SCI, V10, P235, DOI 10.1080/07352689109382313; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Rodriguez VM, 2008, INT J PLANT SCI, V169, P551, DOI 10.1086/528755; Rodriguez V, 2014, MOL BREEDING, V33, P363, DOI 10.1007/s11032-013-9955-4; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Teng S, 2001, CHINESE SCI BULL, V46, P1800, DOI 10.1007/BF02900554; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang WB, 2012, CAN J PLANT SCI, V92, P1381, DOI 10.4141/CJPS2011-098	24	33	39	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152795	10.1371/journal.pone.0152795	http://dx.doi.org/10.1371/journal.pone.0152795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031623	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800137
J	Yang, X; Jiang, L; Jia, YG; Hu, Y; Xu, Q; Xu, X; Huang, H				Yang, Xin; Jiang, Ling; Jia, Yigang; Hu, Yi; Xu, Qing; Xu, Xian; Huang, He			Counteraction of Trehalose on N,N-Dimethylformamide-Induced Candida rugosa Lipase Denaturation: Spectroscopic Insight and Molecular Dynamic Simulation	PLOS ONE			English	Article							INDUCED PROTEIN DENATURATION; BIODIESEL PRODUCTION; INTERNAL-FRICTION; STABILITY; BIOCATALYSIS; ACCUMULATION; SOLVENTS; WATER; PH	Candida rugosa lipase (CRL) has been widely used as a biocatalyst for non-aqueous synthesis in biotechnological applications, which, however, often suffers significant loss of activity in organic solvent. Experimental results show that trehalose could actively counteract the organic-solvent-induced protein denaturation, while the molecular mechanisms still don't unclear. Herein, CRL was used as a model enzyme to explore the effects of trehalose on the retention of enzymatic activity upon incubation in N,N-dimethylformamide (DMF). Results showed that both catalytic activity and conformation changes of CRL influenced by DMF solvent were inhibited by trehalose in a dose-dependent fashion. The simulations further indicated that the CRL protein unfolded in binary DMF solution, but retained the native state in the ternary DMF/trehalose system. Trehalose as the second osmolyte added into binary DMF solution decreased DMF-CRL hydrogen bonds efficiently, whereas increased the intermolecular hydrogen bondings between DMF and trehalose. Thus, the origin of its denaturing effects of DMF on protein is thought to be due to the preferential exclusion of trehalose as well as the intermolecular hydrogen bondings between trehalose and DMF. These findings suggest that trehalose protect the CRL protein from DMF-induced unfolding via both indirect and direct interactions.	[Yang, Xin; Hu, Yi; Xu, Qing; Xu, Xian] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing 210009, Peoples R China; [Jiang, Ling; Jia, Yigang] Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing 210009, Peoples R China; [Huang, He] Nanjing Tech Univ, Coll Pharmaceut Sci, Nanjing 210009, Peoples R China	Nanjing Tech University; Nanjing Tech University; Nanjing Tech University	Jiang, L (corresponding author), Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing 210009, Peoples R China.; Huang, H (corresponding author), Nanjing Tech Univ, Coll Pharmaceut Sci, Nanjing 210009, Peoples R China.	jinagling@njtech.edu.cn; biotech@njtech.edu.cn			National Science Foundation; National Basic Research Program of China; National High Technology Research and Development Program of China; Natural Science Foundation of Jiangsu Province; Six Talent Peaks Project in Jiangsu Province	National Science Foundation(National Science Foundation (NSF)); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Six Talent Peaks Project in Jiangsu Province	The authors are grateful for the support of the National Science Foundation, National Basic Research Program of China, the National High Technology Research and Development Program of China, the Natural Science Foundation of Jiangsu Province, and the Six Talent Peaks Project in Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2011, INT J BIOL MACROMOL, V49, P652, DOI 10.1016/j.ijbiomac.2011.06.025; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Borgia A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2204; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bourot S, 2000, J BIOL CHEM, V275, P1050, DOI 10.1074/jbc.275.2.1050; Colombo G, 2002, J BIOTECHNOL, V96, P23, DOI 10.1016/S0168-1656(02)00034-2; De Los Rios P, 2012, NAT CHEM BIOL, V8, P226, DOI 10.1038/nchembio.791; DePaz RA, 2002, ENZYME MICROB TECH, V31, P765, DOI 10.1016/S0141-0229(02)00173-4; Eisenmenger MJ, 2009, ENZYME MICROB TECH, V45, P331, DOI 10.1016/j.enzmictec.2009.08.001; Gangadhara, 2009, J AM OIL CHEM SOC, V86, P773, DOI 10.1007/s11746-009-1408-1; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; GROCHULSKI P, 1994, BIOCHEMISTRY-US, V33, P3494, DOI 10.1021/bi00178a005; Haque I, 2006, BIOPHYS CHEM, V119, P224, DOI 10.1016/j.bpc.2005.09.016; He F, 2011, PHARM RES-DORDR, V28, P1552, DOI 10.1007/s11095-011-0388-7; Hu Y, 2013, CHINESE J CATAL, V34, P1608, DOI 10.1016/S1872-2067(12)60628-7; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jia R, 2013, ACS CATAL, V3, P1976, DOI 10.1021/cs400404f; Jiang L, 2015, GREEN CHEM, V17, P250, DOI 10.1039/c4gc01256a; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Korman TP, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-70; Lei Y, 2003, J PHYS CHEM A, V107, P1574, DOI 10.1021/jp026638+; Lerbret A, 2007, J PHYS CHEM B, V111, P9410, DOI 10.1021/jp071946z; Li XJ, 2015, IND ENG CHEM RES, V54, P8072, DOI 10.1021/acs.iecr.5b01881; Liu FF, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3453713; Lousa D, 2013, PHYS CHEM CHEM PHYS, V15, P13723, DOI 10.1039/c3cp51761f; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Mattos C, 2001, CURR OPIN STRUC BIOL, V11, P761, DOI 10.1016/S0959-440X(01)00278-0; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pace C N, 1986, Methods Enzymol, V131, P266; Paul S, 2015, J PHYS CHEM B, V119, P10975, DOI 10.1021/acs.jpcb.5b01457; Pazhang M, 2006, J BIOTECHNOL, V127, P45, DOI 10.1016/j.jbiotec.2006.05.017; Reetz MT, 2010, CHEM COMMUN, V46, P8657, DOI 10.1039/c0cc02657c; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Secundo F, 2004, BIOTECHNOL BIOENG, V86, P236, DOI 10.1002/bit.20034; Shu ZY, 2010, J MOL CATAL B-ENZYM, V62, P1, DOI 10.1016/j.molcatb.2009.09.003; Singh R, 2005, J BIOL CHEM, V280, P11035, DOI 10.1074/jbc.M410716200; Stergiou PY, 2013, BIOTECHNOL ADV, V31, P1846, DOI 10.1016/j.biotechadv.2013.08.006; Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012; Villeneuve P, 2000, J MOL CATAL B-ENZYM, V9, P113, DOI 10.1016/S1381-1177(99)00107-1; Wang PM, 2014, BIORESOURCE TECHNOL, V152, P371, DOI 10.1016/j.biortech.2013.11.033; Wensley BG, 2012, P NATL ACAD SCI USA, V109, P17795, DOI 10.1073/pnas.1201793109; Yang J, 2013, BIOCHEM ENG J, V70, P46, DOI 10.1016/j.bej.2012.09.016; Yang X, 2015, BIORESOURCES BIOPROC, V2, P1; Zhang N, 2014, BIOCHEM ENG J, V91, P231, DOI 10.1016/j.bej.2014.08.019; Zhang N, 2012, J PHYS CHEM B, V116, P7040, DOI 10.1021/jp300171h	46	7	7	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152275	10.1371/journal.pone.0152275	http://dx.doi.org/10.1371/journal.pone.0152275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031946	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800049
J	Behr, J; Geissler, AJ; Schmid, J; Zehe, A; Vogel, RF				Behr, Juergen; Geissler, Andreas J.; Schmid, Jonas; Zehe, Anja; Vogel, Rudi F.			The Identification of Novel Diagnostic Marker Genes for the Detection of Beer Spoiling Pediococcus damnosus Strains Using the BlAst Diagnostic Gene findEr	PLOS ONE			English	Article							LACTOBACILLUS-BREVIS; ENTEROCOCCUS-FAECALIS; MICROBIAL GENOMES; VIRULENCE FACTORS; SPOILAGE ABILITY; HOP RESISTANCE; ACID; SEQUENCE; COMPLEXITY; DNA	As the number of bacterial genomes increases dramatically, the demand for easy to use tools with transparent functionality and comprehensible output for applied comparative genomics grows as well. We present BlAst Diagnostic Gene findEr (BADGE), a tool for the rapid prediction of diagnostic marker genes (DMGs) for the differentiation of bacterial groups (e.g. pathogenic / nonpathogenic). DMG identification settings can be modified easily and installing and running BADGE does not require specific bioinformatics skills. During the BADGE run the user is informed step by step about the DMG finding process, thus making it easy to evaluate the impact of chosen settings and options. On the basis of an example with relevance for beer brewing, being one of the oldest biotechnological processes known, we show a straightforward procedure, from phenotyping, genome sequencing, assembly and annotation, up to a discriminant marker gene PCR assay, making comparative genomics a means to an end. The value and the functionality of BADGE were thoroughly examined, resulting in the successful identification and validation of an outstanding novel DMG (fabZ) for the discrimination of harmless and harmful contaminations of Pediococcus damnosus, which can be applied for spoilage risk determination in breweries. Concomitantly, we present and compare five complete P. damnosus genomes sequenced in this study, finding that the ability to produce the unwanted, spoilage associated off-flavor diacetyl is a plasmid encoded trait in this important beer spoiling species.	[Behr, Juergen; Geissler, Andreas J.; Schmid, Jonas; Zehe, Anja; Vogel, Rudi F.] Tech Univ Munich, Lehrstuhl Tech Mikrobiol, Freising Weihenstephan, Germany	Technical University of Munich	Behr, J (corresponding author), Tech Univ Munich, Lehrstuhl Tech Mikrobiol, Freising Weihenstephan, Germany.	juergen.behr@wzw.tum.de		Behr, Juergen/0000-0001-8782-4456	German Ministry of Economics and Technology (via AiF); Wifoe (Wissenschaftsforderung der Deutschen Brauwirtschaft e.V., Berlin) project AiF [17576N]	German Ministry of Economics and Technology (via AiF)(Federal Ministry for Economic Affairs and Energy (BMWi)); Wifoe (Wissenschaftsforderung der Deutschen Brauwirtschaft e.V., Berlin) project AiF	This research project was partly supported by the German Ministry of Economics and Technology (via AiF) and the Wifoe (Wissenschaftsforderung der Deutschen Brauwirtschaft e.V., Berlin) project AiF 17576N.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Behr J, 2006, APPL ENVIRON MICROB, V72, P6483, DOI 10.1128/AEM.00668-06; Behr J, 2010, APPL ENVIRON MICROB, V76, P142, DOI 10.1128/AEM.01693-09; Bergsveinson J, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01411-15; Bergsveinson J, 2015, APPL ENVIRON MICROB, V81, P1234, DOI 10.1128/AEM.02870-14; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Comerlato CB, 2013, MEM I OSWALDO CRUZ, V108, P590, DOI 10.1590/S0074-02762013000500009; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Geissler AJ, 2015, INT J FOOD MICROBIOL; Haakensen M, 2008, J AM SOC BREW CHEM, V66, P63, DOI 10.1094/ASBCJ-2008-0314-01; Hayashi N, 2001, APPL MICROBIOL BIOT, V55, P596, DOI 10.1007/s002530100600; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Kayaoglu G, 2004, CRIT REV ORAL BIOL M, V15, P308, DOI 10.1177/154411130401500506; Kelley DR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1067; Kern CC, 2013, J MICROBIOL METH, V93, P185, DOI 10.1016/j.mimet.2013.03.012; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Lindenstrauss AG, 2011, SYST APPL MICROBIOL, V34, P553, DOI 10.1016/j.syapm.2011.05.002; Liu Weilong, 2012, Mol Gen Mikrobiol Virusol, P14; Mukaka MM, 2012, MALAWI MED J, V24, P69; Niazi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104651; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Palaniappan RUM, 2006, J CLIN MICROBIOL, V44, P1495, DOI 10.1128/JCM.44.4.1495-1501.2006; Pittet V, 2012, J BACTERIOL, V194, P1271, DOI 10.1128/JB.06759-11; Raftis EJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-771; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Riadi G, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/678761; Ruan YF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1272-3; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; Schurr BC, 2015, FOOD MICROBIOL, V46, P501, DOI 10.1016/j.fm.2014.09.018; Schurr BC, 2015, FOOD MICROBIOL, V46, P553, DOI 10.1016/j.fm.2014.09.017; Schurr BC, 2013, EUR FOOD RES TECHNOL, V237, P199, DOI 10.1007/s00217-013-1980-3; SIMPSON WJ, 1992, J APPL BACTERIOL, V72, P327, DOI 10.1111/j.1365-2672.1992.tb01843.x; SIMPSON WJ, 1993, J GEN MICROBIOL, V139, P1041, DOI 10.1099/00221287-139-5-1041; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Suzuki K, 2005, J I BREWING, V111, P328, DOI 10.1002/j.2050-0416.2005.tb00691.x; Suzuki K, 2005, APPL ENVIRON MICROB, V71, P5089, DOI 10.1128/AEM.71.9.5089-5097.2005; Suzuki K, 2004, J APPL MICROBIOL, V97, P712, DOI 10.1111/j.1365-2672.2004.02350.x; Suzuki K, 2006, J I BREWING, V112, P173, DOI 10.1002/j.2050-0416.2006.tb00247.x; Suzuki K, 2011, J I BREWING, V117, P131, DOI 10.1002/j.2050-0416.2011.tb00454.x; Vesth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060120	51	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152747	10.1371/journal.pone.0152747	http://dx.doi.org/10.1371/journal.pone.0152747			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028007	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500064
J	Martinez, O; Wu, E; Levine, EC; Munoz-Laboy, M; Fernandez, MI; Bass, SB; Moya, EM; Frasca, T; Chavez-Baray, S; Icard, LD; Ovejero, H; Carballo-Dieguez, A; Rhodes, SD				Martinez, Omar; Wu, Elwin; Levine, Ethan C.; Munoz-Laboy, Miguel; Fernandez, M. Isabel; Bass, Sarah Bauerle; Moya, Eva M.; Frasca, Timothy; Chavez-Baray, Silvia; Icard, Larry D.; Ovejero, Hugo; Carballo-Dieguez, Alex; Rhodes, Scott D.			Integration of Social, Cultural, and Biomedical Strategies into an Existing Couple-Based Behavioral HIV/STI Prevention Intervention: Voices of Latino Male Couples	PLOS ONE			English	Article							CLUB-DRUG-USE; NEW-YORK-CITY; HIV-PREVENTION; UNITED-STATES; QUALITATIVE DESCRIPTION; COMBINATION PREVENTION; AFRICAN-AMERICAN; SEXUAL HEALTH; HISPANIC MEN; RISK	Introduction Successful HIV prevention and treatment requires evidence-based approaches that combine biomedical strategies with behavioral interventions that are socially and culturally appropriate for the population or community being prioritized. Although there has been a push for a combination approach, how best to integrate different strategies into existing behavioral HIV prevention interventions remains unclear. The need to develop effective combination approaches is of particular importance for men who have sex with men (MSM), who face a disproportionately high risk of HIV acquisition. Materials and Methods We collaborated with Latino male couples and providers to adapt Connect 'n Unite, an evidence-based intervention for Black male couples, for Latino male couples. We conducted a series of three focus groups, each with two cohorts of couples, and one focus group with providers. A purposive stratified sample of 20 couples (N = 40, divided into two cohorts) and 10 providers provided insights into how to adapt and integrate social, cultural, and biomedical approaches in a couples-based HIV/AIDS behavioral intervention. Results The majority (N = 37) of the couple participants had no prior knowledge of the following new biomedical strategies: non-occupational post-exposure prophylaxis (nPEP); pre-exposure prophylaxis (PrEP); and HIV self-testing kits. After they were introduced to these biomedical interventions, all participants expressed a need for information and empowerment through knowledge and awareness of these interventions. In particular, participants suggested that we provide PrEP and HIV self-testing kits by the middle or end of the intervention. Providers suggested a need to address behavioral, social and structural issues, such as language barriers; and the promotion of client-centered approaches to increase access to, adaptation of, and adherence to biomedical strategies. Corroborating what couple participants suggested, providers agreed that biomedical strategies should be offered after providing information about these tools. Regarding culturally sensitive and responsive approaches, participants identified stigma and discrimination associated with HIV and sexual identity as barriers to care, language barriers and documentation status as further barriers to care, the couple-based approach as ideal to health promotion, and the need to include family topics in the intervention. Discussion We successfully adapted an evidence-based behavioral HIV prevention intervention for Latino male couples. The adapted intervention, called Conectando Latinos en Pareja, integrates social, cultural, behavioral and biomedical strategies to address the HIV epidemic among Latino MSM. The study highlights the promise regarding the feasibility of implementing a combination approach to HIV prevention in this population.	[Martinez, Omar; Munoz-Laboy, Miguel; Icard, Larry D.] Temple Univ, Coll Publ Hlth, Sch Social Work, Philadelphia, PA 19122 USA; [Wu, Elwin] Columbia Univ, Sch Social Work, New York, NY USA; [Levine, Ethan C.] Temple Univ, Coll Liberal Arts, Philadelphia, PA 19122 USA; [Fernandez, M. Isabel] Nova SE Univ, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Bass, Sarah Bauerle] Temple Univ, Sch Publ Hlth, Philadelphia, PA 19122 USA; [Moya, Eva M.] Univ Texas El Paso, Sch Social Work, El Paso, TX 79968 USA; [Frasca, Timothy; Carballo-Dieguez, Alex] Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY USA; [Ovejero, Hugo] Lutheran Family Hlth Ctr, New York, NY USA; [Rhodes, Scott D.] Wake Forest Univ, Med Ctr, Winston Salem, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Nova Southeastern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Texas System; University of Texas El Paso; Columbia University; Wake Forest University	Martinez, O (corresponding author), Temple Univ, Coll Publ Hlth, Sch Social Work, Philadelphia, PA 19122 USA.	omar.martinez@temple.edu		Chavez-Baray, Silvia M./0000-0002-6301-1378; Levine, Ethan/0000-0002-9872-2989; Bass, Sarah/0000-0003-2742-1609	center grant from the National Institute of Mental Health [P30-MH43520]; National Institute of Mental Health [T32 MH19139]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520, T32MH019139] Funding Source: NIH RePORTER	center grant from the National Institute of Mental Health; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a center grant from the National Institute of Mental Health to the HIV Center for Clinical and Behavioral Studies at NY State Psychiatric Institute and Columbia University (P30-MH43520; Principal Investigator: Robert H. Remien, Ph.D.). Mr. Omar Martinez was supported by a training grant from the National Institute of Mental Health (T32 MH19139, Behavioral Sciences Research in HIV Infection; Principal Investigator: Theo Sandfort, Ph.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the NIH.	Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Avila RM, 2013, MATERN CHILD HLTH J, V17, P415, DOI 10.1007/s10995-012-0988-9; Ayala G, 1999, SOCIAL OPPRESSION RE; Ayala GX, AM J MENS H IN PRESS; Bekker L-G, 2012, COLD SPRING HARBOR P; Buchbinder SP, 2011, AIDS BEHAV, V15, pS72, DOI 10.1007/s10461-011-9894-1; Carrier Joseph, 1995, OTROS INTIMACY HOMOS; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1145; Centers for Disease Control Prevention, 2013, HIV HISP LAT, P2013; Chan R, 2012, ANN ACAD MED SINGAP, V41, P595; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Deiss RG, 2008, SEX TRANSM DIS, V35, P243, DOI 10.1097/OLQ.0b013e31815abab5; Deschamps M, 1991, HETEROSEXUAL ACTIVIT; Diaz RafaelM., 1999, CULTURE HLTH SEXUALI, V1, DOI [10.1080/136910599301021, DOI 10.1080/136910599301021]; Diaz RM, 1999, HISPANIC J BEHAV SCI, V21, P480, DOI 10.1177/0739986399214007; Dûíaz RM., 1998, LATINO GAY MEN HIV C; Fallon SJ, 2012, AIDS BEHAV, V16, P1739, DOI 10.1007/s10461-012-0258-2; Fernandez MI, 2005, SUBST USE MISUSE, V40, P1347, DOI 10.1081/JA-200066904; Fernandez MI, 2005, J URBAN HEALTH, V82, pI79, DOI 10.1093/jurban/jti027; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greenwood GL, 2002, AM J PUBLIC HEALTH, V92, P1964, DOI 10.2105/AJPH.92.12.1964; Grossman CI, 2013, AM PSYCHOL, V68, P237, DOI 10.1037/a0032711; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hardee K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18619; Hoebbel C, 2003, EFFECT BEHAV COUPLES; Hosek SG, 2013, J HIV-AIDS SOC SERV, V12, P333, DOI 10.1080/15381501.2013.773575; Hosek SG, 2013, JAIDS-J ACQ IMM DEF, V62, P447, DOI 10.1097/QAI.0b013e3182801081; Jarama SL, 2005, AIDS BEHAV, V9, P513, DOI 10.1007/s10461-005-9022-1; Johnson WD, 2002, J ACQ IMMUN DEF SYND, V30, pS118, DOI 10.1097/01.QAI.0000018918.84759.19; King HL, 2014, AIDS BEHAV, V18, P1722, DOI 10.1007/s10461-014-0845-5; Krueger RA, 1988, FOCUS GROUPS A PRACT; Krueger RA., 2000, FOCUS GROUPS A PRACT; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Martinez O, 2014, 9TH INTERNATIONAL CO; Martinez O, 2014, AIDS BEHAV; Martinez O, HLTH ED MON IN PRESS; Martinez O, 2015, AMERICAN JOURNAL OF; Martinez O, 2014, AIDS RES HUM RETROV, V30, pA136, DOI 10.1089/aid.2014.5272b.abstract; Martinez O, 2014, J MED INTERNET RES, V16, P168, DOI 10.2196/jmir.3311; Martinez O, 2014, AIDS EDUC PREV, V26, P68, DOI 10.1521/aeap.2014.26.1.68; Martinez O, 2012, J BISEXUALITY, V12, P283, DOI 10.1080/15299716.2012.674865; Martinez O, 2011, CULT HEALTH SEX, V13, P1073, DOI 10.1080/13691058.2011.600461; Mehta SA, 2011, SEX TRANSM INFECT, V87, P344, DOI 10.1136/sti.2010.046284; Mustanski B, 2014, AIDS BEHAV; New York State, 2014, GOVERNOR CUOMO ANNOU; North Carolina Department of Health and Human Services, 2004, RAC ETHN DIFF HLTH N, P1; Ramirez-Valles J, 2002, HEALTH EDUC RES, V17, P389, DOI 10.1093/her/17.4.389; Ramirez-Valles J., 2005, AIDS BEHAV, V27, P1; Rausch DM, 2013, JAIDS-J ACQ IMM DEF, V63, pS6, DOI 10.1097/QAI.0b013e318292153b; Rhodes SD, 2006, AIDS CARE, V18, P1018, DOI 10.1080/09540120600568731; Rhodes SD, 2006, AIDS EDUC PREV, V18, P375, DOI 10.1521/aeap.2006.18.5.375; Rhodes SD, 2013, HEALTH PROMOT PRACT, V14, P607, DOI 10.1177/1524839912462391; Rhodes SD, 2009, CULT HEALTH SEX, V11, P17, DOI 10.1080/13691050802488405; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Royster MO, 2006, MEN MASC, V8, P389, DOI 10.1177/1097184X04268798; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sandfort TGM, 2007, J SEX RES, V44, P181, DOI 10.1080/00224490701263819; Semaan S, 2002, J ACQ IMMUN DEF SYND, V30, pS30, DOI 10.1097/01.QAI.0000018886.51315.A9; Sharma A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-109; Shedlin MG, 2005, J NATL MED ASSOC, V97, p32S; Shoptaw S, 2008, AIDS CARE, V20, P376, DOI 10.1080/09540120701660353; Snowden LR, 2013, AM J PUBLIC HEALTH, V103, P1628, DOI 10.2105/AJPH.2013.301238; Spinner CD, 2015, INFECTION; Stallworth JM, 2009, AIDS EDUC PREV, V21, P152, DOI 10.1521/aeap.2009.21.5_supp.152; Stappenbeck CA, 2004, WOMENS INDIRECT RISK; Stockman JK, 2004, HIV PREVENTION FATIG, P432; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tjaden P, 1999, Violence Vict, V14, P413; Trost J. E., 1986, QUAL SOCIOL, V9, P54, DOI [10.1007/BF00988249, DOI 10.1007/BF00988249, 10.1007/bf00988249]; Tung WC, 2012, HOME HLTH CARE MAN P, V24, P153, DOI 10.1177/1084822311435544; Waldner-Haugrud L K, 1997, Violence Vict, V12, P173; WATERMAN CK, 1989, J SEX RES, V26, P118, DOI 10.1080/00224498909551495; Wolitski RJ, 2005, J GAY LESBIAN MENT H, V9, P9, DOI 10.1300/J236v09n03_02; Wu E, 2011, AIDS BEHAV, V15, P1745, DOI 10.1007/s10461-011-9997-8; Wu Elwin, 2010, Open AIDS J, V4, P123, DOI 10.2174/1874613601004030123	77	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152361	10.1371/journal.pone.0152361	http://dx.doi.org/10.1371/journal.pone.0152361			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27028873	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500040
J	Kanyangarara, M; Mamini, E; Mharakurwa, S; Munyati, S; Gwanzura, L; Kobayashi, T; Shields, T; Mullany, LC; Mutambu, S; Mason, PR; Curriero, FC; Moss, WJ				Kanyangarara, Mufaro; Mamini, Edmore; Mharakurwa, Sungano; Munyati, Shungu; Gwanzura, Lovemore; Kobayashi, Tamaki; Shields, Timothy; Mullany, Luke C.; Mutambu, Susan; Mason, Peter R.; Curriero, Frank C.; Moss, William J.		Southern Africa Int Ctr Excellence	Reduction in Malaria Incidence following Indoor Residual Spraying with Actellic 300 CS in a Setting with Pyrethroid Resistance: Mutasa District, Zimbabwe	PLOS ONE			English	Article							ANOPHELES-FUNESTUS; PIRIMIPHOS-METHYL; INSECTICIDE RESISTANCE; TRANSMISSION; AFRICA; ZAMBIA; INTERVENTIONS; EFFICACY; RISK	Background More than half of malaria cases in Zimbabwe are concentrated in Manicaland Province, where seasonal malaria epidemics occur despite intensified control strategies. Recently, high levels of pyrethroid and carbamate resistance were detected in Anopheles funestus, the major malaria vector in eastern Zimbabwe. In response, a single round of indoor residual spraying (IRS) using pirimiphos-methyl (an organophosphate) was implemented in four high burden districts of Manicaland Province from November 1, 2014 to December 19, 2014. The objective of this study was to evaluate the effect of this programmatic switch in insecticides on malaria morbidity reported from health care facilities in Mutasa District, one of the worst affected districts in Manicaland Province. Methods The number of weekly malaria cases for each health facility 24 months prior to the 2014 IRS campaign and in the subsequent high transmission season were obtained from passive case surveillance. Environmental variables were extracted from remote-sensing data sources and linked to each health care facility. Negative binomial regression was used to model the weekly number of malaria cases, adjusted for seasonality and environmental variables. Results From December 2012 to May 2015, 124,206 malaria cases were reported from 42 health care facilities in Mutasa District. Based on a higher burden of malaria, 20 out of 31 municipal wards were sprayed in the district. Overall, 87.3% of target structures were sprayed and 92.1% of the target population protected. During the 6 months after the 2014 IRS campaign, a period when transmission would have otherwise peaked, the incidence of malaria was 38% lower than the preceding 24 months at health facilities in the sprayed wards. Conclusions Pirimiphos-methyl had a measurable impact on malaria incidence and is an effective insecticide for the control of An. funestus in eastern Zimbabwe.	[Kanyangarara, Mufaro; Mullany, Luke C.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mamini, Edmore; Mharakurwa, Sungano; Munyati, Shungu; Gwanzura, Lovemore; Mason, Peter R.] Biomed Res Training Inst, Harare, Zimbabwe; [Gwanzura, Lovemore] Univ Zimbabwe, Dept Med Lab Sci, Coll Hlth Sci, Harare, Zimbabwe; [Kobayashi, Tamaki; Shields, Timothy; Curriero, Frank C.; Moss, William J.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mutambu, Susan] Natl Inst Hlth Res, Harare, Zimbabwe	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Biomedical Research Training Institute; University of Zimbabwe; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kanyangarara, M (corresponding author), Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA.	mkanyan1@jhu.edu			Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health as part of the International Centers of Excellence for Malaria Research [U19 AI089680]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089680] Funding Source: NIH RePORTER	Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health as part of the International Centers of Excellence for Malaria Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health as part of the International Centers of Excellence for Malaria Research (U19 AI089680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikpon R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-256; Chanda E, 2013, J MED ENTOMOL, V50, P1275, DOI 10.1603/ME13041; Chikodzi D, 2013, J GEOSCIENCES GEOMAT, P8; Choi KS, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0464-z; Coetzee M, 2013, ANNU REV ENTOMOL, V58, P393, DOI 10.1146/annurev-ento-120811-153628; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Hamainza B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1143-7; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Kanyangarara M, 2016, AM J TROP M IN PRESS; Mabaso MLH, 2005, TROP MED INT HEALTH, V10, P909, DOI 10.1111/j.1365-3156.2005.01462.x; Mabaso Musawenkoi L H, 2006, Int J Health Geogr, V5, P20; Mharakurwa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-223; Midzi S, 2004, ZIMBABWE ROLL BACK M; Moss WJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-163; Ohemeng FD, 2015, INT J APPL GEOSPAT R, V6, P7, DOI 10.4018/ijagr.2015070101; Oxborough RM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-37; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pinchoff J, 2015, AM J TROP MED HYG, V93, P1260, DOI 10.4269/ajtmh.15-0283; PMI, 2014, PMI AFR IRS AIRS PRO; Presidents Malaria Initiative (PMI), 2015, MAL OP PLAN ZIMB FY; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P923, DOI 10.1130/0016-7606(1952)63[923:DBOG]2.0.CO;2; TAYLOR P, 1986, T ROY SOC TROP MED H, V80, P12, DOI 10.1016/0035-9203(86)90185-9; WHOPES, 2013, 16 WHOPES WORKING GR; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zimbabwe Ministry of Health and Child Care, 2012, ZIMB NAT HLTH PROF; Zimbabwe National Statistical Agency, 2012, CENS 2012 PREL REP	27	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151971	10.1371/journal.pone.0151971	http://dx.doi.org/10.1371/journal.pone.0151971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018893	Green Published, Green Submitted, gold			2022-12-26	WOS:000372807800025
J	McCarthy, ID; Owen, SF; Watt, PW; Houlihan, DF				McCarthy, Ian D.; Owen, Stewart F.; Watt, Peter W.; Houlihan, Dominic F.			Individuals Maintain Similar Rates of Protein Synthesis over Time on the Same Plane of Nutrition under Controlled Environmental Conditions	PLOS ONE			English	Article							STANDARD METABOLIC-RATE; STABLE-ISOTOPE TRACER; MYTILUS-EDULIS-L; ONCORHYNCHUS-MYKISS; OXYGEN-CONSUMPTION; NITROGEN-EXCRETION; GROWTH EFFICIENCY; ATLANTIC SALMON; RAINBOW-TROUT; BLUE MUSSEL	Consistent individual differences in animal performance drive individual fitness under variable environmental conditions and provide the framework through which natural selection can operate. Underlying this concept is the assumption that individuals will display consistent levels of performance in fitness-related traits and interest has focused on individual variation and broad sense repeatability in a range of behavioural and physiological traits. Despite playing a central role in maintenance and growth, and with considerable inter-individual variation documented, broad sense repeatability in rates of protein synthesis has not been assessed. In this study we show for the first time that juvenile flounder Platichthys flesus reared under controlled environmental conditions on the same plane of nutrition for 46 days maintain consistent whole-animal absolute rates of protein synthesis (A(s)). By feeding meals containing N-15-labelled protein and using a stochastic end-point model, two non-terminal measures of protein synthesis were made 32 days apart (d(14) and d(46)). A(s) values (mass-corrected to a standard mass of 12 g) showed 2- to 3-fold variation between individuals on d(14) and d(46) but individuals showed similar A(s) values on both days with a broad sense repeatability estimate of 0.684 indicating significant consistency in physiological performance under controlled experimental conditions. The use of non-terminal methodologies in studies of animal ecophysiology to make repeat measures of physiological performance enables known individuals to be tracked across changing conditions. Adopting this approach, repeat measures of protein synthesis under controlled conditions will allow individual ontogenetic changes in protein metabolism to be assessed to better understand the ageing process and to determine individual physiological adaptive capacity, and associated energetic costs of adaptation, to global environmental change.	[McCarthy, Ian D.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [McCarthy, Ian D.] Univ Sao Paulo, Inst Oceanog, Sao Paulo, SP, Brazil; [Owen, Stewart F.] AstraZeneca, Alderley Pk, Macclesfield, Cheshire, England; [Watt, Peter W.] Univ Brighton, Sport & Exercise Sci & Med, Eastbourne, England; [Houlihan, Dominic F.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	Bangor University; Universidade de Sao Paulo; AstraZeneca; University of Brighton; University of Aberdeen	McCarthy, ID (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.; McCarthy, ID (corresponding author), Univ Sao Paulo, Inst Oceanog, Sao Paulo, SP, Brazil.	i.mccarthy@bangor.ac.uk	Owen, Stewart/ABF-1216-2021; McCarthy, Ian D/B-4803-2012	Owen, Stewart/0000-0003-1398-7142	UK Natural Environment Research Council; AstraZeneca	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); AstraZeneca(AstraZeneca)	The research was funded by a standard grant awarded to DFH from the UK Natural Environment Research Council who also provided support in the form of salaries for authors (IDM, SFO) whilst the research was conducted, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SFO is currently an employee of AstraZeneca who provided support in the form of salary for him during the writing of the manuscript and paid the publication fee. AstraZeneca is a biopharmaceutical company that did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne BL, 1997, PHYSIOL ZOOL, V70, P391, DOI 10.1086/515848; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bennett A.F., 1987, P147; Biro PA, 2015, ANIM BEHAV, V105, P223, DOI 10.1016/j.anbehav.2015.04.008; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Carter CG, 1998, J FISH BIOL, V53, P272, DOI 10.1111/j.1095-8649.1998.tb00980.x; Carter CG, 2001, COMP BIOCHEM PHYS A, V130, P799, DOI 10.1016/S1095-6433(01)00409-3; CARTER CG, 1994, J EXP BIOL, V189, P279; CARTER CG, 1993, CAN J ZOOL, V71, P392, DOI 10.1139/z93-055; CARTER CG, 1993, FISH PHYSIOL BIOCHEM, V12, P305, DOI 10.1007/BF00004415; Carter CG, 2001, NITROGEN EXCRETION, P31; Carter CG, 2009, COMP BIOCHEM PHYS A, V153, P185, DOI 10.1016/j.cbpa.2009.02.015; Chown SL, 2006, J INSECT PHYSIOL, V52, P442, DOI 10.1016/j.jinsphys.2005.12.004; Cortes P, 2009, J EXP BIOL, V212, P297, DOI 10.1242/jeb.021212; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Doherty MK, 2012, J PROTEOMICS, V75, P4471, DOI 10.1016/j.jprot.2012.03.025; Doherty MK, 2011, EXPERT REV PROTEOMIC, V8, P325, DOI [10.1586/epr.11.19, 10.1586/EPR.11.19]; Falconer DS, 1981, INTRODUCTION TO QUAN; Ford SE, 2007, FISH SHELLFISH IMMUN, V23, P280, DOI 10.1016/j.fsi.2006.10.013; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Fraser KPP, 1998, AQUAC RES, V29, P289; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; Gasier HG, 2009, COMP BIOCHEM PHYS B, V154, P235, DOI 10.1016/j.cbpb.2009.06.012; GNAIGER E, 1984, OECOLOGIA, V62, P289, DOI 10.1007/BF00384259; Hartl WH, 1998, ANN SURG, V227, P390, DOI 10.1097/00000658-199803000-00011; Hawkins AJS, 1987, FUNCT ECOL, V1, P339, DOI 10.2307/2389790; HAWKINS AJS, 1985, OECOLOGIA, V66, P42, DOI 10.1007/BF00378550; Hawkins AJS, 1999, AM ZOOL, V39, P401; HAWKINS AJS, 1986, PROC R SOC SER B-BIO, V229, P161, DOI 10.1098/rspb.1986.0080; Hayes JP, 1997, J MAMMAL, V78, P274, DOI 10.2307/1382882; Hayes JP, 1998, J MAMMAL, V79, P475, DOI 10.2307/1382978; HEYS SD, 1991, CLIN SCI, V80, P587, DOI 10.1042/cs0800587; Houlihan D.F., 1995, Biochemistry and Molecular Biology of Fishes, V4, P191; Houlihan DF, 1995, ICES MAR SC, V201, P87; HOULIHAN DF, 1989, AQUACULTURE, V79, P103, DOI 10.1016/0044-8486(89)90450-X; Kiorboe T, 2014, AM NAT, V183, pE118, DOI 10.1086/675241; KOLOK AS, 1992, J EXP BIOL, V170, P265; Lamarre SG, 2015, COMP BIOCHEM PHYS B, V182, P1, DOI 10.1016/j.cbpb.2014.11.006; Laming SR, 2013, J EXP BIOL, V216, P3264, DOI 10.1242/jeb.080416; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Martinez M, 2002, PHYSIOL BIOCHEM ZOOL, V75, P90, DOI 10.1086/339213; McCarthy Ian D., 1997, Society for Experimental Biology Seminar Series, V61, P51; McCarthy ID, 2000, J FISH BIOL, V57, P224, DOI 10.1006/jfbi.2000.1313; MCCARTHY ID, 1994, P ROY SOC B-BIOL SCI, V257, P141, DOI 10.1098/rspb.1994.0107; MEYERBURGDORFF KH, 1995, J ANIM PHYSIOL AN N, V73, P113, DOI 10.1111/j.1439-0396.1995.tb00410.x; Moltschaniwskyj NA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P997, DOI 10.1086/656387; Moore DR, 2009, AM J CLIN NUTR, V89, P161, DOI 10.3945/ajcn.2008.26401; Nespolo RF, 2003, REV CHIL HIST NAT, V76, P699; Nespolo RF, 2003, J EXP BIOL, V206, P4309, DOI 10.1242/jeb.00687; Nespolo RF, 2007, J EXP BIOL, V210, P2000, DOI 10.1242/jeb.02780; Owen SF, 2001, COMP BIOCHEM PHYS A, V128, P631, DOI 10.1016/S1095-6433(00)00340-8; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; Rittler P, 2000, AM J PHYSIOL-ENDOC M, V278, pE634, DOI 10.1152/ajpendo.2000.278.4.E634; Rowlands DS, 2015, MED SCI SPORT EXER, V47, P547, DOI 10.1249/MSS.0000000000000447; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Sparkman AM, 2014, COMP BIOCHEM PHYS A, V174, P11, DOI 10.1016/j.cbpa.2014.03.023; SUMMERS RW, 1979, J NAT HIST, V13, P703, DOI 10.1080/00222937900770531; Tieleman BI, 2010, COMP BIOCHEM PHYS A, V156, P537, DOI 10.1016/j.cbpa.2010.04.011; Versteegh MA, COMP BIOCH PHYSL, V208, P452; Wagenmakers AJM, 1999, P NUTR SOC, V58, P987, DOI 10.1017/S0029665199001305; Waterlow JC, 1978, PROTEIN TURNOVER IN; Waterlow JC, 1992, PROTEIN TURNOVER; Watkins TB, 1997, J EXP BIOL, V200, P2663; White CR, 2013, J EXP BIOL, V216, P1763, DOI 10.1242/jeb.076562; Wilkie MP, 2002, J EXP ZOOL, V293, P284, DOI 10.1002/jez.10123; Wood Chris M., 1993, P379; Wright, 1995, NITROGEN METABOLISM; WRIGHT PA, 1995, J EXP BIOL, V198, P273	69	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152239	10.1371/journal.pone.0152239	http://dx.doi.org/10.1371/journal.pone.0152239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018996	Green Published, gold			2022-12-26	WOS:000372807800035
J	Schundeln, MM; Marschke, L; Bauer, JJ; Hauffa, PK; Schweiger, B; Fuhrer-Sakel, D; Lahner, H; Poeppel, TD; Kiewert, C; Hauffa, BP; Grasemann, C				Schuendeln, Michael M.; Marschke, Laura; Bauer, Jens J.; Hauffa, Pia K.; Schweiger, Bernd; Fuehrer-Sakel, Dagmar; Lahner, Harald; Poeppel, Thorsten D.; Kiewert, Cordula; Hauffa, Berthold P.; Grasemann, Corinna			A Piece of the Puzzle: The Bone Health Index of the BoneXpert Software Reflects Cortical Bone Mineral Density in Pediatric and Adolescent Patients	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; X-RAY ABSORPTIOMETRY; BODY-MASS; CHILDREN; AGE; DISEASE; GREULICH; PYLE; DENSITOMETRY; CHILDHOOD	Introduction Suspected osteopathology in chronically ill children often necessitates the assessment of bone mineral density. The most frequently used methods are dual-energy X-ray-absorption (DXA) and peripheral quantitative computed tomography (pQCT). The BoneXpert software provides an automated radiogrammatic method to assess skeletal age from digitalized Xrays of the left hand. Furthermore, the program calculates the Bone Health Index (BHI), a measure of cortical thickness and mineralization, which is obtained from indices of three metacarpal bones. In our study, we analyzed the manner in which BHI information provided by BoneXpert compares with DXA or pQCT measurements in youths. Study Design The BHI was retrospectively obtained using digitalized X-rays of the left hand and compared with the results of 203 corresponding DXA readings (Lunar Prodigy, GE Healthcare) of the lumbar vertebrae and femur as well as 117 pQCT readings (XCT 900, Stratec) of the distal radius. Results The BHI values showed a strong positive correlation with the DXA readings at each and all lumbar vertebrae (L1 -L4: r = 0.73; P < 0.0001). The age-adjusted Z-score of L1 -L4 and the height-adjusted score showed a positive correlation with the BHI-SDS (standard deviation score, r = 0.23; P < 0.002 and r = 0.27; P < 0.001, respectively). Total bone mineral density, as assessed via pQCT, also positively correlated with the BHI (r = 0.39; P < 0.0001), but the trabecular values displayed only a weak correlation. Conclusions The BHI obtained using BoneXpert can be a useful parameter in the assessment of bone health in children in most cases. This technique provides observer-independent information on cortical thickness and mineralization based on X-ray imaging of the hands.	[Schuendeln, Michael M.; Bauer, Jens J.; Hauffa, Pia K.] Univ Klinikum Essen, Kinderklin 3, Pediat Hematol & Oncol, Essen, Germany; [Schuendeln, Michael M.; Marschke, Laura; Bauer, Jens J.; Hauffa, Pia K.; Schweiger, Bernd; Fuehrer-Sakel, Dagmar; Lahner, Harald; Poeppel, Thorsten D.; Kiewert, Cordula; Hauffa, Berthold P.; Grasemann, Corinna] Univ Duisburg Essen, Essen, Germany; [Marschke, Laura; Bauer, Jens J.; Kiewert, Cordula; Hauffa, Berthold P.; Grasemann, Corinna] Univ Klinikum Essen, Kinderklin 2, Pediat Endocrinol & Diabetol, Essen, Germany; [Schweiger, Bernd] Univ Klinikum Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Fuehrer-Sakel, Dagmar; Lahner, Harald] Univ Klinikum Essen, Med Ctr, Dept Endocrinol & Metab, Essen, Germany; [Poeppel, Thorsten D.] Univ Klinikum Essen, Clin Nucl Med, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Grasemann, C (corresponding author), Univ Duisburg Essen, Essen, Germany.; Grasemann, C (corresponding author), Univ Klinikum Essen, Kinderklin 2, Pediat Endocrinol & Diabetol, Essen, Germany.	corinna.grasemann@uk-essen.de	Grasemann, Corinna/AAG-3861-2021; Schündeln, Michael M/W-3455-2018	Schündeln, Michael M/0000-0001-7495-9060; Grasemann, Corinna/0000-0003-1793-4603	IFORES stipend of the Faculty of Medicine, University of Duisburg-Essen; IFORES stipend from the Medical Faculty, University of Duisburg-Essen	IFORES stipend of the Faculty of Medicine, University of Duisburg-Essen; IFORES stipend from the Medical Faculty, University of Duisburg-Essen	An IFORES stipend of the Faculty of Medicine, University of Duisburg-Essen was provided to MS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors thank Hans Henrik Thodberg from Visiana, Holte, Denmark for granting access to the BoneXpert software and discussion of the manuscript. The authors also thank Sandra Moore, University of Aix-Marseille, France, for editorial assistance with the manuscript. Michael Schundeln was supported by an IFORES stipend from the Medical Faculty, University of Duisburg-Essen.	Anink J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0424-1; Bachrach LK, 2011, PEDIATRICS, V127, P189, DOI 10.1542/peds.2010-2961; BARNETT E, 1960, Clin Radiol, V11, P166, DOI 10.1016/S0009-9260(60)80012-8; Bechtold S, 2014, HORM RES PAEDIAT, V82, P171, DOI 10.1159/000362759; Bianchi ML, 2014, J CLIN DENSITOM, V17, P281, DOI 10.1016/j.jocd.2014.01.005; Bull RK, 1999, ARCH DIS CHILD, V81, P172, DOI 10.1136/adc.81.2.172; Crabtree NJ, 2005, OSTEOPOROSIS INT, V16, P2157, DOI 10.1007/s00198-005-2021-2; Crabtree NJ, 2005, BONE, V36, pS42; Crabtree NJ, 2004, BONE, V35, P965, DOI 10.1016/j.bone.2004.06.009; Ellis KJ, 2001, J BONE MINER RES, V16, P1658, DOI 10.1359/jbmr.2001.16.9.1658; EXTONSMITH AN, 1969, LANCET, V2, P1153; GE_Healthcare, 2010, LUN ENCORE PED REF D; Golden NH, 2014, PEDIATRICS, V134, pE1229, DOI 10.1542/peds.2014-2173; Gordon CM, 2014, J CLIN DENSITOM, V17, P219, DOI 10.1016/j.jocd.2014.01.007; Grasemann C, 2013, J CLIN ENDOCR METAB, V98, P3121, DOI 10.1210/jc.2013-1143; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Haine E, 2015, J BONE MINER RES, V30, P1369, DOI 10.1002/jbmr.2471; Hogler W, 2009, CANCER, V115, P4885, DOI 10.1002/cncr.24529; Hogler Wolfgang, 2010, Pediatr Endocrinol Rev, V7, P266; Holick MF, 2006, HIGH PREVALENCE VITA, V02118, P353; Institute of Medicine, 2011, DIETARY REFERENCE IN, DOI [DOI 10.17226/13050, 10.17226/13050]; Kalkwarf HJ, 2007, J CLIN ENDOCR METAB, V92, P2087, DOI 10.1210/jc.2006-2553; Kalkwarf HJ, 2014, J CLIN DENSITOM, V17, P243, DOI 10.1016/j.jocd.2014.01.002; Kilpinen-Loisa P, 2010, DEV MED CHILD NEUROL, V52, P276, DOI 10.1111/j.1469-8749.2009.03464.x; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Martin DD, 2009, BONE, V45, pS60, DOI 10.1016/j.bone.2009.04.047; Martin DD, 2012, PEDIATR RADIOL, V42, P982, DOI 10.1007/s00247-012-2390-6; Martin DD, 2011, J PEDIATR ENDOCR MET, V24, P1009, DOI 10.1515/JPEM.2011.420; Martin DD, 2009, PEDIATR RADIOL, V39, P598, DOI 10.1007/s00247-008-1114-4; Mul D, 2001, PEDIATR RES, V50, P479, DOI 10.1203/00006450-200110000-00010; Neu CM, 2001, BONE, V28, P227, DOI 10.1016/S8756-3282(00)00429-4; Nusken E, 2015, PEDIATR NEPHROL, V30, P1173, DOI 10.1007/s00467-015-3042-5; Pekkinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040090; Rauch F., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P153; Rauch F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P119; Schonau E, 1998, PEDIATR NEPHROL, V12, P420, DOI 10.1007/s004670050479; Schundeln MM, 2015, PEDIATR HEMAT ONCOL, V32, P455, DOI 10.3109/08880018.2015.1048912; Schundeln MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108400; Tanner JM, 1975, ASSESSMENT SKELETAL; Thodberg HH, 2010, OSTEOPOROSIS INT, V21, P1391, DOI 10.1007/s00198-009-1085-9; Thodberg HH, 2009, J CLIN ENDOCR METAB, V94, P2239, DOI 10.1210/jc.2008-2474; Thodberg HH, 2014, ESPE ABSTR, P159; Tsampalieros A, 2014, AM J TRANSPLANT, V14, P124, DOI 10.1111/ajt.12524; van Buuren S, 2009, STAT MED, V28, P1569, DOI 10.1002/sim.3567; van der Sluis IM, 2002, ARCH DIS CHILD, V87, P341, DOI 10.1136/adc.87.4.341; van Rijn RR, 2009, PEDIATR RADIOL, V39, P591, DOI 10.1007/s00247-008-1090-8; van Rijn RR, 2004, CALCIFIED TISSUE INT, V74, P342, DOI 10.1007/s00223-003-0020-x; Zemel BS, 2010, J CLIN ENDOCR METAB, V95, P1265, DOI 10.1210/jc.2009-2057	49	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151936	10.1371/journal.pone.0151936	http://dx.doi.org/10.1371/journal.pone.0151936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27014874	Green Published, gold			2022-12-26	WOS:000372708900034
J	Sharma, A; Liu, X; Hadley, D; Hagopian, W; Liu, E; Chen, WM; Onengut-Gumuscu, S; Simell, V; Rewers, M; Ziegler, AG; Lernmarklo, A; Simell, O; Toppari, J; Krischer, JP; Akolkar, B; Rich, SS; Agardh, D; She, JX				Sharma, Ashok; Liu, Xiang; Hadley, David; Hagopian, William; Liu, Edwin; Chen, Wei-Min; Onengut-Gumuscu, Suna; Simell, Ville; Rewers, Marian; Ziegler, Anette-G.; Lernmarklo, Ake; Simell, Olli; Toppari, Jorma; Krischer, Jeffrey P.; Akolkar, Beena; Rich, Stephen S.; Agardh, Daniel; She, Jin-Xiong		TEDDY Study Grp	Identification of Non-HLA Genes Associated with Celiac Disease and Country-Specific Differences in a Large, International Pediatric Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; TRANSGLUTAMINASE ANTIBODIES; MULTIPLE COMMON; RISK VARIANTS; CHILDREN; SUSCEPTIBILITY; PADI4; METAANALYSIS; POPULATION	Objectives There are significant geographical differences in the prevalence and incidence of celiac disease that cannot be explained by HLA alone. More than 40 loci outside of the HLA region have been associated with celiac disease. We investigated the roles of these non-HLA genes in the development of tissue transglutaminase autoantibodies (tTGA) and celiac disease in a large international prospective cohort study. Methods A total of 424,788 newborns from the US and European general populations and first-degree relatives with type 1 diabetes were screened for specific HLA genotypes. Of these, 21,589 carried 1 of the 9 HLA genotypes associated with increased risk for type 1 diabetes and celiac disease; we followed 8676 of the children in a 15 y prospective follow-up study. Genotype analyses were performed on 6010 children using the Illumina ImmunoChip. Levels of tTGA were measured in serum samples using radio-ligand binding assays; diagnoses of celiac disease were made based on persistent detection of tTGA and biopsy analysis. Data were analyzed using Cox proportional hazards analyses. Results We found 54 single-nucleotide polymorphisms (SNPs) in 5 genes associated with celiac disease (TAGAP, IL18R1, RGS21, PLEK, and CCR9) in time to celiac disease analyses (10(-4)> P> 5.8x10(-6)). The hazard ratios (HR) for the SNPs with the smallest P values in each region were 1.59, 1.45, 2.23, 2.64, and 1.40, respectively. Outside of regions previously associated with celiac disease, we identified 10 SNPs in 8 regions that could also be associated with the disease (P< 10(-4)). A SNP near PKIA (rs117128341, P = 6.5x10(-8), HR = 2.8) and a SNP near PFKFB3 (rs117139146, P< 2.8x10(-7), HR = 4.9) reached the genome-wide association threshold in subjects from Sweden. Analyses of time to detection of tTGA identified 29 SNPs in 2 regions previously associated with celiac disease (CTLA4, P = 1.3x10(-6), HR = 0.76 and LPP, P = 2.8x10(-5), HR =.80) and 6 SNPs in 5 regions not previously associated with celiac disease (P< 10(-4)); non-HLA genes are therefore involved in development of tTGA. Conclusions In conclusion, using a genetic analysis of a large international cohort of children, we associated celiac disease development with 5 non-HLA regions previously associated with the disease and 8 regions not previously associated with celiac disease. We identified 5 regions associated with development of tTGA. Two loci associated with celiac disease progression reached a genome-wide association threshold in subjects from Sweden.	[Sharma, Ashok; She, Jin-Xiong] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Liu, Xiang; Hadley, David; Krischer, Jeffrey P.] Univ S Florida, Dept Pediat, Pediat Epidemiol Ctr, Tampa, FL 33620 USA; [Hadley, David] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Hagopian, William] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Liu, Edwin] Univ Colorado Denver, Childrens Hosp Colorado, Digest Hlth Inst, Aurora, CO USA; [Chen, Wei-Min; Onengut-Gumuscu, Suna; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Simell, Ville; Simell, Olli; Toppari, Jorma] Univ Turku, Dept Pediat, Turku, Finland; [Rewers, Marian] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Ziegler, Anette-G.] Tech Univ Munich, Diabet Res Inst, Helmholtz Zentrum Munchen, D-80290 Munich, Germany; [Ziegler, Anette-G.] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany; [Ziegler, Anette-G.] Forschergrp Diabet eV, Munich, Germany; [Lernmarklo, Ake] Lund Univ CRC, Dept Clin Sci, Malmo, Sweden; [Akolkar, Beena] NIDDK, NIH, Bethesda, MD 20892 USA; [Agardh, Daniel] Lund Univ, Diabet & Celiac Dis Unit, Malmo, Sweden	University System of Georgia; Augusta University; State University System of Florida; University of South Florida; St Georges University London; Pacific Northwest Diabetes Research Institute (PNDRI); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Virginia; University of Turku; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Lund University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Lund University	She, JX (corresponding author), Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA USA.	jshe@gru.edu	Ziegler, Anette-Gabriele/M-4614-2014; Lernmark, Åke/F-8140-2015	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Lernmark, Åke/0000-0003-1735-0499; Rich, Stephen/0000-0003-3872-7793; Kurppa, Kalle/0000-0003-4757-2164; Sharma, Ashok/0000-0001-9597-4374	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [HHSN267200700014C]; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Child Health and Human Development (NICHD); National Institute of Environmental Health Sciences (NIEHS); Juvenile Diabetes Research Foundation (JDRF); Centers for Disease Control and Prevention (CDC);  [DK 63829];  [63861];  [63821];  [63865];  [63863];  [63836];  [63790];  [UC4DK095300]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK063829, UC4DK063829, U01DK063863, U01DK063790, UC4DK063821, UC4DK063861, UC4DK117483, U01DK063821, UC4DK063863, UC4DK112243, UC4DK063865, U01DK063865, U01DK063836, U01DK063861, UC4DK063836] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	None of the authors listed has any financial or other conflicts to disclose relevant to this article. This study was funded by DK 63829, 63861, 63821, 63865, 63863, 63836, 63790 and UC4DK095300 and contract no. HHSN267200700014C from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), Juvenile Diabetes Research Foundation (JDRF), and Centers for Disease Control and Prevention (CDC). The complete TEDDY Study Group is listed in the Supplementary material.	Adlercreutz EH, 2015, PEDIATR DIABETES, V16, P504, DOI 10.1111/pedi.12200; Auricchio R, 2014, AM J GASTROENTEROL, V109, P913, DOI 10.1038/ajg.2014.77; Caponi L, 2005, ANN RHEUM DIS, V64, P587, DOI 10.1136/ard.2004.026831; Chen R, 2011, GENES IMMUN, V12, P314, DOI 10.1038/gene.2011.8; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; DEMARCHI M, 1979, TISSUE ANTIGENS, V14, P309; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Garner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101428; Hadley D, 2015, AM J GASTROENTEROLOG; Hagopian WA, 2011, PEDIATR DIABETES, V12, P733, DOI 10.1111/j.1399-5448.2011.00774.x; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P356, DOI 10.1067/mpd.2000.107582; Holopainen P, 1999, TISSUE ANTIGENS, V53, P470, DOI 10.1034/j.1399-0039.1999.530503.x; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jansen MAE, 2015, CLIN GASTROENTEROL H, V13, P913, DOI 10.1016/j.cgh.2014.09.032; Juuti-Uusitalo K, 2007, CLIN EXP IMMUNOL, V150, P294, DOI 10.1111/j.1365-2249.2007.03500.x; Kang JY, 2013, ALIMENT PHARM THER, V38, P226, DOI 10.1111/apt.12373; Kaukinen K, 2002, AM J GASTROENTEROL, V97, P695, DOI 10.1111/j.1572-0241.2002.05471.x; Kondrashova A, 2008, ANN MED, V40, P223, DOI 10.1080/07853890701678689; Koplin J.J., 2014, ALLERGY; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Kumar V, 2012, SEMIN IMMUNOPATHOL, V34, P567, DOI 10.1007/s00281-012-0312-1; Kurppa K, 2010, J PEDIATR-US, V157, P373, DOI 10.1016/j.jpeds.2010.02.070; Llopis JML, 2010, J PHYSIOL BIOCHEM, V66, P153, DOI 10.1007/s13105-010-0020-z; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; Martinez A, 2005, RHEUMATOLOGY, V44, P1263, DOI 10.1093/rheumatology/kei008; Metzger MH, 2006, EUR J EPIDEMIOL, V21, P359, DOI 10.1007/s10654-006-9002-4; Oberhuber G, 2000, BIOMED PHARMACOTHER, V54, P368, DOI 10.1016/S0753-3322(01)80003-2; Ostensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070174; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; PLOSKI R, 1993, TISSUE ANTIGENS, V41, P173, DOI 10.1111/j.1399-0039.1993.tb01998.x; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; Simmons JH, 2011, J PEDIATR-US, V158, P276, DOI 10.1016/j.jpeds.2010.07.025; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Heel DA, 2005, BEST PRACT RES CL GA, V19, P323, DOI 10.1016/j.bpg.2005.01.001; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	44	29	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152476	10.1371/journal.pone.0152476	http://dx.doi.org/10.1371/journal.pone.0152476			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015091	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708900069
J	Miyazaki, K; Yoshizaki, K; Arai, C; Yamada, A; Saito, K; Ishikawa, M; Xue, H; Funada, K; Haruyama, N; Yamada, Y; Fukumoto, S; Takahashi, I				Miyazaki, Kanako; Yoshizaki, Keigo; Arai, Chieko; Yamada, Aya; Saito, Kan; Ishikawa, Masaki; Xue, Han; Funada, Keita; Haruyama, Naoto; Yamada, Yoshihiko; Fukumoto, Satoshi; Takahashi, Ichiro			Plakophilin-1, a Novel Wnt Signaling Regulator, Is Critical for Tooth Development and Ameloblast Differentiation	PLOS ONE			English	Article							SKIN FRAGILITY SYNDROME; OCULODENTODIGITAL DYSPLASIA; GJA1 MUTATIONS; MOUSE INCISOR; CELL-ADHESION; PKP1 GENE; MORPHOGENESIS; CONNEXIN-43; EXPRESSION; PHENOTYPE	Tooth morphogenesis is initiated by reciprocal interactions between the ectoderm and neural crest-derived mesenchyme, and the Wnt signaling pathway is involved in this process. We found that Plakophilin (PKP) 1, which is associated with diseases such as ectodermal dysplasia/skin fragility syndrome, was highly expressed in teeth and skin, and was upregulated during tooth development. We hypothesized that PKP1 regulates Wnt signaling via its armadillo repeat domain in a manner similar to beta-catenin. To determine its role in tooth development, we performed Pkp1 knockdown experiments using ex vivo organ cultures and cell cultures. Loss of Pkp1 reduced the size of tooth germs and inhibited dental epithelial cell proliferation, which was stimulated by Wnt3a. Furthermore, transfected PKP1-emerald green fluorescent protein was translocated from the plasma membrane to the nucleus upon stimulation with Wnt3a and LiCl, which required the PKP1 N terminus (amino acids 161 to 270). Localization of PKP1, which is known as an adhesion-related desmosome component, shifted to the plasma membrane during ameloblast differentiation. In addition, Pkp1 knockdown disrupted the localization of Zona occludens 1 in tight junctions and inhibited ameloblast differentiation; the two proteins were shown to directly interact by immuno-precipitation. These results implicate the participation of PKP1 in early tooth morphogenesis as an effector of canonical Wnt signaling that controls ameloblast differentiation via regulation of the cell adhesion complex.	[Miyazaki, Kanako; Yoshizaki, Keigo; Arai, Chieko; Xue, Han; Funada, Keita; Haruyama, Naoto; Takahashi, Ichiro] Kyushu Univ, Sect Orthodont & Dentofacial Orthoped, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan; [Yamada, Aya; Saito, Kan; Fukumoto, Satoshi] Tohoku Univ, Div Pediat Dent, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Ishikawa, Masaki] Tohoku Univ, Operat Dent, Dept Restorat Dent, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Yamada, Yoshihiko] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD USA	Kyushu University; Tohoku University; Tohoku University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Yoshizaki, K (corresponding author), Kyushu Univ, Sect Orthodont & Dentofacial Orthoped, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan.; Fukumoto, S (corresponding author), Tohoku Univ, Div Pediat Dent, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Sendai, Miyagi 980, Japan.	yosizaki@dent.kyushu-u.ac.jp; fukumoto@dent.tohoku.ac.jp	Haruyama, Naoto/D-1993-2011; Saito, Kan/AFS-5564-2022; Saito, Kan/AAG-3507-2020	Haruyama, Naoto/0000-0001-6225-5816; Saito, Kan/0000-0002-2151-6204; Saito, Kan/0000-0002-2151-6204; Fukumoto, Satoshi/0000-0002-5046-6891; Yoshizaki, Keigo/0000-0002-0598-5879; HAN, XUE/0000-0001-9728-8159	Ministry of Education, Science, and Culture of Japan [20679006, 26670880]; NEXT program [LS010]; Intramural Research Program of the National Institute of Dental and Craniofacial Research, NIH, USA [DE000720-08];  [15H05688];  [26670886]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000720] Funding Source: NIH RePORTER	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Program of the National Institute of Dental and Craniofacial Research, NIH, USA; ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by Grants-in-aid from the Ministry of Education, Science, and Culture of Japan (20679006 and 26670880 to SF) and the NEXT program (LS010 to SF), the Intramural Research Program of the National Institute of Dental and Craniofacial Research, NIH, USA (DE000720-08 to YY), and a Grant-in-Aid for Scientific Research (15H05688 and 26670886 to KY).; We thank Megumi Kiyota of the Research Support Center, Graduate School of Medical Sciences, Kyushu University for assistance with the microarray analysis. This work was supported in part by Grants-in-aid from the Ministry of Education, Science, and Culture of Japan (20679006 and 26670880 to SF) and the NEXT program (LS010 to SF), the Intramural Research Program of the National Institute of Dental and Craniofacial Research, NIH, USA (DE000720-08 to YY), and Grants-in-Aid for Scientific Research (15H05688 and 26670886 to KY).	Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Boyce AE, 2012, AUSTRALAS J DERMATOL, V53, P61, DOI 10.1111/j.1440-0960.2011.00846.x; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Choi HJ, 2005, J MOL BIOL, V346, P367, DOI 10.1016/j.jmb.2004.11.048; Cowin P, 1996, CURR OPIN CELL BIOL, V8, P56, DOI 10.1016/S0955-0674(96)80049-4; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Hata M, 2010, MED MOL MORPHOL, V43, P102, DOI 10.1007/s00795-009-0482-7; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; Hernandez-Martin A, 2013, CLIN EXP DERMATOL, V38, P787, DOI 10.1111/ced.12109; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Itoh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106621; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Joao SMA, 2003, HISTOCHEM CELL BIOL, V119, P21, DOI 10.1007/s00418-002-0482-3; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Lesot H, 2002, CONNECT TISSUE RES, V43, P191, DOI 10.1080/03008200290000529; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; Munoz WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086784; Narhi K, 2008, DEVELOPMENT, V135, P1019, DOI 10.1242/dev.016550; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Sobolik-Delmaire T, 2010, J INVEST DERMATOL, V130, P2638, DOI 10.1038/jid.2010.191; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106; Tokuda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104994; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Whittock NV, 2000, J INVEST DERMATOL, V115, P368, DOI 10.1046/j.1523-1747.2000.00082.x; Wolf A, 2013, J CELL SCI, V126, P1832, DOI 10.1242/jcs.118992; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Yamada A, 2016, J BIOL CHEM, V291, P904, DOI 10.1074/jbc.M115.674663; Yamamoto S, 2008, J BIOL CHEM, V283, P23139, DOI 10.1074/jbc.M710308200; Yoshida T, 2010, DEV DYNAM, V239, P2558, DOI 10.1002/dvdy.22395; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200; Yoshizaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099991; Yuan GH, 2015, DEVELOPMENT, V142, P128, DOI 10.1242/dev.117887	47	21	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152206	10.1371/journal.pone.0152206	http://dx.doi.org/10.1371/journal.pone.0152206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27015268	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000111
J	Rodriguez, Y; Hinz, JM; Laughery, MF; Wyrick, JJ; Smerdon, MJ				Rodriguez, Yesenia; Hinz, John M.; Laughery, Marian F.; Wyrick, John J.; Smerdon, Michael J.			Site-specific Acetylation of Histone H3 Decreases Polymerase Activity on Nucleosome Core Particles in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						base excision repair (BER); DNA damage; DNA polymerase; histone acetylation; nucleosome; DNA glycosylase	BASE EXCISION-REPAIR; DNA-DAMAGE RESPONSE; LYSINE 56; H3K56 ACETYLATION; APE1 ENDONUCLEASE; GENOME STABILITY; MAMMALIAN-CELLS; CHROMATIN; ACCESSIBILITY; GENE	Histone posttranslational modifications have been associated with changes in chromatin structure necessary for transcription, replication, and DNA repair. Acetylation is one of the most studied and best characterized histone posttranslational modifications, but it is not known if histone acetylation modulates base excision repair of DNA lesions in chromatin. To address this question, we generated nucleosome core particles (NCPs) containing site-specifically acetylated H3K14 or H3K56 and measured repair of uracil and single-nucleotide gaps. We find that H3K56Ac and H3K14Ac do not significantly contribute to removal of uracils by uracil DNA glycosylase regardless of the translational or rotational position of the lesions within NCPs. In repair of single-nucleotide gaps, however, the presence of H3K56Ac or H3K14Ac in NCPs decreases the gap-filling activity of DNA polymerase near the dyad center, with H3K14Ac exhibiting stronger inhibition. To a lesser extent, H3K56Ac induces a similar effect near the DNA ends. Moreover, using restriction enzyme accessibility, we detect no changes in NCP structure or dynamics between H3K14Ac-NCPs and WT-NCPs containing single-nucleotide gaps. Thus, acetylation at H3K56 and H3K14 in nucleosomes may promote alternative gap-filling pathways by inhibiting DNA polymerase activity.	[Rodriguez, Yesenia; Hinz, John M.; Laughery, Marian F.; Wyrick, John J.; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Biochem & Biophys, Pullman, WA 99164 USA; [Rodriguez, Yesenia] NIEHS, Genorne Integr & Struct Biol Lab, NIH, POB 12233,Mail Drop F3-01, Res Triangle Pk, NC 27709 USA	Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Life Sci & Biotechnol Bldg, Pullman, WA 99164 USA.	smerdon@wsu.edu			National Institutes of Health [ES020955, ES002614, ES004106, T32GM008336]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106, R37ES002614, R01ES002614, R21ES020955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES020955 (to J M. H.), ES002614 and ES004106 (NIEHS; to M. J. S.), and Training Grant T32GM008336 (NIGMS; to Y. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Baute J, 2008, CRIT REV BIOCHEM MOL, V43, P239, DOI 10.1080/10409230802309905 ; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Garcia-Diaz M, 2007, CRIT REV PLANT SCI, V26, P105, DOI 10.1080/07352680701252817; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hinz JM, 2014, MUTAT RES-FUND MOL M, V766, P19, DOI 10.1016/j.mrfmmm.2014.05.008; Hinz JM, 2010, P NATL ACAD SCI USA, V107, P4646, DOI 10.1073/pnas.0914443107; Hodges AJ, 2015, GENETICS, V200, P795, DOI 10.1534/genetics.115.175885; Hwang BJ, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0041-9; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Liu XQ, 2000, J BIOL CHEM, V275, P23729, DOI 10.1074/jbc.M002206200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Mann DB, 1997, P NATL ACAD SCI USA, V94, P2215, DOI 10.1073/pnas.94.6.2215; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Menoni H, 2007, MOL CELL BIOL, V27, P5949, DOI 10.1128/MCB.00376-07; Miller KM, 2006, CELL CYCLE, V5, P2561, DOI 10.4161/cc.5.22.3501; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rodriguez Y, 2013, J BIOL CHEM, V288, P13863, DOI 10.1074/jbc.M112.441444; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shimko JC, 2011, J MOL BIOL, V408, P187, DOI 10.1016/j.jmb.2011.01.003; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Stoilov L, 2000, INT J RADIAT BIOL, V76, P1485, DOI 10.1080/09553000050176243; Swygert SG, 2014, BBA-GENE REGUL MECH, V1839, P728, DOI 10.1016/j.bbagrm.2014.02.013; Tims HS, 2007, METHODS, V41, P296, DOI 10.1016/j.ymeth.2007.01.001; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; TULLIUS TD, 1991, FREE RADICAL RES COM, V12-3, P521; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Wang Y, 2012, J BIOL CHEM, V287, P4386, DOI 10.1074/jbc.M111.329417; Widlund HR, 1997, J MOL BIOL, V267, P807, DOI 10.1006/jmbi.1997.0916; Wurtele H, 2012, MOL CELL BIOL, V32, P154, DOI 10.1128/MCB.05415-11; Xu Z, 2015, CELL CYCLE, V14, P269, DOI 10.4161/15384101.2014.980641; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	61	21	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11434	11445		10.1074/jbc.M116.725788	http://dx.doi.org/10.1074/jbc.M116.725788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27033702	Green Published, hybrid			2022-12-26	WOS:000377042100040
J	Beharry, AA; Nagel, ZD; Samson, LD; Kool, ET				Beharry, Andrew A.; Nagel, Zachary D.; Samson, Leona D.; Kool, Eric T.			Fluorogenic Real-Time Reporters of DNA Repair by MGMT, a Clinical Predictor of Antitumor Drug Response	PLOS ONE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE ACTIVITY; HUMAN O(6)-ALKYLGUANINE-DNA ALKYLTRANSFERASE; HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; PROMOTER METHYLATION; SUBSTRATE-SPECIFICITY; IN-VITRO; OLIGONUCLEOTIDE; INACTIVATION; RESISTANCE; MUTANTS	Common alkylating antitumor drugs, such as temozolomide, trigger their cytotoxicity by methylating the O6-position of guanosine in DNA. However, the therapeutic effect of these drugs is dampened by elevated levels of the DNA repair enzyme, O6-methylguanine DNA methyltransferase (MGMT), which directly reverses this alkylation. As a result, assessing MGMT levels in patient samples provides an important predictor of therapeutic response; however, current methods available to measure this protein are indirect, complex and slow. Here we describe the design and synthesis of fluorescent chemosensors that report directly on MGMT activity in a single step within minutes. The chemosensors incorporate a fluorophore and quencher pair, which become separated by the MGMT dealkylation reaction, yielding light-up responses of up to 55-fold, directly reflecting repair activity. Experiments show that the best-performing probe retains near-native activity at mid-nanomolar concentrations. A nuclease-protected probe, NR-1, was prepared and tested in tumor cell lysates, demonstrating an ability to evaluate relative levels of MGMT repair activity in twenty minutes. In addition, a probe was employed to evaluate inhibitors of MGMT, suggesting utility for discovering new inhibitors in a high-throughput manner. Probe designs such as that of NR-1 may prove valuable to clinicians in selection of patients for alkylating drug therapies and in assessing resistance that arises during treatment.	[Beharry, Andrew A.; Kool, Eric T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Nagel, Zachary D.; Samson, Leona D.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nagel, Zachary D.; Samson, Leona D.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Stanford University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kool, ET (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	kool@stanford.edu		Kool, Eric/0000-0002-7310-2935	US National Institutes of Health [GM106067, GM110050, DP1-ES 022576]; Human Frontier Science Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110050, R01GM106067] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the US National Institutes of Health (GM106067, GM110050 to ETK; DP1-ES 022576 to LDS). AAB is supported by a postdoctoral fellowship from the Human Frontier Science Program. LDS is an American Cancer Society Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilina G, 1998, CANCER RES, V58, P135; Bacolod MD, 2004, MOL CANCER THER, V3, P1127; Barr Fritcher EG, 2015, OPTIMIZED SET FLUORE, P1; Brandwein JM, 2014, BRIT J HAEMATOL, V167, P664, DOI 10.1111/bjh.13094; Brian T, 2007, DNA REPAIR, V6, P1161, DOI 10.1016/j.dnarep.2007.03.015; Cabrini G, 2015, INT J ONCOL, V47, P417, DOI 10.3892/ijo.2015.3026; Cancer MC, 2002, CHEMOTHERAPY INDUCED, P3070; Chen ZP, 1997, MOL PHARMACOL, V52, P815, DOI 10.1124/mol.52.5.815; Clemons M, 2005, BRIT J CANCER, V93, P1152, DOI 10.1038/sj.bjc.6602833; Damoiseaux R, 2001, CHEMBIOCHEM, V2, P285, DOI 10.1002/1439-7633(20010401)2:4<285::AID-CBIC285>3.3.CO;2-E; Encell LP, 1999, BIOCHEMISTRY-US, V38, P12097, DOI 10.1021/bi9913606; Folco EG, 2012, JOVE-J VIS EXP, DOI 10.3791/4140; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Gao JM, 2004, J AM CHEM SOC, V126, P12748, DOI 10.1021/ja046910o; Gao JM, 2002, J AM CHEM SOC, V124, P11590, DOI 10.1021/ja027197a; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Ishiguro Kimiko, 2013, J Cancer Ther, V4, P919; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Kreklau EL, 2001, NUCLEIC ACIDS RES, V29, P2558, DOI 10.1093/nar/29.12.2558; Kreth S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017156; Kuwasaki T, 2003, J ANTIMICROB CHEMOTH, V51, P813, DOI 10.1093/jac/dkg174; Lalezari S, 2013, NEURO-ONCOLOGY, V15, P370, DOI 10.1093/neuonc/nos308; Li X, 2012, ORG BIOMOL CHEM, V10, P3189, DOI 10.1039/c2ob25231g; Litzba N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000883; Luu KX, 2002, BIOCHEMISTRY-US, V41, P8689, DOI 10.1021/bi025857i; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Meyer AS, 2003, CHEM RES TOXICOL, V16, P1405, DOI 10.1021/tx0341254; MYRNES B, 1984, CARCINOGENESIS, V5, P1061, DOI 10.1093/carcin/5.8.1061; Nagel G, 2003, ANAL BIOCHEM, V321, P38, DOI 10.1016/S0003-2697(03)00432-9; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Pegg AE, 2001, J PHARMACOL EXP THER, V296, P958; Pegg AE, 1998, J BIOL CHEM, V273, P10863, DOI 10.1074/jbc.273.18.10863; Phillips WP, 1999, CANCER CHEMOTH PHARM, V44, P319, DOI 10.1007/s002800050984; Rabik CA, 2006, CANCER TREAT REV, V32, P261, DOI 10.1016/j.ctrv.2006.03.004; Robinson C, 2010, ANAL BIOCHEM, V405, P263, DOI 10.1016/j.ab.2010.06.019; Ruiz FM, 2008, J CHEM INF MODEL, V48, P844, DOI 10.1021/ci700447r; Terashima I, 1997, CHEM RES TOXICOL, V10, P1234, DOI 10.1021/tx9700580; Thon N, 2013, ONCOTARGETS THER, V6, P1363, DOI 10.2147/OTT.S50208; Tintore M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/632041; Tomaszowski K-H, 2015, MOL PHARM; Voelter V, 2008, INT J CANCER, V123, P1215, DOI 10.1002/ijc.23632; Wang C, 2016, ANGEW CHEM INT EDIT, V55, P2911, DOI 10.1002/anie.201511301; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Xu-Welliver M, 1998, CANCER RES, V58, P1936; Yu W-T, 2015, CHEM SCI; Zhang J, 2012, CURR MOL PHARMACOL, V5, P102, DOI DOI 10.2174/1874467211205010102	49	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152684	10.1371/journal.pone.0152684	http://dx.doi.org/10.1371/journal.pone.0152684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035132	Green Published, gold			2022-12-26	WOS:000373201200031
J	Teng, CJ; Huon, LK; Hu, YW; Yeh, CM; Chien, SH; Chen, SC; Liu, CJ				Teng, Chung-Jen; Huon, Leh-Kiong; Hu, Yu-Wen; Yeh, Chiu-Mei; Chien, Sheng-Hsuan; Chen, San-Chi; Liu, Chia-Jen			Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							STAGE RENAL-DISEASE; 2ND NEOPLASMS; FOLLOW-UP; CANCER; CHILDHOOD; THERAPY; CHEMOTHERAPY; CHILDREN; ADULTS; END	Background Acute lymphoblastic leukemia (ALL) is more common in children than in adults. Secondary neoplasms (SNs) in childhood ALL have been widely reported. However, only one study has demonstrated SNs in adult ALL. Because of the poorer survival of adult ALL, the incidence might be underestimated. Objective To evaluate the incidence and risk factors of secondary solid organ neoplasms among adult and child ALL patients. Methods Newly diagnosed ALL patients between 1997 and 2011 were recruited from the Taiwan National Health Insurance database. Those who had antecedent or combined malignancies were excluded. Standardized incidence ratios (SIRs) were analyzed to compare the risk of our cohort to general population in the same age, sex and calendar year. Risk factors for SN development were analyzed by Cox proportional hazards models. Effects of treatments were treated as time-dependent variables. Results The 15-year cumulative incidence of SN was 1.9% and 8.4% in 1,381 child and 2,154 adult ALL patients, respectively. The SIR was significantly increased in child ALL (SIR 6.06), but not in adult ALL (SIR 1.16). The SIRs of follow-up periods were 5.14, 2.24,.87 and .71 at >= 10 years, 5-10 years, 1-5 years and 0-1, respectively. Overall, 15 SNs developed, and CNS tumors (SIR 11.56) were the most common type. Multivariate analysis showed that age >= 20 years (hazard ratio [HR] 5.04), end-stage renal disease (HR 18.98) and cranial irradiation (HR 8.12) were independent risk factors for cancer development. Conclusions When compared with the general population, child ALL shows a increased risk of developing SNs. CNS tumors are the most common type, and cranial irradiation is an independent risk factor. With longer follow-up, the risk of SNs increases. Hence, physicians need to pay more attention on the risk of developing SNs in long-term ALL survivors with risk factors.	[Teng, Chung-Jen] Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Teng, Chung-Jen; Hu, Yu-Wen; Chien, Sheng-Hsuan; Chen, San-Chi] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huon, Leh-Kiong] Cathay Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Huon, Leh-Kiong] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Yeh, Chiu-Mei] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chien, Sheng-Hsuan; Chen, San-Chi; Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Chen, San-Chi] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Cathay General Hospital; Fu Jen Catholic University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, SC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.; Chen, SC; Liu, CJ (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan.; Chen, SC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.; Liu, CJ (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	sunkist.chen37@gmail.com; chiajenliu@gmail.com	Chien, Sheng-Hsuan/HDM-2486-2022	Hu, Yu-Wen/0000-0002-7983-415X; Chen, San-Chi/0000-0002-9436-5400				Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Brenner H, 2001, CANCER, V92, P1977, DOI 10.1002/1097-0142(20011001)92:7<1977::AID-CNCR1717>3.0.CO;2-W; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chow EJ, 2013, PEDIATR BLOOD CANCER, V60, P110, DOI 10.1002/pbc.24198; Dalton VMK, 1998, J CLIN ONCOL, V16, P2848, DOI 10.1200/JCO.1998.16.8.2848; de Gonzalez AB, 2010, BRIT J CANCER, V102, P220, DOI 10.1038/sj.bjc.6605435; Haddy N, 2006, EUR J CANCER, V42, P2757, DOI 10.1016/j.ejca.2006.05.034; Hijiya N, 2007, JAMA-J AM MED ASSOC, V297, P1207, DOI 10.1001/jama.297.11.1207; Kantarjian H, 2004, CANCER-AM CANCER SOC, V101, P2788, DOI 10.1002/cncr.20668; LARSON RA, 1995, BLOOD, V85, P2025, DOI 10.1182/blood.V85.8.2025.bloodjournal8582025; Linker C, 2002, J CLIN ONCOL, V20, P2464, DOI 10.1200/JCO.2002.07.116; Liu CJ, 2014, INT J CANCER, V135, P250, DOI 10.1002/ijc.28664; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Mody R, 2008, BLOOD, V111, P5515, DOI 10.1182/blood-2007-10-117150; Murray L, 2014, RADIOTHER ONCOL, V110, P213, DOI 10.1016/j.radonc.2013.12.012; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Peterson CC, 2008, PEDIATR BLOOD CANCER, V51, P99, DOI 10.1002/pbc.21544; Robison LL, 2011, HEMATOL-AM SOC HEMAT, P238, DOI 10.1182/asheducation-2011.1.238; Rowe JM, 2005, BLOOD, V106, P3760, DOI 10.1182/blood-2005-04-1623; Schmiegelow K, 2009, BLOOD, V113, P6077, DOI 10.1182/blood-2008-11-187880; Tavernier E, 2007, CANCER-AM CANCER SOC, V110, P2747, DOI 10.1002/cncr.23097; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Vandecruys E, 2012, J CANCER SURVIV, V6, P95, DOI 10.1007/s11764-011-0186-6; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152909	10.1371/journal.pone.0152909	http://dx.doi.org/10.1371/journal.pone.0152909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035574	Green Published, gold, Green Submitted			2022-12-26	WOS:000373201200050
J	Barkal, AA; Srinivasan, S; Hashimoto, T; Gifford, DK; Sherwood, RI				Barkal, Amira A.; Srinivasan, Sharanya; Hashimoto, Tatsunori; Gifford, David K.; Sherwood, Richard I.			Cas9 Functionally Opens Chromatin	PLOS ONE			English	Article							HUMAN GENOME; TARGET DNA; RNA; BINDING; CRISPR; GENES; TRANSPOSITION; TRANSCRIPTION; ENDONUCLEASE; ELEMENT	Using a nuclease-dead Cas9 mutant, we show that Cas9 reproducibly induces chromatin accessibility at previously inaccessible genomic loci. Cas9 chromatin opening is sufficient to enable adjacent binding and transcriptional activation by the settler transcription factor retinoic acid receptor at previously unbound motifs. Thus, we demonstrate a new use for Cas9 in increasing surrounding chromatin accessibility to alter local transcription factor binding.	[Barkal, Amira A.; Srinivasan, Sharanya; Sherwood, Richard I.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Barkal, Amira A.; Srinivasan, Sharanya; Sherwood, Richard I.] Harvard Univ, Sch Med, Boston, MA USA; [Barkal, Amira A.; Srinivasan, Sharanya; Hashimoto, Tatsunori; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gifford, David K.] Harvard Univ, Dept Stem Cell & Regenerat Biol, 7 Divin Ave, Cambridge, MA 02138 USA; [Gifford, David K.] Harvard Univ, Sch Med, 7 Divin Ave, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University	Sherwood, RI (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Sherwood, RI (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	rsherwood@partners.org	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	National Institutes of Health [5UL1DE019581, RL1DE019021, 1K01DK101684-01, 1U01HG007037, 5P01NS055923]; Harvard Stem Cell Institute's Sternlicht Director's Fund award; Human Frontier Science Program grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037, R01HG008754, R01HG008363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019581, RL1DE019021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK101684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute's Sternlicht Director's Fund award; Human Frontier Science Program grant(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge funding from The National Institutes of Health 5UL1DE019581, RL1DE019021, 1K01DK101684-01, 1U01HG007037 and 5P01NS055923; the Harvard Stem Cell Institute's Sternlicht Director's Fund award and Human Frontier Science Program grant to R.I.S.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0	21	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152683	10.1371/journal.pone.0152683	http://dx.doi.org/10.1371/journal.pone.0152683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031353	Green Submitted, gold, Green Published			2022-12-26	WOS:000373121800115
J	Hu, XT; Tai, JD; Qu, ZH; Zhao, SC; Zhang, L; Li, M; Sun, XG; Jiang, YF				Hu, Xintong; Tai, Jiandong; Qu, Zhihui; Zhao, Songchen; Zhang, Li; Li, Man; Sun, Xiguang; Jiang, Yanfang			A Lower Proportion of Regulatory B Cells in Patients with Henoch-Schoenlein Purpura Nephritis	PLOS ONE			English	Article							SCHONLEIN PURPURA; TRANSPLANTATION; PATHOGENESIS; LYMPHOCYTES; HEPATITIS; TARGETS; SUBSET; KIDNEY; RISK	Background Henoch-Schoenlein purpura is the one of most common types of systemic vasculitis that involves impaired renal function and Henoch-Schoenlein purpura nephritis (HSPN). The diagnosis of this condition is largely based on immunohistologic detection of immunoglobulin A1-containing immune complex in the glomerular deposits of mesangium. Despite clinical advances, the etiopathogenesis of HSPN is still largely unknown. Methods In this study, we enrolled 25 newly diagnosed HSPN patients and 14 healthy controls. Then, fractions of B cell subtypes were determined in venous blood using flow cytometry. The serum interleukin (IL)-10 concentration was determined by enzyme-linked immunosorbent assay. Results Compared to those in healthy controls, the numbers of CD38(+)CD19(+), CD86(+)CD19(+), CD38(+)CD86(+)CD19(+), and CD95(+)CD19(+) B cells per microliter of blood were significantly higher in HSPN patients. In contrast, the numbers of CD5(+)CD19(+), IL-10(+)CD19(+), CD5(+)CD1d(+)CD19(+), and IL-10(+)CD5(+)CD1d(+)CD19(+) B cells per microliter of blood and the serum IL-10 concentration were significantly lower in HSPN patients. Following treatment, the numbers of CD38(+)CD19(+) and CD86(+)CD19(+) B cells per microliter of blood were significantly reduced in HSPN patients. However, the numbers of CD5(+)CD1d(+)CD19(+), CD5(+)CD1d(+)IL-10(+)CD19(+), and IL-10(+)CD19(+) B cells per microliter of blood and the serum IL-10 concentration were significantly increased in HSPN patients following treatment. The estimated glomerular filtration rate (eGFR) was negatively correlated with the number of CD38(+)CD19(+) B cells but positively correlated with the numbers of IL-10(+)CD19(+), CD1d(+)CD5(+)CD19(+), and IL-10(+)CD1d(+)CD5(+)CD19(+)B cells per microliter of blood and the serum IL-10 concentration. The 24-h urinary protein concentration was positively correlated with the number of CD38(+)CD19(+)B cells but negatively correlated with the numbers of IL-10(+)CD19(+), CD1d(+-)CD5(+) CD19(+), and IL-10(+)CD1d(+)CD5(+)CD19(+)B cells per microliter of blood and the serum IL-10 concentration. Conclusion Our results suggest that CD38(+)CD19(+) and CD1d(+)CD5(+)CD19(+) B cells (Bregs) contribute to the pathogenesis of HSPN.	[Hu, Xintong; Tai, Jiandong; Zhao, Songchen; Li, Man; Sun, Xiguang; Jiang, Yanfang] Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jilin Univ, Hosp 1, Key Lab Zoonoses Res, Minist Educ, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Qu, Zhihui; Zhang, Li] Jilin Univ, Hosp 1, Dept Nephrol, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Sun, XG; Jiang, YF (corresponding author), Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun 130023, Peoples R China.; Jiang, YF (corresponding author), Jilin Univ, Hosp 1, Key Lab Zoonoses Res, Minist Educ, Changchun 130023, Peoples R China.; Jiang, YF (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	xi-guangsun@hotmail.com; yanfangjiang@jlu.edu.cn						Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Aybar LT, 2015, CLIN EXP IMMUNOL, V180, P178, DOI 10.1111/cei.12483; Berkowska MA, 2014, J ALLERGY CLIN IMMUN, V134, P688, DOI 10.1016/j.jaci.2014.03.036; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Dumoitier N, 2015, AUTOIMMUN REV, V14, P996, DOI 10.1016/j.autrev.2015.06.008; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Florkowski Christopher M, 2011, Clin Biochem Rev, V32, P75; Fremd C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25443; Gunderson AJ, 2013, EXP CELL RES, V319, P1644, DOI 10.1016/j.yexcr.2013.03.005; Jennette JC, 2014, SEMIN IMMUNOPATHOL, V36, P327, DOI 10.1007/s00281-014-0431-y; Ji SM, 2004, CLIN TRANSPLANT, V18, P536, DOI 10.1111/j.1399-0012.2004.00206.x; Jiang YF, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/143026; Kammertoens T, 2012, INT J CANCER, V131, P1499, DOI 10.1002/ijc.27411; Kang Y, 2014, J KOREAN MED SCI, V29, P198, DOI 10.3346/jkms.2014.29.2.198; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Liu Y, 2016, CLIN EXP PHARM PHYSL; Liu Y, 2014, INT IMMUNOPHARMACOL, V22, P98, DOI 10.1016/j.intimp.2014.06.024; Menezes SM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-18; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Moroni G, 2008, NEPHROL DIAL TRANSPL, V23, P3010, DOI 10.1093/ndt/gfn209; Narchi H, 2005, ARCH DIS CHILD, V90, P916, DOI 10.1136/adc.2005.074641; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Nzula S, 2003, CANCER RES, V63, P3275; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Peiseler M, 2012, J HEPATOL, V57, P125, DOI 10.1016/j.jhep.2012.02.029; Pillebout E, 2014, REV MED INTERNE, V35, P372, DOI 10.1016/j.revmed.2013.12.004; Pohl M, 2015, PEDIATR NEPHROL, V30, P245, DOI 10.1007/s00467-014-2815-6; Qi SQ, 2014, REPROD TOXICOL, V50, P108, DOI 10.1016/j.reprotox.2014.10.013; Ronkainen J, 2003, CLIN NEPHROL, V60, P80; Santer DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068308; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Soler MJ, 2005, TRANSPL P, V37, P3705, DOI 10.1016/j.transproceed.2005.09.172; Sun F, 2014, MUSCLE NERVE, V49, P487, DOI 10.1002/mus.23951; Unizony S, 2015, ARTHRITIS RHEUMATOL, V67, P535, DOI 10.1002/art.38916; van der Vlugt LEPM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030883; Wang YY, 2014, SCAND J IMMUNOL, V79, P51, DOI 10.1111/sji.12128; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Ye Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127767; Zhang N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/836157; Zhong XM, 2007, EUR J IMMUNOL, V37, P2405, DOI 10.1002/eji.200737461	45	10	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152368	10.1371/journal.pone.0152368	http://dx.doi.org/10.1371/journal.pone.0152368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030970	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800062
J	Schwarzer, C; Fischer, H; Machen, TE				Schwarzer, Christian; Fischer, Horst; Machen, Terry E.			Chemotaxis and Binding of Pseudomonas aeruginosa to Scratch-Wounded Human Cystic Fibrosis Airway Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; CL-TRANSPORT; IDENTIFICATION; CHEMORECEPTOR; INFECTION; PROTEINS; TISSUE; CF	Confocal imaging was used to characterize interactions of Pseudomonas aeruginosa (PA, expressing GFP or labeled with Syto 11) with CF airway epithelial cells (CFBE41o-, grown as confluent monolayers with unknown polarity on coverglasses) in control conditions and following scratch wounding. Epithelia and PAO1-GFP or PAK-GFP (2 MOI) were incubated with Ringer containing typical extracellular salts, pH and glucose and propidium iodide (PI, to identify dead cells). PAO1 and PAK swam randomly over and did not bind to non-wounded CFBE41o-cells. PA migrated rapidly (began within 20 sec, maximum by 5 mins) and massively (10-80 fold increase, termed "swarming"), but transiently (random swimming after 15 mins), to wounds, particularly near cells that took up PI. Some PA remained immobilized on cells near the wound. PA swam randomly over intact CFBE41o-monolayers and wounded monolayers that had been incubated with medium for 1 hr. Expression of CFTR and altered pH of the media did not affect PA interactions with CFBE41o-wounds. In contrast, PAO1 swarming and immobilization along wounds was abolished in PAO1 (PAO1 Delta cheYZABW, no expression of chemotaxis regulatory components cheY, cheZ, cheA, cheB and cheW) and greatly reduced in PAO1 that did not express amino acid receptors pctA, B and C (PAO1 Delta pctABC) and in PAO1 incubated in Ringer containing a high concentration of mixed amino acids. Non-piliated PAK Delta pilA swarmed normally towards wounded areas but bound infrequently to CFBE41o- cells. In contrast, both swarming and binding of PA to CFBE41o- cells near wounds were prevented in non-flagellated PAK Delta fliC. Data are consistent with the idea that (i) PA use amino acid sensor-driven chemotaxis and flagella-driven swimming to swarm to CF airway epithelial cells near wounds and (ii) PA use pili to bind to epithelial cells near wounds.	[Schwarzer, Christian; Machen, Terry E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Fischer, Horst] Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA	University of California System; University of California Berkeley; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Machen, TE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	tmachen@berkeley.edu						Abou Alaiwa MH, 2014, P NATL ACAD SCI USA, V111, P18703, DOI 10.1073/pnas.1422091112; Alvarez-Ortega C, 2007, APPL ENVIRON MICROB, V73, P7793, DOI 10.1128/AEM.01898-07; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Blohmke CJ, 2012, J IMMUNOL, V189, P5467, DOI 10.4049/jimmunol.1103661; Cao XF, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0191-9; Cho DY, 2011, INT FORUM ALLERGY RH, V1, P123, DOI 10.1002/alr.20028; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Deng XF, 2013, J VIROL, V87, P4097, DOI 10.1128/JVI.03132-12; Falke JJ, 2014, CURR OPIN STRUC BIOL, V29, P85, DOI 10.1016/j.sbi.2014.10.001; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Garvis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000540; Glekas GD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413518; Hampton TH, 2012, AM J PHYSIOL-LUNG C, V303, pL509, DOI 10.1152/ajplung.00226.2011; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Huang JY, 2015, CELL HOST MICROBE, V18, P147, DOI 10.1016/j.chom.2015.07.002; Hybiske K, 2004, CELL MICROBIOL, V6, P49, DOI 10.1046/j.1462-5822.2003.00342.x; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Illek B, 2010, CELL PHYSIOL BIOCHEM, V26, P983, DOI 10.1159/000324011; Jacob T, 2002, INFECT IMMUN, V70, P6399, DOI 10.1128/IAI.70.11.6399-6408.2002; KATO J, 1992, J BACTERIOL, V174, P5149, DOI 10.1128/JB.174.15.5149-5151.1992; Kato J, 2008, J BIOSCI BIOENG, V106, P1, DOI 10.1263/jbb.106.1; KELLYWINTENBERG K, 1994, APPL ENVIRON MICROB, V60, P363, DOI 10.1128/AEM.60.1.363-367.1994; Kong M, 2013, VIRUSES-BASEL, V5, P2260, DOI 10.3390/v5092260; KURODA A, 1995, J BACTERIOL, V177, P7019, DOI 10.1128/jb.177.24.7019-7025.1995; Lacal J, 2010, J BIOL CHEM, V285, P23124, DOI 10.1074/jbc.M110.110403; Lee A, 1999, AM J PHYSIOL-LUNG C, V277, pL204, DOI 10.1152/ajplung.1999.277.1.L204; Liu XX, 2009, J BACTERIOL, V191, P2909, DOI 10.1128/JB.01708-08; Losa D, 2014, J IMMUNOL, V192, P4804, DOI 10.4049/jimmunol.1301294; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Mayer ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016246; Nguyen TNT, 2012, EUR RESPIR J, V40, P1390, DOI 10.1183/09031936.00221711; Oglesby IK, 2013, J IMMUNOL, V190, P3354, DOI 10.4049/jimmunol.1202960; OHGA T, 1993, FEMS MICROBIOL LETT, V113, P63; Parales RE, 2000, APPL ENVIRON MICROB, V66, P4098, DOI 10.1128/AEM.66.9.4098-4104.2000; Pena J, 2009, INFECT IMMUN, V77, P2857, DOI 10.1128/IAI.01355-08; Psoter KJ, 2015, ANN AM THORAC SOC, V12, P385, DOI 10.1513/AnnalsATS.201408-400OC; Rezaee F, 2013, J VIROL, V87, P11088, DOI 10.1128/JVI.01573-13; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Sammak PJ, 1997, J CELL SCI, V110, P465; Schiller KR, 2010, AM J PHYSIOL-CELL PH, V299, pC912, DOI 10.1152/ajpcell.00215.2010; Schmidt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018184; Schwarzer C, 2014, AM J PHYSIOL-CELL PH, V306, pC844, DOI 10.1152/ajpcell.00002.2014; Schwarzer C, 2012, CELL MICROBIOL, V14, P698, DOI 10.1111/j.1462-5822.2012.01753.x; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; Shitashiro M, 2003, J BIOTECHNOL, V101, P11, DOI 10.1016/S0168-1656(02)00285-7; SLY LM, 1993, CAN J MICROBIOL, V39, P1079, DOI 10.1139/m93-163; Taguchi K, 1997, MICROBIOL-UK, V143, P3223, DOI 10.1099/00221287-143-10-3223; Tran CS, 2014, CELL HOST MICROBE, V15, P636, DOI 10.1016/j.chom.2014.04.007; UHLMAN DL, 1982, J GEN MICROBIOL, V128, P415; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yoshizaki K, 2010, INHAL TOXICOL, V22, P610, DOI 10.3109/08958371003621633	54	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0150109	10.1371/journal.pone.0150109	http://dx.doi.org/10.1371/journal.pone.0150109			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031335	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800005
J	Toma, S; Lacquaniti, F				Toma, Simone; Lacquaniti, Francesco			Mapping Muscles Activation to Force Perception during Unloading	PLOS ONE			English	Article							PSYCHOPHYSICAL SENSITIVITY; PERCEIVED HEAVINESS; ARM-MOVEMENT; MOTOR; DISCRIMINATION; SIGNALS; WEIGHT; MOTION; MASS; REPRESENTATION	It has been largely proved that while judging a force humans mainly rely on the motor commands produced to interact with that force (i.e., sense of effort). Despite of a large bulk of previous investigations interested in understanding the contributions of the descending and ascending signals in force perception, very few attempts have been made to link a measure of neural output (i.e., EMG) to the psychophysical performance. Indeed, the amount of correlation between EMG activity and perceptual decisions can be interpreted as an estimate of the contribution of central signals involved in the sensation of force. In this study we investigated this correlation by measuring the muscular activity of eight arm muscles while participants performed a quasi-isometric force detection task. Here we showed a method to quantitatively describe muscular activity ("muscle-metric function") that was directly comparable to the description of the participants' psychophysical decisions about the stimulus force. We observed that under our experimental conditions, muscle-metric absolute thresholds and the shape of the muscle-metric curves were closely related to those provided by the psychophysics. In fact a global measure of the muscles considered was able to predict approximately 60% of the perceptual decisions total variance. Moreover the inter-subjects differences in psychophysical sensitivity showed high correlation with both participants' muscles sensitivity and participants' joint torques. Overall, our findings gave insights into both the role played by the corticospinal motor commands while performing a force detection task and the influence of the gravitational muscular torque on the estimation of vertical forces.	[Toma, Simone; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Toma, Simone; Lacquaniti, Francesco] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Rome Tor Vergata	Toma, S (corresponding author), Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy.; Toma, S (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	stoma1@asu.edu			Italian University Ministry PRIN grant [2010MEFNF7_002]; Italian Space Agency (COREA grants)	Italian University Ministry PRIN grant; Italian Space Agency (COREA grants)	This research was supported by grants from the Italian University Ministry PRIN grant 2010MEFNF7_002 and the Italian Space Agency (COREA grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Alaerts K, 2010, EUR J NEUROSCI, V31, P1144, DOI 10.1111/j.1460-9568.2010.07124.x; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; COLE JD, 1992, J PHYSIOL-LONDON, V449, P503, DOI 10.1113/jphysiol.1992.sp019099; Dalecki M, 2012, EXP BRAIN RES, V218, P41, DOI 10.1007/s00221-012-2999-6; Debats NB, 2010, EUROHAPTICS, V2, P392; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; FLANDERS M, 1994, J NEUROPHYSIOL, V71, P811, DOI 10.1152/jn.1994.71.2.811; Fontana M, 2013, SENSORS-BASEL, V13, P7618, DOI 10.3390/s130607618; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; GANDEVIA SC, 1976, BRAIN RES, V109, P399, DOI 10.1016/0006-8993(76)90542-4; GANDEVIA SC, 1977, J PHYSIOL-LONDON, V272, P673, DOI 10.1113/jphysiol.1977.sp012066; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; Ghosh A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1139; Goodall S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080202; Gottlieb GL, 1997, J NEUROPHYSIOL, V78, P2985, DOI 10.1152/jn.1997.78.6.2985; GOTTLIEB GL, 1994, EXP BRAIN RES, V97, P545; Hamilton AFD, 2006, NEUROIMAGE, V29, P524, DOI 10.1016/j.neuroimage.2005.07.037; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Jones LA, 2003, EXP BRAIN RES, V151, P197, DOI 10.1007/s00221-003-1434-4; JONES LA, 1986, PSYCHOL BULL, V100, P29, DOI 10.1037/0033-2909.100.1.29; JONES LA, 1983, EXP NEUROL, V81, P640, DOI 10.1016/0014-4886(83)90332-1; Kim HR, 2015, J NEUROSCI, V35, P2766, DOI 10.1523/JNEUROSCI.3134-14.2015; Lackner JR, 2000, TRENDS COGN SCI, V4, P279, DOI 10.1016/S1364-6613(00)01493-5; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; Lenzo B, 2015, TRACKHOLD NOVEL PASS; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lewandowsky S., 2011, COMPUTATIONAL MODELI; Linschoten MR, 2001, PERCEPT PSYCHOPHYS, V63, P1330, DOI 10.3758/BF03194546; Lipshits MI, 1998, LIF SCI RES SPAC P 5, P36; McCloskey D. I, 1981, COROLLARY DISCHARGE; McIntyre J, 1998, BRAIN RES REV, V28, P143, DOI 10.1016/S0165-0173(98)00034-4; Miall RC, 2000, EXP BRAIN RES, V133, P491, DOI 10.1007/s002210000433; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Nienborg H, 2012, ANNU REV NEUROSCI, V35, P463, DOI 10.1146/annurev-neuro-062111-150403; Pellegrini JJ, 1996, EXP BRAIN RES, V110, P80; ROSS H, 1984, SCIENCE, V225, P219, DOI 10.1126/science.6729479; Ross H. E., 2008, HUMAN HAPTIC PERCEPT, DOI [10.1007/978-3-7643-7612-3_22, DOI 10.1007/978-3-7643-7612-3_22]; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; ROSS HE, 1987, Q J EXP PSYCHOL-A, V39, P77, DOI 10.1080/02724988743000042; Russo M, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00024; Sakajiri T, 2013, EXP BRAIN RES, V231, P129, DOI 10.1007/s00221-013-3676-0; SANES JN, 1995, CAN J PHYSIOL PHARM, V73, P223, DOI 10.1139/y95-033; Sanes JN, 1990, ATTENTION PERFORM, VXIII, P714; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shemmell J, 2005, J NEUROPHYSIOL, V94, P3046, DOI 10.1152/jn.00670.2004; STEVENS JC, 1959, J EXP PSYCHOL, V58, P405, DOI 10.1037/h0046906; STEVENS JC, 1970, PERCEPT PSYCHOPHYS, V8, P240, DOI 10.3758/BF03210214; Stuttgen MC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00125; Takarada Y, 2014, NEUROSCI RES, V89, P54, DOI 10.1016/j.neures.2014.09.005; Thickbroom GW, 2006, J NEUROL, V253, P1048, DOI 10.1007/s00415-006-0159-2; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Uka T, 2003, J NEUROSCI, V23, P3515; Waller A. D., 1891, BRAIN, V14, P179, DOI [10.1093/brain/14.2-3.179, DOI 10.1093/BRAIN/14.2-3.179]; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wu B, 2011, IEEE T HAPTICS, V4, P221, DOI 10.1109/ToH.2011.3	59	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152552	10.1371/journal.pone.0152552	http://dx.doi.org/10.1371/journal.pone.0152552			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27032087	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800091
J	Xu, YM; Bai, XN; Zhao, AL; Zhang, W; Ba, PB; Liu, K; Jin, YJ; Wang, H; Guo, QS; Sun, H; Xu, JG; Xiong, YW				Xu, Yanmei; Bai, Xiangning; Zhao, Ailan; Zhang, Wang; Ba, Pengbin; Liu, Kai; Jin, Yujuan; Wang, Hong; Guo, Qiusheng; Sun, Hui; Xu, Jianguo; Xiong, Yanwen			Genetic Diversity of Intimin Gene of Atypical Enteropathogenic Escherichia coli Isolated from Human, Animals and Raw Meats in China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; METROPOLITAN-AREA; STRAINS; CHILDREN; DIARRHEA; IDENTIFICATION; PREVALENCE; OUTBREAK; RESISTANCE; SEROTYPES	Atypical enteropathogenic Escherichia coli (aEPEC) is considered to be an emerging enteropathogen that is more prevalent than typical EPEC in developing and developed countries. The major adherence factor, intimin, an outer membrane protein encoded by eae, plays a pivotal role in the pathogenesis of aEPEC. This study investigated the distribution and polymorphisms of intimin subtypes of 143 aEPEC strains from diarrheal patients, healthy carriers, animals, and raw meats in China. These aEPEC strains belonged to more than 71 different serotypes, which comprised 52 O serogroups and 24 H types. Sixty-eight different eae genotypes and 19 intimin subtypes were detected. Eighteen, eight, seven, and five intimin subtypes were identified from 86 diarrheal patients, 14 healthy carriers, 19 animals, and 24 raw meats strains, respectively. Intimin beta 1 was the most prevalent subtype in strains from diarrheal patients (34.88%) and animals (47.37%). There was a statistically significant difference in the distribution of eae-beta 1 between diarrheal patients and healthy carriers (P = 0.004). Intimin-theta was more predominant among raw meat strains (50%) than among diarrheal patients strains (12.79%, P = 0.0003), healthy carrier strains (7.14%, P = 0.007), or animal strains (15.79%, P = 0.020). The two predominant subtypes (eae-beta 1 and eae-theta) had considerable polymorphisms with no significant differences among the four sources. PFGE analysis revealed 119 distinct patterns and the strains were clustered into 11 groups with similarity indices ranging from 63% to 100%. These results suggest that in China, aEPEC strains from different sources are highly heterogeneous. Animals and raw meats are important sources of genetically diverse intimin-harboring aEPEC, which might serve as important transmission vehicles of these bacteria.	[Xu, Yanmei; Bai, Xiangning; Zhao, Ailan; Zhang, Wang; Ba, Pengbin; Liu, Kai; Sun, Hui; Xu, Jianguo; Xiong, Yanwen] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Jin, Yujuan] Longgang Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Wang, Hong] Zigong Ctr Dis Control & Prevent, Zigong, Sichuan Provinc, Peoples R China; [Guo, Qiusheng] Suixian Ctr Dis Control & Prevent, Shangqiu, Henan Province, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Xiong, YW (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xiongyanwen@icdc.cn			National Natural Science Foundation of China [81371762]; State Key Laboratory for Infectious Disease Prevention and Control [2015SKLID504]; National Basic Research Priorities Program of China [2015CB554201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Disease Prevention and Control; National Basic Research Priorities Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (81371762) [http://www.nsfc.gov.cn/publish/portal1/], the State Key Laboratory for Infectious Disease Prevention and Control (2015SKLID504) [http://www.sklid.cn/], and the National Basic Research Priorities Program of China (2015CB554201) [http://www.most.gov.cn/eng/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maldonado NA, 2014, BIOMEDICA, V34, P433, DOI [10.1590/S0120-41572014000300013, 10.7705/biomedica.v34i3.1658]; Bardiau M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-124; Beutin L, 2003, INFECT IMMUN, V71, P3995, DOI 10.1128/IAI.71.7.3995-4002.2003; Bielaszewska M, 2008, CLIN INFECT DIS, V47, P208, DOI 10.1086/589245; Blanco JE, 2004, J CLIN MICROBIOL, V42, P311, DOI 10.1128/JCM.42.1.311-319.2004; Blanco M, 2006, J MED MICROBIOL, V55, P1165, DOI 10.1099/jmm.0.46518-0; Blanco M, 2006, INT MICROBIOL, V9, P103; Chen Y, 2014, CLIN MICROBIOL INFEC, V20, P52, DOI 10.1111/1469-0691.12188; Contreras CA, 2010, J MED MICROBIOL, V59, P25, DOI 10.1099/jmm.0.013706-0; Cookson AL, 2007, FEMS MICROBIOL LETT, V272, P163, DOI 10.1111/j.1574-6968.2007.00755.x; Creuzburg K, 2011, ENVIRON MICROBIOL, V13, P439, DOI 10.1111/j.1462-2920.2010.02349.x; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Donnenberg MS, 2013, TRENDS MICROBIOL, V21, P317, DOI 10.1016/j.tim.2013.05.003; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Franco RT, 2012, DIAGN MICR INFEC DIS, V74, P81, DOI 10.1016/j.diagmicrobio.2012.05.022; FRANKEL G, 1995, INFECT IMMUN, V63, P4323, DOI 10.1128/IAI.63.11.4323-4328.1995; Ghosh PK, 2010, J MED MICROBIOL, V59, P1156, DOI 10.1099/jmm.0.014530-0; Girard F, 2005, INFECT IMMUN, V73, P6005, DOI 10.1128/IAI.73.9.6005-6016.2005; Hao RZ, 2012, J CLIN MICROBIOL, V50, P2450, DOI 10.1128/JCM.00276-12; Hedberg CW, 1997, J INFECT DIS, V176, P1625, DOI 10.1086/517342; Hernandes RT, 2009, FEMS MICROBIOL LETT, V297, P137, DOI 10.1111/j.1574-6968.2009.01664.x; Hu J, 2015, CLIN MICROBIOL INFEC, V21, P729, DOI 10.1016/j.cmi.2015.01.015; Iguchi A, 2008, MICROBIOL-SGM, V154, P559, DOI 10.1099/mic.0.2007/013334-0; Iguchi A, 2015, J CLIN MICROBIOL, V53, P2427, DOI 10.1128/JCM.00321-15; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Moller-Stray J, 2012, EUROSURVEILLANCE B E, V17; Moura RA, 2009, APPL ENVIRON MICROB, V75, P7399, DOI 10.1128/AEM.00636-09; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nguyen RN, 2006, EMERG INFECT DIS, V12, P597; Ochoa TJ, 2008, T ROY SOC TROP MED H, V102, P852, DOI 10.1016/j.trstmh.2008.03.017; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Oh JY, 2012, POULTRY SCI, V91, P2438, DOI 10.3382/ps.2012-02301; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Oswald E, 2000, INFECT IMMUN, V68, P64, DOI [10.1128/IAI.68.1.64-71.2000, 10.1128/IAI.68.11.6402-6410.2000]; Pacheco VCR, 2014, PATHOG DIS, V70, P167, DOI 10.1111/2049-632X.12112; Park JH, 2014, FOODBORNE PATHOG DIS, V11, P775, DOI 10.1089/fpd.2014.1754; Phillips AD, 2000, J INFECT DIS, V181, P1496, DOI 10.1086/315404; Pitondo-Silva A, 2015, APMIS, V123, P128, DOI 10.1111/apm.12314; Ramachandran V, 2003, J CLIN MICROBIOL, V41, P5022, DOI 10.1128/JCM.41.11.5022-5032.2003; Scaletsky ICA, 2010, J CLIN MICROBIOL, V48, P302, DOI 10.1128/JCM.01980-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Wang LL, 2013, APPL ENVIRON MICROB, V79, P1232, DOI 10.1128/AEM.03380-12; Yang K, 2014, APPL ENVIRON MICROB, V80, P119, DOI 10.1128/AEM.02747-13; Yatsuyanagi J, 2002, J CLIN MICROBIOL, V40, P294, DOI 10.1128/JCM.40.1.294-297.2002; Yu JX, 2015, J INFECTION, V71, P19, DOI 10.1016/j.jinf.2015.03.001	47	9	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152571	10.1371/journal.pone.0152571	http://dx.doi.org/10.1371/journal.pone.0152571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031337	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800095
J	Yu, CC; Huang, HB; Hung, SK; Liao, HF; Lee, CC; Lin, HY; Li, SC; Ho, HC; Hung, CL; Su, YC				Yu, Chih-Chia; Huang, Hsien-bin; Hung, Shih-Kai; Liao, Hui-Fen; Lee, Ching-Chih; Lin, Hon-Yi; Li, Szu-Chin; Ho, Hsu-Chueh; Hung, Chung-Lin; Su, Yu-Chieh			AZD2014 Radiosensitizes Oral Squamous Cell Carcinoma by Inhibiting AKT/mTOR Axis and Inducing G1/G2/M Cell Cycle Arrest	PLOS ONE			English	Article							MTORC2; GROWTH; RESISTANCE	Background Oral squamous cell carcinoma (OSCC) is one of the most common malignant neoplasms in Taiwan. Activation of the mTOR signaling pathway has been linked to decreased radiation responsiveness in human oral cancer, thus it limits efficacy of radiotherapy. To address this question, we investigated the effect of AZD2014, a novel small molecular ATP-competitive inhibitor of mTORC1 and mTORC2 kinase, as a radiosensitizer in primary OSCC and OSCC-derived cell line models. Methods We isolated primary tumor cells from OSCC tissues and cell lines. AZD2014 was administered with and without ionizing radiation. The radiosensitizing effect of AZD2014 were then assessed using cell viability assays, clonogenic survival assays, and cell cycle analyses. Western blotting was used to detect protein expression. Results Combination treatment with AZD2014 and irradiation resulted in significant reduction in OSCC cell line and primary OSCC cell colony formation due to the enhanced inhibition of AKT and both mTORC1 and mTORC2 activity. Pre-treatment with AZD2014 in irradiated oral cancer cells induced tumor cell cycle arrest at the G1 and G2/M phases, which led to disruption of cyclin D1-CDK4 and cyclin B1-CDC2 complexes. Moreover, AZD2014 synergized with radiation to promote both apoptosis and autophagy by increasing caspase-3 and LC3 in primary OSCC cells. Conclusions These findings suggest that in irradiated OSCC cells, co-treatment with AZD2014, which targets mTORC1 and mTORC2 blockade, is an effective radiosensitizing strategy for oral squamous cell carcinoma.	[Yu, Chih-Chia; Huang, Hsien-bin; Li, Szu-Chin] Natl Chung Cheng Univ, Dept Life Sci, Chiayi 621, Taiwan; [Yu, Chih-Chia; Huang, Hsien-bin; Li, Szu-Chin] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi 621, Taiwan; [Yu, Chih-Chia; Li, Szu-Chin; Hung, Chung-Lin; Su, Yu-Chieh] Buddhist Dalin Tzu Chi Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Hung, Shih-Kai; Lee, Ching-Chih; Lin, Hon-Yi; Ho, Hsu-Chueh; Su, Yu-Chieh] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hung, Shih-Kai; Lin, Hon-Yi] Buddhist Dalin Tzu Chi Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Lee, Ching-Chih; Ho, Hsu-Chueh] Buddhist Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Liao, Hui-Fen] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi 60004, Taiwan	National Chung Cheng University; National Chung Cheng University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Chiayi University	Su, YC (corresponding author), Buddhist Dalin Tzu Chi Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan.; Su, YC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	hepatoma@gmail.com		Hung, Shih-Kai/0000-0002-4945-528X	Buddhist Dalin Tzu Chi Hospital [DTCRD102(2)-I-15, DTCRD103(2)-I-02]	Buddhist Dalin Tzu Chi Hospital	This study was supported by research grants from the Buddhist Dalin Tzu Chi Hospital (DTCRD102(2)-I-15 and DTCRD103(2)-I-02). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani SH, 2010, INDIAN J MED PAEDIAT, V31, P132, DOI 10.4103/0971-5851.76197; Altman JK, 2011, CLIN CANCER RES, V17, P4378, DOI 10.1158/1078-0432.CCR-10-2285; Anandharaj A, 2011, ACTA BIOCH BIOPH SIN, V43, P292, DOI 10.1093/abbs/gmr012; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Chen BW, 2015, MOL CANCER THER, V14, P1805, DOI 10.1158/1535-7163.MCT-15-0029; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gao Wei, 2012, ISRN Otolaryngol, V2012, P953089, DOI 10.5402/2012/953089; Gogineni VR, 2011, CANCER LETT, V313, P64, DOI 10.1016/j.canlet.2011.08.022; Health Do, 2010, EX YUAN RCRA; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Kahn J, 2014, NEURO-ONCOLOGY, V16, P29, DOI 10.1093/neuonc/not139; Kim KW, 2008, AUTOPHAGY, V4, P659, DOI 10.4161/auto.6058; Kim KW, 2009, CLIN CANCER RES, V15, P6096, DOI 10.1158/1078-0432.CCR-09-0589; Koo J, 2014, CANCER RES, V74, P2555, DOI 10.1158/0008-5472.CAN-13-2946; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liao H, 2015, AM J CANCER RES, V5, P125; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Nassim R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065257; Peyressatre M, 2015, CANCERS, V7, P179, DOI 10.3390/cancers7010179; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Smrz D, 2011, BLOOD, V118, P6803, DOI 10.1182/blood-2011-06-359984; Wei F, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-81; Willems L, 2012, CURR ONCOL REP, V14, P129, DOI 10.1007/s11912-012-0227-y; Wu Si-Han, 2014, Cancer Biology Medicine, V11, P255, DOI 10.7497/j.issn.2095-3941.2014.04.004; Yano T, 2014, CIRC RES, V114, P1268, DOI 10.1161/CIRCRESAHA.114.303562; Yardley DA, 2013, BREAST CANCER-BASIC, V7, P7, DOI 10.4137/BCBCR.S10071; Yu CC, 2014, ANTICANCER RES, V34, P2927	30	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151942	10.1371/journal.pone.0151942	http://dx.doi.org/10.1371/journal.pone.0151942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031247	gold, Green Submitted, Green Published			2022-12-26	WOS:000373121800024
J	Anso, J; Barrabe, L; Desutter-Grandcolas, L; Jourdan, H; Grandcolas, P; Dong, JJ; Robillard, T				Anso, Jeremy; Barrabe, Laure; Desutter-Grandcolas, Laure; Jourdan, Herve; Grandcolas, Philippe; Dong, Jiajia; Robillard, Tony			Old Lineage on an Old Island: Pixibinthus, a New Cricket Genus Endemic to New Caledonia Shed Light on Gryllid Diversification in a Hotspot of Biodiversity	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; ACOUSTIC COMMUNICATION; SOUTHWEST PACIFIC; BODY-SIZE; ORTHOPTERA; GRYLLOIDEA; EVOLUTION; INSECTA; ENEOPTERINAE; PLEISTOCENE	Few studies have focused on the early colonization of New Caledonia by insects, after the re-emergence of the main island, 37 Myr ago. Here we investigate the mode and tempo of evolution of a new endemic cricket genus, Pixibinthus, recently discovered in southern New Caledonia. First we formally describe this new monotypic genus found exclusively in the open shrubby vegetation on metalliferous soils, named 'maquis minier', unique to New Caledonia. We then reconstruct a dated molecular phylogeny based on five mitochondrial and four nuclear loci in order to establish relationships of Pixibinthus within Eneopterinae crickets. Pixibinthus is recovered as thesister clade of the endemic genus Agnotecous, mostly rainforest-dwellers. Dating results show that the island colonization by their common ancestor occurred around 34.7 Myr, shortly after New Caledonia re-emergence. Pixibinthus and Agnotecous are then one of the oldest insect lineages documented so far for New Caledonia. This discovery highlights for the first time two clear-cut ecological specializations between sister clades, as Agnotecous is mainly found in rainforests with 19 species, whereas Pixibinthus is found in open habitats with a single documented species. The preference of Pixibinthus for open habitats and of Agnotecous for forest habitats nicely fits an acoustic specialization, either explained by differences in body size or in acoustic properties of their respective habitats. We hypothesize that landscape dynamics, linked to major past climatic events and recent change in fire regimes are possible causes for both present-day low diversity and rarity in genus Pixibinthus. The unique evolutionary history of this old New Caledonian lineage stresses the importance to increase our knowledge on the faunal biodiversity of 'maquis minier', in order to better understand the origin and past dynamics of New Caledonian biota.	[Anso, Jeremy; Desutter-Grandcolas, Laure; Grandcolas, Philippe; Dong, Jiajia; Robillard, Tony] Univ Paris 04, Museum Natl Hist Nat, CNRS, ISYEB,UMR 7205,UPMC,EPHE, Paris, France; [Anso, Jeremy; Jourdan, Herve] Aix Marseille Univ, Inst Mediterraneen Biodivers & eCOL Marine & Con, Ctr IRD Noumea, CNRS,IRD,Avignon Univ UMR IRD IMBE 237, New Caledonia, France; [Barrabe, Laure] Ctr IRD Noumea, Lab Bot & Ecol Vegetales Appl, UMR Bot & Modelisat Architecture Plantes & Vegeta, Herbarium NOU, New Caledonia, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Anso, J (corresponding author), Univ Paris 04, Museum Natl Hist Nat, CNRS, ISYEB,UMR 7205,UPMC,EPHE, Paris, France.; Anso, J (corresponding author), Aix Marseille Univ, Inst Mediterraneen Biodivers & eCOL Marine & Con, Ctr IRD Noumea, CNRS,IRD,Avignon Univ UMR IRD IMBE 237, New Caledonia, France.	jeremy.anso@ird.fr	Robillard, Tony/H-3523-2011; Jourdan, Herve/D-1452-2011	Robillard, Tony/0000-0002-2177-9549; Jourdan, Herve/0000-0002-3756-4008; Grandcolas, Philippe/0000-0003-1374-1222	PhD grant, 'Bourse d'encouragement a la recherche universitaire - Government of New Caledonia; Grand Observatoire du Pacifique Sud: AAP GOPS / 'Bioacoustique des grillons de Nouvelle-Caledonie'; project entitled "A diachronic study of biodiversity and a test of biogeographic scenarios in New Caledonia as based on field inventories of fossil and present-day insects"	PhD grant, 'Bourse d'encouragement a la recherche universitaire - Government of New Caledonia; Grand Observatoire du Pacifique Sud: AAP GOPS / 'Bioacoustique des grillons de Nouvelle-Caledonie'; project entitled "A diachronic study of biodiversity and a test of biogeographic scenarios in New Caledonia as based on field inventories of fossil and present-day insects"	This study was partly funded by a PhD grant, 'Bourse d'encouragement a la recherche universitaire, attributed to JA by the Government of New Caledonia. The bioacoustic study was supported by a grant from the Grand Observatoire du Pacifique Sud: AAP GOPS 2013 / 'Bioacoustique des grillons de Nouvelle-Caledonie'. The laboratory procedures were realized through the two research programs: Action Transversale du Museum (ATM) 'Biodiversite actuelle et fossile. Crises, stress, restaurations et panchronisme: le message systematique', and ATM 'Barcode'. The Labex BCDIV (Diversites biologiques et culturelles) funded a part of this study, under the project entitled "A diachronic study of biodiversity and a test of biogeographic scenarios in New Caledonia as based on field inventories of fossil and present-day insects". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bauer Aaron M., 2006, Proceedings of the California Academy of Sciences, V57, P503; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Carlquist S, 1965, ISLAND LIFE NATURAL; Chevillotte V, 2006, GEOMORPHOLOGY, V81, P361, DOI 10.1016/j.geomorph.2006.04.020; Chintauan-Marquier IC, 2016, CLADISTICS, V32, P54, DOI 10.1111/cla.12114; Cluzell D, 2012, EPISODES, V35, P72, DOI 10.18814/epiiugs/2012/v35i1/007; Cruaud A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030941; Curt T, 2015, FOREST ECOL MANAG, V337, P48, DOI 10.1016/j.foreco.2014.10.032; DELCOURT PA, 1983, QUATERNARY RES, V19, P265, DOI 10.1016/0033-5894(83)90010-8; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DESUTTER L, 1987, ANN SOC ENTOMOL FR, V23, P213; Desutter-Grandcolas L, 2006, SYST ENTOMOL, V31, P65, DOI 10.1111/j.1365-3113.2005.00299.x; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P525, DOI 10.1046/j.1463-6409.2003.00142.x; Desutter-Grandcolas Laure, 1997, Memoires du Museum National d'Histoire Naturelle, V171, P165; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espeland M, 2010, J EVOLUTION BIOL, V23, P2112, DOI 10.1111/j.1420-9101.2010.02072.x; Espeland M, 2008, MOL PHYLOGENET EVOL, V48, P904, DOI 10.1016/j.ympev.2008.06.006; Espeland M, 2010, J BIOGEOGR, V37, P879, DOI 10.1111/j.1365-2699.2009.02263.x; Fartmann T, 2012, ECOL INDIC, V20, P337, DOI 10.1016/j.ecolind.2012.03.002; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flook PK, 1999, SYST BIOL, V48, P233, DOI 10.1080/106351599260274; FORREST TG, 1994, AM ZOOL, V34, P644; Garamszegi L. Z., 2014, MODERN PHYLOGENETIC; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Gomez C, 2015, ECOL EVOL, V5, P377, DOI 10.1002/ece3.1317; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Grandcolas P, 2014, TRENDS ECOL EVOL, V29, P655, DOI 10.1016/j.tree.2014.10.002; Grandcolas P, 2009, MEM MUS NAT HIST NAT, V198, P373; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hope G, 1998, PALAEOGEOGR PALAEOCL, V142, P1, DOI 10.1016/S0031-0182(97)00140-5; Huang Y, 2000, MOL PHYLOGENET EVOL, V17, P48, DOI 10.1006/mpev.2000.0815; Jaffre T., 1995, DISTRIBUTION ECOLOGY; Jaffre T., 1980, ETUDE ECOLOGIQUE PEU; Jaffre Tanguy, 1998, Adansonia (Paris), V20, P173; Jaiswara R, 2012, ZOOL J LINN SOC-LOND, V164, P285, DOI 10.1111/j.1096-3642.2011.00769.x; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McCoy S, 1999, J BIOGEOGR, V26, P579, DOI 10.1046/j.1365-2699.1999.00309.x; McCracken KG, 1997, P NATL ACAD SCI USA, V94, P3833, DOI 10.1073/pnas.94.8.3833; Miller M.A., 2010, P GAT COMP ENV WORKS; Morat P., 1986, ADANSONIA, V4, P133; Morat P, 2012, ADANSONIA, V34, P179, DOI 10.5252/a2012n2a1; Murienne J, 2008, CLADISTICS, V24, P802, DOI 10.1111/j.1096-0031.2008.00204.x; Murienne J, 2005, CLADISTICS, V21, P2, DOI 10.1111/j.1096-0031.2004.00042.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nattier R, 2012, SECONDARY SYMPATRY C; Nattier R, 2013, CLIMATE SOIL TYPE TO; Nattier R, 2011, J BIOGEOGR, V38, P2195, DOI 10.1111/j.1365-2699.2011.02563.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Paun O, 2015, SYST BIOL; Pelletier B., 2006, COMPENDIUM MARINE SP, VII, P19; Pillon Y, 2008, BIODIVERSITE ORIGINE; Pillon Y, 2012, BOT J LINN SOC, V170, P288, DOI 10.1111/j.1095-8339.2012.01274.x; Pillon Y, 2010, J ECOL, V98, P1108, DOI 10.1111/j.1365-2745.2010.01689.x; Pillon Y, 2009, MOL ECOL, V18, P2263, DOI 10.1111/j.1365-294X.2009.04178.x; Pintaud JC, 2001, CR ACAD SCI III-VIE, V324, P453, DOI 10.1016/S0764-4469(01)01312-9; Poncet V, 2013, MOL ECOL, V22, P6163, DOI 10.1111/mec.12554; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pouteau R, 2015, J BIOGEOGR; PRENTICE IC, 1986, VEGETATIO, V67, P131; Proctor J, 2003, PERSPECT PLANT ECOL, V6, P105, DOI 10.1078/1433-8319-00045; Ragge D.R, 1955, WING VENATION ORTHOP, P159; Ragge D.R, 1998, SONGS GRASSHOPPERS C; Rambaut A, 2009, TRACER V 1 5; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; Robillard T, 2004, BIOL J LINN SOC, V83, P577, DOI 10.1111/j.1095-8312.2004.00417.x; Robillard T, 2004, CLADISTICS, V20, P271, DOI 10.1111/j.1096-0031.2004.00025.x; Robillard T, 2008, ZOOTAXA, P66, DOI 10.11646/zootaxa.1789.1.3; Robillard T, 2006, MOL PHYLOGENET EVOL, V40, P643, DOI 10.1016/j.ympev.2005.10.019; Robillard T, 2014, ZOOTAXA, V3854, P1, DOI 10.11646/zootaxa.3854.1.1; Robillard T, 2013, ZOOTAXA, V3693, P49, DOI 10.11646/zootaxa.3693.1.3; Robillard Tony, 2010, Zootaxa, V2559, P17; Robillard Tony, 2010, Zootaxa, V2386, P25; Robillard T, 2009, ZOOL SCI, V26, P878, DOI 10.2108/zsj.26.878; Robillard T, 2009, ZOOSYSTEMA, V31, P577, DOI 10.5252/z2009n3a11; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Sadlier RA, 2014, MEM MUS NAT HIST NAT, V206, P45; Schellart WP, 2006, EARTH-SCI REV, V76, P191, DOI 10.1016/j.earscirev.2006.01.002; SCHMID M, 1982, Compte Rendu des Seances de la Societe de Biogeographie, V58, P52; Sharma PP, 2012, P ROY SOC LOND B BIO; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Skipwith P, 2014, MEM MUS NAT HIST NAT, V206, P13; SLOWINSKI JB, 1993, AM NAT, V142, P1019, DOI 10.1086/285586; Song HJ, 2015, CLADISTICS, V31, P621, DOI 10.1111/cla.12116; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stevenson J, 2005, QUATERNARY RES, V64, P372, DOI 10.1016/j.yqres.2005.08.011; Stevenson J, 2004, HOLOCENE, V14, P888, DOI 10.1191/0959-683604hl755rp; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vicente NM, 2015, ZOOL ANZ, V258, P82, DOI 10.1016/j.jcz.2015.06.005; Wellstein C, 2011, AGR ECOSYST ENVIRON, V145, P1, DOI 10.1016/j.agee.2011.06.024; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047	103	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150920	10.1371/journal.pone.0150920	http://dx.doi.org/10.1371/journal.pone.0150920			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027632	gold, Green Published			2022-12-26	WOS:000373116500013
J	Kwon, I; Choi, ES				Kwon, Inchan; Choi, Eun Sil			Forced Ambiguity of the Leucine Codons for Multiple-Site-Specific Incorporation of a Noncanonical Amino Acid	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; EXPANDED GENETIC-CODE; ESCHERICHIA-COLI; ANTICODON DUPLEXES; UNMODIFIED ADENOSINE; RECOMBINANT PROTEINS; WOBBLE POSITION; WILD-TYPE; EVOLUTION; RIBOSOME	Multiple-site-specific incorporation of a noncanonical amino acid into a recombinant protein would be a very useful technique to generate multiple chemical handles for bioconjugation and multivalent binding sites for the enhanced interaction. Previously combination of a mutant yeast phenylalanyl-tRNA synthetase variant and the yeast phenylalanyl-tRNA containing the AAA anticodon was used to incorporate a noncanonical amino acid into multiple UUU phenylalanine (Phe) codons in a site-specific manner. However, due to the less selective codon recognition of the AAA anticodon, there was significant misincorporation of a noncanonical amino acid into unwanted UUC Phe codons. To enhance codon selectivity, we explored degenerate leucine (Leu) codons instead of Phe degenerate codons. Combined use of the mutant yeast phenylalanyl-tRNA containing the CAA anticodon and the yPheRS_naph variant allowed incorporation of a phenylalanine analog, 2-naphthylalanine, into murine dihydrofolate reductase in response to multiple UUG Leu codons, but not to other Leu codon sites. Despite the moderate UUG codon occupancy by 2-naphthylalaine, these results successfully demonstrated that the concept of forced ambiguity of the genetic code can be achieved for the Leu codons, available for multiple-site-specific incorporation.	[Kwon, Inchan; Choi, Eun Sil] Gwangju Inst Sci & Technol GIST, Sch Mat Sci & Engn, Gwangju, South Korea; [Kwon, Inchan] Univ Virginia, Dept Chem Engn, Charlottesville, VA USA; [Choi, Eun Sil] Chonnam Natl Univ, Dept Biol Sci, Coll Nat Sci, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); University of Virginia; Chonnam National University	Kwon, I (corresponding author), Gwangju Inst Sci & Technol GIST, Sch Mat Sci & Engn, Gwangju, South Korea.; Kwon, I (corresponding author), Univ Virginia, Dept Chem Engn, Charlottesville, VA USA.	inchan@gist.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A2A1A11050322]; Korea C1 Gas Refinery Program through NRF - Ministry of Science, ICT & Future Planning [2015M3D3A1A01064923]; BioImaging Research Center at the Gwangju Institute of Science and Technology(GIST); National Institutes of Health [R01 GM062523]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea C1 Gas Refinery Program through NRF - Ministry of Science, ICT & Future Planning; BioImaging Research Center at the Gwangju Institute of Science and Technology(GIST); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge financial support from the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (Grant No. 2014R1A2A1A11050322). This study was also partially supported by Korea C1 Gas Refinery Program through NRF funded by the Ministry of Science, ICT & Future Planning (Grant No. 2015M3D3A1A01064923), the BioImaging Research Center at the Gwangju Institute of Science and Technology(GIST), and a National Institutes of Health grant (R01 GM062523). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiram M, 2015, NAT BIOTECHNOL, V33, P1272, DOI 10.1038/nbt.3372; Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Anderson JC, 2003, BIOCHEMISTRY-US, V42, P9598, DOI 10.1021/bi034550w; BOREN T, 1993, J MOL BIOL, V230, P739, DOI 10.1006/jmbi.1993.1196; Budisa N, 2006, ENGINEERING THE GENETIC CODE: EXPANDING THE AMINO ACID REPERTOIRE FOR THE DESIGN OF NOVEL PROTEINS, P1; Budisa N, 2004, BIOL CHEM, V385, P893, DOI 10.1515/BC.2004.117; Chen P, 2002, J MOL BIOL, V317, P481, DOI 10.1006/jmbi.2002.5435; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; CURRAN JF, 1995, NUCLEIC ACIDS RES, V23, P683, DOI 10.1093/nar/23.4.683; de Graaf AJ, 2009, BIOCONJUGATE CHEM, V20, P1281, DOI 10.1021/bc800294a; Fournier GP, 2015, J MOL EVOL, V80, P171, DOI 10.1007/s00239-015-9672-1; Francis MB, 2010, CURR OPIN CHEM BIOL, V14, P771, DOI 10.1016/j.cbpa.2010.11.006; Hartman Hyman, 2014, Life-Basel, V4, P227, DOI 10.3390/life4020227; Hoesl MG, 2015, ANGEW CHEM INT EDIT, V54, P10030, DOI 10.1002/anie.201502868; INAGAKI Y, 1995, J MOL BIOL, V251, P486, DOI 10.1006/jmbi.1995.0450; ISHII Y, 1975, MUTAT RES, V27, P27, DOI 10.1016/0027-5107(75)90271-7; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Kim J, 2013, ANAL CHEM, V85, P1468, DOI 10.1021/ac303089v; Kwon I, 2003, J AM CHEM SOC, V125, P7512, DOI 10.1021/ja0350076; Kwon I, 2006, J AM CHEM SOC, V128, P11778, DOI 10.1021/ja0626281; Kwon I, 2015, ACS SYNTH BIOL, V4, P634, DOI 10.1021/sb500309r; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lim VI, 2001, RNA, V7, P942, DOI 10.1017/S135583820100214X; LIM VI, 1992, FEBS LETT, V313, P133, DOI 10.1016/0014-5793(92)81429-P; LIM VI, 1995, J MOL BIOL, V252, P277, DOI 10.1006/jmbi.1995.0494; Lim VI, 1998, BIOL CHEM, V379, P773; Lim VI, 1997, J MOL BIOL, V266, P877, DOI 10.1006/jmbi.1996.0802; Montclare JK, 2006, ANGEW CHEM INT EDIT, V45, P4518, DOI 10.1002/anie.200600088; MUNZ P, 1981, NATURE, V294, P187, DOI 10.1038/294187a0; Nakayashiki T, 1998, J BACTERIOL, V180, P2931, DOI 10.1128/JB.180.11.2931-2935.1998; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Sachdeva A, 2014, J AM CHEM SOC, V136, P7785, DOI 10.1021/ja4129789; SAMPSON JR, 1992, BIOCHEMISTRY-US, V31, P4161, DOI 10.1021/bi00132a002; Taki M, 2002, J AM CHEM SOC, V124, P14586, DOI 10.1021/ja017714+; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/nchem.1919, 10.1038/NCHEM.1919]; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Watanabe Y, 1997, BBA-GENE STRUCT EXPR, V1350, P119, DOI 10.1016/S0167-4781(96)00211-4; Wiltschi B, 2007, APPL MICROBIOL BIOT, V74, P739, DOI 10.1007/s00253-006-0823-6; Wu P, 2009, P NATL ACAD SCI USA, V106, P3000, DOI 10.1073/pnas.0807820106; Zheng S, 2013, BIOTECHNOL BIOENG, V110, P2361, DOI 10.1002/bit.24911	46	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152826	10.1371/journal.pone.0152826	http://dx.doi.org/10.1371/journal.pone.0152826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028506	Green Submitted, Green Published, gold			2022-12-26	WOS:000373116500069
J	Sim, SH; Kim, JY; Seong, BL; Nguyen, HH; Chang, J				Sim, Sang-Hee; Kim, Joo Young; Seong, Baik Lin; Huan Huu Nguyen; Chang, Jun			Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; B-CELL RESPONSES; MAMMALIAN-CELLS; VIRUS-INFECTION; CIRCUMSPOROZOITE PROTEIN; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; INNATE IMMUNITY; VACCINE; EXPRESSION	The widespread influenza virus infection further emphasizes the need for novel vaccine strategies that effectively reduce the impact of epidemic as well as pandemic influenza. Conventional influenza vaccines generally induce virus neutralizing antibody responses which are specific for a few antigenically related strains within the same subtype. However, antibodies directed against the conserved stalk domain of HA could neutralize multiple sub-types of influenza virus and thus provide broad-spectrum protection. In this study, we designed and constructed a recombinant baculovirus-based vaccine, rBac-HA virus, that expresses full-length HA of pandemic H1N1 influenza virus (A/California/04/09) on the viral envelope. We demonstrated that repeated intranasal immunizations with rBac-HA virus induced HA stalk-specific antibody responses and protective immunity against homologous as well as heterosubtypic virus challenge. The adoptive transfer experiment shows that the cross-protection is conferred by the immune sera which contain HA stalk-specific antibodies. These results warrant further development of rBac-HA virus as a broad-protective vaccine against influenza. The vaccine induced protection against infection with the same subtype as well as different subtype, promising a potential universal vaccine for broad protection against different subtypes to control influenza outbreaks including pandemic.	[Sim, Sang-Hee; Kim, Joo Young; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Seong, Baik Lin] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea; [Huan Huu Nguyen] Int Vaccine Inst, Lab Viral Immunol, Seoul, South Korea	Ewha Womans University; Yonsei University; International Vaccine Institute	Chang, J (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr	Kim, Jooyoung/R-5839-2018	Kim, Jooyoung/0000-0003-4846-6259; CHANG, JUN/0000-0002-8423-5987	Transgovernmental Enterprise for Pandemic Influenza in Korea which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea [A103001]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0826]	Transgovernmental Enterprise for Pandemic Influenza in Korea which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	JC received funding for this work from the Transgovernmental Enterprise for Pandemic Influenza in Korea which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant number: A103001) and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant number: HI13C0826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Abe T, 2003, J IMMUNOL, V171, P1133, DOI 10.4049/jimmunol.171.3.1133; Abe T, 2009, J VIROL, V83, P7629, DOI 10.1128/JVI.00679-09; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Audsley JM, 2008, DRUGS, V68, P1483, DOI 10.2165/00003495-200868110-00002; Bicho D, 2015, CURR GENE THER, V15, P541, DOI 10.2174/1566523215666150929111048; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Browne EP, 2012, IMMUNOLOGY, V136, P370, DOI 10.1111/j.1365-2567.2012.03587.x; Chen CY, 2013, J BIOTECHNOL, V164, P143, DOI 10.1016/j.jbiotec.2012.12.013; Chen CY, 2011, BIOTECHNOL ADV, V29, P618, DOI 10.1016/j.biotechadv.2011.04.004; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; Cox RJ, 2013, HUM VACC IMMUNOTHER, V9, P405, DOI 10.4161/hv.22908; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Grabherr R, 1997, BIOTECHNIQUES, V22, P730, DOI 10.2144/97224rr02; GRAVES PN, 1983, VIROLOGY, V126, P106, DOI 10.1016/0042-6822(83)90465-8; Gronowski AM, 1999, J VIROL, V73, P9944, DOI 10.1128/JVI.73.12.9944-9951.1999; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Harris AK, 2013, P NATL ACAD SCI USA, V110, P4592, DOI 10.1073/pnas.1214913110; Huber VC, 2014, EXPERT REV VACCINES, V13, P31, DOI 10.1586/14760584.2014.852476; Hutter J, 2013, J IMMUNOL, V190, P220, DOI 10.4049/jimmunol.1201060; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Kang SM, 2009, CURR TOP MICROBIOL, V333, P269, DOI 10.1007/978-3-540-92165-3_14; Kim EH, 2014, J VIROL, V88, P9693, DOI 10.1128/JVI.00823-14; Kim Joo Young, 2013, Immune Netw, V13, P275, DOI 10.4110/in.2013.13.6.275; Kim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075460; Kost TA, 1999, CURR OPIN BIOTECH, V10, P428, DOI 10.1016/S0958-1669(99)00005-1; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212; Lindley KM, 2000, J IMMUNOL METHODS, V234, P123, DOI 10.1016/S0022-1759(99)00133-7; Lu HY, 2012, BIOENGINEERED, V3, P271, DOI 10.4161/bioe.20679; Madhan S, 2010, CURR GENE THER, V10, P201, DOI 10.2174/156652310791321233; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; McPherson CE, 2008, BIOLOGICALS, V36, P350, DOI 10.1016/j.biologicals.2008.08.001; Mottershead D, 1997, BIOCHEM BIOPH RES CO, V238, P717, DOI 10.1006/bbrc.1997.7372; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Prabakaran M, 2013, VACCINE, V31, P1385, DOI 10.1016/j.vaccine.2013.01.003; Pushko P, 2010, VACCINE, V28, P4771, DOI 10.1016/j.vaccine.2010.04.093; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang DG, 2007, MOL THER, V15, P989, DOI 10.1038/mt.sj.6300131; Yoshida S, 2003, VIROLOGY, V316, P161, DOI 10.1016/j.virol.2003.08.003; Yu JR, 2008, J VIROL, V82, P2350, DOI 10.1128/JVI.02372-07	51	10	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152485	10.1371/journal.pone.0152485	http://dx.doi.org/10.1371/journal.pone.0152485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023684	gold, Green Published, Green Submitted			2022-12-26	WOS:000373113900063
J	Weiszenstein, M; Pavlikova, N; Elkalaf, M; Halada, P; Seda, O; Trnka, J; Kovar, J; Polak, J				Weiszenstein, Martin; Pavlikova, Nela; Elkalaf, Moustafa; Halada, Petr; Seda, Ondrej; Trnka, Jan; Kovar, Jan; Polak, Jan			The Effect of Pericellular Oxygen Levels on Proteomic Profile and Lipogenesis in 3T3-L1 Differentiated Preadipocytes Cultured on Gas-Permeable Cultureware	PLOS ONE			English	Article							ADIPOSE-TISSUE; GLUTAMINE-METABOLISM; RISK-FACTOR; OBESITY; HYPOXIA; INFLAMMATION; GROWTH; CELLS; DEHYDROGENASE; QUANTITATION	Pericellular oxygen concentration represents an important factor in the regulation of cell functions, including cell differentiation, growth and mitochondrial energy metabolism. Hypoxia in adipose tissue has been associated with altered adipokine secretion profile and suggested as a possible factor in the development of type 2 diabetes. In vitro experiments provide an indispensable tool in metabolic research, however, physical laws of gas diffusion make prolonged exposure of adherent cells to desired pericellular O-2 concentrations questionable. The aim of this study was to investigate the direct effect of various O-2 levels (1%, 4% and 20% O-2) on the proteomic profile and triglyceride accumulation in 3T3-L1 differentiated preadipocytes using gas-permeable cultureware. Following differentiation of cells under desired pericellular O-2 concentrations, cell lysates were subjected to two-dimensional gel electrophoresis and protein visualization using Coomassie blue staining. Spots showing differential expression under hypoxia were analyzed using matrix-assisted laser desorption/ionization mass spectrometry. All identified proteins were subjected to pathway analysis. We observed that protein expression of 26 spots was reproducibly affected by 4% and 1% O-2 (17 upregulated and 9 downregulated). Pathway analysis showed that mitochondrial energy metabolism and triglyceride synthesis were significantly upregulated by hypoxia. In conclusion, this study demonstrated the direct effects of pericellular O-2 levels on adipocyte energy metabolism and triglyceride synthesis, probably mediated through the reversed tricarboxylic acid cycle flux.	[Weiszenstein, Martin; Polak, Jan] Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic; [Pavlikova, Nela; Kovar, Jan] Charles Univ Prague, Fac Med 3, Dept Biochem Cell & Mol Biol, Div Cell & Mol Biol, Prague, Czech Republic; [Elkalaf, Moustafa; Trnka, Jan] Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic; [Halada, Petr] CAS, Inst Microbiol, Lab Mol Struct Characterizat, Vvi, Prague, Czech Republic; [Seda, Ondrej] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic; [Polak, Jan] Natl Inst Publ Hlth, Ctr Toxicol & Hlth Safety, Prague, Czech Republic; [Polak, Jan] Univ Hosp Kralovske Vinohrady, Dept Internal Med 2, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; National Institute of Public Health (SZU) - Czech Republic; University Hospital Vinohrady	Polak, J (corresponding author), Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic.; Polak, J (corresponding author), Natl Inst Publ Hlth, Ctr Toxicol & Hlth Safety, Prague, Czech Republic.; Polak, J (corresponding author), Univ Hosp Kralovske Vinohrady, Dept Internal Med 2, Prague, Czech Republic.	jan.polak@lf3.cuni.cz	Kovář, Jan/Y-7480-2018; Pavlíková, Nela/W-7000-2018; Pavlikova, Nela/AAL-1103-2021; Pavlikova, Nela/D-3763-2013; Trnka, Jan/B-8951-2012; Halada, Petr/H-3330-2014; Elkalaf, Moustafa/AAL-4938-2020; Polak, Jan/J-3404-2014; Seda, Ondrej/A-2058-2008	Kovář, Jan/0000-0001-9432-8960; Pavlíková, Nela/0000-0001-7468-1505; Pavlikova, Nela/0000-0001-7468-1505; Trnka, Jan/0000-0002-1786-7562; Halada, Petr/0000-0002-7229-3450; Elkalaf, Moustafa/0000-0002-0418-2732; Polak, Jan/0000-0001-9964-652X; Seda, Ondrej/0000-0001-8498-5895	Grant Agency of Czech Republic -GACR [P304/13-27735S]; Grant Agency of Charles University-GAUK [226214]; Specific University Research Grant [SVV 260165/2015]; Ministry of Education, Youth and Sports of the Czech Republic [LO1509]; Operational Program Prague - Competitiveness project - EU [CZ.2.16/3.1.00/24023]	Grant Agency of Czech Republic -GACR(Grant Agency of the Czech Republic); Grant Agency of Charles University-GAUK; Specific University Research Grant; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Operational Program Prague - Competitiveness project - EU	This work was supported by Grant Agency of Czech Republic -GACR P304/13-27735S-JP (http://gacr.cz); Grant Agency of Charles University-GAUK 226214-MW (http://www.cuni.cz/UK-33.html); Specific University Research Grant- SVV 260165/2015-JP MW (http://www.cuni.cz/UK-3362.html); and The Ministry of Education, Youth and Sports of the Czech Republic- project LO1509 and Operational Program Prague - Competitiveness project (CZ.2.16/3.1.00/24023) supported by EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CB, 2001, AM J PHYSIOL-LUNG C, V281, pL1021, DOI 10.1152/ajplung.2001.281.4.L1021; Balin AK, 2002, IN VITRO CELL DEV-AN, V38, P305; Bambrick LL, 2011, BIOTECHNOL PROGR, V27, P1185, DOI 10.1002/btpr.622; Carmichael AR, 2006, BJOG-INT J OBSTET GY, V113, P1160, DOI 10.1111/j.1471-0528.2006.01021.x; Coppack SW, 1999, AM J PHYSIOL-ENDOC M, V276, pE233, DOI 10.1152/ajpendo.1999.276.2.E233; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; Dyballa N, 2009, JVISEXP; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Hong SY, 2012, EUR J CANCER PREV, V21, P523, DOI 10.1097/CEJ.0b013e328351c775; HORIKOSHI T, 1986, J INVEST DERMATOL, V86, P424, DOI 10.1111/1523-1747.ep12285695; HORIKOSHI T, 1991, J INVEST DERMATOL, V96, P841, DOI 10.1111/1523-1747.ep12474550; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Lastra G, 2013, HORM MOL BIOL CLIN I, V15, P49, DOI 10.1515/hmbci-2013-0025; MacDougald OA, 2005, P NATL ACAD SCI USA, V102, P10759, DOI 10.1073/pnas.0504965102; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; METZEN E, 1995, RESP PHYSIOL, V100, P101, DOI 10.1016/0034-5687(94)00125-J; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; NUNNARI JJ, 1989, EXP MOL PATHOL, V51, P1, DOI 10.1016/0014-4800(89)90002-6; PAPASIAN CJ, 1987, DIAGN MICR INFEC DIS, V8, P255, DOI 10.1016/0732-8893(87)90058-7; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pavlikova N, 2015, CELL MOL BIOL LETT; Polak J, 2015, GEN PHYSIOL BIOPHYS, V34, P235, DOI 10.4149/gpb_2014043; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Rizzatti V, 2013, EUR J HISTOCHEM, V57, P159, DOI 10.4081/ejh.2013.e24; Semenza GL., 2011, COLD SPRING HARBSYMP; Song X, 2014, NUTRMETAB CARDIOVASC; Spencer M, 2011, J CLIN ENDOCR METAB, V96, pE1990, DOI 10.1210/jc.2011-1567; Trayhurn P, 2008, BRJNUTR; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Wise DR, 2011, PROCNATLACADSCI US; Ye J, 2007, AMJPHYSIOL ENDOCRINO; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200	38	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152382	10.1371/journal.pone.0152382	http://dx.doi.org/10.1371/journal.pone.0152382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023342	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900051
J	DeVries, B; Pratihast, AK; Verbesselt, J; Kooistra, L; Herold, M				DeVries, Ben; Pratihast, Arun Kumar; Verbesselt, Jan; Kooistra, Lammert; Herold, Martin			Characterizing Forest Change Using Community-Based Monitoring Data and Landsat Time Series	PLOS ONE			English	Article							REDD PLUS; TROPICAL FORESTS; DETECTING TRENDS; COVER LOSS; SATELLITE; DEGRADATION; DISTURBANCE; DEFORESTATION; BIODIVERSITY; BIOMASS	Increasing awareness of the issue of deforestation and degradation in the tropics has resulted in efforts to monitor forest resources in tropical countries. Advances in satellite-based remote sensing and ground-based technologies have allowed for monitoring of forests with high spatial, temporal and thematic detail. Despite these advances, there is a need to engage communities in monitoring activities and include these stakeholders in national forest monitoring systems. In this study, we analyzed activity data (deforestation and forest degradation) collected by local forest experts over a 3-year period in an Afromontane forest area in southwestern Ethiopia and corresponding Landsat Time Series (LTS). Local expert data included forest change attributes, geo-location and photo evidence recorded using mobile phones with integrated GPS and photo capabilities. We also assembled LTS using all available data from all spectral bands and a suite of additional indices and temporal metrics based on time series trajectory analysis. We predicted deforestation, degradation or stable forests using random forest models trained with data from local experts and LTS spectral-temporal metrics as model covariates. Resulting models predicted deforestation and degradation with an out of bag (OOB) error estimate of 29% overall, and 26% and 31% for the deforestation and degradation classes, respectively. By dividing the local expert data into training and operational phases corresponding to local monitoring activities, we found that forest change models improved as more local expert data were used. Finally, we produced maps of deforestation and degradation using the most important spectral bands. The results in this study represent some of the first to combine local expert based forest change data and dense LTS, demonstrating the complementary value of both continuous data streams. Our results underpin the utility of both datasets and provide a useful foundation for integrated forest monitoring systems relying on data streams from diverse sources.	[DeVries, Ben; Pratihast, Arun Kumar; Verbesselt, Jan; Kooistra, Lammert; Herold, Martin] Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	DeVries, B (corresponding author), Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, NL-6700 AP Wageningen, Netherlands.	devries.br@gmail.com	Kooistra, Lammert/I-6331-2016; Herold, Martin/F-8553-2012; DeVries, Ben/H-5588-2019; Pratihast, Arun/AAO-8661-2020; Verbesselt, Jan/B-9044-2012; Kooistra, Lammert/AAW-2172-2020	Kooistra, Lammert/0000-0001-5549-5993; Herold, Martin/0000-0003-0246-6886; DeVries, Ben/0000-0003-2136-3401; Verbesselt, Jan/0000-0001-7923-4309; Kooistra, Lammert/0000-0001-5549-5993	German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) International Climate Initiative (IKI); Nature and Biodiversity Conservation Union (NABU); Center for International Forestry Research (CIFOR); Google Earth Engine Research Award	German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) International Climate Initiative (IKI); Nature and Biodiversity Conservation Union (NABU); Center for International Forestry Research (CIFOR)(CGIAR); Google Earth Engine Research Award(Google Incorporated)	This work was supported by German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) International Climate Initiative (IKI) through the project: "Biodiversity under Climate Change: Community Based Conservation, Management and Development Concepts for the Wild Coffee Forests", in partnership with Nature and Biodiversity Conservation Union (NABU), http://www.international-climate-initiative.com/en/, http://www.nabu.de. This work was also supported by German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) International Climate Initiative (IKI) through the project: "From Climate Research to Action under Multilevel Governance: Building Knowledge and Capacity at Landscape Scale", in partnership with the Center for International Forestry Research (CIFOR), http://www.international-climate-initiative.com/en/, http://www.cifor.org. This work was also supported by Google Earth Engine Research Award: "Interactive forest monitoring using satellite data and community-observations in the Google platform", https://research.google.com/university/relations/ee_awards.html.	Aerts R, 2015, SCIENCE, V347, P139, DOI 10.1126/science.347.6218.139-b; Ahmed OS, 2014, CAN J REMOTE SENS, V39, P521, DOI 10.5589/m14-004; Angelsen A., 2009, REALISING REDD NATL; Anokwa Y, 2009, COMPUTER, V42, P97, DOI 10.1109/MC.2009.328; Banskota A, 2014, CAN J REMOTE SENS, V40, P362, DOI 10.1080/07038992.2014.987376; Bellfield H, 2015, FORESTS, V6, P133, DOI 10.3390/f6010133; Bigagli L, 2015, ISPRS INT J GEO-INF, V4, P647, DOI 10.3390/ijgi4020647; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Broich M, 2011, INT J APPL EARTH OBS, V13, P277, DOI 10.1016/j.jag.2010.11.004; Cohen WB, 2010, REMOTE SENS ENVIRON, V114, P2911, DOI 10.1016/j.rse.2010.07.010; Comber A, 2013, INT J APPL EARTH OBS, V23, P37, DOI 10.1016/j.jag.2012.11.002; Confalonieri R, 2013, COMPUT ELECTRON AGR, V96, P67, DOI 10.1016/j.compag.2013.04.019; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Coppin P, 2004, INT J REMOTE SENS, V25, P1565, DOI 10.1080/0143116031000101675; CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619; CRIST EP, 1985, REMOTE SENS ENVIRON, V17, P301, DOI 10.1016/0034-4257(85)90102-6; de Jong R, 2013, REMOTE SENS-BASEL, V5, P1117, DOI 10.3390/rs5031117; De Sy V, 2012, CURR OPIN ENV SUST, V4, P696, DOI 10.1016/j.cosust.2012.09.013; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Delbart N, 2015, REMOTE SENS ENVIRON, V160, P273, DOI 10.1016/j.rse.2015.01.012; DeVries B, 2015, REMOTE SENS ENVIRON, V161, P107, DOI 10.1016/j.rse.2015.02.012; Devries B, 2013, LAW, TROPICAL FORESTS AND CARBON: THE CASE OF REDD+, P151; Dutrieux LP, 2015, ISPRS J PHOTOGRAMM, V107, P112, DOI 10.1016/j.isprsjprs.2015.03.015; FAO, 1984, 50 FAO FAO DEP; Ferster CJ, 2016, INT J DIGIT EARTH, V9, P171, DOI 10.1080/17538947.2014.1002865; Foody GM, 2013, IEEE J-STARS, V6, P1305, DOI 10.1109/JSTARS.2013.2250257; Gomez C, 2014, ISPRS J PHOTOGRAMM, V93, P14, DOI 10.1016/j.isprsjprs.2014.03.008; Gonsamo A, 2013, OIKOS, V122, P1283, DOI 10.1111/j.1600-0706.2013.00369.x; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Herold M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014002; Hirschmugl Manuela, 2014, Remote Sensing, V6, P756, DOI 10.3390/rs6010756; Huang CQ, 2010, REMOTE SENS ENVIRON, V114, P183, DOI 10.1016/j.rse.2009.08.017; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; INPE, 2014, PROJ PRODES MON FLOR; INPE, 2014, DET DESM TEMP REAL; Irons JR, 2012, REMOTE SENS ENVIRON, V122, P11, DOI 10.1016/j.rse.2011.08.026; Jamali S, 2015, REMOTE SENS ENVIRON, V156, P182, DOI 10.1016/j.rse.2014.09.010; Jin SM, 2005, REMOTE SENS ENVIRON, V94, P364, DOI 10.1016/j.rse.2004.10.012; Kennedy RE, 2010, REMOTE SENS ENVIRON, V114, P2897, DOI 10.1016/j.rse.2010.07.008; Key C.H., 2006, LANDSCAPE ASSESSMENT; Lambin EF, 1999, GLOBAL ECOL BIOGEOGR, V8, P191, DOI 10.1046/j.1365-2699.1999.00123.x; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Mertz O, 2012, FORGOTTEN D CHALLENG, P37; Molinario G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/094009; Morales-Barquero L, 2014, FORESTS, V5, P1653, DOI 10.3390/f5071653; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Peng Li, 2014, Remote Sensing, V6, P310, DOI 10.3390/rs6010310; Penman J., 2003, GOOD PRACTICE GUIDAN; Pratihast AK, 2014, FORESTS, V5, P2464, DOI 10.3390/f5102464; Pratihast AK, 2013, SENSORS-BASEL, V13, P21, DOI 10.3390/s130100021; Reiche J, 2015, REMOTE SENS-BASEL, V7, P4973, DOI 10.3390/rs70504973; Reiche J, 2015, REMOTE SENS ENVIRON, V156, P276, DOI 10.1016/j.rse.2014.10.001; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Schnitzer SA, 2011, PLANT SIGNAL BEHAV, V6, P598, DOI 10.4161/psb.6.4.15373; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Senbeta F, 2005, DIVERS DISTRIB, V11, P443, DOI 10.1111/j.1366-9516.2005.00180.x; Skutsch M, 2014, FORESTS, V5, P1596, DOI 10.3390/f5071596; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Thompson ID, 2013, ECOL SOC, V18; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Tyukavina A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044039; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P2970, DOI 10.1016/j.rse.2010.08.003; Vermote EF, 1997, IEEE T GEOSCI REMOTE, V35, P675, DOI 10.1109/36.581987; Wilson EH, 2002, REMOTE SENS ENVIRON, V80, P385, DOI 10.1016/S0034-4257(01)00318-2; World Resource Institute, 2014, GLOB FOR WATCH; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010; Zhu Z, 2014, REMOTE SENS ENVIRON, V144, P152, DOI 10.1016/j.rse.2014.01.011; Zhu Z, 2012, REMOTE SENS ENVIRON, V122, P75, DOI 10.1016/j.rse.2011.10.030; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028	74	52	53	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0147121	10.1371/journal.pone.0147121	http://dx.doi.org/10.1371/journal.pone.0147121			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018852	Green Published, gold, Green Submitted			2022-12-26	WOS:000372807800002
J	Pueyo, E; Dangerfield, CE; Britton, OJ; Virag, L; Kistamas, K; Szentandrassy, N; Jost, N; Varro, A; Nanasi, PP; Burrage, K; Rodriguez, B				Pueyo, E.; Dangerfield, C. E.; Britton, O. J.; Virag, L.; Kistamas, K.; Szentandrassy, N.; Jost, N.; Varro, A.; Nanasi, P. P.; Burrage, K.; Rodriguez, B.			Experimentally-Based Computational Investigation into Beat-To-Beat Variability in Ventricular Repolarization and Its Response to Ionic Current Inhibition	PLOS ONE			English	Article							LATE SODIUM CURRENT; DELAYED RECTIFIER CHANNELS; SHORT-TERM VARIABILITY; ACTION-POTENTIALS; HEART-FAILURE; MYOCYTES; CELLS; ARRHYTHMOGENESIS; PROARRHYTHMIA; ARRHYTHMIAS	Beat-to-beat variability in repolarization (BVR) has been proposed as an arrhythmic risk marker for disease and pharmacological action. Themechanisms are unclear but BVR is thought to be a cell level manifestation of ion channel stochasticity, modulated by cell-to-cell differences in ionic conductances. In this study, we describe the construction of an experimentally-calibrated set of stochastic cardiac cell models that captures both BVR and cell-to-cell differences in BVR displayed in isolated canine action potentialmeasurements using pharmacological agents. Simulated and experimental ranges of BVR are compared in control and under pharmacological inhibition, and the key ionic currents determining BVR under physiological and pharmacological conditions are identified. Results show that the 4-aminopyridine-sensitive transient outward potassium current, I-to1, is a fundamental driver of BVR in control and upon complete inhibition of the slow delayed rectifier potassium current, I-Ks. In contrast, I-Ks and the L-type calcium current, I-CaL, become the major contributors to BVR upon inhibition of the fast delayed rectifier potassiumcurrent, I-Kr. This highlights both I-Ks and I-to1 as key contributors to repolarization reserve. Partial correlation analysis identifies the distribution of I-to1 channel numbers as an important independent determinant of themagnitude of BVR and drug-induced change in BVR in control and under pharmacological inhibition of ionic currents. Distributions in the number of I-Ks and I-CaL channels only become independent determinants of the magnitude of BVR upon complete inhibition of I-Kr. These findings provide quantitative insights into the ionic causes of BVR as a marker for repolarization reserve, both under control condition and pharmacological inhibition.	[Pueyo, E.] Univ Zaragoza, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain; [Pueyo, E.] Univ Zaragoza, Biosignal Interpretat & Computat Simulat Grp, I3A, IIS, Zaragoza, Spain; [Dangerfield, C. E.; Britton, O. J.; Burrage, K.; Rodriguez, B.] Univ Oxford, Dept Comp Sci, Oxford, England; [Virag, L.; Jost, N.; Varro, A.] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, Szeged, Hungary; [Virag, L.; Jost, N.; Varro, A.] Hungarian Acad Sci, MTA SZTE Res Grp Cardiovasc Pharmacol, Szeged, Hungary; [Kistamas, K.; Szentandrassy, N.; Nanasi, P. P.] Univ Debrecen, Dept Physiol, Fac Med, Debrecen, Hungary; [Szentandrassy, N.; Nanasi, P. P.] Univ Debrecen, Fac Dent, Dept Dent Physiol & Pharmacol, Debrecen, Hungary; [Burrage, K.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Burrage, K.] Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Brisbane, Qld 4001, Australia	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Zaragoza; University of Zaragoza; University of Oxford; Szeged University; Hungarian Academy of Sciences; University of Debrecen; University of Debrecen; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Pueyo, E (corresponding author), Univ Zaragoza, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain.; Pueyo, E (corresponding author), Univ Zaragoza, Biosignal Interpretat & Computat Simulat Grp, I3A, IIS, Zaragoza, Spain.	epueyo@unizar.es	Varro, Andras/M-2647-2016; Pueyo, Esther/C-6945-2009; Kistamás, Kornél/AAE-6090-2019; Kistamas, Kornel/H-1305-2015	Pueyo, Esther/0000-0002-1960-407X; Kistamas, Kornel/0000-0003-4705-5327; Rodriguez, Blanca/0000-0001-6361-3339; Britton, Oliver/0000-0002-6422-8990	Spanish Ministry of Economy and Competitiveness (MINECO), Spain [TIN2013-41998-R]; BioSignal Interpretation and Computational Simulation (BSICoS) group from Aragon Government; European Social Fund; Hungarian Research Fund (OTKA) [NK-104331, K-109736, NN-109904]; National Development Agency [TAMOP-4.2.2A-11/1/KONV-2012-0073, TAMOP-4.2.2.A-11/1/KONV-2012-0045]; European Union; Ramon y Cajal program from MINECO, Spain; EPSRC; Engineering and Physical Sciences Research Council; Wellcome Trust [100246/Z/12/Z]; Engineering and Physical Sciences Research Council [984966] Funding Source: researchfish	Spanish Ministry of Economy and Competitiveness (MINECO), Spain; BioSignal Interpretation and Computational Simulation (BSICoS) group from Aragon Government; European Social Fund(European Social Fund (ESF)); Hungarian Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; European Union(European Commission); Ramon y Cajal program from MINECO, Spain; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by project TIN2013-41998-R from Spanish Ministry of Economy and Competitiveness (MINECO), Spain, by BioSignal Interpretation and Computational Simulation (BSICoS) group from Aragon Government and European Social Fund, by grants from the Hungarian Research Fund (OTKA, NK-104331, K-109736 and NN-109904) and by National Development Agency (TAMOP-4.2.2A-11/1/KONV-2012-0073 and TAMOP-4.2.2.A-11/1/KONV-2012-0045), which is co-financed by the European Union and the European Social Fund. Simulations were run using the High Performance Computing facilities of NANBIOSIS ICTS, CIBER-BBN and I3A, Zaragoza, Spain. E.P. acknowledges the financial support of Ramon y Cajal program from MINECO, Spain. C.E.D acknowledges the financial support of the EPSRC PhD Prize Scheme. O.J.B. is supported by an Engineering and Physical Sciences Research Council-funded Systems Biology Doctoral Training Centre studentship. B.R holds a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science (100246/Z/12/Z).	Abi-Gerges N, 2010, BRIT J PHARMACOL, V159, P77, DOI 10.1111/j.1476-5381.2009.00338.x; Altomare C, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1265, DOI 10.1161/CIRCEP.114.002572; Britton OJ, 2013, P NATL ACAD SCI USA, V110, pE2098, DOI 10.1073/pnas.1304382110; Dangerfield CE, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051907; Davies MR, 2012, AM J PHYSIOL-HEART C, V302, pH1466, DOI 10.1152/ajpheart.00808.2011; Decker KF, 2009, AM J PHYSIOL-HEART C, V296, pH1017, DOI 10.1152/ajpheart.01216.2008; FEDIDA D, 1991, J PHYSIOL-LONDON, V442, P191, DOI 10.1113/jphysiol.1991.sp018789; Guia A, 2001, BIOPHYS J, V80, P2742, DOI 10.1016/S0006-3495(01)76242-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heijman J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003202; Hinterseer M, 2010, AM J CARDIOL, V106, P216, DOI 10.1016/j.amjcard.2010.02.033; HORIE M, 1990, JPN J PHYSIOL, V40, P479, DOI 10.2170/jjphysiol.40.479; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Johnson DM, 2013, CIRC RES, V112, P246, DOI 10.1161/CIRCRESAHA.112.275735; Lemay M, 2011, J THEOR BIOL, V281, P84, DOI 10.1016/j.jtbi.2011.04.019; Lerma C, 2007, J STAT PHYS, V128, P347, DOI 10.1007/s10955-006-9191-y; Liu GX, 2004, J PHYSIOL-LONDON, V556, P401, DOI 10.1113/jphysiol.2003.059303; Magyar J, 2015, CURR PHARM DESIGN, V21, P1042; Maltsev VA, 2007, EUR J HEART FAIL, V9, P219, DOI 10.1016/j.ejheart.2006.08.007; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Sanchez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105897; Sarkar AX, 2011, HEART RHYTHM, V8, P1749, DOI 10.1016/j.hrthm.2011.05.023; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Szentandrassy N, 2011, BRIT J PHARMACOL, V163, P499, DOI 10.1111/j.1476-5381.2011.01215.x; Szentandrassy N, 2015, PFLUG ARCH EUR J PHY, V467, P1431, DOI 10.1007/s00424-014-1581-4; Undrovinas Albertas I, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS169; Varkevisser R, 2012, HEART RHYTHM, V9, P1718, DOI 10.1016/j.hrthm.2012.05.016; Varro A, 2011, BRIT J PHARMACOL, V164, P14, DOI 10.1111/j.1476-5381.2011.01367.x; VELDKAMP MW, 1995, CIRCULATION, V92, P3497, DOI 10.1161/01.CIR.92.12.3497; VELDKAMP MW, 1993, CIRC RES, V72, P865, DOI 10.1161/01.RES.72.4.865; Walmsley J, 2015, J THEOR BIOL, V365, P325, DOI 10.1016/j.jtbi.2014.10.029; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; Werry D, 2013, P NATL ACAD SCI USA, V110, pE996, DOI 10.1073/pnas.1214875110; Wolk R, 1999, PHARMACOL THERAPEUT, V84, P207, DOI 10.1016/S0163-7258(99)00033-9; Wu L, 2006, J PHARMACOL EXP THER, V316, P718, DOI 10.1124/jpet.105.094862; Wu L, 2011, CIRCULATION, V123, P1713, DOI 10.1161/CIRCULATIONAHA.110.000661; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677; Zaniboni M, 2007, EXP PHYSIOL, V92, P859, DOI 10.1113/expphysiol.2007.037986	38	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151461	10.1371/journal.pone.0151461	http://dx.doi.org/10.1371/journal.pone.0151461			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019293	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000372807800012
J	Vogl, F; Schnuriger, K; Gerber, H; Taylor, WR				Vogl, Florian; Schnueriger, Karin; Gerber, Hans; Taylor, William R.			Reliability of Phase Velocity Measurements of Flexural Acoustic Waves in the Human Tibia In-Vivo	PLOS ONE			English	Article							ULTRASONICALLY DETERMINED THICKNESS; X-RAY ABSORPTIOMETRY; BONE-MINERAL DENSITY; LONG CORTICAL BONES; AXIAL TRANSMISSION; ULTRASOUND VELOCITY; VITRO EXPERIMENTS; ULTRASONOMETER; OSTEOPOROSIS; SIMULATIONS	Purpose Axial-transmission acoustics have shown to be a promising technique to measure individual bone properties and detect bone pathologies. With the ultimate goal being the in-vivo application of such systems, quantification of the key aspects governing the reliability is crucial to bring this method towards clinical use. Materials and Methods This work presents a systematic reliability study quantifying the sources of variability and their magnitudes of in-vivo measurements using axial-transmission acoustics. 42 healthy subjects were measured by an experienced operator twice per week, over a four-month period, resulting in over 150000 wave measurements. In a complementary study to assess the influence of different operators performing the measurements, 10 novice operators were trained, and each measured 5 subjects on a single occasion, using the same measurement protocol as in the first part of the study. Results The estimated standard error for the measurement protocol used to collect the study data was similar to 17 m/s (similar to 4% of the grand mean) and the index of dependability, as a measure of reliability, was Phi = 0.81. It was shown that the method is suitable for multi-operator use and that the reliability can be improved efficiently by additional measurements with device repositioning, while additional measurements without repositioning cannot improve the reliability substantially. Phase velocity values were found to be significantly higher in males than in females (p < 10(-5)) and an intra-class correlation coefficient of r = 0.70 was found between the legs of each subject. Conclusions The high reliability of this non-invasive approach and its intrinsic sensitivity to mechanical properties opens perspectives for the rapid and inexpensive clinical assessment of bone pathologies, as well as for monitoring programmes without any radiation exposure for the patient.	[Vogl, Florian; Schnueriger, Karin; Gerber, Hans; Taylor, William R.] Swiss Fed Inst Technol Zurich, Dept Hlth Sci & Technol, Inst Biomech, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Taylor, WR (corresponding author), Swiss Fed Inst Technol Zurich, Dept Hlth Sci & Technol, Inst Biomech, Zurich, Switzerland.	taylorb@ethz.ch	Taylor, William R./F-8692-2010	Taylor, William R./0000-0003-4060-4098	Robert Mathys Foundation, Bettlach, Switzerland	Robert Mathys Foundation, Bettlach, Switzerland	This study was partially funded by the Robert Mathys Foundation, Bettlach, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1972, MENTAL TESTS CULTURA; Bossy E, 2004, IEEE T ULTRASON FERR, V51, P71, DOI 10.1109/TUFFC.2004.1268469; Brennan R.L., 2001, GEN THEORY; Calbet JAL, 1999, OSTEOPOROSIS INT, V10, P468, DOI 10.1007/s001980050256; Calbet JAL, 2001, MED SCI SPORT EXER, V33, P1682, DOI 10.1097/00005768-200110000-00011; Camus E, 2000, J ACOUST SOC AM, V108, P3058, DOI 10.1121/1.1290245; CASEZ JP, 1995, BONE, V17, P211, DOI 10.1016/8756-3282(95)00217-2; de Bruin ED, 2005, J REHABIL RES DEV, V42, P55, DOI 10.1682/JRRD.2003.09.0144; de Bruin ED, 1998, PHYS THER, V78, P1166, DOI 10.1093/ptj/78.11.1166; Egorov V, 2014, ULTRASONICS, V54, P1170, DOI 10.1016/j.ultras.2013.08.017; FAH D, 1988, J BIOMECH, V21, P975, DOI 10.1016/0021-9290(88)90136-4; Flynn Timothy W, 2002, Work, V18, P151; Foldes AJ, 1996, NEPHROL DIAL TRANSPL, V11, P1318; Graff K, 1991, WAVE MOTION ELASTIC, P521; Krestan CR, 2004, AM J ROENTGENOL, V183, P639, DOI 10.2214/ajr.183.3.1830639; Laugier P, 2011, BONE QUANTITATIVE ULTRASOUND, P1, DOI 10.1007/978-94-007-0017-8; Moilanen P, 2004, ULTRASOUND MED BIOL, V30, P1517, DOI 10.1016/j.ultrasmedbio.2004.08.017; Moilanen P, 2007, J ACOUST SOC AM, V122, P2439, DOI 10.1121/1.2769619; Moilanen P, 2007, J ACOUST SOC AM, V122, P1818, DOI 10.1121/1.2756758; Moilanen P, 2007, ULTRASOUND MED BIOL, V33, P254, DOI 10.1016/j.ultrasmedbio.2006.07.038; Muller M, 2005, ULTRASOUND MED BIOL, V31, P633, DOI 10.1016/j.ultrasmedbio.2005.02.001; Nicholson PHF, 2002, PHYSIOL MEAS, V23, P755, DOI 10.1088/0967-3334/23/4/313; Sarvazyan A, 2009, ULTRASONICS, V49, P331, DOI 10.1016/j.ultras.2008.10.003; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sievanen H, 2001, OSTEOPOROSIS INT, V12, P399, DOI 10.1007/s001980170109; Talmant M, 2009, ULTRASOUND MED BIOL, V35, P912, DOI 10.1016/j.ultrasmedbio.2008.12.008; Tatarinov A, 2014, ULTRASONICS, V54, P1162, DOI 10.1016/j.ultras.2013.09.025; Tuna H, 2008, YONSEI MED J, V49, P436, DOI 10.3349/ymj.2008.49.3.436; Zadik Z, 2005, J CLIN GASTROENTEROL, V39, P120	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152417	10.1371/journal.pone.0152417	http://dx.doi.org/10.1371/journal.pone.0152417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015093	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900063
J	Yu-Rice, Y; Jin, Y; Han, B; Qu, Y; Johnson, J; Watanabe, T; Cheng, L; Deng, N; Tanaka, H; Gao, B; Liu, Z; Sun, Z; Bose, S; Giuliano, A; Cui, X				Yu-Rice, Y.; Jin, Y.; Han, B.; Qu, Y.; Johnson, J.; Watanabe, T.; Cheng, L.; Deng, N.; Tanaka, H.; Gao, B.; Liu, Z.; Sun, Z.; Bose, S.; Giuliano, A. E.; Cui, X.			FOXC1 is involved in ERa silencing by counteracting GATA3 binding and is implicated in endocrine resistance	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION PATTERNS; BREAST-CANCER CELLS; TRANSCRIPTIONAL REGULATION; FORKHEAD DOMAIN; POOR-PROGNOSIS; TAMOXIFEN; PROTEIN; FOXA1; OVEREXPRESSION	Estrogen receptor-alpha (ER alpha) mediates the essential biological function of estrogen in breast development and tumorigenesis. Multiple mechanisms, including pioneer factors, coregulators and epigenetic modifications have been identified as regulators of ER alpha signaling in breast cancer. However, previous studies of ER alpha regulation have focused on luminal and HER2-positive subtypes rather than basal-like breast cancer (BLBC), in which ER alpha is underexpressed. In addition, mechanisms that account for the decrease or loss of ER expression in recurrent tumors after endocrine therapy remain elusive. Here, we demonstrate a novel FOXC1-driven mechanism that suppresses ERa expression in breast cancer. We find that FOXC1 competes with GATA-binding protein 3 (GATA3) for the same binding regions in the cis-regulatory elements upstream of the ER alpha gene and thereby downregulates ER alpha expression and consequently its transcriptional activity. The forkhead domain of FOXC1 is essential for the competition with GATA3 for DNA binding. Counteracting the action of GATA3 at the ER alpha promoter region, overexpression of FOXC1 hinders recruitment of RNA polymerase II and increases histone H3K9 trimethylation at ER alpha promoters. Importantly, ectopic FOXC1 expression in luminal breast cancer cells reduces sensitivity to estrogen and tamoxifen. Furthermore, in breast cancer patients with ER-positive primary tumors who received adjuvant tamoxifen treatment, FOXC1 expression is associated with decreased or undetectable ER expression in recurrent tumors. Our findings highlight a clinically relevant mechanism that contributes to the low or absent ER alpha expression in BLBC. This study suggests a new paradigm to study ER alpha regulation during breast cancer progression and indicates a role of FOXC1 in the modulation of cellular response to endocrine treatment.	[Yu-Rice, Y.; Jin, Y.; Han, B.; Qu, Y.; Johnson, J.; Watanabe, T.; Tanaka, H.; Gao, B.; Giuliano, A. E.; Cui, X.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Cheng, L.; Sun, Z.] Chongqing Med Univ, Affiliated Hosp 2, Dept Breast & Thyroid Surg, Chongqing, Peoples R China; [Deng, N.; Liu, Z.] Cedars Sinai Med Ctr, Dept Surg, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA; [Bose, S.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Pathol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Chongqing Medical University; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Cui, X (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,Davis Bldg 2065, Los Angeles, CA 90048 USA.	Xiaojiang.Cui@cshs.org		Johnson, Jeffrey/0000-0003-2912-443X; Tanaka, Hisashi/0000-0001-9223-4186	National Institutes of Health [CA151610]; Avon Foundation for Women [02-2014-063]; David Salomon Translational Breast Cancer Research Fund; Eleanor and Glenn Padnick Discovery Fund in Cellular Therapy; Margie and Robert E. Petersen Foundation; Linda and Jim Lippman Research Fund; Fashion Footwear Charitable Foundation of New York, Inc.; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation for Women; David Salomon Translational Breast Cancer Research Fund; Eleanor and Glenn Padnick Discovery Fund in Cellular Therapy; Margie and Robert E. Petersen Foundation; Linda and Jim Lippman Research Fund; Fashion Footwear Charitable Foundation of New York, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Julia Gee for discussion about antiestrogen experiments. This work was supported by the National Institutes of Health (CA151610), the Avon Foundation for Women (02-2014-063) and David Salomon Translational Breast Cancer Research Fund, and Eleanor and Glenn Padnick Discovery Fund in Cellular Therapy to Xiaojiang Cui, the Fashion Footwear Charitable Foundation of New York, Inc., associates for Breast and Prostate Cancer Studies, the Margie and Robert E. Petersen Foundation, and the Linda and Jim Lippman Research Fund to Armando Giuliano.	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Augereau P, 2006, MOL PHARMACOL, V69, P1338, DOI 10.1124/mol.105.017376; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Bartkuhn M, 2008, BBA-MOL CELL RES, V1783, P2161, DOI 10.1016/j.bbamcr.2008.07.011; Becker M, 2005, MOL CANCER THER, V4, P151; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Berry FB, 2008, HUM MOL GENET, V17, P490, DOI 10.1093/hmg/ddm326; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Caizzi L, 2014, P NATL ACAD SCI USA, V111, P4892, DOI 10.1073/pnas.1315445111; Cimino-Mathews A, 2013, HUM PATHOL, V44, P1341, DOI 10.1016/j.humpath.2012.11.003; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Gaughan L, 2013, NUCLEIC ACIDS RES, V41, P6892, DOI 10.1093/nar/gkt469; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; Han BC, 2015, CELL REP, V13, P1046, DOI 10.1016/j.celrep.2015.09.063; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jensen TW, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv148; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Kuukasjarvi T, 1996, J CLIN ONCOL, V14, P2584, DOI 10.1200/JCO.1996.14.9.2584; Ma YX, 2010, MOL ENDOCRINOL, V24, P76, DOI 10.1210/me.2009-0218; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Manavathi B, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00034; Marconett CN, 2010, MOL BIOL CELL, V21, P1166, DOI 10.1091/mbc.E09-08-0689; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Obrero M, 2002, J BIOL CHEM, V277, P45695, DOI 10.1074/jbc.M208092200; Osborne CK, 1998, BREAST CANCER RES TR, V51, P227, DOI 10.1023/A:1006132427948; Oyama M, 2011, J BIOL CHEM, V286, P818, DOI 10.1074/jbc.M110.156877; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Saleem RA, 2004, NUCLEIC ACIDS RES, V32, P4182, DOI 10.1093/nar/gkh742; Saleem RA, 2003, HUM MOL GENET, V12, P2993, DOI 10.1093/hmg/ddg324; Schultz JR, 2003, MOL CELL ENDOCRINOL, V201, P165, DOI 10.1016/S0303-7207(02)00415-X; Sengupta S, 2010, HORM MOL BIOL CLIN I, V2, P235, DOI 10.1515/HMBCI.2010.025; Shenker NS, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1335-5; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sparano JA, 2010, SURG ONCOL CLIN N AM, V19, P581, DOI 10.1016/j.soc.2010.03.008; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Wei LX, 2013, TUMOR BIOL, V34, P941, DOI 10.1007/s13277-012-0629-3; Xia LM, 2013, HEPATOLOGY, V57, P610, DOI 10.1002/hep.26029; Xu Y, 2014, HISTOPATHOLOGY, V64, P963, DOI 10.1111/his.12347; Ye Q, 2015, AM J CANCER RES, V5, P1519; Yoshida T, 2000, CARCINOGENESIS, V21, P2193, DOI 10.1093/carcin/21.12.2193	49	21	25	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 13	2016	35	41					5400	5411		10.1038/onc.2016.78	http://dx.doi.org/10.1038/onc.2016.78			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA5QU	27041579	Green Accepted			2022-12-26	WOS:000386677800006
J	Suzukawa, M; Akashi, S; Nagai, H; Nagase, H; Nakamura, H; Matsui, H; Hebisawa, A; Ohta, K				Suzukawa, Maho; Akashi, Shunsuke; Nagai, Hideaki; Nagase, Hiroyuki; Nakamura, Hiroyuki; Matsui, Hirotoshi; Hebisawa, Akira; Ohta, Ken			Combined Analysis of IFN-gamma, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; GRANULOMA-FORMATION; RELEASE ASSAYS; IP-10; DIAGNOSIS; THERAPY; DISEASE	The QuantiFERON (R)-TB Gold In-Tube test (QFT), an interferon-gamma release assay, is used to diagnose Mycobacterium tuberculosis, but its inaccuracy in distinguishing active tuberculosis from latent infection is a major concern. There is thus a need for an easy and accurate tool for achieving that goal in daily clinical settings. This study aimed to identify candidate cytokines for specifically differentiating active tuberculosis from latent infection. Our study population consisted of 31 active TB (tuberculosis) patients, 29 LTBI (latent tuberculosis infection) patients and 10 healthy control subjects. We assayed for 27 cytokines in QFT supernatants of both specific antigen-stimulated blood samples (TBAg) and negative-control samples (Nil). We analyzed their specificities and sensitivities by creating receiver operating characteristic (ROC) curves and measuring the area under those curves (AUCs). In TBAg-Nil supernatants, IL-10, IFN-gamma, MCP-1 and IL-1RA showed high AUCs of 0.8120, 0.7842, 0.7419 and 0.7375, respectively. Compared with each cytokine alone, combined assay for these top four cytokines showed positive rates in diagnosing active TB, and GDA analysis revealed that MCP-1 and IL-5 are potent in distinguishing active TB from LTBI, with Wilk's lambda = 0.718 (p < 0.001). Furthermore, utilizing the unique characteristic of IL-2 that its TBAg-Nil supernatant levels are higher in LTBI compared to active TB, the difference between IFN-gamma and IL-2 showed a large AUC of 0.8910. In summary, besides IFN-gamma, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatants may be useful for distinguishing active TB from LTBI. Those cytokines may also help us understand the difference in pathogenesis between active TB and LTBI.	[Suzukawa, Maho; Akashi, Shunsuke; Nagai, Hideaki; Matsui, Hirotoshi; Hebisawa, Akira; Ohta, Ken] Natl Hosp Org Tokyo Natl Hosp, Tokyo, Japan; [Nagase, Hiroyuki] Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Tokyo 173, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa 9201192, Japan	Teikyo University; Kanazawa University	Ohta, K (corresponding author), Natl Hosp Org Tokyo Natl Hosp, Tokyo, Japan.	kenohta@tokyo-hosp.jp	Nagase, Hiroyuki/Y-4367-2019	Nagase, Hiroyuki/0000-0002-0296-5901; Suzukawa, Maho/0000-0002-2265-1950	Banyu Life Science Foundation International; Waksman Foundation of Japan, Inc.; Ministry of Health Labour and Welfare of Japan	Banyu Life Science Foundation International(Banyu Life Science Foundation International); Waksman Foundation of Japan, Inc.(Waksman Foundation of Japan Inc.); Ministry of Health Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This project was supported by a grant from Banyu Life Science Foundation International and a grant from the Waksman Foundation of Japan, Inc. to Maho Suzukawa, and a Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare of Japan to Hideaki Nagai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Biancotto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076091; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Borgstrom E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043438; CHAN LS, 1992, J INVEST DERMATOL, V99, P315, DOI 10.1111/1523-1747.ep12616653; Chang KC, 2010, THORAX, V65, P271, DOI 10.1136/thx.2009.126771; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chegou NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064226; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Clifford V, 2015, J INFECTION, V71, P696, DOI 10.1016/j.jinf.2015.08.001; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Cyktor JC, 2013, J IMMUNOL, V190, P2778, DOI 10.4049/jimmunol.1202722; Fiske CT, 2014, INT J TUBERC LUNG D, V18, P421, DOI 10.5588/ijtld.13.0688; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Harada S, 1999, ARTHRITIS RHEUM, V42, P1508, DOI 10.1002/1529-0131(199907)42:7<1508::AID-ANR26>3.0.CO;2-L; Hur YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079742; Jeong YH, 2015, J CLIN MICROBIOL, V53, P504, DOI 10.1128/JCM.02758-14; Juffermans NP, 1998, AM J RESP CRIT CARE, V157, P1328, DOI 10.1164/ajrccm.157.4.9709126; Kruczak K, 2014, SCAND J INFECT DIS, V46, P649, DOI 10.3109/00365548.2014.927955; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; ROLFE MW, 1992, AM J PHYSIOL, V263, pL536, DOI 10.1152/ajplung.1992.263.5.L536; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Ruth JH, 1996, J IMMUNOL, V156, P2503; Tebruegge M, 2015, AM J RESP CRIT CARE, V192, P485, DOI 10.1164/rccm.201501-0059OC; Tonby K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09223; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; Wergeland I, 2015, J INFECTION, V70, P381, DOI 10.1016/j.jinf.2014.12.019; WHO, 2014, GLOB TUB REP 2014	32	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152483	10.1371/journal.pone.0152483	http://dx.doi.org/10.1371/journal.pone.0152483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035669	gold, Green Published			2022-12-26	WOS:000373201200019
J	Estomba, H; Munoa-Hoyos, I; Gianzo, M; Urizar-Arenaza, I; Casis, L; Irazusta, J; Subiran, N				Estomba, Haizea; Munoa-Hoyos, Iraia; Gianzo, Marta; Urizar-Arenaza, Itziar; Casis, Luis; Irazusta, Jon; Subiran, Nerea			Expression and Localization of Opioid Receptors in Male Germ Cells and the Implication for Mouse Spermatogenesis	PLOS ONE			English	Article							ENKEPHALIN-DEGRADING ENZYMES; SPERM MOTILITY; HUMAN SEMEN; MEIOTIC RECOMBINATION; MET-ENKEPHALIN; MALE-FERTILITY; STEM-CELLS; TESTIS; MICE; RAT	The presence of endogenous opioid peptides in different testicular cell types has been extensively characterized and provides evidence for the participation of the opioid system in the regulation of testicular function. However, the exact role of the opioid system during the spermatogenesis has remained controversial since the presence of the mu-, delta-and kappa-opioid receptors in spermatogenic cells was yet to be demonstrated. Through a combination of quantitative real-time PCR, immunofluorescence, immunohistochemistry and flow cytometry approaches, we report for the first time the presence of active mu-, deltaand kappa-opioid receptors in mouse male germ cells. They show an exposition time-dependent response to opioid agonist, hence suggesting their active involvement in spermatogenesis. Our results contribute to understanding the role of the opioid receptors in the spermatogenesis and could help to develop new strategies to employ the opioid system as a biochemical tool for the diagnosis and treatment of male infertility.	[Estomba, Haizea; Munoa-Hoyos, Iraia; Gianzo, Marta; Urizar-Arenaza, Itziar; Casis, Luis; Irazusta, Jon; Subiran, Nerea] Univ Basque Country, Fac Med & Dent, Dept Physiol, Leioa, Bizkaia, Spain	University of Basque Country	Subiran, N (corresponding author), Univ Basque Country, Fac Med & Dent, Dept Physiol, Leioa, Bizkaia, Spain.	nerea.subiran@ehu.es	Subirán, Nerea/AAA-4395-2019; Irazusta, Jon/ABB-1237-2020	Subirán, Nerea/0000-0001-9202-1287; MUNOA HOYOS, IRAIA/0000-0002-5107-6991; CASIS SAENZ, LUIS/0000-0001-9968-3216; Irazusta, Jon/0000-0002-6763-8602; URIZAR ARENAZA, ITZIAR/0000-0002-6390-7887; Gianzo, Marta/0000-0003-2351-4955	Basque Government; University of the Basque Country (UPV/EHU); Merck Serono; Gangoti Barrera Foundation; Basque Government (Zabalduz)	Basque Government(Basque Government); University of the Basque Country (UPV/EHU); Merck Serono(Merck & Company); Gangoti Barrera Foundation; Basque Government (Zabalduz)(Basque Government)	This work was supported by grants from The Basque Government, University of the Basque Country (UPV/EHU) and Merck Serono. HE was supported by a fellowship from the Gangoti Barrera Foundation; MG was supported by a fellowship from Basque Government (Zabalduz); IM was supported by a fellowship from Basque Government and IU was supported by a fellowship from University of Basque Country (UPV/EHU). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.; This work was supported by grants from The Basque Government, University of the Basque Country (UPV/EHU) and Merck Serono. HE was supported by a fellowship from the Gangoti Barrera Foundation; MG was supported by a fellowship from Basque Government (Zabalduz); IM was supported by a fellowship from Basque Government and IU was supported by a fellowship from University of Basque Country (UPV/EHU). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Agirregoitia E, 2006, J CLIN ENDOCR METAB, V91, P4969, DOI 10.1210/jc.2006-0599; Aita M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-8; BADR FM, 1979, MUTAT RES, V68, P235, DOI 10.1016/0165-1218(79)90155-1; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Cicero TJ, 2002, PHARMACOL BIOCHEM BE, V72, P157, DOI 10.1016/S0091-3057(01)00751-1; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Eto K, 2013, ENDOCRINOLOGY, V154, P2891, DOI 10.1210/en.2012-1977; FABBRI A, 1985, ENDOCRINOLOGY, V117, P2544, DOI 10.1210/endo-117-6-2544; FABBRI A, 1988, ENDOCRINOLOGY, V122, P749, DOI 10.1210/endo-122-2-749; Feng Y, 2012, CURR DRUG TARGETS, V13, P230, DOI 10.2174/138945012799201612; Fernandez D, 2002, PEPTIDES, V23, P461, DOI 10.1016/S0196-9781(01)00622-2; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; Gaveriaux-Ruff C, 1999, OPIOID RECEPTORS GEN; Grimaldi P, 2009, P NATL ACAD SCI USA, V106, P11131, DOI 10.1073/pnas.0812789106; HAYWARD NJ, 1993, EUR J NEUROSCI, V5, P961, DOI 10.1111/j.1460-9568.1993.tb00947.x; Hosoya N, 2012, EMBO REP, V13, P44, DOI 10.1038/embor.2011.221; HUANG HFS, 1991, ENDOCRINOLOGY, V128, P3152, DOI 10.1210/endo-128-6-3152; Irazusta J, 2004, J ANDROL, V25, P733; Kalejs M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-6; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Kim E, 2006, J BIOL CHEM, V281, P33749, DOI 10.1074/jbc.M603862200; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kouznetsova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028255; Malendowicz LK, 2005, INT J MOL MED, V15, P841; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Narita M, 2006, J NEUROCHEM, V97, P1494, DOI 10.1111/j.1471-4159.2006.03849.x; OHARA BF, 1994, MOL REPROD DEV, V38, P275, DOI 10.1002/mrd.1080380308; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Russell L.D., 1990, HISTOLOGICAL HISTOPA, P119; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Soverchia L, 2006, MOL REPROD DEV, V73, P1, DOI 10.1002/mrd.20341; Subiran N, 2008, FERTIL STERIL, V89, P1571, DOI 10.1016/j.fertnstert.2007.06.056; Subiran N, 2012, FERTIL STERIL, V98, P617, DOI 10.1016/j.fertnstert.2012.05.036; Subiran N, 2011, MOL MED, V17, P846, DOI 10.2119/molmed.2010.00268; TSONG SD, 1982, ENDOCRINOLOGY, V110, P2204, DOI 10.1210/endo-110-6-2204; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	39	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152162	10.1371/journal.pone.0152162	http://dx.doi.org/10.1371/journal.pone.0152162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031701	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800038
J	Ghaghada, KB; Sato, AF; Starosolski, ZA; Berg, J; Vail, DM				Ghaghada, Ketan B.; Sato, Amy F.; Starosolski, Zbigniew A.; Berg, John; Vail, David M.			Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer	PLOS ONE			English	Article							HYPERSENSITIVITY REACTIONS; CT; LIVER; COMPLEMENT; PERFORMANCE; DOXORUBICIN; ACTIVATION; METASTASES; ANIMALS; MODELS	Objectives Companion dogs with naturally occurring cancer serve as an important large animal model in translational research because they share strong similarities with human cancers. In this study, we investigated a long circulating liposomal-iodine contrast agent (Liposomal-I) for computed tomography (CT) imaging of solid tumors in companion dogs with naturally occurring cancer. Materials and Methods The institutional animal ethics committees approved the study and written informed consent was obtained from all owners. Thirteen dogs (mean age 10.1 years) with a variety of masses including primary and metastatic liver tumors, sarcomas, mammary carcinoma and lung tumors, were enrolled in the study. CT imaging was performed pre-contrast and at 15 minutes and 24 hours after intravenous administration of Liposomal-I (275 mg/kg iodine dose). Conventional contrast-enhanced CT imaging was performed in a subset of dogs, 90 minutes prior to administration of Liposomal-I. Histologic or cytologic diagnosis was obtained for each dog prior to admission into the study. Results Liposomal-I resulted in significant (p < 0.05) enhancement and uniform opacification of the vascular compartment. Non-renal, reticulo-endothelial systemic clearance of the contrast agent was demonstrated. Liposomal-I enabled visualization of primary and metastatic liver tumors. Sub-cm sized liver lesions grossly appeared as hypo-enhanced compared to the surrounding normal parenchyma with improved lesion conspicuity in the post-24 hour scan. Large liver tumors (> 1 cm) demonstrated a heterogeneous pattern of intra-tumoral signal with visibly higher signal enhancement at the post-24 hour time point. Extra-hepatic, extra-splenic tumors, including histiocytic sarcoma, anaplastic sarcoma, mammary carcinoma and lung tumors, were visualized with a heterogeneous enhancement pattern in the post-24 hour scan. Conclusions The long circulating liposomal-iodine contrast agent enabled prolonged visualization of small and large tumors in companion dogs with naturally occurring cancer. The study warrants future work to assess the sensitivity and specificity of the Liposomal-I agent in various types of naturally occurring canine tumors.	[Ghaghada, Ketan B.; Starosolski, Zbigniew A.] Texas Childrens Hosp, Singleton Dept Pediat Radiol, Houston, TX 77030 USA; [Sato, Amy F.; Berg, John] Tufts Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA USA; [Vail, David M.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA	Baylor College of Medicine; University of Wisconsin System; University of Wisconsin Madison	Ghaghada, KB (corresponding author), Texas Childrens Hosp, Singleton Dept Pediat Radiol, Houston, TX 77030 USA.	kbghagha@texaschildrens.org			Marval Pharma Ltd.	Marval Pharma Ltd.	The study was supported by a research grant from Marval Pharma Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NG, 2014, CONTRAST MEDIA MOL I, V9, P3, DOI 10.1002/cmmi.1550; Annapragada Ananth V, 2012, Methodist Debakey Cardiovasc J, V8, P18; [Anonymous], 2011, VET COMP ONCOL; Badea CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034496; Boll H, 2013, ACAD RADIOL, V20, P1137, DOI 10.1016/j.acra.2013.06.002; Dekrafft KE, 2009, ANGEW CHEM INT EDIT, V48, P9901, DOI 10.1002/anie.200904958; Ekdawi SN, 2015, J CONTROL RELEASE, V207, P101, DOI 10.1016/j.jconrel.2015.04.006; Hallouard F, 2010, BIOMATERIALS, V31, P6249, DOI 10.1016/j.biomaterials.2010.04.066; Hansen AE, 2015, ACS NANO, V9, P6985, DOI 10.1021/acsnano.5b01324; Hong S-I, 2015, SCAND J CLIN LAB INV, P1; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Koukourakis MI, 2000, BRIT J CANCER, V83, P1281, DOI 10.1054/bjoc.2000.1459; Labori KJ, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2058460115580877; Lairmore MD, 2014, ILAR J, V55, P1, DOI 10.1093/ilar/ilu022; Langereis S, 2013, NMR BIOMED, V26, P728, DOI 10.1002/nbm.2971; Leander P, 2001, EUR RADIOL, V11, P698, DOI 10.1007/s003300000712; Lee YJ, 2015, RADIOLOGY, V275, P97, DOI 10.1148/radiol.14140690; Li X, 2014, ADV DRUG DELIVER REV, V76, P116, DOI 10.1016/j.addr.2014.07.013; Liu YL, 2012, ACCOUNTS CHEM RES, V45, P1817, DOI 10.1021/ar300150c; Llimpe FLR, 2014, BRIT J CANCER, V111, P667, DOI 10.1038/bjc.2014.351; Maeda H, 2015, ADV DRUG DELIVER REV, V91, P3, DOI 10.1016/j.addr.2015.01.002; McCollough CH, 2015, RADIOLOGY, V276, P637, DOI 10.1148/radiol.2015142631; Moos SI, 2013, EUR J RADIOL, V82, pE387, DOI 10.1016/j.ejrad.2013.04.029; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Phillips WT, 2009, WIRES NANOMED NANOBI, V1, P69, DOI 10.1002/wnan.3; SELTZER SE, 1995, RADIOLOGY, V194, P775, DOI 10.1148/radiology.194.3.7862978; Spinazzi A, 2000, INVEST RADIOL, V35, P1, DOI 10.1097/00004424-200001000-00001; Symon Z, 1999, CANCER, V86, P72, DOI 10.1002/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.3.CO;2-T; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; Szebeni J, 2004, CURR ALLERGY ASTHM R, V4, P25, DOI 10.1007/s11882-004-0038-9; Szebeni J, 2007, J LIPOSOME RES, V17, P107, DOI 10.1080/08982100701375118; Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1105, P193, DOI 10.1016/0005-2736(92)90194-Q; Zheng JZ, 2007, PHARM RES-DORDR, V24, P1193, DOI 10.1007/s11095-006-9220-1; Zheng J, 2009, MOL PHARMACEUT, V6, P571, DOI 10.1021/mp800234r	38	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152718	10.1371/journal.pone.0152718	http://dx.doi.org/10.1371/journal.pone.0152718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031614	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800127
J	Greacen, T; Kersaudy-Rahib, D; Le Gall, JM; Lydie, N; Ghosn, J; Champenois, K				Greacen, Tim; Kersaudy-Rahib, Delphine; Le Gall, Jean-Marie; Lydie, Nathalie; Ghosn, Jade; Champenois, Karen			Comparing the Information and Support Needs of Different Population Groups in Preparation for 2015 Government Approval for HIV Self-testing in France	PLOS ONE			English	Article							HIGH-RISK; INFECTION; DELPHI; MEN; SEX	Context HIV self-tests are currently being introduced in France with the aim of promoting screening both for the general population and for high-risk populations. Objective The current study aimed to identify and compare the information and support needs of the different target population groups. Methods The Delphi process was used to synthesize expert opinions for each population group. Experts were chosen for their experience and expertise in the area of HIV and HIV screening for each population. Each group developed recommendations for a specific population: six high HIV prevalence populations (men who have sex with men; transgender people; substance users; migrants from sub-Saharan Africa; French West Indies; French Guiana) and two low prevalence populations (the general population; people under 25). Each group included expertise from four areas: research, screening and care, policy-making, and community groups. Results A final total of 263 recommendations were grouped into eight main themes: Communicating at both national and community levels about self-test arrival (24% of all recommendations); Providing information adapted to the different community groups' needs (23%); Providing counselling on self-test use and access to care (15%); Making self-tests available to all in terms of accessibility and cost (13%); Preparing community healthcare and screening systems for the arrival of the self-test (11%); Approving only high quality self-tests (6%); Defending self-test users' legal rights (5%); Evaluating self-test use (3%). Although a large number of recommendations were common to several groups of experts, the study highlighted a certain number of recommendations specific to each different population group, particularly with regard to information content and access both to information and to the self-tests themselves. Conclusion Results from the current study should make a significant contribution to policy decisions concerning catering for the specific access, information and support needs of different potential HIV self-test user groups in France.	[Greacen, Tim; Champenois, Karen] EPS Maison Blanche, Lab Rech, Paris, France; [Kersaudy-Rahib, Delphine; Lydie, Nathalie] INPES, St Denis, France; [Le Gall, Jean-Marie] AIDES, Pantin, France; [Ghosn, Jade] Hop Hotel Dieu, AP HP, UF Therapeut Immunoinfectiol, F-75181 Paris, France; [Ghosn, Jade] Univ Paris 05, EA7327, Fac Med Site Necker, Paris, France; [Champenois, Karen] INSERM, U1018, CESP Epidemiol VIH & IST 4, F-94275 Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Greacen, T; Champenois, K (corresponding author), EPS Maison Blanche, Lab Rech, Paris, France.; Champenois, K (corresponding author), INSERM, U1018, CESP Epidemiol VIH & IST 4, F-94275 Le Kremlin Bicetre, France.	tgreacen@ch-maison-blanche.fr; karen.champenois@inserm.fr		Rahib, Delphine/0000-0001-9187-0690	Agence Nationale de Recherche sur le Sida et les hepatites virales (National AIDS and Hepatitis Research Agency) [ANRS 95012]; Laboratoire de recherche, EPS Maison Blanche	Agence Nationale de Recherche sur le Sida et les hepatites virales (National AIDS and Hepatitis Research Agency); Laboratoire de recherche, EPS Maison Blanche	This research project was supported by a research grant from the Agence Nationale de Recherche sur le Sida et les hepatites virales (National AIDS and Hepatitis Research Agency; http://www.anrs.fr) (ANRS 95012). The Laboratoire de recherche, EPS Maison Blanche received the funding (TG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Beltzer N, 2011, KNOWLEDGE ATTITUDES; Cazein F, 2011, B EPIDEMIOLOGIQUE HE, V43-44, P446; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; de la Fuente L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046555; Delpierre C, 2006, AIDS PATIENT CARE ST, V20, P838, DOI 10.1089/apc.2006.20.838; Figueroa C, 2015, AIDS BEHAV; French National AIDS Council, 2013, REC HIV SELF TESTS; French National Health Ethics Advisory Board, 2013, ETH ISS REG COMM HIV; Gordon T, 2006, TECHNOL FORECAST SOC, V73, P321, DOI 10.1016/j.techfore.2005.09.005; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greacen T, 2012, AIDS CARE        JUN, P37; Greacen T, 2012, SEX TRANSM INFECT MA, P1; Greensides DR, 2003, PUBLIC HEALTH REP, V118, P531, DOI 10.1016/S0033-3549(04)50289-3; Grispen JEJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-112; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Hsu CC, 2007, PARE, V12, P1; Hung HL, 2008, EVAL PROGRAM PLANN, V31, P191, DOI 10.1016/j.evalprogplan.2008.02.005; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Lert F, 2009, RISK REDUCTION MISSI; Lorente N, 2013, J SEX TRANSM DIS, V213; Martinez O, 2014, AIDS BEHAV, V18, P2485, DOI 10.1007/s10461-014-0790-3; Myers J, 2012, IDWEEK; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Phillips KA, 2003, AM J PREV MED, V24, P340, DOI 10.1016/S0749-3797(03)00019-9; Spielberg F, 2003, JAIDS-J ACQ IMM DEF, V32, P318, DOI 10.1097/00126334-200303010-00012; Supervie V, 2013, AIDS LOND ENGL, V2014, P1	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152567	10.1371/journal.pone.0152567	http://dx.doi.org/10.1371/journal.pone.0152567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031234	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800094
J	Jia, HQ; Wang, Y; Morris, CD; Jacques, V; Gottesfeld, JM; Rusche, JR; Thomas, EA				Jia, Haiqun; Wang, Ying; Morris, Charles D.; Jacques, Vincent; Gottesfeld, Joel M.; Rusche, James R.; Thomas, Elizabeth A.			The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MUTANT HUNTINGTIN; MOUSE MODEL; EXPRESSION; ACETYLATION; ACTIVATION; DISORDERS; PATHWAY; PROTEIN; PROFILE	An important epigenetic modification in Huntington's disease (HD) research is histone acetylation, which is regulated by histone acetyltransferase and histone deacetylase (HDAC) enzymes. HDAC inhibitors have proven effective in HD model systems, and recent work is now focused on functional dissection of the individual HDAC enzymes in these effects. Histone deacetylase 3 (HDAC3), a member of the class I subfamily of HDACs, has previously been implicated in neuronal toxicity and huntingtin-induced cell death. Hence, we tested the effects of RGFP966 ((E)-N-(2-amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide), a benzamide-type HDAC inhibitor that selectively targets HDAC3, in the N171-82Q transgenic mouse model of HD. We found that RGFP966 at doses of 10 and 25 mg/kg improves motor deficits on rotarod and in open field exploration, accompanied by neuroprotective effects on striatal volume. In light of previous studies implicating HDAC3 in immune function, we measured gene expression changes for 84 immune-related genes elicited by RGFP966 using quantitative PCR arrays. RGFP966 treatment did not cause widespread changes in cytokine/chemokine gene expression patterns, but did significantly alter the striatal expression of macrophage migration inhibitory factor (Mif), a hormone immune modulator associated with glial cell activation, in N171-82Q transgenic mice, but not WT mice. Accordingly, RGFP966-treated mice showed decreased glial fibrillary acidic protein (GFAP) immunoreactivity, a marker of astrocyte activation, in the striatum of N171-82Q transgenic mice compared to vehicle-treated mice. These findings suggest that the beneficial actions of HDAC3 inhibition could be related, in part, with lowered Mif levels and its associated downstream effects.	[Jia, Haiqun; Wang, Ying; Morris, Charles D.; Thomas, Elizabeth A.] Scripps Res Inst, Dept Cellular & Mol Neurosci, La Jolla, CA 92037 USA; [Jia, Haiqun; Wang, Ying] Calif Inst Biomed Res, La Jolla, CA USA; [Jacques, Vincent; Rusche, James R.] Repligen Corp, Waltham, MA USA; [Gottesfeld, Joel M.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Thomas, EA (corresponding author), Scripps Res Inst, Dept Cellular & Mol Neurosci, La Jolla, CA 92037 USA.	bthomas@scripps.edu		Gottesfeld, Joel/0000-0002-4643-5777	National Institutes of Health [U01NS063953]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS063953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Vincent Jacques and James R. Rusche were employees of Repligen Corporation and received funding in the form of salaries. The specific roles of these authors are articulated in the Author Contributions section. This study was also funded by National Institutes of Health grant U01NS063953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2009, CANCER LETT, V280, P211, DOI 10.1016/j.canlet.2009.02.013; Bardai FH, 2013, J NEUROSCI, V33, P11833, DOI 10.1523/JNEUROSCI.5831-12.2013; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; Choo QY, 2013, MOLECULES, V18, P14085, DOI 10.3390/molecules181114085; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; Ellrichmann G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/541259; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; GROUP HSD, 1993, CELL, V72, P971; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jeong Y, 2013, J LEUKOCYTE BIOL; Jia H, 2012, 7 ANN HUNT DIS THER; Jia HQ, 2015, P NATL ACAD SCI USA, V112, pE56, DOI 10.1073/pnas.1415195112; Jia HQ, 2012, HUM MOL GENET, V21, P5280, DOI 10.1093/hmg/dds379; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim Y, 2012, J BIOL CHEM, V287, P25844, DOI 10.1074/jbc.M112.348284; Li SQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0396-3; Malvaez M, 2013, P NATL ACAD SCI US; Moumne L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031080; Nishibori M, 2000, EUR J NEUROSCI, V12, P415, DOI 10.1046/j.1460-9568.2000.00914.x; Ogata A, 1998, NEUROSCI LETT, V246, P173, DOI 10.1016/S0304-3940(98)00203-1; Quinti L., 2010, PLOS CURRENTS, V2; Kalathur RKR, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-47; Rumbaugh G, 2015, NEUROPSYCHOPHARMACOL, V40, P2307, DOI 10.1038/npp.2015.93; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Tang B, 2013, BRAIN BEHAV IMMUN, V30, P168, DOI 10.1016/j.bbi.2013.01.086; Thomas EA, 2001, J NEUROCHEM, V76, P789, DOI 10.1046/j.1471-4159.2001.00027.x; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Thomas EA, 2014, PHARMACEUTICALS, V7, P634, DOI 10.3390/ph7060634	40	57	59	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152498	10.1371/journal.pone.0152498	http://dx.doi.org/10.1371/journal.pone.0152498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031333	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800085
J	Van de Sompel, D; Sasportas, LS; Jokerst, JV; Gambhir, SS				Van de Sompel, Dominique; Sasportas, Laura S.; Jokerst, Jesse V.; Gambhir, Sanjiv S.			Comparison of Deconvolution Filters for Photoacoustic Tomography	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION; IN-VIVO; COMPUTED-TOMOGRAPHY; SYSTEM; RESOLUTION; ALGORITHM	In this work, we compare the merits of three temporal data deconvolution methods for use in the filtered backprojection algorithm for photoacoustic tomography (PAT). We evaluate the standard Fourier division technique, the Wiener deconvolution filter, and a Tikhonov L-2 norm regularized matrix inversion method. Our experiments were carried out on subjects of various appearances, namely a pencil lead, two man-made phantoms, an in vivo subcutaneous mouse tumor model, and a perfused and excised mouse brain. All subjects were scanned using an imaging system with a rotatable hemispherical bowl, into which 128 ultrasound transducer elements were embedded in a spiral pattern. We characterized the frequency response of each deconvolution method, compared the final image quality achieved by each deconvolution technique, and evaluated each method's robustness to noise. The frequency response was quantified by measuring the accuracy with which each filter recovered the ideal flat frequency spectrum of an experimentally measured impulse response. Image quality under the various scenarios was quantified by computing noise versus resolution curves for a point source phantom, as well as the full width at half maximum (FWHM) and contrast-to-noise ratio (CNR) of selected image features such as dots and linear structures in additional imaging subjects. It was found that the Tikhonov filter yielded the most accurate balance of lower and higher frequency content (as measured by comparing the spectra of deconvolved impulse response signals to the ideal flat frequency spectrum), achieved a competitive image resolution and contrast-to-noise ratio, and yielded the greatest robustness to noise. While the Wiener filter achieved a similar image resolution, it tended to underrepresent the lower frequency content of the deconvolved signals, and hence of the reconstructed images after backprojection. In addition, its robustness to noise was poorer than that of the Tikhonov filter. The performance of the Fourier filter was found to be the poorest of all three methods, based on the reconstructed images' lowest resolution (blurriest appearance), generally lowest contrast-to-noise ratio, and lowest robustness to noise. Overall, the Tikhonov filter was deemed to produce the most desirable image reconstructions.	[Van de Sompel, Dominique; Sasportas, Laura S.; Gambhir, Sanjiv S.] Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA; [Jokerst, Jesse V.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA	Stanford University; University of California System; University of California San Diego	Gambhir, SS (corresponding author), Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA.	sgambhir@stanford.edu			Susan G. Komen postdoctoral fellowship; Molecular Imaging Program at Stanford (MIPS); Stanford Molecular Imaging Scholars Program SMIS [R25-T CA118681]; NIH Loan Repayment Program; National Cancer Institute CCNE [U54 CA119367]; In Vivo Cancer Molecular Imaging Center ICMIC [P50 CA114747]; Gambhir laboratory from NCI ICMIC [P50CA114747]; NCI [CCNE-T U54 U54CA151459]; Doris Duke Foundation; Canary Foundation; Ben and Catherine Ivy Foundation; Sir Peter Michael Foundation; NATIONAL CANCER INSTITUTE [U54CA199075, U54CA119367, P50CA114747, U54CA151459, R25CA118681] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL117048] Funding Source: NIH RePORTER	Susan G. Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); Molecular Imaging Program at Stanford (MIPS); Stanford Molecular Imaging Scholars Program SMIS; NIH Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute CCNE; In Vivo Cancer Molecular Imaging Center ICMIC; Gambhir laboratory from NCI ICMIC; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Canary Foundation; Ben and Catherine Ivy Foundation; Sir Peter Michael Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Van de Sompel was supported by a Susan G. Komen postdoctoral fellowship, as well as the Molecular Imaging Program at Stanford (MIPS). Dr. Jokerst is grateful for fellowship support from the Stanford Molecular Imaging Scholars Program SMIS R25-T CA118681, and acknowledges the NIH Loan Repayment Program. This work is also funded in part by the National Cancer Institute CCNE U54 CA119367 (S.S.G.) and In Vivo Cancer Molecular Imaging Center ICMIC P50 CA114747 (S.S.G.). Lastly, the authors would like to acknowledge funding for the Gambhir laboratory from NCI ICMIC P50CA114747, NCI CCNE-T U54 U54CA151459, the Doris Duke Foundation, Canary Foundation, Ben and Catherine Ivy Foundation, and the Sir Peter Michael Foundation.	Balboa RM, 2003, VISION RES, V43, P2527, DOI 10.1016/S0042-6989(03)00471-1; Beard P, 2011, INTERFACE FOCUS, V1, P602, DOI 10.1098/rsfs.2011.0028; Brecht HP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259361; Burgholzer P, 2012, PROC SPIE, V8223, DOI 10.1117/12.908451; Burgholzer P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046706; de la Zerda A, 2011, CONTRAST MEDIA MOL I, V6, P346, DOI 10.1002/cmmi.455; Finch D, 2004, SIAM J MATH ANAL, V35, P1213, DOI 10.1137/S0036141002417814; Gamelin J, 2009, OPT EXPRESS, V17, P10489, DOI 10.1364/OE.17.010489; Gamelin J, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907157; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Ghahramani S., 2000, FUNDAMENTALS PROBABI; Guo ZJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3381187; Hoelen CGA, 2000, APPL OPTICS, V39, P5872, DOI 10.1364/AO.39.005872; Hristova Y, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/5/055006; Jetzfellner T, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3167280; KRUGER RA, 1995, MED PHYS, V22, P1605, DOI 10.1118/1.597429; Kruger RA, 2003, MED PHYS, V30, P856, DOI 10.1118/1.1565340; Kruger RA, 2000, RADIOLOGY, V216, P279, DOI 10.1148/radiology.216.1.r00jl30279; Kruger RA, 2010, MED PHYS, V37, P6096, DOI 10.1118/1.3497677; Ku G, 2005, APPL OPTICS, V44, P770, DOI 10.1364/AO.44.000770; Kunyansky LA, 2007, INVERSE PROBL, V23, P373, DOI 10.1088/0266-5611/23/1/021; Li CH, 2009, PHYS MED BIOL, V54, pR59, DOI 10.1088/0031-9155/54/19/R01; MACKENZIE KV, 1981, J ACOUST SOC AM, V70, P807, DOI 10.1121/1.386920; Manohar S, 2005, PHYS MED BIOL, V50, P2543, DOI 10.1088/0031-9155/50/11/007; Paltauf G, 2002, J ACOUST SOC AM, V112, P1536, DOI 10.1121/1.1501898; Provost J, 2009, IEEE T MED IMAGING, V28, P585, DOI 10.1109/TMI.2008.2007825; Razansky D., 2011, SELECTED TOPICS QUAN, V99, P1; Rosenthal A, 2010, IEEE T MED IMAGING, V29, P1275, DOI 10.1109/TMI.2010.2044584; Tikhonov A. N., 1943, DOKL AKAD NAUK SSSR, V39, P195; Treeby BE, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/11/115003; Treeby BE, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3360308; Vaithilingam S, 2009, IEEE T ULTRASON FERR, V56, P2411, DOI [10.1109/TUFFC.2009.1329, 10.1109/TUFFc.2009.1329]; Van de Sompel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045337; Wang K, 2012, PROC SPIE, V8223, DOI 10.1117/12.909690; Wang K, 2012, PROC SPIE, V8223, DOI 10.1117/12.909610; Wang K, 2011, IEEE T MED IMAGING, V30, P203, DOI 10.1109/TMI.2010.2072514; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang XD, 2002, MED PHYS, V29, P2799, DOI 10.1118/1.1521720; Wang Y, 2004, PHYS MED BIOL, V49, P3117, DOI 10.1088/0031-9155/49/14/006; Wiener N., 1949, INTERPOLATION EXTRAP; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Xu MH, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016706; Xu Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.033902; Yang DW, 2007, OPT EXPRESS, V15, P15566, DOI 10.1364/OE.15.015566; Yin BZ, 2004, PHYS MED BIOL, V49, P1339, DOI 10.1088/0031-9155/49/7/019; Zhang C, 2010, IEEE PHOTONICS J, V2, P57, DOI 10.1109/JPHOT.2010.2042801; Zhang E, 2008, APPL OPTICS, V47, P561, DOI 10.1364/AO.47.000561; Zhang J, 2009, IEEE T MED IMAGING, V28, P1781, DOI 10.1109/TMI.2009.2024082	48	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152597	10.1371/journal.pone.0152597	http://dx.doi.org/10.1371/journal.pone.0152597			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031832	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800099
J	Jachowski, DS; Rota, CT; Dobony, CA; Ford, WM; Edwards, JW				Jachowski, David S.; Rota, Christopher T.; Dobony, Christopher A.; Ford, W. Mark; Edwards, John W.			Seeing the Forest through the Trees: Considering Roost-Site Selection at Multiple Spatial Scales	PLOS ONE			English	Article							ENDANGERED INDIANA BAT; WHITE-NOSE SYNDROME; MYOTIS-SODALIS; RESOURCE SELECTION; INSECTIVOROUS BAT; FORAGING HABITAT; NYCTALUS-NOCTULA; DWELLING BATS; NORTHERN EDGE; N-LEISLERI	Conservation of bat species is one of the most daunting wildlife conservation challenges in North America, requiring detailed knowledge about their ecology to guide conservation efforts. Outside of the hibernating season, bats in temperate forest environments spend their diurnal time in day-roosts. In addition to simple shelter, summer roost availability is as critical as maternity sites and maintaining social group contact. To date, a major focus of bat conservation has concentrated on conserving individual roost sites, with comparatively less focus on the role that broader habitat conditions contribute towards roost-site selection. We evaluated roost-site selection by a northern population of federally-endangered Indiana bats (Myotis sodalis) at Fort Drum Military Installation in New York, USA at three different spatial scales: landscape, forest stand, and individual tree level. During 2007-2011, we radiotracked 33 Indiana bats (10 males, 23 females) and located 348 roosting events in 116 unique roost trees. At the landscape scale, bat roost-site selection was positively associated with northern mixed forest, increased slope, and greater distance from human development. At the stand scale, we observed subtle differences in roost site selection based on sex and season, but roost selection was generally positively associated with larger stands with a higher basal area, larger tree diameter, and a greater sugar maple (Acer saccharum) component. We observed no distinct trends of roosts being near high-quality foraging areas of water and forest edges. At the tree scale, roosts were typically in American elm (Ulmus americana) or sugar maple of large diameter (>30 cm) of moderate decay with loose bark. Collectively, our results highlight the importance of considering day roost needs simultaneously across multiple spatial scales. Size and decay class of individual roosts are key ecological attributes for the Indiana bat, however, larger-scale stand structural components that are products of past and current land use interacting with environmental aspects such as landform also are important factors influencing roost-tree selection patterns.	[Jachowski, David S.] Clemson Univ, Dept Forestry & Environm Conservat, 258 Lehotsky Hall, Clemson, SC 29634 USA; [Jachowski, David S.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Rota, Christopher T.] Univ Missouri, Dept Fisheries & Wildlife Sci, 302 Nat Resources Bldg, Columbia, MO 65201 USA; [Rota, Christopher T.; Edwards, John W.] W Virginia Univ, Div Forestry & Nat Resources, Box 6125, Morgantown, WV 26506 USA; [Dobony, Christopher A.] Nat Resources Branch, Ft Drum Mil Installat, IMNE DRM PWE, 85 First St West, Ft Drum, NY 13602 USA; [Ford, W. Mark] Virginia Polytech Inst & State Univ, US Geol Survey, Virginia Cooperat Fish & Wildlife Res Unit, Dept Fisheries & Wildlife Conservat, 106 Cheatham Hall, Blacksburg, VA 24061 USA	Clemson University; University of Kwazulu Natal; University of Missouri System; University of Missouri Columbia; West Virginia University; United States Department of the Interior; United States Geological Survey; Virginia Polytechnic Institute & State University	Jachowski, DS (corresponding author), Clemson Univ, Dept Forestry & Environm Conservat, 258 Lehotsky Hall, Clemson, SC 29634 USA.; Jachowski, DS (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.	djachowski@gmail.com			Department of the Army; Fort Drum; U.S. Army Engineer and Research Development Center; West Virginia University Division of Forestry and Natural Resources; U.S. Forest Service, Northern Research Station	Department of the Army; Fort Drum; U.S. Army Engineer and Research Development Center; West Virginia University Division of Forestry and Natural Resources; U.S. Forest Service, Northern Research Station(United States Department of Agriculture (USDA)United States Forest Service)	This work was funded by financial and in-kind contributions of the Department of the Army, Fort Drum, the U.S. Army Engineer and Research Development Center, the West Virginia University Division of Forestry and Natural Resources and the U.S. Forest Service, Northern Research Station.	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; [Anonymous], 1991, SUMMER ROOST SELECTI; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Babson DW, 2011, THESIS SYRACUSE U; Barclay Robert M.R., 2007, P17; Belwood Jacqueline J., 2002, P193; BRACK V, 1983, THESIS PURDUE U; Brigham R. Mark, 2007, P1; Britzke ER, 2006, AM MIDL NAT, V155, P181, DOI 10.1674/0003-0031(2006)155[0181:DOSRTU]2.0.CO;2; Britzke ER, 2003, SOUTHEAST NAT, V2, P235, DOI 10.1656/1528-7092(2003)002[0235:IBMSMR]2.0.CO;2; Callahan EV, 1997, J MAMMAL, V78, P818, DOI 10.2307/1382939; Carter TC, 2005, FOREST ECOL MANAG, V219, P259, DOI 10.1016/j.foreco.2005.08.049; Carter TC, 2006, J WILDLIFE MANAGE, V70, P1185, DOI 10.2193/0022-541X(2006)70[1185:IBITMT]2.0.CO;2; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Crampton LH, 1998, CONSERV BIOL, V12, P1347, DOI 10.1046/j.1523-1739.1998.97209.x; Ford WM, 2011, J FISH WILDL MANAG, V2, P125, DOI 10.3996/042011-JFWM-027; Ford WM, 2002, NE378 USDA FOR SER; Ford WM, 2007, LAND MANAGERS GUIDE, P205; Foster RW, 1999, J MAMMAL, V80, P659, DOI 10.2307/1383310; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gelman A., 2021, BAYESIAN DATA ANAL; Hayes John P., 2007, P207; Hobson CS, 1995, BRIMLEYANA, P95; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Hoying KM, 1998, J ZOOL, V245, P15, DOI 10.1111/j.1469-7998.1998.tb00067.x; Ingersoll TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065907; Jachowski DS, 2014, DIVERS DISTRIB, V20, P1002, DOI 10.1111/ddi.12192; Jachowski DS, 2014, ENDANGER SPECIES RES, V24, P149, DOI 10.3354/esr00594; JAMES F C, 1970, Audubon Field Notes, V24, P727; Johnson JB, 2010, J FISH WILDL MANAG, V1, P111, DOI 10.3996/042010-JFWM-007; Kalcounis-Ruppell MC, 2005, WILDLIFE SOC B, V33, P1123, DOI 10.2193/0091-7648(2005)33[1123:TRSBBA]2.0.CO;2; Kent M., 2012, VEGETATION DESCRIPTI, V2nd ed.; Kery M, 2014, BAYESIAN POPULATION; Keyset P. D., 2006, General Technical Report - Northern Research Station, USDA Forest Service, P180; Kniowski AB, 2011, THESIS OHIO STATE U; Kunz T.H., 1982, P1; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; Kurta A, 1996, BC MIN FOR RES PROGR, V23, P102; KURTA A, 1993, AM MIDL NAT, V129, P132, DOI 10.2307/2426441; Loeb SC, 2013, ECOL EVOL, V3, P103, DOI 10.1002/ece3.440; McCullagh P, 1989, GEN LINEAR MODELS; Menzel JM, 2005, J WILDLIFE MANAGE, V69, P430, DOI 10.2193/0022-541X(2005)069&lt;0430:SHUAHA&gt;2.0.CO;2; Menzel JM, 2001, REV FOREST HABITAT R, V284; Miles AC, 2006, J WILDLIFE MANAGE, V70, P1191, DOI 10.2193/0022-541X(2006)70[1191:MRSBEB]2.0.CO;2; Miller DA, 2003, WILDLIFE SOC B, V31, P30; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; Nyland R.D., 1996, MCGRAW HILL SERIES F, V8; Orians G.H., 1979, P155; R Core Team, 2013, R LANG ENV STAT COMP; Romme RC, 1995, E17 3D ENV; Ruczynski I, 2005, J MAMMAL, V86, P921, DOI 10.1644/1545-1542(2005)86[921:RCSBNN]2.0.CO;2; Ruczynski I, 2010, FOREST ECOL MANAG, V259, P1633, DOI 10.1016/j.foreco.2010.01.041; Ruczynski I, 2008, J MAMMAL, V89, P942, DOI 10.1644/07-MAMM-A-134.1; Schuler TM, 2004, CAN J FOREST RES, V34, P985, DOI 10.1139/X03-262; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silvis A, 2012, INT J FOR RES, DOI 10.1155/2012/148106; Silvis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096937; Smith DM, 1986, PRACTICE SILVICULTUR; Sparks Dale W., 2001, Proceedings of the Indiana Academy of Science, V107, P171; Stan Development Team, 2014, RSTAN R INT STAN VER; Stan Development Team, 2014, STAN C LIB PROB SAMP; Thogmartin WE, 2013, BIOL CONSERV, V160, P162, DOI 10.1016/j.biocon.2013.01.010; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P404, DOI 10.2193/0022-541X(2006)70[404:ABREDM]2.0.CO;2; Thomas J.W., 1979, U S Department of Agriculture Agriculture Handbook, P60; Timpone JC, 2010, AM MIDL NAT, V163, P115, DOI 10.1674/0003-0031-163.1.115; US Army, 2011, INT NAT RES MAN PLAN; US Fish and Wildlife Service, 2007, IND BAT MYOT SOD DRA; Vonhof MJ, 1996, CAN J ZOOL, V74, P1797, DOI 10.1139/z96-200; Watrous KS, 2006, J WILDLIFE MANAGE, V70, P1228, DOI 10.2193/0022-541X(2006)70[1228:PMHCFT]2.0.CO;2; WHITAKER J.O., 1998, MAMMALS E US; Whitaker John O. Jr, 2004, Proceedings of the Indiana Academy of Science, V113, P151; Wildlife Management Institute, 2012, NE TERR HAB CLASS SY; Willis CKR, 2005, J MAMMAL, V86, P85, DOI 10.1644/1545-1542(2005)086<0085:PAEAOR>2.0.CO;2	74	18	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150011	10.1371/journal.pone.0150011	http://dx.doi.org/10.1371/journal.pone.0150011			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028116	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500001
J	Matsuoka, S; Ishii, Y; Nakao, A; Abe, M; Ohtsuji, N; Momose, S; Jin, H; Arase, H; Sugimoto, K; Nakauchi, Y; Masutani, H; Maeda, M; Yagita, H; Komatsu, N; Hino, O				Matsuoka, Shuji; Ishii, Yasuyuki; Nakao, Atsuhito; Abe, Masaaki; Ohtsuji, Naomi; Momose, Shuji; Jin, Hui; Arase, Hisashi; Sugimoto, Koichi; Nakauchi, Yusuke; Masutani, Hiroshi; Maeda, Michiyuki; Yagita, Hideo; Komatsu, Norio; Hino, Okio			Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; T-CELLS; APOPTOSIS; RITUXIMAB; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; COMPLEMENT; INHIBITORS; DISEASE; DOMAIN	To develop a new therapeutic monoclonal Antibody (mAb) for Hodgkin lymphoma (HL), we immunized a BALB/c mouse with live HL cell lines, alternating between two HL cell lines. After hybridization, we screened the hybridoma clones by assessing direct cytotoxicity against a HL cell line not used for immunization. We developed this strategy for establishing mAb to reduce the risk of obtaining clonotypic mAb specific for single HL cell line. A newly established mouse anti-human mAb (4713) triggered cytoskeleton-dependent, but complement- and caspase-independent, cell death in HL cell lines, Burkitt lymphoma cell lines, and advanced adult T-cell leukemia cell lines. Intravenous injection of mAb 4713 in tumor-bearing SCID mice improved survival significantly. mAb 4713 was revealed to be a mouse antihuman pan-HLA class II mAb. Treatment with this mAb induced the formation of large pores on the surface of target lymphoma cells within 30 min. This finding suggests that the cell death process induced by this anti-pan HLA-class II mAb may involve the same death signals stimulated by a cytolytic anti-pan MHC class I mAb that also induces large pore formation. This multifaceted study supports the therapeutic potential of mAb 4713 for various forms of lymphoma.	[Matsuoka, Shuji; Abe, Masaaki; Ohtsuji, Naomi; Momose, Shuji; Hino, Okio] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 1138421, Japan; [Ishii, Yasuyuki] RIKEN Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2040022, Japan; [Nakao, Atsuhito] Yamanashi Univ, Fac Med, Dept Immunol, Kofu, Yamanashi 4093898, Japan; [Jin, Hui; Arase, Hisashi] Osaka Univ, Dept Immunochem, WPI Immunol Frontier Res Ctr, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Sugimoto, Koichi] JR Tokyo Hosp, Dept Hematol & Oncol, Tokyo 1518523, Japan; [Nakauchi, Yusuke] Univ Tokyo, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Tokyo 1088639, Japan; [Masutani, Hiroshi; Maeda, Michiyuki] Kyoto Univ, Inst Virus Res, Dept Cell Biol, Kyoto 6068507, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Komatsu, Norio] Juntendo Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo 1138421, Japan	Juntendo University; RIKEN; University of Yamanashi; Osaka University; University of Tokyo; Kyoto University; Juntendo University; Juntendo University	Matsuoka, S (corresponding author), Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 1138421, Japan.	matsuoka@juntendo.ac.jp	; Arase, Hisashi/C-8442-2009	Masutani, Hiroshi/0000-0001-7633-2827; Nakauchi, Yusuke/0000-0002-6943-3811; Arase, Hisashi/0000-0002-1153-3166	Japan Society for the Promotion of Science [15K06880]; Grants-in-Aid for Scientific Research [25460386] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	S. Matsuoka received the grant from Japan Society for the Promotion of Science (Web: https://kaken.nii.ac.jp/d/p/15K06880.en.html, grant number: 15K06880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan MK, 2006, ONCOGENE, V25, P2181, DOI 10.1038/sj.onc.1209256; Altes A, 2013, LEUKEMIA LYMPHOMA, V54, P1706, DOI 10.3109/10428194.2012.752080; Brockhaus F, 1998, EXP CELL RES, V238, P33, DOI 10.1006/excr.1997.3778; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Curnock AP, 1998, CELL IMMUNOL, V187, P77, DOI 10.1006/cimm.1998.1335; Fernandez-Marrero Y, 2011, MABS-AUSTIN, V3, P528, DOI 10.4161/mabs.3.6.17770; Genestier L, 1997, BLOOD, V90, P3629, DOI 10.1182/blood.V90.9.3629; Genestier L, 1998, J BIOL CHEM, V273, P5060, DOI 10.1074/jbc.273.9.5060; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; HELSON L, 1975, CANCER RES, V35, P2594; Honeychurch J, 2012, BLOOD, V119, P3523, DOI 10.1182/blood-2011-12-395541; Ishida T, 2015, BRIT J HAEMATOL, V169, P672, DOI 10.1111/bjh.13338; Ishida T, 2011, INT J HEMATOL, V94, P443, DOI 10.1007/s12185-011-0941-5; Ivanov A, 2009, J CLIN INVEST, V119, P2143, DOI 10.1172/JCI37884; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; MATSUOKA S, 1995, J EXP MED, V181, P2007, DOI 10.1084/jem.181.6.2007; Matsuoka S, 2003, J EXP MED, V198, P497, DOI 10.1084/jem.20021301; NAGATANI T, 1990, CANCER-AM CANCER SOC, V66, P2380, DOI 10.1002/1097-0142(19901201)66:11<2380::AID-CNCR2820661122>3.0.CO;2-H; Nagy ZA, 2002, NAT MED, V8, P801, DOI 10.1038/nm736; O'Brien SM, 2001, J CLIN ONCOL, V19, P2165, DOI 10.1200/JCO.2001.19.8.2165; SCHAADT M, 1980, INT J CANCER, V26, P723, DOI 10.1002/ijc.2910260605; SHELTON MW, 1992, TRANSPLANTATION, V54, P278, DOI 10.1097/00007890-199208000-00017; Shimizu T, 1997, LEUKEMIA, V11, P1238, DOI 10.1038/sj.leu.2400734; Skov S, 1997, J CELL BIOL, V139, P1523, DOI 10.1083/jcb.139.6.1523; Sodeoka M, 2010, CHEM REC, V10, P308, DOI 10.1002/tcr.201000031; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; TRUMAN JP, 1994, INT IMMUNOL, V6, P887, DOI 10.1093/intimm/6.6.887; Tsukasaki Kunihiro, 2012, Leuk Res Treatment, V2012, P101754, DOI 10.1155/2012/101754; Verma D, 2009, CANCER-AM CANCER SOC, V115, P101, DOI 10.1002/cncr.24005; Xie T, 2013, STRUCTURE, V21, P493, DOI 10.1016/j.str.2013.01.016; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zhang CG, 1998, P NATL ACAD SCI USA, V95, P6290, DOI 10.1073/pnas.95.11.6290	33	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150496	10.1371/journal.pone.0150496	http://dx.doi.org/10.1371/journal.pone.0150496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028595	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500006
J	Smart, M; Pettis, J; Rice, N; Browning, Z; Spivak, M				Smart, Matthew; Pettis, Jeff; Rice, Nathan; Browning, Zac; Spivak, Marla			Linking Measures of Colony and Individual Honey Bee Health to Survival among Apiaries Exposed to Varying Agricultural Land Use	PLOS ONE			English	Article							VARROA-DESTRUCTOR ACARI; ANTIMICROBIAL PEPTIDES; POLLEN NUTRITION; PROTEIN COSTS; TRADE-OFF; PESTICIDES; DEFENSE; STORAGE; INSECT; DIET	We previously characterized and quantified the influence of land use on survival and productivity of colonies positioned in six apiaries and found that colonies in apiaries surrounded by more land in uncultivated forage experienced greater annual survival, and generally more honey production. Here, detailed metrics of honey bee health were assessed over three years in colonies positioned in the same six apiaries. The colonies were located in North Dakota during the summer months and were transported to California for almond pollination every winter. Our aim was to identify relationships among measures of colony and individual bee health that impacted and predicted overwintering survival of colonies. We tested the hypothesis that colonies in apiaries surrounded by more favorable land use conditions would experience improved health. We modeled colony and individual bee health indices at a critical time point (autumn, prior to overwintering) and related them to eventual spring survival for California almond pollination. Colony measures that predicted overwintering apiary survival included the amount of pollen collected, brood production, and Varroa destructor mite levels. At the individual bee level, expression of vitellogenin, defensin1, and lysozyme2 were important markers of overwinter survival. This study is a novel first step toward identifying pertinent physiological responses in honey bees that result from their positioning near varying landscape features in intensive agricultural environments.	[Smart, Matthew; Spivak, Marla] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Pettis, Jeff; Rice, Nathan] ARS, USDA, Bee Res Lab, Beltsville, MD USA; [Browning, Zac] Brownings Honey Co, Jamestown, ND USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA)	Smart, M (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN USA.	msmart@usgs.gov	Spivak, Marla/AAI-5088-2020		ARS [ARS-0425645] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Adamo SA, 2010, ANIM BEHAV, V79, P3, DOI 10.1016/j.anbehav.2009.10.012; Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Amdam G.V., 2011, HONEYBEE NEUROBIOLOG, P17; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; Ament SA, 2011, J EXP BIOL, V214, P3808, DOI 10.1242/jeb.060244; Basualdo M, 2014, ENV MICROBIOL REP, V6, P396, DOI 10.1111/1758-2229.12169; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; CANTWELL G E, 1970, American Bee Journal, V110, P222; COCIANCICH S, 1993, J BIOL CHEM, V268, P19239; Collins AM, 2013, APIDOLOGIE, V44, P351, DOI 10.1007/s13592-012-0186-1; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1989, J INSECT PHYSIOL, V35, P595, DOI 10.1016/0022-1910(89)90121-2; CRAILSHEIM K, 1990, APIDOLOGIE, V21, P417, DOI 10.1051/apido:19900504; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; DeGrandi-Hoffman Gloria, 2013, Insects, V4, P71, DOI 10.3390/insects4010071; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Doums C, 2002, ECOL ENTOMOL, V27, P138, DOI 10.1046/j.1365-2311.2002.00388.x; Ellers J, 1996, NETH J ZOOL, V46, P227, DOI 10.1163/156854295X00186; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Farrar CL, 1936, AM BEE J, V76, P452; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Hetru Charles, 1998, P40; Higes M, 1998, ENVIRON MICROBIOL, V10, P2659; Hoffman GD, 2015, CURR OPIN INSECT SCI, V10, P170, DOI DOI 10.1016/j.cois.2015.05.007; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Ilyasov RA, 2013, J EVOL BIOCHEM PHYS+, V49, P1, DOI 10.1134/S0022093013010015; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; JEFFREE EP, 1957, J ECON ENTOMOL, V50, P211, DOI 10.1093/jee/50.2.211; Jeffree EP., 1956, INSECT SOC, V3, P417, DOI [10.1007/BF02225761, DOI 10.1007/BF02225761]; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Keller I, 2005, BEE WORLD, V86, P27, DOI 10.1080/0005772X.2005.11099650; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Lee KP, 2008, FUNCT ECOL, V22, P1052, DOI 10.1111/j.1365-2435.2008.01459.x; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lourenco AP, 2009, ARCH INSECT BIOCHEM, V71, P70, DOI 10.1002/arch.20301; Antonio DSM, 2008, NATURWISSENSCHAFTEN, V95, P953, DOI 10.1007/s00114-008-0413-9; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Mattila HR, 2007, ECOL ENTOMOL, V32, P496, DOI 10.1111/j.1365-2311.2007.00904.x; Meister M, 1997, BIOESSAYS, V19, P1019, DOI 10.1002/bies.950191112; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Nilsen KA, 2011, J EXP BIOL, V214, P1488, DOI 10.1242/jeb.050393; Pettis JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147220; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Ponton F, 2013, J INSECT PHYSIOL, V59, P130, DOI 10.1016/j.jinsphys.2012.10.011; Povey S, 2009, J ANIM ECOL, V78, P437, DOI 10.1111/j.1365-2656.2008.01499.x; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sagili RR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1471, DOI 10.1007/s00265-007-0379-1; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Scofield HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121731; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seeley T., 1995, WISDOM HIVE SOCIAL P; Smart MD, 2015, THESIS U MINNESOTA; SOUTHWICK EE, 1985, J COMP PHYSIOL B, V156, P143, DOI 10.1007/BF00692937; Steinmann N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129956; Strange JP, 2001, J ECON ENTOMOL, V94, P1324, DOI 10.1603/0022-0493-94.6.1324; Tarpy DR, 2012, J ECON ENTOMOL, V105, P20, DOI 10.1603/EC11276; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2000, ANIM BEHAV, V59, P97, DOI 10.1006/anbe.1999.1311; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Traver BE, 2011, J INVERTEBR PATHOL, V107, P43, DOI 10.1016/j.jip.2011.02.003; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wheeler MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05726; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005	78	116	119	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152685	10.1371/journal.pone.0152685	http://dx.doi.org/10.1371/journal.pone.0152685			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27027871	gold, Green Published			2022-12-26	WOS:000373116500063
J	Brinks, R; Hoyer, A; Landwehr, S				Brinks, Ralph; Hoyer, Annika; Landwehr, Sandra			Surveillance of the Incidence of Non-Communicable Diseases (NCDs) with Sparse Resources: A Simulation Study Using Data from a National Diabetes Registry, Denmark, 1995-2004	PLOS ONE			English	Article							PREVALENCE	We propose two new methods to estimate secular trends in the incidence of a chronic disease from a series of prevalence studies and mortality data. One method is a direct inversion formula, the second method is a least squares estimation. Both methods are validated in a simulation study based on data from a diabetes register. The results of the validation show that the proposed methods may be useful in epidemiological settings with sparse resources, where running a register or a series of follow-up studies is difficult or impossible.	[Brinks, Ralph; Hoyer, Annika] German Diabet Ctr, Inst Epidemiol & Biometry, Dusseldorf, Germany; [Brinks, Ralph] Univ Hosp Duesseldorf, Hiller Res Unit Rheumatol, Dusseldorf, Germany; [Landwehr, Sandra] Univ Hosp Duesseldorf, Dept Med Stat, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ)	Brinks, R (corresponding author), German Diabet Ctr, Inst Epidemiol & Biometry, Dusseldorf, Germany.; Brinks, R (corresponding author), Univ Hosp Duesseldorf, Hiller Res Unit Rheumatol, Dusseldorf, Germany.	ralph.brinks@ddz.uni-duesseldorf.de			Hiller Foundation, Erkrath, Germany	Hiller Foundation, Erkrath, Germany	Financial support for this study was provided by a grant from the Hiller Foundation, Erkrath, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnoya J, 2004, CANCER CAUSE CONTROL, V15, P689, DOI 10.1023/B:CACO.0000036187.13805.30; BORGAN O, 1993, BIOMETRICS, V49, P593, DOI 10.2307/2532571; Brinks R, 2015, MATH MED BIOL, V32, P425, DOI 10.1093/imammb/dqu024; Brinks R, 2014, THEOR POPUL BIOL, V92, P62, DOI 10.1016/j.tpb.2013.11.006; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Draper N.R., 2014, WILEY SERIES PROBABI; Efron B., 1994, INTRO BOOTSTRAP; Federation ID., 2015, IDF DIABETES ATLAS, V7; Fix E, 1951, HUM BIOL, P205; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150; Landwehr S, 2015, STAT MED; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189	17	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152046	10.1371/journal.pone.0152046	http://dx.doi.org/10.1371/journal.pone.0152046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023438	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900022
J	Casajus, N; Perie, C; Logan, T; Lambert, MC; de Blois, S; Berteaux, D				Casajus, Nicolas; Perie, Catherine; Logan, Travis; Lambert, Marie-Claude; de Blois, Sylvie; Berteaux, Dominique			An Objective Approach to Select Climate Scenarios when Projecting Species Distribution under Climate Change	PLOS ONE			English	Article							DISTRIBUTION MODELS; UNCERTAINTY; PREDICTION; CONSENSUS; AREAS; TREE	An impressive number of new climate change scenarios have recently become available to assess the ecological impacts of climate change. Among these impacts, shifts in species range analyzed with species distribution models are the most widely studied. Whereas it is widely recognized that the uncertainty in future climatic conditions must be taken into account in impact studies, many assessments of species range shifts still rely on just a few climate change scenarios, often selected arbitrarily. We describe a method to select objectively a subset of climate change scenarios among a large ensemble of available ones. Our k-means clustering approach reduces the number of climate change scenarios needed to project species distributions, while retaining the coverage of uncertainty in future climate conditions. We first show, for three biologically-relevant climatic variables, that a reduced number of six climate change scenarios generates average climatic conditions very close to those obtained from a set of 27 scenarios available before reduction. A case study on potential gains and losses of habitat by three northeastern American tree species shows that potential future species distributions projected from the selected six climate change scenarios are very similar to those obtained from the full set of 27, although with some spatial discrepancies at the edges of species distributions. In contrast, projections based on just a few climate models vary strongly according to the initial choice of climate models. We give clear guidance on how to reduce the number of climate change scenarios while retaining the central tendencies and coverage of uncertainty in future climatic conditions. This should be particularly useful during future climate change impact studies as more than twice as many climate models were reported in the fifth assessment report of IPCC compared to the previous one.	[Casajus, Nicolas; Berteaux, Dominique] Univ Quebec, Canada Res Chair Northern Biodivers, 300 Allee Ursulines, Rimouski, PQ G5L 3A1, Canada; [Casajus, Nicolas; Berteaux, Dominique] Univ Quebec, Ctr Etud Nord, 300 Allee Ursulines, Rimouski, PQ G5L 3A1, Canada; [Perie, Catherine; Lambert, Marie-Claude] Minist Forets Faune & Parcs, Direct Rech Forestiere, Quebec City, PQ G1P 3W8, Canada; [Logan, Travis] Ouranos Consortium Reg Climatol & Adaptat Climate, Montreal, PQ H3A 1B9, Canada; [de Blois, Sylvie] McGill Univ, Dept Plant Sci, Macdonald Campus,21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [de Blois, Sylvie] McGill Univ, McGill Sch Environm, Macdonald Campus,21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada	University of Quebec; University of Quebec; Ouranos Consortium; McGill University; McGill University	Casajus, N; Berteaux, D (corresponding author), Univ Quebec, Canada Res Chair Northern Biodivers, 300 Allee Ursulines, Rimouski, PQ G5L 3A1, Canada.; Casajus, N; Berteaux, D (corresponding author), Univ Quebec, Ctr Etud Nord, 300 Allee Ursulines, Rimouski, PQ G5L 3A1, Canada.	nicolas.casajus@gmail.com; dominique_berteaux@uqar.ca		Perie, Catherine/0000-0003-1785-3950; Casajus, Nicolas/0000-0002-5537-5294	Ducks Unlimited Canada; Government of Canada; Ministry of Natural Resources and Wildlife of Quebec; Ouranos consortium on regional climatology and adaptation to climate change; Natural Sciences and Engineering Research Council of Canada [STPGP 350816-07]	Ducks Unlimited Canada; Government of Canada(CGIAR); Ministry of Natural Resources and Wildlife of Quebec; Ouranos consortium on regional climatology and adaptation to climate change; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Ducks Unlimited Canada (DB, www.ducks.ca/), Government of Canada (DB, http://www.canada.ca/), Ministry of Natural Resources and Wildlife of Quebec (SdB, http://www.mffp.gouv.qc.ca/english/department/index.jsp), Ouranos consortium on regional climatology and adaptation to climate change (DB, http://www.ouranos.ca/en/), and Natural Sciences and Engineering Research Council of Canada (DB, Strategic Project Grant STPGP 350816-07, http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahuhta J, 2011, J BIOGEOGR, V38, P383, DOI 10.1111/j.1365-2699.2010.02412.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P1376, DOI 10.1111/geb.12228; Berteaux D, 2014, CHANGEMENTS CLIMATIQ; Berteaux Dominique, 2010, Diversity, V2, P1181, DOI 10.3390/d2111181; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Field C.B., 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hawkins E, 2011, CLIM DYNAM, V37, P407, DOI 10.1007/s00382-010-0810-6; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Markovic D, 2014, DIVERS DISTRIB, V20, P1097, DOI 10.1111/ddi.12232; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; MILLIGAN GW, 1980, PATTERN RECOGN, V12, P41, DOI 10.1016/0031-3203(80)90001-1; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AD, 2010, SYSTEMATIC EVALUATIO; Prasad A.M., 2003, LITTLES RANGE FIA IM; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; R Core Team, 2021, R LANGUAGE ENV STAT; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Rehfeldt GE, 2006, RMRSGTR165 DEP AGR F; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Virkkala R, 2014, ECOL EVOL, V4, P2991, DOI 10.1002/ece3.1162; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106	50	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152495	10.1371/journal.pone.0152495	http://dx.doi.org/10.1371/journal.pone.0152495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015274	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708900070
J	Zhang, L; Zhang, W; Li, Y; Alvarez, A; Li, Z; Wang, Y; Song, L; Lv, D; Nakano, I; Hu, B; Cheng, SY; Feng, H				Zhang, L.; Zhang, W.; Li, Y.; Alvarez, A.; Li, Z.; Wang, Y.; Song, L.; Lv, D.; Nakano, I.; Hu, B.; Cheng, S-Y; Feng, H.			SHP-2-upregulated ZEB1 is important for PDGFR alpha-driven glioma epithelial-mesenchymal transition and invasion in mice and humans	ONCOGENE			English	Article							PROSTATE-CANCER CELLS; E-CADHERIN; MIR-200 FAMILY; BETA-CATENIN; DEPENDENT MECHANISM; REPRESSORS ZEB1; LUNG-CANCER; STEM-CELLS; GLIOBLASTOMA; GROWTH	Gliomas are highly malignant brain tumors that are highly invasive and resistant to conventional therapy. Receptor tyrosine kinases (RTKs) such as PDGFR alpha (platelet-derived growth factor receptor-alpha), which show frequent aberrant activation in gliomas, are associated with a process of epithelial-mesenchymal transition (EMT), a cellular alteration that confers a more invasive and drug-resistant phenotype. Although this phenomenon is well documented in human cancers, the processes by which RTKs including PDGFR alpha mediate EMT are largely unknown. Here, we report that SHP-2 (encoded by PTPN11) upregulates an EMT inducer, ZEB1, to mediate PDGFR alpha-driven glioma EMT, invasion and growth in glioma cell lines and patient-derived glioma stem cells (GSCs) using cell culture and orthotopic xenograft models. ZEB1 and activated PDGFR alpha were coexpressed in invasive regions of mouse glioma xenografts and clinical glioma specimens. Glioma patients with high levels of both phospho-PDGFR alpha (p-PDGFR alpha) and ZEB1 had significantly shorter overall survival compared with those with low expression of p-PDGFR alpha and ZEB1. Knockdown of ZEB1 inhibited PDGFA/PDGFR alpha-stimulated glioma EMT, tumor growth and invasion in glioma cell lines and patient-derived GSCs. PDGFR alpha mutant deficient of SHP2 binding (PDGFR alpha-F720) or phosphoinositide 3-kinase (PI3K) binding (PDGFR alpha-F731/42), knockdown of SHP2 or treatments of pharmacological inhibitor for PDGFR alpha-signaling effectors attenuated PDGFA/PDGFR alpha-stimulated ZEB1 expression, cell migration and GSC proliferation. Importantly, SHP-2 acts together with PI3K/AKT to regulate a ZEB1-miR-200 feedback loop in PDGFR alpha-driven gliomas. Taken together, our findings uncover a new pathway in which ZEB1 functions as a key regulator for PDGFR alpha-driven glioma EMT, invasiveness and growth, suggesting that ZEB1 is a promising therapeutic target for treating gliomas with high PDGFR alpha activation.	[Zhang, L.; Zhang, W.; Li, Z.; Wang, Y.; Song, L.; Lv, D.; Cheng, S-Y; Feng, H.] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, State Key Lab Oncogenes & Related Genes,Renji Med, Pu Jian Rd 160, Shanghai 200127, Peoples R China; [Li, Y.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Key Lab Pediat Hematol & Oncol,Minist Hlth,Pediat, Shanghai, Peoples R China; [Alvarez, A.; Hu, B.; Cheng, S-Y] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Neurol,Northwestern Brain Tumor Inst,Ctr Gen, Chicago, IL 60611 USA; [Nakano, I.] Univ Alabama Birmingham, Dept Neurosurg Cell Dev & Integrat Biol Biochem &, Birmingham, AL USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Alabama System; University of Alabama Birmingham	Feng, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, State Key Lab Oncogenes & Related Genes,Renji Med, Pu Jian Rd 160, Shanghai 200127, Peoples R China.	Fenghaizhong@sjtu.edu.cn	Nakano, Ichiro/AAR-9562-2020; Feng, Haizhong/E-5795-2017	Nakano, Ichiro/0000-0002-0916-3207; Feng, Haizhong/0000-0003-3552-6865	National Natural Science Foundation of China [81372704, 81572467, 81470315]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Innovation Program of Shanghai Municipal Education Commission [14ZZ111]; State Key Laboratory of Oncogenes and Related Genes in China [90-14-04]; Pujiang Talent Plan of Shanghai City, China [14PJ1406500]; Natural Science Foundation of Tianjin City, China [13JCYBJC39400]; Shanghai Jiao Tong University School of Medicine Hospital Fund [14XJ10069]; Science and Technology Commission of Shanghai Municipality, China [15ZR1425700]; US NIH [CA158911, NS093843, NS95634]; Zell Scholar Award from the Zell Family Foundation; Northwestern Brain Tumor Institute at Northwestern University; Brain Cancer Research Award from the James S McDonnell Foundation; NIH/NCI training grant [T32 CA070085]; NATIONAL CANCER INSTITUTE [R01CA159811, T32CA070085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093843, R01NS083767, R01NS095634] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Innovation Program of Shanghai Municipal Education Commission; State Key Laboratory of Oncogenes and Related Genes in China; Pujiang Talent Plan of Shanghai City, China; Natural Science Foundation of Tianjin City, China(Natural Science Foundation of Tianjin); Shanghai Jiao Tong University School of Medicine Hospital Fund; Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zell Scholar Award from the Zell Family Foundation; Northwestern Brain Tumor Institute at Northwestern University; Brain Cancer Research Award from the James S McDonnell Foundation; NIH/NCI training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E Van Meir for providing glioma cell lines, R Pangeni and N Sastry for editing the manuscript. This work was supported, in part, by National Natural Science Foundation of China (Nos. 81372704 and 81572467) to H Feng and (No. 81470315) (to YL); the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Innovation Program of Shanghai Municipal Education Commission (No. 14ZZ111), the State Key Laboratory of Oncogenes and Related Genes in China (No. 90-14-04) (to HF); the Pujiang Talent Plan of Shanghai City, China (No. 14PJ1406500), Natural Science Foundation of Tianjin City, China (No. 13JCYBJC39400), Shanghai Jiao Tong University School of Medicine Hospital Fund (No. 14XJ10069) (to YL); Science and Technology Commission of Shanghai Municipality, China (15ZR1425700) (to ZL); US NIH Grants (CA158911, NS093843 and NS95634), a Zell Scholar Award from the Zell Family Foundation and funds from Northwestern Brain Tumor Institute at Northwestern University (to S-YC); a Brain Cancer Research Award from the James S McDonnell Foundation (to BH) and a NIH/NCI training grant T32 CA070085 (to AA).	Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen WG, 2013, ONCOL LETT, V6, P1234, DOI 10.3892/ol.2013.1552; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dong PX, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0231-0; Du R, 2014, MOL BIOL CELL, V25, P2650, DOI 10.1091/mbc.E14-01-0044; Feng H, 2012, ONCOGENE, V31, P2691, DOI 10.1038/onc.2011.436; Feng HZ, 2014, J CLIN INVEST, V124, P3741, DOI 10.1172/JCI73093; Feng HZ, 2012, P NATL ACAD SCI USA, V109, P3018, DOI 10.1073/pnas.1121457109; Feng HZ, 2011, J CLIN INVEST, V121, P4670, DOI 10.1172/JCI58559; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grille SJ, 2003, CANCER RES, V63, P2172; Imanishi Y, 2011, J BIOL CHEM, V286, P29249, DOI 10.1074/jbc.M111.235689; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Liu KW, 2011, J CLIN INVEST, V121, P905, DOI 10.1172/JCI43690; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Meng FY, 2015, CANCER RES, V75, P584, DOI 10.1158/0008-5472.CAN-13-3029; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rosenkranz S, 1999, J BIOL CHEM, V274, P28335, DOI 10.1074/jbc.274.40.28335; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Siebzehnrubl FA, 2013, EMBO MOL MED, V5, P1196, DOI 10.1002/emmm.201302827; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Van Stry M, 2005, P NATL ACAD SCI USA, V102, P8233, DOI 10.1073/pnas.0502885102; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu KJ, 2012, CELL SIGNAL, V24, P2273, DOI 10.1016/j.cellsig.2012.08.004; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yoshida S, 1997, J CANCER RES CLIN, V123, P301, DOI 10.1007/s004320050062; Zang MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112908; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	48	66	71	4	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5641	5652		10.1038/onc.2016.100	http://dx.doi.org/10.1038/onc.2016.100			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	27041571	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000386998300007
J	Cifelli, JL; Dozier, L; Chung, TS; Patrick, GN; Yang, J				Cifelli, Jessica L.; Dozier, Lara; Chung, Tim S.; Patrick, Gentry N.; Yang, Jerry			Benzothiazole Amphiphiles Promote the Formation of Dendritic Spines in Primary Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; PATHOLOGY; ANILINE; ACTIN; PLASTICITY; DISORDERS; SYNAPSES; DENSITY; SCHIZOPHRENIA	The majority of excitatory synapses in the brain exist on dendritic spines. Accordingly, the regulation of dendritic spine density in the hippocampus is thought to play a central role in learning and memory. The development of novel methods to control spine density could, therefore, have important implications for treatment of a host of neurodegenerative and developmental cognitive disorders. Herein, we report the design and evaluation of a new class of benzothiazole amphiphiles that exhibit a dose-dependent response leading to an increase in dendritic spine density in primary hippocampal neurons. Cell exposure studies reveal that the increase in spine density can persist for days in the presence of these compounds, but returns to normal spine density levels within 24 h when the compounds are removed, demonstrating the capability to reversibly control spinogenic activity. Time-lapse imaging of dissociated hippocampal neuronal cultures shows that these compounds promote a net increase in spine density through the formation of new spines. Biochemical studies support that promotion of spine formation by these compounds is accompanied by Ras activation. These spinogenic molecules were also capable of inhibiting a suspected mechanism for dendritic spine loss induced by Alzheimer-related aggregated amyloid-beta peptides in primary neurons. Evaluation of this new group of spinogenic agents reveals that they also exhibit relatively low toxicity at concentrations displaying activity. Collectively, these results suggest that small molecules that promote spine formation could be potentially useful for ameliorating cognitive deficiencies associated with spine loss in neurodegenerative diseases such as Alzheimer disease, and may also find use as general cognitive enhancers.	[Cifelli, Jessica L.; Chung, Tim S.; Yang, Jerry] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Dozier, Lara; Patrick, Gentry N.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Yang, J (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jerryyang@ucsd.edu			UCSD Alzheimer's Disease Research Center (National Institutes of Health) [3P50 AG005131]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	UCSD Alzheimer's Disease Research Center (National Institutes of Health); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the UCSD Alzheimer's Disease Research Center (National Institutes of Health Grant 3P50 AG005131). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Chittiboyina AG, 2006, J MED CHEM, V49, P4072, DOI 10.1021/jm0510880; Dennis J, 2013, ANN NEUROL, V74, P328, DOI 10.1002/ana.24001; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Finkelstein H, 1910, BER DTSCH CHEM GES, V43, P1528, DOI 10.1002/cber.19100430257; Furuta T, 2001, J HISTOCHEM CYTOCHEM, V49, P1497, DOI 10.1177/002215540104901203; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; Inbar P, 2006, CHEMBIOCHEM, V7, P1563, DOI 10.1002/cbic.200600119; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kolomeets NS, 2005, SYNAPSE, V57, P47, DOI 10.1002/syn.20153; Kramer JA, 2007, NAT REV DRUG DISCOV, V6, P636, DOI 10.1038/nrd2378; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lai KO, 2013, BBA-MOL BASIS DIS, V1832, P2257, DOI 10.1016/j.bbadis.2013.08.012; Lee NJ, 2016, BBA-MOL BASIS DIS, V1862, P284, DOI 10.1016/j.bbadis.2015.12.007; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Megill A, 2013, J NEUROSCI, V33, P9306, DOI 10.1523/JNEUROSCI.1615-12.2013; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Namboodiri VV, 2002, ORG LETT, V4, P3161, DOI 10.1021/ol026608p; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Park N, 2012, EUR J ORG CHEM, V2012, P1984, DOI 10.1002/ejoc.201101773; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Prangkio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047261; Prangkio P, 2011, BBA-BIOMEMBRANES, V1808, P2877, DOI 10.1016/j.bbamem.2011.08.024; Ranu BC, 2006, EUR J ORG CHEM, V2006, P3767, DOI 10.1002/ejoc.200600335; Rodrigues EM, 2016, J NEUROSCI, V36, P1590, DOI 10.1523/JNEUROSCI.2964-15.2016; Schaumann E., 2007, SULFUR MEDIATED REAR; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Scudder SL, 2014, J NEUROSCI, V34, P16637, DOI 10.1523/JNEUROSCI.2452-14.2014; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Song JM, 2014, EXP NEUROL, V252, P105, DOI 10.1016/j.expneurol.2013.11.023; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Yang J, 2002, J ORG CHEM, V67, P5057, DOI 10.1021/jo020174u; Zhao XB, 2010, ACS CHEM NEUROSCI, V1, P655, DOI 10.1021/cn100067e	48	8	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					11981	11992		10.1074/jbc.M115.701482	http://dx.doi.org/10.1074/jbc.M115.701482			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27022020	Green Published, hybrid			2022-12-26	WOS:000378092800003
J	Pasi, S; Kant, R; Surolia, A				Pasi, Shweta; Kant, Ravi; Surolia, Avadhesha			Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; EARLY RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; DENDRITIC CELLS; PROINFLAMMATORY CYTOKINES; CARTILAGE DESTRUCTION; INTERFERON-GAMMA; II COLLAGEN; T-CELLS; MYD88	Evasion through immunomodulation is one of the several strategies adopted by pathogens to prolong their survival within the host. One such pathogen, Escherichia coli CFT073, utilizes an immunomodulatory protein, TcpC, to combat the host's innate immune defense. TcpC abrogates the function of MyD88 in macrophages, thus perturbing all the signaling processes that involve this adaptor protein. Although central to various signaling pathways initiated by IL-1, IL-18, and toll-like receptors, the precise contribution of MyD88 to the development of autoimmunity, particularly rheumatoid arthritis, still needs extensive exploration. Herein, by using the toll/interleukin-1 receptor (TIR) domain homologous C-terminal motif of TcpC, i.e. TIR-TcpC, we found MyD88 to be critical for the induction and progression of rheumatoid arthritis through its pivotal role in the development of Th17 cells, the subset of CD4(+) T-cells widely implicated in various autoimmune disorders. The TIR-TcpC mediated inhibition of signaling through MyD88, and subsequent amelioration of experimental autoimmune arthritis was observed to be an outcome of perturbations in the NF kappa B-ROR gamma t (RAR-related orphan receptor gamma t) axis.	Natl Inst Immunol, Mol Sci Lab, New Delhi 110067, India; [Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Science (IISC) - Bangalore	Surolia, A (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@mbu.iisc.ernet.in			Council of Scientific and Industrial Research (CSIR), India; CSIR	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Council of Scientific and Industrial Research (CSIR), India ( to A. S.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by CSIR research fellowships.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Aliahmadi E, 2009, EUR J IMMUNOL, V39, P1221, DOI 10.1002/eji.200838742; Bingham CO, 2002, J RHEUMATOL, V29, P3; Braddock M, 2004, EXPERT OPIN BIOL TH, V4, P847, DOI 10.1517/14712598.4.6.847; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Chang J, 2013, P NATL ACAD SCI USA, V110, P2270, DOI 10.1073/pnas.1206048110; Choy E, 2012, CURR MED RES OPIN, V28, P1733, DOI 10.1185/03007995.2012.731388; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; EASTGATE JA, 1988, LANCET, V2, P706; Eriksson U, 2003, J EXP MED, V197, P323, DOI 10.1084/jem.20021788; Hardiman G, 1996, ONCOGENE, V13, P2467; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; Inglis JJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2319; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; KAHLE P, 1992, ANN RHEUM DIS, V51, P731, DOI 10.1136/ard.51.6.731; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; LORD KA, 1990, ONCOGENE, V5, P1095; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Luft T, 2002, J IMMUNOL, V168, P713, DOI 10.4049/jimmunol.168.2.713; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pasi S, 2015, BIOMATERIALS, V42, P121, DOI 10.1016/j.biomaterials.2014.11.041; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Saal JG, 1999, ARTHRITIS RHEUM-US, V42, P1485, DOI 10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7; SAAL JG, 1992, RHEUMATOL INT, V12, P147, DOI 10.1007/BF00274934; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Sarkar S, 2010, CLIN EXP IMMUNOL, V159, P225, DOI 10.1111/j.1365-2249.2009.04016.x; Sarkar S, 2010, RHEUM DIS CLIN N AM, V36, P345, DOI 10.1016/j.rdc.2010.02.006; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Snyder GA, 2013, P NATL ACAD SCI USA, V110, P6985, DOI 10.1073/pnas.1215770110; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; van den Berg WB, 1999, ANN RHEUM DIS, V58, P40; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; WALLE TK, 1990, SCAND J IMMUNOL, V31, P535, DOI 10.1111/j.1365-3083.1990.tb02802.x; Warner N, 2013, J IMMUNOL, V190, P3, DOI 10.4049/jimmunol.1203103; Yadav M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001120; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	54	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12358	12369		10.1074/jbc.M116.722801	http://dx.doi.org/10.1074/jbc.M116.722801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27022030	Green Published, hybrid			2022-12-26	WOS:000378092800034
J	Liu, WN; Xu, C; You, XJ; Olson, DM; Chemtob, S; Gao, L; Ni, X				Liu, Weina; Xu, Chen; You, Xingji; Olson, David M.; Chemtob, Sylvain; Gao, Lu; Ni, Xin			Hydrogen Sulfide Delays LPS-Induced Preterm Birth in Mice via Anti-Inflammatory Pathways	PLOS ONE			English	Article							MOUSE MODEL; LABOR; INFLAMMATION; PARTURITION; EXPRESSION; MYOMETRIUM; INFECTION; DELIVERY	A major cause of preterm labor in pregnant women is intra-amniotic infection, which is mediated by an inflammatory process. Hydrogen sulfide (H2S), a gaseous transmitter, has been implicated to be involved in inflammatory responses. We sought to investigate whether H2S affects infectious preterm birth using the mouse model of lipopolysaccharides (LPS)induced preterm birth. Administration of LPS at 0.4 mg/kg with two injections intraperitoneally (i.p.) on gestational day 14.5 induced preterm labor. LPS significantly increased leukocyte infiltration in uterus, stimulated the expression of pro-inflammatory cytokines interleukin 1 beta (IL-1 beta), IL-6, tumor necrosis factor a (TNF-alpha), CCL2 and CXCL15 in myometrium. Administration of NaHS (i.p.) delayed the onset of labor induced by LPS in a dose-dependent manner. NaHS prevented leukocyte infiltration into intrauterine tissues and inhibited the production of pro-inflammatory cytokines in myometrium and decreased the levels of these cytokines in maternal circulation. H2S also decreased LPS-activated extracellular signal-regulated kinase (ERK) 1/2/nuclear factor (NF)-kappa B signaling pathways in myometrium. This study provides new in vivo evidence for the roles of H2S in attenuating inflammation, and a potential novel therapeutic strategy for infection-related preterm labor.	[Liu, Weina; Xu, Chen; You, Xingji; Gao, Lu; Ni, Xin] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Olson, David M.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Chemtob, Sylvain] CHU St Justine Res Ctr, Dept Pediat, Montreal, PQ, Canada; [Chemtob, Sylvain] CHU St Justine Res Ctr, Dept Ophthalmol, Montreal, PQ, Canada; [Chemtob, Sylvain] CHU St Justine Res Ctr, Dept Pharmacol, Montreal, PQ, Canada; [Liu, Weina] Chinese Peoples Liberat Army, Hosp 413, Zhoushan, Zhejiang, Peoples R China; [Xu, Chen] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China	Naval Medical University; University of Alberta; University of Alberta; University of Alberta; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Fudan University	Gao, L; Ni, X (corresponding author), Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China.	lu.gao@smmu.edu.cn; nixin@smmu.edu.cn	Xingji, You/GQY-5030-2022		National Natural Science Foundation of China [81170596, 81270756, 81370734, 81471479]; Science and Technology Commission of Shanghai Municipals [15PJ1410400, 13430722900]; Global Alliance for the Prevention of Prematurity and Stillbirth (GAPPS): Preventing Preterm Birth Initiative	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipals; Global Alliance for the Prevention of Prematurity and Stillbirth (GAPPS): Preventing Preterm Birth Initiative	This work was supported by National Natural Science Foundation of China No. 81170596 & 81270756 (to LG), No. 81370734 (to XN), and 81471479 (to XY); Science and Technology Commission of Shanghai Municipals No. 15PJ1410400 (to LG) and No. 13430722900 (to XN); and Global Alliance for the Prevention of Prematurity and Stillbirth (GAPPS): Preventing Preterm Birth Initiative (to DMO, SC & XN).	Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bokstrom H, 1997, HUM REPROD, V12, P586; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Cindrova-Davies T, 2013, AM J PATHOL, V182, P1448, DOI 10.1016/j.ajpath.2013.01.001; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Filipovich Y, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.025; Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024; Holwerda KM, 2012, PLACENTA, V33, P518, DOI 10.1016/j.placenta.2012.02.014; Holwerda KM, 2013, HYPERTENSION, V62, P653, DOI 10.1161/HYPERTENSIONAHA.113.01625; Hua W, 2013, CHINESE MED J-PEKING, V126, P1360, DOI 10.3760/cma.j.issn.0366-6999.20122557; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kakinuma C, 1997, OBSTET GYNECOL, V90, P117, DOI 10.1016/S0029-7844(97)00176-2; Kimura H, 2015, ANTIOXID REDOX SIGN, V22, P347, DOI 10.1089/ars.2014.6082; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Lin Y, 2006, J REPROD IMMUNOL, V71, P87, DOI 10.1016/j.jri.2006.01.005; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Faro ML, 2014, NITRIC OXIDE-BIOL CH, V41, P38, DOI 10.1016/j.niox.2014.05.014; Marret S, 2007, OBSTET GYNECOL, V110, P72, DOI 10.1097/01.AOG.0000267498.95402.bd; Muniraj N, 2017, INT J RHEUM DIS, V20, P182, DOI 10.1111/1756-185X.12472; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Osmers R G, 1995, J Obstet Gynaecol (Tokyo 1995), V21, P185; Palinkas Z, 2015, BRIT J PHARMACOL, V172, P1516, DOI 10.1111/bph.12769; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Paul BD, 2012, NAT REV MOL CELL BIO, V13, DOI 10.1038/nrm3391-c2; Ray A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00052; Rinaldi SF, 2014, J IMMUNOL, V192, P2315, DOI 10.4049/jimmunol.1302891; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shynlova O, 2013, J CELL MOL MED, V17, P90, DOI 10.1111/j.1582-4934.2012.01650.x; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Wallace JL, 2015, ANTIOXID REDOX SIGN, V22, P398, DOI 10.1089/ars.2014.5901; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Whiteman M, 2010, ANN NY ACAD SCI, V1203, P146, DOI 10.1111/j.1749-6632.2010.05556.x; You XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023788; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang GS, 2013, AM J PATHOL, V182, P1188, DOI 10.1016/j.ajpath.2012.12.008; Zhi L, 2007, J LEUKOCYTE BIOL, V81, P1322, DOI 10.1189/jlb.1006599	37	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152838	10.1371/journal.pone.0152838	http://dx.doi.org/10.1371/journal.pone.0152838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035826	Green Published, Green Submitted, gold			2022-12-26	WOS:000373201200045
J	Simmons, M; Sun, PF; Putnak, R				Simmons, Monika; Sun, Peifang; Putnak, Robert			Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated Vaccine	PLOS ONE			English	Article							WEST-NILE-VIRUS; IMMUNOLOGICAL-PROPERTIES; STRUCTURAL PROTEINS; MICE; ENCEPHALITIS; IMMUNIZATION; PROTECTION; NEUTRALIZATION; IMMUNOGENICITY; IDENTIFICATION	Dengue virus purified inactivated vaccines (PIV) are highly immunogenic and protective over the short term, but may be poor at inducing cell-mediated immune responses and long-term protection. The dengue nonstructural protein 3 (NS3) is considered the main target for T-cell responses during viral infection. The amino (N)-terminal protease and the carboxy (C)-terminal helicase domains of DENV-2 NS3 were expressed in E.coli and analyzed for their immune-potentiating capacity. Mice were immunized with DENV-2 PIV with and without recombinant NS3 protease or NS3 helicase proteins, and NS3 proteins alone on days 0, 14 and 28. The NS3 helicase but not the NS3 protease was effective in inducing T-cell responses quantified by IFN-gamma ELISPOT. In addition, markedly increased total IgG antibody titer against virus antigen was seen in mice immunized with the PIV/NS3 helicase combination in the ELISA, as well as increased neutralizing antibody titer measured by the plaque reduction neutralization test. These results indicate the potential immunogenic properties of the NS3 helicase protein and its use in a dengue vaccine formulation.	[Simmons, Monika; Sun, Peifang] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA; [Putnak, Robert] Walter Reed Army Inst Res, Div Viral Dis, Silver Spring, MD USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Simmons, M (corresponding author), Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA.	monika.simmons.civ@mail.mil			Military Infectious Disease Research Program (MIDRP), U.S. Army Medical Research and Materiel Command, Fort Detrick, MD [A1325]	Military Infectious Disease Research Program (MIDRP), U.S. Army Medical Research and Materiel Command, Fort Detrick, MD	This work was funded by a grant from the Military Infectious Disease Research Program (MIDRP), U.S. Army Medical Research and Materiel Command, Fort Detrick, MD, work unit number A1325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; BRAY M, 1989, J VIROL, V63, P2853, DOI 10.1128/JVI.63.6.2853-2856.1989; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; CHURDBOONCHART V, 1991, AM J TROP MED HYG, V44, P481, DOI 10.4269/ajtmh.1991.44.481; Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005; Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685; Durbin AP, 2011, VIRUSES-BASEL, V3, P1800, DOI 10.3390/v3101800; Edelman R, 2011, EXPERT REV VACCINES, V10, P133, DOI 10.1586/ERV.10.159; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268; Gao M, 2006, VACCINE, V24, P5491, DOI 10.1016/j.vaccine.2006.04.004; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Haller AA, 2007, VACCINE, V25, P1452, DOI 10.1016/j.vaccine.2006.10.035; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Jiao XM, 2004, J GEN VIROL, V85, P1545, DOI 10.1099/vir.0.79896-0; Kaltenbock A, 2009, VACCINE, V27, P4483, DOI 10.1016/j.vaccine.2009.05.034; Kaufman B, 1989, MONOCLONAL ANTIBODIE; Konishi E, 2003, VACCINE, V21, P3675, DOI 10.1016/S0264-410X(03)00382-7; KURANE I, 1993, J VIROL, V67, P6285, DOI 10.1128/JVI.67.10.6285-6288.1993; Lopez L, 2006, MICROBIAL CELL FA S1, V5, pP59; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Alvarez-Rodriguez LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/956875; Morozova OV, 1999, VIRAL IMMUNOL, V12, P277, DOI 10.1089/vim.1999.12.277; Putnak R, 1996, J INFECT DIS, V174, P1176, DOI 10.1093/infdis/174.6.1176; Ramirez R, 2014, VIRUS GENES, V49, P185, DOI 10.1007/s11262-014-1087-3; Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7; Rau H, 2006, VET RES, V37, P155, DOI 10.1051/vetres:2005049; Rivino L, 2012, J VIROL; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; RUSSELL PK, 1967, J IMMUNOL, V99, P291; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Simmons M, 2001, AM J TROP MED HYG, V65, P420, DOI 10.4269/ajtmh.2001.65.420; Simmons M, 2006, J VIROL, V80, P9577, DOI 10.1128/JVI.00284-06; Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Spaulding AC, 1999, J VIROL, V73, P398, DOI 10.1128/JVI.73.1.398-403.1999; Stephenson JR, 2005, T ROY SOC TROP MED H, V99, P643, DOI 10.1016/j.trstmh.2005.05.003; Thomas SJ, 2011, J INFECT DIS, V203, P299, DOI 10.1093/infdis/jiq060; Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000; Vogelzang A, 2014, J INFECT DIS, V210, P1928, DOI 10.1093/infdis/jiu347; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wuest T, 2004, VACCINE, V22, P2717, DOI 10.1016/j.vaccine.2004.01.048; ZHANG YM, 1988, J VIROL, V62, P3027, DOI 10.1128/JVI.62.8.3027-3031.1988	48	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152811	10.1371/journal.pone.0152811	http://dx.doi.org/10.1371/journal.pone.0152811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035715	gold, Green Published, Green Submitted			2022-12-26	WOS:000373201200044
J	Guo, XM; Dong, ZM; Zhang, Y; Li, YS; Liu, HW; Xia, QY; Zhao, P				Guo, Xiaomeng; Dong, Zhaoming; Zhang, Yan; Li, Youshan; Liu, Huawei; Xia, Qingyou; Zhao, Ping			Proteins in the Cocoon of Silkworm Inhibit the Growth of Beauveria bassiana	PLOS ONE			English	Article							GALLERIA-MELLONELLA LARVAE; BOMBYX-MORI; PROTEASE INHIBITORS; DOMESTICATED SILKWORM; TRYPSIN-INHIBITOR; GENE-EXPRESSION; MANDUCA-SEXTA; HEMOLYMPH; GENOME; INSECT	Silk cocoons are composed of fiber proteins (fibroins) and adhesive glue proteins (sericins), which provide a physical barrier to protect the inside pupa. Moreover, other proteins were identified in the cocoon silk, many of which are immune related proteins. In this study, we extracted proteins from the silkworm cocoon by Tris-HCl buffer (pH7.5), and found that they had a strong inhibitory activity against fungal proteases and they had higher abundance in the outer cocoon layers than in the inner cocoon layers. Moreover, we found that extracted cocoon proteins can inhibit the germination of Beauveria bassiana spores. Consistent with the distribution of protease inhibitors, we found that proteins from the outer cocoon layers showed better inhibitory effects against B. bassiana spores than proteins from the inner layers. Liquid chromatography-tandem mass spectrometry was used to reveal the extracted components in the scaffold silk, the outermost cocoon layer. A total of 129 proteins were identified, 30 of which were annotated as protease inhibitors. Protease inhibitors accounted for 89.1% in abundance among extracted proteins. These protease inhibitors have many intramolecular disulfide bonds to maintain their stable structure, and remained active after being boiled. This study added a new understanding to the antimicrobial function of the cocoon.	[Guo, Xiaomeng; Dong, Zhaoming; Zhang, Yan; Li, Youshan; Liu, Huawei; Xia, Qingyou; Zhao, Ping] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Zhao, P (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	zhaop@swu.edu.cn	Dong, Zhaoming/AAK-1802-2021; Dong, Zhaoming/AAW-3060-2021	Dong, Zhaoming/0000-0001-5665-9953; Dong, Zhaoming/0000-0001-5665-9953	National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31530071, 31472154]; China Postdoctoral Science Foundation [2015M570765]; Fundamental Research Funds for the Central Universities of China [XDJK2016C008]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (2012CB114600), the National Natural Science Foundation of China (31530071 and 31472154), the China Postdoctoral Science Foundation (2015M570765) and the Fundamental Research Funds for the Central Universities of China (XDJK2016C008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charnley A.K., 1991, P267; Charnley A.K., 1984, P229; Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3; Chen FJ, 2013, J EXP BIOL, V216, P2648, DOI 10.1242/jeb.082545; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dong ZM, 2013, J PROTEOME RES, V12, P5213, DOI 10.1021/pr4005772; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; EGUCHI M, 1993, COMP BIOCHEM PHYS B, V104, P537, DOI 10.1016/0305-0491(93)90279-E; Ezzati-Tabrizi R, 2013, CURR PROTEIN PEPT SC, V14, P698; GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9; Gandhe AS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-184; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; GOETTEL MS, 1989, J GEN MICROBIOL, V135, P2233; International Silkworm Genome Consortium, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI DOI 10.1016/J.IBMB.2008.11.004; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Kludkiewicz B, 2005, PROTEIN EXPRES PURIF, V43, P94, DOI 10.1016/j.pep.2005.06.011; Korayem AM, 2007, BIOCHEM BIOPH RES CO, V352, P317, DOI 10.1016/j.bbrc.2006.11.022; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; Kurioka Akira, 1999, Journal of Sericultural Science of Japan, V68, P397; Li Y, 2012, AASRI PROC, V1, P549, DOI 10.1016/j.aasri.2012.06.086; Li YS, 2015, INSECT BIOCHEM MOLEC, V57, P11, DOI 10.1016/j.ibmb.2014.11.006; Li YS, 2012, INSECT BIOCHEM MOLEC, V42, P766, DOI 10.1016/j.ibmb.2012.07.004; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; NAYAR JK, 1992, J PARASITOL, V78, P876, DOI 10.2307/3283321; Nirmala X, 2001, INSECT MOL BIOL, V10, P437, DOI 10.1046/j.0962-1075.2001.00282.x; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Pandiarajan J, 2011, RAPID COMMUN MASS SP, V25, P3203, DOI 10.1002/rcm.5213; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Shaik HA, 2009, J INSECT PHYSIOL, V55, P781, DOI 10.1016/j.jinsphys.2009.04.010; Singh CP, 2014, CELL MICROBIOL, V16, P1354, DOI 10.1111/cmi.12294; Slepneva IA, 2003, BIOCHEM BIOPH RES CO, V300, P188, DOI 10.1016/S0006-291X(02)02766-3; URIEL J, 1968, NATURE, V218, P578, DOI 10.1038/218578b0; Vilcinskas A, 1997, BIOCONTROL SCI TECHN, V7, P591, DOI 10.1080/09583159730640; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xiong Q, 2013, MICRON, V44, P303, DOI 10.1016/j.micron.2012.08.002; YOSHIDA S, 1990, COMP BIOCHEM PHYS B, V95, P559, DOI 10.1016/0305-0491(90)90021-K; Yoshizaki L, 2007, PHYTOCHEMISTRY, V68, P2625, DOI 10.1016/j.phytochem.2007.06.003; Zdybicka-Barabas A, 2014, ARCH INSECT BIOCHEM, V87, P1, DOI 10.1002/arch.21175; Zhang Y., 2015, PLOS ONE, V10; Zhao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031168; Zhong X, 2012, INSECT BIOCHEM MOLEC, V42, P514, DOI 10.1016/j.ibmb.2012.03.009	44	18	23	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151764	10.1371/journal.pone.0151764	http://dx.doi.org/10.1371/journal.pone.0151764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032085	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800021
J	Kim, BJ; Kim, BR; Lee, SY; Kim, GN; Kook, YH; Kim, BJ				Kim, Byoung-Jun; Kim, Bo-Ram; Lee, So-Young; Kim, Ga-Na; Kook, Yoon-Hoh; Kim, Bum-Joon			Molecular Taxonomic Evidence for Two Distinct Genotypes of Mycobacterium yongonense via Genome-Based Phylogenetic Analysis	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; SP-NOV.; AVIUM COMPLEX; SEQUENCE-ANALYSIS; IDENTIFICATION; ABSCESSUS; PROPOSAL; ELEVATE; HSP65	Recently, we introduced a distinct Mycobacterium intracellulare INT-5 genotype, distantly related to other genotypes of M. intracellulare (INT-1 to -4). The aim of this study is to determine the exact taxonomic status of the M. intracellulare INT-5 genotype via genome-based phylogenetic analysis. To this end, genome sequences of the two INT-5 strains, MOTT-H4Y and MOTT-36Y were compared with M. intracellulare ATCC 13950(T) and Mycobacterium yongonense DSM 45126(T). Our phylogenetic analysis based on complete genome sequences, multi-locus sequence typing (MLST) of 35 target genes, and single nucleotide polymorphism (SNP) analysis indicated that the two INT-5 strains were more closely related to M. yongonense DSM 45126T than the M. intracellulare strains. These results suggest their taxonomic transfer from M. intracellulare into M. yongonense. Finally, we selected 5 target genes (argH, dnaA, deaD, hsp65, and recF) and used SNPs for the identification of M. yongonese strains from other M. avium complex (MAC) strains. The application of the SNP analysis to 14 MAC clinical isolates enabled the selective identification of 4 M. yongonense clinical isolates from the other MACs. In conclusion, our genome-based phylogenetic analysis showed that the taxonomic status of two INT-5 strains, MOTT-H4Y and MOTT-36Y should be revised into M. yongonense. Our results also suggest that M. yongonense could be divided into 2 distinct genotypes (the Type I genotype with the M. parascrofulaceum rpoB gene and the Type II genotype with the M. intracellulare rpoB gene) depending on the presence of the lateral gene transfer of rpoB from M. parascrofulaceum.	[Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Dept Biomed Sci Microbiol & Immunol, Canc Res Inst,Inst Endem Dis, Seoul, South Korea; Seoul Natl Univ, Coll Med, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci Microbiol & Immunol, Canc Res Inst,Inst Endem Dis, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/AGY-4274-2022	Kim, Bum Joon/0000-0003-0085-6709	Korean Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [HI13C15620000]; National Research Foundation of Korea [NRF-2014R1A1A2004008]	Korean Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	Funded by www.htdream.kr, Korean Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (Grant No., HI13C15620000) (Bum-Joon Kim) and ernd.nrf.re.kr, National Research Foundation of Korea (Grant No., NRF-2014R1A1A2004008) (YHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Bang D, 2008, INT J SYST EVOL MICR, V58, P2398, DOI 10.1099/ijs.0.65503-0; Ben Salah I, 2009, INT J SYST EVOL MICR, V59, P2803, DOI 10.1099/ijs.0.010637-0; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kim Bu-Yeo, 2013, Evid Based Complement Alternat Med, V2013, P584604, DOI 10.1155/2013/584604; Kim BJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1978-2; Kim BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051846; Kim BJ, 2013, INT J SYST EVOL MICR, V63, P192, DOI 10.1099/ijs.0.037465-0; Kim BJ, 2012, J BACTERIOL, V194, P4141, DOI 10.1128/JB.00752-12; Kim BJ, 2012, J BACTERIOL, V194, P3268, DOI 10.1128/JB.00471-12; Kim BJ, 2012, J BACTERIOL, V194, P2771, DOI 10.1128/JB.00365-12; Kim BJ, 2012, J BACTERIOL, V194, P2750, DOI 10.1128/JB.00295-12; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Macheras E, 2014, RES MICROBIOL, V165, P82, DOI 10.1016/j.resmic.2013.12.003; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Murcia MI, 2006, INT J SYST EVOL MICR, V56, P2049, DOI 10.1099/ijs.0.64190-0; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pagliaro E, 2013, J FORENSIC INV, V1, P5, DOI DOI 10.1128/GEN0MEA.00006-13; Park JH, 2010, J MED MICROBIOL, V59, P1037, DOI 10.1099/jmm.0.020727-0; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tortoli E, 2004, INT J SYST EVOL MICR, V54, P1277, DOI 10.1099/ijs.0.02777-0; Tortoli E, 2013, EMERG INFECT DIS, V19, P1902, DOI 10.3201/eid1911.130911; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; van Ingen J, 2009, INT J SYST EVOL MICR, V59, P2277, DOI 10.1099/ijs.0.008854-0; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152703	10.1371/journal.pone.0152703	http://dx.doi.org/10.1371/journal.pone.0152703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031100	Green Published, gold			2022-12-26	WOS:000373121800123
J	Omar, HA; Mohamed, WR; Arab, HH; Arafa, ESA				Omar, Hany A.; Mohamed, Wafaa R.; Arab, Hany H.; Arafa, El-Shaimaa A.			Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; ACUTE-RENAL-FAILURE; FACTOR-KAPPA-B; POLYMETHOXYLATED FLAVONE; INDUCED HEPATOTOXICITY; INDUCED NEPHROTOXICITY; MOLECULAR-MECHANISMS; BREAST-CANCER; LIVER-INJURY; ACTIVATION	Despite its broad applications, cisplatin affords considerable nephro- and hepatotoxicity through triggering inflammatory and oxidative stress cascades. The aim of the current investigation was to study the possible protective effects of tangeretin on cisplatin-induced hepatotoxicity. The impact of tangeretin on cisplatin-evoked hepatic dysfunction and histopathologic changes along with oxidative stress, inflammatory and apoptotic biomarkers were investigated compared to silymarin. Tangeretin pre-treatment significantly improved liver function tests (ALT and AST), inhibited cisplatin-induced lipid profile aberrations (total cholesterol and triglycerides) and diminished histopathologic structural damage in liver tissues. Tangeretin also attenuated cisplatin-induced hepatic inflammatory events as indicated by suppression of tumor necrosis factor-alpha (TNF-alpha) and enhancement of interleukin-10 (IL-10). Meanwhile, it lowered malondialdehyde (MDA), nitric oxide (NO) and nuclear factor erythroid 2-related factor 2 (NRF-2) levels with restoration of glutathione (GSH), and glutathione peroxidase (GPx). Regarding mitogen-activated protein kinase (MAPK) pathway, tangeretin attenuated cisplatin-induced increase in phospho-p38, phospho-c-Jun Nterminal kinase (p-JNK) and phospho-extracellular signal-regulated kinase (p-ERK1/2) in liver tissues. In addition, tangeretin downregulated Bax expression with augmentation of Bcl-2 promoting liver cell survival. Our results highlight the protective effects of tangeretin against cisplatin-induced acute hepatic injury via the concerted modulation of inflammation, oxidative stress, MAPKs and apoptotic pathways.	[Omar, Hany A.; Mohamed, Wafaa R.; Arafa, El-Shaimaa A.] Beni Suef Univ, Dept Pharmacol & Toxicol, Fac Pharm, Bani Suwayf 62514, Egypt; [Omar, Hany A.] Univ Sharjah, Coll Pharm, Sharjah Inst Med Res, Sharjah 27272, U Arab Emirates; [Arab, Hany H.] Cairo Univ, Dept Biochem, Fac Pharm, Cairo 11562, Egypt; [Arafa, El-Shaimaa A.] Taif Univ, Dept Pharmacol & Toxicol, Fac Pharm, At Taif 21974, Saudi Arabia	Egyptian Knowledge Bank (EKB); Beni Suef University; University of Sharjah; Egyptian Knowledge Bank (EKB); Cairo University; Taif University	Arafa, ESA (corresponding author), Beni Suef Univ, Dept Pharmacol & Toxicol, Fac Pharm, Bani Suwayf 62514, Egypt.; Arafa, ESA (corresponding author), Taif Univ, Dept Pharmacol & Toxicol, Fac Pharm, At Taif 21974, Saudi Arabia.	elshimaa.arafa@pharm.bsu.edu.eg	Omar, Hany/B-7440-2013; Arafa, El-Shaimaa A/C-4777-2013; Arafa, Elshaimaa/Q-1316-2019; Arab, Hany/AAF-3652-2020	Omar, Hany/0000-0002-4670-8149; Arafa, El-Shaimaa A/0000-0002-9034-6624; Arafa, Elshaimaa/0000-0002-9034-6624; Arab, Hany/0000-0002-4195-6901; Mohamed, Wafaa/0000-0003-3652-6648	Deanship of Scientific Research, Taif University, Saudi Arabia [1-434-2830]	Deanship of Scientific Research, Taif University, Saudi Arabia	The current work was financially supported by grant number 1-434-2830 from the Deanship of Scientific Research, Taif University, Saudi Arabia.	Antunes LMG, 2000, PHARMACOL RES, V41, P405, DOI 10.1006/phrs.1999.0600; Arab HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122417; Arafa ESA, 2009, CANCER RES, V69, P8910, DOI 10.1158/0008-5472.CAN-09-1543; Arivazhagan L, 2014, J NUTR BIOCHEM, V25, P1140, DOI 10.1016/j.jnutbio.2014.06.007; Atessahin A, 2006, REPROD TOXICOL, V21, P42, DOI 10.1016/j.reprotox.2005.05.003; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Bentli R, 2013, ARCH MED RES, V44, P521, DOI 10.1016/j.arcmed.2013.09.013; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Buege J A, 1978, Methods Enzymol, V52, P302; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen KH, 2007, BIOCHEM PHARMACOL, V73, P215, DOI 10.1016/j.bcp.2006.09.018; Chou WY, 2006, ACTA PHARMACOL SIN, V27, P469, DOI 10.1111/j.1745-7254.2006.00304.x; Clichici S, 2015, J MED FOOD, V18, P290, DOI 10.1089/jmf.2013.0179; Cui W, 2000, MOL CARCINOGEN, V29, P219, DOI 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Flora K, 1998, AM J GASTROENTEROL, V93, P139, DOI 10.1111/j.1572-0241.1998.00139.x; Francescato HDC, 2007, NEPHROL DIAL TRANSPL, V22, P2138, DOI 10.1093/ndt/gfm144; Gopi K S, 2010, Toxicol Int, V17, P64, DOI 10.4103/0971-6580.72672; Hayakawa K, 2006, AM J PHYSIOL-RENAL, V291, pF1169, DOI 10.1152/ajprenal.00513.2005; Helmy MM, 2014, EUR J PHARMACOL, V730, P133, DOI 10.1016/j.ejphar.2014.03.002; HIRANO T, 1995, BRIT J CANCER, V72, P1380, DOI 10.1038/bjc.1995.518; Hong KO, 2005, ARCH TOXICOL, V79, P231, DOI 10.1007/s00204-004-0623-7; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Iroanya OO, 2014, J CLIN DIAGN RES, V8, pHC15, DOI 10.7860/JCDR/2014/5875.4501; Iseri S, 2007, TOXICOLOGY, V230, P256, DOI 10.1016/j.tox.2006.11.073; Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Kurowska EA, 2004, J AGR FOOD CHEM, V52, P2879, DOI 10.1021/jf035354z; Laekeman G, 2003, J Pharm Belg, V58, P28; Lakshmi A, 2014, BIOCHIMIE, V99, P96, DOI 10.1016/j.biochi.2013.11.017; Lakshmi A, 2014, TOXICOL LETT, V229, P333, DOI 10.1016/j.toxlet.2014.06.845; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Lu YK, 2006, TOXICOL SCI, V89, P515, DOI 10.1093/toxsci/kfj031; Luo JH, 2008, NEPHROL DIAL TRANSPL, V23, P2198, DOI 10.1093/ndt/gfn090; Malik S, 2015, EUR J PHARMACOL, V748, P54, DOI 10.1016/j.ejphar.2014.12.008; Mansour HH, 2006, J BIOCHEM MOL BIOL, V39, P656; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nakagawa Hayato, 2012, Patholog Res Int, V2012, P172894, DOI 10.1155/2012/172894; Naveau S, 2001, PRESSE MED, V30, P1024; Omar HA, 2009, MOL PHARMACOL, V76, P957, DOI 10.1124/mol.109.058180; Pan MH, 2002, CARCINOGENESIS, V23, P1677, DOI 10.1093/carcin/23.10.1677; Parlakpinar H, 2002, J PINEAL RES, V33, P161, DOI 10.1034/j.1600-079X.2002.02910.x; Periyasamy K, 2015, CANCER CHEMOTH PHARM, V75, P263, DOI 10.1007/s00280-014-2629-z; Pratibha R, 2006, EUR J PHARMACOL, V532, P290, DOI 10.1016/j.ejphar.2006.01.007; Pushpavalli G, 2010, FOOD CHEM TOXICOL, V48, P1654, DOI 10.1016/j.fct.2010.03.040; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Ramos AS, 2014, ENVIRON TOXICOL PHAR, V37, P1221, DOI 10.1016/j.etap.2014.04.005; Rehman MU, 2014, PHARMACOL REP, V66, P1050, DOI 10.1016/j.pharep.2014.06.004; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Shaw JiaJiu, 2011, J Exp Ther Oncol, V9, P129; Shi RX, 2007, MOL CANCER THER, V6, P1338, DOI 10.1158/1535-7163.MCT-06-0638; Shu ZP, 2014, INT IMMUNOPHARMACOL, V19, P275, DOI 10.1016/j.intimp.2014.01.011; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Singh D, 2015, J ETHNOPHARMACOL, V161, P186, DOI 10.1016/j.jep.2014.12.025; Singh RP, 2006, CURR DRUG TARGETS, V7, P345, DOI 10.2174/138945006776055004; Sohn JH, 2008, BIOL PHARM BULL, V31, P273, DOI 10.1248/bpb.31.273; Sun Y, 2014, HUM EXP TOXICOL, V33, P855, DOI 10.1177/0960327113511475; Sundaram R, 2015, J FUNCT FOODS, V16, P315, DOI 10.1016/j.jff.2015.03.024; Syed SN, 2014, AFR J TRADIT COMPLEM, V11, P102, DOI 10.4314/ajtcam.v11i3.15; Tadagavadi RK, 2010, J IMMUNOL, V185, P4904, DOI 10.4049/jimmunol.1000383; Tsuruya K, 2003, KIDNEY INT, V63, P72, DOI 10.1046/j.1523-1755.2003.00709.x; Vanhoecke BW, 2005, IN VIVO, V19, P103; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Walle T, 2007, J PHARM PHARMACOL, V59, P857, DOI 10.1211/jpp.59.6.0012; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zicca A, 2002, EUR J PHARMACOL, V442, P265, DOI 10.1016/S0014-2999(02)01537-6	71	85	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151649	10.1371/journal.pone.0151649	http://dx.doi.org/10.1371/journal.pone.0151649			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031695	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800018
J	Yang, WE; Ho, CC; Yang, SF; Lin, SH; Yeh, KT; Lin, CW; Chen, MK				Yang, Wei-En; Ho, Chuan-Chen; Yang, Shun-Fa; Lin, Shu-Hui; Yeh, Kun-Tu; Lin, Chiao-Wen; Chen, Mu-Kuan			Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							CYSTEINE CATHEPSINS; OCCLUDING LOOP; CANCER; INHIBITION; INVASION; METASTASIS; MIGRATION	Background Cathepsin B (CTSB), a member of the cathepsin family, is a cysteine protease that is widely distributed in the lysosomes of cells in various tissues. It is overexpressed in several human cancers and may be related to tumorigenesis. The main purpose of this study was to analyze CTSB expression in oral squamous cell carcinoma (OSCC) and its correlation with patient prognosis. Methodology/Principal Findings Tissue microarrays were used to detect CTSB expression in 280 patients and to examine the association between CTSB expression and clinicopathological parameters. In addition, the metastatic effects of the CTSB knockdown on two oral cancer cell lines were investigated by transwell migration assay. Cytoplasmic CTSB expression was detected in 34.6% (97/280) of patients. CTSB expression was correlated with positive lymph node metastasis (p = 0.007) and higher tumor grade (p = 0.008) but not with tumor size and distant metastasis. In addition, multivariate analysis using a Cox proportional hazards model revealed a higher hazard ratio, demonstrating that CTSB expression was an independent unfavorable prognostic factor in buccal mucosa carcinoma patients. Furthermore, the Kaplan-Meier curve revealed that buccal mucosa OSCC patients with positive CTSB expression had significantly shorter overall survival. Moreover, treatment with the CTSB siRNA exerted an inhibitory effect on migration in OC2 and CAL27 oral cancer cells. Conclusions We conclude that CTSB expression may be useful for determining OSCC prognosis, particularly for patients with lymph node metastasis, and may function as a biomarker of the survival of OSCC patients in Taiwan.	[Yang, Wei-En; Yang, Shun-Fa; Yeh, Kun-Tu; Chen, Mu-Kuan] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Wei-En; Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Yang, Wei-En; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 40201, Taiwan; [Ho, Chuan-Chen] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Ho, Chuan-Chen; Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung 40201, Taiwan; [Lin, Shu-Hui; Yeh, Kun-Tu] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan; [Lin, Shu-Hui] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University	Chen, MK (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Chen, MK (corresponding author), Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan.; Lin, CW (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung 40201, Taiwan.; Lin, CW (corresponding author), Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan.	cwlin@csmu.edu.tw; 53780@cch.org.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	National Science Council, Taiwan [NSC101-2314-B-371-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from National Science Council, Taiwan (NSC101-2314-B-371-002-MY3). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a research grant from National Science Council, Taiwan (NSC101-2314-B-371-002-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapati K, 2014, STEM CELL RES, V12, P716, DOI 10.1016/j.scr.2014.02.008; Bagan J, 2010, ORAL ONCOL, V46, P414, DOI 10.1016/j.oraloncology.2010.03.009; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Fortenberry YM, 2010, BBA-GEN SUBJECTS, V1800, P580, DOI 10.1016/j.bbagen.2010.03.003; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Ha SD, 2010, J BIOL CHEM, V285, P2120, DOI 10.1074/jbc.M109.065813; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Heidtmann HH, 1997, CLIN EXP METASTAS, V15, P368, DOI 10.1023/A:1018494020001; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Knopfova L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-15; Ko CP, 2015, TUMOR BIOL, V36, P7099, DOI 10.1007/s13277-015-3419-x; Kusunoki Takeshi, 1995, Auris Nasus Larynx, V22, P43; Lai WFT, 2004, OSTEOARTHR CARTILAGE, V12, P239, DOI 10.1016/j.joca.2003.11.005; 이혜림, 2013, Journal of Biomedical and Translational Research, V14, P1, DOI 10.12729/jbr.2013.14.1.1; Lin SH, 2014, INT J MOL SCI, V15, P2876, DOI 10.3390/ijms15022876; Lin WJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/525976; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nishikawa H, 2004, GYNECOL ONCOL, V92, P881, DOI 10.1016/j.ygyno.2003.11.017; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Quraishi O, 1999, BIOCHEMISTRY-US, V38, P5017, DOI 10.1021/bi981950o; SLOANE BF, 1981, SCIENCE, V212, P1151, DOI 10.1126/science.7233209; Tong B, 2014, CLIN EXP IMMUNOL, V177, P586, DOI 10.1111/cei.12357; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Vigneswaran N, 2000, HUM PATHOL, V31, P931, DOI 10.1053/hupa.2000.9035; Wickramasinghe NS, 2005, ARCH BIOCHEM BIOPHYS, V436, P187, DOI 10.1016/j.abb.2005.01.023; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Wu D, 2012, HISTOL HISTOPATHOL, V27, P79, DOI 10.14670/HH-27.79; Xu ZZ, 2015, MOL MED REP, V11, P3499, DOI 10.3892/mmr.2014.3140; Yan SQ, 1998, BIOL CHEM, V379, P113; Yang SF, 2015, ONCOTARGET, V6, P2736, DOI 10.18632/oncotarget.3088; Yang X, 2010, INT J ORAL MAX SURG, V39, P174, DOI 10.1016/j.ijom.2009.11.018; Yang YX, 2010, J PROTEOME RES, V9, P4767, DOI 10.1021/pr100492x	35	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152165	10.1371/journal.pone.0152165	http://dx.doi.org/10.1371/journal.pone.0152165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031837	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800039
J	Francez-Charlot, A; Frunzke, J; Zingg, J; Kaczmarczyk, A; Vorholt, JA				Francez-Charlot, Anne; Frunzke, Julia; Zingg, Judith; Kaczmarczyk, Andreas; Vorholt, Julia A.			Multiple sigma(EcfG) and NepR Proteins Are Involved in the General Stress Response in Methylobacterium extorquens	PLOS ONE			English	Article							SIGMA-FACTOR MIMICRY; 2-COMPONENT SYSTEM; STRUCTURAL BASIS; REGULATOR; PHYR; VECTORS; PATHWAY	In Alphaproteobacteria, the general stress response (GSR) is controlled by a conserved partner switch composed of the sigma factor sigma(EcfG), its anti-sigma factor NepR and the anti-sigma factor antagonist PhyR. Many species possess paralogues of one or several components of the system, but their roles remain largely elusive. Among Alphaproteobacteria that have been genome-sequenced so far, the genus Methylobacterium possesses the largest number of sigma(EcfG) proteins. Here, we analyzed the six sigma(EcfG) paralogues of Methylobacterium extorquens AM1. We show that these sigma factors are not truly redundant, but instead exhibit major and minor contributions to stress resistance and GSR target gene expression. We identify distinct levels of regulation for the different sigma factors, as well as two NepR paralogues that interact with PhyR. Our results suggest that in M. extorquens AM1, ecfG and nepR paralogues have diverged in order to assume new roles that might allow integration of positive and negative feedback loops in the regulatory system. Comparison of the core elements of the GSR regulatory network in Methylobacterium species provides evidence for high plasticity and rapid evolution of the GSR core network in this genus.	[Francez-Charlot, Anne; Frunzke, Julia; Zingg, Judith; Kaczmarczyk, Andreas; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Frunzke, Julia] Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany; [Kaczmarczyk, Andreas] Univ Basel, Biozentrum, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Research Center Julich; University of Basel	Francez-Charlot, A (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	fanne@micro.biol.ethz.ch	Frunzke, Julia/A-9918-2012; Vorholt, Julia/K-3514-2016	Frunzke, Julia/0000-0001-6209-7950; Vorholt, Julia/0000-0002-6011-4910; Kaczmarczyk, Andreas/0000-0002-6616-1777	Swiss National Science Foundation [310030B152835]; EMBO long-term fellowship [ALFT-4782008]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO long-term fellowship(European Molecular Biology Organization (EMBO))	This work was supported by Swiss National Science Foundation (Grant 310030B152835 to JAV; http://www.snf.ch/) and a EMBO long-term fellowship grant to Julia Frunzke (ALFT-4782008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2007, MOL MICROBIOL, V66, P1240, DOI 10.1111/j.1365-2958.2007.06005.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bastiat B, 2010, J BACTERIOL, V192, P2255, DOI 10.1128/JB.01666-09; Campagne S, 2012, P NATL ACAD SCI USA, V109, pE1405, DOI 10.1073/pnas.1117003109; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiebig A, 2015, ANNU REV GENET, V49, P603, DOI 10.1146/annurev-genet-112414-054813; Foreman R, 2012, J BACTERIOL, V194, P3038, DOI 10.1128/JB.00182-12; Francez-Charlot A, 2015, TRENDS MICROBIOL, V23, P164, DOI 10.1016/j.tim.2014.12.006; Francez-Charlot A, 2009, P NATL ACAD SCI USA, V106, P3467, DOI 10.1073/pnas.0810291106; Gourion B, 2008, J BACTERIOL, V190, P1027, DOI 10.1128/JB.01483-07; HARDER W, 1973, J GEN MICROBIOL, V78, P155, DOI 10.1099/00221287-78-1-155; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Herrou J, 2012, P NATL ACAD SCI USA, V109, pE1415, DOI 10.1073/pnas.1116887109; Igoshin OA, 2007, J MOL BIOL, V369, P1333, DOI 10.1016/j.jmb.2007.04.021; Jans A, 2013, MICROBIOLOGYOPEN, V2, P976, DOI 10.1002/mbo3.137; Kaczmarczyk A, 2014, P NATL ACAD SCI USA, V111, pE5196, DOI 10.1073/pnas.1410095111; Kaczmarczyk A, 2013, APPL ENVIRON MICROB, V79, P6795, DOI 10.1128/AEM.02296-13; Kaczmarczyk A, 2011, J BACTERIOL, V193, P6629, DOI 10.1128/JB.06006-11; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kim HS, 2014, MOL MICROBIOL, V94, P913, DOI 10.1111/mmi.12809; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lourenco RF, 2011, MOL MICROBIOL, V80, P1598, DOI 10.1111/j.1365-2958.2011.07668.x; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Marx Christopher J, 2008, BMC Res Notes, V1, P1, DOI 10.1186/1756-0500-1-1; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; Metzger LC, 2013, MICROBIOL-SGM, V159, P1067, DOI 10.1099/mic.0.066068-0; Miller JH., 1972, EXPT MOL GENETICS; Okubo Y, 2007, IMPLEMENTATION MICRO; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Sauviac L, 2014, J BACTERIOL, V196, P2526, DOI 10.1128/JB.01623-14; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Staron A, 2010, MOL MICROBIOL, V78, P271, DOI 10.1111/j.1365-2958.2010.07336.x; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vercruysse M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r17; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	42	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152519	10.1371/journal.pone.0152519	http://dx.doi.org/10.1371/journal.pone.0152519			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028226	Green Published, gold			2022-12-26	WOS:000373116500050
J	Yang, HS; Xiong, X; Wang, XC; Tan, B; Li, TJ; Yin, YL				Yang, Huansheng; Xiong, Xia; Wang, Xiaocheng; Tan, Bie; Li, Tiejun; Yin, Yulong			Effects of Weaning on Intestinal Upper Villus Epithelial Cells of Piglets	PLOS ONE			English	Article							CRYPT-VILLUS; TRANSLATION INITIATION; PROTEIN-SYNTHESIS; GENE-EXPRESSION; PIG; TOOL; DYSFUNCTION; SUPPLEMENTATION; DIFFERENTIATION; TRANSPORTERS	The intestinal upper villus epithelial cells represent the differentiated epithelial cells and play key role in digesting and absorbing lumenal nutrients. Weaning stress commonly results in a decrease in villus height and intestinal dysfunction in piglets. However, no study have been conducted to test the effects of weaning on the physiology and functions of upper villus epithelial cells. A total of 40 piglets from 8 litters were weaned at 14 days of age and one piglet from each litter was killed at 0 d (w0d), 1 d (w1d), 3 d (w3d), 5 d (w5d), and 7 d (w7d) after weaning, respectively. The upper villus epithelial cells in mid-jejunum were isolated using the distended intestinal sac method. The expression of proteins in upper villus epithelial cells was analyzed using the isobaric tags for relative and absolute quantification or Western blotting. The expression of proteins involved in energy metabolism, Golgi vesicle transport, protein amino acid glycosylation, secretion by cell, transmembrane transport, ion transport, nucleotide catabolic process, translational initiation, and epithelial cell differentiation and apoptosis, was mainly reduced during the post-weaning period, and these processes may be regulated by mTOR signaling pathway. These results indicated that weaning inhibited various cellular processes in jejunal upper villus epithelial cells, and provided potential new directions for exploring the effects of weaning on the functions of intestine and improving intestinal functions in weaning piglets.	[Yang, Huansheng; Xiong, Xia; Wang, Xiaocheng; Tan, Bie; Li, Tiejun; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Res Ctr Hlth Breeding Livestock & Poultry, Hunan Engn & Res Ctr Anim & Poultry Sci, Changsha, Hunan, Peoples R China; [Yang, Huansheng; Xiong, Xia; Wang, Xiaocheng; Tan, Bie; Li, Tiejun; Yin, Yulong] Minist Agr, Key Lab Agroecol Proc Subtrop Reg, Sci Observ & Expt Stn Anim Nutr & Feed Sci South, Changsha, Hunan, Peoples R China; [Yang, Huansheng; Yin, Yulong] Hunan Normal Univ, Sch Life Sci, Changsha, Peoples R China; [Yang, Huansheng] Fujian Aonong Biotechnol Corp, Xiamen, Fujian, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Ministry of Agriculture & Rural Affairs; Hunan Normal University	Yin, YL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Res Ctr Hlth Breeding Livestock & Poultry, Hunan Engn & Res Ctr Anim & Poultry Sci, Changsha, Hunan, Peoples R China.; Yin, YL (corresponding author), Minist Agr, Key Lab Agroecol Proc Subtrop Reg, Sci Observ & Expt Stn Anim Nutr & Feed Sci South, Changsha, Hunan, Peoples R China.	yinyulong@isa.ac.cn	Yang, Huansheng/AAA-1380-2020		National Natural Science Foundation of China [31330075, 31301988]; National Natural 31 Science Foundation of China [31472106]; Knowledge Innovation Program of Institute of Subtropical Agriculture, Chinese Academy of Sciences [ISACX-LYQY-QN-1205]; Fujian Aonong Biotechnology Corporation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural 31 Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Institute of Subtropical Agriculture, Chinese Academy of Sciences; Fujian Aonong Biotechnology Corporation	This work was supported by: 1. National Natural Science Foundation of China, 31330075, Yulong Yin, http://www.nsfc.gov.cn/; 2. National Natural Science Foundation of China, 31301988, Xia Xiong, http://www.nsfc.gov.cn/; 3. National Natural 31 Science Foundation of China, 31472106, Huansheng Yang, http://www.nsfc.gov.cn/; 4. Knowledge Innovation Program of Institute of Subtropical Agriculture, Chinese Academy of Sciences, ISACX-LYQY-QN-1205, Xia Xiong, http://www.isa.ac.cn/. Fujian Aonong Biotechnology Corporation provided support in the form of salary for author Huansheng Yang and research materials [animal and feed]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERS DH, 1972, J CLIN INVEST, V51, P167, DOI 10.1172/JCI106788; Boudry G, 2004, J NUTR, V134, P2256, DOI 10.1093/jn/134.9.2256; Brooks P. H., 2001, The weaner pig: nutrition and management. Proceedings of a British Society of Animal Science Occasional Meeting, University of Nottingham, UK, September 2000, P153, DOI 10.1079/9780851995328.0153; Chang J, 2008, J PROTEOMICS, V71, P530, DOI 10.1016/j.jprot.2008.08.003; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Roos B, 2008, BRIT J NUTR, V99, pS66, DOI 10.1017/S0007114508006909; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Fan MZ, 2004, AM J PHYSIOL-GASTR L, V287, pG385, DOI 10.1152/ajpgi.00232.2003; Fan MZ, 2001, J ANIM SCI, V79, P371; Forstner Janet F., 1995, P71; Fraser CS, 2009, PROG MOL BIOL TRANSL, V90, P1, DOI 10.1016/S1877-1173(09)90001-1; Gu XH, 2002, ARCH ANIM NUTR, V56, P275, DOI 10.1080/00039420214345; Hansson J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005231; Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Lalles JP, 2004, ANIM RES, V53, P301, DOI 10.1051/animres:2004018; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Lopez-Pedrosa JM, 1998, J NUTR, V128, P224, DOI 10.1093/jn/128.2.224; Mackie A. R., 2012, Food Digestion, V3, P8; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; McCracken BA, 1999, J NUTR, V129, P613, DOI 10.1093/jn/129.3.613; Miller BG, 1997, J VET MED A, V44, P289, DOI 10.1111/j.1439-0442.1997.tb01113.x; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Montagne L, 2007, BRIT J NUTR, V97, P45, DOI 10.1017/S000711450720580X; National Research Council, 1998, NUTR REQ SWIN, Vtenth; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Pluske JR, 1997, LIVEST PROD SCI, V51, P215, DOI 10.1016/S0301-6226(97)00057-2; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spreeuwenberg MAM, 2001, J NUTR, V131, P1520, DOI 10.1093/jn/131.5.1520; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; van Beers-Schreurs HMG, 1998, J NUTR, V128, P947, DOI 10.1093/jn/128.6.947; van der Schoor SRD, 2002, GASTROENTEROLOGY, V123, P1931, DOI 10.1053/gast.2002.37062; van Goudoever JB, 2000, P NATL ACAD SCI USA, V97, P11620, DOI 10.1073/pnas.200371497; Verdonk JMAJ, 2007, LIVEST SCI, V108, P146, DOI 10.1016/j.livsci.2007.01.093; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Xiong X, 2015, AM J PHYSIOL-GASTR L, V309, pG229, DOI 10.1152/ajpgi.00095.2015; Yang C, 2011, THESIS U GUELPH; Yang H, 2013, NUTR PHYSL FUNCT AMI, P29, DOI [DOI 10.1007/978-3-7091-1328-8_3, 10.1007/978-3-7091-1328-8_3]; Yang HS, 2013, J ANIM SCI, V91, P2740, DOI 10.2527/jas.2012-5795; Yang HS, 2012, MOL BIOL REP, V39, P1887, DOI 10.1007/s11033-011-0934-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhu LH, 2014, J ANIM SCI, V92, P996, DOI 10.2527/jas.2013-7551	50	38	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0150216	10.1371/journal.pone.0150216	http://dx.doi.org/10.1371/journal.pone.0150216			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022727	Green Published, Green Submitted, gold			2022-12-26	WOS:000373113900006
J	Bong, SM; Son, KB; Yang, SW; Park, JW; Cho, JW; Kim, KT; Kim, H; Kim, SJ; Kim, YJ; Lee, BI				Bong, Seoung Min; Son, Kka-Bi; Yang, Seung-Won; Park, Jae-Won; Cho, Jea-Won; Kim, Kyung-Tae; Kim, Hackyoung; Kim, Seung Jun; Kim, Young Jun; Lee, Byung Il			Crystal Structure of Human Myotubularin-Related Protein 1 Provides Insight into the Structural Basis of Substrate Specificity	PLOS ONE			English	Article							PI3K-AKT PATHWAY; MUTATIONS; DISEASE; FAMILY; MTMR2; PHOSPHATASE; GENE; 4B; PSEUDOPHOSPHATASE; ELECTROSTATICS	Myotubularin-related protein 1 (MTMR1) is a phosphatase that belongs to the tyrosine/dual-specificity phosphatase superfamily. MTMR1 has been shown to use phosphatidylinositol 3-monophosphate (PI(3)P) and/or phosphatidylinositol 3,5-bisphosphate (PI(3,5)P-2) as substrates. Here, we determined the crystal structure of human MTMR1. The refined model consists of the Pleckstrin homology (PH)-GRAM and phosphatase (PTP) domains. The overall structure was highly similar to the previously reported MTMR2 structure. Interestingly, two phosphate molecules were coordinated by strictly conserved residues located in the C(X)(5)R motif of the active site. Additionally, our biochemical studies confirmed the substrate specificity of MTMR1 for PI(3)P and PI(3,5)P-2 over other phosphatidylinositol phosphates. Our structural and enzymatic analyses provide insight into the catalytic mechanism and biochemical properties of MTMR1.	[Bong, Seoung Min; Yang, Seung-Won; Park, Jae-Won; Cho, Jea-Won; Kim, Kyung-Tae; Lee, Byung Il] Natl Canc Ctr, Res Inst, Goyang 10408, Gyeonggi, South Korea; [Son, Kka-Bi; Kim, Hackyoung; Kim, Young Jun] Konkuk Univ, Dept Biomed Chem, Chungju 27478, South Korea; [Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Daejeon 34141, South Korea	National Cancer Center - Korea (NCC); Konkuk University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, BI (corresponding author), Natl Canc Ctr, Res Inst, Goyang 10408, Gyeonggi, South Korea.; Kim, YJ (corresponding author), Konkuk Univ, Dept Biomed Chem, Chungju 27478, South Korea.	ykim@kku.ac.kr; bilee@ncc.re.kr	Kim, Seung Jun/N-5248-2019	Kim, Seung Jun/0000-0002-6913-6358	National Research Foundation of Korea - Ministry of Science; ICT AMP; Future Planning [NRF-2011-0030032, NRF-2015R1A2A2A01003004]; National Cancer Center Research Grant through National Cancer Center Korea - Ministry of Health and Welfare [1610020]	National Research Foundation of Korea - Ministry of Science; ICT AMP; Future Planning; National Cancer Center Research Grant through National Cancer Center Korea - Ministry of Health and Welfare	Bio & Medical Technology Development Program (NRF-2011-0030032) and Mid-Career Researcher Program (NRF-2015R1A2A2A01003004) through the National Research Foundation of Korea (http://www.nrf.re.kr) was funded by the Ministry of Science; ICT & Future Planning (http://www.msip.go.kr) and National Cancer Center Research Grant (1610020) through National Cancer Center Korea (http://www.ncc.re.kr) was funded by Ministry of Health and Welfare (http://www.mohw.go.kr).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bong SM, 2015, ACTA CRYSTALLOGR F, V71, P261, DOI 10.1107/S2053230X15000606; Buj-Bello A, 2002, HUM MOL GENET, V11, P2297, DOI 10.1093/hmg/11.19.2297; Choudhury P, 2006, J BIOL CHEM, V281, P31762, DOI 10.1074/jbc.M606344200; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P483, DOI 10.1016/S0968-0004(00)01664-9; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Henrick KaK, 2007, J MOL BIOL, V372, P24; Hnia K, 2012, TRENDS MOL MED, V18, P317, DOI 10.1016/j.molmed.2012.04.004; Hoopes RR, 2005, AM J HUM GENET, V76, P260, DOI 10.1086/427887; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Kim SJ, 2012, BMB REP, V45, P693, DOI 10.5483/BMBRep.2012.45.12.240; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 2000, HUM MUTAT, V15, P393, DOI 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R; Li SL, 2005, AM J HUM GENET, V77, P54, DOI 10.1086/431346; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Majerus PW, 2009, J LIPID RES, V50, pS249, DOI 10.1194/jlr.R800072-JLR200; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nandurkar HH, 2002, IUBMB LIFE, V53, P37, DOI 10.1080/15216540210812; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robinson FL, 2005, J BIOL CHEM, V280, P31699, DOI 10.1074/jbc.M505159200; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Santoro M, 2010, EXP MOL PATHOL, V89, P158, DOI 10.1016/j.yexmp.2010.05.007; Taylor GS, 2003, METHOD ENZYMOL, V366, P43; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoo KY, 2015, ACTA CRYSTALLOGR D, V71, P1528, DOI 10.1107/S139900471500927X; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zou Jun, 2012, Adv Biol Regul, V52, P282; Zou J, 2012, P NATL ACAD SCI USA, V109, P9539, DOI 10.1073/pnas.1207021109	50	5	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152611	10.1371/journal.pone.0152611	http://dx.doi.org/10.1371/journal.pone.0152611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018598	Green Published, Green Submitted, gold			2022-12-26	WOS:000372807800063
J	Wu, HW; Liu, HX				Wu, Haiwei; Liu, Huanxiu			Movement Behavior and Host Location Ability of Corythucha ciliata	PLOS ONE			English	Article							TRICHOGRAMMA-OSTRINIAE HYMENOPTERA; SYCAMORE LACE BUG; MARK-RECAPTURE; HEMIPTERA TINGIDAE; DISPERSAL BEHAVIOR; BIOLOGICAL-CONTROL; LARVAE; BEETLE; LEPIDOPTERA; ORIENTATION	Insect movement behavior is highly important in entomological population ecology, behavioral ecology and conservation, and in invasion ecology. In this study, we used an exotic lace bug (Corythucha ciliata) as a model organism to address the hypothesis that an insect species invading a new area has a high host location ability and rapid mobility by which it can be successfully carried to a new habitat. To test this hypothesis, three movement parameters (speed, duration and distance) of C. ciliata were assessed using laboratory and field observations. We found that 5th-instar nymphs of C. ciliata could move as far as 750 cm throughout their lifespan and that they moved an average of 0.038 m/ min during the first 15 minutes after release, which was significantly farther than that of other instars. Of the tested nymphs, 21.85% could locate their host trees; of adults released 20 m from hosts, 11% reached the host trees on the first day, with an average flight distance of 22.14 m and a maximum flight distance of 27 m. The results of this study partly explain the mechanism of rapid diffusion. These results are also important for predicting population spread, improving eradication surveys, and managing future introductions of C. ciliata.	[Wu, Haiwei; Liu, Huanxiu] Shandong Acad Forestry, Jinan, Shandong, Peoples R China		Wu, HW (corresponding author), Shandong Acad Forestry, Jinan, Shandong, Peoples R China.	haiweiw@126.com	wu, haiwei/ABB-1627-2020		National Natural Science Foundation of China [31440033]; Shandong Science and Technology Plans [2013GGB22002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Science and Technology Plans	This research was financially supported by grants from the National Natural Science Foundation of China [grant number 31440033] and the Projects of Shandong Science and Technology Plans [grant number 2013GGB22002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allema AB, 2015, B ENTOMOL RES, V105, P234, DOI 10.1017/S0007485315000012; Arakaki N, 2010, APPL ENTOMOL ZOOL, V45, P297, DOI 10.1303/aez.2010.297; ASCOLI A, 1985, J CHEM ECOL, V11, P837, DOI 10.1007/BF01012072; BACH CE, 1993, J KANSAS ENTOMOL SOC, V66, P86; Bancroft JS, 2005, ENVIRON ENTOMOL, V34, P1517, DOI 10.1603/0046-225X-34.6.1517; Bancroft JS, 2005, ENTOMOL EXP APPL, V116, P83, DOI 10.1111/j.1570-7458.2005.00320.x; Chapman AV, 2009, ENVIRON ENTOMOL, V38, P677, DOI 10.1603/022.038.0319; Chung Yeong-Jin, 1996, Korean Journal of Applied Entomology, V35, P137; Cornelius ML, 1999, J ECON ENTOMOL, V92, P121, DOI 10.1093/jee/92.1.121; Cronin JT, 2001, ECOL ENTOMOL, V26, P16, DOI 10.1046/j.1365-2311.2001.00294.x; D' AGUILAR J., 1977, B SOC ENTOMOLOGIQUE, V82, P2; de Groot P, 2001, AGR FOREST ENTOMOL, V3, P107, DOI 10.1046/j.1461-9563.2001.00087.x; DOAK DF, 1994, ECOLOGY, V75, P615, DOI 10.2307/1941720; Dominiak B. C., 2008, General and Applied Entomology, V37, P27; Doukas D, 2007, J ECON ENTOMOL, V100, P110, DOI 10.1603/0022-0493(2007)100[110:EOUFOT]2.0.CO;2; [范锦胜 Fan Jinsheng], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P233; FEIN BL, 1982, J CHEM ECOL, V8, P1473, DOI 10.1007/BF00989104; Ginzel MD, 2002, J CHEM ECOL, V28, P1037, DOI 10.1023/A:1015265919647; GORDON PL, 1986, ENTOMOL EXP APPL, V40, P104, DOI 10.1007/BF00187031; Gui Hong-Ying, 2011, Chinese Journal of Applied Entomology, V48, P38; HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732; Hedin J, 2002, COMPUT ELECTRON AGR, V35, P171, DOI 10.1016/S0168-1699(02)00017-0; HUANG XP, 1990, ENVIRON ENTOMOL, V19, P1289, DOI 10.1093/ee/19.5.1289; JOHNSON AR, 1992, ECOLOGY, V73, P1968, DOI 10.2307/1941448; Ju RT, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0116; Ju RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054372; Ju RT, 2011, ENTOMOL EXP APPL, V141, P168, DOI 10.1111/j.1570-7458.2011.01180.x; Ju RT, 2009, ENTOMOL NEWS, V120, P409, DOI 10.3157/021.120.0410; Kalinova B, 2000, ENTOMOL EXP APPL, V95, P47, DOI 10.1023/A:1003938120861; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; KAREIVA PM, 1983, OECOLOGIA, V57, P322, DOI 10.1007/BF00377175; KIM C, 1999, JOURNAL OF RESEARCH, V19, P1; Kobori Y, 2011, APPL ENTOMOL ZOOL, V46, P27, DOI 10.1007/s13355-010-0004-z; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Kuussaari M, 1996, J ANIM ECOL, V65, P791, DOI 10.2307/5677; Langhof M, 2005, AGR ECOSYST ENVIRON, V107, P137, DOI 10.1016/j.agee.2004.12.001; LAWRENCE WS, 1987, ECOLOGY, V68, P539, DOI 10.2307/1938459; Levin S.A., 2013, DIFFUSION ECOLOGICAL, Vvol. 14; Li Chuan-Ren, 2007, Acta Zootaxonomica Sinica, V32, P944; LIDICKER W Z JR, 1992, P21; MACELJSKI M, 1986, Bulletin OEPP, V16, P621, DOI 10.1111/j.1365-2338.1986.tb00332.x; MASCANZONI D, 1986, ECOL ENTOMOL, V11, P387, DOI 10.1111/j.1365-2311.1986.tb00317.x; McIntosh RL, 2001, AGR FOREST ENTOMOL, V3, P113, DOI 10.1046/j.1461-9563.2001.00095.x; Meeker JR, 1998, THE SYCAMORE LACE BU; Moerkens R, 2010, ENTOMOL EXP APPL, V137, P19, DOI 10.1111/j.1570-7458.2010.01031.x; Mondy N, 1998, ENTOMOL EXP APPL, V88, P1, DOI 10.1023/A:1003286931364; MORRIS WF, 1991, INSECT PLANT INTERAC, V3, P175; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Orr DB, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P111; Petit JN, 2008, BIOL CONTROL, V45, P344, DOI 10.1016/j.biocontrol.2008.01.020; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; Rabitsch W, 2008, ZOOTAXA, P1; Rudd NT, 1996, ECOL APPL, V6, P285, DOI 10.2307/2269572; Ruther J, 1997, ENTOMOL EXP APPL, V84, P183, DOI 10.1023/A:1003040318376; Rykken JJ, 2011, NORTHWEST SCI, V85, P527, DOI 10.3955/046.085.0403; Schellhorn NA, 2014, ANNU REV ENTOMOL, V59, P559, DOI 10.1146/annurev-ento-011613-161952; Schneider JC, 1999, ECOLOGY, V80, P2740, DOI 10.2307/177254; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Sivakoff FS, 2012, BIOL CONTROL, V63, P296, DOI 10.1016/j.biocontrol.2012.09.008; Smith SM, 1996, ANNU REV ENTOMOL, V41, P375, DOI 10.1146/annurev.en.41.010196.002111; Taylor DB, 2010, ENVIRON ENTOMOL, V39, P1101, DOI 10.1603/EN10057; Tokihiro G., 2003, Research Bulletin of the Plant Protection Service, Japan, P85; TOKRO PG, 1991, ACTA BIOL HUNG, V42, P397; Tuda M, 2002, POPUL ECOL, V44, P251, DOI 10.1007/s101440200028; TURCHIN P, 1989, ECOLOGY, V70, P1008, DOI 10.2307/1941369; Turchin Peter, 1998; Wade O, 1917, THE SYCAMORE LACE BU; Wang RJ, 2004, ECOL ENTOMOL, V29, P367, DOI 10.1111/j.0307-6946.2004.00610.x; Wang RJ, 2011, ECOL ENTOMOL, V36, P251, DOI 10.1111/j.1365-2311.2011.01267.x; Wang XL, 2010, APPL ENTOMOL ZOOL, V45, P557, DOI 10.1303/aez.2010.557; Wei J, 2012, PLANT QUARANTINE, V4, P6; Wright MG, 2001, BIOL CONTROL, V22, P29, DOI 10.1006/bcon.2001.0948; Wu H, 2016, ENTOMOL FENN IN PRES, V27; Wu H. W., 2013, J SHANDONG FORESTRY, V4, P108; Wyatt TD, 1997, PHYSIOL ENTOMOL, V22, P191, DOI 10.1111/j.1365-3032.1997.tb01157.x	75	2	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152205	10.1371/journal.pone.0152205	http://dx.doi.org/10.1371/journal.pone.0152205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018584	Green Published, gold			2022-12-26	WOS:000372807800032
J	Solopova, A; Formosa-Dague, C; Courtin, P; Furlan, S; Veiga, P; Pechoux, C; Armalyte, J; Sadauskas, M; Kok, J; Hols, P; Dufrene, YF; Kuipers, OP; Chapot-Chartier, MP; Kulakauskas, S				Solopova, Ana; Formosa-Dague, Cecile; Courtin, Pascal; Furlan, Sylviane; Veiga, Patrick; Pechoux, Christine; Armalyte, Julija; Sadauskas, Mikas; Kok, Jan; Hols, Pascal; Dufrene, Yves F.; Kuipers, Oscar P.; Chapot-Chartier, Marie-Pierre; Kulakauskas, Saulius			Regulation of Cell Wall Plasticity by Nucleotide Metabolism in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aspartate (aspartic acid); bacteria; cell wall; nucleoside; nucleotide metabolism; peptidoglycan	PEPTIDOGLYCAN; ACID; SYSTEM; DNA; IDENTIFICATION; EXPRESSION; BACTERIA; PLASMID; GROWTH; MURAMIDASE	To ensure optimal cell growth and separation and to adapt to environmental parameters, bacteria have to maintain a balance between cell wall (CW) rigidity and flexibility. This can be achieved by a concerted action of peptidoglycan (PG) hydrolases and PG-synthesizing/modifying enzymes. In a search for new regulatory mechanisms responsible for the maintenance of this equilibrium in Lactococcus lactis, we isolated mutants that are resistant to the PG hydrolase lysozyme. We found that 14% of the causative mutations were mapped in the guaA gene, the product of which is involved in purine metabolism. Genetic and transcriptional analyses combined with PG structure determination of the guaA mutant enabled us to reveal the pivotal role of the pyrB gene in the regulation of CW rigidity. Our results indicate that conversion of l-aspartate (l-Asp) to N-carbamoyl-l-aspartate by PyrB may reduce the amount of l-Asp available for PG synthesis and thus cause the appearance of Asp/Asn-less stem peptides in PG. Such stem peptides do not form PG cross-bridges, resulting in a decrease in PG cross-linking and, consequently, reduced PG thickness and rigidity. We hypothesize that the concurrent utilization of l-Asp for pyrimidine and PG synthesis may be part of the regulatory scheme, ensuring CW flexibility during exponential growth and rigidity in stationary phase. The fact that l-Asp availability is dependent on nucleotide metabolism, which is tightly regulated in accordance with the growth rate, provides L. lactis cells the means to ensure optimal CW plasticity without the need to control the expression of PG synthesis genes.	[Solopova, Ana; Kok, Jan; Kuipers, Oscar P.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Formosa-Dague, Cecile; Hols, Pascal; Dufrene, Yves F.] Catholic Univ Louvain, Inst Life Sci, Croix Sud 4-5,Bte L7-07-06, B-1348 Louvain, Belgium; [Courtin, Pascal; Furlan, Sylviane; Veiga, Patrick; Armalyte, Julija; Sadauskas, Mikas; Chapot-Chartier, Marie-Pierre; Kulakauskas, Saulius] Univ Paris Saclay, AgroParisTech, Inst Natl Rech Agron, Micalis Inst, F-78350 Jouy En Josas, France; [Pechoux, Christine] Univ Paris Saclay, AgroParisTech, Inst Natl Rech Agron, Genet Anim & Biol Integrat, F-78350 Jouy En Josas, France; [Formosa-Dague, Cecile; Hols, Pascal; Dufrene, Yves F.] FNRS, Brussels, Belgium; [Veiga, Patrick] Danone Nutr Res, RD 128,Ave Vauve, F-91767 Palaiseau, France; [Armalyte, Julija] Vilnius State Univ, Fac Nat Sci, Dept Biochem & Mol Biol, MK Ciurlionio 21, LT-03101 Vilnius, Lithuania; [Sadauskas, Mikas] Vilnius State Univ, Fac Nat Sci, Dept Microbiol & Biotechnol, Ciurlionio 21-27, LT-03101 Vilnius, Lithuania	University of Groningen; Universite Catholique Louvain; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Fonds de la Recherche Scientifique - FNRS; Danone Nutricia; Vilnius University; Vilnius University	Kulakauskas, S (corresponding author), Univ Paris Saclay, AgroParisTech, Inst Natl Rech Agron, Micalis Inst, F-78350 Jouy En Josas, France.	Saulius.Kulakauskas@jouy.inra.fr	Kok, Jan/C-9972-2012; Armalyte, Julija/L-5149-2019; Sadauskas, Mikas/ABC-2607-2020; Veiga, Patrick/A-9862-2011; Kuipers, Oscar/B-6752-2009	Armalyte, Julija/0000-0003-0986-9805; Veiga, Patrick/0000-0001-6318-8547; Kuipers, Oscar/0000-0001-5596-7735; Formosa-Dague, Cecile/0000-0002-8627-3784; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519; Dufrene, Yves/0000-0002-7289-4248; Sadauskas, Mikas/0000-0001-9072-6523	Region Ile-de-France; National Foundation for Scientific Research (FNRS); Research Department of the Communaute francaise de Belgique (Concerted Research Action); Region Ile-de-France (Domaine d'Interet Majeur Malinf)	Region Ile-de-France(Region Ile-de-France); National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Research Department of the Communaute francaise de Belgique (Concerted Research Action); Region Ile-de-France (Domaine d'Interet Majeur Malinf)(Region Ile-de-France)	This work was supported in part by the Institut National de la Recherche Agronomique and the Region Ile-de-France (to P. C., S. F., P. V., J. A., M. S., M.-P.C.-C., and S. K.) and the National Foundation for Scientific Research (FNRS) and the Research Department of the Communaute francaise de Belgique (Concerted Research Action) (to C. F.-D., Y. F. D., and P. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from the Region Ile-de-France (Domaine d'Interet Majeur Malinf). Present address: Dept. of Biochemistry and Molecular Biology, Faculty of Natural Sciences, Vilnius University, M. K. Ciurlionio 21, LT-03101 Vilnius, Lithuania.	Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Brouwer R. W. W., 2014, THESIS U GRONINGEN N; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Buckley ND, 1999, APPL ENVIRON MICROB, V65, P3800; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; Cava F, 2014, CURR OPIN MICROBIOL, V18, P46, DOI 10.1016/j.mib.2014.01.004; Chapot-Chartier MP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S9; Chapot-Chartier MP, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P383, DOI 10.1007/978-3-642-05062-6_13; Chopinet L, 2013, MICRON, V48, P26, DOI 10.1016/j.micron.2013.02.003; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; CRUZRODZ AL, 1990, MOL GEN GENET, V224, P152, DOI 10.1007/BF00259462; Daveran-Mingot ML, 1998, J BACTERIOL, V180, P4834, DOI 10.1128/JB.180.18.4834-4842.1998; de Jong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053085; Dufrene YF, 2014, MBIO, V5, DOI 10.1128/mBio.01363-14; Duwat P, 1997, J BACTERIOL, V179, P4473, DOI 10.1128/jb.179.14.4473-4479.1997; Formosa C, 2015, NAT PROTOC, V10, P199, DOI 10.1038/nprot.2015.004; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Ibrahim HR, 2001, J BIOL CHEM, V276, P43767, DOI 10.1074/jbc.M106317200; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lee TK, 2013, CURR OPIN MICROBIOL, V16, P760, DOI 10.1016/j.mib.2013.08.005; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Leloup L, 1997, APPL ENVIRON MICROB, V63, P2117, DOI 10.1128/AEM.63.6.2117-2123.1997; Loskill P, 2014, BIOPHYS J, V107, P1082, DOI 10.1016/j.bpj.2014.07.029; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Martinez B, 2007, MOL MICROBIOL, V64, P473, DOI 10.1111/j.1365-2958.2007.05668.x; Martinussen J, 2001, J BACTERIOL, V183, P2785, DOI 10.1128/JB.183.9.2785-2794.2001; MARTINUSSEN J, 1994, J BACTERIOL, V176, P1514, DOI 10.1128/jb.176.5.1514-1516.1994; Matsuhashi M., 1994, BACTERIAL CELL WALL, P55; Mercier C, 2000, FEMS MICROBIOL LETT, V187, P47, DOI 10.1111/j.1574-6968.2000.tb09135.x; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Moynihan PJ, 2011, INT J BIOCHEM CELL B, V43, P1655, DOI 10.1016/j.biocel.2011.08.007; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Pinto J., 2015, THESIS U GRONINGEN N; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; Regulski K, 2013, J BIOL CHEM, V288, P20416, DOI 10.1074/jbc.M112.446344; Regulski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032301; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Renye JA, 2010, J APPL MICROBIOL, V108, P2142, DOI 10.1111/j.1365-2672.2009.04615.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Shepherd J, 2013, FEBS LETT, V587, P2895, DOI 10.1016/j.febslet.2013.07.036; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; Vollmer W, 2004, J BACTERIOL, V186, P5978, DOI 10.1128/jb.186.18.5978-5987.2004; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Vollmer W, 2012, MOL MICROBIOL, V86, P1031, DOI 10.1111/mmi.12059; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wheeler R, 2015, MBIO, V6, DOI 10.1128/mBio.00660-15; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	69	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11323	11336		10.1074/jbc.M116.714303	http://dx.doi.org/10.1074/jbc.M116.714303			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27022026	Green Published, hybrid			2022-12-26	WOS:000377042100031
J	Gladh, H; Folestad, EB; Muhl, L; Ehnman, M; Tannenberg, P; Lawrence, AL; Betsholtz, C; Eriksson, U				Gladh, Hanna; Folestad, Erika Bergsten; Muhl, Lars; Ehnman, Monika; Tannenberg, Philip; Lawrence, Anna-Lisa; Betsholtz, Christer; Eriksson, Ulf			Mice Lacking Platelet-Derived Growth Factor D Display a Mild Vascular Phenotype	PLOS ONE			English	Article							PROTEASE-ACTIVATED LIGAND; PDGF-D; CARDIAC DEVELOPMENT; ATHEROSCLEROSIS; EXPRESSION; DEFICIENT; ALPHA; CELLS; NOTCH; BETA	Platelet-derived growth factor D (PDGF-D) is the most recently discovered member of the PDGF family. PDGF-D signals through PDGF receptor beta, but its biological role remains largely unknown. In contrast to other members of the PDGF family of growth factors, which have been extensively investigated using different knockout approaches in mice, PDGF-D has until now not been characterized by gene inactivation in mice. Here, we present the phenotype of a constitutive Pdgfd knockout mouse model (Pdgfd(-/-)), carrying a LacZ reporter used to visualize Pdgfd promoter activity. Inactivation of the Pdgfd gene resulted in a mild phenotype in C57BL/6 mice, and the offspring was viable, fertile and generally in good health. We show that Pdgfd reporter gene activity was consistently localized to vascular structures in both postnatal and adult tissues. The expression was predominantly arterial, often localizing to vascular bifurcations. Endothelial cells appeared to be the dominating source for Pdgfd, but reporter gene activity was occasionally also found in sub-populations of mural cells. Tissue-specific analyses of vascular structures revealed that NG2-expressing pericytes of the cardiac vasculature were disorganized in Pdgfd(-/-) mice. Furthermore, Pdgfd(-/-) mice also had a slightly elevated blood pressure. In summary, the vascular expression pattern together with morphological changes in NG2-expressing cells, and the increase in blood pressure, support a function for PDGF-D in regulating systemic arterial blood pressure, and suggests a role in maintaining vascular homeostasis.	[Gladh, Hanna; Folestad, Erika Bergsten; Muhl, Lars; Ehnman, Monika; Tannenberg, Philip; Lawrence, Anna-Lisa; Betsholtz, Christer; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden; [Tannenberg, Philip] Karolinska Univ Hosp, Div Vasc Surg, Dept Surg Sci, Stockholm, Sweden; [Betsholtz, Christer] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Ehnman, Monika] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Lawrence, Anna-Lisa] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet; University of Michigan System; University of Michigan	Folestad, EB; Eriksson, U (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden.	erika.folestad@ki.se; ulf.pe.eriksson@ki.se	Lawrence, Anna-Lisa/GNW-3815-2022; Ehnman, Monika/R-3687-2016	Ehnman, Monika/0000-0003-0468-2531	Swedish Heart and Lung Foundation [2012-0077]; Swedish Cancer Foundation [2014/630]; Swedish Research Council [2011-3861]	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding for this work came from The Swedish Heart and Lung Foundation 2012-0077 (www.hjart-lungfonden.se), The Swedish Cancer Foundation 2014/630 (www.cancerfonden.se), and The Swedish Research Council 2011-3861 (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; [Anonymous], 2015, ASS HLTH STAT SMALL; [Anonymous], 2015, EXT ASS HLTH STAT SM; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Boron WBE., 2005, MED PHYSL, P478; Boron WBE, 2005, MED PHYSL, P236; Changsirikulchai S, 2002, J AM SOC NEPHROL, V13, p78A; Chen JZ, 2005, BIOCHEM BIOPH RES CO, V329, P976, DOI 10.1016/j.bbrc.2005.02.062; Dechamethakun S, 2014, J ATHEROSCLER THROMB, V21, P680; Ehnman M, 2009, ONCOGENE, V28, P534, DOI 10.1038/onc.2008.410; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Karvinen H, 2009, EUR J CLIN INVEST, V39, P320, DOI 10.1111/j.1365-2362.2009.02095.x; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Niessen K, 2007, AM J PHYSIOL-CELL PH, V293, pC1, DOI 10.1152/ajpcell.00415.2006; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Ponten A, 2005, CIRC RES, V97, P1036, DOI 10.1161/01.RES.0000190590.31545.d4; Ray S, 2005, J BIOL CHEM, V280, P8494, DOI 10.1074/jbc.M413570200; Reglin B, 2014, J VASC RES, V51, P376, DOI 10.1159/000369460; Rodt SA, 1996, J PHYSIOL-LONDON, V495, P193, DOI 10.1113/jphysiol.1996.sp021584; Thomas JA, 2009, AM J PHYSIOL-HEART C, V296, pH442, DOI 10.1152/ajpheart.00165.2008; Tuuminen R, 2006, TRANSPLANT P, V38, P3271, DOI 10.1016/j.transproceed.2006.10.056; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Van den Akker NMS, 2008, DEV DYNAM, V237, P494, DOI 10.1002/dvdy.21436; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Zhou PZ, 2012, CURR TOP DEV BIOL, V100, P143, DOI 10.1016/B978-0-12-387786-4.00005-1; Zhou XL, 2014, BRAZ J MED BIOL RES, V47, P1, DOI 10.1590/1414-431X20133177	37	30	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152276	10.1371/journal.pone.0152276	http://dx.doi.org/10.1371/journal.pone.0152276			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032083	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800050
J	Hofmann, N; Galetskiy, D; Rauch, D; Wittmann, T; Marquardt, A; Griese, M; Zarbock, R				Hofmann, Nicole; Galetskiy, Dmitry; Rauch, Daniela; Wittmann, Thomas; Marquardt, Andreas; Griese, Matthias; Zarbock, Ralf			Analysis of the Proteolytic Processing of ABCA3: Identification of Cleavage Site and Involved Proteases	PLOS ONE			English	Article							CATHEPSIN-L; LYSOSOMAL MEMBRANE; CYSTEINE PROTEASES; TRANSPORTER ABCA3; LUNG; PROTEIN; APOPTOSIS; MUTANTS; CELLS	Rationale ABCA3 is a lipid transporter in the limiting membrane of lamellar bodies in alveolar type II cells. Mutations in the ABCA3 gene cause respiratory distress syndrome in new-borns and childhood interstitial lung disease. ABCA3 is N-terminally cleaved by an as yet unknown protease, a process believed to regulate ABCA3 activity. Methods The exact site where ABCA3 is cleaved was localized using mass spectrometry (MS). Proteases involved in ABCA3 processing were identified using small molecule inhibitors and siRNA mediated gene knockdown. Results were verified by in vitro digestion of a synthetic peptide substrate mimicking ABCA3's cleavage region, followed by MS analysis. Results We found that cleavage of ABCA3 occurs after Lys174 which is located in the proteins' first luminal loop. Inhibition of cathepsin L and, to a lesser extent, cathepsin B resulted in attenuation of ABCA3 cleavage. Both enzymes showed activity against the ABCA3 peptide in vitro with cathepsin L being more active. Conclusion We show here that, like some other proteins of the lysosomal membrane, ABCA3 is a substrate of cathepsin L. Therefore, cathepsin L may represent a potential target to therapeutically influence ABCA3 activity in ABCA3-associated lung disease.	[Hofmann, Nicole; Rauch, Daniela; Wittmann, Thomas; Griese, Matthias; Zarbock, Ralf] Univ Munich, Dr von Hauner Childrens Hosp, German Ctr Lung Res, D-80337 Munich, Germany; [Galetskiy, Dmitry; Marquardt, Andreas] Univ Konstanz, Prote Facil, D-78547 Constance, Germany	University of Munich; University of Konstanz	Zarbock, R (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, German Ctr Lung Res, D-80337 Munich, Germany.	Ralf.Zarbock@med.uni-muenchen.de	Zarbock, Ralf/K-9031-2019		Deutsche Forschungsgemeinschaft [GR 970/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to MG (GR 970/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai B, 2014, J PROTEOME RES, V13, P4526, DOI 10.1021/pr5003593; Beers MF, 2013, AM J PHYSIOL-LUNG C, V305, pL970, DOI 10.1152/ajplung.00184.2013; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bromme D, 2001, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2102s21; Buhling F, 2004, EUR RESPIR J, V23, P620, DOI 10.1183/09031936.04.00105304; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Campo I, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-43; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Engelbrecht S, 2010, FEBS LETT, V584, P4306, DOI 10.1016/j.febslet.2010.09.026; Herber-Jonat S, 2013, PEDIATR RES, V74, P384, DOI 10.1038/pr.2013.127; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kaltenborn E, 2012, HUM MOL GENET, V21, P2793, DOI 10.1093/hmg/dds107; Matsumura Y, 2007, FEBS LETT, V581, P3139, DOI 10.1016/j.febslet.2007.05.078; Matsumura Y, 2006, J BIOL CHEM, V281, P34503, DOI 10.1074/jbc.M600071200; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Mulugeta S, 2002, J BIOL CHEM, V277, P22147, DOI 10.1074/jbc.M201812200; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Savalas LRT, 2011, BIOCHEM J, V439, P113, DOI 10.1042/BJ20110166; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Steenhuis P, 2012, BBA-MOL BASIS DIS, V1822, P1617, DOI 10.1016/j.bbadis.2012.05.015; Wambach JA, 2014, AM J RESP CRIT CARE, V189, P1538, DOI 10.1164/rccm.201402-0342OC; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Wenzel JJ, 2007, MED KLIN, V102, P524, DOI 10.1007/s00063-007-1066-8; Wille A, 2004, BIOL CHEM, V385, P665, DOI 10.1515/BC.2004.082; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; Yasuma T, 1998, J MED CHEM, V41, P4301, DOI 10.1021/jm9803065; Zheng X, 2008, BBA-MOL CELL RES, V1783, P2294, DOI 10.1016/j.bbamcr.2008.07.027	30	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152594	10.1371/journal.pone.0152594	http://dx.doi.org/10.1371/journal.pone.0152594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031696	gold, Green Submitted, Green Published			2022-12-26	WOS:000373121800098
J	Pow, EHN; Chen, ZF; Kwong, DLW; Lam, OLT				Pow, Edmond H. N.; Chen, Zhuofan; Kwong, Dora L. W.; Lam, Otto L. T.			Salivary Anionic Changes after Radiotherapy for Nasopharyngeal Carcinoma: A 1-Year Prospective Study	PLOS ONE			English	Article							NECK-CANCER-PATIENTS; QUALITY-OF-LIFE; CHINESE FOLLOWING RADIOTHERAPY; RADIATION-INDUCED XEROSTOMIA; HUMAN WHOLE SALIVA; SOUTHERN CHINESE; ORAL-HEALTH; ION CHROMATOGRAPHY; DIETARY NITRATE; GLAND FUNCTION	Objectives To investigate the salivary anionic changes of patients with nasopharyngeal carcinoma (NPC) treated by radiotherapy. Material and Methods Thirty-eight patients with T1-4, N0-2, M0 NPC received conventional radiotherapy. Stimulated whole saliva was collected at baseline and 2, 6 and 12 months after radiotherapy. Salivary anions levels were measured using ion chromatography. Results A reduction in stimulated saliva flow and salivary pH was accompanied by sustained changes in anionic composition. At 2 months following radiotherapy, there was a significant increase in chloride, sulphate, lactate and formate levels while significant reductions in nitrate and thiocyanate levels were found. No further changes in these anion levels were observed at 6 and 12 months. No significant changes were found in phosphate, acetate, or propionate levels throughout the study period. Conclusions Conventional radiotherapy has a significant and prolonged impact on certain anionic species, likely contributing to increased cariogenic properties and reduced antimicrobial capacities of saliva in NPC patients post-radiotherapy.	[Pow, Edmond H. N.; Lam, Otto L. T.] Univ Hong Kong, Fac Dent, Oral Rehabil, Hong Kong, Hong Kong, Peoples R China; [Chen, Zhuofan] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Oral Implantol, Guangzhou 510275, Guangdong, Peoples R China; [Kwong, Dora L. W.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Sun Yat Sen University; University of Hong Kong	Lam, OLT (corresponding author), Univ Hong Kong, Fac Dent, Oral Rehabil, Hong Kong, Hong Kong, Peoples R China.	ottolam@hku.hk		Chen, Zhuofan/0000-0002-1665-1073				Almstahl A, 2003, ARCH ORAL BIOL, V48, P337, DOI 10.1016/S0003-9969(02)00200-5; Bardow A, 2000, ARCH ORAL BIOL, V45, P1, DOI 10.1016/S0003-9969(99)00119-3; BENARYEH H, 1975, INT J ORAL MAXILLOF, V4, P205, DOI 10.1016/S0300-9785(75)80027-5; Chen C, 2010, ARCH ORAL BIOL, V55, P613, DOI 10.1016/j.archoralbio.2010.05.016; Chen ZF, 2004, ARCH ORAL BIOL, V49, P855, DOI 10.1016/j.archoralbio.2004.05.001; Chen ZF, 2004, ARCH ORAL BIOL, V49, P863, DOI 10.1016/j.archoralbio.2004.05.002; Chen ZF, 2015, CLIN CHIM ACTA, V438, P231, DOI 10.1016/j.cca.2014.08.027; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; COLE DEC, 1985, J CHROMATOGR, V337, P267, DOI 10.1016/0378-4347(85)80040-2; DAWES C, 1974, ARCH ORAL BIOL, V19, P887, DOI 10.1016/0003-9969(74)90051-X; DREIZEN S, 1976, CANCER, V38, P273, DOI 10.1002/1097-0142(197607)38:1<273::AID-CNCR2820380141>3.0.CO;2-8; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; EDGAR WM, 1981, J ORAL PATHOL MED, V10, P284, DOI 10.1111/j.1600-0714.1981.tb01275.x; Furness S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008934.pub2; Gasparoto TH, 2012, GERODONTOLOGY, V29, pE331, DOI 10.1111/j.1741-2358.2011.00476.x; Gupta SC, 2009, INDIAN J OTOLARYNGOL, V61, P286, DOI 10.1007/s12070-009-0084-7; Hahnel S, 2009, SUPPORT CARE CANCER, V17, P1331, DOI 10.1007/s00520-009-0671-x; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Jalil Rosnah Abdul, 1994, Journal of Nihon University School of Dentistry, V36, P254; Kapil V, 2010, HEART, V96, P1703, DOI 10.1136/hrt.2009.180372; KELSAY JL, 1972, J NUTR, V102, P661, DOI 10.1093/jn/102.5.661; LASSITER MO, 1987, J DENT RES, V66, P480, DOI 10.1177/00220345870660021601; MARGOLIS HC, 1994, CRIT REV ORAL BIOL M, V5, P1; Margolis HC, 1999, J DENT RES, V78, P1326, DOI 10.1177/00220345990780070701; McMillan AS, 2004, J ORAL REHABIL, V31, P600, DOI 10.1111/j.1365-2842.2004.01383.x; NAVAZESH M, 1982, J DENT RES, V61, P1158, DOI 10.1177/00220345820610100901; Odajima T, 1998, CONNECT TISSUE RES, V38, P119, DOI 10.3109/03008209809017028; Palmer LB, 2001, AM J RESP CRIT CARE, V164, P464, DOI 10.1164/ajrccm.164.3.2008149; Park YD, 2014, ARCH ORAL BIOL, V59, P1, DOI 10.1016/j.archoralbio.2013.10.006; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Pow EHN, 2003, CLIN ORAL INVEST, V7, P230, DOI 10.1007/s00784-003-0215-6; Pow EHN, 2003, ORAL DIS, V9, P196, DOI 10.1034/j.1601-0825.2003.02924.x; Schwarz E, 1999, J DENT, V27, P21, DOI 10.1016/S0300-5712(98)00024-4; SPIEGELHALDER B, 1976, FOOD COSMET TOXICOL, V14, P545, DOI 10.1016/S0015-6264(76)80005-3; TENOVUO J, 1984, J ORAL PATHOL MED, V13, P573, DOI 10.1111/j.1600-0714.1984.tb01459.x; Tiwana MS, 2011, INDIAN J CANCER, V48, P289, DOI 10.4103/0019-509X.84918; TOBGI R S, 1988, Oral Microbiology and Immunology, V3, P35, DOI 10.1111/j.1399-302X.1988.tb00603.x; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Xia DS, 2003, J DENT RES, V82, P101, DOI 10.1177/154405910308200205; Xie SH, 2013, EUR J CANCER, V49, P150, DOI 10.1016/j.ejca.2012.07.004; Zhang JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123137	43	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152817	10.1371/journal.pone.0152817	http://dx.doi.org/10.1371/journal.pone.0152817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031997	Green Submitted, Green Published, gold			2022-12-26	WOS:000373121800140
J	Rosenberg, YJ; Montefiori, DC; LaBranche, CC; Lewis, MG; Sack, M; Lees, JP; Jiang, XM				Rosenberg, Yvonne J.; Montefiori, David C.; LaBranche, Celia C.; Lewis, Mark G.; Sack, Markus; Lees, Jonathan P.; Jiang, Xiaoming			Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques	PLOS ONE			English	Article							ABSORPTION; POTENT	Intravascular delivery of broadly neutralizing antibodies (bnAbs) has shown promise for prevention and treatment of HIV infection. However, multiple IV administrations in geographic locations with poor accessibility to medical care have practical limitations. We have assessed the efficacy of plant-derived PGT121 delivered subcutaneously (SC) against pre- and post-intravaginal challenge using a rigorous SHIV-SF162P3 macaque protection model. SC administered PGT121 exhibited a longer serum half-life than IV administration and was more consistent than intramuscular delivery. A dose of 3.5mg/kg PGT121 prevented infection at a minimum ID50 neutralization titer of 1:295 while 5mg/kg protected five of six macaques when delivered immediately post-challenge. These results suggest the utility of plant-derived bnAbs delivered SC for HIV prevention.	[Rosenberg, Yvonne J.; Lees, Jonathan P.; Jiang, Xiaoming] PlantVax Corp, Rockville, MD 20850 USA; [Montefiori, David C.; LaBranche, Celia C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Lewis, Mark G.] Bioqual Inc, Rockville, MD 20850 USA; [Sack, Markus] Rhein Westfal TH Aachen, Inst Mol Biotechnol, D-52056 Aachen, Germany	Duke University; BIOQUAL Inc.; RWTH Aachen University	Rosenberg, YJ (corresponding author), PlantVax Corp, Rockville, MD 20850 USA.	yjr@plantvax.com	Sack, Markus/K-6681-2013; Sack, Markus/AAP-9252-2021	Sack, Markus/0000-0002-7380-9228; 	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) [R44AI081621]; NIH/NIAID NHP Humoral Immunology Laboratory [HHSN27201100016C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI081621] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID NHP Humoral Immunology Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	YR received funding from National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) grant # R44AI081621, which provided support in the form of salaries for authors YR, XJ and JL but did not have additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. DCM was funded in part by NIH/NIAID NHP Humoral Immunology Laboratory Contract # HHSN27201100016C.	Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chung HK, 2008, VIRAL IMMUNOL, V21, P411, DOI 10.1089/vim.2008.0076; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Lagenaur LA, 2011, MUCOSAL IMMUNOL, V4, P648, DOI 10.1038/mi.2011.30; Matucci A, 2014, INT TRENDS IMMUNITY, V2, P11; McLennan DN, 2006, PHARM RES, V23, P2060, DOI 10.1007/s11095-006-9064-8; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P157, DOI 10.1016/S0169-409X(01)00153-3; R Core Team, 2013, R LANG ENV STAT COMP; Rosenberg YJ, 2012, INSECTICIDES BASIC O; Rosenberg Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120451; Rosenberg Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058724; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shytaj IL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-71; SUPERSAXO A, 1990, PHARMACEUT RES, V7, P167, DOI 10.1023/A:1015880819328	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152760	10.1371/journal.pone.0152760	http://dx.doi.org/10.1371/journal.pone.0152760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031108	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800133
J	van Alphen, HJM; Volkers, KM; Blankevoort, CG; Scherder, EJA; Hortobagyi, T; van Heuvelen, MJG				van Alphen, Helena J. M.; Volkers, Karin M.; Blankevoort, Christiaan G.; Scherder, Erik J. A.; Hortobagyi, Tibor; van Heuvelen, Marieke J. G.			Older Adults with Dementia Are Sedentary for Most of the Day	PLOS ONE			English	Article							MEASURING PHYSICAL-ACTIVITY; COGNITIVE IMPAIRMENT; ACCELEROMETER OUTPUT; ALZHEIMERS-DISEASE; ACTIVITY PATTERNS; CALIBRATION; EXERCISE; DECLINE	Purpose Self-reported data suggest that older adults with dementia are inactive. The purpose of the present study was to objectively assess the physical activity (PA) levels of community-dwelling and institutionalized ambulatory patients with dementia, and to compare with the PA levels of cognitive healthy older adults. Methods We used actigraphy to assess the PA levels in institutionalized (n = 83, age: 83.0 +/- 7.6, Mini-Mental-State Examination (MMSE): 15.5 +/- 6.5) and community-dwelling dementia patients (n = 37, age: 77.3 +/- 5.6, MMSE-score: 20.8 +/- 4.8), and healthy older adults (n = 26, age: 79.5 +/- 5.6, MMSE-score: 28.2 +/- 1.6). We characterized PA levels based on the raw data and classified <100 counts/min as sedentary behavior. Results Institutionalized dementia patients had the lowest daily PA levels (1.69 +/- 1.33 counts/day), spent 72.1% of the day sedentary, and were most active between 8: 00 and 9: 00 am. Institutionalized vs. community-dwelling dementia patients had 23.5% lower daily PA levels (difference M = 0.52, p =.004) and spent 9.3% longer in sedentariness (difference M = 1.47, p =.032). Community-dwelling dementia patients spent 66.0% of the day sedentary and were most active between 9: 00 to 10: 00 am with a second peak between 14: 00 to 15: 00. Community-dwelling dementia patients vs healthy older adults' daily PA levels and sedentary time were 21.6% lower and 8.9% longer, respectively (difference M = 0.61, p =.007; difference M = 1.29, p =.078). Conclusions Institutionalized and community-dwelling dementia patients are sedentary for most of the day and the little PA they perform is of lower intensity compared to their healthy peers. Their highest PA peak is when they get out of bed in the morning. In addition, it seems that institutionalized living is associated with lower PA levels in dementia patients. These are the first results that objectively characterize institutionalized as well as community-dwelling dementia patients' PA levels and confirm that dementia patients are inactive.	[van Alphen, Helena J. M.; Scherder, Erik J. A.; Hortobagyi, Tibor; van Heuvelen, Marieke J. G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, NL-9713 AV Groningen, Netherlands; [Volkers, Karin M.; Scherder, Erik J. A.] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Blankevoort, Christiaan G.] Lentis, Mental Hlth Care Inst, Zuidlaren, Netherlands	University of Groningen; Vrije Universiteit Amsterdam	van Heuvelen, MJG (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, NL-9713 AV Groningen, Netherlands.	m.j.g.van.heuvelen@umcg.nl		van Alphen, Helena/0000-0003-4130-1187				Allan L, 2006, DEMENT GERIATR COGN, V22, P230, DOI 10.1159/000094971; American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Bossers WJR, 2015, AM J GERIAT PSYCHIAT, V23, P1106, DOI 10.1016/j.jagp.2014.12.191; Burns JM, 2008, ALZ DIS ASSOC DIS, V22, P39, DOI 10.1097/WAD.0b013e31815a9ddc; Chen Kong Y, 2003, Diabetes Technol Ther, V5, P1023, DOI 10.1089/152091503322641088; Davis MG, 2007, EUR J APPL PHYSIOL, V100, P581, DOI 10.1007/s00421-006-0320-8; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; de la Torre JC, 2010, J ALZHEIMERS DIS, V20, P861, DOI 10.3233/JAD-2010-091579; Erickson KI, 2013, J AM GERIATR SOC, V61, P158, DOI 10.1111/jgs.12050; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub4; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Hortobagyi T., 2014, FUTURE HLTH FITNESS, P54; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Imtiaz B, 2014, BIOCHEM PHARMACOL, V88, P661, DOI 10.1016/j.bcp.2014.01.003; James BD, 2012, ALZ DIS ASSOC DIS, V26, P238, DOI 10.1097/WAD.0b013e31822fc3cb; Kemper HGC, 2000, TIJDSCHR SOC GEZONDH, V78, P180; Knochel C, 2012, PROG NEUROBIOL, V96, P46, DOI 10.1016/j.pneurobio.2011.11.007; Kozey S, 2010, J PHYS ACT HEALTH, V7, P508, DOI 10.1123/jpah.7.4.508; Lovden M, 2013, CURR OPIN PSYCHIATR, V26, P239, DOI 10.1097/YCO.0b013e32835f4135; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reid N, 2013, INT J ENV RES PUB HE, V10, P6783, DOI 10.3390/ijerph10126783; Rikli RE, 2000, RES Q EXERCISE SPORT, V71, pS89, DOI 10.1080/02701367.2000.11082791; Routen AC, 2012, J SPORT SCI, V30, P1303, DOI 10.1080/02640414.2012.709266; Stubbs B, 2014, ARCH GERONTOL GERIAT, V59, P195, DOI 10.1016/j.archger.2014.06.006; Takeda M, 2012, PSYCHIAT CLIN NEUROS, V66, P1, DOI 10.1111/j.1440-1819.2011.02304.x; Tariot PN, 1994, ALZ DIS ASSOC DIS, V8, pS12; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tudor-Locke CE, 2001, SPORTS MED, V31, P91, DOI 10.2165/00007256-200131020-00002; Vital TM, 2012, GERIATR GERONTOL INT, V12, P637, DOI 10.1111/j.1447-0594.2011.00830.x; Volkers KM, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-38; Watts A., 2013, CLIN GERONTOLOGIST, V36, P1; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104	43	75	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152457	10.1371/journal.pone.0152457	http://dx.doi.org/10.1371/journal.pone.0152457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031509	Green Published, gold, Green Submitted			2022-12-26	WOS:000373121800076
J	Vernunft, A; Ivell, R; Heng, K; Anand-Ivell, R				Vernunft, Andreas; Ivell, Richard; Heng, Kee; Anand-Ivell, Ravinder			The Male Fetal Biomarker INSL3 Reveals Substantial Hormone Exchange between Fetuses in Early Pig Gestation	PLOS ONE			English	Article							INSULIN-LIKE FACTOR-3; PEPTIDE 3 INSL3; INTRAUTERINE POSITION; TESTICULAR DESCENT; AMNIOTIC-FLUID; HEALTHY BOYS; SEX; CRYPTORCHIDISM; TESTOSTERONE; GUBERNACULUM	The peptide hormone INSL3 is uniquely produced by the fetal testis to promote the transabdominal phase of testicular descent. Because it is fetal sex specific, and is present in only very low amounts in the maternal circulation, INSL3 acts as an ideal biomarker with which to monitor the movement of fetal hormones within the pregnant uterus of a polytocous species, the pig. INSL3 production by the fetal testis begins at around GD30. At GD45 of the ca. 114 day gestation, a time at which testicular descent is promoted, INSL3 evidently moves from male to female allantoic compartments, presumably impacting also on the female fetal circulation. At later time-points (GD63, GD92) there is less inter-fetal transfer, although there still appears to be significant INSL3, presumably of male origin, in the plasma of female fetuses. This study thus provides evidence for substantial transfer of a peptide hormone between fetuses, and probably also across the placenta, emphasizing the vulnerability of the fetus to extrinsic hormonal influences within the uterus.	[Vernunft, Andreas] FBN Leibniz Inst Farm Anim Biol, D-18196 Dummerstorf, Germany; [Ivell, Richard; Heng, Kee; Anand-Ivell, Ravinder] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	Forschungsinstitut fur Nutztierbiologie (FBN); University of Nottingham	Anand-Ivell, R (corresponding author), Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.	ravinder.anand-ivell@nottingham.ac.uk		Anand-Ivell, Ravinder/0000-0002-4976-4314; Ivell, Richard/0000-0001-6513-2109	Leibniz Institute; School of Biosciences, University of Nottingham	Leibniz Institute; School of Biosciences, University of Nottingham	This project was funded by incidental support from the Leibniz Institute for Farm Animal Biology, Dummerstorf, and by the School of Biosciences, University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the support from Ms Yanzhenzi Dai (University of Nottingham) and from the technical staff in the Leibniz Institute for Farm Animal Biology, in particular Ms Katarina Poeppel, as well financial support from the same institute, and from the School of Biosciences, University of Nottingham.	ADHAM IM, 1993, J BIOL CHEM, V268, P26668; Anand-Ivell R, 2013, HUM REPROD, V28, P3093, DOI 10.1093/humrep/det349; Anand-Ivell R, 2006, INT J ANDROL, V29, P618, DOI 10.1111/j.1365-2605.2006.00714.x; Anand-Ivell R, 2014, REPRODUCTION, V147, pR87, DOI 10.1530/REP-13-0486; Anand-Ivell R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019821; Anand-Ivell R, 2009, BIOL REPROD, V81, P480, DOI 10.1095/biolreprod.109.077552; Barthold JS, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119560; Bazer FW, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-23; Bazer FW, 2011, BIOL REPROD, V85, P228, DOI 10.1095/biolreprod.111.091454; Drickamer LC, 1997, J ANIM SCI, V75, P2192; EVEN MD, 1992, J REPROD FERTIL, V96, P709, DOI 10.1530/jrf.0.0960709; GERNEKE W H, 1967, Onderstepoort Journal of Veterinary Research, V34, P219; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; GUTHRIE HD, 2005, J ANIM SCI, V83, pE79, DOI DOI 10.2527/2005.8313_; Hunter RHF, 1996, MOL REPROD DEV, V45, P392, DOI 10.1002/(SICI)1098-2795(199611)45:3<392::AID-MRD17>3.0.CO;2-0; Hutson JM, 2013, ENDOCR REV, V34, P725, DOI 10.1210/er.2012-1089; Ivell R, 2003, MOL HUM REPROD, V9, P175, DOI 10.1093/molehr/gag025; Ivell R, 2002, BIOL REPROD, V67, P699, DOI 10.1095/biolreprod.102.005199; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Johansen ML, 2014, REPRODUCTION, V147, P529, DOI 10.1530/REP-13-0435; Kawate N, 2011, THERIOGENOLOGY, V76, P1632, DOI 10.1016/j.theriogenology.2011.07.011; KNIGHT JW, 1977, J ANIM SCI, V44, P620, DOI 10.2527/jas1977.444620x; Magann EF, 2011, J ULTRAS MED, V30, P1573, DOI 10.7863/jum.2011.30.11.1573; McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676; Minagawa I, 2014, J ENDOCRINOL, V220, P247, DOI 10.1530/JOE-13-0430; Minagawa I, 2012, BIOCHEM J, V441, P265, DOI 10.1042/BJ20111107; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; NONNEMAN DJ, 1992, BIOL REPROD, V47, P723, DOI 10.1095/biolreprod47.5.723; Pailhoux E, 2001, DEV DYNAM, V222, P328, DOI 10.1002/dvdy.1194; PARFET KAR, 1990, J ANIM SCI, V68, P179; Parma P, 1999, BIOL REPROD, V61, P741, DOI 10.1095/biolreprod61.3.741; Preston Jane E, 2014, Adv Pharmacol, V71, P147, DOI 10.1016/bs.apha.2014.06.001; Retnakaran R, 2015, DIABETES CARE, V38, P844, DOI 10.2337/dc14-2551; Russe I, 1991, LEHRBUCH EMBRYOLOGIE, P1; SAAL FSV, 1992, PHYSIOL BEHAV, V52, P163, DOI 10.1016/0031-9384(92)90447-A; Satchell L, 2013, ENDOCRINOLOGY, V154, P1897, DOI 10.1210/en.2012-2232; Schneider F, 2006, REPROD FERT DEVELOP, V18, P857, DOI 10.1071/RD06027; Sembon S, 2008, ZYGOTE, V16, P327, DOI 10.1017/S0967199408004826; Soede NM, 2011, ANIM REPROD SCI, V124, P251, DOI 10.1016/j.anireprosci.2011.02.025; TOBET SA, 1982, HORM BEHAV, V16, P251, DOI 10.1016/0018-506X(82)90025-3; Vallet JL, 2013, J ANIM SCI, V91, P3030, DOI 10.2527/jas.2012-6138; VANDERHOEVEN T, 1992, J PHARMACOL EXP THER, V263, P32; VANVLISSINGEN JMF, 1988, ENDOCRINOLOGY, V123, P2868; VISSER JH, 1995, J UROLOGY, V153, P516, DOI 10.1097/00005392-199502000-00074; Waldmann KH, 2001, LEHRBUCH SCHWEINEKRA, P604; Wikstrom AM, 2006, J CLIN ENDOCR METAB, V91, P4705, DOI 10.1210/jc.2006-0669; WISE TH, 1992, J ANIM SCI, V70, P2787, DOI 10.2527/1992.7092787x; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	48	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152689	10.1371/journal.pone.0152689	http://dx.doi.org/10.1371/journal.pone.0152689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031644	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800117
J	Callister, KE; Griffioen, PA; Avitabile, SC; Haslem, A; Kelly, LT; Kenny, SA; Nimmo, DG; Farnsworth, LM; Taylor, RS; Watson, SJ; Bennett, AF; Clarke, MF				Callister, Kate E.; Griffioen, Peter A.; Avitabile, Sarah C.; Haslem, Angie; Kelly, Luke T.; Kenny, Sally A.; Nimmo, Dale G.; Farnsworth, Lisa M.; Taylor, Rick S.; Watson, Simon J.; Bennett, Andrew F.; Clarke, Michael F.			Historical Maps from Modern Images: Using Remote Sensing to Model and Map Century-Long Vegetation Change in a Fire-Prone Region	PLOS ONE			English	Article							EASTERN IBERIAN PENINSULA; NORTHWEST-TERRITORIES; LANDSCAPE-PERSPECTIVE; MALLEE ECOSYSTEMS; NEURAL-NETWORKS; TM IMAGERY; AUSTRALIA; FOREST; AGE; REGIMES	Understanding the age structure of vegetation is important for effective land management, especially in fire-prone landscapes where the effects of fire can persist for decades and centuries. In many parts of the world, such information is limited due to an inability to map disturbance histories before the availability of satellite images (similar to 1972). Here, we describe a method for creating a spatial model of the age structure of canopy species that established pre-1972. We built predictive neural network models based on remotely sensed data and ecological field survey data. These models determined the relationship between sites of known fire age and remotely sensed data. The predictive model was applied across a 104,000 km(2) study region in semi-arid Australia to create a spatial model of vegetation age structure, which is primarily the result of stand-replacing fires which occurred before 1972. An assessment of the predictive capacity of the model using independent validation data showed a significant correlation (r(s) = 0.64) between predicted and known age at test sites. Application of the model provides valuable insights into the distribution of vegetation age-classes and fire history in the study region. This is a relatively straightforward method which uses widely available data sources that can be applied in other regions to predict age-class distribution beyond the limits imposed by satellite imagery.	[Callister, Kate E.; Avitabile, Sarah C.; Haslem, Angie; Kenny, Sally A.; Farnsworth, Lisa M.; Taylor, Rick S.; Watson, Simon J.; Bennett, Andrew F.; Clarke, Michael F.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Griffioen, Peter A.; Kenny, Sally A.; Bennett, Andrew F.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia; [Kelly, Luke T.; Nimmo, Dale G.; Bennett, Andrew F.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Kelly, Luke T.] Univ Melbourne, Sch Biosci, ARC Ctr Excellence Environm Decis, Parkville, Vic 3052, Australia; [Nimmo, Dale G.] Charles Sturt Univ, Sch Environm Sci, Inst Land Water & Soc, Albury, NSW, Australia; [Taylor, Rick S.] Anindilyakwa Land Council, Alyangula, NT, Australia	La Trobe University; Arthur Rylah Institute for Environmental Research (ARI); Deakin University; University of Melbourne; Charles Sturt University	Callister, KE (corresponding author), La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia.	k.callister@latrobe.edu.au		Kelly, Luke/0000-0002-3127-3111; Callister, Kate/0000-0001-7871-0326	Parks Victoria; Department of Environment, Land, Water Planning (Vic); Mallee Catchment Management Authority; NSW National Parks and Wildlife Service; Department of Environment and Climate Change (NSW); Lower Murray Darling Catchment Management Authority; Department for Environment and Heritage; Land and Water Australia; Natural Heritage Trust; Birdlife Australia (Gluepot Reserve); Murray Mallee Partnership	Parks Victoria; Department of Environment, Land, Water Planning (Vic); Mallee Catchment Management Authority; NSW National Parks and Wildlife Service; Department of Environment and Climate Change (NSW); Lower Murray Darling Catchment Management Authority; Department for Environment and Heritage; Land and Water Australia; Natural Heritage Trust; Birdlife Australia (Gluepot Reserve); Murray Mallee Partnership	This study is part of a larger research project, the Mallee Fire and Biodiversity Project, which received funding and support from: Parks Victoria (http://parkweb.vic.gov.au), Department of Environment, Land, Water & Planning (Vic) (http://www.delwp.vic.gov.au), Mallee Catchment Management Authority (http://www.malleecma.vic.gov.au), NSW National Parks and Wildlife Service (http://www.nationalparks.nsw.gov.au), Department of Environment and Climate Change (NSW) (http://www.environment.nsw.gov.au), Lower Murray Darling Catchment Management Authority (http://murray.lls.nsw.gov.au/home), Department for Environment and Heritage (SA) (http://www.environment.sa.gov.au/Home), Land and Water Australia (http://lwa.gov.au), Natural Heritage Trust (http://www.nationaltrust.org.au/natural-heritage), Birdlife Australia (Gluepot Reserve) (http://www.birdlife.org.au), Australian Wildlife Conservancy (Scotia Sanctuary) (http://www.australianwildlife.org), Murray Mallee Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PM, 1997, INT J REMOTE SENS, V18, P699, DOI 10.1080/014311697217224; Avitabile SC, 2013, LANDSCAPE URBAN PLAN, V117, P81, DOI 10.1016/j.landurbplan.2013.04.017; Blackmore M, 2000, BIOTROPICA, V32, P625, DOI 10.1646/0006-3606(2000)032[0625:CGFLAF]2.0.CO;2; Bowman DMJS, 2003, INT J WILDLAND FIRE, V12, P341, DOI 10.1071/WF03030; Brown S, 2009, BIOL CONSERV, V142, P432, DOI 10.1016/j.biocon.2008.11.005; Buddenbaum H, 2005, INT J REMOTE SENS, V26, P5453, DOI 10.1080/01431160500285076; Bureau of Meteorology, 2014, CLIM DAT ONL AUSTR; Carpenter GA, 1999, REMOTE SENS ENVIRON, V70, P326, DOI 10.1016/S0034-4257(99)00051-6; Clarke MF, 2010, AUST J BOT, V58, P363, DOI 10.1071/BT10051; Department for Environment and Heritage, 2009, FIR MAN PLAN BILL DI; Dye M, 2011, GEOCARTO INT, V26, P275, DOI 10.1080/10106049.2011.562308; Ecological Burning in Box-Ironbark-Phase 1. Literature review, EC BURN BOX IN PHAS; Floyd ML, 2000, ECOL APPL, V10, P1666, DOI 10.1890/1051-0761(2000)010[1666:FHAVPI]2.0.CO;2; Franklin SE, 2003, INT J REMOTE SENS, V24, P1823, DOI 10.1080/01431160210144589; Furby S, 2008, EARTH C STUD MOD SEN; Gerylo GR, 2002, CAN J REMOTE SENS, V28, P68, DOI 10.5589/m02-007; Gosper CR, 2012, AUSTRAL ECOL, V37, P164, DOI 10.1111/j.1442-9993.2011.02259.x; Greenville AC, 2009, INT J WILDLAND FIRE, V18, P631, DOI 10.1071/WF08093; Haslem A, 2012, BIOL CONSERV, V152, P212, DOI 10.1016/j.biocon.2012.04.007; Haslem A, 2011, J APPL ECOL, V48, P247, DOI 10.1111/j.1365-2664.2010.01906.x; Haslem A, 2010, LANDSCAPE URBAN PLAN, V97, P296, DOI 10.1016/j.landurbplan.2010.07.002; Haydon DT, 2000, LANDSCAPE ECOL, V15, P373, DOI 10.1023/A:1008138029197; Hessl A, 2007, PROF GEOGR, V59, P87, DOI 10.1111/j.1467-9272.2007.00593.x; Hudak AT, 2004, INT J REMOTE SENS, V25, P3231, DOI 10.1080/01431160310001632666; Jakubauskas ME, 2000, GEOCARTO INT, V15, P21; Jensen JR, 1999, INT J REMOTE SENS, V20, P2805, DOI 10.1080/014311699211804; JOHNSON EA, 1994, ADV ECOL RES, V25, P239, DOI 10.1016/S0065-2504(08)60216-0; Kayitakire F, 2006, REMOTE SENS ENVIRON, V102, P390, DOI 10.1016/j.rse.2006.02.022; Kelly LT, 2012, J APPL ECOL, V49, P412, DOI 10.1111/j.1365-2664.2012.02124.x; Kelly LT, 2011, DIVERS DISTRIB, V17, P462, DOI 10.1111/j.1472-4642.2011.00754.x; Kraaij T, 2013, INT J WILDLAND FIRE, V22, P277, DOI 10.1071/WF11163; Land Conservation Council, 1987, MALL AR REV; Lans R, 1988, RED CLIFFS; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P319, DOI 10.1071/WF05097; Lloret F, 2002, LANDSCAPE ECOL, V17, P745, DOI 10.1023/A:1022966930861; MILLER DM, 1995, COMPUT GEOSCI, V21, P377, DOI 10.1016/0098-3004(94)00082-6; Morgan P, 2001, INT J WILDLAND FIRE, V10, P329, DOI 10.1071/WF01032; Mouillot F, 2005, GLOBAL CHANGE BIOL, V11, P398, DOI 10.1111/j.1365-2486.2005.00920.x; NIEMANN KO, 1995, PHOTOGRAMM ENG REM S, V61, P1119; Nimmo DG, 2013, CONSERV BIOL, V27, P345, DOI 10.1111/j.1523-1739.2012.01958.x; Nimmo DG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1062, DOI 10.1111/j.1466-8238.2011.00747.x; Noble J, 1980, RANGELAND J, V2, P104, DOI DOI 10.1071/RJ9800104; Noble J. C., 1993, Rangeland Journal, V15, P270, DOI 10.1071/RJ9930270; O'Brien TP., 1989, MEDITERRANEAN LANDSC, P181; Parsons BC, 2011, INT J WILDLAND FIRE, V20, P184, DOI 10.1071/WF09099; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JG, 2007, GLOBAL ECOL BIOGEOGR, V16, P330, DOI 10.1111/j.1466-8238.2006.00283.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Regos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094906; Rollins MG, 2004, ECOL APPL, V14, P75, DOI 10.1890/02-5145; Sandell PR, 2002, WILDLIFE RES, V29, P591, DOI 10.1071/WR00089; Scardi M, 1996, MAR ECOL PROG SER, V139, P289, DOI 10.3354/meps139289; Smith AL, 2013, J APPL ECOL, V50, P1178, DOI 10.1111/1365-2664.12119; Sokal R. R., 2012, BIOMETRY; StatSoft Inc, 2010, STATISTICA; Swetnam TW, 2003, TREE RING RECONSTRUC, P158; Taylor RS, 2013, BIOL CONSERV, V159, P248, DOI 10.1016/j.biocon.2012.12.005; Taylor RS, 2012, DIVERS DISTRIB, V18, P519, DOI 10.1111/j.1472-4642.2011.00842.x; Turner D, 2008, RANGELAND J, V30, P95, DOI 10.1071/RJ07039; Van de Water K, 2010, FOREST ECOL MANAG, V260, P384, DOI 10.1016/j.foreco.2010.04.032; Watson SJ, 2012, ECOL APPL, V22, P685, DOI 10.1890/11-0850.1; WELLINGTON AB, 1985, J ECOL, V73, P657, DOI 10.2307/2260502	62	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150808	10.1371/journal.pone.0150808	http://dx.doi.org/10.1371/journal.pone.0150808			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029046	Green Published, gold			2022-12-26	WOS:000373116500010
J	Yao, H; Zhuang, W; Qian, Y; Xia, BS; Yang, Y; Qian, X				Yao, Hong; Zhuang, Wei; Qian, Yu; Xia, Bisheng; Yang, Yang; Qian, Xin			Estimating and Predicting Metal Concentration Using Online Turbidity Values and Water Quality Models in Two Rivers of the Taihu Basin, Eastern China	PLOS ONE			English	Article							SUSPENDED SEDIMENT CONCENTRATION; HEAVY-METALS; PARTICLE-SIZE; SEASONAL-VARIATION; TRACE-METALS; SOLIDS; RUNOFF; LOAD; POLLUTION; SENSORS	Turbidity (T) has been widely used to detect the occurrence of pollutants in surface water. Using data collected from January 2013 to June 2014 at eleven sites along two rivers feeding the Taihu Basin, China, the relationship between the concentration of five metals (aluminum (Al), titanium (Ti), nickel (Ni), vanadium (V), lead (Pb)) and turbidity was investigated. Metal concentration was determined using inductively coupled plasma mass spectrometry (ICP-MS). The linear regression of metal concentration and turbidity provided a good fit, with R-2 = 0.86-0.93 for 72 data sets collected in the industrial river and R-2 = 0.60-0.85 for 60 data sets collected in the cleaner river. All the regression presented good linear relationship, leading to the conclusion that the occurrence of the five metals are directly related to suspended solids, and these metal concentration could be approximated using these regression equations. Thus, the linear regression equations were applied to estimate the metal concentration using online turbidity data from January 1 to June 30 in 2014. In the prediction, the WASP 7.5.2 (Water Quality Analysis Simulation Program) model was introduced to interpret the transport and fates of total suspended solids; in addition, metal concentration downstream of the two rivers was predicted. All the relative errors between the estimated and measured metal concentration were within 30%, and those between the predicted and measured values were within 40%. The estimation and prediction process of metals' concentration indicated that exploring the relationship between metals and turbidity values might be one effective technique for efficient estimation and prediction of metal concentration to facilitate better long-term monitoring with high temporal and spatial density.	[Yao, Hong; Qian, Yu; Xia, Bisheng; Yang, Yang; Qian, Xin] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China; [Yao, Hong] Nantong Univ, Sch Geog, Nantong, Peoples R China; [Zhuang, Wei] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing, Peoples R China	Nanjing University; Nantong University	Qian, X (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China.	xqian@nju.edu.cn	Xia, Bisheng/HGC-4845-2022		National Water Pollution Control and Management Technology Major Projects of China [2012ZX07506007]; National Natural Science Foundation of China [41501601]	National Water Pollution Control and Management Technology Major Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was sponsored by National Water Pollution Control and Management Technology Major Projects of China (No. 2012ZX07506007) and National Natural Science Foundation of China (No. 41501601). The URL of the National Water Pollution Control and Management Technology Major Projects of China is http://nwpcp.mep.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration S. E. P., 2002, MON AN METH WAT WAST; Aryal R.K., 2009, WATER AIR SOIL POLLU, V9, P339, DOI [10.1007/s11267-009-9243-9, DOI 10.1007/S11267-009-9243-9]; Berndtsson JC, 2014, URBAN WATER J, V11, P284, DOI 10.1080/1573062X.2013.795236; Bilotta GS, 2008, WATER RES, V42, P2849, DOI 10.1016/j.watres.2008.03.018; Bin Omar AF, 2009, SENSORS-BASEL, V9, P8311, DOI 10.3390/s91008311; CLIFFORD NJ, 1995, HYDROLOG SCI J, V40, P771, DOI 10.1080/02626669509491464; Environmental Ministry of China, 2007, POLL SOURC CENS ARCH; EPA C, 2002, 38382002 EPA C GB; Ginting D, 2006, J ENVIRON QUAL, V35, P815, DOI 10.2134/jeq2005.0219; Gray JR, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007063; Grayson RB, 1996, J ENVIRON MANAGE, V47, P257, DOI 10.1006/jema.1996.0051; Helmreich B, 2010, CHEMOSPHERE, V80, P991, DOI 10.1016/j.chemosphere.2010.05.037; Huang YL, 2012, QUATERN INT, V282, P145, DOI 10.1016/j.quaint.2011.05.026; Huey GM, 2010, WATER-SUI, V2, P273, DOI 10.3390/w2020273; Kumar RN, 2013, ENVIRON MONIT ASSESS, V185, P359, DOI 10.1007/s10661-012-2558-4; Landers MN, 2013, WATER RESOUR RES, V49, P5487, DOI 10.1002/wrcr.20394; Lenoble V, 2013, SCI TOTAL ENVIRON, V443, P420, DOI 10.1016/j.scitotenv.2012.10.002; Lenzi MA, 2000, CATENA, V39, P267, DOI 10.1016/S0341-8162(00)00079-5; Lepot M, 2013, WATER SCI TECHNOL, V68, P462, DOI 10.2166/wst.2013.276; Lewis J, 1996, WATER RESOUR RES, V32, P2299, DOI 10.1029/96WR00991; Li SY, 2010, J HAZARD MATER, V181, P1051, DOI 10.1016/j.jhazmat.2010.05.120; Lim HS, 2011, OPT APPL, V41, P631; Loperfido JV, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008293; Luo PP, 2013, ENVIRON SCI-PROC IMP, V15, P1052, DOI 10.1039/c3em30777h; Luo PP, 2011, J ENVIRON MONITOR, V13, P2819, DOI 10.1039/c1em10339c; Marttila H, 2012, J IRRIG DRAIN ENG, V138, P1088, DOI 10.1061/(ASCE)IR.1943-4774.0000509; Matache ML, 2009, ENVIRON MONIT ASSESS, V153, P273, DOI 10.1007/s10661-008-0354-y; Navratil O, 2011, J HYDROL, V398, P246, DOI 10.1016/j.jhydrol.2010.12.025; Nguyen HL, 2005, SCI TOTAL ENVIRON, V340, P213, DOI 10.1016/j.scitotenv.2004.07.032; Packman J., 1999, CANADIAN WATER RESOU; Pavanelli D, 2005, BIOSYST ENG, V90, P75, DOI 10.1016/j.biosystemseng.2004.09.001; Pekey H, 2004, MAR POLLUT BULL, V49, P809, DOI 10.1016/j.marpolbul.2004.06.029; Perianez R, 2009, SCI TOTAL ENVIRON, V407, P3392, DOI 10.1016/j.scitotenv.2009.01.023; Pfannkuche J, 2003, HYDROL PROCESS, V17, P1951, DOI 10.1002/hyp.1220; Price OR, 2010, ENVIRON INT, V36, P521, DOI 10.1016/j.envint.2010.04.003; Protection CsMoE, 2002, MON AN METH WAT WAST; Rugner H, 2013, ENVIRON EARTH SCI, V69, P373, DOI 10.1007/s12665-013-2307-1; Sadeghi SHR, 2012, J EARTH SYST SCI, V121, P63, DOI 10.1007/s12040-012-0143-4; Suk NS, 1998, ESTUAR COAST SHELF S, V46, P383, DOI 10.1006/ecss.1997.0284; Sun H, 2001, J HYDROL, V253, P227, DOI 10.1016/S0022-1694(01)00475-9; Tramblay Y, 2010, SCI TOTAL ENVIRON, V408, P4221, DOI 10.1016/j.scitotenv.2010.05.001; USEPA, WAT QUAL AN SIM PROG; USEPA, 1992, 3010 USEPA; Woitke P, 2003, CHEMOSPHERE, V51, P633, DOI 10.1016/S0045-6535(03)00217-0; Yamamoto K, 2006, WATER SCI TECHNOL, V53, P311, DOI 10.2166/wst.2006.065; Yao H, 2015, RISK ANAL, V35, P265, DOI 10.1111/risa.12259; Yao H, 2014, INT J ENV RES PUB HE, V11, P11860, DOI 10.3390/ijerph111111860; Zhou DM, 2002, J ENVIRON SCI-CHINA, V14, P44	48	14	14	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152491	10.1371/journal.pone.0152491	http://dx.doi.org/10.1371/journal.pone.0152491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028017	Green Published, Green Submitted, gold			2022-12-26	WOS:000373116500048
J	Lavrov, I; Fox, L; Shen, J; Han, YC; Cheng, JG				Lavrov, Igor; Fox, Lyle; Shen, Jun; Han, Yingchun; Cheng, Jianguo			Gap Junctions Contribute to the Regulation of Walking-Like Activity in the Adult Mudpuppy (Necturus Maculatus)	PLOS ONE			English	Article							CULTURED RAT ASTROCYTES; MAMMALIAN SPINAL-CORD; PATTERN IN-VITRO; SYNAPTIC-TRANSMISSION; ELECTRICAL SYNAPSES; INTERCELLULAR COMMUNICATION; CONNEXIN EXPRESSION; CALCIUM-CHANNELS; FLUFENAMIC ACID; NEURAL-NETWORKS	Although gap junctions are widely expressed in the developing central nervous system, the role of electrical coupling of neurons and glial cells via gap junctions in the spinal cord in adults is largely unknown. We investigated whether gap junctions are expressed in the mature spinal cord of the mudpuppy and tested the effects of applying gap junction blocker on the walking-like activity induced by NMDA or glutamate in an in vitro mudpuppy preparation. We found that glial and neural cells in the mudpuppy spinal cord expressed different types of connexins that include connexin 32 (Cx32), connexin 36 (Cx36), connexin 37 (Cx37), and connexin 43 (Cx43). Application of a battery of gap junction blockers from three different structural classes (carbenexolone, flufenamic acid, and long chain alcohols) substantially and consistently altered the locomotor-like activity in a dose-dependent manner. In contrast, these blockers did not significantly change the amplitude of the dorsal root reflex, indicating that gap junction blockers did not inhibit neuronal excitability nonselectively in the spinal cord. Taken together, these results suggest that gap junctions play a significant modulatory role in the spinal neural networks responsible for the generation of walking-like activity in the adult mudpuppy.	[Lavrov, Igor] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Fox, Lyle; Shen, Jun; Cheng, Jianguo] Cleveland Clin, Inst Anesthesiol, Dept Pain Management, Cleveland, OH 44106 USA; [Fox, Lyle; Shen, Jun; Cheng, Jianguo] Cleveland Clin, Inst Anesthesiol, Dept Neurosci, Cleveland, OH 44106 USA; [Han, Yingchun] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA	Kazan Federal University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Cheng, JG (corresponding author), Cleveland Clin, Inst Anesthesiol, Dept Pain Management, Cleveland, OH 44106 USA.; Cheng, JG (corresponding author), Cleveland Clin, Inst Anesthesiol, Dept Neurosci, Cleveland, OH 44106 USA.	chengj@ccf.org	Cheng, Jianguo/I-1990-2019; Lavrov, Igor/E-4334-2016	Cheng, Jianguo/0000-0002-2318-0812; Lavrov, Igor/0000-0002-3885-4509	National Institutes of Health (NINDS) [R01 NS052372]; Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [0-4]; Cleveland Clinic Anesthesiology Institute; Russian Science Foundation (RSF) [15-15-20036]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052372] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT); Cleveland Clinic Anesthesiology Institute; Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to Jianguo Cheng from the National Institutes of Health (NINDS R01 NS052372), the Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT, Grant# 0-4), and the Cleveland Clinic Anesthesiology Institute. Partial support for analysis of the effects of gap junction inhibitors on locomotor activity was provided to Igor Lavrov by the Russian Science Foundation (RSF grant No 15-15-20036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD S, 1990, BRAIN RES, V506, P297, DOI 10.1016/0006-8993(90)91266-J; Ball AK, 1998, J COMP NEUROL, V393, P48, DOI 10.1002/(SICI)1096-9861(19980330)393:1<48::AID-CNE5>3.0.CO;2-Q; Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; BIGIANI A, 1994, NEUROSCI LETT, V176, P212, DOI 10.1016/0304-3940(94)90085-X; Bou-Flores C, 2001, J NEUROPHYSIOL, V85, P1543, DOI 10.1152/jn.2001.85.4.1543; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; Chen MJ, 2012, GLIA, V60, P1660, DOI 10.1002/glia.22384; Cheng J, 2002, EXP BRAIN RES, V145, P190, DOI 10.1007/s00221-002-1102-0; Cheng JG, 1998, J NEUROSCI, V18, P4295; Christ GJ, 1999, AM J PHYSIOL-HEART C, V276, pH1911, DOI 10.1152/ajpheart.1999.276.6.H1911; CHRISTENSEN BN, 1983, J NEUROPHYSIOL, V49, P705, DOI 10.1152/jn.1983.49.3.705; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Delay RJ, 2003, CHEM SENSES, V28, P807, DOI 10.1093/chemse/bjg074; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; FETCHO JR, 1991, BRAIN BEHAV EVOLUT, V37, P298, DOI 10.1159/000114367; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Ghamari-Langroudi M, 2002, J PHYSIOL-LONDON, V545, P537, DOI 10.1113/jphysiol.2002.033589; Giaume C, 2010, BRAIN RES REV, V63, P160, DOI 10.1016/j.brainresrev.2009.11.005; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GOGAN P, 1974, EXP BRAIN RES, V21, P139, DOI 10.1007/BF00234386; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Holthoff K, 2000, GLIA, V29, P288, DOI 10.1002/(SICI)1098-1136(20000201)29:3<288::AID-GLIA10>3.0.CO;2-8; Jahromi SS, 2002, J NEUROPHYSIOL, V88, P1893, DOI 10.1152/jn.2002.88.4.1893; Jovanovic K, 1999, EXP BRAIN RES, V129, P172, DOI 10.1007/s002210050887; Jovanovic K, 1996, EXP BRAIN RES, V111, P57, DOI 10.1007/BF00229556; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kiehn O, 2002, TRENDS NEUROSCI, V25, P108, DOI 10.1016/S0166-2236(02)02038-6; KIMURA H, 1995, EXP CELL RES, V220, P348, DOI 10.1006/excr.1995.1325; Lavrov I, 2004, CAN J PHYSIOL PHARM, V82, P637, DOI 10.1139/Y04-044; Lavrov I, 2008, J NEUROSCI METH, V174, P97, DOI 10.1016/j.jneumeth.2008.07.010; Lee IH, 2005, J COMP NEUROL, V489, P1, DOI 10.1002/cne.20567; Lee RJ, 1996, CELL CALCIUM, V19, P431, DOI 10.1016/S0143-4160(96)90116-5; Li WC, 2009, J PHYSIOL-LONDON, V587, P1677, DOI 10.1113/jphysiol.2008.166942; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Margineanu DG, 2001, NEUROPHARMACOLOGY, V41, P377, DOI 10.1016/S0028-3908(01)00080-6; McCracken CB, 2006, INT REV NEUROBIOL, V73, P125, DOI 10.1016/S0074-7742(06)73004-5; Milner LD, 1999, J NEUROSCI, V19, P3007; NELSON PG, 1966, J NEUROPHYSIOL, V29, P275, DOI 10.1152/jn.1966.29.2.275; POCOCK G, 1993, BRIT J ANAESTH, V71, P134, DOI 10.1093/bja/71.1.134; PUIL E, 1990, J PHARMACOL EXP THER, V255, P955; Ranat S, 2007, NEUROSCI LETT, V415, P45, DOI 10.1016/j.neulet.2006.12.043; Rash JE, 1996, P NATL ACAD SCI USA, V93, P4235, DOI 10.1073/pnas.93.9.4235; REED KE, 1993, J CLIN INVEST, V91, P997, DOI 10.1172/JCI116321; Rekling JC, 2000, J NEUROSCI, V20, part. no.; ROPER S, 1976, J PHYSIOL-LONDON, V254, P427, DOI 10.1113/jphysiol.1976.sp011239; Rorig B, 1996, MOL NEUROBIOL, V12, P225, DOI 10.1007/BF02755590; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Saint-Amant L, 2001, NEURON, V31, P1035, DOI 10.1016/S0896-6273(01)00416-0; SHAPOVALOV AI, 1980, EXP BRAIN RES, V38, P115; Shik ML, 1997, MOTOR CONTROL, V1, P354; Solomon IC, 2003, J NEUROPHYSIOL, V89, P135, DOI 10.1152/jn.00697.2002; Solomon IC, 2002, RESP PHYSIOL NEUROBI, V131, P155, DOI 10.1016/S1569-9048(02)00090-3; Spray DC, 1996, CLIN EXP PHARMACOL P, V23, P1038, DOI 10.1111/j.1440-1681.1996.tb01165.x; Srinivas M, 2003, MOL PHARMACOL, V63, P1389, DOI 10.1124/mol.63.6.1389; Sutor B, 2005, BBA-BIOMEMBRANES, V1719, P59, DOI 10.1016/j.bbamem.2005.09.005; Takahashi M, 2002, J NEUROSCI, V22, P3692; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tegner J, 1997, J NEUROPHYSIOL, V77, P1795, DOI 10.1152/jn.1997.77.4.1795; Todorovic SM, 2000, MOL PHARMACOL, V58, P98, DOI 10.1124/mol.58.1.98; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Vanoye CG, 1999, AM J PHYSIOL-CELL PH, V276, pC279, DOI 10.1152/ajpcell.1999.276.1.C279; Venance L, 1997, J NEUROSCI, V17, P1981; Vernadakis A., 1986, ASTROCYTES, P329, DOI DOI 10.1016/B978-0-12-250451-8.50018-7; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; Wang D, 2006, NEUROPHARMACOLOGY, V51, P1038, DOI 10.1016/j.neuropharm.2006.06.012; WHEATLEY M, 1992, J NEUROSCI METH, V42, P129, DOI 10.1016/0165-0270(92)90143-2; WHEATLEY M, 1992, EXP BRAIN RES, V88, P609; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Winmill RE, 2003, RESP PHYSIOL NEUROBI, V138, P239, DOI 10.1016/j.resp.2003.08.005; Yamamoto K, 2008, ZOOL SCI, V25, P419, DOI 10.2108/zsj.25.419; YAMAMOTO T, 1990, BRAIN RES, V508, P313, DOI 10.1016/0006-8993(90)90415-8; Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200; Zhang HY, 2009, J PHYSIOL-LONDON, V587, P4455, DOI 10.1113/jphysiol.2009.173468	78	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152650	10.1371/journal.pone.0152650	http://dx.doi.org/10.1371/journal.pone.0152650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27023006	Green Published, gold, Green Submitted			2022-12-26	WOS:000373113900088
J	Boink, MA; Roffel, S; Nazmi, K; van Montfrans, C; Bolscher, JGM; Gefen, A; Veerman, ECI; Gibbs, S				Boink, Mireille A.; Roffel, Sanne; Nazmi, Kamran; van Montfrans, Catherine; Bolscher, Jan G. M.; Gefen, Amit; Veerman, Enno C. I.; Gibbs, Susan			The Influence of Chronic Wound Extracts on Inflammatory Cytokine and Histatin Stability	PLOS ONE			English	Article							CHRONIC LEG ULCERS; GROWTH-FACTORS; HUMAN SALIVA; METALLOPROTEINASES; KINEMATICS; CHEMOKINES; CLOSURE	Chronic ulcers represent a major health burden in our society. Despite many available therapies, a large number of ulcers do not heal. Protein based therapies fail in part due to proteolytic activity in the chronic wound bed. The aim of this in vitro study was to determine whether typical inflammatory cytokines and human salivary histatins remain stable when incubated with chronic wound extracts. Furthermore we determined whether a short exposure of histatins or cytokines was sufficient to exert long term effects on fibroblast migration. Stability of human recombinant cytokines IL-6 and CXCL8, and histatin variants (Hst1, Hst2, cyclic Hst1, minimal active domain of Hst1) in the presence of chronic wound extracts isolated from non-healing ulcers, was monitored by capillary zone electrophoresis. Migration-stimulating activity was assessed using a dermal fibroblast wound healing scratch assay. Histatins and cytokines stayed stable in saline for >24h at 37 degrees C, making them ideal as an off-the-shelf product. However, incubation with chronic wound extracts resulted in serious breakdown of Hst1 and Hst2 (similar to 50% in 8h) and to lesser extent cyclic Hst1 and the minimal active domain of Hst1 (similar to 20% in 8h). The cytokines IL-6 and CXCL8 were more stable in chronic wound extracts (similar to 40% degradation in 96h). An initial 8-hour pulse of histatins or cytokines during a 96-hour study period was sufficient to stimulate fibroblast migration equally well as a continuous 96-hour exposure, indicating that they may possibly be used as novel bioactive therapeutics, exerting their activity for up to four days after a single exposure.	[Boink, Mireille A.; Roffel, Sanne; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Biochem, Amsterdam, Netherlands; [Boink, Mireille A.; Roffel, Sanne; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Boink, Mireille A.; Roffel, Sanne; van Montfrans, Catherine; Gibbs, Susan] Vrije Univ Amsterdam, Dept Dermatol, Med Ctr, Amsterdam, Netherlands; [Gefen, Amit] Tel Aviv Univ, Dept Biomed Engn, Fac Engn, Tel Aviv, Israel; [Gibbs, Susan] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [Gibbs, Susan] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Tel Aviv University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Gibbs, S (corresponding author), Vrije Univ Amsterdam, Dept Dermatol, Med Ctr, Amsterdam, Netherlands.; Gibbs, S (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands.; Gibbs, S (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	s.gibbs@acta.nl	Bolscher, Jan/ABF-6102-2021	Bolscher, Jan/0000-0001-5669-6164	Technologiestichting STW [10695]	Technologiestichting STW(Technologiestichting STW)	The study was funded primarily by Technologiestichting STW (NL), (http://www.stw.nl/, grant number 10695, MAB SR KN JGMB ECIV SG) with minor contribution (4%) by A Skin BV, The Netherlands (http://a-skin.nl/). SG is co-founder of ASkin BV which is a VU university medical center start up company (SME) and was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Falanga V., 2005, LANCET, P366; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Gallucci RM, 2004, J INVEST DERMATOL, V122, P764, DOI 10.1111/j.0022-202X.2004.22323.x; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Harding Keith G, 2005, Int Wound J, V2, P364, DOI 10.1111/j.1742-4801.2005.00149.x; Helmerhorst EJ, 1997, BIOCHEM J, V326, P39, DOI 10.1042/bj3260039; Kroeze KL, 2012, WOUND REPAIR REGEN, V20, P294, DOI 10.1111/j.1524-475X.2012.00789.x; Kroeze KL, 2012, J INVEST DERMATOL, V132, P216, DOI 10.1038/jid.2011.245; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; McCarty SM, 2013, ADV WOUND CARE, V2, P438, DOI 10.1089/wound.2012.0370; Mekkes JR, 2003, BRIT J DERMATOL, V148, P388, DOI 10.1046/j.1365-2133.2003.05222.x; Nelson EA, 2011, BMJ CLIN EVID, V2011; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Oudhoff MJ, 2009, J DENT RES, V88, P846, DOI 10.1177/0022034509342951; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2010, BIOL CHEM, V391, P541, DOI 10.1515/BC.2010.057; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Purwins S, 2010, INT WOUND J, V7, P97, DOI 10.1111/j.1742-481X.2010.00660.x; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Soneja A, 2005, PHARMACOL REP, V57, P108; Stanley A, 2001, J VASC SURG, V33, P1206, DOI 10.1067/mva.2001.115379; Topman G, 2013, J BIOMECH, V46, P170, DOI 10.1016/j.jbiomech.2012.09.015; Topman G, 2012, ANN BIOMED ENG, V40, P1929, DOI 10.1007/s10439-012-0545-0; Topman G, 2012, MED ENG PHYS, V34, P225, DOI 10.1016/j.medengphy.2011.07.014; Valencia IC, 2001, J AM ACAD DERMATOL, V44, P401, DOI 10.1067/mjd.2001.111633; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; van Dijk IA, 2015, FASEB J, V29, P3124, DOI 10.1096/fj.14-266825; Gonzalez-Consuegra RV, 2011, J ADV NURS, V67, P926, DOI 10.1111/j.1365-2648.2010.05568.x; Vowden Kathryn R, 2006, Int Wound J, V3, P11, DOI 10.1111/j.1742-4801.2006.00180.x; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590; Zaja-Milatovic S, 2008, HISTOL HISTOPATHOL, V23, P1399, DOI 10.14670/HH-23.1399	34	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152613	10.1371/journal.pone.0152613	http://dx.doi.org/10.1371/journal.pone.0152613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0OS	27018788	Green Published, gold, Green Submitted			2022-12-26	WOS:000402921300001
J	Escobar, A; da Rocha, RW; Pypendop, BH; Zangirolami, D; Sousa, SS; Valadao, CAA				Escobar, Andre; da Rocha, Rozana Wendler; Pypendop, Bruno Henri; Zangirolami Filho, Darcio; Sousa, Samuel Santos; Valadao, Carlos Augusto Araujo			Effects of Methadone on the Minimum Anesthetic Concentration of Isoflurane, and Its Effects on Heart Rate, Blood Pressure and Ventilation during Isoflurane Anesthesia in Hens (Gallus gallus domesticus)	PLOS ONE			English	Article							HAWKS BUTEO-JAMAICENSIS; FOWL NUMIDA-MELEAGRIS; ALVEOLAR CONCENTRATION; INTRAVENOUS METHADONE; BUTORPHANOL TARTRATE; DOSE-RESPONSE; SEVOFLURANE; PARROTS; CHICKENS; DOGS	The aim of this study was to measure the temporal effects of intramuscular methadone administration on the minimum anesthetic concentration (MAC) of isoflurane in hens, and to evaluate the effects of the isoflurane-methadone combination on heart rate and rhythm, blood pressure and ventilation. Thirteen healthy adult hens weighing 1.7 +/- 0.2 kg were used. The MAC of isoflurane was determined in each individual using the bracketing method. Subsequently, the reduction in isoflurane MAC produced by methadone (3 or 6 mg kg(-1), IM) was determined by the up-and-down method. Stimulation was applied at 15 and 30 minutes, and at 45 minutes if the bird had not moved at 30 minutes. Isoflurane MAC reduction was calculated at each time point using logistic regression. After a washout period, birds were anesthetized with isoflurane and methadone, 6 mg kg(-1) IM was administered. Heart rate and rhythm, respiratory rate, blood gas values and invasive blood pressure were measured at 1.0 and 0.7 isoflurane MAC, and during 45 minutes after administration of methadone once birds were anesthetized with 0.7 isoflurane MAC. Fifteen minutes after administration of 3 mg kg(-1) of methadone, isoflurane MAC was reduced by 2 (-9 to 13)%[logistic regression estimate (95% Wald confidence interval)]. Administration of 6 mg kg(-1) of methadone decreased isoflurane MAC by 29 (11 to 46)%, 27 (-3 to 56)% and 10 (-8 to 28)% after 15, 30 and 45 minutes, respectively. Methadone (6 mg kg(-1)) induced atrioventricular block in three animals and ventricular premature contractions in two. Methadone caused an increase in arterial blood pressure and arterial partial pressure of carbon dioxide, while heart rate and pH decreased. Methadone, 6 mg kg(-1) IM significantly reduced isoflurane MAC by 30% in hens 15 minutes after administration. At this dose, methadone caused mild respiratory acidosis and increase in systemic blood pressure.	[Escobar, Andre; da Rocha, Rozana Wendler; Zangirolami Filho, Darcio; Sousa, Samuel Santos; Valadao, Carlos Augusto Araujo] Sao Paulo State Univ, Sch Agr & Veterinarian Sci, Dept Vet Clin & Surg, Jaboticabal, SP, Brazil; [Pypendop, Bruno Henri] Univ Calif Davis, Dept Surg & Radiol Sci, Sch Vet Med, Davis, CA 95616 USA	Universidade Estadual Paulista; University of California System; University of California Davis	Escobar, A (corresponding author), Sao Paulo State Univ, Sch Agr & Veterinarian Sci, Dept Vet Clin & Surg, Jaboticabal, SP, Brazil.	aescobarvet@yahoo.com.br	Sousa, Samuel/GWN-0475-2022; Escobar, Andre/ABC-9862-2021	Pypendop, Bruno/0000-0002-0894-0991	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq - Brazil [475127/2012-9]; Pro-reitoria de Pesquisa UNESP [1769/009/13 PROPe/CDC]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-reitoria de Pesquisa UNESP	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - 475127/2012-9 CNPq - Brazil. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pro-reitoria de Pesquisa UNESP - 1769/009/13 PROPe/CDC. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Abreu M, 2012, LAB ANIM-UK, V46, P200, DOI 10.1258/la.2012.010066; Botman J, 2015, VET ANAESTH ANALG, P1; Brosnan RJ, 2009, AM J VET RES, V70, P1065, DOI 10.2460/ajvr.70.9.1065; Callahan RJ, 2004, ANESTH ANALG, V98, P653, DOI 10.1213/01.ANE.0000099723.75548.DF; Campagnol D, 2012, VET J, V192, P311, DOI 10.1016/j.tvjl.2011.08.019; Ceulemans SM, 2014, AM J VET RES, V75, P705, DOI 10.2460/ajvr.75.8.705; Chan FT, 2013, J VET MED SCI, V75, P1591, DOI 10.1292/jvms.13-0161; CONCANNON KT, 1995, AM J VET RES, V56, P806; Credie RG, 2010, VET ANAESTH ANALG, V37, P240, DOI 10.1111/j.1467-2995.2010.00528.x; CURRO TG, 1994, VET SURG, V23, P429, DOI 10.1111/j.1532-950X.1994.tb00502.x; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Escobar A, 2014, VET ANAESTH ANALG, V41, P284, DOI 10.1111/vaa.12108; Escobar A, 2012, AM J VET RES, V73, P183, DOI 10.2460/ajvr.73.2.183; Escobar A, 2011, J ZOO WILDLIFE MED, V42, P12, DOI 10.1638/2009-0055.1; Ferreira TH, 2011, VET ANAESTH ANALG, V38, P310, DOI 10.1111/j.1467-2995.2011.00618.x; HELLEBREKERS LJ, 1989, J PHARMACOL EXP THER, V248, P329; Keller DL, 2011, AM J VET RES, V72, P741, DOI 10.2460/ajvr.72.6.741; Kim YK, 2011, J ZOO WILDLIFE MED, V42, P499, DOI 10.1638/2010-0151.1; Kristensen K., 1995, LIFE SCI, V56, P45; Kukanich B, 2015, VET ANAESTH ANALG, P207; LASTER MJ, 1993, ANESTH ANALG, V76, P1310, DOI 10.1213/00000539-199376060-00021; LUDDERS JW, 1990, VET SURG, V19, P304, DOI 10.1111/j.1532-950X.1990.tb01193.x; Mama KR, 1999, VET SURG, V28, P121, DOI 10.1053/jvet.1999.0121; Martin-Jurado O, 2008, AM J VET RES, V69, P1254, DOI 10.2460/ajvr.69.10.1254; Mercado JA, 2008, AM J VET RES, V69, P189, DOI 10.2460/ajvr.69.2.189; Paul-Murphy JR, 1999, AM J VET RES, V60, P1218; Pavez JC, 2011, VET ANAESTH ANALG, V38, P344, DOI 10.1111/j.1467-2995.2011.00627.x; PERT CB, 1974, BRAIN RES, V75, P356, DOI 10.1016/0006-8993(74)90761-6; Riggs SM, 2008, AM J VET RES, V69, P596, DOI 10.2460/ajvr.69.5.596; Rudolff AS, 2014, VET ANAESTH ANALG, V41, P386, DOI 10.1111/vaa.12118; Sladky KK, 2006, AM J VET RES, V67, P775, DOI 10.2460/ajvr.67.5.775; Sonner JM, 2003, ANESTH ANALG, V97, P718, DOI 10.1213/01.ANE.0000081063.76651.33; Sonner JM, 2002, ANESTH ANALG, V95, P609, DOI 10.1097/00000539-200209000-00021; Steinmetz HW, 2007, J VET DIAGN INVEST, V19, P382, DOI 10.1177/104063870701900407	34	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152546	10.1371/journal.pone.0152546	http://dx.doi.org/10.1371/journal.pone.0152546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018890	Green Published, gold			2022-12-26	WOS:000372807800057
J	Kolomenskiy, D; Maeda, M; Engels, T; Liu, H; Schneider, K; Nave, JC				Kolomenskiy, Dmitry; Maeda, Masateru; Engels, Thomas; Liu, Hao; Schneider, Kai; Nave, Jean-Christophe			Aerodynamic Ground Effect in Fruitfly Sized Insect Takeoff	PLOS ONE			English	Article							FLUID-STRUCTURE INTERACTION; NUMERICAL-SIMULATION; VOLUME PENALIZATION; FLIGHT INITIATION; DROSOPHILA; FORCE; KINEMATICS; OBSTACLES	Aerodynamic ground effect in flapping-wing insect flight is of importance to comparative morphologies and of interest to the micro-air-vehicle (MAV) community. Recent studies, however, show apparently contradictory results of either some significant extra lift or power savings, or zero ground effect. Here we present a numerical study of fruitfly sized insect takeoff with a specific focus on the significance of leg thrust and wing kinematics. Flappingwing takeoff is studied using numerical modelling and high performance computing. The aerodynamic forces are calculated using a three-dimensional Navier-Stokes solver based on a pseudo-spectral method with volume penalization. It is coupled with a flight dynamics solver that accounts for the body weight, inertia and the leg thrust, while only having two degrees of freedom: the vertical and the longitudinal horizontal displacement. The natural voluntary takeoff of a fruitfly is considered as reference. The parameters of the model are then varied to explore possible effects of interaction between the flapping-wing model and the ground plane. These modified takeoffs include cases with decreased leg thrust parameter, and/ or with periodic wing kinematics, constant body pitch angle. The results show that the ground effect during natural voluntary takeoff is negligible. In the modified takeoffs, when the rate of climb is slow, the difference in the aerodynamic forces due to the interaction with the ground is up to 6%. Surprisingly, depending on the kinematics, the difference is either positive or negative, in contrast to the intuition based on the helicopter theory, which suggests positive excess lift. This effect is attributed to unsteady wing-wake interactions. A similar effect is found during hovering.	[Kolomenskiy, Dmitry; Liu, Hao] Chiba Univ, Grad Sch Engn, Chiba, Japan; [Maeda, Masateru] Lund Univ, Dept Biol, Lund, Sweden; [Engels, Thomas; Schneider, Kai] Univ Aix Marseille, CNRS, M2P2, Marseille, France; [Engels, Thomas] TU Berlin, ISTA, Berlin, Germany; [Liu, Hao] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China; [Liu, Hao] Chiba Univ Int Cooperat Res Ctr, Shanghai, Peoples R China; [Kolomenskiy, Dmitry; Nave, Jean-Christophe] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada	Chiba University; Lund University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Technical University of Berlin; Shanghai Jiao Tong University; McGill University	Kolomenskiy, D; Liu, H (corresponding author), Chiba Univ, Grad Sch Engn, Chiba, Japan.; Liu, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China.; Liu, H (corresponding author), Chiba Univ Int Cooperat Res Ctr, Shanghai, Peoples R China.; Kolomenskiy, D (corresponding author), McGill Univ, Dept Math & Stat, Montreal, PQ, Canada.	dkolom@chiba-u.jp; hliu@faculty.chiba-u.jp	Kolomenskiy, Dmitry/H-3825-2019	Kolomenskiy, Dmitry/0000-0003-0107-6894; Engels, Thomas/0000-0002-9098-1054; Liu, Hao/0000-0002-8687-3237; Schneider, Kai/0000-0003-1243-6621; Maeda, Masateru/0000-0001-5605-0427	CRM-ISM (Centre de Recherches Mathematiques - Institut des Sciences Mathematiques); JSPS (Japan Society for the Promotion of Science) [P15061]; Deutsch-Franzosische Hochschule / Universite Franco-Allemande (DFH-UFA); JSPS [24120007]; IDRIS, Paris [81664]; CRM-ISM; Grants-in-Aid for Scientific Research [15F15061] Funding Source: KAKEN	CRM-ISM (Centre de Recherches Mathematiques - Institut des Sciences Mathematiques); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsch-Franzosische Hochschule / Universite Franco-Allemande (DFH-UFA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); IDRIS, Paris; CRM-ISM; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	DK gratefully acknowledges the financial support from the CRM-ISM (Centre de Recherches Mathematiques - Institut des Sciences Mathematiques) Postdoctoral Fellowship and from the JSPS (Japan Society for the Promotion of Science) Postdoctoral Fellowship P15061. TE and KS thank the Deutsch-Franzosische Hochschule / Universite Franco-Allemande (DFH-UFA) for financial support. HL was partly supported by the Grant-in-Aid for Scientific Research on Innovative Areas of No. 24120007, JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Numerical simulations were carried out using HPC resources of IDRIS, Paris (project 81664) and of Aix-Marseille Universite (project Equip@Meso). DK gratefully acknowledges the financial support from the CRM-ISM Postdoctoral Fellowship and from the JSPS Postdoctoral Fellowship. TE and KS thank the Deutsch-Franzosische Hochschule / Universite Franco-Allemande (DFH-UFA) for financial support. HL was partly supported by the Grant-in-Aid for Scientific Research on Innovative Areas of No. 24120007, JSPS.	Angot P, 1999, NUMER MATH, V81, P497, DOI 10.1007/s002110050401; Aono H, 2008, J EXP BIOL, V211, P239, DOI 10.1242/jeb.008649; Asselin M., 1997, AIRCRAFT DESIGN CONC, VA; Bimbard G, 2013, J EXP BIOL, V216, P3551, DOI 10.1242/jeb.084699; Card G, 2008, J EXP BIOL, V211, P341, DOI 10.1242/jeb.012682; Chen MW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0808; Chen MW, 2014, ACTA MECH SINICA-PRC, V30, P495, DOI 10.1007/s10409-014-0059-0; Chirarattananon P, 2013, IEEE INT C INT ROBOT, P3808, DOI 10.1109/IROS.2013.6696901; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Engels T, 2015, ARXIV150606513; Engels T, 2015, J COMPUT PHYS, V281, P96, DOI 10.1016/j.jcp.2014.10.005; Fontaine EI, 2009, J EXP BIOL, V212, P1307, DOI 10.1242/jeb.025379; Gao T, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2958318; Ishihara D, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/4/046009; Ishihara D, 2009, J EXP BIOL, V212, P1, DOI 10.1242/jeb.020404; Jones BL, 2005, THESIS AIR U OHIO; Kim EJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0505; Kolomenskiy D, 2011, J FLUID STRUCT, V27, P784, DOI 10.1016/j.jfluidstructs.2011.05.002; Kolomenskiy D, 2016, AERODYNAMIC GROUND E, DOI 10.17605/OSF.IO/WURBC; Kolomenskiy D, 2009, J COMPUT PHYS, V228, P5687, DOI 10.1016/j.jcp.2009.04.026; Leishman JG, 2006, PRINCIPLES HELICOPTE; Liu YJ, 2009, ADV APPL MATH MECH, V1, P481, DOI 10.4208/aamm.09-m0915; Maeda M, 2014, THESIS CHIBA U; Maeda M., 2013, J BIOMECH SCI ENG, V8, P344, DOI [10.1299/jbse.8.344, DOI 10.1299/JBSE.8.344, 10.1299/jbse.8.344)]; Quinn DB, 2014, J FLUID MECH, V742, P152, DOI 10.1017/jfm.2013.659; RAYNER JMV, 1991, PHILOS T ROY SOC B, V334, P119, DOI 10.1098/rstb.1991.0101; Schneider K, 2005, COMPUT FLUIDS, V34, P1223, DOI 10.1016/j.compfluid.2004.09.006; Tanaka H, 2011, INTEGR COMP BIOL, V51, P142, DOI 10.1093/icb/icr051; Tanida Y, 2001, JSME INT J B-FLUID T, V44, P481, DOI 10.1299/jsmeb.44.481; Truong TV, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/3/036007; Tobalske BW, 2007, J EXP BIOL, V210, P2368, DOI 10.1242/jeb.005686; Wootton RJ, 2003, PHILOS T R SOC B, V358, P1577, DOI 10.1098/rstb.2003.1351; Wu J, 2014, J BIONIC ENG, V11, P52, DOI 10.1016/S1672-6529(14)60019-6; Zumstein N, 2004, J EXP BIOL, V207, P3515, DOI 10.1242/jeb.01181	34	26	28	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152072	10.1371/journal.pone.0152072	http://dx.doi.org/10.1371/journal.pone.0152072			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019208	Green Submitted, Green Published, gold			2022-12-26	WOS:000372807800028
J	Weber, KL; Welly, BT; Van Eenennaam, AL; Young, AE; Porto-Neto, LR; Reverter, A; Rincon, G				Weber, Kristina L.; Welly, Bryan T.; Van Eenennaam, Alison L.; Young, Amy E.; Porto-Neto, Laercio R.; Reverter, Antonio; Rincon, Gonzalo			Identification of Gene Networks for Residual Feed Intake in Angus Cattle Using Genomic Prediction and RNA-seq	PLOS ONE			English	Article							MEAT QUALITY TRAITS; PHENOTYPIC RELATIONSHIPS; BREEDING VALUES; SAMPLE-SIZE; EFFICIENCY; CARCASS; GROWTH; ASSOCIATION; VALIDATION; EMISSIONS	Improvement in feed conversion efficiency can improve the sustainability of beef cattle production, but genomic selection for feed efficiency affects many underlying molecular networks and physiological traits. This study describes the differences between steer progeny of two influential Angus bulls with divergent genomic predictions for residual feed intake (RFI). Eight steer progeny of each sire were phenotyped for growth and feed intake from 8 mo. of age (average BW 254 kg, with a mean difference between sire groups of 4.8 kg) until slaughter at 14-16 mo. of age (average BW 534 kg, sire group difference of 28.8 kg). Terminal samples from pituitary gland, skeletal muscle, liver, adipose, and duodenum were collected from each steer for transcriptome sequencing. Gene expression networks were derived using partial correlation and information theory (PCIT), including differentially expressed (DE) genes, tissue specific (TS) genes, transcription factors (TF), and genes associated with RFI from a genome-wide association study (GWAS). Relative to progeny of the high RFI sire, progeny of the low RFI sire had -0.56 kg/d finishing period RFI (P = 0.05), -1.08 finishing period feed conversion ratio (P = 0.01), +3.3 kg boolean AND 0.75 finishing period metabolic mid-weight (MMW; P = 0.04), +28.8 kg final body weight (P = 0.01), -12.9 feed bunk visits per day (P = 0.02) with +0.60 min/visit duration (P = 0.01), and +0.0045 carcass specific gravity (weight in air/weight in air-weight in water, a predictor of carcass fat content; P = 0.03). RNA-seq identified 633 DE genes between sire groups among 17,016 expressed genes. PCIT analysis identified >115,000 significant co-expression correlations between genes and 25 TF hubs, i. e. controllers of clusters of DE, TS, and GWAS SNP genes. Pathway analysis suggests low RFI bull progeny possess heightened gut inflammation and reduced fat deposition. This multi-omics analysis shows how differences in RFI genomic breeding values can impact other traits and gene co-expression networks.	[Weber, Kristina L.; Rincon, Gonzalo] Zoetis Inc, VMRD Genet R&D, Kalamazoo, MI USA; [Welly, Bryan T.; Van Eenennaam, Alison L.; Young, Amy E.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Porto-Neto, Laercio R.; Reverter, Antonio] CSIRO Agr, Queensland Biosci Precinct, St Lucia, Qld, Australia	Zoetis; University of California System; University of California Davis; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Weber, KL (corresponding author), Zoetis Inc, VMRD Genet R&D, Kalamazoo, MI USA.	kristina.weber@zoetis.com	Van Eenennaam, Alison L/G-3481-2011; Porto-Neto, Laercio R/D-2594-2012; Reverter, Antonio/C-9699-2013	Van Eenennaam, Alison L/0000-0003-1562-162X; Porto-Neto, Laercio R/0000-0002-3536-8265; Reverter, Antonio/0000-0002-4681-9404; Young, Amy/0000-0002-4181-4233	Zoetis Inc. [201224918]	Zoetis Inc.	Funding for this study was provided through a grant from Zoetis Inc., #201224918. The funder provided support in the form of salaries for authors [GR, KW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alam T, 2012, MOL BIOL REP, V39, P919, DOI 10.1007/s11033-011-0817-z; Alexandre PA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2292-8; Ametaj BN, 2009, J ANIM SCI, V87, P1314, DOI 10.2527/jas.2008-1196; Basarab JA, 2013, ANIMAL, V7, P303, DOI 10.1017/S1751731113000888; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Bhuiyan MSA, 2009, LIVEST SCI, V126, P292, DOI 10.1016/j.livsci.2009.05.019; Bingham GM, 2009, J ANIM SCI, V87, P2685, DOI 10.2527/jas.2009-1851; Boddhireddy P, 2014, J ANIM SCI, V92, P485, DOI 10.2527/jas.2013-6757; Bolormaa S, 2013, J ANIM SCI, V91, P3088, DOI 10.2527/jas.2012-5827; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Canovas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102551; Cassar-Malek I, 2005, EAAP PUBLIC, P385; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Chu JH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-78; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cruz GD, 2012, DAILY METHANE EMISSI; Do DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071509; Gozho GN, 2006, J DAIRY SCI, V89, P4404, DOI 10.3168/jds.S0022-0302(06)72487-0; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Hart SN, 2013, J COMPUT BIOL, V20, P970, DOI 10.1089/cmb.2012.0283; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2013, TRENDS GENET, V29, P206, DOI 10.1016/j.tig.2012.11.009; Herd RM, 2014, J ANIM SCI, V92, P5267, DOI 10.2527/jas.2014-8273; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kelly AK, 2010, J ANIM SCI, V88, P3214, DOI 10.2527/jas.2009-2700; Kelly AK, 2010, J ANIM SCI, V88, P109, DOI 10.2527/jas.2009-2196; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; KRAYBILL HF, 1952, J APPL PHYSIOL, V4, P575, DOI 10.1152/jappl.1952.4.7.575; Lee EA, 2012, MEAT SCI, V92, P36, DOI 10.1016/j.meatsci.2012.03.018; Lkhagvadorj S, 2009, PHYSIOL GENOMICS, V38, P98, DOI 10.1152/physiolgenomics.90372.2008; LOFGREEN GP, 1968, J ANIM SCI, V27, P793; Loyd A. N., 2011, Open Journal of Animal Sciences, V1, P89, DOI 10.4236/ojas.2011.13011; Mani V, 2013, J ANIM SCI, V91, P2141, DOI 10.2527/jas.2012-6053; Mcgee M, 2014, J ANIM SCI, V92, P3580, DOI 10.2527/jas.2013-7360; Meuwissen THE, 2001, GENETICS, V157, P1819; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mujibi FDN, 2011, J ANIM SCI, V89, P3353, DOI 10.2527/jas.2010-3361; Nkrumah JD, 2007, J ANIM SCI, V85, P2711, DOI 10.2527/jas.2006-767; OWENS FN, 1995, J ANIM SCI, V73, P3152; Paradis F, 2015, JOURNAL OF ANIMAL SC, V93, DOI [10.2527/jas2015-8975, DOI 10.2527/JAS2015-8975]; Park SJ, 2015, ANN ANIM SCI, V15, P629, DOI 10.1515/aoas-2015-0022; Pryce JE, 2012, J DAIRY SCI, V95, P2108, DOI 10.3168/jds.2011-4628; Ramsey R., 2005, Journal of Agricultural and Applied Economics, V37, P91, DOI 10.1017/S1074070800007124; Reverter A, 2005, BIOINFORMATICS, V21, P1112, DOI 10.1093/bioinformatics/bti124; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Sahana G, 2013, J ANIM SCI, V91, P1041, DOI 10.2527/jas.2012-5643; SCHMALSTIEG FC, 1995, J CLIN INVEST, V95, P1169, DOI 10.1172/JCI117765; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Snelling WM, 2011, J ANIM SCI, V89, P1731, DOI 10.2527/jas.2010-3526; Tizioto PC, 2013, PHYSIOL GENOMICS, V45, P1012, DOI 10.1152/physiolgenomics.00066.2013; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yamamoto N, 2008, TRANSL ONCOL, V1, P65, DOI 10.1593/tlo.08106; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1364-0; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	59	54	56	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152274	10.1371/journal.pone.0152274	http://dx.doi.org/10.1371/journal.pone.0152274			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019286	gold, Green Submitted, Green Published			2022-12-26	WOS:000372807800037
J	Chang, YJ; Zhou, LL; Binari, R; Manoukian, A; Mak, T; McNeill, H; Stambolic, V				Chang, Ying-Ju; Zhou, Lily; Binari, Richard; Manoukian, Armen; Mak, Tak; McNeill, Helen; Stambolic, Vuk			The Rho Guanine Nucleotide Exchange Factor DRhoGEF2 Is a Genetic Modifier of the PI3K Pathway in Drosophila	PLOS ONE			English	Article							PTEN TUMOR-SUPPRESSOR; CELL-SHAPE CHANGES; SIGNALING PATHWAY; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; INSULIN; GROWTH; GTPASE; CANCER; PROTEIN	The insulin/IGF-1 signaling pathway mediates various physiological processes associated with human health. Components of this pathway are highly conserved throughout eukaryotic evolution. In Drosophila, the PTEN ortholog and its mammalian counterpart downregulate insulin/IGF signaling by antagonizing the PI3-kinase function. From a dominant loss-of-function genetic screen, we discovered that mutations of a Dbl-family member, the guanine nucleotide exchange factor DRhoGEF2 (DRhoGEF(2(l)04291)), suppressed the PTEN-over-expression eye phenotype. dAkt/dPKB phosphorylation, a measure of PI3K signaling pathway activation, increased in the eye discs from the heterozygous DRhoGEF2 wandering third instar larvae. Overexpression of DRhoGEF2, and it's functional mammalian ortholog PDZRhoGEF (ArhGEF11), at various stages of eye development, resulted in both dPKB/Aktdependent and - independent phenotypes, reflecting the complexity in the crosstalk between PI3K and Rho signaling in Drosophila.	[Chang, Ying-Ju; Zhou, Lily; Binari, Richard; Manoukian, Armen; Mak, Tak; Stambolic, Vuk] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Mak, Tak; Stambolic, Vuk] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [McNeill, Helen] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [McNeill, Helen] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Binari, Richard] Harvard Univ, Sch Med, Boston, MA USA; [Manoukian, Armen] Inceptum Res & Therapeut Inc, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Harvard University; Harvard Medical School	Stambolic, V (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Stambolic, V (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	vuks@uhnres.utoronto.ca	McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154; Stambolic, Vuk/0000-0001-8853-3239	Canadian Cancer Society Research Institute Innovation [701683]	Canadian Cancer Society Research Institute Innovation	This work was funded by Canadian Cancer Society Research Institute Innovation Grant number 701683 to VS.; We wish to thank Dr. P. Dutt for critical reading of the manuscript. This work was supported by Canadian Cancer Society Research Institute Innovation Grant number 701683 to VS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Alan Jamie K, 2013, Small GTPases, V4, P208, DOI 10.4161/sgtp.26602; Alvarez-Nunez F, 2006, THYROID, V16, P17, DOI 10.1089/thy.2006.16.17; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Barmchi MP, 2005, J CELL BIOL, V168, P575, DOI 10.1083/jcb.200407124; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Devreotes P, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a005959; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gerisch G, 2012, BIOPHYS J, V103, P1170, DOI [10.1016/j.bpj.2012.08.004, 10.1016/j.bpj.2012.05.00.4]; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Halsell SR, 1998, GENETICS, V148, P1845; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Huang H, 1999, DEVELOPMENT, V126, P5365; Jean S, 2014, J CELL SCI, V127, P923, DOI 10.1242/jcs.093773; Kawaguchi K, 2005, HUM PATHOL, V36, P357, DOI 10.1016/j.humpath.2005.01.017; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Leevers SJ, 2001, CURR BIOL, V11, pR209, DOI 10.1016/S0960-9822(01)00107-5; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Liao Y, 2010, AM J TRANSL RES, V2, P19; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Magie CR, 1999, DEVELOPMENT, V126, P5353; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mirmohammadsadegh A, 2006, CANCER RES, V66, P6546, DOI 10.1158/0008-5472.CAN-06-0384; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; ROTHENBERG PL, 1991, J BIOL CHEM, V266, P8302; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Sepp KJ, 2003, DEVELOPMENT, V130, P1825, DOI 10.1242/dev.00413; Solari F, 2005, ONCOGENE, V24, P20, DOI 10.1038/sj.onc.1207978; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Spradling AC, 1999, GENETICS, V153, P135; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 1997, J BIOL CHEM, V272, P14606, DOI 10.1074/jbc.272.23.14606; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5	58	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152259	10.1371/journal.pone.0152259	http://dx.doi.org/10.1371/journal.pone.0152259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015411	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900047
J	Cugno, G; Parreira, JR; Ferlizza, E; Hernandez-Castellano, LE; Carneiro, M; Renaut, J; Castro, N; Arguello, A; Capote, J; Campos, AMO; Almeida, AM				Cugno, Graziano; Parreira, Jose R.; Ferlizza, Enea; Hernandez-Castellano, Lorenzo E.; Carneiro, Mariana; Renaut, Jenny; Castro, Noemi; Arguello, Anastasio; Capote, Juan; Campos, Alexandre M. O.; Almeida, Andre M.			The Goat (Capra hircus) Mammary Gland Mitochondrial Proteome: A Study on the Effect of Weight Loss Using Blue-Native PAGE and Two-Dimensional Gel Electrophoresis	PLOS ONE			English	Article							AUSTRALIAN MERINO LAMBS; GENETIC-RESOURCES; ANIMAL PRODUCTION; MILK-PRODUCTION; GUINEA-BISSAU; LIVE WEIGHT; PROTEINS; COMPLEX; MUSCLE; IDENTIFICATION	Seasonal weight loss (SWL) is the most important limitation to animal production in the Tropical and Mediterranean regions, conditioning producer's incomes and the nutritional status of rural communities. It is of importance to produce strategies to oppose adverse effects of SWL. Breeds that have evolved in harsh climates have acquired tolerance to SWL through selection. Most of the factors determining such ability are related to changes in biochemical pathways as affected by SWL. In this study, a gel based proteomics strategy (BN: Blue-Native Page and 2DE: Two-dimensional gel electrophoresis) was used to characterize the mitochondrial proteome of the secretory tissue of the goat mammary gland. In addition, we have conducted an investigation of the effects of weight loss in two goat breeds with different levels of adaptation to nutritional stress: Majorera (tolerant) and Palmera (susceptible). The study used Majorera and Palmera dairy goats, divided in 4 sets, 2 for each breed: underfed group fed on wheat straw (restricted diet, so their body weight would be 15-20% reduced by the end of experiment), and a control group fed with an energy-balanced diet. At the end of the experimental period (22 days), mammary gland biopsies were obtained for all experimental groups. The proteomic analysis of the mitochondria enabled the resolution of a total of 277 proteins, and 148 (53%) were identified by MALDI-TOF/TOF mass spectrometry. Some of the proteins were identified as subunits of the glutamate dehydrogenase complex and the respiratory complexes I, II, IV, V from mitochondria, as well as numerous other proteins with functions in: metabolism, development, localization, cellular organization and biogenesis, biological regulation, response to stimulus, among others, that were mapped in both BN and 2DE gels. The comparative proteomics analysis enabled the identification of several proteins: NADH-ubiquinone oxidoreductase 75 kDa subunit and lamin B1 mitochondrial (up-regulated in the Palmera breed), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (up-regulated in the Majorera breed) and cytochrome b-c1 complex subunit 1, mitochondrial and Chain D, Bovine F1-C8 Sub-Complex Of Atp Synthase (down-regulated in the Majorera breed) as a consequence of weight loss.	[Cugno, Graziano; Ferlizza, Enea; Carneiro, Mariana; Campos, Alexandre M. O.] Univ Porto, CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Cugno, Graziano; Hernandez-Castellano, Lorenzo E.; Castro, Noemi; Arguello, Anastasio] Univ Las Palmas Gran Canaria, Dept Anim Sci, Arucas, Gran Canaria, Spain; [Parreira, Jose R.; Almeida, Andre M.] IBET, Oeiras, Portugal; [Parreira, Jose R.; Almeida, Andre M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Ferlizza, Enea] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Hernandez-Castellano, Lorenzo E.] Univ Bern, Vet Physiol, Vetsuisse Fac, Bern, Switzerland; [Renaut, Jenny] LIST, Belvaux, Luxembourg; [Capote, Juan] Inst Canario Invest Agr, Tenerife, Spain; [Almeida, Andre M.] CIISA, Lisbon, Portugal; [Almeida, Andre M.] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi	Universidade do Porto; Universidad de Las Palmas de Gran Canaria; Universidade Nova de Lisboa; University of Bologna; University of Bern; Luxembourg Institute of Science & Technology; Universidade de Lisboa	Almeida, AM (corresponding author), IBET, Oeiras, Portugal.; Almeida, AM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.; Almeida, AM (corresponding author), CIISA, Lisbon, Portugal.	adealmeida@rossvet.edu.kn	Ferlizza, Enea/ABD-9218-2020; Almeida, Andre/I-4369-2013; Ferlizza, Enea/AAE-2655-2019; Renaut, Jenny/K-3216-2012; Castro, N./F-9621-2016; Castellano, Lorenzo E. Hernández/T-1034-2016; Campos, Alexandre/AGP-3558-2022; Castro, Noemí/T-6378-2019; Arguello, Anastasio/B-4493-2010	Almeida, Andre/0000-0002-7810-3988; Ferlizza, Enea/0000-0003-3391-0679; Renaut, Jenny/0000-0002-0450-3866; Castro, N./0000-0002-3026-2031; Castellano, Lorenzo E. Hernández/0000-0003-2729-0434; Campos, Alexandre/0000-0003-4621-885X; Arguello, Anastasio/0000-0002-4426-0678; Carneiro, Mariana/0000-0003-1981-3303; Parreira, Jose/0000-0003-3278-8122	Fundacao para a Ciencia e Tecnologia (FCT, Lisbon, Portugal) [PTDC/CVT/116499/2010]; European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; national funds through FCT - Foundation for Science and Technology [PEst-C/MAR/LA0015/2011]; FCT [SFRH/BPD/103683/2014, PD/BD/113474/2015]; Short Term Scientific Mission - COST action [FA1002]	Fundacao para a Ciencia e Tecnologia (FCT, Lisbon, Portugal)(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; national funds through FCT - Foundation for Science and Technology; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Short Term Scientific Mission - COST action	This research was supported by the research project PTDC/CVT/116499/2010 - Lactation and milk production in Goat (Capra hircus): identifying molecular markers underlying adaptation to seasonal weight loss from Fundacao para a Ciencia e Tecnologia (FCT, Lisbon, Portugal) and by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme and national funds through FCT - Foundation for Science and Technology, under the project "PEst-C/MAR/LA0015/2011". Author AM Almeida contract work is supported by the Ciencia 2007 program, A Campos work by a postdoctoral grant (SFRH/BPD/103683/2014) and J Parreira by a PhD grant (PD/BD/113474/2015) all from FCT. G Cugno was supported by a Short Term Scientific Mission financed by COST action FA1002 Proteomics in Farm Animals to whom network funding is finally acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AM, 2007, SMALL RUMINANT RES, V73, P216, DOI 10.1016/j.smallrumres.2007.02.001; Almeida AM, 2006, TROP ANIM HEALTH PRO, V38, P443, DOI 10.1007/s11250-006-4368-6; Almeida AM, 2015, ANIMAL, V9, P1, DOI 10.1017/S1751731114002602; Almeida AM, 2010, ANIM GENET, V41, P260, DOI 10.1111/j.1365-2052.2009.01994.x; Almeida AM, 2004, SMALL RUMINANT RES, V55, P141, DOI 10.1016/j.smallrumres.2004.01.009; Almeida AM, 2013, TROP ANIM HEALTH PRO, V45, P1305, DOI 10.1007/s11250-013-0361-z; Almeida AM, 2011, TROP ANIM HEALTH PRO, V43, P1427, DOI 10.1007/s11250-011-9868-3; Amills M, 2004, J DAIRY RES, V71, P257, DOI 10.1017/S0022029904000342; Arianmanesh M, 2011, J ENDOCRINOL, V210, P47, DOI 10.1530/JOE-10-0336; Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7; Campos A, 2010, PLANT BIOLOGY, V12, P708, DOI 10.1111/j.1438-8677.2009.00280.x; Campos A, 2013, J SCI FOOD AGR, V93, P1779, DOI 10.1002/jsfa.5977; Capote J, 2006, J DAIRY SCI, V89, P2076, DOI 10.3168/jds.S0022-0302(06)72276-7; Cardoso L. A., 2013, FAO Animal Production and Health Paper, P37; Chaudhary N, 2013, CHEM-BIOL INTERACT, V204, P125, DOI 10.1016/j.cbi.2013.05.004; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P529, DOI 10.1007/s11250-008-9130-9; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P537, DOI 10.1007/s11250-008-9131-8; de Almeida AM, 2012, J PROTEOMICS, V75, P4296, DOI 10.1016/j.jprot.2012.04.010; Eckersall PD, 2012, J PROTEOMICS, V75, P4187, DOI 10.1016/j.jprot.2012.05.014; Escuder A., 2006, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P95; Fan NJ, 2012, J PROTEOMICS, V75, P3977, DOI 10.1016/j.jprot.2012.05.008; Ferlizza E, 2015, VET J, V204, P73, DOI 10.1016/j.tvjl.2015.01.023; Ferreira AM, 2013, J PROTEOMICS, V94, P110, DOI 10.1016/j.jprot.2013.09.012; Fresno M. R., 1994, Archivos de Zootecnia, V43, P181; Giusti L, 2014, PROTEOM CLIN APPL, V8, P258, DOI 10.1002/prca.201300052; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Hernandez-Castellano LE, 2015, J DAIRY SCI, V98, P135, DOI 10.3168/jds.2014-8143; Hernandez-Castellano LE, 2014, CURR PROTEIN PEPT SC, V15, P64, DOI 10.2174/1389203715666140221124622; Hernandez-Castellano LE, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-85; Herrera RG, 2001, J CLIMATE, V14, P3889, DOI 10.1175/1520-0442(2001)014<3889:IOTNAO>2.0.CO;2; Janjanam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102515; Lerias JR, 2015, J DAIRY RES, V82, P416, DOI 10.1017/S0022029915000412; Lerias JR, 2014, J DAIRY RES, V81, P304, DOI 10.1017/S0022029914000235; Lerias JR, 2013, TROP ANIM HEALTH PRO, V45, P1731, DOI 10.1007/s11250-013-0423-2; Makawita S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008599; Martinez-de la Puente J, 2011, VET REC, V168, P377, DOI 10.1136/vr.c6483; McDonald P, 1988, ANIMAL NUTR; MEHARD CW, 1971, CANCER RES, V31, P2148; Miller I, 2014, CURR PROTEIN PEPT SC, V15, P134, DOI 10.2174/1389203715666140221115135; Navarro-Rios M. J., 2011, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P205; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Oliva K, 2013, J ENDOCRINOL, V218, P165, DOI 10.1530/JOE-13-0010; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Paredi G, 2013, J PROTEOMICS, V88, P58, DOI 10.1016/j.jprot.2013.01.029; Paredi G, 2012, J PROTEOMICS, V75, P4275, DOI 10.1016/j.jprot.2012.04.011; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Roberts DJ, 2004, BIOCHEM PHARMACOL, V68, P799, DOI 10.1016/j.bcp.2004.05.044; Rolyan H, 2015, J NEUROSCI, V35, P12002, DOI 10.1523/JNEUROSCI.1668-15.2015; Scanlon TT, 2013, SMALL RUMINANT RES, V109, P101, DOI 10.1016/j.smallrumres.2012.08.004; Soares R, 2012, J PROTEOMICS, V75, P4190, DOI 10.1016/j.jprot.2012.04.009; Torres A, 2013, J DAIRY SCI, V96, P1071, DOI 10.3168/jds.2012-5435; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Ura B, 2015, ONCOL REP, V33, P2219, DOI 10.3892/or.2015.3827; van Harten S, 2003, NUTR RES, V23, P1447, DOI 10.1016/S0271-5317(03)00152-0; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Young SG, 2014, MOL CELL BIOL, V34, P2776, DOI 10.1128/MCB.00486-14	57	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151599	10.1371/journal.pone.0151599	http://dx.doi.org/10.1371/journal.pone.0151599			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031334	Green Published, Green Submitted, gold			2022-12-26	WOS:000373121800015
J	Pratihast, AK; DeVries, B; Avitabile, V; de Bruin, S; Herold, M; Bergsma, A				Pratihast, Arun Kumar; DeVries, Ben; Avitabile, Valerio; de Bruin, Sytze; Herold, Martin; Bergsma, Aldo			Design and Implementation of an Interactive Web-Based Near Real-Time Forest Monitoring System	PLOS ONE			English	Article							VOLUNTEERED GEOGRAPHIC INFORMATION; REDD PLUS; CITIZEN SCIENCE; SOCIAL MEDIA; LANDSAT; DEFORESTATION; OPPORTUNITIES; DISTURBANCE; EMISSIONS; COVER	This paper describes an interactive web-based near real-time (NRT) forest monitoring system using four levels of geographic information services: 1) the acquisition of continuous data streams from satellite and community-based monitoring using mobile devices, 2) NRT forest disturbance detection based on satellite time-series, 3) presentation of forest disturbance data through a web-based application and social media and 4) interaction of the satellite based disturbance alerts with the end-user communities to enhance the collection of ground data. The system is developed using open source technologies and has been implemented together with local experts in the UNESCO Kafa Biosphere Reserve, Ethiopia. The results show that the system is able to provide easy access to information on forest change and considerably improves the collection and storage of ground observation by local experts. Social media leads to higher levels of user interaction and noticeably improves communication among stakeholders. Finally, an evaluation of the system confirms the usability of the system in Ethiopia. The implemented system can provide a foundation for an operational forest monitoring system at the national level for REDD+ MRV applications.	[Pratihast, Arun Kumar; DeVries, Ben; Avitabile, Valerio; de Bruin, Sytze; Herold, Martin; Bergsma, Aldo] Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, POB 47, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research	Pratihast, AK (corresponding author), Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, POB 47, NL-6700 AA Wageningen, Netherlands.	arun.pratihast@wur.nl	Herold, Martin/F-8553-2012; Pratihast, Arun/AAO-8661-2020; de Bruin, Sytze/N-1183-2014; DeVries, Ben/H-5588-2019	Herold, Martin/0000-0003-0246-6886; DeVries, Ben/0000-0003-2136-3401	International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMU) (IKI-1 project) [05/2014-2]; Google Earth Engine Research Awards	International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMU) (IKI-1 project); Google Earth Engine Research Awards(Google Incorporated)	The work presented in this paper has been carried out with in the frame of the project "Forest, Carbon and Biodiversity Monitoring", implemented by the Nature and Biodiversity Conservation Union (NABU), German and Ethiopian branches, with funding from the International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMU) (IKI-1 project number 05/2014-2). Funding for the work of Arun Kumar Pratihast was provided by the Google Earth Engine Research Awards 2015.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Aerts R, 2015, SCIENCE, V347, P139, DOI 10.1126/science.347.6218.139-b; Anderson LO, 2005, IEEE GEOSCI REMOTE S, V2, P315, DOI 10.1109/LGRS.2005.850364; Asner GP, 2001, INT J REMOTE SENS, V22, P3855, DOI 10.1080/01431160010006926; Torres AB, 2014, FORESTS, V5, P3295, DOI 10.3390/f5123295; Torres AB, 2012, FORESTS, V3, P137, DOI 10.3390/f3010137; Bellfield H, 2015, FORESTS, V6, P133, DOI 10.3390/f6010133; Biezen JV, 2015, THESIS UTRECHT U UTR; Bimber O, 2000, COMPUT GRAPH-UK, V24, P851, DOI 10.1016/S0097-8493(00)00088-1; Bocher E, 2012, LECT NOTES GEOINFORM, P247; Borner J, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121544, 10.1371/journal.pone.0116846]; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Bugs G, 2010, CITIES, V27, P172, DOI 10.1016/j.cities.2009.11.008; CIFOR, 2021, CIFOR FORESTS NEWS; Connors JP, 2012, ANN ASSOC AM GEOGR, V102, P1267, DOI 10.1080/00045608.2011.627058; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Danielsen F, 2010, J APPL ECOL, V47, P1166, DOI 10.1111/j.1365-2664.2010.01874.x; Daume S, 2014, FOREST ECOL MANAG, V316, P9, DOI 10.1016/j.foreco.2013.09.004; de Bruin S, 2014, BIOSYST ENG, V120, P15, DOI 10.1016/j.biosystemseng.2013.07.009; de Sassi C, 2015, CURR OPIN ENV SUST, V14, P93, DOI 10.1016/j.cosust.2015.04.003; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; DeVries B, 2015, REMOTE SENS ENVIRON, V161, P107, DOI 10.1016/j.rse.2015.02.012; Devries B, 2013, LAW, TROPICAL FORESTS AND CARBON: THE CASE OF REDD+, P151; Dickson B, 2012, CURR OPIN ENV SUST, V4, P717, DOI 10.1016/j.cosust.2012.09.017; Diga M, 2009, PUBLIC RELAT REV, V35, P440, DOI 10.1016/j.pubrev.2009.07.003; Dragicevic S., 2004, J GEOGRAPHICAL SYSTE, V6, P133, DOI [10.1007/s10109-004-0130-7, DOI 10.1007/S10109-004-0130-7]; Dresen E, 2014, LAND-BASEL, V3, P1137, DOI 10.3390/land3031137; Drusch M, 2012, REMOTE SENS ENVIRON, V120, P25, DOI 10.1016/j.rse.2011.11.026; Eggleston H.S., 2006, GUIDELINES NATL GREE; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Getahun K, 2013, FOREST ECOL MANAG, V304, P171, DOI 10.1016/j.foreco.2013.05.001; GOFC-GOLD, 2014, SOURC METH PROC MON; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Gouveia C, 2004, J ENVIRON MANAGE, V71, P135, DOI 10.1016/j.jenvman.2004.01.009; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P3784, DOI 10.1016/j.rse.2008.05.012; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Herold M, 2012, CURRENT OPINION ENV; Herold M, 2008, REALISING REDD NATL, V7, P85; Keramitsoglou I, 2004, ENVIRON MANAGE, V33, P212, DOI 10.1007/s00267-003-0092-4; Kingston R., 2000, Computers, Environment and Urban Systems, V24, P109, DOI 10.1016/S0198-9715(99)00049-6; Li WeiJiang, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P59; Li ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116781; Lynch J, 2013, NATURE, V496, P293, DOI 10.1038/496293a; Maguire D. J., 2005, Computers, Environment and Urban Systems, V29, P3, DOI 10.1016/j.compenvurbsys.2004.05.012; Moore R.T., 2011, AGU FALL M ABSTR 201; Newman G, 2011, ECOL INFORM, V6, P217, DOI 10.1016/j.ecoinf.2011.03.002; Pocas I, 2014, INT J GEOGR INF SCI, V28, P2356, DOI 10.1080/13658816.2014.924627; Pratihast AK, 2014, FORESTS, V5, P2464, DOI 10.3390/f5102464; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Pratihast AK, 2013, SENSORS-BASEL, V13, P21, DOI 10.3390/s130100021; Reiche J, 2015, REMOTE SENS-BASEL, V7, P4973, DOI 10.3390/rs70504973; Renate Steinmann AK, 2004, 24 URB DAT MAN S; Rocha R, 2019, WORK PAP; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Schmitt CB, 2010, APPL VEG SCI, V13, P291, DOI 10.1111/j.1654-109X.2009.01067.x; Shimabukuro Y., 2007, REVISTAAMBI AGUA, V1, P37, DOI DOI 10.4136/AMBI-AGUA.4; Shrestha S, 2014, FORESTS, V5, P2425, DOI 10.3390/f5102425; Skar C, 2012, NORWEGIAN INT CLIMAT; Skarlatidou A, 2011, INT J GEOGR INF SCI, V25, P1913, DOI 10.1080/13658816.2011.557379; Skutsch MM, 2014, BIODIVERS CONSERV, V23, P233, DOI 10.1007/s10531-013-0594-1; Skutsch Margaret M, 2011, Carbon Balance Manag, V6, P16, DOI 10.1186/1750-0680-6-16; Souza CM, 2009, EARTH SCI INFORM, V2, P205, DOI 10.1007/s12145-009-0035-6; Tomppo E., 2010, NATL FOREST INVENTOR, P541, DOI DOI 10.1007/978-90-481-3233-1; UNFCCC, 2013, GUID PROC TECHN ASS; United Nations Collaborative Programme on Reducing Emissions from Deforestation and Forest Degradation in Developing Countries (UN-REDD), 2009, AB REDD; Vadrevu KP, 2008, J ENVIRON PLANN MAN, V51, P817, DOI 10.1080/09640560802423657; van Oort PAJ, 2010, GEOJOURNAL, V75, P105, DOI 10.1007/s10708-009-9294-5; Verbesselt J, 2012, REMOTE SENS ENVIRON, V123, P98, DOI 10.1016/j.rse.2012.02.022; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Visseren-Hamakers IJ, 2012, CURR OPIN ENV SUST, V4, P590, DOI 10.1016/j.cosust.2012.10.006; Werts JD, 2012, ENVIRON MANAGE, V49, P816, DOI 10.1007/s00267-012-9818-5; Wheeler D, SATELLITE BASED FORE; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010; Xin QC, 2013, REMOTE SENS ENVIRON, V135, P234, DOI 10.1016/j.rse.2013.04.002; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028	81	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0150935	10.1371/journal.pone.0150935	http://dx.doi.org/10.1371/journal.pone.0150935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031694	gold, Green Published, Green Submitted			2022-12-26	WOS:000373121800008
J	Jia, GD; Yu, XX; Fan, DX; Jia, JB				Jia, Guodong; Yu, Xinxiao; Fan, Dengxing; Jia, Jianbo			Mechanism Underlying the Spatial Pattern Formation of Dominant Tree Species in a Natural Secondary Forest	PLOS ONE			English	Article							LOWLAND RAIN-FOREST; BIVARIATE DISTRIBUTION; POSITIVE INTERACTIONS; GROWTH; COMPETITION; ASSOCIATIONS; DIVERSITY; DYNAMICS; BEECH; POINT	Studying the spatial pattern of plant species may provide significant insights into processes and mechanisms that maintain stand stability. To better understand the dynamics of naturally regenerated secondary forests, univariate and bivariate Ripley's L(r) functions were employed to evaluate intra-/interspecific relationships of four dominant tree species (Populus davidiana, Betula platyphylla, Larix gmelinii and Acer mono) and to distinguish the underlying mechanism of spatial distribution. The results showed that the distribution of soil, water and nutrients was not fragmented but presented clear gradients. An overall aggregated distribution existed at most distances. No correlation was found between the spatial pattern of soil conditions and that of trees. Both positive and negative intra-and interspecific relationships were found between different DBH classes at various distances. Large trees did not show systematic inhibition of the saplings. By contrast, the inhibition intensified as the height differences increased between the compared pairs. Except for Larix, universal inhibition of saplings by upper layer trees occurred among other species, and this reflected the vertical competition for light. Therefore, we believe that competition for light rather than soil nutrients underlies the mechanism driving the formation of stand spatial pattern in the rocky mountainous areas examined.	[Jia, Guodong; Yu, Xinxiao; Fan, Dengxing; Jia, Jianbo] Beijing Forestry Univ, Coll Soil & Water Conservat, Key Lab Soil & Water Conservat & Desertificat Com, Minist Educ, Beijing, Peoples R China	Beijing Forestry University	Yu, XX (corresponding author), Beijing Forestry Univ, Coll Soil & Water Conservat, Key Lab Soil & Water Conservat & Desertificat Com, Minist Educ, Beijing, Peoples R China.	yuxinxiao111@163.com			Fundamental Research Funds for the Central Universities [BLX2013032, 2015ZCQ-SB-03]; National Nature Science Foundation of China [41401013]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fundamental Research Funds for the Central Universities (Grant No. BLX2013032), National Nature Science Foundation of China (Grant No. 41401013) and the Fundamental Research Funds for the Central Universities (NO. 2015ZCQ-SB-03).	Aldrich PR, 2003, FOREST ECOL MANAG, V180, P475, DOI 10.1016/S0378-1127(02)00612-6; Barker MG, 1997, OECOLOGIA, V112, P453, DOI 10.1007/s004420050332; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Boyden S, 2005, FOREST ECOL MANAG, V219, P43, DOI 10.1016/j.foreco.2005.08.041; Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; Burslem DFRP, 2001, SCIENCE, V291, P606, DOI 10.1126/science.1055873; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CARSON PL, 1980, N DAK AGR EXP STA BU, P17; Chen Yifeng, 2000, Acta Acustica, V25, P265; Chokkalingam U., 2001, International Forestry Review, V3, P19; CHRISTENSEN NL, 1977, AM MIDL NAT, V97, P176, DOI 10.2307/2424693; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Coomes DA, 2009, J ECOL, V97, P705, DOI 10.1111/j.1365-2745.2009.01507.x; Dimov L, 2013, ANN FOREST SCI, V70, P813, DOI 10.1007/s13595-013-0322-8; Druckenbrod DL, 2005, J VEG SCI, V16, P37, DOI 10.1111/j.1654-1103.2005.tb02336.x; Fang WP, 1988, FLORA CHINA, V46, P94; Freckleton RP, 2001, FUNCT ECOL, V15, P615, DOI 10.1046/j.0269-8463.2001.00558.x; Genet A, 2014, ECOL MODEL, V288, P143, DOI 10.1016/j.ecolmodel.2014.06.002; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Hao ZQ, 2007, FOREST ECOL MANAG, V252, P1, DOI 10.1016/j.foreco.2007.06.026; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Heineman KD, 2011, FOREST ECOL MANAG, V261, P1820, DOI 10.1016/j.foreco.2011.02.005; Kammesheidt L, 2002, AMBIO, V31, P243, DOI 10.1639/0044-7447(2002)031[0243:POSFMI]2.0.CO;2; Kitzberger T, 2000, ECOLOGY, V81, P1914, DOI 10.1890/0012-9658(2000)081[1914:EOCVOF]2.0.CO;2; Kuang KR, 1988, FLORA CHINA, V21, P112; Kubota Y, 2007, PLANT ECOL, V190, P143, DOI 10.1007/s11258-006-9197-1; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Li YF, 2014, FOREST ECOL MANAG, V314, P17, DOI 10.1016/j.foreco.2013.11.012; Li YF, 2012, J VEG SCI, V23, P1180, DOI 10.1111/j.1654-1103.2012.01431.x; Lu R.K, 2000, ANAL METHOD SOIL AGR; MALIK AR, 1976, AUST J BOT, V24, P265, DOI 10.1071/BT9760265; Martinez I, 2010, FOREST ECOL MANAG, V260, P456, DOI 10.1016/j.foreco.2010.04.039; Nanami S, 2011, ECOL RES, V26, P37, DOI 10.1007/s11284-010-0750-y; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Petritan IC, 2015, FOREST ECOL MANAG, V356, P184, DOI 10.1016/j.foreco.2015.07.015; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Raphael JPA, 2016, SOIL TILL RES, V155, P45, DOI 10.1016/j.still.2015.07.020; REBERTUS AJ, 1989, J ECOL, V77, P638, DOI 10.2307/2260975; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROBERTS MR, 1995, ECOL APPL, V5, P969, DOI 10.2307/2269348; Romanya J, 2005, GEODERMA, V124, P169, DOI 10.1016/j.geoderma.2004.04.011; Rozas V, 2003, FOREST ECOL MANAG, V182, P175, DOI 10.1016/S0378-1127(03)00070-7; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Sollins P, 1998, ECOLOGY, V79, P23, DOI 10.1890/0012-9658(1998)079[0023:FISCIT]2.0.CO;2; Stoll P, 2005, J ECOL, V93, P395, DOI 10.1111/j.0022-0477.2005.00989.x; Szwagrzyk J, 2001, FOREST ECOL MANAG, V141, P237, DOI 10.1016/S0378-1127(00)00332-7; SZWAGRZYK J, 1993, J VEG SCI, V4, P469, DOI 10.2307/3236074; van Breugel M, 2012, PLANT ECOL, V213, P25, DOI 10.1007/s11258-011-0003-3; vanBreemen N, 1997, CAN J FOREST RES, V27, P1110, DOI 10.1139/cjfr-27-7-1110; Verzelen N, 2006, ECOL COMPLEX, V3, P209, DOI 10.1016/j.ecocom.2006.03.001; Vyse A, 2009, FOREST ECOL MANAG, V258, pS36, DOI 10.1016/j.foreco.2009.08.027; Wang Z, 1988, FLORA CHINA, V20, P11; Wehenkel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140442; WHIPPLE SA, 1980, B TORREY BOT CLUB, V107, P71, DOI 10.2307/2484854; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2007, AM NAT, V170, pE77, DOI 10.1086/521240; Yan QL, 2010, PLANT SOIL, V329, P469, DOI 10.1007/s11104-009-0172-1; Zhao HY, 2012, MT RES DEV, V32, P187, DOI 10.1659/MRD-JOURNAL-D-11-00125.1; Zheng WJ, 1988, FLORA CHINA, V7, P187	69	8	9	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152596	10.1371/journal.pone.0152596	http://dx.doi.org/10.1371/journal.pone.0152596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028757	Green Published, gold, Green Submitted			2022-12-26	WOS:000373116500055
J	Moreira, CK; Naissant, B; Coppi, A; Bennett, BL; Aime, E; Franke-Fayard, B; Janse, CJ; Coppens, I; Sinnis, P; Templeton, TJ				Moreira, Cristina K.; Naissant, Bernina; Coppi, Alida; Bennett, Brandy L.; Aime, Elena; Franke-Fayard, Blandine; Janse, Chris J.; Coppens, Isabelle; Sinnis, Photini; Templeton, Thomas J.			The Plasmodium PHIST and RESA-Like Protein Families of Human and Rodent Malaria Parasites	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN; FALCIPARUM; VIRULENCE; ERYTHROCYTE; EXPRESSION; EXPORT; REVEALS; ANTIGEN; SURFACE; BERGHEI	The phist gene family has members identified across the Plasmodium genus, defined by the presence of a domain of roughly 150 amino acids having conserved aromatic residues and an all alpha-helical structure. The family is highly amplified in P. falciparum, with 65 predicted genes in the genome of the 3D7 isolate. In contrast, in the rodent malaria parasite P. berghei 3 genes are identified, one of which is an apparent pseudogene. Transcripts of the P. berghei phist genes are predominant in schizonts, whereas in P. falciparum transcript profiles span different asexual blood stages and gametocytes. We pursued targeted disruption of P. berghei phist genes in order to characterize a simplistic model for the expanded phist gene repertoire in P. falciparum. Unsuccessful attempts to disrupt P. berghei PBANKA_114540 suggest that this phist gene is essential, while knockout of phist PBANKA_122900 shows an apparent normal progression and non-essential function throughout the life cycle. Epitope-tagging of P. falciparum and P. berghei phist genes confirmed protein export to the erythrocyte cytoplasm and localization with a punctate pattern. Three P. berghei PEXEL/HT-positive exported proteins exhibit at least partial co-localization, in support of a common vesicular compartment in the cytoplasm of erythrocytes infected with rodent malaria parasites.	[Moreira, Cristina K.; Naissant, Bernina; Templeton, Thomas J.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Coppi, Alida; Bennett, Brandy L.; Sinnis, Photini] NYU, Sch Med, Dept Med Parasitol, New York, NY 10010 USA; [Aime, Elena; Franke-Fayard, Blandine; Janse, Chris J.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden Malaria Res Grp, Leiden, Netherlands; [Coppens, Isabelle; Sinnis, Photini] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Templeton, Thomas J.] Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 8528523, Japan; [Moreira, Cristina K.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA; [Coppi, Alida; Bennett, Brandy L.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Aime, Elena] Univ Perugia, Dept Expt Med, Via Giochetto, I-06126 Perugia, Italy	Cornell University; New York University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Regeneron; University of Perugia	Templeton, TJ (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.; Templeton, TJ (corresponding author), Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 8528523, Japan.	tjt2001@med.cornell.edu		Janse, Chris J/0000-0002-6410-6205; , Blandine/0000-0001-6041-4182	National Institutes of Health of the Clinical and Translational Science Center at Weill Cornell Medical College [KL2RR0204997]; National Institutes of Allergies and Infectious Diseases [1R01AI080754-01A1, R01AI056840]; William Randolph Hearst Foundation; Regeneron Pharmaceuticals, Inc; Clinical and Translational Science Center at Weill Cornell Medical College [KL2RR024997]; NIH/NIAID [1R01AI080754-01A1, R01AI056840]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002385, UL1TR002384] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080754, R01AI056840] Funding Source: NIH RePORTER	National Institutes of Health of the Clinical and Translational Science Center at Weill Cornell Medical College; National Institutes of Allergies and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); William Randolph Hearst Foundation; Regeneron Pharmaceuticals, Inc(Regeneron); Clinical and Translational Science Center at Weill Cornell Medical College; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant KL2RR0204997 of the Clinical and Translational Science Center at Weill Cornell Medical College to C.K.M., the National Institutes of Allergies and Infectious Diseases grant 1R01AI080754-01A1 to T.J.T. and grant R01AI056840 to P.S. This work was also supported by the William Randolph Hearst Foundation to T.J.T. Regeneron Pharmaceuticals, Inc provided support in the form of salaries for authors Alida Coppi and Brandy L. Bennett, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank MR4 for providing us with anti-Pf39 immune serum; Dr. Brian Cooke for providing us with anti-SBP1 immune serum; and Leona Cohen-Gould for assistance at the Optical Microscopy core facility at Weill Cornell Medical College. Peptide synthesis was performed by the Proteomics Resource Center of the Rockefeller University. Pavitra Rao is sincerely thanked for critical reading of the manuscript. This investigation was supported by grant KL2RR024997 of the Clinical and Translational Science Center at Weill Cornell Medical College to Cristina Moreira, by NIH/NIAID grant 1R01AI080754-01A1 and the William Randolph Hearst Foundation to Thomas Templeton, and by NIH/NIAID grant R01AI056840 to Photini Sinnis.	Akinyi S, 2012, MOL MICROBIOL, V84, P816, DOI 10.1111/j.1365-2958.2012.08060.x; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BHASIN VK, 1984, AM J TROP MED HYG, V33, P534, DOI 10.4269/ajtmh.1984.33.534; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; COPPEL RL, 1984, NATURE, V310, P789, DOI 10.1038/310789a0; Curra C, 2012, TRAFFIC, V13, P388, DOI 10.1111/j.1600-0854.2011.01313.x; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Dharia NV, 2010, GENOME RES, V20, P1534, DOI 10.1101/gr.105163.110; Eksi S, 2005, MOL BIOCHEM PARASIT, V143, P90, DOI 10.1016/j.molbiopara.2005.05.010; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guinet F, 1996, J CELL BIOL, V135, P269, DOI 10.1083/jcb.135.1.269; Haase S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061482; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; HernandezRivas R, 1996, MOL BIOCHEM PARASIT, V78, P137, DOI 10.1016/S0166-6851(96)02618-7; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Ingmundson A, 2012, MOL MICROBIOL, V83, P1229, DOI 10.1111/j.1365-2958.2012.08004.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; JANSE CJ, 1989, EXP PARASITOL, V68, P274, DOI 10.1016/0014-4894(89)90109-4; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Jiang HY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-398; Kirkman LA, 2012, CURR OPIN MICROBIOL, V15, P456, DOI 10.1016/j.mib.2012.03.003; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001; Lavazec C, 2006, NUCLEIC ACIDS RES, V34, P6696, DOI 10.1093/nar/gkl942; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; MACKENSTEDT U, 1989, PARASITOL RES, V75, P528, DOI 10.1007/BF00931161; MacKenzie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002405; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matesanz F, 2003, MOL BIOCHEM PARASIT, V126, P109, DOI 10.1016/S0166-6851(02)00242-6; Maurer G., 1902, ZENTRALBL BAKTERIOL, V32, P695; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Moreira CK, 2008, CELL MICROBIOL, V10, P1505, DOI 10.1111/j.1462-5822.2008.01143.x; Oberli A, 2014, FASEB J, V28, P4420, DOI 10.1096/fj.14-256057; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Pachlatko E, 2010, MOL MICROBIOL, V77, P1136, DOI 10.1111/j.1365-2958.2010.07278.x; Parish LA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-160; Pei XH, 2007, BLOOD, V110, P1036, DOI 10.1182/blood-2007-02-076919; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; POLOGE LG, 1988, CELL, V55, P869, DOI 10.1016/0092-8674(88)90142-0; PONNUDURAI T, 1981, TROP GEOGR MED, V33, P50; Prajapati SK, 2013, BLOOD CELL MOL DIS, V51, P195, DOI 10.1016/j.bcmd.2013.06.003; Proellocks NI, 2014, FASEB J, V28, P3103, DOI 10.1096/fj.14-250399; RENIA L, 1988, J IMMUNOL METHODS, V112, P201, DOI 10.1016/0022-1759(88)90358-4; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Schneider AG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-30; Silva MD, 2005, MOL MICROBIOL, V56, P990, DOI 10.1111/j.1365-2958.2005.04603.x; Templeton TJ, 2009, MOL BIOCHEM PARASIT, V166, P109, DOI 10.1016/j.molbiopara.2009.04.003; Templeton TJ, 2005, TRENDS PARASITOL, V21, P399, DOI 10.1016/j.pt.2005.07.006; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	64	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152510	10.1371/journal.pone.0152510	http://dx.doi.org/10.1371/journal.pone.0152510			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022937	gold, Green Published, Green Submitted			2022-12-26	WOS:000373113900067
J	Nuzaihan, MNM; Hashim, U; Arshad, MKM; Ruslinda, AR; Rahman, SFA; Fathil, MFM; Ismail, MH				Nuzaihan, M. M. N.; Hashim, U.; Arshad, M. K. Md; Ruslinda, A. Rahim; Rahman, S. F. A.; Fathil, M. F. M.; Ismail, Mohd H.			Top-Down Nanofabrication and Characterization of 20 nm Silicon Nanowires for Biosensing Applications	PLOS ONE			English	Article							ELECTRON-BEAM LITHOGRAPHY; LABEL-FREE DETECTION; THERMAL-OXIDATION; REAL-TIME; FABRICATION; SENSOR; DEVICES; ARRAYS	A top-down nanofabrication approach is used to develop silicon nanowires from silicon-on-insulator (SOI) wafers and involves direct-write electron beam lithography (EBL), inductively coupled plasma-reactive ion etching (ICP-RIE) and a size reduction process. To achieve nanometer scale size, the crucial factors contributing to the EBL and size reduction processes are highlighted. The resulting silicon nanowires, which are 20 nm in width and 30 nm in height (with a triangular shape) and have a straight structure over the length of 400 mu m, are fabricated precisely at the designed location on the device. The device is applied in biomolecule detection based on the changes in drain current (I-ds), electrical resistance and conductance of the silicon nanowires upon hybridization to complementary target deoxyribonucleic acid (DNA). In this context, the scaled-down device exhibited superior performances in terms of good specificity and high sensitivity, with a limit of detection (LOD) of 10 fM, enables for efficient label-free, direct and higher-accuracy DNA molecules detection. Thus, this silicon nanowire can be used as an improved transducer and serves as novel biosensor for future biomedical diagnostic applications.	[Nuzaihan, M. M. N.; Hashim, U.; Arshad, M. K. Md; Ruslinda, A. Rahim; Fathil, M. F. M.] Univ Malaysia Perlis, Inst Nano Elect Engn, Kangar 01000, Perlis, Malaysia; [Hashim, U.; Arshad, M. K. Md; Ismail, Mohd H.] Univ Malaysia Perlis, Sch Microelect Engn, Pauh 02600, Perlis, Malaysia; [Rahman, S. F. A.] Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang 43400, Selangor, Malaysia	Universiti Malaysia Perlis; Universiti Malaysia Perlis; Universiti Putra Malaysia	Nuzaihan, MNM (corresponding author), Univ Malaysia Perlis, Inst Nano Elect Engn, Kangar 01000, Perlis, Malaysia.	m.nuzaihan@unimap.edu.my	Rahim, Ruslinda A/AAR-5069-2020; BIN NOR, MOHAMMAD NUZAIHAN/R-1132-2019; A.Rahim, Ruslinda/K-7078-2014; Abd Rahman, Siti Fatimah/ABA-6864-2021; FATHIL, MOHAMAD FARIS MOHAMAD/W-1427-2018; Fathil, Mohamad Faris Mohamad/U-3213-2019; M.K., Md Arshad/L-5830-2013	Rahim, Ruslinda A/0000-0001-8549-0077; BIN NOR, MOHAMMAD NUZAIHAN/0000-0001-6828-3762; A.Rahim, Ruslinda/0000-0002-3511-9509; Abd Rahman, Siti Fatimah/0000-0002-9183-7230; FATHIL, MOHAMAD FARIS MOHAMAD/0000-0003-1544-0108; Fathil, Mohamad Faris Mohamad/0000-0003-1544-0108; M.K., Md Arshad/0000-0003-0129-0321	Ministry of Higher Education Malaysia	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	This research was supported by the Ministry of Higher Education Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Rahman SF, 2013, INT J ELECTROCHEM SC, V8, P10946; Adam T., 2013, African Journal of Biotechnology, V12, P5486; Bonifas AP, 2011, MICROELECTRON ENG, V88, P3256, DOI 10.1016/j.mee.2011.08.006; Chen KI, 2011, NANO TODAY, V6, P131, DOI 10.1016/j.nantod.2011.02.001; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Curreli M, 2008, IEEE T NANOTECHNOL, V7, P651, DOI 10.1109/TNANO.2008.2006165; Dai PF, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.121301; Dhahi TS, 2011, SCI ADV MATER, V3, P233, DOI 10.1166/sam.2011.1155; Tran DP, 2014, J MATER CHEM C, V2, P5229, DOI 10.1039/c4tc00046c; Elsner H., 2000, INT C MICRO NANO ENG, V57-58, P291; Enami H, 2007, HITACHI REV, V56, P57; Gao AR, 2014, NANOSCALE, V6, P13036, DOI 10.1039/c4nr03210a; Gao ZQ, 2007, ANAL CHEM, V79, P3291, DOI 10.1021/ac061808q; Goodberlet JG, 2001, J VAC SCI TECHNOL B, V19, P2499, DOI 10.1116/1.1414018; Grigorescu AE, 2008, J MICRO-NANOLITH MEM, V7, DOI 10.1117/1.2841716; Hsiao CY, 2009, BIOSENS BIOELECTRON, V24, P1223, DOI 10.1016/j.bios.2008.07.032; Kim YS, 2008, MICROELECTRON ENG, V85, P582, DOI 10.1016/j.mee.2007.10.005; Lu W, 2006, J PHYS D APPL PHYS, V39, pR387, DOI 10.1088/0022-3727/39/21/R01; Noor MO, 2014, ANAL CHIM ACTA, V825, P1, DOI 10.1016/j.aca.2014.03.016; Nor Farahidah Za'bah, 2012, J APPL PHYS, V112; Nor MNM, 2010, AIP CONF PROC, V1217, P272, DOI 10.1063/1.3377829; Nuzaihan MNM, 2015, CURR NANOSCI, V11, P239; Nuzaihan M. MN, 2013, J APPL SCI RES, V9, P5580; Nuzaihan M, 2014, ADV MATER RES-SWITZ, V832, P415, DOI 10.4028/www.scientific.net/AMR.832.415; Park IY, 2007, BIOSENS BIOELECTRON, V22, P2065, DOI 10.1016/j.bios.2006.09.017; Park I, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/1/015501; Patolsky F, 2006, NAT PROTOC, V1, P1711, DOI 10.1038/nprot.2006.227; Prakash S, 2014, MICRO NANO TECHNOL, P171, DOI 10.1016/B978-1-4377-4469-9.00005-6; Rius G, 2011, AIP CONF PROC, V1336, P239, DOI 10.1063/1.3586095; Ryu SW, 2010, BIOSENS BIOELECTRON, V25, P2182, DOI 10.1016/j.bios.2010.02.010; Shen MY, 2014, BIOSENS BIOELECTRON, V60, P101, DOI 10.1016/j.bios.2014.03.057; Teo BK, 2006, J CLUST SCI, V17, P529, DOI 10.1007/s10876-006-0086-5; Tijjani Adam, 2014, BIOSENS BIOELECTRON, V7184, P1; Tseng AA, 2003, IEEE T ELECTRON PACK, V26, P141, DOI 10.1109/TEPM.2003.817714; Van Binh Pham, 2011, Advances in Natural Sciences: Nanoscience & Nanotechnology, V2, DOI 10.1088/2043-6262/2/2/025010; Voigt A, 1999, PROC SPIE, V3676, P485, DOI 10.1117/12.351078; Vu XT, 2010, SENSOR ACTUAT B-CHEM, V144, P354, DOI 10.1016/j.snb.2008.11.048; Wenga G, 2012, PROCEDIA ENGINEER, V47, P414, DOI 10.1016/j.proeng.2012.09.172; Wu CC, 2009, BIOSENS BIOELECTRON, V25, P820, DOI 10.1016/j.bios.2009.08.031; Za'bah NF, 2013, 2013 IEEE REGIONAL SYMPOSIUM ON MICRO AND NANOELECTRONICS (RSM 2013), P223, DOI 10.1109/RSM.2013.6706514; Zhang GJ, 2012, ANAL CHIM ACTA, V749, P1, DOI 10.1016/j.aca.2012.08.035; Zhang GJ, 2010, SENSOR ACTUAT B-CHEM, V146, P138, DOI 10.1016/j.snb.2010.02.021; Zhang GJ, 2009, BIOSENS BIOELECTRON, V24, P2504, DOI 10.1016/j.bios.2008.12.035; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	44	34	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2016	11	3							e0152318	10.1371/journal.pone.0152318	http://dx.doi.org/10.1371/journal.pone.0152318			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9KB	27022732	gold, Green Submitted, Green Published			2022-12-26	WOS:000373113900046
J	Abe, Y; Matsunaga, A; Matsuzawa, R; Kutsuna, T; Yamamoto, S; Yoneki, K; Harada, M; Ishikawa, R; Watanabe, T; Yoshida, A				Abe, Yoshifumi; Matsunaga, Atsuhiko; Matsuzawa, Ryota; Kutsuna, Toshiki; Yamamoto, Shuhei; Yoneki, Kei; Harada, Manae; Ishikawa, Ryoma; Watanabe, Takaaki; Yoshida, Atsushi			Determinants of Slow Walking Speed in Ambulatory Patients Undergoing Maintenance Hemodialysis	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; MUSCLE STRENGTH; PHYSICAL-ACTIVITY; HIP FRACTURE; GAIT SPEED; REHABILITATION PROGRAM; MYOCARDIAL-INFARCTION; DIABETIC-PATIENTS; POSTURAL CONTROL; OLDER-PEOPLE	Walking ability is significantly lower in hemodialysis patients compared to healthy people. Decreased walking ability characterized by slow walking speed is associated with adverse clinical events, but determinants of decreased walking speed in hemodialysis patients are unknown. The purpose of this study was to identify factors associated with slow walking speed in ambulatory hemodialysis patients. Subjects were 122 outpatients (64 men, 58 women; mean age, 68 years) undergoing hemodialysis. Clinical characteristics including comorbidities, motor function (strength, flexibility, and balance), and maximum walking speed (MWS) were measured and compared across sex-specific tertiles of MWS. Univariate and multivariate logistic regression analyses were performed to examine whether clinical characteristics and motor function could discriminate between the lowest, middle, and highest tertiles of MWS. Significant and common factors that discriminated the lowest and highest tertiles of MWS from other categories were presence of cardiac disease (lowest: odds ratio [OR] = 3.33, 95% confidence interval [CI] = 1.26-8.83, P<0.05; highest: OR = 2.84, 95% CI = 1.18-6.84, P<0.05), leg strength (OR = 0.62, 95% CI = 0.40-0.95, P<0.05; OR = 0.57, 95% CI = 0.39-0.82, P<0.01), and standing balance (OR = 0.76, 95% CI = 0.63-0.92, P<0.01; OR = 0.81, 95% CI = 0.68-0.97, P<0.05). History of fracture (OR = 3.35, 95% CI = 1.08-10.38; P<0.05) was a significant factor only in the lowest tertile. Cardiac disease, history of fracture, decreased leg strength, and poor standing balance were independently associated with slow walking speed in ambulatory hemodialysis patients. These findings provide useful data for planning effective therapeutic regimens to prevent decreases in walking ability in ambulatory hemodialysis patients.	[Abe, Yoshifumi; Matsunaga, Atsuhiko; Yamamoto, Shuhei; Yoneki, Kei; Harada, Manae; Ishikawa, Ryoma; Watanabe, Takaaki] Kitasato Univ, Dept Rehabil Sci, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan; [Matsuzawa, Ryota] Kitasato Univ Hosp, Dept Rehabil, Sagamihara, Kanagawa, Japan; [Kutsuna, Toshiki] Kitasato Univ, Dept Rehabil, East Hosp, Sagamihara, Kanagawa 228, Japan; [Yoneki, Kei; Yoshida, Atsushi] Sagami Junkanki Clin, Hemodialysis Ctr, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Kitasato University	Matsunaga, A (corresponding author), Kitasato Univ, Dept Rehabil Sci, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan.	atsuhikonet@gmail.com	Abe, Yoshifumi/AAF-7286-2020	Kutsuna, Toshiki/0000-0001-9252-4474				Akune T, 2014, OSTEOPOROSIS INT, V25, P1081, DOI 10.1007/s00198-013-2550-z; Andersen H, 2004, DIABETES, V53, P1543, DOI 10.2337/diabetes.53.6.1543; Apelqvist J, 2008, DIABETES-METAB RES, V24, pS181, DOI 10.1002/dmrr.848; Auais MA, 2012, PHYS THER, V92, P1437, DOI 10.2522/ptj.20110274; Ayoubi F, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-128; Azegami M, 2007, NURS HEALTH SCI, V9, P168, DOI 10.1111/j.1442-2018.2007.00317.x; Bartnicki P, 1997, CLIN NEPHROL, V47, P197; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Boulton CF, 1980, CAN J NEUROL SCI, V7, P89; Castronuovo JJ, 1997, J VASC SURG, V26, P629, DOI 10.1016/S0741-5214(97)70062-4; Centomo H, 2007, GAIT POSTURE, V25, P509, DOI 10.1016/j.gaitpost.2006.06.010; Cheema B, 2010, NEPHROLOGY, V15, P454, DOI 10.1111/j.1440-1797.2009.01261.x; Creaby MW, 2012, ARCH PHYS MED REHAB, V93, P822, DOI 10.1016/j.apmr.2011.11.029; Donoghue OA, 2013, GAIT POSTURE, V38, P120, DOI 10.1016/j.gaitpost.2012.10.023; Dumurgier J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4460; Giacomini PG, 1996, DIABETES CARE, V19, P372, DOI 10.2337/diacare.19.4.372; Hatakeyama S, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/385274; Jamal SA, 2006, OSTEOPOROSIS INT, V17, P1390, DOI 10.1007/s00198-006-0133-y; Kanji JN, 2010, JAMA-J AM MED ASSOC, V303, P1526, DOI 10.1001/jama.2010.428; Kart-Koseoglu H, 2005, RHEUMATOL INT, V25, P270, DOI 10.1007/s00296-003-0431-z; Kristensen MT, 2009, CLIN BIOMECH, V24, P218, DOI 10.1016/j.clinbiomech.2008.10.003; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Kutsuna T, 2010, THER APHER DIAL, V14, P193, DOI 10.1111/j.1744-9987.2009.00750.x; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Matsuzawa R, 2012, CLIN J AM SOC NEPHRO, V7, P2010, DOI 10.2215/CJN.03660412; Matsuzawa Y, 2013, J AM COLL CARDIOL, V61, P1964, DOI 10.1016/j.jacc.2013.02.020; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; Michikawa T, 2009, J ORTHOP SCI, V14, P675, DOI 10.1007/s00776-009-1371-6; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; Okamoto K, 2006, AM J KIDNEY DIS, V48, P269, DOI 10.1053/j.ajkd.2006.04.075; Ostir GV, 2012, ARCH INTERN MED, V172, P353, DOI 10.1001/archinternmed.2011.1615; Otsubo S, 2009, NEPHROL DIAL TRANSPL, V24, P1593, DOI 10.1093/ndt/gfn706; Painter P, 2000, AM J KIDNEY DIS, V35, P482, DOI 10.1016/S0272-6386(00)70202-2; Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Rantanen T, 2002, SCAND J MED SCI SPOR, V12, P296, DOI 10.1034/j.1600-0838.2002.102100.x; Rantanen T, 2001, J AM GERIATR SOC, V49, P21, DOI 10.1046/j.1532-5415.2001.49005.x; REGENSTEINER JG, 1993, CIRCULATION, V87, P413, DOI 10.1161/01.CIR.87.2.413; Ringsberg K, 1999, AGE AGEING, V28, P289, DOI 10.1093/ageing/28.3.289; Saitoh M, 2009, KITASATO MED J, V39, P58; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Smieja M, 1999, J GEN INTERN MED, V14, P418, DOI 10.1046/j.1525-1497.1999.05208.x; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; The Japanese Association of Rehabilitation Medicine, 1995, JPN J REHABIL MED; Tiedemann A, 2005, GERONTOLOGY, V51, P390, DOI 10.1159/000088703; Tinetti ME, 1999, ARCH PHYS MED REHAB, V80, P916, DOI 10.1016/S0003-9993(99)90083-7; UCCIOLI L, 1995, DIABETES CARE, V18, P339, DOI 10.2337/diacare.18.3.339; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Wakasugi M, 2013, J BONE MINER METAB, V31, P315, DOI 10.1007/s00774-012-0411-z; Yamamoto S, 2014, INT HEART J, V55, P397, DOI 10.1536/ihj.14-017; Yamamoto S, 2012, INT HEART J, V53, P347, DOI 10.1536/ihj.53.347	56	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151037	10.1371/journal.pone.0151037	http://dx.doi.org/10.1371/journal.pone.0151037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27018891	Green Published, gold, Green Submitted			2022-12-26	WOS:000372807800008
J	Mahmood, K; Hojland, DH; Asp, T; Kristensen, M				Mahmood, Khalid; Hojland, Dorte H.; Asp, Torben; Kristensen, Michael			Transcriptome Analysis of an Insecticide Resistant Housefly Strain: Insights about SNPs and Regulatory Elements in Cytochrome P450 Genes	PLOS ONE			English	Article							MUSCA-DOMESTICA DIPTERA; PYRETHROID RESISTANCE; DNA METHYLATION; MOLECULAR-MECHANISMS; SPINOSAD RESISTANCE; CPG ISLANDS; P450; ORGANIZATION; POPULATIONS; EXPRESSION	Background Insecticide resistance in the housefly, Musca domestica, has been investigated for more than 60 years. It will enter a new era after the recent publication of the housefly genome and the development of multiple next generation sequencing technologies. The genetic background of the xenobiotic response can now be investigated in greater detail. Here, we investigate the 454-pyrosequencing transcriptome of the spinosad-resistant 791spin strain in relation to the housefly genome with focus on P450 genes. Results The de novo assembly of clean reads gave 35,834 contigs consisting of 21,780 sequences of the spinosad resistant strain. The 3,648 sequences were annotated with an enzyme code EC number and were mapped to 124 KEGG pathways with metabolic processes as most highly represented pathway. One hundred and twenty contigs were annotated as P450s covering 44 different P450 genes of housefly. Eight differentially expressed P450s genes were identified and investigated for SNPs, CpG islands and common regulatory motifs in promoter and coding regions. Functional annotation clustering of metabolic related genes and motif analysis of P450s revealed their association with epigenetic, transcription and gene expression related functions. The sequence variation analysis resulted in 12 SNPs and eight of them found in cyp6d1. There is variation in location, size and frequency of CpG islands and specific motifs were also identified in these P450s. Moreover, identified motifs were associated to GO terms and transcription factors using bioinformatic tools. Conclusion Transcriptome data of a spinosad resistant strain provide together with genome data fundamental support for future research to understand evolution of resistance in houseflies. Here, we report for the first time the SNPs, CpG islands and common regulatory motifs in differentially expressed P450s. Taken together our findings will serve as a stepping stone to advance understanding of the mechanism and role of P450s in xenobiotic detoxification.	[Mahmood, Khalid; Hojland, Dorte H.; Kristensen, Michael] Aarhus Univ, Dept Agroecol, Slagelse, Denmark; [Asp, Torben] Aarhus Univ, Dept Mol Biol & Genet, Slagelse, Denmark	Aarhus University; Aarhus University	Kristensen, M (corresponding author), Aarhus Univ, Dept Agroecol, Slagelse, Denmark.	mikr@agro.au.dk	Kristensen, Michael/F-5536-2016; Mahmood, Khalid/E-9731-2016	Kristensen, Michael/0000-0001-7332-3490; Mahmood, Khalid/0000-0001-8607-4518; Hojland, Dorte H./0000-0002-9758-5783	Innovation Fund Denmark EvoPPM [0603-00516B]	Innovation Fund Denmark EvoPPM	This work was funded by Innovation Fund Denmark EvoPPM; 0603-00516B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; Bonde M, 2011, FEMS MICROBIOL LETT, V318, P168, DOI 10.1111/j.1574-6968.2011.02255.x; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Capuano F, 2014, ANAL CHEM, V86, P3697, DOI 10.1021/ac500447w; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dunwell TL, 2014, EPIGENOMICS-UK, V6, P459, DOI [10.2217/EPI.14.46, 10.2217/epi.14.46]; Elango N, 2011, GENETICS, V187, P1077, DOI 10.1534/genetics.110.126094; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; FEYEREISEN R, 1989, P NATL ACAD SCI USA, V86, P1465, DOI 10.1073/pnas.86.5.1465; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Ffrench-Constant RH, 2007, TRENDS GENET, V23, P1, DOI 10.1016/j.tig.2006.11.006; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Good RT, 2014, GENOME BIOL EVOL, V6, P1118, DOI 10.1093/gbe/evu083; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Groeters FR, 2000, J ECON ENTOMOL, V93, P1580, DOI 10.1603/0022-0493-93.6.1580; Gullan P.J., 2010, INSECTS OUTLINE ENTO; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hojland DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103689; Hojland DH, 2014, PEST MANAG SCI, V70, P1114, DOI 10.1002/ps.3655; Hojland DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085965; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2004, J ECON ENTOMOL, V97, P1036, DOI 10.1603/0022-0493(2004)097[1036:FOKGIH]2.0.CO;2; Jang CS, 2006, PLANT PHYSIOL, V142, P1148, DOI 10.1104/pp.106.082891; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kasai S, 2001, INSECT MOL BIOL, V10, P191, DOI 10.1046/j.1365-2583.2001.00256.x; Keiding J., 1986, HOUSE FLY BIOL CONTR; Krinner S, 2014, NUCLEIC ACIDS RES, V42, P3551, DOI 10.1093/nar/gkt1358; Kristensen M, 2004, PEST MANAG SCI, V60, P894, DOI 10.1002/ps.883; Kristensen M, 2004, J ECON ENTOMOL, V97, P1042, DOI 10.1603/0022-0493(2004)097[1042:SOSIMD]2.0.CO;2; Kristensen M, 2003, J ECON ENTOMOL, V96, P1300, DOI 10.1603/0022-0493-96.4.1300; Kristensen M, 2001, PEST MANAG SCI, V57, P82, DOI 10.1002/1526-4998(200101)57:1<82::AID-PS251>3.0.CO;2-8; Kristensen M, 2008, PEST MANAG SCI, V64, P126, DOI 10.1002/ps.1481; Lai Zhao, 2012, Methods Mol Biol, V888, P119, DOI 10.1007/978-1-61779-870-2_8; LEVINE OS, 1991, REV INFECT DIS, V13, P688; Li M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-803; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu N, 1997, INSECT MOL BIOL, V6, P77, DOI 10.1046/j.1365-2583.1997.00160.x; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Malik A, 2007, J ENVIRON SCI HEAL B, V42, P453, DOI 10.1080/03601230701316481; Markussen MDK, 2012, PEST MANAG SCI, V68, P75, DOI 10.1002/ps.2223; Markussen MDK, 2010, PEST MANAG SCI, V66, P1257, DOI 10.1002/ps.2007; Markussen MDK, 2010, PESTIC BIOCHEM PHYS, V98, P50, DOI 10.1016/j.pestbp.2010.04.012; Medvedeva YA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-48; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; Morrow JL, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S7; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0430; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oppold A, 2015, ECOTOX ENVIRON SAFE, V122, P45, DOI 10.1016/j.ecoenv.2015.06.036; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; Salgado VL, 1998, PESTIC BIOCHEM PHYS, V60, P91, DOI 10.1006/pest.1998.2332; Scott H.G., 1962, FLIES PUBLIC HLTH IM; Scott JG, 2008, J PESTIC SCI, V33, P221, DOI 10.1584/jpestics.R08-04; Scott JG, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0466-3; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Seifert J, 2002, PESTIC BIOCHEM PHYS, V72, P40, DOI 10.1006/pest.2001.2577; Sparks TC, 2001, PEST MANAG SCI, V57, P896, DOI 10.1002/ps.358; Sparks TC, 2012, PESTIC BIOCHEM PHYS, V102, P1, DOI 10.1016/j.pestbp.2011.11.004; Takayama S, 2014, GENOME RES, V24, P821, DOI 10.1101/gr.162412.113; TOMITA T, 1995, INSECT MOL BIOL, V4, P135, DOI 10.1111/j.1365-2583.1995.tb00018.x; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zhu F, 2008, INSECT MOL BIOL, V17, P27, DOI 10.1111/j.1365-2583.2008.00777.x	79	4	6	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0151434	10.1371/journal.pone.0151434	http://dx.doi.org/10.1371/journal.pone.0151434			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019205	gold, Green Submitted, Green Published			2022-12-26	WOS:000372807800011
J	Romero, M; Leon-Gomez, E; Lobysheva, I; Rath, G; Dogne, JM; Feron, O; Dessy, C				Romero, Miguel; Leon-Gomez, Elvira; Lobysheva, Irina; Rath, Geraldine; Dogne, Jean-Michel; Feron, Olivier; Dessy, Chantal			Effects of BM-573 on Endothelial Dependent Relaxation and Increased Blood Pressure at Early Stages of Atherosclerosis	PLOS ONE			English	Article							THROMBOXANE RECEPTOR ANTAGONIST; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE SYNTHASE; APOE-KNOCKOUT MICE; DEFICIENT MICE; APOE(-/-) MICE; NADPH OXIDASE; IN-VIVO; DYSFUNCTION; INHIBITOR	Endothelial dysfunction is considered to be an early event in atherosclerosis and plays a pivotal role in the development, progression and clinical complications of atherosclerosis. Previous studies have shown the beneficial effects of combined inhibition of thromboxane synthase and antagonism of thromboxane receptors by BM-573 on atherosclerosis; however our knowledge about the beneficial effects of BM-573 on endothelial function and increased blood pressure related to early stage of atherosclerosis is limited. In the present study, we investigated the effects of short-term (3 mu M, 1 hour) and chronic (10mg/L, 8 weeks) treatments with BM-573 on vasodilatory function, nitric oxide (NO) bioavailability, oxidative stress and systolic blood pressure in 15 weeks old apolipoprotein E-deficient (ApoE-KO) mice. ApoE-KO mice showed a reduced endothelium-derived relaxation. In addition, NO bioavailability was reduced and oxidative stress and blood pressure were increased in ApoE-KO mice versus wild-type mice. BM-573 treatments were able to improve the relaxation profile in ApoE-KO mice. Short-term effects of BM-573 were mainly mediated by an increased phosphorylation of both eNOS and Akt, whereas BM-573 in vivo treatment also reduced oxidative stress and restored NO bioavailability. In addition, chronic administration of BM-573 reduced systolic blood pressure in ApoE-KO mice. In conclusion, pharmacological modulation of TxA2 biosynthesis and biological activities by dual TP antagonism/TxAS inhibition with BM-573, already known to prevent plaque formation, has the potential to correct vasodilatory dysfunction at the early stages of atherosclerosis.	[Romero, Miguel; Leon-Gomez, Elvira; Lobysheva, Irina; Rath, Geraldine; Feron, Olivier; Dessy, Chantal] UCL, Sch Med, Inst Expt & Clin Res IREC, Pole Pharmacol & Therapeut FATH, Brussels, Belgium; [Dogne, Jean-Michel] Univ Namur, Dept Pharm, Namur, Belgium; [Romero, Miguel] Univ Granada, Fac Pharm, Dept Pharmacol, E-18071 Granada, Spain	Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Namur; University of Granada	Romero, M; Dessy, C (corresponding author), UCL, Sch Med, Inst Expt & Clin Res IREC, Pole Pharmacol & Therapeut FATH, Brussels, Belgium.; Romero, M (corresponding author), Univ Granada, Fac Pharm, Dept Pharmacol, E-18071 Granada, Spain.	miguelr@ugr.es; chantal.dessy@uclouvain.be	Romero, Miguel/K-6053-2014; perez, miguel/GXF-5077-2022; Dogné, Jean-Michel/AAD-5773-2021; FERON, Olivier/AAM-6395-2020	Romero, Miguel/0000-0003-0578-1099; FERON, Olivier/0000-0001-5360-0286	Action de Recherche Concertee; FRSM [ARC 06/11339, FRSM 3.4547.03, 3.4.555.08F]; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, RIC [RD12/0042/0011]	Action de Recherche Concertee; FRSM(Fonds de la Recherche Scientifique - FNRS); Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, RIC	This study was funded by the Action de Recherche Concertee and FRSM grants (grant no. ARC 06/11339, FRSM 3.4547.03; 3.4.555.08F). CD and OF are senior research associate and research director (hon) for the FNRS respectively. Miguel Romero was partially supported by grants from Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, RIC (RD12/0042/0011).	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Arruda RMP, 2005, HYPERTENSION, V46, P932, DOI 10.1161/01.HYP.0000182154.61862.52; Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927; Beleznai T, 2011, CARDIOVASC RES, V92, P199, DOI 10.1093/cvr/cvr181; Belhassen L, 2003, J AM COLL CARDIOL, V41, P1198, DOI 10.1016/S0735-1097(03)00048-2; Belton O, 2000, CIRCULATION, V102, P840; Cayatte AJ, 2000, ARTERIOSCL THROM VAS, V20, P1724, DOI 10.1161/01.ATV.20.7.1724; Chen XP, 2010, AM J PHYSIOL-HEART C, V299, pH605, DOI 10.1152/ajpheart.01096.2009; Cherdon C, 2011, PROSTAG OTH LIPID M, V94, P124, DOI 10.1016/j.prostaglandins.2011.03.001; CREAGER MA, 1990, J CLIN INVEST, V86, P228, DOI 10.1172/JCI114688; Cui WH, 2009, J PHARMACOL SCI, V111, P260, DOI 10.1254/jphs.09148FP; Cyrus T, 2007, EUR J PHARMACOL, V561, P105, DOI 10.1016/j.ejphar.2006.12.024; Delannoy E, 2010, CARDIOVASC RES, V85, P582, DOI 10.1093/cvr/cvp292; Desjardins F, 2008, CARDIOVASC RES, V79, P527, DOI 10.1093/cvr/cvn080; Dessy C, 2005, CIRCULATION, V112, P1198, DOI 10.1161/CIRCULATIONAHA.104.532960; Dogne JM, 2005, TRENDS PHARMACOL SCI, V26, P639, DOI 10.1016/j.tips.2005.10.001; Dogne JM, 2004, J PHARMACOL EXP THER, V309, P498, DOI 10.1124/jpet.103.063610; Drouin A, 2011, PFLUG ARCH EUR J PHY, V462, P371, DOI 10.1007/s00424-011-0973-y; Feletou M, 2001, BRIT J PHARMACOL, V164, P894; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Feletou M, 2010, J CARDIOVASC PHARM, V55, P317, DOI 10.1097/FJC.0b013e3181d8bc8a; Gelosa P, 2010, J PHARMACOL EXP THER, V334, P199, DOI 10.1124/jpet.110.165787; Gendron ME, 2007, AM J PHYSIOL-HEART C, V293, pH2508, DOI 10.1152/ajpheart.00352.2007; Ghuysen A, 2004, J PHARMACOL EXP THER, V310, P964, DOI 10.1124/jpet.104.066852; Jiang F, 2003, BRIT J PHARMACOL, V139, P1127, DOI 10.1038/sj.bjp.0705354; Kawashima S, 2004, J PHARMACOL SCI, V96, P411, DOI 10.1254/jphs.FMJ04006X6; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Laursen JB, 2001, CIRCULATION, V103, P1282; Lesault PF, 2011, BRIT J CLIN PHARMACO, V71, P844, DOI 10.1111/j.1365-2125.2010.03858.x; Levine GN, 1996, CIRCULATION, V93, P1107, DOI 10.1161/01.CIR.93.6.1107; Linton MF, 2004, CURR OPIN PHARMACOL, V4, P116, DOI 10.1016/j.coph.2003.12.003; Liu CQ, 2009, BIOCHEM PHARMACOL, V78, P374, DOI 10.1016/j.bcp.2009.04.022; Martinez-Miguel P, 2009, J LIPID RES, V50, P364, DOI 10.1194/jlr.M800215-JLR200; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Pelat M, 2003, CIRCULATION, V107, P2480, DOI 10.1161/01.CIR.0000065601.83526.3E; Petri MH, 2013, BIOCHEM BIOPH RES CO, V441, P393, DOI 10.1016/j.bbrc.2013.10.078; Qian HS, 1999, CIRCULATION, V99, P2979, DOI 10.1161/01.CIR.99.23.2979; Raman KG, 2011, J VASC SURG, V53, P754, DOI 10.1016/j.jvs.2010.09.038; Reilly MP, 1998, CIRCULATION, V98, P2822, DOI 10.1161/01.CIR.98.25.2822; Romero M, 2010, EUR J PHARMACOL, V627, P242, DOI 10.1016/j.ejphar.2009.11.006; Romero M, 2009, ATHEROSCLEROSIS, V202, P58, DOI 10.1016/j.atherosclerosis.2008.03.007; Rouaud F, 2014, ONCOTARGET, V5, P10650, DOI 10.18632/oncotarget.2525; Song P, 2009, J BIOL CHEM, V284, P17120, DOI 10.1074/jbc.M109.012583; Terashima M, 2009, CIRC-CARDIOVASC INTE, V2, P196, DOI 10.1161/CIRCINTERVENTIONS.108.799502; Wong WT, 2013, J CARDIOVASC PHARM, V61, P204, DOI 10.1097/FJC.0b013e31827fe46e; Yang ZH, 2006, CLIN MED RES, V4, P53, DOI 10.3121/cmr.4.1.53; Zhang MA, 2011, ARTERIOSCL THROM VAS, V31, P125, DOI 10.1161/ATVBAHA.110.207712	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152579	10.1371/journal.pone.0152579	http://dx.doi.org/10.1371/journal.pone.0152579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH5EH	27019366	Green Published, gold			2022-12-26	WOS:000372807800062
J	Munk, AJL; Hermann, A; El Shazly, J; Grant, P; Hennig, J				Munk, Aisha J. L.; Hermann, Andrea; El Shazly, Jasmin; Grant, Phillip; Hennig, Juergen			The Idea Is Good, but... : Failure to Replicate Associations of Oxytocinergic Polymorphisms with Face -Inversion in the Ni 70	PLOS ONE			English	Article							RECEPTOR GENE OXTR; AUTISM SPECTRUM DISORDER; SEROTONIN TRANSPORTER; EMOTIONAL FACES; YOUNG-CHILDREN; HUMAN BRAIN; VAL(158)MET GENOTYPE; FACIAL EXPRESSIONS; SOCIAL-BEHAVIOR; FUSIFORM GYRUS	Background In event-related potentials, the N170 manifests itself especially in reaction to faces. In the healthy population, face-inversion leads to stronger negative amplitudes and prolonged latencies of the N170, effects not being present in patients with autism-spectrum-disorder (ASD). ASD has frequently been associated with differences in oxytocinergic neurotransmission. This ERP-study aimed to investigate the face-inversion effect in association with oxytocinergic candidate genes. It was expected that risk-allele-carriers of the oxytocinreceptor-gene-polymorphism (rs53576) and of CD38 (rs379863) responded similar to upright and inverted faces as persons with ASD. Additionally, reactions to different facial emotional expressions were studied. As there have been difficulties with replications of those molecular genetic association studies, we aimed to replicate our findings in a second study. Method Seventy-two male subjects in the first-, and seventy-eight young male subjects in the replication -study conducted a face-inversion-paradigm, while recording EEG. DNA was extracted from buccal cells. Results Results revealed stronger N170-amplitudes and longer latencies in reaction to inverted faces in comparison to upright ones. Furthermore, effects of emotion on N170 were evident. Those effects were present in the first and in the second study. Whereas we found molecular-genetic associations of oxytocinergic polymorphisms with the N170 in the first study, we failed to do so in the replication sample. Conclusion Results indicate that a deeper theoretical understanding of this research-field is needed, in order to generate possible explanations for these findings. Results, furthermore, support the hypotheses that success of reproducibility is correlated with strength of lower original p values and larger effect sizes in the original study.	[Munk, Aisha J. L.; Grant, Phillip; Hennig, Juergen] Univ Giessen, Dept Psychol Personal & Biol Psychol, Otto Behaghel Str 10F, D-35394 Giessen, Germany; [Hermann, Andrea] Univ Giessen, Dept Psychol Psychotherapy & Syst Neurosci, Otto Behaghel Str 10F, D-35394 Giessen, Germany; [El Shazly, Jasmin] Univ Giessen, Fac Med, Ctr Psychiat & Psychotherapy, Steg 28, D-35392 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Munk, AJL (corresponding author), Univ Giessen, Dept Psychol Personal & Biol Psychol, Otto Behaghel Str 10F, D-35394 Giessen, Germany.	aisha.j.munk@psychol.uni-giessen.de		Munk, Aisha Judith Leila/0000-0003-4718-0996				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Althaus M, 2009, CLIN NEUROPHYSIOL, V120, P93, DOI 10.1016/j.clinph.2008.10.012; Apicella F, 2013, BEHAV BRAIN RES, V251, P155, DOI 10.1016/j.bbr.2012.10.040; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Baron-Cohen S, 2006, J AUTISM DEV DISORD, V36, P343, DOI 10.1007/s10803-006-0073-6; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Bartz JA, 2007, BIOESSAYS, V29, P837, DOI 10.1002/bies.20623; Battaglia M, 2005, ARCH GEN PSYCHIAT, V62, P85, DOI 10.1001/archpsyc.62.1.85; Battaglia M, 2007, GENES BRAIN BEHAV, V6, P364, DOI 10.1111/j.1601-183X.2006.00265.x; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Batty M, 2011, J EXP CHILD PSYCHOL, V109, P430, DOI 10.1016/j.jecp.2011.02.001; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Blau Vera C, 2007, Behav Brain Funct, V3, P7; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2004, DEVELOPMENTAL SCI, V7, P340, DOI 10.1111/j.1467-7687.2004.00352.x; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Ebstein RP, 2009, ANN NY ACAD SCI, V1167, P87, DOI 10.1111/j.1749-6632.2009.04541.x; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 1998, NEUROREPORT, V9, P2945, DOI 10.1097/00001756-199809140-00005; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Fallgatter AJ, 2004, NEUROPSYCHOPHARMACOL, V29, P1506, DOI 10.1038/sj.npp.1300409; FARAH MJ, 1995, VISION RES, V35, P2089, DOI 10.1016/0042-6989(94)00273-O; Herrmann MJ, 2007, CEREB CORTEX, V17, P1160, DOI 10.1093/cercor/bhl026; Higashida H, 2010, J NEUROENDOCRINOL, V22, P373, DOI 10.1111/j.1365-2826.2010.01976.x; Higashida H, 2012, HORM BEHAV, V61, P351, DOI 10.1016/j.yhbeh.2011.12.011; Hileman CM, 2011, DEV NEUROPSYCHOL, V36, P214, DOI 10.1080/87565641.2010.549870; Hinojosa JA, 2015, NEUROSCI BIOBEHAV R, V55, P498, DOI 10.1016/j.neubiorev.2015.06.002; Hobson RP, 1998, J AUTISM DEV DISORD, V28, P117, DOI 10.1023/A:1026088531558; Hollander E, 2007, BIOL PSYCHIAT, V61, P498, DOI 10.1016/j.biopsych.2006.05.030; Holmes A, 2008, BIOL PSYCHOL, V77, P159, DOI 10.1016/j.biopsycho.2007.10.003; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Huffmeijer R, 2013, HORM BEHAV, V63, P399, DOI 10.1016/j.yhbeh.2012.11.008; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Jonassen R, 2014, PROG NEUROBIOL, V117, P41, DOI 10.1016/j.pneurobio.2014.02.003; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Kumsta R, 2013, CURR OPIN NEUROBIOL, V23, P11, DOI 10.1016/j.conb.2012.09.004; Labuschagne I, 2010, J PSYCHOPHARMACOL, V24, P1153, DOI 10.1177/0269881108097878; LANGDELL T, 1978, J CHILD PSYCHOL PSYC, V19, P255, DOI 10.1111/j.1469-7610.1978.tb00468.x; Larson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140770; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Lerer E, 2010, AUTISM RES, V3, P293, DOI 10.1002/aur.156; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Liu J, 2010, J COGNITIVE NEUROSCI, V22, P203, DOI 10.1162/jocn.2009.21203; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; Luck SJ., 2011, OXFORD HDB EVENT REL, DOI DOI 10.1093/OXFORDHB/9780195374148.013.0089; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; Luo WB, 2013, BIOL PSYCHOL, V92, P395, DOI 10.1016/j.biopsycho.2012.11.019; Maxwell SE, 2015, AM PSYCHOL, V70, P487, DOI 10.1037/a0039400; McPartland J, 2004, J CHILD PSYCHOL PSYC, V45, P1235, DOI 10.1111/j.1469-7610.2004.00318.x; Meyer A, 2012, GENES BRAIN BEHAV, V11, P695, DOI 10.1111/j.1601-183X.2012.00812.x; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Meyer-Lindenberg A, 2008, PROG BRAIN RES, V170, P463, DOI 10.1016/S0079-6123(08)00436-6; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Munesue T, 2010, NEUROSCI RES, V67, P181, DOI 10.1016/j.neures.2010.03.004; Neumann ID, 2015, BIOL PSYCHIAT; O'Connor K, 2007, INT J PSYCHOPHYSIOL, V63, P283, DOI 10.1016/j.ijpsycho.2006.12.001; Osinsky R, 2012, BRAIN RES, V1452, P108, DOI 10.1016/j.brainres.2012.02.054; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Rangel-Gomez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066469; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Salmina AB, 2010, J NEUROENDOCRINOL, V22, P380, DOI 10.1111/j.1365-2826.2010.01970.x; Saphire-Bernstein S, 2011, P NATL ACAD SCI USA, V108, P15118, DOI 10.1073/pnas.1113137108; Sauer C, 2012, NEUROPSYCHOPHARMACOL, V37, P1474, DOI 10.1038/npp.2011.333; Schmidt A, 2013, PSYCHOPHARMACOLOGY, V225, P227, DOI 10.1007/s00213-012-2811-0; Searcy JH, 1996, J EXP PSYCHOL HUMAN, V22, P904, DOI 10.1037/0096-1523.22.4.904; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; van Beijsterveldt CEM, 2002, BIOL PSYCHOL, V61, P111, DOI 10.1016/S0301-0511(02)00055-8; Waller C, 2015, PSYCHONEUROENDOCRINO, V62, P27, DOI 10.1016/j.psyneuen.2015.07.003; Webb SJ, 2006, J AUTISM DEV DISORD, V36, P881, DOI 10.1007/s10803-006-0126-x; Wong TKW, 2008, EUR J NEUROSCI, V28, P407, DOI 10.1111/j.1460-9568.2008.06328.x; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Young LJ, 2007, NEURON, V54, P353, DOI 10.1016/j.neuron.2007.04.011; Yuan KH, 2005, J EDUC BEHAV STAT, V30, P141, DOI 10.3102/10769986030002141	86	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0151991	10.1371/journal.pone.0151991	http://dx.doi.org/10.1371/journal.pone.0151991			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015428	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900037
J	Peng, XX; Li, SYS; Gilbert, PB; Geraghty, DE; Katze, MG				Peng, Xinxia; Li, Shuying S.; Gilbert, Peter B.; Geraghty, Daniel E.; Katze, Michael G.			FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-gamma Receptors in Human B Cells	PLOS ONE			English	Article							COPY NUMBER VARIATION; DISEASE; TRANSCRIPTOME; POPULATION; ANTIBODIES; INFECTION; EFFICACY; LOCUS; TRIAL	The phase III Thai RV144 vaccine trial showed an estimated vaccine efficacy (VE) to prevent HIV-1 infection of 31.2%, which has motivated the search for immune correlates of vaccine protection. In a recent report, several single nucleotide polymorphisms (SNPs) in FCGR2C were identified to associate with the level of VE in the RV144 trial. To investigate the functional significance of these SNPs, we utilized a large scale B cell RNA sequencing database of 462 individuals from the 1000 Genomes Project to examine associations between FCGR2C SNPs and gene expression. We found that the FCGR2C SNPs that associated with vaccine efficacy in RV144 also strongly associated with the expression of FCGR2A/C and one of them also associated with the expression of Fc receptor-like A (FCRLA), another Fc-gamma receptor (Fc gamma R) gene that was not examined in the previous report. These results suggest that the expression of Fc gamma R genes is influenced by these SNPs either directly or in linkage with other causal variants. More importantly, these results motivate further investigations into the potential for a causal association of expression and alternative splicing of FCGR2C and other Fc gamma R genes with the HIV-1 vaccine protection in the RV144 trial and other similar studies.	[Peng, Xinxia; Katze, Michael G.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Li, Shuying S.; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Dept Biostat Bioinformat & Epidemiol, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Geraghty, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Peng, XX (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	xinxiap@uw.edu			National Institutes of Health, Office of Research Infrastructure Programs [R24OD011172, R24OD010445, P51OD010425]; National Institute of Allergy and Infectious Diseases [1R21AI120713]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201300010C]; Henry Jackson Foundation [694251]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, R21AI125040, R21AI120713] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011172, P51OD010425, R24OD010445] Funding Source: NIH RePORTER	National Institutes of Health, Office of Research Infrastructure Programs; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry Jackson Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, Office of Research Infrastructure Programs (http://dpcpsi.nih.gov/orip) [R24OD011172, R24OD010445, P51OD010425 to MGK]; the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov)[1R21AI120713 to XP]; Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services (https://www.niaid.nih.gov) [HHSN272201300010C, in part]. This work was also supported by Contract #694251 from the Henry Jackson Foundation for the Military HIV Research Program to the Statistical Center for HIV/AIDS Research and Prevention (http://www.hjf.org) [SSL and PBG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Goodridge JP, 2013, J IMMUNOL, V191, P1567, DOI 10.4049/jimmunol.1300080; Hollox EJ, 2014, HUM GENET, V133, P1217, DOI 10.1007/s00439-014-1457-x; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li SYS, 2014, J CLIN INVEST, V124, P3879, DOI 10.1172/JCI75539; Li XR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007097; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Machado LR, 2012, AM J HUM GENET, V90, P973, DOI 10.1016/j.ajhg.2012.04.018; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Prentice HA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639	24	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2016	11	3							e0152425	10.1371/journal.pone.0152425	http://dx.doi.org/10.1371/journal.pone.0152425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3TE	27015273	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708900064
J	Caini, S; Andrade, W; Badur, S; Balmaseda, A; Barakat, A; Bella, A; Bimohuen, A; Brammer, L; Bresee, J; Bruno, A; Castillo, L; Ciblak, MA; Clara, AW; Cohen, C; Cutter, J; Daouda, C; de Lozano, C; De Mora, D; Dorji, K; Emukule, GO; Fasce, RA; Feng, L; de Almeida, WAF; Guiomar, R; Heraud, JM; Holubka, O; Huang, QS; Kadjo, HA; Kiyanbekova, L; Kosasih, H; Kusznierz, G; Lara, J; Li, M; Lopez, L; Hoang, PVM; Henriques, CMP; Matute, ML; Mironenko, A; Moreno, B; Mott, JA; Njouom, R; Nurhayati; Ospanova, A; Owen, R; Pebody, R; Pennington, K; Puzelli, S; Le, MTQ; Razanajatovo, NH; Rodrigues, A; Rudi, JM; Lin, RTP; Venter, M; Vernet, MA; Wangchuk, S; Yang, J; Yu, H; Zambon, M; Schellevis, F; Paget, J				Caini, Saverio; Andrade, Winston; Badur, Selim; Balmaseda, Angel; Barakat, Amal; Bella, Antonino; Bimohuen, Abderrahman; Brammer, Lynnette; Bresee, Joseph; Bruno, Alfredo; Castillo, Leticia; Ciblak, Meral A.; Clara, Alexey W.; Cohen, Cheryl; Cutter, Jeffery; Daouda, Coulibaly; de Lozano, Celina; De Mora, Domenica; Dorji, Kunzang; Emukule, Gideon O.; Fasce, Rodrigo A.; Feng, Luzhao; Ferreira de Almeida, Walquiria Aparecida; Guiomar, Raquel; Heraud, Jean-Michel; Holubka, Olha; Huang, Q. Sue; Kadjo, Herve A.; Kiyanbekova, Lyazzat; Kosasih, Herman; Kusznierz, Gabriela; Lara, Jenny; Li, Ming; Lopez, Liza; Phuong Vu Mai Hoang; Pessanha Henriques, Claudio Maierovitch; Matute, Maria Luisa; Mironenko, Alla; Moreno, Brechla; Mott, Joshua A.; Njouom, Richard; Nurhayati; Ospanova, Akerke; Owen, Rhonda; Pebody, Richard; Pennington, Kate; Puzelli, Simona; Mai Thi Quynh Le; Razanajatovo, Norosoa Harline; Rodrigues, Ana; Rudi, Juan Manuel; Lin, Raymond Tzer Pin; Venter, Marietjie; Vernet, Marie-Astrid; Wangchuk, Sonam; Yang, Juan; Yu, Hongjie; Zambon, Maria; Schellevis, Franois; Paget, John		Global Influenza B Study	Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?	PLOS ONE			English	Article							SEASONAL INFLUENZA; SURVEILLANCE	Introduction Determining the optimal time to vaccinate is important for influenza vaccination programmes. Here, we assessed the temporal characteristics of influenza epidemics in the Northern and Southern hemispheres and in the tropics, and discuss their implications for vaccination programmes. Methods This was a retrospective analysis of surveillance data between 2000 and 2014 from the Global Influenza B Study database. The seasonal peak of influenza was defined as the week with the most reported cases (overall, A, and B) in the season. The duration of seasonal activity was assessed using the maximum proportion of influenza cases during three consecutive months and the minimum number of months with >= 80% of cases in the season. We also assessed whether co-circulation of A and B virus types affected the duration of influenza epidemics. Results 212 influenza seasons and 571,907 cases were included from 30 countries. In tropical countries, the seasonal influenza activity lasted longer and the peaks of influenza A and B coincided less frequently than in temperate countries. Temporal characteristics of influenza epidemics were heterogeneous in the tropics, with distinct seasonal epidemics observed only in some countries. Seasons with co-circulation of influenza A and B were longer than influenza A seasons, especially in the tropics. Discussion Our findings show that influenza seasonality is less well defined in the tropics than in temperate regions. This has important implications for vaccination programmes in these countries. High-quality influenza surveillance systems are needed in the tropics to enable decisions about when to vaccinate.	[Caini, Saverio; Schellevis, Franois; Paget, John] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Andrade, Winston; Fasce, Rodrigo A.] Inst Salud Publ Chile, Secc Virus Resp & Exantemat, Santiago, Chile; [Badur, Selim; Ciblak, Meral A.] Istanbul Univ, Istanbul, Turkey; [Balmaseda, Angel] Minist Hlth, Natl Influenza Ctr, Managua, Nicaragua; [Barakat, Amal; Bimohuen, Abderrahman] Minist Hlth, Inst Natl Hyg, Natl Influenza Ctr, Rabat, Morocco; [Bella, Antonino] NIH, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy; [Brammer, Lynnette; Bresee, Joseph] Ctr Dis Control & Prevent, Epidemiol & Prevent Branch, Influenza Div, Atlanta, GA USA; [Bruno, Alfredo; De Mora, Domenica] INSPI, Ctr Ref Nacl Influenza & Otros Virus Resp, Guayaquil, Ecuador; [Castillo, Leticia] Minist Hlth, Natl Influenza Ctr, Guatemala City, Guatemala; [Clara, Alexey W.] US Ctr Dis Control, Cent Amer Reg, Guatemala City, Guatemala; [Cohen, Cheryl] Natl Inst Communicable Dis, CRDM, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Cutter, Jeffery; Lin, Raymond Tzer Pin] Minist Hlth, Communicable Dis Div, Singapore, Singapore; [Daouda, Coulibaly; Kadjo, Herve A.] Pasteur Inst Cote Ivoire, Resp Viruses Unit, Abidjan, Cote Ivoire; [de Lozano, Celina] Minist Hlth, Natl Influenza Ctr, San Salvador, El Salvador; [Dorji, Kunzang; Wangchuk, Sonam] Minist Hlth, Dept Publ Hlth, Publ Hlth Lab, Thimphu, Bhutan; [Emukule, Gideon O.; Mott, Joshua A.] US Ctr Dis Control & Prevent, Nairobi, Kenya; [Feng, Luzhao; Li, Ming; Yang, Juan; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early warning Infect Dis, Div Infect Dis, Beijing, Peoples R China; [Ferreira de Almeida, Walquiria Aparecida; Pessanha Henriques, Claudio Maierovitch] Minist Hlth, Brasilia, DF, Brazil; [Guiomar, Raquel] Natl Inst Hlth, Dept Infect Dis, Natl Influenza Ref Lab, Lisbon, Portugal; [Heraud, Jean-Michel; Razanajatovo, Norosoa Harline] Inst Pasteur Madagascar, Virol Unit, Natl Influenza Ctr, Antananarivo, Madagascar; [Holubka, Olha; Mironenko, Alla] Natl Acad Med Sci Ukraine, LV Gromashevsky Inst Epidemiol & Infect Dis, Kiev, Ukraine; [Huang, Q. Sue; Lopez, Liza] Inst Environm Sci & Res, Wellington, New Zealand; [Kiyanbekova, Lyazzat; Ospanova, Akerke] Astana Ctr Sanit Epidemiol Expertise, Zonal Virol Lab, Astana, Kazakhstan; [Kosasih, Herman; Nurhayati] US Naval, Med Res Unit 2, Jakarta, Indonesia; [Kusznierz, Gabriela; Rudi, Juan Manuel] Inst Nacl Enfermedades Resp Dr Emilio Coni, Santa Fe, Argentina; [Lara, Jenny] Minist Hlth, Natl Influenza Ctr, San Jose, Costa Rica; [Phuong Vu Mai Hoang; Mai Thi Quynh Le] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Matute, Maria Luisa] Minist Hlth, Natl Influenza Ctr, Tegucigalpa, Honduras; [Moreno, Brechla] IC Gorgas, Natl Influenza Ctr, Panama City, Panama; [Njouom, Richard; Vernet, Marie-Astrid] Ctr Pasteur Cameroun, Serv Virol, Yaounde, Cameroon; [Owen, Rhonda; Pennington, Kate] Off Hlth Protect, Dept Hlth, Hlth Policy Protect Branch, Vaccine Preventable Dis Surveillance Sect, Woden, ACT, Australia; [Pebody, Richard] Publ Hlth England, Dept Resp Dis, Colindale, England; [Puzelli, Simona] Natl Inst Hlth, Natl Influenza Ctr, Rome, Italy; [Rodrigues, Ana] Natl Inst Hlth, Dept Epidemiol, Lisbon, Portugal; [Venter, Marietjie] US CDC, Global Dis Detect, Pretoria, South Africa; [Venter, Marietjie] Univ Pretoria, Zoonoses Res Ctr, Dept Med Virol, ZA-0002 Pretoria, South Africa; [Zambon, Maria] Publ Hlth England, Resp Virus Unit, Colindale, England	Netherlands Institute for Health Services Research; Istanbul University; Centers for Disease Control & Prevention - USA; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Ministry of Health-Singapore; Chinese Center for Disease Control & Prevention; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; National Academy of Medical Sciences of Ukraine; L. V. Gromashevsky Institute of Epidemiology & Infectious Diseases of the National Academy of Medical Sciences of Ukraine; Institute of Environmental Science & Research (ESR) - New Zealand; Naval Medical Research Center (NMRC); US Naval Medical Research Unit-2 (NAMRU-2); National Institute of Hygiene & Epidemiology (NIHE); Centre Pasteur du Cameroun; Public Health England; Istituto Superiore di Sanita (ISS); University of Pretoria; Public Health England	Caini, S (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.	s.caini@nivel.nl	Rizzo, Caterina/H-4092-2012; Dorji, Kunzang/CAF-3728-2022; Bella, Antonino/AAB-9943-2019; Henriques, Claudio/AAW-8044-2021; Mironenko, Alla/AAG-9950-2019; Venter, Marietjie/P-9604-2016; Dorji, Kunzang/ABB-7631-2020; Yu, Hongjie/GZK-5351-2022; Heraud, Jean-Michel/O-1464-2013; Caini, Saverio/AAI-3788-2020; Rodrigues, Ana/GYQ-6273-2022; Mironenko, Alla/O-2870-2016; BRUNO, ALFREDO/AAW-8354-2020; Holubka, Olha/P-5164-2016; Puzelli, Simona/C-2542-2016	Rizzo, Caterina/0000-0002-5583-7508; Mironenko, Alla/0000-0002-2630-1827; Venter, Marietjie/0000-0003-2696-824X; Heraud, Jean-Michel/0000-0003-1107-0859; Caini, Saverio/0000-0002-2262-1102; Mironenko, Alla/0000-0002-2630-1827; BRUNO, ALFREDO/0000-0002-9678-4203; Pebody, Richard/0000-0002-9069-2885; Cohen, Cheryl/0000-0003-0376-2302; Holubka, Olha/0000-0001-8085-1638; Puzelli, Simona/0000-0003-4497-9719; Pechirra, Pedro/0000-0001-6352-1100; Guiomar, Raquel/0000-0002-4563-6315; Dorji, Kunzang/0000-0002-3876-9638; Rodrigues, Ana Paula/0000-0003-2264-4723; Huang, Q. Sue/0000-0002-3923-5195; Nunes, Baltazar/0000-0001-6230-7209	Sanofi Pasteur; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	Sanofi Pasteur; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Global Influenza B Study is supported by an unrestricted research grant from Sanofi Pasteur. The study sponsor had no role in the design of the study; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. The study sponsor had no access to the data in the study.	Alonso WJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-982; Alonso WJ, 2015, INFLUENZA OTHER RESP, V9, P101, DOI 10.1111/irv.12308; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P201; Axelsen JB, 2014, P NATL ACAD SCI USA, V111, P9538, DOI 10.1073/pnas.1321656111; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; Castilla J, 2013, EUROSURVEILLANCE, V18, P17; Central Intelligence Agency, WORLD FACTBOOK; Cox N, 2014, B WORLD HEALTH ORGAN, V92, P311, DOI 10.2471/BLT.14.139428; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Kissling E, 2013, EURO SURVEILL, V18; Koul PA, 2014, EMERG INFECT DIS, V20, P1723, DOI 10.3201/eid2010.140431; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nguyen YT, 2013, VACCINE, V31, P4368, DOI 10.1016/j.vaccine.2013.07.018; Pebody RG, 2013, EUROSURVEILLANCE, V18, P25; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Richard SA, 2010, VACCINE, V28, P2693, DOI 10.1016/j.vaccine.2010.01.053; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Schanzer DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021471; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Soebiyanto RP, 2015, GEOSPATIAL HEALTH, V10, P144, DOI 10.4081/gh.2015.372; Soebiyanto RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100659; Steffen C, 2012, B WORLD HEALTH ORGAN, V90, P301, DOI 10.2471/BLT.11.098244; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; World Health Organization (WHO), STAT WORLDS VACC IMM; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Yu HJ, 2013, INFLUENZA OTHER RESP, V7, P1350, DOI 10.1111/irv.12121	30	56	56	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152310	10.1371/journal.pone.0152310	http://dx.doi.org/10.1371/journal.pone.0152310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27135748	Green Published, gold			2022-12-26	WOS:000373121800053
J	Yang, S; Yao, HP; Li, M; Li, H; Wang, F				Yang, Shuai; Yao, Haipei; Li, Min; Li, Hui; Wang, Fang			Long Non-Coding RNA MALAT1 Mediates Transforming Growth Factor Beta1-Induced Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINOPATHY; TGF-BETA; CANCER METASTASIS; TUMOR-GROWTH; PROMOTES; MECHANISMS; CARCINOMA; MIGRATION	Purpose To study the role of long non-coding RNA (lncRNA) MALAT1 in transforming growth factor beta 1 (TGF-beta 1)-induced epithelial-mesenchymal transition (EMT) of retinal pigment epithelial (RPE) cells. Methods ARPE-19 cells were cultured and exposed to TGF-beta 1. The EMT of APRE-19 cells is confirmed by morphological change, as well as the increased expression of alpha-smooth muscle actin (alpha SMA) and fibronectin, and the down-regulation of E-cadherin and Zona occludin-1( ZO-1) at both mRNA and protein levels. The expression of lncRNA MALAT1 in RPE cells were detected by quantitative real-time PCR. Knockdown of MALAT1 was achieved by transfecting a small interfering RNA (SiRNA). The effect of inhibition of MALAT1 on EMT, migration, proliferation, and TGF beta signalings were observed. MALAT1 expression was also detected in primary RPE cells incubated with proliferative vitreoretinopathy (PVR) vitreous samples. Results The expression of MALAT1 is significantly increased in RPE cells incubated with TGF beta 1. MALAT1 silencing attenuates TGF beta 1-induced EMT, migration, and proliferation of RPE cells, at least partially through activating Smad2/3 signaling. MALAT1 is also significantly increased in primary RPE cells incubated with PVR vitreous samples. Conclusion LncRNA MALAT1 is involved in TGF beta 1-induced EMT of human RPE cells and provides new understandings for the pathogenesis of PVR.	[Yang, Shuai; Yao, Haipei; Li, Min; Li, Hui; Wang, Fang] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai 200072, Peoples R China	Tongji University	Wang, F (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai 200072, Peoples R China.	18917683335@163.com		Yang, Shuai/0000-0001-8359-4032	National Natural Science Foundation of China [81300772, 81500727, 81271029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (No. 81300772(HL), 81500727(ML) and No. 81271029(FW)) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaans J, 2013, INVEST OPHTH VIS SCI, V54, P8306, DOI 10.1167/iovs.13-12383; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chen X, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1155/2014/956141; Chen XY, 2014, INT J MOL MED, V33, P1195, DOI 10.3892/ijmm.2014.1688; Dvashi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122229; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Feist RM, 2014, GRAEF ARCH CLIN EXP, V252, P347, DOI 10.1007/s00417-013-2531-0; Gamulescu MA, 2006, EXP EYE RES, V83, P212, DOI 10.1016/j.exer.2005.12.007; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Hatanaka H, 2012, INVEST OPHTH VIS SCI, V53, P6955, DOI 10.1167/iovs.12-10488; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Kim Ivana K, 2002, Ophthalmol Clin North Am, V15, P81; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Li H, 2014, BIOCHEM BIOPH RES CO, V446, P347, DOI 10.1016/j.bbrc.2014.02.119; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; MACHEMER R, 1978, AM J OPHTHALMOL, V85, P181, DOI 10.1016/S0002-9394(14)75946-X; Matouk IJ, 2014, BBA-MOL CELL RES, V1843, P1414, DOI 10.1016/j.bbamcr.2014.03.023; Mony S, 2013, EXP EYE RES, V115, P113, DOI 10.1016/j.exer.2013.06.007; Peng HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014750; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Ren SC, 2013, J UROLOGY, V190, P2278, DOI 10.1016/j.juro.2013.07.001; Sadaka A, 2012, CLIN OPHTHALMOL, V6, P1325, DOI 10.2147/OPTH.S27896; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Umazume K, 2012, INVEST OPHTH VIS SCI, V53, P4910, DOI 10.1167/iovs.12-9768; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Yang S, 2015, DISCOV MED, V20, P207; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhou X, 2015, SCI REP-UK, V5, DOI 10.1038/srep15972	32	95	104	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152687	10.1371/journal.pone.0152687	http://dx.doi.org/10.1371/journal.pone.0152687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VL	27019196	Green Published, Green Submitted, gold			2022-12-26	WOS:000396347600001
J	Caini, S; Andrade, W; Badur, S; Balmaseda, A; Barakat, A; Bella, A; Bimohuen, A; Brammer, L; Bresee, J; Bruno, A; Castillo, L; Ciblak, MA; Clara, AW; Cohen, C; Daouda, C; de Lozano, C; De Mora, D; Dorji, K; Emukule, GO; Fasce, RA; Feng, L; de Almeida, WAF; Guiomar, R; Heraud, JM; Holubka, O; Huang, QS; Kadjo, HA; Kiyanbekova, L; Kosasih, H; Kusznierz, G; Lee, VJM; Lara, J; Li, M; Lopez, L; Mai, HPV; Pessanha, HCM; Matute, ML; Mironenko, A; Moreno, B; Mott, JA; Njouom, R; Nurhayati; Ospanova, A; Owen, R; Pebody, R; Pennington, K; Puzelli, S; Le, MTQ; Razanajatovo, NH; Rodrigues, A; Rudi, JM; Venter, M; Vernet, MA; Wei, AL; Wangchuk, S; Yang, J; Yu, H; Zambon, M; Schellevis, F; Paget, J				Caini, S.; Andrade, W.; Badur, S.; Balmaseda, A.; Barakat, A.; Bella, A.; Bimohuen, A.; Brammer, L.; Bresee, J.; Bruno, A.; Castillo, L.; Ciblak, M. A.; Clara, A. W.; Cohen, C.; Daouda, C.; de Lozano, C.; De Mora, D.; Dorji, K.; Emukule, G. O.; Fasce, R. A.; Feng, L.; de Almeida, W. A. Ferreira; Guiomar, R.; Heraud, J. M.; Holubka, O.; Huang, Q. S.; Kadjo, H. A.; Kiyanbekova, L.; Kosasih, H.; Kusznierz, G.; Lee, V. J. M.; Lara, J.; Li, M.; Lopez, L.; Mai, Hoang P. V.; Pessanha, Henriques C. M.; Matute, M. L.; Mironenko, A.; Moreno, B.; Mott, J. A.; Njouom, R.; Nurhayati; Ospanova, A.; Owen, R.; Pebody, R.; Pennington, K.; Puzelli, S.; Quynh Le, M. T.; Razanajatovo, N. H.; Rodrigues, A.; Rudi, J. M.; Venter, M.; Vernet, M. A.; Wei, A. L.; Wangchuk, S.; Yang, J.; Yu, H.; Zambon, M.; Schellevis, F.; Paget, J.		Global Influenza B Study	Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? (vol 11, e0152310, 2016)	PLOS ONE			English	Correction									[Lee, V. J. M.] Minist Hlth, Communicable Dis Div, Singapore, Singapore; [Wei, A. L.] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore	Ministry of Health-Singapore; Ministry of Health-Singapore			Rizzo, Caterina/H-4092-2012; Dorji, Kunzang/CAF-3728-2022; Bella, Antonino/AAB-9943-2019; Henriques, Claudio/AAW-8044-2021; Mironenko, Alla/AAG-9950-2019; Venter, Marietjie/P-9604-2016; Dorji, Kunzang/ABB-7631-2020; Yu, Hongjie/GZK-5351-2022; Heraud, Jean-Michel/O-1464-2013; Caini, Saverio/AAI-3788-2020; Rodrigues, Ana/GYQ-6273-2022; Mironenko, Alla/O-2870-2016; BRUNO, ALFREDO/AAW-8354-2020; Holubka, Olha/P-5164-2016; Puzelli, Simona/C-2542-2016	Rizzo, Caterina/0000-0002-5583-7508; Mironenko, Alla/0000-0002-2630-1827; Venter, Marietjie/0000-0003-2696-824X; Heraud, Jean-Michel/0000-0003-1107-0859; Caini, Saverio/0000-0002-2262-1102; Mironenko, Alla/0000-0002-2630-1827; BRUNO, ALFREDO/0000-0002-9678-4203; Pebody, Richard/0000-0002-9069-2885; Cohen, Cheryl/0000-0003-0376-2302; Holubka, Olha/0000-0001-8085-1638; Puzelli, Simona/0000-0003-4497-9719; Pechirra, Pedro/0000-0001-6352-1100; Guiomar, Raquel/0000-0002-4563-6315; Dorji, Kunzang/0000-0002-3876-9638; Rodrigues, Ana Paula/0000-0003-2264-4723; Huang, Q. Sue/0000-0002-3923-5195; Nunes, Baltazar/0000-0001-6230-7209	National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		Caini S, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0155089, 10.1371/journal.pone.0152310]	1	56	56	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0155089	10.1371/journal.pone.0155089	http://dx.doi.org/10.1371/journal.pone.0155089			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135748	Green Published, gold			2022-12-26	WOS:000375674800057
J	Yang, T; Zhang, TL; Guo, YH; Liu, X				Yang, Tao; Zhang, Tian-lei; Guo, You-hao; Liu, Xing			Identification of Hybrids in Potamogeton: Incongruence between Plastid and ITS Regions Solved by a Novel Barcoding Marker PHYB	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; AQUATIC PLANT; CONCERTED EVOLUTION; NUCLEAR; PHYTOCHROME; GENE; SEQUENCES; HYBRIDIZATION; UTILITY; FAMILY	Potamogeton is one of the most difficult groups to clarify in aquatic plants, which has an extensive range of interspecific morphological and ecological diversity. Internal transcribed spacer (ITS) is prevalent for phylogenetic analysis in plants. However, most researches demonstrate that ITS has a high percentage of homoplasy in phylogenetic datasets. In this study, eighteen materials were collected in Potamogeton from China and incongruence was shown between the rbcL and ITS phylogenies. To solve the discrepancy, we employed a novel barcode PHYB to improve resolution and accuracy of the phylogenetic relationships. The PHYB phylogeny successfully resolved the incongruence between the rbcL and ITS phylogenies. In addition, six hybrids were confirmed using PHYB, including P. compressus x P pusillus, P. octandrus x P. oxyphyllus, P. gramineus x P. lucens, P. distinctus x P. natans, P. distinctus x P. wrightii, and S. pectinata x S. amblyophylla. Whereas, only one hybrid was identified (P. compressus x P. pusillus) by ITS, indicating that ITS homoplasy was present in Potamogeton and ITS was completely homogenized to one parental lineage. Thus, ITS might have limited utility for phylogenetic relationships in Potamogeton. It is recommended that a three-locus combination of chloroplast DNA gene, ITS and PHYB is potential to effectively reveal more robust phylogenetic relationships and species identification.	[Yang, Tao; Zhang, Tian-lei; Guo, You-hao; Liu, Xing] Wuhan Univ, Coll Life Sci, Lab Plant Systemat & Evolutionary Biol, Wuhan, Hubei, Peoples R China	Wuhan University	Guo, YH; Liu, X (corresponding author), Wuhan Univ, Coll Life Sci, Lab Plant Systemat & Evolutionary Biol, Wuhan, Hubei, Peoples R China.	yhguo@whu.edu.cn; xingliu@whu.edu.cn		Yang, Shuai/0000-0001-8359-4032	National Natural Science Foundation of China [30870168, 31170203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China 30870168 (http://www.letpub.com.cn/) (XL, data collection and analysis, decision to publish, or preparation of the manuscript); and National Natural Science Foundation of China 31170203 (http://www.letpub.com.cn/).	Aguilar JF, 1999, MOL ECOL, V8, P1341, DOI 10.1046/j.1365-294X.1999.00690.x; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bailey CD, 1999, MOL PHYLOGENET EVOL, V13, P20, DOI 10.1006/mpev.1999.0627; Childs KL, 1997, PLANT PHYSIOL, V113, P611, DOI 10.1104/pp.113.2.611; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Cronn RC, 2002, AM J BOT, V89, P707, DOI 10.3732/ajb.89.4.707; Du ZY, 2011, J SYST EVOL, V49, P246, DOI 10.1111/j.1759-6831.2011.00131.x; Du ZY, 2010, PLANT SYST EVOL, V287, P57, DOI 10.1007/s00606-010-0289-y; Du ZY, 2009, AQUAT BOT, V91, P47, DOI 10.1016/j.aquabot.2009.02.006; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Franzke A, 1999, THEOR APPL GENET, V98, P831, DOI 10.1007/s001220051140; Hagstrom JO, 1916, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0155446; Hoot SB, 2001, AM FERN J, V91, P166, DOI 10.1640/0002-8444(2001)091[0166:TUONIA]2.0.CO;2; Iida S, 2002, J PLANT RES, V115, P11, DOI 10.1007/s102650200002; Iida S, 2007, J PLANT RES, V120, P473, DOI 10.1007/s10265-007-0087-y; Ito Yu, 2014, Biodivers Data J, pe1073, DOI 10.3897/BDJ.2.e1073; Ito Y, 2010, AM J BOT, V97, P1156, DOI 10.3732/ajb.0900168; Kaplan Z, 2008, FOLIA GEOBOT, V43, P159, DOI 10.1007/s12224-008-9010-0; King RA, 2001, BOT J LINN SOC, V135, P67, DOI 10.1006/bojl.2000.0354; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LES DH, 1993, AQUAT BOT, V44, P181, DOI 10.1016/0304-3770(93)90071-4; Les Donald H., 1996, Novon, V6, P389, DOI 10.2307/3392046; Les DH, 2009, SYST BOT, V34, P643, DOI 10.1600/036364409790139727; Li GQ, 2004, BRIEF BIOINFORM, V5, P378, DOI 10.1093/bib/5.4.378; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; Lindqvist C, 2006, CLADISTICS, V22, P568, DOI 10.1111/j.1096-0031.2006.00124.x; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Mathews S, 2000, AM J BOT, V87, P96, DOI 10.2307/2656688; MATHEWS S, 1995, ANN MO BOT GARD, V82, P296, DOI 10.2307/2399882; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Mathews S, 1996, MOL BIOL EVOL, V13, P1141, DOI 10.1093/oxfordjournals.molbev.a025677; Morton BR, 1996, P NATL ACAD SCI USA, V93, P11735, DOI 10.1073/pnas.93.21.11735; Nishimoto Y, 2003, GENES GENET SYST, V78, P139, DOI 10.1266/ggs.78.139; Preston CD., 1995, PONDWEEDS GREAT BRIT; QUAIL PH, 1991, ANNU REV GENET, V25, P389, DOI 10.1146/annurev.ge.25.120191.002133; Sang T, 1997, MOL BIOL EVOL, V14, P994, DOI 10.1093/oxfordjournals.molbev.a025716; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Simmons MP, 2001, AM J BOT, V88, P313, DOI 10.2307/2657021; Tamura K., 2013, MOL BIOL EVOL, P197, DOI DOI 10.1093/M0LBEV/MST197; Wang QD, 2007, PLANT SYST EVOL, V267, P65, DOI 10.1007/s00606-006-0499-5; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiegleb G, 1998, FOLIA GEOBOT, V33, P241, DOI 10.1007/BF03216205; WIEGLEB G, 1990, PLANT SYST EVOL, V169, P245, DOI 10.1007/BF00937678; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Zhang T, 2008, AQUAT BOT, V89, P34, DOI 10.1016/j.aquabot.2008.02.002	46	95	104	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166177	10.1371/journal.pone.0166177	http://dx.doi.org/10.1371/journal.pone.0166177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27019196	Green Submitted, Green Published, gold			2022-12-26	WOS:000387910200020
